PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Climent, B; Moreno, L; Martinez, P; Contreras, C; Sanchez, A; Perez-Vizcaino, F; Garcia-Sacristan, A; Rivera, L; Prieto, D				Climent, Belen; Moreno, Laura; Martinez, Pilar; Contreras, Cristina; Sanchez, Ana; Perez-Vizcaino, Francisco; Garcia-Sacristan, Albino; Rivera, Luis; Prieto, Dolores			Upregulation of SK3 and IK1 Channels Contributes to the Enhanced Endothelial Calcium Signaling and the Preserved Coronary Relaxation in Obese Zucker Rats	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; NITRIC-OXIDE RELEASE; BRADYKININ-INDUCED RELAXATION; SMALL-CONDUCTANCE; HYPERPOLARIZING FACTOR; K(CA)3.1 CHANNELS; FUNCTIONAL-ROLE; TRPV4 CHANNELS; EDHF RESPONSES	Background and Aims: Endothelial small- and intermediate-conductance K-Ca channels, SK3 and IK1, are key mediators in the endothelium-derived hyperpolarization and relaxation of vascular smooth muscle and also in the modulation of endothelial Ca2+ signaling and nitric oxide (NO) release. Obesity is associated with endothelial dysfunction and impaired relaxation, although how obesity influences endothelial SK3/IK1 function is unclear. Therefore we assessed whether the role of these channels in the coronary circulation is altered in obese animals. Methods and Results: In coronary arteries mounted in microvascular myographs, selective blockade of SK3/IK1 channels unmasked an increased contribution of these channels to the ACh- and to the exogenous NO-induced relaxations in arteries of Obese Zucker Rats (OZR) compared to Lean Zucker Rats (LZR). Relaxant responses induced by the SK3/IK1 channel activator NS309 were enhanced in OZR and NO- endothelium-dependent in LZR, whereas an additional endothelium-independent relaxant component was found in OZR. Fura2-AM fluorescence revealed a larger ACh-induced intracellular Ca2+ mobilization in the endothelium of coronary arteries from OZR, which was inhibited by blockade of SK3/IK1 channels in both LZR and OZR. Western blot analysis showed an increased expression of SK3/IK1 channels in coronary arteries of OZR and immunohistochemistry suggested that it takes place predominantly in the endothelial layer. Conclusions: Obesity may induce activation of adaptive vascular mechanisms to preserve the dilator function in coronary arteries. Increased function and expression of SK3/IK1 channels by influencing endothelial Ca2+ dynamics might contribute to the unaltered endothelium-dependent coronary relaxation in the early stages of obesity.	[Climent, Belen; Contreras, Cristina; Sanchez, Ana; Garcia-Sacristan, Albino; Rivera, Luis; Prieto, Dolores] Univ Complutense, Fac Farm, Dept Fisiol, E-28040 Madrid, Spain; [Moreno, Laura; Perez-Vizcaino, Francisco] Univ Complutense, Fac Med, Dept Farmacol, E-28040 Madrid, Spain; [Martinez, Pilar] Univ Complutense, Fac Vet, Dept Anat & Anat Patol Comparadas, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid	Climent, B (corresponding author), Univ Complutense, Fac Farm, Dept Fisiol, E-28040 Madrid, Spain.	bcliment@farm.ucm.es; dprieto@farm.ucm.es	de los Arcos, Luis Rivera/T-2247-2018; Contreras, Cristina/N-7257-2019; Climent, Belen/P-2416-2015; Moreno, Laura/A-9433-2010; Pilar Martinez, P Martinez/E-8591-2016; Perez-Vizcaino, Francisco/A-9735-2011; PRIETO, DOLORES/S-8172-2018	de los Arcos, Luis Rivera/0000-0002-0187-707X; Contreras, Cristina/0000-0002-7015-7922; Climent, Belen/0000-0003-0852-9227; Moreno, Laura/0000-0001-9028-2299; Pilar Martinez, P Martinez/0000-0001-9063-3191; Perez-Vizcaino, Francisco/0000-0001-6309-7418; PRIETO, DOLORES/0000-0001-7049-5991	Spanish Ministry of Science and Innovation [SAF2009-10448]; Spanish Ministry of Economy [SAF2012-31631]; MS program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy(Spanish Government); MS program	This study was supported by: 1. Grant no SAF2009-10448 from the Spanish Ministry of Science and Innovation (http://www.idi.mineco.gob.es/portal/site/MICINN/). 2. Grant no SAF2012-31631 of the Spanish Ministry of Economy (http://www.mineco.gob.es/portal/site/mineco/). 3. LM was supported by MS program (http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-comunicacion/fd-notas-prensa/15mar011XIIIPromocionMiguelServet.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alda JO, 2009, J PHARM PHARMACOL, V61, P641, DOI 10.1211/jpp/61.05.0013; Bagher P, 2012, P NATL ACAD SCI USA, V109, P18174, DOI 10.1073/pnas.1211946109; Bagi Z, 2009, AM J PHYSIOL-REG I, V10595, P556; Bagi Z, 2012, BRIT J PHARMACOL, V165, P544, DOI 10.1111/j.1476-5381.2011.01606.x; Batenburg WW, 2004, BRIT J PHARMACOL, V142, P125, DOI 10.1038/sj.bjp.0705747; Behringer EJ, 2013, ARTERIOSCL THROM VAS, V33, P1892, DOI 10.1161/ATVBAHA.113.301514; Bishara NB, 2010, AM J PHYSIOL-HEART C, V298, pH171, DOI 10.1152/ajpheart.00699.2009; Borbouse L, 2009, AM J PHYSIOL-HEART C, V297, pH1629, DOI 10.1152/ajpheart.00466.2009; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Campia U, 2012, BRIT J PHARMACOL, V165, P561, DOI 10.1111/j.1476-5381.2011.01661.x; Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; Climent B, 2014, CURRVASC PHARM, V12, P1, DOI DOI 10.2174/1570161112666140423221622; Climent B, 2012, BIOCHEM BIOPH RES CO, V417, P1007, DOI 10.1016/j.bbrc.2011.12.076; Contreras C, 2011, ATHEROSCLEROSIS, V217, P331, DOI 10.1016/j.atherosclerosis.2011.03.036; Dalsgaard T, 2010, BRIT J PHARMACOL, V160, P1496, DOI 10.1111/j.1476-5381.2010.00803.x; Danser AHJ, 2000, BRIT J PHARMACOL, V131, P195, DOI 10.1038/sj.bjp.0703555; DAUT J, 1994, J CARDIOVASC ELECTR, V5, P154, DOI 10.1111/j.1540-8167.1994.tb01156.x; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Ellis A, 2008, EUR J PHARMACOL, V601, P111, DOI 10.1016/j.ejphar.2008.10.042; Erdos B, 2002, AM J PHYSIOL-HEART C, V283, pH2472, DOI 10.1152/ajpheart.00516.2002; Feher A, 2010, CARDIOVASC RES, V87, P732, DOI 10.1093/cvr/cvq088; Feletou M, 2012, ANN MED, V44, P694, DOI 10.3109/07853890.2011.585658; Frisbee J, 2002, AM J PHYSIOL-HEART C, V53226, P2160; Fulop T, 2007, ARTERIOSCL THROM VAS, V27, P2348, DOI 10.1161/ATVBAHA.107.147991; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; Ghisdal P, 2001, BRIT J PHARMACOL, V134, P1021, DOI 10.1038/sj.bjp.0704348; Haddock RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016423; Katakam PVG, 2005, AM J PHYSIOL-HEART C, V288, pH854, DOI 10.1152/ajpheart.00715.2004; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Kurian MM, 2011, EXP BIOL MED, V236, P621, DOI 10.1258/ebm.2011.010351; LASKEY RE, 1990, J BIOL CHEM, V265, P2613; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; LUCKHOFF A, 1990, N-S ARCH PHARMACOL, V342, P94; Ma X, 2013, HYPERTENSION, V62, P134, DOI 10.1161/HYPERTENSIONAHA.113.01500; McSherry IN, 2005, CELL CALCIUM, V38, P23, DOI 10.1016/j.ceca.2005.03.007; Mishra RC, 2013, CARDIOVASC RES, V97, P339, DOI 10.1093/cvr/cvs326; Morimura K, 2006, J PHARMACOL SCI, V100, P237, DOI 10.1254/jphs.SC0060011; Motivala AA, 2008, J NUCL CARDIOL, V15, P510, DOI 10.1016/j.nuclcard.2008.02.020; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Oltman CL, 2006, AM J PHYSIOL-HEART C, V291, pH1780, DOI 10.1152/ajpheart.01297.2005; Prieto D, 2014, CURR VASC PHARMACOL, V12, P401, DOI 10.2174/157016111203140518154828; Qian X, 2014, ARTERIOSCL THROM VAS, V34, P127, DOI 10.1161/ATVBAHA.113.302506; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Santiago E, 2013, FREE RADICAL BIO MED, V60, P136, DOI 10.1016/j.freeradbiomed.2013.02.014; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Schuster A, 2001, AM J PHYSIOL-HEART C, V280, pH1088, DOI 10.1152/ajpheart.2001.280.3.H1088; Sheng JZ, 2007, AM J PHYSIOL-CELL PH, V293, pC458, DOI 10.1152/ajpcell.00036.2007; Sheng JZ, 2009, FASEB J, V23, P1138, DOI 10.1096/fj.08-120451; Simonsen U, 1997, EUR J PHARMACOL, V329, P153; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Stankevicius E, 2006, BRIT J PHARMACOL, V149, P560, DOI 10.1038/sj.bjp.0706886; Stankevicius E, 2011, J PHARMACOL EXP THER, V339, P842, DOI 10.1124/jpet.111.179242; Strobaek D, 2004, BBA-BIOMEMBRANES, V1665, P1, DOI 10.1016/j.bbamem.2004.07.006; Takai J, 2013, AM J PHYSIOL-HEART C, V305, pH484, DOI 10.1152/ajpheart.00642.2012; Tharp D. L., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P1; Villalba N, 2009, AM J PHYSIOL-HEART C, V297, pH696, DOI 10.1152/ajpheart.01308.2008; Weston AH, 2005, BRIT J PHARMACOL, V145, P775, DOI 10.1038/sj.bjp.0706256; Wolfle SE, 2005, J VASC RES, V42, P475, DOI 10.1159/000088101; Young EJ, 2008, DIABETOLOGIA, V51, P872, DOI 10.1007/s00125-008-0934-y; Zhao LM, 2012, PFLUG ARCH EUR J PHY, V464, P613, DOI 10.1007/s00424-012-1165-0	64	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109432	10.1371/journal.pone.0109432	http://dx.doi.org/10.1371/journal.pone.0109432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302606	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400057
J	Shi, P; Grobe, JL; Desland, FA; Zhou, GN; Shen, XZ; Shan, ZY; Liu, M; Raizada, MK; Sumners, C				Shi, Peng; Grobe, Justin L.; Desland, Fiona A.; Zhou, Guannan; Shen, Xiao Z.; Shan, Zhiying; Liu, Meng; Raizada, Mohan K.; Sumners, Colin			Direct Pro-Inflammatory Effects of Prorenin on Microglia	PLOS ONE			English	Article							II-INDUCED HYPERTENSION; FACTOR-KAPPA-B; (PRO)RENIN RECEPTOR; ANGIOTENSIN-II; NEUROGENIC HYPERTENSION; PARAVENTRICULAR NUCLEUS; DIABETIC-NEPHROPATHY; NERVOUS-SYSTEM; BLOOD-PRESSURE; CYTOKINES	Neuroinflammation has been implicated in hypertension, and microglia have been proposed to play an important role in the progression of this disease. Here, we have studied whether microglia are activated within cardiovascular regulatory area(s) of the brain during hypertension, especially in high blood pressure that is associated with chronic activation of the renin-angiotensin-system. In addition, we determined whether prorenin, an essential component of the renin-angiotensin-system, exerts direct pro-inflammatory effects on these microglia. Our data indicate that two rodent models which display neurogenic hypertension and over activation of the renin-angiotensin-system in the brain (sRA mice and spontaneously hypertensive rats) exhibit microglial activation, and increased levels of pro-inflammatory cytokines, in the paraventricular nucleus of the hypothalamus, an area crucial for regulation of sympathetic outflow. Further, the renin-angiotensin-system component prorenin elicits direct activation of hypothalamic microglia in culture and induction of pro-inflammatory mechanisms in these cells, effects that involve prorenin receptor-induced NFkB activation. In addition, the prorenin-elicited increases in cytokine expression were fully abolished by microglial inhibitor minocycline, and were potentiated by pretreatment of cells with angiotensin II. Taken together with our previous data which indicate that pro-inflammatory processes in the paraventricular nucleus are involved in the hypertensive action of renin-angiotensin-system, the novel discovery that prorenin exerts direct stimulatory effects on microglial activation and pro-inflammatory cytokine production provides support for the idea that renin-angiotensin-system -induced neurogenic hypertension is not restricted to actions of angiotensin II alone.	[Shi, Peng; Desland, Fiona A.; Zhou, Guannan; Shan, Zhiying; Liu, Meng; Raizada, Mohan K.; Sumners, Colin] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Shi, Peng] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Grobe, Justin L.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA USA; [Shen, Xiao Z.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Shan, Zhiying] Michigan Technol Univ, Dept Kinesiol & Integrat Physiol, Houghton, MI 49931 USA	State University System of Florida; University of Florida; Cedars Sinai Medical Center; University of Iowa; Cedars Sinai Medical Center; Michigan Technological University	Sumners, C (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	csumners@ufl.edu		Sumners, Colin/0000-0002-9689-2255; Grobe, Justin/0000-0001-9737-0873	American Heart Association [AHA11SDG6770006]; UCLA CTSI [UL1TR000124]; National Institutes of Health [HL093186, HL076803, HL033610, HL098276, HL084207]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL033610, K99HL098276, P01HL084207, R01HL033610, R01HL093186, R00HL098276, R01HL076803] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); UCLA CTSI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by grants from the American Heart Association (AHA11SDG6770006 to P. S.), UCLA CTSI (UL1TR000124 to P. S.) and the National Institutes of Health (HL093186 and HL076803 to C. S., HL033610 to M. K. R., and HL098276 and HL084207 to J. L. G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batenburg WW, 2007, J HYPERTENS, V25, P2441, DOI 10.1097/HJH.0b013e3282f05bae; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Cates MJ, 2012, CURR HYPERTENS REP, V14, P261, DOI 10.1007/s11906-012-0267-6; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Dampney RAL, 2005, CLIN EXP PHARMACOL P, V32, P419, DOI 10.1111/j.1440-1681.2005.04205.x; Diana A, 1999, NEUROSCIENCE, V89, P137, DOI 10.1016/S0306-4522(98)00274-7; Esler M, 2011, EXP PHYSIOL, V96, P1, DOI 10.1113/expphysiol.2011.052332; Ferri CC, 2003, J NEUROENDOCRINOL, V15, P126, DOI 10.1046/j.1365-2826.2003.00870.x; Grobe JL, 2010, CELL METAB, V12, P431, DOI 10.1016/j.cmet.2010.09.011; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Kitamura Y, 2001, J NEUROSCI RES, V64, P553, DOI 10.1002/jnr.1107; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Li WC, 2014, HYPERTENSION, V63, P316, DOI 10.1161/HYPERTENSIONAHA.113.02041; Li WC, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/290635; Li WC, 2012, HYPERTENSION, V59, P1188, DOI 10.1161/HYPERTENSIONAHA.111.190108; LIEW FY, 1990, J IMMUNOL, V145, P4306; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Marvar PJ, 2011, CURR OPIN PHARMACOL, V11, P156, DOI 10.1016/j.coph.2010.12.001; Matavelli LC, 2010, CLIN EXP PHARMACOL P, V37, P277, DOI 10.1111/j.1440-1681.2009.05292.x; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Osborn JW, 2007, CURR HYPERTENS REP, V9, P228, DOI 10.1007/s11906-007-0041-3; Paton JFR, 2010, EXP PHYSIOL, V95, P569, DOI 10.1113/expphysiol.2009.047282; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Satofuka S, 2007, INVEST OPHTH VIS SCI, V48, P422, DOI 10.1167/iovs.06-0534; Shan ZY, 2010, CIRC RES, V107, P934, DOI 10.1161/CIRCRESAHA.110.226977; Shi P, 2010, HYPERTENSION, V56, P297, DOI 10.1161/HYPERTENSIONAHA.110.150409; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Takahashi H, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/242786; Ufnal M, 2005, NEUROPEPTIDES, V39, P581, DOI 10.1016/j.npep.2005.08.001; Waki H, 2008, AUTON NEUROSCI-BASIC, V142, P40, DOI 10.1016/j.autneu.2008.07.001; Wilkinson-Berka JL, 2011, CURR OPIN NEPHROL HY, V20, P69, DOI 10.1097/MNH.0b013e328341328a; Yu Y, 2010, HYPERTENSION, V55, P652, DOI 10.1161/HYPERTENSIONAHA.109.142836; Zubcevic J, 2013, HYPERTENSION, V61, P622, DOI 10.1161/HYPERTENSIONAHA.111.199836; Zubcevic J, 2011, HYPERTENSION, V57, P1026, DOI 10.1161/HYPERTENSIONAHA.111.169748	38	49	49	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e92937	10.1371/journal.pone.0092937	http://dx.doi.org/10.1371/journal.pone.0092937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302502	Green Published, gold			2022-12-27	WOS:000343730400001
J	Goodwin, JE; Feng, Y; Velazquez, H; Zhou, H; Sessa, WC				Goodwin, Julie E.; Feng, Yan; Velazquez, Heino; Zhou, Han; Sessa, William C.			Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS	PLOS ONE			English	Article							NF-KAPPA-B; BETA-ISOFORM; EXPRESSION; RESISTANCE; MICE; TRANSCRIPTION; ENDOTOXEMIA; INFLAMMATION; METABOLISM; INDUCTION	Glucocorticoids are normally regarded as anti-inflammatory therapy for a wide variety of conditions and have been used with some success in treating sepsis and sepsis-like syndromes. We previously demonstrated that mice lacking the glucocorticoid receptor in the endothelium (GR (EC KO) mice) are extremely sensitive to low-dose LPS and demonstrate prolonged activation and up regulation of NF-kappa B. In this study we pre-treated these GR (EC KO) mice with dexamethasone and assessed their response to an identical dose of LPS. Surprisingly, the GR (EC KO) mice fared even worse than when given LPS alone demonstrating increased mortality, increased levels of the inflammatory cytokines TNF-alpha and IL-6 and increased nitric oxide release after the dexamethasone pre-treatment. As expected, control animals pre-treated with dexamethasone showed improvement in all parameters assayed. Mechanistically we demonstrate that GR (EC KO) mice show increased iNOS production and NF-kappa B activation despite treatment with dexamethasone.	[Goodwin, Julie E.; Feng, Yan; Zhou, Han] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Velazquez, Heino] Vet Affairs Hosp, Dept Internal Med, West Haven, CT USA; [Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA; [Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Goodwin, JE (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	julie.goodwin@yale.edu	Sessa, William C/B-6844-2011; Goodwin, Julie/AAF-5754-2020	Sessa, William C/0000-0001-5759-1938; 	NIH Mentored Clinical Scientist Research Award [K08-DK078623]; Bartner Research Discovery Scholar Award; National Institutes of Health [HL64793, HL61371, HL081190, HL096670, PO1 HL107205]; Yale Mouse Metabolic Phenotyping Core [U24 DK59635]; George M. O'Brien Kidney Center at Yale: NIH [P30 DK079310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081190, P01HL107205, R37HL061371, R01HL096670, R01HL064793, R01HL061371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, U24DK059635, K08DK078623] Funding Source: NIH RePORTER	NIH Mentored Clinical Scientist Research Award; Bartner Research Discovery Scholar Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Mouse Metabolic Phenotyping Core; George M. O'Brien Kidney Center at Yale: NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an NIH Mentored Clinical Scientist Research Award (K08-DK078623), a Bartner Research Discovery Scholar Award to JG and HL64793, HL61371, HL081190, HL096670 and PO1 HL107205 from the National Institutes of Health to WS. The authors also acknowledge the Yale Mouse Metabolic Phenotyping Core: U24 DK59635 and the George M. O'Brien Kidney Center at Yale: NIH grant P30 DK079310. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BERRY LJ, 1964, J EXP MED, V120, P721, DOI 10.1084/jem.120.5.721; Bonin CP, 2013, BIOCHEM BIOPH RES CO, V432, P256, DOI 10.1016/j.bbrc.2013.02.002; Chauhan SD, 2003, FASEB J, V17, P773, DOI 10.1096/fj.02-0668fje; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; FIGLEWICZ DP, 1978, CIRC SHOCK, V5, P317; Goodwin JE, 2013, P NATL ACAD SCI USA, V110, P306, DOI 10.1073/pnas.1210200110; Goodwin JE, 2011, J HYPERTENS, V29, P1347, DOI [10.1093/gerona/glr171, 10.1097/HJH.0b013e328347da54]; Guerrero J, 2013, CRIT CARE, V17, DOI 10.1186/cc12774; Gupte R, 2013, P NATL ACAD SCI USA, V110, P14616, DOI 10.1073/pnas.1309898110; Haim YO, 2014, SCI REP-UK, V4, DOI 10.1038/srep04323; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Kaddoura S, 1996, BIOCHEM BIOPH RES CO, V218, P641, DOI 10.1006/bbrc.1996.0115; Langklotz S, 2011, J BACTERIOL, V193, P1090, DOI 10.1128/JB.01043-10; Laubach VE, 1998, AM J PHYSIOL-HEART C, V275, pH2211, DOI 10.1152/ajpheart.1998.275.6.H2211; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lee JI, 1998, J CLIN PHARMACOL, V38, P981, DOI 10.1177/009127009803801101; Ling J, 2012, CANCER LETT, V322, P119, DOI 10.1016/j.canlet.2012.02.033; Oakley RH, 1996, J BIOL CHEM, V271, P9550, DOI 10.1074/jbc.271.16.9550; Oakley RH, 1997, ENDOCRINOLOGY, V138, P5028, DOI 10.1210/en.138.11.5028; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sorrells SF, 2013, J NEUROSCI, V33, P7877, DOI 10.1523/JNEUROSCI.4705-12.2013; SPINK WW, 1954, J CLIN INVEST, V33, P540, DOI 10.1172/JCI102924; Stolte EH, 2006, J ENDOCRINOL, V190, P17, DOI 10.1677/joe.1.06703; Taniguchi Y, 2010, ENDOCRINOLOGY, V151, P3204, DOI 10.1210/en.2009-1254; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098	30	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108126	10.1371/journal.pone.0108126	http://dx.doi.org/10.1371/journal.pone.0108126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299055	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200010
J	Wang, S; Liu, XM; Zhang, J; Zhang, YQ				Wang, Shu; Liu, Xian-Ming; Zhang, Jian; Zhang, Yu-Qing			An Efficient Preparation of Mulberroside A from the Branch Bark of Mulberry and Its Effect on the Inhibition of Tyrosinase Activity	PLOS ONE			English	Article							MUSHROOM TYROSINASE; RAMULUS-MORI; IN-VITRO; OXYRESVERATROL; 2,5-DIHYDROXY-4,3'-DI(BETA-D-GLUCOPYRANOSYLOXY)-TRANS-STILBENE; METABOLITES	A bioactive ingredient in an ethanol extract from the branch bark of cultivated mulberry Husang-32 (Morus multicaulis Perr.) was isolated using a macroporous resin column. The primary component, which was purified by semi-preparative high-performance liquid chromatography diode array detection (HPLC-DAD), was identified as mulberroside A (MA) by liquid chromatograph-mass spectrometer (LC-MS), H-1 and C-13 nuclear magnetic resonance (NMR) spectra. In total, 4.12 g MA was efficiently extracted from one kilogram of mulberry bark. The enzymatic analysis showed that MA inhibited the generation of dopachrome by affecting the activities of monophenolase and diphenolase of tyrosinase in vitro. This analysis indicated that MA and oxyresveratrol (OR), which is the the aglycone of mulberroside A, exhibited strong inhibition of the monophenolase activity with IC50 values of 1.29 mu mol/L and 0.12 mu mol/L, respectively. However, the former showed weaker inhibitory activity than the latter for diphenolase. For the monophenolase activity, the inhibitory activity of MA and OR was reversible and showed mixed type 1 inhibition. Additionally, the inhibition constant K-I (the inhibition constant of the effectors on tyrosinase) values were 0.385 mu mol/L and 0.926 mu mol/L, respectively, and the K-IS (the inhibition constants of the enzyme-substrate complex) values were 0.177 mu mol/L and 0.662 mu mol/L, respectively. However, MA showed competitive inhibition of diphenolase activity, and K-I was 4.36 mu mol/L. In contrast, OR showed noncompetitive inhibition and K-I = K-IS = 2.95 mu mol/L. Taken together, these results provide important information concerning the inhibitory mechanism of MA on melanin synthesis, which is widely used in whitening cosmetics.	[Wang, Shu; Liu, Xian-Ming; Zhang, Yu-Qing] Soochow Univ, Sch Basic Med & Biol Sci, Silk Biotechnol Lab, Suzhou, Peoples R China; [Zhang, Jian] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Zhang, J (corresponding author), Soochow Univ, Sch Basic Med & Biol Sci, Silk Biotechnol Lab, Suzhou, Peoples R China.	jianzhang@suda.edu.cn; sericult@suda.edu.cn		Zhang, Yu-Qing/0000-0001-7670-386X	earmarked fund for China Agriculture Research System (CARS) [CARS-22-ZJ0504]; Priority Academic Program Development of Jiangsu Higher Education Institutions, P. R. China	earmarked fund for China Agriculture Research System (CARS); Priority Academic Program Development of Jiangsu Higher Education Institutions, P. R. China	The authors gratefully acknowledge the earmarked fund (CARS-22-ZJ0504) for China Agriculture Research System (CARS) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen QX, 2003, J ENZYM INHIB MED CH, V18, P491, DOI 10.1080/14756360310001613094; Chung KO, 2003, J PHARM PHARMACOL, V55, P1695, DOI 10.1211/0022357022313; de Rigal D, 2001, INT J FOOD SCI TECH, V36, P677, DOI 10.1046/j.1365-2621.2001.00498.x; Heo SI, 2007, J MED FOOD, V10, P602, DOI 10.1089/jmf.2006.0241; Jin YS, 2007, PHYTOTHER RES, V21, P605, DOI 10.1002/ptr.2121; Jin YS, 2006, FREE RADICAL RES, V40, P986, DOI 10.1080/10715760600803823; Jin Ying-Shan, 2009, Journal of Yangzhou University (Agricultural and Life Science Edition), V30, P18; [阚启明 KAN Qiming], 2006, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V23, P388; Kim J-H, 2006, Patent No. [US2006216253A1, 2006216253]; Kim JK, 2012, J ENZYM INHIB MED CH, V27, P495, DOI 10.3109/14756366.2011.598866; Kim JK, 2010, J IND MICROBIOL BIOT, V37, P631, DOI 10.1007/s10295-010-0722-9; Kim JS, 2012, BIOSCI BIOTECH BIOCH, V76, P1425, DOI 10.1271/bbb.111002; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Lee KT, 2003, J COSMET SCI, V54, P133; MAYER AM, 1987, PHYTOCHEMISTRY, V26, P11; Mei M, 2012, J AGR FOOD CHEM, V60, P2299, DOI 10.1021/jf204495t; Qiu F, 1996, BIOL PHARM BULL, V19, P1463, DOI 10.1248/bpb.19.1463; Qiu F, 2005, China Patent, Patent No. [CN1679597, 1679597]; Qiu Feng, 1996, Natural Medicines, V50, P103; Satooka H, 2011, J AGR FOOD CHEM, V59, P8908, DOI 10.1021/jf2014149; Shu S-M, 2008, CHINESE TRADITIONAL, V39, P35; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; [吴石磊 WU Shi-Lei], 2009, [蚕业科学, Acta Sericologica Sinica], V35, P671; Yang ZZ, 2012, FOOD CHEM, V131, P617, DOI 10.1016/j.foodchem.2011.09.040; Zhang M, 2009, FITOTERAPIA, V80, P475, DOI 10.1016/j.fitote.2009.06.009; Zhang Y-Q, 2009, China Patent, Patent No. [CN10133694A, 10133694]; Zhang ZF, 2008, ENVIRON TOXICOL PHAR, V26, P325, DOI 10.1016/j.etap.2008.06.008; Zhaxi MC, 2010, PLANTA MED, V76, P362, DOI 10.1055/s-0029-1186160	28	13	14	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109396	10.1371/journal.pone.0109396	http://dx.doi.org/10.1371/journal.pone.0109396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299075	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200051
J	Fraley, RC; Vazire, S				Fraley, R. Chris; Vazire, Simine			The N-Pact Factor: Evaluating the Quality of Empirical Journals with Respect to Sample Size and Statistical Power	PLOS ONE			English	Article							PSYCHOLOGICAL-RESEARCH; REPLICABILITY; CONSEQUENCES; SCIENCE; CRISIS; FALSE	The authors evaluate the quality of research reported in major journals in social-personality psychology by ranking those journals with respect to their N-pact Factors (NF)-the statistical power of the empirical studies they publish to detect typical effect sizes. Power is a particularly important attribute for evaluating research quality because, relative to studies that have low power, studies that have high power are more likely to (a) to provide accurate estimates of effects, (b) to produce literatures with low false positive rates, and (c) to lead to replicable findings. The authors show that the average sample size in social-personality research is 104 and that the power to detect the typical effect size in the field is approximately 50%. Moreover, they show that there is considerable variation among journals in sample sizes and power of the studies they publish, with some journals consistently publishing higher power studies than others. The authors hope that these rankings will be of use to authors who are choosing where to submit their best work, provide hiring and promotion committees with a superior way of quantifying journal quality, and encourage competition among journals to improve their NF rankings.	[Fraley, R. Chris] Univ Illinois, Dept Psychol, Champaign, IL 61801 USA; [Vazire, Simine] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis	Fraley, RC (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61801 USA.	rcfraley@uiuc.edu; simine@gmail.com		Vazire, Simine/0000-0002-3933-9752				Aarts AA, 2014, REPROD PROJECT PSYCH; ABELSON RP, 1985, PSYCHOL BULL, V97, P129, DOI 10.1037/0033-2909.97.1.129; Basken P, 2013, RES SCI GROUPS MAKE; Bornmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014331; Brembs B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00291; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cumming G., 2012, UNDERSTANDING NEW ST; Davis P, 2011, GAMING IMPACT FACTOR; Donnellan MB, EMOTION IN PRESS; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fraley R.C., 2007, HDB RES METHODS PERS, P149; Francis G, 2012, PSYCHON B REV, V19, P151, DOI 10.3758/s13423-012-0227-9; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; FUNDER DC, 1983, J PERS SOC PSYCHOL, V44, P107, DOI 10.1037/0022-3514.44.1.107; Harrison C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067494; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kraus M, 2013, QUALITY V QUANTITY I; LeBel EP, 2011, REV GEN PSYCHOL, V15, P371, DOI 10.1037/a0025172; Maxwell SE, 2004, PSYCHOL METHODS, V9, P147, DOI 10.1037/1082-989X.9.2.147; MEEHL PE, 1978, J CONSULT CLIN PSYCH, V46, P806, DOI 10.1037/0022-006X.46.4.806; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; MOOK DG, 1983, AM PSYCHOL, V38, P379, DOI 10.1037/0003-066X.38.4.379; Newman DA, 2007, J APPL PSYCHOL, V92, P1394, DOI 10.1037/0021-9010.92.5.1394; Nosek BA, 2014, REPLICATIONS IMPORTA; Oakes M. W., 1986, STAT INFERENCE COMME; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P531, DOI 10.1177/1745691612463401; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pashler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042510; PRENTICE DA, 1992, PSYCHOL BULL, V112, P160, DOI 10.1037/0033-2909.112.1.160; REIS HT, 1992, PERS SOC PSYCHOL B, V18, P465, DOI 10.1177/0146167292184011; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; Roediger III HL, 2013, OBSERVER, V26; ROSENTHAL R, 1979, J APPL SOC PSYCHOL, V9, P395, DOI 10.1111/j.1559-1816.1979.tb02713.x; ROSSI JS, 1990, J CONSULT CLIN PSYCH, V58, P646, DOI 10.1037/0022-006X.58.5.646; SARASON IG, 1975, J PERS SOC PSYCHOL, V32, P199, DOI 10.1037/0022-3514.32.2.199; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Schmidt FL, 1996, PSYCHOL METHODS, V1, P115, DOI 10.1037/1082-989X.1.2.115; SEDLMEIER P, 1989, PSYCHOL BULL, V105, P309, DOI 10.1037/0033-2909.105.2.309; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Simmons J. P., 2013, M SOC PERS SOC PSYCH, P17, DOI DOI 10.2139/SSRN.2205186; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Tracy JL, 2009, J PERS SOC PSYCHOL, V96, P1206, DOI 10.1037/a0015173; Vanclay JK, 2012, SCIENTOMETRICS, V92, P211, DOI 10.1007/s11192-011-0561-0; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yong E, 2012, FAILED REPLICATION A; Yuan KH, 2005, J EDUC BEHAV STAT, V30, P141, DOI 10.3102/10769986030002141	51	223	223	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109019	10.1371/journal.pone.0109019	http://dx.doi.org/10.1371/journal.pone.0109019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296159	Green Published, gold			2022-12-27	WOS:000345204000031
J	Huang, XF; Wang, JM; Chen, Q; Jiang, JL				Huang, Xiongfeng; Wang, Jianmin; Chen, Qiao; Jiang, Jielin			Mediastinal Lymph Node Dissection versus Mediastinal Lymph Node Sampling for Early Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED-TRIAL; PUBLICATION BIAS; LYMPHADENECTOMY; STATISTICS; SURVIVAL; SURGERY; PATIENT; NUMBER	Objective: This systematic review and meta-analysis aimed to evaluate the overall survival, local recurrence, distant metastasis, and complications of mediastinal lymph node dissection (MLND) versus mediastinal lymph node sampling (MLNS) in stage I-IIIA non-small cell lung cancer (NSCLC) patients. Methods: A systematic search of published literature was conducted using the main databases (MEDLINE, PubMed, EMBASE, and Cochrane databases) to identify relevant randomized controlled trials that compared MLND vs. MLNS in NSCLC patients. Methodological quality of included randomized controlled trials was assessed according to the criteria from the Cochrane Handbook for Systematic Review of Interventions (Version 5.1.0). Meta-analysis was performed using The Cochrane Collaboration's Review Manager 5.3. The results of the meta-analysis were expressed as hazard ratio (HR) or risk ratio (RR), with their corresponding 95% confidence interval (CI). Results: We included results reported from six randomized controlled trials, with a total of 1,791 patients included in the primary meta-analysis. Compared to MLNS in NSCLC patients, there was no statistically significant difference in MLND on overall survival (HR = 0.77, 95% CI 0.55 to 1.08; P = 0.13). In addition, the results indicated that local recurrence rate (RR = 0.93, 95% CI 0.68 to 1.28; P = 0.67), distant metastasis rate (RR = 0.88, 95% CI 0.74 to 1.04; P = 0.15), and total complications rate (RR = 1.10, 95% CI 0.67 to 1.79; P = 0.72) were similar, no significant difference found between the two groups. Conclusions: Results for overall survival, local recurrence rate, and distant metastasis rate were similar between MLND and MLNS in early stage NSCLC patients. There was no evidence that MLND increased complications compared with MLNS. Whether or not MLND is superior to MLNS for stage II-IIIA remains to be determined.	[Huang, Xiongfeng; Wang, Jianmin; Chen, Qiao; Jiang, Jielin] Jiangxi Univ Tradit Chinese Med, Nanchang, Peoples R China	Jiangxi University of Traditional Chinese Medicine	Huang, XF (corresponding author), Jiangxi Univ Tradit Chinese Med, Nanchang, Peoples R China.	xiongfeng186@126.com	wang, jian/GVS-0711-2022					ALBERTI W, 1995, BRIT MED J, V311, P899; Allen MS, 2006, ANN THORAC SURG, V81, P1013, DOI 10.1016/j.athoracsur.2005.06.066; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Darling GE, 2011, J THORAC CARDIOV SUR, V141, P662, DOI 10.1016/j.jtcvs.2010.11.008; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Gajra A, 2003, J CLIN ONCOL, V21, P1029, DOI 10.1200/JCO.2003.07.010; Gridelli C, 2009, ONCOLOGIST, V14, P909, DOI 10.1634/theoncologist.2009-0017; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; IZBICKI JR, 1994, BRIT J SURG, V81, P229, DOI 10.1002/bjs.1800810223; Izbicki JR, 1998, ANN SURG, V227, P138, DOI 10.1097/00000658-199801000-00020; Keller SM, 2000, ANN THORAC SURG, V70, P358, DOI 10.1016/S0003-4975(00)01673-8; Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Little AG, 2005, ANN THORAC SURG, V80, P2051, DOI 10.1016/j.athoracsur.2005.06.071; Manser R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004699.pub2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mueller KF, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-60; Ou SHI, 2008, J THORAC ONCOL, V3, P880, DOI 10.1097/JTO.0b013e31817dfced; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Passlick B, 2002, EUR J CARDIO-THORAC, V21, P520, DOI 10.1016/S1010-7940(02)00004-0; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sugi K, 1998, WORLD J SURG, V22, P290, DOI 10.1007/s002689900384; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Wright G, 2006, THORAX, V61, P597, DOI 10.1136/thx.2005.051995; Wu YL, 2002, LUNG CANCER-J IASLC, V36, P1, DOI 10.1016/S0169-5002(01)00445-7; Xu F, 2013, CLIN LUNG CANCER, V14, P181, DOI 10.1016/j.cllc.2012.09.002; Yang MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073220	35	34	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109979	10.1371/journal.pone.0109979	http://dx.doi.org/10.1371/journal.pone.0109979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296033	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000107
J	Mentzoni, RA; Saetrevik, B; Molde, H; Wiium, N; Hetland, J; Fagerland, I; Nordnes, LT; Storemark, SS; Fossum, IN; Pallesen, S				Mentzoni, Rune Aune; Saetrevik, Bjorn; Molde, Helge; Wiium, Nora; Hetland, Jorn; Fagerland, Ida; Nordnes, Linn Tinnesand; Storemark, Sunniva Straume; Fossum, Ingrid Nesdal; Pallesen, Stale			Attentional Bias in Snus Users: An Experimental Study	PLOS ONE			English	Article							SMOKING-RELATED CUES; SWEDISH MOIST SNUFF; SMOKELESS TOBACCO; STROOP TASK; ALCOHOL-CONSUMPTION; ADDICTIVE BEHAVIORS; COGNITIVE BIASES; SOCIAL DRINKERS; CURRENT SMOKERS; EYE-MOVEMENTS	The use of nicotine in the form of "snus" is substantial and increasing in some geographic areas, in particular among young people. It has previously been suggested that addictions may operate through a mechanism of attentional bias, in which stimuli representative of the dependent substance increase in salience, thus increasing the addictive behavior. However, this hypothesis has not been tested for the case of snus. The current experiment used a modified Stroop task and a dot-probe task to investigate whether 40 snus users show an attentional bias towards snus-relevant stimuli, compared to 40 non-snus users. There were no significant differences between the two groups on reaction times or accuracy on either Stroop or dot-probe task, thus failing to show an attentional bias towards snus-relevant stimuli for snus users. This could imply that other mechanisms may contribute to maintenance of snus use than for other addictions. However, this is the first experimental study investigating attentional bias in snus users, and more research is warranted.	[Mentzoni, Rune Aune; Saetrevik, Bjorn; Wiium, Nora; Hetland, Jorn; Fagerland, Ida; Nordnes, Linn Tinnesand; Storemark, Sunniva Straume; Fossum, Ingrid Nesdal; Pallesen, Stale] Univ Bergen, Fac Psychol, Dept Psychosocial Sci, Bergen, Norway; [Molde, Helge] Univ Bergen, Fac Psychol, Dept Clin Psychol, Bergen, Norway	University of Bergen; University of Bergen	Mentzoni, RA (corresponding author), Univ Bergen, Fac Psychol, Dept Psychosocial Sci, Bergen, Norway.	rune.mentzoni@psysp.uib.no		Saetrevik, Bjorn/0000-0002-9367-6987; Wiium, Nora/0000-0002-3430-9271	Department of Psychosocial Science at University of Bergen	Department of Psychosocial Science at University of Bergen	The study was funded by the Department of Psychosocial Science at University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boffetta P, 2005, INT J CANCER, V114, P992, DOI 10.1002/ijc.20811; Boffetta P, 2009, BRIT MED J, P339; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Cox WM, 2006, PSYCHOL BULL, V132, P443, DOI 10.1037/0033-2909.132.3.443; Djordjevic Mirjana V, 2009, Handb Exp Pharmacol, P61, DOI 10.1007/978-3-540-69248-5_3; Ehrman RN, 2002, DRUG ALCOHOL DEPEN, V67, P185, DOI 10.1016/S0376-8716(02)00065-0; Fadardi JS, 2009, DRUG ALCOHOL DEPEN, V101, P137, DOI 10.1016/j.drugalcdep.2008.11.015; Field M, 2005, PSYCHOPHARMACOLOGY, V183, P350, DOI 10.1007/s00213-005-0202-5; Field M, 2004, PSYCHOPHARMACOLOGY, V176, P88, DOI 10.1007/s00213-004-1855-1; Field M, 2004, PSYCHOPHARMACOLOGY, V173, P116, DOI 10.1007/s00213-003-1689-2; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Franken IHA, 2000, J PSYCHOPHARMACOL, V14, P395, DOI 10.1177/026988110001400408; Fridrici C, 2013, PSYCHOL ADDICT BEHAV, V27, P62, DOI 10.1037/a0029139; Hatsukami D K, 1999, Nicotine Tob Res, V1, P21, DOI 10.1080/14622299050011131; Hergens MP, 2007, J INTERN MED, V262, P351, DOI 10.1111/j.1365-2796.2007.01816.x; Hester R, 2006, DRUG ALCOHOL DEPEN, V81, P251, DOI 10.1016/j.drugalcdep.2005.07.002; HOLM H, 1992, PSYCHOPHARMACOLOGY, V108, P507, DOI 10.1007/BF02247429; Honsi A, 2013, J GAMBL STUD, V29, P359, DOI 10.1007/s10899-012-9315-z; Kallischnigg Gerd, 2008, BMC Oral Health, V8, P13, DOI 10.1186/1472-6831-8-13; Lagergren J, 2000, INT J CANCER, V85, P340; Lubman DI, 2000, PSYCHOL MED, V30, P169, DOI 10.1017/S0033291799001269; Luo J, 2007, LANCET, V369, P2015, DOI 10.1016/S0140-6736(07)60678-3; McCusker CG, 2001, ADDICTION, V96, P47, DOI 10.1046/j.1360-0443.2001.961474.x; McCusker CG, 1997, BRIT J CLIN PSYCHOL, V36, P543, DOI 10.1111/j.2044-8260.1997.tb01259.x; Mogg K, 2003, ADDICTION, V98, P825, DOI 10.1046/j.1360-0443.2003.00392.x; Munafo M, 2003, J PSYCHOPHARMACOL, V17, P310, DOI 10.1177/02698811030173013; Overland Simon Nygaard, 2008, Tidsskr Nor Laegeforen, V128, P1820; Post A, 2010, ADDICTION, V105, P740, DOI 10.1111/j.1360-0443.2009.02852.x; Rooke SE, 2008, ADDICT BEHAV, V33, P1314, DOI 10.1016/j.addbeh.2008.06.009; Ryan F, 2002, ADDICT BEHAV, V27, P471, DOI 10.1016/S0306-4603(01)00183-6; Schildt EB, 1998, INT J CANCER, V77, P341, DOI 10.1002/(SICI)1097-0215(19980729)77:3<341::AID-IJC6>3.0.CO;2-O; Sharma D, 2001, ADDICTION, V96, P285, DOI 10.1046/j.1360-0443.2001.96228512.x; Sharma D, 1998, MEM COGNITION, V26, P1033, DOI 10.3758/BF03201181; Stormark KM, 2000, J STUD ALCOHOL, V61, P18, DOI 10.15288/jsa.2000.61.18; STROOP JR, 1992, J EXP PSYCHOL GEN, V121, P15; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Townshend JM, 2001, PSYCHOPHARMACOLOGY, V157, P67, DOI 10.1007/s002130100764; Wiium N, 2011, SCAND J PSYCHOL, V52, P64, DOI 10.1111/j.1467-9450.2010.00823.x	38	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108897	10.1371/journal.pone.0108897	http://dx.doi.org/10.1371/journal.pone.0108897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296339	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000025
J	Peng, ZC; Andersson, K; Lindholm, J; Bodin, I; Pramana, S; Pawitan, Y; Nister, M; Nilsson, S; Li, CD				Peng, Zhuochun; Andersson, Karl; Lindholm, Johan; Bodin, Inger; Pramana, Setia; Pawitan, Yudi; Nister, Monica; Nilsson, Sten; Li, Chunde			Operator Dependent Choice of Prostate Cancer Biopsy Has Limited Impact on a Gene Signature Analysis for the Highly Expressed Genes IGFBP3 and F3 in Prostate Cancer Epithelial Cells	PLOS ONE			English	Article							PROGNOSTIC-FACTORS	Background: Predicting the prognosis of prostate cancer disease through gene expression analysis is receiving increasing interest. In many cases, such analyses are based on formalin-fixed, paraffin embedded (FFPE) core needle biopsy material on which Gleason grading for diagnosis has been conducted. Since each patient typically has multiple biopsy samples, and since Gleason grading is an operator dependent procedure known to be difficult, the impact of the operator's choice of biopsy was evaluated. Methods: Multiple biopsy samples from 43 patients were evaluated using a previously reported gene signature of IGFBP3, F3 and VGLL3 with potential prognostic value in estimating overall survival at diagnosis of prostate cancer. A four multiplex one-step qRT-PCR test kit, designed and optimized for measuring the signature in FFPE core needle biopsy samples was used. Concordance of gene expression levels between primary and secondary Gleason tumor patterns, as well as benign tissue specimens, was analyzed. Results: The gene expression levels of IGFBP3 and F3 in prostate cancer epithelial cell-containing tissue representing the primary and secondary Gleason patterns were high and consistent, while the low expressed VGLL3 showed more variation in its expression levels. Conclusion: The assessment of IGFBP3 and F3 gene expression levels in prostate cancer tissue is independent of Gleason patterns, meaning that the impact of operator's choice of biopsy is low.	[Peng, Zhuochun; Bodin, Inger; Nister, Monica; Nilsson, Sten; Li, Chunde] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Andersson, Karl] Uppsala Univ, Dept Oncol Radiol & Radiat Sci, Uppsala, Sweden; [Lindholm, Johan; Nister, Monica; Nilsson, Sten; Li, Chunde] Karolinska Univ Hosp, Stockholm, Sweden; [Pramana, Setia; Pawitan, Yudi] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Li, Chunde] Chundsell Med AB, Stockholm, Sweden; [Andersson, Karl] Ridgeview Instruments AB, Uppsala, Sweden; [Pramana, Setia] Sekolah Tinggi Ilmu Stat Inst Stat, Jakarta, Indonesia	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Li, CD (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Chunde.li@ki.se		Pramana, Setia/0000-0002-8590-1451; Li, Chunde/0000-0003-4331-079X	Uppsala Bio; Swedish Cancer Society; King Gustaf V Jubilee Foundation; Stockholm county council	Uppsala Bio; Swedish Cancer Society(Swedish Cancer Society); King Gustaf V Jubilee Foundation; Stockholm county council(Stockholm County Council)	This work was financed by Uppsala Bio (http://www.uppsalabio.com/), the Swedish Cancer Society (http://www.cancerfonden.se/sv/Information-in-English/), the King Gustaf V Jubilee Foundation (http://www.rahfo.se/Metamenyn/In-English/), and the Stockholm county council (http://www.sll.se/om-landstinget/Information-in-English1/). The funders provided support in the form of salaries for Zhuochun Peng, Karolinska Institutet, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crook J, 2013, SEMIN RADIAT ONCOL, V23, P165, DOI 10.1016/j.semradonc.2013.01.002; Fischer A. H., 2008, CSH PROTOC; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Peng Z, 2014, PROSTATE CANCER P D, V17, P81, DOI 10.1038/pcan.2013.57; Sooriakumaran P, 2005, CLIN ONCOL-UK, V17, P655, DOI 10.1016/j.clon.2005.06.011; Yeo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089395	8	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109610	10.1371/journal.pone.0109610	http://dx.doi.org/10.1371/journal.pone.0109610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296164	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000087
J	Trier, S; Linderoth, L; Bjerregaard, S; Andresen, TL; Rahbek, UL				Trier, Sofie; Linderoth, Lars; Bjerregaard, Simon; Andresen, Thomas Lars; Rahbek, Ulrik Lytt			Acylation of Glucagon-Like Peptide-2: Interaction with Lipid Membranes and In Vitro Intestinal Permeability	PLOS ONE			English	Article							FATTY-ACIDS; TRYPTOPHAN FLUORESCENCE; REVERSIBLE LIPIDIZATION; DRUG-DELIVERY; ABSORPTION; PREDICTION; ANALOG; GLP-2; CHROMATOGRAPHY; PROTRACTION	Background: Acylation of peptide drugs with fatty acid chains has proven beneficial for prolonging systemic circulation as well as increasing enzymatic stability without disrupting biological potency. Acylation has furthermore been shown to increase interactions with the lipid membranes of mammalian cells. The extent to which such interactions hinder or benefit delivery of acylated peptide drugs across cellular barriers such as the intestinal epithelia is currently unknown. The present study investigates the effect of acylating peptide drugs from a drug delivery perspective. Purpose: We hypothesize that the membrane interaction is an important parameter for intestinal translocation, which may be used to optimize the acylation chain length for intestinal permeation. This work aims to characterize acylated analogues of the intestinotrophic Glucagon-like peptide-2 by systematically increasing acyl chain length, in order to elucidate its influence on membrane interaction and intestinal cell translocation in vitro. Results: Peptide self-association and binding to both model lipid and cell membranes was found to increase gradually with acyl chain length, whereas translocation across Caco-2 cells depended non-linearly on chain length. Short and medium acyl chains increased translocation compared to the native peptide, but long chain acylation displayed no improvement in translocation. Co-administration of a paracellular absorption enhancer was found to increase translocation irrespective of acyl chain length, whereas a transcellular enhancer displayed increased synergy with the long chain acylation. Conclusions: These results show that membrane interactions play a prominent role during intestinal translocation of an acylated peptide. Acylation benefits permeation for shorter and medium chains due to increased membrane interactions, however, for longer chains insertion in the membrane becomes dominant and hinders translocation, i.e. the peptides get 'stuck' in the cell membrane. Applying a transcellular absorption enhancer increases the dynamics of membrane insertion and detachment by fluidizing the membrane, thus facilitating its effects primarily on membrane associated peptides.	[Trier, Sofie; Andresen, Thomas Lars] Tech Univ Denmark, Ctr Nanomed & Theranost, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Trier, Sofie; Linderoth, Lars; Bjerregaard, Simon; Rahbek, Ulrik Lytt] Diabet Res Unit, Novo Nordisk, Maaloev, Denmark	Technical University of Denmark; Novo Nordisk	Rahbek, UL (corresponding author), Diabet Res Unit, Novo Nordisk, Maaloev, Denmark.	ulyr@novonordisk.com	Andresen, Thomas L/B-5324-2012	FCCN, Bogus/0000-0001-6282-8004; Andresen, Thomas Lars/0000-0002-1048-127X	Danish Agency for Science, Technology and Innovation; Technical University of Denmark; Novo Nordisk A/S	Danish Agency for Science, Technology and Innovation; Technical University of Denmark; Novo Nordisk A/S(Novo Nordisk)	ST was partially funded by The Danish Agency for Science, Technology and Innovation, and TLA was funded by the Technical University of Denmark. The funder Novo Nordisk A/S provided support in the form of salaries for authors ST, LL, SB and ULR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Balon K, 1999, PHARMACEUT RES, V16, P882, DOI 10.1023/A:1018882221008; Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7; Dasgupta P, 2002, BIOL PHARM BULL, V25, P29, DOI 10.1248/bpb.25.29; Deli MA, 2009, BBA-BIOMEMBRANES, V1788, P892, DOI 10.1016/j.bbamem.2008.09.016; Drucker DJ, 1999, TRENDS ENDOCRIN MET, V10, P153, DOI 10.1016/S1043-2760(98)00136-2; Etzerodt T, 2011, BIOPHYS J, V100, P399, DOI 10.1016/j.bpj.2010.11.040; FUJINARI EM, 1992, J CHROMATOGR, V592, P209, DOI 10.1016/0021-9673(92)85087-A; Gozes I, 1996, P NATL ACAD SCI USA, V93, P427, DOI 10.1073/pnas.93.1.427; Hartmann B, 2000, PEPTIDES, V21, P73, DOI 10.1016/S0196-9781(99)00176-X; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jeppesen PB, 2012, THER ADV GASTROENTER, V5, P159, DOI 10.1177/1756283X11436318; Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Kramer SD, 1999, PHARM SCI TECHNOL TO, V2, P373, DOI 10.1016/S1461-5347(99)00188-1; Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Morishita M, 2006, DRUG DISCOV TODAY, V11, P905, DOI 10.1016/j.drudis.2006.08.005; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; Palasek SA, 2007, J PEPT SCI, V13, P143, DOI 10.1002/psc.804; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Pinheiro CIC, 2012, IND ENG CHEM RES, V51, P1, DOI 10.1021/ie200743c; ROGERS JA, 1980, INT J PHARM, V6, P339, DOI 10.1016/0378-5173(80)90117-9; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Sakai M, 1998, J PHARM PHARMACOL, V50, P1101, DOI 10.1111/j.2042-7158.1998.tb03319.x; Sams A, 2006, EUR J PHARMACOL, V532, P18, DOI 10.1016/j.ejphar.2005.12.001; Tavares W, 2000, AM J PHYSIOL-ENDOC M, V278, pE134, DOI 10.1152/ajpendo.2000.278.1.E134; te Welscher YM, 2014, J CONTROL RELEASE, V175, P72, DOI 10.1016/j.jconrel.2013.12.013; Thulesen J, 2002, REGUL PEPTIDES, V103, P9, DOI 10.1016/S0167-0115(01)00316-0; Uchiyama T, 2000, PHARM RES, V17; Wallis K, 2007, ALIMENT PHARM THER, V25, P365, DOI 10.1111/j.1365-2036.2006.03193.x; Wang J, 2000, INT J PHARM, V204, P111, DOI 10.1016/S0378-5173(00)00489-0; Wang J, 2003, J CONTROL RELEASE, V88, P369, DOI 10.1016/S0168-3659(03)00008-7; Yuan LY, 2005, PHARM RES-DORDR, V22, P220, DOI 10.1007/s11095-004-1189-z; Zhang L, 2012, CURR MED CHEM, V19, P1602	38	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109939	10.1371/journal.pone.0109939	http://dx.doi.org/10.1371/journal.pone.0109939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295731	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000105
J	Wobser, D; Ali, L; Grohmann, E; Huebner, J; Sakinc, T				Wobser, Dominique; Ali, Liaqat; Grohmann, Elisabeth; Huebner, Johannes; Sakinc, Tuerkan			A Novel Role for D-Alanylation of Lipoteichoic Acid of Enterococcus faecalis in Urinary Tract Infection	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; TEICHOIC-ACIDS; D-ALANINE; POLYSACCHARIDE BIOSYNTHESIS; ANTIMICROBIAL PEPTIDES; BACILLUS-SUBTILIS; BIOFILM FORMATION; GENE-CLUSTER; MOUSE MODEL; VIRULENCE	Background: Enterococci are the third most common cause of healthcare-associated infections, which include urinary tract infections, bacteremia and endocarditis. Cell-surface structures such as lipoteichoic acid (LTA) have been poorly examined in E. faecalis, especially with respect to urinary tract infections (UTIs). The dlt operon is responsible for the D-alanylation of LTA and includes the gene dltA, which encodes the D-alanyl carrier protein ligase (Dcl). The involvement of LTA in UTI infection by E. faecalis has not been studied so far. Here, we examined the role of teichoic acid alanylation in the adhesion of enterococci to uroepithelial cells. Results: In a mouse model of urinary tract infection, we showed that E. faecalis 12030 Delta dltA mutant colonizes uroepithelial surfaces more efficiently than wild type bacteria. We also demonstrated that this mutant adhered four fold better to human bladder carcinoma cell line T24 compared to the wild type strain. Bacterial adherence could be significantly inhibited by purified lipoteichoic acid (LTA) and inhibition was specific. Conclusion: In contrast to bacteraemia model and adherence to colon surfaces, E. faecalis 12030 Delta dltA mutant colonized uroepithelial surfaces more efficiently than wild-type bacteria. In the case of the uroepithelial surface the adherence to specific host cells could be prevented by purified LTA. Our results therefore suggest a novel function of alanylation of LTA in E. faecalis.	[Wobser, Dominique; Ali, Liaqat; Grohmann, Elisabeth; Huebner, Johannes; Sakinc, Tuerkan] Univ Hosp Freiburg, Dept Internal Med 2, Div Infect Dis, Freiburg, Germany; [Ali, Liaqat; Grohmann, Elisabeth] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Huebner, Johannes] Univ Munich, Dr Von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany	University of Freiburg; University of Freiburg; University of Munich	Sakinc, T (corresponding author), Univ Hosp Freiburg, Dept Internal Med 2, Div Infect Dis, Freiburg, Germany.	tuerkan.sakinc@uniklinik-freiburg.de		Grohmann, Elisabeth/0000-0003-3061-6490; Huebner, Johannes/0000-0003-1232-4646	German Ministry of Science and Education [BMBF:UroGenOmics0315833C]	German Ministry of Science and Education	This work was supported by grants from the German Ministry of Science and Education (BMBF:UroGenOmics0315833C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; FISCHER W, 1990, BIOCHEM CELL BIOL, V68, P33, DOI 10.1139/o90-005; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Guiton PS, 2010, INFECT IMMUN, V78, P4166, DOI 10.1128/IAI.00711-10; GUZMAN CA, 1991, MICROB PATHOGENESIS, V11, P399, DOI 10.1016/0882-4010(91)90036-A; HIDRON AI, 2009, INFECT CONT HOSP EP, V30, P107; Hufnagel M, 2006, INFECTION, V34, P22, DOI 10.1007/s15010-006-4100-5; Johnson JR, 2004, INFECT IMMUN, V72, P2445, DOI 10.1128/IAI.72.4.2445-2448.2004; Kau AL, 2005, INFECT IMMUN, V73, P2461, DOI 10.1128/IAI.73.4.2461-2468.2005; Koch S, 2004, VACCINE, V22, P822, DOI 10.1016/j.vaccine.2003.11.027; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; KUNIN CM, 1994, CLIN INFECT DIS, V18, P1, DOI 10.1093/clinids/18.1.1; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Sillanpaa J, 2004, MICROBIOL-SGM, V150, P2069, DOI 10.1099/mic.0.27074-0; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; Svenborg Eden C, 1993, PROG ALLERGY, V33, P175; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Torelli R, 2012, J INFECT DIS, V206, P952, DOI 10.1093/infdis/jis440; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000	38	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107827	10.1371/journal.pone.0107827	http://dx.doi.org/10.1371/journal.pone.0107827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296179	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000010
J	Houldcroft, CJ; Petrova, V; Liu, JZ; Frampton, D; Anderson, CA; Gall, A; Kellam, P				Houldcroft, Charlotte J.; Petrova, Velislava; Liu, Jimmy Z.; Frampton, Dan; Anderson, Carl A.; Gall, Astrid; Kellam, Paul			Host Genetic Variants and Gene Expression Patterns Associated with Epstein-Barr Virus Copy Number in Lymphoblastoid Cell Lines	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HODGKIN LYMPHOMA; SUSCEPTIBILITY; DIFFERENTIATION; DETERMINANTS; POLYMORPHISM; GENOTYPES; LATENCY; GROWTH; PCR	Lymphoblastoid cell lines (LCLs) are commonly used in molecular genetics, supplying DNA for the HapMap and 1000 Genomes Projects, used to test chemotherapeutic agents, and informing the basis of a number of population genetics studies of gene expression. The process of transforming human B cells into LCLs requires the presence of Epstein-Barr virus (EBV), a double-stranded DNA virus which through B-cell immortalisation maintains an episomal virus genome in every cell of an LCL at variable copy numbers. Previous studies have reported that EBV alters host-gene expression and EBV copy number may be under host genetic control. We performed a genome-wide association study of EBV genome copy number in LCLs and found the phenotype to be highly heritable, although no individual SNPs achieved a significant association with EBV copy number. The expression of two host genes (CXCL16 and AGL) was positively correlated and expression of ADARB2 was negatively correlated with EBV copy number in a genotype-independent manner. This study shows an association between EBV copy number and the gene expression profile of LCLs, and suggests that EBV copy number should be considered as a covariate in future studies of host gene expression in LCLs.	[Houldcroft, Charlotte J.; Petrova, Velislava; Liu, Jimmy Z.; Anderson, Carl A.; Gall, Astrid; Kellam, Paul] Wellcome Trust Sanger Inst, Cambridge, England; [Houldcroft, Charlotte J.] Univ Cambridge, Div Biol Anthropol, Dept Archaeol & Anthropol, Cambridge, England; [Frampton, Dan; Kellam, Paul] UCL, Dept Infect, Div Infect & Immun, London, England	Wellcome Trust Sanger Institute; University of Cambridge; University of London; University College London	Kellam, P (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	pk5@sanger.ac.uk	Houldcroft, Charlotte/L-2497-2019	Houldcroft, Charlotte/0000-0002-1833-5285; Kellam, Paul/0000-0003-3166-4734; Gall, Astrid/0000-0001-6452-5816; Anderson, Carl/0000-0003-1719-7009	Wellcome Trust [098051]; MRC Doctoral Training Grant [G0900209]; ERC FP7 [261213]	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC FP7	This work is supported by the Wellcome Trust (grant 098051), providing funding to CJH, VP, JZL, CAA, AG and PK. CJH is also supported by MRC Doctoral Training Grant G0900209 and ERC FP7 grant 261213. The funders had no role in study design, data collection and analysis, preparation of the manuscript, or in the decision to publish.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Arguello M, 2003, ONCOGENE, V22, P964, DOI 10.1038/sj.onc.1206270; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Besson C, 2009, J INFECT DIS, V199, P1121, DOI 10.1086/597424; Caignard G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003637; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Davies ML, 2010, VIROLOGY, V400, P53, DOI 10.1016/j.virol.2010.01.002; Dolken L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001150; Du Y, 2013, GENE, V512, P64, DOI 10.1016/j.gene.2012.09.094; Durovic B, 2013, J VIROL; Elefant N, 2011, NUCLEIC ACIDS RES, V39, pD188, DOI 10.1093/nar/gkq1233; Fafi-Kremer S, 2005, J INFECT DIS, V191, P985, DOI 10.1086/428097; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881; Friborg JT, 2010, CLIN VACCINE IMMUNOL, V17, P1484, DOI 10.1128/CVI.00527-09; Ghesquieres H, 2013, LEUK LYMPHOMA; Ghesquieres H, 2013, CYTOKINE; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hatta K, 2007, HAEMATOLOGICA, V92, P1470, DOI 10.3324/haematol.11147; Hobbs MR, 2008, J INFECT DIS, V197, P340, DOI 10.1086/525540; Holmoy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075021; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hwang AE, 2012, EPIDEMIOL INFECT, V140, P2089, DOI 10.1017/S0950268811002457; Im HK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002525; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kriesel JD, 2011, J INFECT DIS, V204, P1654, DOI 10.1093/infdis/jir633; Kuparinen T, 2012, GENES IMMUN, V13, P184, DOI 10.1038/gene.2011.71; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Li DF, 2012, ANIM GENET; Listgarten J, 2013, NAT GENET, V45, P470, DOI 10.1038/ng.2620; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Shen GP, 2011, INT J CANCER, V129, P1459, DOI 10.1002/ijc.25759; Stark AL, 2010, AM J HUM GENET, V87, P829, DOI 10.1016/j.ajhg.2010.10.018; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Uphoff CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/904767; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Wojkowska DW, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/590409; Wolc A, 2013, AVIAN DIS, V57, P395, DOI 10.1637/10409-100312-Reg.1	55	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108384	10.1371/journal.pone.0108384	http://dx.doi.org/10.1371/journal.pone.0108384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290448	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000017
J	Wang, YP; Wang, MC; Lin, HC; Chou, P				Wang, Ying-Piao; Wang, Mao-Che; Lin, Hung-Ching; Chou, Pesus			The Impact of Prior Tonsillitis and Treatment Modality on the Recurrence of Peritonsillar Abscess: A Nationwide Cohort Study	PLOS ONE			English	Article							DEEP NECK INFECTION; MANAGEMENT; TONSILLECTOMY; CHILDREN; GUIDELINES; EXPERIENCE; DIAGNOSIS; INCISION; DRAINAGE; HEALTH	Background: Studies suggest an increased risk of peritonsillar abscess (PTA) recurrence in patients with prior tonsillitis. However, this association is inconsistent and could be confounded by different treatment modalities. This study aimed to assess the risk of recurrence among PTA patients with different degrees of prior tonsillitis and treatment modalities, and the role of tonsillectomy in current practice. Methods: All in-patients with peritonsillar abscess between January 2001 and December 2009 were identified in a nationwide, retrospective cohort study. Recurrence was defined as the first occurrence of PTA >= 30 days from the initial PTA. Factors independently associated with recurrence were analyzed using Cox proportional hazard model after adjusting for demographic and clinical data. Results: There were 28,837 patients, with a 5.15% recurrence rate and 4.74 years of follow-up. The recurrence rates were significantly higher among subjects with more than five prior tonsillitis or 1-4 prior tonsillitis compared to those without prior tonsillitis (adjusted hazard ratio, 2.82 [95% confidence interval, 2.39-3.33] and 1.59 [95% CI: 1.38-1.82]). The adjusted HR in patients treated with needle aspiration was 1.08 compared to those treated with incision & drainage (95% CI: 0.85-1.38). After age stratification, the adjusted HRs of more than five prior tonsillitis increased to 2.92 and 3.50 in patients aged <= 18 and 19-29 years respectively. The adjusted HR ofneedle aspiration only increased in patients <= 18 years old (aHR: 1.98 [95% CI: 0.99-3.97]). The overall tonsillectomy rate was 1.48% during our study period. Conclusions: The risk of PTA recurrence increases with higher degrees of prior tonsillitis in all age groups and management by needle aspiration only in the pediatric population. Patients younger than 30 years old with PTA and more than five prior tonsillitis have the greatest risk of recurrence.	[Wang, Ying-Piao; Lin, Hung-Ching] Mackay Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Wang, Ying-Piao; Wang, Mao-Che; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wang, Ying-Piao; Wang, Mao-Che; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Wang, Ying-Piao; Lin, Hung-Ching] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City, Taiwan; [Wang, Ying-Piao; Lin, Hung-Ching] Mackay Med Coll, Sch Med, New Taipei City, Taiwan; [Wang, Mao-Che] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei 112, Taiwan; [Wang, Mao-Che] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Medical College; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw			Mackay Memorial Hospital [MMH-100-063]	Mackay Memorial Hospital	This study was funded by the Mackay Memorial Hospital (MMH-100-063), and no additional external funding was received for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hussaini A, 2013, EUR ARCH OTO-RHINO-L, V270, P1959, DOI 10.1007/s00405-013-2345-z; APOSTOLPOULOS NJ, 1995, INT J PEDIATR OTORHI, V31, P129, DOI 10.1016/0165-5876(94)01077-B; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Bottin R, 2003, EUR ARCH OTO-RHINO-L, V260, P576, DOI 10.1007/s00405-003-0634-7; EPPERLY TD, 1990, AM FAM PHYSICIAN, V42, P102; HARRIS WE, 1991, CLIN OTOLARYNGOL, V16, P271, DOI 10.1111/j.1365-2273.1991.tb00928.x; HERBILD O, 1981, ARCH OTOLARYNGOL, V107, P540; HERZON FS, 1995, LARYNGOSCOPE, V105, P1, DOI 10.1288/00005537-199508002-00001; Huang TT, 2004, HEAD NECK-J SCI SPEC, V26, P854, DOI 10.1002/hed.20014; Johnson RF, 2003, OTOLARYNG HEAD NECK, V128, P332, DOI 10.1067/mhn.2003.93; Johnson Romaine F, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P157, DOI 10.1097/01.moo.0000162259.42115.38; Khayr Walid, 2005, Am J Ther, V12, P344, DOI 10.1097/01.mjt.00001= 67430.81464.04; KRONENBERG J, 1987, AM J OTOLARYNG, V8, P82, DOI 10.1016/S0196-0709(87)80028-5; MAHARAJ D, 1991, J LARYNGOL OTOL, V105, P743, DOI 10.1017/S0022215100117189; Mak CCY, 2012, CLIN OTOLARYNGOL, V37, P87, DOI 10.1111/j.1749-4486.2011.02426.x; Mehanna HM, 2002, POSTGRAD MED J, V78, P545, DOI 10.1136/pmj.78.923.545; Powell J, 2012, CLIN OTOLARYNGOL, V37, P136, DOI 10.1111/j.1749-4486.2012.02452.x; Rana RS, 2011, RADIOL CLIN N AM, V49, P165, DOI 10.1016/j.rcl.2010.07.013; Randel A, 2011, AM FAM PHYSICIAN, V84, P566; Raut V V, 2000, Ear Nose Throat J, V79, P206; Ridder GJ, 2005, OTOLARYNG HEAD NECK, V133, P709, DOI 10.1016/j.otohns.2005.07.001; SAVOLAINEN S, 1993, ARCH OTOLARYNGOL, V119, P521; Schraff S, 2001, INT J PEDIATR OTORHI, V57, P213, DOI 10.1016/S0165-5876(00)00447-X; Steyer TE, 2002, AM FAM PHYSICIAN, V65, P93; STRINGER SP, 1988, ARCH OTOLARYNGOL, V114, P296; Szuhay G, 1998, J OTOLARYNGOL, V27, P206; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wiksten J, 2012, EUR ARCH OTO-RHINO-L, V269, P1281, DOI 10.1007/s00405-011-1807-4; WOLF M, 1994, ANN OTO RHINOL LARYN, V103, P554, DOI 10.1177/000348949410300709; WOLF M, 1988, INT J PEDIATR OTORHI, V16, P113, DOI 10.1016/S0165-5876(98)90034-9	30	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109887	10.1371/journal.pone.0109887	http://dx.doi.org/10.1371/journal.pone.0109887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291179	gold, Green Submitted, Green Published			2022-12-27	WOS:000342798000096
J	Adams, SV; Newcomb, PA; Burnett-Hartman, AN; Wurscher, MA; Mandelson, M; Upton, MP; Zhu, LC; Potter, JD; Makar, KW				Adams, Scott V.; Newcomb, Polly A.; Burnett-Hartman, Andrea N.; Wurscher, Michelle A.; Mandelson, Margaret; Upton, Melissa P.; Zhu, Lee-Ching; Potter, John D.; Makar, Karen W.			Rare Circulating MicroRNAs as Biomarkers of Colorectal Neoplasia	PLOS ONE			English	Article							CANCER; ADENOMAS; PLASMA; BLOOD; SERUM; RISK; SIGNATURES; DISEASES; MARKERS; POLYPS	Background: MicroRNAs (miRNAs) are regulatory RNAs, stable in circulation, and implicated in colorectal cancer (CRC) etiology and progression. Therefore they are promising as early detection biomarkers of colorectal neoplasia. However, many circulating miRNAs are highly expressed in blood cells, and therefore may not be specific to colorectal neoplasia. Methods: We selected 7 miRNA candidates with previously reported elevated expression in adenoma tissue but low expression in blood cells ("rare'' miRNAs), 2 previously proposed as adenoma biomarkers, and 3 implicated in CRC. We conducted a colonoscopy-based case-control study including 48 polyp-free controls, 43 advanced adenomas, 73 non-advanced adenomas, and 8 CRC cases. miRNAs from plasma were quantified by qRT-PCR. Correlations between miRNA expression levels, adjusted for age and sex, were assessed. We used polytomous logistic regression to estimate odds ratios (ORs) and 95% confidence intervals quantifying the association between expression levels of miRNAs and case groups. We also conducted nonparametric receiver operating characteristic (ROC) analyses and estimated area under the curve (AUC). Results: miRNAs with high expression levels were statistically significantly correlated with one another. No miRNAs were significantly associated with non-advanced or advanced adenomas. Strong (ORs>5) and significant associations with CRC were observed for 6 miRNA candidates, with corresponding AUCs significantly >0.5. Conclusions: These candidate miRNAs, assayed by qRT-PCR, are probably unsuitable as blood-based adenoma biomarkers. Strong associations between miRNAs and CRC were observed, but primarily with miRNAs highly expressed in blood cells. These results suggest that rare miRNAs will require new detection methods to serve as circulating biomarkers of adenomas.	[Adams, Scott V.; Newcomb, Polly A.; Burnett-Hartman, Andrea N.; Wurscher, Michelle A.; Potter, John D.; Makar, Karen W.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Burnett-Hartman, Andrea N.; Potter, John D.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Mandelson, Margaret; Upton, Melissa P.] Univ Washington, Sch Med, Seattle, WA USA; [Zhu, Lee-Ching] Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Massey University	Adams, SV (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	sadams@fhcrc.org		Potter, John/0000-0001-5439-1500	Listwin Family Foundation; Gregory Fund Pilot Award; US National Institutes of Health (NIH)/National Cancer Institute [P01 CA074184, R03 CA165153, K05 CA152715]; NIH/National Center for Advancing Translational Sciences [KL2 TR00042]; NATIONAL CANCER INSTITUTE [K05CA152715, R03CA165153, P01CA074184] Funding Source: NIH RePORTER	Listwin Family Foundation; Gregory Fund Pilot Award; US National Institutes of Health (NIH)/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/National Center for Advancing Translational Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was primarily supported by a Listwin Family Foundation and Gregory Fund Pilot Award. Additional support was provided by US National Institutes of Health (NIH)/National Cancer Institute grants P01 CA074184 (PAN, JDP), R03 CA165153 (KWM), K05 CA152715 (PAN), and NIH/National Center for Advancing Translational Sciences KL2 TR00042 (ABH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2011, NUTR CANCER, V63, P319, DOI 10.1080/01635581.2011.535960; Ahmed FE, 2012, CANCER GENOM PROTEOM, V9, P179; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartley AN, 2011, CLIN CANCER RES, V17, P7283, DOI 10.1158/1078-0432.CCR-11-1452; Burnett-Hartman AN, 2013, AM J EPIDEMIOL, V177, P625, DOI 10.1093/aje/kws282; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Chia VM, 2007, CANCER EPIDEM BIOMAR, V16, P2697, DOI 10.1158/1055-9965.EPI-07-0467; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Giraldez MD, 2013, CLIN GASTROENTEROL H, V11, P681, DOI 10.1016/j.cgh.2012.12.009; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nishida N, 2011, INT J ONCOL, V38, P1437, DOI 10.3892/ijo.2011.969; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pritchard CC, 2011, CANC PREV RES PHILA; Taguchi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066714; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108668	10.1371/journal.pone.0108668	http://dx.doi.org/10.1371/journal.pone.0108668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286412	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700027
J	Wu, CL; Wu, HM; Chiu, PF; Liou, HH; Chang, CB; Tarng, DC; Chang, CC				Wu, Chia-Lin; Wu, Hung-Ming; Chiu, Ping-Fang; Liou, Hung-Hsiang; Chang, Chirn-Bin; Tarng, Der-Cherng; Chang, Chia-Chu			Associations between the Duration of Dialysis, Endotoxemia, Monocyte Chemoattractant Protein-1, and the Effects of a Short-Dwell Exchange in Patients Requiring Continuous Ambulatory Peritoneal Dialysis	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; SYSTEMIC INFLAMMATION; MESENCHYMAL TRANSITION; CARDIOVASCULAR-DISEASE; PLASMA-LEVELS; TNF-ALPHA; MCP-1; HEMODIALYSIS; CELLS; SERUM	Background: Endotoxemia is exaggerated and contributes to systemic inflammation and atherosclerosis in patients requiring continuous ambulatory peritoneal dialysis (CAPD). The risk of mortality is substantially increased in patients requiring CAPD for >2 years. However, little is known about the effects of long-term CAPD on circulating endotoxin and cytokine levels. Therefore, the present study evaluated the associations between plasma endotoxin levels, cytokine levels, and clinical parameters with the effects of a short-dwell exchange on endotoxemia and cytokine levels in patients on longterm CAPD. Methods: A total of 26 patients were enrolled and divided into two groups (short-term or long-term CAPD) according to the 2-year duration of CAPD. Plasma endotoxin and cytokine levels were measured before and after a short-dwell exchange (4-h dwell) during a peritoneal equilibration test (a standardized method to evaluate the solute transport function of peritoneal membrane). These data were analyzed to determine the relationship of circulating endotoxemia, cytokines and clinical characteristics between the two groups. Results: Plasma endotoxin and monocyte chemotactic protein-1 (MCP-1) levels were significantly elevated in the long-term group. PD duration was significantly correlated with plasma endotoxin (r = 0.479, P = 0.016) and MCP-1 (r = 0.486, P = 0.012). PD duration was also independently associated with plasma MCP-1 levels in multivariate regression. Plasma MCP-1 levels tended to decrease (13.3% reduction, P = 0.077) though endotoxin levels did not decrease in the long-term PD group after the 4-h short-dwell exchange. Conclusion: Long-term PD may result in exaggerated endotoxemia and elevated plasma MCP-1 levels. The duration of PD was significantly correlated with circulating endotoxin and MCP-1 levels, and was an independent predictor of plasma MCP1 levels. Short-dwell exchange seemed to have favorable effects on circulating MCP-1 levels in patients on long-term PD.	[Wu, Chia-Lin; Chiu, Ping-Fang; Chang, Chirn-Bin; Chang, Chia-Chu] Changhua Christian Hosp, Dept Internal Med, Div Nephrol, Changhua, Taiwan; [Wu, Chia-Lin; Chiu, Ping-Fang; Chang, Chirn-Bin; Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Chia-Lin; Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Hung-Ming] Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan; [Liou, Hung-Hsiang] Hsin Jen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Tarng, DC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	dctarng@vghtpe.gov.tw; Chiachu@cch.org.tw	Wu, Chia-Lin/V-8888-2017; Bin Chang, Chirn/E-8605-2010	Wu, Chia-Lin/0000-0001-6045-6956; Chang, Chirn-Bin/0000-0001-9423-7655	Changhua Christian Hospital Research Foundation [100-CCH-IRP-17, 102-CCH-IRP-010]	Changhua Christian Hospital Research Foundation	This study was funded by grants 100-CCH-IRP-17 and 102-CCH-IRP-010 from the Changhua Christian Hospital Research Foundation. The funder had no role in study design, data collection and analysis, the decision to publish the results, or the preparation of the manuscript.	Al-Attas OS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-20; Anker SD, 1997, AM J CARDIOL, V79, P1426, DOI 10.1016/S0002-9149(97)00159-8; Aoyama T, 2010, TOLL LIKE RECEPTOR S; Borazan A, 2004, MEDIAT INFLAMM, V13, P201, DOI 10.1080/09511920410001713493; Braun N, 2011, NEPHROL THER, V7, P162, DOI 10.1016/j.nephro.2010.12.011; Cengiz MI, 2007, J PERIODONTOL, V78, P1926, DOI 10.1902/jop.2007.060499; Chaudhary K, 2011, CLIN J AM SOC NEPHRO, V6, P447, DOI 10.2215/CJN.07920910; Chiu Y W, 2010, Indian J Nephrol, V20, P59, DOI 10.4103/0971-4065.65296; Davi G, 2009, J ATHEROSCLER THROMB, V16, P707; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; DESCAMPSLATSCHA B, 1995, J IMMUNOL, V154, P882; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Estruch M, 2013, ATHEROSCLEROSIS, V229, P356, DOI 10.1016/j.atherosclerosis.2013.05.011; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; Gohh R., 2013, R I MED J, V104, P14; Goldstein SL, 2006, CLIN J AM SOC NEPHRO, V1, P979, DOI 10.2215/CJN.02291205; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Heesen M, 2006, CLIN VACCINE IMMUNOL, V13, P156, DOI 10.1128/CVI.13.1.156-159.2006; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Jaar BG, 2005, ANN INTERN MED, V143, P174, DOI 10.7326/0003-4819-143-3-200508020-00003; Jialal I, 2012, DIABETES CARE, V35, P900, DOI 10.2337/dc11-2375; Juskewitch JE, 2012, AM J PATHOL, V180, P32, DOI 10.1016/j.ajpath.2011.10.001; Kato S, 2004, J AM SOC NEPHROL, V15, P1289; Kubotera N, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/954956; Lambie M, 2013, J AM SOC NEPHROL, V24, P2071, DOI 10.1681/ASN.2013030314; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lee JK, 2012, NUTR METAB CARDIOVAS, V22, P974, DOI 10.1016/j.numecd.2011.01.001; Lee SH, 2012, LAB INVEST, V92, P1698, DOI 10.1038/labinvest.2012.132; Lee YC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-35; Leypoldt JK, 2002, J AM SOC NEPHROL, V13, pS84; Lucas R, 2013, CYTOKINE, V64, P310, DOI 10.1016/j.cyto.2013.05.025; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Malik AR, 2007, J NEPHROL, V20, P340; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Mortier S, 2003, J AM SOC NEPHROL, V14, P1296, DOI 10.1097/01.ASN.0000060681.91079.30; Mujais S, 1999, Contrib Nephrol, V129, P255; Navarro-Gonzalez JF, 2011, CLIN J AM SOC NEPHRO, V6, P2272, DOI 10.2215/CJN.01650211; Okyay GU, 2013, THER APHER DIAL, V17, P193, DOI 10.1111/j.1744-9987.2012.01141.x; Pawlak K, 2007, CLIN BIOCHEM, V40, P81, DOI 10.1016/j.clinbiochem.2006.09.001; PEREIRA BJG, 1994, KIDNEY INT, V45, P890, DOI 10.1038/ki.1994.117; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramnath RD, 2008, INT IMMUNOPHARMACOL, V8, P810, DOI 10.1016/j.intimp.2008.01.033; Rucker D, 2009, NAT REV NEPHROL, V5, P287, DOI 10.1038/nrneph.2009.42; Shioya M, 2013, NEPHROLOGY, V18, P539, DOI 10.1111/nep.12106; STRAUSS FG, 1993, ADV PERIT D, V9, P49; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Tang XY, 2013, AM J PATHOL, V183, P470, DOI 10.1016/j.ajpath.2013.04.020; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; Wu M.-S., 2011, ACTA NEPHROL, V25, P148; Wu M-S, 2012, ACTA NEPHROLOGICA, V26, P104	57	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109558	10.1371/journal.pone.0109558	http://dx.doi.org/10.1371/journal.pone.0109558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286027	Green Submitted, gold, Green Published			2022-12-27	WOS:000345743700072
J	Xu, JS; Yin, LY; Xu, Y; Li, YY; Zalzala, M; Cheng, G; Zhang, YQ				Xu, Jiesi; Yin, Liya; Xu, Yang; Li, Yuanyuan; Zalzala, Munaf; Cheng, Gang; Zhang, Yanqiao			Hepatic Carboxylesterase 1 Is Induced by Glucose and Regulates Postprandial Glucose Levels	PLOS ONE			English	Article							CENTER-DOT-MLX; GENE-EXPRESSION; REDUCES ATHEROSCLEROSIS; TRANSGENIC EXPRESSION; INSULIN-RESISTANCE; LIVER; CHREBP; MICE; CELLS; TRANSCRIPTION	Metabolic syndrome, characterized by obesity, hyperglycemia, dyslipidemia and hypertension, increases the risks for cardiovascular disease, diabetes and stroke. Carboxylesterase 1 (CES1) is an enzyme that hydrolyzes triglycerides and cholesterol esters, and is important for lipid metabolism. Our previous data show that over-expression of mouse hepatic CES1 lowers plasma glucose levels and improves insulin sensitivity in diabetic ob/ob mice. In the present study, we determined the physiological role of hepatic CES1 in glucose homeostasis. Hepatic CES1 expression was reduced by fasting but increased in diabetic mice. Treatment of mice with glucose induced hepatic CES1 expression. Consistent with the in vivo study, glucose stimulated CES1 promoter activity and increased acetylation of histone 3 and histone 4 in the CES1 chromatin. Knockdown of ATP-citrate lyase (ACL), an enzyme that regulates histone acetylation, abolished glucose-mediated histone acetylation in the CES1 chromatin and glucose-induced hepatic CES1 expression. Finally, knockdown of hepatic CES1 significantly increased postprandial blood glucose levels. In conclusion, the present study uncovers a novel glucose-CES1-glucose pathway which may play an important role in regulating postprandial blood glucose levels.	[Xu, Jiesi; Yin, Liya; Xu, Yang; Li, Yuanyuan; Zalzala, Munaf; Zhang, Yanqiao] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Zalzala, Munaf] Univ Baghdad, Dept Pharmacol & Toxicol, Coll Pharm, Baghdad, Iraq; [Cheng, Gang] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA	Northeast Ohio Medical University (NEOMED); University of Baghdad; University System of Ohio; University of Akron	Zhang, YQ (corresponding author), Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA.	yzhang@neomed.edu	Li, Yuanyuan/AAC-5432-2019; Xu, Jiesi/X-3355-2018; Li, Yuanyuan/N-4447-2015; Zalzala, Munaf H./AAE-1494-2020	Zalzala, Munaf H./0000-0003-0552-6469	National Institutes of Health (NIH) [R01HL103227, R01DK095895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095895] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants R01HL103227 and R01DK095895 to Y.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DS, 2001, SOUTH MED J, V94, P804; Bie JH, 2014, J LIPID RES, V55, P729, DOI 10.1194/jlr.M046524; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Edwards Mina, 2013, Methods Mol Biol, V987, P283, DOI 10.1007/978-1-62703-321-3_24; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Ge XM, 2011, J LIPID RES, V52, P1561, DOI 10.1194/jlr.M015859; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Jernas M, 2009, BIOCHEM BIOPH RES CO, V383, P63, DOI 10.1016/j.bbrc.2009.03.120; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kahn R, 2001, DIABETES CARE, V24, P775; Kannu PD, 1999, PROCEEDING OF THE INTERNATIONAL CONFERENCE ON ELECTROMAGNETIC INTERFERENCE AND COMPATIBILITY '99, P479; Ko KWS, 2009, BBA-MOL CELL BIOL L, V1791, P1133, DOI 10.1016/j.bbalip.2009.07.006; Li TG, 2010, J LIPID RES, V51, P832, DOI 10.1194/jlr.M002782; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Mastrodonato M, 2011, EUR J CLIN INVEST, V41, P642, DOI 10.1111/j.1365-2362.2010.02459.x; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Quiroga AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049515; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Rachek LI, 2014, PROG MOL BIOL TRANSL, V121, P267, DOI 10.1016/B978-0-12-800101-1.00008-9; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Satoh T, 2006, CHEM-BIOL INTERACT, V162, P195, DOI 10.1016/j.cbi.2006.07.001; SHIMADA A, 1994, BBA-LIPID LIPID MET, V1215, P126, DOI 10.1016/0005-2760(94)90101-5; Thompson GM, 2004, ANAL BIOCHEM, V330, P21, DOI 10.1016/j.ab.2004.03.061; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; VAULONT S, 1995, TRANSGENIC RES, V4, P247, DOI 10.1007/BF01969118; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Wang QO, 2010, J LIPID RES, V51, P2516, DOI 10.1194/jlr.M003335; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xiong J, 2014, LIFE SCI, V112, P41, DOI 10.1016/j.lfs.2014.07.019; Xu JS, 2014, HEPATOLOGY, V59, P1761, DOI 10.1002/hep.26714; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828; Zhang T, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-15; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	40	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109663	10.1371/journal.pone.0109663	http://dx.doi.org/10.1371/journal.pone.0109663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285996	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700081
J	Badiga, S; Johanning, GL; Macaluso, M; Azuero, A; Chambers, MM; Siddiqui, NR; Piyathilake, CJ				Badiga, Suguna; Johanning, Gary L.; Macaluso, Maurizio; Azuero, Andres; Chambers, Michelle M.; Siddiqui, Nuzhat R.; Piyathilake, Chandrika J.			A Lower Degree of PBMC Li Methylation in Women with Lower Folate Status May Explain the MTHFR C677T Polymorphism Associated Higher Risk of CIN in the US Post Folic Acid Fortification Era	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; REPETITIVE DNA HYPOMETHYLATION; CERVICAL-CANCER; PERIPHERAL-BLOOD; COMMON MUTATION; DISEASE; GENE; MS	Background: Studies in populations unexposed to folic acid (FA) fortification have demonstrated that MTHFR C677T polymorphism is associated with increased risk of higher grades of cervical intraepithelial neoplasia (CIN 2+). However, it is unknown whether exposure to higher folate as a result of the FA fortification program has altered the association between IVITHFR C677T and risk of CIN, or the mechanisms involved with such alterations. The current study investigated the following in a FA fortified population: 1) The association between MTHFR C677T polymorphism and risk of CIN 2+; 2) The modifying effects of plasma folate concentrations on this association; and 3) The modifying effects of plasma folate on the association between the polymorphism and degree of methylation of long interspersed nucleotide elements (Us), in peripheral blood mononuclear cell (PBMC) DNA, a documented biomarker of CIN risk. Methods: The study included 457 US women diagnosed with either CIN 2+ (cases) or < CIN 1 (non-cases). Unconditional logistic regression models were used to test the associations after adjusting for relevant risk factors for CIN. Results: The 677CT11T MTHFR genotypes were not associated with the risk of CIN 2+. Women with CT/TT genotype with lower folate, however, were more likely to be diagnosed with CIN 2+ compared to women with CTaT genotype with higher folate (OR =2.41, P =0.030). Women with CT/TT genotype with lower folate were less likely to have a higher degree of PBMC Li methylation compared to women with CT/TT genotype with higher folate (OR =0.28, P =0.017). Conclusions: This study provides the first evidence that the MTHFR 677CT/TT genotype-associated lower degree of PBMC Li methylation increases the risk of CIN 2+ in women in the US post-FA fortification era. Thus, even in the post-FA fortification era, not all women have adequate folate status to overcome MTHFR 677CT/TT genotype-associated lower degree of L1 methylation.	[Badiga, Suguna; Chambers, Michelle M.; Siddiqui, Nuzhat R.; Piyathilake, Chandrika J.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Johanning, Gary L.] SRI Int, Ctr Canc & Metab, Biosci Div, Menlo Pk, CA 94025 USA; [Macaluso, Maurizio] Univ Cincinnati, Coll Med, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH USA; [Azuero, Andres] Univ Alabama Birmingham, Dept Community Hlth Outcomes & Syst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; SRI International; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham	Piyathilake, CJ (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA.	piyathic@uab.edu	Macaluso, Maurizio/J-2076-2015	Macaluso, Maurizio/0000-0002-2977-9690	National Cancer Institute [R01 CA105448]; UAB Comprehensive Cancer Center Collaborative Programmatic Developmental Award, CCSG [P30 CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA105448] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UAB Comprehensive Cancer Center Collaborative Programmatic Developmental Award, CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01 CA105448 funded by the National Cancer Institute and the UAB Comprehensive Cancer Center Collaborative Programmatic Developmental Award, CCSG P30 CA013148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Berry RJ, 2010, FOOD NUTR BULL, V31, pS22, DOI 10.1177/15648265100311S103; Botezatu A, 2013, J CELL MOL MED, V17, P543, DOI 10.1111/jcmm.12032; Cash HL, 2011, EPIGENETICS-US, V6, P1257, DOI 10.4161/epi.6.10.17728; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Friso S, 2005, CANCER EPIDEM BIOMAR, V14, P938, DOI 10.1158/1055-9965.EPI-04-0601; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gonzalez-Herrera L, 2014, INT J BIOL MARKER, V29, pE142, DOI 10.5301/jbm.5000070; Goodman MT, 2001, CANCER EPIDEM BIOMAR, V10, P1275; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Henao OL, 2005, INT J CANCER, V113, P991, DOI 10.1002/ijc.20695; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Hughes LB, 2006, ANN RHEUM DIS, V65, P1213, DOI 10.1136/ard.2005.046797; Jackson K, 2004, CANCER BIOL THER, V3, P1225, DOI 10.4161/cbt.3.12.1222; KANG SS, 1988, AM J HUM GENET, V43, P414; Kennedy DA, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/952508; Lambropoulos AF, 2003, CANCER LETT, V191, P187, DOI 10.1016/S0304-3835(02)00675-4; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Long SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052381; Manshadi SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084635; McDowell Margaret A, 2008, NCHS Data Brief, P1; Park SY, 2009, J PATHOL, V219, P410, DOI 10.1002/path.2596; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Piyathilake CJ, 2007, NUTRITION, V23, P203, DOI 10.1016/j.nut.2006.12.002; Piyathilake CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054544; Piyathilake CJ, 2011, NUTRITION, V27, P513, DOI 10.1016/j.nut.2010.08.018; Piyathilake CJ, 2010, INT J WOMENS HEALTH, V2, P7; Piyathilake CJ, 2004, CANCER RES, V64, P8788, DOI 10.1158/0008-5472.CAN-04-2402; Piyathilake CJ, 2000, ANTICANCER RES, V20, P1751; Rao GG, 2006, GYNECOL ONCOL, V101, P250, DOI 10.1016/j.ygyno.2005.10.019; Roman-Gomez J, 2008, LEUKEMIA RES, V32, P487, DOI 10.1016/j.leukres.2007.07.021; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; Sull JW, 2004, GYNECOL ONCOL, V95, P557, DOI 10.1016/j.ygyno.2004.08.008; Tong SY, 2011, CANCER CAUSE CONTROL, V22, P63, DOI 10.1007/s10552-010-9675-6; Tong SY, 2010, CANCER CAUSE CONTROL, V21, P23, DOI 10.1007/s10552-009-9430-z; Ulrich CM, 1999, CANCER EPIDEM BIOMAR, V8, P659; Ulrich CM, 2006, CANCER EPIDEM BIOMAR, V15, P189, DOI 10.1158/1055-9965.EPI-152CO; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257, DOI 10.1001/jama.269.10.1257; Yu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055835; Zhu J, 2013, MOL MED REP, V8, P919, DOI 10.3892/mmr.2013.1589; Zhuo WL, 2012, MOL BIOL REP, V39, P8723, DOI 10.1007/s11033-012-1732-7; Zoodsma M, 2005, HUM GENET, V116, P247, DOI 10.1007/s00439-004-1233-4	50	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110093	10.1371/journal.pone.0110093	http://dx.doi.org/10.1371/journal.pone.0110093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302494	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400111
J	Stawski, L; Haines, P; Fine, A; Rudnicka, L; Trojanowska, M				Stawski, Lukasz; Haines, Paul; Fine, Alan; Rudnicka, Lidia; Trojanowska, Maria			MMP-12 Deficiency Attenuates Angiotensin II-Induced Vascular Injury, M2 Macrophage Accumulation, and Skin and Heart Fibrosis	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; MATRIX METALLOPROTEINASE-12; ENDOTHELIAL-CELLS; PULMONARY-FIBROSIS; CARDIAC FIBROSIS; DISEASE; TISSUE; ANGIOGENESIS; EXPRESSION; SCLERODERMA	MMP-12, a macrophage-secreted elastase, is elevated in fibrotic diseases, including systemic sclerosis (SSc) and correlates with vasculopathy and fibrosis. The goal of this study was to investigate the role of MMP-12 in cardiac and cutaneous fibrosis induced by angiotensin II infusion. Ang II-induced heart and skin fibrosis was accompanied by a marked increase of vascular injury markers, including vWF, Thrombospondin-1 (TSP-1) and MMP-12, as well as increased number of PDGFR beta(+) cells. Furthermore Ang II infusion led to an accumulation of macrophages (Mac(3+)) in the skin and in the perivascular and interstitial fibrotic regions of the heart. However, alternatively activated (Arg 1(+)) macrophages were mainly present in the Ang II infused mice and were localized to the perivascular heart regions and to the skin, but were not detected in the interstitial heart regions. Elevated expression of MMP-12 was primarily found in macrophages and endothelial cells (CD31(+)) cells, but MMP-12 was not expressed in the collagen producing cells. MMP-12 deficient mice (MMP12KO) showed markedly reduced expression of vWF, TSP1, and PDGFR beta around vessels and attenuation of dermal fibrosis, as well as the perivascular fibrosis in the heart. However, MMP-12 deficiency did not affect interstitial heart fibrosis, suggesting a heterogeneous nature of the fibrotic response in the heart. Furthermore, MMP-12 deficiency almost completely prevented accumulation of Arg 1(+) cells, whereas the number of Mac(3+) cells was partially reduced. Moreover production of profibrotic mediators such as PDGFBB, TGF beta 1 and pSMAD2 in the skin and perivascular regions of the heart was also inhibited. Together, the results of this study show a close correlation between vascular injury markers, Arg 1(+) macrophage accumulation and fibrosis and suggest an important role of MMP-12 in regulating these processes.	[Stawski, Lukasz; Haines, Paul; Trojanowska, Maria] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA; [Fine, Alan] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Rudnicka, Lidia] Med Univ Warsaw, Fac Hlth Sci, Warsaw, Poland; [Rudnicka, Lidia] Polish Acad Sci, Mossakowski Med Res, Dept Neuropeptides, Warsaw, Poland	Boston University; Boston University; Medical University of Warsaw; Polish Academy of Sciences	Trojanowska, M (corresponding author), Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA.	trojanme@bu.edu	Rudnicka, Lidia/L-7529-2019	Rudnicka, Lidia/0000-0002-8308-1023	National Institutes of Health (NIAMS) [RO1 AR42334, AR044883]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044883, R56AR044883, R01AR042334] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health (NIAMS) grant RO1 AR42334 and AR044883 to M. Trojanowska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2006, JOINT BONE SPINE, V73, P363, DOI 10.1016/j.jbspin.2005.12.003; ALPERT MA, 1992, CHEST, V102, P1407, DOI 10.1378/chest.102.5.1407; Amaral Tn, 2013, SEMIN ARTHRITIS RHEU; [Anonymous], 1991, ANN INTERN MED, V114, P249; Asano Y, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0382-7; Avouac J, 2011, RHEUMATOLOGY, V50, P1494, DOI 10.1093/rheumatology/keq448; BANDA MJ, 1981, BIOCHEM J, V193, P589, DOI 10.1042/bj1930589; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Braitsch CM, 2013, J MOL CELL CARDIOL, V65, P108, DOI 10.1016/j.yjmcc.2013.10.005; Brecher P, 1996, TRENDS CARDIOVAS MED, V6, P193, DOI 10.1016/S1050-1738(96)00072-2; Chan MF, 2013, J CELL SCI, V126, P3948, DOI [10.1242/jcs.28033, 10.1242/jcs.128033]; D'Alessio S, 2004, ARTHRITIS RHEUM-US, V50, P3275, DOI 10.1002/art.20562; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dimmeler S, 1997, CIRC RES, V81, P970; England KA, 2011, AM J PHYSIOL-LUNG C, V301, pL519, DOI 10.1152/ajplung.00383.2009; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Garbacki N, 2009, PULM PHARMACOL THER, V22, P267, DOI 10.1016/j.pupt.2009.03.001; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsu YH, 2004, J VASC RES, V41, P64, DOI 10.1159/000076247; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kawaguchi Y, 2004, ARTHRITIS RHEUM-US, V50, P216, DOI 10.1002/art.11364; Kim S, 2000, PHARMACOL REV, V52, P11; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Konttinen YT, 2003, CLIN RHEUMATOL, V22, P196, DOI 10.1007/s10067-003-0698-1; Leach Hg, 2013, AM J RESP CELL MOL B; Ma X, 2014, INT J CARDIOL; Macko RF, 2002, J RHEUMATOL, V29, P2565; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Manetti M, 2013, ANN RHEUM DIS; Manetti M, 2012, ANN RHEUM DIS, V71, P1064, DOI 10.1136/annrheumdis-2011-200837; Manoury Boris, 2006, J Inflamm (Lond), V3, P2, DOI 10.1186/1476-9255-3-2; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Matute-Bello G, 2007, AM J RESP CELL MOL, V37, P210, DOI 10.1165/rcmb.2006-0471OC; Meznarich J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057837; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Morgan-Rowe L, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-13; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Nakashima Hidekatsu, 2006, Current Vascular Pharmacology, V4, P67, DOI 10.2174/157016106775203126; Pignone A, 2007, ANN RHEUM DIS, V66, P1305, DOI 10.1136/ard.2006.064493; Rajkumar VS, 1999, ARTHRITIS RHEUM-US, V42, P930, DOI 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1; Richard L, 1999, Methods Mol Med, V18, P261, DOI 10.1385/0-89603-516-6:261; Samuel Chrishan S., 2009, V466, P223, DOI 10.1007/978-1-59745-352-3_16; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shivshankar P, 2014, J MOL CELL CARDIOL; Soria A, 2008, DERMATOLOGY, V216, P109, DOI 10.1159/000111507; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Stawski L, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4028; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trojanowska M, 2010, NAT REV RHEUMATOL, V6, P453, DOI 10.1038/nrrheum.2010.102; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Warnholtz A, 1999, CIRCULATION, V99, P2027, DOI 10.1161/01.CIR.99.15.2027; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu ZW, 2008, ONCOL REP, V20, P81; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	57	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109763	10.1371/journal.pone.0109763	http://dx.doi.org/10.1371/journal.pone.0109763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302498	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400078
J	Kagawa, T; Narita, N; Iwaki, S; Kawasaki, S; Kamiya, K; Minakuchi, S				Kagawa, Tomonori; Narita, Noriyuki; Iwaki, Sunao; Kawasaki, Shingo; Kamiya, Kazunobu; Minakuchi, Shunsuke			Does Shape Discrimination by the Mouth Activate the Parietal and Occipital Lobes? - Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VISUAL WORKING-MEMORY; TACTILE PERCEPTION; FUNCTIONAL BRAIN; MASTICATORY PERFORMANCE; STEREOGNOSTIC ABILITY; CORTICAL ACTIVITY; MINDS EYE; CORTEX; MRI	A cross-modal association between somatosensory tactile sensation and parietal and occipital activities during Braille reading was initially discovered in tests with blind subjects, with sighted and blindfolded healthy subjects used as controls. However, the neural background of oral stereognosis remains unclear. In the present study, we investigated whether the parietal and occipital cortices are activated during shape discrimination by the mouth using functional near-infrared spectroscopy (fNIRS). Following presentation of the test piece shape, a sham discrimination trial without the test pieces induced posterior parietal lobe (BA7), extrastriate cortex (BA18, BA19), and striate cortex (BA17) activation as compared with the rest session, while shape discrimination of the test pieces markedly activated those areas as compared with the rest session. Furthermore, shape discrimination of the test pieces specifically activated the posterior parietal cortex (precuneus/BA7), extrastriate cortex (BA18, 19), and striate cortex (BA17), as compared with sham sessions without a test piece. We concluded that oral tactile sensation is recognized through tactile/visual cross-modal substrates in the parietal and occipital cortices during shape discrimination by the mouth.	[Kagawa, Tomonori; Minakuchi, Shunsuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Gerodontol & Oral Rehabil Dept Gerontol & Gerodon, Tokyo, Japan; [Narita, Noriyuki; Kamiya, Kazunobu] Nihon Univ, Sch Dent, Dept Removable Prosthodont, Matsudo, Chiba 271, Japan; [Iwaki, Sunao] Natl Inst Adv Ind Sci & Technol, AIST, Human Technol Res Inst, Cognit & Act Res Grp, Tsukuba, Japan; [Kawasaki, Shingo] Hitachi Med Corp, Applicat Dev Off, Chiba, Japan	Tokyo Medical & Dental University (TMDU); Nihon University; National Institute of Advanced Industrial Science & Technology (AIST); Hitachi Limited	Narita, N (corresponding author), Nihon Univ, Sch Dent, Dept Removable Prosthodont, Matsudo, Chiba 271, Japan.	narita.noriyuki@nihon-u.ac.jp	Iwaki, Sunao/B-1079-2011	Iwaki, Sunao/0000-0002-7123-7203	Grants-in-Aid for Scientific Research [23300102] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amarasena J, 2010, J ORAL BIOSCI, V52, P181, DOI 10.2330/joralbiosci.52.181; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Engelen L, 2004, J DENT RES, V83, P388, DOI 10.1177/154405910408300507; Fujii R, 2011, J CLIN NEUROSCI, V18, P1520, DOI 10.1016/j.jocn.2011.03.005; Garrett N R, 1994, Int J Prosthodont, V7, P567; Hannula H, 2008, NEUROSCI LETT, V437, P144, DOI 10.1016/j.neulet.2008.03.093; Hirano K, 2004, J ORAL REHABIL, V31, P199, DOI 10.1111/j.1365-2842.2004.01175.x; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Ichikawa N, 2001, MEDIX, V34, P47; Ikebe K, 2007, J ORAL REHABIL, V34, P345, DOI 10.1111/j.1365-2842.2007.01687.x; Ikebe K, 2007, INT J PROSTHODONT, V20, P245; Jacobs R, 1998, Clin Oral Investig, V2, P3, DOI 10.1007/s007840050035; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Kaiba Yoshinori, 2006, Journal of Medical and Dental Sciences, V53, P1; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; Kawagishi S, 2009, J ORAL REHABIL, V36, P872, DOI 10.1111/j.1365-2842.2009.02005.x; Keehner M, 2006, NEUROIMAGE, V33, P391, DOI 10.1016/j.neuroimage.2006.06.043; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kojima H, 2010, NEUROPSYCHOLOGIA, V48, P349, DOI 10.1016/j.neuropsychologia.2009.09.028; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kumamoto Y, 2010, J PROSTHODONT RES, V54, P92, DOI 10.1016/j.jpor.2009.11.006; Lacey S, 2012, NEURAL BASES MULTISE; Leung KCM, 2002, J ORAL REHABIL, V29, P497, DOI 10.1046/j.1365-2842.2002.00879.x; Maehara G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2815720; Marumo K, 2014, NEUROIMAGE, V85, P518, DOI 10.1016/j.neuroimage.2013.04.050; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Narita N, 2009, J PROSTHODONT RES, V53, P126, DOI 10.1016/j.jpor.2009.02.005; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Parra MA, 2014, NEUROPSYCHOLOGIA, V52, P27, DOI 10.1016/j.neuropsychologia.2013.09.036; Pasalar S, 2010, EUR J NEUROSCI, V31, P1783, DOI 10.1111/j.1460-9568.2010.07193.x; Pow E H, 2001, Clin Oral Investig, V5, P112, DOI 10.1007/s007840100110; Prather SC, 2004, NEUROPSYCHOLOGIA, V42, P1079, DOI 10.1016/j.neuropsychologia.2003.12.013; Ptito M, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/304045; Qin W, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/864920; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Sathian K, 2002, BEHAV BRAIN RES, V135, P127, DOI 10.1016/S0166-4328(02)00141-9; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sawa M, 2012, EUR ARCH PSY CLIN N, V262, P493, DOI 10.1007/s00406-012-0296-9; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Stoesz MR, 2003, INT J PSYCHOPHYSIOL, V50, P41, DOI 10.1016/S0167-8760(03)00123-5; Stokes M, 2011, NEUROIMAGE, V56, P1540, DOI 10.1016/j.neuroimage.2011.02.071; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Takahashi K, 2000, J BIOMED OPT, V5, P93, DOI 10.1117/1.429973; Tamura M, 1997, PHILOS T ROY SOC B, V352, P737, DOI 10.1098/rstb.1997.0056; Tian FH, 2014, NEUROIMAGE, V85, P166, DOI 10.1016/j.neuroimage.2013.07.016; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Ven V, 2013, BEHAV BRAIN RES, V236, P67, DOI 10.1016/j.bbr.2012.08.001; Weisser V, 2005, EXP BRAIN RES, V166, P572, DOI 10.1007/s00221-005-2397-4; Yamamura K, 2008, IADR 86 GEN SESS EXH; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108685	10.1371/journal.pone.0108685	http://dx.doi.org/10.1371/journal.pone.0108685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299397	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200021
J	Kasonta, R; Holsteg, M; Duchow, K; Dekker, JW; Cussler, K; Bendall, JG; Bastian, M				Kasonta, Rahel; Holsteg, Mark; Duchow, Karin; Dekker, James W.; Cussler, Klaus; Bendall, Justin G.; Bastian, Max			Colostrum from Cows Immunized with a Vaccine Associated with Bovine Neonatal Pancytopenia Contains Allo-Antibodies that Cross-React with Human MHC-I Molecules	PLOS ONE			English	Article							FC-RECEPTOR; IGG; BNP; EXPRESSION; ANTIBODIES; TRANSPORT	In 2006, a new haemorrhagic syndrome affecting newborn calves, Bovine Neonatal Pancytopenia (BNP), was reported in southern Germany. It is characterized by severe bleeding, destruction of the red bone marrow, and a high case fatality rate. The syndrome is caused by alloreactive, maternal antibodies that are ingested by the calf with colostrum and result from a dam vaccination with one particular vaccine against Bovine-Viral-Diarrhoea-Virus. Because bovine colostrum is increasingly gaining interest as a dietary supplement for human consumption, the current study was initiated to elucidate whether BNP alloantibodies from BNP dams (i.e. animals that gave birth to a BNP-affected calf) cross-react with human cells, which could pose a health hazard for human consumers of colostral products. The present study clearly demonstrates that BNP alloantibodies cross-react with human lymphocytes in vitro. In agreement with previous reports on BNP, the cross-reactive antibodies are specific for MHC-I molecules, and sensitize opsonised human cells for in vitro complement lysis. Cross-reactive antibodies are present in serum and colostrum of individual BNP dams. They can be traced in commercial colostrum powder manufactured from cows immunized with the vaccine associated with BNP, but are absent from commercial powder manufactured from colostrum excluding such vaccinated cows. In humans alloreactive, MHC-I specific antibodies are generally not believed to cause severe symptoms. However, to minimize any theoretical risk for human consumers, manufacturers of bovine colostrum for human consumption should consider using only colostrum from animals that have not been exposed to the vaccine associated with BNP.	[Kasonta, Rahel; Duchow, Karin; Cussler, Klaus; Bastian, Max] Paul Ehrlich Inst, Div Vet Med, Langen, Germany; [Dekker, James W.; Bendall, Justin G.] Fonterra Res & Dev Ctr, Palmerston North, New Zealand; [Holsteg, Mark] Landwirtschaftskammer Nordrhein Westfalen, Bonn, Germany	Paul Ehrlich Institute; Fonterra	Bastian, M (corresponding author), Paul Ehrlich Inst, Div Vet Med, Langen, Germany.	basma@pei.de	Bastian, Max/AGB-3131-2022	Bastian, Max/0000-0001-7926-8568	Paul-Ehrlich-Institut; Fonterra Research and Development Centre	Paul-Ehrlich-Institut; Fonterra Research and Development Centre(Fonterra)	The authors received no specific funding for this work. Funding for this work was provided by the Paul-Ehrlich-Institut and the Fonterra Research and Development Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad A, 2012, VET IMMUNOL IMMUNOP, V147, P25, DOI 10.1016/j.vetimm.2012.04.012; Bastian M, 2011, VACCINE, V29, P5267, DOI 10.1016/j.vaccine.2011.05.012; Bridger PS, 2011, VET IMMUNOL IMMUNOP, V141, P1, DOI 10.1016/j.vetimm.2011.01.001; Butler I, 2011, RECALL DVD VACCINE N; Butler JE, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1763, DOI 10.1016/B978-012491543-5/50107-8; Curtis BR, 2014, VOX SANG, V106, P93, DOI 10.1111/vox.12085; Davison G, 2010, BRIT J NUTR, V103, P1425, DOI 10.1017/S0007114509993503; Deutskens F, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-97; Diaz TM, 2004, TRANSPL IMMUNOL, V13, P313, DOI 10.1016/j.trim.2004.09.001; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; *EMA, 2010, OP FOLL ART 78 PROC; Evans C, 2004, EUR J ENDOCRINOL, V150, P265, DOI 10.1530/eje.0.1500265; Foucras G, 2011, J IMMUNOL, V187, P6564, DOI 10.4049/jimmunol.1102533; Friedrich A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-10; Friedrich A, 2009, TIERAERZTL UMSCHAU, V64, P423; Gill RK, 1999, INDIAN J BIOCHEM BIO, V36, P252; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; Kasonta R, 2014, VET RECORD CASE REPO, V2, DOI DOI 10.1136/VETRECCR-2014-000082; Kasonta R, 2012, VACCINE, V30, P6649, DOI 10.1016/j.vaccine.2012.08.069; Kelly Gregory S, 2003, Altern Med Rev, V8, P378; Khan Z, 2002, ALIMENT PHARM THER, V16, P1917, DOI 10.1046/j.1365-2036.2002.01354.x; Klauninger R, 2009, LUPUS, V18, P792, DOI 10.1177/0961203309103188; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Pardon B, 2011, VET IMMUNOL IMMUNOP, V141, P293, DOI 10.1016/j.vetimm.2011.02.017; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Peterson JA, 2013, BRIT J HAEMATOL, V161, P3, DOI 10.1111/bjh.12235; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; REESE J, 1994, J PAEDIATR CHILD H, V30, P447, DOI 10.1111/j.1440-1754.1994.tb00700.x; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Shah U, 2003, PEDIATR RES, V53, P295, DOI 10.1203/01.PDR.0000047663.81816.E3; Shainwright_Consulting, 2007, COL STRAT REV OPP AP; Uruakpa FO, 2002, NUTR RES, V22, P755, DOI 10.1016/S0271-5317(02)00373-1; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109239	10.1371/journal.pone.0109239	http://dx.doi.org/10.1371/journal.pone.0109239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299190	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200044
J	Koseki, H; Yonekura, A; Shida, T; Yoda, I; Horiuchi, H; Morinaga, Y; Yanagihara, K; Sakoda, H; Osaki, M; Tomita, M				Koseki, Hironobu; Yonekura, Akihiko; Shida, Takayuki; Yoda, Itaru; Horiuchi, Hidehiko; Morinaga, Yoshitomo; Yanagihara, Katsunori; Sakoda, Hideyuki; Osaki, Makoto; Tomita, Masato			Early Staphylococcal Biofilm Formation on Solid Orthopaedic Implant Materials: In Vitro Study	PLOS ONE			English	Article							SURFACE-FREE-ENERGY; STREPTOCOCCUS-SANGUIS CH3; OF-THE-LITERATURE; BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; QUANTITATIVE-ANALYSIS; HYDROPHOBIC SURFACES; EPIDERMIDIS BIOFILM; INFECTION	Biofilms forming on the surface of biomaterials can cause intractable implant-related infections. Bacterial adherence and early biofilm formation are influenced by the type of biomaterial used and the physical characteristics of implant surface. In this in vitro research, we evaluated the ability of Staphylococcus epidermidis, the main pathogen in implant-related infections, to form biofilms on the surface of the solid orthopaedic biomaterials, oxidized zirconium-niobium alloy, cobalt-chromium- molybdenum alloy (Co-Cr-Mo), titanium alloy (Ti-6Al-4V), commercially pure titanium (cp-Ti) and stainless steel. A bacterial suspension of Staphylococcus epidermidis strain RP62A (ATCC35984) was added to the surface of specimens and incubated. The stained biofilms were imaged with a digital optical microscope and the biofilm coverage rate (BCR) was calculated. The total amount of biofilm was determined with the crystal violet assay and the number of viable cells in the biofilm was counted using the plate count method. The BCR of all the biomaterials rose in proportion to culture duration. After culturing for 2-4 hours, the BCR was similar for all materials. However, after culturing for 6 hours, the BCR for Co-CrMo alloy was significantly lower than for Ti-6Al-4V, cp-Ti and stainless steel (P < 0.05). The absorbance value determined in the crystal violet assay and the number of viable cells on Co-Cr-Mo were not significantly lower than for the other materials (P > 0.05). These results suggest that surface properties, such as hydrophobicity or the low surface free energy of Co-Cr-Mo, may have some influence in inhibiting or delaying the two-dimensional expansion of biofilm on surfaces with a similar degree of smoothness.	[Koseki, Hironobu; Yonekura, Akihiko; Shida, Takayuki; Yoda, Itaru; Horiuchi, Hidehiko; Osaki, Makoto; Tomita, Masato] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Nagasaki 852, Japan; [Morinaga, Yoshitomo; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 852, Japan; [Sakoda, Hideyuki] Natl Inst Hlth Sci, Div Med Devices, Tokyo, Japan	Nagasaki University; Nagasaki University; National Institute of Health Sciences - Japan	Koseki, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Nagasaki 852, Japan.	koseki@nagasaki-u.ac.jp		Sakoda, Hideyuki/0000-0002-2665-4665	JSPS KAKENHI [24592236]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24592236 (http://www.jsps.go.jp/j-grantsinaid/16_rule/rule.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031; Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533; Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; Braem A, 2013, J BIOMED MAT RES A; Busscher H J, 1997, Adv Dent Res, V11, P24; BUSSCHER HJ, 1986, APPL ENVIRON MICROB, V51, P910, DOI 10.1128/AEM.51.5.910-914.1986; Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007; CHANG CC, 1991, J ORTHOPAED RES, V9, P284, DOI 10.1002/jor.1100090217; Chibowski E, 2003, ADV COLLOID INTERFAC, V103, P149, DOI 10.1016/S0001-8686(02)00093-3; Chu Vivian H, 2005, Am J Med, V118, P1416, DOI 10.1016/j.amjmed.2005.06.011; Clint JH, 2001, CURR OPIN COLLOID IN, V6, P28, DOI 10.1016/S1359-0294(00)00084-4; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Donlan RM, 2005, CLIN ORTHOP RELAT R, P12, DOI 10.1097/01.blo.0000175120.66051.29; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GLANTZ PO, 1971, J COLLOID INTERF SCI, V37, P281, DOI 10.1016/0021-9797(71)90294-3; Gottenbos B, 1999, J MATER SCI-MATER M, V10, P853, DOI 10.1023/A:1008989416939; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014; Ha KY, 2005, SPINE, V30, P38, DOI 10.1097/01.brs.0000147801.63304.8a; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Henrique MA, 2004, COLLOIDS SURF BIOINT, V33, P7; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; Hoyle B D, 1991, Prog Drug Res, V37, P91; HUNTER G, 2005, J ASTM INT, V2; Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019; Lee BC, 2011, J ADV PROSTHODONT, V3, P81, DOI 10.4047/jap.2011.3.2.81; Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103; Phillips CB, 2003, J BONE JOINT SURG AM, V85A, P20, DOI 10.2106/00004623-200301000-00004; Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1; Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081; QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x; Scarano Antonio, 2003, J Oral Implantol, V29, P80, DOI 10.1563/1548-1336(2003)029<0080:BAOTNA>2.3.CO;2; Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717; Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005; Sheehan E, 2004, J ORTHOP RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616; Tang PF, 2011, J NANOMATER, V2011, DOI 10.1155/2011/178921; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005; VANPELT AWJ, 1985, APPL ENVIRON MICROB, V49, P1270, DOI 10.1128/AEM.49.5.1270-1275.1985; Wijekoon CP, 2008, J MICROBIOL METH, V74, P94, DOI 10.1016/j.mimet.2008.03.008; WYMENGA AB, 1992, ACTA ORTHOP SCAND, V63, P665, DOI 10.1080/17453679209169732; Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9	60	61	61	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e107588	10.1371/journal.pone.0107588	http://dx.doi.org/10.1371/journal.pone.0107588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299658	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200008
J	Park, MJ; Aja, S; Li, Q; Degano, AL; Penati, J; Zhuo, J; Roe, CR; Ronnett, GV				Park, Min Jung; Aja, Susan; Li, Qun; Degano, Alicia L.; Penati, Judith; Zhuo, Justin; Roe, Charles R.; Ronnett, Gabriele V.			Anaplerotic Triheptanoin Diet Enhances Mitochondrial Substrate Use to Remodel the Metabolome and Improve Lifespan, Motor Function, and Sociability in MeCP2-Null Mice	PLOS ONE			English	Article							FAT OXIDATION DISORDERS; CPG-BINDING PROTEIN-2; RETT-SYNDROME; MOUSE MODEL; PHOSPHOENOLPYRUVATE CARBOXYKINASE; PERMEABILITY TRANSITION; ENTERAL METABOLISM; REPERFUSION INJURY; DISEASE; DYSFUNCTION	Rett syndrome (RTT) is an autism spectrum disorder (ASD) caused by mutations in the X-linked MECP2 gene that encodes methyl-CpG binding protein 2 (MeCP2). Symptoms range in severity and include psychomotor disabilities, seizures, ataxia, and intellectual disability. Symptom onset is between 6-18 months of age, a critical period of brain development that is highly energy-dependent. Notably, patients with RTT have evidence of mitochondrial dysfunction, as well as abnormal levels of the adipokines leptin and adiponectin, suggesting overall metabolic imbalance. We hypothesized that one contributor to RTT symptoms is energy deficiency due to defective nutrient substrate utilization by the TCA cycle. This energy deficit would lead to a metabolic imbalance, but would be treatable by providing anaplerotic substrates to the TCA cycle to enhance energy production. We show that dietary therapy with triheptanoin significantly increased longevity and improved motor function and social interaction in male mice hemizygous for Mecp2 knockout. Anaplerotic therapy in Mecp2 knockout mice also improved indicators of impaired substrate utilization, decreased adiposity, increased glucose tolerance and insulin sensitivity, decreased serum leptin and insulin, and improved mitochondrial morphology in skeletal muscle. Untargeted metabolomics of liver and skeletal muscle revealed increases in levels of TCA cycle intermediates with triheptanoin diet, as well as normalizations of glucose and fatty acid biochemical pathways consistent with the improved metabolic phenotype in Mecp2 knockout mice on triheptanoin. These results suggest that an approach using dietary supplementation with anaplerotic substrate is effective in improving symptoms and metabolic health in RTT.	[Park, Min Jung; Aja, Susan; Li, Qun; Degano, Alicia L.; Roe, Charles R.; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21218 USA; [Park, Min Jung; Aja, Susan; Li, Qun; Degano, Alicia L.; Penati, Judith; Zhuo, Justin; Roe, Charles R.; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA; [Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD USA; [Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Degano, Alicia L.] Univ Nacl Cordoba, CIQUIBIC CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina; [Ronnett, Gabriele V.] DGIST, Dept Brain Sci, Taegu, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Aja, S (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21218 USA.	saja1@jhmi.edu		Park, Min Jung/0000-0001-5644-9585; Degano, Alicia/0000-0001-5338-9118	SA; Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center - Korean Ministry of Education, Science, and Technology [10-BD-04]; National Institutes of Health National Institute of Neurological Disorders and Stroke [R01 NS041079]; Agilent Technologies Research [2703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041079] Funding Source: NIH RePORTER	SA; Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center - Korean Ministry of Education, Science, and Technology; National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Agilent Technologies Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Research Collaboration between SA and the Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center, funded by grant #10-BD-04 from Korean Ministry of Education, Science, and Technology; by National Institutes of Health National Institute of Neurological Disorders and Stroke Grant R01 NS041079 to GVR; and by Agilent Technologies Research Gift #2703 to GVR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Blardi P, 2007, J PEDIATR-US, V150, P37, DOI 10.1016/j.jpeds.2006.10.061; Blardi P, 2009, CLIN ENDOCRINOL, V70, P706, DOI 10.1111/j.1365-2265.2008.03386.x; Borges K, 2011, EPILEPSY RES; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Buchovecky CM, 2013, NAT GENET; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; COKER SB, 1991, J CHILD NEUROL, V6, P164, DOI 10.1177/088307389100600216; CORNFORD ME, 1994, J CHILD NEUROL, V9, P424, DOI 10.1177/088307389400900419; De Felice C, 2012, EUR HEART J-CARD IMG, V13, P339, DOI 10.1093/ejechocard/jer256; De Filippis B, 2012, NEUROPSYCHOPHARMACOL, V37, P1152, DOI 10.1038/npp.2011.301; Degano AL, 2014, MOL CELL NEUROSCI, V59, P63, DOI 10.1016/j.mcn.2014.01.005; Degano AL, 2009, MOL CELL NEUROSCI, V42, P243, DOI 10.1016/j.mcn.2009.07.009; Deng S, 2009, J BIOL CHEM, V284, P27799, DOI 10.1074/jbc.M109.048744; Dhar SS, 2009, BBA-MOL CELL RES, V1793, P1604, DOI 10.1016/j.bbamcr.2009.07.001; DOTTI MT, 1993, BRAIN DEV-JPN, V15, P103, DOI 10.1016/0387-7604(93)90045-A; EEGOLOFSSON O, 1990, J CHILD NEUROL, V5, P210, DOI 10.1177/088307389000500311; EEGOLOFSSON O, 1988, BRAIN DEV-JPN, V10, P260, DOI 10.1016/S0387-7604(88)80010-X; EEGOLOFSSON O, 1989, AM J MED GENET, V32, P142, DOI 10.1002/ajmg.1320320131; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Grosser E, 2012, NEUROBIOL DIS, V48, P102, DOI 10.1016/j.nbd.2012.06.007; Gu L, 2010, AM J PHYSIOL-ENDOC M, V298, pE362, DOI 10.1152/ajpendo.00384.2009; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAAS RH, 1986, AM J MED GENET, V24, P225; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Heilstedt HA, 2002, AM J MED GENET, V111, P238, DOI 10.1002/ajmg.10633; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; Johnston Michael V., 2001, Indian Journal of Pediatrics, V68, P423, DOI 10.1007/BF02723021; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kaufmann WE, 2005, BRAIN DEV-JPN, V27, pS77, DOI 10.1016/j.braindev.2004.10.008; Kim TH, 2013, EPILEPSY RES, V103, P101, DOI 10.1016/j.eplepsyres.2012.09.016; Kinman RP, 2006, AM J PHYSIOL-ENDOC M, V291, pE860, DOI 10.1152/ajpendo.00366.2005; KOZINETZ CA, 1993, PEDIATRICS, V91, P445; Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05; Landi S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00045; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Liebhaber GM, 2003, J CHILD NEUROL, V18, P74, DOI 10.1177/08830738030180011801; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; LOPES-CARDOZO M, 1972, Biochimica et Biophysica Acta, V283, P1, DOI 10.1016/0005-2728(72)90092-8; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Mochel F, 2005, MOL GENET METAB, V84, P305, DOI 10.1016/j.ymgme.2004.09.007; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; NOMURA Y, 1984, BRAIN DEV-JPN, V6, P475, DOI 10.1016/S0387-7604(84)80030-3; Nomura Y, 2001, BRAIN DEV-JPN, V23, pS50, DOI 10.1016/S0387-7604(01)00379-5; NOMURA Y, 1992, BRAIN DEV-JPN, V14, pS21; NOSADINI R, 1989, DIABETES METAB REV, V5, P299, DOI 10.1002/dmr.5610050307; OBRIEN RM, 1990, DIABETES CARE, V13, P327, DOI 10.2337/diacare.13.3.327; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Percy AK, 2001, BRAIN DEV-JPN, V23, pS202, DOI 10.1016/S0387-7604(01)00350-3; Pitcher MR, 2013, HUM MOL GENET, V22, P2626, DOI 10.1093/hmg/ddt111; Pratte M, 2011, BEHAV BRAIN RES, V216, P313, DOI 10.1016/j.bbr.2010.08.011; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; RIDGE KD, 1988, P NATL ACAD SCI USA, V85, P9489, DOI 10.1073/pnas.85.24.9489; Roe CR, 2008, NEUROLOGY, V71, P260, DOI 10.1212/01.wnl.0000318283.42961.e9; Roe CR, 2007, MOL GENET METAB, V92, P346, DOI 10.1016/j.ymgme.2007.07.012; Roe CR, 2006, J INHERIT METAB DIS, V29, P332, DOI 10.1007/s10545-006-0290-3; Roe CR, 2010, MOL GENET METAB, V101, P246, DOI 10.1016/j.ymgme.2010.06.017; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; RUCH A, 1989, PEDIATR NEUROL, V5, P320, DOI 10.1016/0887-8994(89)90027-1; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Segawa M, 2001, BRAIN DEV-JPN, V23, pS94, DOI 10.1016/S0387-7604(01)00352-7; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Sirikul B, 2006, AM J PHYSIOL-ENDOC M, V291, pE724, DOI 10.1152/ajpendo.00364.2005; Valenti D., 2014, NEUROSCI BIOBEHAV RE; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Willis S, 2010, NEUROBIOL DIS, V40, P565, DOI 10.1016/j.nbd.2010.07.017; Yamada T, 2010, AM J PHYSIOL-ENDOC M, V299, pE364, DOI 10.1152/ajpendo.00142.2010; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005; ZIMMER DB, 1990, J HISTOCHEM CYTOCHEM, V38, P171, DOI 10.1177/38.2.1688895	82	42	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109527	10.1371/journal.pone.0109527	http://dx.doi.org/10.1371/journal.pone.0109527			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299635	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200056
J	Pastore, F; Greif, PA; Schneider, S; Ksienzyk, B; Mellert, G; Zellmeier, E; Braess, J; Sauerland, CM; Heinecke, A; Krug, U; Berdel, WE; Buechner, T; Woermann, B; Hiddemann, W; Spiekermann, K				Pastore, Friederike; Greif, Philipp A.; Schneider, Stephanie; Ksienzyk, Bianka; Mellert, Gudrun; Zellmeier, Evelyn; Braess, Jan; Sauerland, Cristina M.; Heinecke, Achim; Krug, Utz; Berdel, Wolfgang E.; Buechner, Thomas; Woermann, Bernhard; Hiddemann, Wolfgang; Spiekermann, Karsten			The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; NORMAL KARYOTYPE; GENE-MUTATIONS; FAVORABLE PROGNOSIS; NUCLEOPHOSMIN; SUBTYPE	NPM1 mutations represent frequent genetic alterations in patients with acute myeloid leukemia (AML) associated with a favorable prognosis. Different types of NPM1 mutations have been described. The purpose of our study was to evaluate the relevance of different NPM1 mutation types with regard to clinical outcome. Our analyses were based on 349 NPM1-mutated AML patients treated in the AMLCG99 trial. Complete remission rates, overall survival and relapse-free survival were not significantly different between patients with NPM1 type A or rare type mutations. The NPM1 mutation type does not seem to play a role in risk stratification of cytogenetically normal AML.	[Pastore, Friederike; Greif, Philipp A.; Schneider, Stephanie; Ksienzyk, Bianka; Mellert, Gudrun; Zellmeier, Evelyn; Hiddemann, Wolfgang; Spiekermann, Karsten] LMU, Univ Hosp Munich Grosshadern, Dept Internal Med 3, Lab Leukemia Diagnost, Munich, Germany; [Pastore, Friederike; Greif, Philipp A.; Hiddemann, Wolfgang; Spiekermann, Karsten] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Pathogenesis Acute Myeloid Leuk, Munich, Germany; [Pastore, Friederike; Greif, Philipp A.; Hiddemann, Wolfgang; Spiekermann, Karsten] German Canc Consortium DKTK, Heidelberg, Germany; [Pastore, Friederike; Greif, Philipp A.; Hiddemann, Wolfgang; Spiekermann, Karsten] German Canc Res Ctr, Heidelberg, Germany; [Braess, Jan] Krankenhaus Barmherzige Bruder, Dept Hematol & Oncol, Regensburg, Germany; [Sauerland, Cristina M.; Heinecke, Achim] Univ Munster, Inst Biostat & Clin Res, Munster, Germany; [Krug, Utz; Berdel, Wolfgang E.; Buechner, Thomas] Univ Munster, Dept Internal Med A, Munster, Germany; [Woermann, Bernhard] German Soc Hematol & Oncol, Berlin, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Munster; University of Munster	Pastore, F (corresponding author), LMU, Univ Hosp Munich Grosshadern, Dept Internal Med 3, Lab Leukemia Diagnost, Munich, Germany.	Friederike.Pastore@med.uni-muenchen.de	Sauerland, Maria Cristina/A-4154-2014	Greif, Philipp/0000-0002-3744-7936				Alpermann T, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.51.51; Benthaus T, 2008, BRIT J HAEMATOL, V143, P230, DOI 10.1111/j.1365-2141.2008.07328.x; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Dufour A, 2010, J CLIN ONCOL, V28, P570, DOI 10.1200/JCO.2008.21.6010; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Koh Y, 2009, INT J HEMATOL, V90, P1, DOI 10.1007/s12185-009-0350-1; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schneider F, 2012, BLOOD, V119, P4383, DOI 10.1182/blood-2010-12-327072; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; SHAFFER LG, 2013, ISCN 2013 INT SYSTEM, P140; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326	15	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109759	10.1371/journal.pone.0109759	http://dx.doi.org/10.1371/journal.pone.0109759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299584	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200071
J	Soonsawad, P; Paavolainen, L; Upla, P; Weerachatyanukul, W; Rintanen, N; Espinoza, J; McNerney, G; Marjomaki, V; Cheng, RH				Soonsawad, Pan; Paavolainen, Lassi; Upla, Paula; Weerachatyanukul, Wattana; Rintanen, Nina; Espinoza, Juan; McNerney, Gregory; Marjomaki, Varpu; Cheng, R. Holland			Permeability Changes of Integrin-Containing Multivesicular Structures Triggered by Picornavirus Entry	PLOS ONE			English	Article							CALPAIN; REPLICATION; ECHOVIRUS-1; ACTIVATION; REQUIRES; RAFTS	Cellular uptake of clustered alpha 2 beta 1-integrin induces the formation of membrane compartments that subsequently mature into a multivesicular body (MVB). Enhanced internalization mediated by clustered integrins was observed upon infection by the picornavirus echovirus 1 (EVI). We elucidated the structural features of virus-induced MVBs (vMVBs) in comparison to antibody-induced control MVBs (mock infection) by means of high-pressure cryo fixation of cells followed by immuno electron tomography during early entry of the virus. Three-dimensional tomograms revealed a marked increase in the size and complexity of these vMVBs and the intraluminal vesicles (ILVs) at 2 and 3.5 hours post infection (p.i.), in contrast to the control MVBs without virus. Breakages in the membranes of vMVBs were detected from tomograms after 2 and especially after 3.5 h suggesting that these breakages could facilitate the genome release to the cytoplasm. The in situ neutral-red labeling of viral genome showed that virus uncoating starts as early as 30 min p.i., while an increase of permeability was detected in the vMVBs between 1 and 3 hours p.i., based on a confocal microscopy assay. Altogether, the data show marked morphological changes in size and permeability of the endosomes in the infectious entry pathway of this non-enveloped enterovirus and suggest that the formed breakages facilitate the transfer of the genome to the cytoplasm for replication.	[Soonsawad, Pan; Weerachatyanukul, Wattana; Espinoza, Juan; McNerney, Gregory; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Paavolainen, Lassi; Upla, Paula; Rintanen, Nina; McNerney, Gregory; Marjomaki, Varpu] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm, Jyvaskyla, Finland; [Soonsawad, Pan; Weerachatyanukul, Wattana] Mahidol Univ, Fac Dent, Dept Anat, Bangkok 10700, Thailand	University of California System; University of California Davis; University of Jyvaskyla; Mahidol University	Cheng, RH (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	rhch@ucdavis.edu	Cheng, Holland/A-8973-2008	Marjomaki, Varpu/0000-0002-4592-5926	National Institutes of Health [AI095382]; Academy of Finland; Tekes FiDiPro [1913/31/2012]; Discovery Grant [UCDG178969]; NSF fellowship; Thailand Commission of Higher Education scholarship; Thailand Research Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Tekes FiDiPro(Finnish Funding Agency for Technology & Innovation (TEKES)); Discovery Grant; NSF fellowship(National Science Foundation (NSF)); Thailand Commission of Higher Education scholarship; Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by National Institutes of Health (AI095382) http://www.nih.gov/, Academy of Finland http://www.aka.fi/en-gb/a/, Tekes FiDiPro, (1913/31/2012) http://www.tekes.fi/en/fidipro/, Discovery Grant (UCDG178969), NSF fellowship for doctoral dissertation enhancement program (G.M.), Thailand Commission of Higher Education scholarship and Thailand Research Fund (P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabec M, 2005, J VIROL, V79, P1008, DOI 10.1128/JVI.79.2.1008-1016.2005; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Debiasi RL, 1999, J VIROL, V73, P695, DOI 10.1128/JVI.73.1.695-701.1999; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; Kalamvoki M, 2004, J VIROL, V78, P11865, DOI 10.1128/JVI.78.21.11865-11878.2004; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Karjalainen M, 2011, CELL MICROBIOL, V13, P1975, DOI 10.1111/j.1462-5822.2011.01685.x; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070; Rintanen N, 2012, MOL BIOL CELL, V23, P448, DOI 10.1091/mbc.E11-06-0548; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Soonsawad P, 2010, J VIROL, V84, P11145, DOI 10.1128/JVI.00036-10; Teranishi F, 2003, BIOCHEM BIOPH RES CO, V303, P940, DOI 10.1016/S0006-291X(03)00447-9; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Upla P, 2008, J VIROL, V82, P1581, DOI 10.1128/JVI.01375-07; Urata S, 2006, J VIROL, V80, P4191, DOI 10.1128/JVI.80.8.4191-4195.2006; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108948	10.1371/journal.pone.0108948	http://dx.doi.org/10.1371/journal.pone.0108948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299706	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200025
J	Houben, T; Coomans, CP; Meijer, JH				Houben, Thijs; Coomans, Claudia P.; Meijer, Johanna H.			Regulation of Circadian and Acute Activity Levels by the Murine Suprachiasmatic Nuclei	PLOS ONE			English	Article							REST-ACTIVITY RHYTHM; SLEEP-PHASE SYNDROME; IN-VIVO; ELECTRICAL-ACTIVITY; FUNCTIONAL-ANALYSIS; PERIPHERAL-TISSUES; LOCOMOTOR-ACTIVITY; PACEMAKER NEURONS; NOCTURNAL RODENTS; CELL AUTONOMY	The suprachiasmatic nuclei (SCN) coordinate the daily sleep-wake cycle by generating a circadian rhythm in electrical impulse frequency. While period and phase of the SCN rhythm have been considered as major output parameters, we propose that the waveform of the rhythm of the SCN also has significance. Using implanted micro-electrodes, we recorded SCN impulse frequency in freely moving mice and manipulated its circadian waveform by exposing mice to light-dark (LD) cycle durations ranging from 22 hours (LD 11:11) to 26 hours (LD 13:13). Adaptation to long T-cycles (>24 h) resulted in a trough in electrical activity at the beginning of the night while in short T-cycles (<24 h), SCN activity reached a trough at the end of night. In all T-cycle durations, the intensity of behavioral activity was maximal during the trough of SCN electrical activity and correlated negatively with increasing levels of SCN activity. Interestingly, small changes in T-cycle duration could induce large changes in waveform and in the time of trough (about 3.5 h), and accordingly in the timing of behavioral activity. At a smaller timescale (minutes to hours), we observed a negative correlation between SCN activity and behavioral activity, and acute silencing of SCN neurons by tetrodotoxin (TTX) during the inactive phase of the animal triggered behavioral activity. Thus, the SCN electrical activity levels appear crucially involved in determining the temporal profile of behavioral activity and controls behavior beyond the circadian time domain.	[Houben, Thijs; Coomans, Claudia P.; Meijer, Johanna H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Meijer, JH (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands.	J.H.Meijer@lumc.nl	Coomans, Claudia/A-4458-2013	Coomans, Claudia/0000-0003-0883-458X	European Commission [018741]; Netherlands Organization for Scientific Research [818.02.016]	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by the European Commission (http://europa.eu) grant EUCLOCK to JHM (no. 018741) and by the Netherlands Organization for Scientific Research (http://www.nwo.nl/en), TOPGO grant to JHM (no. 818.02.016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2006, MOL CELL ENDOCRINOL, V252, P46, DOI 10.1016/j.mce.2006.03.036; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Granada AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059464; Houben T, 2009, J BIOL RHYTHM, V24, P477, DOI 10.1177/0748730409349895; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2008, J BIOL RHYTHM, V23, P265, DOI 10.1177/0748730408316166; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kalsbeek A, 2000, EUR J NEUROSCI, V12, P3146, DOI 10.1046/j.1460-9568.2000.00202.x; Kalsbeek A, 1996, J NEUROENDOCRINOL, V8, P299, DOI 10.1046/j.1365-2826.1996.04597.x; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Lee CH, 2008, CHANNELS, V2, P407, DOI 10.4161/chan.2.6.7429; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Molyneux PC, 2008, BRAIN RES, V1228, P127, DOI 10.1016/j.brainres.2008.05.091; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakamura W, 2008, CURR BIOL, V18, P381, DOI 10.1016/j.cub.2008.02.024; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Oosterman JM, 2009, J SLEEP RES, V18, P129, DOI 10.1111/j.1365-2869.2008.00704.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Perreau-Lenz S, 2004, EUR J NEUROSCI, V19, P318, DOI 10.1111/j.0953-816X.2003.03132.x; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Todd WD, 2012, J COMP NEUROL, V520, P3277, DOI 10.1002/cne.23098; Tribukait B, 1956, J COMP PHYSIOL A, V38, P479; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	46	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110172	10.1371/journal.pone.0110172	http://dx.doi.org/10.1371/journal.pone.0110172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295522	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000117
J	Kwon, J; Ogawa, K; Miyake, Y				Kwon, Jinhwan; Ogawa, Ken-ichiro; Miyake, Yoshihiro			The Effect of Visual Apparent Motion on Audiovisual Simultaneity	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENTS; TIME PERCEPTION; SENSORY MODALITY; SHORT-RANGE; PRIOR ENTRY; ATTENTION; VENTRILOQUISM; MOVEMENT; STIMULI; INFORMATION	Visual motion information from dynamic environments is important in multisensory temporal perception. However, it is unclear how visual motion information influences the integration of multisensory temporal perceptions. We investigated whether visual apparent motion affects audiovisual temporal perception. Visual apparent motion is a phenomenon in which two flashes presented in sequence in different positions are perceived as continuous motion. Across three experiments, participants performed temporal order judgment (TOJ) tasks. Experiment 1 was a TOJ task conducted in order to assess audiovisual simultaneity during perception of apparent motion. The results showed that the point of subjective simultaneity (PSS) was shifted toward a sound - lead stimulus, and the just noticeable difference (JND) was reduced compared with a normal TOJ task with a single flash. This indicates that visual apparent motion affects audiovisual simultaneity and improves temporal discrimination in audiovisual processing. Experiment 2 was a TOJ task conducted in order to remove the influence of the amount of flash stimulation from Experiment 1. The PSS and JND during perception of apparent motion were almost identical to those in Experiment 1, but differed from those for successive perception when long temporal intervals were included between two flashes without motion. This showed that the result obtained under the apparent motion condition was unaffected by the amount of flash stimulation. Because apparent motion was produced by a constant interval between two flashes, the results may be accounted for by specific prediction. In Experiment 3, we eliminated the influence of prediction by randomizing the intervals between the two flashes. However, the PSS and JND did not differ from those in Experiment 1. It became clear that the results obtained for the perception of visual apparent motion were not attributable to prediction. Our findings suggest that visual apparent motion changes temporal simultaneity perception and improves temporal discrimination in audiovisual processing.	[Kwon, Jinhwan; Ogawa, Ken-ichiro; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology	Kwon, J (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	kwon@myk.dis.titech.ac.jp						Allik J, 1998, PSYCHOL SCI, V9, P135, DOI 10.1111/1467-9280.00025; ANSTIS SM, 1980, PHILOS T ROY SOC B, V290, P153, DOI 10.1098/rstb.1980.0088; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; BRIGGS RM, 1972, J EXP PSYCHOL, V92, P83, DOI 10.1037/h0032148; Busse L, 2008, P NATL ACAD SCI USA, V105, P16380, DOI 10.1073/pnas.0707369105; Coull JT, 1998, J NEUROSCI, V18, P7426; DAWSON MRW, 1991, PSYCHOL REV, V98, P569, DOI 10.1037/0033-295X.98.4.569; DUNCAN J, 1980, COGNITIVE PSYCHOL, V12, P75, DOI 10.1016/0010-0285(80)90004-3; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Finney DJ, 1952, PROBIT ANAL STAT TRE; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; Getzmann S, 2007, PERCEPTION, V36, P1089, DOI 10.1068/p5741; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; GROSSBERG S, 1992, PSYCHOL REV, V99, P78, DOI 10.1037/0033-295X.99.1.78; Harrar V, 2008, PERCEPT PSYCHOPHYS, V70, P807, DOI 10.3758/PP.70.5.807; HIKOSAKA O, 1993, VISION RES, V33, P1219, DOI 10.1016/0042-6989(93)90210-N; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jaskoski P, 2000, CONSCIOUS COGN, V9, P435, DOI 10.1006/ccog.2000.0461; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kanabus M, 2002, ACTA NEUROBIOL EXP, V62, P263; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Keetels M, 2005, EXP BRAIN RES, V167, P635, DOI 10.1007/s00221-005-0067-1; KLEIN RM, 1977, J EXP PSYCHOL HUMAN, V3, P365, DOI 10.1037/0096-1523.3.3.365; LARSEN A, 1983, PSYCHOL RES-PSYCH FO, V45, P11, DOI 10.1007/BF00309348; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Mattes S, 1998, PERCEPT PSYCHOPHYS, V60, P1305, DOI 10.3758/BF03207993; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Petrini K, 2009, COGNITION, V110, P432, DOI 10.1016/j.cognition.2008.11.015; Poppel E., 1988, MINDWORKS TIME CONSC; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; RAMACHANDRAN VS, 1986, SCI AM, V254, P102, DOI 10.1038/scientificamerican0686-102; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P389, DOI 10.3758/BF03211906; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; STRYBEL TZ, 1990, PERCEPT PSYCHOPHYS, V47, P439, DOI 10.3758/BF03208177; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; WATSON AB, 1986, J OPT SOC AM A, V3, P300, DOI 10.1364/JOSAA.3.000300; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	54	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110224	10.1371/journal.pone.0110224	http://dx.doi.org/10.1371/journal.pone.0110224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25295594	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000118
J	Lu, Y; Wu, ZT; Peng, QL; Ma, LP; Zhang, XL; Zhao, JY; Qin, X; Li, S				Lu, Yu; Wu, Zhitong; Peng, Qiliu; Ma, Liping; Zhang, Xiaolian; Zhao, Jiangyang; Qin, Xue; Li, Shan			Role of IL-4 Gene Polymorphisms in HBV-Related Hepatocellular Carcinoma in a Chinese Population	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; INTERLEUKIN-4 GENE; ASSOCIATION; RECEPTOR; CYTOKINES; SUSCEPTIBILITY; INFECTION; RISK; INFLAMMATION; ACTIVATION	Background: Interleukin-4 (IL-4) is best known as an important mediator and modulator of immune and inflammatory responses. Hepatocellular carcinoma (HCC) is a typical inflammation-related cancer, and genetic variations in the IL-4 gene may be associated with the risk of hepatitis B virus (HBV)-related HCC. However, few studies have been conducted on their association. Objectives: To clarify the effects of IL-4 gene polymorphisms on the risk of HBV-related HCC, two common variants, -590C/T (rs2243250) and -33C/T (rs2070874), and their relationship with HBV-related disease risk were investigated in a Chinese population. Methods: IL-4 -590C/T and -33C/T polymorphisms were examined in 154 patients with HBV-related HCC, 62 patients with HBV-induced liver cirrhosis (LC), 129 patients with chronic hepatitis B (CHB), and 94 healthy controls, using the polymerase chain reaction-restriction fragment length polymorphism method and DNA sequencing. Results: Overall, no significant differences were observed regarding the IL-4 -590C/T and -33C/T polymorphism genotypes, alleles, or haplotypes between the patient groups and the healthy controls. However, the CC genotypes of IL-4 -590C/T and -33C/T polymorphisms were observed to be significantly associated with CHB in subgroup analysis in males [CC versus TT (OR: 4.193, 95% CI: 1.094-16.071, P = 0.037; and OR: 3.438, 95% CI: 1.032-11.458, P = 0.044) and CC versus TT+ CT (OR: 4.09, 95% CI: 1.08-15.49, P = 0.038; and OR: 3.43, 95% CI: 1.04-11.28, P = 0.042)]. Conclusions: These findings suggest that genetic variants in IL-4 -590C/T and -33C/T polymorphisms may be a risk factor for CHB in Chinese males but not for HBV-related LC or HCC.	[Lu, Yu; Peng, Qiliu; Ma, Liping; Zhang, Xiaolian; Zhao, Jiangyang; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Wu, Zhitong] Guigang Peoples Hosp, Dept Clin Lab, Guigang, Guangxi, Peoples R China	Guangxi Medical University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com			National Natural Science Foundation of China [81260302]; Youth Science Foundation of Guangxi Medical University [GXMUYSF201334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Guangxi Medical University	This research was supported by National Natural Science Foundation of China (No. 81260302) and Youth Science Foundation of Guangxi Medical University (GXMUYSF201334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 2004, HEPATOLOGY, V39, P1430, DOI 10.1002/hep.20205; Capece D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187204; Chemin I, 2009, CANCER LETT, V286, P52, DOI 10.1016/j.canlet.2008.12.003; Chen LP, 2012, EUR J CANCER, V48, P1977, DOI 10.1016/j.ejca.2012.01.015; Chen TY, 2007, TRANSL RES, V150, P116, DOI 10.1016/j.trsl.2007.01.007; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Cui W, 2013, GENE, V525, P35, DOI 10.1016/j.gene.2013.04.065; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; Gao QJ, 2009, WORLD J GASTROENTERO, V15, P5610, DOI 10.3748/wjg.15.5610; Gao QJ, 2012, MED PHARM J CLIN PEO, V24, P8; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Han YF, 2011, WORLD J GASTROENTERO, V17, P4258, DOI 10.3748/wjg.v17.i38.4258; Iseki M, 2012, INT IMMUNOL, V24, P183, DOI 10.1093/intimm/dxr113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kelly-Welch Ann, 2005, Sci STKE, V2005, pcm8, DOI 10.1126/stke.2932005cm8; Landi S, 2007, EUR J CANCER, V43, P762, DOI 10.1016/j.ejca.2006.10.024; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu Q, 2007, CHIN J INTEGR TRADIT, V17, P211; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Naslednikova IO, 2007, B EXP BIOL MED+, V143, P706, DOI 10.1007/s10517-007-0220-x; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nieters A, 2005, CANCER, V103, P740, DOI 10.1002/cncr.20842; Ognjanovic S, 2009, CARCINOGENESIS, V30, P758, DOI 10.1093/carcin/bgn286; Peng QL, 2013, INFECT GENET EVOL, V16, P1, DOI 10.1016/j.meegid.2013.01.015; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Puthothu B, 2006, J INFECT DIS, V193, P438, DOI 10.1086/499316; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suppiah V, 2005, INT J IMMUNOGENET, V32, P383, DOI 10.1111/j.1744-313X.2005.00542.x; Takabayashi A, 1999, J HUM GENET, V44, P352, DOI 10.1007/s100380050176; Tang Z Y YQ, 2009, STROKE NEVOUS DIS, V16, P11; Tsai MH, 2005, J CLIN LAB ANAL, V19, P93, DOI 10.1002/jcla.20060; Wang K, 2006, CHIN J CURR ADV GEN, V9, P171; Wierenga EA, 2000, AM J RESP CRIT CARE, V162, pS81, DOI 10.1164/ajrccm.162.supplement_2.ras-5; Wu MC, 2003, LUPUS, V12, P21, DOI 10.1191/0961203303lu249oa; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018; Zeng Z, 2014, WORLD J GASTROENTERO, V20, P7696, DOI 10.3748/wjg.v20.i24.7696; Zheng Z, 2013, DNA CELL BIOL, V32, P443, DOI 10.1089/dna.2013.2020; Zhu QR, 2005, CHINESE MED J-PEKING, V118, P1604	51	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110061	10.1371/journal.pone.0110061	http://dx.doi.org/10.1371/journal.pone.0110061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295591	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000111
J	Sei, JJ; Ochoa, AS; Bishop, E; Barlow, JW; Golde, WT				Sei, Janet J.; Ochoa, Amanda S.; Bishop, Elizabeth; Barlow, John W.; Golde, William T.			Phenotypic, Ultra-Structural, and Functional Characterization of Bovine Peripheral Blood Dendritic Cell Subsets	PLOS ONE			English	Article							INTERFERON-PRODUCING-CELLS; MONOCLONAL-ANTIBODY NLDC-145; TOLL-LIKE RECEPTORS; AFFERENT LYMPH; CROSS-PRESENTATION; CD8 EXPRESSION; MOUSE THYMUS; I INTERFERON; IFN-ALPHA; T-CELLS	Dendritic cells (DC) are multi-functional cells that bridge the gap between innate and adaptive immune systems. In bovine, significant information is lacking on the precise identity and role of peripheral blood DC subsets. In this study, we identify and characterize bovine peripheral blood DC subsets directly ex vivo, without further in vitro manipulation. Multi-color flow cytometric analysis revealed that three DC subsets could be identified. Bovine plasmacytoid DC were phenotypically identified by a unique pattern of cell surface protein expression including CD4, exhibited an extensive endoplasmic reticulum and Golgi apparatus, efficiently internalized and degraded exogenous antigen, and were the only peripheral blood cells specialized in the production of type I IFN following activation with Toll-like receptor (TLR) agonists. Conventional DC were identified by expression of a different pattern of cell surface proteins including CD11c, MHC class II, and CD80, among others, the display of extensive dendritic protrusions on their plasma membrane, expression of very high levels of MHC class II and co-stimulatory molecules, efficient internalization and degradation of exogenous antigen, and ready production of detectable levels of TNF-alpha in response to TLR activation. Our investigations also revealed a third novel DC subset that may be a precursor of conventional DC that were MHC class II+ and CD11c(-). These cells exhibited a smooth plasma membrane with a rounded nucleus, produced TNF-alpha in response to TLR-activation (albeit lower than CD11C(+) DC), and were the least efficient in internalization/degradation of exogenous antigen. These studies define three bovine blood DC subsets with distinct phenotypic and functional characteristics which can be analyzed during immune responses to pathogens and vaccinations of cattle.	[Sei, Janet J.; Bishop, Elizabeth; Golde, William T.] USDA ARS, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA; [Sei, Janet J.; Ochoa, Amanda S.; Barlow, John W.] Univ Vermont, Dept Anim Sci, Burlington, VT 05405 USA	United States Department of Agriculture (USDA); University of Vermont	Golde, WT (corresponding author), USDA ARS, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA.	william.golde@ars.usda.gov	Barlow, John W/C-4876-2013	Barlow, John W/0000-0002-7815-9383	United States Department of Agriculture (USDA), Agricultural Research Service [CRIS 1940-32000-057-00D]; National Science Foundation under the BREAD program [0965346]	United States Department of Agriculture (USDA), Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation under the BREAD program	This work was funded by the United States Department of Agriculture (USDA), Agricultural Research Service under CRIS 1940-32000-057-00D (WTG). This work was also funded in part by the National Science Foundation grant #0965346, under the BREAD program (JWB, WTG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Artz J, 2014, VIROLOGY, V452-453, P12; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bajer AA, 2003, J LEUKOCYTE BIOL, V73, P100, DOI 10.1189/jlb.0302128; Balmelli C, 2005, EUR J IMMUNOL, V35, P2406, DOI 10.1002/eji.200525998; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Bautista EM, 2007, VET IMMUNOL IMMUNOP, V115, P56, DOI 10.1016/j.vetimm.2006.09.010; Bautista EM, 2002, VET IMMUNOL IMMUNOP, V88, P131, DOI 10.1016/S0165-2427(02)00152-6; Brooke GP, 1998, EUR J IMMUNOL, V28, P1, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;1::AID-IMMU1&gt;3.0.CO;2-V; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; FITZGERALDBOCARSLY P, 1993, PHARMACOL THERAPEUT, V60, P39, DOI 10.1016/0163-7258(93)90021-5; Franchini M, 2006, VET IMMUNOL IMMUNOP, V110, P37, DOI 10.1016/j.vetimm.2005.09.002; Fray MD, 2001, J IMMUNOL METHODS, V249, P235, DOI 10.1016/S0022-1759(00)00359-8; Gibson A, 2012, DEV COMP IMMUNOL, V36, P332, DOI 10.1016/j.dci.2011.05.002; Gliddon DR, 2004, IMMUNOLOGY, V111, P262, DOI 10.1111/j.0019-2805.2004.01820.x; Griebel PJ, 2005, VET IMMUNOL IMMUNOP, V108, P11, DOI 10.1016/j.vetimm.2005.07.012; Guzylack-Piriou L, 2004, IMMUNOLOGY, V112, P28, DOI 10.1111/j.1365-2567.2004.01856.x; Guzylack-Piriou L, 2006, EUR J IMMUNOL, V36, P1674, DOI 10.1002/eji.200635866; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heller MC, 2012, VET IMMUNOL IMMUNOP, V149, P255, DOI 10.1016/j.vetimm.2012.07.006; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hope JC, 2006, NAT PROTOC, V1, P982, DOI 10.1038/nprot.2006.125; Hope JC, 2001, J LEUKOCYTE BIOL, V69, P271; Howard CJ, 1997, J IMMUNOL, V159, P5372; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kalady MF, 2004, J SURG RES, V116, P24, DOI 10.1016/j.jss.2003.09.003; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kohrgruber N, 1999, J IMMUNOL, V163, P3250; Lahoud MH, 2012, P NATL ACAD SCI USA, V109, P16270, DOI 10.1073/pnas.1208796109; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Lee SR, 2008, COMP IMMUNOL MICROB, V31, P403, DOI 10.1016/j.cimid.2007.06.006; Lorenzi S, 2011, J IMMUNOL, V186, P5142, DOI 10.4049/jimmunol.1004163; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McCurley N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011949; MCKEEVER DJ, 1991, J IMMUNOL, V147, P3703; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Megjugorac NJ, 2004, J LEUKOCYTE BIOL, V75, P504, DOI 10.1189/jlb.0603291; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mirkovitch J, 2006, VET IMMUNOL IMMUNOP, V114, P1, DOI 10.1016/j.vetimm.2006.06.004; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Miyazawa K, 2006, RES VET SCI, V81, P40, DOI 10.1016/j.rvsc.2005.09.003; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Nfon CK, 2010, VIRAL IMMUNOL, V23, P29, DOI 10.1089/vim.2009.0078; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Osugi Y, 2002, BLOOD, V100, P2858, DOI 10.1182/blood.V100.8.2858; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pinchuk LM, 2003, COMP IMMUNOL MICROB, V26, P233, DOI 10.1016/S0147-9571(02)00061-9; Reid E, 2011, J VIROL, V85, P4297, DOI 10.1128/JVI.02495-10; Renjifo X, 1997, VET IMMUNOL IMMUNOP, V60, P77, DOI 10.1016/S0165-2427(97)00092-5; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SIMMONS D, 1988, NATURE, V333, P568, DOI 10.1038/333568a0; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Steinman RM, 2006, NOVART FDN SYMP, V279, P216, DOI [10.1002/9780470035399, DOI 10.1002/9780470035399, DOI 10.1002/9780470035399.CH9]; Stephens SA, 2003, IMMUNOLOGY, V110, P48, DOI 10.1046/j.1365-2567.2003.01712.x; Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x; SWIGGARD WJ, 1995, CELL IMMUNOL, V165, P302, DOI 10.1006/cimm.1995.1218; Tel J, 2011, EUR J IMMUNOL, V41, P1014, DOI 10.1002/eji.201040790; THOMAS R, 1993, J IMMUNOL, V151, P6840; THOMAS R, 1994, J IMMUNOL, V153, P4016; Toka FN, 2011, J IMMUNOL, V186, P4853, DOI 10.4049/jimmunol.1003599; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Vremec D, 1997, J IMMUNOL, V159, P565; Werling D, 2002, J LEUKOCYTE BIOL, V72, P297; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513	74	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109273	10.1371/journal.pone.0109273	http://dx.doi.org/10.1371/journal.pone.0109273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295753	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204000056
J	Nakamura, K; Islam, MR; Takayanagi, M; Yasumuro, H; Inami, W; Kunahong, A; Casco-Robles, RM; Toyama, F; Chiba, C				Nakamura, Kenta; Islam, Md. Rafiqul; Takayanagi, Miyako; Yasumuro, Hirofumi; Inami, Wataru; Kunahong, Ailidana; Casco-Robles, Roman M.; Toyama, Fubito; Chiba, Chikafumi			A Transcriptome for the Study of Early Processes of Retinal Regeneration in the Adult Newt, Cynops pyrrhogaster	PLOS ONE			English	Article							PIGMENT EPITHELIUM-CELLS; RNA-BINDING PROTEIN; MEK-ERK; EXPRESSION; MUSASHI-1; INDUCTION; URODELA	Retinal regeneration in the adult newt is a useful system to uncover essential mechanisms underlying the regeneration of body parts of this animal as well as to find clues to treat retinal disorders such as proliferative vitreoretinopathy. Here, to facilitate the study of early processes of retinal regeneration, we provide a de novo assembly transcriptome and inferred proteome of the Japanese fire bellied newt (Cynops pyrrhogaster), which was obtained from eyeball samples of day 0-14 after surgical removal of the lens and neural retina. This transcriptome (237,120 in silico transcripts) contains most information of cDNAs/ESTs which has been reported in newts (C. pyrrhogaster, Pleurodeles waltl and Notophthalmus viridescence) thus far. On the other hand, de novo assembly transcriptomes reported lately for N. viridescence only covered 16-31% of this transcriptome, suggesting that most constituents of this transcriptome are specific to the regenerating eye tissues of C. pyrrhogaster. A total of 87,102 in silico transcripts of this transcriptome were functionally annotated. Coding sequence prediction in combination with functional annotation revealed that 76,968 in silico transcripts encode protein/ peptides recorded in public databases so far, whereas 17,316 might be unique. qPCR and Sanger sequencing demonstrated that this transcriptome contains much information pertaining to genes that are regulated in association with cell reprogramming, cell-cycle re-entry/proliferation, and tissue patterning in an early phase of retinal regeneration. This data also provides important insight for further investigations addressing cellular mechanisms and molecular networks underlying retinal regeneration as well as differences between retinal regeneration and disorders. This transcriptome can be applied to ensuing comprehensive gene screening steps, providing candidate genes, regardless of whether annotated or unique, to uncover essential mechanisms underlying early processes of retinal regeneration.	[Islam, Md. Rafiqul; Takayanagi, Miyako; Yasumuro, Hirofumi; Inami, Wataru; Kunahong, Ailidana; Casco-Robles, Roman M.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Kenta; Chiba, Chikafumi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Toyama, Fubito] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 321, Japan	University of Tsukuba; University of Tsukuba; Utsunomiya University	Toyama, F (corresponding author), Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 321, Japan.	fubito@is.utsunomiya-u.ac.jp; chichiba@biol.tsukuba.ac.jp	Chiba, Chikafumi/GWV-8167-2022		Ministry of Education, Culture, Sports, Science and Technology [23124502, 221S0002]; Japan Society for the Promotion of Science [24650229, 25870096, 21300150, 24240062]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (23124502; 221S0002) and the Japan Society for the Promotion of Science (24650229; 25870096; 21300150; 24240062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullayev I, 2013, EXP CELL RES, V319, P1187, DOI 10.1016/j.yexcr.2013.02.013; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Casco-Robles MM, 2011, NAT PROTOC, V6, P600, DOI 10.1038/nprot.2011.334; Chiba C, 2006, J COMP NEUROL, V495, P391, DOI 10.1002/cne.20880; Chiba Chakafumi, 2007, P15; Chiba C, 2014, EXP EYE RES, V123, P107, DOI 10.1016/j.exer.2013.07.009; Eguchi G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1389; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Islam MR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06043; Kaneko J, 2009, NEUROSCI LETT, V450, P252, DOI 10.1016/j.neulet.2008.11.031; Litvinchuk SN, 2007, GENOME, V50, P333, DOI 10.1139/G07-010; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mizuno A, 2012, NEUROSCI LETT, V523, P39, DOI 10.1016/j.neulet.2012.06.037; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Susaki K, 2007, PIGM CELL RES, V20, P364, DOI 10.1111/j.1600-0749.2007.00407.x; Susaki K, 2009, EXP EYE RES, V88, P347, DOI 10.1016/j.exer.2008.06.019; Tominaga A, 2013, MOL PHYLOGENET EVOL, V66, P654, DOI 10.1016/j.ympev.2012.10.015; Tsonis PA, 2011, NAT PROTOC, V6, P593, DOI 10.1038/nprot.2011.341; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshikawa T, 2012, PIGM CELL MELANOMA R, V25, P66, DOI 10.1111/j.1755-148X.2011.00935.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	30	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109831	10.1371/journal.pone.0109831	http://dx.doi.org/10.1371/journal.pone.0109831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290450	gold, Green Published, Green Submitted			2022-12-27	WOS:000342798000093
J	Seridi, L; Ryu, T; Ravasi, T				Seridi, Loqmane; Ryu, Taewoo; Ravasi, Timothy			Dynamic Epigenetic Control of Highly Conserved Noncoding Elements	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; GENOMIC REGULATORY BLOCKS; ULTRACONSERVED ELEMENTS; DROSOPHILA-MELANOGASTER; ARABIDOPSIS-THALIANA; REPLICATION ORIGINS; GENUS DROSOPHILA; HISTONE H3.3; GENES; BINDING	Background: Many noncoding genomic loci have remained constant over long evolutionary periods, suggesting that they are exposed to strong selective pressures. The molecular functions of these elements have been partially elucidated, but the fundamental reason for their extreme conservation is still unknown. Results: To gain new insights into the extreme selection of highly conserved noncoding elements (HCNEs), we used a systematic analysis of multi-omic data to study the epigenetic regulation of such elements during the development of Drosophila melanogaster. At the sequence level, HCNEs are GC-rich and have a characteristic oligomeric composition. They have higher levels of stable nucleosome occupancy than their flanking regions, and lower levels of mononucleosomes and H3.3, suggesting that these regions reside in compact chromatin. Furthermore, these regions showed remarkable modulations in histone modification and the expression levels of adjacent genes during development. Although HCNEs are primarily initiated late in replication, about 10% were related to early replication origins. Finally, HCNEs showed strong enrichment within lamina-associated domains. Conclusion: HCNEs have distinct and protective sequence properties, undergo dynamic epigenetic regulation, and appear to be associated with the structural components of the chromatin, replication origins, and nuclear matrix. These observations indicate that such elements are likely to have essential cellular functions, and offer insights into their epigenetic properties.	[Seridi, Loqmane; Ryu, Taewoo; Ravasi, Timothy] King Abdullah Univ Sci & Technol, Div Appl Math & Comp Sci, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Ravasi, Timothy] Univ Calif San Diego, Dept Med, Div Genet, La Jolla, CA 92093 USA	King Abdullah University of Science & Technology; University of California System; University of California San Diego	Ryu, T (corresponding author), King Abdullah Univ Sci & Technol, Div Appl Math & Comp Sci, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia.	taewoo.ryu@kaust.edu.sa; timothy.ravasi@kaust.edu.sa	Ravasi, Timothy/B-8777-2008; Ryu, Taewoo/AAN-2634-2020	Seridi, Loqmane/0000-0001-7028-3024; Ravasi, Timothy/0000-0002-9950-465X	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This was supported by King Abdullah University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; ANDERSEN AH, 1985, NUCLEIC ACIDS RES, V13, P1543, DOI 10.1093/nar/13.5.1543; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Daniel C, 2012, NUCLEIC ACIDS RES, V40, P9876, DOI 10.1093/nar/gks691; De Grassi A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000275; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; DOLECKI GJ, 1988, NUCLEIC ACIDS RES, V16, P11543, DOI 10.1093/nar/16.24.11543; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Frisch M, 2002, GENOME RES, V12, P349, DOI 10.1101/gr.206602.ArticlepublishedonlinebeforeprintinJanuary2002; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Harmston N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0021; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kenigsberg E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003512; Kenigsberg E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001039; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kritsas K, 2012, GENOME RES, V22, P2455, DOI 10.1101/gr.129346.111; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEHNER CF, 1987, J CELL BIOL, V105, P577, DOI 10.1083/jcb.105.1.577; Lin MB, 2012, CANCER-AM CANCER SOC, V118, P6188, DOI 10.1002/cncr.27653; Linnemann AK, 2009, HUM MOL GENET, V18, P645, DOI 10.1093/hmg/ddn394; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; Royo JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024824; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Martinez F, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-54; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Meier I, 2007, J EXP BOT, V58, P27, DOI 10.1093/jxb/erl009; Muller CA, 2012, GENOME RES, V22, P1953, DOI 10.1101/gr.139477.112; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rowntree RK, 2006, MOL CELL BIOL, V26, P3707, DOI 10.1128/MCB.26.10.3707-3717.2006; Ryu T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-236; Sahagun V, 2012, GENOME BIOL EVOL, V4, P1054, DOI 10.1093/gbe/evs089; Sakuraba Y, 2008, MAMM GENOME, V19, P703, DOI 10.1007/s00335-008-9152-7; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; St Pierre SE, 2013, NUCL ACIDS RES; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Tetko IV, 2006, PLOS COMPUT BIOL, V2, P136, DOI 10.1371/journal.pcbi.0020021; Tracy RB, 1997, GENE DEV, V11, P3423, DOI 10.1101/gad.11.24.3423; Tseng HHE, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-432; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; Vavouri T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r15; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Walter K, 2005, TRENDS GENET, V21, P436, DOI 10.1016/j.tig.2005.06.003; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Westenberger SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-610; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Xiao S, 2012, CELL, V149, P1381, DOI 10.1016/j.cell.2012.04.029; Yang RX, 2008, CARCINOGENESIS, V29, P351, DOI 10.1093/carcin/bgm290	73	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109326	10.1371/journal.pone.0109326	http://dx.doi.org/10.1371/journal.pone.0109326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289637	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000054
J	Bednarsek, N; Tarling, GA; Bakker, DCE; Fielding, S; Feely, RA				Bednarsek, Nina; Tarling, Geraint A.; Bakker, Dorothee C. E.; Fielding, Sophie; Feely, Richard A.			Dissolution Dominating Calcification Process in Polar Pteropods Close to the Point of Aragonite Undersaturation	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CARBON-DIOXIDE; SOUTHERN-OCEAN; SCOTIA SEA; SATURATION; IMPACT; CO2; SEAWATER; PACIFIC; CALCITE	Thecosome pteropods are abundant upper-ocean zooplankton that build aragonite shells. Ocean acidification results in the lowering of aragonite saturation levels in the surface layers, and several incubation studies have shown that rates of calcification in these organisms decrease as a result. This study provides a weight-specific net calcification rate function for thecosome pteropods that includes both rates of dissolution and calcification over a range of plausible future aragonite saturation states (Omega(ar)). We measured gross dissolution in the pteropod Limacina helicina antarctica in the Scotia Sea (Southern Ocean) by incubating living specimens across a range of aragonite saturation states for a maximum of 14 days. Specimens started dissolving almost immediately upon exposure to undersaturated conditions (Omega(ar) similar to 0.8), losing 1.4% of shell mass per day. The observed rate of gross dissolution was different from that predicted by rate law kinetics of aragonite dissolution, in being higher at Omega(ar) levels slightly above 1 and lower at Omega(ar) levels of between 1 and 0.8. This indicates that shell mass is affected by even transitional levels of saturation, but there is, nevertheless, some partial means of protection for shells when in undersaturated conditions. A function for gross dissolution against Omega(ar) derived from the present observations was compared to a function for gross calcification derived by a different study, and showed that dissolution became the dominating process even at Omega(ar) levels close to 1, with net shell growth ceasing at an Omega(ar) of 1.03. Gross dissolution increasingly dominated net change in shell mass as saturation levels decreased below 1. As well as influencing their viability, such dissolution of pteropod shells in the surface layers will result in slower sinking velocities and decreased carbon and carbonate fluxes to the deep ocean.	[Bednarsek, Nina; Feely, Richard A.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Bednarsek, Nina; Tarling, Geraint A.; Fielding, Sophie] British Antarctic Survey, Cambridge CB3 0ET, England; [Bednarsek, Nina; Bakker, Dorothee C. E.] Univ E Anglia, Sch Environm Sci, Ctr Ocean & Atmospher Sci, Norwich NR4 7TJ, Norfolk, England	National Oceanic Atmospheric Admin (NOAA) - USA; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of East Anglia	Bednarsek, N (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	nina.bednarsek@noaa.gov	Bednarsek, Nina/Q-8937-2017; Bakker, Dorothee C E/E-4951-2015; Feely, Richard A./ABI-5740-2020; bednarsek, nina/AAM-7748-2021	Bakker, Dorothee C E/0000-0001-9234-5337; bednarsek, nina/0000-0002-9177-6626	FAASIS (Fellowships in Antarctic Air-Sea-Ice Science), a European Union Marie Curie Early Stage Training Network [MEST-CT-2004-514159]; Ecosystems Programme at the British Antarctic Survey; UK Ocean Acidification Research Programme - Natural Environment Research Council; Department for Environment, Food and Rural Affairs; Department for Energy and Climate Change [NE/H017267/1]; NOAA Ocean Acidification Program; NERC [NE/H017267/1, bas0100025, NE/H017038/1] Funding Source: UKRI; Natural Environment Research Council [NE/H017038/1, bas0100025, NE/H017267/1] Funding Source: researchfish	FAASIS (Fellowships in Antarctic Air-Sea-Ice Science), a European Union Marie Curie Early Stage Training Network; Ecosystems Programme at the British Antarctic Survey; UK Ocean Acidification Research Programme - Natural Environment Research Council; Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Department for Energy and Climate Change; NOAA Ocean Acidification Program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	NB was supported by the FAASIS (Fellowships in Antarctic Air-Sea-Ice Science, MEST-CT-2004-514159), a European Union Marie Curie Early Stage Training Network. GT and SOF were supported by the Ecosystems Programme at the British Antarctic Survey. GT and DCEB received additional support from the UK Ocean Acidification Research Programme, funded by the Natural Environment Research Council, the Department for Environment, Food and Rural Affairs and the Department for Energy and Climate Change (grant no. NE/H017267/1). RF was supported by the NOAA Ocean Acidification Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Be AWH, 1977, OCEANIC MICROPALEONT, V1, P733; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; Bednarsek N., 2012, Global Change Biology, V18, P2378, DOI 10.1111/j.1365-2486.2012.02668.x; Bednarsek N, 2012, DEEP-SEA RES PT II, V59, P105, DOI 10.1016/j.dsr2.2011.08.003; BERNER RA, 1981, SCIENCE, V211, P940, DOI 10.1126/science.211.4485.940; BERNER RA, 1977, LIMNOL OCEANOGR, V22, P781, DOI 10.4319/lo.1977.22.5.0781; BETZER PR, 1984, SCIENCE, V226, P1074, DOI 10.1126/science.226.4678.1074; Busenberg E., 1986, STUDIES DIAGENESIS U, V1578, P139; BYRNE RH, 1984, NATURE, V312, P321, DOI 10.1038/312321a0; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; DAVIS CS, 1985, J GEOPHYS RES-OCEANS, V90, P8871, DOI 10.1029/JC090iC05p08871; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; EMERSON S, 1980, EARTH PLANET SC LETT, V49, P57, DOI 10.1016/0012-821X(80)90150-8; FABRY VJ, 1989, DEEP-SEA RES, V36, P1735, DOI 10.1016/0198-0149(89)90069-1; FABRY VJ, 1990, J MAR RES, V48, P209, DOI 10.1357/002224090784984614; FEELY RA, 1988, MAR CHEM, V25, P227, DOI 10.1016/0304-4203(88)90052-7; FEELY RA, 1982, GEOPHYS RES LETT, V9, P1294, DOI 10.1029/GL009i011p01294; FEELY RA, 1984, J GEOPHYS RES-OCEANS, V89, P631, DOI 10.1029/JC089iC06p10631; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2002, GLOBAL BIOGEOCHEM CY, V16, P91; Feely RA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004157; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Gangsto R, 2008, BIOGEOSCIENCES, V5, P1057, DOI 10.5194/bg-5-1057-2008; Gangsto R, 2011, BIOGEOSCIENCES, V8, P433, DOI 10.5194/bg-8-433-2011; GARDNER WD, 1983, J MAR RES, V41, P195, DOI 10.1357/002224083788520180; Gehlen M, 2007, BIOGEOSCIENCES, V4, P505, DOI 10.5194/bg-4-505-2007; HARBISON GR, 1986, DEEP-SEA RES, V33, P1017, DOI 10.1016/0198-0149(86)90027-0; Harper EM, 2000, J ZOOL, V251, P179, DOI 10.1111/j.1469-7998.2000.tb00602.x; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; KEIR RS, 1980, GEOCHIM COSMOCHIM AC, V44, P241, DOI 10.1016/0016-7037(80)90135-0; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; LARSON RJ, 1986, J EXP MAR BIOL ECOL, V99, P107, DOI 10.1016/0022-0981(86)90231-5; Le Fevre J, 1998, J MARINE SYST, V17, P325, DOI 10.1016/S0924-7963(98)00047-5; Lewis E., 1998, ORNLCDIAC105 US DEP; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Lischka S, 2012, GLOBAL CHANGE BIOL, V18, P3517, DOI 10.1111/gcb.12020; MCGOWAN JA, 1978, DEEP-SEA RES, V25, P771, DOI 10.1016/0146-6291(78)90023-1; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Morse JW, 2007, CHEM REV, V107, P342, DOI 10.1021/cr050358j; MORSE JW, 1980, GEOCHIM COSMOCHIM AC, V44, P85, DOI 10.1016/0016-7037(80)90178-7; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PRICE BA, 1985, MAR GEOL, V64, P217, DOI 10.1016/0025-3227(85)90106-9; Ries JB, 2012, NAT GEOSCI, V5, P845, DOI 10.1038/ngeo1655; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Sato-Okoshi W, 2010, POLAR BIOL, V33, P1577, DOI 10.1007/s00300-010-0849-1; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Tarling GA, 2004, MAR ECOL PROG SER, V272, P165, DOI 10.3354/meps272165; Trotter J, 2011, EARTH PLANET SC LETT, V303, P163, DOI 10.1016/j.epsl.2011.01.030; WAITE JH, 1979, J COMP PHYSIOL, V130, P301; WHITFIELD M, 1974, NATURE, V247, P523, DOI 10.1038/247523a0; Zar JH, 1999, BIOSTATISTICAL ANAL; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	57	67	69	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109183	10.1371/journal.pone.0109183	http://dx.doi.org/10.1371/journal.pone.0109183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285916	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000345743700052
J	Chen, A; Dowdy, DW				Chen, Anders; Dowdy, David W.			Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; DIRECT MEDICAL COST; UNITED-STATES; HOMOSEXUAL-MEN; INFECTION; TRANSMISSION; PREVALENCE; PREVENTION; HEALTH; CARE	Background: Oral pre-exposure prophylaxis (PrEP) can be clinically effective and cost-effective for HIV prevention in high-risk men who have sex with men (MSM). However, individual patients have different risk profiles, real-world populations vary, and no practical tools exist to guide clinical decisions or public health strategies. We introduce a practical model of HIV acquisition, including both a personalized risk calculator for clinical management and a cost-effectiveness calculator for population-level decisions. Methods: We developed a decision-analytic model of PrEP for MSM. The primary clinical effectiveness and cost-effectiveness outcomes were the number needed to treat (NNT) to prevent one HIV infection, and the cost per quality-adjusted life-year (QALY) gained. We characterized patients according to risk factors including PrEP adherence, condom use, sexual frequency, background HIV prevalence and antiretroviral therapy use. Results: With standard PrEP adherence and national epidemiologic parameters, the estimated NNT was 64 (95% uncertainty range: 26, 176) at a cost of $160,000 (cost saving, $740,000) per QALY - comparable to other published models. With high (35%) HIV prevalence, the NNT was 35 (21, 57), and cost per QALY was $27,000 (cost saving, $160,000), and with high PrEP adherence, the NNT was 30 (14, 69), and cost per QALY was $3,000 (cost saving, $200,000). In contrast, for monogamous, serodiscordant relationships with partner antiretroviral therapy use, the NNT was 90 (39, 157) and cost per QALY was $280,000 ($14,000, $670,000). Conclusions: PrEP results vary widely across individuals and populations. Risk calculators may aid in patient education, clinical decision-making, and cost-effectiveness evaluation.	[Chen, Anders] Johns Hopkins Univ, Sch Med, Dept Internal Med, Baltimore, MD 21218 USA; [Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chen, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Internal Med, Baltimore, MD 21218 USA.	ddowdy@jhsph.edu		Chen, Anders/0000-0002-1376-0629				Anglemyer A, 2013, COCHRANE DB SYST REV, V4; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2010, MMWR-MORBID MORTAL W, V59, P1201; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P1618; [Anonymous], MED CAR COMP CONS PR; Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Centers for Disease Control and Prevention, 2012, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, HIV GAY BIS MEN; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guzder RN, 2005, DIABETIC MED, V22, P554, DOI 10.1111/j.1464-5491.2005.01494.x; Hosek S, 2012, J ACQUIR IMMUNE DEFI; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Koppenhaver RT, 2011, JAIDS-J ACQ IMM DEF, V58, pE51, DOI 10.1097/QAI.0b013e31822b74fe; Mimiaga MJ, 2009, SEX TRANSM DIS, V36, P507, DOI 10.1097/OLQ.0b013e3181a2ad98; Morris SR, 2006, CLIN INFECT DIS, V43, P1284, DOI 10.1086/508460; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Schackman BR, 2012, CURR OPIN HIV AIDS, V7, P587, DOI 10.1097/COH.0b013e3283582c8b; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; US Public Health Service Centers for Disease Control and Prevention, 2014, PRE EXP PROPH PREV H; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; World Health Organization, 2004, GLOB BURD DIS 2004 U; Xiridou M, 2003, AIDS, V17, P1029, DOI 10.1097/00002030-200305020-00012; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b	41	43	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108742	10.1371/journal.pone.0108742	http://dx.doi.org/10.1371/journal.pone.0108742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285793	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700031
J	Rist, CL; Arriola, CS; Rubin, C				Rist, Cassidy Logan; Arriola, Carmen Sofia; Rubin, Carol			Prioritizing Zoonoses: A Proposed One Health Tool for Collaborative Decision-Making	PLOS ONE			English	Article							INFECTIOUS-DISEASES; PUBLIC-HEALTH; METHODOLOGY	Emerging and re-emerging zoonotic diseases pose a threat to both humans and animals. This common threat is an opportunity for human and animal health agencies to coordinate across sectors in a more effective response to zoonotic diseases. An initial step in the collaborative process is identification of diseases or pathogens of greatest concern so that limited financial and personnel resources can be effectively focused. Unfortunately, in many countries where zoonotic diseases pose the greatest risk, surveillance information that clearly defines burden of disease is not available. We have created a semi-quantitative tool for prioritizing zoonoses in the absence of comprehensive prevalence data. Our tool requires that human and animal health agency representatives jointly identify criteria (e.g., pandemic potential, human morbidity or mortality, economic impact) that are locally appropriate for defining a disease as being of concern. The outcome of this process is a ranked disease list that both human and animal sectors can support for collaborative surveillance, laboratory capacity enhancement, or other identified activities. The tool is described in a five-step process and its utility is demonstrated for the reader.	[Rist, Cassidy Logan; Arriola, Carmen Sofia; Rubin, Carol] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Rubin, C (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	chr1@cdc.gov	Rist, Cassidy/AAT-1611-2020	Rist, Cassidy/0000-0002-7558-8094				[Anonymous], COMMUN DIS REP CDR S; Balabanova Y., 2011, PLOS ONE, V6; Batsukh Z, 2013, CURR TOP MICROBIOL, V366, P123, DOI 10.1007/82_2012_253; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Cediel N, 2013, REV PANAM SALUD PUBL, V33, P316, DOI 10.1590/S1020-49892013000500002; Doherty J A, 2000, Can J Infect Dis, V11, P21; Eliot and Associates, 2005, GUID COND FOC GROUP; Gilsdorf A, 2011, EUROSURVEILLANCE, V16, P15; Gore SM, 1987, MED RES COUNC NEWS, V35, P19; Grace D., 2012, MAPPING POVERTY LIKE; Grace D., 2011, ZOONOSES WILDLIFE LI ZOONOSES WILDLIFE LI; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Hsu C. C., 2007, CREATING MARKET SOCI; Humblet M.F., 2012, EMERG INFECT DIS, V18; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Krause G, 2008, EURO SURVEILL, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Kurowicka D, 2010, RISK ANAL, V30, P715, DOI 10.1111/j.1539-6924.2010.01378.x; Maino M, 2012, REV SCI TECH OIE, V31, P889; McKenzie J, 2007, PREV VET MED, V81, P194, DOI 10.1016/j.prevetmed.2007.04.003; Mourits MCM, 2010, PREV VET MED, V96, P201, DOI 10.1016/j.prevetmed.2010.06.010; Ng V, 2012, PLOS ONE, V7; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Saaty TL., 2008, INT J SERV SCI, V1, P2008, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Sekar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017120; Sharken Simon J, 1999, CONDUCT FOCUS GROUP; Skinner DC, 2009, INTRO DECISION ANAL, P150; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Toloie-Eshlaghy A., 2011, AM J SCI RES, V24, P6; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	32	47	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109986	10.1371/journal.pone.0109986	http://dx.doi.org/10.1371/journal.pone.0109986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302612	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400101
J	Wang, SS; Wang, JJ; Wang, PX; Chen, RL				Wang, Shan-Shan; Wang, Jia-Ji; Wang, Pei-Xi; Chen, Ruoling			Determinants of Fatigue after First-Ever lschemic Stroke NE during Acute Phase	PLOS ONE			English	Article							POSTSTROKE FATIGUE; FOLLOW-UP; SEVERITY SCALE; YOUNG-ADULTS; FREQUENCY; DEPRESSION	Background and Purpose: Fatigue after stroke is common and has a negative impact on rehabilitation and survival. However, its pathogenesis and contributing factors remain unclear. The purpose of this study was to identify factors influencing the occurrence of fatigue after first-ever ischemic stroke in acute phase. Methods: We examined 265 consecutive patients with first-ever ischemic stroke during acute phase (within 2 weeks) in two tertiary stroke care hospitals in Henan, China. We documented patients demographic and clinical characteristics through face-to-face interviews using structured questionnaires and reviews of medical records. Post-stroke fatigue was defined as a score of >4 using the Fatigue Severity Scale. Multivariate logistic regression was used to examine post-stroke fatigue in relation to socio-demographic, lifestyle, clinical characteristics and family function. Results: About 40% first-ever ischemic stroke patients experienced post-stroke fatigue in acute phase. Post-stroke fatigue was associated with lack of exercise before stroke (adjusted odds ratio 4.01, 95% Cl 1.95-8.24), family dysfunction (2.63, 1.20-5.80), depression (2.39, 1.02-5.58), the presence of pre-stroke fatigue (4.89, 2.13-11.21), use of sedative medications (4.14, 1.58-10.88), coronary heart disease (3.38, 1.46-7.79) and more severe Modified Rankin Scale (2.55, 1.65-3.95). Conclusions:The causes of post-stroke fatigue are multifaceted. More physical exercise, improving family function, reducing depression and appropriate use of sedative medications may be helpful in preventing post-stroke fatigue.	[Wang, Shan-Shan; Wang, Pei-Xi] Henan Univ, Sch Nursing, Inst Publ Hlth, Kaifeng, Peoples R China; [Wang, Jia-Ji; Wang, Pei-Xi] Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China; [Chen, Ruoling] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Chen, Ruoling] Wolverhampton Univ, CHSCI, Wolverhampton WV1 1DJ, W Midlands, England	Henan University; Guangzhou Medical University; University of London; King's College London; University of Wolverhampton	Wang, PX (corresponding author), Henan Univ, Sch Nursing, Inst Publ Hlth, Kaifeng, Peoples R China.	peixi001@163.com; ruoling.chen@kcl.ac.uk	WANG, Jia Ji/E-9059-2015	Chen, Ruoling/0000-0002-3033-8753				Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Andersen G, 2012, ACTA NEUROL SCAND, V125, P248, DOI 10.1111/j.1600-0404.2011.01557.x; Annoni JM, 2008, NEUROL SCI, V29, pS244, DOI 10.1007/s10072-008-0951-0; Appelros P, 2006, INT J REHABIL RES, V29, P329, DOI 10.1097/MRR.0b013e328010c7b8; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bellon Saameno J A, 1996, Aten Primaria, V18, P289; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784; Choi-Kwon S, 2011, INT J STROKE, V6, P328, DOI 10.1111/j.1747-4949.2011.00624.x; Christensen D, 2008, CEREBROVASC DIS, V26, P134, DOI 10.1159/000139660; Craig LE, 2010, STROKE, V41, P2632, DOI 10.1161/STROKEAHA.110.588244; Crosby GA, 2012, DISABIL REHABIL, V34, P633, DOI 10.3109/09638288.2011.613517; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Gardner W, 2001, J FAM PRACTICE, V50, P19; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; Horton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065752; Jaracz K, 2007, NEUROL NEUROCHIR POL, V41, P36; 박연환, 2002, [Korean Journal of Adult Nursing, 성인간호학회지], V14, P348; Lerdal A, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/126275; Lerdal A, 2011, INT J NURS STUD, V48, P1258, DOI 10.1016/j.ijnurstu.2011.02.019; Lerdal A, 2011, DISABIL REHABIL, V33, P334, DOI 10.3109/09638288.2010.490867; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Naess H, 2006, STROKE, V37, P1232, DOI 10.1161/01.STR.0000217652.42273.02; Naess H, 2005, CEREBROVASC DIS, V20, P245, DOI 10.1159/000087706; Naess H, 2012, J NEUROL SCI, V312, P138, DOI 10.1016/j.jns.2011.08.002; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Snaphaan L, 2011, EUR J NEUROL, V18, P611, DOI 10.1111/j.1468-1331.2010.03217.x; Soyuer F, 2011, ARCH GERONTOL GERIAT, V53, pE164, DOI 10.1016/j.archger.2010.08.006; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2011, ARCH PHYS MED REHAB, V92, P1336, DOI 10.1016/j.apmr.2011.02.018; The neuroscience society, 1996, CHIN J NEUROLOGY, V29, P379; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vigil JM, 2008, J FAM PSYCHOL, V22, P176, DOI 10.1037/0893-3200.22.1.176	35	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110037	10.1371/journal.pone.0110037	http://dx.doi.org/10.1371/journal.pone.0110037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25302807	gold, Green Submitted, Green Published			2022-12-27	WOS:000343730400103
J	Li, Z; Yu, X; Liang, JQ; Wu, WKK; Yu, J; Shen, JX				Li, Zheng; Yu, Xin; Liang, Jinqian; Wu, William Ka Kei; Yu, Jun; Shen, Jianxiong			Leptin Downregulates Aggrecan through the p38-ADAMST Pathway in Human Nucleus Pulposus Cells	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; LOW-BACK-PAIN; HUMAN CHONDROCYTES; GENE-EXPRESSION; ADAMTS FAMILY; DEGENERATION; MAPK; PROLIFERATION; OBESITY; CLONING	The mechanistic basis of obesity-associated intervertebral disc degeneration (IDD) is unclear. Aberrant expression of aggrecan and its degrading enzymes ADAMTS-4 and ADAMTS-5 is implicated in the development of IDD. Here, we investigated the effect of leptin, a hormone with increased circulating levels in obesity, on the expression of aggrecan and ADAMTSs in primary human nucleus pulposus (NP) cells. Real-time PCR and Western blots showed that leptin increased the mRNA and protein expression of ADAMTS-4 and ADAMTS-5 and reduced the level of aggrecan in NP cells, accompanied by a prominent induction of p38 phosphorylation. Treatment of NP cells with SB203580 (a p38 inhibitor) abolished the regulation of aggrecan and ADAMTSs by leptin. Knockdown of ADAMTS-4 and ADAMTS-5 by siRNAs also attenuated the degradation of aggrecan in leptin-stimulated NP cells. To conclude, we demonstrated that leptin induces p38 to upregulate ADAMTSs and thereby promoting aggrecan degradation in human NP cells. These results provide a novel mechanistic insight into the molecular pathogenesis of obesity-associated IDD.	[Li, Zheng; Yu, Xin; Liang, Jinqian; Shen, Jianxiong] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100021, Peoples R China; [Yu, Xin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Yu, Xin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, William Ka Kei; Yu, Jun] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese University of Hong Kong	Shen, JX (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100021, Peoples R China.	shenjianxiong@medmail.com.cn	wu, william/HII-5817-2022; Yu, Jun/D-8569-2015; Shen, Jianxiong/AAH-6200-2019; Sánchez-Margalet, Victor/AAB-9986-2021; Wu, William K.K./A-3277-2009	Yu, Jun/0000-0001-5008-2153; Sánchez-Margalet, Victor/0000-0001-8638-8680; Wu, William K.K./0000-0002-5662-5240	National Natural Science Foundation of P.R. China [81272053, 81330044, 81301596, 81401847]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Numbers: 81272053, 81330044, 81301596 and 81401847). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbah SA, 2011, SPINE PHILA PA 1976; Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Akhatib B, 2013, J BIOL CHEM, V288, P19280, DOI 10.1074/jbc.M112.443010; Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; Bateman JF, 2013, ARTHRITIS RHEUM-US, V65, P1547, DOI 10.1002/art.37900; Cabraja M, 2013, J NEUROSURG SCI, V57, P307; Carlton ED, 2012, HORM BEHAV; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Freitas VM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-2; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Furtwangler T, 2013, SPINE PHILA PA 1976; Gruber HE, 2007, SPINE J, V7, P437, DOI 10.1016/j.spinee.2006.08.001; Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1; Hou N, 2011, CLIN EXP PHARMACOL P, V38, P905, DOI 10.1111/j.1440-1681.2011.05619.x; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Hsieh AH, 2010, J BIOMECH, V43, P137, DOI 10.1016/j.jbiomech.2009.09.019; Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC; l'Allemand D, 2002, EUR J ENDOCRINOL, V146, P537, DOI 10.1530/eje.0.1460537; Li Z, 2013, J ORTHOP RES, V31, P847, DOI 10.1002/jor.22308; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Liang C, 2013, INT IMMUNOPHARMACOL, V15, P620, DOI 10.1016/j.intimp.2013.01.014; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Radons J, 2006, INT J MOL MED, V17, P661; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Saito T, 2013, OSTEOARTHR CARTILAGE, V21, P165, DOI 10.1016/j.joca.2012.09.003; Samartzis D, 2011, J BONE JOINT SURG AM, V93A, P662, DOI 10.2106/JBJS.I.01568; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Speed C, 2004, BRIT MED J, V328, P1119, DOI 10.1136/bmj.328.7448.1119; Thompson KJ, 2011, HPB, V13, P225, DOI 10.1111/j.1477-2574.2010.00259.x; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Zhao CQ, 2008, SPINE, V33, pE858, DOI 10.1097/BRS.0b013e31818338e5	37	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109595	10.1371/journal.pone.0109595	http://dx.doi.org/10.1371/journal.pone.0109595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299465	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200062
J	Osakabe, A; Takahashi, Y; Murakami, H; Otawa, K; Tachiwana, H; Oma, Y; Nishijima, H; Shibahara, K; Kurumizaka, H; Harata, M				Osakabe, Akihisa; Takahashi, Yuichiro; Murakami, Hirokazu; Otawa, Kenji; Tachiwana, Hiroaki; Oma, Yukako; Nishijima, Hitoshi; Shibahara, Kei-ich; Kurumizaka, Hitoshi; Harata, Masahiko			DNA Binding Properties of the Actin-Related Protein Arp8 and Its Role in DNA Repair	PLOS ONE			English	Article							STRAND BREAK REPAIR; CHROMATIN-REMODELING COMPLEXES; REPLICATION FORKS; INO80 COMPLEX; HOMOLOGOUS RECOMBINATION; CELLULAR-RESPONSE; DAMAGE; NUCLEUS; IDENTIFICATION; ORGANIZATION	Actin and actin-related proteins (Arps), which are members of the actin family, are essential components of many of these remodeling complexes. Actin, Arp4, Arp5, and Arp8 are found to be evolutionarily conserved components of the INO80 chromatin remodeling complex, which is involved in transcriptional regulation, DNA replication, and DNA repair. A recent report showed that Arp8 forms a module in the INO80 complex and this module can directly capture a nucleosome. In the present study, we showed that recombinant human Arp8 binds to DNAs, and preferentially binds to single-stranded DNA. Analysis of the binding of adenine nucleotides to Arp8 mutants suggested that the ATP-binding pocket, located in the evolutionarily conserved actin fold, plays a regulatory role in the binding of Arp8 to DNA. To determine the cellular function of Arp8, we derived tetracycline-inducible Arp8 knockout cells from a cultured human cell line. Analysis of results obtained after treating these cells with aphidicolin and camptothecin revealed that Arp8 is involved in DNA repair. Together with the previous observation that Arp8, but not gamma-H2AX, is indispensable for recruiting INO80 complex to DSB in human, results of our study suggest an individual role for Arp8 in DNA repair.	[Takahashi, Yuichiro; Murakami, Hirokazu; Oma, Yukako; Harata, Masahiko] Tohoku Univ, Grad Sch Agr Sci, Mol Biol Lab, Sendai, Miyagi 980, Japan; [Osakabe, Akihisa; Otawa, Kenji; Tachiwana, Hiroaki; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan; [Nishijima, Hitoshi; Shibahara, Kei-ich] Natl Inst Genet, Dept Integrated Genet, Mishima, Shizuoka 411, Japan	Tohoku University; Waseda University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kurumizaka, H (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan.	kurumizaka@waseda.jp; mharata@biochem.tohoku.ac.jp	Harata, Masahiko/T-5281-2019; Tachiwana, Hiroaki/AHB-3091-2022	Tachiwana, Hiroaki/0000-0001-9227-7653; Kurumizaka, Hitoshi/0000-0001-7412-3722; Osakabe, Akihisa/0000-0002-2526-3398	Japanese Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Human Frontier Science Program [RGP0017]; Waseda Research Institute for Science and Engineering	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Waseda Research Institute for Science and Engineering	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas from the Japanese Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and by the Human Frontier Science Program (RGP0017). H. Kurumizaka was also supported by the Waseda Research Institute for Science and Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama N, 2008, EXP CELL RES, V314, P859, DOI 10.1016/j.yexcr.2007.11.020; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bennett G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3084; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bhatia S, 2010, GENES CELLS, V15, P725, DOI 10.1111/j.1365-2443.2010.01416.x; Boyer LA, 2000, BIOESSAYS, V22, P666, DOI 10.1002/1521-1878(200007)22:7<666::AID-BIES9>3.0.CO;2-Y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Chambers AL, 2012, PROG MOL BIOL TRANSL, V110, P229, DOI 10.1016/B978-0-12-387665-2.00009-2; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Kapoor P, 2013, NAT STRUCT MOL BIOL, V20, P426, DOI 10.1038/nsmb.2529; Kashiwaba S, 2010, BIOCHEM BIOPH RES CO, V402, P619, DOI 10.1016/j.bbrc.2010.10.066; Kast DJ, 2011, EMBO J, V30, P2097, DOI 10.1038/emboj.2011.150; Kawashima S, 2007, BIOCHEM BIOPH RES CO, V355, P835, DOI 10.1016/j.bbrc.2007.02.036; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; Nishijima H, 2009, BIOSCI TRENDS, V3, P161; Nishimoto N, 2012, J CELL SCI; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Oma Y, 2011, NUCLEUS-PHILA, V2, P38, DOI 10.4161/nucl.2.1.14510; Ono T, 2009, J BIOTECHNOL, V141, P1, DOI 10.1016/j.jbiotec.2008.12.010; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Saravanan M, 2012, P NATL ACAD SCI USA, V109, P20883, DOI 10.1073/pnas.1214735109; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Sunada R, 2005, YEAST, V22, P753, DOI 10.1002/yea.1239; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Yonetani Y, 2005, NUCLEIC ACIDS RES, V33, P4544, DOI 10.1093/nar/gki766	39	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108354	10.1371/journal.pone.0108354	http://dx.doi.org/10.1371/journal.pone.0108354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299602	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200015
J	Alonso-Ayuso, M; Gabriel, JL; Quemada, M				Alonso-Ayuso, Maria; Luis Gabriel, Jose; Quemada, Miguel			The Kill Date as a Management Tool for Cover Cropping Success	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; VETCH-RYE MIXTURE; SOIL-MOISTURE; HAIRY VETCH; VEGETABLE CROPS; CAPACITANCE PROBES; N AVAILABILITY; WINTER CEREAL; CATCH CROPS; CORN	Integrating cover crops (CC) in rotations provides multiple ecological services, but it must be ensured that management does not increase pre-emptive competition with the subsequent crop. This experiment was conducted to study the effect of kill date on: (i) CC growth and N content; (ii) the chemical composition of residues; (iii) soil inorganic N and potentially mineralizable N; and (iv) soil water content. Treatments were fallow and a CC mixture of barley (Hordeum vulgare L.) and vetch (Vicia sativa L.) sown in October and killed on two different dates in spring. Above-ground biomass and chemical composition of CC were determined at harvest, and ground cover was monitored based on digital image analysis. Soil mineral N was determined before sowing and after killing the CC, and potentially mineralizable N was measured by aerobic incubation at the end of the experiment. Soil water content was monitored daily to a depth of 1.1 m using capacitance sensors. Under the present conditions of high N availability, delaying kill date increased barley above-ground biomass and N uptake from deep soil layers; little differences were observed in vetch. Postponing kill date increased the C/N ratio and the fiber content of plant residues. Ground cover reached >80% by the first kill date (similar to 1250 degrees C days). Kill date was a means to control soil inorganic N by balancing the N retained in the residue and soil, and showed promise for mitigating N losses. The early kill date decreased the risk of water and N pre-emptive competition by reducing soil depletion, preserving rain harvested between kill dates and allowing more time for N release in spring. The soil potentially mineralizable N was enhanced by the CC and kill date delay. Therefore kill date is a crucial management variable for maximizing the CC benefits in agricultural systems.	[Alonso-Ayuso, Maria; Luis Gabriel, Jose; Quemada, Miguel] Tech Univ Madrid, Sch Agr Engn, Madrid, Spain	Universidad Politecnica de Madrid	Quemada, M (corresponding author), Tech Univ Madrid, Sch Agr Engn, Madrid, Spain.	miguel.quemada@upm.es	Quemada, Miguel/K-4214-2014; Alonso-Ayuso, María/D-8899-2016; Gabriel, Jose Luis/B-9605-2013	Quemada, Miguel/0000-0001-5793-2835; Alonso-Ayuso, María/0000-0002-4401-790X; Gabriel, Jose Luis/0000-0002-5508-4120	Spanish Comision Interministerial de Ciencia y Tecnologia [AGL 2011-24732]; Regional Government of Madrid [S2009/AGR-1630]	Spanish Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Regional Government of Madrid	This work was funded by the Spanish Comision Interministerial de Ciencia y Tecnologia (project AGL 2011-24732) and the Regional Government of Madrid (Project AGRISOST, S2009/AGR-1630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abawi GS, 2000, APPL SOIL ECOL, V15, P37, DOI 10.1016/S0929-1393(00)00070-6; Arregui LM, 2008, AGRON J, V100, P277, DOI 10.2134/agronj2007.0187; Benincasa P, 2010, J SUSTAIN AGR, V34, P705, DOI 10.1080/10440046.2010.507452; Benincasa P, 2011, HORTTECHNOLOGY, V21, P266, DOI 10.21273/HORTTECH.21.3.266; Bodner G, 2010, AGRON SUSTAIN DEV, V30, P455, DOI 10.1051/agro/2009029; Clark AJ, 2007, AGRON J, V99, P43, DOI 10.2134/agronj2005.0362; Clark AJ, 1997, AGRON J, V89, P434, DOI 10.2134/agronj1997.00021962008900030011x; CLARK AJ, 1994, AGRON J, V86, P1065, DOI 10.2134/agronj1994.00021962008600060025x; Clark AJ, 1997, AGRON J, V89, P427, DOI 10.2134/agronj1997.00021962008900030010x; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; CROOKE WM, 1971, J SCI FOOD AGR, V22, P9, DOI 10.1002/jsfa.2740220104; Gabriel JL, 2012, AGR ECOSYST ENVIRON, V155, P50, DOI 10.1016/j.agee.2012.03.021; Gabriel JL, 2011, EUR J AGRON, V34, P133, DOI 10.1016/j.eja.2010.11.006; Goering H.R., 1970, AGR HDB ARS USDA, V379; Keeney D.R, 1982, AGRON MONOGR, P643; Krueger ES, 2011, AGRON J, V103, P316, DOI 10.2134/agronj2010.0327; Kuo S, 1997, SOIL SCI SOC AM J, V61, P145, DOI 10.2136/sssaj1997.03615995006100010022x; Loeppert H.R., 1996, METHODS SOIL ANAL, P437, DOI DOI 10.2136/SSSAB00KSER5.3.C15; Gabriel JL, 2010, SOIL SCI SOC AM J, V74, P593, DOI 10.2136/sssaj2009.0157; McGuire AM, 1998, AGRON J, V90, P404, DOI 10.2134/agronj1998.00021962009000030015x; Mitchell JP, 1999, J SUSTAIN AGR, V15, P19, DOI 10.1300/J064v15n02_04; Nelson D.W., 1996, METHODS SOIL ANAL PA, V5, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; OFORI F, 1987, FIELD CROP RES, V16, P43, DOI 10.1016/0378-4290(87)90052-9; Paltineanu IC, 1997, SOIL SCI SOC AM J, V61, P1576, DOI 10.2136/sssaj1997.03615995006100060006x; Papadakis J., 1966, CLIMATES WORLD THEIR; QUEMADA M, 1995, SOIL SCI SOC AM J, V59, P1059, DOI 10.2136/sssaj1995.03615995005900040015x; Quemada M, 1997, AGRON J, V89, P723, DOI 10.2134/agronj1997.00021962008900050003x; QUEMADA M, 1995, SOIL SCI SOC AM J, V59, P471, DOI 10.2136/sssaj1995.03615995005900020029x; Quemada M, 2002, PLANT SOIL, V238, P295, DOI 10.1023/A:1014404003851; Quemada M, 2007, COMMUN SOIL SCI PLAN, V38, P2061, DOI 10.1080/00103620701548795; Quinton JN, 1997, SOIL USE MANAGE, V13, P143, DOI 10.1111/j.1475-2743.1997.tb00575.x; Ramirez-Garcia J, 2015, J AGR SCI-CAMBRIDGE, V153, P1174, DOI 10.1017/S0021859614000811; Ramirez-Garcia J, 2012, PLANT SOIL ENVIRON, V58, P385, DOI 10.17221/195/2012-PSE; Richardson MD, 2001, CROP SCI, V41, P1884, DOI 10.2135/cropsci2001.1884; Saini M, 2008, SO CONSERVATION AGR, P137; Salmeron M, 2011, FIELD CROP RES, V123, P89, DOI 10.1016/j.fcr.2011.05.006; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; STANFORD G, 1972, SOIL SCI SOC AM PRO, V36, P465, DOI 10.2136/sssaj1972.03615995003600030029x; Stipesevic B, 2005, PLANT SOIL ENVIRON, V51, P255, DOI 10.17221/3583-PSE; Stubbs TL, 2009, AGRON J, V101, P538, DOI 10.2134/agronj2008.0107x; TEASDALE JR, 1993, AGRON J, V85, P673, DOI 10.2134/agronj1993.00021962008500030029x; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; THORUPKRISTENSEN K, 1994, FERT RES, V37, P227, DOI 10.1007/BF00748941; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Tosti G., 2010, Italian Journal of Agronomy, V5, P239; Tosti G, 2014, EUR J AGRON, V54, P34, DOI 10.1016/j.eja.2013.11.012; Tosti G, 2012, EUR J AGRON, V43, P136, DOI 10.1016/j.eja.2012.06.004; Unkovich M., 2008, Measuring plant-associated nitrogen fixation in agricultural systems; Vazquez N, 2006, AGR ECOSYST ENVIRON, V112, P313, DOI 10.1016/j.agee.2005.07.009; Vazquez N, 2005, PLANT SOIL, V269, P297, DOI 10.1007/s11104-004-0630-8; WAGGER MG, 1989, AGRON J, V81, P236, DOI 10.2134/agronj1989.00021962008100020020x; Wagger MG, 1998, J SOIL WATER CONSERV, V53, P214; WHITMORE AP, 1991, J SOIL SCI, V42, P289, DOI 10.1111/j.1365-2389.1991.tb00410.x	53	93	93	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109587	10.1371/journal.pone.0109587	http://dx.doi.org/10.1371/journal.pone.0109587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296333	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000081
J	Heinicke, K; Dimitrov, IE; Romain, N; Cheshkov, S; Ren, JM; Malloy, CR; Haller, RG				Heinicke, Katja; Dimitrov, Ivan E.; Romain, Nadine; Cheshkov, Sergey; Ren, Jimin; Malloy, Craig R.; Haller, Ronald G.			Reproducibility and Absolute Quantification of Muscle Glycogen in Patients with Glycogen Storage Disease by C-13 NMR Spectroscopy at 7 Tesla	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; MCARDLE-DISEASE; EXERCISE; DEFICIENCY; METABOLISM; INVIVO	Carbon-13 magnetic resonance spectroscopy (C-13 MRS) offers a noninvasive method to assess glycogen levels in skeletal muscle and to identify excess glycogen accumulation in patients with glycogen storage disease (GSD). Despite the clinical potential of the method, it is currently not widely used for diagnosis or for follow-up of treatment. While it is possible to perform acceptable C-13 MRS at lower fields, the low natural abundance of C-13 and the inherently low signal-to-noise ratio of C-13 MRS makes it desirable to utilize the advantage of increased signal strength offered by ultra-high fields for more accurate measurements. Concomitant with this advantage, however, ultra-high fields present unique technical challenges that need to be addressed when studying glycogen. In particular, the question of measurement reproducibility needs to be answered so as to give investigators insight into meaningful inter-subject glycogen differences. We measured muscle glycogen levels in vivo in the calf muscle in three patients with McArdle disease (MD), one patient with phosphofructokinase deficiency (PFKD) and four healthy controls by performing C-13 MRS at 7T. Absolute quantification of the MRS signal was achieved by using a reference phantom with known concentration of metabolites. Muscle glycogen concentration was increased in GSD patients (31.5 +/- 2.9 g/kg w. w.) compared with controls (12.4 +/- 2.2 g/kg w. w.). In three GSD patients glycogen was also determined biochemically in muscle homogenates from needle biopsies and showed a similar 2.5-fold increase in muscle glycogen concentration in GSD patients compared with controls. Repeated inter-subject glycogen measurements yield a coefficient of variability of 5.18%, while repeated phantom measurements yield a lower 3.2% system variability. We conclude that noninvasive ultra-high field C-13 MRS provides a valuable, highly reproducible tool for quantitative assessment of glycogen levels in health and disease.	[Heinicke, Katja; Romain, Nadine; Haller, Ronald G.] Texas Hlth Presbyterian Hosp, Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA; [Heinicke, Katja; Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Dimitrov, Ivan E.; Cheshkov, Sergey; Ren, Jimin; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Dimitrov, Ivan E.] Philips Med Syst, Cleveland, OH USA; [Haller, Ronald G.] North Texas VA Med Ctr, Dept Neurol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Philips; Philips Healthcare; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Heinicke, K (corresponding author), Texas Hlth Presbyterian Hosp, Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA.	katjaheinicke@hotmail.com		Romain, Nadine/0000-0003-2492-549X; Malloy, Craig/0000-0001-5077-0642; Dimitrov, Ivan/0000-0003-2686-6884	Muscular Dystrophy Association; Giant Tiger Foundation; Texas Health Presbyterian Hospital Dallas; National Center for Research Resources; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [DK058398, EB015908]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Giant Tiger Foundation; Texas Health Presbyterian Hospital Dallas; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by the Muscular Dystrophy Association, the Giant Tiger Foundation, Texas Health Presbyterian Hospital Dallas, National Center for Research Resources, and the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health through Grant Number DK058398 and EB015908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ST, 2008, ARCH NEUROL-CHICAGO, V65, P786, DOI 10.1001/archneur.65.6.786; AVISON MJ, 1988, P NATL ACAD SCI USA, V85, P1634, DOI 10.1073/pnas.85.5.1634; BECKMANN N, 1990, MAGN RESON MED, V16, P150, DOI 10.1002/mrm.1910160114; BERGSTROM J, 1966, NATURE, V210, P309, DOI 10.1038/210309a0; Boesch C, 2007, J MAGN RESON IMAGING, V25, P321, DOI 10.1002/jmri.20806; Di Mauro S, 2007, Acta Myol, V26, P35; DIMAURO S, 1979, ANN NEUROL, V5, P422, DOI 10.1002/ana.410050504; Haller R, 2004, MYOLOGY, V3rd, P665; Haller RG, 2004, NEUROLOGY, V62, P82, DOI 10.1212/WNL.62.1.82; Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395; Haller RG, 2006, ANN NEUROL, V59, P922, DOI 10.1002/ana.20881; JEHENSON P, 1995, J CHIM PHYS PCB, V92, P1797, DOI 10.1051/jcp/1995921797; Jehenson P, 1991, Neuromuscul Disord, V1, P99, DOI 10.1016/0960-8966(91)90056-X; Kreis R, 1997, PROG NUCL MAG RES SP, V31, P155, DOI 10.1016/S0079-6565(97)00014-9; Lucia A, 2008, NAT CLIN PRACT NEURO, V4, P568, DOI 10.1038/ncpneuro0913; Mate-Munoz JL, 2007, CLIN J SPORT MED, V17, P297; MENDEZ J, 1960, METABOLISM, V9, P184; Murphy E, 2000, NUTR REV, V58, P304, DOI 10.1111/j.1753-4887.2000.tb01825.x; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Sharp LJ, 2014, NEUROL CLIN, V32, P777, DOI 10.1016/j.ncl.2014.05.001; Stephenson MC, 2011, WORLD J RADIOL, V3, P105, DOI 10.4329/wjr.v3.i4.105; TAYLOR R, 1992, MAGNET RESON MED, V27, P13, DOI 10.1002/mrm.1910270103; VISSING J, 1992, J APPL PHYSIOL, V72, P1773; Wary C, 2003, NEUROMUSCULAR DISORD, V13, P545, DOI 10.1016/S0960-8966(03)00069-5; ZANG LH, 1990, BIOCHEMISTRY-US, V29, P6815, DOI 10.1021/bi00481a009	25	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108706	10.1371/journal.pone.0108706	http://dx.doi.org/10.1371/journal.pone.0108706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296331	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000018
J	Jaspard, E; Hunault, G				Jaspard, Emmanuel; Hunault, Gilles			Comparison of Amino Acids Physico-Chemical Properties and Usage of Late Embryogenesis Abundant Proteins, Hydrophilins and WHy Domain	PLOS ONE			English	Article							LEA PROTEINS; DESICCATION; WATER; BINDING; STRESS; EXPRESSION; MEMBRANE; DATABASE; SURFACE; FAMILY	Late Embryogenesis Abundant proteins (LEAPs) comprise several diverse protein families and are mostly involved in stress tolerance. Most of LEAPs are intrinsically disordered and thus poorly functionally characterized. LEAPs have been classified and a large number of their physico-chemical properties have been statistically analyzed. LEAPs were previously proposed to be a subset of a very wide family of proteins called hydrophilins, while a domain called WHy (Water stress and Hypersensitive response) was found in LEAP class 8 (according to our previous classification). Since little is known about hydrophilins and WHy domain, the cross-analysis of their amino acids physico-chemical properties and amino acids usage together with those of LEAPs helps to describe some of their structural features and to make hypothesis about their function. Physico-chemical properties of hydrophilins and WHy domain strongly suggest their role in dehydration tolerance, probably by interacting with water and small polar molecules. The computational analysis reveals that LEAP class 8 and hydrophilins are distinct protein families and that not all LEAPs are a protein subset of hydrophilins family as proposed earlier. Hydrophilins seem related to LEAP class 2 (also called dehydrins) and to Heat Shock Proteins 12 (HSP12). Hydrophilins are likely unstructured proteins while WHy domain is structured. LEAP class 2, hydrophilins and WHy domain are thus proposed to share a common physiological role by interacting with water or other polar/charged small molecules, hence contributing to dehydration tolerance.	[Jaspard, Emmanuel] Univ Angers, UMR IRHS 1345, SFR QUASAV 4207, F-49045 Angers, France; [Jaspard, Emmanuel] INRA, UMR IRHS 1345, Beaucouze, France; [Jaspard, Emmanuel] Agrocampus Ouest, UMR IRHS 1345, Angers, France; [Hunault, Gilles] Univ Angers, Lab Hemodynam Interact Fibrose & Invasiv Tumorale, UPRES 3859, IFR 132, F-49045 Angers, France	Universite d'Angers; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers	Jaspard, E (corresponding author), Univ Angers, UMR IRHS 1345, SFR QUASAV 4207, F-49045 Angers, France.	emmanuel.jaspard@univ-angers.fr			Universite d'Angers	Universite d'Angers	This work was supported by a grant from Universite d'Angers "Decouverte de motifs souples au sein de classes de proteines intrinsequement non structurees ou pleinement structurees". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh MK, 2005, PLANT CELL ENVIRON, V28, P1114, DOI 10.1111/j.1365-3040.2005.01348.x; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Boucher V, 2010, PLANT CELL ENVIRON, V33, P418, DOI 10.1111/j.1365-3040.2009.02093.x; Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Ciccarelli FD, 2005, BIOINFORMATICS, V21, P1304, DOI 10.1093/bioinformatics/bti221; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Dang NX, 2014, PLANTA, V240, P325, DOI 10.1007/s00425-014-2089-z; Dang NX, 2011, CRYOBIOLOGY, V62, P188, DOI 10.1016/j.cryobiol.2011.03.002; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; Eriksson UK, 2013, SCIENCE, V340, P1346, DOI 10.1126/science.1234306; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695; GALAU GA, 1981, BIOCHEMISTRY-US, V20, P4169, DOI 10.1021/bi00517a034; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Hara M, 2004, PLANT PHYSIOL BIOCH, V42, P657, DOI 10.1016/j.plaphy.2004.06.004; He SY, 1996, PLANT PHYSIOL, V112, P865, DOI 10.1104/pp.112.3.865; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hughes SL, 2013, PLANT PHYSIOL, V163, P1376, DOI 10.1104/pp.113.226803; Hunault G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-221; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jaspard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036968; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kruger C, 2002, J BIOL CHEM, V277, P25062, DOI 10.1074/jbc.M201896200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li DX, 2009, BIOMACROMOLECULES, V10, P1469, DOI 10.1021/bm9002688; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Lopez-Martinez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033324; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rahman LN, 2013, BBA-BIOMEMBRANES, V1828, P967, DOI 10.1016/j.bbamem.2012.11.031; Raschke TM, 2006, CURR OPIN STRUC BIOL, V16, P152, DOI 10.1016/j.sbi.2006.03.002; Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6; Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x; Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x; Rodriguez-Porrata B, 2012, J APPL MICROBIOL, V112, P512, DOI 10.1111/j.1365-2672.2011.05219.x; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Teixeira J, 2009, GEN PHYSIOL BIOPHYS, V28, P168, DOI 10.4149/gpb_2009_02_168; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	65	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109570	10.1371/journal.pone.0109570	http://dx.doi.org/10.1371/journal.pone.0109570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296175	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000080
J	Leng, YX; Zhang, K; Fan, J; Yi, M; Ge, QG; Chen, L; Zhang, L; Yao, GQ				Leng, Yuxin; Zhang, Kuo; Fan, Jie; Yi, Min; Ge, Qinggang; Chen, Li; Zhang, Lu; Yao, Gaiqi			Effect of Acute, Slightly Increased Intra-Abdominal Pressure on Intestinal Permeability and Oxidative Stress in a Rat Model	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; CRITICALLY-ILL PATIENTS; BACTERIAL TRANSLOCATION; INTERNATIONAL-CONFERENCE; BLOOD-FLOW; HYPERTENSION; GUT; INJURY; ISCHEMIA; HYPOPERFUSION	Introduction: Intra-abdominal hypertension (IAH) is known as a common, serious complication in critically ill patients. Bacterial translocation and permeability changes are considered the pathophysiological bases for IAH-induced enterogenic endotoxemia and subsequent multiorgan failure. Nevertheless, the effects of slightly elevated intra-abdominal pressures (IAPs) on the intestinal mucosa and the associated mechanisms remain unclear. Methods: To investigate the acute effects of different nitrogen pneumoperitoneum grades on colonic mucosa, male Sprague-Dawley rats were assigned to six groups with different IAPs (0 [control], 4, 8, 12, 16, and 20 mmHg, n=6/group). During 90 min of exposure, we dynamically monitored the heart rate and noninvasive hemodynamic parameters. After gradual decompression, arterial blood gas analyses were conducted. Thereafter, structural injuries to the colonic mucosa were identified using light microscopy. Colon permeability was determined using the expression of tight junction proteins, combined with fluorescein isothiocyanate dextran (FD-4) absorption. The pro-oxidant-antioxidant balance was determined based on the levels of malondialdehyde (MDA) and antioxidant enzymes. Results: IAH significantly affected the histological scores of the colonic mucosa, tight junction protein expression, mucosal permeability, and pro-oxidant-antioxidant balance. Interestingly, elevations of IAP that were lower than the threshold for IAH also showed a similar, undesirable effect. In the 8 mmHg group, mild hyponatremia, hypocalcemia, and hypoxemia occurred, accompanied by reduced blood and abdominal perfusion pressures. Mild microscopic inflammatory infiltration and increased MDA levels were also detected. Moreover, an 8-mm Hg IAP markedly inhibited the expression of tight junction proteins, although no significant differences in FD-4 permeability were observed between the 0- and 8-mmHg groups. Conclusions: Acute exposure to slightly elevated IAP may result in adverse effects on intestinal permeability and the pro-oxidant-antioxidant balance. Therefore, in patients with critical illnesses, IAP should be dynamically monitored and corrected, as soon as possible, to prevent intestinal mucosal injury and subsequent gut-derived sepsis.	[Leng, Yuxin; Fan, Jie; Yi, Min; Ge, Qinggang; Yao, Gaiqi] Peking Univ, Hosp 3, Dept Intens Care Unit, Beijing 100871, Peoples R China; [Zhang, Kuo] Peking Univ, Hlth Sci Ctr, Lab Anim Ctr, Beijing 100871, Peoples R China; [Chen, Li] Peking Univ, Hosp 3, Dept Cent Lab, Beijing 100871, Peoples R China; [Zhang, Lu] Peking Univ, Hosp 3, Dept Gastroenterol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Leng, YX (corresponding author), Peking Univ, Hosp 3, Dept Intens Care Unit, Beijing 100871, Peoples R China.	Lengyuxin1980@126.com; bngzhaoo@126.com	leng, yuxin/AFS-0190-2022	leng, yuxin/0000-0001-5634-8936	Peking University - Tsinghua University Joint Center for Life Sciences; Beijing science and technology plan [Z141107002514020]	Peking University - Tsinghua University Joint Center for Life Sciences; Beijing science and technology plan	The work was supported by the following: Peking University - Tsinghua University Joint Center for Life Sciences and Beijing science and technology plan - Z141107002514020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahrani AZ, 2010, PANCREAS, V39, P1064, DOI 10.1097/MPA.0b013e3181da8d51; Ameloot K, 2012, SURG CLIN N AM, V92, P207, DOI 10.1016/j.suc.2012.01.009; Baroncini S, 2002, Minerva Anestesiol, V68, P406; Blobner M, 1999, ANASTH INTENSIV NOTF, V34, P94; Cheatham ML, 2007, INTENS CARE MED, V33, P951, DOI 10.1007/s00134-007-0592-4; Cheng Jun-tao, 2003, Zhonghua Shao Shang Za Zhi, V19, P229; Cheng JT, 2013, CRIT CARE, V17, DOI 10.1186/cc13146; Chionh JJL, 2006, ANZ J SURG, V76, P1106, DOI 10.1111/j.1445-2197.2006.03849.x; Claiborne Robert A, 1985, CRC HDB METHODS OXYG, P283; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; DEITCH EA, 1990, J TRAUMA, V30, pS184; DEITCH EA, 1990, SURGERY, V107, P411; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; DEVASAGAYAM TPA, 1986, BIOCHIM BIOPHYS ACTA, V876, P507, DOI 10.1016/0005-2760(86)90038-X; DIEBEL LN, 1992, J TRAUMA, V33, P45, DOI 10.1097/00005373-199207000-00010; Duzgun AP, 2006, DIGEST DIS SCI, V51, P2400, DOI 10.1007/s10620-006-9334-7; Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002; Fanning AS, 1999, J AM SOC NEPHROL, V10, P1337; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gong GW, 2011, J TRAUMA, V70, P775, DOI 10.1097/TA.0b013e318210fa1c; Gong GW, 2009, J INVEST SURG, V22, P362, DOI 10.1080/08941930903214719; Gong GW, 2009, FREE RADICAL RES, V43, P470, DOI 10.1080/10715760902846157; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; Ihtiyar E, 2011, J SURG RES, V167, P113, DOI 10.1016/j.jss.2009.09.048; IKEDA K, 1991, LAB ANIM-UK, V25, P26, DOI 10.1258/002367791780808176; Kao RLC, 2011, J TRAUMA, V71, pS456, DOI 10.1097/TA.0b013e318232e782; Kaussen T, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S17; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Kim IB, 2012, ANAESTH INTENS CARE, V40, P79, DOI 10.1177/0310057X1204000107; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Kotidis E, 2012, J SURG RES, V176, P102, DOI 10.1016/j.jss.2011.07.020; Li GZ, 2012, WORLD J GASTROENTERO, V18, P5042, DOI 10.3748/wjg.v18.i36.5042; Madl C, 2003, BEST PRACT RES CL GA, V17, P445, DOI 10.1016/S1521-6918(03)00022-2; Malbrain MLNG, 2006, INTENS CARE MED, V32, P1722, DOI 10.1007/s00134-006-0349-5; Marshall JC, 1998, CAN J PHYSIOL PHARM, V76, P479, DOI 10.1139/cjpp-76-5-479; Mogilner JG, 2008, EUR J PEDIATR SURG, V18, P380, DOI 10.1055/s-2008-1038920; Moore-Olufemi SD, 2005, SHOCK, V23, P571, DOI 10.1097/01.shk.0000161388.61935.e6; Olofsson PH, 2009, CRIT CARE MED, V37, P230, DOI 10.1097/CCM.0b013e318192ff51; Ortiz-Diaz E, 2014, SHOCK, V41, P175, DOI 10.1097/SHK.0000000000000100; PARK PO, 1990, SURGERY, V107, P574; Polat CK, 2003, YONSEI MED J, V44, P259, DOI 10.3349/ymj.2003.44.2.259; Sanchez NC, 2001, AM SURGEON, V67, P243; Schachtrupp A, 2007, ACTA CLIN BELG, V62, P225, DOI 10.1179/acb.2007.62.s1.031; Scheffe H, 1959, ANAL VARIANCE; SFEZ M, 1995, PAEDIATR ANAESTH, V5, P89, DOI 10.1111/j.1460-9592.1995.tb00250.x; Shen WF, 2009, PHARMACOL RES, V60, P296, DOI 10.1016/j.phrs.2009.04.007; SHIROYAMA Y, 1991, Neurological Surgery, V19, P407; Sugerman H, 1997, J INTERN MED, V241, P71, DOI 10.1046/j.1365-2796.1997.89104000.x; Sukhotnik I, 2006, J LAPAROENDOSC ADV S, V16, P404, DOI 10.1089/lap.2006.16.404; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Vogel HG, 2007, DRUG DISCOVERY EVALU, V3rd; Wang L, 2007, AM J PHYSIOL-GASTR L, V292, pG1559, DOI 10.1152/ajpgi.00567.2006; Yagci Gokhan, 2005, J Chin Med Assoc, V68, P172	53	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109350	10.1371/journal.pone.0109350	http://dx.doi.org/10.1371/journal.pone.0109350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295715	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000063
J	Booher, RN; Hatch, H; Dolinski, BM; Nguyen, T; Harmonay, L; Al-Assaad, AS; Ayers, M; Nebozhyn, M; Loboda, A; Hirsch, HA; Zhang, T; Shi, B; Merkel, CE; Angagaw, MH; Wang, YL; Long, BJ; Lennon, XQ; Miselis, N; Pucci, V; Monahan, JW; Lee, J; Kondic, AG; Im, EK; Mauro, D; Blanchard, R; Gilliland, G; Fawell, SE; Zawel, L; Schuller, AG; Strack, P				Booher, Robert N.; Hatch, Harold; Dolinski, Brian M.; Nguyen, Thi; Harmonay, Lauren; Al-Assaad, Ali-Samer; Ayers, Mark; Nebozhyn, Michael; Loboda, Andrey; Hirsch, Heather A.; Zhang, Theresa; Shi, Bin; Merkel, Carrie E.; Angagaw, Minilik H.; Wang, Yaolin; Long, Brian J.; Lennon, Xianlu Q.; Miselis, Nathan; Pucci, Vincenzo; Monahan, James W.; Lee, Junghoon; Kondic, Anna Georgieva; Im, Eun Kyung; Mauro, David; Blanchard, Rebecca; Gilliland, Gary; Fawell, Stephen E.; Zawel, Leigh; Schuller, Alwin G.; Strack, Peter			MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; CELL-CYCLE; SCH 727965; POTENT; PROLIFERATION; EXPRESSION; MECHANISM; ABT-263; GROWTH; BAX	Dinaciclib is a potent CDK1, 2, 5 and 9 inhibitor being developed for the treatment of cancer. Additional understanding of antitumor mechanisms and identification of predictive biomarkers are important for its clinical development. Here we demonstrate that while dinaciclib can effectively block cell cycle progression, in vitro and in vivo studies, coupled with mouse and human pharmacokinetics, support a model whereby induction of apoptosis is a main mechanism of dinaciclib's antitumor effect and relevant to the clinical duration of exposure. This was further underscored by kinetics of dinaciclib-induced downregulation of the antiapoptotic BCL2 family member MCL1 and correlation of sensitivity with the MCL1-to-BCLxL mRNA ratio or MCL1 amplification in solid tumor models in vitro and in vivo. This MCL1-dependent apoptotic mechanism was additionally supported by synergy with the BCL2, BCL-xL and BCL-w inhibitor navitoclax (ABT-263). These results provide the rationale for investigating MCL1 and BCL-xL as predictive biomarkers for dinaciclib antitumor response and testing combinations with BCL2 family member inhibitors.	[Booher, Robert N.; Hatch, Harold; Dolinski, Brian M.; Nguyen, Thi; Harmonay, Lauren; Al-Assaad, Ali-Samer; Fawell, Stephen E.; Zawel, Leigh; Strack, Peter] Merck Res Labs, Discovery Oncol, Boston, MA 02115 USA; [Ayers, Mark; Nebozhyn, Michael; Loboda, Andrey; Hirsch, Heather A.; Zhang, Theresa] Merck Res Labs, BioInformatics, Boston, MA USA; [Shi, Bin; Merkel, Carrie E.; Angagaw, Minilik H.; Wang, Yaolin; Long, Brian J.; Schuller, Alwin G.] Merck Res Labs, In Vivo Pharmacol, Boston, MA USA; [Lennon, Xianlu Q.; Miselis, Nathan] Merck Res Labs, Biomarkers, Boston, MA USA; [Pucci, Vincenzo; Monahan, James W.] Merck Res Labs, Pharmacokinet Pharmacodynam & Drug Metab, Boston, MA USA; [Lee, Junghoon; Kondic, Anna Georgieva] Merck Res Labs, Quantitat Pharmacol & Pharmacometr, Boston, MA USA; [Im, Eun Kyung; Mauro, David; Blanchard, Rebecca; Gilliland, Gary] Merck Res Labs, Clin Oncol, Boston, MA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Strack, P (corresponding author), Merck Res Labs, Discovery Oncol, Boston, MA 02115 USA.	cpstrack@verizon.net		Pucci, Vincenzo/0000-0002-1222-8366; Strack, Peter/0000-0003-4042-0416				Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blachly JS, 2013, LEUKEMIA LYMPHOMA, V54, P2133, DOI 10.3109/10428194.2013.783911; Bose P, 2013, EXPERT OPIN INV DRUG, V22, P723, DOI 10.1517/13543784.2013.789859; Cai DP, 2006, CANCER RES, V66, P9270, DOI 10.1158/0008-5472.CAN-06-1758; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Chen R, 2009, BLOOD, V113, P4637, DOI 10.1182/blood-2008-12-190256; Desai BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059588; Feldmann G, 2011, CANCER BIOL THER, V12, P598, DOI 10.4161/cbt.12.7.16475; Fu W, 2011, MOL CANCER THER, V10, P1018, DOI 10.1158/1535-7163.MCT-11-0167; Graidist P, 2004, J BIOL CHEM, V279, P40868, DOI 10.1074/jbc.M401454200; Guha M, 2012, NAT REV DRUG DISCOV, V11, P892, DOI 10.1038/nrd3908; Gutierrez MI, 1999, CANCER RES, V59, P696; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hardwick JS, 2005, MOL CANCER THER, V4, P413; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; Horiuchi D, 2012, P NATL ACAD SCI USA, V109, pE1019, DOI 10.1073/pnas.1111317109; Hussain A, 2003, HAEMATOLOGICA, V88, P167; Johnson AJ, 2012, LEUKEMIA, V26, P2554, DOI 10.1038/leu.2012.144; Kutuk O, 2010, EUR J CANCER, V46, P2494, DOI 10.1016/j.ejca.2010.06.011; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Meijerink JPP, 1998, BLOOD, V91, P2991, DOI 10.1182/blood.V91.8.2991.2991_2991_2997; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; Mita M, 2013, CLIN BREAST CANCER, V10.01, P1; Mpakou VE, 2013, LEUKEMIA RES, V37, P175, DOI 10.1016/j.leukres.2012.10.011; Nemunaitis JJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-259; Nguyen TK, 2014, MOL CANCER THER, V13, P662, DOI 10.1158/1535-7163.MCT-13-0714; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Shi B, 2010, J HISTOTECHNOL, V33, P15, DOI 10.1179/his.2010.33.1.15; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Stephenson JJ, 2014, LUNG CANCER, V83, P219, DOI 10.1016/j.lungcan.2013.11.020; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Thomas LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045088; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559	42	40	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108371	10.1371/journal.pone.0108371	http://dx.doi.org/10.1371/journal.pone.0108371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289887	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000014
J	Dorrie, J; Krug, C; Hofmann, C; Muller, I; Wellner, V; Knippertz, I; Schierer, S; Thomas, S; Zipperer, E; Printz, D; Fritsch, G; Schuler, G; Schaft, N; Geyeregger, R				Doerrie, Jan; Krug, Christian; Hofmann, Christian; Mueller, Ina; Wellner, Verena; Knippertz, Ilka; Schierer, Stephan; Thomas, Simone; Zipperer, Elke; Printz, Dieter; Fritsch, Gerhard; Schuler, Gerold; Schaft, Niels; Geyeregger, Rene			Human Adenovirus-Specific gamma/delta and CD8(+) T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article							TCR GENE-TRANSFER; GAMMA-DELTA; ADOPTIVE IMMUNOTHERAPY; DENDRITIC CELLS; VIRAL-INFECTIONS; IFN-GAMMA; LYMPHOCYTES; ANTIGEN; RNA; CANCER	Human adenovirus infection is life threatening after allogeneic haematopoietic stem cell transplantation (HSCT). Immunotherapy with donor-derived adenovirus-specific T cells is promising; however, 20% of all donors lack adenovirus-specific T cells. To overcome this, we transfected alpha/beta T cells with mRNA encoding a T-cell receptor (TCR) specific for the HLA-A*0101-restricted peptide LTDLGQNLLY from the adenovirus hexon protein. Furthermore, since allo-reactive endogenous TCR of donor T lymphocytes would induce graft-versus-host disease (GvHD) in a mismatched patient, we transferred the TCR into gamma/delta T cells, which are not allo-reactive. TCR-transfected gamma/delta T cells secreted low quantities of cytokines after antigen-specific stimulation, which were increased dramatically after co-transfection of CD8 alpha-encoding mRNA. In direct comparison with TCR-transfected alpha/beta T cells, TCR-CD8 alpha-co-transfected gamma/delta T cells produced more tumor necrosis factor (TNF), and lysed peptide-loaded target cells as efficiently. Most importantly, TCR-transfected alpha/beta T cells and TCR-CD8 alpha-co-transfected gamma/delta T cells efficiently lysed adenovirus-infected target cells. We show here, for the first time, that not only alpha/beta T cells but also gamma/delta T cells can be equipped with an adenovirus specificity by TCR-RNA electroporation. Thus, our strategy offers a new means for the immunotherapy of adenovirus infection after allogeneic HSCT.	[Doerrie, Jan; Krug, Christian; Hofmann, Christian; Mueller, Ina; Wellner, Verena; Schierer, Stephan; Schuler, Gerold; Schaft, Niels] Univ Klinikum Erlangen, Dept Dermatol, Erlangen, Germany; [Knippertz, Ilka] Univ Klinikum Erlangen, Dept Dermatol, Dept Immune Modulat, Erlangen, Germany; [Zipperer, Elke; Printz, Dieter; Fritsch, Gerhard; Geyeregger, Rene] St Anna Kinderkrebsforsch eV, Childrens Canc Res Inst, Vienna, Austria; [Fritsch, Gerhard] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Thomas, Simone] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany; [Krug, Christian; Schuler, Gerold; Schaft, Niels] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Saint Anna Children's Hospital; Medical University of Vienna; University of Regensburg; University of Erlangen Nuremberg	Schaft, N (corresponding author), Univ Klinikum Erlangen, Dept Dermatol, Erlangen, Germany.	niels.schaft@uk-erlangen.de	Schaft, Niels/H-3713-2011; Dörrie, Jan/H-3678-2011; Thomas, Simone/G-7445-2019	Schaft, Niels/0000-0001-8236-9298; Dörrie, Jan/0000-0002-3478-0741; Thomas, Simone/0000-0001-6308-3649	German Research Foundation [DFG] [SCHA-1247/1-1]; Bayerisches Immuntherapie-Netzwerk [D2-F5121.7.1.1/10/12]; Children's Cancer Research Institute in Vienna, Austria	German Research Foundation [DFG](German Research Foundation (DFG)); Bayerisches Immuntherapie-Netzwerk; Children's Cancer Research Institute in Vienna, Austria	This work was supported by the German Research Foundation [DFG SCHA-1247/1-1] to NS, www.dfg.de; Bayerisches Immuntherapie-Netzwerk [D2-F5121.7.1.1/10/12] to NS and JD, www.bayimmunet.de; and the Children's Cancer Research Institute in Vienna, Austria to RG, www.science.ccri.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden Bernhard, 1995, Immunogenetics, V42, P455; Birkholz K, 2009, GENE THER, V16, P596, DOI 10.1038/gt.2008.189; Birkholz K, 2009, J IMMUNOL METHODS, V346, P45, DOI 10.1016/j.jim.2009.05.001; Breuer S, 2012, MOL DIAGN THER, V16, P63, DOI 10.2165/11631490-000000000-00000; Dorrie J, 2008, CANCER IMMUNOL IMMUN, V57, P467, DOI 10.1007/s00262-007-0385-1; Dokouhaki P, 2010, CANCER LETT, V297, P126, DOI 10.1016/j.canlet.2010.05.005; Eiz-Vesper B, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00410; Felzmann T, 2000, CANCER LETT, V161, P241, DOI 10.1016/S0304-3835(00)00618-2; Feuchtinger T, 2006, BRIT J HAEMATOL, V134, P64, DOI 10.1111/j.1365-2141.2006.06108.x; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Geyeregger R, 2014, J IMMUNOTHER, V37, P245, DOI 10.1097/CJI.0000000000000034; Geyeregger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059592; Hanagiri T, 2012, CANCER SCI, V103, P1414, DOI 10.1111/j.1349-7006.2012.02337.x; Hanley PJ, 2009, BLOOD, V114, P1958, DOI 10.1182/blood-2009-03-213256; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Hofmann C, 2008, AIDS, V22, P1577, DOI 10.1097/QAD.0b013e3283063a17; Hoyer S, 2014, EUR J IMMUNOL, V44, P3543, DOI 10.1002/eji.201444477; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Knippertz I, 2009, J IMMUNOTHER, V32, P524, DOI 10.1097/CJI.0b013e3181a28422; Kobayashi H, 2010, ANTICANCER RES, V30, P575; Koh S, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.43; KONING F, 1987, J EXP MED, V166, P595, DOI 10.1084/jem.166.2.595; Krug C, 2014, CANCER IMMUNOL IMMUN, V63, P999, DOI 10.1007/s00262-014-1572-5; Leen AM, 2004, BLOOD, V104, P2432, DOI 10.1182/blood-2004-02-0646; Leen AM, 2013, BLOOD, V121, P5113, DOI 10.1182/blood-2013-02-486324; Leen AM, 2009, BLOOD, V114, P4283, DOI 10.1182/blood-2009-07-232454; Lehner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031210; Matthes-Martin S, 2012, TRANSPL INFECT DIS, V14, P555, DOI 10.1111/tid.12022; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morris EC, 2005, P NATL ACAD SCI USA, V102, P7934, DOI 10.1073/pnas.0500357102; Nakajima J, 2010, EUR J CARDIO-THORAC, V37, P1191, DOI 10.1016/j.ejcts.2009.11.051; Oevermann L, 2012, ANN NY ACAD SCI, V1266, P161, DOI 10.1111/j.1749-6632.2012.06606.x; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; Qasim W, 2011, BRIT J HAEMATOL, V154, P150, DOI 10.1111/j.1365-2141.2011.08579.x; SAITO T, 1988, J EXP MED, V168, P1003, DOI 10.1084/jem.168.3.1003; Salot S, 2009, J IMMUNOL METHODS, V347, P12, DOI 10.1016/j.jim.2009.05.006; Schaft N, 2006, INT IMMUNOL, V18, P591, DOI 10.1093/intimm/dxh401; Schaft N, 2006, CANCER IMMUNOL IMMUN, V55, P1132, DOI 10.1007/s00262-005-0098-2; Schierer S, 2008, INT J CANCER, V122, P219, DOI 10.1002/ijc.23074; Schub A, 2009, J IMMUNOL, V183, P6819, DOI 10.4049/jimmunol.0902233; Siegers GM, 2013, CANCER IMMUNOL IMMUN, V62, P571, DOI 10.1007/s00262-012-1353-y; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Sun CJ, 2011, VACCINE, V29, P3837, DOI 10.1016/j.vaccine.2011.03.042; Symeonidis N, 2007, TRANSPL INFECT DIS, V9, P108, DOI 10.1111/j.1399-3062.2006.00184.x; Thomas S, 2012, EUR J IMMUNOL, V42, P3442, DOI 10.1002/eji.201242666; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Tsuda J, 2011, J IMMUNOL, V186, P2003, DOI 10.4049/jimmunol.1001919; Uhlin M, 2012, CLIN INFECT DIS, V55, P1064, DOI 10.1093/cid/cis625; van der Veken LT, 2009, J IMMUNOL, V182, P164, DOI 10.4049/jimmunol.182.1.164; van der Veken LT, 2006, CANCER RES, V66, P3331, DOI 10.1158/0008-5472.CAN-05-4190; van Lent AU, 2007, J IMMUNOL, V179, P4959, DOI 10.4049/jimmunol.179.8.4959; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	54	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109944	10.1371/journal.pone.0109944	http://dx.doi.org/10.1371/journal.pone.0109944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289687	Green Published, gold			2022-12-27	WOS:000342798000100
J	Sookias, RB; Bohmer, C; Clack, JA				Sookias, Roland B.; Boehmer, Christine; Clack, Jennifer A.			Redescription and Phylogenetic Analysis of the Mandible of an Enigmatic Pennsylvanian (Late Carboniferous) Tetrapod from Nova Scotia, and the Lability of Meckelian Jaw Ossification	PLOS ONE			English	Article							STEM TETRAPOD; CRANIAL MORPHOLOGY; TEMNOSPONDYLI; GREERERPETON; EVOLUTION; ANATOMY; GENUS; SKULL	The lower jaw of an unidentified Pennsylvanian (Late Carboniferous) tetrapod from Nova Scotia - the "Parrsboro jaw" - is redescribed in the light of recent tetrapod discoveries and work on evolution of tetrapod mandibular morphology and placed for the first time in a numerical cladistics analysis. All phylogenetic analyses place the jaw in a crownward polytomy of baphetids, temnospondyls, and embolomeres. Several features resemble baphetids and temnospondyls including dermal ornamentation, absence of coronoid teeth, and presence of coronoid shagreen. Dentary dentition is most similar to Baphetes. An adsymphysial toothplate may not preclude temnospondyl affinity. An apparent large exomeckelian fenestra, with the dorsal foraminal margins formed by an unossified element, echoes the morphology of the stem tetrapod Sigournea and is unusually primitive given the other features of the jaw. The jaw may thus provide an example of an intermediate stage in Meckelian element evolution.	[Sookias, Roland B.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Sookias, Roland B.; Boehmer, Christine] Univ Munich, GeoBioctr, Munich, Germany; [Boehmer, Christine] Univ Munich, Dept Geo & Umweltwissensch, Munich, Germany; [Boehmer, Christine] Bayer Staatssammlung Palaontol & Geol Munchen, Munich, Germany; [Clack, Jennifer A.] Univ Museum Zool Cambridge, Cambridge, England	University of Birmingham; University of Munich; University of Munich; University of Cambridge	Sookias, RB (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	sookias.r.b@gmail.com	Böhmer, Christine/G-2357-2011; Sookias, Roland B./ABC-7840-2021	Böhmer, Christine/0000-0003-1931-0888; Sookias, Roland B./0000-0002-5189-4011	Emmy Noether Programme Award from the Deutschen Forschungsgemeinschaft [BU 2587/3-1]; Studienstiftung des Deutschen Volkes; RIKEN institute; Natural Environment Research Council [NE/J022713/1]; NERC [NE/J022713/1] Funding Source: UKRI	Emmy Noether Programme Award from the Deutschen Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; RIKEN institute; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RBS is supported by an Emmy Noether Programme Award from the Deutschen Forschungsgemeinschaft (BU 2587/3-1) to Dr. Richard J. Butler. CB was supported during completion of this work by a doctoral fellowship of the Studienstiftung des Deutschen Volkes (http://www.studienstiftung.de) as well as a collaborative postdoctoral fellowship of the RIKEN institute (http://www.riken.jp) and the Studienstiftung des Deutschen Volkes. JAC is partially supported by Natural Environment Research Council grant NE/J022713/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Anderson J, 2006, J VERTEBR PALEONTOL, V26, p36A; BAIRD D, 1955, SCIENCE, V122, P202, DOI 10.1126/science.122.3161.202; Beaumont EH, 1998, ZOOL J LINN SOC-LOND, V122, P187, DOI 10.1006/zjls.1997.0118; BEAUMONT EH, 1977, PHILOS T ROY SOC B, V280, P29, DOI 10.1098/rstb.1977.0099; Bolt JR, 2006, J PALEONTOL, V80, P717, DOI 10.1666/0022-3360(2006)80[717:SMANST]2.0.CO;2; Bolt JR, 2001, J PALEONTOL, V75, P1016, DOI 10.1666/0022-3360(2001)075<1016:TMOTPT>2.0.CO;2; Carroll RL, 1972, 24 INT GEOL C; CLACK JA, 1987, PHILOS T ROY SOC B, V318, P1, DOI 10.1098/rstb.1987.0082; Clack JA, 2003, CAN J EARTH SCI, V40, P483, DOI 10.1139/E02-065; Clack JA, 2001, T ROY SOC EDIN-EARTH, V92, P75, DOI 10.1017/S0263593300000055; Clack JA, 2004, RECENT ADV ORIGIN EA, P309; Clack JA, 2012, PALAEONTOLOGY, V55, P73, DOI 10.1111/j.1475-4983.2011.01117.x; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; Damiani R, 2009, ZOOL J LINN SOC-LOND, V155, P348, DOI 10.1111/j.1096-3642.2008.00444.x; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; GODFREY SJ, 1989, CAN J EARTH SCI, V26, P1036, DOI 10.1139/e89-084; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff P, 2008, CLADISTICS, V24, P91; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; GROSS W, 1941, ABHANDLUNGEN PREUSSI, V7, P1; HAWORTH A. H, 1825, PHILOS MAGAZINE J, V65, P372; Heaton M, 1980, CURATOR, V23, P95; Holmes RB, 1998, J VERTEBR PALEONTOL, V18, P64, DOI 10.1080/02724634.1998.10011034; Huxley TH., 1880, P R SOC LOND, V43, P649, DOI DOI 10.1111/J.1469-7998.1869.TB07343.X; Lombard R. Eric, 2006, P21; Milner AC, 1998, ZOOL J LINN SOC-LOND, V122, P211, DOI 10.1111/j.1096-3642.1998.tb02530.x; MILNER AR, 1982, J PALEONTOL, V56, P1302; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Ruta M, 2002, T ROY SOC EDIN-EARTH, V92, P229, DOI 10.1017/S0263593300000249; Sequeira SEK, 2004, T ROY SOC EDIN-EARTH, V94, P21, DOI 10.1017/S0263593300000511; Watson DMS, 1926, PHILOS T R SOC LON B, V214, P189, DOI 10.1098/rstb.1926.0006	34	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109717	10.1371/journal.pone.0109717	http://dx.doi.org/10.1371/journal.pone.0109717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290449	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000082
J	Hardmeier, M; Hatz, F; Bousleiman, H; Schindler, C; Stam, CJ; Fuhr, P				Hardmeier, Martin; Hatz, Florian; Bousleiman, Habib; Schindler, Christian; Stam, Cornelis Jan; Fuhr, Peter			Reproducibility of Functional Connectivity and Graph Measures Based on the Phase Lag Index (PLI) and Weighted Phase Lag Index (wPLI) Derived from High Resolution EEG	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; INTRACLASS CORRELATION-COEFFICIENT; RESTING-STATE NETWORKS; THEORETICAL ANALYSIS; VOLUME-CONDUCTION; ELECTROENCEPHALOGRAPHIC RECORDINGS; BRAIN NETWORKS; MEG; SYNCHRONIZATION; OSCILLATIONS	Functional connectivity (FC) and graph measures provide powerful means to analyze complex networks. The current study determines the inter-subject-variability using the coefficient of variation (CoV) and long-term test-retest-reliability (TRT) using the intra-class correlation coefficient (ICC) in 44 healthy subjects with 35 having a follow-up at years 1 and 2. FC was estimated from 256-channel-EEG by the phase-lag-index (PLI) and weighted PLI (wPLI) during an eyes-closed resting state condition. PLI quantifies the asymmetry of the distribution of instantaneous phase differences of two time-series and signifies, whether a consistent non-zero phase lag exists. WPLI extends the PLI by additionally accounting for the magnitude of the phase difference. Signal-space global and regional PLI/wPLI and weighted first-order graph measures, i.e. normalized clustering coefficient (gamma), normalized average path length (lambda), and the small-world-index (SWI) were calculated for theta-, alpha1-, alpha2- and beta-frequency bands. Inter-subject variability of global PLI was low to moderate over frequency bands (0.12<CoV<0.28), higher for wPLI (0.25<CoV<0.55) and very low for gamma, lambda and SWI (CoV<0.048). TRT was good to excellent for global PLI/wPLI (0.68<ICC<0.80), regional PLI/wPLI (0.58<ICC<0.77), and fair to good for graph measures (0.32<ICC<0.73) except wPLI-based lambda in alpha1 (ICC = 0.12). Inter-electrode distance correlated very weakly with inter-electrode PLI (-0.06<rho<0) and weakly with inter-electrode wPLI (-0.22<rho<-0.18). Global PLI/wPLI and topographic connectivity patterns differed between frequency bands, and all individual networks showed a small-world-configuration. PLI/wPLI based network characterization derived from high-resolution EEG has apparently good reliability, which is one important requirement for longitudinal studies exploring the effects of chronic brain diseases over several years.	[Hardmeier, Martin; Hatz, Florian; Bousleiman, Habib; Fuhr, Peter] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Bousleiman, Habib; Schindler, Christian] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Stam, Cornelis Jan] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol & Magnetoencephalog, Amsterdam, Netherlands	University of Basel; University of Basel; Swiss Tropical & Public Health Institute; Vrije Universiteit Amsterdam	Fuhr, P (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	peter.fuhr@usb.ch	Hardmeier, Martin/ABE-9351-2020; Schindler, Christian/D-3472-2015	Hardmeier, Martin/0000-0003-1451-7337; Stam, Cornelis/0000-0001-9163-7274	Swiss National Science Foundation [33CM30_124115, 326030_128775, 33CM30_140338]; Novartis Research Foundation [09B35]; Swiss Multiple Sclerosis Society	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Research Foundation; Swiss Multiple Sclerosis Society	The study has been supported by the Swiss National Science Foundation (grants 33CM30_124115, 326030_128775 and 33CM30_140338), Novartis Research Foundation (grant 09B35), and the Swiss Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atenafu EG, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-126; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; da Silva FL, 2013, NEURON, V80, P1112, DOI 10.1016/j.neuron.2013.10.017; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; de Waal H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086558; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Dubbelink KTEO, 2014, BRAIN, V137, P197, DOI 10.1093/brain/awt316; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hardmeier M, 2014, CLIN NEUROPHYSIOL, V125, pS56; Hatz F, 2014, CLIN NEUROPHYSIOL; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jin SH, 2011, J NEUROPHYSIOL, V106, P2888, DOI 10.1152/jn.00335.2011; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kondacs A, 1999, CLIN NEUROPHYSIOL, V110, P1708, DOI 10.1016/S1388-2457(99)00122-4; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Laufs H, 2008, HUM BRAIN MAPP, V29, P762, DOI 10.1002/hbm.20600; Malmivuo J, 2012, BRAIN TOPOGR, V25, P1, DOI 10.1007/s10548-011-0202-1; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Meunier D, 2014, NEUROBIOL AGING, V35, P42, DOI 10.1016/j.neurobiolaging.2013.07.003; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; Napflin M, 2007, CLIN NEUROPHYSIOL, V118, P2519, DOI 10.1016/j.clinph.2007.07.022; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026121; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez P, 2010, BRAIN MIND STRUCTURE; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Okada Y, 1999, CLIN NEUROPHYSIOL, V110, P214, DOI 10.1016/S0013-4694(98)00111-4; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Peraza LR, 2012, J NEUROSCI METH, V207, P189, DOI 10.1016/j.jneumeth.2012.04.007; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Rouhinen S, 2013, J NEUROSCI, V33, P19023, DOI 10.1523/JNEUROSCI.1666-13.2013; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Schutte NM, 2013, TWIN RES HUM GENET, V16, P962, DOI 10.1017/thg.2013.55; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Tewarie P, 2014, NEUROIMAGE, V88, P308, DOI 10.1016/j.neuroimage.2013.10.022; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027	63	121	123	10	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108648	10.1371/journal.pone.0108648	http://dx.doi.org/10.1371/journal.pone.0108648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286380	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000345743700026
J	Iwasaki, K; Sudo, H; Yamada, K; Higashi, H; Ohnishi, T; Tsujimoto, T; Iwasaki, N				Iwasaki, Koji; Sudo, Hideki; Yamada, Katsuhisa; Higashi, Hideaki; Ohnishi, Takashi; Tsujimoto, Takeru; Iwasaki, Norimasa			Effects of Single Injection of Local Anesthetic Agents on Intervertebral Disc Degeneration: Ex Vivo and Long-Term In Vivo Experimental Study	PLOS ONE			English	Article							RABBIT MODEL; CULTURE-SYSTEM; CASPASE 3; BUPIVACAINE; VITRO; CHONDROCYTES; DISCOGRAPHY; CELLS; VIABILITY; EXPOSURE	Background: Analgesic discography (discoblock) can be used to diagnose or treat discogenic low back pain by injecting a small amount of local anesthetics. However, recent in vitro studies have revealed cytotoxic effects of local anesthetics on intervertebral disc (IVD) cells. Here we aimed to investigate the deteriorative effects of lidocaine and bupivacaine on rabbit IVDs using an organotypic culture model and an in vivo long-term follow-up model. Methods: For the organotypic culture model, rabbit IVDs were harvested and cultured for 3 or 7 days after intradiscal injection of local anesthetics (1% lidocaine or 0.5% bupivacaine). Nucleus pulposus (NP) cell death was measured using confocal microscopy. Histological and TUNEL assays were performed. For in vivo study, each local anesthetic was injected into rabbit lumbar IVDs under a fluoroscope. Six or 12 months after the injection, each IVD was prepared for magnetic resonance imaging (MRI) and histological analysis. Results: In the organotypic culture model, both anesthetic agents induced time-dependent NP cell death; when compared with injected saline solution, significant effects were detected within 7 days. Compared with the saline group, TUNEL-positive NP cells were significantly increased in the bupivacaine group. In the in vivo study, MRI analysis did not show any significant difference. Histological analysis revealed that IVD degeneration occurred to a significantly level in the saline-and local anesthetics-injected groups compared with the untreated control or puncture-only groups. However, there was no significant difference between the saline and anesthetic agents groups. Conclusions/Significance: In the in vivo model using healthy IVDs, there was no strong evidence to suggest that discoblock with local anesthetics has the potential of inducing IVD degeneration other than the initial mechanical damage of the pressurized injection. Further studies should be performed to investigate the deteriorative effects of the local injection of analgesic agents on degenerated IVDs.	[Iwasaki, Koji; Yamada, Katsuhisa; Ohnishi, Takashi; Tsujimoto, Takeru; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Sudo, Hideki] Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan; [Higashi, Hideaki] Hokkaido Univ, Res Ctr Zoonosis Control, Div Infect & Immun, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Sudo, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan.	hidekisudo@yahoo.co.jp	Sudo, Hideki/G-2748-2012; Higashi, Hideaki/F-6872-2012	Iwasaki, Koji/0000-0002-4525-9150	Nakatomi Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26670651] Funding Source: KAKEN	Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding support from Nakatomi Foundation (http://www.nakatomi.or.jp/en/index.html) and Takeda Science Foundation (http://www.takeda-sci.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayda-Bruno M, 2014, EUR SPINE J, V23, pS315, DOI 10.1007/s00586-013-2960-9; Carragee EJ, 2006, SPINE, V31, P505, DOI 10.1097/01.brs.0000201242.85984.76; Carragee EJ, 2006, SPINE, V31, P2115, DOI 10.1097/01.brs.0000231436.30262.dd; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Chee AV, 2014, SPINE J, V14, P491, DOI 10.1016/j.spinee.2013.06.095; Chu CR, 2006, ARTHROSCOPY, V22, P693, DOI 10.1016/j.arthro.2006.05.006; Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Grishko V, 2010, J BONE JOINT SURG AM, V92A, P609, DOI 10.2106/JBJS.H.01847; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; Haschtmann D, 2006, SPINE, V31, P2918, DOI 10.1097/01.brs.0000247954.69438.ae; Iwasaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092442; Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d; Leckie SK, 2012, SPINE J, V12, P7, DOI 10.1016/j.spinee.2011.09.011; Lee H, 2010, SPINE J, V10, P159, DOI 10.1016/j.spinee.2009.08.445; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Mo JH, 2013, CLIN EXP OTORHINOLAR, V6, P82, DOI 10.3342/ceo.2013.6.2.82; Moon JH, 2012, SPINE J, V12, P665, DOI 10.1016/j.spinee.2012.06.009; Ohtori S, 2013, ASIAN SPINE J, V7, P212, DOI 10.4184/asj.2013.7.3.212; Ohtori Seiji, 2009, Spine (Phila Pa 1976), V34, P1345, DOI 10.1097/BRS.0b013e3181a401bf; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Quero L, 2011, SPINE J, V11, P46, DOI 10.1016/j.spinee.2010.11.001; Sowa G, 2008, SPINE, V33, P1821, DOI 10.1097/BRS.0b013e31817e2ce3; Sowa GA, 2012, SPINE J, V12, P674, DOI 10.1016/j.spinee.2012.08.017; Sudo H, 2011, ARTHRITIS RHEUM-US, V63, P1648, DOI 10.1002/art.30251; Sumida K, 1999, SPINE, V24, P1066, DOI 10.1097/00007632-199906010-00004; Wang D, 2011, SPINE J, V11, P139, DOI 10.1016/j.spinee.2010.11.017; Yamada K, 2014, AM J PATHOL, V184, P753, DOI 10.1016/j.ajpath.2013.11.010	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109851	10.1371/journal.pone.0109851	http://dx.doi.org/10.1371/journal.pone.0109851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286407	Green Published, gold			2022-12-27	WOS:000345743700096
J	Sun, C; Roboti, P; Puumalainen, MR; Fryknas, M; Wang, X; D'Arcy, P; Hult, M; High, S; Linder, S; Swanton, E				Sun, Chao; Roboti, Peristera; Puumalainen, Marjo-Riitta; Fryknas, Marten; Wang, Xin; D'Arcy, Padraig; Hult, Malin; High, Stephen; Linder, Stig; Swanton, Eileithyia			Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases	PLOS ONE			English	Article							NEWLY SYNTHESIZED PROTEINS; HEAT-SHOCK; CANCER-THERAPY; COTRANSLATIONAL TRANSLOCATION; ENDOPLASMIC-RETICULUM; PROTEOTOXIC STRESS; MULTIPLE-MYELOMA; QUALITY-CONTROL; DEGRADATION; SYSTEM	Inhibitors of the catalytic activity of the 20S proteasome are cytotoxic to tumor cells and are currently in clinical use for treatment of multiple myeloma, whilst the deubiquitinase activity associated with the 19S regulatory subunit of the proteasome is also a valid target for anti-cancer drugs. The mechanisms underlying the therapeutic efficacy of these drugs and their selective toxicity towards cancer cells are not known. Here, we show that increasing the cellular levels of proteasome substrates using an inhibitor of Sec61-mediated protein translocation significantly increases the extent of apoptosis that is induced by inhibition of proteasomal deubiquitinase activity in both cancer derived and non-transformed cell lines. Our results suggest that increased generation of misfolded proteasome substrates may contribute to the mechanism(s) underlying the increased sensitivity of tumor cells to inhibitors of the ubiquitin-proteasome system.	[Sun, Chao; Wang, Xin; D'Arcy, Padraig; Linder, Stig] Karolinska Inst, Dept Pathol & Oncol, Canc Ctr Karolinska, Stockholm, Sweden; [Roboti, Peristera; Puumalainen, Marjo-Riitta; High, Stephen; Swanton, Eileithyia] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Fryknas, Marten] Uppsala Univ, Dept Med Sci, Div Clin Pharmacol, Uppsala, Sweden; [Hult, Malin] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden	Karolinska Institutet; University of Manchester; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Swanton, E (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	lisa.swanton@manchester.ac.uk	D'Arcy, Pádraig/AAB-5045-2019; D'Arcy, Pádraig/F-7633-2018	D'Arcy, Pádraig/0000-0001-6671-7600; D'Arcy, Pádraig/0000-0001-6671-7600; Roboti, Peristera/0000-0002-3360-9088; High, Stephen/0000-0002-4532-8152; Swanton, Eileithyia/0000-0002-3299-4228	Cancerfonden; Cancerforeningen in Stockholm; Vetenskapsradet [LSHC-CT-2007-037665]; King Gustav V Jubilee Foundation; Wellcome Trust [081671/B/06/Z]	Cancerfonden(Swedish Cancer Society); Cancerforeningen in Stockholm; Vetenskapsradet(Swedish Research Council); King Gustav V Jubilee Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by Cancerfonden www.cancerfonden.se, Cancerforeningen in Stockholm www.rahfo.se, Vetenskapsradet www.vr.se, EU FP6 (LSHC-CT-2007-037665) http://ec.europa.eu/programmes/horizon2020/, King Gustav V Jubilee Foundation and the Wellcome Trust (081671/B/06/Z) www.wellcome.ac.uk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2002, CURR OPIN ONCOL, V14, P628, DOI 10.1097/00001622-200211000-00007; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Berndtsson M, 2009, INT J CANCER, V124, P1463, DOI 10.1002/ijc.24004; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Brnjic S, 2014, ANTIOXID REDOX SIGN, V21, P2271, DOI 10.1089/ars.2013.5322; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Caravita T, 2006, NAT CLIN PRACT ONCOL, V3, P374, DOI 10.1038/ncponc0555; Chakrabarti O, 2011, MOL BIOL CELL, V22, P1625, DOI 10.1091/mbc.E10-07-0638; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; D'Arcy P, 2012, INT J BIOCHEM CELL B, V44, P1729, DOI 10.1016/j.biocel.2012.07.011; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gabai VL, 2005, ONCOGENE, V24, P3328, DOI 10.1038/sj.onc.1208495; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Hagg M, 2002, INVEST NEW DRUG, V20, P253, DOI 10.1023/A:1016249728664; Harant H, 2007, MOL PHARMACOL, V71, P1657, DOI 10.1124/mol.107.034249; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lashuel HA, 2005, SCI AGING KNOWLEDGE, V2005, ppe28; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Neznanov N, 2011, ONCOTARGET, V2, P209, DOI 10.18632/oncotarget.246; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P219, DOI 10.1379/CSC-278.1; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Oromendia AB, 2014, DIS MODEL MECH, V7, P15, DOI 10.1242/dmm.013391; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Salomons FA, 2009, MOL CELL BIOL, V29, P1774, DOI 10.1128/MCB.01485-08; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; Williams SA, 2003, CANCER RES, V63, P7338; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108839	10.1371/journal.pone.0108839	http://dx.doi.org/10.1371/journal.pone.0108839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286379	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700036
J	McCasker, N; Humphries, P; Meredith, S; Klomp, N				McCasker, Nicole; Humphries, Paul; Meredith, Shaun; Klomp, Nicholas			Contrasting Patterns of Larval Mortality in Two Sympatric Riverine Fish Species: A Test of the Critical Period Hypothesis	PLOS ONE			English	Article							EARLY-LIFE; SURVIVAL; SIZE; RECRUITMENT; RATES; ONTOGENY; BEHAVIOR; GROWTH; HYPSELEOTRIS; TEMPERATURE	Understanding the causal mechanisms that determine recruitment success is critical to the effective conservation of wild fish populations. Although recruitment strength is likely determined during early life when mortality is greatest, few studies have documented age-specific mortality rates for fish during this period. We investigated age-specific mortality of individual cohorts of two species of riverine fish from yolksac larvae to juveniles, assaying for the presence of a "critical period": A time when mortality is unusually high. Early life stages of carp gudgeons (Hypseleotris spp.) and unspecked hardyhead (Craterocephalus stercusmuscarum fulvus)-two fishes that differ in fecundity, egg size and overlap between endogenous and exogenous feeding-were collected every second day for four months. We fitted survivorship curves to 22 carp gudgeon and 15 unspecked hardyhead four-day cohorts and tested several mortality functions. Mortality rates declined with age for carp gudgeon, with mean instantaneous mortality rates (-Z) ranging from 1.40-0.03. In contrast, mortality rates for unspecked hardyhead were constant across the larval period, with a mean -Z of 0.15. There was strong evidence of a critical period for carp gudgeon larvae from hatch until 6 days old, and no evidence of a critical period for unspecked hardyhead. Total larval mortality for carp gudgeon and unspecked hardyhead up to 24 days of age was estimated to be 97.8 and 94.3%, respectively. We hypothesise that life history strategy may play an important role in shaping overall mortality and the pattern of mortality during early life in these two fishes.	[McCasker, Nicole; Humphries, Paul] Charles Sturt Univ, Sch Environm Sci, Albury, NSW, Australia; [McCasker, Nicole; Humphries, Paul] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia; [Klomp, Nicholas] Univ Canberra, Bruce, ACT, Australia	Charles Sturt University; Charles Sturt University; University of Canberra	McCasker, N (corresponding author), Charles Sturt Univ, Sch Environm Sci, Albury, NSW, Australia.	nmccasker@csu.edu.au		Humphries, Paul/0000-0003-1850-6707; Klomp, Nicholas/0000-0002-2367-0125; McCasker, Nicole/0000-0002-5175-7615	Murray Darling Freshwater Research Centre, Lower Basin Laboratory, Mildura, Australia	Murray Darling Freshwater Research Centre, Lower Basin Laboratory, Mildura, Australia	A PhD scholarship for Nicole McCasker was funded by the Murray Darling Freshwater Research Centre, Lower Basin Laboratory, Mildura, Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1971, AUST J MAR FRESH RES, V22, P139; Bertozzi T, 2000, MAR FRESHWATER RES, V51, P805, DOI 10.1071/MF00039; BRY C, 1995, J FISH BIOL, V46, P99, DOI 10.1111/j.1095-8649.1995.tb05949.x; Bunnell DB, 2003, CAN J FISH AQUAT SCI, V60, P1314, DOI [10.1139/f03-112, 10.1139/F03-112]; BUTLER JL, 1991, CAN J FISH AQUAT SCI, V48, P1713, DOI 10.1139/f91-203; CADA GF, 1980, T AM FISH SOC, V109, P479, DOI 10.1577/1548-8659(1980)109<479:NMROFD>2.0.CO;2; Castro LR, 2000, T AM FISH SOC, V129, P1107, DOI 10.1577/1548-8659(2000)129<1107:ELSOTA>2.0.CO;2; Chambers RC, 2001, J SEA RES, V45, P231, DOI 10.1016/S1385-1101(01)00058-2; CHAMBERS RC, 1989, CAN J FISH AQUAT SCI, V46, P1633, DOI 10.1139/f89-208; Chesney EJ, 2008, J EXP MAR BIOL ECOL, V362, P117, DOI 10.1016/j.jembe.2008.06.011; CRECCO V, 1983, CAN J FISH AQUAT SCI, V40, P1719, DOI 10.1139/f83-199; DAHLBERG MD, 1979, MAR FISH REV, V41, P1; FORTIER L, 1985, MAR ECOL PROG SER, V25, P245, DOI 10.3354/meps025245; FRANK KT, 1994, ANNU REV ECOL SYST, V25, P401, DOI 10.1146/annurev.es.25.110194.002153; Fuiman L.A., 2002, FISHERY SCI UNIQUE C; Fuiman LA, 2003, ECOLOGY, V84, P53, DOI 10.1890/0012-9658(2003)084[0053:BARSIF]2.0.CO;2; GULLAND JA, 1965, SPEC PUBL INT COMM N, V6, P365; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; JOHNSTON TA, 1994, ENVIRON BIOL FISH, V40, P189, DOI 10.1007/BF00002545; Jordaan A, 2003, CAN J FISH AQUAT SCI, V60, P1289, DOI [10.1139/f03-108, 10.1139/F03-108]; Kelso William E., 1996, P255; King AJ, 2005, MAR FRESHWATER RES, V56, P215, DOI 10.1071/MF04117; King AJ, 2013, ECOLOGY OF AUSTRALIAN FRESHWATER FISHES, P159; Lake J. S., 1967, MARINE FRESHWATER RE, V18, P155, DOI [10.1071/MF9670155, DOI 10.1071/MF9670155]; Laurel BJ, 2001, J FISH BIOL, V59, P884, DOI 10.1006/jfbi.2001.1704; Letcher BH, 1997, CAN J FISH AQUAT SCI, V54, P405, DOI 10.1139/cjfas-54-2-405; Lintermans M., 2007, FISHES MURRAY DARLIN; LLEWELLYN L C, 1979, Australian Zoologist, V20, P269; LO NCH, 1986, FISH B-NOAA, V84, P395; Low M, 2009, J ANIM ECOL, V78, P761, DOI 10.1111/j.1365-2656.2009.01543.x; MARR JOHN C., 1956, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V21, P160; May R.C., 1974, EARLY LIFE HIST FISH, P3, DOI [10.1007/978-3-642-65852-5_1, DOI 10.1007/978-3-642-65852-5_1]; May R.C., 1974, EARLY LIFE HIST FISH; Mccallum Hamish, 2008, POPULATION PARAMETER, DOI 10.1002/9780470757468; McCasker NG, 2009, THESIS C STURT U ALB; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; MILLER TJ, 1992, CAN J FISH AQUAT SCI, V49, P805, DOI 10.1139/f92-091; MILLS CA, 1982, J FISH BIOL, V20, P645, DOI 10.1111/j.1095-8649.1982.tb03974.x; PEPIN P, 1993, CAN J FISH AQUAT SCI, V50, P2166, DOI 10.1139/f93-242; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; POST JR, 1989, CAN J FISH AQUAT SCI, V46, P1958, DOI 10.1139/f89-246; Post JR, 1996, CAN J FISH AQUAT SCI, V53, P910, DOI 10.1139/cjfas-53-4-910; Power M, 1996, FISH RES, V25, P77, DOI 10.1016/0165-7836(95)00395-9; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; PURCELL JE, 1987, MAR BIOL, V94, P157, DOI 10.1007/BF00392927; Quinlan John A., 1999, Fisheries Oceanography, V8, P124; R Core Team, 2018, R LANG ENV STAT COMP; Remmel T, 2009, J ANIM ECOL, V78, P973, DOI 10.1111/j.1365-2656.2009.01566.x; SECOR DH, 1995, ESTUARIES, V18, P527, DOI 10.2307/1352370; Semple GP, 1985, FISH SAHUL, V3, P97; Sibly RM, 2009, AM NAT, V173, pE185, DOI 10.1086/598680; TAGGART CT, 1987, MAR ECOL PROG SER, V41, P205, DOI 10.3354/meps041205; THORISSON K, 1994, ENVIRON BIOL FISH, V40, P23, DOI 10.1007/BF00002180; Tonkin Z, 2008, ECOL FRESHW FISH, V17, P312, DOI 10.1111/j.1600-0633.2007.00283.x; TREASURER JW, 1989, J FISH BIOL, V34, P913, DOI 10.1111/j.1095-8649.1989.tb03374.x; Unmack PJ, 2000, FISH SAHUL, V14, P645; VLADIMIROV V I, 1975, Journal of Ichthyology, V15, P851; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; WINEMILLER KO, 1993, AM NAT, V142, P585, DOI 10.1086/285559	59	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109317	10.1371/journal.pone.0109317	http://dx.doi.org/10.1371/journal.pone.0109317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299441	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200046
J	Wei, ZQ; Wu, SH; Yan, X; Zhou, SL				Wei, Zongqiang; Wu, Shaohua; Yan, Xiao; Zhou, Shenglu			Density and Stability of Soil Organic Carbon beneath Impervious Surfaces in Urban Areas	PLOS ONE			English	Article							UNITED-STATES; NITROGEN; STORAGE; MINERALIZATION; ECOSYSTEMS; MATTER; FLUXES; STOCKS; POOLS; CHINA	Installation of impervious surfaces in urban areas has attracted increasing attention due to its potential hazard to urban ecosystems. Urban soils are suggested to have robust carbon (C) sequestration capacity; however, the C stocks and dynamics in the soils covered by impervious surfaces that dominate urban areas are still not well characterized. We compared soil organic C (SOC) densities and their stabilities under impervious surface, determined by a 28-d incubation experiment, with those in open areas in Yixing City, China. The SOC density (0-20 cm) under impervious surfaces was, on average, 68% lower than that in open areas. Furthermore, there was a significantly (P<0.05) positive correlation between the densities of SOC and total nitrogen (N) in the open soils, whereas the correlation was not apparent for the impervious-covered soils, suggesting that the artificial soil sealing in urban areas decoupled the cycle of C and N. Cumulative CO2-C evolved during the 28-d incubation was lower from the impervious-covered soils than from the open soils, and agreed well with a first-order decay model (C-t = C-1+C-0(1-e(-kt))). The model results indicated that the SOC underlying capped surfaces had weaker decomposability and lower turnover rate. Our results confirm the unique character of urban SOC, especially that beneath impervious surface, and suggest that scientific and management views on regional SOC assessment may need to consider the role of urban carbon stocks.	[Wei, Zongqiang; Wu, Shaohua; Zhou, Shenglu] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China; [Wei, Zongqiang; Yan, Xiao] Jiangxi Agr Univ, Sch Environm & Land Resource Management, Nanchang, Peoples R China	Nanjing University; Jiangxi Agricultural University	Wu, SH (corresponding author), Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China.	shaohuawu@126.com	zhou, sheng/GYJ-6012-2022	Wei, Zongqiang/0000-0002-7680-4617; Wu, shaohua/0000-0002-8202-836X	National Natural Science Foundation of China [41001047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (41001047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, SOILS YIX COUNT; Beesley L, 2012, J ENVIRON MANAGE, V104, P158, DOI 10.1016/j.jenvman.2012.03.024; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Churkina G, 2010, GLOBAL CHANGE BIOL, V16, P135, DOI 10.1111/j.1365-2486.2009.02002.x; Edmondson JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00963; Elvidge CD, 2007, SENSORS-BASEL, V7, P1962, DOI 10.3390/s7091962; Gee G.W., 2002, METHODS SOIL ANAL 4, P255, DOI DOI 10.2136/SSSABOOKSER5.4.C12; Goyal S, 1999, BIOL FERT SOILS, V29, P196, DOI 10.1007/s003740050544; Haile-Mariam S, 2008, SOIL SCI SOC AM J, V72, P370, DOI 10.2136/sssaj2007.0126; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; IUSS Working Group WRB, 2007, WORLD SOIL RES REP; Jo HK, 2002, J ENVIRON MANAGE, V64, P115, DOI 10.1006/jema.2001.0491; JONES CA, 1984, COMMUN SOIL SCI PLAN, V15, P23, DOI 10.1080/00103628409367451; Kaye JP, 2008, ECOL APPL, V18, P132, DOI 10.1890/06-1952.1; Liu Y, 2013, CHINESE GEOGR SCI, V23, P26, DOI 10.1007/s11769-013-0585-x; Lorenz K, 2005, SOIL BIOL BIOCHEM, V37, P1373, DOI 10.1016/j.soilbio.2004.12.009; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pan XZ, 2007, CATENA, V69, P65, DOI 10.1016/j.catena.2006.04.016; Pouyat R, 2002, ENVIRON POLLUT, V116, pS107, DOI 10.1016/S0269-7491(01)00263-9; Pouyat RV, 2006, J ENVIRON QUAL, V35, P1566, DOI 10.2134/jeq2005.0215; Raciti SM, 2012, ECOL APPL, V22, P1015, DOI 10.1890/11-1250.1; Raciti SM, 2012, ENVIRON POLLUT, V164, P248, DOI 10.1016/j.envpol.2012.01.046; Raciti SM, 2011, ECOSYSTEMS, V14, P287, DOI 10.1007/s10021-010-9409-3; Rao P, 2013, URBAN ECOSYST, V16, P593, DOI 10.1007/s11252-013-0291-6; Rossi AM, 2008, SOIL SCI SOC AM J, V72, P1591, DOI 10.2136/sssaj2008.0072N; Scalenghe R, 2009, LANDSCAPE URBAN PLAN, V90, P1, DOI 10.1016/j.landurbplan.2008.10.011; Scalenghe R, 2011, ENVIRON SCI TECHNOL, V45, P5112, DOI 10.1021/es1039437; Su SL, 2011, REG ENVIRON CHANGE, V11, P651, DOI 10.1007/s10113-010-0197-2; Townsend-Small A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041675; UN, 2008, WORLD URB PROSP 2007; Wei ZQ, 2014, PEDOSPHERE, V24, P56, DOI 10.1016/S1002-0160(13)60080-6; Wei ZQ, 2013, SOIL RES, V51, P59, DOI 10.1071/SR12089; Zhang ZD, 2010, CAN J SOIL SCI, V90, P551, DOI 10.4141/CJSS09081	34	23	24	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109380	10.1371/journal.pone.0109380	http://dx.doi.org/10.1371/journal.pone.0109380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299685	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200049
J	Chitwood, DH				Chitwood, Daniel H.			Imitation, Genetic Lineages, and Time Influenced the Morphological Evolution of the Violin	PLOS ONE			English	Article							CREMONESE	Violin design has been in flux since the production of the first instruments in 16th century Italy. Numerous innovations have improved the acoustical properties and playability of violins. Yet, other attributes of the violin affect its performance less, and with fewer constraints, are potentially more sensitive to historical vagaries unrelated to quality. Although the coarse shape of violins is integral to their design, details of the body outline can vary without significantly compromising sound quality. What can violin shapes tell us about their makers and history, including the degree that luthiers have influenced each other and the evolution of complex morphologies over time? Here, I provide an analysis of morphological evolution in the violin family, sampling the body shapes of over 9,000 instruments over 400 years of history. Specific shape attributes, which discriminate instruments produced by different luthiers, strongly correlate with historical time. Linear discriminant analysis reveals luthiers who likely copied the outlines of their instruments from others, which historical accounts corroborate. Clustering of averaged violin shapes places luthiers into four major groups, demonstrating a handful of discrete shapes predominate in most instruments. Violin shapes originating from multi-generational luthier families tend to cluster together, and familial origin is a significant explanatory factor of violin shape. Together, the analysis of four centuries of violin shapes demonstrates not only the influence of history and time leading to the modern violin, but widespread imitation and the transmission of design by human relatedness.	Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Chitwood, DH (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	dchitwood@danforthcenter.org	Chitwood, Daniel/M-2841-2013	Chitwood, Daniel/0000-0003-4875-1447				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; [Anonymous], 2014, R LANG ENV STAT COMP; Bachmann A, 1925, ENCY VIOLIN; BARLOW CY, 1988, NATURE, V332, P313, DOI 10.1038/332313a0; BISSINGER G, 1995, J ACOUST SOC AM, V97, P3154, DOI 10.1121/1.411876; Bissinger G, 2006, J ACOUST SOC AM, V120, P482, DOI 10.1121/1.2207576; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Burckle Lloyd, 2003, Dendrochronologia, V21, P41, DOI 10.1078/1125-7865-00033; Claude J, 2008, MORPHOMETRICS R; Claude J, 2013, HYSTRIX, V24, P94, DOI 10.4404/hystrix-24.1-6316; Darwin C, 1859, ORIGIN SPECIES MEANS; Fritz C, 2014, P NATL ACAD SCI USA, V111, P7224, DOI 10.1073/pnas.1323367111; Fritz C, 2012, P NATL ACAD SCI USA, V109, P760, DOI 10.1073/pnas.1114999109; Hart G., 1880, VIOLIN ITS FAMOUS MA; Hill W. H., 1909, ANTONIO STRADIVARI H; Hill WE, 1891, SALABUE STRADIVARI H; HUTCHINS CM, 1983, J ACOUST SOC AM, V73, P1421, DOI 10.1121/1.389430; Iwata H, 1998, EUPHYTICA, V102, P143, DOI 10.1023/A:1018392531226; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Jansson E., 1970, Physica Scripta, V2, P243, DOI 10.1088/0031-8949/2/6/002; Jeong SC, 2012, THESIS U ALABAMA; Jones Sterling, 1995, LIRA BRACCIO; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; MARSHALL KD, 1985, J ACOUST SOC AM, V77, P695, DOI 10.1121/1.392338; MEINEL H, 1957, J ACOUST SOC AM, V29, P817, DOI 10.1121/1.1909064; Nagyvary J, 2006, NATURE, V444, P565, DOI 10.1038/444565a; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Saunders FA, 1937, J ACOUST SOC AM, V9, P81, DOI 10.1121/1.1915912; Savart F., 1819, MEMOIRE CONSTRUCTION; SCHELLENG JC, 1963, J ACOUST SOC AM, V35, P326, DOI 10.1121/1.1918462; Stoel BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046629; Stoel BC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002554; Venables WN., 2002, MODERN APPL STAT S 4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodfield I, 1988, EARLY HIST VIOL	35	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109229	10.1371/journal.pone.0109229	http://dx.doi.org/10.1371/journal.pone.0109229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295734	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000049
J	Lopes, AP; Macedo, TF; Coutinho, ESF; Figueira, I; Ventura, PR				Lopes, Alessandra Pereira; Macedo, Tania Fagundes; Freire Coutinho, Evandro Silva; Figueira, Ivan; Ventura, Paula Rui			Systematic Review of the Efficacy of Cognitive-Behavior Therapy Related Treatments for Victims of Natural Disasters: A Worldwide Problem	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PROLONGED EXPOSURE; CHILDREN; INTERVENTION; ADOLESCENTS; DEPRESSION; SURVIVORS; SYMPTOMS; TRIAL	Natural disasters can have devastating consequences. Each year, about 225 million people are victims of natural disasters worldwide, and up to 13,5 million of these people can develop post-traumatic stress disorder (PTSD) in the first or second year following the disaster. Cognitive-behavior therapy (CBT) is the first-choice treatment for this disorder. In order to evaluate the efficacy of psychotherapeutic treatment based on cognitive-behavior therapy for people who developed post traumatic stress disorder after natural disasters we conducted a systematic search of published studies. We used the terms reported below in the electronic databases ISI Web of Science, PsycINFO, PubMed, PILOTS and Scopus with no restrictions of language or publication date. Articles that described randomized controlled, non-randomized controlled and non controlled studies on the efficacy of cognitive-behavior therapy for individuals diagnosed with post-traumatic stress disorder after exposure to a natural disaster were eligible for inclusion. The studies were required to use a standardized measure of effectiveness before and after the intervention and have a group of patients who had used cognitive-behavior therapy as the only intervention. Our search identified 820 studies, and 11 were selected for this review. These 11 studies involved 742 subjects, 10 related to earthquakes and 1 to a hurricane. The cognitive-behavior therapy techniques used were various: 7 studies used exposure therapy, 2 studies used problem solving, and the only 2 studies with adolescents used techniques including reconstructions and reprocessing of the traumatic experience. As limitations, the search involved only five electronic databases, no experts in the field were consulted, and the heterogeneity of the findings made it impossible to perform a meta-analysis. The results suggest the efficacy of cognitive-behavior therapy, particularly exposure techniques, for the treatment of post-traumatic stress disorder after earthquakes. However, further studies with stronger methodologies, i.e. randomized-control trials and non-randomized controlled trials, are needed.	[Lopes, Alessandra Pereira; Macedo, Tania Fagundes; Freire Coutinho, Evandro Silva; Figueira, Ivan; Ventura, Paula Rui] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil; [Lopes, Alessandra Pereira] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Freire Coutinho, Evandro Silva] Escola Nacl Saude Publica, Dept Epidemiol, Rio De Janeiro, Brazil; [Ventura, Paula Rui] Univ Fed Rio de Janeiro, Inst Psychol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro	Lopes, AP (corresponding author), Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.	alessandra.perlopes@gmail.com	Fagundes, Tania/ABB-5995-2022	Fagundes, Tania/0000-0002-9342-7008; Coutinho, Evandro/0000-0002-4649-7353				American Psychological Association, 2014, MAN DIAGN EST TRANST; Barrera TL, 2013, CLIN PSYCHOL REV, V33, P24, DOI 10.1016/j.cpr.2012.09.005; Basoglu M, 2005, J TRAUMA STRESS, V18, P1, DOI 10.1002/jts.20011; Basoglu M, 2003, PSYCHOL MED, V33, P647, DOI 10.1017/S0033291703007360; Basoglu M, 2007, PSYCHOL MED, V37, P203, DOI 10.1017/S0033291706009123; Bisson J, 2006, PSYCHOL TREATMENT PO; Bokszczanin A, 2007, J TRAUMA STRESS, V20, P347, DOI 10.1002/jts.20220; Brake HT, 2009, NURS HEALTH SCI, V11, P336, DOI 10.1111/j.1442-2018.2009.00491.x; Briere J, 2000, J TRAUMA STRESS, V13, P661, DOI 10.1023/A:1007814301369; Bryant RA, 2006, J CLIN PSYCHIAT S2, V67; Descilo T, 2010, ACTA PSYCHIAT SCAND, V121, P289, DOI 10.1111/j.1600-0447.2009.01466.x; Dossa NI, 2012, SCI WORLD J, DOI 10.1100/2012/181847; Ferdos G, 2007, PAK J MED SCI, V23, P736; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; Giannopoulou Ioanna, 2006, Clin Child Psychol Psychiatry, V11, P543; Goenjian AK, 1997, AM J PSYCHIAT, V154, P536; Goenjian AK, 2005, AM J PSYCHIAT, V162, P2302, DOI 10.1176/appi.ajp.162.12.2302; Guha-Sapir D., 2004, 30 YEARS NATURAL DIS; Higgins J, 2011, HDB SYSTEMATIC REV I; Jaycox LH, 2010, J TRAUMA STRESS, V23, P223, DOI 10.1002/jts.20518; Kar N, 2011, NEUROPSYCH DIS TREAT, V7, P167, DOI 10.2147/NDT.S10389; Kar Nilamadhab, 2009, Indian J Med Sci, V63, P327; Knaevelsrud C, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-13; Kowalik J, 2011, J BEHAV THER EXP PSY, V42, P405, DOI 10.1016/j.jbtep.2011.02.002; Lagrega AM, 1996, J CONSULT CLIN PSYCH, V64, P721; Leenarts LEW, 2013, EUR CHILD ADOLES PSY, V22, P269, DOI 10.1007/s00787-012-0367-5; Liberati A, 2009, ANN INTERN MED, V151; McLean CP, 2013, J ANXIETY DISORD, V27, P788, DOI 10.1016/j.janxdis.2013.03.004; Mendes DD, 2008, INT J PSYCHIAT MED, V38, P241, DOI 10.2190/PM.38.3.b; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Oflaz F, 2008, J CLIN NURS, V17, P677, DOI 10.1111/j.1365-2702.2007.02047.x; Pielke Jr RA, 2006, OCEANOGRAPHY, V19, P138; PINCUS HA, 1993, AM J PSYCHIAT, V150, P135; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Smith P, 2013, CURR OPIN PSYCHIATR, V26, P66, DOI 10.1097/YCO.0b013e32835b2c01; Spence J, 2011, DEPRESS ANXIETY, V28, P541, DOI 10.1002/da.20835; Stormberg D, 2007, J ECON PERSPECT, V21, P199; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Zang YY, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-41; Zhang Y, 2011, J TRADIT CHIN MED, V31, P60, DOI 10.1016/S0254-6272(11)60014-9	40	25	25	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109013	10.1371/journal.pone.0109013	http://dx.doi.org/10.1371/journal.pone.0109013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296020	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000030
J	McCluney, KE; Sabo, JL				McCluney, Kevin E.; Sabo, John L.			Sensitivity and Tolerance of Riparian Arthropod Communities to Altered Water Resources along a Drying River	PLOS ONE			English	Article							SAN-PEDRO RIVER; MIDDLE RIO-GRANDE; DESERT STREAM; SOUTHEASTERN ARIZONA; BRACHINUS COLEOPTERA; FLOW INTERMITTENCY; SPECIES-DIVERSITY; TERRESTRIAL PREY; AQUATIC INSECTS; NEW-MEXICO	Background: Rivers around the world are drying with increasing frequency, but little is known about effects on terrestrial animal communities. Previous research along the San Pedro River in southeastern AZ, USA, suggests that changes in the availability of water resources associated with river drying lead to changes in predator abundance, community composition, diversity, and abundance of particular taxa of arthropods, but these observations have not yet been tested manipulatively. Methods and Results:In this study, we constructed artificial pools in the stream bed adjacent to a drying section of the San Pedro River and maintained them as the river dried. We compared pitfall trapped arthropods near artificial pools to adjacent control sites where surface waters temporarily dried. Assemblage composition changed differentially at multiple taxonomic levels, resulting in different assemblages at pools than at control sites, with multiple taxa and richness of carabid beetle genera increasing at pools but not at controls that dried. On the other hand, predator biomass, particularly wolf spiders, and diversity of orders and families were consistently higher at control sites that dried. These results suggest an important role for colonization dynamics of pools, as well as the ability of certain taxa, particularly burrowing wolf spiders, to withstand periods of temporary drying. Conclusions: Overall, we found some agreement between this manipulative study of water resources and a previous analysis of river drying that showed shifts in composition, changes in diversity, and declines in abundance of certain taxa (e.g. carabid beetles). However, colonization dynamics of pools, as well as compensatory strategies of predatory wolf spiders seem to have led to patterns that do not match previous research, with control sites maintaining high diversity, despite drying. Tolerance of river drying by some species may allow persistence of substantial diversity in the face of short-term drying. The long-term effects of drying remain to be investigated.	[McCluney, Kevin E.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	McCluney, KE (corresponding author), Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA.	kmcclun@bgsu.edu		McCluney, Kevin/0000-0002-3574-0354	EPA STAR [FP-91649201]; Brian Daniel Corrigan Foundation	EPA STAR(United States Environmental Protection Agency); Brian Daniel Corrigan Foundation	This study was funded by EPA STAR grant FP-91649201 to K. McCluney and the Brian Daniel Corrigan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2006, J ARID ENVIRON, V64, P626, DOI 10.1016/j.jaridenv.2005.06.022; ARMS K, 1974, SCIENCE, V185, P372, DOI 10.1126/science.185.4148.372; Arnett RH, 2000, AM BEETLES; Arscott DB, 2010, J N AM BENTHOL SOC, V29, P530, DOI 10.1899/08-124.1; Bastow JL, 2002, OECOLOGIA, V131, P261, DOI 10.1007/s00442-002-0879-7; Boersma KS, 2014, FRESHWATER BIOL, V59, P491, DOI 10.1111/fwb.12280; Bogan MT, 2013, FRESHWATER BIOL, V58, P1016, DOI 10.1111/fwb.12105; Bogan MT, 2011, FRESHWATER BIOL, V56, P2070, DOI 10.1111/j.1365-2427.2011.02638.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonn A, 2002, RIVER RES APPL, V18, P43, DOI 10.1002/rra.632; Borror D.J., 1992, INTRO STUDY INSECTS; Cartron JLE, 2003, ENVIRON ENTOMOL, V32, P1075, DOI 10.1603/0046-225X-32.5.1075; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clarke A, 2010, CAN J FISH AQUAT SCI, V67, P1649, DOI 10.1139/F10-087; Colby B, 2005, NAT RESOUR J, V45, P15; Corti R, 2014, FRESHWATER BIOL, V59, P666, DOI 10.1111/fwb.12294; DeVito J, 2004, CAN J ZOOL, V82, P1119, DOI 10.1139/Z04-090; Ellis LM, 2001, REGUL RIVER, V17, P1, DOI 10.1002/1099-1646(200101/02)17:1&lt;1::AID-RRR603&gt;3.0.CO;2-L; Ellis LM, 2000, SOUTHWEST NAT, V45, P456, DOI 10.2307/3672594; Gleick PH, 2002, WORLDS WATER 2002 20; Glennon Robert Jerome, 2002, WATER FOLLIES GROUND; Graham AK, 2003, J ARACHNOL, V31, P78, DOI 10.1636/0161-8202(2003)031[0078:HAOSLN]2.0.CO;2; Greenwood MJ, 2010, FRESHWATER BIOL, V55, P2062, DOI 10.1111/j.1365-2427.2010.02462.x; Hadley N. F, 1994, WATER RELATIONS TERR; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HUMPHREYS WF, 1975, OECOLOGIA, V21, P291, DOI 10.1007/BF00345823; IPCC, 2007, AR4 SYNTH REP; JULIANO S A, 1984, Coleopterists Bulletin, V38, P358; JULIANO SA, 1985, CAN J ZOOL, V63, P1683, DOI 10.1139/z85-250; JULIANO SA, 1986, CAN J ZOOL, V64, P73, DOI 10.1139/z86-011; Kearsley M.J., 2003, INVENTORY MONITORING; Lambeets K, 2008, BIODIVERS CONSERV, V17, P3133, DOI 10.1007/s10531-007-9313-0; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Lite SJ, 2005, BIOL CONSERV, V125, P153, DOI 10.1016/j.biocon.2005.01.020; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; McCluney KE, 2010, IMPACTS ALTERED WATE; McCluney KE, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3201; McCluney KE, 2012, BIOL REV, V87, P563, DOI 10.1111/j.1469-185X.2011.00209.x; Mccluney KE, 2012, FRESHWATER BIOL, V57, P91, DOI 10.1111/j.1365-2427.2011.02698.x; McCluney KE, 2009, ECOLOGY, V90, P1463, DOI 10.1890/08-1626.1; McKinnon S, 2007, WORRIES INCREASE SAN; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Paetzold A, 2005, ECOSYSTEMS, V8, P748, DOI 10.1007/s10021-005-0004-y; Paetzold A, 2005, J N AM BENTHOL SOC, V24, P395, DOI 10.1899/04-049.1; Paetzold A, 2008, J APPL ECOL, V45, P894, DOI 10.1111/j.1365-2664.2008.01463.x; Paetzold A, 2006, FRESHWATER BIOL, V51, P1103, DOI 10.1111/j.1365-2427.2006.01559.x; Pearce F, 2006, RIVERS RUN DRY WATER; Pool D, 1999, HYDROGEOLOGIC INVEST; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Reznikova Z, 2004, PEDOBIOLOGIA, V48, P15, DOI 10.1016/j.pedobi.2003.06.002; Rothenbucher J, 2006, BASIC APPL ECOL, V7, P398, DOI 10.1016/j.baae.2006.05.005; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Sabo JL, 2002, J N AM BENTHOL SOC, V21, P336, DOI 10.2307/1468420; Sabo JL, 2002, ECOLOGY, V83, P3023, DOI 10.1890/0012-9658(2002)083[3023:NROLTA]2.0.CO;2; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.2307/3071770; Sabo JL, 2008, ECOL MONOGR, V78, P615, DOI 10.1890/07-1382.1; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Sanzone DM, 2003, OECOLOGIA, V134, P238, DOI 10.1007/s00442-002-1113-3; Scoble M. J., 1995, LEPIDOPTERA FORM FUN; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; Sponseller RA, 2010, GLOBAL CHANGE BIOL, V16, P2891, DOI 10.1111/j.1365-2486.2010.02200.x; STANLEY EH, 1994, AM MIDL NAT, V131, P288, DOI 10.2307/2426255; Stromberg J, 1998, J ARID ENVIRON, V40, P133, DOI 10.1006/jare.1998.0438; Stromberg J, 2013, ECOSYSTEMS, P1; Stromberg J. C, 2009, ECOLOGY CONSERVATION; Stromberg JC, 2005, RIVER RES APPL, V21, P925, DOI 10.1002/rra.858; Stromberg JC, 1996, ECOL APPL, V6, P113, DOI 10.2307/2269558; Ubick D, 2005, SPIDERS N AM IDENTIF; Valeix M, 2008, AFR J ECOL, V46, P402, DOI 10.1111/j.1365-2028.2007.00874.x	69	6	6	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109276	10.1371/journal.pone.0109276	http://dx.doi.org/10.1371/journal.pone.0109276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295874	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000057
J	Valentini, S; Castagnetti, C; Musella, V; Spinella, G				Valentini, Simona; Castagnetti, Carolina; Musella, Vincenzo; Spinella, Giuseppe			Assessment of Intraocular Measurements in Neonatal Foals and Association with Gender, Laterality, and Body Weight: A Clinical Study	PLOS ONE			English	Article							CORNEAL DIAMETER; KERATOMETRY; PREDICTION	Objective of this study was to describe intraocular measurements in newly born foals (17 days of age) and assess the association between globe measurements and gender, laterality, and body weight. B-scan ultrasonographic biometry was performed on both eyes of 22 healthy foals (44 eyes) ages 17 days using a 10-MHz transducer. Intraocular measurements (anterior chamber depth, central lens thickness, vitreous chamber depth, axial globe length, longitudinal globe length, lens poles distance) were carried out using the ultrasound internal calipers. The influence of gender (male or female), laterality (right or left eye), and body weight (light <48 kg; heavy >= 48 kg) on ocular measurements was analysed by the Student t test. Values of P<0.05 were accepted as significant for all analyses. Mean anterior chamber depth was 2.2 +/- 0.5 mm (Standard Deviation); central lens thickness was 9.9 +/- 0.8 mm; vitreous chamber depth was 15.5 +/- 1.1 mm; axial globe length was 27.6 +/- 1.6 mm; longitudinal globe length was 35.8 +/- 1.2 mm, and lens poles distance was 16.4 +/- 1.0 mm. Intraocular measurements were not influenced by gender, laterality nor body weight. This study provides reference values for intraocular measurements in neonatal foals and may be useful in the diagnosis and treatment of congenital and acquired pathologies involving the globe.	[Valentini, Simona; Castagnetti, Carolina; Spinella, Giuseppe] Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, BO, Italy; [Musella, Vincenzo] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Germaneto, CZ, Italy	University of Bologna; Magna Graecia University of Catanzaro	Valentini, S (corresponding author), Univ Bologna, Dept Vet Med Sci, Ozzano Dellemilia, BO, Italy.	simona.valentini@unibo.it		CASTAGNETTI, CAROLINA/0000-0001-5533-7637; Musella, Vincenzo/0000-0002-4448-8832				Barsotti G, 2013, VET OPHTHALMOL, V16, P245, DOI 10.1111/j.1463-5224.2012.01063.x; Grinninger P, 2010, AM J VET RES, V71, P677, DOI 10.2460/ajvr.71.6.677; Labelle AL, 2011, JAVMA-J AM VET MED A, V239, P486, DOI 10.2460/javma.239.4.486; McMullen RJ, 2006, VET OPHTHALMOL, V9, P357, DOI 10.1111/j.1463-5224.2006.00493.x; Mouney MC, 2012, AM J VET RES, V73, P1977, DOI 10.2460/ajvr.73.12.1977; Plummer CE, 2003, AM J VET RES, V64, P661, DOI 10.2460/ajvr.2003.64.661; Renaudin C D, 2000, J Reprod Fertil Suppl, P651; Scotty N. C., 2005, Clinical Techniques in Equine Practice, V4, P106, DOI 10.1053/j.ctep.2005.03.007; Townsend WM, 2012, EQUINE VET J, V44, P238, DOI 10.1111/j.2042-3306.2011.00392.x; Turner RM, 2006, THERIOGENOLOGY, V66, P331, DOI 10.1016/j.theriogenology.2005.11.019; Valentini S, 2010, J EQUINE VET SCI, V30, P150, DOI 10.1016/j.jevs.2010.01.058	11	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109491	10.1371/journal.pone.0109491	http://dx.doi.org/10.1371/journal.pone.0109491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296286	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000074
J	Liao, CL; Zhang, WC; Yang, M; Ma, QF; Li, GW; Zhong, WX				Liao, Chenlong; Zhang, Wenchuan; Yang, Min; Ma, Qiufeng; Li, Guowei; Zhong, Wenxiang			Surgical Decompression of Painful Diabetic Peripheral Neuropathy: The Role of Pain Distribution	PLOS ONE			English	Article							NERVE DECOMPRESSION; AXONAL-TRANSPORT; LOWER-EXTREMITY; TINEL SIGN; MECHANISMS; MANAGEMENT; COMPRESSION; VALIDATION; SURGERY; UTILITY	Objective: To investigate the effect of surgical decompression on painful diabetic peripheral neuropathy (DPN) patients and discuss the role which pain distribution and characterization play in the management of painful DPN as well as the underlying mechanism involved. Methods: A total of 306 patients with painful diabetic lower-extremity neuropathy were treated with Dellon surgical nerve decompression in our department. Clinical evaluation including Visual analogue scale (VAS), Brief Pain Inventory Short Form for diabetic peripheral neuropathy (BPI-DPN) questionnaire, two-point discrimination (2-PD), nerve conduction velocity (NCV) and high-resolution ultrasonography (cross-sectional area, CSA) were performed in all cases preoperatively, and at 6 month intervals for 2 years post-decompression. The patients who underwent surgery were retrospectively assigned into two subgroups (focal and diffuse pain) according to the distribution of the diabetic neuropathic pain. The control group included 92 painful DPN patients without surgery. Results: The levels of VAS, scores in BPI-DPN, 2-PD, NCV results and CSA were all improved in surgical group when compared to the control group (P < 0.05). More improvement of VAS, scores in BPI-DPN and CSA was observed in focal pain group than that in diffuse group (P < 0.05). Conclusions: Efficacy of decompression of multiple lower-extremity peripheral nerves in patients with painful diabetic neuropathy was confirmed in this study. While both focal and diffuse group could benefit from surgical decompression, pain relief and morphological restoration could be better achieved in focal group.	[Liao, Chenlong; Zhang, Wenchuan; Yang, Min; Ma, Qiufeng; Li, Guowei; Zhong, Wenxiang] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, WC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China.	zhangwench88@hotmail.com			National Science Foundation of China;  [81371373]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This study was supported by the grant from the National Science Foundation of China. The grant number: 81371373. The URL of the funder's website: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Aszmann O, 2004, ANN PLAS SURG, V53, P517, DOI 10.1097/01.sap.0000143605.60384.4e; Aszmann OC, 2000, PLAST RECONSTR SURG, V106, P816, DOI 10.1097/00006534-200009040-00010; Barrett Stephen L, 2010, Foot Ankle Spec, V3, P132, DOI 10.1177/1938640010368028; Biddinger Kent R, 2004, Foot Ankle Clin, V9, P239, DOI 10.1016/j.fcl.2003.12.001; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Caffee HH, 2000, PLAST RECONSTR SURG, V106, P813, DOI 10.1097/00006534-200009040-00009; Chaudhry V, 2006, NEUROLOGY, V66, P1805, DOI 10.1212/01.wnl.0000219631.89207.a9; Chaudhry V, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006152.pub2; Cornblath DR, 2007, DIABETES CARE, V30, P421, DOI 10.2337/dc06-2324; DAHLIN LB, 1986, DIABETOLOGIA, V29, P181, DOI 10.1007/BF02427090; DEJONG RN, 1977, POSTGRAD MED, V61, P101, DOI 10.1080/00325481.1977.11714510; Dellon AL, 2012, J RECONSTR MICROSURG, V28, P235, DOI 10.1055/s-0032-1306371; DELLON AL, 1992, PLAST RECONSTR SURG, V89, P689, DOI 10.1097/00006534-199204000-00018; Eaton SEM, 2001, LANCET, V358, P35, DOI 10.1016/S0140-6736(00)05268-5; FINK DJ, 1987, DIABETES, V36, P996, DOI 10.2337/diabetes.36.9.996; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; JAKOBSEN J, 1978, DIABETOLOGIA, V14, P113, DOI 10.1007/BF01263449; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; Kapur D, 2003, DIABETES-METAB RES, V19, pS9, DOI 10.1002/dmrr.359; Karagoz H, 2008, J RECONSTR MICROSURG, V24, P95, DOI 10.1055/s-2008-1064923; Lee CH, 2004, ANN PLAS SURG, V53, P523, DOI 10.1097/01.sap.0000141379.55618.87; MEDORI R, 1985, P NATL ACAD SCI USA, V82, P7716, DOI 10.1073/pnas.82.22.7716; Melenhorst WB, 2009, ANN PLAS SURG, V63, P217, DOI 10.1097/SAP.0b013e31818ba768; Quattrini C, 2003, DIABETES-METAB RES, V19, pS2, DOI 10.1002/dmrr.360; Rader AJ, 2005, J AM PODIAT MED ASSN, V95, P446, DOI 10.7547/0950446; SCOTT J, 1976, PAIN, V2, P175, DOI 10.1016/0304-3959(76)90113-5; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Siemionow M, 2006, ANN PLAS SURG, V57, P385, DOI 10.1097/01.sap.0000221979.13847.30; Suzuki C, 2000, NEUROLOGY, V54, P1932, DOI 10.1212/WNL.54.10.1932; Tesfaye S, 2005, DIABETOLOGIA, V48, P805, DOI 10.1007/s00125-005-1721-7; Tesfaye S, 1996, DIABETOLOGIA, V39, P329; Tesfaye S, 2013, DIABETES CARE, V36, P2456, DOI 10.2337/dc12-1964; THOMAS P K, 1973, Journal of the Royal College of Physicians of London, V7, P154; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; UPTON ARM, 1973, LANCET, V2, P359, DOI 10.1016/S0140-6736(73)93196-6; Valdivia JMV, 2013, ANN PLAS SURG, V70, P675, DOI 10.1097/SAP.0b013e3182764fb0; Vinik A, 2010, J CLIN ENDOCR METAB, V95, P4802, DOI 10.1210/jc.2010-0892; Vinik AI, 2013, DIABETES METAB SYNDR, V6, P57, DOI 10.2147/DMSO.S24825; Vinik AI, 2000, DIABETOLOGIA, V43, P957, DOI 10.1007/s001250051477; WIEMAN TJ, 1995, ANN SURG, V221, P660, DOI 10.1097/00000658-199506000-00005; Wood William A, 2003, J Foot Ankle Surg, V42, P268, DOI 10.1016/S1067-2516(03)00313-2; Zelman DC, 2005, J VASC NURS, V23, P97, DOI 10.1016/j.jvn.2005.06.004; Zhang W, 2013, BR J NEUROSURG	46	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109827	10.1371/journal.pone.0109827	http://dx.doi.org/10.1371/journal.pone.0109827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290338	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000092
J	MacNeil, LG; Glover, E; Bergstra, TG; Safdar, A; Tarnopolsky, MA				MacNeil, Lauren G.; Glover, Elisa; Bergstra, T. Graham; Safdar, Adeel; Tarnopolsky, Mark A.			The Order of Exercise during Concurrent Training for Rehabilitation Does Not Alter Acute Genetic Expression, Mitochondrial Enzyme Activity or Improvements in Muscle Function	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; RESISTANCE EXERCISE; AEROBIC EXERCISE; ADAPTIVE RESPONSES; PROTEIN-SYNTHESIS; NEUROMUSCULAR ADAPTATIONS; LIMB IMMOBILIZATION; MOLECULAR RESPONSES; ENDURANCE EXERCISE; YOUNG MEN	Concurrent exercise combines different modes of exercise (e.g., aerobic and resistance) into one training protocol, providing stimuli meant to increase muscle strength, aerobic capacity and mass. As disuse is associated with decrements in strength, aerobic capacity and muscle size concurrent training is an attractive modality for rehabilitation. However, interference between the signaling pathways may result in preferential improvements for one of the exercise modes. We recruited 18 young adults (10 O*, 8 female) to determine if order of exercise mode during concurrent training would differentially affect gene expression, protein content and measures of strength and aerobic capacity after 2 weeks of knee-brace induced disuse. Concurrent exercise sessions were performed 3x/week for 6 weeks at gradually increasing intensities either with endurance exercise preceding (END>RES) or following (RES>END) resistance exercise. Biopsies were collected from the vastus lateralis before, 3 h after the first exercise bout and 48 h after the end of training. Concurrent exercise altered the expression of genes involved in mitochondrial biogenesis (PGC-1 alpha, PRC, PPAR gamma), hypertrophy (PGC-1 alpha 4, REDD2, Rheb) and atrophy (MuRF-1, Runx1), increased electron transport chain complex protein content, citrate synthase and mitochondrial cytochrome c oxidase enzyme activity, muscle mass, maximum isometric strength and VO2peak. However, the order in which exercise was completed (END>RES or RES>END) only affected the protein content of mitochondrial complex II subunit. In conclusion, concurrent exercise training is an effective modality for the rehabilitation of the loss of skeletal muscle mass, maximum strength, and peak aerobic capacity resulting from disuse, regardless of the order in which the modes of exercise are performed.	[MacNeil, Lauren G.; Glover, Elisa; Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Bergstra, T. Graham] McMaster Univ, Dept Hlth Sci, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	tarnopol@mcmaster.ca		Safdar, Adeel/0000-0003-2469-0467	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada [CHRP 365655-2009]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Financial support for this study was awarded to MT as a Collaborative Health Research Project from Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada (CHRP 365655-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P39, DOI 10.1111/j.1600-0838.2010.01197.x; Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Alkner BA, 2004, EUR J APPL PHYSIOL, V93, P294, DOI 10.1007/s00421-004-1172-8; Allen J, 2011, CLIN GERIATR MED, V27, P661, DOI 10.1016/j.cger.2011.07.010; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Balabinis CP, 2003, J STRENGTH COND RES, V17, P393, DOI 10.1519/00124278-200305000-00030; Batt J, 2005, FASEB J, V19, P115, DOI 10.1096/fj.04-3640fje; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Berg HE, 1996, ACTA PHYSIOL SCAND, V157, P63, DOI 10.1046/j.1365-201X.1996.476217000.x; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Campbell EL, 2013, BIOGERONTOLOGY, V14, P247, DOI 10.1007/s10522-013-9427-6; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Coffey VG, 2009, AM J PHYSIOL-REG I, V297, pR1441, DOI 10.1152/ajpregu.00351.2009; Coffey VG, 2009, J APPL PHYSIOL, V106, P1187, DOI 10.1152/japplphysiol.91221.2008; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Creer A, 2005, J APPL PHYSIOL, V99, P950, DOI 10.1152/japplphysiol.00110.2005; Cunha TF, 2012, J APPL PHYSIOL, V112, P1839, DOI 10.1152/japplphysiol.00346.2011; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Di Donato DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1025, DOI 10.1152/ajpendo.00487.2013; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Glover EI, 2010, APPL PHYSIOL NUTR ME, V35, P125, DOI 10.1139/H09-137; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Hakkinen K, 2003, EUR J APPL PHYSIOL, V89, P42, DOI 10.1007/s00421-002-0751-9; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Hawley JA, 2009, APPL PHYSIOL NUTR ME, V34, P355, DOI 10.1139/H09-023; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; Hu SM, 2012, MOL ENDOCRINOL, V26, P977, DOI 10.1210/me.2011-1253; Hvid L, 2010, J APPL PHYSIOL, V109, P1628, DOI 10.1152/japplphysiol.00637.2010; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Loviscach M, 2000, DIABETOLOGIA, V43, P304, DOI 10.1007/s001250050048; Lundberg TR, 2012, MED SCI SPORT EXER, V44, P1680, DOI 10.1249/MSS.0b013e318256fbe8; Lundberg TR, 2014, ACTA PHYSL OXF; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; McCarthy JP, 2002, MED SCI SPORT EXER, V34, P511, DOI 10.1097/00005768-200203000-00019; MCCARTHY JP, 1995, MED SCI SPORT EXER, V27, P429; Mortensen OH, 2007, J APPL PHYSIOL, V103, P1536, DOI 10.1152/japplphysiol.00575.2007; Murakami T, 2011, BIOCHEM BIOPH RES CO, V405, P615, DOI 10.1016/j.bbrc.2011.01.078; Niklas P, 2010, EUR J APPL PHYSIOL, V110, P597, DOI 10.1007/s00421-010-1544-1; Oates BR, 2010, MUSCLE NERVE, V42, P539, DOI 10.1002/mus.21721; Park KS, 1997, DIABETES, V46, P1230, DOI 10.2337/diabetes.46.7.1230; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stefanetti RJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00030; Stefanetti RJ, 2014, J APPL PHYSL; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; Ydfors M, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.140	66	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109189	10.1371/journal.pone.0109189	http://dx.doi.org/10.1371/journal.pone.0109189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289940	gold, Green Submitted, Green Published			2022-12-27	WOS:000342798000047
J	Matsuda, T; Morishita, M; Hinomoto, N; Gotoh, T				Matsuda, Tomoko; Morishita, Maiko; Hinomoto, Norihide; Gotoh, Tetsuo			Phylogenetic Analysis of the Spider Mite Sub-Family Tetranychinae (Acari: Tetranychidae) Based on the Mitochondrial COI Gene and the 18S and the 5 ' End of the 28S rRNA Genes Indicates That Several Genera Are Polyphyletic	PLOS ONE			English	Article							SPECIES ACARI; LIFE-HISTORY; SEQUENCES; DIVERSITY; INFERENCE; DNA; IDENTIFICATION; PROSTIGMATA; ARTHROPODS; EVOLUTION	The spider mite sub-family Tetranychinae includes many agricultural pests. The internal transcribed spacer (ITS) region of nuclear ribosomal RNA genes and the cytochrome c oxidase subunit I (COI) gene of mitochondrial DNA have been used for species identification and phylogenetic reconstruction within the sub-family Tetranychinae, although they have not always been successful. The 18S and 28S rRNA genes should be more suitable for resolving higher levels of phylogeny, such as tribes or genera of Tetranychinae because these genes evolve more slowly and are made up of conserved regions and divergent domains. Therefore, we used both the 18S (1,825-1,901 bp) and 28S (the 5' end of 646-743 bp) rRNA genes to infer phylogenetic relationships within the sub-family Tetranychinae with a focus on the tribe Tetranychini. Then, we compared the phylogenetic tree of the 18S and 28S genes with that of the mitochondrial COI gene (618 bp). As observed in previous studies, our phylogeny based on the COI gene was not resolved because of the low bootstrap values for most nodes of the tree. On the other hand, our phylogenetic tree of the 18S and 28S genes revealed several well-supported clades within the sub-family Tetranychinae. The 18S and 28S phylogenetic trees suggest that the tribes Bryobiini, Petrobiini and Eurytetranychini are monophyletic and that the tribe Tetranychini is polyphyletic. At the genus level, six genera for which more than two species were sampled appear to be monophyletic, while four genera (Oligonychus, Tetranychus, Schizotetranychus and Eotetranychus) appear to be polyphyletic. The topology presented here does not fully agree with the current morphology-based taxonomy, so that the diagnostic morphological characters of Tetranychinae need to be reconsidered.	[Matsuda, Tomoko; Morishita, Maiko; Gotoh, Tetsuo] Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ibaraki, Japan; [Hinomoto, Norihide] Natl Agr & Food Res Org, NARO Agr Res Ctr, Ibaraki, Japan	Ibaraki University; National Agriculture & Food Research Organization - Japan	Gotoh, T (corresponding author), Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ibaraki, Japan.	gotoh@mx.ibaraki.ac.jp	HINOMOTO, Norihide/K-8828-2012; Hinomoto, Norihide/T-9465-2019	HINOMOTO, Norihide/0000-0001-9767-3225; Matsuda, Tomoko/0000-0002-4709-4302	Japan Society for the Promotion of Science [25292033]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding provided by Grant number 25292033, Japan Society for the Promotion of Science, http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-David T, 2007, EXP APPL ACAROL, V41, P169, DOI 10.1007/s10493-007-9058-1; Bennett GM, 2012, MOL PHYLOGENET EVOL, V65, P705, DOI 10.1016/j.ympev.2012.07.024; Bolland HR., 1998, WORLD CATALOGUE SPID; Burger TD, 2013, TICKS TICK-BORNE DIS, V4, P265, DOI 10.1016/j.ttbdis.2013.02.002; Burger TD, 2012, MOL PHYLOGENET EVOL, V64, P45, DOI 10.1016/j.ympev.2012.03.004; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Ehara Shozo, 1996, Journal of the Acarological Society of Japan, V5, P17; Ehara Shozo, 1999, Species Diversity, V4, P63; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gotoh T, 2009, INT J ACAROL, V35, P485, DOI 10.1080/01647950903431156; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; HELLE W, 1985, SPIDER MITES THEIR B, V1; Helle W., 1985, SPIDER MITES THEIR A, V1; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Klicka J, 2005, MOL PHYLOGENET EVOL, V34, P486, DOI 10.1016/j.ympev.2004.10.001; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Matsuda T, 2013, J ECON ENTOMOL, V106, P463, DOI 10.1603/EC12328; Matsuda T, 2012, J ECON ENTOMOL, V105, P1043, DOI 10.1603/EC11404; Migeon A., 2006, SPIDER MITES WEB COM; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; Navajas M, 2003, P ROY SOC B-BIOL SCI, V270, pS124, DOI 10.1098/rsbl.2003.0034; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Palumbi Stephen R., 1996, P205; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Rambaut A, 2013, TRACER V1 6; Ros VID, 2007, EXP APPL ACAROL, V42, P239, DOI 10.1007/s10493-007-9092-z; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanabe A.S, 2008, MRBAYES5D; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Toda S, 2000, EXP APPL ACAROL, V24, P821, DOI 10.1023/A:1006484018547; Wauthy G, 1998, ACAROLOGIA, V39, P233; Zhang Zhi-Qiang, 2000, Systematic and Applied Acarology, V5, P69; Zhang ZhiQiang, 2003, Mites of greenhouses: identification, biology and control, DOI 10.1079/9780851995908.0000; Zhao YE, 2012, PARASITOL RES, V111, P2109, DOI 10.1007/s00436-012-3058-8	39	49	51	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108672	10.1371/journal.pone.0108672	http://dx.doi.org/10.1371/journal.pone.0108672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289639	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000021
J	Stothart, CR; Simons, DJ; Boot, WR; Kramer, AF				Stothart, Cary R.; Simons, Daniel J.; Boot, Walter R.; Kramer, Arthur F.			Is the Effect of Aerobic Exercise on Cognition a Placebo Effect?	PLOS ONE			English	Article							OLDER-ADULTS; FITNESS	A number of studies and meta-analyses conclude that aerobic fitness (walking) interventions improve cognition. Such interventions typically compare improvements from these interventions to an active control group in which participants engage in non-aerobic activities (typically stretching and toning) for an equivalent amount of time. However, in the absence of a double-blind design, the presence of an active control group does not necessarily control for placebo effects; participants might expect different amounts of improvement for the treatment and control interventions [1]. We conducted a large survey to explore whether people expect greater cognitive benefits from an aerobic exercise intervention compared to a control intervention. If participants expect greater improvement following aerobic exercise, then the benefits of such interventions might be due in part to a placebo effect. In general, expectations did not differ between aerobic and non-aerobic interventions. If anything, some of the results suggest the opposite (e.g., respondents expected the control, non-aerobic intervention to yield bigger memory gains). These results provide the first evidence that cognitive improvements following aerobic fitness training are not due to differential expectations.	[Stothart, Cary R.; Boot, Walter R.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Simons, Daniel J.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Champaign, IL USA	State University System of Florida; Florida State University; University of Illinois System; University of Illinois Urbana-Champaign	Stothart, CR (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	stothart@psy.fsu.edu	Simons, Daniel J./P-3625-2019; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724; Stothart, Cary/0000-0001-6620-3298	NIA, Project CREATE III - Center for Research and Education on Aging and Technology Enhancement [3 PO1 AG017211]; NATIONAL INSTITUTE ON AGING [P01AG017211] Funding Source: NIH RePORTER	NIA, Project CREATE III - Center for Research and Education on Aging and Technology Enhancement; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA 3 PO1 AG017211, Project CREATE III - Center for Research and Education on Aging and Technology Enhancement (www.create-center.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baniqued PL, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01010; Baym CL, 2014, J COGNITIVE NEUROSCI; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Boot Walter R., 2013, FRONTIERS PSYCHOL, V4; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Hindin SB, 2012, J AM GERIATR SOC, V60, P136, DOI 10.1111/j.1532-5415.2011.03761.x; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001	10	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109557	10.1371/journal.pone.0109557	http://dx.doi.org/10.1371/journal.pone.0109557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ4VK	25289674	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000067
J	Fabrizii, M; Moinfar, F; Jelinek, HF; Karperien, A; Ahammer, H				Fabrizii, Markus; Moinfar, Farid; Jelinek, Herbert F.; Karperien, Audrey; Ahammer, Helmut			Fractal Analysis of Cervical Intraepithelial Neoplasia	PLOS ONE			English	Article							EUROPEAN GUIDELINES; CLINICAL MANAGEMENT; QUALITY-ASSURANCE; DIMENSIONS; CYTOLOGY	Introduction: Cervical intraepithelial neoplasias (CIN) represent precursor lesions of cervical cancer. These neoplastic lesions are traditionally subdivided into three categories CIN 1, CIN 2, and CIN 3, using microscopical criteria. The relation between grades of cervical intraepithelial neoplasia (CIN) and its fractal dimension was investigated to establish a basis for an objective diagnosis using the method proposed. Methods: Classical evaluation of the tissue samples was performed by an experienced gynecologic pathologist. Tissue samples were scanned and saved as digital images using Aperio scanner and software. After image segmentation the box counting method as well as multifractal methods were applied to determine the relation between fractal dimension and grades of CIN. A total of 46 images were used to compare the pathologist's neoplasia grades with the predicted groups obtained by fractal methods. Results: Significant or highly significant differences between all grades of CIN could be found. The confusion matrix, comparing between pathologist's grading and predicted group by fractal methods showed a match of 87.1%. Multifractal spectra were able to differentiate between normal epithelium and low grade as well as high grade neoplasia. Conclusion: Fractal dimension can be considered to be an objective parameter to grade cervical intraepithelial neoplasia.	[Fabrizii, Markus; Ahammer, Helmut] Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria; [Moinfar, Farid] Med Univ Graz, Inst Pathol, Unit Breast & Gynaecol Pathol, Graz, Austria; [Moinfar, Farid] Hosp Sisters Char, Dept Pathol, Linz, Austria; [Jelinek, Herbert F.; Karperien, Audrey] Charles Sturt Univ, Ctr Res Complex Syst, Albury, NSW, Australia; [Jelinek, Herbert F.] Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia	Medical University of Graz; Medical University of Graz; Charles Sturt University; Charles Sturt University	Ahammer, H (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria.	helmut.ahammer@medunigraz.at	Jelinek, Herbert/AAQ-6825-2020; Jelinek, Herbert F/S-6779-2019; Karperien, Audrey/H-2142-2013	Jelinek, Herbert F/0000-0001-5457-6193; Ahammer, Helmut/0000-0001-5400-294X; Karperien, Audrey/0000-0002-8190-6327				Ahammer H, 2011, CHAOS SOLITON FRACT, V44, P86, DOI 10.1016/j.chaos.2010.12.004; American College of Obstetricians and Gynecologists Committee, 2010, OBSTET GYNECOL, V116, P469; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Aslani FS, 2013, IRAN J MED SCI, V38, P15; Baish JW, 2000, CANCER RES, V60, P3683; Chalut KJ, 2009, CANCER RES, V69, P1199, DOI 10.1158/0008-5472.CAN-08-3079; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; Feder J, 1988, FRACTALS; Fritz A, 2000, INT CLASSIFICATION D; Jayalalitha G, 2011, FRACTALS, V19, P125, DOI 10.1142/S0218348X11005154; Jelinek H.F., 2012, P 9 IASTED INT C BIO, P25, DOI [10.2316/P.2012.764-039, DOI 10.2316/P.2012.764-039]; Jelinek HF, 2013, ADV INTELL SYST, V187, P177; Jelinek Herbert F., 2006, ComPlexUs, V3, P66, DOI 10.1159/000094189; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Jordan J, 2009, CYTOPATHOLOGY, V20, P5, DOI 10.1111/j.1365-2303.2008.00636.x; Karperien A, 2013, FRACLAC IMAGEJ VERSI; Mashiah A, 2008, ACTA HAEMATOL-BASEL, V119, P142, DOI 10.1159/000125551; Metze K, 2013, EXPERT REV MOL DIAGN, V13, P719, DOI 10.1586/14737159.2013.828889; Regitnig P, 2007, PATHOLOGE, V28, P339, DOI 10.1007/s00292-007-0931-9; Reishofer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041148; Sedivy R, 1999, GYNECOL ONCOL, V75, P78, DOI 10.1006/gyno.1999.5516; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Solomon D, 2004, BETHESDA SYSTEM REPO, P191; Waliszewski P, 2005, BIOSYSTEMS, V82, P61, DOI 10.1016/j.biosystems.2005.05.011; Waliszewski P, 2003, CHAOS SOLITON FRACT, V16, P665, DOI 10.1016/S0960-0779(02)00469-1	26	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108457	10.1371/journal.pone.0108457	http://dx.doi.org/10.1371/journal.pone.0108457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302712	Green Published, gold			2022-12-27	WOS:000343730400014
J	Holtgrawe, D; Sorensen, TR; Viehover, P; Schneider, J; Schulz, B; Borchardt, D; Kraft, T; Himmelbauer, H; Weisshaar, B				Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Viehover, Prisca; Schneider, Jessica; Schulz, Britta; Borchardt, Dietrich; Kraft, Thomas; Himmelbauer, Heinz; Weisshaar, Bernd			Reliable In Silico Identification of Sequence Polymorphisms and Their Application for Extending the Genetic Map of Sugar Beet (Beta vulgaris)	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; WIDE SNP DISCOVERY; LINKAGE GROUPS; L.; TRANSCRIPTOME; POPULATIONS; GENERATION	Molecular markers are a highly valuable tool for creating genetic maps. Like in many other crops, sugar bee Beta vulgar's L. breeding is increasingly supported by the application of such genetic markers. Single nucleotide polymorphism (SNP) based markers have a high potential for automated analysis and high-throughout genotyping. We developed a workflow that uses Sanger and 2nd-generation sequence data for detection, evaluation and verification of new transcript-associated SNPs from sugar beet. RNAseq data from one parent of an established mapping population were produced by 454-FLX sequencing and compared to Sanger ESTs derived from the other parent. The workflow established or SNP detection considers the quality values of both types of reads, provides polymorphic alignments as well as selection criteria for reliable SNP detection and allows painless generation of new genetic markers within genes. We obtained a total of 14,323 genic SNPs and InDels. According to empirically optimised settings for the quality parameters, we classified these SNPs into four usability categories. Validation of a subset of the in silico genotyping the mapping population indicated a high success rate of the SNP detection Finally, a total of 307 new markers were integrated with existing data into a new genetic map of sugar beet which offers proved resolution and the integration of terminal markers.	[Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Viehover, Prisca; Schneider, Jessica; Weisshaar, Bernd] Univ Bielefeld, CeBiTec, Bielefeld, Germany; [Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Viehover, Prisca; Schneider, Jessica; Weisshaar, Bernd] Univ Bielefeld, Dept Biol, Bielefeld, Germany; [Schulz, Britta; Borchardt, Dietrich] KWS Saat AG, Mol Breeding Sugarbeet, Einbeck, Germany; [Kraft, Thomas] Syngenta Seeds AB, Landskrona, Sweden; [Himmelbauer, Heinz] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Himmelbauer, Heinz] Ctr Genom Regulat, Barcelona, Spain	University of Bielefeld; University of Bielefeld; KWS Saat AG; Syngenta; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Holtgrawe, D (corresponding author), Univ Bielefeld, CeBiTec, Bielefeld, Germany.	dholtgra@cebitec.uni-bielefeld.de	Weisshaar, Bernd/B-3859-2014	Weisshaar, Bernd/0000-0002-7635-3473; Holtgrawe, Daniela/0000-0002-1062-4576; Himmelbauer, Heinz/0000-0001-8897-2928	Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI-Beet Physical map' [FKZ 0313127A, FKZ 0313127D]; Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI BeetSeq' [FKZ 0315069A, FKZ 0315069B]	Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI-Beet Physical map'; Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI BeetSeq'	This work was supported by the Ministry of Education and Science (BMBF) grant 'Verbundprojekt GABI-Beet Physical map', FKZ 0313127A and FKZ 0313127D and by the 'Verbundprojekt GABI BeetSeq', FKZ 0315069A and FKZ 0315069B. Co-authors BS and DB are employed by KWS Saat AG. KWS Saat AG provided support in the form of salaries for authors BS and DB, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. TK is employed by Syngenta Seeds AB. Syngenta Seeds AB provided support in the form of salary for author TK, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; [Anonymous], GS FLX TIT GEN LIB P; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barker G, 2003, BIOINFORMATICS, V19, P421, DOI 10.1093/bioinformatics/btf881; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Dohm JC, 2012, PLANT J, V70, P528, DOI 10.1111/j.1365-313X.2011.04898.x; Dohm JC, 2009, PLANT J, V57, P14, DOI 10.1111/j.1365-313X.2008.03665.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Herwig R, 2002, PLANT J, V32, P845, DOI 10.1046/j.1365-313X.2002.01457.x; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lange C, 2010, THEOR APPL GENET, V121, P549, DOI 10.1007/s00122-010-1329-2; Le Dantec L, 2004, PLANT MOL BIOL, V54, P461, DOI 10.1023/B:PLAN.0000036376.11710.6f; Liang S, 2012, BIORESOURCE TECHNOL, V125, P312, DOI 10.1016/j.biortech.2012.08.097; Magana C, 2011, BIORESOURCE TECHNOL, V102, P9542, DOI 10.1016/j.biortech.2011.07.045; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mutasa-Gottgens ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-99; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Paesold S, 2012, PLANT J, V72, P600, DOI 10.1111/j.1365-313X.2012.05102.x; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider K, 2007, THEOR APPL GENET, V115, P601, DOI 10.1007/s00122-007-0591-4; Schondelmaier J, 1997, THEOR APPL GENET, V95, P590, DOI 10.1007/s001220050600; Simko I, 2012, PLANT SCI, V184, P54, DOI 10.1016/j.plantsci.2011.12.009; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Telles GP, 2001, GENET MOL BIOL, V24, P17, DOI 10.1590/S1415-47572001000100004; Van K, 2005, J HERED, V96, P529, DOI 10.1093/jhered/esi069; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wurschum T, 2011, THEOR APPL GENET, V123, P1121, DOI 10.1007/s00122-011-1653-1; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59	39	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110113	10.1371/journal.pone.0110113	http://dx.doi.org/10.1371/journal.pone.0110113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302600	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400112
J	Sano, O; Ito, S; Kato, R; Shimizu, Y; Kobayashi, A; Kimura, Y; Kioka, N; Hanada, K; Ueda, K; Matsuo, M				Sano, Osamu; Ito, Shiho; Kato, Reiko; Shimizu, Yuji; Kobayashi, Aya; Kimura, Yasuhisa; Kioka, Noriyuki; Hanada, Kentaro; Ueda, Kazumitsu; Matsuo, Michinori			ABCA1, ABCG1, and ABCG4 Are Distributed to Distinct Membrane Meso-Domains and Disturb Detergent-Resistant Domains on the Plasma Membrane	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; CELLULAR CHOLESTEROL EFFLUX; CASSETTE TRANSPORTERS G1; LIPID RAFTS; TANGIER-DISEASE; P-GLYCOPROTEIN; EXTRACELLULAR DOMAIN; MEDIATE CHOLESTEROL; ATPASE ACTIVITY	ATP-binding cassette A1 (ABCA1), ABCG1, and ABCG4 are lipid transporters that mediate the efflux of cholesterol from cells. To analyze the characteristics of these lipid transporters, we examined and compared their distributions and lipid efflux activity on the plasma membrane. The efflux of cholesterol mediated by ABCA1 and ABCG1, but not ABCG4, was affected by a reduction of cellular sphingomyelin levels. Detergent solubility and gradient density ultracentrifugation assays indicated that ABCA1, ABCG1, and ABCG4 were distributed to domains that were solubilized by Triton X-100 and Brij 96, resistant to Triton X-100 and Brij 96, and solubilized by Triton X-100 but resistant to Brij 96, respectively. Furthermore, ABCG1, but not ABCG4, was colocalized with flotillin-1 on the plasma membrane. The amounts of cholesterol extracted by methyl-beta-cyclodextrin were increased by ABCA1, ABCG1, or ABCG4, suggesting that cholesterol in non-raft domains was increased. Furthermore, ABCG1 and ABCG4 disturbed the localization of caveolin-1 to the detergent-resistant domains and the binding of cholera toxin subunit B to the plasma membrane. These results suggest that ABCA1, ABCG1, and ABCG4 are localized to distinct membrane meso-domains and disturb the meso-domain structures by reorganizing lipids on the plasma membrane; collectively, these observations may explain the different substrate profiles and lipid efflux roles of these transporters.	[Sano, Osamu; Ito, Shiho; Kato, Reiko; Shimizu, Yuji; Kobayashi, Aya; Kimura, Yasuhisa; Kioka, Noriyuki; Ueda, Kazumitsu; Matsuo, Michinori] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo, Kyoto, Japan; [Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo, Kyoto, Japan; [Matsuo, Michinori] Kyoto Womens Univ, Fac Home Econ, Dept Food & Nutr, Kyoto, Japan	Kyoto University; National Institute of Infectious Diseases (NIID); Kyoto University; Kyoto Womens University	Matsuo, M (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo, Kyoto, Japan.	matsuomi@kyoto-wu.ac.jp	Kobayashi, Aya/AAA-2530-2020	Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X; Kimura, Yasuhisa/0000-0001-6466-1324; Hanada, Kentaro/0000-0003-1383-2781	JSPS KAKENHI [21688007, 24580139, 26660071, 20056016]; World Premier International Research Center Initiative (WPI initiative) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; BRAIN (the Bio-oriented Technology Research Advancement Institution)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); World Premier International Research Center Initiative (WPI initiative) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; BRAIN (the Bio-oriented Technology Research Advancement Institution)	This work was supported by a Grant-in-aid for Scientific Research for Young Scientists (A) (JSPS KAKENHI Grant Number 21688007), by a Grant-in-aid for Scientific Research (B), by a Grant-in-aid for Scientific Research (B) (JSPS KAKENHI Grant Number 24580139), by a Grant-in-aid for Exploratory Research (JSPS KAKENHI Grant Number 26660071), by a Grant-in-aid for Scientific Research on Priority Areas (MEXT KAKENHI Grant Number 20056016), and by the World Premier International Research Center Initiative (WPI initiative) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants from BRAIN (the Bio-oriented Technology Research Advancement Institution). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; ALVAREZ E, 1993, MECH AGEING DEV, V71, P1, DOI 10.1016/0047-6374(93)90030-U; Bacso Z, 2004, CYTOM PART A, V61A, P105, DOI 10.1002/cyto.a.20081; Baldan A, 2006, J BIOL CHEM, V281, P29401, DOI 10.1074/jbc.M606597200; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; DRESSLER KA, 1991, J BIOL CHEM, V266, P11522; Feigenson GW, 2006, NAT CHEM BIOL, V2, P560, DOI 10.1038/nchembio1106-560; Fielding CJ, 2003, BBA-BIOMEMBRANES, V1610, P219, DOI 10.1016/S0005-2736(03)00020-8; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gu HM, 2014, BBA-MOL CELL BIOL L, V1841, P847, DOI 10.1016/j.bbalip.2014.02.002; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hirata T, 2009, BIOSCI BIOTECH BIOCH, V73, P619, DOI 10.1271/bbb.80694; Hirayama H, 2013, J LIPID RES, V54, P496, DOI 10.1194/jlr.M033209; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Ismair MG, 2009, HEPATOLOGY, V49, P1673, DOI 10.1002/hep.22807; Jacobs C, 2004, FEBS LETT, V565, P70, DOI 10.1016/j.febslet.2004.03.076; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Matsuo M, 2011, BBA-MOL CELL BIOL L, V1811, P31, DOI 10.1016/j.bbalip.2010.10.004; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Nagao K, 2007, J BIOL CHEM, V282, P14868, DOI 10.1074/jbc.M611230200; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; OKWU AK, 1994, J LIPID RES, V35, P644; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Radeva G, 2005, FEBS J, V272, P4924, DOI 10.1111/j.1742-4658.2005.04905.x; RICARDO MJ, 1986, J IMMUNOL, V136, P1054; Rocchi E, 2000, BIOCHEM BIOPH RES CO, V271, P42, DOI 10.1006/bbrc.2000.2590; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sano O, 2007, J LIPID RES, V48, P2377, DOI 10.1194/jlr.M700139-JLR200; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Seres L, 2008, BBA-BIOMEMBRANES, V1778, P2378, DOI 10.1016/j.bbamem.2008.06.010; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Terasaka N, 2010, ARTERIOSCL THROM VAS, V30, P2219, DOI 10.1161/ATVBAHA.110.213215; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; Wojcik AJ, 2008, J IMMUNOL, V180, P4273, DOI 10.4049/jimmunol.180.6.4273; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, CIRC RES, V106, P1861, DOI 10.1161/CIRCRESAHA.110.217281; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	67	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109886	10.1371/journal.pone.0109886	http://dx.doi.org/10.1371/journal.pone.0109886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302608	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400090
J	Vandervoort, KG; Brelles-Marino, G				Vandervoort, Kurt G.; Brelles-Marino, Graciela			Plasma-Mediated Inactivation of Pseudomonas aeruginosa Biofilms Grown on Borosilicate Surfaces under Continuous Culture System	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE; STERILIZATION	Biofilms are microbial communities attached to a surface and embedded in a matrix composed of exopolysaccharides and excreted nucleic acids. Bacterial biofilms are responsible for undesirable effects such as disease, prostheses colonization, biofouling, equipment damage, and pipe plugging. Biofilms are also more resilient than free-living cells to regular sterilization methods and therefore it is indispensable to develop better ways to control and remove them. The use of gas discharge plasmas is a good alternative since plasmas contain a mixture of reactive agents well-known for their decontamination potential against free microorganisms. We have previously reported that Pseudomonas aeruginosa biofilms were inactivated after a 1-min plasma exposure. We determined that the adhesiveness and the thickness of Pseudomonas biofilms grown on borosilicate were reduced. We also reported sequential morphological changes and loss of viability upon plasma treatment. However, the studies were carried out in batch cultures. The use of a continuous culture results in a more homogenous environment ensuring reproducible biofilm growth. The aim of this work was to study plasma-mediated inactivation of P. aeruginosa biofilms grown on borosilicate in a continuous culture system. In this paper we show that biofilms grown on glass under continuous culture can be inactivated by using gas discharge plasma. Both biofilm architecture and cell culturabilty are impacted by the plasma treatment. The inactivation kinetics is similar to previously described ones and cells go through sequential changes ranging from minimal modification without loss of viability at short plasma exposure times, to major structure and viability loss at longer exposure times. We report that changes in biofilm structure leading to the loss of culturability and viability are related to a decrease of the biofilm matrix adhesiveness. To our knowledge, there has been no attempt to evaluate the inactivation/sterilization of biofilms grown in a continuous system.	[Vandervoort, Kurt G.] Calif State Polytech Univ Pomona, Dept Phys & Astron, Pomona, CA 91768 USA; [Brelles-Marino, Graciela] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona; California State University System; California State Polytechnic University Pomona	Brelles-Marino, G (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Ctr Res & Dev Ind Fermentat, La Plata, Argentina.	gbrelles@biotec.quimica.unlp.edu.ar			National Institutes of Health Grant SCORE SC3 [1SC3GM088070]; National Science Foundation Nanotechnology Undergraduate Education Program [0406533]; Agencia Nacional de Promocion Cientifica y Tecnologica Proyectos de Investigacion Cientifica y Tecnologica Argentina [PICT-2009-0047]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM088070] Funding Source: NIH RePORTER	National Institutes of Health Grant SCORE SC3(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Nanotechnology Undergraduate Education Program(National Science Foundation (NSF)); Agencia Nacional de Promocion Cientifica y Tecnologica Proyectos de Investigacion Cientifica y Tecnologica Argentina; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant SCORE SC3 # 1SC3GM088070 to GBM, National Science Foundation Nanotechnology Undergraduate Education Program, award # 0406533 to KGV and Agencia Nacional de Promocion Cientifica y Tecnologica Proyectos de Investigacion Cientifica y Tecnologica Argentina PICT-2009-0047 to GBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Akishev, 2012, PLASMA BIODECONTAMIN, P135, DOI DOI 10.1007/978-94-007-2852-3_11; Akishev YS, 2005, P 2 INT WORKSH COLD, P69; Akishev Y, 2008, PURE APPL CHEM, V80, P1953, DOI 10.1351/pac200880091953; Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Becker K, 2005, PLASMA PHYS CONTR F, V47, pB513, DOI 10.1088/0741-3335/47/12B/S37; Brelles-Marino G, 2010, ENVIRON RES ADV, P75; BRELLESMARINO G, 2005, P 2 INT WORKSH COLD, P69; Bryers JD, 2004, ASM NEWS, V70, P232; Davies D, 1999, CLIN MICROBIAL INFEC, V5, p5S7; Gillis RJ, 2004, J CLIN MICROBIOL, V42, P5842, DOI 10.1128/JCM.42.12.5842-5845.2004; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; International Standard, 2000, 14937 ISO; ISO, 1994, 11134 ISO; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Jones R, 2002, LANGMUIR, V18, P8045, DOI 10.1021/la0259196; Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482; Laroussi M, 1996, IEEE T PLASMA SCI, V24, P1188, DOI 10.1109/27.533129; Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899; Laroussi M, 2010, BIOL ENV APPL GAS DI, P3; Oh YJ, 2009, ULTRAMICROSCOPY, V109, P874, DOI 10.1016/j.ultramic.2009.03.042; Park SR, 2001, WATER RES, V35, P1624, DOI 10.1016/S0043-1354(00)00582-0; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887; Tanaka G, 2000, CHEMOTHERAPY, V46, P36, DOI 10.1159/000007254; Tummler B, 1999, MOL MED TODAY, V5, P351, DOI 10.1016/S1357-4310(99)01506-3; Vandervoort KG, 2008, IEEE T PLASMA SCI, V36, P1296, DOI 10.1109/TPS.2008.917953; Zelaya AJ, 2010, IEEE T PLASMA SCI, V38, P3398, DOI 10.1109/TPS.2010.2082570; Zhao LM, 2005, APPL ENVIRON MICROB, V71, P955, DOI 10.1128/AEM.71.2.955-960.2005	30	32	32	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108512	10.1371/journal.pone.0108512	http://dx.doi.org/10.1371/journal.pone.0108512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302815	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400015
J	Bohn, AB; Wittenborn, T; Brems-Eskildsen, AS; Laurberg, T; Bertelsen, LB; Nielsen, T; Stodkilde-Jorgensen, H; Moller, BK; Horsman, MR				Bohn, Anja Bille; Wittenborn, Thomas; Brems-Eskildsen, Anne Sofie; Laurberg, Tinne; Bertelsen, Lotte Bonde; Nielsen, Thomas; Stodkilde-Jorgensen, Hans; Moller, Bjarne Kuno; Horsman, Michael R.			A Combretastatin-Mediated Decrease in Neutrophil Concentration in Peripheral Blood and the Impact on the Anti-Tumor Activity of This Drug in Two Different Murine Tumor Models	PLOS ONE			English	Article							VASCULAR-TARGETING AGENT; A-4 DISODIUM PHOSPHATE; PHASE-I TRIAL; A4 PHOSPHATE; NORMAL-TISSUES; THERAPEUTIC GAIN; ADVANCED CANCER; COMBINATION; ANGIOGENESIS; THERAPIES	The vascular disrupting agent combretastatin A-4 disodium phosphate (CA4P) induces fluctuations in peripheral blood neutrophil concentration. Because neutrophils have the potential to induce both vascular damage and angiogenesis we analyzed neutrophil involvement in the anti-tumoral effects of CA4P in C3H mammary carcinomas in CDF1 mice and in SCCVII squamous cell carcinomas in C3H/HeN mice. Flow cytometry analyses of peripheral blood before and up to 144 h after CA4P administration (25 and 250 mg/kg) revealed a decrease 1 h after treatment, followed by an early (3-6 h) and a late (. 72 h) increase in the granulocyte concentration. We suggest that the early increase (3-6 h) in granulocyte concentration was caused by the initial decrease at 1 h and found that the late increase was associated with tumor size, and hence independent of CA4P. No alterations in neutrophil infiltration into the C3H tumor after CA4P treatment (25 and 250 mg/kg) were found. Correspondingly, neutrophil depletion in vivo, using an anti-neutrophil antibody, followed by CA4P treatment (25 mg/kg) did not increase the necrotic fraction in C3H tumors significantly. However, by increasing the CA4P dose to 250 mg/kg we found a significant increase of 359% in necrotic fraction when compared to neutrophil-depleted mice; in mice with no neutrophil depletion CA4P induced an 89% change indicating that the presence of neutrophils reduced the effect of CA4P. In contrast, neither CA4P nor 1A8 affected the necrotic fraction in the SCCVII tumors significantly. Hence, we suggest that the initial decrease in granulocyte concentration was caused by non-tumor-specific recruitment of neutrophils and that neutrophils may attenuate CA4P-mediated anti-tumor effect in some tumor models.	[Bohn, Anja Bille; Wittenborn, Thomas; Laurberg, Tinne; Nielsen, Thomas; Horsman, Michael R.] Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark; [Brems-Eskildsen, Anne Sofie] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark; [Bertelsen, Lotte Bonde; Stodkilde-Jorgensen, Hans] Aarhus Univ Hosp, MR Res Ctr, DK-8000 Aarhus, Denmark; [Moller, Bjarne Kuno] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Horsman, MR (corresponding author), Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark.	mike@oncology.dk		Horsman, Michael/0000-0003-1578-5691; Laurberg, Tinne/0000-0002-7555-2665; Stodkilde-Jorgensen, Hans/0000-0002-8649-4173; Bertelse, Lotte Bonde/0000-0002-2491-3184	Danish Cancer Society; Danish Council for Independent Research: Medical Sciences; Radiumstationens research foundation; foundation in memory of Sigvald and Edith Anelise Celine Kristine Rasmussen, born Poulsen	Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research: Medical Sciences(Det Frie Forskningsrad (DFF)); Radiumstationens research foundation; foundation in memory of Sigvald and Edith Anelise Celine Kristine Rasmussen, born Poulsen	Financial support for this study was provided by The Danish Cancer Society (www.cancer.dk), The Danish Council for Independent Research: Medical Sciences (www.fivu.dk), Radiumstationens research foundation, and The foundation in memory of Sigvald and Edith Anelise Celine Kristine Rasmussen, born Poulsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2008, J NAT PROD, V71, P492, DOI 10.1021/np0705716; Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bilenker JH, 2005, CLIN CANCER RES, V11, P1527, DOI 10.1158/1078-0432.CCR-04-1434; Bohn AB, 2012, AM J PHYSIOL-REG I, V303, pR186, DOI 10.1152/ajpregu.00572.2011; Busk M, 2011, VASC PHARMACOL, V54, P13, DOI 10.1016/j.vph.2010.10.002; Chaplin DJ, 1999, ANTICANCER RES, V19, P189; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dark GG, 1997, CANCER RES, V57, P1829; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Dowlati A, 2002, CANCER RES, V62, P3408; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gaudry M, 1997, BLOOD, V90, P4153, DOI 10.1182/blood.V90.10.4153; He XX, 2011, BRIT J CLIN PHARMACO, V71, P860, DOI 10.1111/j.1365-2125.2011.03928.x; HIRST DG, 1982, BRIT J CANCER, V46, P109, DOI 10.1038/bjc.1982.172; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Horsman MR, 2000, ADV EXP MED BIOL, V476, P311; Horsman MR, 2002, INT J RADIAT ONCOL, V54, P1518, DOI 10.1016/S0360-3016(02)03926-3; KANAZAWA H, 1988, CANCER RES, V48, P3158; Korbelik M, 1999, CANCER LETT, V137, P91, DOI 10.1016/S0304-3835(98)00349-8; Li L, 2002, ACTA ONCOL, V41, P91, DOI 10.1080/028418602317314127; Murata R, 2001, RADIOTHER ONCOL, V60, P155, DOI 10.1016/S0167-8140(01)00384-X; Murata R, 2001, INT J RADIAT BIOL, V77, P195; Nathan P, 2012, CLIN CANCER RES, V18, P3428, DOI 10.1158/1078-0432.CCR-11-3376; OVERGAARD J, 1980, INT J RADIAT ONCOL, V6, P1507, DOI 10.1016/0360-3016(80)90008-5; OVERGAARD K, 1972, EUR J CANCER, V8, P65, DOI 10.1016/0014-2964(72)90085-0; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Parkins CS, 2000, BRIT J CANCER, V83, P811, DOI 10.1054/bjoc.2000.1361; Prise VE, 2002, INT J ONCOL, V21, P717; Reichel CA, 2012, BLOOD, V120, P880, DOI 10.1182/blood-2012-01-402164; Rustin GJS, 2003, J CLIN ONCOL, V21, P2815, DOI 10.1200/JCO.2003.05.185; Salmon BA, 2007, EUR J CANCER, V43, P1622, DOI 10.1016/j.ejca.2007.03.018; Salmon HW, 2006, CLIN CANCER RES, V12, P4090, DOI 10.1158/1078-0432.CCR-06-0163; Siemann DW, 2005, CLIN CANCER RES, V11, P416; Stevenson JP, 2003, J CLIN ONCOL, V21, P4428, DOI 10.1200/JCO.2003.12.986; Tarnawski AS, 2003, J MOL MED, V81, P627, DOI 10.1007/s00109-003-0479-y; Taylor M, 2012, CANCER DISCOV, V2, P434, DOI 10.1158/2159-8290.CD-11-0171; Tozer GM, 1999, CANCER RES, V59, P1626; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wang LCS, 2009, NEOPLASIA, V11, P793, DOI 10.1593/neo.09506; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; WESTLIN WF, 1993, AM J PATHOL, V142, P117	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110091	10.1371/journal.pone.0110091	http://dx.doi.org/10.1371/journal.pone.0110091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299269	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200101
J	Palanichamy, MG; Mitra, B; Debnath, M; Agrawal, S; Chaudhuri, TK; Zhang, YP				Palanichamy, Malliya Gounder; Mitra, Bikash; Debnath, Monojit; Agrawal, Suraksha; Chaudhuri, Tapas Kumar; Zhang, Ya-Ping			Tamil Merchant in Ancient Mesopotamia	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; MACROHAPLOGROUP-M; INDIA; PHYLOGENY; EXPANSION; ASIA	Recent analyses of ancient Mesopotamian mitochondrial genomes have suggested a genetic link between the Indian subcontinent and Mesopotamian civilization. There is no consensus on the origin of the ancient Mesopotamians. They may be descendants of migrants, who founded regional Mesopotamian groups like that of Terqa or they may be merchants who were involved in trans Mesopotamia trade. To identify the Indian source population showing linkage to the ancient Mesopotamians, we screened a total of 15,751 mitochondrial DNAs (11,432 from the literature and 4,319 from this study) representing all major populations of India. Our results although suggest that south India (Tamil Nadu) and northeast India served as the source of the ancient Mesopotamian mtDNA gene pool, mtDNA of these ancient Mesopotamians probably contributed by Tamil merchants who were involved in the Indo-Roman trade.	[Palanichamy, Malliya Gounder; Mitra, Bikash; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Debnath, Monojit; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Mitra, Bikash; Chaudhuri, Tapas Kumar] Univ N Bengal, Cellular Immunol Lab, Darjeeling, India; [Agrawal, Suraksha] Sanjay Gandhi Inst Med Sci, Dept Med Genet, Lucknow, Uttar Pradesh, India	Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; University of North Bengal; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Palanichamy, MG (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China.	empalani@yahoo.com; zhangyp1@263.net.cn	Debnath, Monojit/G-2725-2010		Yunnan University; Yunnan provincial Science and Technology Department; National Natural Science Foundation of China [31060156, 31240018]	Yunnan University; Yunnan provincial Science and Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Yunnan University and the Yunnan provincial Science and Technology Department, as well as from grants from National Natural Science Foundation of China (31060156 and 31240018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Blue L., 2012, NAVIGATED SPACES CON, P91; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Eaaswarkhanth M, 2010, EUR J HUM GENET, V18, P354, DOI 10.1038/ejhg.2009.168; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Gazi NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075064; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Prasad M, 2011, INDIAS FOREIGN TRADE, P21; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Rej P., 2013, MEASURING MITOCHONDR; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Selvakumar V., 2009, MIGRATION TRADE PE 1, P29; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Summerer M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-17; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Witas HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073682	19	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109331	10.1371/journal.pone.0109331	http://dx.doi.org/10.1371/journal.pone.0109331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AS0AP	25299580	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200047
J	Hodulova, M; Sedova, L; Krenova, D; Liska, F; Krupkova, M; Kazdova, L; Tremblay, J; Hamet, P; Kren, V; Seda, O				Hodulova, Miloslava; Sedova, Lucie; Krenova, Drahomira; Liska, Frantisek; Krupkova, Michaela; Kazdova, Ludmila; Tremblay, Johanne; Hamet, Pavel; Kren, Vladimir; Seda, Ondrej			Genomic Determinants of Triglyceride and Cholesterol Distribution into Lipoprotein Fractions in the Rat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SPONTANEOUSLY HYPERTENSIVE-RAT; RECOMBINANT INBRED STRAINS; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; INDUCED HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; GENETIC-DETERMINANTS; LINKAGE ANALYSIS	The plasma profile of major lipoprotein classes and its subdivision into particular fractions plays a crucial role in the pathogenesis of atherosclerosis and is a major predictor of coronary artery disease. Our aim was to identify genomic determinants of triglyceride and cholesterol distribution into lipoprotein fractions and lipoprotein particle sizes in the recombinant inbred rat set PXO, in which alleles of two rat models of the metabolic syndrome (SHR and PD inbred strains) segregate together with those from Brown Norway rat strain. Adult male rats of 15 PXO strains (n = 8-13/strain) and two progenitor strains SHR-Lx (n = 13) and BXH2/Cub (n = 18) were subjected to one-week of high-sucrose diet feeding. We performed association analyses of triglyceride (TG) and cholesterol (C) concentrations in 20 lipoprotein fractions and the size of major classes of lipoprotein particles utilizing 704 polymorphic microsatellite markers, the genome-wide significance was validated by 2,000 permutations per trait. Subsequent in silico focusing of the identified quantitative trait loci was completed using a map of over 20,000 single nucleotide polymorphisms. In most of the phenotypes we identified substantial gradient among the strains (e.g. VLDL-TG from 5.6 to 66.7 mg/dl). We have identified 14 loci (encompassing 1 to 65 genes) on rat chromosomes 3, 4, 7, 8, 11 and 12 showing suggestive or significant association to one or more of the studied traits. PXO strains carrying the SHR allele displayed significantly higher values of the linked traits except for LDL-TG and adiposity index. Cholesterol concentrations in large, medium and very small LDL particles were significantly associated to a haplotype block spanning part of a single gene, low density lipoprotein receptor-related protein 1B (Lrp1b). Using genome-wide association we have identified new genetic determinants of triglyceride and cholesterol distribution into lipoprotein fractions in the recombinant inbred panel of rat model strains.	[Hodulova, Miloslava; Sedova, Lucie; Krenova, Drahomira; Liska, Frantisek; Krupkova, Michaela; Kren, Vladimir; Seda, Ondrej] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Hodulova, Miloslava; Sedova, Lucie; Krenova, Drahomira; Liska, Frantisek; Krupkova, Michaela; Kren, Vladimir; Seda, Ondrej] Gen Teaching Hosp, Prague, Czech Republic; [Kazdova, Ludmila] Inst Clin & Expt Med, Dept Metab & Diabet, Prague, Czech Republic; [Tremblay, Johanne; Hamet, Pavel] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Hodulova, Miloslava; Seda, Ondrej] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Institute for Clinical & Experimental Medicine (IKEM); Universite de Montreal; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Seda, O (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.	oseda@lf1.cuni.cz	Cossette, Suzanne/I-8008-2016; Liska, Frantisek/N-9192-2017; Krupkova, Michaela/L-2373-2017; Seda, Ondrej/A-2058-2008; Sedova, Lucie/D-1089-2017	Liska, Frantisek/0000-0002-9588-806X; Krupkova, Michaela/0000-0002-9371-2511; Seda, Ondrej/0000-0001-8498-5895; Sedova, Lucie/0000-0003-3783-2946	Ministry of Education, Youth and Sports of the Czech Republic [LK11217]; Charles University in Prague [PRVOUK-P25/LF1/2, GAUK 434313]; European Regional Development Fund [CZ.1.05/1.1.0/02.0109]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; European Regional Development Fund(European Commission)	This work was supported by Project LK11217 from the Ministry of Education, Youth and Sports of the Czech Republic; PRVOUK-P25/LF1/2 and GAUK 434313 research projects of Charles University in Prague, and by the project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" (CZ.1.05/1.1.0/02.0109), from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell C, 2013, J LIPID RES, V54, P984, DOI 10.1194/jlr.M033035; Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Asahina M, 2005, J LIPID RES, V46, P2289, DOI 10.1194/jlr.M500257-JLR200; Austin MA, 1998, AM J HUM GENET, V62, P406, DOI 10.1086/301712; Baguhl R, 2009, OBESITY, V17, P1215, DOI 10.1038/oby.2008.658; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bottger A, 1996, J CLIN INVEST, V98, P856, DOI 10.1172/JCI118858; Burgdorf KS, 2012, DIABETOLOGIA, V55, P105, DOI 10.1007/s00125-011-2320-4; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cox A, 2010, HEREDITY, V105, P426, DOI 10.1038/hdy.2010.75; Damasceno NRT, 2013, ATHEROSCLEROSIS, V230, P347, DOI 10.1016/j.atherosclerosis.2013.08.014; Festa A, 2005, CIRCULATION, V111, P3465, DOI 10.1161/CIRCULATIONAHA.104.512079; Frazier-Wood AC, 2013, HUM GENET, V132, P405, DOI 10.1007/s00439-012-1256-1; Gardner J, 2012, BIOCHEM BIOPH RES CO, V418, P1, DOI 10.1016/j.bbrc.2011.11.117; Gibson S, 2013, CRIT REV FOOD SCI, V53, P591, DOI 10.1080/10408398.2012.691574; Greenawalt DM, 2012, AM J EPIDEMIOL, V176, P423, DOI 10.1093/aje/kws123; Guay SP, 2013, ATHEROSCLEROSIS, V228, P413, DOI 10.1016/j.atherosclerosis.2013.03.033; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Haas J, 2011, ATHEROSCLEROSIS, V216, P342, DOI 10.1016/j.atherosclerosis.2011.02.030; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hamet P, 1998, KIDNEY INT, V53, P1488, DOI 10.1046/j.1523-1755.1998.00938.x; Herrera VLM, 2007, J HYPERTENS, V25, P1608, DOI 10.1097/HJH.0b013e328182df1a; Hirayama S, 2012, CLIN CHIM ACTA, V414, P215, DOI 10.1016/j.cca.2012.09.010; Holmes M.V., 2014, EUR HEART J; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Johnson MP, 2013, MOL HUM REPROD, V19, P423, DOI 10.1093/molehr/gat011; Kaess B, 2008, J LIPID RES, V49, P715, DOI 10.1194/jlr.M700338-JLR200; Kemlink D, 2003, FOLIA BIOL-PRAGUE, V49, P165; Kikkawa K, 2014, CLIN CHIM ACTA; Klevstig MJ, 2011, MOL CELL BIOCHEM, V357, P163, DOI 10.1007/s11010-011-0886-2; Kloting I, 2001, BIOCHEM BIOPH RES CO, V284, P150, DOI 10.1006/bbrc.2001.4932; Kovacs P, 1998, ARCH BIOCHEM BIOPHYS, V354, P139, DOI 10.1006/abbi.1998.0686; Kovacs P, 2000, BIOCHEM BIOPH RES CO, V269, P660, DOI 10.1006/bbrc.2000.2352; Krupkova M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-38; Krupkova M, 2009, PHARMACOGENOMICS, V10, P1915, DOI 10.2217/PGS.09.113; Kulkarni H, 2013, HYPERTENSION, V62, P621, DOI 10.1161/HYPERTENSIONAHA.113.01396; Langley SR, 2013, CARDIOVASC RES, V97, P653, DOI 10.1093/cvr/cvs329; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Mashimo T, 2007, PHYSIOL GENOMICS, V30, P95, DOI 10.1152/physiolgenomics.00211.2006; Melenovsky Vojtech, 2002, Am Heart J, V144, pE6, DOI 10.1016/S0002-8703(02)00142-4; Mishina H, 2014, CIRC RES, V114, P493, DOI 10.1161/CIRCRESAHA.114.302319; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Nsengimana J, 2007, EUR J HUM GENET, V15, P313, DOI 10.1038/sj.ejhg.5201752; Ogino T, 2000, GENOMICS, V70, P19, DOI 10.1006/geno.2000.6349; Okazaki M, 2006, CLIN CHEM, V52, P2049, DOI 10.1373/clinchem.2006.070094; Osborn O, 2012, J CLIN INVEST, V122, P2444, DOI 10.1172/JCI61953; Petersen AK, 2012, HUM MOL GENET, V21, P1433, DOI 10.1093/hmg/ddr580; Printz MP, 2003, J APPL PHYSIOL, V94, P2510, DOI 10.1152/japplphysiol.00064.2003; Robinson JG, 2014, FUTUR CARDIOL, V10, P149, DOI [10.2217/fca.14.8, 10.2217/FCA.14.8]; Ruel IL, 2002, ARTERIOSCL THROM VAS, V22, P1181, DOI 10.1161/01.ATV.0000020677.33243.1C; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Seda O, 2005, PHYSIOL GENOMICS, V21, P243, DOI 10.1152/physiolgenomics.00230.2004; Seda O, 2002, FOLIA BIOL-PRAGUE, V48, P81; Seda O, 2006, Prague Med Rep, V107, P251; Seda O, 2006, PHYSIOL GENOMICS, V27, P95, DOI 10.1152/physiolgenomics.00039.2006; Sedova L, 2000, FOLIA BIOL-PRAGUE, V46, P99; Sedova L, 2007, AM J PHYSIOL-ENDOC M, V292, pE1318, DOI 10.1152/ajpendo.00526.2006; Shah S, 2013, CIRC-CARDIOVASC GENE, V6, P63, DOI 10.1161/CIRCGENETICS.112.963140; Simonis M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r31; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stancakova A, 2011, DIABETES, V60, P1608, DOI 10.2337/db10-1655; Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Ueno T, 2004, PHYSIOL GENOMICS, V17, P38, DOI 10.1152/physiolgenomics.00043.2003; Usui S, 2002, J LIPID RES, V43, P805; VRANA A, 1993, ANN NY ACAD SCI, V683, P57, DOI 10.1111/j.1749-6632.1993.tb35692.x; Watanabe T, 2005, BIOCHEM BIOPH RES CO, V329, P879, DOI 10.1016/j.bbrc.2005.02.053; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wood RJ, 2006, J NUTR, V136, P384, DOI 10.1093/jn/136.2.384; Zhang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-704	70	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109983	10.1371/journal.pone.0109983	http://dx.doi.org/10.1371/journal.pone.0109983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296178	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000108
J	Jimenez-Soto, E; Durham, J; Hodge, A				Jimenez-Soto, Eliana; Durham, Jo; Hodge, Andrew			Entrenched Geographical and Socioeconomic Disparities in Child Mortality: Trends in Absolute and Relative Inequalities in Cambodia	PLOS ONE			English	Article							HEALTH-SERVICES; WEALTH INEQUALITY; USER FEES; EQUITY; ACCESS; IMPROVEMENTS; DISTRICT; SURVIVAL; UNDER-5; CARE	Background: Cambodia has made considerable improvements in mortality rates for children under the age of five and neonates. These improvements may, however, mask considerable disparities between subnational populations. In this paper, we examine the extent of the country's child mortality inequalities. Methods: Mortality rates for children under-five and neonates were directly estimated using the 2000, 2005 and 2010 waves of the Cambodian Demographic Health Survey. Disparities were measured on both absolute and relative scales using rate differences and ratios, and where applicable, slope and relative indices of inequality by levels of rural/urban location, regions and household wealth. Findings: Since 2000, considerable reductions in under-five and to a lesser extent in neonatal mortality rates have been observed. This mortality decline has, however, been accompanied by an increase in relative inequality in both rates of child mortality for geography-related stratifying markers. For absolute inequality amongst regions, most trends are increasing, particularly for neonatal mortality, but are not statistically significant. The only exception to this general pattern is the statistically significant positive trend in absolute inequality for under-five mortality in the Coastal region. For wealth, some evidence for increases in both relative and absolute inequality for neonates is observed. Conclusion: Despite considerable gains in reducing under-five and neonatal mortality at a national level, entrenched and increased geographical and wealth-based inequality in mortality, at least on a relative scale, remain. As expected, national progress seems to be associated with the period of political and macroeconomic stability that started in the early 2000s. However, issues of quality of care and potential non-inclusive economic growth might explain remaining disparities, particularly across wealth and geography markers. A focus on further addressing key supply and demand side barriers to accessing maternal and child health care and on the social determinants of health will be essential in narrowing inequalities.	[Jimenez-Soto, Eliana; Durham, Jo; Hodge, Andrew] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Queensland	Hodge, A (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	a.hodge@uq.edu.au	Durham, Jo/A-1977-2014; Hodge, Andrew/C-4779-2014	Durham, Jo/0000-0003-0544-9424; Hodge, Andrew/0000-0002-7203-9233	Department of Foreign Affairs and Trade, Australia [47734]	Department of Foreign Affairs and Trade, Australia	The research described in this paper is made possible through the Department of Foreign Affairs and Trade, Australia, grant ID 47734. The funders of the study had no role in the study design, data collection, the analysis or the interpretation of the results, or the writing of this paper.	Ahmed S, 2011, B WORLD HEALTH ORGAN, V89, P12, DOI 10.2471/BLT.10.076851; [Anonymous], 2003, REV INCOME WEALTH; Asian Development Bank, 2012, CAMB COUNTR POV AN; Bauze AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037861; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Cleveland W, 1996, STAT THEORY COMPUTAT; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Dettrick Z, 2014, MATERN CHILD HLTH J, V18, P960, DOI 10.1007/s10995-013-1324-8; Dingle A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-51; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Hardeman W, 2004, HEALTH POLICY PLANN, V19, P22, DOI 10.1093/heapol/czh003; Harper S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063362; Hayes LJ, 2002, J EPIDEMIOL COMMUN H, V56, P762, DOI 10.1136/jech.56.10.762; Hong R, 2007, ASIA-PAC J PUBLIC HE, V19, P37, DOI 10.1177/10105395070190020701; Hong R, 2006, J HEALTH POPUL NUTR, V24, P89; Hong R, 2010, MATERN CHILD HLTH J, V14, P446, DOI 10.1007/s10995-009-0466-1; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS EST 20; Ir P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-1; Jacobs B, 2004, HEALTH POLICY PLANN, V19, P310, DOI 10.1093/heapol/czh036; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Kanbur R, 2014, INEQUALITY IN ASIA AND THE PACIFIC: TRENDS, DRIVERS, AND POLICY IMPLICATIONS, P1; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Liljestrand J, 2012, REPROD HEALTH MATTER, V20, P62, DOI 10.1016/S0968-8080(12)39620-1; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Marriott BP, 2010, MATERN CHILD NUTR, V6, P358, DOI 10.1111/j.1740-8709.2009.00217.x; Ministry of Health, 2006, NAT STRAT REPR SEX H; MoH Cambodia, 2006, CAMB CHILD SURV STRA; Moser C, 2007, 87 CPRC U MANCH; Mulholland EK, 2008, B WORLD HEALTH ORGAN, V86, P399, DOI 10.2471/BLT.07.044545; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; National Institute of Statistics, 2011, CAMB DEM HLTH SURV 2; Nguyen K-H, 2012, J EPIDEMIOLOGY COMMU; PAMUK ER, 1985, POP STUD-J DEMOG, V39, P17, DOI 10.1080/0032472031000141256; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Sasaki Y, 2010, J PEDIATR NURS, V25, P463, DOI 10.1016/j.pedn.2009.04.010; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026856; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wagstaff A, 2003, HEALTH ECON, V12, P885, DOI 10.1002/hec.805; Wang W, 2013, DHS FURTHER ANAL REP, V86; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032	43	6	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109044	10.1371/journal.pone.0109044	http://dx.doi.org/10.1371/journal.pone.0109044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25295528	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000033
J	Kowshile, J; Baba, AB; Giri, H; Reddy, GD; Dixit, M; Nagini, S				Kowshile, J.; Baba, Abdul Basit; Giri, Hemant; Reddy, G. Deepak; Dixit, Madhulika; Nagini, Siddavaram			Astaxanthin Inhibits JAK/STAT-3 Signaling to Abrogate Cell Proliferation, Invasion and Angiogenesis in a Hamster Model of Oral Cancer	PLOS ONE			English	Article							NF-KAPPA-B; INDUCE INTRINSIC APOPTOSIS; IN-VITRO; HEPATOCELLULAR-CARCINOMA; WNT/BETA-CATENIN; STAT3 ACTIVATION; ANIMAL-MODEL; PATHWAY; TRANSCRIPTION; CAROTENOIDS	Identifying agents that inhibit STAT-3, a cytosolic transcription factor involved in the activation of various genes implicated in tumour progression is a promising strategy for cancer chemoprevention. In the present study, we investigated the effect of dietary astaxanthin on JAK-2/STAT-3 signaling in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis model by examining the mRNA and protein expression of JAK/STAT-3 and its target genes. Quantitative RT-PCR, immunoblotting and immunohistochemical analyses revealed that astaxanthin supplementation inhibits key events in JAK/STAT signaling especially STAT-3 phosphorylation and subsequent nuclear translocation of STAT-3. Furthermore, astaxanthin downregulated the expression of STAT-3 target genes involved in cell proliferation, invasion and angiogenesis, and reduced microvascular density, thereby preventing tumour progression. Molecular docking analysis confirmed inhibitory effects of astaxanthin on STAT signaling and angiogenesis. Cell culture experiments with the endothelial cell line ECV304 substantiated the role of astaxanthin in suppressing angiogenesis. Taken together, our data provide substantial evidence that dietary astaxanthin prevents the development and progression of HBP carcinomas through the inhibition of JAK-2/STAT-3 signaling and its downstream events. Thus, astaxanthin that functions as a potent inhibitor of tumour development and progression by targeting JAK/STAT signaling may be an ideal candidate for cancer chemoprevention.	[Kowshile, J.; Baba, Abdul Basit; Nagini, Siddavaram] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India; [Giri, Hemant; Dixit, Madhulika] Indian Inst Technol, Dept Biotechnol, Lab Vasc Biol, Chennai 600036, Tamil Nadu, India; [Reddy, G. Deepak] Vishnu Inst Pharmaceut Educ & Res, Med Chem Res Div, Narsapur, India	Annamalai University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Nagini, S (corresponding author), Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India.	s_nagini@yahoo.com	Giri, Hemant/Y-8093-2019	Gade, Deepak Reddy/0000-0003-2999-0151	Department of Biotechnology, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by a grant from the Department of Biotechnology, New Delhi, India under the 7th FP of the Indo-EU Joint Collaborative Project on 'FUNCFOOD'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Anitha P, 2013, EUR J NUTR, V52, P75, DOI 10.1007/s00394-011-0288-y; Aparicio-Siegmund S, 2014, ONCOTARGET, V5, P2131, DOI 10.18632/oncotarget.1852; Ben-Yosef Y, 2002, CIRC RES, V90, P784, DOI 10.1161/01.RES.0000015588.70132.DC; Bhatia D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/371813; Bournazou Eirini, 2013, JAKSTAT, V2, pe23828, DOI 10.4161/jkst.23828; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Denley SM, 2013, J GASTROINTEST SURG, V17, P887, DOI 10.1007/s11605-013-2168-7; Gurbuz V, 2014, ONCOL LETT, V7, P755, DOI 10.3892/ol.2014.1795; Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168; Izumi-Nagai K, 2008, INVEST OPHTH VIS SCI, V49, P1679, DOI 10.1167/iovs.07-1426; Jeon KS, 2005, BIOCHEM BIOPH RES CO, V330, P1268, DOI 10.1016/j.bbrc.2005.03.109; Kavitha K, 2013, BBA-GEN SUBJECTS, V1830, P4433, DOI 10.1016/j.bbagen.2013.05.032; Kumar GH, 2010, INVEST NEW DRUG, V28, P392, DOI 10.1007/s10637-009-9263-3; Lamy S, 2012, EXP CELL RES, V318, P1586, DOI 10.1016/j.yexcr.2012.04.004; Legrand-Poels S, 2000, BIOCHEM J, V349, P765, DOI 10.1042/bj3490765; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maoka T, 2012, MAR DRUGS, V10, P1391, DOI 10.3390/md10061391; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nagendraprabhu P, 2011, INVEST NEW DRUG, V29, P207, DOI 10.1007/s10637-009-9342-5; Prabhu PN, 2009, FUND CLIN PHARMACOL, V23, P225, DOI 10.1111/j.1472-8206.2009.00669.x; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rajendran P, 2012, CANCER PREV RES, V5, P631, DOI 10.1158/1940-6207.CAPR-11-0420; Samsonov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068391; Senggunprai L, 2014, PHYTOTHER RES, V28, P841, DOI 10.1002/ptr.5061; Shklar G, 1999, J DENT RES, V78, P1768; Siddavaram N, 2012, CELL ONCOL, V35, P385, DOI 10.1007/s13402-012-0099-z; Silver-Morse L., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.26090; Song XD, 2011, BIOL PHARM BULL, V34, P839, DOI 10.1248/bpb.34.839; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Tanaka T, 2012, MOLECULES, V17, P3202, DOI 10.3390/molecules17033202; Thiyagarajan P, 2012, FOOD CHEM TOXICOL, V50, P867, DOI 10.1016/j.fct.2011.12.019; Trecul A, 2012, GENES NUTR, V7, P111, DOI 10.1007/s12263-012-0281-y; Tu YY, 2011, MED ONCOL, V28, P15, DOI 10.1007/s12032-010-9435-1; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050508; Wang MR, 2013, FOOD CHEM TOXICOL, V56, P450, DOI 10.1016/j.fct.2013.03.004; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Yan S, 2013, ONCOTARGET, V4, P433, DOI 10.18632/oncotarget.930; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; You ZB, 2012, CLIN TRANSL ONCOL, V14, P143, DOI 10.1007/s12094-012-0774-6; Zgheib A, 2013, J BIOL CHEM, V288, P13378, DOI 10.1074/jbc.M113.456533; Zhang J, 2014, FOOD FUNCT, V5, P413, DOI 10.1039/c3fo60607d; Zhang X, 2011, ARCH BIOCHEM BIOPHYS, V512, P96, DOI 10.1016/j.abb.2011.05.004	49	93	101	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109114	10.1371/journal.pone.0109114	http://dx.doi.org/10.1371/journal.pone.0109114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296162	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000038
J	Li, L; Lin, M; Krassilnikova, M; Ostrow, K; Bader, A; Radbill, B; Uribarri, J; Tokita, J; Leisman, S; Lapsia, V; Albrecht, RA; Garcia-Sastre, A; Branch, AD; Heeger, PS; Mehrotra, A				Li, Lily; Lin, Marvin; Krassilnikova, Maria; Ostrow, Katya; Bader, Amanda; Radbill, Brian; Uribarri, Jaime; Tokita, Joji; Leisman, Staci; Lapsia, Vijay; Albrecht, Randy A.; Garcia-Sastre, Adolfo; Branch, Andrea D.; Heeger, Peter S.; Mehrotra, Anita			Effect of Cholecalciferol Supplementation on Inflammation and Cellular Alloimmunity in Hemodialysis Patients: Data from a Randomized Controlled Pilot Trial	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; T-CELL; ALLOGRAFT SURVIVAL; MINERAL METABOLISM; DIFFERENTIATION; POSTTRANSPLANT; MATURATION; REJECTION; IMMUNITY; BARRIER	Background: Memory T-cells are mediators of transplant injury, and no therapy is known to prevent the development of cross-reactive memory alloimmunity. Activated vitamin D is immunomodulatory, and vitamin D deficiency, common in hemodialysis patients awaiting transplantation, is associated with a heightened alloimmune response. Thus, we tested the hypothesis that vitamin D-3 supplementation would prevent alloreactive T-cell memory formation in vitamin D-deficient hemodialysis patients. Methods and Findings: We performed a 12-month single-center pilot randomized, controlled trial of 50,000 IU/week of cholecalciferol (D-3) versus no supplementation in 96 hemodialysis patients with serum 25(OH)D<25 ng/mL, measuring effects on serum 25(OH) D and phenotypic and functional properties of T-cells. Participants were randomized 2: 1 to active treatment versus control. D-3 supplementation increased serum 25(OH) D at 6 weeks (13.5 [ 11.2] ng/mL to 42.5 [ 18.5] ng/mL, p<0.001) and for the duration of the study. No episodes of sustained hypercalcemia occurred in either group. Results of IFN gamma ELISPOT-based panel of reactive T-cell assays (PRT), quantifying alloreactive memory, demonstrated greater increases in the controls over 1 year compared to the treatment group (delta PRT in treatment 104.8+/2330.8 vs 252.9+/2431.3 in control), but these changes in PRT between groups did not reach statistical significance (p = 0.25). Conclusions: D-3 supplements are safe, effective at treating vitamin D deficiency, and may prevent time-dependent increases in T-cell alloimmunity in hemodialysis patients, but their effects on alloimmunity need to be confirmed in larger studies. These findings support the routine supplementation of vitamin D-deficient transplant candidates on hemodialysis and highlight the need for large-scale prospective studies of vitamin D supplementation in transplant candidates and recipients.	[Li, Lily; Lin, Marvin; Krassilnikova, Maria; Ostrow, Katya; Bader, Amanda; Radbill, Brian; Uribarri, Jaime; Tokita, Joji; Leisman, Staci; Lapsia, Vijay; Heeger, Peter S.; Mehrotra, Anita] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY 10029 USA; [Li, Lily; Lin, Marvin; Krassilnikova, Maria; Ostrow, Katya; Bader, Amanda; Radbill, Brian; Uribarri, Jaime; Tokita, Joji; Leisman, Staci; Lapsia, Vijay; Garcia-Sastre, Adolfo; Branch, Andrea D.; Heeger, Peter S.; Mehrotra, Anita] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Heeger, Peter S.] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, New York, NY 10029 USA; [Heeger, Peter S.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Branch, Andrea D.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Mehrotra, A (corresponding author), Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY 10029 USA.	anita.mehrotra@mssm.edu	Li, Lily/AAN-6297-2020; Albrecht, Randy A./H-5119-2019	Li, Lily/0000-0002-9794-8468; Albrecht, Randy A./0000-0003-4008-503X; Garcia-Sastre, Adolfo/0000-0002-6551-1827	Doris Duke Charitable Foundation; National Kidney Foundation; American Heart Association; National Institute of Health from the National Center for Advancing Translational Sciences [DK090317, DA0301095, U01AI063594, U19AI089987, UL1TR000067]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089987, U01AI063594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090317] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Kidney Foundation; American Heart Association(American Heart Association); National Institute of Health from the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Doris Duke Charitable Foundation (LL), National Kidney Foundation (PSH), American Heart Association (AM), and National Institute of Health: DK090317, DA0301095 (ADB), U01AI063594 (PSH), U19AI089987 (AG-S, RA), and UL1TR000067 from the National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Adorini L, 2001, TRANSPLANT P, V33, P58, DOI 10.1016/S0041-1345(00)02262-4; Augustine JF, 2007, J AM SOC NEPHROL, V18, P1602, DOI 10.1681/ASN.2006101105; BHALLA AK, 1984, J IMMUNOL, V133, P1748; Bienaime F, 2013, J AM SOC NEPHROLOGY; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; de Baey A, 2001, EUR J IMMUNOL, V31, P1646, DOI 10.1002/1521-4141(200106)31:6<1646::AID-IMMU1646>3.0.CO;2-X; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Heeger PS, 1999, J IMMUNOL, V163, P2267; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Hewison M, 2011, VITAM HORM, V86, P23, DOI 10.1016/B978-0-12-386960-9.00002-2; Hricik DE, 2003, AM J TRANSPLANT, V3, P878, DOI 10.1034/j.1600-6143.2003.00132.x; Jean G, 2008, NEPHROL DIAL TRANSPL, V23, P3670, DOI 10.1093/ndt/gfn339; Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786; Kim H, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-22; Lavin PJ, 2007, RENAL FAILURE, V29, P785, DOI 10.1080/08860220701540417; Lee JR, 2014, TRANSPLANTATION, V98, P292, DOI 10.1097/TP.0000000000000055; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Looker Anne C, 2011, NCHS Data Brief, P1; Matias PJ, 2010, CLIN J AM SOC NEPHRO, V5, P905, DOI 10.2215/CJN.06510909; Nadazdin O, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002093; Nair V, 2012, CLIN TRANSPLANT, V26, pE261, DOI 10.1111/j.1399-0012.2012.01657.x; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Poggio ED, 2007, TRANSPLANTATION, V83, P847, DOI 10.1097/01.tp.0000258730.75137.39; Pramyothin P, 2012, CURR OPIN GASTROEN, V28, P139, DOI 10.1097/MOG.0b013e32835004dc; Saab G, 2007, NEPHRON CLIN PRACT, V105, P132, DOI 10.1159/000098645; Saghaei Mahmood, 2004, BMC Med Res Methodol, V4, P26, DOI 10.1186/1471-2288-4-26; Sawinski D, 2010, AM J TRANSPLANT, V10, P2287, DOI 10.1111/j.1600-6143.2010.03264.x; Schenk AD, 2008, AM J TRANSPLANT, V8, P1652, DOI 10.1111/j.1600-6143.2008.02302.x; Valujskikh A, 2002, AM J TRANSPLANT, V2, P501, DOI 10.1034/j.1600-6143.2002.20603.x; Wasse H, 2012, AM J CLIN NUTR, V95, P522, DOI 10.3945/ajcn.111.025502; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965; Zand MS, 2005, AM J TRANSPLANT, V5, P76, DOI 10.1111/j.1600-6143.2003.00637.x; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	36	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109998	10.1371/journal.pone.0109998	http://dx.doi.org/10.1371/journal.pone.0109998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296334	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000109
J	Nakano, K; Park, K; Zheng, RC; Fang, F; Ohori, M; Nakamura, H; Kumagai, Y; Okada, H; Teramura, K; Nakayama, S; Irimajiri, A; Taoka, H; Okada, S				Nakano, Kimihiko; Park, Kaechang; Zheng, Rencheng; Fang, Fang; Ohori, Masanori; Nakamura, Hiroki; Kumagai, Yasuhiho; Okada, Hiroshi; Teramura, Kazuhiko; Nakayama, Satoshi; Irimajiri, Akinori; Taoka, Hiroshi; Okada, Satoshi			Leukoaraiosis Significantly Worsens Driving Performance of Ordinary Older Drivers	PLOS ONE			English	Article							SERIAL ADDITION TEST; WORKING-MEMORY; SAFETY IMPLICATIONS; ATTENTION; YOUNG; FOCUS	Background: Leukoaraiosis is defined as extracellular space caused mainly by atherosclerotic or demyelinated changes in the brain tissue and is commonly found in the brains of healthy older people. A significant association between leukoaraiosis and traffic crashes was reported in our previous study; however, the reason for this is still unclear. Method: This paper presents a comprehensive evaluation of driving performance in ordinary older drivers with leukoaraiosis. First, the degree of leukoaraiosis was examined in 33 participants, who underwent an actual-vehicle driving examination on a standard driving course, and a driver skill rating was also collected while the driver carried out a paced auditory serial addition test, which is a calculating task given verbally. At the same time, a steering entropy method was used to estimate steering operation performance. Results: The experimental results indicated that a normal older driver with leukoaraiosis was readily affected by external disturbances and made more operation errors and steered less smoothly than one without leukoaraiosis during driving; at the same time, their steering skill significantly deteriorated. Conclusions: Leukoaraiosis worsens the driving performance of older drivers because of their increased vulnerability to distraction.	[Nakano, Kimihiko] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan; [Park, Kaechang] Kochi Univ Technol, Res Org Reg Alliances, Traff Med Lab, Kami, Kochi, Japan; [Park, Kaechang] Kochi Kenshin Clin, Brain Checkup Ctr, Kochi, Japan; [Zheng, Rencheng; Fang, Fang; Ohori, Masanori] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Nakamura, Hiroki] Kanagawa Univ, Fac Engn, Yokohama, Kanagawa, Japan; [Kumagai, Yasuhiho] Kochi Univ Technol, Res Org Reg Alliances, Reg ITS Res Lab, Kami, Kochi, Japan; [Okada, Hiroshi; Teramura, Kazuhiko; Nakayama, Satoshi; Irimajiri, Akinori; Taoka, Hiroshi; Okada, Satoshi] Kochi Prefectural Police Dept, Drivers License Ctr, Kochi, Japan	University of Tokyo; Kochi University Technology; University of Tokyo; Kanagawa University; Kochi University Technology	Nakano, K (corresponding author), Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan.	knakano@iis.u-tokyo.ac.jp			Japan Society for the Promotion of Science [22656114, 23656161, 21360248]; Grants-in-Aid for Scientific Research [26289177] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Exploratory Research (no. 22656114), Grant-in-Aid for Exploratory Research (no. 23656161), and Grant-in-Aid for Scientific Research (B) (no. 21360248) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Bellinger DB, 2009, TRANSPORT RES F-TRAF, V12, P441, DOI 10.1016/j.trf.2009.08.007; Boer E. R., 2005, P 3 INT DRIV S HUM F, P25, DOI DOI 10.17077/DRIVINGASSESSMENT.1139; Boer ER, 2001, P 1 INT DRIV S HUM F, P1; Brain dock guideline, 2008, BRAIN DOCK GUID; BROUWER WH, 1991, HUM FACTORS, V33, P573, DOI 10.1177/001872089103300508; Cooper PJ, 1999, ACCIDENT ANAL PREV, V22, P499; Donmez B, 2007, ACCIDENT ANAL PREV, V39, P581, DOI 10.1016/j.aap.2006.10.003; Fisk JD, 2001, J INT NEUROPSYCH SOC, V7, P363, DOI 10.1017/S1355617701733103; Griffith HR, 2013, J GERIATR PSYCH NEUR, V26, P259, DOI 10.1177/0891988713509138; Hachinski VC, 2013, ARCH NEUROL-CHICAGO, V26, P259; Hakamies-Blomqvist L., 2002, TRANSP RES F, V5, P271, DOI [10.1016/S1369-8478(03)00005-6, DOI 10.1016/S1369-8478(03)00005-6]; Lamble D, 1999, ACCIDENT ANAL PREV, V31, P617, DOI 10.1016/S0001-4575(99)00018-4; Nakayama O, 1999, DEV STEERING ENTRO 1, V1, P1686, DOI DOI 10.4271/1999-01-0892; Park K, 2007, NEUROLOGY, V69, P974, DOI 10.1212/01.wnl.0000266562.54684.bf; Park KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052779; Parmenter BA, 2006, J INT NEUROPSYCH SOC, V12, P677, DOI 10.1017/S1355617706060826; Paul A., 2005, P 3 INT DRIV S HUM F, P441, DOI [10.17077/drivingassessment.1196, DOI 10.17077/DRIVINGASSESSMENT.1196]; Pavlou D, 2013, P 3 INT C DRIV DISTR; Ponds RW, 1998, J GERONTOL, V43, P151; Radford K, 2004, DISABIL REHABIL, V26, P65, DOI 10.1080/09638280310001629633; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Uc EY, 2006, NEUROLOGY, V67, P1774, DOI 10.1212/01.wnl.0000245086.32787.61; Uc EY, 2009, NEUROLOGY, V73, P2112, DOI 10.1212/WNL.0b013e3181c67b77; Verhaeghen P, 2005, Q J EXP PSYCHOL-A, V58, P134, DOI 10.1080/02724980443000241; Wiens AN, 1997, J CLIN EXP NEUROPSYC, V19, P473, DOI 10.1080/01688639708403737; Zhang J, 1998, PUBLIC HEALTH, V112, P289, DOI 10.1038/sj.ph.1900485	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108333	10.1371/journal.pone.0108333	http://dx.doi.org/10.1371/journal.pone.0108333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295736	gold, Green Published			2022-12-27	WOS:000345204000014
J	Di, Z; Klop, MJD; Rogkoti, VM; Le Devedec, SE; van de Water, B; Verbeek, FJ; Price, LS; Meerman, JHN				Di, Zi; Klop, Maarten J. D.; Rogkoti, Vasiliki-Maria; Le Devedec, Sylvia E.; van de Water, Bob; Verbeek, Fons J.; Price, Leo S.; Meerman, John H. N.			Ultra High Content Image Analysis and Phenotype Profiling of 3D Cultured Micro-Tissues	PLOS ONE			English	Article							CANCER CELL-LINES; BREAST-CANCER; MODELS; RECOGNITION; DISCOVERY; NETWORKS; SUBTYPES; SCREENS	In many situations, 3D cell cultures mimic the natural organization of tissues more closely than 2D cultures. Conventional methods for phenotyping such 3D cultures use either single or multiple simple parameters based on morphology and fluorescence staining intensity. However, due to their simplicity many details are not taken into account which limits system-level study of phenotype characteristics. Here, we have developed a new image analysis platform to automatically profile 3D cell phenotypes with 598 parameters including morphology, topology, and texture parameters such as wavelet and image moments. As proof of concept, we analyzed mouse breast cancer cells (4T1 cells) in a 384-well plate format following exposure to a diverse set of compounds at different concentrations. The result showed concentration dependent phenotypic trajectories for different biologically active compounds that could be used to classify compounds based on their biological target. To demonstrate the wider applicability of our method, we analyzed the phenotypes of a collection of 44 human breast cancer cell lines cultured in 3D and showed that our method correctly distinguished basal-A, basal-B, luminal and ERBB2+ cell lines in a supervised nearest neighbor classification method.	[Di, Zi; Rogkoti, Vasiliki-Maria; Le Devedec, Sylvia E.; van de Water, Bob; Price, Leo S.; Meerman, John H. N.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands; [Klop, Maarten J. D.; Price, Leo S.] OcellO BV, Bio Partner Ctr Leiden, Leiden, Netherlands; [Verbeek, Fons J.] Leiden Univ, Leiden Inst Adv Comp Sci, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Price, LS (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Div Toxicol, Leiden, Netherlands.	lsprice@lacdr.leidenuniv.nl	Le Dévédec, Sylvia/AAC-1208-2020	Le Dévédec, Sylvia/0000-0002-0615-9616; Price, Leo/0000-0002-4562-9086	Netherlands Toxicogenomics Centre, Dutch Genomics Initiative	Netherlands Toxicogenomics Centre, Dutch Genomics Initiative	This work was supported by a Grant from the Netherlands Toxicogenomics Centre which is part of the Dutch Genomics Initiative. http://www.toxicogenomics.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Bilgin CC, 2013, BIOINFORMATICS, V29, P3087, DOI 10.1093/bioinformatics/btt535; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Cao L, 2011, LECT N BIOINFORMAT, V7036, P330, DOI 10.1007/978-3-642-24855-9_29; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364; Duda R.O., 2006, PATTERN CLASSIFICATI; Gaggioli C, 2007, PIGM CELL RES, V20, P161, DOI 10.1111/j.1600-0749.2007.00378.x; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hollestelle A, 2010, BREAST CANCER RES TR, V122, P125, DOI 10.1007/s10549-009-0545-4; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Kuan Yan, 2012, Leveraging Applications of Formal Methods, Verification and Validation. Applications and Case Studies. Proceedings of the 5th International Symposium, ISoLA 2012, P25, DOI 10.1007/978-3-642-34032-1_4; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu CJ, 2000, IEEE T IMAGE PROCESS, V9, P132, DOI 10.1109/83.817604; Muschler J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003202; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niblack W., 1986, INTRO DIGITAL IMAGE, P115; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Rajaram S, 2012, NAT METHODS, V9, P635, DOI 10.1038/nmeth.2097; Raudys S, 1998, PATTERN RECOGN LETT, V19, P385, DOI 10.1016/S0167-8655(98)00016-6; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Wang J, 2008, J BIOMOL SCREEN, V13, P29, DOI 10.1177/1087057107311223; Webb A. R., 2002, STAT PATTERN RECOGNI, P123; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9	33	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109688	10.1371/journal.pone.0109688	http://dx.doi.org/10.1371/journal.pone.0109688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289886	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000079
J	Jiang, GM; Jiang, XQ; Lu, PT; Liu, JT; Gao, JP; Zhang, CQ				Jiang, Guimei; Jiang, Xinqiang; Lu, Peitao; Liu, Jitao; Gao, Junping; Zhang, Changqing			The Rose (Rosa hybrida) NAC Transcription Factor 3 Gene, RhNAC3, Involved in ABA Signaling Pathway Both in Rose and Arabidopsis	PLOS ONE			English	Article							DROUGHT STRESS TOLERANCE; ACTING REGULATORY ELEMENTS; ABSCISIC-ACID; OSMOTIC-STRESS; ABIOTIC STRESS; TRANSGENIC ARABIDOPSIS; DEHYDRATION TOLERANCE; FUNCTIONAL-ANALYSIS; POSITIVE REGULATOR; BZIP PROTEIN	Plant transcription factors involved in stress responses are generally classified by their involvement in either the abscisic acid (ABA)-dependent or the ABA-independent regulatory pathways. A stress-associated NAC gene from rose (Rosa hybrida), RhNAC3, was previously found to increase dehydration tolerance in both rose and Arabidopsis. However, the regulatory mechanism involved in RhNAC3 action is still not fully understood. In this study, we isolated and analyzed the upstream regulatory sequence of RhNAC3 and found many stress-related cis-elements to be present in the promoter, with five ABA-responsive element (ABRE) motifs being of particular interest. Characterization of Arabidopsis thaliana plants transformed with the putative RhNAC3 promoter sequence fused to the beta-glucuronidase (GUS) reporter gene revealed that RhNAC3 is expressed at high basal levels in leaf guard cells and in vascular tissues. Moreover, the ABRE motifs in the RhNAC3 promoter were observed to have a cumulative effect on the transcriptional activity of this gene both in the presence and absence of exogenous ABA. Overexpression of RhNAC3 in A. thaliana resulted in ABA hypersensitivity during seed germination and promoted leaf closure after ABA or drought treatments. Additionally, the expression of 11 ABA-responsive genes was induced to a greater degree by dehydration in the transgenic plants overexpressing RhNAC3 than control lines transformed with the vector alone. Further analysis revealed that all these genes contain NAC binding cis-elements in their promoter regions, and RhNAC3 was found to partially bind to these putative NAC recognition sites. We further found that of 219 A. thaliana genes previously shown by microarray analysis to be regulated by heterologous overexpression RhNAC3, 85 are responsive to ABA. In rose, the expression of genes downstream of the ABA-signaling pathways was also repressed in RhNAC3-silenced petals. Taken together, we propose that the rose RhNAC3 protein could mediate ABA signaling both in rose and in A. thaliana.	[Jiang, Guimei; Lu, Peitao; Liu, Jitao; Gao, Junping; Zhang, Changqing] China Agr Univ, Dept Ornamental Hort, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Jiang, Xinqiang] Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao, Peoples R China	China Agricultural University; Qingdao Agricultural University	Zhang, CQ (corresponding author), China Agr Univ, Dept Ornamental Hort, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	chqzhang@cau.edu.cn	Lü, Peitao/B-4641-2019	Lu, Peitao/0000-0002-4894-6458	National Natural Science Foundation of China [31372096]; Beijing Nova Program [2009B51]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China (Grant No. 31372096) and Beijing Nova Program (Grant No. 2009B51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Bonetta D, 1998, TRENDS PLANT SCI, V3, P231, DOI 10.1016/S1360-1385(98)01241-2; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ithal N, 2004, PLANT SCI, V166, P1505, DOI 10.1016/j.plantsci.2004.02.002; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Ji XY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-151; Jiang XQ, 2014, PLANT BIOTECHNOL J, V12, P38, DOI 10.1111/pbi.12114; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kim SJ, 2012, BIOCHEM BIOPH RES CO, V420, P141, DOI 10.1016/j.bbrc.2012.02.131; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li YH, 2009, PLANT CELL REP, V28, P185, DOI 10.1007/s00299-008-0629-3; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; Ryu MY, 2010, PLANT PHYSIOL, V154, P1983, DOI 10.1104/pp.110.164749; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Xian LH, 2014, PLANTA, V239, P61, DOI 10.1007/s00425-013-1963-4; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yan F, 2012, PLANT GROWTH REGUL, V68, P383, DOI 10.1007/s10725-012-9727-x; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang LC, 2012, J EXP BOT, V63, P5873, DOI 10.1093/jxb/ers237	50	15	19	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109415	10.1371/journal.pone.0109415	http://dx.doi.org/10.1371/journal.pone.0109415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290154	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000059
J	Kenchington, E; Murillo, FJ; Lirette, C; Sacau, M; Koen-Alonso, M; Kenny, A; Ollerhead, N; Wareham, V; Beazley, L				Kenchington, Ellen; Javier Murillo, Francisco; Lirette, Camille; Sacau, Mar; Koen-Alonso, Mariano; Kenny, Andrew; Ollerhead, Neil; Wareham, Vonda; Beazley, Lindsay			Kernel Density Surface Modelling as a Means to Identify Significant Concentrations of Vulnerable Marine Ecosystem Indicators	PLOS ONE			English	Article							SEA SPONGE GROUNDS; NORTHWEST ATLANTIC; FLEMISH PASS; WATER CORALS; GRAND-BANKS; HOME-RANGE; DEEP; ABUNDANCE; PROTECTION; DIVERSITY	The United Nations General Assembly Resolution 61/105, concerning sustainable fisheries in the marine ecosystem, calls for the protection of vulnerable marine ecosystems (VME) from destructive fishing practices. Subsequently, the Food and Agriculture Organization (FAO) produced guidelines for identification of VME indicator species/taxa to assist in the implementation of the resolution, but recommended the development of case-specific operational definitions for their application. We applied kernel density estimation (KDE) to research vessel trawl survey data from inside the fishing footprint of the Northwest Atlantic Fisheries Organization (NAFO) Regulatory Area in the high seas of the northwest Atlantic to create biomass density surfaces for four VME indicator taxa: large-sized sponges, sea pens, small and large gorgonian corals. These VME indicator taxa were identified previously by NAFO using the fragility, life history characteristics and structural complexity criteria presented by FAO, along with an evaluation of their recovery trajectories. KDE, a non-parametric neighbour-based smoothing function, has been used previously in ecology to identify hotspots, that is, areas of relatively high biomass/abundance. We present a novel approach of examining relative changes in area under polygons created from encircling successive biomass categories on the KDE surface to identify "significant concentrations" of biomass, which we equate to VMEs. This allows identification of the VMEs from the broader distribution of the species in the study area. We provide independent assessments of the VMEs so identified using underwater images, benthic sampling with other gear types (dredges, cores), and/or published species distribution models of probability of occurrence, as available. For each VME indicator taxon we provide a brief review of their ecological function which will be important in future assessments of significant adverse impact on these habitats here and elsewhere.	[Kenchington, Ellen; Javier Murillo, Francisco; Lirette, Camille; Beazley, Lindsay] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Javier Murillo, Francisco] Univ Santiago de Compostela, Fac Biol, Dept Zool & Antropol Fis, Santiago De Compostela, Spain; [Sacau, Mar] Ctr Oceanog Vigo, Inst Espanol Oceanog, Programa Pesquerias Lejanas, Vigo, Spain; [Koen-Alonso, Mariano; Ollerhead, Neil; Wareham, Vonda] Northwest Atlant Fisheries Ctr, Dept Fisheries & Oceans, St John, NF, Canada; [Kenny, Andrew] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Universidade de Santiago de Compostela; Spanish Institute of Oceanography; Fisheries & Oceans Canada; Centre for Environment Fisheries & Aquaculture Science	Kenchington, E (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	Ellen.Kenchington@dfo-mpo.gc.ca	Sacau Cuadrado, M del Mar/L-9002-2014; Murillo, Francisco Javier/C-7182-2019; Sacau, Mar/AAD-4137-2020	Sacau Cuadrado, M del Mar/0000-0002-6529-3110; Sacau, Mar/0000-0002-6529-3110	International Governance Strategy (IGS) of the Department of Fisheries and Oceans	International Governance Strategy (IGS) of the Department of Fisheries and Oceans	Funding was received from the International Governance Strategy (IGS) fund of the Department of Fisheries and Oceans to EK. The purpose of this fund is to strengthen scientific research in support of international governance of fisheries resources, support healthy ocean ecosystems, protect Canada's economic and environmental interests and position Canada as a global leader in high-seas issues. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillon S, 2012, FRONT ECOL ENVIRON, V10, P351, DOI 10.1890/120022; Beazley LI, 2013, 1376 NAFO SCR; Beazley LI, 2013, ICES J MAR SCI, V70, P1471, DOI 10.1093/icesjms/fst124; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; BIRKELAND C, 1974, ECOL MONOGR, V44, P211, DOI 10.2307/1942312; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Downs JA, 2012, COMPUT ENVIRON URBAN, V36, P302, DOI 10.1016/j.compenvurbsys.2011.12.001; Edinger EN, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P101; FAO Food and Agriculture Organization of the United Nations; Rome, 2009, INT GUID MAN DEEP SE; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Frojan CRSB, 2012, ICES J MAR SCI, V69, P213, DOI 10.1093/icesjms/fss004; Fuller S.D., 2008, 0822 NAFO SCR; Murillo FJ, 2012, MAR BIOL RES, V8, P842, DOI 10.1080/17451000.2012.682583; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kenchington E, 2013, MAR ECOL PROG SER, V477, P217, DOI 10.3354/meps10127; Kenchington E, 2011, 1175 NAFO SCR; Kenchington E, 2009, 096 NAFO SCR; Knudby A, 2013, 1378 NAFO SCR; Knudby A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082306; KRIEGER KJ, 1993, FISH B-NOAA, V91, P87; Murillo FJ, 2011, ICES J MAR SCI, V68, P319, DOI 10.1093/icesjms/fsq071; Murillo F. J., 2010, 1007 NAFO SCR; Murillo F. J., 2011, 1173 NAFO SCR; NAFO, 2008, SCI COUNC M 22 30 OC; NAFO, 2012, SCI COUNC M 2012; NAFO, 2011, 1024 NAFO SCR; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; O'Brien SH, 2012, BIOL CONSERV, V156, P15, DOI 10.1016/j.biocon.2011.12.033; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; Rooper CN, 2014, MAR ECOL PROG SER, V503, P157, DOI 10.3354/meps10710; Tissot BN, 2006, FISH B-NOAA, V104, P167	33	49	51	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109365	10.1371/journal.pone.0109365	http://dx.doi.org/10.1371/journal.pone.0109365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289667	Green Published, gold			2022-12-27	WOS:000342798000055
J	Neto, EC; Bare, JC; Margolin, AA				Neto, Elias Chaibub; Bare, J. Christopher; Margolin, Adam A.			Simulation Studies as Designed Experiments: The Comparison of Penalized Regression Models in the "Large p, Small n" Setting	PLOS ONE			English	Article							A-PRIORI DISTINCTIONS; LEARNING ALGORITHMS; DRUG-SENSITIVITY; CANCER; REGULARIZATION; SELECTION	New algorithms are continuously proposed in computational biology. Performance evaluation of novel methods is important in practice. Nonetheless, the field experiences a lack of rigorous methodology aimed to systematically and objectively evaluate competing approaches. Simulation studies are frequently used to show that a particular method outperforms another. Often times, however, simulation studies are not well designed, and it is hard to characterize the particular conditions under which different methods perform better. In this paper we propose the adoption of well established techniques in the design of computer and physical experiments for developing effective simulation studies. By following best practices in planning of experiments we are better able to understand the strengths and weaknesses of competing algorithms leading to more informed decisions about which method to use for a particular task. We illustrate the application of our proposed simulation framework with a detailed comparison of the ridge-regression, lasso and elastic-net algorithms in a large scale study investigating the effects on predictive performance of sample size, number of features, true model sparsity, signal-to-noise ratio, and feature correlation, in situations where the number of covariates is usually much larger than sample size. Analysis of data sets containing tens of thousands of features but only a few hundred samples is nowadays routine in computational biology, where "omics" features such as gene expression, copy number variation and sequence data are frequently used in the predictive modeling of complex phenotypes such as anticancer drug response. The penalized regression approaches investigated in this study are popular choices in this setting and our simulations corroborate well established results concerning the conditions under which each one of these methods is expected to perform best while providing several novel insights.	[Neto, Elias Chaibub; Bare, J. Christopher; Margolin, Adam A.] Sage Bionetworks, Seattle, WA 98109 USA		Neto, EC (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	elias.chaibub.neto@sagebase.org		Bare, J. Christopher/0000-0003-1006-1491	National Cancer Institute (NCI) Integrative Cancer Biology Program (ICBP) [U54-CA149237]; NATIONAL CANCER INSTITUTE [U54CA149237] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Integrative Cancer Biology Program (ICBP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Cancer Institute (NCI) Integrative Cancer Biology Program (ICBP) grant U54-CA149237 (http://icbp.nci.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Box EP., 1978, STAT EXPT; Carnell R., 2012, LHS LATIN HYPERCUBE; Cox RD, 1984, INT STAT REV, V52, P1; Davison AC, 1997, BOOTSTRAP METHODS TH; Franco J., 2014, DICEDESIGN DESIGNS C; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI [DOI 10.2307/1267351, DOI 10.1080/00401706.1970.10488634]; Jang I.S., 2014, PAC S BIOCOMPUT, V19, P63; JOHNSON ME, 1990, J STAT PLAN INFER, V26, P131, DOI 10.1016/0378-3758(90)90122-B; Lewis B, 2014, DOREDIS FOREACH PARA; Lewis BW, 2013, RREDIS REDIS CLIENT; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Neto EC, 2014, BIOCOMPUT-PAC SYM, P27; Pronzato L, 2012, STAT COMPUT, V22, P681, DOI 10.1007/s11222-011-9242-3; Rizzo ML, 2010, ANN APPL STAT, V4, P1034, DOI 10.1214/09-AOAS245; Rizzo ML, 2014, ENERGY E STAT ENERGY; Santner T. J, 2003, DESIGN ANAL COMPUTER; Schaffer C, 1994, INT C MACH LEARN, P295; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Venables WN., 2002, MODERN APPL STAT S 4; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wolpert DH, 1996, NEURAL COMPUT, V8, P1391, DOI 10.1162/neco.1996.8.7.1391; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	27	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107957	10.1371/journal.pone.0107957	http://dx.doi.org/10.1371/journal.pone.0107957			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289666	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000011
J	Telfer, S; Erdemir, A; Woodburn, J; Cavanagh, PR				Telfer, Scott; Erdemir, Ahmet; Woodburn, James; Cavanagh, Peter R.			What Has Finite Element Analysis Taught Us about Diabetic Foot Disease and Its Management? A Systematic Review	PLOS ONE			English	Review							PEAK PLANTAR PRESSURE; INSOLE DESIGN; HEEL-PAD; THERAPEUTIC FOOTWEAR; PATHOLOGICAL FOOT; IN-SHOE; MODEL; ULCERS; NEUROPATHY; MECHANICS	Background: Over the past two decades finite element (FE) analysis has become a popular tool for researchers seeking to simulate the biomechanics of the healthy and diabetic foot. The primary aims of these simulations have been to improve our understanding of the foot's complicated mechanical loading in health and disease and to inform interventions designed to prevent plantar ulceration, a major complication of diabetes. This article provides a systematic review and summary of the findings from FE analysis-based computational simulations of the diabetic foot. Methods: A systematic literature search was carried out and 31 relevant articles were identified covering three primary themes: methodological aspects relevant to modelling the diabetic foot; investigations of the pathomechanics of the diabetic foot; and simulation-based design of interventions to reduce ulceration risk. Results: Methodological studies illustrated appropriate use of FE analysis for simulation of foot mechanics, incorporating nonlinear tissue mechanics, contact and rigid body movements. FE studies of pathomechanics have provided estimates of internal soft tissue stresses, and suggest that such stresses may often be considerably larger than those measured at the plantar surface and are proportionally greater in the diabetic foot compared to controls. FE analysis allowed evaluation of insole performance and development of new insole designs, footwear and corrective surgery to effectively provide intervention strategies. The technique also presents the opportunity to simulate the effect of changes associated with the diabetic foot on non-mechanical factors such as blood supply to local tissues. Discussion: While significant advancement in diabetic foot research has been made possible by the use of FE analysis, translational utility of this powerful tool for routine clinical care at the patient level requires adoption of cost-effective (both in terms of labour and computation) and reliable approaches with clear clinical validity for decision making.	[Telfer, Scott; Woodburn, James] Glasgow Caledonian Univ, Inst Appl Hlth Res, Glasgow G4 0BA, Lanark, Scotland; [Telfer, Scott; Cavanagh, Peter R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Erdemir, Ahmet] Cleveland Clin, Dept Biomed Engn, Computat Biomodeling CoBi Core, Cleveland, OH 44106 USA	Glasgow Caledonian University; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation	Telfer, S (corresponding author), Glasgow Caledonian Univ, Inst Appl Hlth Res, Glasgow G4 0BA, Lanark, Scotland.	scott.telfer@gcu.ac.uk		Erdemir, Ahmet/0000-0002-4629-8055; Woodburn, James/0000-0002-5497-8739	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA [PIOF-GA-2012-329133]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA	ST is funded through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7 2007-2013) under REA Grant Agreement No. PIOF-GA-2012-329133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis RL, 2008, MED BIOL ENG COMPUT, V46, P363, DOI 10.1007/s11517-008-0311-5; Actis RL, 2006, MED BIOL ENG COMPUT, V44, P653, DOI 10.1007/s11517-006-0078-5; Agic A, 2008, COLLEGIUM ANTROPOL, V32, P881; Barani Zohreh, 2005, Technol Health Care, V13, P185; Boulton AJM, 2008, DIABETES-METAB RES, V24, pS3, DOI 10.1002/dmrr.833; Buchanan G.R, 1994, SCHAUMS OUTLINE FINI, P288; Budhabhatti SP, 2007, J BIOMECH ENG-T ASME, V129, P750, DOI 10.1115/1.2768108; Bus SA, 2004, DIABETES CARE, V27, P2376, DOI 10.2337/diacare.27.10.2376; Cavanagh PR, 2012, J AM PODIAT MED ASSN, V100, P360; Chen WM, 2012, J BIOMECH, V45, P1783, DOI 10.1016/j.jbiomech.2012.04.024; Chen WM, 2010, MED ENG PHYS, V32, P324, DOI 10.1016/j.medengphy.2010.01.001; Chen WP, 2003, CLIN BIOMECH, V18, pS17, DOI 10.1016/S0268-0033(03)00080-9; Cheung JTM, 2008, MED ENG PHYS, V30, P269, DOI 10.1016/j.medengphy.2007.05.002; Cheung JTM, 2005, J BIOMECH, V38, P1045, DOI 10.1016/j.jbiomech.2004.05.035; Cheung JTM, 2005, ARCH PHYS MED REHAB, V86, P353, DOI 10.1016/j.apmr.2004.03.031; Crawford F, 2007, QJM-INT J MED, V100, P65; Dai XQ, 2006, CLIN BIOMECH, V21, P314, DOI 10.1016/j.clinbiomech.2005.10.002; Erdemir A, 2005, J BIOMECH, V38, P1798, DOI 10.1016/j.jbiomech.2004.09.009; Erdemir A, 2006, J BIOMECH, V39, P1279, DOI 10.1016/j.jbiomech.2005.03.007; Erdemira A, 2012, J BIOMECH, V45, P625, DOI 10.1016/j.jbiomech.2011.11.038; Fernandez JW, 2012, INT J NUMER METH BIO, V28, P1056, DOI 10.1002/cnm.2494; Gefen A, 2003, MED ENG PHYS, V25, P491, DOI 10.1016/S1350-4533(03)00029-8; Goske S, 2006, J BIOMECH, V39, P2363, DOI 10.1016/j.jbiomech.2005.08.006; Gu YD, 2011, COMPUT METHOD BIOMEC, V14, P747, DOI 10.1080/10255842.2010.493886; Gu YD, 2010, SKIN RES TECHNOL, V16, P291, DOI 10.1111/j.1600-0846.2010.00425.x; Isvilanonda V, 2012, CLIN BIOMECH, V27, P837, DOI 10.1016/j.clinbiomech.2012.05.005; Jacob Shanti, 1999, Frontiers of Medical and Biological Engineering, V9, P211; Jones AC, 2008, MED ENG PHYS, V30, P1287, DOI 10.1016/j.medengphy.2008.09.006; Klaesner JW, 2002, ARCH PHYS MED REHAB, V83, P1796, DOI 10.1053/apmr.2002.35661; Lemmon D, 1997, J BIOMECH, V30, P615, DOI 10.1016/S0021-9290(97)00006-7; Lewis G, 2003, BIO-MED MATER ENG, V13, P75; Luo GM, 2011, J BIOMECH, V44, P1559, DOI 10.1016/j.jbiomech.2011.02.083; Mithraratne K, 2012, INT J NUMER METH BIO, V28, P1071, DOI 10.1002/cnm.2493; Oosterwaal M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-256; Pai S, 2010, J BIOMECH, V43, P1754, DOI 10.1016/j.jbiomech.2010.02.021; Petre M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023695; Prompers L, 2008, DIABETOLOGIA, V51, P1826, DOI 10.1007/s00125-008-1089-6; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Schaper NC, 2004, DIABETES-METAB RES, V20, pS90, DOI 10.1002/dmrr.464; Shariatmadari MR, 2010, IOP CONF SER-MAT SCI, V10, DOI 10.1088/1757-899X/10/1/012126; Shariatmadari MR, 2009, IFMBE PROC, V23, P1627; Stops A, 2012, COMPUT METHOD BIOMEC, V15, P963, DOI 10.1080/10255842.2011.567983; Tadepalli SC, 2011, J BIOMECH, V44, P2337, DOI 10.1016/j.jbiomech.2011.05.006; Telfer S, 2014, GAIT POSTURE, V39, P328, DOI 10.1016/j.gaitpost.2013.07.118; Thomas VJ, 2004, MED BIOL ENG COMPUT, V42, P230, DOI 10.1007/BF02344636; Ulbrecht JS, 2014, DIABETES CARE, V37, P1982, DOI 10.2337/dc13-2956; Viceconti M, 2005, CLIN BIOMECH, V20, P451, DOI 10.1016/j.clinbiomech.2005.01.010; Williams DSB, 2007, J APPL BIOMECH, V23, P251, DOI 10.1123/jab.23.4.251; Yarnitzky G, 2006, J BIOMECH, V39, P2673, DOI 10.1016/j.jbiomech.2005.08.021; Yavuz M, 2007, DIABETES CARE, V30, P2643, DOI 10.2337/dc07-0862	50	18	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109994	10.1371/journal.pone.0109994	http://dx.doi.org/10.1371/journal.pone.0109994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290098	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000102
J	Usenko, T; Chan, G; Torlakovic, E; Klingmuller, U; Neel, BG				Usenko, Tatiana; Chan, Gordon; Torlakovic, Emina; Klingmueller, Ursula; Neel, Benjamin G.			Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice	PLOS ONE			English	Article							PTPN11; RECEPTOR; SIGNALS; CELLS; SHP2	Src homology 2 (SH2) domain-containing phosphatase 2 (SHP2), encoded by PTPN11, regulates signaling networks and cell fate in many tissues. Expression of oncogenic PTPN11 in the hematopoietic compartment causes myeloproliferative neoplasm (MPN) in humans and mice. However, the stage-specific effect(s) of mutant Ptpn11 on erythroid development have remained unknown. We found that expression of an activated, leukemogenic Ptpn11 allele, Ptpn11(D61Y), specifically in the erythroid lineage causes dyserythropoiesis in mice. Ptpn11(D61Y) progenitors produce excess cKIT(+) CD71(+) Ter119(-) cells and aberrant numbers of cKIT(Io) CD71(+) erythroblasts. Mutant erythroblasts show elevated activation of ERK, AKT and STAT3 in response to EPO stimulation, and MEK inhibitor treatment blocks Ptpn11(D61Y)-evoked erythroid hyperproliferation in vitro. Thus, the expression of oncogenic Ptpn11 causes dyserythropoiesis in a cell-autonomous manner in vivo.	[Usenko, Tatiana; Chan, Gordon; Neel, Benjamin G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Torlakovic, Emina] Univ Hlth Network, Toronto Gen Hosp, Dept Lab Hematol, Toronto, ON, Canada; [Klingmueller, Ursula] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Neel, Benjamin G.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University of Toronto	Neel, BG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	bneel@uhnresearch.ca	Klingmüller, Ursula/G-8477-2013	Klingmüller, Ursula/0000-0001-9845-3099	 [RO1 CA114945];  [R37CA49132]; NATIONAL CANCER INSTITUTE [R01CA114945] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by RO1 CA114945 (www.nih.gov), and R37CA49132 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun BS, 2006, BLOOD, V108, P2041, DOI 10.1182/blood-2006-01-013490; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chan G, 2009, BLOOD, V113, P4414, DOI 10.1182/blood-2008-10-182626; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Klingmuller U, 1997, EUR J BIOCHEM, V249, P637, DOI 10.1111/j.1432-1033.1997.t01-1-00637.x; Loh ML, 2011, BRIT J HAEMATOL, V152, P677, DOI 10.1111/j.1365-2141.2010.08525.x; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Neel B. G., 2009, HDB CELL SIGNALING, P771; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Zhang J, 2007, BLOOD, V109, P5238, DOI 10.1182/blood-2006-09-047050; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476	15	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109682	10.1371/journal.pone.0109682	http://dx.doi.org/10.1371/journal.pone.0109682			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289670	Green Submitted, gold, Green Published			2022-12-27	WOS:000342798000077
J	Focareta, L; Sesso, S; Cole, AG				Focareta, Laura; Sesso, Salvatore; Cole, Alison G.			Characterization of Homeobox Genes Reveals Sophisticated Regionalization of the Central Nervous System in the European Cuttlefish Sepia officinalis	PLOS ONE			English	Article							FIN CHROMATOPHORE MOTONEURONS; HOX GENES; MOTOR-NEURON; DEVELOPMENTAL EXPRESSION; CEPHALOPOD MOLLUSKS; HIGH-RESOLUTION; SPINAL-CORD; HOMEODOMAIN; EVOLUTION; ELEGANS	Cephalopod mollusks possess a number of anatomical traits that often parallel vertebrates in morphological complexity, including a centralized nervous system with sophisticated cognitive functionality. Very little is known about the genetic mechanisms underlying patterning of the cephalopod embryo to arrive at this anatomical structure. Homeodomain (HD) genes are transcription factors that regulate transcription of downstream genes through DNA binding, and as such are integral parts of gene regulatory networks controlling the specification and patterning of body parts across lineages. We have used a degenerate primer strategy to isolate homeobox genes active during late-organogenesis from the European cuttlefish Sepia officinalis. With this approach we have isolated fourteen HD gene fragments and examine the expression profiles of five of these genes during late stage (E24-28) embryonic development (Sof-Gbx, Sof-Hox3, Sof-Arx, Sof-Lhx3/4, Sof-Vsx). All five genes are expressed within the developing central nervous system in spatially restricted and largely non-overlapping domains. Our data provide a first glimpse into the diversity of HD genes in one of the largest, yet least studied, metazoan clades and illustrate how HD gene expression patterns reflect the functional partitioning of the cephalopod brain.	[Focareta, Laura; Sesso, Salvatore; Cole, Alison G.] IRGS, Biogem, Avellino, Italy		Cole, AG (corresponding author), IRGS, Biogem, Avellino, Italy.	agcole05@gmail.com	Cole, Alison G./J-8436-2019	Cole, Alison G./0000-0002-7515-7489	BIOGEM from Universita degli Studi del Sannio; Marie Curie FP7-Reintegration Grant [246680]	BIOGEM from Universita degli Studi del Sannio; Marie Curie FP7-Reintegration Grant	This work was supported by a BIOGEM (www.biogem.it) doctoral scholarship from the Universita degli Studi del Sannio to LF and Marie Curie FP7-Reintegration Grant no. 246680: "SepiaCartilage" to AGC (http://cordis.europa.eu/mariecurie-actions/erg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata R, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-68; Appel B, 1995, DEVELOPMENT, V121, P4117; Bookout A.L., 2006, CURR PROTOC MOL BIOL; BOYCOTT BB, 1961, PROC R SOC SER B-BIO, V153, P503, DOI 10.1098/rspb.1961.0015; Budelrnann B, 1995, NERVOUS SYSTEM INVER, P115; Buresi A, 2013, J COMP NEUROL, V521, P1482, DOI 10.1002/cne.23231; Buresi A, 2012, GENE EXPR PATTERNS, V12, P109, DOI 10.1016/j.gep.2012.02.001; Cole AG, 2009, ZOOLOGY, V112, P2, DOI 10.1016/j.zool.2008.01.003; CORNWELL CJ, 1993, BRAIN RES, V621, P353, DOI 10.1016/0006-8993(93)90127-9; Erclik T, 2008, CURR BIOL, V18, P1278, DOI 10.1016/j.cub.2008.07.076; Erclik T, 2009, DEV BIOL, V332, P70, DOI 10.1016/j.ydbio.2009.05.565; Farfan C, 2009, EVOL DEV, V11, P354, DOI 10.1111/j.1525-142X.2009.00342.x; Fiorito G, 2014, INVERTEBR NEUROSCI, V14, P13, DOI 10.1007/s10158-013-0165-x; Friocourt G, 2006, EUR J NEUROSCI, V23, P869, DOI 10.1111/j.1460-9568.2006.04629.x; Gaston Michelle R., 2006, Invertebrate Neuroscience, V6, P81, DOI 10.1007/s10158-006-0021-3; Gaston MR, 2004, J EXP BIOL, V207, P3089, DOI 10.1242/jeb.01145; GEHRING WJ, 1993, GENE, V135, P215, DOI 10.1016/0378-1119(93)90068-E; Gill Gordon N, 2003, Trans Am Clin Climatol Assoc, V114, P179; Graindorge N, 2006, BEHAV NEUROSCI, V120, P1151, DOI 10.1037/0735-7044.120.5.1151; Grasso FW, 2009, BRAIN BEHAV EVOLUT, V74, P231, DOI 10.1159/000258669; Hinman VF, 2003, EVOL DEV, V5, P508, DOI 10.1046/j.1525-142X.2003.03056.x; Hirth F, 2007, EVOLUTION NERVOUS SY; Holland PWH, 2013, WIRES DEV BIOL, V2, P31, DOI 10.1002/wdev.78; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Lee PN, 2003, NATURE, V424, P1061, DOI 10.1038/nature01872; LEMAIRE J, 1970, Bulletin de la Societe Zoologique de France, V95, P773; Little MH, 2007, GENE EXPR PATTERNS, V7, P680, DOI 10.1016/j.modgep.2007.03.002; Mattiello T, 2012, DEV DYNAM, V241, P390, DOI 10.1002/dvdy.23722; Melkman T, 2005, DEVELOPMENT, V132, P1935, DOI 10.1242/dev.01788; Miljkovic-Licina M, 2004, BIOSYSTEMS, V76, P75, DOI 10.1016/j.biosystems.2004.05.030; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Navet S, 2009, GENE EXPR PATTERNS, V9, P461, DOI 10.1016/j.gep.2009.08.001; Nomaksteinsky M, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-53; Norekian TP, 2005, J NEUROPHYSIOL, V93, P305, DOI 10.1152/jn.00722.2004; Norris AD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-38; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Passini MA, 1998, DEV BRAIN RES, V109, P129, DOI 10.1016/S0165-3806(98)00069-8; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Steinmetz PRH, 2011, EVOL DEV, V13, P72, DOI 10.1111/j.1525-142X.2010.00457.x; Stolfi A, 2011, DEVELOPMENT, V138, P995, DOI 10.1242/dev.061507; SVENDSEN PC, 1995, DEVELOPMENT, V121, P1253; Takahashi T, 2005, BRAIN RES BULL, V66, P510, DOI 10.1016/j.brainresbull.2005.03.013; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Van Buskirk C, 2010, DEVELOPMENT, V137, P2065, DOI 10.1242/dev.040881; Wolanski M, 2009, GENESIS, V47, P19, DOI 10.1002/dvg.20449; Wollesen T, 2010, EVOL DEV, V12, P113, DOI 10.1111/j.1525-142X.2010.00398.x; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhong YF, 2008, EVOL DEV, V10, P516, DOI 10.1111/j.1525-142X.2008.00266.x; Zhong YF, 2011, EVOL DEV, V13, P567, DOI 10.1111/j.1525-142X.2011.00513.x	51	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109627	10.1371/journal.pone.0109627	http://dx.doi.org/10.1371/journal.pone.0109627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286399	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700076
J	Rogers, L; Koch, A				Rogers, Lock; Koch, Alan			Condition Dependent Effects on Sex Allocation and Reproductive Effort in Sequential Hermaphrodites	PLOS ONE			English	Article							MATERNAL DOMINANCE; NATURAL-SELECTION; RATIO; SIZE; EVOLUTION	Theory predicts he optimal timing of sex change will be the age or size at h h half of an individual's expected fitness comes through reproduction as a male and half through reprodLiction as a female. In this way, sex allocation across lifetime of a sequential hermaphrodite parallels the sex allocation of an outbreeding species exhibiting a 1:1 ratio of sons daughters. However, the expectation of a 1:1 sex ratio is sensitive to variation in individual condition. If individuals within population vary in condition, high-condition individuals are predicted to make increased allocations to the sex with higher variance in reproductive success. An oft-cited example of this effect is seen in red deer, Cervus elaphus, in which not hers of high condition are more likely to produce sons, while those in low condition are more likely to produce daughters. Here, we show that individual condition is predicted to similarly affect the pattern of sex allocation, and thus the allocation of reproductive effort, in sequential hermaphrodites. High-condition sex-changers are expected to obtain more than half of their fitness in the high-payoff second sex and, as a result, are expected to reduce the allocation of reproductive fort in the initial sex. While the sex ratio in populations of sequential hermaphrodites is always skewed towards an excess of the initial sex, condition dependence is predicted to increase this effect.	[Rogers, Lock] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA; [Koch, Alan] Agnes Scott Coll, Dept Math, Decatur, GA 30030 USA		Rogers, L (corresponding author), Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA.	lrogers@agnesscott.edu						ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bellman R., 1957, DYNAMIC PROGRAMMING; CHARNOV E L, 1982; CHARNOV EL, 1986, J THEOR BIOL, V119, P283, DOI 10.1016/S0022-5193(86)80141-2; CHARNOV EL, 1989, J THEOR BIOL, V139, P431, DOI 10.1016/S0022-5193(89)80063-3; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Fisher RA, 1930, GENETICAL THEORY NAT; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; GHISELIN MT, 1969, Q REV BIOL, V44, P189, DOI 10.1086/406066; LEIGH EG, 1976, P NATL ACAD SCI USA, V73, P3656, DOI 10.1073/pnas.73.10.3656; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; Mangel M., 1988, DYNAMIC MODELING BEH; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Roff Derek A., 1992; Rogers L, 2003, BEHAV ECOL, V14, P447, DOI 10.1093/beheco/14.3.447; Rogers L, 2001, AM NAT, V158, P543, DOI 10.1086/323119; Rogers L, 2011, EVOL ECOL RES, V13, P387; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Stearns S.C., 1992, pi; StMary CM, 1997, AM NAT, V150, P73, DOI 10.1086/286057; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WARNER RR, 1980, EVOLUTION, V34, P508, DOI 10.1111/j.1558-5646.1980.tb04840.x; WARNER RR, 1975, AM NAT, V109, P61, DOI 10.1086/282974; WARNER RR, 1975, SCIENCE, V190, P633, DOI 10.1126/science.1188360; Warner RR., 1978, SMITHSON CONTRIB ZOO, V254, P1, DOI [10.5479/si.00810282.254, DOI 10.5479/SI.00810282.254]; Williams G. C., 1966, P307; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002	32	0	0	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109626	10.1371/journal.pone.0109626	http://dx.doi.org/10.1371/journal.pone.0109626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302941	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400071
J	Bautista-Espana, D; Anastacio-Marcelino, E; Horta-Valerdi, G; Celestino-Montes, A; Kojic, M; Negrete-Abascal, E; Reyes-Cervantes, H; Vazquez-Cruz, C; Guzman, P; Sanchez-Alonso, P				Bautista-Espana, Dolores; Anastacio-Marcelino, Estela; Horta-Valerdi, Guillermo; Celestino-Montes, Antonio; Kojic, Milorad; Negrete-Abascal, Erasmo; Reyes-Cervantes, Hortensia; Vazquez-Cruz, Candelario; Guzman, Plinio; Sanchez-Alonso, Patricia			The Telomerase Reverse Transcriptase Subunit from the Dimorphic Fungus Ustilago maydis	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; DNA-REPAIR; IN-VITRO; MAINTENANCE; RECOMBINATION; PROTEINS; SYSTEM; CELLS; HAPLOINSUFFICIENCY	In this study, we investigated the reverse transcriptase subunit of telomerase in the dimorphic fungus Ustilago maydis. This protein (Trt1) contains 1371 amino acids and all of the characteristic TERT motifs. Mutants created by disrupting trt1 had senescent traits, such as delayed growth, low replicative potential, and reduced survival, that were reminiscent of the traits observed in est2 budding yeast mutants. Telomerase activity was observed in wild-type fungus sporidia but not those of the disruption mutant. The introduction of a self-replicating plasmid expressing Trt1 into the mutant strain restored growth proficiency and replicative potential. Analyses of trt1 crosses in planta suggested that Trt1 is necessary for teliospore formation in homozygous disrupted diploids and that telomerase is haploinsufficient in heterozygous diploids. Additionally, terminal restriction fragment analysis in the progeny hinted at alternative survival mechanisms similar to those of budding yeast.	[Bautista-Espana, Dolores; Anastacio-Marcelino, Estela; Horta-Valerdi, Guillermo; Celestino-Montes, Antonio; Vazquez-Cruz, Candelario; Sanchez-Alonso, Patricia] Benemerita Univ Autonoma Puebla, Ctr Invest Ciencias Microbiol, Inst Ciencias, Puebla, Mexico; [Guzman, Plinio] Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Irapuato, Guanajuato, Mexico; [Kojic, Milorad] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Negrete-Abascal, Erasmo] UNAM, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Reyes-Cervantes, Hortensia] Benemerita Univ Autonoma Puebla, Fac Ciencias Fis Matemat, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Belgrade; Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla	Sanchez-Alonso, P (corresponding author), Benemerita Univ Autonoma Puebla, Ctr Invest Ciencias Microbiol, Inst Ciencias, Puebla, Mexico.	maria.sanchez@correo.buap.mx		horta valerdi, guillermo manuel/0000-0003-3152-2947; Vazquez-Cruz, Candelario/0000-0002-9105-5669; Kojic, Milorad/0000-0002-0507-4231	CONACyT [46378-Q, CB106140-P2]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT 46378-Q and CONACyT CB106140-P2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Chen XF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000535; Chiang YJ, 2010, P NATL ACAD SCI USA, V107, P10148, DOI 10.1073/pnas.0913125107; Choudhary Bibha, 2012, Front Biosci (Schol Ed), V4, P16; Christensen JJ., 1963, AM PHYTOPATHOLOGY SO, V2, P1, DOI DOI 10.5962/BHL.TITLE.62035; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cifuentes-Rojas C, 2012, MUTAT RES-FUND MOL M, V730, P20, DOI 10.1016/j.mrfmmm.2011.10.003; Cukusic A, 2008, CYTOGENET GENOME RES, V122, P263, DOI 10.1159/000167812; Dalla Torre CA, 2002, BRAZ J MED BIOL RES, V35, P65, DOI 10.1590/S0100-879X2002000100009; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Ding DQ, 2013, FEBS J, V280, P3205, DOI 10.1111/febs.12258; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; GILLISSEN B, 1992, CELL, V68, P647, DOI 10.1016/0092-8674(92)90141-X; GOLD SE, 1994, GENE, V142, P225, DOI 10.1016/0378-1119(94)90265-8; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; GUZMAN PA, 1994, MICROBIOL-UK, V140, P551, DOI 10.1099/00221287-140-3-551; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Holliday R, 2004, DNA REPAIR, V3, P671, DOI 10.1016/j.dnarep.2004.02.002; HOLLIDAY R, 1974, HDB GENETICS, P575; Holloman WK, 2008, FUNGAL GENET BIOL, V45, pS31, DOI 10.1016/j.fgb.2008.04.006; Hu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003208; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Kalmbach KH, 2013, FERTIL STERIL, V99, P23, DOI 10.1016/j.fertnstert.2012.11.039; KAMPER J, 1995, CELL, V81, P73, DOI 10.1016/0092-8674(95)90372-0; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lendvay TS, 1996, GENETICS, V144, P1399; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Makovets S, 2008, GENETICS, V178, P245, DOI 10.1534/genetics.107.083030; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; Gomez DLM, 2013, INT J ONCOL, V43, P1351, DOI 10.3892/ijo.2013.2104; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; PUHALLA JE, 1968, GENETICS, V60, P461; Redon S, 2013, NUCLEIC ACIDS RES, V41, P9117, DOI 10.1093/nar/gkt695; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez-Alonso P, 1998, GENETICS, V148, P1043; SanchezAlonso P, 1996, MICROBIOL-SGM, V142, P2931, DOI 10.1099/13500872-142-10-2931; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; SPELLIG T, 1994, EMBO J, V13, P1620, DOI 10.1002/j.1460-2075.1994.tb06425.x; Teng SC, 1999, MOL CELL BIOL, V19, P8083; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; VazquezCruz C, 1997, J BACTERIOL, V179, P6341, DOI 10.1128/jb.179.20.6341-6348.1997; Vollmeister E, 2012, FEMS MICROBIOL REV, V36, P59, DOI 10.1111/j.1574-6976.2011.00296.x; Walbot V, 2010, SEX PLANT REPROD, V23, P1, DOI 10.1007/s00497-009-0109-0; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Yu EY, 2013, DNA REPAIR, V12, P472, DOI 10.1016/j.dnarep.2013.04.027; Zvereva MI, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1563, DOI 10.1134/S0006297910130055	57	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109981	10.1371/journal.pone.0109981	http://dx.doi.org/10.1371/journal.pone.0109981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299159	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200091
J	Fallesen, P; Emanuel, N; Wildeman, C				Fallesen, Peter; Emanuel, Natalia; Wildeman, Christopher			Cumulative Risks of Foster Care Placement for Danish Children	PLOS ONE			English	Article							MALTREATMENT; OUTCOMES; IMPACT	Although recent research suggests that the cumulative risk of foster care placement is far higher for American children than originally suspected, little is known about the cumulative risk of foster care placement in other countries, which makes it difficult to gauge the degree to which factor foster care placement is salient in other contexts. In this article, we provide companion estimates to those provided in recent work on the US by using Danish registry data and synthetic cohort life tables to show how high and unequally distributed the cumulative risk of foster care placement is for Danish children. Results suggest that at the beginning of the study period (in 1998) the cumulative risk of foster care placement for Danish children was roughly in line with the risk for American children. Yet, by the end of the study period (2010), the risk had declined to half the risk for American children. Our results also show some variations by parental ethnicity and sex, but these differences are small. Indeed, they appear quite muted relative to racial/ethnic differences in these risks in the United States. Last, though cumulative risks are similar between Danish and American children (especially at the beginning of the study period), the age-specific risk profiles are markedly different, with higher risks for older Danish children than for older American children.	[Fallesen, Peter] Rockwool Fdn Res Unit, Copenhagen, Denmark; [Fallesen, Peter] Univ Copenhagen, Dept Sociol, Copenhagen, Denmark; [Emanuel, Natalia] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Wildeman, Christopher] Cornell Univ, Dept Policy Anal & Management, Ithaca, NY USA	University of Copenhagen; Yale University; Cornell University	Fallesen, P (corresponding author), Rockwool Fdn Res Unit, Copenhagen, Denmark.	pf@rff.dk	Fallesen, Peter/AAO-4801-2021	Fallesen, Peter/0000-0003-0544-9977	Rockwool Foundation	Rockwool Foundation	The study was funded by the Rockwool Foundation (http://www.rockwoolfonden.dk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S. H., 2010, NAR MAN ANBRINGER BA, P13; Andersen SH, 2014, SOC FORCES, V93, P269, DOI 10.1093/sf/sou027; Berger LM, 2009, CHILD DEV, V80, P1856, DOI 10.1111/j.1467-8624.2009.01372.x; Dalsgaard S, 2013, J CHILD ADOL PSYCHOP, V23, P432, DOI 10.1089/cap.2012.0111; Doyle JJ, 2008, J POLITICAL EC, V116, P1583; Doyle JJ, 2007, AM ECON REV, V97, P1583, DOI 10.1257/aer.97.5.1583; Ejrnaes M, 2011, CHILD INDIC RES, V4, P21, DOI 10.1007/s12187-010-9066-2; Fallesen P, 2013, J ADOLESCENCE, V36, P1003, DOI 10.1016/j.adolescence.2013.08.010; Frederiksen S., 2012, THESIS AARHUS U; Harman JS, 2000, ARCH PEDIAT ADOL MED, V154, P1114, DOI 10.1001/archpedi.154.11.1114; Hestbak A.D., 2011, CHILD PROTECTION SYS, P131; Kvist AP, 2013, SOC SCI MED, V88, P30, DOI 10.1016/j.socscimed.2013.04.001; Lery B, 2009, CHILD YOUTH SERV REV, V31, P331, DOI 10.1016/j.childyouth.2008.08.001; Magruder J, 2008, CHILD WELFARE, V87, P169; Preston S., 2000, DEMOGRAPHY MEASURING; Putnam-Hornstein E, 2011, CHILD MALTREATMENT, V16, P163, DOI 10.1177/1077559511411179; Putnam-Hornstein E, 2011, CHILD ABUSE REV, V20, P256, DOI 10.1002/car.1191; Sabol W, 2004, CHILD ABUSE NEGLECT, V28, P967, DOI 10.1016/j.chiabu.2004.03.014; Simkiss DE, 2013, CHILD CARE HLTH DEV, V39, P628, DOI 10.1111/cch.12010; Statistics Denmark, 2013, QUAL DECL ASS CHILDR; Swann CA, 2006, DEMOGRAPHY, V43, P309, DOI 10.1353/dem.2006.0019; U. S. Department of Health and Human Services, 2006, 12 AFCARS US DEP HLT; U.S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2012, FED REP SYST AD FOST; U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics CDC WONDER Online Database, 2011, BRIDG RAC POP EST 19; United States Department of Health and Human Services), 2012, 19 AFCARS US DEP HLT; US Dep. Health Hum. Serv, 2012, TRENDS FOST CAR AD F; WALD MS, 1988, PROTECTING ABUSED NE; Waldfogel Jane, 2004, REV ECON HOUSEHOLD, V2, P387, DOI DOI 10.1007/S11150-004-5654-6; Warburton WP, 2014, CAN J ECON, V47, P35, DOI 10.1111/caje.12064; Wildeman C, 2014, ANN REV SOC IN PRESS; Wildeman C, 2004, JAMA PEDIAT IN PRESS; Wildeman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092785; Wulczyn F, 2009, FUTURE CHILD, V19, P39	33	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109207	10.1371/journal.pone.0109207	http://dx.doi.org/10.1371/journal.pone.0109207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299657	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200041
J	Garstang, M; Davis, RE; Leggett, K; Frauenfeld, OW; Greco, S; Zipser, E; Peterson, M				Garstang, Michael; Davis, Robert E.; Leggett, Keith; Frauenfeld, Oliver W.; Greco, Steven; Zipser, Edward; Peterson, Michael			Response of African Elephants (Loxodonta africana) to Seasonal Changes in Rainfall	PLOS ONE			English	Article							DESERT-DWELLING ELEPHANTS; HOANIB RIVER; MOVEMENT; DISTRIBUTIONS; DYNAMICS	The factors that trigger sudden, seasonal movements of elephants are uncertain. We hypothesized that savannah elephant movements at the end of the dry season may be a response to their detection of distant thunderstorms. Nine elephants carrying Global Positioning System (GPS) receivers were tracked over seven years in the extremely dry and rugged region of northwestern Namibia. The transition date from dry to wet season conditions was determined annually from surface- and satellite-derived rainfall. The distance, location, and timing of rain events relative to the elephants were determined using the Tropical Rainfall Measurement Mission (TRMM) satellite precipitation observations. Behavioral Change Point Analysis (BCPA) was applied to four of these seven years demonstrating a response in movement of these elephants to intra- and inter-seasonal occurrences of rainfall. Statistically significant changes in movement were found prior to or near the time of onset of the wet season and before the occurrence of wet episodes within the dry season, although the characteristics of the movement changes are not consistent between elephants and years. Elephants in overlapping ranges, but following separate tracks, exhibited statistically valid non-random near-simultaneous changes in movements when rainfall was occurring more than 100 km from their location. While the environmental trigger that causes these excursions remains uncertain, rain-system generated infrasound, which can travel such distances and be detected by elephants, is a possible trigger for such changes in movement.	[Garstang, Michael; Davis, Robert E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Leggett, Keith] Univ New S Wales, Sch Biol Earth & Environm Sci, Fowlers Gap Arid Zone Res Stn, Kensington, NSW 2033, Australia; [Frauenfeld, Oliver W.] Texas A&M Univ, Dept Geog, College Stn, TX USA; [Greco, Steven] Simpson Weather Associates Inc, Charlottesville, VA USA; [Zipser, Edward; Peterson, Michael] Univ Utah, Dept Atmospher Sci, Salt Lake City, UT USA	University of Virginia; University of New South Wales Sydney; Texas A&M University System; Texas A&M University College Station; Utah System of Higher Education; University of Utah	Garstang, M (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	mxg@swa.com	Frauenfeld, Oliver W./ABE-9259-2020; Frauenfeld, Oliver W./AAE-1869-2020; Davis, Robert/A-9078-2008; Zixuan, Huang/ABI-3557-2020	/0000-0002-6079-2658; Peterson, Michael/0000-0002-7683-0655; Greco, Steven/0000-0001-7934-8779	Simpson Weather Associates; Department of Environmental Sciences, University of Virginia	Simpson Weather Associates; Department of Environmental Sciences, University of Virginia	The communities and conservancies of northwestern Namibia, and the Ministry of Environment and Tourism are thanked for their previous support of the tracking studies used in this paper. We also acknowledge Earthwatch Institute, Denver Zoo, U.S. Fish and Wildlife Service, Wilderness Trust, Wildlife Conservation society, Ikahirongo Elephant Lodge, and Wilderness Safaris for their previous support. We wish to thank E. Gurarie for his guidance and provision of the BCPA program. Our thanks also go to Mary Morris for all of her bibliographic research, preparation and production of the manuscript and to Simpson Weather Associates and the Department of Environmental Sciences, University of Virginia for their support of this research. We would also wish to acknowledge and thank the Editor and three reviewers for their careful and critical reading of earlier drafts of this manuscript.	Birkett PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038363; Boettiger AN, 2011, ECOLOGY, V92, P1648; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; Christo C, 2009, WALKING THUNDER FOOT; Dominoni DM, 2014, J ANIM ECOL, V83, P681, DOI 10.1111/1365-2656.12150; Fleming CH, 2014, AM NAT, V183, pE154, DOI 10.1086/675504; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Groning K., 1999, ELEPHANTS CULTURAL N; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Johnson DS, 2011, J AGR BIOL ENVIR ST, V16, P357, DOI 10.1007/s13253-011-0056-8; Kelley Michael C., 2013, Animals, V3, P349, DOI 10.3390/ani3020349; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Leggett K, 2005, J ARID ENVIRON, V62, P587, DOI 10.1016/j.jaridenv.2005.01.020; Leggett K, 2003, AFR ZOOL, V38, P305; Leggett K., 2006, PACHYDERM, V40, P40; Leggett K, 2010, AFR J ECOL, V48, P197, DOI 10.1111/j.1365-2028.2009.01101.x; Leggett KEA, 2011, PACHYDERM, P20; LINDEQUE M, 1991, AFR J ECOL, V29, P196, DOI 10.1111/j.1365-2028.1991.tb01002.x; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Love TB, 2004, AMS 14 C APPL MET SE; Moss CJ, 2011, AMBOSELI ELEPHANT EL, P292; Otter LB, 2002, ATMOS ENVIRON, V36, P4265, DOI 10.1016/S1352-2310(02)00333-3; Scholes R. J., 2008, ELEPHANT MANAGEMENT; Thiebault A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1013, DOI 10.1007/s00265-013-1546-1; VILJOEN PJ, 1989, J ZOOL, V219, P1, DOI 10.1111/j.1469-7998.1989.tb02561.x; VILJOEN PJ, 1990, S AFR J WILDL RES, V20, P69; Yackulic CB, 2011, J ANIM ECOL, V80, P1088, DOI 10.1111/j.1365-2656.2011.01851.x; Zipser EJ, 2006, B AM METEOROL SOC, V87, P1057, DOI 10.1175/BAMS-87-8-1057	29	17	17	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108736	10.1371/journal.pone.0108736	http://dx.doi.org/10.1371/journal.pone.0108736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299514	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200022
J	Jin, JH; Lin, FM; Liao, SY; Bao, QY; Ni, LY				Jin, Jianhua; Lin, Faming; Liao, Shiyu; Bao, Qiyu; Ni, Liyan			Effects of SNPs (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C), Smoking, and Drinking on Susceptibility to Laryngeal Cancer among Han Chinese	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CYTOCHROME P4501B1; GENETIC POLYMORPHISMS; INCREASED RISK; NECK-CANCER; CYP1B1 GENE; HEAD; ASSOCIATION; CYP2E1; 1B1	Purpose: This study was conducted to explore the effects of genetic polymorphisms (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C) and environmental factors (smoking and drinking) on susceptibility to laryngeal cancer in a Han Chinese study group. Methods: This case-control study included 552 Han Chinese patients diagnosed with laryngeal cancer and 666 healthy control subjects of the same ethnicity, similar age, and gender. Genetic polymorphisms were examined using multi-PCR and Matrix Assisted Laser Desorption Ionization - Time of Flight (MALDI-TOF MS) methodology. The association of these genetic and environmental factors with susceptibility to laryngeal cancer was evaluated using a statistical approach. Results: The frequencies of all three polymorphisms in the patient cohort were significantly different from those in the control cohort. Compared to the control cohort, carriers of variant alleles of CYP1B1*2 355T and CYP2E1*5 -1293C showed a higher risk for developing laryngeal cancer (for CYP1B1*2 355T, adjusted OR = 2.657, P <0.001; for CYP2E1*5 -1293C, adjusted OR = 1.938, P <0.001), while carriers of mutation allele CYP1B1*3 4326G showed a lower risk (adjusted OR = 0.562, P <0.001). Joint effects of these polymorphisms were observed. When compared to haplotype G(355)C(4326)G(-1293), haplotypes T(355)C(4326)G(-1293) (adjusted OR = 1.809, P <0.001), G(355)C(4326)C(-1293) (adjusted OR = 1.644, P = 0.044), and T355C4326C-1293 (adjusted OR = 3.104, P <0.001) were associated with a significantly higher laryngeal cancer risk. The adjusted ORs for nonsmokers, non-drinkers, smokers, and drinkers with the GT/TT genotype at CYP1B1*2 G355T were 2.190 (P = 0.006), 2.008 (P = 0.001), 5.875 (P <0.001), and 4.518 (P <0.001), respectively. Conclusions: CYP1B1*2 355T and CYP2E1*5 -1293C are associated with an increased laryngeal cancer risk, while CYP1B1*3 4326G is associated with a decreased risk. These polymorphisms showed joint effects on laryngeal cancer risk. Smoking and drinking showed collaborative effects with two high risk alleles (CYP1B1*2 355T and CYP1B1*3 4326G) for promoting laryngeal cancer risk.	[Jin, Jianhua] Wenzhou Med Univ, Sch Basic Med, Wenzhou, Peoples R China; [Lin, Faming; Liao, Shiyu; Ni, Liyan] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China; [Bao, Qiyu] Wenzhou Med Univ, Sch Life Sci, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Ni, LY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China.	nily2001@126.com	Bao, Qiyu/AAH-6113-2020	Bao, Qiyu/0000-0001-6523-8763	Science and Technology Foundation of Wenzhou City, Zhejiang Province, China [H20090025]; Science and Technology Foundation of Health bureau of Zhejiang Province, China [2012ZB106]	Science and Technology Foundation of Wenzhou City, Zhejiang Province, China; Science and Technology Foundation of Health bureau of Zhejiang Province, China	This work is supported by the Science and Technology Foundation of Wenzhou City, Zhejiang Province, China (H20090025, URL: http://www.wzkj.gov.cn) and the Science and Technology Foundation of Health bureau of Zhejiang Province, China (2012ZB106, URL: http://zgj.zjtcm.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklillu E, 2002, MOL PHARMACOL, V61, P586, DOI 10.1124/mol.61.3.586; Bin B, 2009, CHINESE J CANC PREVE, V16, P315; Buters JTM, 2002, CHEM RES TOXICOL, V15, P1127, DOI 10.1021/tx020017q; Chen B, 2010, LUNG CANCER, V70, P247, DOI 10.1016/j.lungcan.2010.03.011; Cury NM, 2012, MOL BIOL REP, V39, P1055, DOI 10.1007/s11033-011-0831-1; Gajecka M, 2005, MUTAT RES-FUND MOL M, V574, P112, DOI 10.1016/j.mrfmmm.2005.01.027; Ghoshal U, 2013, GASTRIC CANC; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Guo Li-ke, 2012, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V34, P390, DOI 10.3881/j.issn.1000-503X.2012.04.015; Harth V, 2008, J TOXICOL ENV HEAL A, V71, P887, DOI 10.1080/15287390801988160; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Helmig S, 2010, EUR J EPIDEMIOL, V25, P867, DOI 10.1007/s10654-010-9505-x; Huang LP, 2010, ALCOHOL, V6, P57; Ickstadt K, 2008, J TOXICOL ENV HEAL A, V71, P803, DOI 10.1080/15287390801985745; INGELMANSUNDBERG M, 1993, ALCOHOL, V10, P447, DOI 10.1016/0741-8329(93)90063-T; Jaworowska E, 2006, BREAST CANCER RES TR, V97, P215, DOI 10.1007/s10549-005-9116-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ko Y, 2001, CANCER RES, V61, P4398; Lu D, 2011, MOL BIOL REP, V38, P2409, DOI 10.1007/s11033-010-0375-9; Ohshima H, 2005, MUTAT RES-FUND MOL M, V591, P110, DOI 10.1016/j.mrfmmm.2005.03.030; Roos Peter H, 2005, Expert Opin Drug Metab Toxicol, V1, P187, DOI 10.1517/17425255.1.2.187; Ruwali M, 2009, ENVIRON MOL MUTAGEN, V50, P473, DOI 10.1002/em.20488; Salinas-Sanchez AS, 2012, J UROLOGY, V187, P700, DOI 10.1016/j.juro.2011.10.063; Shah PP, 2008, MUTAT RES-FUND MOL M, V643, P4, DOI 10.1016/j.mrfmmm.2008.05.001; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Shimada T, 2001, XENOBIOTICA, V31, P163, DOI 10.1080/00498250110043490; Singh AP, 2008, MUTAT RES-FUND MOL M, V639, P11, DOI 10.1016/j.mrfmmm.2007.10.007; Sissung TM, 2006, MOL CANCER RES, V4, P135, DOI 10.1158/1541-7786.MCR-05-0101; Sun Qian, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P3; Tai J, 2010, CANCER GENET CYTOGEN, V196, P76, DOI 10.1016/j.cancergencyto.2009.08.015; Tang KF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-575; Teng Y, 2013, INT J GYNECOL CANCER, V23, P422, DOI 10.1097/IGC.0b013e3182849e0d; Trubicka J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-420; Ulusoy G, 2007, ARCH TOXICOL, V81, P711, DOI 10.1007/s00204-007-0200-y; Wu RM, 2002, J NEURAL TRANSM, V109, P1403, DOI 10.1007/s00702-002-0721-8; Xu WH, 2012, MOL BIOL REP, V39, P2821, DOI 10.1007/s11033-011-1041-6; Yoo Wonsuk, 2012, Int J Appl Sci Technol, V2, P268; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]	39	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e106580	10.1371/journal.pone.0106580	http://dx.doi.org/10.1371/journal.pone.0106580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299224	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200004
J	Loohuis, LO; Caravagna, G; Graudenzi, A; Ramazzotti, D; Mauri, G; Antoniotti, M; Mishra, B				Loohuis, Loes Olde; Caravagna, Giulio; Graudenzi, Alex; Ramazzotti, Daniele; Mauri, Giancarlo; Antoniotti, Marco; Mishra, Bud			Inferring Tree Causal Models of Cancer Progression with Probability Raising	PLOS ONE			English	Article							ONCOGENETIC TREE; PATHWAYS; HYBRIDIZATION; CONSTRUCTION; ALGORITHMS; DISTANCE; GENES	Existing techniques to reconstruct tree models of progression for accumulative processes, such as cancer, seek to estimate causation by combining correlation and a frequentist notion of temporal priority. In this paper, we define a novel theoretical framework called CAPRESE (CAncer PRogression Extraction with Single Edges) to reconstruct such models based on the notion of probabilistic causation defined by Suppes. We consider a general reconstruction setting complicated by the presence of noise in the data due to biological variation, as well as experimental or measurement errors. To improve tolerance to noise we define and use a shrinkage-like estimator. We prove the correctness of our algorithm by showing asymptotic convergence to the correct tree under mild constraints on the level of noise. Moreover, on synthetic data, we show that our approach outperforms the state-of-the-art, that it is efficient even with a relatively small number of samples and that its performance quickly converges to its asymptote as the number of samples increases. For real cancer datasets obtained with different technologies, we highlight biologically significant differences in the progressions inferred with respect to other competing techniques and we also show how to validate conjectured biological relations with progression models.	[Loohuis, Loes Olde] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Caravagna, Giulio; Graudenzi, Alex; Ramazzotti, Daniele; Mauri, Giancarlo; Antoniotti, Marco] Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz, Milan, Italy; [Mishra, Bud] NYU, Courant Inst Math Sci, New York, NY USA	University of California System; University of California Los Angeles; University of Milano-Bicocca; New York University	Loohuis, LO (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA.	l.oldeloohuis@gmail.com	Mauri, Giancarlo/M-3258-2013; Graudenzi, Alex/AAY-5241-2020; Caravagna, Giulio/F-5011-2015	Mauri, Giancarlo/0000-0003-3520-4022; Graudenzi, Alex/0000-0001-5452-1918; Caravagna, Giulio/0000-0003-4240-3265; RAMAZZOTTI, DANIELE/0000-0002-6087-2666	National Science Foundation [CCF-0836649, CCF-0926166]; Regione Lombardia (Italy) under ASTIL [12-4-5148000-40]; NEDD [ID14546A Rif SAL-7]	National Science Foundation(National Science Foundation (NSF)); Regione Lombardia (Italy) under ASTIL; NEDD	This work was supported by the National Science Foundation grants CCF-0836649 and CCF-0926166 and by Regione Lombardia (Italy) under the research projects RetroNet through the ASTIL [12-4-5148000-40]; U.A 053 and NEDD Project [ID14546A Rif SAL-7] Fondo Accordi Istituzionali 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerenwinkel N, 2005, J COMPUT BIOL, V12, P584, DOI 10.1089/cmb.2005.12.584; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P2106, DOI 10.1093/bioinformatics/bti274; Beerenwinkel N, 2007, BERNOULLI, V13, P893, DOI 10.3150/07-BEJ6133; Bell D, 2011, NATURE; CARTWRIGHT N, 1979, NOUS, V13, P419, DOI 10.2307/2215337; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Desper R, 2000, J COMPUT BIOL, V7, P789, DOI 10.1089/10665270050514936; Efron B, 2013, LARGE SCALE INFERENC; Efron B., 1982, JACKKNIFE BOOTSTRAP; Frank S, 2007, DYNAMICS CANC; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505; Gunawan B, 2007, J PATHOL, V211, P463, DOI 10.1002/path.2128; Gupta A, 2008, IEEE ACM T COMPUT BI, V5, P172, DOI 10.1109/TCBB.2007.70233; Hainke K, 2012, BIOMETRICAL J, V54, P617, DOI 10.1002/bimj.201100186; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hitchcock C., 2012, STANFORD ENCY PHILOS; Hjelm M, 2006, J COMPUT BIOL, V13, P853, DOI 10.1089/cmb.2006.13.853; Huang Q, 2002, GENE CHROMOSOME CANC, V34, P224, DOI 10.1002/gcc.10062; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Ionita I, 2006, AM J HUM GENET, V79, P13, DOI 10.1086/504354; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; Kleinberg S., 2012, CAUSALITY PROBABILIT; Longerich T, 2012, INT J CANCER, V130, P575, DOI 10.1002/ijc.26063; Loohuis LO, 2014, INFORM COMPUT, V236, P68, DOI 10.1016/j.ic.2014.01.013; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Pathare S, 2009, INT J CANCER, V124, P2864, DOI 10.1002/ijc.24267; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Radmacher MD, 2001, J THEOR BIOL, V212, P535, DOI 10.1006/jtbi.2001.2395; Ramakrishnan N, 2010, P NATL ACAD SCI USA, V107, P12511, DOI 10.1073/pnas.1006283107; Reichenbach H., 1956, DIRECTION TIME; Samuelson E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-352; Suppes P., 1970, PROBABILISTIC THEORY; Szabo A, 2002, MATH BIOSCI, V176, P219, DOI 10.1016/S0025-5564(02)00086-X; Szabo A., 2008, HDB CANC MODELS APPL; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Von Heydebreck A, 2004, BIOSTATISTICS, V5, P545, DOI 10.1093/biostatistics/kxh007; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109	45	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108358	10.1371/journal.pone.0108358	http://dx.doi.org/10.1371/journal.pone.0108358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299648	Green Submitted, gold, Green Published			2022-12-27	WOS:000343941200016
J	Narumi, M; Kashiwagi, Y; Namba, H; Ohe, R; Yamakawa, M; Yamashita, H				Narumi, Mari; Kashiwagi, Yoshiko; Namba, Hiroyuki; Ohe, Rintaro; Yamakawa, Mitsunori; Yamashita, Hidetoshi			Contribution of Corneal Neovascularization to Dendritic Cell Migration into the Central Area during Human Corneal Infection	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; ACTIVIN-A; SECRETION	Compared with the peripheral corneal limbus, the human central cornea lacks blood vessels, which is responsible for its immunologically privileged status and high transparency. Dendritic cells (DCs) are present in the central avascular area of inflamed corneas, but the mechanisms of their migration to this location are poorly understood. Here, we investigated the contribution of vessel formation to DC migration into the central cornea, and analyzed the DC chemotactic factors produced by human corneal epithelial (HCE) cells. Using human eyes obtained from surgical procedures, we then assessed vessel formation, DC distribution, and activin A expression immunohistochemically. The results demonstrated increased numbers of vessels and DCs in the central area of inflamed corneas, and a positive correlation between the number of vessels and DCs. Activin A was expressed in the subepithelial space and the endothelium of newly formed blood vessels in the inflamed cornea. In infected corneas, DCs were present in the central area but no vascularization was observed, suggesting the presence of chemotactic factors that induced DC migration from the limbal vessels. To test this hypothesis, we assessed the migration of monocyte-derived DCs toward HCE cell supernatants with or without lipopolysaccharide (LPS) stimulation of HCE cells and inflammatory cytokines (released by HCE cells). DCs migrated toward tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-6, and activin A, as well as LPS-stimulated HCE cell supernatants. The supernatant contained elevated TNF-alpha, IL-6, and activin A levels, suggesting that they were produced by HCE cells after LPS stimulation. Therefore, vessels in the central cornea might constitute a DC migration route, and activin A expressed in the endothelium of newly formed vessels might contribute to corneal vascularization. Activin A also functions as a chemotactic factor, similar to HCE-produced TNF-alpha and IL-6. These findings enhance our understanding of the pathophysiology of corneal inflammation during infection.	[Narumi, Mari; Namba, Hiroyuki; Yamashita, Hidetoshi] Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata 990, Japan; [Kashiwagi, Yoshiko] Yamagata Prefectural Yonezawa Womens Jr Coll, Dept Hlth & Nutr, Yamagata, Japan; [Ohe, Rintaro; Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 990, Japan	Yamagata University; Yamagata University	Narumi, M (corresponding author), Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata 990, Japan.	mari.narumi1101@gmail.com	Ohe, Rintaro/AAP-1604-2020	Ohe, Rintaro/0000-0002-8035-791X	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2008, CELLULAR MOL IMMUNOL, V5th, P94; Davis AA, 2000, MOL CELL NEUROSCI, V15, P11, DOI 10.1006/mcne.1999.0806; Ebihara N, 2011, INVEST OPHTH VIS SCI, V52, P8549, DOI 10.1167/iovs.11-7956; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Gibbs S, 2013, TOXICOL IN VITRO, V27, P1170, DOI 10.1016/j.tiv.2012.05.016; Hamrah Pedram, 2007, Chem Immunol Allergy, V92, P58, DOI 10.1159/000099254; Henry CR, 2012, OPHTHALMOLOGY, V119, P2443, DOI 10.1016/j.ophtha.2012.06.030; Knickelbein JE, 2009, OPHTHALMOL EYE DIS, V1, P45; Lu JM, 2012, MOL VIS, V18, P2255; Luisi S, 2001, EUR J ENDOCRINOL, V145, P225, DOI 10.1530/eje.0.1450225; Mastropasqua L, 2006, AM J OPHTHALMOL, V142, P736, DOI 10.1016/j.ajo.2006.06.057; Mayer WJ, 2007, INVEST OPHTH VIS SCI, V48, P4459, DOI 10.1167/iovs.06-1184; Nakao S, 2012, J OPTHALMOL, DOI [10.1155/2012/783163, DOI 10.1155/2012/783163.]; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Poulaki V, 2004, AM J PATHOL, V164, P1293, DOI 10.1016/S0002-9440(10)63216-6; Regina M, 2007, CLIN EXP OPHTHALMOL, V35, P541, DOI 10.1111/j.1442-9071.2007.01549.x; Robson NC, 2008, BLOOD, V111, P2733, DOI 10.1182/blood-2007-03-080994; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Salogni L, 2009, BLOOD, V113, P5848, DOI 10.1182/blood-2008-12-194597; Scutera S, 2008, EUR CYTOKINE NETW, V19, P60, DOI 10.1684/ecn.2008.0121; Ueta M, 2010, BRAIN RES BULL, V81, P219, DOI 10.1016/j.brainresbull.2009.10.001; Yamagami S, 2005, INVEST OPHTH VIS SCI, V46, P4489, DOI 10.1167/iovs.05-0054; Yamashita H, 1997, JPN J OPHTHALMOL, V101, P927; Zhang J, 2005, CURR EYE RES, V30, P527, DOI 10.1080/02713680590968150	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109859	10.1371/journal.pone.0109859	http://dx.doi.org/10.1371/journal.pone.0109859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299318	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200077
J	Raft, S; Coate, TM; Kelley, MW; Crenshaw, EB; Wu, DK				Raft, Steven; Coate, Thomas M.; Kelley, Matthew W.; Crenshaw, E. Bryan, III; Wu, Doris K.			Pou3f4-Mediated Regulation of Ephrin-B2 Controls Temporal Bone Development in the Mouse	PLOS ONE			English	Article							PROGRESSIVE MIXED DEAFNESS; CONDUCTIVE HEARING-LOSS; X-LINKED DEAFNESS; INNER-EAR; PERILYMPHATIC GUSHER; CELL-PROLIFERATION; OTIC CAPSULE; MIDDLE-EAR; GENE-EXPRESSION; JOINT FORMATION	The temporal bone encases conductive and sensorineural elements of the ear. Mutations of POU3F4 are associated with unique temporal bone abnormalities and X-linked mixed deafness (DFNX2/DFN3). However, the target genes and developmental processes controlled by POU3F4 transcription factor activity have remained largely uncharacterized. Ephrin-B2 (Efnb2) is a signaling molecule with well-documented effects on cell adhesion, proliferation, and migration. Our analyses of targeted mouse mutants revealed that Efnb2 loss-of-function phenocopies temporal bone abnormalities of Pou3f4 hemizygous null neonates: qualitatively identical malformations of the stapes, styloid process, internal auditory canal, and cochlear capsule were present in both mutants. Using failed/insufficient separation of the stapes and styloid process as a quantitative trait, we found that single gene Efnb2 loss-of-function and compound Pou3f4/Efnb2 loss-of-function caused a more severe phenotype than single gene Pou3f4 loss-of-function. Pou3f4 and Efnb2 gene expression domains overlapped at the site of impending stapes-styloid process separation and at subcapsular mesenchyme surrounding the cochlea; at both these sites, Efnb2 expression was attenuated in Pou3f4 hemizygous null mutants relative to control. Results of immunoprecipitation experiments using chromatin isolated from nascent middle ear mesenchyme supported the hypothesis of a physical association between Pou3f4 and specific non-coding sequence of Efnb2. We propose that Efnb2 is a target of Pou3f4 transcription factor activity and an effector of mesenchymal patterning during temporal bone development.	[Raft, Steven; Wu, Doris K.] NIDCD, Sect Sensory Cell Regenerat & Dev, NIH, Bethesda, MD 20892 USA; [Coate, Thomas M.; Kelley, Matthew W.] NIDCD, Lab Cochlear Dev, NIH, Bethesda, MD USA; [Crenshaw, E. Bryan, III] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Raft, S (corresponding author), NIDCD, Sect Sensory Cell Regenerat & Dev, NIH, Bethesda, MD 20892 USA.	rafts@nidcd.nih.gov; wud@nidcd.nih.gov			Intramural Program of the National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC013107, ZIADC000021, ZIADC000059] Funding Source: NIH RePORTER	Intramural Program of the National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work was funded by the Intramural Program of the National Institute on Deafness and Other Communication Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. C., 2010, SCHUKNECHTS PATHOLOG, P54; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Amin S, 2006, DEV DYNAM, V235, P1326, DOI 10.1002/dvdy.20666; Amin S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-134; Ann KJ, 2009, GENESIS, V47, P137, DOI 10.1002/dvg.20454; BACH I, 1992, AM J HUM GENET, V51, P38; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Braunstein EM, 2000, J ASS RES OTOLARYGOL, V9, P33; Bush JO, 2010, GENE DEV, V24, P2068, DOI 10.1101/gad.1963210; Cauldwell EW, 1942, ARCHIV OTOLARYNGOL, V36, P891; Choi BY, 2013, EUR ARCH OTO-RHINO-L, V270, P3057, DOI 10.1007/s00405-013-2386-3; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Cowan CA, 2004, DEV BIOL, V271, P263, DOI 10.1016/j.ydbio.2004.03.026; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; CREMERS CWRJ, 1985, ARCH OTOLARYNGOL, V111, P249; CREMERS CWRJ, 1985, AM J OTOL, V6, P243; CREMERS CWRJ, 1983, CLIN OTOLARYNGOL, V8, P235, DOI 10.1111/j.1365-2273.1983.tb01434.x; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Depew M.J., 2002, MOUSE DEV PATTERNING, P421; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gerety SS, 2002, DEVELOPMENT, V129, P1397; GLASSCOC.ME, 1973, ARCH OTOLARYNGOL, V98, P82; HANSON JR, 1962, ARCHIV OTOLARYNGOL, V76, P200; Heydemann A, 2001, DEV BRAIN RES, V128, P83, DOI 10.1016/S0165-3806(01)00137-7; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; HUBER I, 1994, HUM MOL GENET, V3, P1151, DOI 10.1093/hmg/3.7.1151; Hwang CH, 2008, HUM MOL GENET, V17, P844, DOI 10.1093/hmg/ddm356; Jeong J, 2008, DEVELOPMENT, V135, P2905, DOI 10.1242/dev.019778; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; MCPHEE JR, 1985, ANAT REC, V213, P566, DOI 10.1002/ar.1092130413; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; Merchant SN, 2008, OTOL NEUROTOL, V29, P282, DOI 10.1097/mao.0b013e318161ab24; Miko IJ, 2008, HEARING RES, V235, P39, DOI 10.1016/j.heares.2007.09.003; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Mroz K, 1999, DEV BIOL, V207, P229, DOI 10.1006/dbio.1998.9160; NANCE W E, 1971, Birth Defects Original Article Series, V7, P64; Nandapalan V, 2000, AM J OTOL, V21, P71, DOI 10.1016/S0196-0709(00)80115-5; Naranjo S, 2010, HUM GENET, V128, P411, DOI 10.1007/s00439-010-0864-x; O'Gorman S, 2005, DEV DYNAM, V234, P124, DOI 10.1002/dvdy.20402; Ohashi M, 2006, HEARING RES, V213, P11, DOI 10.1016/j.heares.2005.11.007; Okazawa H, 1996, P NATL ACAD SCI USA, V93, P11933, DOI 10.1073/pnas.93.21.11933; Sanchez-Guardado LO, 2011, J COMP NEUROL, V519, P125, DOI 10.1002/cne.22508; PHELPS PD, 1991, NEURORADIOLOGY, V33, P326, DOI 10.1007/BF00587816; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Phippard D, 1998, HEARING RES, V120, P77, DOI 10.1016/S0378-5955(98)00059-8; Phippard D, 2000, HUM MOL GENET, V9, P79, DOI 10.1093/hmg/9.1.79; PIUSSAN C, 1995, AM J HUM GENET, V56, P224; Raft S, 2014, DEV BIOL, V390, P51, DOI 10.1016/j.ydbio.2014.02.019; Robert-Moreno A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015907; Rodriguez-Vazquez JF, 2005, J ANAT, V207, P165, DOI 10.1111/j.1469-7580.2005.00441.x; Ruest LB, 2009, DEV BIOL, V328, P94, DOI 10.1016/j.ydbio.2009.01.005; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Samadi DS, 2005, HEARING RES, V199, P11, DOI 10.1016/j.heares.2004.07.013; SNIK AFM, 1995, AM J OTOL, V16, P241; Sobal SE, 2005, ARCH OTOLARYNGOL, V131, P41, DOI 10.1001/archotol.131.1.41; Sohl M, 2009, GENE, V437, P54, DOI 10.1016/j.gene.2009.02.017; Song MH, 2011, BIOCHEM BIOPH RES CO, V404, P528, DOI 10.1016/j.bbrc.2010.12.019; Thompson H, 2012, DEV DYNAM, V241, P1396, DOI 10.1002/dvdy.23831; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xu NJ, 2012, SEMIN CELL DEV BIOL, V23, P58, DOI 10.1016/j.semcdb.2011.10.024; Zhou CQ, 2011, LARYNGOSCOPE, V121, P1541, DOI 10.1002/lary.21861	69	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109043	10.1371/journal.pone.0109043	http://dx.doi.org/10.1371/journal.pone.0109043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299585	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200031
J	Szilagyi, A; Kun, A; Szathmary, E				Szilagyi, Andras; Kun, Adam; Szathmary, Eoers			Local Neutral Networks Help Maintain Inaccurately Replicating Ribozymes	PLOS ONE			English	Article							IN-VITRO SELECTION; HEPATITIS-C-VIRUS; HIGH-AFFINITY APTAMERS; PROTEIN-KINASE-C; RNA APTAMERS; MOLECULAR RECOGNITION; BINDING RNA; INHIBITS TRANSLATION; DIRECTED EVOLUTION; ACTIVE-SITE	The error threshold of replication limits the selectively maintainable genome size against recurrent deleterious mutations for most fitness landscapes. In the context of RNA replication a distinction between the genotypic and the phenotypic error threshold has been made; where the latter concerns the maintenance of secondary structure rather than sequence. RNA secondary structure is treated as a proxy for function. The phenotypic error threshold allows higher per digit mutation rates than its genotypic counterpart, and is known to increase with the frequency of neutral mutations in sequence space. Here we show that the degree of neutrality, i.e. the frequency of nearest-neighbour (one-step) neutral mutants is a remarkably accurate proxy for the overall frequency of such mutants in an experimentally verifiable formula for the phenotypic error threshold; this we achieve by the full numerical solution for the concentration of all sequences in mutation-selection balance up to length 16. We reinforce our previous result that currently known ribozymes could be selectively maintained by the accuracy known from the best available polymerase ribozymes. Furthermore, we show that in silico stabilizing selection can increase the mutational robustness of ribozymes due to the fact that they were produced by artificial directional selection in the first place. Our finding offers a better understanding of the error threshold and provides further insight into the plausibility of an ancient RNA world.	[Szilagyi, Andras; Kun, Adam; Szathmary, Eoers] Parmenides Ctr Conceptual Foundat Sci, Munich, Germany; [Szilagyi, Andras; Szathmary, Eoers] MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Budapest, Hungary; [Szathmary, Eoers] Eotvos Lorand Univ, Inst Biol, Dept Plant Systemat Ecol & Theoret Biol, Budapest, Hungary; [Kun, Adam] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Eotvos Lorand University; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH)	Szathmary, E (corresponding author), Parmenides Ctr Conceptual Foundat Sci, Munich, Germany.	szathmary.eors@gmail.com	Kun, Ádám/A-5571-2011; Szathmary, Eors/AAS-1202-2021	Kun, Ádám/0000-0002-8409-8521; Szathmary, Eors/0000-0001-5227-2997; Szilagyi, Andras/0000-0002-6894-4652	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC [294332]; Hungarian National Office for Research and Technology (NAP) [2005/KCKHA005]; European Union; European Social Fund [TAMOP 4.2.1/B-09/1/KMR-2010-0003]	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Hungarian National Office for Research and Technology (NAP); European Union(European Commission); European Social Fund(European Social Fund (ESF))	Financial support has been provided by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no [294332] and the Hungarian National Office for Research and Technology (NAP 2005/KCKHA005). AS and AK acknowledge support by the European Union and co-financed by the European Social Fund (grant agreement no. TAMOP 4.2.1/B-09/1/KMR-2010-0003). This work was carried out as part of EU COST action CM1304 "Emergence and Evolution of Complex Chemical Systems''. AK gratefully acknowledges a Ja nos Bolyai Research Fellowship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/nchem.1781, 10.1038/NCHEM.1781]; Balay S, 2008, PETSC USERS MANUAL; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; Bell SD, 1998, J BIOL CHEM, V273, P14309, DOI 10.1074/jbc.273.23.14309; Berens C, 2001, BIOORGAN MED CHEM, V9, P2549, DOI 10.1016/S0968-0896(01)00063-3; Bernhardt HS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-23; Bridonneau P, 1998, J MED CHEM, V41, P778, DOI 10.1021/jm970579k; Brockstedt U, 2004, BIOCHEM BIOPH RES CO, V313, P1004, DOI 10.1016/j.bbrc.2003.12.030; Cech TR, 2005, RNA WORLD; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Chumachenko NV, 2009, J AM CHEM SOC, V131, P5257, DOI 10.1021/ja809419f; Coleman TM, 2002, CHEM BIOL, V9, P1227, DOI 10.1016/S1074-5521(02)00264-8; Conn MM, 1996, J AM CHEM SOC, V118, P7012, DOI 10.1021/ja961249c; Conrad R, 1996, ANAL BIOCHEM, V242, P261, DOI 10.1006/abio.1996.0462; CONRAD R, 1994, J BIOL CHEM, V269, P32051; Cox JC, 1998, BIOTECHNOL PROGR, V14, P845, DOI 10.1021/bp980097h; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; Czaran T., 2000, GEOMETRY ECOLOGICAL, P116, DOI [10.1017/cbo9780511525537.009, DOI 10.1017/CBO9780511525537.009]; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Dworkin JP, 2003, J THEOR BIOL, V222, P127, DOI 10.1016/S0022-5193(03)00020-1; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M, 1988, J PHYS CHEM, V92; Eulberg D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni044; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Flintoft L, 2005, NAT REV GENET, V6, P724, DOI 10.1038/nrg1712; FONTANA W, 1993, BIOPOLYMERS, V33, P1389, DOI 10.1002/bip.360330909; Fukuda K, 2000, EUR J BIOCHEM, V267, P3685, DOI 10.1046/j.1432-1327.2000.01400.x; Fusz S, 2005, CHEM BIOL, V12, P941, DOI 10.1016/j.chembiol.2005.06.008; Gal SW, 1998, EUR J BIOCHEM, V252, P553, DOI 10.1046/j.1432-1327.1998.2520553.x; Gebhardt K, 2000, BIOCHEMISTRY-US, V39, P7255, DOI 10.1021/bi000295t; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Gening LV, 2006, NUCLEIC ACIDS RES, V34, P2579, DOI 10.1093/nar/gkl326; Gevertz J, 2005, RNA, V11, P853, DOI 10.1261/rna.7271405; Gruner W, 1996, MONATSH CHEM, V127, P375, DOI 10.1007/BF00810882; Hager AJ, 1997, CHEM BIOL, V4, P607, DOI 10.1016/S1074-5521(97)90246-5; Haller AA, 1997, P NATL ACAD SCI USA, V94, P8521, DOI 10.1073/pnas.94.16.8521; Hamm J, 1997, P NATL ACAD SCI USA, V94, P12839, DOI 10.1073/pnas.94.24.12839; Hartmann R, 1998, J BIOL CHEM, V273, P3236, DOI 10.1074/jbc.273.6.3236; Hayden EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045351; Hernandez V, 2005, ACM T MATH SOFTWARE, V31, P351, DOI 10.1145/1089014.1089019; Hesselberth JR, 2000, J BIOL CHEM, V275, P4937, DOI 10.1074/jbc.275.7.4937; Hirao I, 2004, BIOCHEMISTRY-US, V43, P3214, DOI 10.1021/bi0356146; Hirao I, 1998, MOL DIVERS, V4, P75, DOI 10.1023/A:1026401917416; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hornung V, 1998, BIOCHEMISTRY-US, V37, P7260, DOI 10.1021/bi972969e; Huang FQ, 1997, BIOCHEMISTRY-US, V36, P6557, DOI 10.1021/bi970475b; Huang FQ, 2000, BIOCHEMISTRY-US, V39, P15548, DOI 10.1021/bi002061f; Hubai AG, 2013, EMERGENCE EVOLUTION; Hwang B, 2002, BIOCHEM BIOPH RES CO, V290, P656, DOI 10.1006/bbrc.2001.6252; Illangasekare M, 1999, RNA, V5, P1482, DOI 10.1017/S1355838299991264; Illangasekare M, 1999, P NATL ACAD SCI USA, V96, P5470, DOI 10.1073/pnas.96.10.5470; Jadhav VR, 2002, BIOCHEMISTRY-US, V41, P723, DOI 10.1021/bi011803h; Jayasena VK, 1997, P NATL ACAD SCI USA, V94, P10612, DOI 10.1073/pnas.94.20.10612; Jenne A, 1998, CHEM BIOL, V5, P23, DOI 10.1016/S1074-5521(98)90084-9; Jeong S, 2001, BIOCHEM BIOPH RES CO, V281, P237, DOI 10.1006/bbrc.2001.4327; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; JONES BL, 1976, B MATH BIOL, V38, P15; Jones LA, 2006, ANTIMICROB AGENTS CH, V50, P3019, DOI 10.1128/AAC.01603-05; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Katahira M, 1999, Nucleic Acids Symp Ser, P269; Khvorova A, 1999, P NATL ACAD SCI USA, V96, P10649, DOI 10.1073/pnas.96.19.10649; Kikuchi K, 2005, NUCLEIC ACIDS RES, V33, P683, DOI 10.1093/nar/gki215; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V291, P925, DOI 10.1006/bbrc.2002.6521; Kimoto M, 2002, EUR J BIOCHEM, V269, P697, DOI 10.1046/j.0014-2956.2001.02703.x; Konnyu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020931; Koizumi M, 2000, BIOCHEMISTRY-US, V39, P8983, DOI 10.1021/bi000149n; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; Kumar PKR, 1997, VIROLOGY, V237, P270, DOI 10.1006/viro.1997.8773; Kumar RK, 2001, BIOCHEMISTRY-US, V40, P6998, DOI 10.1021/bi010710x; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; KUN A, 2005, APTAMER HDB, P54; Lafontaine DA, 2002, BIOCHEM SOC T, V30, P1170, DOI 10.1042/bst0301170; Lee JF, 2004, NUCLEIC ACIDS RES, V32, pD95, DOI 10.1093/nar/gkh094; Lee SK, 2005, BIOCHEM BIOPH RES CO, V327, P294, DOI 10.1016/j.bbrc.2004.12.011; Legiewicz M, 2005, J BIOL CHEM, V280, P19815, DOI 10.1074/jbc.M502329200; Li N, 2005, BIOCHEMISTRY-US, V44, P4582, DOI 10.1021/bi047576b; Lorger M, 2003, EUKARYOT CELL, V2, P84, DOI 10.1128/EC.2.1.84-94.2003; Lupold SE, 2002, CANCER RES, V62, P4029; Mannironi C, 2000, RNA, V6, P520, DOI 10.1017/S1355838200991763; Maurel MC, 2005, ADV ASTROBIOL BIOGEO, P571, DOI 10.1007/10913406_17; Maynard Smith John., 1995, MAJOR TRANSITION EVO; Meli M, 2003, J BIOL CHEM, V278, P9835, DOI 10.1074/jbc.M213058200; Meyers LA, 2004, J MOL EVOL, V58, P681, DOI 10.1007/s00239-004-2590-2; Missailidis S, 2005, J IMMUNOL METHODS, V296, P45, DOI 10.1016/j.jim.2004.10.011; Miyakawa S, 2006, RNA, V12, P1825, DOI 10.1261/rna.2169406; Murphy MB, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng110; NOWAK M, 1989, J THEOR BIOL, V137, P375, DOI 10.1016/S0022-5193(89)80036-0; Ogawa A, 2004, BIOORG MED CHEM LETT, V14, P4001, DOI 10.1016/j.bmcl.2004.05.042; Piganeau N, 2001, J MOL BIOL, V312, P1177, DOI 10.1006/jmbi.2001.4981; Rajamani S, 2010, J AM CHEM SOC, V132, P5880, DOI 10.1021/ja100780p; Reidys C, 2001, B MATH BIOL, V63, P57, DOI 10.1006/bulm.2000.0206; Ryu Y, 2006, CHEM COMMUN, P1439, DOI 10.1039/b517160a; Saito H, 2001, EMBO J, V20, P1797, DOI 10.1093/emboj/20.7.1797; Santos M, 2004, J MOL EVOL, V59, P507, DOI 10.1007/s00239-004-2642-7; Schurer H, 2001, BIOORGAN MED CHEM, V9, P2557, DOI 10.1016/S0968-0896(01)00030-X; SCHUSTER P, 1988, B MATH BIOL, V50, P635, DOI 10.1016/S0092-8240(88)80059-4; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Schuster P, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-374153-0.00001-1; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Seiwert SD, 2000, CHEM BIOL, V7, P833, DOI 10.1016/S1074-5521(00)00032-6; Sengle G, 2001, CHEM BIOL, V8, P459, DOI 10.1016/S1074-5521(01)00026-6; SMITH JM, 1983, PROC R SOC SER B-BIO, V219, P315, DOI 10.1098/rspb.1983.0076; Soukup GA, 2000, J MOL BIOL, V298, P623, DOI 10.1006/jmbi.2000.3704; Stich M, 2011, J THEOR BIOL, V280, P117, DOI 10.1016/j.jtbi.2011.03.010; Sun LL, 2002, CHEM BIOL, V9, P619, DOI 10.1016/S1074-5521(02)00141-2; Swetina J, 1982, BIOPHYSICAL CHEM, V46, P187; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; Szathmary E, 1987, J THEORETICAL BIOL, V128; Tahiri-Alaoui A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e45; Takeuchi N, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-9; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Thomas M, 1997, J BIOL CHEM, V272, P27980, DOI 10.1074/jbc.272.44.27980; THOMPSON C J, 1974, Mathematical Biosciences, V21, P127, DOI 10.1016/0025-5564(74)90110-2; Tok JBH, 2000, NUCLEIC ACIDS RES, V28, P2902, DOI 10.1093/nar/28.15.2902; Tuschl T, 1998, EMBO J, V17, P2637, DOI 10.1093/emboj/17.9.2637; Ulrich H, 1998, P NATL ACAD SCI USA, V95, P14051, DOI 10.1073/pnas.95.24.14051; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; Urvil PT, 1997, EUR J BIOCHEM, V248, P130, DOI 10.1111/j.1432-1033.1997.t01-1-00130.x; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wallace ST, 1998, RNA, V4, P112; Wang Y, 1996, BIOCHEMISTRY-US, V35, P12338, DOI 10.1021/bi960878w; Wecker M, 1996, RNA, V2, P982; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Welch M, 1997, BIOCHEMISTRY-US, V36, P6614, DOI 10.1021/bi963135j; White RR, 2003, P NATL ACAD SCI USA, V100, P5028, DOI 10.1073/pnas.0831159100; Wilke CO, 2001, PHYS REP, V349, P395, DOI 10.1016/S0370-1573(00)00118-6; WILLIAMS KP, 1995, EMBO J, V14, P4551, DOI 10.1002/j.1460-2075.1995.tb00134.x; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Yarus M., 2011, LIFE RNA WORLD ANCES; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	135	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109987	10.1371/journal.pone.0109987	http://dx.doi.org/10.1371/journal.pone.0109987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299454	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000343941200094
J	Bayati, M; Braverman, M; Gillam, M; Mack, KM; Ruiz, G; Smith, MS; Horvitz, E				Bayati, Mohsen; Braverman, Mark; Gillam, Michael; Mack, Karen M.; Ruiz, George; Smith, Mark S.; Horvitz, Eric			Data-Driven Decisions for Reducing Readmissions for Heart Failure: General Methodology and Case Study	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAMS; HOSPITAL READMISSION; 30-DAY READMISSION; RANDOMIZED TRIAL; RISK PREDICTION; OLDER PATIENTS; INTERVENTION; METAANALYSIS; PREVENT; SUPPORT	Background: Several studies have focused on stratifying patients according to their level of readmission risk, fueled in part by incentive programs in the U.S. that link readmission rates to the annual payment update by Medicare. Patient-specific predictions about readmission have not seen widespread use because of their limited accuracy and questions about the efficacy of using measures of risk to guide clinical decisions. We construct a predictive model for readmissions for congestive heart failure (CHF) and study how its predictions can be used to perform patient-specific interventions. We assess the cost-effectiveness of a methodology that combines prediction and decision making to allocate interventions. The results highlight the importance of combining predictions with decision analysis. Methods: We construct a statistical classifier from a retrospective database of 793 hospital visits for heart failure that predicts the likelihood that patients will be rehospitalized within 30 days of discharge. We introduce a decision analysis that uses the predictions to guide decisions about post-discharge interventions. We perform a cost-effectiveness analysis of 379 additional hospital visits that were not included in either the formulation of the classifiers or the decision analysis. We report the performance of the methodology and show the overall expected value of employing a real-time decision system. Findings: For the cohort studied, readmissions are associated with a mean cost of $13,679 with a standard error of $1,214. Given a post-discharge plan that costs $1,300 and that reduces 30-day rehospitalizations by 35%, use of the proposed methods would provide an 18.2% reduction in rehospitalizations and save 3.8% of costs. Conclusions: Classifiers learned automatically from patient data can be joined with decision analysis to guide the allocation of post-discharge support to CHF patients. Such analyses are especially valuable in the common situation where it is not economically feasible to provide programs to all patients.	[Bayati, Mohsen] Stanford Univ, Stanford, CA 94305 USA; [Braverman, Mark] Princeton Univ, Princeton, NJ 08544 USA; [Gillam, Michael; Mack, Karen M.; Ruiz, George; Smith, Mark S.] MedStar Hlth, Washington, DC USA; [Gillam, Michael; Mack, Karen M.; Ruiz, George; Smith, Mark S.] Washington Hosp Ctr, Washington, DC 20010 USA; [Horvitz, Eric] Microsoft Res, Redmond, WA 98052 USA; [Horvitz, Eric] Univ Washington, Sch Med, Redmond, WA USA	Stanford University; Princeton University; MedStar Washington Hospital Center; Microsoft; University of Washington	Horvitz, E (corresponding author), Microsoft Res, Redmond, WA 98052 USA.	horvitz@microsoft.com		Mack, Karen/0000-0002-2839-5812; Bayati, Mohsen/0000-0002-7280-912X	Microsoft Research, a basic science research unit of Microsoft; Microsoft Research; National Science Foundation [1216011]; Natural Science and Engineering Research Council of Canada; Alfred P. Sloan Fellowship; National Science Foundation; Division of Computing and Communication Foundations [1216011] Funding Source: National Science Foundation	Microsoft Research, a basic science research unit of Microsoft(Microsoft); Microsoft Research(Microsoft); National Science Foundation(National Science Foundation (NSF)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The research was supported as a project at Microsoft Research (http://research.microsoftcom/en-us/), a basic science research unit of Microsoft. Microsoft Research is an open research laboratory (with no publication controls) exploring curiosity-driven research with multiple concentrations in basic and applied computer science. MBa was also a postdoctoral researcher in Microsoft Research during 2007-2009 and received research support from Microsoft Research during 2010-12. MBa also received support by National Science Foundation award number 1216011. MBr was a postdoctoral researcher in Microsoft Research during 2008-2010 and received research support from Microsoft Research during 2010-11. MBr was also supported by a Natural Science and Engineering Research Council of Canada through its Discovery Grant program. MBr was supported by Microsoft Research (http://research.microsoft.com/en-us/) and also by the Natural Science and Engineering Research Council of Canada through its Discovery Grant program, by the Alfred P. Sloan Fellowship and by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Anderson Cheryl, 2005, Congest Heart Fail, V11, P315, DOI 10.1111/j.1527-5299.2005.04458.x; Boutwell A, 2009, EFFECTIVE INTERVENTI; Center for Medicare and Medicaid Services, 2009, FED REG, V74, P24166; Chen S., 1994, SIGN SYST COMP 1994, V1, P41; Coglianese EE, 2012, AM J CARDIOL, V109, P241, DOI 10.1016/j.amjcard.2011.08.037; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Giamouzis G, 2011, J CARD FAIL, V17, P54, DOI 10.1016/j.cardfail.2010.08.010; Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jovicic Aleksandra, 2006, BMC Cardiovasc Disord, V6, P43, DOI 10.1186/1471-2261-6-43; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Koelling Todd M, 2005, Evid Based Cardiovasc Med, V9, P138; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Medicare Payment Advisory Commission, 2013, PROM GREAT EFF MED R; Peikes D, 2002, JAMA-J AM MED ASSOC, V301, P603; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vaduganathan M, 2012, CIRC-HEART FAIL, V5, P750, DOI 10.1161/CIRCHEARTFAILURE.112.970525; VanWalraven C, 2010, CMAJ, V6, P51; Wang L, 2012, AM J CARDIOL, V110, P1342, DOI 10.1016/j.amjcard.2012.06.038	27	58	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109264	10.1371/journal.pone.0109264	http://dx.doi.org/10.1371/journal.pone.0109264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295524	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000054
J	Jones, NRV; Conklin, AI; Suhrcke, M; Monsivais, P				Jones, Nicholas R. V.; Conklin, Annalijn I.; Suhrcke, Marc; Monsivais, Pablo			The Growing Price Gap between More and Less Healthy Foods: Analysis of a Novel Longitudinal UK Dataset	PLOS ONE			English	Article							ENERGY-DENSITY; COST; DIET; AFFORDABILITY; OBESITY; TRENDS; POLICY	Objectives: The UK government has noted the public health importance of food prices and the affordability of a healthy diet. Yet, methods for tracking change over time have not been established. We aimed to investigate the prices of more and less healthy foods over time using existing government data on national food prices and nutrition content. Methods: We linked economic data for 94 foods and beverages in the UK Consumer Price Index to food and nutrient data from the UK Department of Health's National Diet and Nutrition Survey, producing a novel dataset across the period 2002-2012. Each item was assigned to a food group and also categorised as either "more healthy" or "less healthy" using a nutrient profiling model developed by the Food Standards Agency. We tested statistical significance using a t-test and repeated measures ANOVA. Results: The mean (standard deviation) 2012 price/1000 kcal was 2.50 pound (0.29) for less healthy items and 7.49 pound (1.27) for more healthy items. The ANOVA results confirmed that all prices had risen over the period 2002-2012, but more healthy items rose faster than less healthy ones in absolute terms:0.17 pound compared to 0.07 pound/1000 kcal per year on average for more and less healthy items, respectively (p<0.001). Conclusions: Since 2002, more healthy foods and beverages have been consistently more expensive than less healthy ones, with a growing gap between them. This trend is likely to make healthier diets less affordable over time, which may have implications for individual food security and population health, and it may exacerbate social inequalities in health. The novel data linkage employed here could be used as the basis for routine food price monitoring to inform public health policy.	[Jones, Nicholas R. V.; Conklin, Annalijn I.; Suhrcke, Marc; Monsivais, Pablo] Univ Cambridge, Sch Clin Med, Addenbrookes Treatment Ctr, UKCRC Ctr Diet & Act Res,Dept MRC Epidemiol, Cambridge, England; [Suhrcke, Marc] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England	University of Cambridge; University of East Anglia	Monsivais, P (corresponding author), Univ Cambridge, Sch Clin Med, Addenbrookes Treatment Ctr, UKCRC Ctr Diet & Act Res,Dept MRC Epidemiol, Cambridge Biomed Campus, Cambridge, England.	pm491@medschl.cam.ac.uk	Suhrcke, Marc/AAE-9024-2019	Conklin, Annalijn/0000-0002-6532-8790; Monsivais, Pablo/0000-0002-7088-6674; Suhrcke, Marc/0000-0001-7263-8626	British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under the UK Clinical Research Collaboration; Gates Cambridge Trust; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [1166526, ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under the UK Clinical Research Collaboration(Wellcome Trust); Gates Cambridge Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The present study was undertaken by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. The authors gratefully acknowledge the funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration. AIC was fully supported by the Gates Cambridge Trust. The funding sources had no role in the design and conduct of the study or in the collection, management, analysis, and interpretation of the data.	Andreyeva T, 2008, HEALTH AFFAIR, V27, P1381, DOI 10.1377/hlthaff.27.5.1381; [Anonymous], 2013, FOOD STAT POCK 2013; [Anonymous], 2011, LIVEWELL BALANCE HLT; Anriquez G, 2010, MEASURING DIETARY EN; Burns C, 2008, AUST NZ J PUBL HEAL, V32, P450, DOI 10.1111/j.1753-6405.2008.00278.x; Carlson A., 2012, ARE HLTH FOODS REALL; Change4Life, 2013, HLTH LIV TIPS BEN YO; Department for Environment Food and Rural Affairs, 2010, UK FOOD SEC ASS DET; Department of Health, 2012, NAT DIET NUTR SURV H; Department of Health, 2011, NAT DIET NUTR SURV Y; Dowler E, 2008, P NUTR SOC, V67, P289, DOI 10.1017/S0029665108008586; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; European Union, 2007, COMM ORG AGR MARK; FAO, 1996, WORLD FOOD SUMMIT; Griffith R., 2012, FOOD PURCHASES NUTR; Harrison M, 2010, AUST NZ J PUBL HEAL, V34, P179, DOI 10.1111/j.1753-6405.2010.00504.x; Kuchler F., 2008, PRICE TRENDS ARE SIM; Lee A, 2013, OBES REV, V14, P82, DOI 10.1111/obr.12078; Lee JH, 2011, NUTR DIET, V68, P248, DOI 10.1111/j.1747-0080.2011.01554.x; Lloyd-Williams F, 2008, B WORLD HEALTH ORGAN, V86, P535, DOI 10.2471/BLT.08.053728; Monsivais P, 2007, J AM DIET ASSOC, V107, P2071, DOI 10.1016/j.jada.2007.09.009; Monsivais P, 2010, FOOD POLICY, V35, P514, DOI 10.1016/j.foodpol.2010.06.004; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; National Health Service, EATW PLAT; Ni Mhurchu Cliona, 2007, N Z Med J, V120, pU2388; O'Dowd A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3578; Office for National Statistics, 2012, CONS PRIC IND TECHN; Office for National Statistics, 2012, LIV COST FOOD SURV; Pinstrup-Andersen P, 2009, FOOD SECUR, V1, P5, DOI 10.1007/s12571-008-0002-y; R Core Team, 2018, R LANG ENV STAT COMP; Rao M, 2013, HLTH FOODS DIET PATT; Rayner M, 2009, UK OFCOM NUTR PROFIL; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P337, DOI 10.1017/S1368980007666671; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; StataCorp, 2011, STAT STAT SOFTW REL, P173; Taylor-Robinson D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7157; The World Bank, MEAS POV LIN; U.S. Department of Agriculture Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; UK Data Service, NAT DIET NUTR SURV 2; United States Department of Agriculture, 1975, AGR HDB, V102; Veerman JL, 2006, EUR J PUBLIC HEALTH, V16, P31, DOI 10.1093/eurpub/cki166; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams P, 2009, NUTR DIET, V66, P27, DOI 10.1111/j.1747-0080.2008.01314.x; World Health Organization, 2004, GLOB STRAT DIET PHYS	45	124	125	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109343	10.1371/journal.pone.0109343	http://dx.doi.org/10.1371/journal.pone.0109343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296332	gold, Green Published, Green Accepted			2022-12-27	WOS:000345204000060
J	Ramadaniati, HU; Lee, YP; Hughes, JD				Ramadaniati, Hesty Utami; Lee, Ya Ping; Hughes, Jeffery David			The Difference in Pharmacists' Interventions across the Diverse Settings in a Children's Hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ADVERSE DRUG EVENTS; CLINICAL PHARMACIST; MEDICATION ERRORS; PEDIATRIC INPATIENTS; SERVICES; KINGDOM; IMPACT	Aims: This study aimed to document and compare the nature of clinical pharmacists' interventions made in different practice settings within a children's hospital. Methods: The primary investigator observed and documented all clinical interventions performed by clinical pharmacists for between 35-37 days on each of the five study wards from the three practice settings, namely general medical, general surgical and hematology-oncology. The rates, types and significance of the pharmacists' interventions in the different settings were compared. Results: A total of 982 interventions were documented, related to the 16,700 medication orders reviewed on the five wards in the three practice settings over the duration of the study. Taking medication histories and/or patient counselling were the most common pharmacists' interventions in the general settings; constituting more than half of all interventions. On the Hematology-Oncology Ward the pattern was different with drug therapy changes being the most common interventions (n = 73/195, 37.4% of all interventions). Active interventions (pharmacists' activities leading to a change in drug therapy) constituted less than a quarter of all interventions on the general medical and surgical wards compared to nearly half on the specialty Hematology-Oncology Ward. The majority (n = 37/42, 88.1%) of a random sample of the active interventions reviewed were rated as clinically significant. Dose adjustment was the most frequent active interventions in the general settings, whilst drug addition constituted the most common active interventions on the Hematology-Oncology Ward. The degree of acceptance of pharmacists' active interventions by prescribers was high (n = 223/244, 91.4%). Conclusions: The rate of pharmacists' active interventions differed across different practice settings, being most frequent in the specialty hematology-oncology setting. The nature and type of the interventions documented in the hematology-oncology were also different compared to those in the general medical and surgical settings.	[Ramadaniati, Hesty Utami] Curtin Univ, Sch Pharm, Bentley, WA, Australia; Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia	Curtin University; Curtin University	Ramadaniati, HU (corresponding author), Curtin Univ, Sch Pharm, Bentley, WA, Australia.	h.ramadaniati@postgrad.curtin.edu.au	Ramadaniati, Hesty Utami/GQO-8586-2022					Alderman C P, 2001, J Qual Clin Pract, V21, P99, DOI 10.1046/j.1440-1762.2001.00428.x; Barber ND, 1997, AM J HEALTH-SYST PH, V54, P397, DOI 10.1093/ajhp/54.4.397; Boardman H, 2001, PHARM WORLD SCI, V23, P55, DOI 10.1023/A:1011270507539; Bond CA, 2002, PHARMACOTHERAPY, V22, P134, DOI 10.1592/phco.22.3.134.33551; Bright JM, 2000, AUST J HOSP PHARM, V30, P10; Carter MK, 2006, AM J HEALTH-SYST PH, V63, P2500, DOI 10.2146/ajhp060028; Chan DS, 1998, J PEDIAT PHARM PRACT, V3, P144; Condren ME, 2004, ANN PHARMACOTHER, V38, P574, DOI 10.1345/aph.1D384; COTTER SM, 1994, AM J HOSP PHARM, V51, P2676, DOI 10.1093/ajhp/51.21.2676; Coutsouvelis J, 2010, SUPPORT CARE CANCER, V18, P811, DOI 10.1007/s00520-009-0713-4; Fernandez-Llamazares CM, 2012, ARCH DIS CHILD, V97, P564, DOI 10.1136/archdischild-2011-301239; Fortescue EB, 2003, PEDIATRICS, V111, P722, DOI 10.1542/peds.111.4.722; Gardner B, 2009, JT COMM J QUAL PATIE, V35, P278, DOI 10.1016/S1553-7250(09)35039-4; Guy J, 2003, J Child Health Care, V7, P277, DOI 10.1177/13674935030074004; Kaushal R, 2008, AM J HEALTH-SYST PH, V65, P1254, DOI 10.2146/ajhp070522; Krupicka MI, 2002, CRIT CARE MED, V30, P919, DOI 10.1097/00003246-200204000-00035; Lau PM, 2004, SUPPORT CARE CANCER, V12, P626, DOI 10.1007/s00520-004-0622-5; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; Maat B, 2013, ARCH DIS CHILD, V98, P222, DOI 10.1136/archdischild-2012-302817; Pedersen CA, 2011, AM J HEALTH-SYST PH, V68, P669, DOI [10.2146/ajhp100711, 10.2146/ajhp090596]; Pharmaceutical Society of Australia The Royal Australian College of General Practitioners Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 2014, AUSTR MED HDB 2014; Ruder Aimee Danette, 2011, J Oncol Pharm Pract, V17, P425, DOI 10.1177/1078155210389216; Society of Hospital Pharmacists Australia Committee of Specialty Practice in Clinical Pharmacy, 2005, J PHARM PRACT RES, V35, P122, DOI DOI 10.1002/j.2055-2335.2005.tb00322.x; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stemer G, 2012, EUR J HOSP PHARM-S P, V19, P529, DOI 10.1136/ejhpharm-2012-000131; Virani A., 2003, CAN J HOSP PHARM, V56, P158; Waddell J A, 1998, J Am Pharm Assoc (Wash), V38, P451; WHO, 2010, INT STAT CLASS DIS R; Williams M, 2011, ANN PHARMACOTHER, V45, P1067, DOI 10.1345/aph.1Q138; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030856	30	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110168	10.1371/journal.pone.0110168	http://dx.doi.org/10.1371/journal.pone.0110168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296280	Green Published, gold			2022-12-27	WOS:000345204000116
J	Safo, MK; Musayev, FN; Mosier, PD; Zhou, QB; Xie, H; Desai, UR				Safo, Martin K.; Musayev, Faik N.; Mosier, Philip D.; Zhou, Qibing; Xie, Hang; Desai, Umesh R.			Crystal Structures of Influenza A Virus Matrix Protein M1: Variations on a Theme	PLOS ONE			English	Article							NUCLEAR EXPORT; LOW PH; ELECTRON-MICROSCOPY; NS2 PROTEIN; MEMBRANE; BINDING; LOCALIZATION; TRANSPORT; DOMAIN; RIBONUCLEOPROTEINS	Matrix protein 1 (M1) of the influenza A virus plays multiple roles in virion assembly and infection. Interest in the pH dependence of M1's multiple functions led us to study the effect of subtle pH changes on M1 structure, resulting in the elucidation of a unique low-pH crystal structure of the N1-165-domain of A/WSN/33 (H1N1) M1 that has never been reported. Although the 2.2 angstrom crystal structure of M1 N-terminus shows a dimer with the two monomers interacting in a face-to-face fashion at low pH as observed earlier, a 44 degrees rotation of the second monomer has led to a significantly different dimer interface that possibly affects dimer stability. More importantly, while one of the monomers is fully defined, the N-terminal half of the second monomer shows considerable disorder that appears inherent in the protein and is potentially physiologically relevant. Such disorder has not been observed in any other previously reported structure at either low or high pH conditions, despite similar crystallization pH conditions. By comparing our novel N1-165-domain structure with other low-pH or neutral-pH M1 structures, it appears that M1 can energetically access different monomer and dimer conformations, as well as oligomeric states, with varying degree of similarities. The study reported here provides further insights into M1 oligomerization that may be essential for viral propagation and infectivity.	[Safo, Martin K.; Musayev, Faik N.; Mosier, Philip D.; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA; [Safo, Martin K.; Musayev, Faik N.; Mosier, Philip D.; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Zhou, Qibing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Mat Med, Wuhan, Hubei, Peoples R China; [Xie, Hang] US FDA, Div Viral Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	Virginia Commonwealth University; Virginia Commonwealth University; Huazhong University of Science & Technology; US Food & Drug Administration (FDA)	Safo, MK (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA.	msafo@vcu.edu; Hang.Xie@fda.hhs.gov	Musayev, Faik/AAY-2010-2020; Safo, Martin/AAJ-9833-2020; Xie, Hang/AAC-9092-2019; Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597; Xie, Hang/0000-0001-8318-5554	National Institutes of Health [P01 HL107152, CA16059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	URD acknowledges the research support provided by grant P01 HL107152 from the National Institutes of Health. Structural biology resources were provided in part by National Institutes of Health grant CA16059 to the VCU Massey Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Arzt S, 2004, VIRUS RES, V99, P115, DOI 10.1016/j.virusres.2003.10.010; Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Das SC, 2012, J VIROL, V86, P1522, DOI 10.1128/JVI.06230-11; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; Fontana J, 2013, J VIROL, V87, P5621, DOI 10.1128/JVI.00276-13; Fontana J, 2012, J VIROL, V86, P2919, DOI 10.1128/JVI.06698-11; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; KEMLER I, 1994, VIROLOGY, V202, P1028, DOI 10.1006/viro.1994.1432; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; Ponstingl H, 2000, PROTEINS, V41, P47; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; RUIGROK RWH, 1989, VIROLOGY, V173, P311, DOI 10.1016/0042-6822(89)90248-1; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Sakaguchi A, 2003, VIROLOGY, V306, P244, DOI 10.1016/S0042-6822(02)00013-2; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shtykova EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082431; WARD AC, 1995, ARCH VIROL, V140, P2067, DOI 10.1007/BF01322693; Whittaker G, 1996, J VIROL, V70, P2743, DOI 10.1128/JVI.70.5.2743-2756.1996; WRIGLEY NG, 1979, BRIT MED BULL, V35, P35, DOI 10.1093/oxfordjournals.bmb.a071539; Xie H, 2013, J VIROL, V87, P345, DOI 10.1128/JVI.02024-12; YASUDA J, 1993, VIROLOGY, V196, P249, DOI 10.1006/viro.1993.1473; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786; ZHIRNOV OP, 1992, VIROLOGY, V186, P324, DOI 10.1016/0042-6822(92)90090-C	37	27	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109510	10.1371/journal.pone.0109510	http://dx.doi.org/10.1371/journal.pone.0109510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295515	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000075
J	Kassas, A; Moura, IC; Yamashita, Y; Scheffel, J; Guerin-Marchand, C; Blank, U; Sims, PJ; Wiedmer, T; Monteiro, RC; Rivera, J; Charles, N; Benhamou, M				Kassas, Asma; Moura, Ivan C.; Yamashita, Yumi; Scheffel, Jorg; Guerin-Marchand, Claudine; Blank, Ulrich; Sims, Peter J.; Wiedmer, Therese; Monteiro, Renato C.; Rivera, Juan; Charles, Nicolas; Benhamou, Marc			Regulation of the Tyrosine Phosphorylation of Phospholipid Scramblase 1 in Mast Cells That Are Stimulated through the High-Affinity IgE Receptor	PLOS ONE			English	Article							LEUKEMIA RBL-2H3 CELLS; GROWTH-FACTOR RECEPTOR; PLASMA-MEMBRANE; FC-RECEPTORS; TRANSBILAYER MOVEMENT; MONOCLONAL-ANTIBODIES; HISTAMINE-RELEASE; APOPTOTIC CELLS; GENE-EXPRESSION; PROTEIN	Engagement of high-affinity immunoglobulin E receptors (Fc epsilon RI) activates two signaling pathways in mast cells. The Lyn pathway leads to recruitment of Syk and to calcium mobilization whereas the Fyn pathway leads to phosphatidylinositol 3-kinase recruitment. Mapping the connections between both pathways remains an important task to be completed. We previously reported that Phospholipid Scramblase 1 (PLSCR1) is phosphorylated on tyrosine after cross-linking Fc epsilon RI on RBL-2H3 rat mast cells, amplifies mast cell degranulation, and is associated with both Lyn and Syk tyrosine kinases. Here, analysis of the pathway leading to PLSCR1 tyrosine phosphorylation reveals that it depends on the FcR gamma chain. Fc epsilon RI aggregation in Fyn-deficient mouse bone marrow-derived mast cells (BMMC) induced a more robust increase in Fc epsilon RI-dependent tyrosine phosphorylation of PLSCR1 compared to wild-type cells, whereas PLSCR1 phosphorylation was abolished in Lyn-deficient BMMC. Lyn association with PLSCR1 was not altered in Fyn-deficient BMMC. PLSCR1 phosphorylation was also dependent on the kinase Syk and significantly, but partially, dependent on detectable calcium mobilization. Thus, the Lyn/Syk/calcium axis promotes PLSCR1 phosphorylation in multiple ways. Conversely, the Fyn-dependent pathway negatively regulates it. This study reveals a complex regulation for PLSCR1 tyrosine phosphorylation in Fc epsilon RI-activated mast cells and that PLSCR1 sits at a crossroads between Lyn and Fyn pathways.	[Kassas, Asma; Moura, Ivan C.; Guerin-Marchand, Claudine; Blank, Ulrich; Monteiro, Renato C.; Charles, Nicolas; Benhamou, Marc] Univ Paris 07, INSERM, U1149, Paris, France; [Kassas, Asma; Moura, Ivan C.; Guerin-Marchand, Claudine; Blank, Ulrich; Monteiro, Renato C.; Charles, Nicolas; Benhamou, Marc] Univ Paris Diderot, Sorbonne Paris Cite, Lab Excellence INFLAMEX, DHU FIRE, Paris, France; [Yamashita, Yumi; Scheffel, Jorg; Rivera, Juan] NIAMSD, Immunogenet Mol Lab, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sims, Peter J.; Wiedmer, Therese] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Rochester	Charles, N (corresponding author), Univ Paris 07, INSERM, U1149, Paris, France.	nicolas.charles@inserm.fr; marc.benhamou@inserm.fr	CHARLES, Nicolas/P-5430-2014; Monteiro, Renato C/U-8633-2017; CHARLES, Nicolas/S-2214-2019; Cruz Moura, Ivan/A-9510-2013	CHARLES, Nicolas/0000-0002-5416-5834; Monteiro, Renato C/0000-0001-5202-5646; CHARLES, Nicolas/0000-0002-5416-5834; Cruz Moura, Ivan/0000-0002-8418-2803; Moura, Ivan/0000-0002-2977-0354; Blank, Ulrich/0000-0002-2661-2983; Benhamou, Marc/0000-0001-7763-3795	Fondation de France [2002004544]; Ligue Nationale Contre le Cancer; Intramural Research Program, NIAMS, NIH; Investissements d'Avenir programme [ANR-11-IDEX-0005-02]; Sorbonne Paris Cite; Laboratoire d'excellence INFLAMEX	Fondation de France(Fondation de France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Intramural Research Program, NIAMS, NIH; Investissements d'Avenir programme(French National Research Agency (ANR)); Sorbonne Paris Cite; Laboratoire d'excellence INFLAMEX	This work was supported in part by a grant from the Fondation de France (2002004544). N.C. was supported in part by a grant from the Ligue Nationale Contre le Cancer. The work of Y.Y., J.S. and J.R. was supported by the Intramural Research Program, NIAMS, NIH. A.K. was supported by Investissements d'Avenir programme ANR-11-IDEX-0005-02, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Moazami O, 2008, J BIOL CHEM, V283, P25514, DOI 10.1074/jbc.M705320200; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BEAVEN MA, 1984, J BIOL CHEM, V259, P7129; Ben-Efraim I, 2004, BIOCHEMISTRY-US, V43, P3518, DOI 10.1021/bi0356911; BENHAMOU M, 1992, J BIOL CHEM, V267, P7310; Bevers EM, 1998, BIOL CHEM, V379, P973; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Charles N, 2004, J BIOL CHEM, V279, P12312, DOI 10.1074/jbc.M309456200; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; EISEMAN E, 1992, NATURE, V355, P78; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Furumoto Y, 2004, IMMUNOL RES, V30, P241, DOI 10.1385/IR:30:2:241; Furumoto Y, 2006, J IMMUNOL, V176, P5167, DOI 10.4049/jimmunol.176.9.5167; Kasukabe T, 1997, BLOOD, V89, P2975, DOI 10.1182/blood.V89.8.2975; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Launay P, 1999, J BIOL CHEM, V274, P7216, DOI 10.1074/jbc.274.11.7216; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Martin S, 2000, INT ARCH ALLERGY IMM, V123, P249, DOI 10.1159/000024451; MONTEIRO RC, 1992, J IMMUNOL, V148, P1764; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; PFEFFERKORN LC, 1994, J IMMUNOL, V153, P3228; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; Sahu SK, 2009, BBA-GEN SUBJECTS, V1790, P1274, DOI 10.1016/j.bbagen.2009.06.008; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Silverman RH, 2002, CANCER RES, V62, P397; Smrz D, 2008, J BIOL CHEM, V283, P10904, DOI 10.1074/jbc.M710386200; Stout JG, 1998, BIOCHEMISTRY-US, V37, P14860, DOI 10.1021/bi9812930; STRACKE ML, 1987, MOL IMMUNOL, V24, P347, DOI 10.1016/0161-5890(87)90176-3; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Wiedmer T, 2004, P NATL ACAD SCI USA, V101, P13296, DOI 10.1073/pnas.0405354101; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yokoyama A, 2004, LEUKEMIA RES, V28, P149, DOI 10.1016/S0145-2126(03)00189-9; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zhou QS, 2000, BLOOD, V95, P2593, DOI 10.1182/blood.V95.8.2593.008k32_2593_2599; Zhou QS, 1998, BIOCHEMISTRY-US, V37, P2356, DOI 10.1021/bi972625o; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	53	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109800	10.1371/journal.pone.0109800	http://dx.doi.org/10.1371/journal.pone.0109800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289695	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000089
J	Kim, MA; Lee, YS; Seo, K				Kim, Min-A; Lee, You Sun; Seo, Kyung			Assessment of Predictive Markers for Placental Inflammatory Response in Preterm Births	PLOS ONE			English	Article							AMNIOTIC-FLUID INTERLEUKIN-6; NEUTROPHIL-LYMPHOCYTE RATIO; C-REACTIVE PROTEIN; BLOOD-CELL COUNT; CHORIOAMNIONITIS; INFECTION; LABOR; LESIONS; PARTURITION; FUNISITIS	Placental inflammatory response (PIR) is associated with adverse neonatal outcomes such as sepsis, cerebral palsy, low birth weight, preterm birth, and neonatal mortality. However, there is an urgent need for noninvasive and sensitive biomarkers for prediction of PIR. In this study, we evaluated the clinical usefulness of maternal serum inflammatory markers for prediction of PIR in women with impending preterm birth. We conducted a retrospective cohort study of 483 patients who delivered preterm neonates. Serum levels of leukocyte differential counts, C-reactive protein (CRP), and neutrophil to lymphocyte ratio (NLR) were compared between women with no placental inflammation and women with PIR. The mean neutrophil counts, CRP levels, and NLR in both the patients with histologic chorioamnionitis (HCA) alone and those with HCA with funisitis were significantly higher than those in women with no placental inflammation. Compared to leukocyte subset or CRP, NLR in women with funisitis was significantly higher than in women with HCA alone and showed higher predictive accuracy, along with 71.4% sensitivity, 77.9% specificity, 80.7% positive predictive value, and 67.8% negative predictive value for prediction of PIR. On Kaplan-Meier survival analysis, women with both an elevated level of CRP and a high NLR had a shorter admission-to-delivery interval compared to women with either an elevated level of CRP or a high NLR alone. NLR may be a predictive marker of PIR and could be used as a cost-effective parameter for identifying women at risk of PIR.	[Kim, Min-A; Lee, You Sun; Seo, Kyung] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol,Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System	Seo, K (corresponding author), Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol,Gangnam Severance Hosp, Seoul, South Korea.	kyungseo@yuhs.ac						BERRY SM, 1995, AM J OBSTET GYNECOL, V173, P1315, DOI 10.1016/0002-9378(95)91378-5; Cecic I, 2002, CANCER LETT, V183, P43, DOI 10.1016/S0304-3835(02)00092-7; Chaiworapongsa T, 2002, AM J OBSTET GYNECOL, V186, P1178, DOI 10.1067/mob.2002.124042; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; De Felice C, 2001, J PEDIATR-US, V138, P101, DOI 10.1067/mpd.2001.109605; GAUTHIER DW, 1992, AM J OBSTET GYNECOL, V167, P1092, DOI 10.1016/S0002-9378(12)80044-5; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; GRAVETT MG, 1994, AM J OBSTET GYNECOL, V171, P1660, DOI 10.1016/0002-9378(94)90418-9; Holcroft CJ, 2004, AM J OBSTET GYNECOL, V191, P2010, DOI 10.1016/j.ajog.2004.05.005; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Kemp K, 2002, INFECT IMMUN, V70, P5019, DOI 10.1128/IAI.70.9.5019-5025.2002; Kim MA, 2011, EUR J CLIN INVEST, V41, P773, DOI 10.1111/j.1365-2362.2011.02469.x; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Pacora P, 2002, J Matern Fetal Neonatal Med, V11, P18, DOI 10.1080/713605445; Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019; Park KH, 2000, KOREAN J OBSTET GYNE, V43, P1019; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1382, DOI 10.1016/0002-9378(92)91609-E; ROMERO R, 1990, J CLIN INVEST, V85, P1392, DOI 10.1172/JCI114583; SEO K, 1992, OBSTET GYNECOL, V79, P75; Trochez-Martinez RD, 2007, BJOG-INT J OBSTET GY, V114, P796, DOI 10.1111/j.1471-0528.2007.01385.x; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Watterberg KL, 1996, PEDIATRICS, V97, P210; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035; Yoon BH, 1996, OBSTET GYNECOL, V87, P231, DOI 10.1016/0029-7844(95)00380-0	27	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107880	10.1371/journal.pone.0107880	http://dx.doi.org/10.1371/journal.pone.0107880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291377	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000009
J	Lieu, FK; Lin, CY; Wang, PS; Jian, CY; Yeh, YH; Chen, YA; Wang, KL; Lin, YC; Chang, LL; Wang, GJ; Wang, SW				Lieu, Fu-Kong; Lin, Chih-Yung; Wang, Paulus S.; Jian, Cai-Yun; Yeh, Yung-Hsing; Chen, Yi-An; Wang, Kai-Lee; Lin, Yi-Chun; Chang, Ling-Ling; Wang, Guei-Jane; Wang, Shyi-Wu			Effect of Swimming on the Production of Aldosterone in Rats	PLOS ONE			English	Article							ZONA GLOMERULOSA CELLS; ANGIOTENSIN-II; GRADED-EXERCISE; RENIN-ACTIVITY; LACTATE; SECRETION; BLOOD; RESPONSES; SODIUM; CAMP	It has been demonstrated that exercise is one of the stresses known to increase the aldosterone secretion. Both potassium and angiotensin II (Ang II) levels are shown to be correlated with aldosterone production during exercise, but the mechanism is still unclear. In an in vivo study, male rats were catheterized via right jugular vein (RJV), and divided into four groups namely water immersion, swimming, lactate infusion (13 mg/kg/min) and pyruvate infusion (13 mg/kg/min) groups. Each group was treated for 10 min. Blood samples were collected at 0, 10, 15, 30, 60 and 120 min from RJV after administration. In an in vitro study, rat zona glomerulosa (ZG) cells were challenged by lactate (1-10 mM) in the presence or absence of Ang II (10(-8) M) for 60 min. The levels of aldosterone in plasma and medium were measured by radioimmunoassay. Cell lysates were analyzed by immunoblotting assay. After exercise and lactate infusion, plasma levels of aldosterone and lactate were significantly higher than those in the control group. Swimming for 10 min significantly increased the plasma Ang II levels in male rats. Administration of lactate plus Ang II significantly increased aldosterone production and enhanced protein expression of steroidogenic acute regulatory protein (StAR) in ZG cells. These results demonstrated that acute exercise led to the increase of both aldosterone and Ang II secretion, which is associated with lactate action on ZG cells and might be dependent on the activity of renin-angiotensin system.	[Lieu, Fu-Kong; Lin, Yi-Chun] Cheng Hsin Gen Hosp, Dept Rehabil, Taipei, Taiwan; [Lin, Chih-Yung; Wang, Paulus S.; Jian, Cai-Yun; Yeh, Yung-Hsing; Chen, Yi-An; Wang, Kai-Lee] Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei 112, Taiwan; [Wang, Paulus S.] China Med Univ, Coll Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Wang, Paulus S.] China Med Univ Hosp, Med Ctr Aging Res, Taichung, Taiwan; [Chang, Ling-Ling] Chinese Culture Univ, Coll Engn, Dept Chem Engn, Taipei, Taiwan; [Wang, Shyi-Wu] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan; [Wang, Guei-Jane] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Guei-Jane] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Wang, Guei-Jane] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Wang, Paulus S.] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Wang, Paulus S.] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan	Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chinese Culture University; Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Asia University Taiwan; Taipei Veterans General Hospital	Wang, SW (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan.	swwang@mail.cgu.edu.tw		Wang, Kai-Lee/0000-0002-3058-3804	Cheng Hsin General Hospital [101F195cy16]; China Medical University [DMR-102-124]; Chang Gung Memorial Hospital, Taiwan, ROC [CMRPD100041, CMRPD100042]	Cheng Hsin General Hospital; China Medical University(China Medical University); Chang Gung Memorial Hospital, Taiwan, ROC(Chang Gung Memorial Hospital)	This study was supported by the grant (No. 101F195cy16) from Cheng Hsin General Hospital, the grant (DMR-102-124) from China Medical University, and the grant (CMRPD100041 and CMRPD100042) from Chang Gung Memorial Hospital, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1993, J STEROID BIOCHEM, V45, P147, DOI 10.1016/0960-0760(93)90134-I; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang LL, 2008, J BIOMED SCI, V15, P463, DOI 10.1007/s11373-008-9241-3; Chang LL, 2008, J CELL BIOCHEM, V104, P359, DOI 10.1002/jcb.21627; Chang LL, 2012, ADAPT MED, V4, P75; Ciampone S, 2011, J RENIN-ANGIO-ALDO S, V12, P394, DOI 10.1177/1470320311408750; Clark BJ, 1999, ENDOCRINOLOGY, V140, P4390, DOI 10.1210/en.140.10.4390; Clark BJ, 2004, ENDOCR RES, V30, P685, DOI 10.1081/ERC-200043973; CONVERTINO VA, 1981, J APPL PHYSIOL, V50, P123, DOI 10.1152/jappl.1981.50.1.123; Costill D L, 1977, Ann N Y Acad Sci, V301, P160, DOI 10.1111/j.1749-6632.1977.tb38195.x; Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166; Dullaart RPF, 2008, CLIN ENDOCRINOL, V69, P359, DOI 10.1111/j.1365-2265.2008.03196.x; Elsworth R, 1996, BODY FLUID BALANCE E, P352; FRANCESCONI RP, 1983, J APPL PHYSIOL, V55, P1790, DOI 10.1152/jappl.1983.55.6.1790; Ganong WH, 2003, REV MED PHYSL, P366; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Kau MM, 1999, J CELL BIOCHEM, V72, P286, DOI 10.1002/(SICI)1097-4644(19990201)72:2<286::AID-JCB13>3.0.CO;2-4; Kau MM, 1999, J CELL BIOCHEM, V73, P137, DOI 10.1002/(SICI)1097-4644(19990401)73:1<137::AID-JCB15>3.0.CO;2-7; KELLY KP, 1995, MED SCI SPORT EXER, V27, P65; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Lee TH, 2008, J ETHNOPHARMACOL, V116, P518, DOI 10.1016/j.jep.2007.12.019; Lin H, 2001, J CELL BIOCHEM, V83, P147, DOI 10.1002/jcb.1213; LIN YS, 1995, MED SCI SPORT EXER, V27, P73; Lo MJ, 1998, AM J PHYSIOL-ENDOC M, V274, pE238, DOI 10.1152/ajpendo.1998.274.2.E238; Lu SS, 1997, MED SCI SPORT EXER, V29, P1048, DOI 10.1097/00005768-199708000-00010; MAHER JT, 1975, J APPL PHYSIOL, V39, P18; Meier RK, 2012, ENDOCRINOLOGY, V153, P1256, DOI 10.1210/en.2011-1744; MELIN B, 1980, EUR J APPL PHYSIOL O, V44, P141, DOI 10.1007/BF00421092; Moura LZ, 2010, ARQ BRAS CARDIOL, V95, P381, DOI 10.1590/S0066-782X2010005000110; Oopik V, 2010, APPL PHYSIOL NUTR ME, V35, P278, DOI 10.1139/H10-018; Otis M, 2007, MOL CELL ENDOCRINOL, V265, P126, DOI 10.1016/j.mce.2006.12.008; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pu H.F., 2012, ADAPT MED, V4, P245; QUINN SJ, 1988, ANNU REV PHYSIOL, V50, P409, DOI 10.1146/annurev.ph.50.030188.002205; Ragnarsson O, 2013, EUR J ENDOCRINOL, V168, P243, DOI 10.1530/EJE-12-0873; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Sharp RL, 2006, J AM COLL NUTR, V25, p231S, DOI 10.1080/07315724.2006.10719572; Steel R, 1960, PRINCIPLES PROCEDURE, P86; Thrivikraman KV, 2002, BRAIN RES PROTOC, V10, P84, DOI 10.1016/S1385-299X(02)00185-X; Wang GJ, 2007, J ETHNOPHARMACOL, V112, P221, DOI 10.1016/j.jep.2007.02.025; WHITE PC, 1994, NEW ENGL J MED, V331, P250; WHITEHOUSE BJ, 1994, J MOL ENDOCRINOL, V12, P195, DOI 10.1677/jme.0.0120195; Williams JS, 2003, J CLIN ENDOCR METAB, V88, P2364, DOI 10.1210/jc.2003-030490	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e87080	10.1371/journal.pone.0087080	http://dx.doi.org/10.1371/journal.pone.0087080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289701	gold, Green Submitted, Green Published			2022-12-27	WOS:000342798000001
J	Liu, CH; Liu, W; Feng, ZB; Li, DM				Liu, Chunhong; Liu, Wen; Feng, Zhibiao; Li, Dongmei			Aggregation of Whey Protein Hydrolysate Using Alcalase 2.4 L	PLOS ONE			English	Article							PLASTEIN REACTION; INFRARED-SPECTROSCOPY; SOY PROTEIN; MECHANISM; GLYCININ; PAPAIN; PH	Here, we describe peptide aggregation, which is also known as enzymatic protein resynthesis. Whey protein hydrolysate (WPH) is the starting material for assembling peptides. Analyses of the involved amino acids, intrinsic fluorescence, fluorescence phase diagram, secondary structure, turbidity, and surface hydrophobicity were performed to investigate the reaction process. The aggregation mechanism consists of two parts: 1) formation and 2) aggregation of the building blocks that form the ordered secondary beta-sheet structure. Constructing the building blocks requires at least one intermediate state, which is formed after 0.5 hours. Non-synergistic changes in the secondary and tertiary structures then allow the intermediate state to emerge.	[Liu, Chunhong; Liu, Wen; Feng, Zhibiao; Li, Dongmei] Northeast Agr Univ, Dept Appl Chem, Coll Sci, Harbin, Peoples R China	Northeast Agricultural University - China	Feng, ZB (corresponding author), Northeast Agr Univ, Dept Appl Chem, Coll Sci, Harbin, Peoples R China.	fengzhibiao@neau.edu.cn	feng, zhibiao/G-4594-2018; Liu, Chunhong/ABB-2942-2021	feng, zhibiao/0000-0001-5553-1077; 	Youth Natural Science Fund of Heilongjiang Province, China [QC2010029]; Science Fund of NEAU	Youth Natural Science Fund of Heilongjiang Province, China; Science Fund of NEAU	Funding was provided by the Youth Natural Science Fund of Heilongjiang Province, China (Project No: QC2010029), and the Science Fund of NEAU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott TP, 1996, J AGR FOOD CHEM, V44, P2220, DOI 10.1021/jf950340h; ANDREWS AT, 1990, FOOD CHEM, V35, P243, DOI 10.1016/0308-8146(90)90015-V; [Anonymous], 1994, DET AM AC FOODS; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Arternova NV, 2008, BIOCHEM BIOPH RES CO, V377, P595, DOI 10.1016/j.bbrc.2008.10.015; BYLER DM, 1988, J IND MICROBIOL, V3, P73, DOI 10.1007/BF01569549; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; da Costa EL, 2007, INT DAIRY J, V17, P632, DOI 10.1016/j.idairyj.2006.09.003; EDWARDS JH, 1978, J FOOD SCI, V43, P1215, DOI 10.1111/j.1365-2621.1978.tb15272.x; Graveland-Bikker JF, 2006, NANO LETT, V6, P616, DOI 10.1021/nl052205h; Guo J, 2012, J AGR FOOD CHEM, V60, P3782, DOI 10.1021/jf300409y; Gustot A, 2013, CELL MOL LIFE SCI, V70, P2999, DOI 10.1007/s00018-012-1245-5; Imm JY, 1999, J AGR FOOD CHEM, V47, P2360, DOI 10.1021/jf9811020; JACKSON M, 1991, BIOCHEMISTRY-US, V30, P9681, DOI 10.1021/bi00104a016; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Milto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068684; Otte J, 1997, J AGR FOOD CHEM, V45, P4889, DOI 10.1021/jf9704571; Ringgenberg E, 2013, FOOD HYDROCOLLOID, V30, P463, DOI 10.1016/j.foodhyd.2012.05.011; Stevenson DE, 1998, ENZYME MICROB TECH, V22, P100, DOI 10.1016/S0141-0229(97)00135-X; Streets AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054541; SUKAN G, 1982, J DAIRY RES, V49, P279, DOI 10.1017/S0022029900022378; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Synowiecki J, 1996, FOOD CHEM, V57, P435, DOI 10.1016/S0308-8146(96)00005-2; Vonhoff S, 2010, J PHARMACEUT BIOMED, V51, P39, DOI 10.1016/j.jpba.2009.07.031; YAMASHITA M, 1979, J AGR FOOD CHEM, V27, P52, DOI 10.1021/jf60221a045; YAMASHITA M, 1975, J AGR FOOD CHEM, V23, P27, DOI 10.1021/jf60197a027; Yuan Y, 2013, LWT-FOOD SCI TECHNOL, V50, P657, DOI 10.1016/j.lwt.2012.07.034	28	4	5	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109439	10.1371/journal.pone.0109439	http://dx.doi.org/10.1371/journal.pone.0109439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290460	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000061
J	Wang, WM; Luo, JQ; Xiang, F; Liu, XT; Jiang, ML; Liao, LJ; Hu, JY				Wang, Wenmeng; Luo, Junqing; Xiang, Fang; Liu, Xueting; Jiang, Manli; Liao, Lingjuan; Hu, Jinyue			Nucleolin Down-Regulation Is Involved in ADP-Induced Cell Cycle Arrest in S Phase and Cell Apoptosis in Vascular Endothelial Cells	PLOS ONE			English	Article							BCL-2 MESSENGER-RNA; G-RICH OLIGONUCLEOTIDES; PROTEIN-KINASE PATHWAYS; NUCLEOTIDE RECEPTORS; EXTRACELLULAR NUCLEOTIDES; NASOPHARYNGEAL CARCINOMA; SURFACE NUCLEOLIN; PLATELET-FUNCTION; P2Y(12) RECEPTOR; LEUKEMIA-CELLS	High concentration of extracellular ADP has been reported to induce cell apoptosis, but the molecular mechanisms remain not fully elucidated. In this study, we found by serendipity that ADP treatment of human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC) down-regulated the protein level of nucleolin in a dose- and time-dependent manner. ADP treatment did not decrease the transcript level of nucloelin, suggesting that ADP might induce nucleolin protein degradation. HUVEC and HAEC expressed ADP receptor P2Y13 receptor, but did not express P2Y1 or P2Y12 receptors. However, P2Y1, 12, 13 receptor antagonists MRS2179, PSB0739, MRS2211 did not inhibit ADP-induced down-regulation of nucleolin. Moreover, MRS2211 itself down-regulated nucleolin protein level. In addition, 2-MeSADP, an agonist for P2Y1, 12 and 13 receptors, did not down-regulate nucleolin protein. These results suggested that ADP-induced nucleolin down-regulation was not due to the activation of P2Y1, 12, or 13 receptors. We also found that ADP treatment induced cell cycle arrest in S phase, cell apoptosis and cell proliferation inhibition via nucleolin down-regulation. The overexpression of nucleolin by gene transfer partly reversed ADP-induced cell cycle arrest, cell apoptosis and cell proliferation inhibition. Furthermore, ADP sensitized HUVEC to cisplatin-induced cell death by the down-regulation of Bcl-2 expression. Taken together, we found, for the first time to our knowledge, a novel mechanism by which ADP regulates cell proliferation by induction of cell cycle arrest and cell apoptosis via targeting nucelolin.	[Wang, Wenmeng; Luo, Junqing; Xiang, Fang] Hunan Armed Police Forces Hosp, Dept Internal Med, Changsha, Hunan, Peoples R China; [Wang, Wenmeng; Liu, Xueting; Jiang, Manli; Liao, Lingjuan; Hu, Jinyue] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China		Hu, JY (corresponding author), Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.	jinyueh@yahoo.com			National Natural Science Foundation of China [81172042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81172042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Amisten S, 2010, DIABETOLOGIA, V53, P1927, DOI 10.1007/s00125-010-1807-8; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Battista AG, 2009, J NEUROCHEM, V111, P600, DOI 10.1111/j.1471-4159.2009.06352.x; Ben Addi A, 2010, J IMMUNOL, V185, P5900, DOI 10.4049/jimmunol.0901799; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; Cancio-Lonches C, 2011, J VIROL, V85, P8056, DOI 10.1128/JVI.01878-10; Czajkowski R, 2004, BRIT J PHARMACOL, V141, P497, DOI 10.1038/sj.bjp.0705639; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; Gachet C, 1997, THROMB HAEMOSTASIS, V78, P271; Ginisty H, 1999, J CELL SCI, V112, P761; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Kudirka JC, 2007, J CELL PHYSIOL, V213, P54, DOI 10.1002/jcp.21087; Lee YH, 2010, J CELL SCI, V123, P1634, DOI 10.1242/jcs.063545; Lv QS, 2012, MOLECULES, V17, P3599, DOI 10.3390/molecules17043599; Lyubchenko T, 2011, AM J PHYSIOL-CELL PH, V300, pC266, DOI 10.1152/ajpcell.00237.2010; Maaser K, 2002, BRIT J CANCER, V86, P636, DOI 10.1038/sj.bjc.6600100; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Otake Y, 2005, MOL PHARMACOL, V67, P319, DOI 10.1124/mol.104.006080; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Rong WF, 2003, J NEUROSCI, V23, P11315; Sagou K, 2010, J VIROL, V84, P2110, DOI 10.1128/JVI.02007-09; Schafer R, 2006, FEBS J, V273, P3756, DOI 10.1111/j.1742-4658.2006.05384.x; Schwartz TR, 2008, OLIGONUCLEOTIDES, V18, P51, DOI 10.1089/oli.2007.0109; Sellers LK, 2001, J BIOL CHEM, V276, P16379, DOI 10.1074/jbc.M006617200; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; Song QB, 2013, INT IMMUNOPHARMACOL, V16, P148, DOI 10.1016/j.intimp.2013.03.034; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Strang BL, 2010, J VIROL, V84, P1771, DOI 10.1128/JVI.01510-09; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Tan CY, 2010, CELL MOL LIFE SCI, V67, P445, DOI 10.1007/s00018-009-0191-3; Tayyari F, 2011, NAT MED; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Vitolo OV, 1998, BRAIN RES, V809, P297, DOI 10.1016/S0006-8993(98)00713-6; von Albertini M, 1998, BIOCHEM BIOPH RES CO, V248, P822, DOI 10.1006/bbrc.1998.9055; WANG DJ, 1992, J CELL PHYSIOL, V153, P221, DOI 10.1002/jcp.1041530202; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Watanabe T, 2010, BIOL PHARM BULL, V33, P796, DOI 10.1248/bpb.33.796; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Zhang Y, 2009, CANCER BIOL THER, V8, P1826, DOI 10.4161/cbt.8.19.9437; Zhuo W, 2010, J PATHOL, V222, P249, DOI 10.1002/path.2760	55	12	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e110101	10.1371/journal.pone.0110101	http://dx.doi.org/10.1371/journal.pone.0110101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290311	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000103
J	Wanrooij, K; Boersma, P; van Zuijen, TL				Wanrooij, Karin; Boersma, Paul; van Zuijen, Titia L.			Distributional Vowel Training Is Less Effective for Adults than for Infants. A Study Using the Mismatch Response	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; PHONEME REPRESENTATIONS; SELECTIVE-ATTENTION; SPEECH-PERCEPTION; LEARNING PHONEMES; BRAIN RESPONSES; 1ST YEAR; NEGATIVITY; MATURATION; WORDS	Distributional learning of speech sounds (i.e., learning from simple exposure to frequency distributions of speech sounds in the environment) has been observed in the lab repeatedly in both infants and adults. The current study is the first attempt to examine whether the capacity for using the mechanism is different in adults than in infants. To this end, a previous even-trelated potential study that had shown distributional learning of the English vowel contrast /ae/similar to/epsilon/ in 2-to-3-month old Dutch infants was repeated with Dutch adults. Specifically, the adults were exposed to either a bimodal distribution that suggested the existence of the two vowels (as appropriate in English), or to a unimodal distribution that did not (as appropriate in Dutch). After exposure the participants were tested on their discrimination of a representative [ae] and a representative [epsilon], in an oddball paradigm for measuring mismatch responses (MMRs). Bimodally trained adults did not have a significantly larger MMR amplitude, and hence did not show significantly better neural discrimination of the test vowels, than unimodally trained adults. A direct comparison between the normalized MMR amplitudes of the adults with those of the previously tested infants showed that within a reasonable range of normalization parameters, the bimodal advantage is reliably smaller in adults than in infants, indicating that distributional learning is a weaker mechanism for learning speech sounds in adults (if it exists in that group at all) than in infants.	[Wanrooij, Karin; Boersma, Paul] Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands; [van Zuijen, Titia L.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Wanrooij, K (corresponding author), Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands.	karin.wanrooij@uva.nl	van Zuijen, Titia/F-5063-2012	van Zuijen, Titia/0000-0002-2578-4396; Wanrooij, Karin/0000-0002-9247-9850	Netherlands Organization for Scientific Research [277.70.008]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by grant 277.70.008 from the Netherlands Organization for Scientific Research (http://www.nwo.nl/en) awarded to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN O, 1987, BIOL PSYCHOL, V24, P197, DOI 10.1016/0301-0511(87)90002-0; Aaltonen O, 1997, J ACOUST SOC AM, V101, P1090, DOI 10.1121/1.418031; Adank P, 2004, J ACOUST SOC AM, V116, P1729, DOI 10.1121/1.1779271; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Boersma P., 2014, PRAAT DOING PHONETIC; Broersma M, 2005, J ACOUST SOC AM, V117, P3890, DOI 10.1121/1.1906060; Capel D. J. H., 2011, SOUND SOUNDS STUDIES, P33; Carral V, 2005, EUR J NEUROSCI, V21, P3201, DOI 10.1111/j.1460-9568.2005.04144.x; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Cheour M, 1998, INT J PSYCHOPHYSIOL, V29, P217, DOI 10.1016/S0167-8760(98)00017-8; Cheour M, 2002, SCAND J PSYCHOL, V43, P33, DOI 10.1111/1467-9450.00266; Cheour M, 1997, DEV NEUROPSYCHOL, V13, P167, DOI 10.1080/87565649709540676; CHEOURLUHTANEN M, 1995, HEARING RES, V82, P53, DOI 10.1016/0378-5955(94)00164-L; Dehaene-Lambertz G, 2000, J COGNITIVE NEUROSCI, V12, P449, DOI 10.1162/089892900562264; Dehaene-Lambertz G, 1998, NEUROREPORT, V9, P1885, DOI 10.1097/00001756-199806010-00040; Escudero P, 2008, J PHONETICS, V36, P345, DOI 10.1016/j.wocn.2007.11.002; Escudero P, 2011, J ACOUST SOC AM, V130, pEL206, DOI 10.1121/1.3629144; Escudero P, 2010, LANG SPEECH, V53, P343, DOI 10.1177/0023830910371447; Fikkert P., 2010, LAB PHONOLOGY10 VARI, P227, DOI DOI 10.1515/9783110224917.3.227; Friederici AD, 2002, NEUROREPORT, V13, P1251, DOI 10.1097/00001756-200207190-00006; Friedrich M, 2004, PSYCHOPHYSIOLOGY, V41, P772, DOI 10.1111/j.1469-8986.2004.00202.x; Guenther FH, 1996, J ACOUST SOC AM, V100, P1111, DOI 10.1121/1.416296; Gulian M., 2007, P INT C PHON SCI SAA; Halle PA, 1996, INFANT BEHAV DEV, V19, P463, DOI 10.1016/S0163-6383(96)90007-7; Hawkins S., 2005, J INT PHON ASSOC, V35, P183, DOI DOI 10.1017/S0025100305002124; Hayes-Harb R, 2007, SECOND LANG RES, V23, P65, DOI 10.1177/0267658307071601; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; JAMIESON DG, 1986, PERCEPT PSYCHOPHYS, V40, P205, DOI 10.3758/BF03211500; Jusczyk PW, 1997, SCIENCE, V277, P1984, DOI 10.1126/science.277.5334.1984; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kondaurova MV, 2010, J PHONETICS, V38, P569, DOI 10.1016/j.wocn.2010.08.003; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kraus N, 1999, J SPEECH LANG HEAR R, V42, P1042, DOI 10.1044/jslhr.4205.1042; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kushnerenko E, 2002, NEUROREPORT, V13, P47, DOI 10.1097/00001756-200201210-00014; Kushnerenko E., 2003, THESIS U HELSINKI; Lacerda F., 1995, P 13 INT C PHON SCI, V2, P140; Lahiri A, 2010, J PHONETICS, V38, P44, DOI 10.1016/j.wocn.2010.01.002; Leussen van J. W., 2011, P 17 INT C PHON SCI, P1194; Martynova O, 2003, NEUROSCI LETT, V340, P75, DOI 10.1016/S0304-3940(02)01401-5; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Maye J, 2001, PROC ANN BUCLD, P480; Maye J, 2000, PROC ANN BUCLD, P522; Maye J, 2008, DEVELOPMENTAL SCI, V11, P122, DOI 10.1111/j.1467-7687.2007.00653.x; Moore JK, 2007, INT J AUDIOL, V46, P460, DOI 10.1080/14992020701383019; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7, DOI 10.1177/00034894021110S502; Moore JK, 2001, JARO-J ASSOC RES OTO, V2, P297, DOI 10.1007/s101620010052; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R., 2018, ATTENTION BRAIN FUNC; Pakarinen S, 2009, BIOL PSYCHOL, V82, P219, DOI 10.1016/j.biopsycho.2009.07.008; Pang EW, 1998, INT J PSYCHOPHYSIOL, V29, P227, DOI 10.1016/S0167-8760(98)00018-X; Partanen E, 2013, CLIN NEUROPHYSIOL, V124, P1578, DOI 10.1016/j.clinph.2013.02.014; Polka L, 1996, J ACOUST SOC AM, V100, P577, DOI 10.1121/1.415884; Polka L, 2003, SPEECH COMMUN, V41, P221, DOI 10.1016/S0167-6393(02)00105-X; Pons F, 2006, J EXP PSYCHOL ANIM B, V32, P97, DOI 10.1037/0097-7403.32.1.97; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Roelfsema PR, 2011, SCIENCE, V332, P1512, DOI 10.1126/science.1208564; Schouten M. E. H., 1975, THESIS UTRECHT U; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; Shafer VL, 2011, J PHONETICS, V39, P527, DOI 10.1016/j.wocn.2010.11.010; van Zuijen TL, 2013, DEVELOPMENTAL SCI, V16, P554, DOI 10.1111/desc.12049; Wanrooij K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00077; Wanrooij K, 2013, J PHONETICS, V41, P307, DOI 10.1016/j.wocn.2013.03.005; Wanrooij K, 2013, J ACOUST SOC AM, V133, pEL398, DOI 10.1121/1.4798618; Weber A, 2004, J MEM LANG, V50, P1, DOI 10.1016/S0749-596X(03)00105-0; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; Werner LA, 1996, EAR HEARING, V17, P438, DOI 10.1097/00003446-199610000-00010; WERNER LA, 1990, INFANT BEHAV DEV, V13, P355, DOI 10.1016/0163-6383(90)90040-F; Winkler I, 1999, COGNITIVE BRAIN RES, V7, P357, DOI 10.1016/S0926-6410(98)00039-1; Yoshida KA, 2010, INFANCY, V15, P420, DOI 10.1111/j.1532-7078.2009.00024.x	78	17	17	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109806	10.1371/journal.pone.0109806	http://dx.doi.org/10.1371/journal.pone.0109806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ4VK	25289935	gold, Green Published, Green Submitted			2022-12-27	WOS:000342798000090
J	Yang, ES; Jin, MU; Hong, JH; Kim, YS; Choi, SY; Kim, TH; Cho, YS; Bae, YC				Yang, Eun Sun; Jin, Myoung Uk; Hong, Jae Hyun; Kim, Yun Sook; Choi, So Young; Kim, Tae Heon; Cho, Yi Sul; Bae, Yong Chul			Expression of Vesicular Glutamate Transporters VGLUT1 and VGLUT2 in the Rat Dental Pulp and Trigeminal Ganglion following Inflammation	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; DORSAL-ROOT GANGLIA; PRIMARY AFFERENT NEURONS; GENE-RELATED PEPTIDE; SPINAL-CORD; TOOTH-PULP; MECHANICAL ALLODYNIA; MUSTARD-OIL; SUBSTANCE-P; RELEASE	Background: There is increasing evidence that peripheral glutamate signaling mechanism is involved in the nociceptive transmission during pathological conditions. However, little is known about the glutamate signaling mechanism and related specific type of vesicular glutamate transporter (VGLUT) in the dental pulp following inflammation. To address this issue, we investigated expression and protein levels of VGLUT1 and VGLUT2 in the dental pulp and trigeminal ganglion (TG) following complete Freund's adjuvant (CFA) application to the rat dental pulp by light microscopic immunohistochemistry and Western blot analysis. Results: The density of VGLUT2-immunopositive (+) axons in the dental pulp and the number of VGLUT2+ soma in the TG increased significantly in the CFA-treated group, compared to control group. The protein levels of VGLUT2 in the dental pulp and TG were also significantly higher in the CFA-treated group than control group by Western blot analysis. The density of VGLUT1+ axons in the dental pulp and soma in the TG remained unchanged in the CFA-treated group. Conclusions: These findings suggest that glutamate signaling that is mediated by VGLUT2 in the pulpal axons may be enhanced in the inflamed dental pulp, which may contribute to pulpal axon sensitization leading to hyperalgesia following inflammation.	[Yang, Eun Sun; Jin, Myoung Uk; Hong, Jae Hyun; Kim, Yun Sook; Choi, So Young; Kim, Tae Heon; Cho, Yi Sul; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea	Kyungpook National University	Bae, YC (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea.	ycbae@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012-0009328]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-0009328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Beirith A, 2002, BRAIN RES, V924, P219, DOI 10.1016/S0006-8993(01)03240-1; Bereiter DA, 1996, PAIN, V67, P451, DOI 10.1016/0304-3959(96)03156-9; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; BYERS MR, 1984, INT REV NEUROBIOL, V25, P39, DOI 10.1016/S0074-7742(08)60677-7; Chiang CY, 1998, J NEUROPHYSIOL, V80, P2621, DOI 10.1152/jn.1998.80.5.2621; Chiang CY, 2005, J NEUROPHYSIOL, V94, P1751, DOI 10.1152/jn.00223.2005; Curi TCP, 1997, AM J PHYSIOL-CELL PH, V273, pC1124, DOI 10.1152/ajpcell.1997.273.4.C1124; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; Du JH, 2001, PAIN, V89, P187, DOI 10.1016/S0304-3959(00)00362-6; Fehrenbacher JC, 2009, PAIN, V144, P253, DOI 10.1016/j.pain.2009.03.027; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; FRIED K, 1988, BRAIN RES, V463, P118, DOI 10.1016/0006-8993(88)90533-1; FRIED K, 1989, NEUROSCIENCE, V33, P101, DOI 10.1016/0306-4522(89)90314-X; Fried K, 2011, PAIN, V152, P2685, DOI 10.1016/j.pain.2011.08.004; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; HILDEBRAND C, 1995, PROG NEUROBIOL, V45, P165, DOI 10.1016/0301-0082(94)00045-J; HOLZER P, 1988, NEUROSCIENCE, V24, P739, DOI 10.1016/0306-4522(88)90064-4; JACKSON DL, 1995, EUR J PHARMACOL, V284, P321, DOI 10.1016/0014-2999(95)00449-U; Jackson DL, 1999, J DENT RES, V78, P54, DOI 10.1177/00220345990780010801; Jean YH, 2008, OSTEOARTHR CARTILAGE, V16, P1442, DOI 10.1016/j.joca.2008.04.008; Jin YH, 2006, NEUROSCIENCE, V138, P1329, DOI 10.1016/j.neuroscience.2005.12.049; Klegeris A, 1997, J NEUROSCI RES, V49, P229, DOI 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W; Kumar N, 2013, NEUROCHEM INT, V62, P831, DOI 10.1016/j.neuint.2013.02.022; Lagerstrom MC, 2011, P NATL ACAD SCI USA, V108, P5789, DOI 10.1073/pnas.1013602108; Landry M, 2004, J COMP NEUROL, V468, P380, DOI 10.1002/cne.10988; Lawand NB, 2000, PAIN, V86, P69, DOI 10.1016/S0304-3959(99)00311-5; Leo S, 2009, EUR J PAIN, V13, P1008, DOI 10.1016/j.ejpain.2008.12.001; Li JL, 2003, J COMP NEUROL, V463, P212, DOI 10.1002/cne.10755; Li JL, 2003, J COMP NEUROL, V457, P236, DOI 10.1002/cne.10556; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; LOUIS SM, 1989, NEUROSCI LETT, V102, P257, DOI 10.1016/0304-3940(89)90088-8; Malet M, 2013, NEUROSCIENCE, V248, P95, DOI 10.1016/j.neuroscience.2013.05.044; MARFURT CF, 1984, J COMP NEUROL, V223, P535, DOI 10.1002/cne.902230406; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; Narita N, 2012, NEUROSCIENCE, V218, P359, DOI 10.1016/j.neuroscience.2012.05.016; Omote K, 1998, BRAIN RES, V787, P161, DOI 10.1016/S0006-8993(97)01568-0; Paik SK, 2009, NEUROSCIENCE, V162, P1279, DOI 10.1016/j.neuroscience.2009.05.046; Paik SK, 2012, J ENDODONT, V38, P470, DOI 10.1016/j.joen.2011.12.012; PARPURA V, 1995, J NEUROSCI, V15, P5831; PRIGENT AF, 1990, EUR J CLIN INVEST, V20, P323, DOI 10.1111/j.1365-2362.1990.tb01864.x; Rogoz K, 2012, PAIN, V153, P1525, DOI 10.1016/j.pain.2012.04.017; Scherrer G, 2010, P NATL ACAD SCI USA, V107, P22296, DOI 10.1073/pnas.1013413108; Scott A, 2008, J ORTHOP RES, V26, P685, DOI 10.1002/jor.20536; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Spang C, 2012, INFLAMMATION, V35, P39, DOI 10.1007/s10753-010-9287-z; SUGIMOTO T, 1988, PAIN, V32, P375, DOI 10.1016/0304-3959(88)90050-4; Svensson P, 2003, PAIN, V101, P221, DOI 10.1016/S0304-3959(02)00079-9; Takeda M, 2005, PAIN, V116, P375, DOI 10.1016/j.pain.2005.05.007; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yasuda M, 2012, NEUROSCI LETT, V528, P67, DOI 10.1016/j.neulet.2012.08.067	53	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109723	10.1371/journal.pone.0109723	http://dx.doi.org/10.1371/journal.pone.0109723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290694	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000083
J	Zhang, YX; Cai, W; Song, JM; Miao, L; Zhang, B; Xu, Q; Zhang, LJ; Yao, H				Zhang, Yuexin; Cai, Wen; Song, Jiangmei; Miao, Lei; Zhang, Bei; Xu, Qin; Zhang, Lijuan; Yao, Hua			Association between the PNPLA3 I148M Polymorphism and Non-Alcoholic Fatty Liver Disease in the Uygur and Han Ethnic Groups of Northwestern China	PLOS ONE			English	Article							HEPATIC STEATOSIS; GENETIC-VARIATION; SUSCEPTIBILITY; POPULATION; RISK; PREVALENCE; RS738409	Objective: Multiple common gene variants play a role in non-alcoholic fatty liver disease (NAFLD) susceptibility. Our goal was to investigate the association between variants polymorphisms and NAFLD in the Uygur and Han from Northwestern China. Methods: Eight tag single nucleotide polymorphisms (tSNPs) previously reported to be associated with NAFLD were characterized in 396 NAFLD individuals and 399 controls. The association of variants with NAFLD in the Uygur and Han was assessed using the chi-squared (chi(2)) test in different gene models. Unconditional logistic regression analysis was performed to obtain the odds ratios (ORs) for risk of NAFLD and their 95% confidence intervals (CI), adjusted for confounding factors. Finally, stratified analysis was used to explore the potential gene-environment interactions on the risk of NAFLD. Results: In a recessive model, we found a potential association between rs738409 and NAFLD in both ethnic groups: Chinese Han (OR = 1.84, 95% CI: 1.03-3.27, p = 0.036), Uygur (OR = 2.25, 95% CI: 1.23-4.09, p = 0.006). The multiple logistic regression revealed that PNPLA3 rs738409 GG genotype may increase the risk of NAFLD by adjusting some confounding factors: Han (OR = 5.22, 95% CI: 1.94-14.04, p = 0.001), Uygur (OR = 4.29, 95% CI: 1.60-11.48, p = 0.004). Stratified analysis found that rs738409 polymorphism appeared to have interaction with sex, smoking status in Uygur, and have interaction with sex, age, BMI stage, lifestyle in Han. Conclusion: Our data suggest the PNPLA3 I148M polymorphism influences susceptibility to NAFLD in the Han and Uygur of Northwestern China.	[Zhang, Yuexin; Song, Jiangmei; Xu, Qin; Zhang, Lijuan] Xinjiang Med Univ, Ctr Infect Dis, Affiliated Hosp 1, Urumqi, Peoples R China; [Cai, Wen] Xinjiang Med Univ, Sch Nursing, Urumqi, Peoples R China; [Miao, Lei] Xinjiang Med Univ, Sch Publ Hlth, Urumqi, Peoples R China; [Zhang, Bei] Xinjiang Med Univ, Sch Basic Med, Urumqi, Peoples R China; [Yao, Hua] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Yao, H (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China.	huayao1959@163.com	Zhang, Li/GWM-7501-2022		National Key Basic Research and Development Program (973 Program) of China [2012CB722403]; National Natural Science Foundation of China [81160115]	National Key Basic Research and Development Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The sources of funding are National Key Basic Research and Development Program (also called the 973 Program) of China (No. 2012CB722403) and the National Natural Science Foundation of China (No. 81160115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Charatcharoenwitthaya Phunchai, 2007, Clin Liver Dis, V11, P37, DOI 10.1016/j.cld.2007.02.014; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Cox AJ, 2011, DIABETES METAB, V37, P452, DOI 10.1016/j.diabet.2011.05.001; Fan JG, 2007, HEPATOB PANCREAT DIS, V6, P572; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Hyysalo J, 2012, J GASTROEN HEPATOL, V27, P951, DOI 10.1111/j.1440-1746.2011.07045.x; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Li YL, 2012, HEPATOLOGY, V55, P327, DOI 10.1002/hep.24659; Lin YC, 2011, J PEDIATR-US, V158, P740, DOI 10.1016/j.jpeds.2010.11.016; Liu Pengju, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P53, DOI 10.3760/cma.j.issn.1007-3418.2014.01.012; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Mottin CC, 2004, OBES SURG, V14, P635, DOI 10.1381/096089204323093408; Niu TH, 2014, WORLD J GASTROENTERO, V20, P3655, DOI 10.3748/wjg.v20.i13.3655; Peng XE, 2014, LIVER INT, V34, P118, DOI 10.1111/liv.12220; Peng XE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050256; Pirazzi C, 2012, J HEPATOL, V57, P1276, DOI 10.1016/j.jhep.2012.07.030; Rae-Whitcombe SM, 2010, BIOCHEM BIOPH RES CO, V402, P767, DOI 10.1016/j.bbrc.2010.10.106; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Romero-Gomez M, 2011, J HEPATOL, V55, P1184, DOI 10.1016/j.jhep.2011.06.003; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Zhou YJ, 2010, J GASTROEN HEPATOL, V25, P772, DOI 10.1111/j.1440-1746.2009.06144.x	28	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108381	10.1371/journal.pone.0108381	http://dx.doi.org/10.1371/journal.pone.0108381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290313	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000016
J	Habauzit, D; Le Quement, C; Zhadobov, M; Martin, C; Aubry, M; Sauleau, R; Le Drean, Y				Habauzit, Denis; Le Quement, Catherine; Zhadobov, Maxim; Martin, Catherine; Aubry, Marc; Sauleau, Ronan; Le Drean, Yves			Transcriptome Analysis Reveals the Contribution of Thermal and the Specific Effects in Cellular Response to Millimeter Wave Exposure	PLOS ONE			English	Article							T-CELL; GENE-EXPRESSION; MOBILE PHONES; BRAIN-TUMORS; CYCLOPHOSPHAMIDE; GHZ; METALLOPROTEINASES; RISK	Radiofrequency radiations constitute a new form of environmental pollution. Among them, millimeter waves (MMW) will be widely used in the near future for high speed communication systems. This study aimed therefore to evaluate the biocompatibility of MMW at 60 GHz. For this purpose, we used a whole gene expression approach to assess the effect of acute 60 GHz exposure on primary cultures of human keratinocytes. Controls were performed to dissociate the electromagnetic from the thermal effect of MMW. Microarray data were validated by RT-PCR, in order to ensure the reproducibility of the results. MMW exposure at 20 mW/cm(2), corresponding to the maximum incident power density authorized for public use (local exposure averaged over 1 cm(2)), led to an increase of temperature and to a strong modification of keratinocyte gene expression (665 genes differentially expressed). Nevertheless, when temperature is artificially maintained constant, no modification in gene expression was observed after MMW exposure. However, a heat shock control did not mimic exactly the MMW effect, suggesting a slight but specific electromagnetic effect under hyperthermia conditions (34 genes differentially expressed). By RT-PCR, we analyzed the time course of the transcriptomic response and 7 genes have been validated as differentially expressed: ADAMTS6, NOG, IL7R, FADD, JUNB, SNAI2 and HIST1H1A. Our data evidenced a specific electromagnetic effect of MMW, which is associated to the cellular response to hyperthermia. This study raises the question of co-exposures associating radiofrequencies and other environmental sources of cellular stress.	[Habauzit, Denis; Le Quement, Catherine; Martin, Catherine; Le Drean, Yves] Univ Rennes 1, INSERM, IRSET Inst Res Environm & Occupat Hlth, Transcript Environm & Canc Grp,U1085, Rennes, France; [Zhadobov, Maxim; Sauleau, Ronan] Univ Rennes 1, IETR, UMR CNRS 6164, Rennes, France; [Aubry, Marc] Univ Rennes 1, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Rennes; Universite de Rennes	Le Drean, Y (corresponding author), Univ Rennes 1, INSERM, IRSET Inst Res Environm & Occupat Hlth, Transcript Environm & Canc Grp,U1085, Rennes, France.	yves.le-drean@univ-rennes1.fr	Martin, Catherine/K-1925-2015; Habauzit, Denis/K-1779-2015; Aubry, Marc/GNW-2661-2022; Le Dréan, Yves/L-4822-2015; Zhadobov, Maxim/P-6492-2016	Habauzit, Denis/0000-0001-8101-3839; Sauleau, Ronan/0000-0001-7510-9762; Zhadobov, Maxim/0000-0002-3809-110X	French National Research Agency (Agence Nationale de la Recherche, ANR) [09-RPDOC-003-01, 10-CESA-017-01]	French National Research Agency (Agence Nationale de la Recherche, ANR)(French National Research Agency (ANR))	This work was supported by the French National Research Agency (Agence Nationale de la Recherche, ANR), under grants number 09-RPDOC-003-01 (Bio-CEM project) and number 10-CESA-017-01 (BioREF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Alekseev SI, 2010, BIOELECTROMAGNETICS, V31, P180, DOI 10.1002/bem.20547; Ashbaugh JJ, 2013, J IMMUNOL, V190, P4525, DOI 10.4049/jimmunol.1203214; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Badot V, 2011, J CELL MOL MED, V15, P2335, DOI 10.1111/j.1582-4934.2010.01228.x; Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; Cardis E, 2011, OCCUP ENVIRON MED, V68, P631, DOI 10.1136/oemed-2011-100155; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Debouzy JC, 2007, PATHOL BIOL, V55, P246, DOI 10.1016/j.patbio.2006.02.006; Gonzalez-Garcia S, 2012, CURR TOP MICROBIOL, V360, P47, DOI 10.1007/82_2012_231; Hardell L, 2011, INT J EPIDEMIOL, V40, P1126, DOI 10.1093/ije/dyq246; Hardell Lennart, 2009, Pathophysiology, V16, P113, DOI 10.1016/j.pathophys.2009.01.003; IARC (International Agency for Research on Cancer), 2013, IARC MONOGRAPHS EVAL, V102; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Le Drean Y, 2013, CR PHYS, V14, P402, DOI 10.1016/j.crhy.2013.02.005; Le Quement C, 2012, BIOELECTROMAGNETICS, V33, P147, DOI 10.1002/bem.20693; Lee AS, 2013, GENE, V527, P440, DOI 10.1016/j.gene.2013.05.069; Logani MK, 2012, IMMUNOPHARM IMMUNOT, V34, P107, DOI 10.3109/08923973.2011.583252; Makar V, 2003, BIOELECTROMAGNETICS, V24, P356, DOI 10.1002/bem.10104; Makar VR, 2006, BIOELECTROMAGNETICS, V27, P458, DOI 10.1002/bem.20230; Makar VR, 2005, BIOELECTROMAGNETICS, V26, P10, DOI 10.1002/bem.20046; Millenbaugh NJ, 2008, RADIAT RES, V169, P288, DOI 10.1667/RR1121.1; Moulder JE, 2012, RADIAT RES, V177, P723, DOI 10.1667/RR2897.1; Nicolaz CN, 2009, BIOELECTROMAGNETICS, V30, P365, DOI 10.1002/bem.20481; Pellegrini A, 2013, IEEE ANTENN PROPAG M, V55, P262, DOI 10.1109/MAP.2013.6645205; Pongratz G, 2013, ANN RHEUM DIS; Przemyslaw L, 2013, BMB REP, V46, P139, DOI 10.5483/BMBRep.2013.46.3.176; Radzievsky AA, 2000, LIFE SCI, V66, P2101, DOI 10.1016/S0024-3205(00)00536-1; Ribeiro Daniel, 2013, Adv Biol Regul, V53, P211, DOI 10.1016/j.jbior.2012.10.005; Rifas L, 2007, J CELL BIOCHEM, V100, P824, DOI 10.1002/jcb.21132; Rojavin MA, 1998, QJM-MON J ASSOC PHYS, V91, P57, DOI 10.1093/qjmed/91.1.57; ROTKOVSKA D, 1993, ENVIRON HEALTH PERSP, V101, P134, DOI 10.2307/3431422; Sakurai T, 2011, J RADIAT RES, V52, P185, DOI 10.1269/jrr.10116; Swerdlow AJ, 2011, ENVIRON HEALTH PERSP, V119, P1534, DOI 10.1289/ehp.1103693; Usichenko TI, 2003, ACUPUNCTURE ELECTRO, V28, P11, DOI 10.3727/036012903815901723; Vo NV, 2013, SPINE J, V13, P331, DOI 10.1016/j.spinee.2012.02.027; Zhadobov M, 2007, BIOELECTROMAGNETICS, V28, P188, DOI 10.1002/bem.20285; Zhadobov M, 2012, BIOELECTROMAGNETICS, V33, P55, DOI 10.1002/bem.20685; Zhadobov M, 2011, INT J MICROW WIREL T, V3, P237, DOI 10.1017/S1759078711000122	39	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109435	10.1371/journal.pone.0109435	http://dx.doi.org/10.1371/journal.pone.0109435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302706	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400058
J	Heidrich, B; Wiegand, SB; Buggisch, P; Hinrichsen, H; Link, R; Moller, B; Boker, KHW; Teuber, G; Klinker, H; Zehnter, E; Naumann, U; Busch, HW; Maasoumy, B; Baum, U; Hardtke, S; Manns, MP; Wedemeyer, H; Petersen, J; Cornberg, M				Heidrich, Benjamin; Wiegand, Steffen B.; Buggisch, Peter; Hinrichsen, Holger; Link, Ralph; Moeller, Bernd; Boeker, Klaus H. W.; Teuber, Gerlinde; Klinker, Hartwig; Zehnter, Elmar; Naumann, Uwe; Busch, Heiner W.; Maasoumy, Benjamin; Baum, Undine; Hardtke, Svenja; Manns, Michael P.; Wedemeyer, Heiner; Petersen, Joerg; Cornberg, Markus		HepNet Study Grp	Treatment of Naive Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA	PLOS ONE			English	Article							PEGINTERFERON ALPHA-2B; HCV GENOTYPE-2; SOFOSBUVIR; EPIDEMIOLOGY	Evidence based clinical guidelines are implemented to treat patients efficiently that include efficacy, tolerability but also health economic considerations. This is of particular relevance to the new direct acting antiviral agents that have revolutionized treatment of chronic hepatitis C. For hepatitis C genotypes 2/3 interferon free treatment is already available with sofosbuvir plus ribavirin. However, treatment with sofosbuvir-based regimens is 10-20 times more expensive compared to pegylated interferon alfa and ribavirin (PegIFN/RBV). It has to be discussed if PegIFN/RBV is still an option for easy to treat patients. We assessed the treatment of patients with chronic hepatitis C genotypes 2/3 with PegIFN/RBV in a real world setting according to the latest German guidelines. Overall, 1006 patients were recruited into a prospective patient registry with 959 having started treatment. The intention-to-treat analysis showed poor SVR (GT2 61%, GT3 47%) while patients with adherence had excellent SVR in the per protocol analysis (GT2 96%, GT3 90%). According to guidelines, 283 patients were candidates for shorter treatment duration, namely a treatment of 16 weeks (baseline HCV-RNA <800.000 IU/mL, no cirrhosis and RVR). However, 65% of these easy to treat patients have been treated longer than recommended that resulted in higher costs but not higher SVR rates. In conclusion, treatment with PegIFN/RBV in a real world setting can be highly effective yet similar effective than PegIFN +/- sofosbuvir/RBV in well-selected naive G2/3 patients. Full adherence to guidelines could be further improved, because it would be important in the new era with DAA, especially to safe resources.	[Heidrich, Benjamin; Wiegand, Steffen B.; Maasoumy, Benjamin; Baum, Undine; Hardtke, Svenja; Manns, Michael P.; Wedemeyer, Heiner; Cornberg, Markus] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Heidrich, Benjamin; Wiegand, Steffen B.; Maasoumy, Benjamin; Baum, Undine; Hardtke, Svenja; Manns, Michael P.; Wedemeyer, Heiner; Cornberg, Markus] German Liver Fdn, HepNet Study House, Hannover, Germany; [Buggisch, Peter] German Ctr Infect Res DZIF, Braunschweig, Germany; [Hinrichsen, Holger] Gastroenterol Schwerpunkt Praxis, Kiel, Germany; [Link, Ralph] St Josefs Hosp, Offenburg, Germany; [Boeker, Klaus H. W.] Leberpraxis, Hannover, Germany; [Klinker, Hartwig] Univ Wurzburg, Dept Internal Med 2, D-97070 Wurzburg, Germany; [Naumann, Uwe] Praxiszentrum Kaiserdamm, Ctr Addiction Med Hepatol & HIV, Berlin, Germany	Hannover Medical School; German Center for Infection Research; University of Wurzburg	Cornberg, M (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Cornberg.Markus@mh-hannover.de	Klinker, Hartwig/AAC-1134-2021; Cornberg, Markus/AAN-6939-2021	Cornberg, Markus/0000-0002-9141-8001; Maasoumy, Benjamin/0000-0002-3250-3177	MSD Sharp Dohme GmbH; German Center for Infectious Disease Research (DZIF)	MSD Sharp Dohme GmbH; German Center for Infectious Disease Research (DZIF)	This registry was financially supported by MSD Sharp & Dohme GmbH (manufacturer of pegylated interferon alpha-2b) (http://www.msd.de/). The protocol and the contracts did not intend to influence the decision to treat patients with pegylated interferon alpha-2b. The HepNet study house of the German Liver Foundation, which was supported by the German Center for Infectious Disease Research (DZIF), coordinated and formally sponsored the registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD & IDSA, 2014, REC TEST MAN TREAT H; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Cornberg Markus, 2006, Expert Rev Anti Infect Ther, V4, P781, DOI 10.1586/14787210.4.5.781; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Dalgard O, 2008, HEPATOLOGY, V47, P35, DOI 10.1002/hep.21975; Dusheiko G, 2012, GUT, V61, P1647, DOI 10.1136/gutjnl-2012-302910; Hadziyannis SJ, 2004, HEPATOL RES, V29, P129, DOI 10.1016/j.hepres.2004.02.011; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Lawitz E, HEPATOL BALTIM MD, V58; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Maasoumy B, 2012, BEST PRACT RES CL GA, V26, P401, DOI 10.1016/j.bpg.2012.09.009; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Manns M, 2011, J HEPATOL, V55, P554, DOI 10.1016/j.jhep.2010.12.024; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; The price of good health, 2014, NAT MED, V20, P319, DOI [10.1038/nm.3538, DOI 10.1038/NM.3538/NM.3538]; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Zeuzem S, 2013, HEPATOLOGY, V58, p733A	21	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108751	10.1371/journal.pone.0108751	http://dx.doi.org/10.1371/journal.pone.0108751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302676	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400025
J	Al Dhaheri, Y; Attoub, S; Ramadan, G; Arafat, K; Bajbouj, K; Karuvantevida, N; AbuQamar, S; Eid, A; Iratni, R				Al Dhaheri, Yusra; Attoub, Samir; Ramadan, Gaber; Arafat, Kholoud; Bajbouj, Khuloud; Karuvantevida, Noushad; AbuQamar, Synan; Eid, Ali; Iratni, Rabah			Carnosol Induces ROS-Mediated Beclin1-Independent Autophagy and Apoptosis in Triple Negative Breast Cancer	PLOS ONE			English	Article							CELL-DEATH; DOWN-REGULATION; HISTONE H3; RESVERATROL; INDUCTION; MECHANISMS; EXPRESSION; P21	Background: In this study we investigated the in vitro and in vivo anticancer effect of carnosol, a naturally occurring polyphenol, in triple negative breast cancer. Results: We found that carnosol significantly inhibited the viability and colony growth induced G2 arrest in the triple negative MDA-MB-231. Blockade of the cell cycle was associated with increased p21/WAF1 expression and downregulation of p27. Interestingly, carnosol was found to induce beclin1-independent autophagy and apoptosis in MDA-MB-231 cells. The coexistence of both events, autophagy and apoptosis, was confirmed by electron micrography. Induction of autophagy was found to be an early event, detected within 3 h post-treatment, which subsequently led to apoptosis. Carnosol treatment also caused a dose-dependent increase in the levels of phosphorylated extracellular signal-regulated kinase 1 and 2 (pERK1/2). Moreover, we show that carnosol induced DNA damage, reduced the mitochondrial potential and triggered the activation of the intrinsic and extrinsic apoptotic pathway. Furthermore, we found that carnosol induced a dose-dependent generation of reactive oxygen species (ROS) and inhibition of ROS by tiron, a ROS scavenger, blocked the induction of autophagy and apoptosis and attenuated DNA damage. To our knowledge, this is the first report to identify the induction of autophagy by carnosol. Conclusion: In conclusion our findings provide strong evidence that carnosol may be an alternative therapeutic candidate against the aggressive form of breast cancer and hence deserves more exploration.	[Al Dhaheri, Yusra; Ramadan, Gaber; Bajbouj, Khuloud; Karuvantevida, Noushad; AbuQamar, Synan; Iratni, Rabah] United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Attoub, Samir; Arafat, Kholoud] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [Eid, Ali] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar	United Arab Emirates University; United Arab Emirates University; Qatar University	Iratni, R (corresponding author), United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates.	R_iratni@uaeu.ac.ae	Attoub, Samir/N-6852-2018; Eid, Ali Hussein/ABD-6291-2021; Karuvantevida, Noushad/GOP-3177-2022; AbuQamar, Synan/AAV-1229-2021	Eid, Ali Hussein/0000-0003-3004-5675; AbuQamar, Synan/0000-0002-2129-7689; Karuvantevida, Noushad/0000-0002-9836-0316; Bajbouj, Khuloud/0000-0001-7344-6095	UAEU Program for Advanced Research [31S111-UPAR]; Faculty of Science interdisciplinary research grant UAE University [31S033-FOS]	UAEU Program for Advanced Research; Faculty of Science interdisciplinary research grant UAE University	This work was supported by UAEU Program for Advanced Research (Grant 31S111-UPAR) and the Faculty of Science interdisciplinary research grant UAE University (Grant 31S033-FOS) to Rabah Iratni. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2013, ONCOL REP, V29, P1333, DOI 10.3892/or.2013.2242; Al Dhaheri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056649; Al Dhaheri Y, 2013, BBA-GEN SUBJECTS, V1830, P3121, DOI 10.1016/j.bbagen.2013.01.010; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Dorrie J, 2001, CANCER LETT, V170, P33, DOI 10.1016/S0304-3835(01)00549-3; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Johanson JJ, 2011, CANC LETT, V305, P1; Johnson JH, 2011, VENICE INCOGNITO: MASKS IN THE SERENE REPUBLIC, P3; Johnson JJ, 2008, PHARM RES-DORDR, V25, P2125, DOI 10.1007/s11095-008-9552-0; Kaczirek K, 2004, J CLIN ENDOCR METAB, V89, P2397, DOI 10.1210/jc.2003-031314; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Karna P, 2010, J BIOL CHEM, V285, P18737, DOI 10.1074/jbc.M109.091694; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Li X, 2012, INT J BIOL SCI, V8, P901, DOI 10.7150/ijbs.4554; Ling LU, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.12; Lopez-Jimenez A, 2013, EUR J NUTR, V52, P85, DOI 10.1007/s00394-011-0289-x; Martin KR, 2006, EXP BIOL MED, V231, P117; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Park KW, 2014, INT J ONCOL, V44, P1309, DOI 10.3892/ijo.2014.2281; Puissant A, 2012, AM J CANCER RES, V2, P397; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Rabi T, 2009, BREAST CANCER RES TR, V115, P223, DOI 10.1007/s10549-008-0118-y; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Reuben SC, 2012, MOL NUTR FOOD RES, V56, P14, DOI 10.1002/mnfr.201100619; Rikiishi Hidemi, 2012, Int J Cell Biol, V2012, P317645, DOI 10.1155/2012/317645; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Shrivastava A, 2011, MOL CANCER THER, V10, P1161, DOI 10.1158/1535-7163.MCT-10-1100; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Su MF, 2013, J ONCOL, V2013, DOI 10.1155/2013/102735; Wang S, 2008, ONCOGENE, V27, P6207, DOI 10.1038/onc.2008.298; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang L, 2012, BREAST CARE, V7, P13, DOI 10.1159/000336539	41	70	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109630	10.1371/journal.pone.0109630	http://dx.doi.org/10.1371/journal.pone.0109630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299698	Green Published, gold			2022-12-27	WOS:000343941200065
J	Carsillo, T; Huey, D; Levinsky, A; Obojes, K; Schneider-Schaulies, J; Niewiesk, S				Carsillo, Thomas; Huey, Devra; Levinsky, Amy; Obojes, Karola; Schneider-Schaulies, Juergen; Niewiesk, Stefan			Cotton Rat (Sigmodon hispidus) Signaling Lymphocyte Activation Molecule (CD150) Is an Entry Receptor for Measles Virus	PLOS ONE			English	Article							CELLULAR RECEPTOR; IMMUNE SUPPRESSION; SLAM CDW150; WILD-TYPE; REPLICATION; CD46; MORBILLIVIRUSES; GLYCOPROTEINS; STRAINS; SPREAD	Cotton rats (Sigmodon hispidus) replicate measles virus (MV) after intranasal infection in the respiratory tract and lymphoid tissue. We have cloned the cotton rat signaling lymphocytic activation molecule (CD150, SLAM) in order to investigate its role as a potential receptor for MV. Cotton rat CD150 displays 58% and 78% amino acid homology with human and mouse CD150, respectively. By staining with a newly generated cotton rat CD150 specific monoclonal antibody expression of CD150 was confirmed in cotton rat lymphoid cells and in tissues with a pattern of expression similar to mouse and humans. Previously, binding of MV hemagglutinin has been shown to be dependent on amino acids 60, 61 and 63 in the V region of CD150. The human molecule contains isoleucine, histidine and valine at these positions and binds to MV-H whereas the mouse molecule contains valine, arginine and leucine and does not function as a receptor for MV. In the cotton rat molecule, amino acids 61 and 63 are identical with the mouse molecule and amino acid 60 with the human molecule. After transfection with cotton rat CD150 HEK 293 T cells became susceptible to infection with single cycle VSV pseudotype virus expressing wild type MV glycoproteins and with a MV wildtype virus. After infection, cells expressing cotton rat CD150 replicated virus to lower levels than cells expressing the human molecule and formed smaller plaques. These data might explain why the cotton rat is a semipermissive model for measles virus infection.	[Carsillo, Thomas; Huey, Devra; Levinsky, Amy; Niewiesk, Stefan] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Carsillo, Thomas; Huey, Devra; Levinsky, Amy; Niewiesk, Stefan] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Obojes, Karola; Schneider-Schaulies, Juergen] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Wurzburg	Niewiesk, S (corresponding author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.	Niewiesk.1@osu.edu		Schneider-Schaulies, Jurgen/0000-0001-7713-5518	National Institute of Allergy and Infectious Disease [R03AI065971-01]; NIH/NIAID [1-T32-AI-065411]; NRSA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI065971, T32AI065411] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the National Institute of Allergy and Infectious Disease award #R03AI065971-01. T.C. was supported by NIH/NIAID award #1-T32-AI-065411, a NRSA training grant administered by the Center for Microbial Interface Biology (CMIB), at The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 1999, VET MICROBIOL, V69, P3, DOI 10.1016/S0378-1135(99)00080-2; Bieringer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057488; Carsillo M, 2010, J VIROL, V84, P2180, DOI 10.1128/JVI.01316-09; Castro AG, 1999, J IMMUNOL, V163, P5860; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Erlenhofer C, 2002, J GEN VIROL, V83, P1431, DOI 10.1099/0022-1317-83-6-1431; Johnston ICD, 1999, J VIROL, V73, P6903, DOI 10.1128/JVI.73.8.6903-6915.1999; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; MENEZES J, 1975, BIOMEDICINE, V22, P276; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Navaratnarajah CK, 2009, CURR TOP MICROBIOL, V329, P59; Niewiesk S, 1997, J VIROL, V71, P7214, DOI 10.1128/JVI.71.10.7214-7219.1997; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ohno S, 2003, J GEN VIROL, V84, P2381, DOI 10.1099/vir.0.19248-0; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Ono N, 2001, J VIROL, V75, P1594, DOI 10.1128/JVI.75.4.1594-1600.2001; Pfeuffer J, 2003, J VIROL, V77, P150, DOI 10.1128/JVI.77.1.150-158.2003; REED L. J., 1938, AMER JOUR HYG, V27, P493; RICHARDSON CD, 1980, VIROLOGY, V105, P205, DOI 10.1016/0042-6822(80)90168-3; Rima BK, 1997, J GEN VIROL, V78, P97, DOI 10.1099/0022-1317-78-1-97; Shields MJ, 1998, TISSUE ANTIGENS, V51, P567, DOI 10.1111/j.1399-0039.1998.tb02994.x; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takeda M, 2008, J CLIN INVEST, V118, P2386, DOI 10.1172/JCI36251; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Tatsuo H, 2000, J VIROL, V74, P4139, DOI 10.1128/JVI.74.9.4139-4145.2000; Wang N, 2001, IMMUNOGENETICS, V53, P382, DOI 10.1007/s002510100337; Whitt MA, 2010, J VIROL METHODS, V169, P365, DOI 10.1016/j.jviromet.2010.08.006; WYDE PR, 1992, P SOC EXP BIOL MED, V201, P80, DOI 10.3181/00379727-201-43483; Wyde PR, 1999, P SOC EXP BIOL MED, V221, P53, DOI 10.1046/j.1525-1373.1999.d01-54.x; Yanagi Y, 2009, CURR TOP MICROBIOL, V329, P13	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110120	10.1371/journal.pone.0110120	http://dx.doi.org/10.1371/journal.pone.0110120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295727	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000112
J	Freitag, J; Heink, S; Roth, E; Wittmann, J; Jack, HM; Kamradt, T				Freitag, Jenny; Heink, Sylvia; Roth, Edith; Wittmann, Juergen; Jaeck, Hans-Martin; Kamradt, Thomas			Towards the Generation of B-Cell Receptor Retrogenic Mice	PLOS ONE			English	Article							TRANSGENIC MICE; AVIAN LYSOZYME; IN-VIVO; CLEAVAGE; LYMPHOCYTES; EXPRESSION; POLYPROTEIN; ANTIBODIES; PROTEINS; FURIN	Transgenic expression of B- and T-cell receptors (BCRs and TCRs, respectively) has been a standard tool to study lymphocyte development and function in vivo. The generation of transgenic mice is time-consuming and, therefore, a faster method to study the biology of defined lymphocyte receptors in vivo would be highly welcome. Using 2A peptide-linked multicistronic retroviral vectors to transduce stem cells, TCRs can be expressed rapidly in mice of any background. We aimed at adopting this retrogenic technology to the in vivo expression of BCRs. Using a well characterised BCR specific for hen egg lysozyme (HEL), we achieved surface expression of the retrogenically encoded BCR in a Rag-deficient pro B-cell line in vitro. In vivo, retrogenic BCRs were detectable only intracellularly but not on the surface of B cells from wild type or Rag2-deficient mice. This data, together with the fact that no BCR retrogenic mouse model has been published in the 7 years since the method was originally published for TCRs, strongly suggests that achieving BCR-expression in vivo with retrogenic technology is highly challenging if not impossible.	[Freitag, Jenny; Heink, Sylvia; Kamradt, Thomas] Univ Hosp Jena, Dept Immunol, Jena, Germany; [Roth, Edith; Wittmann, Juergen; Jaeck, Hans-Martin] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Dept Internal Med 3, Div Mol Immunol, D-91054 Erlangen, Germany	Friedrich Schiller University of Jena; University of Erlangen Nuremberg	Kamradt, T (corresponding author), Univ Hosp Jena, Dept Immunol, Jena, Germany.	thomas.kamradt@med.uni-jena.de	Kamradt, Thomas/E-9971-2018	Jack, Hans-Martin/0000-0002-6332-8463; Heink, Sylvia/0000-0002-3276-6313; Kamradt, Thomas/0000-0001-8443-5893	Deutsche Forschungsgemeinschaft [KA 755/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is supported by KA 755/5-1, www.dfg.de, Deutsche Forschungsgemeinschaft (TK, JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bettini ML, 2012, IMMUNOLOGY, V136, P265, DOI 10.1111/j.1365-2567.2012.03574.x; BOYD AW, 1981, J IMMUNOL, V126, P2466; Corfe SA, 2007, J IMMUNOL METHODS, V325, P9, DOI 10.1016/j.jim.2007.05.010; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Dylke J, 2007, IMMUNOL LETT, V112, P47, DOI 10.1016/j.imlet.2007.06.005; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Haan C, 2000, BIOCHEM J, V349, P261, DOI 10.1042/0264-6021:3490261; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Kim JH, 2011, PLOS ONE, V6; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Milne CD, 2008, J IMMUNOL, V180, P2839, DOI 10.4049/jimmunol.180.5.2839; Nakagawa R, 2006, NAT PROTOC, V1, P1185, DOI 10.1038/nprot.2006.178; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; ROEBROEK AJM, 1994, BIOCHIMIE, V76, P210, DOI 10.1016/0300-9084(94)90148-1; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; SMITHGILL SJ, 1984, J IMMUNOL, V132, P963; SMITHGILL SJ, 1984, J IMMUNOL, V133, P384; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109199	10.1371/journal.pone.0109199	http://dx.doi.org/10.1371/journal.pone.0109199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296340	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000046
J	Kelsey, TW; Li, LQ; Mitchell, RT; Whelan, A; Anderson, RA; Wallaces, WHB				Kelsey, Thomas W.; Li, Lucy Q.; Mitchell, Rod T.; Whelan, Ashley; Anderson, Richard A.; Wallaces, W. Hamish B.			A Validated Age-Related Normative Model for Male Total Testosterone Shows Increasing Variance but No Decline after Age 40 Years	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HORMONE-BINDING GLOBULIN; COMMUNITY-DWELLING MEN; SERUM TESTOSTERONE; OLDER MEN; AGING MEN; REFERENCE INTERVALS; SEX-HORMONES; ELDERLY-MEN; LONGITUDINAL CHANGES	The diagnosis of hypogonadism in human males includes identification of low serum testosterone levels, and hence there is an underlying assumption that normal ranges of testosterone for the healthy population are known for all ages. However, to our knowledge, no such reference model exists in the literature, and hence the availability of an applicable biochemical reference range would be helpful for the clinical assessment of hypogonadal men. In this study, using model selection and validation analysis of data identified and extracted from thirteen studies, we derive and validate a normative model of total testosterone across the lifespan in healthy men. We show that total testosterone peaks [mean (2.597.5 percentile)] at 15.4 (7.231.1) nmol/L at an average age of 19 years, and falls in the average case [mean (2.597.5 percentile)] to 13.0 (6.6-25.3) nmol/L by age 40 years, but we find no evidence for a further fall in mean total testosterone with increasing age through to old age. However we do show that there is an increased variation in total testosterone levels with advancing age after age 40 years. This model provides the age related reference ranges needed to support research and clinical decision making in males who have symptoms that may be due to hypogonadism.	[Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland; [Li, Lucy Q.; Whelan, Ashley] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Mitchell, Rod T.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Mitchell, Rod T.; Anderson, Richard A.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Wallaces, W. Hamish B.] Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Edinburgh	Wallaces, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458; Li, Lucy/0000-0002-1572-8470; Mitchell, Rod/0000-0003-4650-3765; wallace, william, hamish/0000-0001-8080-5674	EPSRC [EP/H004092/1]; Wellcome Trust Intermediate Clinical Fellowship [098522]; MRC [G1002118, G1002033] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004092/1] Funding Source: researchfish; Medical Research Council [G1002033, G1002118] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TWK is supported by EPSRC grant EP/H004092/1. http://gosw.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef = EP/H004092/1. RTM is supported by a Wellcome Trust Intermediate Clinical Fellowship (Grant No 098522) http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Fellowships/Clinical-fellowships/wtd004402.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahaman A, 2005, METABOLISM, V54, P91, DOI 10.1016/j.metabol.2004.07.018; Altman D.G., 1991, PRACTICAL STATISTIC; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Bergada I, 2006, J CLIN ENDOCR METAB, V91, P4092, DOI 10.1210/jc.2006-1079; BOLTON NJ, 1989, CLIN ENDOCRINOL, V31, P201, DOI 10.1111/j.1365-2265.1989.tb01243.x; Boyce MJ, 2004, BJU INT, V94, P881, DOI 10.1111/j.1464-410X.2004.05051.x; Brawer Michael K, 2004, Rev Urol, V6 Suppl 6, pS9; Camacho EM, 2013, EUR J ENDOCRINOL, V168, P445, DOI 10.1530/EJE-12-0890; Carnahan RM, 2004, DRUG AGING, V21, P361, DOI 10.2165/00002512-200421060-00002; Casey R, 2008, CUAJ-CAN UROL ASSOC, V2, P47; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Elmlinger MW, 2005, CLIN LAB, V51, P625; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Fleming R, 2012, FERTIL STERIL, V98, P1097, DOI 10.1016/j.fertnstert.2012.07.1114; FOREST MG, 1973, J CLIN ENDOCR METAB, V36, P1132, DOI 10.1210/jcem-36-6-1132; FOREST MG, 1974, J CLIN INVEST, V53, P819, DOI 10.1172/JCI107621; Friedrich N, 2008, J ANDROL, V29, P610, DOI 10.2164/jandrol.108.005561; Frost M, 2013, CLIN ENDOCRINOL, V78, P743, DOI 10.1111/cen.12042; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Halmenschlager G, 2011, WORLD J UROL, V29, P541, DOI 10.1007/s00345-011-0724-x; Handelsman DJ, 2013, J CLIN ENDOCR METAB, V98, P3971, DOI 10.1210/jc.2013-3375; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Huhtaniemi IT, 2012, EUR J ENDOCRINOL, V166, P983, DOI 10.1530/EJE-11-1051; Janse F, 2011, EUR J ENDOCRINOL, V165, P925, DOI 10.1530/EJE-11-0482; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Kelsey TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071465; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Kyriakopoulou L, 2013, CLIN BIOCHEM, V46, P642, DOI 10.1016/j.clinbiochem.2013.01.002; Leifke E, 2000, CLIN ENDOCRINOL, V53, P689, DOI 10.1046/j.1365-2265.2000.01159.x; Liverman CT, 2004, TESTOSTERONE AGING C; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Mohr BA, 2005, CLIN ENDOCRINOL, V62, P64, DOI 10.1111/j.1365-2265.2004.02174.x; Morales A, 2008, CUAJ-CAN UROL ASSOC, V2, P43; Morley JE, 1997, METABOLISM, V46, P410, DOI 10.1016/S0026-0495(97)90057-3; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Orwoll E, 2006, J CLIN ENDOCR METAB, V91, P1336, DOI 10.1210/jc.2005-1830; PHILLIPS GB, 1994, ARTERIOSCLER THROMB, V14, P701, DOI 10.1161/01.ATV.14.5.701; Pierik FH, 2009, INT J ANDROL, V32, P453, DOI 10.1111/j.1365-2605.2008.00877.x; Pye SR, 2013, J CLIN ENDOCR METAB; Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9; Rohrmann S, 2011, CLIN ENDOCRINOL, V75, P232, DOI 10.1111/j.1365-2265.2011.04043.x; Rosano G M C, 2005, J Endocrinol Invest, V28, P32; Rucker D, 2004, CLIN ENDOCRINOL, V60, P491, DOI 10.1111/j.1365-2265.2004.02006.x; Ruige JB, 2013, J CLIN ENDOCR METAB, V98, P4300, DOI 10.1210/jc.2013-1970; Sartorius G, 2012, CLIN ENDOCRINOL, V77, P755, DOI 10.1111/j.1365-2265.2012.04432.x; Scaglia HE, 2012, REV ARG ENDOCRINOL M, V49, P159; Schatzl G, 2003, UROLOGY, V61, P629, DOI 10.1016/S0090-4295(02)02252-5; SHARPE RM, 1984, BIOL REPROD, V30, P29, DOI 10.1095/biolreprod30.1.29; Shi ZM, 2013, J CLIN ENDOCR METAB, V98, P3289, DOI 10.1210/jc.2012-3842; SIMON D, 1992, AM J EPIDEMIOL, V135, P783, DOI 10.1093/oxfordjournals.aje.a116365; Snyder PJ, 2008, J CLIN ENDOCR METAB, V93, P2477, DOI 10.1210/jc.2008-0922; Swerdloff RS, 2004, BEST PRACT RES CL EN, V18, P349, DOI 10.1016/j.beem.2004.03.011; Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287; Wespes E, 2002, INT J IMPOT RES, V14, pS93, DOI 10.1038/sj.ijir.3900798; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108; Yeap BB, 2007, EUR J ENDOCRINOL, V156, P585, DOI 10.1530/EJE-06-0714; Yeap BB, 2014, J CLIN ENDOCR METAB, V99, pE9, DOI 10.1210/jc.2013-3272	63	77	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109346	10.1371/journal.pone.0109346	http://dx.doi.org/10.1371/journal.pone.0109346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295520	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000061
J	Simmons, SC; Jamsa, H; Silva, D; Cortez, CM; McKenzie, EA; Bitu, CC; Salo, S; Nurmenniemi, S; Nyberg, P; Risteli, J; deAlmeida, CEB; Brenchley, PEC; Salo, T; Missailidisi, S				Simmons, Suzanne C.; Jaemsae, Hannaleena; Silva, Dilson; Cortez, Celia M.; McKenzie, Edward A.; Bitu, Carolina C.; Salo, Sirpa; Nurmenniemi, Sini; Nyberg, Pia; Risteli, Juha; deAlmeida, Carlos E. B.; Brenchley, Paul E. C.; Salo, Tuula; Missailidisi, Sotiris			Anti-Heparanase Aptamers as Potential Diagnostic and Therapeutic Agents for Oral Cancer	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EXTRACELLULAR-MATRIX; MAMMALIAN HEPARANASE; PROTEIN INTERACTIONS; DNA APTAMERS; LASER-DESORPTION/IONIZATION; MASS-SPECTROMETRY; CELL CARCINOMA; IN-VIVO; EXPRESSION	Heparanase is an endoglycosidase enzyme present in activated leucocytes, mast cells, placental tissue, neutrophils and macrophages, and is involved in tumour metastasis and tissue invasion. It presents a potential target for cancer therapies and various molecules have been developed in an attempt to inhibit the enzymatic action of heparanase. In an attempt to develop a novel therapeutic with an associated diagnostic assay, we have previously described high affinity aptamers selected against heparanase. In this work, we demonstrated that these anti-heparanase aptamers are capable of inhibiting tissue invasion of tumour cells associated with oral cancer and verified that such inhibition is due to inhibition of the enzyme and not due to other potentially cytotoxic effects of the aptamers. Furthermore, we have identified a short 30 bases aptamer as a potential candidate for further studies, as this showed a higher ability to inhibit tissue invasion than its longer counterpart, as well as a reduced potential for complex formation with other non-specific serum proteins. Finally, the aptamer was found to be stable and therefore suitable for use in human models, as it showed no degradation in the presence of human serum, making it a potential candidate for both diagnostic and therapeutic use.	[Simmons, Suzanne C.; deAlmeida, Carlos E. B.] Open Univ, Dept Chem & Analyt Sci, Milton Keynes MK7 6AA, Bucks, England; [Silva, Dilson; Cortez, Celia M.] Univ Estado Rio De Janeiro, Inst Math & Stat, Rio De Janeiro, Brazil; [McKenzie, Edward A.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Jaemsae, Hannaleena; Bitu, Carolina C.; Salo, Sirpa; Nurmenniemi, Sini; Nyberg, Pia; Salo, Tuula] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Jaemsae, Hannaleena; Bitu, Carolina C.; Nyberg, Pia; Salo, Tuula] Med Res Ctr, Oulu, Finland; [Jaemsae, Hannaleena; Bitu, Carolina C.; Nyberg, Pia; Salo, Tuula] Oulu Univ Hosp, Oulu, Finland; [Risteli, Juha] Univ Oulu, Dept Clin Chem, Inst Diagnost, Oulu, Finland; [deAlmeida, Carlos E. B.] Inst Radioprotecao & Dosimetria, Radiobiol Lab, Rio De Janeiro, Brazil; [Brenchley, Paul E. C.] Univ Manchester, Renal Res Grp, Manchester, Lancs, England; [Salo, Tuula] Univ Estadual Campinas, Piracicaba Dent Sch, Grad Program Estomatopatol, Sao Paulo, Brazil; [Salo, Tuula] Univ Helsinki, Inst Dent, Helsinki, Finland; [Missailidisi, Sotiris] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil	Open University - UK; Universidade do Estado do Rio de Janeiro; University of Manchester; University of Oulu; University of Oulu; University of Oulu; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; University of Manchester; Universidade Estadual de Campinas; University of Helsinki; Universidade Federal do Rio de Janeiro	Salo, T (corresponding author), Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland.	tuula.salo@oulu.fi; sotirismissailidis@gmail.com	DE ALMEIDA, CARLOS EDUARDO BONACOSSA/M-7511-2013; , tuula/ABG-2051-2021; De Marco, Paulo/B-2209-2009; Vilela, Bruno/L-1594-2015; Nemésio, André/D-1920-2012; Silva, Daniel Paiva/F-8052-2010; Cortez, Celia/X-3247-2018	DE ALMEIDA, CARLOS EDUARDO BONACOSSA/0000-0003-0108-3998; De Marco, Paulo/0000-0002-3628-6405; Vilela, Bruno/0000-0003-4072-0558; Silva, Daniel Paiva/0000-0002-2457-6245; Brenchley, Paul/0000-0003-1290-9919; Salo, Sirpa/0000-0002-4113-4000; Cortez, Celia/0000-0002-7857-1167; Salo, Tuula/0000-0001-6039-0088; Silva, Dilson/0000-0001-9726-2442	Conselho Nacional de Pesquisa Cientifica - CNPq; Academy of Finland; Finnish Cancer Organisations; Finnish Dental Society Apollonia; Oulu University Hospital KEVO	Conselho Nacional de Pesquisa Cientifica - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Finnish Dental Society Apollonia; Oulu University Hospital KEVO	Dr. Bonacossa was supported by a post-doctoral fellowship from Conselho Nacional de Pesquisa Cientifica - CNPq, on the scope of the programme Science with no Borders, MCTI, Brazil. Dr. Missailidis would like to acknowledge the financial support from Conselho Nacional de Pesquisa Cientifica - CNPq, on the scope of a senior visiting researcher programme at FIOCRUZ for part of this project. The research group of Prof. Salo was supported by the Academy of Finland, the Finnish Cancer Organisations, Finnish Dental Society Apollonia and the Oulu University Hospital KEVO grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; Aberem MB, 2006, ADV MATER, V18, P2703, DOI 10.1002/adma.200601651; ADAMS DH, 1994, LANCET, V343, P831, DOI 10.1016/S0140-6736(94)92029-X; Arnold S, 2012, BIOL CHEM, V393, P343, DOI 10.1515/hsz-2011-0253; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; Cao ZH, 2009, ANGEW CHEM INT EDIT, V48, P6494, DOI 10.1002/anie.200901452; Cole JR, 2007, ANAL CHEM, V79, P273, DOI 10.1021/ac061256b; Cortez CM, 2012, SPECTROCHIM ACTA A, V95, P270, DOI 10.1016/j.saa.2012.04.053; Courtney SM, 2005, BIOORG MED CHEM LETT, V15, P2295, DOI 10.1016/j.bmcl.2005.03.014; Da Pieve C, 2010, BIOCONJUGATE CHEM, V21, P169, DOI 10.1021/bc900397s; Dick LW, 2004, ANAL CHEM, V76, P3037, DOI 10.1021/ac049860e; ELDOR A, 1987, SEMIN THROMB HEMOST, V13, P475, DOI 10.1055/s-2007-1003524; Famulok M, 1999, CURR TOP MICROBIOL, V243, P123; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; He XT, 2004, CANCER RES, V64, P3928, DOI 10.1158/0008-5472.CAN-03-2718; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Hianik T, 2005, BIOORG MED CHEM LETT, V15, P291, DOI 10.1016/j.bmcl.2004.10.083; Hicke BJ, 2006, J NUCL MED, V47, P668; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ikuta M, 2001, ORAL ONCOL, V37, P177, DOI 10.1016/S1368-8375(00)00077-4; Ishida K, 2004, MOL CANCER THER, V3, P1069; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Kawde AN, 2005, ELECTROCHEM COMMUN, V7, P537, DOI 10.1016/j.elecom.2005.03.008; Koliopanos A, 2001, CANCER RES, V61, P4655; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Li JP, 2009, THROMB HAEMOSTASIS, V102, P823, DOI 10.1160/TH09-02-0091; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Marchetti D, 2001, ADV ENZYME REGUL, V41, P343, DOI 10.1016/S0065-2571(00)00016-9; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; McKenzie E, 2003, BIOCHEM J, V373, P423, DOI 10.1042/BJ20030318; Meirovitz A, 2013, FEBS J, V280, P2307, DOI 10.1111/febs.12184; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; Missailidis S, 2005, J IMMUNOL METHODS, V296, P45, DOI 10.1016/j.jim.2004.10.011; Nurmenniemi S, 2012, ORAL ONCOL, V48, P136, DOI 10.1016/j.oraloncology.2011.09.002; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Pisano C, 2014, BIOCH PHARM; PUCHALSKI MM, 1991, FRESEN J ANAL CHEM, V340, P341, DOI 10.1007/BF00321578; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Scaggiante B, 2013, CURR DRUG METAB, V14, P565, DOI 10.2174/13892002113149990010; Silva D, 2013, J PHOTOCH PHOTOBIO B, V127, P68, DOI 10.1016/j.jphotobiol.2013.06.015; Simmons SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037938; Tang WH, 2002, MODERN PATHOL, V15, P593, DOI 10.1038/modpathol.3880571; Thompson CA, 2013, J BIOL CHEM, V288, P10093, DOI 10.1074/jbc.C112.444562; Vivekananda J, 2006, LAB INVEST, V86, P610, DOI 10.1038/labinvest.3700417; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Wang YH, 2011, BIOSENS BIOELECTRON, V26, P3536, DOI 10.1016/j.bios.2011.01.041; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Zeng C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0403-9	65	46	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e96846	10.1371/journal.pone.0096846	http://dx.doi.org/10.1371/journal.pone.0096846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295847	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000001
J	Wongtrakool, C; Grooms, K; Bijli, KM; Crothers, K; Fitzpatrick, AM; Hart, CM				Wongtrakool, Cherry; Grooms, Kora; Bijli, Kaiser M.; Crothers, Kristina; Fitzpatrick, Anne M.; Hart, C. Michael			Nicotine Stimulates Nerve Growth Factor in Lung Fibroblasts through an NF kappa B-Dependent Mechanism	PLOS ONE			English	Article							MESENCHYMAL TROPHIC UNIT; TRACHEAL SMOOTH-MUSCLE; TOBACCO-SMOKE EXPOSURE; AIRWAY HYPERRESPONSIVENESS; PULMONARY-FUNCTION; CIGARETTE-SMOKE; PROTEIN-KINASE; ASTHMA; ACTIVATION; EXPRESSION	Rationale: Airway hyperresponsiveness (AHR) is classically found in asthma, and persistent AHR is associated with poor asthma control. Although airway smooth muscle (ASM) cells play a critical pathophysiologic role in AHR, the paracrine contributions of surrounding cells such as fibroblasts to the contractile phenotype of ASM cells have not been examined fully. This study addresses the hypothesis that nicotine promotes a contractile ASM cell phenotype by stimulating fibroblasts to increase nerve growth factor (NGF) secretion into the environment. Methods: Primary lung fibroblasts isolated from wild type and alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) deficient mice were treated with nicotine (50 mu g/ml) in vitro for 72 hours. NGF levels were measured in culture media and in bronchoalveolar lavage (BAL) fluid from asthmatic, smoking and non-smoking subjects by ELISA. The role of the NF kappa B pathway in nicotine-induced NGF expression was investigated by measuring NF kappa B nuclear translocation, transcriptional activity, chromatin immunoprecipitation assays, and si-p65 NF kappa B knockdown. The ability of nicotine to stimulate a fibroblast-mediated, contractile ASM cell phenotype was confirmed by examining expression of contractile proteins in ASM cells cultured with fibroblast-conditioned media or BAL fluid. Results: NGF levels were elevated in the bronchoalveolar lavage fluid of nicotine-exposed mice, current smokers, and asthmatic children. Nicotine increased NGF secretion in lung fibroblasts in vitro in a dose-dependent manner and stimulated NF kappa B nuclear translocation, p65 binding to the NGF promoter, and NF kappa B transcriptional activity. These responses were attenuated in alpha 7 nAChR deficient fibroblasts and in wild type fibroblasts following NF kappa B inhibition. Nicotine-treated, fibroblast-conditioned media increased expression of contractile proteins in ASM cells. Conclusion: Nicotine stimulates NGF release by lung fibroblasts through alpha 7 nAChR and NF kappa B dependent pathways. These novel findings suggest that the nicotine-alpha 7 nAChR-NF kappa B-NGF axis may provide novel therapeutic targets to attenuate tobacco smoke-induced AHR.	[Wongtrakool, Cherry; Bijli, Kaiser M.; Hart, C. Michael] Atlanta VA Med Ctr, Decatur, GA 30033 USA; [Wongtrakool, Cherry; Grooms, Kora; Bijli, Kaiser M.; Hart, C. Michael] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Crothers, Kristina] Univ Washington, Seattle, WA 98195 USA; [Fitzpatrick, Anne M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; University of Washington; University of Washington Seattle; Emory University	Wongtrakool, C (corresponding author), Atlanta VA Med Ctr, Decatur, GA 30033 USA.	cwongtr@emory.edu		Crothers, Kristina/0000-0001-9702-0371; Fitzpatrick, Anne/0000-0002-2933-5926; Hart, C. Michael/0000-0002-9145-9938	Department of Veterans Affairs [BX001306, BX001910]; National Institutes of Health [HL102167, DK074518, HL090342]; American Thoracic Society Foundation Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167, R01HL090342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074518] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001910, IK2BX001306] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society Foundation Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Department of Veterans Affairs: BX001306 (CW) and BX001910 (CMH); National Institutes of Health: HL102167 (CMH), DK074518 (CMH), HL090342 (KC); American Thoracic Society Foundation Research Program (CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Bijli KM, 2012, AM J RESP CELL MOL, V47, P660, DOI 10.1165/rcmb.2012-0047OC; Braun A, 2001, INT ARCH ALLERGY IMM, V124, P205, DOI 10.1159/000053711; Bullo M, 2007, EUR J ENDOCRINOL, V157, P303, DOI 10.1530/EJE-06-0716; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chitano P, 2005, PEDIATR PULM, V39, P108, DOI 10.1002/ppul.20150; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; EBERT RV, 1983, JAMA-J AM MED ASSOC, V250, P2840, DOI 10.1001/jama.250.20.2840; Eisner MD, 2002, ENVIRON HEALTH PERSP, V110, P765, DOI 10.1289/ehp.02110765; Eisner MD, 2002, CHEST, V122, P826, DOI 10.1378/chest.122.3.826; Evans MJ, 1999, AM J RESP CELL MOL, V21, P655, DOI 10.1165/ajrcmb.21.6.3807; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Fu XW, 2009, AM J RESP CELL MOL, V41, P93, DOI 10.1165/rcmb.2008-0352OC; Garrido R, 2003, NEUROSCI RES, V47, P349, DOI 10.1016/S0168-0102(03)00222-0; GOLDSTEIN RA, 1990, AM REV RESPIR DIS, V142, P481; Hazari MS, 2007, AM J PHYSIOL-LUNG C, V292, pL992, DOI 10.1152/ajplung.00216.2006; Hoglund CO, 2002, EUR RESPIR J, V20, P1110, DOI 10.1183/09031936.02.00205402; Hoglund CO, 2002, PULM PHARMACOL THER, V15, P51, DOI 10.1006/pupt.2001.0314; Holgate ST, 2001, INT ARCH ALLERGY IMM, V124, P253, DOI 10.1159/000053726; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Koh YY, 2002, AM J RESP CRIT CARE, V166, P340, DOI 10.1164/rccm.2101158; KONG SK, 1990, AM J PHYSIOL, V259, pL53, DOI 10.1152/ajplung.1990.259.2.L53; Liu J, 2011, AM J PHYSIOL-LUNG C, V300, pL710, DOI 10.1152/ajplung.00337.2010; MCNABB ME, 1982, JAMA-J AM MED ASSOC, V248, P865, DOI 10.1001/jama.248.7.865; Michalik M, 2009, MED SCI MONITOR, V15, pBR194; Nakao S, 2009, ARCH ORAL BIOL, V54, P251, DOI 10.1016/j.archoralbio.2008.11.006; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Olgart C, 2001, EUR RESPIR J, V18, P115, DOI 10.1183/09031936.01.00069901; Pena G, 2010, EUR J IMMUNOL, V40, P2580, DOI 10.1002/eji.201040540; Roman J, 2004, FASEB J, V18, P1436, DOI 10.1096/fj.03-0826fje; ROWELL PP, 1983, J PHARMACOL METHOD, V9, P249, DOI 10.1016/0160-5402(83)90064-5; Sekhon HS, 2005, CELL TISSUE RES, V320, P287, DOI 10.1007/s00441-005-1077-9; Sekhon HS, 2001, AM J RESP CRIT CARE, V164, P989, DOI 10.1164/ajrccm.164.6.2011097; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Sheller JR, 2009, EXP LUNG RES, V35, P883, DOI 10.3109/01902140903019710; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Urrego F, 2009, PEDIATR PULM, V44, P1075, DOI 10.1002/ppul.21099; Vernon MK, 2012, J ASTHMA, V49, P991, DOI 10.3109/02770903.2012.738268; Vestbo J, 2001, THORAX, V56, P11; Volbeda F, 2013, THORAX, V68, P19, DOI 10.1136/thoraxjnl-2012-201861; Wongtrakool C, 2007, AM J PHYSIOL-LUNG C, V293, pL611, DOI 10.1152/ajplung.00038.2007; Wongtrakool C, 2012, AM J RESP CELL MOL, V46, P695, DOI 10.1165/rcmb.2011-0028OC; Wu ZX, 2012, AM J PHYSIOL-LUNG C, V302, pL152, DOI 10.1152/ajplung.00071.2011; Xu Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-13	50	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109602	10.1371/journal.pone.0109602	http://dx.doi.org/10.1371/journal.pone.0109602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296021	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000086
J	Rocha, SC; Pessoa, MTC; Neves, LDR; Alves, SLG; Silva, LM; Santos, HL; Oliveira, SMF; Taranto, AG; Comar, M; Gomes, IV; Santos, FV; Paixao, N; Quintas, LEM; Noel, F; Pereira, AF; Tessis, ACSC; Gomes, NLS; Moreira, OC; Rincon-Heredia, R; Varotti, FP; Blanco, G; Villar, JAFP; Contreras, RG; Barbosa, LA				Rocha, Sayonarah C.; Pessoa, Marco T. C.; Neves, Luiza D. R.; Alves, Silmara L. G.; Silva, Luciana M.; Santos, Herica L.; Oliveira, Soraya M. F.; Taranto, Alex G.; Comar, Moacyr; Gomes, Isabella V.; Santos, Fabio V.; Paixao, Natasha; Quintas, Luis E. M.; Noel, Francois; Pereira, Antonio F.; Tessis, Ana C. S. C.; Gomes, Natalia L. S.; Moreira, Otacilio C.; Rincon-Heredia, Ruth; Varotti, Fernando P.; Blanco, Gustavo; Villar, Jose A. F. P.; Contreras, Ruben G.; Barbosa, Leandro A.			21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na, K-ATPase and Epithelial Tight Junctions	PLOS ONE			English	Article							OUABAIN INDUCES ENDOCYTOSIS; CARDIAC-GLYCOSIDES; BREAST-CANCER; IN-VITRO; NA+/K+-ATPASE; ADHESION MOLECULE; POLARIZED EXPRESSION; GROWTH-INHIBITION; CRYSTAL-STRUCTURE; CYCLE ARREST	Cardiotonic steroids are used to treat heart failure and arrhythmia and have promising anticancer effects. The prototypic cardiotonic steroid ouabain may also be a hormone that modulates epithelial cell adhesion. Cardiotonic steroids consist of a steroid nucleus and a lactone ring, and their biological effects depend on the binding to their receptor, Na, K-ATPase, through which, they inhibit Na+ and K+ ion transport and activate of several intracellular signaling pathways. In this study, we added a styrene group to the lactone ring of the cardiotonic steroid digoxin, to obtain 21-benzylidene digoxin (21-BD), and investigated the effects of this synthetic cardiotonic steroid in different cell models. Molecular modeling indicates that 21-BD binds to its target Na, K-ATPase with low affinity, adopting a different pharmacophoric conformation when bound to its receptor than digoxin. Accordingly, 21-DB, at relatively high mu M amounts inhibits the activity of Na, K-ATPase alpha(1), but not alpha(2) and alpha(3) isoforms. In addition, 21-BD targets other proteins outside the Na, K-ATPase, inhibiting the multidrug exporter Pdr5p. When used on whole cells at low mu M concentrations, 21-BD produces several effects, including: 1) up-regulation of Na, K-ATPase expression and activity in HeLa and RKO cancer cells, which is not found for digoxin, 2) cell specific changes in cell viability, reducing it in HeLa and RKO cancer cells, but increasing it in normal epithelial MDCK cells, which is different from the response to digoxin, and 3) changes in cell-cell interaction, altering the molecular composition of tight junctions and elevating transepithelial electrical resistance of MDCK monolayers, an effect previously found for ouabain. These results indicate that modification of the lactone ring of digoxin provides new properties to the compound, and shows that the structural change introduced could be used for the design of cardiotonic steroid with novel functions.	[Rocha, Sayonarah C.; Pessoa, Marco T. C.; Neves, Luiza D. R.; Santos, Herica L.; Barbosa, Leandro A.] Univ Fed Sao Joao del Rei, Lab Bioquim Celular, Divinopolis, MG, Brazil; [Alves, Silmara L. G.; Villar, Jose A. F. P.] Univ Fed Sao Joao del Rei, Lab Sintese Organ, Divinopolis, MG, Brazil; [Oliveira, Soraya M. F.; Taranto, Alex G.; Comar, Moacyr] Univ Fed Sao Joao del Rei, Lab Bioinformat, Divinopolis, MG, Brazil; [Gomes, Isabella V.; Santos, Fabio V.] Univ Fed Sao Joao del Rei, Lab Biol Celular & Mutagenicidade, Divinopolis, MG, Brazil; [Varotti, Fernando P.] Univ Fed Sao Joao del Rei, Lab Bioquim Parasitos, Divinopolis, MG, Brazil; [Silva, Luciana M.] Fundacao Ezequiel Dias, Lab Biol Celular & Inovacao Biotecnol, Belo Horizonte, MG, Brazil; [Paixao, Natasha; Quintas, Luis E. M.; Noel, Francois] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Bioquim & Mol, Rio De Janeiro, RJ, Brazil; [Pereira, Antonio F.; Tessis, Ana C. S. C.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Lab Bioquim Microbiana, Rio De Janeiro, RJ, Brazil; [Tessis, Ana C. S. C.] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro IFR, Rio De Janeiro, RJ, Brazil; [Gomes, Natalia L. S.; Moreira, Otacilio C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, Rio De Janeiro, RJ, Brazil; [Rincon-Heredia, Ruth; Contreras, Ruben G.] CINVESTAV, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Mexico City 14000, DF, Mexico; [Blanco, Gustavo] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Kansas; University of Kansas Medical Center	Contreras, RG (corresponding author), CINVESTAV, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Mexico City 14000, DF, Mexico.	rcontrer@fisio.cinvestav.mx; leaugust@yahoo.com.br	Silva, Luciana M/R-6340-2018; Silva, Luciana M/I-4353-2014; Taranto, Alex/GMW-4021-2022; Comar, Moacyr/H-7462-2017; Noël, François/C-3402-2009; Taranto, Alex G/F-8618-2012; Barbosa, Leandro/K-1008-2013; Villar, José Augusto Ferreira Perez/AAB-5849-2019; Santos, Fabio V/G-4912-2011; Moreira, Otacilio/AAS-5839-2020; Quintas, Luis Eduardo M/C-3308-2009; Ferreira-Pereira, Antonio/A-2910-2011; Contreras, Rubén G./F-2309-2018; Varotti, Fernando/J-4764-2015; Santos, Fabio Vieira dos/ABG-2051-2020; Villar, José Augusto F. P. Ferreira Perez/V-4142-2018	Silva, Luciana M/0000-0002-2038-0405; Silva, Luciana M/0000-0002-2038-0405; Taranto, Alex/0000-0002-6086-1043; Noël, François/0000-0001-6813-1347; Taranto, Alex G/0000-0002-6086-1043; Barbosa, Leandro/0000-0002-4631-0130; Villar, José Augusto Ferreira Perez/0000-0003-1580-0644; Santos, Fabio V/0000-0003-0389-1737; Moreira, Otacilio/0000-0002-5340-8697; Quintas, Luis Eduardo M/0000-0002-0767-1240; Ferreira-Pereira, Antonio/0000-0002-0474-8388; Contreras, Rubén G./0000-0001-7311-1615; Varotti, Fernando/0000-0002-2939-7780; Santos, Fabio Vieira dos/0000-0003-0389-1737; Villar, José Augusto F. P. Ferreira Perez/0000-0003-1580-0644; RINCON-HEREDIA, RUTH/0000-0002-5070-938X; Carvalho Rocha, Sayonarah/0000-0001-9453-0536	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) [APQ-01114-12, APQ-02596-12]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [472394/2012-6]; NIH [DK081431]; University of Sao Paulo through the NAP-CatSinQ (Research Core in Catalysis and Chemical Synthesis); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081431] Funding Source: NIH RePORTER	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Sao Paulo through the NAP-CatSinQ (Research Core in Catalysis and Chemical Synthesis); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) APQ-01114-12, APQ-02596-12, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) 472394/2012-6 and NIH DK081431. The authors are grateful for the financial and structural support offered by the University of Sao Paulo through the NAP-CatSinQ (Research Core in Catalysis and Chemical Synthesis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Alonso E, 2013, STEROIDS, V78, P1110, DOI 10.1016/j.steroids.2013.07.010; [Anonymous], 2010, DISC STUD 3 1 HELP; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bettero GM, 2011, PLANTA MED, V77, P1702, DOI 10.1055/s-0030-1271084; Bielawski K, 2006, BIOL PHARM BULL, V29, P1493, DOI 10.1248/bpb.29.1493; BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, pC1367, DOI 10.1152/ajpcell.1993.264.6.C1367; Brambilla G, 2009, MUTAT RES-REV MUTAT, V681, P209, DOI 10.1016/j.mrrev.2008.09.002; BROWER LP, 1974, NATURE, V249, P280, DOI 10.1038/249280b0; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cereijido M, 2012, AM J PHYSIOL-CELL PH, V302, pC473, DOI 10.1152/ajpcell.00083.2011; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Chen JQ, 2006, BREAST CANCER RES TR, V96, P1, DOI 10.1007/s10549-005-9053-3; Chen ZC, 2013, HORM METAB RES, V45, P364, DOI 10.1055/s-0032-1330021; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Conseil G, 2003, BBA-BIOMEMBRANES, V1614, P131, DOI 10.1016/S0005-2736(03)00193-7; Contreras RG, 1999, J CELL SCI, V112, P4223; CONTRERAS RG, 1989, AM J PHYSIOL, V257, pC896, DOI 10.1152/ajpcell.1989.257.5.C896; Cunha GA, 2010, TOXICON, V56, P339, DOI 10.1016/j.toxicon.2010.03.021; da Silva FR, 2011, J NAT PROD, V74, P279, DOI 10.1021/np1006247; Didiot MC, 2013, J BIOMOL SCREEN, V18, P407, DOI 10.1177/1087057112466698; Ding Lei, 2013, Cancer Manag Res, V5, P367, DOI 10.2147/CMAR.S38294; DULLEY JR, 1975, ANAL BIOCHEM, V67, P91, DOI 10.1016/0003-2697(75)90275-4; Efferth T, 2002, BLOOD CELL MOL DIS, V28, P160, DOI 10.1006/bcmd.2002.0492; Elbaz HA, 2012, TOXICOL APPL PHARM, V258, P51, DOI 10.1016/j.taap.2011.10.007; EMERIT I, 1994, FREE RADICAL BIO MED, V16, P99, DOI 10.1016/0891-5849(94)90246-1; Escudero-Esparza A, 2011, FRONT BIOSCI-LANDMRK, V16, P1069, DOI 10.2741/3736; Fiske CH, 1925, J BIOL CHEM, V66, P375; Flores-Benitez D, 2009, AM J PHYSIOL-CELL PH, V297, pC611, DOI 10.1152/ajpcell.00622.2008; Frisch G. W., 2013, GAUSSIAN 09; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Garcia O, 2004, MUTAT RES-FUND MOL M, V556, P25, DOI 10.1016/j.mrfmmm.2004.06.035; Garcia-Hernandez V, 2014, J CELL PHYSL; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; Gupta S, 2012, HYPERTENSION, V59, P665, DOI 10.1161/HYPERTENSIONAHA.111.176727; Haux J, 1999, MED HYPOTHESES, V53, P543, DOI 10.1054/mehy.1999.0985; Hilario FF, 2011, CHEM BIOL DRUG DES, V78, P477, DOI 10.1111/j.1747-0285.2011.01154.x; Hinds JW, 2013, CHEMMEDCHEM, V8, P63, DOI 10.1002/cmdc.201200465; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ihenetu K, 2007, CLIN CHEM, V53, P1315, DOI 10.1373/clinchem.2006.082081; Ikari A, 2012, J CELL BIOCHEM, V113, P499, DOI 10.1002/jcb.23373; Jensen M, 2011, BIOORGAN MED CHEM, V19, P2407, DOI 10.1016/j.bmc.2011.02.016; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kwon MJ, 2013, INT J MOL SCI, V14, P18148, DOI 10.3390/ijms140918148; Langenhan JM, 2005, P NATL ACAD SCI USA, V102, P12305, DOI 10.1073/pnas.0503270102; Langenhan JM, 2011, CARBOHYD RES, V346, P2663, DOI 10.1016/j.carres.2011.09.019; Larre I, 2011, P NATL ACAD SCI USA, V108, P20591, DOI 10.1073/pnas.1102617108; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lelievre SA, 2010, J MAMMARY GLAND BIOL, V15, P49, DOI 10.1007/s10911-010-9168-y; Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597; Liu B, 2013, FEBS J, V280, P3632, DOI 10.1111/febs.12355; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu LJ, 2005, J GEN PHYSIOL, V126, p72A; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Mijatovic T, 2007, DRUG DEVELOP RES, V68, P164, DOI 10.1002/ddr.20178; Mijatovic T, 2006, NEOPLASIA, V8, P402, DOI 10.1593/neo.05850; Mijatovic T, 2013, PLANTA MED, V79, P189, DOI 10.1055/s-0032-1328243; Mijatovic T, 2009, CANCER LETT, V282, P30, DOI 10.1016/j.canlet.2009.02.048; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nasu K, 2005, MOL HUM REPROD, V11, P817, DOI 10.1093/molehr/gah249; Nocedal JWS, 1999, NUMERICAL OPTMIZATIO; Noel F, 2011, N-S ARCH PHARMACOL, V383, P101, DOI 10.1007/s00210-010-0578-6; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Oselkin M, 2010, NEUROSCI LETT, V473, P67, DOI 10.1016/j.neulet.2009.10.021; Padilla-Benavides T, 2010, MOL BIOL CELL, V21, P2217, DOI 10.1091/mbc.E10-01-0081; Perez-Victoria FJ, 2003, CELL MOL LIFE SCI, V60, P526, DOI 10.1007/s000180300044; Piacente S, 2009, J NAT PROD, V72, P1087, DOI 10.1021/np800810f; Platonova A, 2011, J MEMBRANE BIOL, V241, P145, DOI 10.1007/s00232-011-9371-9; Pocas ESC, 2003, BIOCHEM PHARMACOL, V66, P2169, DOI 10.1016/j.bcp.2003.08.005; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, pC1497, DOI 10.1152/ajpcell.00355.2002; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Ramirez-Ortega M, 2006, EUR J PHARMACOL, V534, P71, DOI 10.1016/j.ejphar.2006.01.035; Rangel LP, 2010, FEMS YEAST RES, V10, P244, DOI [10.1111/j.1567-1364.2009.00603.x, 10.1111/j.1567-1364.2010.00603.x]; Reyes JL, 2002, KIDNEY INT, V62, P476, DOI 10.1046/j.1523-1755.2002.00479.x; Rincon-Heredia R, 2014, EXP CELL RES, V320, P108, DOI 10.1016/j.yexcr.2013.10.008; Rosen H, 2004, MOL BIOL CELL, V15, P1044, DOI 10.1091/mbc.E03-06-0391; Runkle EA, 2013, CANCER LETT, V337, P41, DOI 10.1016/j.canlet.2013.05.038; Sanchez G, 2006, J ANDROL, P42; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; SHIRATORI O, 1967, GANN, V58, P521; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; Shoshani L, 2005, J GEN PHYSIOL, V126, p40A; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snyder RD, 2001, MUTAT RES-REV MUTAT, V488, P151, DOI 10.1016/S1383-5742(01)00055-2; STENKVIST B, 1979, LANCET, V1, P563; STENKVIST B, 1982, NEW ENGL J MED, V306, P484; STENKVIST B, 1980, ANAL QUANT CYTOL, V2, P49; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Sun L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep082; Takai N, 2008, INT J MOL MED, V21, P637; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; TICE RR, 1991, ADV EXP MED BIOL, V283, P157; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin O, 2012, AM J PHYSIOL-CELL PH, V302, pC1271, DOI 10.1152/ajpcell.00456.2011; Van Quaquebeke E, 2005, J MED CHEM, V48, P849, DOI 10.1021/jm049405a; Wang HYL, 2011, ACS MED CHEM LETT, V2, P264, DOI 10.1021/ml100290d; Wang HYL, 2011, ACS MED CHEM LETT, V2, P259, DOI 10.1021/ml100291n; Ward SC, 2002, HYPERTENSION, V39, P536, DOI 10.1161/hy0202.103048; WATSKY MA, 1992, CELL TISSUE RES, V269, P57, DOI 10.1007/BF00384726; Winnicka K, 2008, BIOL PHARM BULL, V31, P1131, DOI 10.1248/bpb.31.1131; Winnicka K, 2007, ARCH PHARM RES, V30, P1216, DOI 10.1007/BF02980262; Winnicka K, 2010, NAT PROD RES, V24, P274, DOI 10.1080/14786410902991878; Xu HW, 2007, ORG BIOMOL CHEM, V5, P1247, DOI 10.1039/b701051f; Yang PY, 2009, MOL CANCER THER, V8, P2319, DOI 10.1158/1535-7163.MCT-08-1085; Ye M, 2004, J STEROID BIOCHEM, V91, P87, DOI 10.1016/j.jsbmb.2004.01.010; Yu CH, 2008, CANCER SCI, V99, P2467, DOI 10.1111/j.1349-7006.2008.00966.x; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201; Zhao M, 2007, J NAT PROD, V70, P1098, DOI 10.1021/np068066g	120	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108776	10.1371/journal.pone.0108776	http://dx.doi.org/10.1371/journal.pone.0108776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290152	gold, Green Published			2022-12-27	WOS:000342798000025
J	Wang, FL; Gao, S; Chen, F; Fu, ZY; Yin, H; Lu, X; Yu, J; Lu, C				Wang, Fengliang; Gao, Sheng; Chen, Fei; Fu, Ziyi; Yin, Hong; Lu, Xun; Yu, Jing; Lu, Cheng			Mammary Fat of Breast Cancer: Gene Expression Profiling and Functional Characterization	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GLAND DEVELOPMENT; DIFFERENTIATION; PROGRESSION; GROWTH; TISSUE; ROLES; MICROENVIRONMENT; CARCINOGENESIS; THERMOGENESIS	Mammary fat is the main composition of breast, and is the most probable candidate to affect tumor behavior because the fat produces hormones, growth factors and adipokines, a heterogeneous group of signaling molecules. Gene expression profiling and functional characterization of mammary fat in Chinese women has not been reported. Thus, we collected the mammary fat tissues adjacent to breast tumors from 60 subjects, among which 30 subjects had breast cancer and 30 had benign lesions. We isolated and cultured the stromal vascular cell fraction from mammary fat. The expression of genes related to adipose function (including adipogenesis and secretion) was detected at both the tissue and the cellular level. We also studied mammary fat browning. The results indicated that fat tissue close to malignant and benign lesions exhibited distinctive gene expression profiles and functional characteristics. Although the mammary fat of breast tumors atrophied, it secreted tumor growth stimulatory factors. Browning of mammary fat was observed and browning activity of fat close to malignant breast tumors was greater than that close to benign lesions. Understanding the diversity between these two fat depots may possibly help us improve our understanding of breast cancer pathogenesis and find the key to unlock new anticancer therapies.	[Wang, Fengliang; Gao, Sheng; Chen, Fei; Fu, Ziyi; Yin, Hong; Lu, Cheng] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China; [Lu, Xun] Jinling High Sch, Nanjing, Jiangsu, Peoples R China; [Yu, Jing] Nanjing Med Univ, Hosp 1, Dept Geratol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yu, J (corresponding author), Nanjing Med Univ, Hosp 1, Dept Geratol, Nanjing, Jiangsu, Peoples R China.	tianqu1981@126.com; lucheng66@126.com	Yu, Jing/AAL-5498-2021	Yu, Jing/0000-0002-5062-7069	national natural science foundation of China [81172501]; science and technology development foundation of Nanjing Medical University [2012NJMU186]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); science and technology development foundation of Nanjing Medical University	Funding support from the national natural science foundation of China (81172501) and science and technology development foundation of Nanjing Medical University (2012NJMU186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann MW, 1997, J MOL MED, V75, P429, DOI 10.1007/s001090050128; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0; Bujalska IJ, 1999, ENDOCRINOLOGY, V140, P3188, DOI 10.1210/en.140.7.3188; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon Barbara, 2008, V456, P109, DOI 10.1007/978-1-59745-245-8_8; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Gonzalez-Perez Ruben Rene, 2013, Cancers (Basel), V5, P1140, DOI 10.3390/cancers5031140; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lago CU, 2012, ONCOGENE, V31, P4725, DOI 10.1038/onc.2011.630; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; Miyoshi Y, 2006, INT J CANCER, V118, P1414, DOI 10.1002/ijc.21543; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Robbins D, 2011, INT J MOL SCI, V12, P5285, DOI 10.3390/ijms12085285; Russo IH, 1998, J MAMMARY GLAND BIOL, V3, P49, DOI 10.1023/A:1018770218022; Sanchez-Alvarez R, 2013, CELL CYCLE, V12, P172, DOI 10.4161/cc.23058; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431	29	33	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109742	10.1371/journal.pone.0109742	http://dx.doi.org/10.1371/journal.pone.0109742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291184	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000085
J	Deming, DA; Maher, ME; Leystra, AA; Grudzinski, JP; Clipson, L; Albrecht, DM; Washington, MK; Matkowskyj, KA; Hall, LT; Lubner, SJ; Weichert, JP; Halberg, RB				Deming, Dustin A.; Maher, Molly E.; Leystra, Alyssa A.; Grudzinski, Joseph P.; Clipson, Linda; Albrecht, Dawn M.; Washington, Mary Kay; Matkowskyj, Kristina A.; Hall, Lance T.; Lubner, Sam J.; Weichert, Jamey P.; Halberg, Richard B.			Phospholipid Ether Analogs for the Detection of Colorectal Tumors	PLOS ONE			English	Article							COLON-CANCER; LIPID RAFTS; FLUOROURACIL; APOPTOSIS; SURVIVAL; CELLS; GENE	The treatment of localized colorectal cancer (CRC) depends on resection of the primary tumor with adequate margins and sufficient lymph node sampling. A novel imaging agent that accumulates in CRCs and the associated lymph nodes is needed. Cellectar Biosciences has developed a phospholipid ether analog platform that is both diagnostic and therapeutic. CLR1502 is a near-infrared fluorescent molecule, whereas I-124/131-CLR1404 is under clinical investigation as a PET tracer/therapeutic agent imaged by SPECT. We investigated the use of CLR1502 for the detection of intestinal cancers in a murine model and I-131-CLR1404 in a patient with metastatic CRC. Mice that develop multiple intestinal tumors ranging from adenomas to locally advanced adenocarcinomas were utilized. After 96 hours post CLR1502 injection, the intestinal tumors were analyzed using a Spectrum IVIS (Perkin Elmer) and a Fluobeam (Fluoptics). The intensity of the fluorescent signal was correlated with the histological characteristics for each tumor. Colon adenocarcinomas demonstrated increased accumulation of CLR1502 compared to non-invasive lesions (total radiant efficiency: 1.76x10(10) vs 3.27x10(9) respectively, p = 0.006). Metastatic mesenteric tumors and uninvolved lymph nodes were detected with CLR1502. In addition, SPECT imaging with I-131-CLR1404 was performed as part of a clinical trial in patients with advanced solid tumors. I-131-CLR1404 was shown to accumulate in metastatic tumors in a patient with colorectal adenocarcinoma. Together, these compounds might enhance our ability to properly resect CRCs through better localization of the primary tumor and improved lymph node identification as well as detect distant disease.	[Deming, Dustin A.; Maher, Molly E.; Lubner, Sam J.] Univ Wisconsin Madison, Div Hematol & Oncol, Dept Med, Madison, WI USA; [Leystra, Alyssa A.; Clipson, Linda] Univ Wisconsin Madison, Dept Oncol, Madison, WI USA; [Grudzinski, Joseph P.] Univ Wisconsin Madison, Dept Med Phys, Madison, WI USA; [Albrecht, Dawn M.; Halberg, Richard B.] Univ Wisconsin Madison, Div Gastroenterol & Hepatol, Dept Med, Madison, WI 53706 USA; [Grudzinski, Joseph P.] Cellectar Biosci, Madison, WI USA; [Washington, Mary Kay] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Washington, Mary Kay] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Matkowskyj, Kristina A.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA; [Hall, Lance T.; Weichert, Jamey P.] Univ Wisconsin Madison, Dept Radiol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Halberg, RB (corresponding author), Univ Wisconsin Madison, Div Gastroenterol & Hepatol, Dept Med, Madison, WI 53706 USA.	rbhalberg@medicine.wisc.edu		Lubner, Sam/0000-0002-5732-2938	U.S. National Institutes of Health [T32 CA009614, T32 CA009135, P50 CA095103]; Specialized Program of Research Excellence Grant, Vanderbilt Ingram Cancer Center) [R01 CA123438]; UW Division of Gastroenterology and Hepatology; UW Department of Medicine; UW School of Medicine and Public Health;  [P30 CA014520]; NATIONAL CANCER INSTITUTE [R01CA123438, P30CA014520, P50CA095103, T32CA009135, T32CA009614] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Program of Research Excellence Grant, Vanderbilt Ingram Cancer Center); UW Division of Gastroenterology and Hepatology; UW Department of Medicine; UW School of Medicine and Public Health; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by a grant from Cellectar Biosciences (http://cellectar.com/), the Conquer Cancer Foundation of the American Society of Clinical Oncology through a Young Investigator Award (http://www. conquercancerfoundation. org/) to D. A. D.; the National Cancer Institute of the U.S. National Institutes of Health (http://www.cancer. gov/) through T32 CA009614 (PI McNeel; D.A.D.), T32 CA009135 (PI Sugden; A. A. L.), P50 CA095103 (Gastrointestinal Specialized Program of Research Excellence Grant, Vanderbilt Ingram Cancer Center), R01 CA123438 (R. B. H.), P30 CA014520 (Core Grant, University of Wisconsin Carbone Cancer Center); and start-up funds (R.B.H.) from the UW Division of Gastroenterology and Hepatology, the UW Department of Medicine, and the UW School of Medicine and Public Health. The funder provided support in the form of salaries for J. G. and J. W., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	American Cancer Society, 2013, CANC FACTS FIG 2013; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Deming DA, 2014, ONCOGENE, V33, P2245, DOI 10.1038/onc.2013.167; Gray RG, 2000, LANCET, V355, P1588; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Pazoles C, 2012, 124I CLR1404 131I CL; Pinchuk AN, 2006, J MED CHEM, V49, P2155, DOI 10.1021/jm050252g; Ratto C, 1999, DIS COLON RECTUM, V42, P143, DOI 10.1007/BF02237119; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; van der Luit AH, 2007, MOL CANCER THER, V6, P2337, DOI 10.1158/1535-7163.MCT-07-0202; Weichert JP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007646; Wong JH, 1999, J CLIN ONCOL, V17, P2896, DOI 10.1200/JCO.1999.17.9.2896	17	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109668	10.1371/journal.pone.0109668	http://dx.doi.org/10.1371/journal.pone.0109668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286226	Green Published, gold			2022-12-27	WOS:000345743700083
J	Chowdhury, FA; Woldman, W; FitzGerald, THB; Elwes, RDC; Nashef, L; Terry, JR; Richardson, MP				Chowdhury, Fahmida A.; Woldman, Wessel; FitzGerald, Thomas H. B.; Elwes, Robert D. C.; Nashef, Lina; Terry, John R.; Richardson, Mark P.			Revealing a Brain Network Endophenotype in Families with Idiopathic Generalised Epilepsy	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; ELECTROENCEPHALOGRAPHIC RECORDINGS; FUNCTIONAL CONNECTIVITY; 15Q13.3 MICRODELETIONS; ABSENCE SEIZURES; EEG; CHILDHOOD; DYNAMICS; GENETICS	Idiopathic generalised epilepsy (IGE) has a genetic basis. The mechanism of seizure expression is not fully known, but is assumed to involve large-scale brain networks. We hypothesised that abnormal brain network properties would be detected using EEG in patients with IGE, and would be manifest as a familial endophenotype in their unaffected first-degree relatives. We studied 117 participants: 35 patients with IGE, 42 unaffected first-degree relatives, and 40 normal controls, using scalp EEG. Graph theory was used to describe brain network topology in five frequency bands for each subject. Frequency bands were chosen based on a published Spectral Factor Analysis study which demonstrated these bands to be optimally robust and independent. Groups were compared, using Bonferroni correction to account for nonindependent measures and multiple groups. Degree distribution variance was greater in patients and relatives than controls in the 6-9 Hz band (p = 0.0005, p = 0.0009 respectively). Mean degree was greater in patients than healthy controls in the 6-9 Hz band (p = 0.0064). Clustering coefficient was higher in patients and relatives than controls in the 6-9 Hz band (p = 0.0025, p = 0.0013). Characteristic path length did not differ between groups. No differences were found between patients and unaffected relatives. These findings suggest brain network topology differs between patients with IGE and normal controls, and that some of these network measures show similar deviations in patients and in unaffected relatives who do not have epilepsy. This suggests brain network topology may be an inherited endophenotype of IGE, present in unaffected relatives who do not have epilepsy, as well as in affected patients. We propose that abnormal brain network topology may be an endophenotype of IGE, though not in itself sufficient to cause epilepsy.	[Chowdhury, Fahmida A.; FitzGerald, Thomas H. B.; Richardson, Mark P.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Chowdhury, Fahmida A.; Elwes, Robert D. C.; Nashef, Lina; Richardson, Mark P.] Kings Coll London, Ctr Epilepsy, London, England; [Woldman, Wessel; Terry, John R.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [FitzGerald, Thomas H. B.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of London; King's College London; University of London; King's College London; University of Exeter; University of London; University College London	Richardson, MP (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.	mark.richardson@kcl.ac.uk	Terry, John/ABA-2609-2020; Richardson, Mark P/E-5385-2010; Terry, John/P-6585-2014	Terry, John/0000-0002-6829-5736; Richardson, Mark P/0000-0001-8925-3140; FitzGerald, Thomas/0000-0002-3855-1591	Clinical Research Training Fellowship from the Medical Research Council UK [G0701310]; National Institute for Health Research Biomedical Research Centre at the South London; Maudsley NHS Foundation Trust; Medical Research Council UK Programme Grant [MR/K013998/1]; MRC [G0701310, MR/K013998/1] Funding Source: UKRI; Medical Research Council [G0701310, MR/K013998/1] Funding Source: researchfish	Clinical Research Training Fellowship from the Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre at the South London; Maudsley NHS Foundation Trust; Medical Research Council UK Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	FAC was funded by a Clinical Research Training Fellowship from the Medical Research Council UK (G0701310, www.mrc.ac.uk). MPR was supported in part by the National Institute for Health Research Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust (http://www.nihr.ac.uk/infrastructure/Pages/infrastructure_biomedical_ research_centres.aspx). MPR and JRT are supported by a Medical Research Council UK Programme Grant (MR/K013998/1, www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; Andermann F, 2001, EPILEPSIA, V42, P317, DOI 10.1046/j.1528-1157.2001.36400.x; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chahboune H, 2009, NEUROIMAGE, V47, P459, DOI 10.1016/j.neuroimage.2009.04.060; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Chowdhury FA, EPILEPSIA IN PRESS; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; DEGEN R, 1990, EPILEPSIA, V31, P784, DOI 10.1111/j.1528-1157.1990.tb05520.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dibbens LM, 2009, HUM MOL GENET, V18, P3626, DOI 10.1093/hmg/ddp311; DOOSE H, 1987, NEUROPEDIATRICS, V18, P1, DOI 10.1055/s-2008-1052489; GERKEN H, 1973, NEUROPADIATRIE, V4, P88, DOI 10.1055/s-0028-1091730; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GREGORY RP, 1993, ELECTROEN CLIN NEURO, V86, P75, DOI 10.1016/0013-4694(93)90069-8; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Jayalakshmi SS, 2006, SEIZURE-EUR J EPILEP, V15, P177, DOI 10.1016/j.seizure.2005.12.011; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Motelow Joshua E., 2009, V489, P189, DOI 10.1007/978-1-59745-543-5_9; O'Muircheartaigh J, 2011, NEUROLOGY, V76, P34, DOI 10.1212/WNL.0b013e318203e93d; Pal DK, 2008, EPILEPSIA, V49, P386, DOI 10.1111/j.1528-1167.2007.01416.x; Peraza LR, 2012, J NEUROSCI METH, V207, P189, DOI 10.1016/j.jneumeth.2012.04.007; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Quraan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068609; Richardson M, 2010, CLIN NEUROPHYSIOL, V121, P1153, DOI 10.1016/j.clinph.2010.01.004; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shackman AJ, 2010, NEUROIMAGE, V51, P1319, DOI 10.1016/j.neuroimage.2010.03.037; Smit DJA, 2010, BEHAV GENET, V40, P167, DOI 10.1007/s10519-009-9330-8; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; TUUNAINEN A, 1995, EPILEPSIA, V36, P817, DOI 10.1111/j.1528-1157.1995.tb01620.x; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Xue KQ, 2014, EPILEPSY RES, V108, P125, DOI 10.1016/j.eplepsyres.2013.10.002; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	43	61	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110136	10.1371/journal.pone.0110136	http://dx.doi.org/10.1371/journal.pone.0110136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302690	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000343730400113
J	Lina, TT; Khajanchi, BK; Azmi, IJ; Islam, MA; Mahmood, B; Akter, M; Banik, A; Alim, R; Navarro, A; Perez, G; Cravioto, A; Talukder, KA				Lina, Taslima T.; Khajanchi, Bijay K.; Azmi, Ishrat J.; Islam, Mohammad Aminul; Mahmood, Belal; Akter, Mahmuda; Banik, Atanu; Alim, Rumana; Navarro, Armando; Perez, Gabriel; Cravioto, Alejandro; Talukder, Kaisar A.			Phenotypic and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Bangladesh	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; GRAM-NEGATIVE BACTERIA; KLEBSIELLA-PNEUMONIAE; FLUOROQUINOLONE RESISTANCE; TRANSFERABLE RESISTANCE; MULTIDRUG-RESISTANT; FECAL CARRIAGE; PREVALENCE; STRAINS; ENTEROBACTERIACEAE	Background: Resistance to cephalosporins in Enterobacteriaceae is mainly due to the production of extended-spectrum beta-lactamase (ESBL). Little is known about ESBL-producing bacteria in Bangladesh. Therefore, the study presents results of phenotypic and molecular characterization of ESBL-producing Escherichia coli from hospitals in Bangladesh. Methods: A total of 339 E. coli isolated from patients with urinary tract and wound infections attending three different medical hospitals in urban and rural areas of Bangladesh between 2003-2007 were screened for ESBL-production by the double disk diffusion test. Isolates with ESBL-phenotype were further characterized by antibiotic susceptibility testing, PCR and sequencing of different beta-lactamase and virulence genes, serotyping, and XbaI-macrorestriction followed by pulsed-field gel electrophoresis (PFGE). Results: We identified 40 E. coli with ESBL phenotype. These isolates were resistant to ceftriaxone, ceftazidime, cefotaxime, aztreonam, cefepime, and nalidixic acid but remained susceptible to imipenem. All but one isolate were additionally resistant to ciprofloxacin, and 3 isolates were resistant to cefoxitin. ESBL genes of blaCTX-M-1-group were detected in all isolates; blaTEM-type and blaOXA-1-type genes were detected in 33 (82.5%) and 19 (47.5%) isolates, respectively. Virulence genes that are present in diarrhoeagenic E. coli were not found. Class-1 integron was present in 20 (50%) isolates. All the ESBL-producing E. coli isolates harbored plasmids ranging between 1.1 and 120 MDa. PFGE-typing revealed 26 different pulsotypes, but identical pulsotype showed 6 isolates of serotype O25:H4. Conclusion: The prevalence of multidrug-resistant ESBL-producing E. coli isolates appears to be high and the majority of the isolates were positive for bla(CTX-M). Although there was genetic heterogeneity among isolates, presence of a cluster of isolates belonging to serotype O25: H4 indicates dissemination of the pandemic uropathogenic E. coli clone in Bangladesh.	[Lina, Taslima T.; Khajanchi, Bijay K.; Azmi, Ishrat J.; Islam, Mohammad Aminul; Mahmood, Belal; Akter, Mahmuda; Banik, Atanu; Alim, Rumana; Cravioto, Alejandro; Talukder, Kaisar A.] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh; [Navarro, Armando; Perez, Gabriel] Univ Nacl Autonoma Mexico, Fac Med, Dept Publ Hlth, Mexico City 04510, DF, Mexico	International Centre for Diarrhoeal Disease Research (ICDDR); Universidad Nacional Autonoma de Mexico	Talukder, KA (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, GPO Box 128, Dhaka 1000, Bangladesh.	kaisar@icddrb.org	Navarro, Armando/AAE-3832-2022; NAVARRO, ARMANDO/AAO-7368-2020	NAVARRO, ARMANDO/0000-0002-6693-7168	icddr,b; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	icddr,b; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by icddr,b and its donors which provide unrestricted support to icddr,b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). We gratefully acknowledge these donors for their support and commitment to icddr, b's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Boyd DA, 2006, J ANTIMICROB CHEMOTH, V58, P224, DOI 10.1093/jac/dkl154; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610; Canton R, 2003, CURR OPIN INFECT DIS, V16, P315, DOI 10.1097/00001432-200308000-00003; Carattoli A, 2008, J CLIN MICROBIOL, V46, P103, DOI 10.1128/JCM.01542-07; Chakraborty S, 2001, J CLIN MICROBIOL, V39, P3241, DOI 10.1128/JCM.39.9.3241-3246.2001; Clinical and Laboratory Standard Institute (CLSI), 2010, M100S20U CLSI; Coudron PE, 1997, J CLIN MICROBIOL, V35, P2593, DOI 10.1128/JCM.35.10.2593-2597.1997; Dashti AA, 2006, J MED MICROBIOL, V55, P417, DOI 10.1099/jmm.0.46177-0; Doublet B, 2009, ANTIMICROB AGENTS CH, V53, P1944, DOI 10.1128/AAC.01581-08; Dromigny JA, 2005, J ANTIMICROB CHEMOTH, V56, P236, DOI 10.1093/jac/dki158; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Forbes B. A., 2001, BAILEY SCOTTS DIAGNO; Guerra B, 2001, ANTIMICROB AGENTS CH, V45, P1305, DOI 10.1128/AAC.45.4.1305-1308.2001; Hasan B, 2014, VET MICROBIOL, V168, P221, DOI 10.1016/j.vetmic.2013.09.033; Hernandez JR, 2005, ANTIMICROB AGENTS CH, V49, P2122, DOI 10.1128/AAC.49.5.2122-2125.2005; Heuvelink AE DBE, 1994, WARE CHEM, V24, P25; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Islam MA, 2012, EUR J CLIN MICROBIOL, V31, P2593, DOI 10.1007/s10096-012-1601-2; JACOBY GA, 1991, ANTIMICROB AGENTS CH, V35, P164, DOI 10.1128/AAC.35.1.164; JARLIER V, 1988, REV INFECT DIS, V10, P867; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Lavilla S, 2008, J ANTIMICROB CHEMOTH, V61, P291, DOI 10.1093/jac/dkm448; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Machado E, 2005, ANTIMICROB AGENTS CH, V49, P1823, DOI 10.1128/AAC.49.5.1823-1829.2005; Mehrgan H, 2008, INT J ANTIMICROB AG, V31, P147, DOI 10.1016/j.ijantimicag.2007.09.008; Morgan-Linnell SK, 2007, ANTIMICROB AGENTS CH, V51, P4205, DOI 10.1128/AAC.00647-07; Mugnaioli C, 2006, ANTIMICROB AGENTS CH, V50, P2700, DOI 10.1128/AAC.00068-06; Muzaheed, 2008, J ANTIMICROB CHEMOTH, V61, P1393, DOI 10.1093/jac/dkn109; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1; Pitout JDD, 1998, ANTIMICROB AGENTS CH, V42, P1350, DOI 10.1128/AAC.42.6.1350; Prelog M, 2008, INFECTION, V36, P362, DOI 10.1007/s15010-008-7309-7; Radice M, 2002, ANTIMICROB AGENTS CH, V46, P602, DOI 10.1128/AAC.46.2.602-604.2002; Rahman MM, 2004, INT J ANTIMICROB AG, V24, P508, DOI 10.1016/j.ijantimicag.2004.05.007; Ryoo NH, 2005, J ANTIMICROB CHEMOTH, V56, P698, DOI 10.1093/jac/dki324; Salyers WD, 2005, BACTERIAL PATHOGENES; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; Talukdar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061090; Talukder KA, 2006, CURR MICROBIOL, V52, P108, DOI 10.1007/s00284-005-0140-9; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valverde A, 2004, J CLIN MICROBIOL, V42, P4769, DOI 10.1128/JCM.42.10.4769-4775.2004; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Villa L, 2000, ANTIMICROB AGENTS CH, V44, P2911, DOI 10.1128/AAC.44.10.2911-2914.2000	50	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108735	10.1371/journal.pone.0108735	http://dx.doi.org/10.1371/journal.pone.0108735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302491	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400023
J	Diwan, F; Makana, G; McKenzie, D; Paruzzolo, S				Diwan, Faizan; Makana, Grace; McKenzie, David; Paruzzolo, Silvia			Invitation Choice Structure Has No Impact on Attendance in a Female Business Training Program in Kenya	PLOS ONE			English	Article								Business training programs are a common form of support to small businesses, but organizations providing this training often struggle to get business owners to attend. We evaluate the role of invitation choice structure in determining agreement to participate and actual attendance. A field experiment randomly assigned female small business owners in Kenya (N = 1172) to one of three invitation types: a standard opt-in invitation; an active choice invitation where business owners had to explicitly say yes or no to the invitation; and an enhanced active choice invitation which highlighted the costs of saying no. We find no statistically significant effect of these alternative choice structures on willingness to participate in training, attending at least one day, and completing the course. The 95 percent confidence interval for the active treatment effect on attendance is [-1.9%, +9.5%], while for the enhanced active choice treatment it is [-4.1%, +7.7%]. The effect sizes consistent with our data are smaller than impacts measured in health and retirement savings studies in the United States. We examine several potential explanations for the lack of effect in a developing country setting. We find evidence consistent with two potential reasons being limited decision-making power amongst some women, and lower levels of cognition making the enhanced active choice wording less effective.	[Diwan, Faizan; Makana, Grace] Innovat Poverty Act, Kisumu and Kakamega, Kenya; [McKenzie, David] World Bank, Dev Res Grp, Washington, DC 20433 USA; [Paruzzolo, Silvia] Int Labor Org, Geneva, Switzerland	Innovations for Poverty Action (IPA); The World Bank	McKenzie, D (corresponding author), World Bank, Dev Res Grp, 1818 H St NW, Washington, DC 20433 USA.	dmckenzie@worldbank.org			International Initiative for Impact Evaluation (3ie); ILO	International Initiative for Impact Evaluation (3ie); ILO	This work was funded by grants from the International Initiative for Impact Evaluation (3ie) and the ILO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorvatn K, 2010, J EUR ECON ASSOC, V8, P561, DOI 10.1111/j.1542-4774.2010.tb00526.x; Botti S, 2006, J CONSUM RES, V33, P211, DOI 10.1086/506302; Bruhn M, 2013, J DEV EFFECT, V5, P232, DOI 10.1080/19439342.2013.780090; Bruhn M, 2009, AM ECON J-APPL ECON, V1, P200, DOI 10.1257/app.1.4.200; Carroll GD, 2009, Q J ECON, V124, P1639, DOI 10.1162/qjec.2009.124.4.1639; Cioffi D, 1996, PERS SOC PSYCHOL B, V22, P133, DOI 10.1177/0146167296222003; de Mel S, 2014, J DEV ECON, V106, P199, DOI 10.1016/j.jdeveco.2013.09.005; International Labour Office, 2011, GET AH WOM ENT TRAIN; Karlan D, 2011, REV ECON STAT, V93, P510, DOI 10.1162/REST_a_00074; Keller PA, 2011, J CONSUM PSYCHOL, V21, P376, DOI 10.1016/j.jcps.2011.06.003; Linda Deelen, 2004, GENDER ENTREPRENEURS; McKenzie D, 2014, WORLD BANK RES OBSER, V29, P48, DOI 10.1093/wbro/lkt007; Sunstein C.R., 2012, IMPERSONAL DEFAULT R; Thaler R.H., 2021, NUDGE FINAL EDITION; Valdivia M., 2013, BUSINESS TRAINING PL	15	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109873	10.1371/journal.pone.0109873	http://dx.doi.org/10.1371/journal.pone.0109873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299647	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200080
J	Kellner, E; Gall, P; Gunther, M; Reisert, M; Mader, I; Fleysher, R; Kiselev, VG				Kellner, Elias; Gall, Peter; Guenther, Matthias; Reisert, Marco; Mader, Irina; Fleysher, Roman; Kiselev, Valerij G.			Blood Tracer Kinetics in the Arterial Tree	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; ULTRASOUND TECHNIQUES; BOLUS DISPERSION; VASCULAR TREES; CONTRAST MRI; SCALING LAWS; FLOW; QUANTIFICATION; HEMODYNAMICS; BIFURCATION	Evaluation of blood supply of different organs relies on labeling blood with a suitable tracer. The tracer kinetics is linear: Tracer concentration at an observation site is a linear response to an input somewhere upstream the arterial flow. The corresponding impulse response functions are currently treated empirically without incorporating the relation to the vascular morphology of an organ. In this work we address this relation for the first time. We demonstrate that the form of the response function in the entire arterial tree is reduced to that of individual vessel segments under approximation of good blood mixing at vessel bifurcations. The resulting expression simplifies significantly when the geometric scaling of the vascular tree is taken into account. This suggests a new way to access the vascular morphology in vivo using experimentally determined response functions. However, it is an ill-posed inverse problem as demonstrated by an example using measured arterial spin labeling in large brain arteries. We further analyze transport in individual vessel segments and demonstrate that experimentally accessible tracer concentration in vessel segments depends on the measurement principle. Explicit expressions for the response functions are obtained for the major middle part of the arterial tree in which the blood flow in individual vessel segments can be treated as laminar. When applied to the analysis of regional cerebral blood flow measurements for which the necessary arterial input is evaluated in the carotid arteries, present theory predicts about 20% underestimation, which is in agreement with recent experimental data.	[Kellner, Elias; Reisert, Marco; Kiselev, Valerij G.] Univ Med Ctr Freiburg, Dept Radiol, Freiburg, Germany; [Gall, Peter] Siemens AG, Healthcare Sect, Erlangen, Germany; [Guenther, Matthias] Inst Med Image Comp, Fraunhofer MEVIS, Bremen, Germany; [Mader, Irina] Univ Med Ctr Freiburg, Dept Neuroradiol, Freiburg, Germany; [Fleysher, Roman] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Dept Radiol, New York, NY USA	University of Freiburg; Siemens AG; Siemens Germany; University of Freiburg; Yeshiva University	Kellner, E (corresponding author), Univ Med Ctr Freiburg, Dept Radiol, Freiburg, Germany.	elias.kellner@uniklinik-freiburg.de	Kiselev, Valerij G./E-5535-2014	Kiselev, Valerij G./0000-0002-5349-5399	National Institutes of Health (NIH) [2P01AG003949-26A2]; COST Action on ASL in Dementia (AID) [BM1103]; NATIONAL INSTITUTE ON AGING [P01AG003949] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COST Action on ASL in Dementia (AID); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	RF was supported in part by National Institutes of Health (NIH) grant 2P01AG003949-26A2. Collaboration between two German groups (VGK and MG) was partially supported by COST Action BM1103 on ASL in Dementia (AID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Bosworth R, 1948, PHILOS MAG, V39, P847; Calamante F, 2005, J MAGN RESON IMAGING, V22, P718, DOI 10.1002/jmri.20454; Calamante F, 2002, STROKE, V33, P1146, DOI 10.1161/01.STR.0000014208.05597.33; Calamante F, 2000, MAGN RESON MED, V44, P466, DOI 10.1002/1522-2594(200009)44:3<466::AID-MRM18>3.0.CO;2-M; Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; Cassot F, 2009, MICROCIRCULATION, V16, P331, DOI 10.1080/10739680802662607; Cassot F, 2010, BRAIN RES, V1313, P62, DOI 10.1016/j.brainres.2009.12.007; Gallichan D, 2008, MAGN RESON MED, V60, P53, DOI 10.1002/mrm.21654; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Hudetz AG, 1997, MICROCIRCULATION, V4, P233, DOI 10.3109/10739689709146787; Ibaraki M, 2007, J CEREBR BLOOD F MET, V27, P404, DOI 10.1038/sj.jcbfm.9600337; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; Kellner E, 2013, MAGN RESON MED; Kellner E, 2013, MAGN RESON MED, V69, P771, DOI 10.1002/mrm.24319; Kinsman JM, 1929, AM J PHYSIOL, V89, P322, DOI 10.1152/ajplegacy.1929.89.2.322; Kirbas C, 2004, ACM COMPUT SURV, V36, P81, DOI 10.1145/1031120.1031121; KU DN, 1987, J BIOMECH, V20, P407, DOI 10.1016/0021-9290(87)90048-0; Liu J, 2013, HYPERTENSION, V62, P973, DOI 10.1161/HYPERTENSIONAHA.113.01867; Lorthois S, 2010, J THEOR BIOL, V262, P614, DOI 10.1016/j.jtbi.2009.10.037; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Meckel S, 2013, NEURORADIOLOGY, V55, P389, DOI 10.1007/s00234-012-1103-z; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Mouannes-Srour JJ, 2012, MAGN RESON MED, V68, P495, DOI 10.1002/mrm.23257; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Murray CD, 1926, J GEN PHYSIOL, V9, P835, DOI 10.1085/jgp.9.6.835; Oktar SO, 2006, AM J NEURORADIOL, V27, P363; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; PAWLIK G, 1981, BRAIN RES, V208, P35, DOI 10.1016/0006-8993(81)90619-3; Qian H, 2000, J THEOR BIOL, V205, P261, DOI 10.1006/jtbi.2000.2060; SHEPPARD C W, 1954, Minn Med, V37, P93; Shin WY, 2007, MAGN RESON MED, V58, P1232, DOI 10.1002/mrm.21420; Silvennoinen MJ, 2003, MAGNET RESON MED, V49, P568, DOI 10.1002/mrm.10370; Sommer K, 2014, ANN BIOMED ENG, V42, P787, DOI 10.1007/s10439-013-0950-z; Srour JM, 2011, J CEREBR BLOOD F MET, V31, P1272, DOI 10.1038/jcbfm.2010.215; Stewart G N, 1893, J Physiol, V15, P1; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; TAYLOR G, 1953, PROC R SOC LON SER-A, V219, P186, DOI 10.1098/rspa.1953.0139; Turner R, 2002, NEUROIMAGE, V16, P1062, DOI 10.1006/nimg.2002.1082; Vakil P, 2013, RADIOLOGY, V266, P879, DOI 10.1148/radiol.12120756; Varela M, 2011, NMR BIOMED, V24, P80, DOI 10.1002/nbm.1559; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Wetzel S, 2007, AM J NEURORADIOL, V28, P433; Wu Y, 2007, J CEREBR BLOOD F MET, V27, P632, DOI 10.1038/sj.jcbfm.9600374; Yang J, 2010, AM J PHYSIOL-HEART C, V298, pH1249, DOI 10.1152/ajpheart.00363.2009; Zierler K, 2000, ANN BIOMED ENG, V28, P836, DOI 10.1114/1.1308496	47	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109230	10.1371/journal.pone.0109230	http://dx.doi.org/10.1371/journal.pone.0109230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299048	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200042
J	Bazzini, C; Benedetti, L; Civello, D; Zanoni, C; Rossetti, V; Marchesi, D; Garavaglia, ML; Paulmichi, M; Francolini, M; Meyer, G; Rodighiero, S				Bazzini, Claudia; Benedetti, Lorena; Civello, Davide; Zanoni, Chiara; Rossetti, Valeria; Marchesi, Davide; Garavaglia, Maria Lisa; Paulmichi, Markus; Francolini, Maura; Meyer, Giuliano; Rodighiero, Simona			ICln: A New Regulator of Non-Erythroid 4.1R Localisation and Function	PLOS ONE			English	Article							CELL-VOLUME REGULATION; PROTEIN 4.1R-DEFICIENT MICE; RED-BLOOD-CELLS; ERYTHROCYTE-MEMBRANE; CHLORIDE CHANNEL; ANION CHANNELS; MULTIPROTEIN COMPLEX; SURFACE EXPRESSION; ACTIN-FILAMENT; BINDING-SITE	To optimise the efficiency of cell machinery, cells can use the same protein (often called a hub protein) to participate in different cell functions by simply changing its target molecules. There are large data sets describing protein-protein interactions ("interactome") but they frequently fail to consider the functional significance of the interactions themselves. We studied the interaction between two potential hub proteins, ICln and 4.1R (in the form of its two splicing variants 4.1R(80) and 4.1R(135)), which are involved in such crucial cell functions as proliferation, RNA processing, cytoskeleton organisation and volume regulation. The sub-cellular localisation and role of native and chimeric 4.1R over-expressed proteins in human embryonic kidney (HEK) 293 cells were examined. ICln interacts with both 4.1R(80) and 4.1R(135) and its over-expression displaces 4.1R from the membrane regions, thus affecting 4.1R interaction with beta-actin. It was found that 4.1R(80) and 4.1R(135) are differently involved in regulating the swelling activated anion current (I-Cl,I-swell) upon hypotonic shock, a condition under which both isoforms are dislocated from the membrane region and thus contribute to I-Cl,I-swell current regulation. Both 4.1R isoforms are also differently involved in regulating cell morphology, and ICln counteracts their effects. The findings of this study confirm that 4.1R plays a role in cell volume regulation and cell morphology and indicate that ICln is a new negative regulator of 4.1R functions.	[Bazzini, Claudia; Civello, Davide; Rossetti, Valeria; Garavaglia, Maria Lisa; Meyer, Giuliano] Univ Milan, Dept Biosci, Milan, Italy; [Benedetti, Lorena; Francolini, Maura] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Benedetti, Lorena; Marchesi, Davide; Francolini, Maura; Rodighiero, Simona] Fdn Filarete Biosci & Innovat, Milan, Italy; [Zanoni, Chiara] Univ Milan, Pharmaceut Sci Dept DISFARM, Milan, Italy; [Paulmichi, Markus] Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria	University of Milan; University of Milan; University of Milan; Paracelsus Private Medical University	Rodighiero, S (corresponding author), Fdn Filarete Biosci & Innovat, Milan, Italy.	simona.rodighiero@fondazionefilarete.com	Rodighiero, Simona/AAP-9816-2020; Garavaglia, Maria Lisa/AFV-3214-2022	Benedetti, Lorena/0000-0003-3510-0258; CIVELLO, DAVIDE ANTONIO/0000-0003-4133-8211; Rodighiero, Simona/0000-0003-4236-7823; FRANCOLINI, MAURA/0000-0002-3126-1575	Italian Ministry of Education, Universities and Research [PRIN 2008 - Prot. 2008W5AZEC_002]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by grant PRIN 2008 - Prot. 2008W5AZEC_002 from the Italian Ministry of Education, Universities and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; Baines AJ, 2013, BIOCH BIOPHYS ACTA; Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Baines AJ, 2009, BLOOD CELL MOL DIS, V42, P211, DOI 10.1016/j.bcmd.2009.01.016; Ben Soussia I, 2012, PFLUG ARCH EUR J PHY, V464, P273, DOI 10.1007/s00424-012-1139-2; Binda AV, 2002, MOL PHARMACOL, V62, P507, DOI 10.1124/mol.62.3.507; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buyse G, 1996, BIOCHEM BIOPH RES CO, V218, P822, DOI 10.1006/bbrc.1996.0146; Byfield FJ, 2006, ACTA PHYSIOL, V187, P285, DOI 10.1111/j.1748-1716.2006.01555.x; Cai S, 1998, AM J PHYSIOL-CELL PH, V275, pC1349, DOI 10.1152/ajpcell.1998.275.5.C1349; Calinisan V, 2006, FRONT BIOSCI-LANDMRK, V11, P1646, DOI 10.2741/1911; Cantiello HF, 1997, J EXP ZOOL, V279, P425, DOI 10.1002/(SICI)1097-010X(19971201)279:5<425::AID-JEZ4>3.0.CO;2-Q; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen LX, 2011, J CELL SCI, V124, P2478, DOI 10.1242/jcs.078170; CONBOY JG, 1988, P NATL ACAD SCI USA, V85, P9062, DOI 10.1073/pnas.85.23.9062; CORREAS I, 1986, J BIOL CHEM, V261, P3362; Cunha SR, 2008, CIRC RES, V103, P779, DOI 10.1161/CIRCRESAHA.108.186460; Demion M, 2006, J CARDIOVASC ELECTR, V17, P60, DOI 10.1111/j.1540-8167.2005.00255.x; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Douyard J, 2007, J COMP NEUROL, V502, P141, DOI 10.1002/cne.21294; Du XY, 1999, PFLUG ARCH EUR J PHY, V437, P227, DOI 10.1007/s004240050773; Elsing C, 2007, ACTA PHYSIOL, V190, P199, DOI 10.1111/j.1748-1716.2007.01682.x; Emma F, 1998, BBA-MOL CELL RES, V1404, P321, DOI 10.1016/S0167-4889(98)00073-1; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; Furst J, 2006, ACTA PHYSIOL, V187, P43, DOI 10.1111/j.1748-1716.2006.01549.x; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Furst J, 2000, PFLUG ARCH EUR J PHY, V440, P100; Gadella, 2009, FRET FLIM TECHN; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; Gauthier E, 2011, BIOCHEMISTRY-US, V50, P4561, DOI 10.1021/bi200154g; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Grimm C, 2013, MOL CELL, V49, P692, DOI 10.1016/j.molcel.2012.12.009; GSCHWENTNER M, 1995, PFLUG ARCH EUR J PHY, V430, P464, DOI 10.1007/BF00373882; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hoffmann EK, 2011, CELL PHYSIOL BIOCHEM, V28, P1061, DOI 10.1159/000335843; Huang SC, 2005, MOL BIOL CELL, V16, P117, DOI 10.1091/mbc.E04-05-0426; Hubert MD, 2000, BBA-BIOMEMBRANES, V1466, P105, DOI 10.1016/S0005-2736(00)00177-2; Jeremy KP, 2009, HAEMATOL-HEMATOL J, V94, P1354, DOI 10.3324/haematol.2009.006585; Jung Y, 2012, BIOCHEM BIOPH RES CO, V426, P578, DOI 10.1016/j.bbrc.2012.08.129; Kang QZ, 2009, BLOOD, V113, P6128, DOI 10.1182/blood-2008-10-182329; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Klausen TK, 2006, AM J PHYSIOL-CELL PH, V291, pC757, DOI 10.1152/ajpcell.00029.2006; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; Kurbannazarova RS, 2011, INT J MOL SCI, V12, P9125, DOI 10.3390/ijms12129125; Lang F, 1998, CELL PHYSIOL BIOCHEM, V8, P1, DOI 10.1159/000016269; Larkin D, 2004, J BIOL CHEM, V279, P27286, DOI 10.1074/jbc.M402159200; Larkin D, 2009, BRIT J HAEMATOL, V144, P580, DOI 10.1111/j.1365-2141.2008.07483.x; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li CH, 1998, J GEN PHYSIOL, V112, P727, DOI 10.1085/jgp.112.6.727; Liu CR, 2013, J BIOL CHEM, V288, P11407, DOI 10.1074/jbc.M112.436659; Livshits Leonid, 2012, Rev Diabet Stud, V9, P94, DOI 10.1900/RDS.2012.9.94; Lospitao E, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-51; Luque CM, 2003, J BIOL CHEM, V278, P2686, DOI 10.1074/jbc.M201521200; Luque CM, 2000, J CELL SCI, V113, P2485; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Mullins RD, 2013, CURR OPIN CELL BIOL, V25, P6, DOI 10.1016/j.ceb.2012.11.007; Musch MW, 1998, PFLUG ARCH EUR J PHY, V436, P415, DOI 10.1007/s004240050651; Nunomura W, 2006, FRONT BIOSCI-LANDMRK, V11, P1522, DOI 10.2741/1901; Nunomura W, 2012, BIOCHEM J, V446, P427, DOI 10.1042/BJ20120535; Nunomura W, 2009, BIOCHEM J, V417, P141, DOI 10.1042/BJ20081372; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Parra MK, 2012, MOL CELL BIOL, V32, P2044, DOI 10.1128/MCB.05716-11; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Pedersen SF, 2011, J AM SOC NEPHROL, V22, P1587, DOI 10.1681/ASN.2010121284; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Pu WT, 2000, J BIOL CHEM, V275, P12363, DOI 10.1074/jbc.275.17.12363; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; REID ME, 1990, BLOOD, V75, P2229; Ritter M, 2003, J BIOL CHEM, V278, P50163, DOI 10.1074/jbc.M300374200; Rivera A, 2006, AM J PHYSIOL-CELL PH, V291, pC880, DOI 10.1152/ajpcell.00436.2005; Rodighiero S, 2008, CELL PHYSIOL BIOCHEM, V21, P489, DOI 10.1159/000129642; Rose M, 2008, J NEUROCHEM, V105, P2375, DOI 10.1111/j.1471-4159.2008.05331.x; Ruiz-Saenz A, 2011, J CELL SCI, V124, P2529, DOI 10.1242/jcs.083634; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Schedlbauer A, 2011, CELL PHYSIOL BIOCHEM, V28, P1203, DOI 10.1159/000335852; Schischmanoff PO, 1997, J BIOL CHEM, V272, P10254, DOI 10.1074/jbc.272.15.10254; Schwartz RS, 1997, BIOCHEM J, V327, P609; Seo PS, 2009, BBA-MOL CELL RES, V1793, P281, DOI 10.1016/j.bbamcr.2008.09.012; Shen L, 2000, J NEUROSCI, V20, P7932; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; Stepensky D, 2007, BIOCHEM BIOPH RES CO, V359, P752, DOI 10.1016/j.bbrc.2007.05.180; Takakuwa Y, 2000, INT J HEMATOL, V72, P298; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V28, P1191, DOI 10.1159/000335851; Tang CJC, 1998, BLOOD, V92, P1442, DOI 10.1182/blood.V92.4.1442.416k14_1442_1447; Tang T K, 1988, Adv Exp Med Biol, V241, P81; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; VENEZIA ND, 1992, J CLIN INVEST, V90, P1713, DOI 10.1172/JCI116044; Verveer PJ, 2006, CSH PROTOC, V2006; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Wang GX, 2005, J MEMBRANE BIOL, V208, P15, DOI 10.1007/s00232-005-0815-y; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940	104	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108826	10.1371/journal.pone.0108826	http://dx.doi.org/10.1371/journal.pone.0108826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295618	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000020
J	Ding, MZ; Yan, HF; Li, LF; Zhai, F; Shang, LQ; Yin, Z; Yuan, YJ				Ding, Ming-zhu; Yan, Hui-fang; Li, Lin-feng; Zhai, Fang; Shang, Lu-qing; Yin, Zheng; Yuan, Ying-jin			Biosynthesis of Taxadiene in Saccharomyces cerevisiae : Selection of Geranylgeranyl Diphosphate Synthase Directed by a Computer-Aided Docking Strategy	PLOS ONE			English	Article							ANTIMALARIAL-DRUG PRECURSOR; MEVALONATE PATHWAY; GENES; CHAIN; YEAST; OVERPRODUCTION; MILTIRADIENE; EXPRESSION; OXYGEN; LEVEL	Identification of efficient key enzymes in biosynthesis pathway and optimization of the fitness between functional modules and chassis are important for improving the production of target compounds. In this study, the taxadiene biosynthesis pathway was firstly constructed in yeast by transforming ts gene and overexpressing erg20 and thmgr. Then, the catalytic capabilities of six different geranylgeranyl diphosphate synthases (GGPPS), the key enzyme in mevalonic acid (MVA) pathway catalyzing famesyl diphosphate (FPP) to geranylgeranyl diphosphate (GGPP), were predicted using enzyme-substrate docking strategy. GGPPSs from Taxus baccata x Taxus cuspidate (GGPPSbc), Erwinia herbicola (GGPPSeh), and S. cerevisiae (GGPPSsc) which ranked 1st, 4th and 6th in docking with FPP were selected for construction. The experimental results were consistent with the computer prediction that the engineered yeast with GGPPSbc exhibited the highest production. In addition, two chassis YSG50 and W303-1A were chosen, and the titer of taxadiene reached 72.8 mg/L in chassis YSG50 with GGPPSbc. Metabolomic study revealed that the contents of tricarboxylic acid cycle (TCA) intermediates and their precursor amino acids in chassis YSG50 was lower than those in W303-1A, indicating less carbon flux was divided into TCA cycle. Furthermore, the levels of TCA intermediates in the taxadiene producing yeasts were lower than those in chassis YSG50. Thus, it may result in more carbon flux in MVA pathway in chassis YSG50, which suggested that YSG50 was more suitable for engineering the taxadiene producing yeast. These results indicated that computer-aided protein modeling directed isoenzyme selection strategy and metabolomic study could guide the rational design of terpenes biosynthetic cells.	[Ding, Ming-zhu; Yan, Hui-fang; Zhai, Fang; Yuan, Ying-jin] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; [Ding, Ming-zhu; Yan, Hui-fang; Zhai, Fang; Yuan, Ying-jin] Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Tianjin 300072, Peoples R China; [Ding, Ming-zhu; Yan, Hui-fang; Li, Lin-feng; Zhai, Fang; Shang, Lu-qing; Yin, Zheng; Yuan, Ying-jin] Collaborat Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China; [Li, Lin-feng; Shang, Lu-qing; Yin, Zheng] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Li, Lin-feng; Shang, Lu-qing; Yin, Zheng] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	Tianjin University; Tianjin University; Nankai University; Nankai University	Yin, Z (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	zheng_yin@nankai.edu.cn; yjyuan@tju.edu.cn	yin, zheng/A-4825-2012	yin, zheng/0000-0002-7346-6325; Li, Linfeng/0000-0001-6185-4999	Ministry of Science and Technology of China [2012AA02A701, 2012CB721105]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was funded by the Ministry of Science and Technology of China ("863" Program: 2012AA02A701 and "973" Program: 2012CB721105). The authors also thank Huimin Zhao of University of Illinois at Urbana-Champaign for kindly providing yeast YSG50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Albertsen L, 2011, APPL ENVIRON MICROB, V77, P1033, DOI 10.1128/AEM.01361-10; Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Asadollahi MA, 2010, BIOTECHNOL BIOENG, V106, P86, DOI 10.1002/bit.22668; Boghigian BA, 2012, APPL MICROBIOL BIOT, V93, P2063, DOI 10.1007/s00253-011-3725-1; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Carrau FM, 2005, FEMS MICROBIOL LETT, V243, P107, DOI 10.1016/j.femsle.2004.11.050; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Chang MCY, 2006, NAT CHEM BIOL, V2, P674, DOI 10.1038/nchembio836; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Conolly JD, 1991, DICT TERPENOIDS; Dai ZB, 2012, BIOTECHNOL BIOENG, V109, P2845, DOI 10.1002/bit.24547; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; Ding MZ, 2012, METABOLOMICS, V8, P232, DOI 10.1007/s11306-011-0303-6; Ding MZ, 2010, METABOLOMICS, V6, P42, DOI 10.1007/s11306-009-0173-3; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; JIANG Y, 1995, J BIOL CHEM, V270, P21793, DOI 10.1074/jbc.270.37.21793; Kampranis SC, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210006; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Rico J, 2010, APPL ENVIRON MICROB, V76, P6449, DOI 10.1128/AEM.02987-09; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Takahashi S, 2007, BIOTECHNOL BIOENG, V97, P170, DOI 10.1002/bit.21216; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wang CW, 1999, BIOTECHNOL BIOENG, V62, P235, DOI 10.1002/(SICI)1097-0290(19990120)62:2<235::AID-BIT14>3.0.CO;2-U; Zhou YJJ, 2012, J AM CHEM SOC, V134, P3234, DOI 10.1021/ja2114486	35	43	51	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109348	10.1371/journal.pone.0109348	http://dx.doi.org/10.1371/journal.pone.0109348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295588	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000062
J	Drogemuller, M; Jagannathan, V; Welle, MM; Graubner, C; Straub, R; Gerber, V; Burger, D; Signer-Hasler, H; Poncet, PA; Klopfenstein, S; von Niederhausern, R; Tetens, J; Thaller, G; Rieder, S; Drogemuller, C; Leeb, T				Drogemuller, Michaela; Jagannathan, Vidhya; Welle, Monika M.; Graubner, Claudia; Straub, Reto; Gerber, Vinzenz; Burger, Dominik; Signer-Hasler, Heidi; Poncet, Pierre-Andre; Klopfenstein, Stephane; von Niederhaeusern, Ruedi; Tetens, Jens; Thaller, Georg; Rieder, Stefan; Drogemuller, Cord; Leeb, Tosso			Congenital Hepatic Fibrosis in the Franches-Montagnes Horse Is Associated with the Polycystic Kidney and Hepatic Disease 1 (PKHD1) Gene	PLOS ONE			English	Article							CAROLIS-DISEASE; LIVER FIBROSIS; PROTEIN; GENOME; DYSGENESIS; ALIGNMENT; ENCODES; BILIARY; ARPKD; MODEL	Congenital hepatic fibrosis has been described as a lethal disease with monogenic autosomal recessive inheritance in the Swiss Franches-Montagnes horse breed. We performed a genome-wide association study with 5 cases and 12 controls and detected an association on chromosome 20. Subsequent homozygosity mapping defined a critical interval of 952 kb harboring 10 annotated genes and loci including the polycystic kidney and hepatic disease 1 (autosomal recessive) gene (PKHD1). PKHD1 represents an excellent functional candidate as variants in this gene were identified in human patients with autosomal recessive polycystic kidney and hepatic disease (ARPKD) as well as several mouse and rat mutants. Whereas most pathogenic PKHD1 variants lead to polycystic defects in kidney and liver, a small subset of the human ARPKD patients have only liver symptoms, similar to our horses with congenital hepatic fibrosis. The PKHD1 gene is one of the largest genes in the genome with multiple alternative transcripts that have not yet been fully characterized. We sequenced the genomes of an affected foal and 46 control horses to establish a comprehensive list of variants in the critical interval. We identified two missense variants in the PKHD1 gene which were strongly, but not perfectly associated with congenital hepatic fibrosis. We speculate that reduced penetrance and/or potential epistatic interactions with hypothetical modifier genes may explain the imperfect association of the detected PKHD1 variants. Our data thus indicate that horses with congenital hepatic fibrosis represent an interesting large animal model for the liver-restricted subtype of human ARPKD.	[Drogemuller, Michaela; Jagannathan, Vidhya; Drogemuller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Drogemuller, Michaela; Jagannathan, Vidhya; Signer-Hasler, Heidi; von Niederhaeusern, Ruedi; Rieder, Stefan; Drogemuller, Cord; Leeb, Tosso] Univ Bern, Bern Univ Appl Sci HAFL & Agroscope, Swiss Competence Ctr Anim Breeding & Genet, Bern, Switzerland; [Welle, Monika M.] Univ Bern, Inst Anim Pathol, Bern, Switzerland; [Graubner, Claudia; Straub, Reto; Gerber, Vinzenz; Burger, Dominik] Univ Bern & Agroscope, Swiss Inst Equine Med, Bern, Switzerland; [Signer-Hasler, Heidi] Bern Univ Appl Sci HAFL, Zollikofen, Switzerland; [Poncet, Pierre-Andre] HIPPOP, Lignerolle, Switzerland; [Klopfenstein, Stephane] Swiss Franches Montagnes Breeding Assoc, Avenches, Switzerland; [von Niederhaeusern, Ruedi; Rieder, Stefan] Swiss Natl Stud Farm, Avenches, Switzerland; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	University of Bern; Swiss Federal Research Station Agroscope; University of Bern; University of Bern; Swiss Federal Research Station Agroscope; University of Bern; University of Kiel	Leeb, T (corresponding author), Univ Bern, Inst Genet, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Welle, Monika Maria/ABF-6113-2021; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Drogemuller, Cord/0000-0001-9773-522X; Tetens, Jens/0000-0001-5352-464X	Swiss Federal Office for Agriculture; Swiss Federal Food Safety and Veterinary Office; Swiss Franches-Montagnes Breeding Association	Swiss Federal Office for Agriculture; Swiss Federal Food Safety and Veterinary Office; Swiss Franches-Montagnes Breeding Association	This study was financed in part by contributions from the Swiss Federal Office for Agriculture, the Swiss Federal Food Safety and Veterinary Office, and the Swiss Franches-Montagnes Breeding Association. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva M, 2006, MEDICINE, V85, P1, DOI 10.1097/01.md.0000200165.90373.9a; Bourque AC, 2001, CAN VET J, V42, P145; Brown DL, 2010, VET PATHOL, V47, P102, DOI 10.1177/0300985809353313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Gallagher AR, 2008, AM J PATHOL, V172, P417, DOI 10.2353/ajpath.2008.070381; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Haechler S, 2000, VET PATHOL, V37, P669, DOI 10.1354/vp.37-6-669; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moser M, 2005, HEPATOLOGY, V41, P1113, DOI 10.1002/hep.20655; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Stocker H, 1996, Tierarztl Prax, V24, P44; Straub R, 2003, TIERAERZTL PRAX G N, V31, P162; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wallace S, 2009, VET PATHOL, V46, P84, DOI 10.1354/vp.46-1-84; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Yoshikawa H, 2002, VET PATHOL, V39, P143, DOI 10.1354/vp.39-1-143; Zandvliet MMJM, 2005, J VET INTERN MED, V19, P765, DOI 10.1892/0891-6640(2005)19[765:APSICS]2.0.CO;2; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101	25	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110125	10.1371/journal.pone.0110125	http://dx.doi.org/10.1371/journal.pone.0110125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295861	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000113
J	Lee, S; Rahnenfuhrer, J; Lang, M; De Preter, K; Mestdagh, P; Koster, J; Versteeg, R; Stallings, RL; Varesio, L; Asgharzadeh, S; Schulte, JH; Fielitz, K; Schwermer, M; Morik, K; Schramm, A				Lee, Sangkyun; Rahnenfuehrer, Joerg; Lang, Michel; De Preter, Katleen; Mestdagh, Pieter; Koster, Jan; Versteeg, Rogier; Stallings, Raymond L.; Varesio, Luigi; Asgharzadeh, Shahab; Schulte, Johannes H.; Fielitz, Kathrin; Schwermer, Melanie; Morik, Katharina; Schramm, Alexander			Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling	PLOS ONE			English	Article							HUMAN NEUROBLASTOMA-CELLS; MITOTIC CHECKPOINT GENES; BREAST-CANCER; CLINICOPATHOLOGICAL SIGNIFICANCE; VARIABLE SELECTION; MESSENGER-RNA; HUMAN LUNG; EXPRESSION; REGRESSION; STABILITY	Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughput studies. Signatures, composed of features such as mRNAs, miRNAs, SNPs or other molecular variables, are often non-overlapping, even though they have been identified from similar experiments considering samples with the same type of disease. The lack of a consensus is mostly due to the fact that sample sizes are far smaller than the numbers of candidate features to be considered, and therefore signature selection suffers from large variation. We propose a robust signature selection method that enhances the selection stability of penalized regression algorithms for predicting survival risk. Our method is based on an aggregation of multiple, possibly unstable, signatures obtained with the preconditioned lasso algorithm applied to random (internal) subsamples of a given cohort data, where the aggregated signature is shrunken by a simple thresholding strategy. The resulting method, RS-PL, is conceptually simple and easy to apply, relying on parameters automatically tuned by cross validation. Robust signature selection using RS-PL operates within an (external) subsampling framework to estimate the selection probabilities of features in multiple trials of RS-PL. These probabilities are used for identifying reliable features to be included in a signature. Our method was evaluated on microarray data sets from neuroblastoma, lung adenocarcinoma, and breast cancer patients, extracting robust and relevant signatures for predicting survival risk. Signatures obtained by our method achieved high prediction performance and robustness, consistently over the three data sets. Genes with high selection probability in our robust signatures have been reported as cancer-relevant. The ordering of predictor coefficients associated with signatures was well-preserved across multiple trials of RS-PL, demonstrating the capability of our method for identifying a transferable consensus signature. The software is available as an R package rsig at CRAN (http://cran.r-project.org).	[Lee, Sangkyun; Morik, Katharina] TU Dortmund Univ, Dept Comp Sci, Dortmund, Germany; [Rahnenfuehrer, Joerg; Lang, Michel] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [De Preter, Katleen; Mestdagh, Pieter] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Varesio, Luigi] Giannina Gaslini Inst, Mol Biol Lab, Genoa, Italy; [Asgharzadeh, Shahab] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Schulte, Johannes H.; Fielitz, Kathrin; Schwermer, Melanie; Schramm, Alexander] Univ Childrens Hosp Essen, Dept Pediat Oncol & Hematol, Essen, Germany; [Schulte, Johannes H.] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany; [Schulte, Johannes H.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Essen, Germany; [Schulte, Johannes H.] German Canc Consortium DKTK, Heidelberg, Germany; [Schulte, Johannes H.] German Canc Res Ctr, Heidelberg, Germany	Dortmund University of Technology; Dortmund University of Technology; Ghent University; Ghent University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Royal College of Surgeons - Ireland; University of Genoa; IRCCS Istituto Giannina Gaslini; Children's Hospital Los Angeles; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Lee, S (corresponding author), TU Dortmund Univ, Dept Comp Sci, Dortmund, Germany.	sangkyun.lee@tu-dortmund.de	Stallings, Raymond/A-7213-2008; Versteeg, Rogier/AAQ-1765-2020; Schwermer, Melanie/AAG-1810-2021; varesio, luigi/J-8261-2016; Koster, Jan/C-5934-2008; De Preter, Katleen/I-7135-2013; Lee, Sangkyun/AAE-5272-2019; Schulte, Johannes H./V-2474-2018; Schramm, Alexander/G-5688-2010	varesio, luigi/0000-0001-5659-2218; Koster, Jan/0000-0002-0890-7585; De Preter, Katleen/0000-0002-7726-5096; Lee, Sangkyun/0000-0001-8415-6368; Schramm, Alexander/0000-0001-7670-7529; Rahnenfuhrer, Jorg/0000-0002-8947-440X; Mestdagh, Pieter/0000-0001-7821-9684; Lang, Michel/0000-0001-9754-0393; Versteeg, Rogier/0000-0001-7172-0388; Asgharzadeh, Shahab/0000-0002-0510-3848; Schulte, Johannes Hubertus/0000-0003-0671-1201	Deutsche Forschungs-gemeinschaft (DFG) within the Collaborative Research Center [SFB 876]; Italian Association for Cancer Research; ENCCA network; Italian Ministry of Health	Deutsche Forschungs-gemeinschaft (DFG) within the Collaborative Research Center(German Research Foundation (DFG)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); ENCCA network; Italian Ministry of Health(Ministry of Health, Italy)	The authors acknowledge the support of Deutsche Forschungs-gemeinschaft (DFG) within the Collaborative Research Center SFB 876 (http://sfb876.tu-dortmund.de) "Providing Information by Resource-Constrained Analysis", projects A3 and Cl. L. Varesio was supported by grants from the Italian Association for Cancer Research, the ENCCA network, the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Alaminos M, 2003, CANCER RES, V63, P4538; Asgharzadeh S, 2012, J CLIN ONCOL, V30, P3525, DOI 10.1200/JCO.2011.40.9169; Bach FR., 2008, P 25 INT C MACHINE L, V33, P40, DOI [10.1145/1390156.1390161, DOI 10.1145/1390156.1390161]; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bischl B, 2014, J STAT SOFTWARE; Bogdanova N, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-12; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boukovinas I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003695; Bravo HC, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-272; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Broom BM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S10; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Cao F, 2013, ASIAN PAC J CANCER P, V14, P195, DOI 10.7314/APJCP.2013.14.1.195; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Chou JL, 2010, LAB INVEST, V90, P414, DOI 10.1038/labinvest.2009.138; COX DR, 1972, J R STAT SOC B, V34, P187; Cox dr, 1984, ANAL SURVIVAL DATA, DOI DOI 10.1201/9781315137438; CZERWINSKI M, 1994, CANCER RES, V54, P1085; Davis CA, 2006, BIOINFORMATICS, V22, P2356, DOI 10.1093/bioinformatics/btl400; Decock A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R95, 10.1186/gb-2012-13-10-r95]; DibHajj SD, 1996, FEBS LETT, V384, P78, DOI 10.1016/0014-5793(96)00273-6; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Gatta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015965; Gui J, 2005, BIOINFORMATICS, V21, P3001, DOI 10.1093/bioinformatics/bti422; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Haruki N, 2001, CANCER LETT, V162, P201, DOI 10.1016/S0304-3835(00)00675-3; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jurman G, 2008, BIOINFORMATICS, V24, P258, DOI 10.1093/bioinformatics/btm550; Kalousis A, 2007, KNOWL INF SYST, V12, P95, DOI 10.1007/s10115-006-0040-8; Kikuchi J, 2011, LUNG CANCER, V72, P229, DOI 10.1016/j.lungcan.2010.08.020; Ko JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086569; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; Lin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018608; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; MATSUI T, 1993, J CLIN INVEST, V92, P1153, DOI 10.1172/JCI116684; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-137; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mefford D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037646; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Mishra PK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002303; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Paul D, 2008, ANN STAT, V36, P1595, DOI 10.1214/009053607000000578; Planck M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078614; Pupa SM, 2007, CANCER RES, V67, P4271, DOI 10.1158/0008-5472.CAN-06-4162; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Schulte JH, 2005, ONCOGENE, V24, P165, DOI 10.1038/sj.onc.1208000; Scifo E, 2013, J PROTEOME RES, V12, P2101, DOI 10.1021/pr301125k; Stav D, 2007, INT J BIOL MARKER, V22, P108, DOI 10.1177/172460080702200204; Sugahara T, 2007, CANCER SCI, V98, P900, DOI 10.1111/j.1349-7006.2007.00466.x; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Ugolini F, 1999, ONCOGENE, V18, P1903, DOI 10.1038/sj.onc.1202739; Volchenboum SL, 2009, CANCER RES, V69, P4143, DOI 10.1158/0008-5472.CAN-08-3112; Vrekoussis T, 2007, ONCOL REP, V17, P1115; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075083; Yang MY, 2013, CELL REP, V3, P1457, DOI 10.1016/j.celrep.2013.04.019; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhao P, 2006, J MACH LEARN RES, V7, P2541; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	70	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108818	10.1371/journal.pone.0108818	http://dx.doi.org/10.1371/journal.pone.0108818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295525	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000019
J	Parsons, LM; Mizanur, RM; Jankowska, E; Hodgkin, J; O'Rourke, D; Stroud, D; Ghosh, S; Cipollo, JF				Parsons, Lisa M.; Mizanur, Rahman M.; Jankowska, Ewa; Hodgkin, Jonathan; O'Rourke, Delia; Stroud, Dave; Ghosh, Salil; Cipollo, John F.			Caenorhabditis elegans Bacterial Pathogen Resistant bus-4 Mutants Produce Altered Mucins	PLOS ONE			English	Article							O-GLYCANS; GENES; BINDING; IDENTIFICATION; GLYCOPROTEINS; VIRULENCE; ADHESION; REVEALS; CUTICLE; WORM	Caenorabditis elegans bus-4 glycosyltransferase mutants are resistant to infection by Microbacterium nematophilum, Yersinia pestis and Yersinia pseudotuberculosis and have altered susceptibility to two Leucobacter species Verde1 and Verde2. Our objective in this study was to define the glycosylation changes leading to this phenotype to better understand how these changes lead to pathogen resistance. We performed MALDI-TOF MS, tandem MS and GC/MS experiments to reveal fine structural detail for the bus-4 N- and O-glycan pools. We observed dramatic changes in O-glycans and moderate ones in N-glycan pools compared to the parent strain. Ce core-I glycans, the nematode's mucin glycan equivalent, were doubled in abundance, halved in charge and bore shifts in terminal substitutions. The fucosyl O-glycans, Ce core-II and neutral fucosyl forms, were also increased in abundance as were fucosyl N-glycans. Quantitative expression analysis revealed that two mucins, let-653 and osm-8, were upregulated nearly 40 fold and also revealed was a dramatic increase in GDP-Man 4,6 dehydratease expression. We performed detailed lectin binding studies that showed changes in glycoconjugates in the surface coat, cuticle surface and intestine. The combined changes in cell surface glycoconjugate distribution, increased abundance and altered properties of mucin provide an environment where likely the above pathogens are not exposed to normal glycoconjugate dependent cues leading to barriers to these bacterial infections.	[Parsons, Lisa M.; Mizanur, Rahman M.; Jankowska, Ewa; Ghosh, Salil; Cipollo, John F.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Hodgkin, Jonathan; O'Rourke, Delia; Stroud, Dave] Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	US Food & Drug Administration (FDA); University of Oxford	Cipollo, JF (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	John.Cipollo@fda.hhs.gov	Jankowska, Ewa A/AAY-3040-2020; Jankowska, Ewa/ABD-4073-2021	Jankowska, Ewa A/0000-0002-9202-432X; 	Oak Ridge Institute for Scientific Education (ORISE); Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA); Medical Research Council UK [G0600238]; MRC [G0600238, MR/J001309/1] Funding Source: UKRI; Medical Research Council [MR/J001309/1, G0600238] Funding Source: researchfish	Oak Ridge Institute for Scientific Education (ORISE); Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported in part by Oak Ridge Institute for Scientific Education (ORISE), and the Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA). The work from JH is supported by Medical Research Council UK, Grant G0600238. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashline D, 2005, ANAL CHEM; Barrows BD, 2007, J INVERTEBR PATHOL, V95, P198, DOI 10.1016/j.jip.2007.04.002; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; BORGONIE G, 1994, HISTOCHEMISTRY, V101, P379, DOI 10.1007/BF00269000; BRENNER S, 1974, GENETICS, V77, P71; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brockhausen I, 2009, OGALNAC GLYCANS; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Cipollo JF, 2002, J BIOL CHEM, V277, P49143, DOI 10.1074/jbc.M208020200; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Costello CE, 2007, J AM SOC MASS SPECTR, V18, P1799, DOI 10.1016/j.jasms.2007.07.016; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Darby C, 2007, GENETICS, V176, P221, DOI 10.1534/genetics.106.067496; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; ELWOOD PC, 1988, ANAL BIOCHEM, V175, P202, DOI 10.1016/0003-2697(88)90379-X; Gravato-Nobre MJ, 2011, GENETICS, V187, P141, DOI 10.1534/genetics.110.122002; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Gravato-Nobre MJ, 2010, GLYCOSYLATION UNPUB; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; HASLAM SM, 2002, BIOCH SOC S, V69, P117; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Hodgkin J, 2013, CURR BIOL, V23, P2157, DOI 10.1016/j.cub.2013.08.060; Hoeflich J, 2004, J BIOL CHEM; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; KAMERLING JP, 1975, BIOCHEM J, V151, P491, DOI 10.1042/bj1510491; KARLSSON KA, 1992, APMIS, V100, P71; Kimura T, 2012, RADIAT RES, V178, P313, DOI 10.1667/RR2989.1; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; LINK CD, 1992, GENETICS, V131, P867; Palaima E, 2010, J BIOL CHEM, V285, P17662, DOI 10.1074/jbc.M109.065433; Parsons LM, 2014, MICROBES INFECT, V16, P356, DOI 10.1016/j.micinf.2014.01.002; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; POLITZ SM, 1990, P NATL ACAD SCI USA, V87, P2901, DOI 10.1073/pnas.87.8.2901; PRESANT CA, 1972, J BIOL CHEM, V247, P6937; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Vanmaele RP, 1999, INFECT IMMUN, V67, P3302, DOI 10.1128/IAI.67.7.3302-3307.1999; Venkatakrishnan V, 2013, EXPERT REV RESP MED, V7, P553, DOI 10.1586/17476348.2013.837752; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087; Zhang R., 2013, ISRN MICROBIOL, V2013	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107250	10.1371/journal.pone.0107250	http://dx.doi.org/10.1371/journal.pone.0107250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296196	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000004
J	Sancini, G; Farina, F; Battaglia, C; Cifola, I; Mangano, E; Mantecca, P; Camatini, M; Palestini, P				Sancini, Giulio; Farina, Francesca; Battaglia, Cristina; Cifola, Ingrid; Mangano, Eleonora; Mantecca, Paride; Camatini, Marina; Palestini, Paola			Health Risk Assessment for Air Pollutants: Alterations in Lung and Cardiac Gene Expression in Mice Exposed to Milano Winter Fine Particulate Matter (PM2.5)	PLOS ONE			English	Article							OXIDATIVE STRESS; MESSENGER-RNA; PHYSICOCHEMICAL CHARACTERIZATION; CARDIOVASCULAR-DISEASE; HYDROCARBON RECEPTOR; HEART-FAILURE; POLLUTION; URBAN; MYELOPEROXIDASE; INFLAMMATION	Oxidative stress, pulmonary and systemic inflammation, endothelial cell dysfunction, atherosclerosis and cardiac autonomic dysfunction have been linked to urban particulate matter exposure. The chemical composition of airborne pollutants in Milano is similar to those of other European cities though with a higher PM2.5 fraction. Milano winter fine particles (PM2.5win) are characterized by the presence of nitrate, organic carbon fraction, with high amount of polycyclic aromatic hydrocarbons and elements such as Pb, Al, Zn, V, Fe, Cr and others, with a negligible endotoxin presence. In BALB/c mice, we examined, at biochemical and transcriptomic levels, the adverse effects of repeated Milano PM2.5win exposure in lung and heart. We found that ET-1, Hsp70, Cyp1A1, Cyp1B1 and Hsp-70, HO-1, MPO respectively increased within lung and heart of PM2.5win-treated mice. The PM2.5win exposure had a strong impact on global gene expression of heart tissue (181 upregulated and 178 down-regulated genes) but a lesser impact on lung tissue (14 up-regulated genes and 43 downregulated genes). Focusing on modulated genes, in lung we found two-to three-fold changes of those genes related to polycyclic aromatic hydrocarbons exposure and calcium signalling. Within heart the most striking aspect is the twofold to threefold increase in collagen and laminin related genes as well as in genes involved in calcium signaling. The current study extends our previous findings, showing that repeated instillations of PM2.5win trigger systemic adverse effects. PM2.5win thus likely poses an acute threat primarily to susceptible people, such as the elderly and those with unrecognized coronary artery or structural heart disease. The study of genomic responses will improve understanding of disease mechanisms and enable future clinical testing of interventions against the toxic effects of air pollutant.	[Sancini, Giulio; Farina, Francesca; Palestini, Paola] Univ Milano Bicocca, POLARIS Res Ctr, Dept Hlth Sci, Monza, Italy; [Battaglia, Cristina] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, Segrate, Italy; [Mantecca, Paride; Camatini, Marina] Univ Milano Bicocca, POLARIS Res Ctr, Dept Environm Sci, Milan, Italy; [Battaglia, Cristina; Cifola, Ingrid; Mangano, Eleonora] CNR, Inst Biomed Technol, Segrate, Italy	University of Milano-Bicocca; University of Milan; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Farina, F (corresponding author), Univ Milano Bicocca, POLARIS Res Ctr, Dept Hlth Sci, Monza, Italy.	francesca.farina1@unimib.it	Palestini, PAOLA/AAD-9376-2019; Sancini, Giulio/I-5136-2012; Battaglia, Cristina/E-5166-2017; Mangano, Eleonora/P-7028-2018	Palestini, PAOLA/0000-0002-1045-8838; Sancini, Giulio/0000-0003-2567-109X; Battaglia, Cristina/0000-0003-3025-9657; Mangano, Eleonora/0000-0002-4040-4654; Mantecca, Paride/0000-0002-6962-049X; CIFOLA, INGRID/0000-0003-2819-1171	TOSCA Project, Cariplo Foundation	TOSCA Project, Cariplo Foundation	This work is funded by TOSCA Project (MC, PP), Cariplo Foundation, http://www.fondazionecariplo.it/it/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas I, 2013, J APPL TOXICOL, V33, P109, DOI 10.1002/jat.1722; ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; Backes C, 2007, GENETRAIL ADV GENE S; BARRY WH, 1993, CIRCULATION, V87, P1806, DOI 10.1161/01.CIR.87.6.1806; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bessette EE, 2009, J BIOCHEM MOL TOXIC, V23, P222, DOI 10.1002/jbt.20283; Billet S, 2007, ENVIRON RES, V105, P212, DOI 10.1016/j.envres.2007.03.001; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; Bourotte Christine Laure Marie, 2011, Rev. bras. meteorol., V26, P419, DOI 10.1590/S0102-77862011000300008; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cao Q, 2007, TOXICOL LETT, V171, P126, DOI 10.1016/j.toxlet.2007.05.007; Chen Qing-Wen, 2004, Yaoxue Xuebao, V39, P500; Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9; Clark NA, 2010, ENVIRON HEALTH PERSP, V118, P284, DOI 10.1289/ehp.0900916; Dergham M, 2012, CHEM RES TOXICOL, V25, P904, DOI 10.1021/tx200529v; Dieme D, 2012, ENVIRON RES, V113, P1, DOI 10.1016/j.envres.2011.11.009; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Farina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056636; Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031; FELDMAN AM, 1991, CIRCULATION, V83, P1866, DOI 10.1161/01.CIR.83.6.1866; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Garcon G, 2006, TOXICOL IN VITRO, V20, P519, DOI 10.1016/j.tiv.2005.09.012; Goldie RG, 1999, RESP PHARM PHARMACOT; Golubinskaya V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/128046; Graff DW, 2004, ENVIRON HEALTH PERSP, V112, P792, DOI 10.1289/ehp.112-1241994; Gualtieri M, 2012, TOXICOL LETT, V209, P136, DOI 10.1016/j.toxlet.2011.11.015; Gualtieri M, 2009, TOXICOL LETT, V188, P52, DOI 10.1016/j.toxlet.2009.03.003; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908; Harrigan JA, 2004, TOXICOL SCI, V77, P307, DOI 10.1093/toxsci/kfh030; Holloway JW, 2012, RESPIROLOGY, V17, P590, DOI 10.1111/j.1440-1843.2012.02164.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito T, 2008, TOXICOLOGY, V243, P271, DOI 10.1016/j.tox.2007.10.013; JACQUIERSARLIN MR, 1994, EXPERIENTIA, V50, P1031, DOI 10.1007/BF01923458; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kim GB, 1998, ENVIRON POLLUT, V99, P255, DOI 10.1016/S0269-7491(97)00121-8; Kress S, 1997, CANCER RES, V57, P1264; Lin P, 2003, LUNG CANCER-J IASLC, V42, P255, DOI 10.1016/S0169-5002(03)00359-3; Liu W, 2009, EXP LUNG RES, V35, P29, DOI 10.1080/01902140802395757; LOGAN WPD, 1953, LANCET, V264, P336; Longhin E, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-63; Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002; Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023; MATSUBARA H, 1988, BIOCHEM BIOPH RES CO, V156, P619, DOI 10.1016/S0006-291X(88)80888-X; Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nemery B, 2001, LANCET, V357, P704, DOI 10.1016/S0140-6736(00)04135-0; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Oh SM, 2011, MUTAT RES-GEN TOX EN, V723, P142, DOI 10.1016/j.mrgentox.2011.04.003; Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358; Perrone MG, 2012, SCI TOTAL ENVIRON, V414, P343, DOI 10.1016/j.scitotenv.2011.11.026; Perrone MG, 2010, CHEMOSPHERE, V78, P1368, DOI 10.1016/j.chemosphere.2009.12.071; Pessah IN, 2001, PEST MANAG SCI, V57, P941, DOI 10.1002/ps.391; Pessah IN, 2001, MOL PHARMACOL, V59, P506, DOI 10.1124/mol.59.3.506; Pleil JD, 2010, J CHROMATOGR B, V878, P1753, DOI 10.1016/j.jchromb.2010.04.035; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rojas M, 2001, CARCINOGENESIS, V22, P1015, DOI 10.1093/carcin/22.7.1015; Rudolph V, 2010, CLIN CHEM, V56, P881, DOI 10.1373/clinchem.2010.147231; Saarikoski ST, 1998, INT J CANCER, V77, P33, DOI 10.1002/(SICI)1097-0215(19980703)77:1<33::AID-IJC7>3.0.CO;2-0; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Shah SJ, 2014, AM J PHYSIOL-HEART C, V306, pH88, DOI 10.1152/ajpheart.00642.2013; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Tankersley CG, 2013, TOXICOL SCI, V131, P95, DOI 10.1093/toxsci/kfs273; Tsukue N, 2010, TOXICOL IN VITRO, V24, P363, DOI 10.1016/j.tiv.2009.11.004; Wang T, 2008, ENVIRON HEALTH PERSP, V116, P1500, DOI 10.1289/ehp.11229; Watterson TL, 2007, J TOXICOL ENV HEAL A, V70, P1731, DOI 10.1080/15287390701457746; Watterson TL, 2009, TOXICOL SCI, V112, P111, DOI 10.1093/toxsci/kfp186; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wong Simon S, 2011, Res Rep Health Eff Inst, P3; Zhang YY, 2013, AQUAT TOXICOL, V142, P26, DOI 10.1016/j.aquatox.2013.07.014	74	70	74	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109685	10.1371/journal.pone.0109685	http://dx.doi.org/10.1371/journal.pone.0109685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296036	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000093
J	Li, YL; Shi, WM; Wang, XX				Li, Yilin; Shi, Weiming; Wang, Xingxiang			New Insights into How Increases in Fertility Improve the Growth of Rice at the Seedling Stage in Red Soil Regions of Subtropical China	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; NITROGEN-USE EFFICIENCY; OXYGEN-EXCHANGE; CULTIVARS; ARCHAEA; NITRIFICATION; RHIZOSPHERE; ROOTS; METHANE; MICROSENSOR	The differences in rhizosphere nitrification activities between high-and low-fertility soils appear to be related to differences in dissolved oxygen concentrations in the soil, implying a relationship to differences in the radial oxygen loss (ROL) of rice roots in these soils. A miniaturised Clark-type oxygen microelectrode system was used to determine rice root ROL and the rhizosphere oxygen profile, and rhizosphere nitrification activity was studied using a short-term nitrification activity assay. Rice planting significantly altered the oxygen cycling in the water-soil system due to rice root ROL. Although the oxygen content in control high-fertility soil (without rice plants) was lower than that in control low-fertility soil, high rice root ROL significantly improved the rhizosphere oxygen concentration in the high-fertility soil. High soil fertility improved the rice root growth and root porosity as well as rice root ROL, resulting in enhanced rhizosphere nitrification. High fertility also increased the content of nitrification-induced nitrate in the rhizosphere, resulting in enhanced ammonium uptake and assimilation in the rice. Although high ammonium pools in the high-fertility soil increased rhizosphere nitrification, rice root ROL might also contribute to rhizosphere nitrification improvement. This study provides new insights into the reasons that an increase in soil fertility may enhance the growth of rice. Our results suggest that an amendment of the fertiliser used in nutrient-and nitrification-poor paddy soils in the red soil regions of China may significantly promote rice growth and rice N nutrition.	[Li, Yilin; Shi, Weiming; Wang, Xingxiang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Wang, Xingxiang] Jiangxi Key Lab Ecol Res Red Soil, Yingtan, Jiangxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS	Wang, XX (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	xxwang@issas.ac.cn			National Natural Science Foundation of China [31471948]; Special Fund for Agro-scientific Research in the Public Interest [201203050-3]; GanPo 555 Talents Program of Jiangxi Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; GanPo 555 Talents Program of Jiangxi Province, China	This research was financially supported by the National Natural Science Foundation of China (No. 31471948), the Special Fund for Agro-scientific Research in the Public Interest (No. 201203050-3) and the GanPo 555 Talents Program of Jiangxi Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 1998, PLANT SOIL, V200, P265, DOI 10.1023/A:1004398520150; Alef K, 1995, ASSAY NITRIFICATION, P241; ARMSTRONG W, 1991, AQUAT BOT, V39, P57, DOI 10.1016/0304-3770(91)90022-W; ARMSTRONG W, 1964, NATURE, V204, P801, DOI 10.1038/204801b0; ARMSTRONG W, 1971, PHYSIOL PLANTARUM, V25, P192, DOI 10.1111/j.1399-3054.1971.tb01427.x; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; Arth I, 2000, BIOL FERT SOILS, V31, P427, DOI 10.1007/s003749900190; Baluska F, 2010, TRENDS PLANT SCI, V15, P402, DOI 10.1016/j.tplants.2010.04.007; BERG P, 1985, BIOL FERT SOILS, V1, P131, DOI 10.1007/BF00301780; Briones AM, 2002, APPL ENVIRON MICROB, V68, P3067, DOI 10.1128/AEM.68.6.3067-3075.2002; Chen XP, 2008, ENVIRON MICROBIOL, V10, P1978, DOI 10.1111/j.1462-2920.2008.01613.x; Chu HY, 2007, APPL ENVIRON MICROB, V73, P485, DOI 10.1128/AEM.01536-06; Colmer TD, 1998, PLANT CELL ENVIRON, V21, P240, DOI 10.1046/j.1365-3040.1998.00261.x; Duan YH, 2007, ANN BOT-LONDON, V99, P1153, DOI 10.1093/aob/mcm051; Fan XR, 2007, J EXP BOT, V58, P1729, DOI 10.1093/jxb/erm033; FAO, 1998, FAO WORLD SOIL RES R, V84; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; FRENZEL P, 1992, BIOL FERT SOILS, V14, P84, DOI 10.1007/BF00336255; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; JENSEN CR, 1969, AGRON J, V61, P474, DOI 10.2134/agronj1969.00021962006100030045x; Kim JD, 1999, BOT BULL ACAD SINICA, V40, P185; KLUDZE HK, 1993, SOIL SCI SOC AM J, V57, P386, DOI 10.2136/sssaj1993.03615995005700020017x; KLUDZE HK, 1994, AGRON J, V86, P483, DOI 10.2134/agronj1994.00021962008600030005x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kronzucker HJ, 1999, PLANT PHYSIOL, V119, P1041, DOI 10.1104/pp.119.3.1041; Kronzucker HJ, 2000, NEW PHYTOL, V145, P471, DOI 10.1046/j.1469-8137.2000.00606.x; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li YL, 2007, BIOL FERT SOILS, V43, P417, DOI 10.1007/s00374-006-0119-0; Li YL, 2008, PLANT CELL ENVIRON, V31, P73, DOI 10.1111/j.1365-3040.2007.01737.x; Mugnai S, 2012, PLANT CELL PHYSIOL, V53, P912, DOI 10.1093/pcp/pcs034; Ogawa T, 1999, PLANT CELL REP, V18, P576, DOI 10.1007/s002990050625; RAMAN DR, 1995, BIORESOURCE TECHNOL, V53, P125, DOI 10.1016/0960-8524(95)98138-E; Ratering S, 2001, ENVIRON MICROBIOL, V3, P100, DOI 10.1046/j.1462-2920.2001.00163.x; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Revsbech NP, 1999, BIOL FERT SOILS, V29, P379, DOI 10.1007/s003740050568; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Sorrell BK, 1999, PLANT CELL ENVIRON, V22, P1587, DOI 10.1046/j.1365-3040.1999.00517.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang YA, 2009, SYST APPL MICROBIOL, V32, P27, DOI 10.1016/j.syapm.2008.09.007; Wang YueFu, 2003, Plant Nutrition and Fertilizer Science, V9, P39; Yuan F, 2005, BIOL FERT SOILS, V41, P22, DOI 10.1007/s00374-004-0802-y; Zhang CF, 1997, PLANT SCI, V125, P163, DOI 10.1016/S0168-9452(97)00075-7; Zhang MK, 2005, SOIL TILL RES, V80, P13, DOI 10.1016/j.still.2004.02.019; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001	44	3	3	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109161	10.1371/journal.pone.0109161	http://dx.doi.org/10.1371/journal.pone.0109161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291182	gold, Green Published, Green Submitted			2022-12-27	WOS:000342798000042
J	Raghunathan, VK; Dreier, B; Morgan, JT; Tuyen, BC; Rose, BW; Reilly, CM; Russell, P; Murphy, CJ				Raghunathan, Vijay Krishna; Dreier, Britta; Morgan, Joshua T.; Tuyen, Binh C.; Rose, Brad W.; Reilly, Christopher M.; Russell, Paul; Murphy, Christopher J.			Involvement of YAP, TAZ and HSP90 in Contact Guidance and Intercellular Junction Formation in Corneal Epithelial Cells	PLOS ONE			English	Article							NANOSCALE TOPOGRAPHY; EXTRACELLULAR-MATRIX; TGF-BETA; TRABECULAR MESHWORK; BASEMENT-MEMBRANE; MESENCHYMAL TRANSITION; MECHANOTRANSDUCERS YAP; SUBSTRATUM TOPOGRAPHY; STEM-CELLS; E-CADHERIN	The extracellular environment possesses a rich milieu of biophysical and biochemical signaling cues that are simultaneously integrated by cells and influence cellular phenotype. Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (WWTR1; TAZ), two important signaling molecules of the Hippo pathway, have been recently implicated as nuclear relays of cytoskeletal changes mediated by substratum rigidity and topography. These proteins intersect with other important intracellular signaling pathways (e.g. Wnt and TGF beta). In the cornea, epithelial cells adhere to the stroma through a 3-dimensional topography-rich basement membrane, with features in the nano-submicron size-scale that are capable of profoundly modulating a wide range of fundamental cell behaviors. The influences of substratum-topography, YAP/TAZ knockdown, and HSP90 inhibition on cell morphology, YAP/TAZ localization, and the expression of TGF beta 2 and CTGF, were investigated. The results demonstrate (a) that knockdown of TAZ enhances contact guidance in a YAP dependent manner, (b) that CTGF is predominantly regulated by YAP and not TAZ, and (c) that TGF beta 2 is regulated by both YAP and TAZ in these cells. Additionally, inhibition of HSP90 resulted in nuclear localization and subsequent transcriptional-activation of YAP, formation of cell-cell junctions and co-localization of E-cadherin and beta-catenin at adherens junctions. Results presented in this study reflect the complexities underlying the molecular relationships between the cytoskeleton, growth factors, heat shock proteins, and co-activators of transcription that impact mechanotransduction. The data reveal the importance of YAP/TAZ on the cell behaviors, and gene and protein expression.	[Raghunathan, Vijay Krishna; Dreier, Britta; Morgan, Joshua T.; Tuyen, Binh C.; Rose, Brad W.; Russell, Paul; Murphy, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Reilly, Christopher M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Murphy, Christopher J.] Univ Calif Davis, Sch Med, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Murphy, CJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	cjmurphy@ucdavis.edu	Raghunathan, Vijaykrishna/D-2911-2015	Raghunathan, Vijaykrishna/0000-0003-1702-591X; Morgan, Joshua/0000-0001-8033-0285	National Institutes of Health through grants from the National Eye Institute [R01EY01613404, R01EY019970, P30EY12576]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY012576, R01EY019970] Funding Source: NIH RePORTER	National Institutes of Health through grants from the National Eye Institute; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was supported by the National Institutes of Health through grants from the National Eye Institute R01EY01613404, R01EY019970 and P30EY12576 and by an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2002, CELLS TISSUES ORGANS, V170, P251, DOI 10.1159/000047929; Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049; Blalock TD, 2003, INVEST OPHTH VIS SCI, V44, P1879, DOI 10.1167/iovs.02-0860; Calzado-Martin A, 2011, ACTA BIOMATER, V7, P1890, DOI 10.1016/j.actbio.2010.11.035; Carter RT, 2007, CORNEA, V26, P1213, DOI 10.1097/ICO.0b013e31814b8a28; Chen YM, 2012, INT J CLIN EXP PATHO, V5, P522; Chou CL, 2012, TISSUE ENG A; COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201; Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8; Dreier B, 2013, AM J PHYSL CELL PHYS; Dreier B, 2012, ACTA BIOMATER, V8, P4285, DOI 10.1016/j.actbio.2012.07.004; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fossdal R, 2004, HUM MOL GENET, V13, P975, DOI 10.1093/hmg/ddh106; Fraser SA, 2008, J BIOMED MATER RES A, V86A, P725, DOI 10.1002/jbm.a.31519; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; Garrana RMR, 1999, INVEST OPHTH VIS SCI, V40, P1266; Gipson I K, 1995, Curr Opin Ophthalmol, V6, P3; Hau JC, 2013, CHEMBIOCHEM, V14, P1218, DOI 10.1002/cbic.201300163; Hong W, 2012, YAP TAZ TRANSCRIPTIO; Huntoon CJ, 2010, CANCER RES, V70, P8642, DOI 10.1158/0008-5472.CAN-10-1345; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Kantarci A, 2006, J PATHOL, V210, P59, DOI 10.1002/path.2000; Karuri NW, 2008, SCANNING, V30, P405, DOI 10.1002/sca.20123; Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744; Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045; Liu YQ, 2010, INVEST OPHTH VIS SCI, V51, P3372, DOI 10.1167/iovs.09-4321; McKee CT, 2011, BIOPHYS J, V101, P2139, DOI 10.1016/j.bpj.2011.09.042; Meng W.X., 2009, COLD SPRING HARBOR P, V1; Morgan JT, 2013, EXP EYE RES, V115, P1, DOI 10.1016/j.exer.2013.06.012; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Myrna KE, 2012, INVEST OPHTH VIS SCI, V53, P811, DOI 10.1167/iovs.11-7982; Nakamura K, 2002, INVEST OPHTH VIS SCI, V43, P2603; Nakamura K, 2001, BRIT J OPHTHALMOL, V85, P209, DOI 10.1136/bjo.85.2.209; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Nicolay BN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000918; Odom TW, 2002, LANGMUIR, V18, P5314, DOI 10.1021/la020169l; Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Phanish MK, 2005, NEPHRON EXP NEPHROL, V100, pE156, DOI 10.1159/000085445; Pot SA, 2010, INVEST OPHTH VIS SCI, V51, P1373, DOI 10.1167/iovs.09-4074; Raghunathan VK, 2013, J BIOMED MATER RES A, V101, P1069, DOI 10.1002/jbm.a.34417; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Raghunathan V, 2013, TISSUE ENG PT A, V19, P1713, DOI [10.1089/ten.tea.2012.0584, 10.1089/ten.TEA.2012.0584]; Rajnicek AM, 1997, J CELL SCI, V110, P2905; Rajnicek AM, 1997, J CELL SCI, V110, P2915; Reka AK, 2011, J THORAC ONCOL, V6, P1784, DOI 10.1097/JTO.0b013e31822adfb0; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Russell P, 2008, INVEST OPHTH VIS SCI, V49, P629, DOI 10.1167/iovs.07-1192; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Sugioka K, 2010, TOHOKU J EXP MED, V222, P45, DOI 10.1620/tjem.222.45; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Suzuki K, 2000, INVEST OPHTH VIS SCI, V41, P2495; Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044; Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Terai K, 2011, INVEST OPHTH VIS SCI, V52, P8208, DOI 10.1167/iovs.11-8017; Thomasy SM, 2013, EXP EYE RES, V113, P66, DOI 10.1016/j.exer.2013.05.014; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Tocce EJ, 2013, ACTA BIOMATER, V9, P5040, DOI 10.1016/j.actbio.2012.10.007; Tocce EJ, 2012, J BIOMED MATER RES A, V100A, P84, DOI 10.1002/jbm.a.33233; Tocce EJ, 2010, BIOMATERIALS, V31, P4064, DOI 10.1016/j.biomaterials.2010.01.101; Tomcik M, 2013, ANN RHEUMATIC DIS; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wallace DM, 2013, INVEST OPHTH VIS SCI, V54, P7836, DOI 10.1167/iovs.13-12494; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wilbanks GA, 2005, EUROPEAN J IMMUNOLOG, V22, P165; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang HQ, 2012, DEV BIOL, V361, P103, DOI 10.1016/j.ydbio.2011.10.017; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070	90	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109811	10.1371/journal.pone.0109811	http://dx.doi.org/10.1371/journal.pone.0109811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290150	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000091
J	Vazquez-Munoz, R; Avalos-Borja, M; Castro-Longoria, E				Vazquez-Munoz, Roberto; Avalos-Borja, Miguel; Castro-Longoria, Ernestina			Ultrastructural Analysis of Candida albicans When Exposed to Silver Nanoparticles	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; INFECTIOUS-DISEASES; ANTIFUNGAL ACTIVITY; ANTIBIOTICS; CYTOTOXICITY; EPIDEMIOLOGY; MECHANISMS; GENERATION	Candida albicans is the most common fungal pathogen in humans, and recently some studies have reported the antifungal activity of silver nanoparticles (AgNPs) against some Candida species. However, ultrastructural analyses on the interaction of AgNPs with these microorganisms have not been reported. In this work we evaluated the effect of AgNPs on C. albicans, and the minimum inhibitory concentration (MIC) was found to have a fungicidal effect. The IC50 was also determined, and the use of AgNPs with fluconazole (FLC), a fungistatic drug, reduced cell proliferation. In order to understand how AgNPs interact with living cells, the ultrastructural distribution of AgNPs in this fungus was determined. Transmission electron microscopy (TEM) analysis revealed a high accumulation of AgNPs outside the cells but also smaller nanoparticles (NPs) localized throughout the cytoplasm. Energy dispersive spectroscopy (EDS) analysis confirmed the presence of intracellular silver. From our results it is assumed that AgNPs used in this study do not penetrate the cell, but instead release silver ions that infiltrate into the cell leading to the formation of NPs through reduction by organic compounds present in the cell wall and cytoplasm.	[Vazquez-Munoz, Roberto; Castro-Longoria, Ernestina] Ctr Invest Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico; [Avalos-Borja, Miguel] Inst Potosino Invest Cient & Tecnol IPICYT, Div Mat Avanzados, San Luis Potosi, Slp, Mexico; [Avalos-Borja, Miguel] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Nacional Autonoma de Mexico	Castro-Longoria, E (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	Vazquez-Muñoz, Roberto/L-8502-2017; Vazquez Muñoz, Roberto/C-7966-2018; Castro-Longoria, Ernestina/GYV-4776-2022	Vazquez-Muñoz, Roberto/0000-0002-3847-1305; Vazquez Muñoz, Roberto/0000-0002-3847-1305; Avalos-Borja, Miguel/0000-0003-4515-6415	SEP-CONACyT grant [CB2011/169154]; CONACyT	SEP-CONACyT grant; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by a SEP-CONACyT grant (CB2011/169154). The authors also thank CONACyT for a grant to Roberto Vazquez-Munoz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Buhler V, 2005, EXCIPIENTS PHARM POV, P1; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cassell GH, 2001, JAMA-J AM MED ASSOC, V285, P601, DOI 10.1001/jama.285.5.601; Cuellar-Cruz M, 2012, EUR J CLIN MICROBIOL, V31, P2513, DOI 10.1007/s10096-012-1634-6; Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029; de Souza A, 2006, CURR SCI INDIA, V91, P926; El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n; Espinel-Ingroff A, 2009, J CLIN MICROBIOL, V47, P2766, DOI 10.1128/JCM.00654-09; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; Fothergill AW, 2006, INFECT DIS CLIN N AM, V20, P699, DOI 10.1016/j.idc.2006.06.008; Gajbhiye M, 2009, NANOMED-NANOTECHNOL, V5, P382, DOI 10.1016/j.nano.2009.06.005; Ghosh S, 2010, CARBOHYD RES, V345, P2220, DOI 10.1016/j.carres.2010.08.001; Graybill JR, 1997, EUR J CLIN MICROBIOL, V16, P42, DOI 10.1007/BF01575120; Hidalgo E, 1998, TOXICOL LETT, V98, P169, DOI 10.1016/S0378-4274(98)00114-3; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Hwang IS, 2012, FEBS J, V279, P1327, DOI 10.1111/j.1742-4658.2012.08527.x; Ishida K, 2013, MEM I O CRUZ, P1; Jain J, 2009, MOL PHARMACEUT, V6, P1388, DOI 10.1021/mp900056g; Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482; Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Kwon HB, 2009, ANN DERMATOL, V21, P308, DOI 10.5021/ad.2009.21.3.308; Lansdown Alan B G, 2006, Curr Probl Dermatol, V33, P17; Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082; Lionakis MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003079; Martinez-Gutierrez F, 2013, BIOFOULING, V29, P651, DOI 10.1080/08927014.2013.794225; Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101; Moran G, 2012, CANDIDA CANDIDIASIS, P387; Nadworny PL, 2008, NANOMED-NANOTECHNOL, V4, P241, DOI 10.1016/j.nano.2008.04.006; Nasrollahi A, 2011, INT J NANO DIMENS, V1, P233, DOI 10.7508/ijnd.2010.03.007; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Papon N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003550; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Reidy B, 2013, MATERIALS, V6, P2295, DOI 10.3390/ma6062295; Roe D, 2008, J ANTIMICROB CHEMOTH, V61, P869, DOI 10.1093/jac/dkn034; Rogers JV, 2008, NANOSCALE RES LETT, V3, P129, DOI 10.1007/s11671-008-9128-2; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stevanovic MM, 2012, POLYMER, V53, P2818, DOI 10.1016/j.polymer.2012.04.057; Stevens DA, 2005, DIAGN MICR INFEC DIS, V51, P173, DOI 10.1016/j.diagmicrobio.2004.10.006; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; White JML, 2003, CLIN EXP DERMATOL, V28, P254, DOI 10.1046/j.1365-2230.2003.01214.x; White RJ., 2001, BR J NURS, V10, pS3, DOI [10.12968/bjon.2001.10.sup4.16079, DOI 10.12968/BJON.2001.10.SUP4.16079, 10.12968/bjon.2001.10.Sup4.16079]	49	97	99	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108876	10.1371/journal.pone.0108876	http://dx.doi.org/10.1371/journal.pone.0108876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290909	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000029
J	Ravazzani, G; Ghilardi, M; Mendlik, T; Gobiet, A; Corbari, C; Mancini, M				Ravazzani, Giovanni; Ghilardi, Matteo; Mendlik, Thomas; Gobiet, Andreas; Corbari, Chiara; Mancini, Marco			Investigation of Climate Change Impact on Water Resources for an Alpine Basin in Northern Italy: Implications for Evapotranspiration Modeling Complexity	PLOS ONE			English	Article							RIVER-BASINS; ALPS; TEMPERATURE; CALIFORNIA; GLACIERS; BALANCE; PRECIPITATION; HYDROGRAPH; SIMULATION; CATCHMENTS	Assessing the future effects of climate change on water availability requires an understanding of how precipitation and evapotranspiration rates will respond to changes in atmospheric forcing. Use of simplified hydrological models is required beacause of lack of meteorological forcings with the high space and time resolutions required to model hydrological processes in mountains river basins, and the necessity of reducing the computational costs. The main objective of this study was to quantify the differences between a simplified hydrological model, which uses only precipitation and temperature to compute the hydrological balance when simulating the impact of climate change, and an enhanced version of the model, which solves the energy balance to compute the actual evapotranspiration. For the meteorological forcing of future scenario, at-site bias-corrected time series based on two regional climate models were used. A quantile-based error-correction approach was used to downscale the regional climate model simulations to a point scale and to reduce its error characteristics. The study shows that a simple temperature-based approach for computing the evapotranspiration is sufficiently accurate for performing hydrological impact investigations of climate change for the Alpine river basin which was studied. .	[Ravazzani, Giovanni; Ghilardi, Matteo; Corbari, Chiara; Mancini, Marco] Politecn Milan, I-20133 Milan, Italy; [Mendlik, Thomas; Gobiet, Andreas] Graz Univ, Wegener Ctr Climate & Global Change, Graz, Austria; [Mendlik, Thomas; Gobiet, Andreas] Graz Univ, Inst Geophys Astrophys & Meteorol, Graz, Austria	Polytechnic University of Milan; University of Graz; University of Graz	Ravazzani, G (corresponding author), Politecn Milan, Piazza Leonardo da Vinci, I-20133 Milan, Italy.	giovanni.ravazzani@polimi.it	Gobiet, Andreas/AAF-6039-2020; Ravazzani, Giovanni/A-2740-2013; Gobiet, Andreas/AAX-2537-2020	Gobiet, Andreas/0000-0001-5751-2961; Ravazzani, Giovanni/0000-0002-6850-0883; Corbari, Chiara/0000-0002-1490-3847	ACQWA EU/FP7 project [212250]	ACQWA EU/FP7 project	This work was supported by ACQWA EU/FP7 project (grant number 212250) "Assessing Climate impacts on the Quantity and quality of WAter" [link:http://www.acqwa.ch]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Amengual A, 2012, J CLIMATE, V25, P939, DOI 10.1175/JCLI-D-10-05024.1; Bacchi B, 2003, HYDROL EARTH SYST SC, V7, P784, DOI 10.5194/hess-7-785-2003; Beniston M., 2004, CLIMATIC CHANGE ITS; Beniston M, 2011, INT J CLIMATOL, V31, P1257, DOI 10.1002/joc.2151; Boe J, 2007, INT J CLIMATOL, V27, P1643, DOI 10.1002/joc.1602; Boscarello L, 2014, HYDROL PROCESS, V28, P496, DOI 10.1002/hyp.9588; CEC, 2000, CORINE LAND COV TECH; Ceppi A, 2013, NAT HAZARD EARTH SYS, V13, P1051, DOI 10.5194/nhess-13-1051-2013; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Corbari C, 2010, HYDROL EARTH SYST SC, V14, P2141, DOI 10.5194/hess-14-2141-2010; Corbari C, 2009, HYDROL EARTH SYST SC, V13, P639, DOI 10.5194/hess-13-639-2009; Corbari C, 2014, J HYDROL ENG UNPUB; Corbari C, 2011, HYDROL PROCESS, V25, P1443, DOI 10.1002/hyp.7910; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Dettinger MD, 2004, CLIMATIC CHANGE, V62, P283, DOI 10.1023/B:CLIM.0000013683.13346.4f; Dile YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079296; Diolaiuti GA, 2011, PROG PHYS GEOG, V35, P161, DOI 10.1177/0309133311399494; Dobler A, 2008, METEOROL Z, V17, P499, DOI 10.1127/0941-2948/2008/0306; DUrso G, 1995, P SOC PHOTO-OPT INS, V2585, P41, DOI 10.1117/12.227167; Ficklin DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071297; Gaudard L, 2014, SCI TOTAL ENVIRON, V493, P1211, DOI 10.1016/j.scitotenv.2013.10.012; Gobiet A, 2014, SCI TOTAL ENVIRON, V493, P1138, DOI 10.1016/j.scitotenv.2013.07.050; HARGREAVES GH, 1994, J IRRIG DRAIN ENG, V120, P1132, DOI 10.1061/(ASCE)0733-9437(1994)120:6(1132); Heinrich G, 2011, 012011 EGC EU U GRAZ; Jacob D, 2001, METEOROL ATMOS PHYS, V77, P61, DOI 10.1007/s007030170017; Jacobs AFG, 2008, BOUND-LAY METEOROL, V126, P125, DOI 10.1007/s10546-007-9209-2; Jiang T, 2007, J HYDROL, V336, P316, DOI 10.1016/j.jhydrol.2007.01.010; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Maraun D, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051210; Meyers TP, 2004, AGR FOREST METEOROL, V125, P105, DOI 10.1016/j.agrformet.2004.03.001; Montaldo N, 2004, HYDROL PROCESS, V18, P545, DOI 10.1002/hyp.1337; Montaldo N, 2001, J HYDROMETEOROL, V2, P571, DOI 10.1175/1525-7541(2001)002<0571:OTUOTF>2.0.CO;2; Montaldo N, 2007, HYDROL PROCESS, V21, P608, DOI 10.1002/hyp.6260; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Null SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009932; Pal JS, 2007, B AM METEOROL SOC, V88, P1395, DOI 10.1175/BAMS-88-9-1395; Pellegrini M, 2011, THESIS POLITECNICO M; Piani C, 2010, THEOR APPL CLIMATOL, V99, P187, DOI 10.1007/s00704-009-0134-9; Pianosi F, 2010, HYDROL PROCESS, V24, P3195, DOI 10.1002/hyp.7745; Planton S., 2013, CLIMAGE CHANGE 2013; Rabuffetti D, 2008, NAT HAZARD EARTH SYS, V8, P161, DOI 10.5194/nhess-8-161-2008; Ravazzani G., 2007, Quantification and reduction of predictive uncertainty for sustainable water resources management, P407; Ravazzani G, 2011, ENVIRON MODELL SOFTW, V26, P634, DOI 10.1016/j.envsoft.2010.11.011; Ravazzani G, 2014, J HYDROL ENG, V19, P235, DOI 10.1061/(ASCE)HE.1943-5584.0000764; Ravazzani G, 2013, COMPUT GEOSCI-UK, V51, P1, DOI 10.1016/j.cageo.2012.08.007; Ravazzani G, 2012, J IRRIG DRAIN ENG, V138, P592, DOI 10.1061/(ASCE)IR.1943-4774.0000453; Ravazzani G, 2009, URBAN WATER J, V6, P221, DOI 10.1080/15730620902781434; Roeckner E., 2003, 349 MPI; Senatore A, 2011, J HYDROL, V399, P70, DOI 10.1016/j.jhydrol.2010.12.035; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Soncini A, 2011, COLD REG SCI TECHNOL, V68, P113, DOI 10.1016/j.coldregions.2011.06.011; Themessl MJ, 2012, CLIMATIC CHANGE, V112, P449, DOI 10.1007/s10584-011-0224-4; Themessl MJ, 2011, INT J CLIMATOL, V31, P1530, DOI 10.1002/joc.2168; Verbunt M, 2003, J HYDROL, V282, P36, DOI 10.1016/S0022-1694(03)00251-8; Viviroli D, 2009, J HYDROL, V377, P191, DOI 10.1016/j.jhydrol.2009.08.023; Wilcke RAI, 2013, CLIMATIC CHANGE, V120, P871, DOI 10.1007/s10584-013-0845-x; Wilks D. S., 1995, INT GEOPHYS SERIES, V59; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e; Xu CY, 2005, ADV ATMOS SCI, V22, P789, DOI 10.1007/BF02918679	61	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109053	10.1371/journal.pone.0109053	http://dx.doi.org/10.1371/journal.pone.0109053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285917	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700042
J	Singla, AK; Gurram, RK; Chauhan, A; Khatri, N; Vohra, RM; Jolly, RS; Agrewala, JN				Singla, Arvind K.; Gurram, Rama Krishna; Chauhan, Arun; Khatri, Neeraj; Vohra, Rakesh M.; Jolly, Ravinder S.; Agrewala, Javed N.			Caerulomycin A Suppresses Immunity by Inhibiting T Cell Activity	PLOS ONE			English	Article							STREPTOMYCES-CAERULEUS BALDACCI; GROWTH-FACTOR-BETA; GRAFT-REJECTION; CYCLOSPORINE-A; IMMUNOSUPPRESSIVE DRUGS; CALCINEURIN-INHIBITORS; KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; RAPAMYCIN; ACTIVATION	Background: Caerulomycin A (CaeA) is a known antifungal and antibiotic agent. Further, CaeA is reported to induce the expansion of regulatory T cell and prolongs the survival of skin allografts in mouse model of transplantation. In the current study, CaeA was purified and characterized from a novel species of actinomycetes, Actinoalloteichus spitiensis. The CaeA was identified for its novel immunosuppressive property by inhibiting in vitro and in vivo function of T cells. Methods: Isolation, purification and characterization of CaeA were performed using High Performance Flash Chromatography (HPFC), NMR and mass spectrometry techniques. In vitro and in vivo T cell studies were conducted in mice using flowcytometry, ELISA and thymidine-[methyl/H-3] incorporation. Results: CaeA significantly suppressed T cell activation and IFN-gamma secretion. Further, it inhibited the T cells function at G1 phase of cell cycle. No apoptosis was noticed by CaeA at a concentration responsible for inducing T cell retardation. Furthermore, the change in the function of B cells but not macrophages was observed. The CaeA as well exhibited substantial inhibitory activity in vivo. Conclusion: This study describes for the first time novel in vitro and in vivo immunosuppressive function of CaeA on T cells and B cells. CaeA has enough potential to act as a future immunosuppressive drug.	[Gurram, Rama Krishna; Chauhan, Arun; Agrewala, Javed N.] CSIR Inst Microbial Technol, Immunol Lab, Chandigarh, India; [Singla, Arvind K.; Vohra, Rakesh M.] CSIR Inst Microbial Technol, Biochem Engn Res & Proc Dev Ctr, Chandigarh, India; [Khatri, Neeraj] CSIR Inst Microbial Technol, Expt Anim Facil, Chandigarh, India; [Jolly, Ravinder S.] CSIR Inst Microbial Technol, Dept Chem, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Agrewala, JN (corresponding author), CSIR Inst Microbial Technol, Immunol Lab, Chandigarh, India.	javed@imtech.res.in	Agrewala, Javed Naim/AAS-8449-2021; Gurram, Rama/AAO-4940-2020	Gurram, Rama/0000-0002-1956-0249	Council of Scientific and Industrial Research, New Delhi; Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	AKS, GR, and AC are the recipient of the fellowships of Council of Scientific and Industrial Research, New Delhi. Authors are thankful to Council of Scientific and Industrial Research, New Delhi, India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2004, AUTOIMMUN REV, V3, P471, DOI 10.1016/j.autrev.2004.07.004; Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Borel JF, 2002, WIEN KLIN WOCHENSCHR, V114, P433; Chang JH, 2009, EUR J IMMUNOL, V39, P1241, DOI 10.1002/eji.200838913; Crespo-Leiro MG, 2003, TRANSPLANT P, V35, P1981, DOI 10.1016/S0041-1345(03)00566-9; DIVEKAR PV, 1967, CAN J CHEMISTRY, V45, P1215, DOI 10.1139/v67-201; FUNK A, 1959, CAN J MICROBIOL, V5, P317, DOI 10.1139/m59-039; Gallagher MP, 2010, J AM SOC NEPHROL, V21, P852, DOI 10.1681/ASN.2009101043; GALVIN F, 1993, EUR J IMMUNOL, V23, P283, DOI 10.1002/eji.1830230145; Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2; Gurram RK, 2014, J BIOL CHEM, V289, P17515, DOI 10.1074/jbc.M113.545871; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hoorn EJ, 2012, J NEPHROL, V25, P269, DOI 10.5301/jn.5000174; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; Kahan BD, 1999, TRANSPLANT P, V31, p14S, DOI 10.1016/S0041-1345(98)02074-0; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lutterotti A, 2008, LANCET NEUROL, V7, P538, DOI 10.1016/S1474-4422(08)70110-8; Manivasagan P, 2014, MICROBIOL RES, V169, P262, DOI 10.1016/j.micres.2013.07.014; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; MERRILL JE, 1992, P NATL ACAD SCI USA, V89, P574, DOI 10.1073/pnas.89.2.574; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mourad M, 2001, CLIN CHEM, V47, P88; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Ortiz AM, 2000, J RHEUMATOL, V27, P2329; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Raichlin E, 2007, TRANSPLANTATION, V84, P467, DOI 10.1097/01.tp.0000276959.56959.69; Schlitt HJ, 2001, LANCET, V357, P587, DOI 10.1016/S0140-6736(00)04055-1; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; SHINDO K, 1994, J ANTIBIOT, V47, P1072, DOI 10.7164/antibiotics.47.1072; Singla AK, 2005, INT J SYST EVOL MICR, V55, P2561, DOI 10.1099/ijs.0.63720-0; Singla AK, 2014, TRANSPLANTATION, V97, pE57, DOI 10.1097/TP.0000000000000119; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Tang Q, 2013, COLD SPRING HARB PER, V3; THOMSON AW, 1991, IMMUNOL LETT, V29, P105, DOI 10.1016/0165-2478(91)90209-S; Tsai SF, 2012, TRANSPL P, V44, P190, DOI 10.1016/j.transproceed.2011.12.018; Weatherly K, 2011, METHODS MOL BIOL, V677, P419, DOI 10.1007/978-1-60761-869-0_26; Wiederrecht G J, 1995, Prog Cell Cycle Res, V1, P53; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	43	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e107051	10.1371/journal.pone.0107051	http://dx.doi.org/10.1371/journal.pone.0107051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286329	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700006
J	Tang, ZZ; Wu, XH; Li, GJ; Shen, ZY; Zhang, HM; Lan, GH; Feng, X; Lin, R; Abdullah, AS; Wu, ZY; Shi, CX				Tang, Zhenzhu; Wu, Xinghua; Li, Guojian; Shen, Zhiyong; Zhang, Hongman; Lan, Guanghua; Feng, Xue; Lin, Rui; Abdullah, Abu S.; Wu, Zunyou; Shi, Cynthia X.			Aphrodisiac Use Associated with HIV Infection in Elderly Male Clients of Low-Cost Commercial Sex Venues in Guangxi, China: A Matched Case-Control Study	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; OLDER-ADULTS; MEN; SILDENAFIL; EPIDEMIC; RISK	Background: Rising HIV infection rates have been observed among elderly people in Guangxi, China. Inexpensive aphrodisiacs are available for purchase in suburban and rural areas. This study aims to investigate the association between aphrodisiac use and increased HIV risk for middle-aged and elderly men in Guangxi. Methods: A matched case-control study of aphrodisiac use-associated HIV infection was performed among male subjects over 50 years old who were clients of low-cost commercial sex venues in Guangxi. The cases were defined as clients who were HIV-positive and two controls were selected for each case. The cases and the controls were matched on the visited sex venue, age (+/-3 years), number of years of purchasing sex (+/-3 years), and educational attainment. Subjects were interviewed and tested for HIV. Paired t-test or McNemar Chi-squared test were used to compare the characteristics between the cases and controls. A stepwise conditional logistic regression was used to identify risk factors associated with HIV infection. Findings: This study enrolled 103 cases and 206 controls. Aphrodisiac use (P = 0.02, odds ratio (OR) = 1.81, 95% CI = 1.08-3.04), never using condom during commercial sex encounter (P = 0.03, odds ratio (OR) = 1.82, 95% CI = 1.08-3.07), and lacking a stable partner (P = 0.03, odds ratio (OR) = 1.76, 95% CI = 1.05-2.98) were found to be risk factors for HIV infection among the study groups. For subjects reporting aphrodisiac use, the frequency of purchasing sex was positively correlated with the frequency of aphrodisiac use (r = 0.3; p = 0.02). Conclusions: Aphrodisiac use was significantly associated with increased HIV infection risk in men over 50 years old who purchased commercial sex in the suburban and rural areas of Guangxi. Further research and interventions should address the links between aphrodisiac use, commercial sex work, condom use, and increased HIV transmission.	[Tang, Zhenzhu; Li, Guojian] Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Nanning, Guangxi, Peoples R China; [Wu, Xinghua; Shen, Zhiyong; Zhang, Hongman; Lan, Guanghua; Feng, Xue; Lin, Rui] Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Dept HIV AIDS Control & Prevent, Nanning, Guangxi, Peoples R China; [Feng, Xue] W Virginia Univ, Dept Pharmaceut Syst & Policy, Morgantown, WV 26506 USA; [Abdullah, Abu S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Abdullah, Abu S.] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China; [Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Shi, Cynthia X.] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Shi, Cynthia X.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	West Virginia University; Boston University; Guangxi Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health	Wu, XH (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Dept HIV AIDS Control & Prevent, Nanning, Guangxi, Peoples R China.	blankwoo@126.com			National Science and Technology Major Project, AIDS epidemiological and intervention large-scale field study on Guangxi; Ministry of Science and Technology, China [2012ZX10004910]	National Science and Technology Major Project, AIDS epidemiological and intervention large-scale field study on Guangxi; Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was funded through grants from National Science and Technology Major Project, AIDS epidemiological and intervention large-scale field study on Guangxi, the Ministry of Science and Technology, China (project number: 2012ZX10004910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Ministry of Health, 2012, UPD HIV AIDS EP CHIN; Chinese Ministry of Health, 2013, CHIN AIDS PREV CONTR; Hao C, 2014, CULTURE HLTH SEXUALI, V16, P1; Jin Y, 2002, CHINESE J HLTH INSPE, V9, P70; Karlovsky M, 2004, SCAND J UROL NEPHROL, V38, P247, DOI 10.1080/00365590410025488; Lan G, 2011, THESIS GUANGXI MED U; Lare SB, 2000, AM J PSYCHIAT, V157, P2055, DOI 10.1176/appi.ajp.157.12.2055-a; Lim SH, 2012, AIDS BEHAV, V16, P590, DOI 10.1007/s10461-011-9916-z; Liu HJ, 2012, AIDS PATIENT CARE ST, V26, P565, DOI 10.1089/apc.2012.0227; Liu HJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-563; Liu W, 2001, DIS SURVEILLANCE, V16, P290; Luther VP, 2007, CLIN GERIATR MED, V23, P567, DOI 10.1016/j.cger.2007.02.004; Morales A, 1998, INT J IMPOT RES, V10, P69, DOI 10.1038/sj.ijir.3900354; Nachtsheim D, 2005, W J MED, V169, P112; Orchi N, 2008, AIDS CARE, V20, P419, DOI 10.1080/09540120701867073; Swearingen SG, 2005, AM J MED, V118, P571, DOI 10.1016/j.amjmed.2005.01.042; Tan H. H., 2006, SMJ Singapore Medical Journal, V47, P886; Teles AG, 2008, J SEX MED, V5, P1317, DOI 10.1111/j.1743-6109.2007.00745.x; Wang Y, 2013, S CHINA J PREV MED, V39, P6; Wei CY, 2012, DRUG ALCOHOL DEPEN, V120, P246, DOI 10.1016/j.drugalcdep.2011.07.016; Whipple B, 1996, AM J NURS, V96, P23, DOI 10.1097/00000446-199602000-00023; Wu, 2013, CHIN J AIDS STD, V19, P560; Wu Y, 2013, J MED PEST CONTROL, V29, P1144; Xu Yan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1166; Zhou Y, 2013, CHINESE J PUBLIC HLT, V4, P579; Zhou Y, 2008, J APPL PREVENTIVE ME, V14, P47; Zhou Y, 2013, PRACTICAL PREVENTIVE, V20, P801	27	16	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109452	10.1371/journal.pone.0109452	http://dx.doi.org/10.1371/journal.pone.0109452			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286369	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700065
J	Guo, J; Cheng, C; Yan, WP; Xu, GH; Feng, JZ; Wang, TZ; Chen, CS; Qin, XY				Guo, Jia; Cheng, Chuang; Yan, Weiping; Xu, Guanghui; Feng, Jinzhou; Wang, Tianzhu; Chen, Cindy Si; Qin, Xinyue			Systematic Review of Clinical Practice Guidelines Related to Multiple Sclerosis	PLOS ONE			English	Article							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; AGREE II; DIAGNOSIS; IMPLEMENTATION; THERAPEUTICS; MANAGEMENT; THERAPIES; QUALITY	Background: High quality clinical practice guidelines (CPGs) can provide clinicians with explicit recommendations on how to manage health conditions and bridge the gap between research and clinical practice. Unfortunately, the quality of CPGs for multiple sclerosis (MS) has not been evaluated. Objective: To evaluate the methodological quality of CPGs on MS using the AGREE II instrument. Methods: According to the inclusion and exclusion criteria, we searched four databases and two websites related to CPGs, including the Cochrane library, PubMed, EMBASE, DynaMed, the National Guideline Clearinghouse (NGC), and Chinese Biomedical Literature database (CBM). The searches were performed on September 20th 2013. All CPGs on MS were evaluated by the AGREE II instrument. The software used for analysis was SPSS 17.0. Results: A total of 27 CPGs on MS met inclusion criteria. The overall agreement among reviews was good or substantial (ICC was above 0.70). The mean scores for each of all six domains were presented as follows: scope and purpose (mean +/- SD: 59.05 +/- 16.13), stakeholder involvement (mean +/- SD: 29.53 +/- 17.67), rigor of development (mean +/- SD: 31.52 +/- 21.50), clarity of presentation (mean +/- SD: 60.39 +/- 13.73), applicability (mean +/- SD: 27.08 +/- 17.66), editorial independence (mean +/- SD: 28.70 +/- 22.03). Conclusions: The methodological quality of CPGs for MS was acceptable for scope, purpose and clarity of presentation. The developers of CPGs need to pay more attention to editorial independence, applicability, rigor of development and stakeholder involvement during the development process. The AGREE II instrument should be adopted by guideline developers.	[Guo, Jia; Cheng, Chuang; Yan, Weiping; Feng, Jinzhou; Wang, Tianzhu; Qin, Xinyue] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Xu, Guanghui] Third Peoples Hosp Chengdu, Dept Neurol, Chengdu, Peoples R China; [Chen, Cindy Si] Drexel Univ, Coll Med, Dept Med, Philadelphia, PA 19104 USA	Chongqing Medical University; Drexel University	Qin, XY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	qinxinyue@yahoo.com			National Key Clinical Specialties Construction Program of China	National Key Clinical Specialties Construction Program of China	This study is supported by National Key Clinical Specialties Construction Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; American Association of Neuroscience Nurses (AANN) Association of Rehabilitation Nurses (ARN) International Organization of Multiple Sclerosis Nurses (IOMSN), 2011, NURS MAN PAT MULT SC; ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Boster A, 2008, LANCET NEUROL, V7, P173, DOI 10.1016/S1474-4422(08)70020-6; Brouwers MC, 2012, J CLIN EPIDEMIOL, V65, P526, DOI 10.1016/j.jclinepi.2011.10.008; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; De Stefano N, 2007, NEUROLOGY, V69, P1942, DOI 10.1212/01.wnl.0000291557.62706.d3; Fieschi C, 1996, ITAL J NEUROL SCI, V17, P175; Filippi M, 2008, EUROPEAN HDB NEUROLO; Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2003, BRIT J CANCER, V89, pS4, DOI 10.1038/sj.bjc.6601077; Huang TW, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-191; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Lo Vecchio A, 2011, J PEDIATR GASTR NUTR, V52, P183, DOI 10.1097/MPG.0b013e3181e233ac; Marriott JJ, 2010, NEUROLOGY, V74, P1463, DOI 10.1212/WNL.0b013e3181dc1ae0; Nordqvist Christian, 2013, WHAT IS MS WHAT IS M; Palace J, 2009, NAT CLIN PRACT NEURO, V5, P134, DOI 10.1038/ncpneuro1047; Poolman RW, 2009, ACTA ORTHOP, V80, P113, DOI 10.1080/17453670902807458; Sellner J, 2010, EUR J NEUROL, V17, P1019, DOI 10.1111/j.1468-1331.2010.03066.x	23	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e106762	10.1371/journal.pone.0106762	http://dx.doi.org/10.1371/journal.pone.0106762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302678	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400003
J	Landgraf, SS; Silva, LS; Peruchetti, DB; Sirtoli, GM; Moraes-Santos, F; Portella, VG; Silva, JL; Pinheiro, CS; Abreu, TP; Takiya, CM; Benjamin, CF; Pinheiro, AAS; Canetti, C; Caruso-Neves, C				Landgraf, Sharon Schilling; Silva, Leandro Souza; Peruchetti, Diogo Barros; Sirtoli, Gabriela Modenesi; Moraes-Santos, Felipe; Portella, Viviane Gomes; Silva-Filho, Joao Luiz; Pinheiro, Carla Silva; Abreu, Thiago Pereira; Takiya, Christina Maeda; Benjamin, Claudia Farias; Sa Pinheiro, Ana Acacia; Canetti, Claudio; Caruso-Neves, Celso			5-Lypoxygenase Products Are Involved in Renal Tubulointerstitial Injury Induced by Albumin Overload in Proximal Tubules in Mice	PLOS ONE			English	Article							NF-KAPPA-B; 5-LIPOXYGENASE ACTIVATING PROTEIN; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; LEUKOTRIENE B-4; ENDOGENOUS INTERLEUKIN-6; IMMUNOMODULATOR AS101; MEDIATED ENDOCYTOSIS; OXIDATIVE STRESS; ANGIOTENSIN-II	The role of albumin overload in proximal tubules (PT) in the development of tubulointerstitial injury and, consequently, in the progression of renal disease has become more relevant in recent years. Despite the importance of leukotrienes (LTs) in renal disease, little is known about their role in tubulointerstitial injury. The aim of the present work was to investigate the possible role of LTs on tubulointerstitial injury induced by albumin overload. An animal model of tubulointerstitial injury challenged by bovine serum albumin was developed in SV129 mice (wild-type) and 5-lipoxygenase-deficient mice (5-LO-/-). The changes in glomerular morphology and nestin expression observed in wild-type mice subjected to kidney insult were also observed in 5-LO-/- mice. The levels of urinary protein observed in the 5-LO-/- mice subjected or not to kidney insult were lower than those observed in respective wild-type mice. Furthermore, the increase in lactate dehydrogenase activity, a marker of tubule damage, observed in wild-type mice subjected to kidney insult did not occur in 5-LO-/- mice. LTB4 and LTD4, 5-LO products, decreased the uptake of albumin in LLC-PK1 cells, a well-characterized porcine PT cell line. This effect correlated with activation of protein kinase C and inhibition of protein kinase B. The level of proinflammatory cytokines, tumor necrosis factor-alpha and interleukin (IL)-6, increased in mice subjected to kidney insult but this effect was not modified in 5-LO-/- mice. However, 5-LO-/- mice subjected to kidney insult presented lower macrophage infiltration and higher levels of IL-10 than wild-type mice. Our results reveal that LTs have an important role in tubulointerstitial disease induced by albumin overload.	[Landgraf, Sharon Schilling; Silva, Leandro Souza; Peruchetti, Diogo Barros; Sirtoli, Gabriela Modenesi; Moraes-Santos, Felipe; Portella, Viviane Gomes; Silva-Filho, Joao Luiz; Pinheiro, Carla Silva; Abreu, Thiago Pereira; Sa Pinheiro, Ana Acacia; Canetti, Claudio; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS, Rio De Janeiro, Brazil; [Landgraf, Sharon Schilling] Inst Fed Educ Ciencia & Tecnol, Rio De Janeiro, Brazil; [Takiya, Christina Maeda; Benjamin, Claudia Farias] Univ Fed Rio de Janeiro, CCS, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Sa Pinheiro, Ana Acacia] Inst Nacl Pesquisa Translac Saude & Ambiente Regi, CCS, Dept Fisiol & Biofis, Rio De Janeiro, Brazil; [Caruso-Neves, Celso] Inst Nacl Ciencia Tecnol & Biol & Bioimagem, CCS, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Instituto Federal do Sertao Pernambucano; Universidade Federal do Rio de Janeiro	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS, Rio De Janeiro, Brazil.	caruso@biof.ufrj.br	Peruchetti, Diogo B/L-3706-2017; Benjamim, Claudia/T-5090-2019; Takiya, Christina/AAU-5959-2021; Caruso-Neves, Celso/C-4014-2013; Silva-Filho, João Luiz/I-5704-2016; Claudio, Canetti A/C-2774-2009; Sila, Leandro/B-1381-2018	Peruchetti, Diogo B/0000-0002-7572-9731; Benjamim, Claudia/0000-0001-6247-9596; Takiya, Christina/0000-0002-8019-628X; Caruso-Neves, Celso/0000-0002-2415-7753; Silva-Filho, João Luiz/0000-0003-4762-2205; Sila, Leandro/0000-0001-8720-0088; Pinheiro, Ana Acacia/0000-0002-3894-1645	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INBEB/CNPq/MCT); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INBEB/CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Abreu TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093634; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Aoki Y, 1998, AM J PHYSIOL-LUNG C, V274, pL1030, DOI 10.1152/ajplung.1998.274.6.L1030; Atakan A, 2008, TRANSPL P, V40, P279, DOI 10.1016/j.transproceed.2007.11.026; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; BRACH MA, 1992, EUR J IMMUNOL, V22, P2705, DOI 10.1002/eji.1830221034; Brock TG, 2005, J CELL BIOCHEM, V96, P1203, DOI 10.1002/jcb.20662; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Camara NOS, 2009, CURR OPIN NEPHROL HY, V18, P21, DOI 10.1097/MNH.0b013e32831a9df7; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Choi YK, 2003, GENE THER, V10, P559, DOI 10.1038/sj.gt.3301926; Christman JW, 2000, BRAIN PATHOL, V10, P153; Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dahle MK, 2004, INFECT IMMUN, V72, P5704, DOI 10.1128/IAI.72.10.5704-5711.2004; EDDY AA, 1989, AM J PATHOL, V135, P719; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Gekle M, 1998, J AM SOC NEPHROL, V9, P960; Gekle M, 1997, AM J PHYSIOL-RENAL, V272, pF668, DOI 10.1152/ajprenal.1997.272.5.F668; Goulet JL, 2001, J IMMUNOL, V167, P6631, DOI 10.4049/jimmunol.167.11.6631; Guasch A, 1999, KIDNEY INT, V56, P261, DOI 10.1046/j.1523-1755.1999.00537.x; Hadi NR, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-70; Hagar HH, 2012, J SURG RES, V178, pE25, DOI 10.1016/j.jss.2012.02.022; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Hedi H, 2004, J BIOMED BIOTECHNOL, P99, DOI 10.1155/S1110724304310041; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Hefler LA, 2001, AM J PHYSIOL-REG I, V280, pR174, DOI 10.1152/ajpregu.2001.280.1.R174; Herrmann O, 2003, J CEREBR BLOOD F MET, V23, P406, DOI 10.1097/01.WCB.0000055177.50448.FA; Ishola DA, 2006, NEPHROL DIAL TRANSPL, V21, P591, DOI 10.1093/ndt/gfi303; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Kalechman Y, 2004, J BIOL CHEM, V279, P24724, DOI 10.1074/jbc.M312006200; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; KATOH T, 1993, J CLIN INVEST, V91, P1507, DOI 10.1172/JCI116356; Kitching AR, 2002, CLIN EXP IMMUNOL, V128, P36, DOI 10.1046/j.1365-2249.2002.01793.x; Lakkis FG, 1996, KIDNEY INT, V49, P117, DOI 10.1038/ki.1996.16; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Lepley RA, 1998, ARCH BIOCHEM BIOPHYS, V356, P71, DOI 10.1006/abbi.1998.0744; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luchtefeld M, 2003, BIOCHEM BIOPH RES CO, V308, P668, DOI 10.1016/S0006-291X(03)01456-6; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; Maalole T, 2011, PROSTAG LEUKOTR ESS, V85, P37, DOI 10.1016/j.plefa.2011.04.004; Matsuyama M, 2009, TRANSPL P, V41, P73, DOI 10.1016/j.transproceed.2008.08.153; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Monteiro APT, 2011, J IMMUNOL, V186, P6562, DOI 10.4049/jimmunol.1002400; MOORE KP, 1991, ADV PROSTAG THROMB L, V21, P697; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Mysliwska J, 2005, EUR CYTOKINE NETW, V16, P117; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Patel NSA, 2004, MOL PHARMACOL, V66, P220, DOI 10.1124/mol.66.2.220; Peruchetti DB, 2011, J BIOL CHEM, V286, P45041, DOI 10.1074/jbc.M111.260737; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; PETRIC R, 1995, J LIPID MEDIAT CELL, V11, P231, DOI 10.1016/0929-7855(94)00040-J; Portella VG, 2013, CRIT CARE MED, V41, P1056, DOI 10.1097/CCM.0b013e3182746696; Poudel B, 2012, N AM J MED SCI, V4, P331, DOI 10.4103/1947-2714.99501; Reinhold SW, 2006, AM J PHYSIOL-RENAL, V290, pF864, DOI 10.1152/ajprenal.00169.2005; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schock-Kusch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071519; Sener G, 2007, PROSTAG OTH LIPID M, V83, P257, DOI 10.1016/j.prostaglandins.2007.01.013; Sener G, 2006, PHARMACOL RES, V54, P65, DOI 10.1016/j.phrs.2006.02.007; Sinuani Inna, 2013, World J Transplant, V3, P91, DOI 10.5500/wjt.v3.i4.91; Su W, 2007, AM J PHYSIOL-REG I, V292, pR1761, DOI 10.1152/ajpregu.00319.2006; Sun ZL, 2003, GASTROENTEROLOGY, V125, P202, DOI 10.1016/S0016-5085(03)00696-6; Taccone-Gallucci M, 2006, KIDNEY INT, V69, P1450, DOI 10.1038/sj.ki.5000291; Taccone-Gallucci M, 2000, CONTRIB NEPHROL, V130, P130; Takada M, 1997, J CLIN INVEST, V99, P2682, DOI 10.1172/JCI119457; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; Valdivielso JM, 2003, J NEPHROL, V16, P85; Won JS, 2005, GLIA, V51, P13, DOI 10.1002/glia.20178; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yokota N, 2003, AM J NEPHROL, V23, P13, DOI 10.1159/000066301; Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023	80	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e107549	10.1371/journal.pone.0107549	http://dx.doi.org/10.1371/journal.pone.0107549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302946	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400005
J	Chalopin, M; Soleti, R; Benameur, T; Tesse, A; Faure, S; Martinez, MC; Andriantsitohaina, R				Chalopin, Matthieu; Soleti, Raffaella; Benameur, Tarek; Tesse, Angela; Faure, Sebastien; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson			Red Wine Polyphenol Compounds Favor Neovascularisation through Estrogen Receptor alpha-Independent Mechanism in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOTHELIUM-DEPENDENT VASORELAXATION; NITRIC-OXIDE SYNTHASE; MOUSE MODEL; ANGIOGENESIS; SIRT1; VEGF; RATS; DELPHINIDIN; INVOLVEMENT	Red wine polyphenol compounds (RWPC) exert paradoxical effects depending on the dose on post-ischemic neovascularisation. Low dose RWPC (0.2 mg/kg/day) is pro-angiogenic, whereas high dose (20 mg/kg/day) is anti-angiogenic. We recently reported that the endothelial effect of RWPC is mediated through the activation of a redox-sensitive pathway, mitochondrial biogenesis and the activation of alpha isoform of the estrogen receptor (ER alpha). Here, we investigated the implication of ER alpha on angiogenic properties of RWPC. Using ovariectomized mice lacking ER alpha treated with high dose of RWPC after hindlimb ischemia, we examined blood flow reperfusion, vascular density, nitric oxide (NO) production, expression and activation of proteins involved in angiogenic process and muscle energy sensing network. As expected, high dose of RWPC treatment reduced both blood flow and vascular density in muscles of mice expressing ER alpha. These effects were associated with reduced NO production resulting from diminished activity of eNOS. In the absence of RWPC, ER alpha deficient mice showed a reduced neo-vascularisation associated with a decreased NO production. Surprisingly in mice lacking ER alpha, high dose of RWPC increased blood flow and capillary density in conjunction with increased NO pathway and production as well as VEGF expression. Of particular interest is the activation of Sirt-1, AMPK alpha and PGC-1 alpha/beta axis in ischemic hindlimb from both strains. Altogether, the results highlight a pro-angiogenic property of RWPC via an ER alpha-independent mechanism that is associated with an up-regulation of energy sensing network. This study brings a corner stone of a novel pathway for RWPC to correct cardiovascular diseases associated with failed neovascularisation.	[Chalopin, Matthieu; Soleti, Raffaella; Benameur, Tarek; Tesse, Angela; Faure, Sebastien; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] INSERM, U1063, Angers, France; [Andriantsitohaina, Ramaroson] CHU Angers, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Andriantsitohaina, R (corresponding author), INSERM, U1063, Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	B, T/ABD-6713-2020; SOLETI, RAFFAELLA/ABB-5455-2020; Clere, Nicolas/K-4414-2015; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; soleti, raffaella/AAC-1678-2021; Tesse, Angela/D-4803-2015; BENAMEUR, TAREK/P-9053-2019	SOLETI, RAFFAELLA/0000-0002-0271-0490; Tesse, Angela/0000-0002-2153-4357; andriantsitohaina, ramaroson/0000-0002-4770-3585; Faure, Sebastien/0000-0001-7524-8295; chalopin, matthieu/0000-0002-9285-8869	INSERM; Universite d'Angers; Contrat d'Interface INSERM; French Education Ministry	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite d'Angers; Contrat d'Interface INSERM; French Education Ministry	This work was supported by institutional grants from INSERM and Universite d'Angers. RA was supported by a Contrat d'Interface INSERM. MC is the recipient of a doctoral fellowship from French Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005557; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; Andriambeloson E, 1998, J NUTR, V128, P2324, DOI 10.1093/jn/128.12.2324; Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brandes RP, 2008, CARDIOVASC RES, V80, P163, DOI 10.1093/cvr/cvn245; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chalopin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008554; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Donnini S, 2006, BRIT J NUTR, V95, P1016, DOI 10.1079/BJN20061753; Duluc L, 2013, INT J BIOCHEM CELL B, V45, P783, DOI 10.1016/j.biocel.2013.01.007; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Favot L, 2003, CARDIOVASC RES, V59, P479, DOI 10.1016/S0008-6363(03)00433-4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jesmin S, 2010, EUR J PHARMACOL, V641, P168, DOI 10.1016/j.ejphar.2010.05.020; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Martin S, 2003, BIOCHEM PHARMACOL, V65, P669, DOI 10.1016/S0006-2952(02)01568-X; Martin S, 2002, BRIT J PHARMACOL, V135, P1579, DOI 10.1038/sj.bjp.0704603; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Ranaivo HR, 2004, BRIT J PHARMACOL, V142, P671, DOI 10.1038/sj.bjp.0705833; Raval AP, 2006, J CEREBR BLOOD F MET, V26, P1141, DOI 10.1038/sj.jcbfm.9600262; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Ritz MF, 2008, J NUTR, V138, P519, DOI 10.1093/jn/138.3.519; Robich MP, 2010, SURGERY, V148, P453, DOI 10.1016/j.surg.2010.04.013; Szekanecz Z, 2009, AUTOIMMUNITY, V42, P563, DOI 10.1080/08916930903143083; Walter A, 2010, FASEB J, V24, P3360, DOI 10.1096/fj.09-149419; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188	41	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110080	10.1371/journal.pone.0110080	http://dx.doi.org/10.1371/journal.pone.0110080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299185	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200100
J	Zhi, F; Wang, Q; Deng, DN; Shao, NY; Wang, R; Xue, L; Wang, SN; Xia, XW; Yang, YL				Zhi, Feng; Wang, Qiang; Deng, Danni; Shao, Naiyuan; Wang, Rong; Xue, Lian; Wang, Suinuan; Xia, Xiwei; Yang, Yilin			MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma	PLOS ONE			English	Article							MALIGNANT GLIOMAS; HUMAN CANCERS; MICRORNA-181B; EXPRESSION; RNA; SENSITIVITY; TARGETS; SYNAPSE; PROTEIN; BRAIN	MicroRNAs (miRNAs) are small, short noncoding RNAs that modulate the expression of numerous genes by targeting their mRNA. Numerous abnormal miRNA expression patterns are observed in various human malignancies, and certain miRNAs can act as oncogenes or tumor suppressors. Astrocytoma, the most common neuroepithelial cancer, represents the majority of malignant brain tumors in humans. In our previous studies, we found that the downregulation of miR-181b-5p in astrocytomas is associated with a poor prognosis. The aim of the present study was to investigate the functional role of miR-181b-5p and its possible target genes. miR-181b-5p was significantly downregulated in astrocytoma specimens, and the reduced expression of miR-181b-5p was inversely correlated with the clinical stage. The ectopic expression of miR-181b-5p inhibited proliferation, migration and invasion and induced apoptosis in astrocytoma cancer cells in vitro. The NOVA1 (neuro-oncological ventral antigen 1) gene was further identified as a novel direct target of miR-181b-5p. Specifically, miR-181b-5p bound directly to the 3'-untranslated region (UTR) of NOVA1 and suppressed its expression. In clinical specimens, NOVA1 was overexpressed, and its protein levels were inversely correlated with miR-181b-5p expression. Furthermore, the changing level of NOVA1 was significantly associated with a poor survival outcome. Similar to restoring miR-181b-5p expression, downregulating NOVA1 inhibited cell growth, migration and invasion. Overexpression of NOVA1 reversed the inhibitory effects of miR-181b-5p. Our results indicate that miR-181b-5p is a tumor suppressor in astrocytoma that inhibits tumor progression by targeting NOVA1. These findings suggest that miR-181b-5p may serve as a novel therapeutic target for astrocytoma.	[Zhi, Feng; Deng, Danni; Wang, Rong; Xue, Lian; Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Jiangsu, Peoples R China; [Wang, Qiang; Shao, Naiyuan; Wang, Suinuan; Xia, Xiwei] Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Xia, XW (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China.	xia_xiwei@126.com; yilinyang.czfph@gmail.com		Shao, Naiyuan/0000-0001-5523-7142; Deng, Danni/0000-0001-9409-1318	National Natural Science Foundation of China [31071046, 81302197]; Changzhou Social Development Project [CS20092015, CS20102010]; Changzhou Health Bureau Project [ZD200903, ZD201007]; Changzhou Science Technology Bureau Guiding Project [CY20119004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Social Development Project; Changzhou Health Bureau Project; Changzhou Science Technology Bureau Guiding Project	This work was supported by National Natural Science Foundation of China (31071046, 81302197), Changzhou Social Development Project (CS20092015, CS20102010), Changzhou Health Bureau Project (ZD200903, ZD201007), Changzhou Science Technology Bureau Guiding Project (CY20119004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bisso A, 2013, CELL CYCLE, V12, P1679, DOI 10.4161/cc.24757; Cai BB, 2013, ONCOL REP, V29, P1769, DOI 10.3892/or.2013.2297; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen L, 2012, IUBMB LIFE, V64, P628, DOI 10.1002/iub.1030; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gabayan AJ, 2006, NEUROSURGERY, V58, P701, DOI 10.1227/01.NEU.0000194836.07848.69; Guo JX, 2012, ASIAN PAC J CANCER P, V13, P2263, DOI 10.7314/APJCP.2012.13.5.2263; He L, 2013, GENET MOL RES, V12, P1012, DOI 10.4238/2013.April.2.17; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HL, 2013, J HISTOCHEM CYTOCHEM, V61, P45, DOI 10.1369/0022155412461255; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926; Park E, 2011, J BIOL CHEM, V286, P25301, DOI 10.1074/jbc.M110.206540; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shi ZM, 2013, RNA, V19, P552, DOI 10.1261/rna.035972.112; Takiuchi D, 2013, PANCREATOLOGY, V13, P517, DOI 10.1016/j.pan.2013.06.007; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang J, 2013, CANCER CHEMOTH PHARM, V72, P147, DOI 10.1007/s00280-013-2180-3; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072390; Zhi F, 2012, INT J BIOL SCI, V8, P289, DOI 10.7150/ijbs.3520; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	31	54	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109124	10.1371/journal.pone.0109124	http://dx.doi.org/10.1371/journal.pone.0109124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299073	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200035
J	Zuo, L; Diaz, PT; Chien, MT; Roberts, WJ; Kishek, J; Best, TM; Wagner, PD				Zuo, Li; Diaz, Philip T.; Chien, Michael T.; Roberts, William J.; Kishek, Juliana; Best, Thomas M.; Wagner, Peter D.			PO2 Cycling Reduces Diaphragm Fatigue by Attenuating ROS Formation	PLOS ONE			English	Article							OXYGEN SPECIES FORMATION; TNF-ALPHA OVEREXPRESSION; REACTIVE OXYGEN; SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; MAMMALIAN SKELETAL; MITOCHONDRIA; ANTIOXIDANTS; CONTRACTIONS; METABOLISM	Prolonged muscle exposure to low PO2 conditions may cause oxidative stress resulting in severe muscular injuries. We hypothesize that PO2 cycling preconditioning, which involves brief cycles of diaphragmatic muscle exposure to a low oxygen level (40 Torr) followed by a high oxygen level (550 Torr), can reduce intracellular reactive oxygen species (ROS) as well as attenuate muscle fatigue in mouse diaphragm under low PO2. Accordingly, dihydrofluorescein (a fluorescent probe) was used to monitor muscular ROS production in real time with confocal microscopy during a lower PO2 condition. In the control group with no PO2 cycling, intracellular ROS formation did not appear during the first 15 min of the low PO2 period. However, after 20 min of low PO2, ROS levels increased significantly by similar to 30% compared to baseline, and this increase continued until the end of the 30 min low PO2 condition. Conversely, muscles treated with PO2 cycling showed a complete absence of enhanced fluorescence emission throughout the entire low PO2 period. Furthermore, PO2 cycling-treated diaphragm exhibited increased fatigue resistance during prolonged low PO2 period compared to control. Thus, our data suggest that PO2 cycling mitigates diaphragm fatigue during prolonged low PO2. Although the exact mechanism for this protection remains to be elucidated, it is likely that through limiting excessive ROS levels, PO2 cycling initiates ROS-related antioxidant defenses.	[Zuo, Li; Roberts, William J.] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Davis Heart & Lung Res Inst,Radiol Sci & Resp The, Columbus, OH 43210 USA; [Wagner, Peter D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zuo, Li; Roberts, William J.; Kishek, Juliana] Oakland Univ, Dept Biol Sci, Rochester, MI 48063 USA; [Best, Thomas M.] Ohio State Univ, Sports Hlth & Performance Inst, Dept Family Med, Div Sports Med, Columbus, OH 43210 USA; [Chien, Michael T.] Kalamazoo Coll, Dept Biol, Kalamazoo, MI 49007 USA; [Diaz, Philip T.] Ohio State Univ, Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of California System; University of California San Diego; Oakland University; University System of Ohio; Ohio State University; Kalamazoo College; University System of Ohio; Ohio State University	Zuo, L (corresponding author), Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Davis Heart & Lung Res Inst,Radiol Sci & Resp The, Columbus, OH 43210 USA.	zuo.4@osu.edu			Oakland University General Fund [G110]; Research Excellence Fund of Biomedical Research; Ohio State University-Health and Rehabilitation Sciences fund [013000]	Oakland University General Fund; Research Excellence Fund of Biomedical Research; Ohio State University-Health and Rehabilitation Sciences fund	Funding provided by Oakland University General Fund G110, Research Excellence Fund of Biomedical Research, and The Ohio State University-Health and Rehabilitation Sciences fund 013000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Brotto MAP, 1996, J APPL PHYSIOL, V81, P731, DOI 10.1152/jappl.1996.81.2.731; CALDARERA CM, 1973, B SOC ITAL BIOL SPER, V49, P72; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen CF, 2003, J PHYSIOL-LONDON, V552, P561, DOI 10.1113/jhysiol.2003.045559; Choi YS, 2007, EXP MOL MED, V39, P556, DOI 10.1038/emm.2007.61; CRISWELL D, 1993, MED SCI SPORT EXER, V25, P1135; GROSS GJ, 1992, CIRC RES, V70, P223, DOI 10.1161/01.RES.70.2.223; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Henriksen EJ, 2013, METHOD ENZYMOL, V528, P269, DOI 10.1016/B978-0-12-405881-1.00016-1; JENKINS RR, 1984, INT J SPORTS MED, V5, P11, DOI 10.1055/s-2008-1025872; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; MACFARLANE NG, 1992, CIRC RES, V70, P1217, DOI 10.1161/01.RES.70.6.1217; Mohanraj P, 1998, J APPL PHYSIOL, V84, P1960, DOI 10.1152/jappl.1998.84.6.1960; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Muza SR, 2007, MED SCI SPORT EXER, V39, P1625, DOI 10.1249/mss.0b013e3180de49fe; Penheiter AR, 2007, J BIOL CHEM, V282, P4336, DOI 10.1074/jbc.M609499200; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Ravingerova T, 1998, MOL CELL BIOCHEM, V186, P53, DOI 10.1023/A:1006857527652; REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797; Reid MB, 2008, FREE RADICAL BIO MED, V44, P169, DOI 10.1016/j.freeradbiomed.2007.03.002; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Roberts WJ, 2012, GSTF JBIO, V2, P42, DOI DOI 10.5176/2251-3140_2.1.20; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; SEN CK, 1995, J APPL PHYSIOL, V79, P675, DOI 10.1152/jappl.1995.79.3.675; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Wagner PD, 2012, EUR J APPL PHYSIOL, V112, P1, DOI 10.1007/s00421-011-1955-7; Wang JA, 2008, ACTA PHARMACOL SIN, V29, P74, DOI 10.1111/j.1745-7254.2008.00716.x; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zuo L, 2005, AM J PHYSIOL-CELL PH, V289, pC207, DOI 10.1152/ajpcell.00449.2004; Zuo L, 2002, METHOD ENZYMOL, V352, P307; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058; Zuo L, 2014, AM J PHYSIOL-REG I, V306, pR75, DOI 10.1152/ajpregu.00425.2013; Zuo Li, 2013, [Frontiers in Biology, 生物学前沿], V8, P305; Zuo L, 2013, AM J PHYSIOL-REG I, V304, pR1009, DOI 10.1152/ajpregu.00563.2012; Zuo Li, 2012, [Frontiers in Biology, 生物学前沿], V7, P506; Zuo L, 2011, AM J PHYSIOL-REG I, V301, pR1025, DOI 10.1152/ajpregu.00126.2011; Zuo L, 2011, J APPL PHYSIOL, V111, P898, DOI 10.1152/japplphysiol.00398.2011	40	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109884	10.1371/journal.pone.0109884	http://dx.doi.org/10.1371/journal.pone.0109884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299212	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000343941200084
J	Callieri, C; Bertoni, R; Contesini, M; Bertoni, F				Callieri, Cristiana; Bertoni, Roberto; Contesini, Mario; Bertoni, Filippo			Lake Level Fluctuations Boost Toxic Cyanobacterial "Oligotrophic Blooms"	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; CLIMATE; EUTROPHICATION; PHYTOPLANKTON; LIGHT	Global warming has been shown to strongly influence inland water systems, producing noticeable increases in water temperatures. Rising temperatures, especially when combined with widespread nutrient pollution, directly favour the growth of toxic cyanobacteria. Climate changes have also altered natural water level fluctuations increasing the probability of extreme events as dry periods followed by heavy rains. The massive appearance of Dolichospermum lemmermannii (= planktonic Anabaena), a toxic species absent from the pelagic zone of the subalpine oligotrophic Lake Maggiore before 2005, could be a consequence of the unusual fluctuations of lake level in recent years. We hypothesized that these fluctuations may favour the cyanobacterium as result of nutrient pulses from the biofilms formed in the littoral zone when the lake level is high. To help verify this, we exposed artificial substrates in the lake, and evaluated their nutrient enrichment and release after desiccation, together with measurements of fluctuations in lake level, precipitation and D.lemmermannii population. The highest percentage of P release and the lowest C:P molar ratio of released nutrients coincided with the summer appearance of the D.lemmermannii bloom. The P pulse indicates that fluctuations in level counteract nutrient limitation in this lake and it is suggested that this may apply more widely to other oligotrophic lakes. In view of the predicted increase in water level fluctuations due to climate change, it is important to try to minimize such fluctuations in order to mitigate the occurrence of cyanobacterial blooms.	[Callieri, Cristiana; Bertoni, Roberto; Contesini, Mario] Inst Ecosyst Study CNR, Verbania, Italy; [Bertoni, Filippo] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); University of Amsterdam	Callieri, C (corresponding author), Inst Ecosyst Study CNR, Verbania, Italy.	c.callieri@ise.cnr.it		Bertoni, Filippo/0000-0001-7037-5949	Project INTERREG STRADA Lombardy Region	Project INTERREG STRADA Lombardy Region	Funding provided by Project INTERREG STRADA Lombardy Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 1999, NEW PHYTOL, V144, P3, DOI 10.1046/j.1469-8137.1999.00505.x; Ambrosetti Walter, 2003, Journal of Limnology, V62, P1; Ambrosetti W, 2010, J LIMNOL, V69, P3, DOI 10.4081/jlimnol.2010.3; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Bates B.C., 2008, CLIMATE CHANGE WATER; Bergey EA, 2006, HYDROBIOLOGIA, V563, P247, DOI 10.1007/s10750-006-0016-4; Bertoni R, 1978, MEM I ITAL IDROBIOL, V36, P297; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Cronberg G., 2006, MANUAL AQUATIC CYANO; ENGEL S, 1994, J FRESHWATER ECOL, V9, P97, DOI 10.1080/02705060.1994.9664436; Gallina N, 2013, AQUAT ECOL, V47, P177, DOI 10.1007/s10452-013-9433-4; Guillizoni P., 1989, MEM I ITAL IDROBIOL, V46, P197; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Heriksen P, 1997, TOXICON, V35, P901; Hoeger SJ, 2007, ENVIRON SCI TECHNOL, V41, P2609, DOI 10.1021/es062681p; Mehnert G, 2010, J PLANKTON RES, V32, P1009, DOI 10.1093/plankt/fbq033; Morabito G, 2007, RICERCHE EVOLUZIONE, P97; Morabito Giuseppe, 2002, Journal of Limnology, V61, P129; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Paul VJ, 2008, ADV EXP MED BIOL, V619, P239, DOI 10.1007/978-0-387-75865-7_11; Posch T, 2012, NAT CLIM CHANGE, V2, P809, DOI [10.1038/nclimate1581, 10.1038/NCLIMATE1581]; REYNOLDS CS, 1987, NEW ZEAL J MAR FRESH, V21, P379, DOI 10.1080/00288330.1987.9516234; Rigosi A, 2014, LIMNOL OCEANOGR, V59, P99, DOI 10.4319/lo.2014.59.1.0099; Rogora M., 2013, RICERCHE SULLEVOLUZI, P119; Salmaso N, 2000, HYDROBIOLOGIA, V438, P43, DOI 10.1023/A:1004157828049; Salmaso N, 2011, ADV OCEANOGR LIMNOL, V1, P29; Salmaso N, 2012, AQUAT SCI, V74, P555, DOI 10.1007/s00027-012-0248-5; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Shiklomanov IA, 1998, WORLD WATER RESOURCE; SMITH VH, 1986, CAN J FISH AQUAT SCI, V43, P148, DOI 10.1139/f86-016; Song KY, 2007, SCI TOTAL ENVIRON, V380, P13, DOI 10.1016/j.scitotenv.2006.11.035; Wacklin P, 2009, FOTTEA, V9, P59, DOI 10.5507/fot.2009.005; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Whitton B. A., 2012, ECOLOGY CYANOBACTERI, V2, P15	36	42	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109526	10.1371/journal.pone.0109526	http://dx.doi.org/10.1371/journal.pone.0109526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295866	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000078
J	Chen, D; Bobko, AA; Gross, AC; Evans, R; Marsh, CB; Khramtsov, VV; Eubank, TD; Friedman, A				Chen, Duan; Bobko, Andrey A.; Gross, Amy C.; Evans, Randall; Marsh, Clay B.; Khramtsov, Valery V.; Eubank, Timothy D.; Friedman, Avner			Involvement of Tumor Macrophage HIFs in Chemotherapy Effectiveness: Mathematical Modeling of Oxygen, pH, and Glutathione	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERFUSED-RAT-LIVER; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; DRUG-RESISTANCE; PROTON-TRANSFER; CELL-LINES; CANCER; HYPOXIA; ANGIOGENESIS	The four variables, hypoxia, acidity, high glutathione (GSH) concentration and fast reducing rate (redox) are distinct and varied characteristics of solid tumors compared to normal tissue. These parameters are among the most significant factors underlying the metabolism and physiology of solid tumors, regardless of their type or origin. Low oxygen tension contributes to both inhibition of cancer cell proliferation and therapeutic resistance of tumors; low extracellular pH, the reverse of normal cells, mainly enhances tumor invasion; and dysregulated GSH and redox potential within cancer cells favor their proliferation. In fact, cancer cells under these microenvironmental conditions appreciably alter tumor response to cytotoxic anti-cancer treatments. Recent experiments measured the in vivo longitudinal data of these four parameters with tumor development and the corresponding presence and absence of tumor macrophage HIF-1 alpha or HIF-2 alpha in a mouse model of breast cancer. In the current paper, we present a mathematical model-based system of (ordinary and partial) differential equations to monitor tumor growth and susceptibility to standard chemotherapy with oxygen level, pH, and intracellular GSH concentration. We first show that our model simulations agree with the corresponding experiments, and then we use our model to suggest treatments of tumors by altering these four parameters in tumor microenvironment. For example, the model qualitatively predicts that GSH depletion can raise the level of reactive oxygen species (ROS) above a toxic threshold and result in inhibition of tumor growth.	[Chen, Duan] Univ N Carolina, Dept Math & Stat, Charlotte, NC 28223 USA; [Bobko, Andrey A.; Gross, Amy C.; Evans, Randall; Marsh, Clay B.; Khramtsov, Valery V.; Eubank, Timothy D.] Ohio State Univ, Coll Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University of North Carolina; University of North Carolina Charlotte; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Eubank, TD (corresponding author), Ohio State Univ, Coll Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	Tim.Eubank@osumc.edu; afriedman@math.osu.edu	Bobko, Andrey/M-4997-2015	Eubank, Tim/0000-0002-8225-7824	National Science Foundation [0635561]; NCI [5R00CA131552, R01 HL067167]; NATIONAL CANCER INSTITUTE [R00CA131552] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Science Foundation Award 0635561, NCI 5R00CA131552 (TDE) and R01 HL067167 (CBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; ANTUNES F, 1995, FREE RADICAL BIO MED, V19, P669, DOI 10.1016/0891-5849(95)00040-5; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; BARD S, 1986, BRIT J CANCER, V53, P637, DOI 10.1038/bjc.1986.107; Bobko AA, 2012, MAGN RESON MED, V67, P1827, DOI 10.1002/mrm.23196; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Breward CJW, 2001, EUR J APPL MATH, V12, P529, DOI 10.1017/S095679250100448X; Butterworth E A, 1967, BRIT J CANCER, V21; Calvert P, 1998, CHEM-BIOL INTERACT, V112, P213, DOI 10.1016/S0009-2797(98)00008-8; Cameron AC, 1997, J ECONOMETRICS, V77, P329; CASCIARI JJ, 1988, CANCER RES, V48, P3905; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Cook JA, 2004, SEMIN RADIAT ONCOL, V14, P259, DOI 10.1016/j.semradonc.2004.04.001; Coso S, 2012, ANTIOXID REDOX SIGN, V16, P1229, DOI 10.1089/ars.2011.4489; Dai L, 2002, J BIOL CHEM, V277, P11368; Eubank TD, 2011, BLOOD, V117, P323, DOI 10.1182/blood-2010-01-261792; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Flohe L, 1978, Ciba Found Symp, P95; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Harguindey S, 2009, ANTICANCER RES, V29, P2127; Hochwald SN, 1997, ANN SURG ONCOL, V4, P303, DOI 10.1007/BF02303579; Hu YM, 2005, J BIOL CHEM, V280, P39485, DOI 10.1074/jbc.M503296200; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; Khramtsov VV, 2014, ANTIOXID REDOX SIGN, V21, P723, DOI 10.1089/ars.2014.5864; Laurent A, 2005, CANCER RES, V65, P948; LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402; LEWIS AD, 1988, CARCINOGENESIS, V9, P1283, DOI 10.1093/carcin/9.7.1283; Li SJ, 2000, CANCER RES, V60, P3927; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; LUZ Z, 1964, J AM CHEM SOC, V86, P4768, DOI 10.1021/ja01076a008; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; MACDOUGALL JD, 1967, NATURE, V215, P1173, DOI 10.1038/2151173a0; Manda G, 2009, CURR CHEM BIOL, V3, P342, DOI DOI 10.2174/187231309787158271; MARTIN GR, 1994, CANCER RES, V54, P5670; Martin NK, 2010, J THEOR BIOL, V267, P461, DOI 10.1016/j.jtbi.2010.08.028; Melillo G, 1999, CANCER RES, V59, P5433; MULCAHY RT, 1994, MOL PHARMACOL, V46, P909; Ng CF, 2007, FREE RADICAL RES, V41, P1201, DOI 10.1080/10715760701625075; OBrien ML, 1996, EUR J CANCER, V32A, P967, DOI 10.1016/0959-8049(96)00051-2; OOKHTENS M, 1985, J CLIN INVEST, V75, P258, DOI 10.1172/JCI111682; Oren H, 2001, PEDIATRICS, V108, P329, DOI 10.1542/peds.108.2.329; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; OSHINO N, 1973, ARCH BIOCHEM BIOPHYS, V154, P117, DOI 10.1016/0003-9861(73)90040-4; Owen MR, 1997, J THEOR BIOL, V189, P63, DOI 10.1006/jtbi.1997.0494; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Plank MJ, 2004, J THEOR BIOL, V229, P435, DOI 10.1016/j.jtbi.2004.04.012; Pyaskovskaya O. N., 2008, Experimental Oncology, V30, P269; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P309, DOI 10.1016/S0006-2952(98)00306-2; Ribeiro Maria de Lourdes C, 2012, J Nutr Food Sci, V2, P6; Roda JM, 2011, J IMMUNOL, V187, P1970, DOI 10.4049/jimmunol.1100841; Roshchupkina GI, 2008, FREE RADICAL BIO MED, V45, P312, DOI 10.1016/j.freeradbiomed.2008.04.019; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schugart RC, 2008, P NATL ACAD SCI USA, V105, P2628, DOI 10.1073/pnas.0711642105; Sekhar RV, 2011, AM J CLIN NUTR, V94, P847, DOI 10.3945/ajcn.110.003483; Smallbone K, 2008, J THEOR BIOL, V255, P106, DOI 10.1016/j.jtbi.2008.08.002; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; STUBBS M, 1992, NMR BIOMED, V5, P351, DOI 10.1002/nbm.1940050606; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tang SS, 2000, CHINESE SCI BULL, V45, P1697, DOI 10.1007/BF02898990; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Utting JC, 2010, CELL BIOCHEM FUNCT, V28, P374, DOI 10.1002/cbf.1660; Vaupel P, 2003, CANCER RES, V63, P7634; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vicioso L, 2006, AM J CLIN PATHOL, V125, P111, DOI 10.1309/0864AF2U3LGPCF3J; Vincensini D, 2007, MAGNETIC RESONANCE I, V25; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wathen KA, 2011, HUM REPROD, V26, P221, DOI 10.1093/humrep/deq304; Wraight CA, 2006, BBA-BIOENERGETICS, V1757, P886, DOI 10.1016/j.bbabio.2006.06.017; Wu FTH, 2010, AM J PHYSIOL-HEART C, V298, pH2174, DOI 10.1152/ajpheart.00365.2009; Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108; Xu L, 2002, J BIOL CHEM, V277, P11368, DOI 10.1074/jbc.M108347200; Youn BS, 2006, BIOTECHNOL PROGR, V22, P801, DOI 10.1021/bp050430z	82	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107511	10.1371/journal.pone.0107511	http://dx.doi.org/10.1371/journal.pone.0107511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295611	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000006
J	da Silva, F; Almeida-Neto, M; Arena, MVN				da Silva, Fernando Rodrigues; Almeida-Neto, Mario; Nicolosi Arena, Mariana Victorino			Amphibian Beta Diversity in the Brazilian Atlantic Forest: Contrasting the Roles of Historical Events and Contemporary Conditions at Different Spatial Scales	PLOS ONE			English	Article							SPECIES RICHNESS; GLOBAL PATTERNS; PHYLOGENETIC DIVERSITY; RELATIVE ROLES; BIOGEOGRAPHY; BIODIVERSITY; SPECIATION; RESOLUTION; EVOLUTION; TURNOVER	Current patterns of biodiversity distribution result from a combination of historical and contemporary processes. Here, we compiled checklists of amphibian species to assess the roles of long-term climate stability (Quaternary oscillations), contemporary environmental gradients and geographical distance as determinants of change in amphibian taxonomic and phylogenetic composition in the Brazilian Atlantic Forest. We calculated beta diversity as both variation in species composition (CBD) and phylogenetic differentiation (PBD) among the assemblages. In both cases, overall beta diversity was partitioned into two basic components: species replacement and difference in species richness. Our results suggest that the CBD and PBD of amphibians are determined by spatial turnover. Geographical distance, current environmental gradients and long-term climatic conditions were complementary predictors of the variation in CBD and PBD of amphibian species. Furthermore, the turnover components between sites from different regions and between sites within the stable region were greater than between sites within the unstable region. On the other hand, the proportion of beta-diversity due to species richness difference for both CBD and PBD was higher between sites in the unstable region than between sites in the stable region. The high turnover components from CBD and PBD between sites in unstable vs stable regions suggest that these distinct regions have different biogeographic histories. Sites in the stable region shared distinct clades that might have led to greater diversity, whereas sites in the unstable region shared close relatives. Taken together, these results indicate that speciation, environmental filtering and limited dispersal are complementary drivers of beta-diversity of amphibian assemblages in the Brazilian Atlantic Forest.	[da Silva, Fernando Rodrigues; Nicolosi Arena, Mariana Victorino] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sorocaba, SP, Brazil; [Almeida-Neto, Mario] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Goias	da Silva, F (corresponding author), Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sorocaba, SP, Brazil.	fernandors@ufscar.br	Arena, Mariana Victorino Nicolosi/AAY-7727-2021; da Silva, Fernando Rodrigues/G-3026-2012; Almeida-Neto, M./A-6389-2009; Victorino Nicolosi Arena, Mariana/A-1569-2019	da Silva, Fernando Rodrigues/0000-0002-0983-3207; Almeida-Neto, M./0000-0002-2161-2968; Victorino Nicolosi Arena, Mariana/0000-0003-3455-790X	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo [Proc. 2013/50714-0, Proc. 2011/22618-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [Proc. 483486/2011-6, Proc. 306870/2012-6]	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FRdS and MVNA were supported by Fundacao de Amparo a Pesquisa no Estado de Sao Paulo ((http://www.fapesp.br/), Proc. 2013/50714-0 and Proc. 2011/22618-0, respectively). FRdS and MAN were supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico ((http://www.cnpq.br/), Proc. 483486/2011-6 and Proc. 306870/2012-6, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Baselga A, 2013, BETAPART PARTITIONIN; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carvalho JC, 2013, OIKOS, V122, P825, DOI 10.1111/j.1600-0706.2012.20980.x; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; da Silva FR, 2012, J BIOGEOGR, V39, P1720, DOI 10.1111/j.1365-2699.2012.02726.x; de Sa RO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-241; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fouquet A, 2013, MOL PHYLOGENET EVOL, V67, P445, DOI 10.1016/j.ympev.2013.02.009; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Graham CH, 2014, ECOGRAPHY, V37, P711, DOI 10.1111/ecog.00578; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; HADDAD C.F.B., 2013, GUIA ANFIBIOS MATA A; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HIjMAns R.J., 2012, DIVA GIS VERSION 7 5; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hua X, 2013, AM NAT, V182, P1, DOI 10.1086/670690; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Kozak KH, 2012, ECOLOGY, V93, pS167, DOI 10.1890/11-0542.1; Leprieur F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042760; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Lessard JP, 2012, P ROY SOC B-BIOL SCI, V279, P266, DOI 10.1098/rspb.2011.0552; Loyola RD, 2014, ECOGRAPHY, V37, P65, DOI 10.1111/j.1600-0587.2013.00396.x; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lynch J.D., 1986, P478; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; Mittermeier R. A., 2005, HOTSPOTS EARTHS BIOL; Navas CA, 2004, INT CONGR SER, V1275, P298, DOI 10.1016/j.ics.2004.08.061; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Oberdorff T, 1997, J BIOGEOGR, V24, P461, DOI 10.1111/j.1365-2699.1997.00113.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peixoto FP, 2014, J BIOGEOGR, V41, P762, DOI 10.1111/jbi.12241; Porto TJ, 2013, DIVERS DISTRIB, V19, P330, DOI 10.1111/j.1472-4642.2012.00944.x; Pyron RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1622; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P1152, DOI 10.1111/geb.12076; R Core Team, 2021, R LANGUAGE ENV STAT; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Svenning JC, 2005, J BIOGEOGR, V32, P1019, DOI 10.1111/j.1365-2699.2005.01219.x; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Villalobos F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056073; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	69	26	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109642	10.1371/journal.pone.0109642	http://dx.doi.org/10.1371/journal.pone.0109642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295514	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000089
J	Dienes, L; Kranitz, K; Juhasz, E; Gyenes, A; Takacs, A; Mihaltz, K; Nagy, ZZ; Kovacs, I				Dienes, Lorant; Kranitz, Kinga; Juhasz, Eva; Gyenes, Andrea; Takacs, Agnes; Mihaltz, Kata; Nagy, Zoltan Z.; Kovacs, Illes			Evaluation of Intereye Corneal Asymmetry in Patients with Keratoconus. A Scheimpflug Imaging Study	PLOS ONE			English	Article							UNILATERAL KERATOCONUS; SUBCLINICAL KERATOCONUS; PARAMETERS; THICKNESS; ELEVATION; PENTACAM; EYES; REPEATABILITY; TOMOGRAPHY; TOPOGRAPHY	Purpose: To assess the correlation between keratoconus severity and intereye asymmetry of pachymetric data and posterior elevation values and to evaluate their combined accuracy in discriminating normal corneas from those with keratoconus. Methods: This study included 97 patients: 65 subjects with bilateral normal corneas (NC) and 32 with keratoconus (KC). Central corneal thickness (CCT), thinnest corneal thickness (ThCT) and posterior elevation (PE) at the thinnest point of the cornea were measured in both eyes using Scheimpflug imaging. Intereye asymmetry and its correlation with keratoconus severity were calculated for each variable. The area under the receiver operating characteristic curve (AUROC) was used to compare predictive accuracy of different variables for keratoconus. Results: In normal eyes, intereye differences were significantly lower compared with the keratoconus eyes (p<0.001, for CCT, ThCT and PE). There was a significant exponential correlation between disease severity and intereye asymmetry of steep keratometry (r(2) = 0.55, p<0.001), CCT (r(2) = 0.39, p<0.001), ThCT (r(2) = 0.48, p<0.001) and PE (r(2) = 0.64, p<0.001). After adjustment for keratoconus severity, asymmetry in thinnest pachymetry proved to be the best parameter to characterize intereye corneal asymmetry in keratoconus. This variable had high accuracy and significantly better discriminating ability (AUROC: 0.99) for KC than posterior elevation (AUROC: 0.96), ThCT (AUROC: 0.94) or CCT (AUROC: 0.92) alone. Conclusions: There is an increased intereye asymmetry in keratometry, pachymetry and posterior corneal elevation values in keratoconic patients compared to subjects with normal corneas. Keratoconus patients with more severe disease are also more asymmetric in their disease status which should be taken into account during clinical care.	[Dienes, Lorant; Kranitz, Kinga; Juhasz, Eva; Gyenes, Andrea; Takacs, Agnes; Nagy, Zoltan Z.; Kovacs, Illes] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [Mihaltz, Kata] Karl Landsteiner Inst Proc Optimalizat, Vienna, Austria; [Mihaltz, Kata] QM Cataract Surg, Vienna, Austria	Semmelweis University	Kovacs, I (corresponding author), Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary.	kovacs.illes@med.semmelweis-univ.hu	Nagy, Zoltan Zsolt/T-6180-2017		Hungarian Scientific Research Fund OTKA [NN106649]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund OTKA NN106649 research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio R, 2003, J REFRACT SURG, V19, P24; Ambrosio R, 2011, J REFRACT SURG, V27, P753, DOI 10.3928/1081597X-20110721-01; Ambrosio R, 2010, J REFRACT SURG, V26, P847, DOI 10.3928/1081597X-20101006-01; Bae GH, 2014, AM J OPHTHALMOL, V157, P103, DOI 10.1016/j.ajo.2013.08.014; Berti TB, 2013, J REFRACT SURG, V29, P430, DOI 10.3928/1081597X-20130515-05; Burns DM, 2004, BRIT J OPHTHALMOL, V88, P1252, DOI 10.1136/bjo.2003.033670; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; de Sanctis U, 2008, OPHTHALMOLOGY, V115, P1534, DOI 10.1016/j.ophtha.2008.02.020; De Sanctis U, 2007, AM J OPHTHALMOL, V144, P712, DOI 10.1016/j.ajo.2007.07.021; Demir S, 2013, CORNEA, V32, P1470, DOI 10.1097/ICO.0b013e3182a7387f; Dutta D, 2013, OPHTHALMOLOGY, V120, P457, DOI 10.1016/j.ophtha.2012.08.036; Emre S, 2007, J CATARACT REFR SURG, V33, P1708, DOI 10.1016/j.jcrs.2007.06.020; Fam HB, 2006, J CATARACT REFR SURG, V32, P1281, DOI 10.1016/j.jcrs.2006.02.060; Henriquez MA, 2013, CORNEA, V32, P779, DOI 10.1097/ICO.0b013e31827b14ae; Holland DR, 1997, OPHTHALMOLOGY, V104, P1409, DOI 10.1016/S0161-6420(97)30123-7; Khachikian SS, 2009, OPHTHALMOLOGY, V116, P816, DOI 10.1016/j.ophtha.2009.01.009; LEE LR, 1995, AUST NZ J OPHTHALMOL, V23, P129, DOI 10.1111/j.1442-9071.1995.tb00141.x; Li XH, 2004, OPHTHALMOLOGY, V111, P440, DOI 10.1016/j.ophtha.2003.06.020; McMahon TT, 2006, CORNEA, V25, P794, DOI 10.1097/01.ico.0000226359.26678.d1; Mihaltz K, 2009, CORNEA, V28, P976, DOI 10.1097/ICO.0b013e31819e34de; Nichols JJ, 2004, BRIT J OPHTHALMOL, V88, P788, DOI 10.1136/bjo.2003.034520; Nishida T, 2005, CORNEA, V1, P232; Pflugfelder SC, 2002, OPHTHALMOLOGY, V109, P2336, DOI 10.1016/S0161-6420(02)01276-9; Pinero DP, 2012, J CATARACT REFR SURG, V38, P2167, DOI 10.1016/j.jcrs.2012.10.022; Prakash G, 2012, EYE, V26, P650, DOI 10.1038/eye.2011.365; Quisling S, 2006, OPHTHALMOLOGY, V113, P1629, DOI [10.1016/j.ophtha.2006.03.046, 10.1016/j.ophtha.2006.06.046]; RABINOWITZ YS, 1993, OPHTHALMOLOGY, V100, P181; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Smadja D, 2013, AM J OPHTHALMOL, V156, P237, DOI 10.1016/j.ajo.2013.03.034; Ucakhan OO, 2011, J CATARACT REFR SURG, V37, P1116, DOI 10.1016/j.jcrs.2010.12.049; WALTER SD, 1983, AM J EPIDEMIOL, V118, P865, DOI 10.1093/oxfordjournals.aje.a113705; Wei RH, 2011, J REFRACT SURG, V27, P745, DOI 10.3928/1081597X-20110426-01; WILSON SE, 1991, CORNEA, V10, P2; Zadnik K, 2002, CORNEA, V21, P671, DOI 10.1097/00003226-200210000-00008	34	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108882	10.1371/journal.pone.0108882	http://dx.doi.org/10.1371/journal.pone.0108882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296183	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000024
J	Kaprio, T; Hagstrom, J; Mustonen, H; Koskensalo, S; Andersson, LC; Haglund, C				Kaprio, Tuomas; Hagstrom, Jaana; Mustonen, Harri; Koskensalo, Selja; Andersson, Leif C.; Haglund, Caj			REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer	PLOS ONE			English	Article							IV EXPRESSION; GENE FAMILY; PROTEIN; OVEREXPRESSION; GROWTH; SERUM; RELP	Introduction: Colorectal cancer (CRC) is one of the world's three most common cancers and its incidence is rising. To identify patients who benefit from adjuvant therapy requires novel biomarkers. The regenerating islet-derived gene (REG) 4 belongs to a group of small secretory proteins involved in cell proliferation and regeneration. Its up-regulated expression occurs in inflammatory bowel diseases also in gastrointestinal cancers. Reports on the association of REG4 expression with CRC prognosis have been mixed. Our aim was to investigate tumor REG4 expression in CRC patients and its coexpression with other intestinal markers. Methods: Tumor expression of REG4 was evaluated by immunohistochemistry in 840 consecutive surgically treated CRC patients at Helsinki University Central Hospital. Expression of MUC1, MUC2, MUC5AC, synapthophysin, and chromogranin was evaluated in a subgroup of 220 consecutively operated CRC patients. REG4 expression with clinicopathological parameters, other intestinal markers, and the impact of REG4 expression on survival were assessed. Results: REG4 expression associated with favorable clinicopathological parameters and with higher overall survival from non-mucinous CRC (p = 0.019). For such patients under 65, its expression was an independent marker of lower risk of death within 5 years that cancer; univariable hazard ratio (HR) = 0.57; 95% confidence interval (CI) (0.34-0.94); multivariable HR = 0.55; 95% CI (0.33-0.92). In non-mucinous CRC, REG4 associated with positive MUC2, MUC4, and MUC5AC expression. Conclusion: We show, to our knowledge for the first time, that REG4 IHC expression to be an independent marker of favorable prognosis in non-mucinous CRC. Our results contradict those from studies based on quantification of REG4 mRNA levels, a discrepancy warranting further studies.	[Kaprio, Tuomas; Mustonen, Harri; Koskensalo, Selja; Haglund, Caj] Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland; [Kaprio, Tuomas; Hagstrom, Jaana; Haglund, Caj] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Hagstrom, Jaana; Andersson, Leif C.] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; [Hagstrom, Jaana; Andersson, Leif C.] HUSLAB, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Kaprio, T (corresponding author), Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland.	tuomas.kaprio@helsinki.fi	Kaprio, Tuomas/AAD-8042-2020; Hagström, Jaana/G-1468-2018; Haglund, Caj/N-1240-2019	Kaprio, Tuomas/0000-0002-0377-9975; Hagström, Jaana/0000-0001-6079-7881; Mustonen, Harri Kalevi/0000-0001-5632-6796	Finska Lakaresallskapet; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation; Medicinska understodsforeningen Liv och Halsa, K. Albin Johansson Foundation	Finska Lakaresallskapet; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medicinska understodsforeningen Liv och Halsa, K. Albin Johansson Foundation	This study was supported by grants from Finska Lakaresallskapet, the Kurt och Doris Palander Foundation, the Sigrid Juselius Foundation, and Medicinska understodsforeningen Liv och Halsa, K. Albin Johansson Foundation, and a special governmental subsidy for research and training. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Bockelman C, 2012, CANCER BIOL THER, V13, P289, DOI [10.4161/cbt.18922, 10.4161/cbt.13.5.18922]; Broekaert D, 2002, EUR CYTOKINE NETW, V13, P78; DUSETTI NJ, 1994, GENOMICS, V19, P108, DOI 10.1006/geno.1994.1019; Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Heiskala K, 2006, VIRCHOWS ARCH, V448, P295, DOI 10.1007/s00428-005-0105-1; Heiskala K, 2010, HISTOL HISTOPATHOL, V25, P63, DOI 10.14670/HH-25.63; Ho MR, 2010, J MOL BIOL, V402, P682, DOI 10.1016/j.jmb.2010.07.061; Kamarainen M, 2003, AM J PATHOL, V163, P11, DOI 10.1016/S0002-9440(10)63625-5; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Li XH, 2010, HISTOL HISTOPATHOL, V25, P473, DOI 10.14670/HH-25.473; Macadam RCA, 2000, BRIT J CANCER, V83, P188; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Numata M, 2011, J SURG ONCOL, V104, P205, DOI 10.1002/jso.21906; Ohara S, 2008, CANCER SCI, V99, P1570, DOI 10.1111/j.1349-7006.2008.00846.x; Oue N, 2005, J PATHOL, V207, P185, DOI 10.1002/path.1827; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Sasahira T, 2008, HISTOPATHOLOGY, V53, P667, DOI 10.1111/j.1365-2559.2008.03188.x; Schroder N, 2006, GASTROENTEROLOGY, V130, P902, DOI 10.1053/j.gastro.2005.12.025; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Tamura H, 2009, HUM PATHOL, V40, P1686, DOI 10.1016/j.humpath.2009.06.001; Tao HQ, 2011, HUM PATHOL, V42, P1401, DOI 10.1016/j.humpath.2010.08.023; Zheng HC, 2011, J HISTOCHEM CYTOCHEM, V59, P106, DOI 10.1369/jhc.2010.956961	24	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109600	10.1371/journal.pone.0109600	http://dx.doi.org/10.1371/journal.pone.0109600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295732	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000084
J	Kim, SY; Koh, WJ; Kim, YH; Jeong, BH; Park, HY; Jeon, K; Kim, JS; Cho, SN; Shin, SJ				Kim, Su-Young; Koh, Won-Jung; Kim, Yee Hyung; Jeong, Byeong-Ho; Park, Hye Yun; Jeon, Kyeongman; Kim, Jong-Seok; Cho, Sang-Nae; Shin, Sung Jae			Importance of Reciprocal Balance of T Cell Immunity in Mycobacterium abscessus Complex Lung Disease	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; ACTIVE TUBERCULOSIS; INDUCIBLE PROTEIN-10; PULMONARY-DISEASE; PERIPHERAL-BLOOD; AVIUM COMPLEX; TH17 CELLS; IFN-GAMMA; IN-VIVO; EXPRESSION	Background: Little is known about the nature of the host immune response to Mycobacterium abscessus complex (MABC) infection. The aim of the present study was to investigate whether alterations in serum immunomolecule levels after treating MABC lung disease patients with antibiotics can reflect the disease-associated characteristics. Methods: A total of 22 immunomolecules in 24 MABC lung disease patients before and after antibiotic therapy were quantitatively analyzed using a multiplex bead-based system. Results: In general, the pre-treatment levels of T helper type 1 (Th1)-related cytokines, i.e., interferon (IFN)-gamma and interleukin (IL)-12, and Th2-related cytokines, i.e., IL-4 and IL-13, were significantly decreased in patients compared with control subjects. In contrast, the pre-treatment levels of Th17-related cytokines, i.e., IL-17 and IL-23, were significantly increased in MABC patients. Interestingly, significantly higher levels of IFN-gamma-induced protein (IP)-10 and monokine induced by IFN-gamma protein (MIG) were detected in patients with failure of sputum conversion at post-treatment compared to patients with successful sputum conversion. Conclusion: Reduced Th1 and Th2 responses and enhanced Th17 responses in patients may perpetuate MABC lung disease, and the immunomolecules IP-10 and MIG, induced through IFN-gamma, may serve as key markers for indicating the treatment outcome.	[Kim, Su-Young; Koh, Won-Jung; Kim, Yee Hyung; Jeong, Byeong-Ho; Park, Hye Yun; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Kim, Jong-Seok; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol,Brain Korea PLUS Project Med Sci 2, Seoul 120749, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol,Brain Korea PLUS Project Med Sci 2, Seoul 120749, South Korea.	sjshin@yuhs.ac	Jeon, Kyeongman/F-5963-2019; Kim, Su-Young/GVT-4242-2022; Koh, Won-Jung/D-9586-2018; park, hy/O-5934-2014; Koh, Won Jung/C-9595-2011	Jeon, Kyeongman/0000-0002-4822-1772; Kim, Su-Young/0000-0002-6369-3399; Koh, Won-Jung/0000-0002-4756-3527; Shin, Sung Jae/0000-0003-0854-4582; Jeong, Byeong-Ho/0000-0002-3124-1718	Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A120647]	Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This work was supported by a grant of the Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A120647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand M, 2014, J INFECTION, V68, P62, DOI 10.1016/j.jinf.2013.08.005; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bajoriuniene I, 2012, LUNG, V190, P487, DOI 10.1007/s00408-012-9411-y; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; Cho YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081560; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Dheda K, 2008, THORAX, V63, P566, DOI 10.1136/thx.2007.092205; Ellner JJ, 2010, CTS-CLIN TRANSL SCI, V3, P23, DOI 10.1111/j.1752-8062.2010.00180.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Harada T, 2012, J CLIN MICROBIOL, V50, P3556, DOI 10.1128/JCM.01175-12; Howard ST, 2013, TUBERCULOSIS, V93, pS15, DOI 10.1016/S1472-9792(13)70005-2; Vargas-Rojas MI, 2011, RESP MED, V105, P1648, DOI 10.1016/j.rmed.2011.05.017; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim SY, 2014, CLIN EXP IMMUNOL, V176, P93, DOI 10.1111/cei.12253; Kim TS, 2014, J CLIN IMMUNOL, V34, P212, DOI 10.1007/s10875-013-9978-y; Koh WJ, 2014, INT J TUBERC LUNG D, V18, P1141, DOI 10.5588/ijtld.14.0134; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1474, DOI 10.1164/ajrccm.155.4.9105097; Kushwah R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-138; Kwon YS, 2007, LUNG, V185, P337, DOI 10.1007/s00408-007-9040-z; Lande R, 2003, J IMMUNOL, V170, P1174, DOI 10.4049/jimmunol.170.3.1174; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Lim A, 2010, DIS MARKERS, V29, P103, DOI [10.3233/DMA-2010-0732, 10.1155/2010/347142]; Lim A, 2010, CLIN IMMUNOL, V137, P296, DOI 10.1016/j.clim.2010.07.011; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Narumi S, 2000, CYTOKINE, V12, P1007, DOI 10.1006/cyto.1999.0672; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Perna V, 2013, EUR CYTOKINE NETW, V24, P157, DOI 10.1684/ecn.2014.0346; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ryu YJ, 2007, EUR RESPIR J, V30, P736, DOI 10.1183/09031936.00039507; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Shin DM, 2008, CELL MICROBIOL, V10, P1608, DOI 10.1111/j.1462-5822.2008.01151.x; ten Berge B, 2012, RHEUMATOLOGY, V51, P37, DOI 10.1093/rheumatology/ker316; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Vankayalapati R, 2001, J INFECT DIS, V183, P478, DOI 10.1086/318087; Wang XJ, 2012, TUBERCULOSIS, V92, P513, DOI 10.1016/j.tube.2012.06.005; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317	40	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109941	10.1371/journal.pone.0109941	http://dx.doi.org/10.1371/journal.pone.0109941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295870	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000106
J	Siedlecka, M; Klimza, A; Lukowska, M; Wierzchon, M				Siedlecka, Marta; Klimza, Anna; Lukowska, Marta; Wierzchon, Michal			Rubber Hand Illusion Reduces Discomfort Caused by Cold Stimulus	PLOS ONE			English	Article							BODY AWARENESS; PAIN; OWNERSHIP; ATTENTION; FEEL; SELF; UNPLEASANTNESS; ANXIETY; BRAIN; TOUCH	There is a growing interest in body-ownership disruptions and their consequences for subjective experiences such as tactile sensations or pain. Here, we investigated the effect of the rubber hand illusion (RHI) on the perceived discomfort caused by cold stimulus applied to the real hand. The results showed reduced discomfort to cold reflected in behavioural and subjective measures. The stronger the illusion, the later the cold temperature became unpleasant and the less intense the experience was rated. We discuss the link between thermoception and body ownership as well as possible theoretical and methodological implications for studies on pain experience under RHI.	[Siedlecka, Marta; Lukowska, Marta; Wierzchon, Michal] Jagiellonian Univ, Inst Psychol, Consciousness Lab, Krakow, Poland; [Klimza, Anna] Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland	Jagiellonian University; SWPS University of Social Sciences & Humanities	Siedlecka, M (corresponding author), Jagiellonian Univ, Inst Psychol, Consciousness Lab, Krakow, Poland.	marta.siedlecka@uj.edu.pl	Siedlecka, Marta/B-9001-2015; Siedlecka, Marta/AAP-2503-2020; Wierzchon, Michal/B-7207-2012	Wierzchon, Michal/0000-0002-7347-2696; Siedlecka, Marta/0000-0002-0688-4500; Lukowska, Marta/0000-0002-0428-8190	National Science Centre, Poland [2012/07/E/HS6/01037]	National Science Centre, Poland(National Science Centre, Poland)	The publication was supported by the National Science Centre, Poland [grant 2012/07/E/HS6/01037] http://www.ncn.gov.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Auvray M, 2010, NEUROSCI BIOBEHAV R, V34, P214, DOI 10.1016/j.neubiorev.2008.07.008; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bunning S, 2005, PROG BRAIN RES, V150, P331, DOI 10.1016/S0079-6123(05)50024-4; Capelari EDP, 2009, PERCEPTION, V38, P92, DOI 10.1068/p5892; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; de Vignemont F, 2011, CONSCIOUS COGN, V20, P82, DOI 10.1016/j.concog.2010.09.004; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2009, PERCEPTION, V38, P310, DOI 10.1068/p6304; Ferri F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1140; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Greenspan JD, 2003, SOMATOSENS MOT RES, V20, P19, DOI 10.1080/0899022031000083807; Guterstam A, 2012, CONSCIOUS COGN, V21, P1037, DOI 10.1016/j.concog.2012.01.018; Guterstam A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017208; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Hansel A, 2011, EUR J PAIN, V15, P874, DOI 10.1016/j.ejpain.2011.03.013; Hegedus G, 2014, EUR J PAIN, V18, P1173, DOI 10.1002/j.1532-2149.2014.00466.x; Hofle M, 2012, PAIN, V153, P1074, DOI 10.1016/j.pain.2012.02.010; Janig W, 2003, LANCET NEUROL, V2, P687, DOI 10.1016/S1474-4422(03)00557-X; Kammers MPM, 2011, NEUROPSYCHOLOGIA, V49, P1316, DOI 10.1016/j.neuropsychologia.2011.02.039; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; KLEMENT W, 1992, J PHYSIOL-LONDON, V449, P73, DOI 10.1113/jphysiol.1992.sp019075; Kulkarni B, 2005, EUR J NEUROSCI, V21, P3133, DOI 10.1111/j.1460-9568.2005.04098.x; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2009, J NEUROSCI, V29, P12125, DOI 10.1523/JNEUROSCI.3072-09.2009; Mohan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052400; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; Moseley GL, 2007, PHYS THER REV, V12, P169, DOI 10.1179/108331907X223010; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Moseley GL, 2008, CURR BIOL, V18, pR1047, DOI 10.1016/j.cub.2008.09.031; Moseley GL, 2005, NEUROLOGY, V65, P773, DOI 10.1212/01.wnl.0000174515.07205.11; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Perlman DM, 2010, EMOTION, V10, P65, DOI 10.1037/a0018440; Pia L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00298; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Spence C, 2002, BEHAV BRAIN RES, V135, P57, DOI 10.1016/S0166-4328(02)00155-9; Symons FJ, 2001, AM J MENT RETARD, V106, P336, DOI 10.1352/0895-8017(2001)106<0336:PSOAST>2.0.CO;2; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Valenzuela Moguillansky Camila, 2013, Front Hum Neurosci, V7, P659, DOI 10.3389/fnhum.2013.00659; Valenzuela-Moguillansky C, 2011, J CONSCIOUSNESS STUD, V18, P110; van Stralen HE, 2014, COGNITION, V131, P147, DOI 10.1016/j.cognition.2013.11.020; Verhoeven K, 2010, PAIN, V149, P229, DOI 10.1016/j.pain.2010.01.019; Villemure C, 2003, PAIN, V106, P101, DOI 10.1016/S0304-3959(03)00297-5; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005	59	24	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109909	10.1371/journal.pone.0109909	http://dx.doi.org/10.1371/journal.pone.0109909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25295527	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000103
J	Danek, A; Deorowicz, S; Grabowski, S				Danek, Agnieszka; Deorowicz, Sebastian; Grabowski, Szymon			Indexes of Large Genome Collections on a PC	PLOS ONE			English	Article							COMPRESSION; TEXT; ALIGNMENT; STORAGE; SEARCH; SPACE	The availability of thousands of individual genomes of one species should boost rapid progress in personalized medicine or understanding of the interaction between genotype and phenotype, to name a few applications. A key operation useful in such analyses is aligning sequencing reads against a collection of genomes, which is costly with the use of existing algorithms due to their large memory requirements. We present MuGI, Multiple Genome Index, which reports all occurrences of a given pattern, in exact and approximate matching model, against a collection of thousand(s) genomes. Its unique feature is the small index size, which is customisable. It fits in a standard computer with 16-32 GB, or even 8 GB, of RAM, for the 1000GP collection of 1092 diploid human genomes. The solution is also fast. For example, the exact matching queries (of average length 150 bp) are handled in average time of 39 mu s and with up to 3 mismatches in 373 mu s on the test PC with the index size of 13.4 GB. For a smaller index, occupying 7.4 GB in memory, the respective times grow to 76 mu s and 917 mu s.	[Danek, Agnieszka; Deorowicz, Sebastian] Silesian Tech Univ, Inst Informat, Gliwice, Poland; [Grabowski, Szymon] Lodz Univ Technol, Inst Appl Comp Sci, Lodz, Poland	Silesian University of Technology; Lodz University of Technology	Deorowicz, S (corresponding author), Silesian Tech Univ, Inst Informat, Gliwice, Poland.	sebastian.deorowicz@polsl.pl	Deorowicz, Sebastian/F-8386-2014; Grabowski, Szymon/AAJ-2398-2021	Grabowski, Szymon/0000-0003-1714-1224; Danek, Agnieszka/0000-0003-1953-0880; Deorowicz, Sebastian/0000-0002-9496-733X	Polish Ministry of Science and Higher Education [DEC-2013/09/B/ST6/03117]; European Social Fund [UDA-POKL.04.01.01-00-106/09]; GeCONiI-Upper Silesian Center for Computational Science and Engineering [POIG.02.03.01-24-099/13]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Social Fund(European Social Fund (ESF)); GeCONiI-Upper Silesian Center for Computational Science and Engineering	The work was supported by the Polish Ministry of Science and Higher Education under the project DEC-2013/09/B/ST6/03117 and European Social Fund project UDA-POKL.04.01.01-00-106/09. The work was performed using the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GeCONiI-Upper Silesian Center for Computational Science and Engineering". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Brandon MC, 2009, BIOINFORMATICS, V25, P1731, DOI 10.1093/bioinformatics/btp319; Christley S, 2009, BIOINFORMATICS, V25, P274, DOI 10.1093/bioinformatics/btn582; Claude Francisco, 2010, 2010 International Conference on BioInformatics and BioEngineering (BIBE), P86, DOI 10.1109/BIBE.2010.22; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Deorowicz S, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-25; Deorowicz S, 2013, BIOINFORMATICS, V29, P2572, DOI 10.1093/bioinformatics/btt460; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Ferrada H, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0137; Gagie T, 2011, LECT NOTES COMPUT SC, V7074, P653, DOI 10.1007/978-3-642-25591-5_67; Garcia SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016065; Giancarlo R, 2014, BRIEF BIOINFORM, V15, P390, DOI 10.1093/bib/bbt088; Grabowski S, 2014, SAMPLING SUFFIX ARRA; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Hon WK, 2013, J DISCRET ALGORITHMS, V19, P23, DOI 10.1016/j.jda.2012.12.003; Huang L, 2013, BIOINFORMATICS, V29, P361, DOI 10.1093/bioinformatics/btt215; Huang SB, 2010, LECT NOTES COMPUT SC, V6124, P180, DOI 10.1007/978-3-642-14355-7_19; KARKKAINEN J, 1996, LNCS, V1090, P219, DOI DOI 10.1007/3-540-61332-3_; Kreft S, 2013, THEOR COMPUT SCI, V483, P115, DOI 10.1016/j.tcs.2012.02.006; Kuruppu S., 2011, P 34 AUSTR COMP SCI, V113, P91; Kuruppu S, 2010, LECT NOTES COMPUT SC, V6393, P201, DOI 10.1007/978-3-642-16321-0_20; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Navarro G, 2007, ACM COMPUT SURV, V39, DOI 10.1145/1216370.1216372; Pavlichin DS, 2013, BIOINFORMATICS, V29, P2199, DOI 10.1093/bioinformatics/btt362; Rahn R, 2014, BIOINFORMATICS, V30, P3499, DOI 10.1093/bioinformatics/btu438; Sadakane K, 2001, Genome Inform, V12, P175; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Siren J, 2014, IEEE ACM T COMPUT BI, V11, P375, DOI 10.1109/TCBB.2013.2297101; Thachuk C, 2013, THEOR COMPUT SCI, V483, P22, DOI 10.1016/j.tcs.2012.08.011; Vyverman M, 2012, NUCLEIC ACIDS RES, V40, P6993, DOI 10.1093/nar/gks408; Wandelt S, 2013, PROC VLDB ENDOW, V6, P1534, DOI 10.14778/2536258.2536265; Wandelt S, 2013, IEEE ACM T COMPUT BI, V10, P1275, DOI 10.1109/TCBB.2013.122; Yang XC, 2013, PROC INT CONF DATA, P961, DOI 10.1109/ICDE.2013.6544889	38	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109384	10.1371/journal.pone.0109384	http://dx.doi.org/10.1371/journal.pone.0109384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289699	Green Submitted, gold, Green Published			2022-12-27	WOS:000342798000057
J	Mora-Obando, D; Fernandez, J; Montecucco, C; Gutierrez, JM; Lomonte, B				Mora-Obando, Diana; Fernandez, Julian; Montecucco, Cesare; Gutierrez, Jose Maria; Lomonte, Bruno			Synergism between Basic Asp49 and Lys49 Phospholipase A(2) Myotoxins of Viperid Snake Venom In Vitro and In Vivo	PLOS ONE			English	Article							BOTHROPS-ASPER; STRUCTURAL DETERMINANTS; BIOLOGICAL-ACTIVITIES; SYNTHETIC PEPTIDES; MUSCLE NECROSIS; MECHANISMS; EVOLUTION; LYS-49; REGION; TOXIN	Two subtypes of phospholipases A(2) (PLA(2)s) with the ability to induce myonecrosis, 'Asp49' and 'Lys49' myotoxins, often coexist in viperid snake venoms. Since the latter lack catalytic activity, two different mechanisms are involved in their myotoxicity. A synergism between Asp49 and Lys49 myotoxins from Bothrops asper was previously observed in vitro, enhancing Ca2+ entry and cell death when acting together upon C2C12 myotubes. These observations are extended for the first time in vivo, by demonstrating a clear enhancement of myonecrosis by the combined action of these two toxins in mice. In addition, novel aspects of their synergism were revealed using myotubes. Proportions of Asp49 myotoxin as low as 0.1% of the Lys49 myotoxin are sufficient to enhance cytotoxicity of the latter, but not the opposite. Sublytic amounts of Asp49 myotoxin also enhanced cytotoxicity of a synthetic peptide encompassing the toxic region of Lys49 myotoxin. Asp49 myotoxin rendered myotubes more susceptible to osmotic lysis, whereas Lys49 myotoxin did not. In contrast to myotoxic Asp49 PLA(2), an acidic non-toxic PLA(2) from the same venom did not markedly synergize with Lys49 myotoxin, revealing a functional difference between basic and acidic PLA(2) enzymes. It is suggested that Asp49 myotoxins synergize with Lys49 myotoxins by virtue of their PLA(2) activity. In addition to the membrane-destabilizing effect of this activity, Asp49 myotoxins may generate anionic patches of hydrolytic reaction products, facilitating electrostatic interactions with Lys49 myotoxins. These data provide new evidence for the evolutionary adaptive value of the two subtypes of PLA(2) myotoxins acting synergistically in viperid venoms.	[Mora-Obando, Diana; Fernandez, Julian; Gutierrez, Jose Maria; Lomonte, Bruno] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Montecucco, Cesare] Univ Padua, Dept Biomed Sci, Padua, Italy	Universidad Costa Rica; University of Padua	Lomonte, B (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.	bruno.lomonte@ucr.ac.cr	Gutiérrez, José/GSJ-1846-2022; Lomonte, Bruno/B-8862-2019	Lomonte, Bruno/0000-0003-2419-6469; Gutierrez, Jose Maria/0000-0001-8385-3081; MORA OBANDO, DIANA LORENA/0000-0003-4462-9698	Graduate Studies Program, Universidad de Costa Rica; International Centre for Genetic Engineering and Biotechnology, Italy [CRP/COS13-01]; Vicerrectoria de Investigacion, Universidad de Costa Rica [741-B4-100]	Graduate Studies Program, Universidad de Costa Rica; International Centre for Genetic Engineering and Biotechnology, Italy; Vicerrectoria de Investigacion, Universidad de Costa Rica	Funding support by the Graduate Studies Program, Universidad de Costa Rica; International Centre for Genetic Engineering and Biotechnology, Italy (CRP/COS13-01); and Vicerrectoria de Investigacion, Universidad de Costa Rica (741-B4-100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo Y, 2005, CELL BIOCHEM FUNCT, V23, P307, DOI 10.1002/cbf.1208; Angulo Y, 2002, INT J BIOCHEM CELL B, V34, P1268, DOI 10.1016/S1357-2725(02)00060-2; Angulo Y, 2009, TOXICON, V54, P949, DOI 10.1016/j.toxicon.2008.12.014; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bustillo S, 2012, TOXICON, V59, P338, DOI 10.1016/j.toxicon.2011.11.007; Caccin P, 2013, BIOCHEM BIOPH RES CO, V430, P1289, DOI 10.1016/j.bbrc.2012.11.129; Chioato L, 2003, TOXICON, V42, P869, DOI 10.1016/j.toxicon.2003.11.027; Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092; Cintra-Francischinelli M, 2009, CELL MOL LIFE SCI, V66, P1718, DOI 10.1007/s00018-009-9053-2; Cintra-Francischinelli M, 2010, P NATL ACAD SCI USA, V107, P14140, DOI 10.1073/pnas.1009128107; Cintra-Francischinelli M, 2010, TOXICON, V55, P590, DOI 10.1016/j.toxicon.2009.10.013; DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N; DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; dos Santos JI, 2009, PROTEIN PEPTIDE LETT, V16, P887, DOI 10.2174/092986609788923310; Fernandes CAH, 2010, J STRUCT BIOL, V171, P31, DOI 10.1016/j.jsb.2010.03.019; Fernandez J, 2013, FEBS J, V280, P3878, DOI 10.1111/febs.12386; Fernandez J, 2010, BIOCHIMIE, V92, P273, DOI 10.1016/j.biochi.2009.12.006; FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Gutierrez J.M, 1997, VENOM PHOSPHOLIPASE, P321; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; GUTIERREZ JM, 1984, TOXICON, V22, P115, DOI 10.1016/0041-0101(84)90144-2; GUTIERREZ JM, 1995, EXP MOL PATHOL, V62, P28, DOI 10.1006/exmp.1995.1004; Gutierrez Jose Maria, 1995, P645; HARRIS JB, 1990, ELECTRON MICROSC REV, V3, P183, DOI 10.1016/0892-0354(90)90001-9; Holzer M, 1996, TOXICON, V34, P1149, DOI 10.1016/0041-0101(96)00057-8; KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2; KIHARA H, 1992, BIOCHEM INT, V28, P895; Kini R., 1997, VENOM PHOSPHOLIPASE, P511; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1; Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008; Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1; LOMONTE B, 1994, J BIOL CHEM, V269, P29867; Lomonte B, 1999, TOXICON, V37, P145, DOI 10.1016/S0041-0101(98)00171-8; Lomonte B, 2012, TOXICON, V60, P520, DOI 10.1016/j.toxicon.2012.02.007; Lomonte B, 2011, ACTA CHIM SLOV, V58, P647; Lomonte B, 2009, PROTEIN PEPTIDE LETT, V16, P860, DOI 10.2174/092986609788923356; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839; Gutierrez JM, 2013, TOXICON, V62, P27, DOI 10.1016/j.toxicon.2012.09.006; McCue MD, 2006, COPEIA, P818, DOI 10.1643/0045-8511(2006)6[818:COPVIT]2.0.CO;2; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Mora-Obando D, 2014, PEER J IN PRESS; Morgenstern D, 2013, TOXICON, V63, P120, DOI 10.1016/j.toxicon.2012.11.022; MOURADASILVA AM, 1995, J MOL EVOL, V41, P174, DOI 10.1007/BF00170670; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6; Petan T, 2007, BIOCHEMISTRY-US, V46, P12795, DOI 10.1021/bi701304e; RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018; SCOTT DL, 1992, J BIOL CHEM, V267, P22645; SHEN Z, 1995, INT J BIOCHEM CELL B, V27, P1009, DOI 10.1016/1357-2725(95)00072-W; Soares AM, 2003, TOXICON, V42, P855, DOI 10.1016/j.toxicon.2003.11.004; Tsai IH, 2001, ARCH BIOCHEM BIOPHYS, V394, P236, DOI 10.1006/abbi.2001.2524; Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2	58	54	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109846	10.1371/journal.pone.0109846	http://dx.doi.org/10.1371/journal.pone.0109846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290688	Green Published, gold			2022-12-27	WOS:000342798000094
J	Payne, CJ; Ritchie, EG; Kelly, LT; Nimmo, DG				Payne, Catherine J.; Ritchie, Euan G.; Kelly, Luke T.; Nimmo, Dale G.			Does Fire Influence the Landscape-Scale Distribution of an Invasive Mesopredator?	PLOS ONE			English	Article							FOXES VULPES-VULPES; SMALL VERTEBRATE FAUNA; RED FOXES; HOME-RANGE; BIODIVERSITY CONSERVATION; VEGETATION STRUCTURE; WESTERN-AUSTRALIA; HEIRISSON PRONG; CANIS-LUPUS; HABITAT USE	Predation and fire shape the structure and function of ecosystems globally. However, studies exploring interactions between these two processes are rare, especially at large spatial scales. This knowledge gap is significant not only for ecological theory, but also in an applied context, because it limits the ability of landscape managers to predict the outcomes of manipulating fire and predators. We examined the influence of fire on the occurrence of an introduced and widespread mesopredator, the red fox (Vulpes vulpes), in semi-arid Australia. We used two extensive and complimentary datasets collected at two spatial scales. At the landscape-scale, we surveyed red foxes using sand-plots within 28 study landscapes - which incorporated variation in the diversity and proportional extent of fire-age classes - located across a 104 000 km(2) study area. At the site-scale, we surveyed red foxes using camera traps at 108 sites stratified along a century-long post-fire chronosequence (0-105 years) within a 6630 km(2) study area. Red foxes were widespread both at the landscape and site-scale. Fire did not influence fox distribution at either spatial scale, nor did other environmental variables that we measured. Our results show that red foxes exploit a broad range of environmental conditions within semi-arid Australia. The presence of red foxes throughout much of the landscape is likely to have significant implications for native fauna, particularly in recently burnt habitats where reduced cover may increase prey species' predation risk.	[Payne, Catherine J.; Ritchie, Euan G.; Nimmo, Dale G.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia; [Kelly, Luke T.] Univ Melbourne, Sch Bot, Australian Res Council, Ctr Excellence Environm Decis, Melbourne, Vic, Australia	Deakin University; University of Melbourne	Nimmo, DG (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia.	dale@deakin.edu.au	Ritchie, Euan/N-1088-2014	Ritchie, Euan/0000-0003-4410-8868; Kelly, Luke/0000-0002-3127-3111	Victorian government's Department of Environment and Primary Industries under the Mallee Hawkeye [313764]; Land and Water Australia; Mallee Catchment Management Authority, Parks Victoria; Department Sustainability and Environment Victoria, Department Environment and Heritage SA, Lower Murray-Darling Catchment Management Authority; Department Environment and Climate Change NSW, Australian Wildlife Conservancy and Birds Australia	Victorian government's Department of Environment and Primary Industries under the Mallee Hawkeye; Land and Water Australia; Mallee Catchment Management Authority, Parks Victoria; Department Sustainability and Environment Victoria, Department Environment and Heritage SA, Lower Murray-Darling Catchment Management Authority; Department Environment and Climate Change NSW, Australian Wildlife Conservancy and Birds Australia	Funding for the site-scale study was provided by the Victorian government's Department of Environment and Primary Industries, under the Mallee Hawkeye project (Contract Number 313764). Funding and logistical support for the landscape-scale study was provided by Land and Water Australia, the Mallee Catchment Management Authority, Parks Victoria, Department Sustainability and Environment Victoria, Department Environment and Heritage SA, Lower Murray-Darling Catchment Management Authority, Department Environment and Climate Change NSW, Australian Wildlife Conservancy and Birds Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur AD, 2012, AUSTRAL ECOL, V37, P958, DOI 10.1111/j.1442-9993.2011.02355.x; Avitabile SC, 2013, LANDSCAPE URBAN PLAN, V117, P81, DOI 10.1016/j.landurbplan.2013.04.017; Barton K., 2012, MUMIN MULTIMODEL INF; Bates D, 2012, LME4 LINEAR MIXED EF; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradstock Ross A., 2002, P238; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carter A, 2012, AUST MAMMAL, V34, P175, DOI 10.1071/AM11041; CATLING PC, 1995, WILDLIFE RES, V22, P535, DOI 10.1071/WR9950535; CATLING PC, 1988, AUST WILDLIFE RES, V15, P307, DOI 10.1071/WR9880307; Catling PC, 2001, WILDLIFE RES, V28, P555, DOI 10.1071/WR00041; Clarke MF, 2010, AUST J BOT, V58, P363, DOI 10.1071/BT10051; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Environmental Systems Research Institute, 2007, ARC VIEW VERS 9 2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Frey SN, 2006, J WILDLIFE MANAGE, V70, P1111, DOI 10.2193/0022-541X(2006)70[1111:HUBMIA]2.0.CO;2; Glen A. S., 2006, Australian Mammalogy, V28, P101; Gosper CR, 2013, J APPL ECOL, V50, P1187, DOI 10.1111/1365-2664.12120; Gosselink TE, 2003, J WILDLIFE MANAGE, V67, P90, DOI 10.2307/3803065; Graham CA, 2012, WILDLIFE RES, V39, P661, DOI 10.1071/WR12008; Haslem A, 2011, J APPL ECOL, V48, P247, DOI 10.1111/j.1365-2664.2010.01906.x; Haslem A, 2010, LANDSCAPE URBAN PLAN, V97, P296, DOI 10.1016/j.landurbplan.2010.07.002; ITT, 2005, ENVI VERS 4 2; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Kelly LT, 2013, AUSTRAL ECOL, V38, P786, DOI 10.1111/aec.12018; Kelly LT, 2012, J APPL ECOL, V49, P412, DOI 10.1111/j.1365-2664.2012.02124.x; KINNEAR JE, 1988, AUST WILDLIFE RES, V15, P435; Leckie FM, 1998, ECOGRAPHY, V21, P599, DOI 10.1111/j.1600-0587.1998.tb00552.x; Letnic M, 2005, AUSTRAL ECOL, V30, P24, DOI 10.1111/j.1442-9993.2004.01410.x; Letnic M, 2005, J MAMMAL, V86, P689, DOI 10.1644/1545-1542(2005)086[0689:TROMTL]2.0.CO;2; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Lucherini M, 1995, J ZOOL, V237, P577, DOI 10.1111/j.1469-7998.1995.tb05016.x; Meek PD, 2000, WILDLIFE RES, V27, P663, DOI 10.1071/WR98030; Moseby KE, 2009, WILDLIFE RES, V36, P422, DOI 10.1071/WR08098; Nimmo DG, 2013, CONSERV BIOL, V27, P345, DOI 10.1111/j.1523-1739.2012.01958.x; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Pavey CR, 2008, J MAMMAL, V89, P674, DOI 10.1644/07-MAMM-A-168R.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Risbey DA, 1999, WILDLIFE RES, V26, P621; Risbey DA, 2000, WILDLIFE RES, V27, P223, DOI 10.1071/WR98092; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Smit IPJ, 2010, ECOL APPL, V20, P1865, DOI 10.1890/09-0929.1; Smith AL, 2012, BIOL CONSERV, V145, P139, DOI 10.1016/j.biocon.2011.10.023; Southgate R, 2007, J ARID ENVIRON, V68, P438, DOI 10.1016/j.jaridenv.2006.06.006; Sutherland EF, 1999, WILDLIFE RES, V26, P405, DOI 10.1071/WR97045; Towerton AL, 2011, WILDLIFE RES, V38, P208, DOI 10.1071/WR10213; Watson SJ, 2012, ECOL APPL, V22, P685, DOI 10.1890/11-0850.1; White JG, 2006, WILDLIFE RES, V33, P175, DOI 10.1071/WR05037; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Zuur Alain F., 2009, P1	53	15	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107862	10.1371/journal.pone.0107862	http://dx.doi.org/10.1371/journal.pone.0107862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291186	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000008
J	Savinainen, JR; Patel, JZ; Parkkari, T; Navia-Paldanius, D; Marjamaa, JJT; Laitinen, T; Nevalainen, T; Laitinen, JT				Savinainen, Juha R.; Patel, Jayendra Z.; Parkkari, Teija; Navia-Paldanius, Dina; Marjamaa, Joona J. T.; Laitinen, Tuomo; Nevalainen, Tapio; Laitinen, Jarmo T.			Biochemical and Pharmacological Characterization of the Human Lymphocyte Antigen B-Associated Transcript 5 (BAT5/ABHD16A)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MONOACYLGLYCEROL LIPASE; SERINE HYDROLASES; IN-VIVO; INHIBITORS; DISEASE; GENES; IDENTIFICATION; POLYMORPHISMS; METABOLISM	Background: Human lymphocyte antigen B-associated transcript 5 (BAT5, also known as ABHD16A) is a poorly characterized 63 kDa protein belonging to the alpha/beta-hydrolase domain (ABHD) containing family of metabolic serine hydrolases. Its natural substrates and biochemical properties are unknown. Methodology/Principal Findings: Amino acid sequence comparison between seven mammalian BAT5 orthologs revealed that the overall primary structure was highly (>= 95%) conserved. Activity-based protein profiling (ABPP) confirmed successful generation of catalytically active human (h) and mouse (m) BAT5 in HEK293 cells, enabling further biochemical characterization. A sensitive fluorescent glycerol assay reported hBAT5-mediated hydrolysis of medium-chain saturated (C14:0), long-chain unsaturated (C18:1, C18:2, C20:4) monoacylglycerols (MAGs) and 15-deoxy-Delta(12,14)-prostaglandin J(2)-2-glycerol ester (15d-PGJ(2)-G). In contrast, hBAT5 possessed only marginal diacylglycerol (DAG), triacylglycerol (TAG), or lysophospholipase activity. The best MAG substrates were 1-linoleylglycerol (1-LG) and 15d-PGJ(2)-G, both exhibiting low-micromolar K-m values. BAT5 had a neutral pH optimum and showed preference for the 1(3)-vs. 2-isomers of MAGs C18:1, C18:2 and C20:4. Inhibitor profiling revealed that beta-lactone-based lipase inhibitors were nanomolar inhibitors of hBAT5 activity (palmostatin B. tetrahydrolipstatin. ebelactone A). Moreover, the hormone-sensitive lipase inhibitor C7600 (5-methoxy-3-(4-phenoxyphenyl)-3H-[1,3,4] oxadiazol-2-one) was identified as a highly potent inhibitor (IC50 8.3 nM). Phenyl and benzyl substituted analogs of C7600 with increased BAT5 selectivity were synthesized and a preliminary SAR analysis was conducted to obtain initial insights into the active site dimensions. Conclusions/Significance: This study provides an initial characterization of BAT5 activity, unveiling the biochemical and pharmacological properties with in vitro substrate preferences and inhibitor profiles. Utilization of glycerolipid substrates and sensitivity to lipase inhibitors suggest that BAT5 is a genuine lipase with preference for long-chain unsaturated MAGs and could in this capacity regulate glycerolipid metabolism in vivo as well. This preliminary SAR data should pave the way towards increasingly potent and BAT5-selective inhibitors.	[Savinainen, Juha R.; Navia-Paldanius, Dina; Marjamaa, Joona J. T.; Laitinen, Jarmo T.] Univ Eastern Finland, Fac Hlth Sci, Inst Biomed, Sch Med, Kuopio, Finland; [Patel, Jayendra Z.; Parkkari, Teija; Laitinen, Tuomo; Nevalainen, Tapio] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Laitinen, JT (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Inst Biomed, Sch Med, Kuopio, Finland.	jarmo.laitinen@uef.fi		Laitinen, Tuomo/0000-0003-1539-2142; Laitinen, Jarmo T/0000-0002-9490-3686; Savinainen, Juha/0000-0002-1301-9064; Patel, Jayendra Z./0000-0002-2562-1888	Academy of Finland [139620, 139140]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland (grant 139620 to JTL and grant 139140 to TN) (http://www.aka.fi/en-GB/A/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen N, 2013, CHEM BIOL, V20, P379, DOI 10.1016/j.chembiol.2013.01.012; Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Ben Ali Y, 2006, BIOCHEMISTRY-US, V45, P14183, DOI 10.1021/bi0613978; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Fontanesi L, 2012, J ANIM SCI, V90, P2450, DOI 10.2527/jas.2011-4797; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hsieh YY, 2010, J CLIN LAB ANAL, V24, P262, DOI 10.1002/jcla.20409; Laitinen T, 2014, MOL PHARMACOL, V85, P510, DOI 10.1124/mol.113.090795; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Minkkila A, 2009, CHEMMEDCHEM, V4, P1253, DOI 10.1002/cmdc.200900137; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Parkkari T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098286; Patel JZ, 2013, J MED CHEM, V56, P8484, DOI 10.1021/jm400923s; Point V, 2012, EUR J MED CHEM, V58, P452, DOI 10.1016/j.ejmech.2012.10.040; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Saario SM, 2006, J MED CHEM, V49, P4650, DOI 10.1021/jm060394q; Savinainen JR, 2010, ANAL BIOCHEM, V399, P132, DOI 10.1016/j.ab.2009.12.009; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; SPIES T, 1989, P NATL ACAD SCI USA, V86, P8955, DOI 10.1073/pnas.86.22.8955; SPIES T, 1989, SCIENCE, V243, P214, DOI 10.1126/science.2911734; Wang R, 2013, BIOCHEMISTRY-US, V52, P7559, DOI 10.1021/bi401138s; Xie SQ, 2010, CHEM RES TOXICOL, V23, P1890, DOI 10.1021/tx1002194	30	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109869	10.1371/journal.pone.0109869	http://dx.doi.org/10.1371/journal.pone.0109869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290914	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000095
J	Li, ZZ; Li, YM; Lei, XY; Zhang, D; Liu, L; Tang, SY; Chen, LZ				Li, Zhan-Zhan; Li, Ya-Ming; Lei, Xian-Yang; Zhang, Dan; Liu, Li; Tang, Si-Yuan; Chen, Lizhang			Prevalence of Suicidal Ideation in Chinese College Students: A Meta-Analysis	PLOS ONE			English	Article							STRESSFUL LIFE EVENTS; RISK-FACTORS; FAMILY COHESION; DEPRESSION; ADOLESCENTS; ORIENTATION; SUPPORT	Background: About 1 million people worldwide commit suicide each year, and college students with suicidal ideation are at high risk of suicide. The prevalence of suicidal ideation in college students has been estimated extensively, but quantitative syntheses of overall prevalence are scarce, especially in China. Accurate estimates of prevalence are important for making public policy. In this paper, we aimed to determine the prevalence of suicidal ideation in Chinese college students. Objective and Methods: Databases including PubMed, Web of Knowledge, Chinese Web of Knowledge, Wangfang (Chinese database) and Weipu (Chinese database) were systematically reviewed to identify articles published between 2004 to July 2013, in either English or Chinese, reporting prevalence estimates of suicidal ideation among Chinese college students. The strategy also included a secondary search of reference lists of records retrieved from databases. Then the prevalence estimates were summarized using a random effects model. The effects of moderator variables on the prevalence estimates were assessed using a meta-regression model. Results: A total of 41 studies involving 160339 college students were identified, and the prevalence ranged from 1.24% to 26.00%. The overall pooled prevalence of suicidal ideation among Chinese college students was 10.72% (95% CI: 8.41% to 13.28%). We noted substantial heterogeneity in prevalence estimates. Subgroup analyses showed that prevalence of suicidal ideation in females is higher than in males. Conclusions: The prevalence of suicidal ideation in Chinese college students is relatively high, although the suicide rate is lower compared with the entire society, suggesting the need for local surveys to inform the development of health services for college students.	[Li, Zhan-Zhan; Chen, Lizhang] Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Li, Ya-Ming; Zhang, Dan; Liu, Li; Tang, Si-Yuan] Cent S Univ, Dept Nursing, Changsha, Hunan, Peoples R China; [Li, Ya-Ming; Lei, Xian-Yang] Cent S Univ, Affiliated Hosp 2, Xiangya Med Sch, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Chen, LZ (corresponding author), Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China.	liche4005@126.com			Hunan Province Science and Technology Project [2014FJ3093]	Hunan Province Science and Technology Project	This study was supported by Hunan Province Science and Technology Project (2014FJ3093). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arria AM, 2009, ARCH SUICIDE RES, V13, P230, DOI 10.1080/13811110903044351; Au ACY, 2009, ADOLESCENCE, V44, P851; Bao DX, 2009, CHIN J SCH HLTH, V30, P939; Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P420, DOI 10.1080/j.1440-1614.2000.00691.x; Brittain EH, 2012, BIOSTATISTICS, V13, P637, DOI 10.1093/biostatistics/kxs006; Cai Y, 2012, CHIN PRE MED, V13, P480; Canetto SS, 1998, SUICIDE LIFE-THREAT, V28, P1; Cao HY, 2009, CHIN J SCH HLTH, V30, P38; Chao XC, 2008, HLTH MED RES PRACTIC, V5, P42; Chen Jian-mei, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P290; Chen YF, 2008, CHIN J DIS CONTROL P, V12, P450; Choi JH, 2015, NURS HEALTH SCI, V17, P119, DOI 10.1111/nhs.12142; Chootrakool H, 2011, STAT MED, V30, P1183, DOI 10.1002/sim.4143; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUBOW EF, 1991, CHILD DEV, V62, P583, DOI 10.1111/j.1467-8624.1991.tb01554.x; Ellis JB, 2007, DEATH STUD, V31, P845, DOI 10.1080/07481180701537303; Fan YG, 2008, STUDY INFLUENCING FA; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Gau SSF, 2008, J AM COLL HEALTH, V57, P135, DOI 10.3200/JACH.57.2.135-142; Gunn John F 3rd, 2011, Int J Emerg Ment Health, V13, P147; Hardt J, 2010, PSYCHOSOC MED, V7, pc5; Harris TL, 2000, SUICIDE LIFE-THREAT, V30, P341; Hiramura H, 2008, ARCH SUICIDE RES, V12, P238, DOI 10.1080/13811110802100924; Huang Q., 2007, CHIN J HLTH PSYCHOL, V3, P4, DOI [10.3969/j.issn.1005-1252.2007.03.011, DOI 10.3969/J.ISSN.1005-1252.2007.03.011]; Jiang MJ, 2007, AM J PSYCHIAT, V164, P1758, DOI 10.1176/appi.ajp.2007.07060948; [阚双余 Kan Shuangyu], 2013, [中国公共卫生, China Public Health], V29, P167; Kirmayer LJ, 2009, 14 CULT MENT HLTH RE; Kong G, 2012, J BENGBU MED COLL, V37, P1240; Kuo PH, 2002, DRUG ALCOHOL DEPEN, V67, P27, DOI 10.1016/S0376-8716(02)00006-6; Lee HS, 2008, PSYCHIAT INVEST, V5, P86, DOI 10.4306/pi.2008.5.2.86; Li FH, 2007, CHIN J SCH DOCTOR, V21, P290; Li H, 2009, CHINA J HLTH PSYCHOL, V17, P963; [李雪霓 LI XueNi], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P806; Liu Bao-Hua, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P128; Liu GH, 2013, CHINA J HLTH PSYCHOL, V21, P456; Liu QQ, 2007, CHINA J HLTH PSYCHOL, V15, P57; Luo MY, 2010, CHINA YOUTH STUDY, V11, P32; Mackenzie S, AM J ORTHOPSYCHIATRY, V81, P101; National Research Council, 2002, REDUCING SUICIDE NAT; Park S, 2013, ARCH PSYCHIAT NURS, V27, P253, DOI 10.1016/j.apnu.2013.06.001; Perez VW, 2005, SUICIDE LIFE-THREAT, V35, P35, DOI 10.1521/suli.35.1.35.59267; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Qian WC, 2008, CHIN J PUBLIC HLTH, V24, P1285; Ran CF, 2006, J PREV MEDINF, V22, P548; Sakamoto S, 2014, INT J SOC PSYCHIAT; Shang YX, 2008, CHIN J PUBLIC HLTH, V24, P934; Sharp C, 2012, J PERS DISORD, V26, P927, DOI 10.1521/pedi.2012.26.6.927; Shi WJ, 2007, CHIN J SCH HLTH, V28, P999; Shi XL, 2013, POPULAR SCI TECHNOLO, V15, P114; Silenzio VMB, 2007, AM J PUBLIC HEALTH, V97, P2017, DOI 10.2105/AJPH.2006.095943; Stuart A, 1994, KENDALLS ADV THEORY; Sun AY, 2010, J QILU NURSING, V16, P55; Swahn MH, 2012, INT J ENV RES PUB HE, V9, P596, DOI 10.3390/ijerph9020596; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017977; Tu YM, 2013, ED CIRCLES, V15, P60; [王冰蔚 Wang Bingwei], 2012, [中国公共卫生, China Public Health], V28, P1086; Wang H, 2011, FOREIGN MED SCI SECT, V32, P188; Wang T, 2011, J KUNMING MED U, V12, P44; Wang XL, 2006, CHIN J PUBLIC HLTH, V22, P653; Wang Y, 2010, CHIN J SCH DOCTOR, V24, P202; Wu Jiao, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P1111; Xu Hui-lan, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P288; Yan HH, 2009, MODERN PREVENTIVE ME, V36, P476; Yang C, 2013, CHINESE J SOC MED, V30, P193; Yang XH, 2007, CHIN J SCH HLTH, V28, P527; Yang Yan-jie, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1103; Yi L, 2009, CHIN J SCH DOCTOR, V23, P388; [张小远 ZHANG XiaoYuan], 2007, [第四军医大学学报, Journal of the Fourth Military Medical University], V28, P747; Zhang XY, 2012, J ADOLESCENCE, V35, P683, DOI 10.1016/j.adolescence.2011.10.003; [赵国香 Zhao Guoxiang], 2011, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V20, P357; Zhao JB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-668; 朱相华, 2011, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V20, P461; 宋玉梅, 2010, [中国卫生统计, Chinese Journal of Health Statistics], V27, P178	73	69	74	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e104368	10.1371/journal.pone.0104368	http://dx.doi.org/10.1371/journal.pone.0104368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XC	25285890	Green Published, gold			2022-12-27	WOS:000345743700002
J	Poust, S; Yoon, I; Adams, PD; Katz, L; Petzold, CJ; Keasling, JD				Poust, Sean; Yoon, Isu; Adams, Paul D.; Katz, Leonard; Petzold, Christopher J.; Keasling, Jay D.			Understanding the Role of Histidine in the GHSxG Acyltransferase Active Site Motif: Evidence for Histidine Stabilization of the Malonyl-Enzyme Intermediate	PLOS ONE			English	Article							CARRIER PROTEIN TRANSACYLASE; COA-ACP TRANSACYLASE; STREPTOMYCES-COELICOLOR; POLYKETIDE SYNTHASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SPECIFICITY; DOMAIN	Acyltransferases determine which extender units are incorporated into polyketide and fatty acid products. The ping-pong acyltransferase mechanism utilizes a serine in a conserved GHSxG motif. However, the role of the conserved histidine in this motif is poorly understood. We observed that a histidine to alanine mutation (H640A) in the GHSxG motif of the malonyl-CoA specific yersiniabactin acyltransferase results in an approximately seven-fold higher hydrolysis rate over the wildtype enzyme, while retaining transacylation activity. We propose two possibilities for the reduction in hydrolysis rate: either H640 structurally stabilizes the protein by hydrogen bonding with a conserved asparagine in the ferredoxin-like subdomain of the protein, or a water-mediated hydrogen bond between H640 and the malonyl moiety stabilizes the malonyl-O-AT ester intermediate.	[Poust, Sean; Yoon, Isu; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Katz, Leonard; Keasling, Jay D.] Synthet Biol Engn Res Ctr, Emeryville, CA USA; [Adams, Paul D.; Katz, Leonard; Petzold, Christopher J.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Petzold, Christopher J.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012; Adams, Paul David/A-1977-2013	Keasling, Jay D/0000-0003-4170-6088; Adams, Paul David/0000-0001-9333-8219; Petzold, Christopher/0000-0002-8270-5228	Joint BioEnergy Institute - Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation [EEC-0540879]; Department of Energy, ARPA-E Electrofuels Program [DE-0000206-1577]; National Science Foundation Graduate Research Fellowship Program [DGE 1106400]	Joint BioEnergy Institute - Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy; National Science Foundation(National Science Foundation (NSF)); Department of Energy, ARPA-E Electrofuels Program(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by the Joint BioEnergy Institute which is funded by the Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy (Contract No. DE-AC02-05CH11231), by the National Science Foundation (award No. EEC-0540879 to the Synthetic Biology Research Center), by the Department of Energy, ARPA-E Electrofuels Program (Contract No. DE-0000206-1577), and by the National Science Foundation Graduate Research Fellowship Program (Grant No. DGE 1106400, to SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bumpus SB, 2008, CURR OPIN CHEM BIOL, V12, P475, DOI 10.1016/j.cbpa.2008.07.022; Dreier J, 2001, BIOCHEMISTRY-US, V40, P12407, DOI 10.1021/bi011108+; Dunn BJ, 2013, BIOCHEMISTRY-US, V52, P1839, DOI 10.1021/bi400185v; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Liew CW, 2012, J BIOL CHEM, V287, P23203, DOI 10.1074/jbc.M112.362210; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Molnos J, 2003, ANAL BIOCHEM, V319, P171, DOI 10.1016/S0003-2697(03)00327-0; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Szafranska AE, 2002, BIOCHEMISTRY-US, V41, P1421, DOI 10.1021/bi012001p; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7	12	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109421	10.1371/journal.pone.0109421	http://dx.doi.org/10.1371/journal.pone.0109421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286165	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700063
J	Molkov, YI; Shevtsova, NA; Park, C; Ben-Tal, A; Smith, JC; Rubin, JE; Rybak, IA				Molkov, Yaroslav I.; Shevtsova, Natalia A.; Park, Choongseok; Ben-Tal, Alona; Smith, Jeffrey C.; Rubin, Jonathan E.; Rybak, Ilya A.			A Closed-Loop Model of the Respiratory System: Focus on Hypercapnia and Active Expiration	PLOS ONE			English	Article							MAMMALIAN BRAIN-STEM; FUNCTIONAL ARCHITECTURE; REFLEX PROLONGATION; INTEGRATED MODEL; GAS-EXCHANGE; NEWBORN RAT; RHYTHM; PATTERN; INSPIRATION; NEURONS	Breathing is a vital process providing the exchange of gases between the lungs and atmosphere. During quiet breathing, pumping air from the lungs is mostly performed by contraction of the diaphragm during inspiration, and muscle contraction during expiration does not play a significant role in ventilation. In contrast, during intense exercise or severe hypercapnia forced or active expiration occurs in which the abdominal "expiratory" muscles become actively involved in breathing. The mechanisms of this transition remain unknown. To study these mechanisms, we developed a computational model of the closed-loop respiratory system that describes the brainstem respiratory network controlling the pulmonary subsystem representing lung biomechanics and gas (O-2 and CO2) exchange and transport. The lung subsystem provides two types of feedback to the neural subsystem: a mechanical one from pulmonary stretch receptors and a chemical one from central chemoreceptors. The neural component of the model simulates the respiratory network that includes several interacting respiratory neuron types within the Botzinger and pre-Botzinger complexes, as well as the retrotrapezoid nucleus/parafacial respiratory group (RTN/pFRG) representing the central chemoreception module targeted by chemical feedback. The RTN/pFRG compartment contains an independent neural generator that is activated at an increased CO2 level and controls the abdominal motor output. The lung volume is controlled by two pumps, a major one driven by the diaphragm and an additional one activated by abdominal muscles and involved in active expiration. The model represents the first attempt to model the transition from quiet breathing to breathing with active expiration. The model suggests that the closed-loop respiratory control system switches to active expiration via a quantal acceleration of expiratory activity, when increases in breathing rate and phrenic amplitude no longer provide sufficient ventilation. The model can be used for simulation of closed-loop control of breathing under different conditions including respiratory disorders.	[Molkov, Yaroslav I.] Purdue Univ, Indiana Univ, Dept Math Sci, Indianapolis, IN USA; [Shevtsova, Natalia A.; Rybak, Ilya A.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Park, Choongseok; Rubin, Jonathan E.] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Ben-Tal, Alona] Massey Univ, Inst Informat & Math Sci, Auckland, New Zealand; [Smith, Jeffrey C.] NINDS, Cellular & Syst Neurobiol Sect, NIH, Bethesda, MD 20892 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massey University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Rybak, IA (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA.	rybak@drexel.edu	Molkov, Yaroslav/C-6336-2012; smith, jeremy c/B-7287-2012; RUBIN, JONATHAN/AAD-9071-2019	Molkov, Yaroslav/0000-0002-0862-1974; smith, jeremy c/0000-0002-2978-3227; Rubin, Jonathan/0000-0002-1513-1551	National Institutes of Health (NIH) [R01NS069220]; National Science Foundation [DMS 1021701, 1312508]; Indiana University - Purdue University, Indianapolis; NIH, National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003108] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Indiana University - Purdue University, Indianapolis; NIH, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	IAR, AB-T, and NAS are funded by grant R01NS069220 from the National Institutes of Health (NIH) (http://www.nih.gov); JER and CP are funded by grants DMS 1021701 and 1312508 from the National Science Foundation (http://www.nsf.gov); YIM is funded by Indiana University - Purdue University, Indianapolis (http://http://www.iupui.edu); and JCS is funded by Intramural Research Program of the NIH, National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2011, J NEUROSCI, V31, P16410, DOI 10.1523/JNEUROSCI.3280-11.2011; Abdala APL, 2009, J PHYSIOL-LONDON, V587, P3539, DOI 10.1113/jphysiol.2008.167502; Abu-Shaweesh JM, 1999, J APPL PHYSIOL, V87, P484, DOI 10.1152/jappl.1999.87.2.484; Aliverti A, 1997, J APPL PHYSIOL, V83, P1256, DOI 10.1152/jappl.1997.83.4.1256; BAINTON CR, 1979, J PHYSIOL-LONDON, V296, P291, DOI 10.1113/jphysiol.1979.sp013006; Ben-Tal A, 2006, J THEOR BIOL, V238, P474, DOI 10.1016/j.jtbi.2005.06.005; Ben-Tal A, 2008, J THEOR BIOL, V251, P480, DOI 10.1016/j.jtbi.2007.12.018; Ben-Tal A, 2013, WIRES SYST BIOL MED, V5, P687, DOI 10.1002/wsbm.1244; Ben-Tal A, 2010, RESP PHYSIOL NEUROBI, V170, P103, DOI 10.1016/j.resp.2009.10.008; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Cheng LM, 2010, RESP PHYSIOL NEUROBI, V174, P4, DOI 10.1016/j.resp.2010.06.001; CLARK FJ, 1972, J PHYSIOL-LONDON, V222, P267, DOI 10.1113/jphysiol.1972.sp009797; COHEN MI, 1979, PHYSIOL REV, V59, P1105, DOI 10.1152/physrev.1979.59.4.1105; DETROYER A, 1989, J APPL PHYSIOL, V66, P20, DOI 10.1152/jappl.1989.66.1.20; Eldridge FL, 1996, BIOENGINEERING APPROACHES TO PULMONARY PHYSIOLOGY AND MEDICINE, P25, DOI 10.1007/978-0-585-34964-0_2; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P679, DOI 10.1162/neco.1994.6.4.679; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; GRODINS FS, 1967, J APPL PHYSIOL, V22, P260, DOI 10.1152/jappl.1967.22.2.260; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Guyenet PG, 2010, RESP PHYSIOL NEUROBI, V173, P244, DOI 10.1016/j.resp.2010.02.005; Hayashi F, 1996, J NEUROSCI, V16, P6526; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; JODKOWSKI JS, 1994, NEUROSCI LETT, V172, P67, DOI 10.1016/0304-3940(94)90664-5; LAWSON EE, 1981, J APPL PHYSIOL, V50, P874, DOI 10.1152/jappl.1981.50.4.874; Longobardo G, 2005, RESP PHYSIOL NEUROBI, V148, P285, DOI 10.1016/j.resp.2005.02.005; Lu K., 2003, CARDIOVASC ENG, V3, P1; Marina N, 2010, J NEUROSCI, V30, P12466, DOI 10.1523/JNEUROSCI.3141-10.2010; Molkov YI, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00016; Molkov YI, 2011, J NEUROPHYSIOL, V105, P3080, DOI 10.1152/jn.00070.2011; Molkov YI, 2010, J NEUROPHYSIOL, V104, P2713, DOI 10.1152/jn.00334.2010; MORRISON SF, 1994, BRAIN RES, V652, P83, DOI 10.1016/0006-8993(94)90320-4; O'Connor R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00264; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; REMMERS JE, 1986, PFLUG ARCH EUR J PHY, V407, P190, DOI 10.1007/BF00580675; Rubin JE, 2011, J COMPUT NEUROSCI, V30, P607, DOI 10.1007/s10827-010-0281-0; Rubin JE, 2009, J NEUROPHYSIOL, V101, P2146, DOI 10.1152/jn.90958.2008; Rybak I.A., 2012, PRIMER AUTONOMIC NER; Rybak IA, 2004, RESP PHYSIOL NEUROBI, V143, P307, DOI 10.1016/j.resp.2004.03.020; Rybak IA, 1997, J NEUROPHYSIOL, V77, P2027, DOI 10.1152/jn.1997.77.4.2027; Rybak IA, 2007, PROG BRAIN RES, V165, P201, DOI 10.1016/S0079-6123(06)65013-9; SAETTA M, 1987, J APPL PHYSIOL, V62, P506, DOI 10.1152/jappl.1987.62.2.506; SEARS TA, 1977, FED PROC, V36, P2412; Smith JC, 2007, J NEUROPHYSIOL, V98, P3370, DOI 10.1152/jn.00985.2007; Smith JC, 2013, TRENDS NEUROSCI, V36, P152, DOI 10.1016/j.tins.2012.11.004; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Takakura AC, 2014, EXP PHYSIOL, V99, P571, DOI 10.1113/expphysiol.2013.076752; Tin C, 2012, RESP PHYSIOL NEUROBI, V181, P79, DOI 10.1016/j.resp.2012.01.008; Topor ZL, 2004, ANN BIOMED ENG, V32, P1530, DOI 10.1114/B:ABME.0000049037.65204.4c; Ursino M, 2001, CLIN PHYSIOL, V21, P447, DOI 10.1046/j.1365-2281.2001.00349.x; West JB., 2008, WESTS RESP PHYSL ESS, V9th; Zhou D, 1996, RESP PHYSIOL, V104, P11, DOI 10.1016/0034-5687(95)00098-4	52	42	43	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109894	10.1371/journal.pone.0109894	http://dx.doi.org/10.1371/journal.pone.0109894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302708	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400091
J	Nordgren, H; Aaltonen, K; Sironen, T; Kinnunen, PM; Kivisto, I; Raunio-Saarnisto, M; Moisander-Jylha, AM; Korpela, J; Kokkonen, UM; Hetzel, U; Sukura, A; Vapalahti, O				Nordgren, Heli; Aaltonen, Kirsi; Sironen, Tarja; Kinnunen, Paula M.; Kivisto, Ilkka; Raunio-Saarnisto, Mirja; Moisander-Jylha, Anna-Maria; Korpela, Johanna; Kokkonen, Ulla-Maija; Hetzel, Udo; Sukura, Antti; Vapalahti, Olli			Characterization of a New Epidemic Necrotic Pyoderma in Fur Animals and Its Association with Arcanobacterium phocae Infection	PLOS ONE			English	Article							GENUS ARCANOBACTERIUM; EMENDED DESCRIPTION; CANINE PARVOVIRUS; SP NOV.; HAEMOLYTICUM; VIRUS	A new type of pyoderma was detected in Finnish fur animals in 2007. The disease continues to spread within and between farms, with severe and potentially fatal symptoms. It compromises animal welfare and causes considerable economic losses to farmers. A case-control study was performed in 2010-2011 to describe the entity and to identify the causative agent. Altogether 99 fur animals were necropsied followed by pathological and microbiological examination. The data indicated that the disease clinically manifests in mink (Neovison vison) by necrotic dermatitis of the feet and facial skin. In finnraccoons (Nyctereutes procyonoides), it causes painful abscesses in the paws. Foxes (Vulpes lagopus) are affected by severe conjunctivitis and the infection rapidly spreads to the eyelids and facial skin. A common finding at necropsy was necrotic pyoderma. Microbiological analysis revealed the presence of a number of potential causative agents, including a novel Streptococcus sp. The common finding from all diseased animals of all species was Arcanobacterium phocae. This bacterium has previously been isolated from marine mammals with skin lesions but this is the first report of A. phocae isolated in fur animals with pyoderma. The results obtained from this study implicate A. phocae as a potential causative pathogen of fur animal epidemic necrotic pyoderma (FENP) and support observations that the epidemic may have originated in a species - shift of the causative agent from marine mammals. The variable disease pattern and the presence of other infectious agents (in particular the novel Streptococcus sp.) suggest a multifactorial etiology for FENP, and further studies are needed to determine the environmental, immunological and infectious factors contributing to the disease.	[Nordgren, Heli] Finnish Food Safety Author Evira, Prod Anim Sect, Seinajoki, Finland; [Aaltonen, Kirsi; Sironen, Tarja; Kinnunen, Paula M.; Hetzel, Udo; Sukura, Antti; Vapalahti, Olli] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Aaltonen, Kirsi; Sironen, Tarja; Kivisto, Ilkka; Vapalahti, Olli] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Raunio-Saarnisto, Mirja] Finnish Food Safety Author Evira, Seinajoki Lab Sect, Seinajoki, Finland; [Moisander-Jylha, Anna-Maria; Korpela, Johanna] Finnish Breeders Assoc FFBA, Vantaa, Finland; [Kokkonen, Ulla-Maija] Finnish Food Safety Author Evira, Sect Poultry Wild & Lab Anim, Seinajoki, Finland; [Vapalahti, Olli] Hosp Dist Helsinki & Uusimaa, HUSLAB, Dept Virol & Immunol, Helsinki, Finland	Finnish Food Authority; University of Helsinki; University of Helsinki; Finnish Food Authority; Finnish Food Authority; University of Helsinki; Helsinki University Central Hospital	Nordgren, H (corresponding author), Finnish Food Safety Author Evira, Prod Anim Sect, Seinajoki, Finland.	heli.nordgren@profur.fi		Kivisto, Ilkka/0000-0002-9657-0555; Sironen, Tarja/0000-0002-2344-2755; Vapalahti, Olli/0000-0003-2270-6824; Aaltonen, Kirsi/0000-0001-8901-6866; Sukura, Antti Kalle Kalervo/0000-0002-8992-1695	Finnish Fur Breeders' association	Finnish Fur Breeders' association	Co-authors Anna-Maria Moisander-Jylha and Johanna Korpela are employed by the Finnish Fur Breeders' association. The funder provided support in the form of salary for authors Anna-Maria Moisander-Jylha and Johanna Korpela, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	BARRETT T, 1993, VIROLOGY, V193, P1010, DOI 10.1006/viro.1993.1217; Brojer C, 2000, THESIS U GUELPH CANA; CARMICHAEL LE, 1980, AM J VET RES, V41, P784; COLLINS MD, 1982, J GEN MICROBIOL, V128, P1279; Ek-Kommonen C, 1997, VET REC, P383; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Hijazin M, 2013, INT J SYST EVOL MICR, V63, P2019, DOI 10.1099/ijs.0.045591-0; Hijazin M, 2012, INT J SYST EVOL MICR, V62, P2201, DOI 10.1099/ijs.0.037150-0; Johnson SP, 2003, J WILDLIFE DIS, V39, P136, DOI 10.7589/0090-3558-39.1.136; Knuuttila A, 2009, CLIN VACCINE IMMUNOL, V16, P1360, DOI 10.1128/CVI.00148-09; MACKENZIE A, 1995, CLIN INFECT DIS, V21, P177, DOI 10.1093/clinids/21.1.177; Malik R, 2004, VET DERMATOLOGY S, V15, DOI [10.1111/j.1365-3164.2004.00410_5-1.x, DOI 10.1111/J.1365-3164.2004.00410_5-1.X]; Onderka D, 1996, MINK BIOL HLTH DIS, P151; Ramos CP, 1997, INT J SYST BACTERIOL, V32, P419; Skov RL, 1998, EUR J CLIN MICROBIOL, V17, P578, DOI 10.1007/s100960050135; UWATOKO K, 1995, VET MICROBIOL, V43, P315, DOI 10.1016/0378-1135(94)00102-3; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Wagner DC, 1991, PEDIATR INFECT DIS J, V10, P933; Yassin AF, 2011, INT J SYST EVOL MICR, V61, P1265, DOI 10.1099/ijs.0.020032-0	19	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110210	10.1371/journal.pone.0110210	http://dx.doi.org/10.1371/journal.pone.0110210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302603	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000343730400123
J	Zhang, CY; Zhao, YX; Xia, RH; Han, J; Wang, BS; Tian, Z; Wang, LZ; Hu, YH; Li, J				Zhang, Chun-Ye; Zhao, Yang-Xing; Xia, Rong-Hui; Han, Jing; Wang, Bing-Shun; Tian, Zhen; Wang, Li-Zhen; Hu, Yu-Hua; Li, Jiang			RASSF1A Promoter Hypermethylation Is a Strong Biomarker of Poor Survival in Patients with Salivary Adenoid Cystic Carcinoma in a Chinese Population	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; DOMAIN FAMILY PROTEIN; HIGH-FREQUENCY; CLINICOPATHOLOGICAL ANALYSIS; EPIGENETIC INACTIVATION; BREAST-CANCER; CHROMOSOME 3P; LUNG-CANCER; METHYLATION; HEAD	In addition to the clinicopathological parameters, molecular biomarkers are becoming increasingly important in the prognostic evaluation of cancer patients. This study aimed to determine the molecular alterations in the RAS association domain family protein1A gene (RASSF1A) in salivary adenoid cystic carcinoma (ACC) and to evaluate the potential of such alterations as prognostic markers. One hundred and sixty-seven ACC tumor tissues and 50 samples of matched normal salivary gland tissues from the same patients were analyzed for RASSF1A promoter methylation status by bisulfite sequencing PCR (BSP) and/or methylation-specific PCR (MSP). Fifty ACC tumor tissues and matched normal salivary gland tissues were analyzed for loss of heterozygosity (LOH) by examining two microsatellite markers (D3S1478, D351621) at 3p21. RASSF1A gene mutations were detected by direct sequencing of all six exons in 50 tumor and normal tissue specimens. Over-all, RASSF1A promoter hypermethylation was detected in 35.3% (59/167) of ACC tissues and was associated with histologically solid tumor pattern (P=0.002) and advanced TNM stage (P=0.014). RASSF1A LOH was observed in 18.0% (9/50 cases, and no somatic mutation of RASSF1A was detected in any cases. RASSF1A promoter methlyation was associated h the poor over-all survival (Log-rank test, P<0.001) and disease-free survival (Log-rank test, P<0.001) and identified as independent predicator of over-all patient survival (P=0.009) and disease-free survival (P<0.001). It was concluded that RASSF1A methylation is involved in the development, differentiation and progression of ACC and is a strong independent biomarker of poor survival in ACC patients in a Chinese population.	[Zhang, Chun-Ye; Xia, Rong-Hui; Han, Jing; Tian, Zhen; Wang, Li-Zhen; Hu, Yu-Hua; Li, Jiang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Oral Pathol, Shanghai 200030, Peoples R China; [Zhao, Yang-Xing] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200030, Peoples R China; [Wang, Bing-Shun] Shanghai Jiao Tong Univ, Sch Med, Dept Biostat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, J (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Oral Pathol, Shanghai 200030, Peoples R China.	lijiang182000@126.com	Wang, Bing-shun/B-8698-2013	Wang, Bingshun/0000-0002-0435-2543	Natural Science Fund of China [81372910, 81302360]; Research Fund for the Doctoral Program of Ministry of Education of China [20120073110085]; Youth Research Foundation of Shanghai Municipal Health Bureau [20134Y057]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Ministry of Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Youth Research Foundation of Shanghai Municipal Health Bureau	This work was supported by 1. The Natural Science Fund of China (Nos. 81372910, 81302360) to JL and CYZ (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list); 2. The Research Fund for the Doctoral Program of Ministry of Education of China (No. 20120073110085) to JL (http://www.cutech.edu.cn/cn/zxgz/2012/12/1354173228992896.htm); and 3. Youth Research Foundation of Shanghai Municipal Health Bureau (20134Y057) (http://www.wsjsw.gov.cn/wsj/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Buckingham L, 2010, INT J CANCER, V126, P1630, DOI 10.1002/ijc.24896; Buhmeida A, 2011, ANTICANCER RES, V31, P2975; Choi CH, 2007, CANCER LETT, V255, P26, DOI 10.1016/j.canlet.2007.03.015; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; de Fraipont F, 2012, CLIN CANCER RES, V18, P2976, DOI 10.1158/1078-0432.CCR-11-2797; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; El Naggar AK, 2005, WHO CLASSIFICATION T, P221; Ellis GLA., 2008, AFIP ATLAS TUMOR PAT, P301; Gobel G, 2011, BREAST CANC RES TREA; Gondivkar SM, 2011, ORAL ONCOL, V47, P231, DOI 10.1016/j.oraloncology.2011.01.009; Grote HJ, 2006, CANCER CYTOPATHOL, V108, P129, DOI 10.1002/cncr.21717; Jiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036780; Karray-Chouayekh S, 2010, J CANCER RES CLIN, V136, P203, DOI 10.1007/s00432-009-0649-6; Kim JS, 2012, CLIN GENITOURIN CANC, V10, P114, DOI 10.1016/j.clgc.2011.12.003; Ku JL, 2011, METHODS MOL BIOL, V791, P23, DOI 10.1007/978-1-61779-316-5_3; Li J, 2004, ARCH PATHOL LAB MED, V128, P1385; Li J, 2005, CANCER-AM CANCER SOC, V104, P771, DOI 10.1002/cncr.21215; Licchesi Julien D. F., 2009, V507, P305, DOI 10.1007/978-1-59745-522-0_22; Lo KW, 2001, CANCER RES, V61, P3877; Miranda E, 2006, BRIT J CANCER, V95, P1101, DOI 10.1038/sj.bjc.6603337; NASCIMENTO AG, 1986, CANCER, V57, P312, DOI 10.1002/1097-0142(19860115)57:2<312::AID-CNCR2820570220>3.0.CO;2-A; Ohshima J, 2012, PEDIAT BLOOD CANC; Oliveira C, 2005, ONCOGENE, V24, P7630, DOI 10.1038/sj.onc.1208906; Pan ZG, 2005, CANCER BIOL THER, V4, P1116, DOI 10.4161/cbt.4.10.2023; Rapidis AD, 2005, ORAL ONCOL, V41, P328, DOI 10.1016/j.oraloncology.2004.12.004; Reed K, 2010, ANAL BIOCHEM, V397, P96, DOI 10.1016/j.ab.2009.10.021; Riquelme E, 2007, CANCER LETT, V250, P100, DOI 10.1016/j.canlet.2006.09.019; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Shen CY, 2012, ORAL ONCOL, V48, P445, DOI 10.1016/j.oraloncology.2011.12.002; Shinozaki M, 2005, CLIN CANCER RES, V11, P2156, DOI 10.1158/1078-0432.CCR-04-1810; SPIRO RH, 1979, AM J SURG, V138, P579, DOI 10.1016/0002-9610(79)90423-9; Tian Z, 2010, INT J ORAL MAX SURG, V39, P235, DOI 10.1016/j.ijom.2009.10.016; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Yeo W, 2005, PATHOLOGY, V37, P125, DOI 10.1080/00313020500058623; Yu MY, 2003, INT J CANCER, V105, P204, DOI 10.1002/ijc.11051; Zhang CY, 2007, CANCER-AM CANCER SOC, V110, P87, DOI 10.1002/cncr.22758; Zhang CY, 2013, OR SURG OR MED OR PA, V115, P368, DOI 10.1016/j.oooo.2012.11.018	40	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110159	10.1371/journal.pone.0110159	http://dx.doi.org/10.1371/journal.pone.0110159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302792	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400114
J	Vermandere, H; Naanyu, V; Mabeya, H; Broeck, DV; Michielsen, K; Degomme, O				Vermandere, Heleen; Naanyu, Violet; Mabeya, Hillary; Broeck, Davy Vanden; Michielsen, Kristien; Degomme, Olivier			Determinants of Acceptance and Subsequent Uptake of the HPV Vaccine in a Cohort in Eldoret, Kenya	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; MIDDLE-INCOME COUNTRIES; CERVICAL-CANCER RISK; VIRUS VACCINE; DELIVERY STRATEGIES; DECISION-MAKING; HIGH COVERAGE; ACCEPTABILITY; PARENTS; KNOWLEDGE	The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight against cervical cancer. Many acceptability studies have revealed high interest in these vaccines, but acceptance is only a precursor of behavior, and many factors, at personal, community and provider level, may inhibit the translation of willingness to vaccinate into actual uptake. Through a longitudinal study in Eldoret, Kenya, HPV vaccine acceptability was measured before a vaccination program (n = 287) and vaccine uptake, as reported by mothers, once the program was finished (n = 256). In between baseline and follow-up, a pilot HPV vaccination program was implemented via the GARDASIL Access Program, in which parents could have their daughter vaccinated for free at the referral hospital. The program was promoted at schools: Health staff informed teachers who were then asked to inform students and parents. Even though baseline acceptance was very high (88.1%), only 31.1% of the women reported at follow-up that their daughter had been vaccinated. The vaccine was declined by 17.7%, while another 51.2% had wanted the vaccination but were obstructed by practical barriers. Being well-informed about the program and baseline awareness of cervical cancer were independently associated with vaccine uptake, while baseline acceptance was correlated in bivariate analysis. Side effects were of great concern, even among those whose daughter was vaccinated. Possible partner disapproval lowered acceptance at baseline, and women indeed reported at follow-up that they had encountered his opposition. In Kenya, women prove to be very willing to have their daughter vaccinated against cervical cancer. However, in this study, uptake was more determined by program awareness than by HPV vaccine acceptance. School-based vaccination might improve coverage since it reduces operational problems for parents. In addition, future HPV vaccination campaigns should address concerns about side effects, targeting men and women, given both their involvement in HPV vaccination decision-making.	[Vermandere, Heleen; Broeck, Davy Vanden; Michielsen, Kristien; Degomme, Olivier] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Naanyu, Violet] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya; [Mabeya, Hillary] Moi Univ, Coll Hlth Sci, Sch Med, Dept Reprod Hlth, Eldoret, Kenya	Ghent University; Moi University; Moi University	Vermandere, H (corresponding author), Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium.	Heleen.vermandere@ugent.be	Mabeya, Hillary/HHC-7512-2022; Naanyu, Violet/GNM-8783-2022; Naanyu, Violet/AAL-6106-2020	Naanyu, Violet/0000-0003-0182-1719; Naanyu, Violet/0000-0003-0182-1719; vermandere, heleen/0000-0003-1274-8537; Michielsen, Kristien/0000-0002-4119-6770	Research Foundation Flanders (FWO) [1194113N]; Moi University (Kenya)-VLIR UOS (Belgium)	Research Foundation Flanders (FWO)(FWO); Moi University (Kenya)-VLIR UOS (Belgium)	Funding of the Research Foundation Flanders (FWO) supported Heleen Vermandere and the study (#1194113N). Funds for the vaccination pilot program were provided by the Moi University (Kenya)-VLIR UOS (Belgium) collaborative program. The vaccines were donated to Moi Teaching and Referral Hospital by Axios Healthcare Development (AHD) as part of the Gardasil Access Program, which was made possible by a pledge from Merck & Co., Inc. This donation was used for the study presented in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Ayissi CA, 2012, J COMMUN HEALTH, V37, P1127, DOI 10.1007/s10900-012-9554-z; Babirye JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-723; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Bingham A, 2009, OPEN VACCINE J; Bingham A, 2009, SOCIOCULTURAL ISSUES; Black LL, 2009, VACCINE, V27, P1668, DOI 10.1016/j.vaccine.2009.01.035; Brabin L, 2008, VACCINE, V26, P4120, DOI 10.1016/j.vaccine.2008.04.055; Brewer NT, 2011, SEX TRANSM DIS, V38, P197, DOI 10.1097/OLQ.0b013e3181f12dbf; Coleman MA, 2011, VACCINE, V29, P3945, DOI 10.1016/j.vaccine.2011.03.093; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Cover JK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-629; Dempsey AF, 2009, ANN EPIDEMIOL, V19, P531, DOI 10.1016/j.annepidem.2009.03.011; DiAngi YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025481; Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116; Francis SA, 2010, VACCINE, V28, P8026, DOI 10.1016/j.vaccine.2010.08.090; Galagan SR, 2013, VACCINE, V31, P3072, DOI 10.1016/j.vaccine.2013.04.056; Gerend MA, 2013, HEALTH PSYCHOL, V32, P361, DOI 10.1037/a0026248; Globocan, 2012, EST CANC INC MORT PR; Grabenstein JD, 2013, VACCINE, V31, P2011, DOI 10.1016/j.vaccine.2013.02.026; Harries J, 2009, VACCINE, V27, P38, DOI 10.1016/j.vaccine.2008.10.033; Hendry M, 2013, VACCINE, V31, P5152, DOI 10.1016/j.vaccine.2013.08.091; Hertweck SP, 2013, J PEDIATR ADOL GYNEC, V26, P96, DOI 10.1016/j.jpag.2012.10.009; Hopkins TG, 2013, VACCINE, V31, P1673, DOI 10.1016/j.vaccine.2013.01.028; Iliyasu Z, 2010, J OBSTET GYNAECOL, V30, P857, DOI 10.3109/01443615.2010.511724; Katahoire R A, 2008, Afr J Reprod Health, V12, P159; Ladner J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-670; Ladner J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-370; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; Marlow LAV, 2011, BRIT J CANCER, V105, P486, DOI 10.1038/bjc.2011.272; Moodley I, 2013, SAMJ S AFR MED J, V103, P318, DOI 10.7196/SAMJ.6414; Morhason-Bello Imran O, 2013, Afr J Reprod Health, V17, P150; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Paul P, 2014, VACCINE, V32, P320, DOI 10.1016/j.vaccine.2013.11.070; Perlman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090912; Poole DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056402; Reiter PL, 2013, AM J PUBLIC HEALTH, V103, P1419, DOI 10.2105/AJPH.2012.301189; Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Ugwu EO, 2013, NIGER J CLIN PRACT, V16, P249, DOI 10.4103/1119-3077.110141; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Watson M, 2009, AUST NZ J PUBL HEAL, V33, P365, DOI 10.1111/j.1753-6405.2009.00409.x; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045231; Watson-Jones D, 2012, J INFECT DIS, V206, P678, DOI 10.1093/infdis/jis407; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; Winkler JL, 2008, VACCINE, V26, pL73, DOI 10.1016/j.vaccine.2008.05.027; World Health Organization, 2009, WEEKLY EPIDEMIOLOGIC, V84, P117; Young A, 2010, ASIAN PAC J CANCER P, V11, P641; Zimet GD, 2013, PREV MED, V57, P414, DOI 10.1016/j.ypmed.2013.05.013	53	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109353	10.1371/journal.pone.0109353	http://dx.doi.org/10.1371/journal.pone.0109353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299646	Green Published, gold			2022-12-27	WOS:000343941200048
J	Grecucci, A; Giorgetta, C; Rattin, A; Guerreschi, C; Sanfey, AG; Bonini, N				Grecucci, Alessandro; Giorgetta, Cinzia; Rattin, Andrea; Guerreschi, Cesare; Sanfey, Alan G.; Bonini, Nicolao			Time Devours Things: How Impulsivity and Time Affect Temporal Decisions in Pathological Gamblers	PLOS ONE			English	Article							SELF-CONTROL; BEHAVIORAL MANIPULATIONS; DELAYED REINFORCEMENT; SENSATION SEEKING; PREFRONTAL CORTEX; DRUG-ADDICTION; GO/NO-GO; DOPAMINE; TASK; PERSONALITY	Impulsivity is associated with several psychiatric disorders in which the loss of control of a specific behavior determines the syndrome itself. One particularly interesting population characterized by reported high impulsivity and problematic decision-making are those diagnosed with pathological gambling. However the association between impulsivity and decision making in pathological gambling has been only partially confirmed until now. We tested 23 normal controls and 23 diagnosed pathological gamblers in an intertemporal choice task, as well as other personality trait measurements. Results showed that gamblers scored higher on impulsivity questionnaires, and selected a higher percentage of impatient choices (higher percentage of smaller, sooner rewards), when compared to normal controls. Moreover, gamblers were faster in terms of reaction times at selecting the smaller, sooner options and discounted rewards more rapidly over time. Importantly, regression analyses clarified that self-reported measures of impulsivity played a significant role in biasing decisions towards small but more rapidly available rewards. In the present study we found evidence for impulsivity in personality traits and decisions in pathological gamblers relative to controls. We conclude by speculating on the need to incorporate impulsivity and decision biases in the conceptualization of pathological gambling for a better understanding and treatment of this pathology.	[Grecucci, Alessandro; Rattin, Andrea] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy; [Giorgetta, Cinzia] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Guerreschi, Cesare] Soc Italiana Intervento Patol Compuls SIIPAC, Bolzano, Italy; [Sanfey, Alan G.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Sanfey, Alan G.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Bonini, Nicolao] Univ Trento, Dept Econ & Management, Trento, Italy	University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Arizona; Radboud University Nijmegen; University of Trento	Grecucci, A (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy.	alessandro.grecucci@unitn.it	Sanfey, Alan G/D-2350-2010; grecucci, alessandro/O-4609-2019	grecucci, alessandro/0000-0001-6043-2196; Sanfey, Alan/0000-0002-7421-8294; Bonini, Nicolao/0000-0001-8871-0936	Comune of Rovereto	Comune of Rovereto	The authors would like to thank Comune of Rovereto for the grant and Michele Graffeo for his assistance with statistical analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; BACHOROWSKI JA, 1990, J PERS SOC PSYCHOL, V58, P512, DOI 10.1037/0022-3514.58.3.512; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2004, NEUROPSYCHOLOGY, V18, P152, DOI 10.1037/0894-4105.18.1.152; Bergh C, 1997, PSYCHOL MED, V27, P473, DOI 10.1017/S0033291796003789; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P447, DOI 10.1007/PL00005490; Blanco C, 2001, Semin Clin Neuropsychiatry, V6, P167, DOI 10.1053/scnp.2001.22921; Blanco Carlos, 2002, Ann Clin Psychiatry, V14, P9, DOI 10.3109/10401230209147393; Blaszczynski A, 1997, ADDICTION, V92, P75; Brevers D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050647; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; CASTELLANI B, 1995, INT J ADDICT, V30, P275, DOI 10.3109/10826089509048726; Cyders MA, 2008, PERS INDIV DIFFER, V45, P503, DOI 10.1016/j.paid.2008.06.002; Dannon PN, 2010, ISR MED ASSOC J, V12, P243; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; DICKERSON M, 1987, BRIT J ADDICT, V82, P673; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Evans J. St. B. T., 2009, 2 MINDS DUAL PROCESS, P31, DOI DOI 10.1093/ACPROF:OSO/9780199230167.003.0002; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gianotti LRR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00054; Gilbert DT, 2004, PSYCHOL SCI, V15, P346, DOI 10.1111/j.0956-7976.2004.00681.x; Giorgetta C, 2014, PSYCHIAT RES, V219, P562, DOI 10.1016/j.psychres.2014.06.042; Giorgetta C, 2012, EMOTION, V12, P1373, DOI 10.1037/a0029119; Goldstein AL, 2009, PSYCHOL ADDICT BEHAV, V23, P113, DOI 10.1037/a0013912; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Goudriaan AE, 2006, DRUG ALCOHOL DEPEN, V84, P231, DOI 10.1016/j.drugalcdep.2006.02.007; Grecucci A, 2013, COGNITION EMOTION, V27, P230, DOI 10.1080/02699931.2012.698982; GROSSBARD CL, 1986, J EXP ANAL BEHAV, V45, P305, DOI 10.1901/jeab.1986.45-305; Hardisty DJ, 2009, J EXP PSYCHOL GEN, V138, P329, DOI 10.1037/a0016433; Hollander E, 1998, AM J PSYCHIAT, V155, P1781, DOI 10.1176/ajp.155.12.1781; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; Isles AR, 2004, J NEUROSCI, V24, P6733, DOI 10.1523/JNEUROSCI.1650-04.2004; Isles AR, 2003, PSYCHOPHARMACOLOGY, V170, P376, DOI 10.1007/s00213-003-1551-6; Kahneman D., 2011, THINKING FAST SLOW; Kalenscher T, 2005, J EXP ANAL BEHAV, V84, P521, DOI 10.1901/jeab.2005.86-04; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; Kirby KN, 2010, PERS INDIV DIFFER, V48, P704, DOI 10.1016/j.paid.2010.01.019; Kuhl J, 2008, J PERS SOC PSYCHOL, V95, P456, DOI 10.1037/0022-3514.95.2.456; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Louie K, 2006, ANN M SOC NEUR; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Mason L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047754; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; MAZUR JE, 1984, J EXP PSYCHOL ANIM B, V10, P426, DOI 10.1037/0097-7403.10.4.426; Millon T, 1994, PERSONALITY DISORDER, P279; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nordin C, 1999, CNS Spectr, V4, P25; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; Potenza MN, 2013, CURR OPIN NEUROBIOL, V23, P660, DOI 10.1016/j.conb.2013.03.004; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Scheres A, 2008, J NEURAL TRANSM, V115, P221, DOI 10.1007/s00702-007-0813-6; Shaffer HJ, 1999, AM J PUBLIC HEALTH, V89, P1369, DOI 10.2105/AJPH.89.9.1369; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Steel Z, 1996, J Gambl Stud, V12, P3, DOI 10.1007/BF01533186; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; van Holst RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030909; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Vuchinich RE, 1998, EXP CLIN PSYCHOPHARM, V6, P292, DOI 10.1037/1064-1297.6.3.292; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y	70	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109197	10.1371/journal.pone.0109197	http://dx.doi.org/10.1371/journal.pone.0109197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296184	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000045
J	Katsev, S; Aaberg, AA; Crowe, SA; Hecky, RE				Katsev, Sergei; Aaberg, Arthur A.; Crowe, Sean A.; Hecky, Robert E.			Recent Warming of Lake Kivu	PLOS ONE			English	Article							DEEP-WATER; CLIMATE; TEMPERATURE; TANGANYIKA	Lake Kivu in East Africa has gained notoriety for its prodigious amounts of dissolved methane and dangers of limnic eruption. Being meromictic, it is also expected to accumulate heat due to rising regional air temperatures. To investigate the warming trend and distinguish between atmospheric and geothermal heating sources, we compiled historical temperature data, performed measurements with logging instruments, and simulated heat propagation. We also performed isotopic analyses of water from the lake's main basin and isolated Kabuno Bay. The results reveal that the lake surface is warming at the rate of 0.12 degrees C per decade, which matches the warming rates in other East African lakes. Temperatures increase throughout the entire water column. Though warming is strongest near the surface, warming rates in the deep waters cannot be accounted for solely by propagation of atmospheric heat at presently assumed rates of vertical mixing. Unless the transport rates are significantly higher than presently believed, this indicates significant contributions from subterranean heat sources. Temperature time series in the deep monimolimnion suggest evidence of convection. The progressive deepening of the depth of temperature minimum in the water column is expected to accelerate the warming in deeper waters. The warming trend, however, is unlikely to strongly affect the physical stability of the lake, which depends primarily on salinity gradient.	[Katsev, Sergei; Hecky, Robert E.] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Katsev, Sergei; Aaberg, Arthur A.] Univ Minnesota, Dept Phys, Duluth, MN 55812 USA; [Crowe, Sean A.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Hecky, Robert E.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of British Columbia; University of Minnesota System; University of Minnesota Duluth	Katsev, S (corresponding author), Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA.	skatsev@d.umn.edu			University of Minnesota Office of International Programs Seed Grant	University of Minnesota Office of International Programs Seed Grant	The work was supported by the University of Minnesota Office of International Programs Seed Grant to SK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg AA, 2013, THESIS U MINNESOTA D; Borges AV, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001673; CONRAD R, 1990, ARCH MICROBIOL, V155, P94, DOI 10.1007/BF00291281; Damas H, 1937, ANN SOC R ZOOL BELG, V68, P121; Degens ET, 1973, GEOL RUNDSCH, V62, P245, DOI DOI 10.1007/BF01826830; DEUSER WG, 1973, SCIENCE, V181, P51, DOI 10.1126/science.181.4094.51; Halbwachs M, 2002, TECHNICAL REPORT; HECKY RE, 1994, LIMNOL OCEANOGR, V39, P1476, DOI 10.4319/lo.1994.39.6.1476; Hirslund F, 2012, J LIMNOL, V71, P45, DOI 10.4081/jlimnol.2012.e4; Houghton J. T., 2001, CLIMATE CHANGE 2001; Katsev S, 2010, LIMNOL OCEANOGR, V55, P763, DOI 10.4319/lo.2009.55.2.0763; LEHMAN J. T., 1998, ENV CHANGE RESPONSE, P157; Lorke A, 2004, LIMNOL OCEANOGR, V49, P778, DOI 10.4319/lo.2004.49.3.0778; NEWMAN FC, 1976, J PHYS OCEANOGR, V6, P157, DOI 10.1175/1520-0485(1976)006<0157:TSILKA>2.0.CO;2; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Pasche N, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001690; Pasche N, 2009, LIMNOL OCEANOGR, V54, P1863, DOI 10.4319/lo.2009.54.6.1863; REICHERT P, 1994, WATER SCI TECHNOL, V30, P21, DOI 10.2166/wst.1994.0025; Ross KA, 2014, GEOMORPHOLO IN PRESS; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M, 2002, ACTA VULCANOL, V14, P115, DOI DOI 10.1400/19084; Schmid M., 2012, LAKE KIVU LIMNOLOGY; Schmid M, 2012, J LIMNOL, V71, P330, DOI 10.4081/jlimnol.2012.e35; Schmid M, 2010, LIMNOL OCEANOGR, V55, P225, DOI 10.4319/lo.2010.55.1.0225; Schmitz D. M., 1955, ACAD ROY SCI COLONIA, V1, P326; Sommer T, 2013, J GEOPHYS RES-OCEANS, V118, P6092, DOI 10.1002/2013JC009166; Tassi F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002191; Tietze K, 1978, THESIS CHRISTIAN ALB; Verburg P, 2003, SCIENCE, V301, P505, DOI 10.1126/science.1084846; Verburg P, 2009, LIMNOL OCEANOGR, V54, P2418, DOI 10.4319/lo.2009.54.6_part_2.2418; Vollmer MK, 2005, LIMNOL OCEANOGR, V50, P727, DOI 10.4319/lo.2005.50.2.0727; Zhang YX, 2006, ANNU REV EARTH PL SC, V34, P293, DOI 10.1146/annurev.earth.34.031405.125001	33	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109084	10.1371/journal.pone.0109084	http://dx.doi.org/10.1371/journal.pone.0109084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295730	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000035
J	Kong, HG; Bae, JY; Lee, HJ; Joo, HJ; Jung, EJ; Chung, E; Lee, SW				Kong, Hyun Gi; Bae, Ju Young; Lee, Hyoung Ju; Joo, Hae Jin; Jung, Eun Joo; Chung, Eunsook; Lee, Seon-Woo			Induction of the Viable but Nonculturable State of Ralstonia solanacearum by Low Temperature in the Soil Microcosm and Its Resuscitation by Catalase	PLOS ONE			English	Article							NON-CULTURABLE STATE; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; PSEUDOMONAS-SOLANACEARUM; VIBRIO-CHOLERAE; OXIDATIVE STRESS; GENE-EXPRESSION; TOMATO PLANTS; SURVIVAL; STARVATION; BACTERIA	Ralstonia solanacearum is the causal agent of bacterial wilt on a wide variety of plants, and enters a viable but nonculturable (VBNC) state under stress conditions in soil and water. Here, we adopted an artificial soil microcosm (ASM) to investigate the VBNC state of R. solanacearum induced by low temperature. The culturability of R. solanacearum strains SL341 and GMI1000 rapidly decreased at 4 degrees C in modified ASM (mASM), while it was stably maintained at 25 degrees C in mASM. We hypothesized that bacterial cells at 4 degrees C in mASM are viable but nonculturable. Total protein profiles of SL341 cells at 4 degrees C in mASM did not differ from those of SL341 culturable cells at 25 degrees C in mASM. Moreover, the VBNC cells maintained in the mASM retained respiration activity. Catalase treatment effectively restored the culturability of nonculturable cells in mASM, while temperature increase or other treatments used for resuscitation of other bacteria were not effective. The resuscitated R. solanacearum from VBNC state displayed normal level of bacterial virulence on tomato plants compared with its original culturable bacteria. Expression of omp, oxyR, rpoS, dps, and the 16S rRNA gene quantified by RT-qPCR did not differ significantly between the culturable and VBNC states of R. solanacearum. Our results suggested that the VBNC bacterial cells in mASM induced by low temperature exist in a physiologically unique state.	[Kong, Hyun Gi; Bae, Ju Young; Lee, Hyoung Ju; Joo, Hae Jin; Jung, Eun Joo; Chung, Eunsook; Lee, Seon-Woo] Dong A Univ, Dept Appl Biosci, Pusan, South Korea	Dong A University	Lee, SW (corresponding author), Dong A Univ, Dept Appl Biosci, Pusan, South Korea.	seonlee@dau.ac.kr		Lee, Seon-Woo/0000-0001-6142-7612	National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2012R1A2A2A01045039]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ0082012014]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was supported by the Mid-career Researcher Program through the National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (NRF-2012R1A2A2A01045039) and by a grant from the Next-Generation BioGreen 21 Program (No. PJ0082012014), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander E, 1999, APPL ENVIRON MICROB, V65, P3754; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Alvarez B, 2008, MICROBIOL-SGM, V154, P3590, DOI 10.1099/mic.0.2008/019448-0; Arana I, 2007, FEMS MICROBIOL ECOL, V62, P1, DOI 10.1111/j.1574-6941.2007.00362.x; Artz RRE, 2006, CAN J MICROBIOL, V52, P482, DOI 10.1139/W05-149; Asakura H, 2007, ENVIRON MICROBIOL, V9, P869, DOI 10.1111/j.1462-2920.2006.01206.x; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39; Bogosian G, 2001, EMBO REP, V2, P770, DOI 10.1093/embo-reports/kve182; Caruso P, 2005, APPL ENVIRON MICROB, V71, P140, DOI 10.1128/AEM.71.1.140-148.2005; Chattopadhyay MK, 2011, CURR MICROBIOL, V62, P544, DOI 10.1007/s00284-010-9742-y; Colburn-Clifford JM, 2010, APPL ENVIRON MICROB, V76, P7392, DOI 10.1128/AEM.01742-10; Cook KL, 1997, MICROBIAL ECOL, V34, P237, DOI 10.1007/s002489900053; Coutard F, 2007, ISME J, V1, P111, DOI 10.1038/ismej.2007.1; Ellis RJ, 2004, J MICROBIOL METH, V56, P287, DOI 10.1016/j.mimet.2003.10.005; Fera MT, 2008, APPL ENVIRON MICROB, V74, P3266, DOI 10.1128/AEM.00059-08; Flavier AB, 1998, MOL MICROBIOL, V28, P475, DOI 10.1046/j.1365-2958.1998.00804.x; Flavier AB, 1997, J BACTERIOL, V179, P7089, DOI 10.1128/jb.179.22.7089-7097.1997; Flores-Cruz Z, 2011, APPL ENVIRON MICROB, V77, P64236; Ghezzi JI, 1999, FEMS MICROBIOL ECOL, V30, P203, DOI 10.1111/j.1574-6941.1999.tb00648.x; Gonzalez-Escalona N, 2006, ENVIRON MICROBIOL, V8, P658, DOI 10.1111/j.1462-2920.2005.00943.x; Grey BE, 2001, APPL ENVIRON MICROB, V67, P3866, DOI 10.1128/AEM.67.9.3866-3872.2001; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Imazaki I, 2010, J GEN PLANT PATHOL, V76, P52, DOI 10.1007/s10327-009-0208-7; Imazaki I, 2009, J GEN PLANT PATHOL, V75, P213, DOI 10.1007/s10327-009-0166-0; Jeong Y, 2007, PLANT DIS, V91, P1277, DOI 10.1094/PDIS-91-10-1277; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Makino SI, 2000, APPL ENVIRON MICROB, V66, P5536, DOI 10.1128/AEM.66.12.5536-5539.2000; Mizunoe Y, 1999, ARCH MICROBIOL, V172, P63, DOI 10.1007/s002030050741; Nieman JKC, 2005, ARCH ENVIRON CON TOX, V49, P283, DOI 10.1007/s00244-004-0138-5; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; OLIVER JD, 1991, APPL ENVIRON MICROB, V57, P2640, DOI 10.1128/AEM.57.9.2640-2644.1991; Ordax M, 2006, APPL ENVIRON MICROB, V72, P3482, DOI 10.1128/AEM.72.5.3482-3488.2006; Reissbrodt R, 2002, APPL ENVIRON MICROB, V68, P4788, DOI 10.1128/AEM.68.10.4788-4794.2002; RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801, DOI 10.1128/AEM.58.6.1801-1808.1992; Saddler GS, 2005, MANAGEMENT BACTERIAL, P121; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Taskin B, 2011, APPL ENVIRON MICROB, V77, P4329, DOI 10.1128/AEM.02895-10; Um HY, 2013, PLANT PATHOLOGY J, V29, P374, DOI 10.5423/PPJ.OA.07.2013.0067; van Elsas JD, 2000, PHYTOPATHOLOGY, V90, P1358, DOI 10.1094/PHYTO.2000.90.12.1358; van Elsas JD, 2001, CAN J MICROBIOL, V47, P842, DOI 10.1139/cjm-47-9-842; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241; WALLIS FM, 1978, PHYSIOL PLANT PATHOL, V13, P307, DOI 10.1016/0048-4059(78)90047-4; Wong HC, 2004, FEMS MICROBIOL LETT, V233, P269, DOI 10.1111/j.1574-6968.2004.tb09491.x; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; Zhong L, 2009, LETT APPL MICROBIOL, V48, P247, DOI 10.1111/j.1472-765X.2008.02522.x; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	54	26	29	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109792	10.1371/journal.pone.0109792	http://dx.doi.org/10.1371/journal.pone.0109792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296177	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000094
J	Alexander, BE; Liebrand, K; Osinga, R; van der Geest, HG; Admiraal, W; Cleutjens, JPM; Schutte, B; Verheyen, F; Ribes, M; van Loon, E; de Goeij, JM				Alexander, Brittany E.; Liebrand, Kevin; Osinga, Ronald; van der Geest, Harm G.; Admiraal, Wim; Cleutjens, Jack P. M.; Schutte, Bert; Verheyen, Fons; Ribes, Marta; van Loon, Emiel; de Goeij, Jasper M.			Cell Turnover and Detritus Production in Marine Sponges from Tropical and Temperate Benthic Ecosystems	PLOS ONE			English	Article							STEM-CELLS; TISSUE HOMEOSTASIS; IN-VITRO; DEMOSPONGIAE; KINETICS; CYCLE; DIFFERENTIATION; PROLIFERATION; REGENERATION; CULTIVATION	This study describes in vivo cell turnover (the balance between cell proliferation and cell loss) in eight marine sponge species from tropical coral reef, mangrove and temperate Mediterranean reef ecosystems. Cell proliferation was determined through the incorporation of 5-bromo-2'-deoxyuridine (BrdU) and measuring the percentage of BrdU-positive cells after 6 h of continuous labeling (10 h for Chondrosia reniformis). Apoptosis was identified using an antibody against active caspase-3. Cell loss through shedding was studied quantitatively by collecting and weighing sponge-expelled detritus and qualitatively by light microscopy of sponge tissue and detritus. All species investigated displayed substantial cell proliferation, predominantly in the choanoderm, but also in the mesohyl. The majority of coral reef species (five) showed between 16.1 +/- 15.9% and 19.0 +/- 2.0% choanocyte proliferation (mean +/- SD) after 6 h and the Mediterranean species, C. reniformis, showed 16.6 +/- 3.2% after 10 h BrdU-labeling. Monanchora arbuscula showed lower choanocyte proliferation (8.1 +/- 3.7%), whereas the mangrove species Mycale microsigmatosa showed relatively higher levels of choanocyte proliferation (70.5 +/- 6.6%). Choanocyte proliferation in Haliclona vansoesti was variable (2.8-73.1%). Apoptosis was negligible and not the primary mechanism of cell loss involved in cell turnover. All species investigated produced significant amounts of detritus (2.5-18% detritus bodyweight(-1) d(-1)) and cell shedding was observed in seven out of eight species. The amount of shed cells observed in histological sections may be related to differences in residence time of detritus within canals. Detritus production could not be directly linked to cell shedding due to the degraded nature of expelled cellular debris. We have demonstrated that under steady-state conditions, cell turnover through cell proliferation and cell shedding are common processes to maintain tissue homeostasis in a variety of sponge species from different ecosystems. Cell turnover is hypothesized to be the main underlying mechanism producing sponge-derived detritus, a major trophic resource transferred through sponges in benthic ecosystems, such as coral reefs.	[Alexander, Brittany E.; Liebrand, Kevin; van der Geest, Harm G.; Admiraal, Wim; de Goeij, Jasper M.] Univ Amsterdam, Dept Aquat Ecol & Ecotoxicol, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Alexander, Brittany E.; Osinga, Ronald; de Goeij, Jasper M.] Porifarma BV Poelbos 3, Ede, Netherlands; [Cleutjens, Jack P. M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Schutte, Bert] Maastricht Univ, Res Inst Growth & Dev, Dept Mol Cell Biol, Maastricht, Netherlands; [Verheyen, Fons] CRISP, Electron Microscopy Unit, Maastricht, Netherlands; [Ribes, Marta] Inst Ciencies Mar Consejo Super Invest, Barcelona, Spain; [van Loon, Emiel] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Computat Geoecol, Amsterdam, Netherlands	University of Amsterdam; Maastricht University; Maastricht University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Amsterdam	Alexander, BE (corresponding author), Univ Amsterdam, Dept Aquat Ecol & Ecotoxicol, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	B.E.Alexander@uva.nl	Cleutjens, Jack P.M./F-6242-2012; van Loon, Emiel/T-3858-2019; Ribes, Marta/B-2495-2013; de Goeij, Jasper/L-6992-2017	Cleutjens, Jack P.M./0000-0002-4346-1785; van Loon, Emiel/0000-0002-8895-0427; Ribes, Marta/0000-0001-9747-295X; Alexander, Brittany/0000-0003-4626-4872; de Goeij, Jasper/0000-0002-3411-3084	European Union Seventh Framework Programme(FP7) [KBBE-2010-266033]; Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI) [863.10.009]; Spanish Government [CGL2010-18466]	European Union Seventh Framework Programme(FP7); Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI); Spanish Government(Spanish GovernmentEuropean Commission)	Porifarma B.V. received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. KBBE-2010-266033 to undertake the research leading to these results. Funding was also received from The Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI; 863.10.009; personal grant to JMdG). Mediterranean sampling was partially funded by the grant CGL2010-18466 from the Spanish Government to MR. BEA, RO, and JMdG are affiliated with Porifarma B.V. Porifarma B.V. provided support in the form of salaries for authors BEA, RO, and JMdG, but no employees of Porifarma B.V. other than BEA, RO, and JMdG had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALDEWACHI HS, 1975, J ANAT, V119, P105; AYLING AL, 1983, BIOL BULL, V165, P343, DOI 10.2307/1541200; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Chaudhary M, 2000, DIGESTION, V61, P223, DOI 10.1159/000007762; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; De Goeij JM, 2009, J EXP BIOL, V212, P3892, DOI 10.1242/jeb.034561; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Ellison AM, 1996, ECOLOGY, V77, P2431, DOI 10.2307/2265744; Funayama N, 2013, DEV GENES EVOL, V223, P23, DOI 10.1007/s00427-012-0417-5; GOODLAD RA, 1987, CLIN SCI, V72, P297, DOI 10.1042/cs0720297; Granek EF, 2009, ECOSYSTEMS, V12, P462, DOI 10.1007/s10021-009-9235-7; Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hunting ER, 2010, B MAR SCI, V86, P871, DOI 10.5343/bms.2010.1001; Kenward MG, 2009, COMPUT STAT DATA AN, V53, P2583, DOI 10.1016/j.csda.2008.12.013; Koopmans M, 2011, MAR BIOL, V158, P9, DOI 10.1007/s00227-010-1538-x; Lee Y., 2006, GEN LINEAR MODELS RA; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Luter HM, 2012, HYDROBIOLOGIA, V687, P227, DOI 10.1007/s10750-011-0887-x; Maldonado M, 2012, ADV MAR BIOL, V62, P113, DOI 10.1016/B978-0-12-394283-8.00003-5; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mueller B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090152; Muller WEG, 1998, NATURWISSENSCHAFTEN, V85, P11, DOI 10.1007/s001140050444; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; REISWIG H M, 1981, Marine Ecology, V2, P273, DOI 10.1111/j.1439-0485.1981.tb00271.x; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Ribes M, 1999, MAR ECOL PROG SER, V176, P179, DOI 10.3354/meps176179; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Schippers KJ, 2012, ADV MAR BIOL, V62, P273, DOI 10.1016/B978-0-12-394283-8.00006-0; Schippers KJ, 2011, IN VITRO CELL DEV-AN, V47, P302, DOI 10.1007/s11626-011-9391-x; SCHMIDT T, 1986, J CELL SCI, V85, P197; SHORE RE, 1971, J EXP ZOOL, V177, P359, DOI 10.1002/jez.1401770310; Simpson T., 1984, CELL BIOL SPONGES; Sipkema D, 2006, MAR BIOTECHNOL, V8, P40, DOI 10.1007/s10126-005-5002-8; Sun LM, 2007, CELL TISSUE RES, V328, P223, DOI 10.1007/s00441-006-0342-x; TANAKA K, 1984, ZOOL SCI, V1, P561; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Tepsuporn S, 2003, BIOL BULL-US, V205, P199, DOI 10.2307/1543251; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Vacelet J., 1987, EUROPEAN CONTRIBUTIO, P5; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Weissenfels N, 1976, ZOOMORPHOLOGY, P73; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Wiens M, 2006, CAN J ZOOL, V84, P307, DOI 10.1139/Z05-165; Witte U, 1997, MAR ECOL PROG SER, V154, P241, DOI 10.3354/meps154241; Wong WM, 1999, J CLIN PATHOL, V52, P321, DOI 10.1136/jcp.52.5.321; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141	56	60	61	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109486	10.1371/journal.pone.0109486	http://dx.doi.org/10.1371/journal.pone.0109486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289641	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000065
J	Liu, Z; Que, FX; Liao, L; Zhou, M; You, LX; Zhao, Q; Li, YY; Niu, H; Wu, SY; Huang, R				Liu, Zhen; Que, Fengxia; Liao, Li; Zhou, Min; You, Lixiang; Zhao, Qing; Li, Yuanyuan; Niu, Hua; Wu, Shuyan; Huang, Rui			Study on the Promotion of Bacterial Biofilm Formation by a Salmonella Conjugative Plasmid and the Underlying Mechanism	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; VIRULENCE; GENE; RESISTANCE; MULTIPLE	To investigate the effect of the pR(ST98) plasmid, originally isolated from Salmonella enterica serovar Typhi (S. Typhi), on biofilm (BF) formation, we carried out in vitro experiments using S. Typhi, Salmonella enterica serovar Typhimurium (S. Typhimurium) and Escherichia coli (E. coli). We further explored the effects of pR(ST98) in vivo by establishing two animal models, a tumor-bearing mouse model and a mouse urethral catheter model. Moreover, we examined the relationship between the quorum-sensing (QS) system and pR(ST98)-mediated BF formation. These studies showed that pR(ST98) enhanced BF formation in different bacteria in vitro. In both animal models, pR(ST98) promoted BF formation and caused more severe pathological changes. It was previously reported that Salmonella senses exogenous N-acylhomoserine lactones (AHLs) through the regulatory protein SdiA and regulates the expression of genes including the virulence gene rck, which is located on the virulence plasmid of some serotypes of Salmonella. In this study, we confirmed the locus of the rck gene on pR(ST98) and found that AHLs increased rck expression in pR(ST98)-carrying strains, thereby enhancing bacterial adherence, serum resistance and bacterial BF formation. In conclusion, the Salmonella conjugative plasmid pR(ST98) promotes bacterial BF formation both in vitro and in vivo, and the mechanism may relate to the AHL-SdiA-Rck signaling pathway.	[Liu, Zhen; Que, Fengxia; Liao, Li; Zhou, Min; You, Lixiang; Zhao, Qing; Li, Yuanyuan; Niu, Hua; Wu, Shuyan; Huang, Rui] Soochow Univ, Coll Med, Suzhou, Peoples R China	Soochow University - China	Wu, SY (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	hruisdm@163.com; shuyanzw@aliyun.com		Niu, Hua/0000-0002-6860-2599	Natural Science Foundation of P. R. China [30972768]; Special Research Fund for the Doctoral Program of High Education [20103201110009]; Natural Science Foundation of Jiangsu province [BK2011286]; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents	Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Special Research Fund for the Doctoral Program of High Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents	This study was supported by the Natural Science Foundation of P. R. China (No. 30972768), Special Research Fund for the Doctoral Program of High Education (No. 20103201110009), Natural Science Foundation of Jiangsu province (No. BK2011286), and sponsored by Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Cann SAH, 2003, POSTGRAD MED J, V79, P672; Chu Y, 2014, MICROBES INFECT; Cooley W.B., 1893, AM J MED SCI, V105, P487, DOI [10.1097/00000441-189305000-00001, DOI 10.1097/00000441-189305000-00001]; Crull K, 2011, CELL MICROBIOL, V13, P1223, DOI 10.1111/j.1462-5822.2011.01612.x; D'Alvise PW, 2010, FEMS MICROBIOL LETT, V312, P84, DOI 10.1111/j.1574-6968.2010.02105.x; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; He X, 2011, FEMS MICROBIOL LETT, V325, P180, DOI 10.1111/j.1574-6968.2011.02429.x; HEFFERNAN EJ, 1992, J BACTERIOL, V174, P84, DOI 10.1128/jb.174.1.84-91.1992; HEFFERNAN EJ, 1992, J CLIN INVEST, V90, P953, DOI 10.1172/JCI115972; Ho DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027546; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Howe K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-197; Huang R, 2005, CELL MOL IMMUNOL, V2, P136; Huang Rui, 2001, Zhonghua Weishengwuxue He Mianyixue Zazhi, V21, P302; Huang Rui, 2000, Zhonghua Weishengwuxue He Mianyixue Zazhi, V20, P323; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kasinskas RW, 2007, CANCER RES, V67, P3201, DOI 10.1158/0008-5472.CAN-06-2618; Lee JT, 2009, APPL ENVIRON MICROB, V75, P1703, DOI 10.1128/AEM.02081-08; Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; May T, 2008, J BACTERIOL, V190, P7479, DOI 10.1128/JB.00823-08; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ong CLY, 2009, APPL ENVIRON MICROB, V75, P6783, DOI 10.1128/AEM.00974-09; Roder HL, 2013, FEMS MICROBIOL LETT, V344, P186, DOI 10.1111/1574-6968.12175; Savage VJ, 2013, ANTIMICROB AGENTS CH, V57, P1968, DOI 10.1128/AAC.02008-12; Steenackers H, 2012, FOOD RES INT, V45, P502, DOI 10.1016/j.foodres.2011.01.038; Teodosio JS, 2012, J APPL MICROBIOL, V113, P373, DOI 10.1111/j.1365-2672.2012.05332.x; Wang R, 2013, J FOOD PROTECT, V76, P1513, DOI 10.4315/0362-028X.JFP-13-077; Wu SY, 2014, FRONT BIOSCI-LANDMRK, V19, P490, DOI 10.2741/4220; Yang XO, 2008, APPL ENVIRON MICROB, V74, P2690, DOI 10.1128/AEM.02809-07; Zautner AE, 2013, EUR J MICROBIOL IMMU, V3, P204, DOI 10.1556/EuJMI.3.2013.3.9	38	20	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109808	10.1371/journal.pone.0109808	http://dx.doi.org/10.1371/journal.pone.0109808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299072	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200075
J	Firman, RC; Simmons, LW				Firman, Renee C.; Simmons, Leigh W.			No Evidence of Conpopulation Sperm Precedence between Allopatric Populations of House Mice	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; GAMETE RECOGNITION; ADAPTIVE EVOLUTION; RAPID EVOLUTION; MUS-MUSCULUS; FERTILIZATION; COMPETITION; GENUS; COEVOLUTION; MATURATION	Investigations into the evolution of reproductive barriers have traditionally focused on closely related species, and the prevalence of conspecific sperm precedence. The effectiveness of conspecific sperm precedence at limiting gene exchange between species suggests that gametic isolation is an important component of reproductive isolation. However, there is a paucity of tests for evidence of sperm precedence during the earlier stages of divergence, for example among isolated populations. Here, we sourced individuals from two allopatric populations of house mice (Mus domesticus) and performed competitive in vitro fertilisation assays to test for conpopulation sperm precedence specifically at the gametic level. We found that ova population origin did not influence the outcome of the sperm competitions, and thus provide no evidence of conpopulation or heteropopulation sperm precedence. Instead, we found that males from a population that had evolved under a high level of postcopulatory sexual selection consistently outcompeted males from a population that had evolved under a relatively lower level of postcopulatory sexual selection. We standardised the number of motile sperm of each competitor across the replicate assays. Our data therefore show that competitive fertilizing success was directly attributable to differences in sperm fertilizing competence.	[Firman, Renee C.; Simmons, Leigh W.] Univ Western Australia, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia	University of Western Australia	Firman, RC (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia.	renee.firman@uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Ian, 1995, CALMScience, V1, P259; Albuquerque GS, 1996, EVOLUTION, V50, P1598, DOI 10.1111/j.1558-5646.1996.tb03932.x; BIDDLE FG, 1987, GENOME, V29, P389, DOI 10.1139/g87-067; Birkhead TR, 1995, P ROY SOC B-BIOL SCI, V262, P329, DOI 10.1098/rspb.1995.0213; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Boschetto C, 2011, BEHAV ECOL SOCIOBIOL, V65, P813, DOI 10.1007/s00265-010-1085-y; BRITTON J, 1978, BIOCHEM GENET, V16, P213, DOI 10.1007/BF00484079; Brown DV, 2001, EVOLUTION, V55, P2257, DOI 10.1111/j.0014-3820.2001.tb00740.x; Chang AS, 2004, EVOLUTION, V58, P781; Dean MD, 2008, MOL BIOL EVOL, V25, P383, DOI 10.1093/molbev/msm265; Dean MD, 2009, EVOLUTION, V63, P20, DOI 10.1111/j.1558-5646.2008.00499.x; Dixon SM, 2003, MOL ECOL, V12, P1179, DOI 10.1046/j.1365-294X.2003.01742.x; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Firman RC, 2014, P R SOC B, V280; Firman RC, 2008, BEHAV ECOL, V19, P695, DOI 10.1093/beheco/arm158; Firman RC, 2014, AM NAT, V183, P565, DOI 10.1086/675395; Firman RC, 2014, BEHAV ECOL SOCIOBIOL, V68, P283, DOI 10.1007/s00265-013-1643-1; Firman RC, 2013, EVOLUTION, V67, P3061, DOI 10.1111/evo.12164; Firman RC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-19; Fricke C, 2004, ANIM BEHAV, V67, P729, DOI 10.1016/j.anbehav.2003.08.014; Fry CL, 2004, EVOLUTION, V58, P1622, DOI 10.1111/j.0014-3820.2004.tb01743.x; Gasparini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012146; Geyer LB, 2005, EVOLUTION, V59, P97; Gilbert S., 1997, DEV BIOL; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; GREGORY PG, 1994, EVOLUTION, V48, P705, DOI [10.2307/2410480, 10.1111/j.1558-5646.1994.tb01355.x]; Hosken DJ, 2002, P ROY SOC B-BIOL SCI, V269, P1701, DOI 10.1098/rspb.2002.2094; Hosken DJ, 2001, CURR BIOL, V11, P489, DOI 10.1016/S0960-9822(01)00146-4; Howard DJ, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P367, DOI 10.1016/B978-0-12-372568-4.00009-4; HOWARD DJ, 1993, PHILOS T ROY SOC B, V340, P231, DOI 10.1098/rstb.1993.0062; LAMBERT H, 1984, J REPROD FERTIL, V70, P281, DOI 10.1530/jrf.0.0700281; Levitan DR, 2002, EVOLUTION, V56, P1599, DOI 10.1111/j.0014-3820.2002.tb01472.x; Ludlow AM, 2006, P ROY SOC B-BIOL SCI, V273, P2477, DOI 10.1098/rspb.2006.3605; Martin-Coello J, 2008, THERIOGENOLOGY, V70, P1004, DOI 10.1016/j.theriogenology.2008.06.002; Martin-Coello J, 2009, EVOLUTION, V63, P613, DOI 10.1111/j.1558-5646.2008.00585.x; Mayr E, 1942, SYSTEMATICS ORIGIN S; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; PALUMBI SR, 1991, MOL BIOL EVOL, V8, P227; Parker GA, 1998, SEXUAL SELECTION REP, P123; Price CSC, 1997, NATURE, V388, P663, DOI 10.1038/41753; Price CSC, 2001, EVOLUTION, V55, P81, DOI 10.1111/j.0014-3820.2001.tb01274.x; R Core Development Team, 2011, R LANG ENV STAT COMP; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; ROLDAN ERS, 1989, J EXP ZOOL, V250, P321, DOI 10.1002/jez.1402500312; Rowe L, 2003, P ROY SOC B-BIOL SCI, V270, P2009, DOI 10.1098/rspb.2003.2453; Simmons L. W., 2001, MG BEH ECOL; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Tyler F, 2013, MOL ECOL, V22, P1640, DOI 10.1111/mec.12187; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Wedekind C, 1996, HEREDITY, V77, P400, DOI 10.1038/hdy.1996.160; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	54	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107472	10.1371/journal.pone.0107472	http://dx.doi.org/10.1371/journal.pone.0107472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295521	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000005
J	Kurtz, SL; Chou, AY; Kubelkova, K; Cua, DJ; Elkins, KL				Kurtz, Sherry L.; Chou, Alicia Y.; Kubelkova, Klara; Cua, Daniel J.; Elkins, Karen L.			IL-23 p19 Knockout Mice Exhibit Minimal Defects in Responses to Primary and Secondary Infection with Francisella tularensis LVS	PLOS ONE			English	Article							LIVE VACCINE STRAIN; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS INFECTION; ADAPTIVE IMMUNITY; IL-12 P70; AUTOIMMUNE INFLAMMATION; INTRACELLULAR BACTERIUM; GAMMA-INTERFERON; P40 HOMODIMER; HOST-DEFENSE	Our laboratory's investigations into mechanisms of protective immunity against Francisella tularensis Live Vaccine Strain (LVS) have uncovered mediators important in host defense against primary infection, as well as those correlated with successful vaccination. One such potential correlate was IL-12p40, a pleiotropic cytokine that promotes Th1 T cell function as part of IL-12p70. LVS-infected IL-12p40 deficient knockout (KO) mice maintain a chronic infection, but IL-12p35 KO mice clear LVS infection; thus the role that IL-12p40 plays in immunity to LVS is independent of the IL-12p70 heterodimer. IL-12p40 can also partner with IL-23p19 to create the heterodimeric cytokine IL-23. Here, we directly tested the role of IL-23 in LVS resistance, and found IL-23 to be largely dispensable for immunity to LVS following intradermal or intranasal infection. IL-23p19 KO splenocytes were fully competent in controlling intramacrophage LVS replication in an in vitro overlay assay. Further, antibody responses in IL-23p19 KO mice were similar to those of normal wild type mice after LVS infection. IL-23p19 KO mice or normal wild type mice that survived primary LVS infection survived maximal doses of LVS secondary challenge. Thus p40 has a novel role in clearance of LVS infection that is unrelated to either IL-12 or IL-23.	[Kurtz, Sherry L.; Chou, Alicia Y.; Kubelkova, Klara; Elkins, Karen L.] US FDA, Ctr Biol Evaluat & Res, Div Bacterial Parasit & Allergen Prod, Lab Mycobacterial Dis & Cellular Immunol, Rockville, MD 20857 USA; [Cua, Daniel J.] Merck Res Labs, Palo Alto, CA USA	US Food & Drug Administration (FDA); Merck & Company	Elkins, KL (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Bacterial Parasit & Allergen Prod, Lab Mycobacterial Dis & Cellular Immunol, Rockville, MD 20857 USA.	Karen.elkins@fda.hhs.gov		Kurtz, Sherry/0000-0002-2281-8984	CBER/U.S. FDA; Ministry of Defence of the Czech Republic via Health Problems of Weapons of Mass Destruction [1011]	CBER/U.S. FDA; Ministry of Defence of the Czech Republic via Health Problems of Weapons of Mass Destruction	This study was funded by CBER/U.S. FDA; Klara Kubelkova was supported by the Ministry of Defence of the Czech Republic via a grant entitled Health Problems of Weapons of Mass Destruction (long-term organization development plan 1011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; Conlan JW, 2011, CURR PROTOC IMMUNOL, V93; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Elkins KL, 2011, CURR PROTOC IMMUNOL, V93, P142511; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Graeber KE, 2012, INFLAMM RES, V61, P87, DOI 10.1007/s00011-011-0419-1; Gran B, 2004, CRIT REV IMMUNOL, V24, P111, DOI 10.1615/CritRevImmunol.v24.i2.20; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Jana M, 2009, IMMUNOLOGY, V127, P312, DOI 10.1111/j.1365-2567.2008.02985.x; Jana M, 2009, MOL IMMUNOL, V46, P773, DOI 10.1016/j.molimm.2008.10.033; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lehmann J, 2001, J IMMUNOL, V167, P5304, DOI 10.4049/jimmunol.167.9.5304; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Lin Y, 2009, IMMUNITY; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Nigg AP, 2007, J IMMUNOL, V178, P7251, DOI 10.4049/jimmunol.178.11.7251; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Stenmark S, 1999, INFECT IMMUN, V67, P1789; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Wozniak TM, 2006, J IMMUNOL, V177, P8684, DOI 10.4049/jimmunol.177.12.8684; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109898	10.1371/journal.pone.0109898	http://dx.doi.org/10.1371/journal.pone.0109898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296161	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000101
J	Munyaka, P; Rabbi, MF; Pavlov, VA; Tracey, KJ; Khafipour, E; Ghia, JE				Munyaka, Pens; Rabbi, Mohammad F.; Pavlov, Valentin A.; Tracey, Kevin J.; Khafipour, Ehsan; Ghia, Jean-Eric			Central Muscarinic Cholinergic Activation Alters Interaction between Splenic Dendritic Cell and CD4(+)CD25(-) T Cells in Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; VAGUS NERVE; ANTIINFLAMMATORY PATHWAY; ULCERATIVE-COLITIS; KAPPA-B; CYTOKINES; NICOTINE; IMMUNE; EXPRESSION; IL-23	Background: The cholinergic anti-inflammatory pathway (CAP) is based on vagus nerve (VN) activity that regulates macrophage and dendritic cell responses in the spleen through alpha-7 nicotinic acetylcholine receptor (a7nAChR) signaling. Inflammatory bowel disease (IBD) patients present dysautonomia with decreased vagus nerve activity, dendritic cell and T cell over-activation. The aim of this study was to investigate whether central activation of the CAP alters the function of dendritic cells (DCs) and sequential CD4(+)/CD25(-)T cell activation in the context of experimental colitis. Methods: The dinitrobenzene sulfonic acid model of experimental colitis in C57BL/6 mice was used. Central, intracerebroventricular infusion of the M1 muscarinic acetylcholine receptor agonist McN-A-343 was used to activate CAP and vagus nerve and/or splenic nerve transection were performed. In addition, the role of alpha 7nAChR signaling and the NF-kB pathway was studied. Serum amyloid protein (SAP)-A, colonic tissue cytokines, IL-12p70 and IL-23 in isolated splenic DCs, and cytokines levels in DC-CD4(+)CD25(-)T cell co-culture were determined. Results: McN-A-343 treatment reduced colonic inflammation associated with decreased pro-inflammatory Th1/Th17 colonic and splenic cytokine secretion. Splenic DCs cytokine release was modulated through alpha 7nAChR and the NF-kB signaling pathways. Cholinergic activation resulted in decreased CD4(+)CD25(-)T cell priming. The anti-inflammatory efficacy of central cholinergic activation was abolished in mice with vagotomy or splenic neurectomy. Conclusions: Suppression of splenic immune cell activation and altered interaction between DCs and T cells are important aspects of the beneficial effect of brain activation of the CAP in experimental colitis. These findings may lead to improved therapeutic strategies in the treatment of IBD.	[Munyaka, Pens; Rabbi, Mohammad F.; Ghia, Jean-Eric] Univ Manitoba, Dept Immunol & Internal Med, Gastroenterol Sect, Winnipeg, MB, Canada; [Pavlov, Valentin A.; Tracey, Kevin J.] Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY USA; [Khafipour, Ehsan] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Ghia, Jean-Eric] Univ Manitoba, Inflammatory Bowel Dis Clin & Res Ctr, Winnipeg, MB, Canada	University of Manitoba; Northwell Health; University of Manitoba; University of Manitoba	Ghia, JE (corresponding author), Univ Manitoba, Dept Immunol & Internal Med, Gastroenterol Sect, Winnipeg, MB, Canada.	jeghia@med.umanitoba.ca	Khafipour, Ehsan/W-9803-2019; Khafipour, Ehsan/E-4140-2016	Khafipour, Ehsan/0000-0003-4673-7633; Khafipour, Ehsan/0000-0003-4673-7633; Pavlov, Valentin/0000-0002-1994-2853; Ghia, Jean-Eric/0000-0002-3018-9719; Tracey, Kevin J/0000-0003-1884-6314	Manitoba Health Research Council; Canada Foundation for Innovation; National Institute of General Medical Sciences, National Institutes of Health [R01GM057226, R01GM089807]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226, R01GM089807] Funding Source: NIH RePORTER	Manitoba Health Research Council; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Manitoba Health Research Council and the Canada Foundation for Innovation to JEG. This work was also supported by the following grants from the National Institute of General Medical Sciences, National Institutes of Health: R01GM057226 (to KJT) and R01GM089807 (to VAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Bernstein CN, 2000, AM J GASTROENTEROL, V95, P677; Bonaz B, 2013, Minerva Gastroenterol Dietol, V59, P241; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Camoglio L, 2002, EUR J IMMUNOL, V32, P261, DOI 10.1002/1521-4141(200201)32:1<261::AID-IMMU261>3.0.CO;2-X; Clarencon D, 2014, BRAIN STIMU IN PRESS; Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x; DAPOIGNY M, 1992, AM J PHYSIOL, V262, pG231, DOI 10.1152/ajpgi.1992.262.2.G231; de Baey A, 2001, EUR J IMMUNOL, V31, P1646, DOI 10.1002/1521-4141(200106)31:6<1646::AID-IMMU1646>3.0.CO;2-X; Dotan I, 2010, GUT, V59, P760, DOI 10.1136/gut.2009.179994; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG711, DOI 10.1152/ajpgi.00240.2007; Ghia JE, 2011, INFLAMM BOWEL DIS, V17, P1474, DOI 10.1002/ibd.21531; GOTTWALD TP, 1995, ADV EXP MED BIOL, V371, P303; Han X, 2007, GUT, V56, P73, DOI 10.1136/gut.2006.094490; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hasler WL, 2011, GASTROENTEROL CLIN N, V40, P21, DOI 10.1016/j.gtc.2010.12.004; Huang ST, 2005, AM J CHINESE MED, V33, P157, DOI 10.1142/S0192415X0500276X; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Ikeda Y, 2001, EUR J GASTROEN HEPAT, V13, P841, DOI 10.1097/00042737-200107000-00013; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; JOYNER K, 1993, AM J PHYSIOL, V264, pR912, DOI 10.1152/ajpregu.1993.264.5.R912; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Koval L M, 2009, Ukr Biokhim Zh (1999), V81, P5; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Kubota Y, 2001, COGNITIVE BRAIN RES, V11, P281, DOI 10.1016/S0926-6410(00)00086-0; Lee ST, 2010, BRAIN RES, V1309, P164, DOI 10.1016/j.brainres.2009.10.076; MACDERMOTT RP, 1994, MED CLIN N AM, V78, P1207, DOI 10.1016/S0025-7125(16)30096-7; Matteoli G, 2014, GUT, V63, P938, DOI 10.1136/gutjnl-2013-304676; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; Monteleone I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-122; Murugaiyan G, 2010, P NATL ACAD SCI USA, V107, P11495, DOI 10.1073/pnas.1002099107; Neurath MF, 1998, GUT, V43, P856, DOI 10.1136/gut.43.6.856; Nouri-Shirazi M, 2007, IMMUNOL LETT, V109, P155, DOI 10.1016/j.imlet.2007.02.005; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PAHLIN PE, 1976, ACTA PHYSIOL SCAND, V96, P433, DOI 10.1111/j.1748-1716.1976.tb10213.x; Paul-Labrador M, 2006, ARCH INTERN MED, V166, P1218, DOI 10.1001/archinte.166.11.1218; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Perrier C, 2011, IMMUNOTHERAPY-UK, V3, P1341, DOI [10.2217/imt.11.122, 10.2217/IMT.11.122]; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; ROSENWALD A, 1993, ACTA NEUROPATHOL, V86, P182, DOI 10.1007/BF00334887; Sakai S, 2007, AUTON NEUROSCI-BASIC, V133, P158, DOI 10.1016/j.autneu.2007.01.001; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; The FO, 2011, BRIT J PHARMACOL, V163, P1007, DOI 10.1111/j.1476-5381.2011.01296.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Valdes-Ferrer S, 2010, J IMMUNOL, V184; Van der Zanden EP, 2009, NEUROGASTROENT MOTIL, V21, P6, DOI 10.1111/j.1365-2982.2008.01252.x; Velde AAT, 2003, EUR J IMMUNOL, V33, P143, DOI 10.1002/immu.200390017; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; Vukelic M, 2013, J IMMUNOL, V191, P1800, DOI 10.4049/jimmunol.1203467; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	69	59	61	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109272	10.1371/journal.pone.0109272	http://dx.doi.org/10.1371/journal.pone.0109272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295619	Green Published, gold			2022-12-27	WOS:000345204000055
J	Smith, CA; Holahan, MR				Smith, Catherine A.; Holahan, Matthew R.			Reduced Hippocampal Dendritic Spine Density and BDNF Expression following Acute Postnatal Exposure to Di(2-Ethylhexyl) Phthalate in Male Long Evans Rats	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; SYNAPSE DENSITY; DIETHYLHEXYL PHTHALATE; SUPPRESSES ESTRADIOL; INTERNAL EXPOSURE; GONADAL-HORMONES; DENTATE GYRUS; GRANULE CELLS; IN-UTERO; TESTOSTERONE	Early developmental exposure to di(2-ethylhexyl) phthalate (DEHP) has been linked to a variety of neurodevelopmental changes, particularly in rodents. The primary goal of this work was to establish whether acute postnatal exposure to a low dose of DEHP would alter hippocampal dendritic morphology and BDNF and caspase-3 mRNA expression in male and female Long Evans rats. Treatment with DEHP in male rats led to a reduction in spine density on basal and apical dendrites of neurons in the CA3 dorsal hippocampal region compared to vehicle-treated male controls. Dorsal hippocampal BDNF mRNA expression was also down-regulated in male rats exposed to DEHP. No differences in hippocampal spine density or BDNF mRNA expression were observed in female rats treated with DEHP compared to controls. DEHP treatment did not affect hippocampal caspase-3 mRNA expression in male or female rats. These results suggest a gender-specific vulnerability to early developmental DEHP exposure in male rats whereby postnatal DEHP exposure may interfere with normal synaptogenesis and connectivity in the hippocampus. Decreased expression of BDNF mRNA may represent a molecular mechanism underlying the reduction in dendritic spine density observed in hippocampal CA3 neurons. These findings provide initial evidence for a link between developmental exposure to DEHP, reduced levels of BDNF and hippocampal atrophy in male rats.	[Smith, Catherine A.; Holahan, Matthew R.] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Smith, CA (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	catherinesmith@cmail.carleton.ca	Holahan, Matthew/GZK-5814-2022	Holahan, Matthew/0000-0001-7653-9262	National Science and Engineering Research Council of Canada [315827]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by National Science and Engineering Research Council of Canada Discovery to MRH [grant number 315827]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011; Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015; COTMAN C, 1973, BRAIN RES, V63, P205, DOI 10.1016/0006-8993(73)90089-9; Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4; Danzer SC, 2002, J NEUROSCI, V22, P9754; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Frotscher M, 2000, CEREB CORTEX, V10, P946, DOI 10.1093/cercor/10.10.946; Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909; GOULD E, 1990, J NEUROSCI, V10, P1286; Han BH, 2000, NEUROBIOL DIS, V7, P38; Hatanaka Y, 2009, BIOCHEM BIOPH RES CO, V381, P728, DOI 10.1016/j.bbrc.2009.02.130; Henze DA, 1996, J COMP NEUROL, V369, P331, DOI 10.1002/(SICI)1096-9861(19960603)369:3<331::AID-CNE1>3.0.CO;2-6; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Holahan MR, 2007, HIPPOCAMPUS, V17, P58, DOI 10.1002/hipo.20242; Horch HW, 2004, REV NEUROSCIENCE, V15, P117; Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254; Kellner Y, 2014, FRONT SYNAP IN PRESS; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270; Kovacs EG, 2003, NEUROSCIENCE, V122, P807, DOI 10.1016/j.neuroscience.2003.08.046; Leranth C, 2000, NEUROSCIENCE, V101, P349, DOI 10.1016/S0306-4522(00)00369-9; Leranth C, 2003, J NEUROSCI, V23, P1588; Leranth C, 2004, J NEUROSCI, V24, P495, DOI 10.1523/JNEUROSCI.4516-03.2004; Leranth C, 2002, J COMP NEUROL, V447, P34, DOI 10.1002/cne.10230; Li XJ, 2013, ENVIRON TOXICOL PHAR, V36, P392, DOI 10.1016/j.etap.2013.05.001; Li YF, 2010, ENVIRON TOXICOL PHAR, V29, P32, DOI 10.1016/j.etap.2009.09.003; Lin CH, 2013, GASTROENT RES PRACT, V2013, P1; Lin CH, 2011, TOXICOL LETT, V206, P245, DOI 10.1016/j.toxlet.2011.08.002; Liu ZP, 2001, J COMP NEUROL, V441, P1, DOI 10.1002/cne.1393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Mankidy R, 2013, TOXICOL LETT, V217, P50, DOI 10.1016/j.toxlet.2012.11.025; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Nguyen TVV, 2005, J NEUROCHEM, V94, P1639, DOI 10.1111/j.1471-4159.2005.03318.x; Noriega NC, 2009, TOXICOL SCI, V111, P163, DOI 10.1093/toxsci/kfp129; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Pike CJ, 1999, J NEUROCHEM, V72, P1552, DOI 10.1046/j.1471-4159.1999.721552.x; Pike CJ, 2001, BRAIN RES, V919, P160, DOI 10.1016/S0006-8993(01)03024-4; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Qiao XX, 2001, J NEUROSCI RES, V64, P268, DOI 10.1002/jnr.1075; Richburg JH, 1999, TOXICOL APPL PHARM, V160, P271, DOI 10.1006/taap.1999.8786; Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith CA, 2011, NEUROSCIENCE, V193, P100, DOI 10.1016/j.neuroscience.2011.06.082; Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Tailby C, 2005, P NATL ACAD SCI USA, V102, P4631, DOI 10.1073/pnas.0402747102; Tsurugizawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1345, DOI 10.1016/j.bbrc.2005.09.188; Witter MP, 2007, LEARN MEMORY, V14, P705, DOI 10.1101/lm.725207; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Yokoyama Y, 2003, TOXICOL LETT, V144, P371, DOI 10.1016/S0378-4274(03)00256-X; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029	63	54	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109522	10.1371/journal.pone.0109522	http://dx.doi.org/10.1371/journal.pone.0109522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295592	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000076
J	Venugopal, PD; Coffey, PL; Dively, GP; Lamp, WO				Venugopal, P. Dilip; Coffey, Peter L.; Dively, Galen P.; Lamp, William O.			Adjacent Habitat Influence on Stink Bug (Hemiptera: Pentatomidae) Densities and the Associated Damage at Field Corn and Soybean Edges	PLOS ONE			English	Article							HETEROPTERA-PENTATOMIDAE; NEZARA-VIRIDULA; POPULATION-DYNAMICS; SEASONAL ABUNDANCE; EUSCHISTUS-SERVUS; LANDSCAPE CONTEXT; COTTON; QUALITY; YIELD; DISPERSAL	The local dispersal of polyphagous, mobile insects within agricultural systems impacts pest management. In the mid-Atlantic region of the United States, stink bugs, especially the invasive Halyomorpha halys (Stal 1855), contribute to economic losses across a range of cropping systems. Here, we characterized the density of stink bugs along the field edges of field corn and soybean at different study sites. Specifically, we examined the influence of adjacent managed and natural habitats on the density of stink bugs in corn and soybean fields at different distances along transects from the field edge. We also quantified damage to corn grain, and to soybean pods and seeds, and measured yield in relation to the observed stink bug densities at different distances from field edge. Highest density of stink bugs was limited to the edge of both corn and soybean fields. Fields adjacent to wooded, crop and building habitats harbored higher densities of stink bugs than those adjacent to open habitats. Damage to corn kernels and to soybean pods and seeds increased with stink bug density in plots and was highest at the field edges. Stink bug density was also negatively associated with yield per plant in soybean. The spatial pattern of stink bugs in both corn and soybeans, with significant edge effects, suggests the use of pest management strategies for crop placement in the landscape, as well as spatially targeted pest suppression within fields.	[Venugopal, P. Dilip; Coffey, Peter L.; Dively, Galen P.; Lamp, William O.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Venugopal, PD (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	venugopal.dilip@gmail.com	Lamp, William/G-6081-2015	Lamp, William/0000-0002-8565-1560; Venugopal, Dilip/0000-0001-6339-5087	United Soybean Board; Maryland Soybean Board; Maryland Grain Producers Utilization Board; Cosmos Club Foundation; Northeast Sustainable Agriculture Research and Education - Graduate Student grant [GNE-12-047]; Arthur B. Gahan Fellowship, Dept. of Entomology, Univ. of Maryland; United States Department of Agriculture - National Institute of Food & Agriculture Hatch Project [MD-ENTM-1016]; UMD Libraries Open Access Publishing Fund	United Soybean Board; Maryland Soybean Board; Maryland Grain Producers Utilization Board; Cosmos Club Foundation; Northeast Sustainable Agriculture Research and Education - Graduate Student grant; Arthur B. Gahan Fellowship, Dept. of Entomology, Univ. of Maryland; United States Department of Agriculture - National Institute of Food & Agriculture Hatch Project; UMD Libraries Open Access Publishing Fund	This work is supported by the United Soybean Board, http://unitedsoybean.org/ (GPD PDV); Maryland Soybean Board, http://mdsoy.com/ (GPD); Maryland Grain Producers Utilization Board, http://www.marylandgrain.com/ (GPD); Cosmos Club Foundation, http://www.cosmosclubfoundation.org/ (PDV); Northeast Sustainable Agriculture Research and Education - Graduate Student grant - GNE-12-047, http://www.nesare.org/ (PDV, WOL, GPD); Arthur B. Gahan Fellowship, Dept. of Entomology, Univ. of Maryland, http://entomology.umd.edu/academics/graduate/awardopportunities/gahanfellowshipfund (PDV); and United States Department of Agriculture - National Institute of Food & Agriculture Hatch Project #MD-ENTM-1016, http://www.csrees.usda.gov/ (WOL). Funding for Open Access provided by the UMD Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K., 2013, MUMIN MULTIMODEL INT; Bates D., 2013, LME4 LINEAR MIXED EF; BMSB IPM Working Group & Northeastern IPM Center, 2013, HOST PLANTS BROWN MA; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRIER HB, 1991, J AUST ENTOMOL SOC, V30, P123; CABI, 2014, INVASIVE SPECIES COM; CLARKE RG, 1971, J ECON ENTOMOL, V64, P222, DOI 10.1093/jee/64.1.222; Correa-Ferreira BS, 2002, AGR FOREST ENTOMOL, V4, P145, DOI 10.1046/j.1461-9563.2002.00136.x; DAUGHERTY DM, 1964, J ECON ENTOMOL, V57, P719, DOI 10.1093/jee/57.5.719; Ekbom B., 2000, INTERCHANGES INSECTS; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fox J, 2013, EFFECTS EFFECT DISPL; HANWAY JJ, 1963, AGRON J, V55, P487, DOI 10.2134/agronj1963.00021962005500050024x; Harrell FE, 2013, RMS REGRESSION MODEL; Herbert JJ, 2011, ANN ENTOMOL SOC AM, V104, P909, DOI 10.1603/AN11060; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hooks CRR, 2011, AGRON NEWS, V2, P1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JONES WA, 1982, ENVIRON ENTOMOL, V11, P867, DOI 10.1093/ee/11.4.867; Kennedy G. G., 1985, Bulletin of the Entomological Society of America, V31, P21; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Kery M., 2010, INTRO WINBUGS ECOLOG; Kuhn M., 2013, CONTRAST COLLECTION; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; MCPHERSON RM, 1979, J ECON ENTOMOL, V72, P188, DOI 10.1093/jee/72.2.188; MCPHERSON RM, 1993, J ENTOMOL SCI, V28, P61, DOI 10.18474/0749-8004-28.1.61; Medrano EG, 2009, CURR MICROBIOL, V59, P405, DOI 10.1007/s00284-009-9452-5; Mitchell PL, 2004, NEOTROP ENTOMOL, V33, P519, DOI 10.1590/S1519-566X2004000500001; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NEGRON JF, 1987, J ECON ENTOMOL, V80, P666, DOI 10.1093/jee/80.3.666; Nestel D, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P45; Ni XZ, 2010, J ECON ENTOMOL, V103, P2072, DOI 10.1603/EC09301; Nielsen AL, 2011, ENVIRON ENTOMOL, V40, P231, DOI 10.1603/EN10187; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Olson DM, 2011, ENTOMOL EXP APPL, V139, P161, DOI 10.1111/j.1570-7458.2011.01116.x; Outward R, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.0901; Owens DR, 2013, J ECON ENTOMOL, V106, P1317, DOI 10.1603/EC12488; PANIZZI AR, 1985, FLA ENTOMOL, V68, P184, DOI 10.2307/3494344; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Pease CG, 2010, J APPL ENTOMOL, V134, P626, DOI 10.1111/j.1439-0418.2009.01452.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reay-Jones FPF, 2010, ENVIRON ENTOMOL, V39, P944, DOI 10.1603/EN09274; Reeves RB, 2010, ENVIRON ENTOMOL, V39, P1420, DOI 10.1603/EN09194; Reisig DD, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.16801; SCHUMANN FW, 1982, J ECON ENTOMOL, V75, P748, DOI 10.1093/jee/75.4.748; STINNER RE, 1983, ANNU REV ENTOMOL, V28, P319, DOI 10.1146/annurev.en.28.010183.001535; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; Tillman PG, 2011, ENVIRON ENTOMOL, V40, P1159, DOI 10.1603/EN10243; Tillman PG, 2009, ENVIRON ENTOMOL, V38, P1038, DOI 10.1603/022.038.0411; Tillman PG, 2010, ENVIRON ENTOMOL, V39, P1765, DOI 10.1603/EN09281; TODD JW, 1974, J ECON ENTOMOL, V67, P421, DOI 10.1093/jee/67.3.421; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; Toews MD, 2009, J ECON ENTOMOL, V102, P1515, DOI 10.1603/029.102.0416; TOSCANO NC, 1976, J ECON ENTOMOL, V69, P96, DOI 10.1093/jee/69.1.96; Tscharntke T, 2005, ANN ZOOL FENN, V42, P421; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; USDA National Agricultural Statistics Service, 2014, CROP PRODUCTION; WALTERS H J, 1980, Plant Disease, V64, P961, DOI 10.1094/PD-64-961; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zuur Alain F., 2009, P1	64	65	65	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109917	10.1371/journal.pone.0109917	http://dx.doi.org/10.1371/journal.pone.0109917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295593	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000104
J	Yen, ZH; Dai, CL; Feng, HS; Liu, YF; Wang, SL				Yen, Zhihu; Dai, Caili; Feng, Haishun; Liu, Yifei; Wang, Shilu			Study of the Formation and Solution Properties of Worm-Like Micelles Formed Using Both N-Hexadecyl-N-Methylpiperidinium Bromide-Based Cationic Surfactant and Anionic Surfactant	PLOS ONE			English	Article							IONIC LIQUID; LIVING POLYMERS; DYNAMICS; SYSTEMS; MIXTURES; RHEOLOGY; CRYSTALS; ENERGY	The viscoelastic properties of worm-like micelles formed by mixing the cationic surfactant N-hexadecyl-N-methylpiperidinium bromide (C16MDB) with the anionic surfactant sodium laurate (SL) in aqueous solutions were investigated using rheological measurements. The effects of sodium laurate and temperature on the worm-like micelles and the mechanism of the observed shear thinning phenomenon and pseudoplastic behavior were systematically investigated. Additionally, cryogenic transmission electron microscopy images further ascertained existence of entangled worm-like micelles.	[Yen, Zhihu; Dai, Caili; Feng, Haishun; Liu, Yifei; Wang, Shilu] China Univ Petr Huadong, Sch Petr Engn, Qingdao, Peoples R China	China University of Petroleum	Yen, ZH (corresponding author), China Univ Petr Huadong, Sch Petr Engn, Qingdao, Peoples R China.	zhihuyan@126.com; daicl306@163.com		Dai, Cai li/0000-0002-7477-8865	National Natural Science Foundation of China [51174221, 21303268]; Program for New Century Excellent Talents in University [20110226]; China Postdoctoral Science Foundation [2013T60689]; National Ministry of Education [20120133110010]; Fundamental Research Funds for the Central Universities [14CX02041A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by National Natural Science Foundation of China (51174221, 21303268), the Program for New Century Excellent Talents in University (20110226), China Postdoctoral Science Foundation funded project (2013T60689), Doctoral Fund from National Ministry of Education (No. 20120133110010) and the Fundamental Research Funds for the Central Universities (14CX02041A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araos MU, 2005, J PHYS CHEM B, V109, P14275, DOI 10.1021/jp052862y; CANDAU SJ, 1988, J COLLOID INTERF SCI, V122, P430, DOI 10.1016/0021-9797(88)90377-3; Cates ME, 2006, ADV PHYS, V55, P799, DOI 10.1080/00018730601082029; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; CATES ME, 1988, J PHYS-PARIS, V49, P1593, DOI 10.1051/jphys:019880049090159300; Couillet I, 2004, LANGMUIR, V20, P9541, DOI 10.1021/la049046m; Dreiss CA, 2007, SOFT MATTER, V3, P956, DOI 10.1039/b705775j; Forster S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.017803; Gonzalez YI, 2005, CURR OPIN COLLOID IN, V10, P256, DOI 10.1016/j.cocis.2005.09.007; GRANEK R, 1992, J CHEM PHYS, V96, P4758, DOI 10.1063/1.462787; Lava K, 2009, J PHYS CHEM B, V113, P9506, DOI 10.1021/jp903667e; Lin Z, 1996, LANGMUIR, V12, P1729, DOI 10.1021/la950570q; Lu JM, 2009, PROG POLYM SCI, V34, P431, DOI 10.1016/j.progpolymsci.2008.12.001; Manero O, 2002, J NON-NEWTON FLUID, V106, P1, DOI 10.1016/S0377-0257(02)00082-4; Peters JE, 2008, MACROMOLECULES, V41, P7274, DOI 10.1021/ma8011569; Raghavan SR, 2002, LANGMUIR, V18, P3797, DOI 10.1021/la0115583; Razak NA, 2013, RHEOL ACTA, V52, P927, DOI 10.1007/s00397-013-0731-5; REHAGE H, 1988, J PHYS CHEM-US, V92, P4712, DOI 10.1021/j100327a031; Samuel MM, 1999, SPE DRILL COMPLETION, V14, P240, DOI 10.2118/59478-PA; SHINODA K, 1987, LANGMUIR, V3, P135, DOI 10.1021/la00074a001; Snyder SA, 2003, ENVIRON ENG SCI, V20, P449, DOI 10.1089/109287503768335931; UCHEGBU IF, 1995, ADV COLLOID INTERFAC, V58, P1, DOI 10.1016/0001-8686(95)00242-I; Varade D, 2005, COLLOID SURFACE A, V259, P95, DOI 10.1016/j.colsurfa.2005.02.018; Zhao GX, 1996, J COLLOID INTERF SCI, V177, P513, DOI 10.1006/jcis.1996.0065; Zhao MW, 2011, PHYS CHEM CHEM PHYS, V13, P1332, DOI 10.1039/c0cp00342e; Zhao YR, 2009, J PHYS CHEM B, V113, P983, DOI 10.1021/jp809048u	26	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110155	10.1371/journal.pone.0110155	http://dx.doi.org/10.1371/journal.pone.0110155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296131	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000115
J	Zacharopoulos, G; Binetti, N; Walsh, V; Kanai, R				Zacharopoulos, George; Binetti, Nicola; Walsh, Vincent; Kanai, Ryota			The Effect of Self-Efficacy on Visual Discrimination Sensitivity	PLOS ONE			English	Article							ATTRIBUTION; CONCEPTIONS; PERFORMANCE; MECHANISMS; ABILITY	Can subjective belief about one's own perceptual competence change one's perception? To address this question, we investigated the influence of self-efficacy on sensory discrimination in two low-level visual tasks: contrast and orientation discrimination. We utilised a pre-post manipulation approach whereby two experimental groups (high and low self-efficacy) and a control group made objective perceptual judgments on the contrast or the orientation of the visual stimuli. High and low self-efficacy were induced by the provision of fake social-comparative performance feedback and fictional research findings. Subsequently, the post-manipulation phase was performed to assess changes in visual discrimination thresholds as a function of the self-efficacy manipulations. The results showed that the high self-efficacy group demonstrated greater improvement in visual discrimination sensitivity compared to both the low self-efficacy and control groups. These findings suggest that subjective beliefs about one's own perceptual competence can affect low-level visual processing.	[Zacharopoulos, George; Binetti, Nicola; Walsh, Vincent; Kanai, Ryota] UCL, Sch Psychol, Inst Cognit Neurosci, London, England; [Kanai, Ryota] Univ Sussex, Sackler Ctr Consciousness Sci, Sch Psychol, Brighton, E Sussex, England	University of London; University College London; University of Sussex	Zacharopoulos, G (corresponding author), UCL, Sch Psychol, Inst Cognit Neurosci, London, England.	george.zacharopoulos.11@ucl.ac.uk		Kanai, Ryota/0000-0002-0186-2687	PRESTO grant from Japan Science and Technology Agency (JST)	PRESTO grant from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by PRESTO grant from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; BANDURA A, 1987, J PERS SOC PSYCHOL, V53, P563, DOI 10.1037/0022-3514.53.3.563; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; BOUFFARDBOUCHARD T, 1990, J SOC PSYCHOL, V130, P353, DOI 10.1080/00224545.1990.9924591; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CHAMBLISS C, 1979, COGNITIVE THER RES, V3, P91, DOI 10.1007/BF01172723; CHAMBLISS CA, 1979, COGNITIVE THER RES, V3, P349, DOI 10.1007/BF01184448; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037/0033-295X.95.2.256; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; IBM Corp, 2010, IBM SPSS STAT WIND V; JACOBS B, 1984, BASIC APPL SOC PSYCH, V5, P333, DOI 10.1207/s15324834basp0504_6; Kanai R, 2010, CONSCIOUS COGN, V19, P1045, DOI 10.1016/j.concog.2010.06.003; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LITT MD, 1988, J PERS SOC PSYCHOL, V54, P149, DOI 10.1037/0022-3514.54.1.149; Maddux J.E., 1995, SELF EFFICACY ADAPTA; MARTOCCHIO JJ, 1994, J APPL PSYCHOL, V79, P819, DOI 10.1037/0021-9010.79.6.819; Rahnev D, 2012, J NEUROPHYSIOL, V107, P1556, DOI 10.1152/jn.00985.2011; ROSSI AF, 1995, VISION RES, V35, P621, DOI 10.1016/0042-6989(94)00156-G; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Sedikides C, 1998, J PERS SOC PSYCHOL, V74, P378, DOI 10.1037/0022-3514.74.2.378; Seitz AR, 2006, J VISION, V6, P966, DOI 10.1167/6.9.9; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Shibata K, 2009, VISION RES, V49, P2574, DOI 10.1016/j.visres.2009.06.009; Song C, 2011, CONSCIOUS COGN, V20, P1787, DOI 10.1016/j.concog.2010.12.011; Vickers D., 1979, DECISION PROCESSES V; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Weinberg R., 1979, J SPORT EXERC PSYCHO, V1, P320; WOOD R, 1989, ACAD MANAGE REV, V14, P361, DOI 10.2307/258173; WOOD R, 1989, J PERS SOC PSYCHOL, V56, P407, DOI 10.1037/0022-3514.56.3.407	40	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109392	10.1371/journal.pone.0109392	http://dx.doi.org/10.1371/journal.pone.0109392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25295529	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000345204000068
J	Ha, CT; Li, XH; Fu, DD; Moroni, M; Fisher, C; Arnott, R; Srinivasan, V; Xiao, M				Ha, Cam T.; Li, Xiang-Hong; Fu, Dadin; Moroni, Maria; Fisher, Carolyn; Arnott, Robert; Srinivasan, Venkataraman; Xiao, Mang			Circulating Interleukin-18 as a Biomarker of Total-Body Radiation Exposure in Mice, Minipigs, and Nonhuman Primates (NHP)	PLOS ONE			English	Article							IONIZING-RADIATION; DELTA-TOCOTRIENOL; BIODOSIMETRY APPLICATIONS; SIGNALING PATHWAYS; GAMMA-IRRADIATION; MODEL; INJURY; MOUSE; IL-1-BETA; FAMILY	We aim to develop a rapid, easy-to-use, inexpensive and accurate radiation dose-assessment assay that tests easily obtained samples (e.g., blood) to triage and track radiological casualties, and to evaluate the radioprotective and therapeutic effects of radiation countermeasures. In the present study, we evaluated the interleukin (IL)-1 family of cytokines, IL-1 beta, IL-18 and IL-33, as well as their secondary cytokines' expression and secretion in CD2F1 mouse bone marrow (BM), spleen, thymus and serum in response to gamma-radiation from sublethal to lethal doses (5, 7, 8, 9, 10, or 12 Gy) at different time points using the enzyme-linked immune sorbent assay (ELISA), immunoblotting, and cytokine antibody array. Our data identified increases of IL-1 beta, IL-18, and/or IL-33 in mouse thymus, spleen and BM cells after total-body irradiation (TBI). However, levels of these cytokines varied in different tissues. Interestingly, IL-18 but not IL-1 beta or IL-33 increased significantly (2.5-24 fold) and stably in mouse serum from day 1 after TBI up to 13 days in a radiation dose-dependent manner. We further confirmed our finding in total-body gamma-irradiated nonhuman primates (NHPs) and minipigs, and demonstrated that radiation significantly enhanced IL-18 in serum from NHPs 2-4 days post-irradiation and in minipig plasma 1-3 days post-irradiation. Finally, we compared circulating IL-18 with the well known hematological radiation biomarkers lymphocyte and neutrophil counts in blood of mouse, minipigs and NHPs and demonstrated close correlations between these biomarkers in response to radiation. Our results suggest that the elevated levels of circulating IL-18 after radiation proportionally reflect radiation dose and severity of radiation injury and may be used both as a potential biomarker for triage and also to track casualties after radiological accidents as well as for therapeutic radiation exposure.	[Ha, Cam T.; Li, Xiang-Hong; Fu, Dadin; Moroni, Maria; Fisher, Carolyn; Arnott, Robert; Srinivasan, Venkataraman; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Xiao, M (corresponding author), Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Bethesda, MD 20814 USA.	mang.xiao@usuhs.edu			AFRRI intramural grant [RAB22676]; NIHMS [Y01 AI001759-101]; DMRDP [D10-I-AR-J7-116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001759] Funding Source: NIH RePORTER	AFRRI intramural grant; NIHMS; DMRDP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by AFRRI intramural grant RAB22676 to MX, NIHMS Y01 AI001759-101 to MM, and DMRDP D10-I-AR-J7-116 to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakely WE, 2009, RADIAT RES, V171, P127, DOI 10.1667/RR1549.1; Blakely WF, 2010, HEALTH PHYS, V99, pS184, DOI 10.1097/HP.0b013e3181f26895; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Coleman CN, 2004, SCIENCE, V304, P693, DOI 10.1126/science.1095956; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Farese AM, 2012, HEALTH PHYS, V103, P367, DOI 10.1097/HP.0b013e31825f75a7; Fukumoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058389; Ha CT, 2013, RADIAT RES, V180, P316, DOI 10.1667/RR3326.1; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Ivanov VN, 2010, CELL SIGNAL, V22, P1076, DOI 10.1016/j.cellsig.2010.02.010; Kang S, 2009, CLIN EXP RHEUMATOL, V27, P54; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Li XH, 2013, RADIAT RES, V180, P649, DOI 10.1667/RR13398.1; Li XH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039690, 10.1371/journal.pone.0036604]; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Liew FY, 2002, ANN RHEUM DIS, V61, P100; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Lukens JR, 2012, J IMMUNOL, V188, P3107, DOI 10.4049/jimmunol.1103308; MacVittie TJ, 2012, HEALTH PHYS, V103, P411, DOI 10.1097/HP.0b013e31826525f0; MCBRIDE WH, 1989, CANCER RES, V49, P169; McGeough MD, 2013, J CLIN INVEST; Moroni M, 2013, INT J MOL SCI, V14, P14119, DOI 10.3390/ijms140714119; Moroni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025210; Nasti TH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1111, DOI 10.1111/j.1751-1097.2012.01182.x; Ossetrova NI, 2014, HEALTH PHYS, V106, P772, DOI 10.1097/HP.0000000000000094; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Prasad KN, 2004, EXP BIOL MED, V229, P378, DOI 10.1177/153537020422900505; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Satyamitra MM, 2011, RADIAT RES, V175, P736, DOI 10.1667/RR2460.1; Shan YX, 2007, RADIAT ENVIRON BIOPH, V46, P21, DOI 10.1007/s00411-006-0076-x; Shih KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042389; Somosy Z, 2002, MICRON, V33, P167, DOI 10.1016/S0968-4328(01)00013-0; van de Veerdonk FL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00167; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Williams JP, 2011, INT J RADIAT BIOL, V87, P851, DOI 10.3109/09553002.2011.560996; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Xiao M, 2009, EXP HEMATOL, V37, P52, DOI 10.1016/j.exphem.2008.09.001; Zhang M, 2012, CYTOKINE; Zhang M, 2012, CYTOKINE, V58, P169, DOI 10.1016/j.cyto.2011.12.023	44	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109249	10.1371/journal.pone.0109249	http://dx.doi.org/10.1371/journal.pone.0109249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290447	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000050
J	Jones, KS; Corbin, JG; Huntsman, MM				Jones, Kevin S.; Corbin, Joshua G.; Huntsman, Molly M.			Neonatal NMDA Receptor Blockade Disrupts Spike Timing and Glutamatergic Synapses in Fast Spiking Interneurons in a NMDA Receptor Hypofunction Model of Schizophrenia	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; GABAERGIC INTERNEURONS; INHIBITORY NEURONS; BARREL CORTEX; PREFRONTAL CORTEX; CRITICAL PERIOD; PHENCYCLIDINE; MATURATION; DIVERSITY; NEOCORTEX	The dysfunction of parvalbumin-positive, fast-spiking interneurons (FSI) is considered a primary contributor to the pathophysiology of schizophrenia (SZ), but deficits in FSI physiology have not been explicitly characterized. We show for the first time, that a widely-employed model of schizophrenia minimizes first spike latency and increases GluN2B-mediated current in neocortical FSIs. The reduction in FSI first-spike latency coincides with reduced expression of the Kv1.1 potassium channel subunit which provides a biophysical explanation for the abnormal spiking behavior. Similarly, the increase in NMDA current coincides with enhanced expression of the GluN2B NMDA receptor subunit, specifically in FSIs. In this study mice were treated with the NMDA receptor antagonist, MK-801, during the first week of life. During adolescence, we detected reduced spike latency and increased GluN2B-mediated NMDA current in FSIs, which suggests transient disruption of NMDA signaling during neonatal development exerts lasting changes in the cellular and synaptic physiology of neocortical FSIs. Overall, we propose these physiological disturbances represent a general impairment to the physiological maturation of FSIs which may contribute to schizophrenia-like behaviors produced by this model.	[Jones, Kevin S.] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Jones, Kevin S.; Corbin, Joshua G.] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Huntsman, Molly M.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Huntsman, Molly M.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	Howard University; Children's National Health System; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Huntsman, MM (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	Molly.Huntsman@UCDenver.edu			NIH NINDS [R01 NS053719]; NIH NICHD [R01DA020140]; Children's Research Institute: EUNICE KENNEDY SHRIVER NICHD Training Grant [5P30HD040677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, T32HD046388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020140] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Research Institute: EUNICE KENNEDY SHRIVER NICHD Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH NINDS R01 NS053719 (Molly M Huntsman); NIH NICHD R01DA020140 (Joshua G Corbin); Children's Research Institute: EUNICE KENNEDY SHRIVER NICHD Training Grant 5P30HD040677 (Kevin S Jones). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abekawa T, 2007, PSYCHOPHARMACOLOGY, V192, P303, DOI 10.1007/s00213-007-0729-8; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Bacci A, 2003, J NEUROSCI, V23, P859; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Coleman LG, 2009, PHARMACOL BIOCHEM BE, V93, P322, DOI 10.1016/j.pbb.2009.04.017; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dodson PD, 2002, J NEUROSCI, V22, P6953; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Fontaine B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003560; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gittelman JX, 2006, J NEUROPHYSIOL, V96, P1203, DOI 10.1152/jn.00092.2005; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Goldberg EM, 2011, CEREB CORTEX, V21, P666, DOI 10.1093/cercor/bhq138; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Inan M, 2012, NEUROBIOL DIS; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Laube B, 1998, J NEUROSCI, V18, P2954; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li P, 2014, NEUROSCIENCE, V265, P60, DOI 10.1016/j.neuroscience.2014.01.033; Lim AL, 2012, BEHAV BRAIN RES, V227, P276, DOI 10.1016/j.bbr.2011.10.052; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Owczarek S, 2011, NEUROREPORT, V22, P935, DOI 10.1097/WNR.0b013e32834d2ef7; Pangratz-Fuehrer S, 2011, J NEUROSCI, V31, P10767, DOI 10.1523/JNEUROSCI.6655-10.2011; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Powell SB, 2012, NEUROPHARMACOLOGY, V62, P1322, DOI 10.1016/j.neuropharm.2011.01.049; Qian A, 2005, J PHYSIOL-LONDON, V562, P319, DOI 10.1113/jphysiol.2004.076737; Rotaru DC, 2012, REV NEUROSCIENCE, V23, P97, DOI 10.1515/revneuro-2011-0059; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wang CZ, 2008, NEUROPSYCHOPHARMACOL, V33, P2442, DOI 10.1038/sj.npp.1301647; WESSINGER WD, 1995, EUR J PHARMACOL, V277, P107, DOI 10.1016/0014-2999(95)00107-V; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wintrip N, 1998, NEUROSCI LETT, V242, P151, DOI 10.1016/S0304-3940(98)00069-X; Zhang Z, 2011, DEV NEUROBIOL, V71, P221, DOI 10.1002/dneu.20844	51	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109303	10.1371/journal.pone.0109303	http://dx.doi.org/10.1371/journal.pone.0109303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290690	Green Published, gold			2022-12-27	WOS:000342798000051
J	Shen, CF; Liu, W; Wang, XX; Wu, L; Zhan, R; Qian, LJ				Shen Chengfeng; Liu Wei; Wang Xinxing; Wu Lei; Zhan Rui; Qian Lingjia			Hyperhomocysteinemia Is a Result, Rather than a Cause, of Depression under Chronic Stress	PLOS ONE			English	Article							CHRONIC MILD STRESS; TOTAL PLASMA HOMOCYSTEINE; MODEL; VITAMIN-B-12; FOLATE; ANTIDEPRESSANTS; METABOLISM; FLUOXETINE; BEHAVIOR; WOMEN	Background: Although the accumulation of homocysteine (Hcy) has been implicated in the pathogenesis of depression, whether Hcy is directly involved and acts as the primary cause of depressive symptoms remains unclear. The present study was designed to clarify whether increased Hcy plays an important role in stress-induced depression. Results: We employed the chronic unpredictable mild stress model (CUMS) of depression for 8 weeks to observe changes in the plasma Hcy level in the development of depression. The results showed that Wistar rats exposed to a series of mild, unpredictable stressors for 4 weeks displayed depression-like symptoms such as anhedonia (decreased sucrose preferences) and a decreased 5-Hydroxy Tryptophan (5-HT) concentration in the hippocampus. At the end of 8 weeks, the plasma Hcy level increased in the CUMS rats. The anti-depressant sertraline could decrease the plasma Hcy level and improve the depression-like symptoms in the CUMS rats. RhBHMT, an Hcy metabolic enzyme, could decrease the plasma Hcy level significantly, although it could not improve the depressive symptoms in the CUMS rats. Conclusions: The results obtained from the experiments did not support the hypothesis that the increased Hcy concentration mediated the provocation of depression in CUMS rats, and the findings suggested that the increased Hcy concentration in the plasma might be the result of stress-induced depression.	[Shen Chengfeng] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Wang Xinxing; Zhan Rui; Qian Lingjia] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Liu Wei; Wang Xinxing; Wu Lei] Inst Hlth & Environm Med, Tianjin, Peoples R China	Tianjin Center for Disease Control & Prevention; Academy of Military Medical Sciences - China	Wang, XX (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	wxxchf@gmail.com; wxxemail@sohu.com	Wang, Xinxing/AAU-6356-2021		National Natural Science Foundation of China [81372124, 81000584]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by research grant from the National Natural Science Foundation of China (grant no. 81372124, 81000584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso J, 2005, REV NEUROSCIENCE, V16, P43; Almeida OP, 2005, NEUROBIOL AGING, V26, P251, DOI 10.1016/j.neurobiolaging.2004.03.007; Bottiglieri T, 2005, PROG NEURO-PSYCHOPH, V29, P1103, DOI 10.1016/j.pnpbp.2005.06.021; Bottiglieri T, 2000, J NEUROL NEUROSUR PS, V69, P228, DOI 10.1136/jnnp.69.2.228; Budge MM, 2002, J AM GERIATR SOC, V50, P2014, DOI 10.1046/j.1532-5415.2002.50614.x; DAquila PS, 1997, PHYSIOL BEHAV, V62, P421, DOI 10.1016/S0031-9384(97)00042-5; de Oliveira AC, 2004, PHARMACOL BIOCHEM BE, V77, P269, DOI 10.1016/j.pbb.2003.11.003; Fava M, 1997, AM J PSYCHIAT; Gamaro GD, 2003, NEUROCHEM INT, V42, P107, DOI 10.1016/S0197-0186(02)00080-3; GRIFFITHS J, 1992, PHARMACOL BIOCHEM BE, V42, P219, DOI 10.1016/0091-3057(92)90519-L; Grippo AJ, 2003, PHYSIOL BEHAV, V78, P703, DOI 10.1016/S0031-9384(03)00050-7; Grippo AJ, 2002, AM J PHYSIOL-REG I, V282, pR1333, DOI 10.1152/ajpregu.00614.2001; Harro J, 2001, BRAIN RES, V899, P227, DOI 10.1016/S0006-8993(01)02256-9; Kelly CB, 2004, J PSYCHOPHARMACOL, V18, P567, DOI 10.1177/0269881104047285; Lentz SR, 1997, LIFE SCI, V61, P1205, DOI 10.1016/S0024-3205(97)00392-5; Li JM, 2003, LIFE SCI, V74, P55, DOI 10.1016/j.lfs.2003.06.030; Loria-Kohen V, 2013, NUTR HOSP, V28, P807, DOI 10.3305/nh.2013.28.3.6335; Meijer WEE, 2004, EUR J CLIN PHARMACOL, V60, P57, DOI 10.1007/s00228-004-0726-3; MUSCAT R, 1992, PSYCHOPHARMACOLOGY, V109, P433, DOI 10.1007/BF02247719; Nygard O, 1999, J INTERN MED, V246, P425, DOI 10.1046/j.1365-2796.1999.00512.x; Parissis JT, 2005, DEPRESSION CHRONIC H; Penninx BWJH, 2000, AM J PSYCHIAT, V157, P715, DOI 10.1176/appi.ajp.157.5.715; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Plante GE, 2005, METABOLISM, V54, P45, DOI 10.1016/j.metabol.2005.01.013; Reis ED, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/958209; Sachdev PS, 2005, PSYCHOL MED, V35, P529, DOI 10.1017/S0033291704003721; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Setnik B, 2004, PHARMACOL BIOCHEM BE, V77, P155, DOI 10.1016/j.pbb.2003.10.006; Stoney CM, 1999, LIFE SCI, V64, P2359, DOI 10.1016/S0024-3205(99)00189-7; Strik JTMH, 2000, PSYCHOSOM MED, V62, P783, DOI 10.1097/00006842-200011000-00007; Tiemeier H, 2002, AM J PSYCHIAT, V159, P2099, DOI 10.1176/appi.ajp.159.12.2099; Tolmunen T, 2004, AM J CLIN NUTR, V80, P1574, DOI 10.1093/ajcn/80.6.1574; Vollmayr B, 2003, CLIN NEUROSCI RES, V3, P245, DOI 10.1016/S1566-2772(03)00086-0; Wang XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088427; Watanabe H, 2010, BIOSCIENCE TRENDS, V4; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456	37	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e106625	10.1371/journal.pone.0106625	http://dx.doi.org/10.1371/journal.pone.0106625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286230	Green Submitted, gold, Green Published			2022-12-27	WOS:000345743700005
J	Duraffourd, C; Kumala, E; Anselmi, L; Brecha, NC; Sternini, C				Duraffourd, Celine; Kumala, Erica; Anselmi, Laura; Brecha, Nicholas C.; Sternini, Catia			Opioid-Induced Mitogen-Activated Protein Kinase Signaling in Rat Enteric Neurons following Chronic Morphine Treatment	PLOS ONE			English	Article							RECEPTOR DESENSITIZATION; MYENTERIC NEURONS; BETA-ARRESTIN; IN-VITRO; ENDOCYTOSIS; INTERNALIZATION; TOLERANCE; TRAFFICKING; MICE; PHOSPHORYLATION	Opioids, acting at mu opioid receptors, are commonly used for pain management. Chronic opioid treatment induces cellular adaptations, which trigger long-term side effects, including constipation mediated by enteric neurons. We tested the hypothesis that chronic opioid treatment induces alterations of t opioid receptor signaling in enteric neurons, which are likely to serve as mechanisms underlying opioid-induced constipation. In cultured rat enteric neurons, either untreated (na ve) or exposed to morphine for 4 days (chronic), we compared the effect of morphine and DAMGO (D-A(1)a(2),MePhe(4),GlyO(1)5 enkephalin) on IA opioid receptor internalization and downstream signaling by examining the activation of the mitogenactivated protein kinase/extracellular signal-regulated kinases 1 and 2 (MAPK/ERK) pathway, cAMP accumulation and transcription factor cAMP Response Element-Binding protein (CREB) expression. ti opioid receptor internalization and MAPK/ERK phosphorylation were induced by DAMGO, but not morphine in na ve neurons, and by both mu opioids in chronic neurons. MAPK/ERK activation was prevented by the receptor antagonist naloxone, by blocking receptor trafficking with hypertonic sucrose, dynamin inhibitor, or neuronal transfection with mutated dynamin, and by MAPK inhibitor. Morphine and DAMGO inhibited cAMP in na ve and chronic enteric neurons, and induced desensitization of cAMP signaling. Chronic morphine treatment suppressed desensitization of cAMP and MAPK signaling, increased CREB phosphorylation through a MAPK/ERK pathway and induced delays of gastrointestinal transit, which was prevented by MAPK/ERK blockade. This study showed that opioids induce endocytosis- and dynamin-dependent MAPK/ERK activation in enteric neurons and that chronic morphine treatment triggers changes at the receptor level and downstream signaling resulting in MAPK/ERK-dependent CREB activation. Blockade of this signaling pathway prevents the development of gastrointestinal motility impairment induced by chronic morphine treatment. These findings suggest that alterations in IA opioid receptor downstream signaling including MAPK/ERK pathway in enteric neurons chronically treated with morphine contribute to the development of opioid-induced constipation.	[Duraffourd, Celine; Kumala, Erica; Anselmi, Laura; Brecha, Nicholas C.; Sternini, Catia] Univ Calif Los Angeles, Div Digest Dis, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Duraffourd, Celine; Kumala, Erica; Anselmi, Laura; Brecha, Nicholas C.; Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Duraffourd, Celine; Kumala, Erica; Brecha, Nicholas C.; Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.; Sternini, Catia] Veteran Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sternini, C (corresponding author), Univ Calif Los Angeles, Div Digest Dis, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA.	csternin@ucla.edu			National Institutes of Health (NIH) [R01-DK054155, P30-DK041301]; UCLA Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK054155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants R01-DK054155 and P30-DK041301, and UCLA Academic Senate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi L, 2009, J NEUROSCI RES, V87, P1107, DOI 10.1002/jnr.21923; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Arttamangkul S, 2008, MOL PHARMACOL, V74, P972, DOI 10.1124/mol.108.048512; Borgland SL, 2003, J BIOL CHEM, V278, P18776, DOI 10.1074/jbc.M300525200; Camilleri M, 2011, AM J GASTROENTEROL, V106, P835, DOI 10.1038/ajg.2011.30; Chen ZX, 2007, INT J PARASITOL, V37, P743, DOI 10.1016/j.ijpara.2006.12.018; Dang VC, 2012, BRIT J PHARMACOL, V165, P1704, DOI 10.1111/j.1476-5381.2011.01482.x; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Eisinger DA, 2002, J NEUROSCI, V22, P10192; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Ho A, 2003, J COMP NEUROL, V458, P404, DOI 10.1002/cne.10606; Holzer P, 2009, REGUL PEPTIDES, V155, P11, DOI 10.1016/j.regpep.2009.03.012; Ignatova EG, 1999, J NEUROSCI, V19, P56, DOI 10.1523/JNEUROSCI.19-01-00056.1999; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kang MH, 2012, J PHARMACOL EXP THER, V340, P567, DOI 10.1124/jpet.111.186320; Karim F, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-2; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; KROMER W, 1990, DIGEST DIS, V8, P361, DOI 10.1159/000171269; Kromer W, 1990, OPIOID PEPTIDES RECE; Kurz A, 2003, DRUGS, V63, P649, DOI 10.2165/00003495-200363070-00003; Lopez de Armentia M, 2007, J NEUROSCI, V27, P13909, DOI 10.1523/JNEUROSCI.3850-07.2007; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MILLER MS, 1981, J PHARMACOL METHOD, V6, P211, DOI 10.1016/0160-5402(81)90110-8; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Patierno S, 2011, GASTROENTEROLOGY, V140, P618, DOI 10.1053/j.gastro.2010.11.005; Polakiewicz RD, 1998, J BIOL CHEM, V273, P12402, DOI 10.1074/jbc.273.20.12402; Robinson C B, 2000, Clin J Oncol Nurs, V4, P79; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Roy S, 1998, MOL BRAIN RES, V56, P281, DOI 10.1016/S0169-328X(98)00051-5; Saccani F, 2012, J NEUROSCI RES, V90, P2146, DOI 10.1002/jnr.23108; Sakoda T, 1999, J MOL CELL CARDIOL, V31, P2037, DOI 10.1006/jmcc.1999.1035; Schmidlin F, 2001, J BIOL CHEM, V276, P25427, DOI 10.1074/jbc.M101688200; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; Walwyn WM, 2006, NEUROSCIENCE, V142, P493, DOI 10.1016/j.neuroscience.2006.06.021; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wood JD, 2004, NEUROGASTROENT MOTIL, V16, P17, DOI 10.1111/j.1743-3150.2004.00554.x; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	49	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110230	10.1371/journal.pone.0110230	http://dx.doi.org/10.1371/journal.pone.0110230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302800	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400125
J	Tan, RZ; Chiam, KH				Tan, Rui Zhen; Chiam, Keng-Hwee			Computational Modeling Reveals that a Combination of Chemotaxis and Differential Adhesion Leads to Robust Cell Sorting during Tissue Patterning	PLOS ONE			English	Article							MORPHOGEN GRADIENTS; POSITIONAL INFORMATION; POTTS-MODEL; ZEBRAFISH; EXPRESSION; MESODERM; EMBRYO; PROLIFERATION; DICTYOSTELIUM; SIMULATION	Robust tissue patterning is crucial to many processes during development. The "French Flag" model of patterning, whereby naive cells in a gradient of diffusible morphogen signal adopt different fates due to exposure to different amounts of morphogen concentration, has been the most widely proposed model for tissue patterning. However, recently, using time-lapse experiments, cell sorting has been found to be an alternative model for tissue patterning in the zebrafish neural tube. But it remains unclear what the sorting mechanism is. In this article, we used computational modeling to show that two mechanisms, chemotaxis and differential adhesion, are needed for robust cell sorting. We assessed the performance of each of the two mechanisms by quantifying the fraction of correct sorting, the fraction of stable clusters formed after correct sorting, the time needed to achieve correct sorting, and the size variations of the cells having different fates. We found that chemotaxis and differential adhesion confer different advantages to the sorting process. Chemotaxis leads to high fraction of correct sorting as individual cells will either migrate towards or away from the source depending on its cell type. However after the cells have sorted correctly, there is no interaction among cells of the same type to stabilize the sorted boundaries, leading to cell clusters that are unstable. On the other hand, differential adhesion results in low fraction of correct clusters that are more stable. In the absence of morphogen gradient noise, a combination of both chemotaxis and differential adhesion yields cell sorting that is both accurate and robust. However, in the presence of gradient noise, the simple combination of chemotaxis and differential adhesion is insufficient for cell sorting; instead, chemotaxis coupled with delayed differential adhesion is required to yield optimal sorting.	[Tan, Rui Zhen; Chiam, Keng-Hwee] ASTAR, Bioinformat Inst, Singapore, Singapore; [Chiam, Keng-Hwee] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore	Chiam, KH (corresponding author), ASTAR, Bioinformat Inst, Singapore, Singapore.	chiamkh@bii.a-star.edu.sg			Agency of Science, Technology and Research (A*STAR) of Singapore; Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore; Singapore Ministry of Education	Agency of Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by the Agency of Science, Technology and Research (A*STAR) of Singapore, as well as the Seed Fund of the Mechanobiology Institute, Research Centre of Excellence financed by the National Research Foundation of Singapore and the Singapore Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Ahtiainen L, 2014, DEV CELL, V28, P588, DOI 10.1016/j.devcel.2014.02.003; Anderson A., 2007, SINGLE CELL BASED MO; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Bollenbach T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018103; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Garrod D R, 1978, Symp Soc Exp Biol, V32, P173; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Jiang Y, 1998, BIOPHYS J, V75, P2615, DOI 10.1016/S0006-3495(98)77707-0; Kafer J, 2006, PLOS COMPUT BIOL, V2, P518, DOI 10.1371/journal.pcbi.0020056; Kay RR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001503; Kim D, 2007, DEV BIOL, V307, P290, DOI 10.1016/j.ydbio.2007.04.051; Lin JT, 2012, J COMP NEUROL, V520, P1509, DOI 10.1002/cne.22808; Little SC, 2013, CELL, V153, P509, DOI 10.1016/j.cell.2013.04.021; Maree AFM, 2007, SINGLE CELL BASED MO, P107, DOI DOI 10.1007/978-3-7643-8123-3_5; MARTIN P, 1990, International Journal of Developmental Biology, V34, P323; Murakami T, 2006, DEV DYNAM, V235, P506, DOI 10.1002/dvdy.20622; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Raper KB, 1941, AM J BOT, V28, P69, DOI 10.2307/2437063; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Savill NJ, 2003, DEV BIOL, V258, P141, DOI 10.1016/S0012-1606(03)00107-6; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; STERN CD, 1990, NATURE, V343, P273, DOI 10.1038/343273a0; Stott EL, 1999, MATH COMPUT MODEL, V30, P183, DOI 10.1016/S0895-7177(99)00156-9; Streit A, 2002, DEV BIOL, V249, P237, DOI 10.1006/dbio.2002.0739; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wong E, 2002, DEVELOPMENT, V129, P3839; Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024999	40	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109286	10.1371/journal.pone.0109286	http://dx.doi.org/10.1371/journal.pone.0109286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302949	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400049
J	Asztalos, BF; Horan, MS; Horvath, KV; McDermott, AY; Chalasani, NP; Schaefer, EJ				Asztalos, Bela F.; Horan, Michael S.; Horvath, Katalin V.; McDermott, Ann Y.; Chalasani, Naga P.; Schaefer, Ernst J.			Obesity Associated Molecular Forms of C-Reactive Protein in Human	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; ENDOTHELIAL-CELLS; BINDING; ATHEROSCLEROSIS; INFLAMMATION; EVENTS	Objective: To describe novel C-reactive protein (CRP) molecular forms (mf) in human plasma. Design and Methods: Five novel CRP-mfs, disctinct from the previously described native (nCRP) and modified (mCRP) C-reactive proteins, were separated from human plasma by polyacrylamide gel electrophoresis and immunodetected by western blot in subjects with or without increased BMI, cardiovascular disease (CVD), and diabetes (n = 1800). Results: Three of the five CRP-mfs were present in all samples. One, CRPmf-4, was present in a subgroup of subjects and its presence was associated with elevated body mass index (BMI). CRP-mf-5 was present in about 2% of the subjects and was not associated with any other parameters. The presence or distribution of the 5 CRP-mfs were not Ca2+-dependent. Crossed immuno-localization experiments indicated that none of the CRP-mfs were complexed with any of the lipoprotein classes or with signature proteins of the complement-factor. Moreover, the distribution of CRP-mfs were not significantly correlated with plasma CRP levels. CRP-mf-4 was significantly associated with increased BMI, but not with other parameters of the metabolic syndrome (HDL-C and triglyceride levels, and diabetes). Conclusions: We have identified five new CRP-mfs out of which CRP-mf-4 was significantly associated with obesity. We have shown that oligomerization of CRP was not calcium dependent. We hypothesize that adipose tissue produces a factor which influences the formation of CRP mf-4. CRP-mfs might be used as an obesity-associated inflammatory marker.	[Asztalos, Bela F.; Horan, Michael S.; Horvath, Katalin V.; McDermott, Ann Y.; Schaefer, Ernst J.] Tufts Univ, Human Nutr Res Ctr Aging, Lipid Metab Lab, Boston, MA 02111 USA; [Chalasani, Naga P.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Tufts University; United States Department of Agriculture (USDA); Indiana University System; Indiana University Bloomington	Asztalos, BF (corresponding author), Tufts Univ, Human Nutr Res Ctr Aging, Lipid Metab Lab, Boston, MA 02111 USA.	bela.asztalos@tufts.edu			United States Department of Agriculture Research Service [53-3K-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064738] Funding Source: NIH RePORTER	United States Department of Agriculture Research Service(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the United States Department of Agriculture Research Service Contract 53-3K-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens I, 2011, BASIC RES CARDIOL, V106, P879, DOI 10.1007/s00395-011-0191-y; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; DEBEER FC, 1982, J EXP MED, V156, P230, DOI 10.1084/jem.156.1.230; Devaraj S, 2006, ATHEROSCLEROSIS, V184, P48, DOI 10.1016/j.atherosclerosis.2005.03.031; Eisenhardt SU, 2009, CELL CYCLE, V8, P3885, DOI 10.4161/cc.8.23.10068; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Kresl JJ, 1998, INT J BIOCHEM CELL B, V30, P1415, DOI 10.1016/S1357-2725(98)00078-8; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; NUNOMURA W, 1990, Hokkaido Journal of Medical Science, V65, P474; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; PAINTER RH, 1982, ANN NY ACAD SCI, V389, P199, DOI 10.1111/j.1749-6632.1982.tb22138.x; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Swarbrick MM, 2008, DIABETOLOGIA, V51, P1901, DOI 10.1007/s00125-008-1118-5; Taskinen S, 2005, BIOCHEM BIOPH RES CO, V329, P1208, DOI 10.1016/j.bbrc.2005.02.091; WOOD SP, 1988, J MOL BIOL, V202, P169, DOI 10.1016/0022-2836(88)90529-3	26	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109238	10.1371/journal.pone.0109238	http://dx.doi.org/10.1371/journal.pone.0109238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299074	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200043
J	Jiang, CB; Hsi, HC; Fan, CH; Chien, LC				Jiang, Chuen-Bin; Hsi, Hsing-Cheng; Fan, Chun-Hua; Chien, Ling-Chu			Fetal Exposure to Environmental Neurotoxins in Taiwan	PLOS ONE			English	Article							BLOOD LEAD LEVELS; SEYCHELLES CHILD-DEVELOPMENT; BIRTH-WEIGHT INFANTS; FISH CONSUMPTION; ARSENIC EXPOSURE; METHYLMERCURY EXPOSURE; SPONTANEOUS-ABORTION; PRENATAL EXPOSURE; MECONIUM ANALYSIS; MERCURY EXPOSURE	Mercury (Hg), lead (Pb), cadmium (Cd), and arsenic (As) are recognized neurotoxins in children that particularly affect neurodevelopment and intellectual performance. Based on the hypothesis that the fetal basis of adult disease is fetal toxic exposure that results in adverse outcomes in adulthood, we explored the concentrations of key neurotoxins (i. e., Hg, Pb, Cd, and As) in meconium to identify the risk factors associated with these concentrations. From January 2007 to December 2009, 545 mother-infant pairs were recruited. The geometric mean concentrations of Pb and As in the meconium of babies of foreign-born mothers (22.9 and 38.1 mu g/kg dry weight, respectively) were significantly greater than those of babies of Taiwan-born mothers (17.5 and 33.0 mu g/kg dry weight, respectively). Maternal age (>= 30 y), maternal education, use of traditional Chinese herbs during pregnancy, and fish cutlet consumption (>= 3 meals/wk) were risk factors associated with concentrations of key prenatal neurotoxins. The Taiwan government should focus more attention on providing intervention programs for immigrant mothers to help protect the health of unborn babies. Further investigation on how multiple neurotoxins influence prenatal neurodevelopment is warranted.	[Jiang, Chuen-Bin] Taipei Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Jiang, Chuen-Bin] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Hsi, Hsing-Cheng] Natl Taiwan Univ, Grad Inst Environm Engn, Taipei 10764, Taiwan; [Fan, Chun-Hua; Chien, Ling-Chu] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Taiwan University; Taipei Medical University	Chien, LC (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.	lcchien@tmu.edu.tw		Chien, Ling-Chu/0000-0001-5539-8974; Hsi, Hsing-Cheng/0000-0001-5558-2077	National Science Council, Republic of China NSC [98-2314-B-038-025-MY3]	National Science Council, Republic of China NSC	This work was supported by Grants NSC 98-2314-B-038-025-MY3 from the National Science Council, Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr DB, 2007, REPROD TOXICOL, V23, P260, DOI 10.1016/j.reprotox.2007.03.003; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Binns HJ, 2007, PEDIATRICS, V120, pE1285, DOI 10.1542/peds.2005-1770; Borja-Aburto VH, 1999, AM J EPIDEMIOL, V150, P590, DOI 10.1093/oxfordjournals.aje.a010057; CALLAHAN CM, 1992, J PEDIATR-US, V120, P763, DOI 10.1016/S0022-3476(05)80245-8; Chien LC, 2006, CHEMOSPHERE, V64, P79, DOI 10.1016/j.chemosphere.2005.11.059; Coscia JM, 2003, CHILD NEUROPSYCHOL, V9, P10, DOI 10.1076/chin.9.1.10.14498; Crump KS, 1998, RISK ANAL, V18, P701, DOI 10.1023/B:RIAN.0000005917.52151.e6; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294; Finkelstein Y, 1998, BRAIN RES REV, V27, P168, DOI 10.1016/S0165-0173(98)00011-3; Gardella C, 2001, OBSTET GYNECOL SURV, V56, P231, DOI 10.1097/00006254-200104000-00024; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Gundacker C, 2010, SCI TOTAL ENVIRON, V408, P5744, DOI 10.1016/j.scitotenv.2010.07.079; Heindel JJ, 2005, BIRTH DEFECTS RES A, V73, P131, DOI 10.1002/bdra.20119; Hertz-Picciotto I, 2000, AM J IND MED, V38, P300, DOI 10.1002/1097-0274(200009)38:3<300::AID-AJIM9>3.0.CO;2-C; Hsu CS, 2007, BJOG-INT J OBSTET GY, V114, P81, DOI 10.1111/j.1471-0528.2006.01142.x; Jiang CB, 2010, SCI TOTAL ENVIRON, V408, P518, DOI 10.1016/j.scitotenv.2009.10.043; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Lin CM, 2011, OCCUP ENVIRON MED, V68, P641, DOI 10.1136/oem.2010.059758; Llanos MN, 2009, REPROD TOXICOL, V27, P88, DOI 10.1016/j.reprotox.2008.11.057; Mahaffey KR, 2009, ENVIRON HEALTH PERSP, V117, P47, DOI 10.1289/ehp.11674; MAYNARD EC, 1991, AM J DIS CHILD, V145, P650, DOI 10.1001/archpedi.1991.02160060068022; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1006/toxs.1998.2436; National Research Council, 2008, PHTHAL CUM RISK ASS; OSTREA EM, 1992, PEDIATRICS, V89, P107; Ostrea EM, 2002, NEUROTOXICOLOGY, V23, P329, DOI 10.1016/S0161-813X(02)00077-3; OSTREA EM, 1993, J PEDIATR-US, V122, P152, DOI 10.1016/S0022-3476(05)83509-7; Ostrea Jr EM, 1998, PEDIATR RES, V43, P224; Paulson JA, 2011, PEDIATRICS, V127, P983, DOI 10.1542/peds.2011-0523; Pueschel SM, 1996, LEAD POISONING CHILD; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Rastogi S, 2007, J PERINAT MED, V35, P492, DOI 10.1515/JPM.2007.131; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; Tian LL, 2009, BIOL TRACE ELEM RES, V132, P51, DOI 10.1007/s12011-009-8391-0; Trasande L, 2005, ENVIRON HEALTH PERSP, V113, P590, DOI 10.1289/ehp.7743; Turker G, 2006, BIOL NEONATE, V89, P244, DOI 10.1159/000089953; U.S. Environmental Protection Agency, 2013, EPA VIEWS CHILDH SEQ; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; von Ehrenstein OS, 2006, AM J EPIDEMIOL, V163, P662, DOI 10.1093/aje/kwj089; Wang SL, 2007, ENVIRON INT, V33, P805, DOI 10.1016/j.envint.2007.03.004; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wu WT, 2009, SCI TOTAL ENVIRON, V407, P5931, DOI 10.1016/j.scitotenv.2009.07.025; Yu XD, 2011, NEUROTOXICOL TERATOL, V33, P437, DOI 10.1016/j.ntt.2011.05.010	46	49	51	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109984	10.1371/journal.pone.0109984	http://dx.doi.org/10.1371/journal.pone.0109984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299345	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200093
J	Luo, S; Li, SW; Jin, S; Li, Y; Zhang, YY				Luo, Shan; Li, Shangwei; Jin, Song; Li, Ya; Zhang, Yaoyao			Effectiveness of GnRH Antagonist in the Management of Subfertile Couples Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: A Meta-Analysis	PLOS ONE			English	Article							PREMATURE LH SURGE; PREGNANCY RATES; HORMONE ANTAGONIST; CYCLES; OVULATION; LUTEINIZATION; MULTICENTER; CETRORELIX; GANIRELIX; FSH	Background: Recent studies have indicated the use of gonadotropin-releasing hormone antagonists (GnRH-ant) as an adjuvant treatment to prevent premature luteinization (PL) and improve the clinical outcomes in patients undergoing controlled ovarian stimulation (COS) with intrauterine insemination (IUI). However, the results of these studies are conflicting. Methods: We conducted a systematic review and meta-analysis of randomized trials aiming to compare the clinical efficacy of GnRH-ant in COS/IUI cycles. Twelve studies were identified that met inclusion criteria and comprised 2,577 cycles assigned to COS/IUI combined GnRH-ant or COS/IUI alone. Results: Meta-analysis results suggested that GnRH-ant can significantly increase the clinical pregnancy rate (CPR) (OR = 1.42; 95% CI, 1.13-1.78) and decrease the PL rate (OR = 0.22, 95% CI, 0.16-0.30) in COS/IUI cycles. Subgroup analysis results suggested statistically significant improvement in the CPR in non-PCOS patients (OR = 1.54; 95% CI, 1.03-2.31) but not in the PCOS population (OR = 1.65; 95% CI, 0.93-2.94) and multiple mature follicle cycles (OR = 1.87; 95% CI, 0.27-12.66). There were no difference in the miscarriage and multiple pregnancy rates between the groups. Conclusion: This meta-analysis suggested that GnRH-ant can reduce the incidence of PL and increase the CPR when used in COS/IUI cycles, and it was especially useful for non-PCOS patients. However, evidence to support its use in PCOS patients is still insufficient	[Luo, Shan; Li, Shangwei; Jin, Song; Li, Ya; Zhang, Yaoyao] Sichuan Univ, West China Univ Hosp 2, Div Reprod Med Ctr, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Li, SW (corresponding author), Sichuan Univ, West China Univ Hosp 2, Div Reprod Med Ctr, Chengdu 610064, Sichuan, Peoples R China.	lswivf2013@sina.com	Zhang, Yaoyao/GWD-0693-2022					Allegra A, 2007, HUM REPROD, V22, P101, DOI 10.1093/humrep/del337; Bakas P, 2011, FERTIL STERIL, V95, P2024, DOI 10.1016/j.fertnstert.2011.01.167; Cantineau AEP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005356.pub2; Cantineau AEP, 2011, HUM REPROD, V26, P1104, DOI 10.1093/humrep/der033; Cantineau AEP, 2007, FERTIL STERIL, V88, P107, DOI 10.1016/j.fertnstert.2006.11.136; Checa MA, 2006, FERTIL STERIL, V85, P573, DOI 10.1016/j.fertnstert.2005.08.040; Crosignani PG, 2007, HUM REPROD, V22, P500, DOI 10.1093/humrep/del416; Ertunc D, 2010, FERTIL STERIL, V93, P1179, DOI 10.1016/j.fertnstert.2008.11.030; Gomez-Palomares JL, 2005, HUM REPROD, V20, P368, DOI 10.1093/humrep/deh602; Gomez-Palomares JL, 2008, FERTIL STERIL, V89, P620, DOI 10.1016/j.fertnstert.2007.03.035; Graziano A, 2013, EUR REV MED PHARMACO, V17, P1604; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; Houmard BS, 2002, FERTIL STERIL, V77, P384, DOI 10.1016/S0015-0282(01)02990-9; Kamath MS, 2013, EUR J OBSTET GYN R B, V166, P168, DOI 10.1016/j.ejogrb.2012.09.023; Kosmas IP, 2008, FERTIL STERIL, V90, P367, DOI 10.1016/j.fertnstert.2007.06.064; Lambalk CB, 2006, HUM REPROD, V21, P632, DOI 10.1093/humrep/dei386; Lee TH, 2008, FERTIL STERIL, V90, P113, DOI 10.1016/j.fertnstert.2007.06.029; Lin YH, 2008, REPROD BIOMED ONLINE, V16, P772, DOI 10.1016/S1472-6483(10)60141-1; LOUMAYE E, 1989, FERTIL STERIL, V51, P105; Martinez-Salazar J, 2009, REPROD BIOMED ONLINE, V19, P156, DOI 10.1016/S1472-6483(10)60066-1; Matorras R, 2002, HUM REPROD, V17, P2107, DOI 10.1093/humrep/17.8.2107; Matorras R, 2006, J ASSIST REPROD GEN, V23, P51, DOI 10.1007/s10815-005-9019-8; Ragni G, 2001, HUM REPROD, V16, P2258, DOI 10.1093/humrep/16.11.2258; Ragni G, 2004, HUM REPROD, V19, P54, DOI 10.1093/humrep/deh023; Ragni G, 2004, FERTIL STERIL, V82, P25, DOI 10.1016/j.fertnstert.2004.01.028; Stadtmauer LA, 2011, FERTIL STERIL, V95, P216, DOI 10.1016/j.fertnstert.2010.05.023; Steward RG, 2011, FERTIL STERIL, V95, P434, DOI 10.1016/j.fertnstert.2010.07.1076; The European and Middle East Orgalutran Study Group, 2001, HUM REPROD, V16, P644; Verhulst SM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001838.pub3; Williams RS, 2004, AM J OBSTET GYNECOL, V191, P648, DOI 10.1016/j.ajog.2004.06.072	33	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109133	10.1371/journal.pone.0109133	http://dx.doi.org/10.1371/journal.pone.0109133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299186	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200036
J	Passini, R; Cecatti, JG; Lajos, GJ; Tedesco, RP; Nomura, ML; Dias, TZ; Haddad, SM; Rehder, PM; Pacagnella, RC; Costa, ML; Sousa, MH				Passini, Renato, Jr.; Cecatti, Jose G.; Lajos, Giuliane J.; Tedesco, Ricardo P.; Nomura, Marcelo L.; Dias, Tabata Z.; Haddad, Samira M.; Rehder, Patricia M.; Pacagnella, Rodolfo C.; Costa, Maria L.; Sousa, Maria H.		Brazilian Multicentre Study Preter	Brazilian Multicentre Study on Preterm Birth (EMIP): Prevalence and Factors Associated with Spontaneous Preterm Birth	PLOS ONE			English	Article							MULTIPLE PREGNANCY; SHORT CERVIX; EPIDEMIOLOGY; METAANALYSIS; COUNTRIES; RISK	Background: Preterm birth rate is increasing and is currently a worldwide concern. The purpose of this study was to estimate the prevalence of preterm birth in a sample of health facilities in Brazil and to identify the main risk factors associated with spontaneous preterm births. Methods and Findings: This was a multicentre cross sectional study on preterm births in 20 referral obstetric hospitals with a case-control component to identify factors associated with spontaneous preterm birth. Surveillance was implemented at all centres to identify preterm births. For eligible consenting women, data were collected through a post-delivery questionnaire completed with information from all mother-newborn medical records until death or discharge or at a maximum of 60 days post-delivery, whichever came first. The risk of spontaneous preterm birth was estimated with OR and 95%CI for several predictors. A non-conditional logistic regression analysis was then performed to identify independently associated factors. The overall prevalence of preterm birth was 12.3%. Among them, 64.6% were spontaneous and 35.4% therapeutic. In the case-control component, 2,682 spontaneous preterm births were compared to a sample of 1,146 term births. Multivariate analyses identified the following as risk factors for spontaneous preterm birth among women with at least one previous birth: a previous preterm birth (ORadj = 3.19, 2.30-4.43), multiple pregnancy (ORadj = 29.06, 8.43-100.2), cervical insufficiency (ORadj = 2.93, 1.07-8.05), foetal malformation (ORadj = 2.63, 1.43-4.85), polyhydramnios (ORadj = 2.30, 1.17-4.54), vaginal bleeding (ORadj = 2.16, 1.50-3.11), and previous abortion (ORadj = 1.39, 1.08-1.78). High BMI (ORadj = 0.94, 0.91-0.97) and weight gain during gestation (ORadj = 0.92, 0.89-0.95) were found to be protective factors. Conclusions: The preterm birth rate in these health facilities in Brazil is high and spontaneous preterm births account for two thirds of them. A better understanding of the factors associated with spontaneous preterm birth is of utmost importance for planning effective measures to reduce the burden of its increasing rates.	[Passini, Renato, Jr.; Cecatti, Jose G.; Lajos, Giuliane J.; Tedesco, Ricardo P.; Nomura, Marcelo L.; Dias, Tabata Z.; Haddad, Samira M.; Rehder, Patricia M.; Pacagnella, Rodolfo C.; Costa, Maria L.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil; [Cecatti, Jose G.; Sousa, Maria H.] Ctr Studies Reprod Hlth Campinas CEMICAMP, Campinas, SP, Brazil; [Tedesco, Ricardo P.] Jundiai Sch Med, Jundiai, Brazil	Universidade Estadual de Campinas; Faculdade de Medicina de Jundiai	Passini, R (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.	passini@caism.unicamp.br	Nomura, Marcelo Luís/H-9534-2019; Sousa, Maria/HCI-9642-2022; Souza, Renato T/G-4205-2017; Rehder, Patricia Moretti/N-6731-2015; Passini Junior, Renato/O-6169-2016; Dias, TÃbata/U-4512-2019; de Carvalho Pacagnella, Rodolfo/H-9390-2019; BORGES, VERA T/B-7363-2014; Quintana, Silvana Maria/D-6953-2015; Cecatti, Jose Guilherme/M-5945-2013; Jesus Lajos, Giuliane/GQZ-0157-2022; Amorim, Melania/C-5807-2013; VETTORAZZI, JANETE/H-7484-2013	Nomura, Marcelo Luís/0000-0002-2664-4475; Souza, Renato T/0000-0002-9075-9269; Passini Junior, Renato/0000-0001-8247-4549; de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; BORGES, VERA T/0000-0002-9347-9641; Quintana, Silvana Maria/0000-0002-9311-786X; Cecatti, Jose Guilherme/0000-0003-1285-8445; Amorim, Melania/0000-0003-1047-2514; VETTORAZZI, JANETE/0000-0001-9278-6861; costa, maria laura/0000-0001-8280-3234	CNPq (Brazilian National Research Council); Fapesp (Foundation for Support to Research of the State of Sao Paulo) [Fapesp 2009/53245-5 (Call AP.PPSUS-1)]	CNPq (Brazilian National Research Council)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapesp (Foundation for Support to Research of the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank the CNPq (Brazilian National Research Council) and Fapesp (Foundation for Support to Research of the State of Sao Paulo) for the financial sponsorship of this study, Process Fapesp 2009/53245-5 (Call AP.PPSUS-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aleem H, 2013, COCHRANE DB SYST REV, V5; Ananth CV, 2006, AM J OBSTET GYNECOL, V195, P1557, DOI 10.1016/j.ajog.2006.05.021; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Blondel B, 2006, BJOG-INT J OBSTET GY, V113, P528, DOI 10.1111/j.1471-0528.2006.00923.x; Brazil. United Nation Organisation, 2013, UNICEF SUPP STUD WAR; Brazilian Ministry of Health, 2011, SINASC NAT INF SYST; da Fonseca EB, 2009, SEMIN PERINATOL, V33, P334, DOI 10.1053/j.semperi.2009.06.006; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Hamilton BE, 2011, NATL VITAL STAT REP, V60, P1; Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021; Lajos GJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-54; Lim K, 2011, J OBSTET GYNAECOL CA, V33, P486, DOI 10.1016/S1701-2163(16)34884-8; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Passini R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-22; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Polyzos NP, 2009, AM J OBSTET GYNECOL, V200, P225, DOI 10.1016/j.ajog.2008.09.020; Reis Liane G., 2008, Rev. Bras. Saude Mater. Infant., V8, P217, DOI 10.1590/S1519-38292008000200009; Serruya Suzanne Jacob, 2004, Cad. Saúde Pública, V20, P1281, DOI 10.1590/S0102-311X2004000500022; Shiozaki A, 2014, J OBSTET GYNAECOL RE, V40, P53, DOI 10.1111/jog.12120; Steer P, 2005, BJOG-INT J OBSTET GY, V112, P1, DOI 10.1111/j.1471-0528.2005.00575.x; Tedesco RP, 2013, MATERN CHILD HLTH J, V17, P1638, DOI 10.1007/s10995-012-1177-6; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Zhang YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052780	31	60	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109069	10.1371/journal.pone.0109069	http://dx.doi.org/10.1371/journal.pone.0109069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299699	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200033
J	Daly, R; Smale, MJ; Cowley, PD; Froneman, PW				Daly, Ryan; Smale, Malcolm J.; Cowley, Paul D.; Froneman, Pierre W.			Residency Patterns and Migration Dynamics of Adult Bull Sharks (Carcharhinus leucas) on the East Coast of Southern Africa	PLOS ONE			English	Article							SITE FIDELITY; MOVEMENT PATTERNS; TERM MOVEMENTS; APEX PREDATOR; HABITAT USE; CONSERVATION; ECOSYSTEM; BEHAVIOR; OCEAN; MANAGEMENT	Bull sharks (Carcharhinus leucas) are globally distributed top predators that play an important ecological role within coastal marine communities. However, little is known about the spatial and temporal scales of their habitat use and associated ecological role. In this study, we employed passive acoustic telemetry to investigate the residency patterns and migration dynamics of 18 adult bull sharks (195283 cm total length) tagged in southern Mozambique for a period of between 10 and 22 months. The majority of sharks (n = 16) exhibited temporally and spatially variable residency patterns interspersed with migration events. Ten individuals undertook coastal migrations that ranged between 433 and 709 km (mean = 533 km) with eight of these sharks returning to the study site. During migration, individuals exhibited rates of movement between 2 and 59 km.d(-1) (mean = 17.58 km.d(-1)) and were recorded travelling annual distances of between 450 and 3760 km (mean = 1163 km). Migration towards lower latitudes primarily took place in austral spring and winter and there was a significant negative correlation between residency and mean monthly sea temperature at the study site. This suggested that seasonal change is the primary driver behind migration events but further investigation is required to assess how foraging and reproductive activity may influence residency patterns and migration. Results from this study highlight the need for further understanding of bull shark migration dynamics and suggest that effective conservation strategies for this vulnerable species necessitate the incorporation of congruent trans-boundary policies over large spatial scales.	[Daly, Ryan; Froneman, Pierre W.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Daly, Ryan; Smale, Malcolm J.] Humewood, Port Elizabeth Museum Bayworld, Port Elizabeth, South Africa; [Cowley, Paul D.] SAIAB, Grahamstown, South Africa; [Smale, Malcolm J.] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa	Rhodes University; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Nelson Mandela University	Daly, R (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa.	ryandaly.mail@gmail.com	Froneman, William/C-9085-2012; Froneman, William/GLS-0460-2022; Cowley, Paul/M-4264-2017	Froneman, William/0000-0003-0615-1355; Cowley, Paul/0000-0003-1246-4390; Smale, Malcolm/0000-0002-1135-8687	Professional Development Programme of the South African National Research Foundation; Port Elizabeth Museum at Bayworld; Rhodes University; Bayworld Centre for Research and Education; Ocean Tracking Network; Save Our Seas Foundation; National Research Foundation of South Africa	Professional Development Programme of the South African National Research Foundation; Port Elizabeth Museum at Bayworld; Rhodes University; Bayworld Centre for Research and Education; Ocean Tracking Network; Save Our Seas Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa)	Funding and support were provided by the Professional Development Programme of the South African National Research Foundation (www.nrf.ac.za), Port Elizabeth Museum at Bayworld (www.bayworld.co.za), Rhodes University (www.ru.ac.za), and Bayworld Centre for Research and Education who administered the grant, 3 Fathoms Research, the Acoustic Tracking Array Platform maintained by the South African Institute for Aquatic Biodiversity (www.saiab.co.za) with support from the Ocean Tracking Network (www.oceantrackingnetwork.org) funded in part by the Save Our Seas Foundation (www.saveourseas.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the contributing funders of this study (the National Research Foundation of South Africa) only provided funding for one of the authors' salaries (RD). This funding was awarded to the Port Elizabeth Museum at Bayworld and administered by the Bayworld Centre for Research and Education. The Port Elizabeth Museum at Bayworld and Bayworld Centre for Research and Education are not commercial businesses. The Port Elizabeth Museum at Bayworld had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes KG, 2011, MAR ECOL PROG SER, V442, P133, DOI 10.3354/meps09395; Bansemer CS, 2011, MAR FRESHWATER RES, V62, P596, DOI 10.1071/MF10152; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Batschelet E, 1981, CIRCULAR STAT BIOL; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Compagno LJV, 1984, FAO FISHERIES SYNO 2, P250; Daly R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078229; DiGirolamo AL, 2012, J FISH BIOL, V80, P1436, DOI 10.1111/j.1095-8649.2012.03263.x; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Filmalter JD, 2013, MAR BIOL, V160, P2425, DOI 10.1007/s00227-013-2237-1; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Holdo RM, 2011, ANIMAL MIGRATION: A SYNTHESIS, P131; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Kessel ST, 2013, REV FISH BIOL FISHER, P1; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; Mann B. Q., 2000, SO AFRICAN MARINE LI; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; RAMSAY PJ, 1994, MAR GEOL, V120, P225, DOI 10.1016/0025-3227(94)90060-4; RIEGL B, 1995, B MAR SCI, V56, P676; Russell GS, 1996, COMMUNICATIONS STAT, V24, P879; Shuter JL, 2011, ANIMAL MIGRATION: A SYNTHESIS, P172; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Sink K, 2004, S AFRICAN NATL SPATI, V4; Smale MJ., 1986, S AFRICAN J MARINE S, V4, P11, DOI [10.2989/025776186784461873, DOI 10.2989/025776186784461873]; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Speed CW, 2012, CORAL REEFS, V31, P357, DOI 10.1007/s00338-011-0850-3; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stevens JD, 1999, FISH MOVEMENT MIGRAT, P65; Turpie JK, 2000, BIOL CONSERV, V92, P59, DOI 10.1016/S0006-3207(99)00063-4; Warkentin IG, 1996, BIOL CONSERV, V77, P143, DOI 10.1016/0006-3207(95)00146-8; Welsh JQ, 2012, CORAL REEFS, V31, P991, DOI 10.1007/s00338-012-0922-z; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Wintner SP, 2002, MAR FRESHWATER RES, V53, P557, DOI 10.1071/MF01062; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	54	58	59	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109357	10.1371/journal.pone.0109357	http://dx.doi.org/10.1371/journal.pone.0109357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295972	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000065
J	Ernest, HB; Vickers, TW; Morrison, SA; Buchalski, MR; Boyce, WM				Ernest, Holly B.; Vickers, T. Winston; Morrison, Scott A.; Buchalski, Michael R.; Boyce, Walter M.			Fractured Genetic Connectivity Threatens a Southern California Puma (Puma concolor) Population	PLOS ONE			English	Article							MOUNTAIN LIONS; EMPIRICAL-EVALUATION; COMPUTER-PROGRAM; RELATEDNESS; SIZE; MICROSATELLITES; ASSIGNMENT; INFERENCE; PARENTAGE; SOFTWARE	Pumas (Puma concolor; also known as mountain lions and cougars) in southern California live among a burgeoning human population of roughly 20 million people. Yet little is known of the consequences of attendant habitat loss and fragmentation, and human-caused puma mortality to puma population viability and genetic diversity. We examined genetic status of pumas in coastal mountains within the Peninsular Ranges south of Los Angeles, in San Diego, Riverside, and Orange counties. The Santa Ana Mountains are bounded by urbanization to the west, north, and east, and are separated from the eastern Peninsular Ranges to the southeast by a ten lane interstate highway (I-15). We analyzed DNA samples from 97 pumas sampled between 2001 and 2012. Genotypic data for forty-six microsatellite loci revealed that pumas sampled in the Santa Ana Mountains (n = 42) displayed lower genetic diversity than pumas from nearly every other region in California tested (n = 257), including those living in the Peninsular Ranges immediately to the east across I-15 (n = 55). Santa Ana Mountains pumas had high average pairwise relatedness, high individual internal relatedness, a low estimated effective population size, and strong evidence of a bottleneck and isolation from other populations in California. These and ecological findings provide clear evidence that Santa Ana Mountains pumas have been experiencing genetic impacts related to barriers to gene flow, and are a warning signal to wildlife managers and land use planners that mitigation efforts will be needed to stem further genetic and demographic decay in the Santa Ana Mountains puma population.	[Ernest, Holly B.; Vickers, T. Winston; Buchalski, Michael R.; Boyce, Walter M.] Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; [Ernest, Holly B.; Buchalski, Michael R.] Univ Calif Davis, Sch Vet Med, Vet Genet Lab, Wildlife & Ecol Unit, Davis, CA 95616 USA; [Morrison, Scott A.] Nature Conservancy, San Francisco, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; Nature Conservancy	Ernest, HB (corresponding author), Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA.	hernest@uwyo.edu	Ernest, Holly/D-5731-2012	Ernest, Holly/0000-0002-0205-8818	California State Parks; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation	California State Parks; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation(National Science Foundation (NSF))	The work was supported by the following: California State Parks (WMB; http://www.parks.ca.gov/), California Department of Fish and Wildlife (HBE, WMB; https://www.dfg.ca.gov/), The Nature Conservancy (WMB, SAM; http://www.nature.org/); The McBeth Foundation (WMB; http://mcbethfoundation.com/); The Anza Borrego Foundation (WMB; http://theabf.org/), Nature Reserve of Orange County (WMB; http://www.naturereserveoc.org/); The National Science Foundation (WMB; http://www.nsf.gov/); and private donors (HBE, WMB). The Nature Conservancy (SAM) helped with sample and data collection and preparation of the manuscript. California Department of Fish and Wildlife, helped with sample and data collection. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho JS, 2010, MOL ECOL RESOUR, V10, P720, DOI 10.1111/j.1755-0998.2010.02830.x; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; [Anonymous], 1978, MULTIVARIATE ANAL VE; Barbour E, 2002, METROPOLITAN GROWTH, P246; BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beier Paul, 1996, P293; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Culver M, 2008, ANIM CONSERV, V11, P104, DOI 10.1111/j.1469-1795.2007.00154.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ernest HB, 2000, MOL ECOL, V9, P433, DOI 10.1046/j.1365-294x.2000.00890.x; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kurushima JD, 2006, MOL ECOL NOTES, V6, P1260, DOI 10.1111/j.1471-8286.2006.01508.x; Logan K, 2001, DESERT PUMA EVOLUTIO, P464; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Luke C, 2004, REPORT UNPUB; Lynch M, 1999, GENETICS, V152, P1753; Mansfield TM, 1994, P 16 VERT PEST C SAN; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Morrison SA, 2009, CONSERV BIOL, V23, P275, DOI 10.1111/j.1523-1739.2008.01079.x; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2002, DOCUMENTATION STRUCT; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Riley SPD, 2014, CURR BIOL, V24, P1989, DOI 10.1016/j.cub.2014.07.029; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; US Census Bureau, 2012, 2010 CENS POP HOUS S; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang JL, 2012, GENETICS, V191, P183, DOI 10.1534/genetics.111.138149; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	55	50	50	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107985	10.1371/journal.pone.0107985	http://dx.doi.org/10.1371/journal.pone.0107985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295530	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000012
J	Feng, Y; Di, Y; Chen, T; Liu, J; Tong, X; Yang, L; Da, M; Shen, ST; Fan, CF; Wang, S; Mo, XM				Feng, Yu; Yu, Di; Chen, Tao; Liu, Jin; Tong, Xing; Yang, Lei; Da, Min; Shen, Shutong; Fan, Changfeng; Wang, Song; Mo, Xuming			Maternal Parity and the Risk of Congenital Heart Defects in Offspring: A Dose-Response Meta-Analysis of Epidemiological Observational Studies	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; FOLIC-ACID; CARDIOVASCULAR DEFECTS; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; CARDIAC DEFECTS; BIRTH OUTCOMES; DISEASE; TEXAS; ASSOCIATION	Background: Epidemiological studies have reported conflicting results regarding maternal parity and the risk of congenital heart defects (CHDs). However, a meta-analysis of the association between maternal parity and CHDs in offspring has not been conducted. Methods: We searched MEDLINE and EMBASE for articles catalogued between their inception and March 8, 2014; we identified relevant published studies that assessed the association between maternal parity and CHD risk. Two authors independently assessed the eligibility of the retrieved articles and extracted data from them. Study-specific relative risk estimates were pooled by random-effects or fixed-effects models. From the 11272 references, a total of 16 case-control studies and 3 cohort studies were enrolled in this meta-analysis. Results: The overall relative risk of CHD in parous versus nulliparous women was 1.01 (95% CI, 0.97-1.06; Q = 32.34; P = 0.006; I-2 = 53.6%). Furthermore, we observed a significant association between the highest versus lowest parity number, with an overall RR = 1.20 (95% CI, 1.10-1.31; (Q = 74.61, P<0.001, I-2 = 82.6%). A dose-response analysis also indicated a positive effect of maternal parity on CHD risk, and the overall increase in relative risk per one live birth was 1.06 (95% CI, 1.02-1.09); Q = 68.09; P<0.001; I-2 = 80.9%). We conducted stratified and meta-regression analyses to identify the origin of the heterogeneity among studies. A Galbraith plot was created to graphically assess the sources of heterogeneity. Conclusion: In summary, this meta-analysis provided a robust estimate of the positive association between maternal parity and risk of CHD.	[Feng, Yu; Yu, Di; Yang, Lei; Da, Min; Fan, Changfeng; Wang, Song; Mo, Xuming] Nanjing Med Univ, Affiliated Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Chen, Tao; Liu, Jin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Tong, Xing] Nanjing Med Univ, Atherosclerosis Res Ctr, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Shen, Shutong] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Mo, XM (corresponding author), Nanjing Med Univ, Affiliated Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China.	mohsuming15@sina.com		Liu, Jin/0000-0002-0557-026X				ADAMS MM, 1989, J AM COLL CARDIOL, V14, P432, DOI 10.1016/0735-1097(89)90199-X; Agopian A, 2009, AM J MED GENET A, V149A, P2129, DOI 10.1002/ajmg.a.33000; Alverson CJ, 2011, PEDIATRICS, V127, pE647, DOI 10.1542/peds.2010-1399; Baird J T Jr, 1972, Vital Health Stat 11, P1; Batra M, 2007, ARCH PEDIAT ADOL MED, V161, P89, DOI 10.1001/archpedi.161.1.89; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benjamin BG, 2010, BIRTH DEFECTS RES A, V88, P178, DOI 10.1002/bdra.20642; BERNSTEIN L, 1986, J NATL CANCER I, V76, P1035; Bianca S, 2003, DIS ESOPHAGUS, V16, P39, DOI 10.1046/j.1442-2050.2003.00283.x; Brentlinger PE, 2001, NEW ENGL J MED, V344, P933; Canfield MA, 2009, PAEDIATR PERINAT EP, V23, P41, DOI 10.1111/j.1365-3016.2008.00975.x; Carmichael SL, 2007, PAEDIATR PERINAT EP, V21, P210, DOI 10.1111/j.1365-3016.2007.00809.x; Cedergren MI, 2006, EUR J OBSTET GYN R B, V125, P211, DOI 10.1016/j.ejogrb.2005.07.006; Cedergren MI, 2002, SCAND J WORK ENV HEA, V28, P12, DOI 10.5271/sjweh.641; Chubak J, 2004, CANCER EPIDEM BIOMAR, V13, P1296; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Duong HT, 2012, BIRTH DEFECTS RES A, V94, P230, DOI 10.1002/bdra.22889; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GIBSON S, 1952, AMA AM J DIS CHILD, V83, P317, DOI 10.1001/archpedi.1952.02040070063007; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Grisaru-Granovsky S, 2009, CONTRACEPTION, V80, P512, DOI 10.1016/j.contraception.2009.06.006; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hashmi SS, 2005, AM J MED GENET A, V134A, P368, DOI 10.1002/ajmg.a.30618; HAY S, 1972, TERATOLOGY, V6, P271, DOI 10.1002/tera.1420060304; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Langlois PH, 2009, BIRTH DEFECTS RES A, V85, P764, DOI 10.1002/bdra.20586; Liu SL, 2013, CIRCULATION, V128, P583, DOI 10.1161/CIRCULATIONAHA.112.001054; Long J, 2010, BIRTH DEFECTS RES A, V88, P971, DOI 10.1002/bdra.20724; Luo YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081369; Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Padula AM, 2013, PAEDIATR PERINAT EP, V27, P329, DOI 10.1111/ppe.12055; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pradat P, 2003, PEDIATR CARDIOL, V24, P195, DOI 10.1007/s00246-002-9401-6; Rosenquist TH, 1996, P NATL ACAD SCI USA, V93, P15227, DOI 10.1073/pnas.93.26.15227; Rovas L, 2006, ULTRASOUND OBST GYN, V28, P761, DOI 10.1002/uog.2857; Smedts HPM, 2012, NUTR METAB CARDIOVAS, V22, P477, DOI 10.1016/j.numecd.2010.07.016; STOLL C, 1989, EUR J EPIDEMIOL, V5, P382, DOI 10.1007/BF00144842; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; STUCKEY D, 1956, BRIT HEART J, V18, P519; Torfs CP, 1999, EPIDEMIOLOGY, V10, P264, DOI 10.1097/00001648-199905000-00013; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Vereczkey A, 2013, BIRTH DEFECTS RES A, V97, P217, DOI 10.1002/bdra.23124; Vereczkey A, 2012, J MATERN-FETAL NEO M, V25, P2536, DOI 10.3109/14767058.2012.712568; Vieira AR, 2004, J NEUROL SCI, V217, P65, DOI 10.1016/j.jns.2003.08.014; Wells G., 2013, NEWCASTLE OTTAWA SCA; Werler MM, 2009, BIRTH DEFECTS RES A, V85, P52, DOI 10.1002/bdra.20524; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Zhu JL, 2013, PEDIATRICS, V131, pE1225, DOI 10.1542/peds.2012-3024	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108944	10.1371/journal.pone.0108944	http://dx.doi.org/10.1371/journal.pone.0108944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295723	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000028
J	Kiel, S; Glodny, J; Birgel, D; Bulot, LG; Campbell, KA; Gaillard, C; Graziano, R; Kaim, A; Lazar, I; Sandy, MR; Peckmann, J				Kiel, Steffen; Glodny, Johannes; Birgel, Daniel; Bulot, Luc G.; Campbell, Kathleen A.; Gaillard, Christian; Graziano, Roberto; Kaim, Andrzej; Lazar, Iuliana; Sandy, Michael R.; Peckmann, Joern			The Paleoecology, Habitats, and Stratigraphic Range of the Enigmatic Cretaceous Brachiopod Peregrinella	PLOS ONE			English	Article							METHANE-SEEP DEPOSITS; STRONTIUM ISOTOPE STRATIGRAPHY; PLATFORM GARGANO PROMONTORY; MESOZOIC CONVERGENT MARGIN; ANCIENT HYDROCARBON SEEPS; FORE-ARC BASIN; COLD-SEEP; HYDROTHERMAL VENT; ANAEROBIC OXIDATION; ALEXANDER ISLAND	Modern and Cenozoic deep-sea hydrothermal-vent and methane-seep communities are dominated by large tubeworms, bivalves and gastropods. In contrast, many Early Cretaceous seep communities were dominated by the largest Mesozoic rhynchonellid brachiopod, the dimerelloid Peregrinella, the paleoecologic and evolutionary traits of which are still poorly understood. We investigated the nature of Peregrinella based on 11 occurrences world wide and a literature survey. All in situ occurrences of Peregrinella were confirmed as methane-seep deposits, supporting the view that Peregrinella lived exclusively at methane seeps. Strontium isotope stratigraphy indicates that Peregrinella originated in the late Berriasian and disappeared after the early Hauterivian, giving it a geologic range of ca. 9.0 (+1.45/-0.85) million years. This range is similar to that of rhynchonellid brachiopod genera in general, and in this respect Peregrinella differs from seep-inhabiting mollusks, which have, on average, longer geologic ranges than marine mollusks in general. Furthermore, we found that (1) Peregrinella grew to larger sizes at passive continental margins than at active margins; (2) it grew to larger sizes at sites with diffusive seepage than at sites with advective fluid flow; (3) despite its commonly huge numerical abundance, its presence had no discernible impact on the diversity of other taxa at seep sites, including infaunal chemosymbiotic bivalves; and (4) neither its appearance nor its extinction coincides with those of other seep-restricted taxa or with global extinction events during the late Mesozoic. A preference of Peregrinella for diffusive seepage is inferred from the larger average sizes of Peregrinella at sites with more microcrystalline carbonate (micrite) and less seep cements. Because other seep-inhabiting brachiopods occur at sites where such cements are very abundant, we speculate that the various vent- and seep-inhabiting dimerelloid brachiopods since Devonian time may have adapted to these environments in more than one way.	[Kiel, Steffen] Univ Gottingen, Geowissensch Zentrum, Abt Geobiol, D-37073 Gottingen, Germany; [Glodny, Johannes] Deutsch GeoForschungsZentrum GFZ, Sekt Anorgan & Isotopengeochem 4 2, Potsdam, Germany; [Birgel, Daniel; Peckmann, Joern] Univ Vienna, Erdwissensch Zentrum, Dept Geodynam & Sedimentol, Vienna, Austria; [Bulot, Luc G.] Univ Aix Marseille 1, Ctr Sedimentol Paleontol, FRE CNRS 2761, Marseille, France; [Campbell, Kathleen A.] Univ Auckland, Sch Environm Sci, Geol Programme, Auckland 1, New Zealand; [Gaillard, Christian] Univ Lyon 1, UMR CNRS Paleoenvironm & Paleobiosphere 5125, F-69622 Villeurbanne, France; [Graziano, Roberto] Univ Naples Federico II, Dipartimento Sci Terra Ambiente & Risorse, Naples, Italy; [Kaim, Andrzej] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Lazar, Iuliana] Univ Bucharest, Fac Geol & Geophys, Dept Geol, Bucharest, Romania; [Sandy, Michael R.] Univ Dayton, Dept Geol, Dayton, OH 45469 USA	University of Gottingen; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Vienna; UDICE-French Research Universities; Aix-Marseille Universite; University of Auckland; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Naples Federico II; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Bucharest; University of Dayton	Kiel, S (corresponding author), Univ Gottingen, Geowissensch Zentrum, Abt Geobiol, D-37073 Gottingen, Germany.	skiel@uni-goettingen.de	Bulot, Luc G/C-8255-2013; Kaim, Andrzej/G-6244-2010; Bulot, Luc/M-7815-2019; Glodny, Johannes/P-7959-2017; Kiel, Steffen/C-3150-2009	Bulot, Luc G/0000-0002-2817-9327; Kaim, Andrzej/0000-0001-6186-5356; Bulot, Luc/0000-0002-2817-9327; Glodny, Johannes/0000-0002-7812-5933; Kiel, Steffen/0000-0001-6281-100X; Peckmann, Jorn/0000-0002-8572-0060; Lazar, Iuliana/0000-0003-1111-7207; Graziano, Roberto/0000-0002-0318-5835; Campbell, Kathleen/0000-0002-4815-2519	Deutsche Forschungsgemeinschaft [Ki802/6-1]; National Science Centre, Poland [2012/07/B/ST/10/04189]; American Chemical Society - Petroleum Research Fund; Open Access Publication Funds of the Georg-August-University Gottingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Centre, Poland(National Science Centre, Poland); American Chemical Society - Petroleum Research Fund(American Chemical Society); Open Access Publication Funds of the Georg-August-University Gottingen	Financial support was provided by the Deutsche Forschungsgemeinschaft through grant Ki802/6-1 to SK; by the National Science Centre, Poland, through grant 2012/07/B/ST/10/04189 to AK; by the donors of the American Chemical Society - Petroleum Research Fund to MRS; and by the Open Access Publication Funds of the Georg-August-University Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager D. V., 1965, Palaeogeography Palaeoclimatology Palaeoecology, V1, P143, DOI 10.1016/0031-0182(65)90011-8; Ager D.V., 1986, Modern Geology, V10, P377; Agirrezabala LM, 2013, PALAEOGEOGR PALAEOCL, V390, P94, DOI 10.1016/j.palaeo.2012.11.020; Aharon P, 1997, GEOL SOC AM BULL, V109, P568, DOI 10.1130/0016-7606(1997)109<0568:RDOSHS>2.3.CO;2; Amano K, 2007, VELIGER, V49, P270; Amano K, 2007, VELIGER, V49, P84; Anderson F. M., 1938, Geological Society of America Special Paper, V16, P1; ASCHER E., 1906, BEITRAGE PALAONTOLOG, VXIX, P135; Bailey TR, 2000, CHEM GEOL, V167, P313, DOI 10.1016/S0009-2541(99)00235-1; BERKLAND JO, 1973, GEOL SOC AM BULL, V84, P2389, DOI 10.1130/0016-7606(1973)84<2389:RVOSOC>2.0.CO;2; Biernat G., 1957, ACTA PALAEONTOL POL, V2, P19; Birgel D, 2008, GEOLOGY, V36, P543, DOI 10.1130/G24690A.1; Birgel D, 2008, ORG GEOCHEM, V39, P152, DOI 10.1016/j.orggeochem.2007.08.013; Birgel D, 2006, ORG GEOCHEM, V37, P1289, DOI 10.1016/j.orggeochem.2006.02.004; Birgel D, 2008, ORG GEOCHEM, V39, P1659, DOI 10.1016/j.orggeochem.2008.01.023; Bodin S, 2006, PALAEOGEOGR PALAEOCL, V235, P245, DOI 10.1016/j.palaeo.2005.09.030; Boller K., 1963, Eclogae Geologicae Helvetiae, V56, P15; Bosellini A, 1997, CRETACEOUS RES, V18, P51, DOI 10.1006/cres.1996.0049; Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9; Brooks JM, 2009, 2 US DEP INT MIN MGM; Campbell K.A., 1993, ADV SEDIMENTARY GEOL, V73, P37; Campbell KA, 2006, PALAEOGEOGR PALAEOCL, V232, P362, DOI 10.1016/j.palaeo.2005.06.018; Campbell KA, 2002, GEOFLUIDS, V2, P63, DOI 10.1046/j.1468-8123.2002.00022.x; Campbell KA, 1995, PALEOBIOLOGY, V21, P461, DOI 10.1017/S0094837300013488; CAMPBELL KA, 1995, GEOLOGY, V23, P321, DOI 10.1130/0091-7613(1995)023<0321:BACBIP>2.3.CO;2; Campbell KA, 2008, J PALEONTOL, V82, P140, DOI 10.1666/05-025.1; Carroll M, 2008, GEO-MAR LETT, V28, P369, DOI 10.1007/s00367-008-0117-3; Chryploff G, 1958, Z ANGEW GEOL, V4, P70; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Gabb W. M., 1869, CALIFORNIA GEOLOGICA, V2, P1; Gabb W.M., 1866, CALIF GEOL SURV PALE, V2, P1; GAILLARD C, 1992, Palaios, V7, P451, DOI 10.2307/3514829; Gischler E, 2003, J PALEONTOL, V77, P293, DOI 10.1666/0022-3360(2003)077<0293:ICFARA>2.0.CO;2; GOOSSENS H, 1984, NATURE, V312, P440, DOI 10.1038/312440a0; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Graziano R, 1999, TERRA NOVA, V11, P245, DOI 10.1046/j.1365-3121.1999.00256.x; Graziano R, 2008, B SOC GEOL ITAL, V127, P407; Hammer O, 2011, PALAEOGEOGR PALAEOCL, V306, P15, DOI 10.1016/j.palaeo.2011.03.019; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Jenkins RG, 2007, GEOBIOLOGY, V5, P127, DOI 10.1111/j.1472-4669.2007.00106.x; Jenkins RG, 2013, ACTA PALAEONTOL POL, V58, P357, DOI 10.4202/app.2011.0026; Kaim A, 2008, ZOOL J LINN SOC-LOND, V154, P421, DOI 10.1111/j.1096-3642.2008.00431.x; Kaim A, 2014, ZOOTAXA, V3861, P401, DOI 10.11646/zootaxa.3861.5.1; Kaim A, 2013, PALAEOGEOGR PALAEOCL, V390, P42, DOI 10.1016/j.palaeo.2013.03.010; Kaim A, 2009, ACTA PALAEONTOL POL, V54, P463, DOI 10.4202/app.2009.0042; Kaim A, 2009, ANTARCT SCI, V21, P279, DOI 10.1017/S0954102009001813; Kaminski M.A., 1998, GRZYBOWSKI FDN SPECI, V6, P1; Keenan KE, 2010, THESIS U CALIFORNIA; Kelly SRA, 2000, GEOL SOC SPEC PUBL, V177, P227, DOI 10.1144/GSL.SP.2000.177.01.13; KELLY SRA, 1995, J SEDIMENT RES A, V65, P274; Kiel S, 2008, PALAIOS, V23, P751, DOI 10.2110/palo.2008.p08-052r; Kiel S, 2008, J PALEONTOL, V82, P1215, DOI 10.1666/08-003.1; Kiel S, 2008, ACTA PALAEONTOL POL, V53, P525, DOI 10.4202/app.2008.0310; Kiel S, 2006, SCIENCE, V313, P1429, DOI 10.1126/science.1126286; Kiel S, 2013, PALAEOGEOGR PALAEOCL, V390, P17, DOI 10.1016/j.palaeo.2012.10.033; Kiel S, 2013, J MOLLUS STUD, V79, P346, DOI 10.1093/mollus/eyt035; Kiel S, 2013, J PALEONTOL, V87, P589, DOI 10.1666/12-135; Kiel S, 2010, ZOOTAXA, P26, DOI 10.11646/zootaxa.2390.1.2; Kiel S, 2012, GEOLOGY, V40, P839, DOI 10.1130/G33300.1; Kiel S, 2010, PALAEOGEOGR PALAEOCL, V295, P245, DOI 10.1016/j.palaeo.2010.05.042; Kiel S, 2008, ACTA PALAEONTOL POL, V53, P679, DOI 10.4202/app.2008.0412; Lazar I, 2011, FACIES, V57, P627, DOI 10.1007/s10347-010-0261-x; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LEMOINE M, 1982, B SOC GEOL FR, V24, P641, DOI 10.2113/gssgfbull.S7-XXIV.3.641; Little CTS, 1999, GEOLOGY, V27, P167, DOI 10.1130/0091-7613(1999)027<0167:EJHVCF>2.3.CO;2; Luff R, 2003, GEOCHIM COSMOCHIM AC, V67, P3403, DOI 10.1016/S0016-7037(03)00127-3; MACDONALD IR, 1998, STABILITY CHANGE GUL; Macsotay O, 1980, THESIS U CLAUDE BERN; Mancenido MO, 2001, SYST ASSOC SPEC VOL, P189; McArthur JM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P127, DOI 10.1016/B978-0-444-59425-9.00007-X; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; MCARTHUR JM, 1994, TERRA NOVA, V6, P331, DOI 10.1111/j.1365-3121.1994.tb00507.x; Newman WA, 2006, DENISIA, V18, P359; Nielsen SN, 2009, PALAEOGEOGR PALAEOCL, V280, P480, DOI 10.1016/j.palaeo.2009.06.035; Niemann H, 2009, BIOGEOSCIENCES, V6, P2383, DOI 10.5194/bg-6-2383-2009; Nobuhara Takami, 2008, Fossils (Tokyo), P47; Ortiz-Hernandez L. E., 2003, REV MEX CIENC GEOL, V20, P27; PAULL CK, 1991, MAR GEOL, V102, P265, DOI 10.1016/0025-3227(91)90011-R; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Peckmann J, 2004, CHEM GEOL, V205, P443, DOI 10.1016/j.chemgeo.2003.12.025; Peckmann J, 2013, PALAEOGEOGR PALAEOCL, V390, P4, DOI 10.1016/j.palaeo.2013.01.003; Peckmann J, 2011, J GEOL, V119, P207, DOI 10.1086/658199; Peckmann J, 2007, PALAIOS, V22, P114, DOI 10.2110/palo.2005.p05-115r; Peckmann J, 2009, GEOLOGY, V37, P847, DOI 10.1130/G25658A.1; Posenato R, 1999, CRETACEOUS RES, V20, P641, DOI 10.1006/cres.1999.0171; Puceat E, 2005, EARTH PLANET SC LETT, V236, P705, DOI 10.1016/j.epsl.2005.03.015; Reinhardt EG, 2000, CHEM GEOL, V164, P331, DOI 10.1016/S0009-2541(99)00147-3; Remes M, 1903, VERHANDLUNGEN KK GEO, V11, P223; Renngarten V., 1924, IZVESTIIA GEOL KOMIT, V42, P119; Sahling H, 2002, MAR ECOL PROG SER, V231, P121, DOI 10.3354/meps231121; Sandy MR, 2012, PALAEOGEOGR PALAEOCL, V323, P42, DOI 10.1016/j.palaeo.2012.01.026; Sandy M.R., 1995, FOLDTANI KOZLONY, V125, P241; Sandy MR, 2010, TOP GEOBIOL, V33, P279, DOI 10.1007/978-90-481-9572-5_9; Sandy MR, 1996, BRACHIOPODS, P239; SANDY MR, 1994, J PALEONTOL, V68, P1243, DOI 10.1017/S0022336000034247; Scotese CR, 2004, J GEOL, V112, P729, DOI 10.1086/424867; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Short EJ, 2005, GEOL SOC AM ABSTR PR, V37, P81; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Stanton T.W., 1895, B US GEOLOGICAL SURV, V133, P1; Sun D, 1986, PALAEONTOLOGIA CATHA, V2, P211; Thayer C.W., 1981, STUDIES GEOLOGY NOTE, V5, P110; THIEULOY J-P, 1972, Geobios (Villeurbanne), V5, P5, DOI 10.1016/S0016-6995(72)80004-4; Thuy B, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2624; Toula F., 1911, Abhandlungen der Geologischen Reichsanstalt Wien, V20; Trumpy R., 1956, Eclogae Geologicae Helvetiae, V49, P573; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD	110	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109260	10.1371/journal.pone.0109260	http://dx.doi.org/10.1371/journal.pone.0109260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296341	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000053
J	Biville, F; Brezillon, C; Giorgini, D; Taha, MK				Biville, Francis; Brezillon, Christophe; Giorgini, Dario; Taha, Muhamed-Kheir			Pyrophosphate-Mediated Iron Acquisition from Transferrin in Neisseria meningitidis Does Not Require TonB Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI; BINDING-PROTEIN; OUTER-MEMBRANE; EXOGENOUS PYROPHOSPHATE; PATHOGENIC NEISSERIA; FERRIC ENTEROBACTIN; EXBD GENES; IN-VITRO; GONORRHOEAE; TRANSPORT	The ability to acquire iron from various sources has been demonstrated to be a major determinant in the pathogenesis of Neisseria meningitidis. Outside the cells, iron is bound to transferrin in serum, or to lactoferrin in mucosal secretions. Meningococci can extract iron from iron-loaded human transferrin by the TbpA/TbpB outer membrane complex. Moreover, N. meningitidis expresses the LbpA/LbpB outer membrane complex, which can extract iron from iron-loaded human lactoferrin. Iron transport through the outer membrane requires energy provided by the ExbB-ExbD-TonB complex. After transportation through the outer membrane, iron is bound by periplasmic protein FbpA and is addressed to the FbpBC inner membrane transporter. Iron-complexing compounds like citrate and pyrophosphate have been shown to support meningococcal growth ex vivo. The use of iron pyrophosphate as an iron source by N. meningitidis was previously described, but has not been investigated. Pyrophosphate was shown to participate in iron transfer from transferrin to ferritin. In this report, we investigated the use of ferric pyrophosphate as an iron source by N. meningitidis both ex vivo and in a mouse model. We showed that pyrophosphate was able to sustain N. meningitidis growth when desferal was used as an iron chelator. Addition of a pyrophosphate analogue to bacterial suspension at millimolar concentrations supported N. meningitidis survival in the mouse model. Finally, we show that pyrophosphate enabled TonB-independent ex vivo use of iron-loaded human or bovine transferrin as an iron source by N. meningitidis. Our data suggest that, in addition to acquiring iron through sophisticated systems, N. meningitidis is able to use simple strategies to acquire iron from a wide range of sources so as to sustain bacterial survival.	[Biville, Francis; Brezillon, Christophe; Giorgini, Dario; Taha, Muhamed-Kheir] Inst Pasteur, Dept Infect & Epidemiol, Unite Infect Bacteriennes Invas, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Biville, F (corresponding author), Inst Pasteur, Dept Infect & Epidemiol, Unite Infect Bacteriennes Invas, Paris, France.	fbiville@pasteur.fr			Pasteur Institute; Institut de veille sanitaire	Pasteur Institute; Institut de veille sanitaire	This work was supported by Pasteur Institute and the Institut de veille sanitaire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P, 1996, J BACTERIOL, V178, P2145, DOI 10.1128/jb.178.7.2145-2149.1996; ARCHIBALD FS, 1980, INFECT IMMUN, V27, P322, DOI 10.1128/IAI.27.2.322-334.1980; Biswas GD, 1997, MOL MICROBIOL, V24, P169, DOI 10.1046/j.1365-2958.1997.3421692.x; BIVILLE F, 1985, FEMS MICROBIOL LETT, V28, P73; Biville F, 2003, J MOL MICROB BIOTECH, V5, P37, DOI 10.1159/000068722; Biville F, 1996, RES MICROBIOL, V147, P597, DOI 10.1016/0923-2508(96)84015-0; Braun V, 2006, BIOMETALS, V19, P103, DOI 10.1007/s10534-005-8253-y; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Brook CE, 2005, INORG CHEM, V44, P5183, DOI 10.1021/ic050411m; Carson SDB, 1999, J BACTERIOL, V181, P2895, DOI 10.1128/JB.181.9.2895-2901.1999; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cornelissen CN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00117; Harris WR, 2004, J INORG BIOCHEM, V98, P1824, DOI 10.1016/j.jinorgbio.2004.08.008; Jadhav SR, 2013, J COLLOID INTERF SCI, V390, P211, DOI 10.1016/j.jcis.2012.09.031; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Khun HH, 1998, INFECT IMMUN, V66, P2330, DOI 10.1128/IAI.66.5.2330-2336.1998; KONOPKA K, 1980, EUR J BIOCHEM, V107, P433; KONOPKA K, 1980, BIOCHEM BIOPH RES CO, V96, P1408, DOI 10.1016/0006-291X(80)90107-2; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAHTI R, 1983, MICROBIOL REV, V47, P169, DOI 10.1128/MMBR.47.2.169-178.1983; LEFAOU AE, 1991, BIOL MET, V4, P126; LEWIS LA, 1995, J BACTERIOL, V177, P1299, DOI 10.1128/jb.177.5.1299-1306.1995; Matzanke BF, 2004, BIOCHEMISTRY-US, V43, P1386, DOI 10.1021/bi0357661; MIZUNO T, 1983, J BIOL CHEM, V258, P6932; NASSIF X, 1991, J BACTERIOL, V173, P2147, DOI 10.1128/JB.173.7.2147-2154.1991; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Noinaj N, 2012, MOL MICROBIOL, V86, P246, DOI 10.1111/mmi.12002; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Perrotte-Piquemal M, 1999, BIOCHIMIE, V81, P245, DOI 10.1016/S0300-9084(99)80058-3; PYNES GD, 1967, J BIOL CHEM, V242, P2119; Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375; Rohde KH, 2002, MOL MICROBIOL, V43, P335, DOI 10.1046/j.1365-2958.2002.02745.x; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Rudel T, 1996, CELL, V85, P391, DOI 10.1016/S0092-8674(00)81117-4; Schroder I, 2003, FEMS MICROBIOL REV, V27, P427, DOI 10.1016/S0168-6445(03)00043-3; SCHRYVERS AB, 1988, INFECT IMMUN, V56, P1144, DOI 10.1128/IAI.56.5.1144-1149.1988; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Siburt CJP, 2012, BBA-GEN SUBJECTS, V1820, P379, DOI 10.1016/j.bbagen.2011.09.001; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Song JM, 1999, BIOPHYS J, V76, P804, DOI 10.1016/S0006-3495(99)77244-9; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; Stojiljkovic I, 1997, J BACTERIOL, V179, P805, DOI 10.1128/jb.179.3.805-812.1997; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Strange HR, 2011, INFECT IMMUN, V79, P267, DOI 10.1128/IAI.00807-10; Szatanik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022210; TAHA MK, 1988, EMBO J, V7, P4367, DOI 10.1002/j.1460-2075.1988.tb03335.x; Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; TOMMASSEN J, 1990, INFECT IMMUN, V58, P1355, DOI 10.1128/IAI.58.5.1355-1359.1990; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; Veggi D, 2012, BIOCHEMISTRY-US, V51, P9384, DOI 10.1021/bi301161w; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; YANCEY RJ, 1981, INFECT IMMUN, V32, P592, DOI 10.1128/IAI.32.2.592-599.1981; Zarantonelli ML, 2007, INFECT IMMUN, V75, P5609, DOI 10.1128/IAI.00781-07; Zeth K, 2013, BIOCHEM J, V454, P359, DOI 10.1042/BJ4540359; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000; Zola TA, 2010, INFECT IMMUN, V78, P2429, DOI 10.1128/IAI.00228-10	59	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107612	10.1371/journal.pone.0107612	http://dx.doi.org/10.1371/journal.pone.0107612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290693	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000006
J	Fernandes, AL; Lopes-Silva, JP; Bertuzzi, R; Casarini, DE; Arita, DY; Bishop, DJ; Lima-Silva, AE				Fernandes, Alan Lins; Lopes-Silva, Joao Paulo; Bertuzzi, Romulo; Casarini, Dulce Elena; Arita, Danielle Yuri; Bishop, David John; Lima-Silva, Adriano Eduardo			Effect of Time of Day on Performance, Hormonal and Metabolic Response during a 1000-M Cycling Time Trial	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; EXERCISE PERFORMANCE; PACING STRATEGY; POWER; VARIABILITY	The aim of this study was to determine the effect of time of day on performance, pacing, and hormonal and metabolic responses during a 1000-m cycling time-trial. Nine male, recreational cyclists visited the laboratory four times. During the 1st visit the participants performed an incremental test and during the 2nd visit they performed a 1000-m cycling familiarization trial. On the 3rd and 4th visits, the participants performed a 1000-m TT at either 8 am or 6 pm, in randomized, repeated-measures, crossover design. The time to complete the time trial was lower in the evening than in the morning (88.2 +/- 8.7 versus 94.7 +/- 10.9 s, respectively, p<0.05), but there was no significant different in pacing. However, oxygen uptake and aerobic mechanical power output at 600 and 1000 m tended to be higher in the evening (p<0.07 and 0.09, respectively). There was also a main effect of time of day for insulin, cortisol, and total and free testosterone concentration, which were all higher in the morning (+60%, +26%, +31% and +22%, respectively, p<0.05). The growth hormone, was twofold higher in the evening (p<0.05). The plasma glucose was similar to 11% lower in the morning (p<0.05). Glucagon, norepinephrine, epinephrine and lactate were similar for the morning and evening trials (p<0.05), but the norepinephrine response to the exercise was increased in the morning (+46%, p<0.05), and it was accompanied by a 5-fold increase in the response of glucose. Muscle recruitment, as measured by electromyography, was similar between morning and evening trials (p<0.05). Our findings suggest that performance was improved in the evening, and it was accompanied by an improved hormonal and metabolic milieu.	[Fernandes, Alan Lins; Lopes-Silva, Joao Paulo; Lima-Silva, Adriano Eduardo] Univ Fed Alagoas, Sports Sci Res Grp, Maceio, Alagoas, Brazil; [Fernandes, Alan Lins; Lopes-Silva, Joao Paulo; Lima-Silva, Adriano Eduardo] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Anta, PE, Brazil; [Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp, Sao Paulo, Brazil; [Casarini, Dulce Elena; Arita, Danielle Yuri] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Bishop, David John] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia	Universidade Federal de Alagoas; Universidade Federal de Pernambuco; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Victoria University	Lima-Silva, AE (corresponding author), Univ Fed Alagoas, Sports Sci Res Grp, Maceio, Alagoas, Brazil.	adrianosilva@usp.br	Lopes-Silva, João/R-6909-2016; Fernandes, Alan Lins/R-7248-2019; Bertuzzi, Romulo/E-7048-2012; Lima-Silva, Adriano Eduardo/C-2800-2013; Silva, João Paulo/L-4396-2017; Bishop, David John/X-9826-2019; Casarini, Dulce E/D-4091-2012; Lima-Silva, Adriano/Y-2404-2019	Lopes-Silva, João/0000-0002-2033-365X; Fernandes, Alan Lins/0000-0002-6786-3922; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; Silva, João Paulo/0000-0002-2033-365X; Bishop, David John/0000-0002-6956-9188; Lima-Silva, Adriano/0000-0002-0613-5104; Casarini, Dulce/0000-0003-1912-4292	Alagoas Research Foundation (FAPEAL) [20110825-011-0025-0004]	Alagoas Research Foundation (FAPEAL)	This work was supported by Alagoas Research Foundation (FAPEAL, process number: 20110825-011-0025-0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessot N, 2006, CHRONOBIOL INT, V23, P1009, DOI 10.1080/07420520600920726; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; Bosco C, 2000, MED SCI SPORT EXER, V32, P202; Deschenes MR, 1998, EUR J APPL PHYSIOL O, V77, P249, DOI 10.1007/s004210050329; DiConstanzo CA, 2006, AM J PHYSIOL-ENDOC M, V290, P9; Edwards BJ, 2005, INT J SPORTS MED, V26, P651, DOI 10.1055/s-2004-830439; Galliven EA, 1997, J APPL PHYSIOL, V83, P1822; Giacomoni M, 2006, INT J SPORTS MED, V27, P468, DOI 10.1055/s-2005-865822; HAKKINEN K, 1988, INT J SPORTS MED, V9, P422, DOI 10.1055/s-2007-1025044; Hammouda O, 2012, BIOL RHYTHM RES, V43, P431, DOI 10.1080/09291016.2011.599638; Hayes LD, 2010, CHRONOBIOL INT, V27, P675, DOI 10.3109/07420521003778773; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hettinga FJ, 2012, BRIT J SPORT MED, V46, P30, DOI 10.1136/bjsm.2009.064261; HILL DW, 1992, CAN J SPORT SCI, V17, P316; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; KANABROCKI EL, 1990, CHRONOBIOL INT, V7, P445, DOI 10.3109/07420529009059156; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lericollais R, 2009, CHRONOBIOL INT, V26, P1622, DOI 10.3109/07420520903534492; Lima-Silva AE, 2010, APPL PHYSIOL NUTR ME, V35, P541, DOI 10.1139/H10-043; Mora-Rodriguez R, 2000, AM J PHYSIOL-ENDOC M, V278, pE669, DOI 10.1152/ajpendo.2000.278.4.E669; Peiffer JJ, 2011, INT J SPORTS MED, V32, P353, DOI 10.1055/s-0031-1271772; Puschel GP, 2004, ANAT REC PART A, V280A, P854, DOI 10.1002/ar.a.20091; Racinais S, 2006, INT J SPORTS MED, V27, P49, DOI 10.1055/s-2005-837503; Racinais S, 2010, CHRONOBIOL INT, V27, P855, DOI 10.3109/07420521003668412; REILLY T, 1992, J SPORT MED PHYS FIT, V32, P343; Romijn JA, 1995, J APPL PHYSIOL, V79, P1939, DOI 10.1152/jappl.1995.79.6.1939; SALE DG, 1988, MED SCI SPORT EXER, V20, pS135, DOI 10.1249/00005768-198810001-00009; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; SCHENAU GJV, 1992, INT J SPORTS MED, V13, P447; Souissi N, 2007, CHRONOBIOL INT, V24, P739, DOI 10.1080/07420520701535811; Stone MR, 2011, EUR J APPL PHYSIOL, V111, P1807, DOI 10.1007/s00421-010-1818-7; TAKAHASHI Y, 1968, J CLIN INVEST, V47, P2079, DOI 10.1172/JCI105893; Teo WP, 2011, J SPORT SCI MED, V10, P600	35	53	55	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109954	10.1371/journal.pone.0109954	http://dx.doi.org/10.1371/journal.pone.0109954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289885	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000342798000101
J	Habibi, I; Emamian, ES; Abdi, A				Habibi, Iman; Emamian, Effat S.; Abdi, Ali			Advanced Fault Diagnosis Methods in Molecular Networks	PLOS ONE			English	Article							SIGNALING NETWORKS; PROTEIN; DISCOVERY; CANCER	Analysis of the failure of cell signaling networks is an important topic in systems biology and has applications in target discovery and drug development. In this paper, some advanced methods for fault diagnosis in signaling networks are developed and then applied to a caspase network and an SHP2 network. The goal is to understand how, and to what extent, the dysfunction of molecules in a network contributes to the failure of the entire network. Network dysfunction (failure) is defined as failure to produce the expected outputs in response to the input signals. Vulnerability level of a molecule is defined as the probability of the network failure, when the molecule is dysfunctional. In this study, a method to calculate the vulnerability level of single molecules for different combinations of input signals is developed. Furthermore, a more complex yet biologically meaningful method for calculating the multi-fault vulnerability levels is suggested, in which two or more molecules are simultaneously dysfunctional. Finally, a method is developed for fault diagnosis of networks based on a ternary logic model, which considers three activity levels for a molecule instead of the previously published binary logic model, and provides equations for the vulnerabilities of molecules in a ternary framework. Multi-fault analysis shows that the pairs of molecules with high vulnerability typically include a highly vulnerable molecule identified by the single fault analysis. The ternary fault analysis for the caspase network shows that predictions obtained using the more complex ternary model are about the same as the predictions of the simpler binary approach. This study suggests that by increasing the number of activity levels the complexity of the model grows; however, the predictive power of the ternary model does not appear to be increased proportionally.	[Habibi, Iman; Abdi, Ali] New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ 07102 USA; [Emamian, Effat S.] Adv Technol Novel Therapeut, Enterprise Dev Ctr, Newark, NJ USA; [Abdi, Ali] New Jersey Inst Technol, Dept Biol Sci, Newark, NJ 07102 USA	New Jersey Institute of Technology; New Jersey Institute of Technology	Abdi, A (corresponding author), New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ 07102 USA.	ali.abdi@njit.edu	Abdi, Ali/GRS-8219-2022					Abdi A, 2010, CHEM BIODIVERS, V7, P1111, DOI 10.1002/cbdv.200900315; Abdi A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000008; Adams SJ, 2012, MOL CANCER RES, V10, P1265, DOI 10.1158/1541-7786.MCR-12-0352; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Emamian ES, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00033; Emamian ES, 2011, SOC NEUR ANN M WASH; Hardesty L, 2009, MIT TECHNOLOGY R JAN; Helikar T, 2011, OPEN BIOINFORMATICS, V4, P16, DOI [DOI 10.1186/1687-4153-2011-797251, 10.2174/1875036201105010016, DOI 10.2174/1875036201105010016]; Iqbal Nida, 2014, Chemother Res Pract, V2014, P357027, DOI 10.1155/2014/357027; Iyengar R, 2009, J BIOL CHEM, V284, P5425, DOI 10.1074/jbc.R800066200; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Lu MY, 2013, J PHYS CHEM B, V117, P13164, DOI 10.1021/jp403156m; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; MUKAIDONO M, 1986, IEEE T COMPUT, V35, P179, DOI 10.1109/TC.1986.1676738; Papoulis A., 1991, PROBABILITY RANDOM V; Saadatpour A, 2013, METHODS, V62, P3, DOI 10.1016/j.ymeth.2012.10.012; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Scott LM, 2010, CURR PHARM DESIGN, V16, P1843; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001	22	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108830	10.1371/journal.pone.0108830	http://dx.doi.org/10.1371/journal.pone.0108830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290670	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000028
J	Njimona, I; Yang, R; Lamparter, T				Njimona, Ibrahim; Yang, Rui; Lamparter, Tilman			Temperature Effects on Bacterial Phytochrome	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; SIGNAL-TRANSDUCTION; AGROBACTERIUM-TUMEFACIENS; CYANOBACTERIUM SYNECHOCYSTIS; PSEUDOMONAS-AERUGINOSA; ARABIDOPSIS-THALIANA; SENSORY MODULE; GROUND-STATE; RED-LIGHT; CHROMOPHORE	Bacteriophytochromes (BphPs) are light-sensing regulatory proteins encoded in photosynthetic and non-photosynthetic bacteria. This protein class incorporate bilin as their chromophore, with majority of them bearing a light-regulated His kinase or His kinase related module in the C-terminal. We studied the His kinase actives in the temperature range of 5 degrees C to 40 degrees C on two BphPs, Agp1 from Agrobacterium tumefaciens and Cph1 from cyanobacterium Synechocystis PCC 6803. As reported, the phosphorylation activities of the far red (FR) irradiated form of the holoprotein is stronger than that of the red (R) irradiated form in both phytochromes. We observed for the apoprotein and FR irradiated holoprotein of Agp1 an increase in the phosphorylation activities from 5 degrees C to 25 degrees C and a decrease from 25 degrees C to 40 degrees C. At 5 degrees C the activities of the apoprotein were significantly lower than those of the FR irradiated holoprotein, which was opposite at 40 degrees C. A similar temperature pattern was observed for Cph1, but the maximum of the apoprotein was at 20 degrees C while the maximum of the FR irradiated holoprotein was at 10 degrees C. At 40 degrees C, prolonged R irradiation leads to an irreversible bleaching of Cph1, an effect which depends on the C-terminal His kinase module. A more prominent and reversible temperature effect on spectral properties of Agp1, mediated by the His kinase, has been reported before. His kinases in phytochromes could therefore share similar temperature characteristics. We also found that phytochrome B mutants of Arabidopsis have reduced hypocotyl growth at 37 degrees C in darkness, suggesting that this phytochrome senses the temperature or mediates signal transduction of temperature effects.	[Njimona, Ibrahim; Yang, Rui; Lamparter, Tilman] Karlsruhe Inst Technol, Inst Bot, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Lamparter, T (corresponding author), Karlsruhe Inst Technol, Inst Bot, D-76021 Karlsruhe, Germany.	tilman.lamparter@kit.edu	Lamparter, Tilman/E-4421-2013	Lamparter, Tilman/0000-0003-4327-9737	Deutsche Forschungsgemeinschaft [La 799/8-1]; Open Access Publishing Fund of Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	The work was funded by the Deutsche Forschungsgemeinschaft, La 799/8-1. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Barkovits K, 2008, FEMS MICROBIOL LETT, V280, P160, DOI 10.1111/j.1574-6968.2007.01058.x; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Burgie ES, 2014, P NATL ACAD SCI US; COWL JS, 1994, PLANT PHYSIOL, V106, P813, DOI 10.1104/pp.106.2.813; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; FIELDING A, 1992, PHOTOCHEM PHOTOBIOL, V56, P623, DOI 10.1111/j.1751-1097.1992.tb02212.x; Foreman J, 2011, PLANT J, V65, P441, DOI 10.1111/j.1365-313X.2010.04434.x; Franklin KA, 2009, CURR OPIN PLANT BIOL, V12, P63, DOI 10.1016/j.pbi.2008.09.007; FRY KT, 1971, BIOCHEM BIOPH RES CO, V45, P1466, DOI 10.1016/0006-291X(71)90185-9; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Vescovi EG, 2010, CURR OPIN MICROBIOL, V13, P210, DOI 10.1016/j.mib.2009.12.012; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Heyes D. J., 2012, PLOS ONE, V7; Hubschmann T, 2005, FEBS LETT, V579, P1613, DOI 10.1016/j.febslet.2005.01.075; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; JIN SG, 1993, J BACTERIOL, V175, P6830, DOI 10.1128/jb.175.21.6830-6835.1993; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; KAY SA, 1989, NUCLEIC ACIDS RES, V17, P2865, DOI 10.1093/nar/17.7.2865; Kim PW, 2014, BIOCHEMISTRY-US, V53, P2818, DOI 10.1021/bi500108s; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Mironov KS, 2012, BBA-BIOENERGETICS, V1817, P1352, DOI 10.1016/j.bbabio.2011.12.011; Mironov KS, 2014, J PHOTOCHEMISTRY P B; Mizuno T, 1998, J BIOCHEM, V123, P555; Mougel C, 2001, TRENDS BIOCHEM SCI, V26, P582, DOI 10.1016/S0968-0004(01)01969-7; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Njimona I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025977; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; PAYNE PI, 1972, NATURE-NEW BIOL, V235, P145, DOI 10.1038/newbio235145a0; Poppe C, 1998, PLANT J, V16, P465, DOI 10.1046/j.1365-313x.1998.00322.x; Quail PH, 1997, BIOESSAYS, V19, P571, DOI 10.1002/bies.950190708; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; SCHNEIDERPOETSCH HAW, 1991, FEBS LETT, V281, P245, DOI 10.1016/0014-5793(91)80403-P; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Strauss HM, 2005, FEBS LETT, V579, P3970, DOI 10.1016/j.febslet.2005.06.025; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	53	18	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109794	10.1371/journal.pone.0109794	http://dx.doi.org/10.1371/journal.pone.0109794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289638	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000087
J	Silva, DP; Vilela, B; De Marco, P; Nemesio, A				Silva, Daniel P.; Vilela, Bruno; De Marco, Paulo, Jr.; Nemesio, Andre			Using Ecological Niche Models and Niche Analyses to Understand Speciation Patterns: The Case of Sister Neotropical Orchid Bees	PLOS ONE			English	Article							ATLANTIC FOREST; MOLECULAR PHYLOGENY; SOUTH-AMERICA; CONSERVATISM; HYMENOPTERA; APIDAE; AMAZONIA; CLIMATE; DISTRIBUTIONS; BIOGEOGRAPHY	The role of past connections between the two major South American forested biomes on current species distribution has been recognized a long time ago. Climatic oscillations that further separated these biomes have promoted parapatric speciation, in which many species had their continuous distribution split, giving rise to different but related species (i.e., different potential distributions and realized niche features). The distribution of many sister species of orchid bees follow this pattern. Here, using ecological niche models and niche analyses, we (1) tested the role of ecological niche differentiation on the divergence between sister orchid-bees (genera Eulaema and Eufriesea) from the Amazon and Atlantic forests, and (2) highlighted interesting areas for new surveys. Amazonian species occupied different realized niches than their Atlantic sister species. Conversely, species of sympatric but distantly related Eulaema bees occupied similar realized niches. Amazonian species had a wide potential distribution in South America, whereas Atlantic Forest species were more limited to the eastern coast of the continent. Additionally, we identified several areas in need of future surveys. Our results show that the realized niche of Atlantic-Amazonian sister species of orchid bees, which have been previously treated as allopatric populations of three species, had limited niche overlap and similarity. These findings agree with their current taxonomy, which treats each of those populations as distinct valid species.	[Silva, Daniel P.; Vilela, Bruno] Univ Fed Goias, Dept Ecol, ICB, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [De Marco, Paulo, Jr.] Univ Fed Goias, Dept Ecol, Inst Ciencias Biol, Theory Metapopulat & Landscape Lab, Goiania, Go, Brazil; [Nemesio, Andre] Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Uberlandia	Nemesio, A (corresponding author), Univ Fed Uberlandia, Inst Biol, Rua Ceara ,Campus Umuarama, Uberlandia, MG, Brazil.	andre.nemesio@gmail.com	DE ALMEIDA, CARLOS EDUARDO BONACOSSA/M-7511-2013; , tuula/ABG-2051-2021; De Marco, Paulo/B-2209-2009; Vilela, Bruno/L-1594-2015; Nemésio, André/D-1920-2012; Silva, Daniel Paiva/F-8052-2010; Cortez, Celia/X-3247-2018	DE ALMEIDA, CARLOS EDUARDO BONACOSSA/0000-0003-0108-3998; De Marco, Paulo/0000-0002-3628-6405; Vilela, Bruno/0000-0003-4072-0558; Silva, Daniel Paiva/0000-0002-2457-6245; Brenchley, Paul/0000-0003-1290-9919; Salo, Sirpa/0000-0002-4113-4000; Cortez, Celia/0000-0002-7857-1167; Salo, Tuula/0000-0001-6039-0088; Silva, Dilson/0000-0001-9726-2442	CNPq - Conselho Nacional deDesenvolvimento Cientifico; CAPES-Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior; CNPqgrants	CNPq - Conselho Nacional deDesenvolvimento Cientifico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPqgrants	DPS received a doctorate fellowship from CNPq - Conselho Nacional deDesenvolvimento Cientifico. BV received a doctorate fellowship from CAPES-Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior. PDMJ has been continuously supported by CNPqgrants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AJC, 2007, ZOOL J LINN SOC-LOND, V151, P511, DOI 10.1111/j.1096-3642.2007.00328.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Brown K.S. Jr, 1987, Oxford Monographs on Biogeography, P66; Camara ID, 2003, STATE HOTS, P31; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; da Silva JMC., 1996, ORNITOL NEOTROP, V7, P1; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; de Vivo M, 2004, J BIOGEOGR, V31, P943, DOI 10.1111/j.1365-2699.2004.01068.x; de Vivo Mario, 1997, Journal of Comparative Biology, V2, P65; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; DRESSLER RL, 1979, BIOTROPICA, V11, P144, DOI 10.2307/2387794; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Faria LRR, 2012, ZOOLOGIA-CURITIBA, V29, P349, DOI 10.1590/S1984-46702012000400008; Faria LRR, 2011, REV BRAS ENTOMOL, V55, P35, DOI 10.1590/S0085-56262011000100007; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P172, DOI 10.1111/j.1752-4598.2010.00091.x; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Fouquet A, 2012, MOL PHYLOGENET EVOL, V62, P826, DOI 10.1016/j.ympev.2011.11.023; Google Inc, 2013, GOOGL EARTH VERS 7 0; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hinojosa-Diaz IA, 2012, ZOOKEYS, P63, DOI 10.3897/zookeys.221.3659; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lopez-Uribe MM, 2014, MOL ECOL, V23, P1874, DOI 10.1111/mec.12689; Martinez-Gordillo D, 2010, J EVOLUTION BIOL, V23, P259, DOI 10.1111/j.1420-9101.2009.01897.x; McInerny GJ, 2012, J BIOGEOGR, V39, P2112, DOI 10.1111/jbi.12031; McInerny GJ, 2012, J BIOGEOGR, V39, P2096, DOI 10.1111/jbi.12033; McInerny GJ, 2012, J BIOGEOGR, V39, P2103, DOI 10.1111/jbi.12032; Méio Beatriz B., 2003, Braz. J. Bot., V26, P437, DOI 10.1590/S0100-84042003000400002; Moure J.S., 2003, ACTA BIOL PARANAENSE, V29, P1; MOURE J.S., 2007, CATALOGUE BEES HYMEN, P214; Nemesio A, 2006, J BIOGEOGR, V33, P91, DOI 10.1111/j.1365-2699.2005.01370.x; Nemesio A, 2013, BRAZ J BIOL, V73, P367, DOI 10.1590/S1519-69842013000200017; Nemesio Andre, 2007, Lundiana, V8, P57; Nemesio A, 2012, ZOOTAXA, P35; Nemesio A, 2011, ZOOTAXA, P43, DOI 10.11646/zootaxa.3006.1.2; Nemesio A, 2011, ZOOTAXA, P12; Nemesio A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.2892.1.6; Nemesio A, 2010, ZOOTAXA, P51; Nemesio A, 2011, ZOOTAXA, P1; Nemesio A, 2009, ZOOTAXA, P1; Nemesio A, 2012, ZOOKEYS, P47, DOI 10.3897/zookeys.222.3382; Nemesio A, 2012, J INSECT CONSERV, V16, P745, DOI 10.1007/s10841-012-9459-2; Nemesio A, 2012, BIOSCI J, V28, P118; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Oliveira M.L, 2008, LUNDIANA, V8, P113; Oliveira Marcio Luiz de, 2006, Acta Amaz., V36, P121, DOI 10.1590/S0044-59672006000100015; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pineiro R, 2007, MOL ECOL, V16, P2155, DOI 10.1111/j.1365-294X.2007.03280.x; Prance, 1979, REV BRAS BOT, V2, P19; PRANCE G T, 1973, Acta Amazonica, V3, P5; R Core Team, 2021, R LANGUAGE ENV STAT; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; RAW A, 1989, Revista Brasileira de Entomologia, V33, P103; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; REDFORD KH, 1986, BIOTROPICA, V18, P126, DOI 10.2307/2388755; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; ROUBIK DW, 2004, ORCHID BEES TROPICAL; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Silva DP, 2013, APIDOLOGIE, V44, P673, DOI 10.1007/s13592-013-0216-7; Silva JMC, 2003, ATLANTIC FOREST S AM, P43; Simpson GC, 1969, BIOGEOGRAPHY ECOLOGY, V1, P113; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Strubbe D, 2013, GLOBAL ECOL BIOGEOGR, V22, P962, DOI 10.1111/geb.12050; Tocchio LJ, 2015, ZOOL SCR, V44, P1, DOI 10.1111/zsc.12082; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wielstra B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046671; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; WILEY EO, 1981, PHYLOGENETICS THEORY	91	46	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113246	10.1371/journal.pone.0113246	http://dx.doi.org/10.1371/journal.pone.0113246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25295847	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700028
J	Razali, FN; Ismail, A; Abidin, NZ; Shuib, AS				Razali, Faizan Naeem; Ismail, Amirah; Abidin, Nurhayati Zainal; Shuib, Adawiyah Suriza			Stimulatory Effects of Polysaccharide Fraction from Solanum nigrum on RAW 264.7 Murine Macrophage Cells	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; ANTITUMOR-ACTIVITY; NITRIC-OXIDE; IMMUNOMODULATION; ACTIVATION; PLANTS; INOS	The polysaccharide fraction from Solanum nigrum Linne has been shown to have antitumor activity by enhancing the CD4(+)/CD8(+) ratio of the T-lymphocyte subpopulation. In this study, we analyzed a polysaccharide extract of S. nigrum to determine its modulating effects on RAW 264.7 murine macrophage cells since macrophages play a key role in inducing both innate and adaptive immune responses. Crude polysaccharide was extracted from the stem of S. nigrum and subjected to ion-exchange chromatography to partially purify the extract. Five polysaccharide fractions were then subjected to a cytotoxicity assay and a nitric oxide production assay. To further analyze the ability of the fractionated polysaccharide extract to activate macrophages, the phagocytosis activity and cytokine production were also measured. The polysaccharide fractions were not cytotoxic, but all of the fractions induced nitric oxide in RAW 264.7 cells. Of the five fractions tested, SN-ppF3 was the least toxic and also induced the greatest amount of nitric oxide, which was comparable to the inducible nitric oxide synthase expression detected in the cell lysate. This fraction also significantly induced phagocytosis activity and stimulated the production of tumor necrosis factor-alpha and interleukin-6. Our study showed that fraction SN-ppF3 could classically activate macrophages. Macrophage induction may be the manner in which polysaccharides from S. nigrum are able to prevent tumor growth.	[Razali, Faizan Naeem; Ismail, Amirah; Abidin, Nurhayati Zainal; Shuib, Adawiyah Suriza] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Shuib, Adawiyah Suriza] Univ Malaya, Fac Med, Ctr Prote Res, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Shuib, AS (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	adawiyah@um.edu.my	SHUIB, ADAWIYAH SURIZA/B-8136-2010; ABIDIN, NURHAYATI ZAINAL/B-9429-2010; ISMAIL, AMIRAH/A-1801-2019	Shuib, Adawiyah Suriza/0000-0001-5525-2713; RAZALI, FAIZAN NAEEM/0000-0002-6458-6915	Ministry of Higher Education, Malaysia [FRGS FP001/2011A]; University Malaya Postgraduate Research Grant [PPP PG057-2012B]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); University Malaya Postgraduate Research Grant	This work was funded by the Ministry of Higher Education, Malaysia (FRGS FP001/2011A) and University Malaya Postgraduate Research Grant (PPP PG057-2012B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Soheimi SS, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-58; AKHTAR MS, 1989, J ETHNOPHARMACOL, V27, P163, DOI 10.1016/0378-8741(89)90088-3; Bae IY, 2013, FOOD RES INT, V51, P195, DOI 10.1016/j.foodres.2012.12.008; Batovska DI, 2008, NAT PROD RES, V22, P1237, DOI 10.1080/14786410701725865; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/732860; Cartea ME, 2011, MOLECULES, V16, P251, DOI 10.3390/molecules16010251; Chen HX, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P225, DOI 10.1016/B978-0-12-384937-3.00019-7; Chen JN, 2010, J AGR FOOD CHEM, V58, P12117, DOI 10.1021/jf103576r; Chen RZ, 2010, CARBOHYD POLYM, V80, P845, DOI 10.1016/j.carbpol.2009.12.042; Edmonds J.M., 1997, BLACK NIGHTSHADES SO, DOI DOI 10.1016/j.bcab.2020.101524; Fan YJ, 2011, AFR J PHARM PHARMACO, V5, P415, DOI 10.5897/AJPP11.089; Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Han SB, 2001, INT IMMUNOPHARMACOL, V1, P1969, DOI 10.1016/S1567-5769(01)00124-2; Heo KS, 2004, TOXICOL IN VITRO, V18, P755, DOI 10.1016/j.tiv.2004.03.003; Houghton RA, 1998, LAB HDB FRACTIONATIO; Hu K, 1999, PLANTA MED, V65, P35, DOI 10.1055/s-1999-13958; Jain R, 2011, ALTERN MED REV, V16, P78; Khoo LT, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/614273; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Lee CC, 2005, J ETHNOPHARMACOL, V100, P237, DOI 10.1016/j.jep.2005.01.064; Li JA, 2010, J ETHNOPHARMACOL, V129, P350, DOI 10.1016/j.jep.2010.03.033; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Park HY, 2012, FASEB J, V26, P323; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Shin KS, 1996, PROGR BIOTECHNOL, V14, P623, DOI 10.1016/S0921-0423(96)80295-4; SULTANA S, 1995, J ETHNOPHARMACOL, V45, P189, DOI 10.1016/0378-8741(94)01214-K; Sun X B, 1994, Phytomedicine, V1, P225, DOI 10.1016/S0944-7113(11)80069-3; Thakur M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq012; Xu HS, 2009, CARBOHYD POLYM, V78, P316, DOI 10.1016/j.carbpol.2009.04.007; Yu MY, 2009, EUR FOOD RES TECHNOL, V228, P477, DOI 10.1007/s00217-008-0955-2	35	26	27	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108988	10.1371/journal.pone.0108988	http://dx.doi.org/10.1371/journal.pone.0108988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299340	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200029
J	Watanabe, S; Amiya, E; Watanabe, M; Takata, M; Ozeki, A; Watanabe, A; Kawarasaki, S; Nakao, T; Hosoya, Y; Nagata, K; Nagai, R; Komuro, I				Watanabe, Shogo; Amiya, Eisuke; Watanabe, Masafumi; Takata, Munenori; Ozeki, Atsuko; Watanabe, Aya; Kawarasaki, Shuichi; Nakao, Tomoko; Hosoya, Yumiko; Nagata, Kohzo; Nagai, Ryozo; Komuro, Issei			Elevated C-Reactive Protein Levels and Enhanced High Frequency Vasomotion in Patients with Ischemic Heart Disease during Brachial Flow-Mediated Dilation	PLOS ONE			English	Article							LASER-DOPPLER FLOWMETRY; SYNTHASE MESSENGER-RNA; NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE; VASCULAR-RESISTANCE; PRIMARY PREVENTION; OSCILLATIONS; ARTERY; HUMANS; VASODILATION	Purpose: The physiological role of vasomotion, rhythmic oscillations in vascular tone or diameter, and its underlying mechanisms are unknown. We investigated the characteristics of brachial artery vasomotion in patients with ischemic heart disease (IHD). Methods: We performed a retrospective study of 37 patients with IHD. Endothelial function was assessed using flow-mediated dilation (FMD), and power spectral analysis of brachial artery diameter oscillations during FMD was performed. Frequency-domain components were calculated by integrating the power spectrums in three frequency bands (in ms(2)) using the MemCalc (GMS, Tokyo, Japan): very-low frequency (VLF), 0.003-0.04 Hz; low frequency (LF), 0.04-0.15 Hz; and high frequency (HF), 0.15-0.4 Hz. Total spectral power (TP) was calculated as the sum of all frequency bands, and each spectral component was normalized against TP. Results: Data revealed that HF/TP closely correlated with FMD (r = -0.33, p = 0.04), whereas VLF/TP and LF/TP did not. We also explored the relationship between elevated C-reactive protein (CRP) levels and vasomotion. HF/TP was significantly increased in subjects with high CRP levels (CRP;>0.08 mg/dL) compared with subjects with low CRP levels (0.052 +/- 0.026 versus 0.035 +/- 0.022, p<0.05). The HF/TP value closely correlated with CRP (r = 0.24, p = 0.04), whereas the value of FMD did not (r = 0.023, p = 0.84). In addition, elevated CRP levels significantly increased the value of HF/TP after adjustment for FMD and blood pressure (beta = 0.33, p<0.05). Conclusion: The HF component of brachial artery diameter oscillation during FMD measurement correlated well with FMD and increased in the presence of elevated CRP levels in subjects with IHD.	[Watanabe, Shogo; Amiya, Eisuke; Watanabe, Masafumi; Takata, Munenori; Ozeki, Atsuko; Watanabe, Aya; Kawarasaki, Shuichi; Nakao, Tomoko; Hosoya, Yumiko; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Watanabe, Shogo; Nagata, Kohzo] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4648601, Japan; [Nagai, Ryozo] Jichi Med Sch, Mibu, Tochigi, Japan	University of Tokyo; Nagoya University; Jichi Medical University	Amiya, E (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	amiyae-tky@umin.ac.jp	Amiya, Eisuke/O-4981-2019	Amiya, Eisuke/0000-0003-2810-8040	Japan Society for the Promotion of Science; Fukuda Foundation for Medical Technology; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23790837]; Grants-in-Aid for Scientific Research [26860545] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukuda Foundation for Medical Technology(Fukuda Foundation for Medical Technology); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology program, research grants from the Fukuda Foundation for Medical Technology (to E.A.), and Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid 23790837 (to E.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi L, 1997, CARDIOVASC RES, V34, P185, DOI 10.1016/S0008-6363(97)00017-5; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Cary TW, 2014, MED PHYS, V41, DOI 10.1118/1.4862508; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; DIEHL RR, 1991, NEUROSCI LETT, V127, P5, DOI 10.1016/0304-3940(91)90880-3; FUNK W, 1983, INT J MICROCIRC, V2, P11; Gupta NK, 2012, J AM COLL CARDIOL, V60, P1148, DOI 10.1016/j.jacc.2012.04.050; HAYOZ D, 1993, AM J PHYSIOL, V264, pH2080, DOI 10.1152/ajpheart.1993.264.6.H2080; KASTRUP J, 1989, INT J MICROCIRC, V8, P205; Kvandal P, 2003, MICROVASC RES, V65, P160, DOI 10.1016/S0026-2862(03)00006-2; Kvernmo HD, 1999, MICROVASC RES, V57, P298, DOI 10.1006/mvre.1998.2139; Lamboley M, 2003, AM J PHYSIOL-HEART C, V285, pH562, DOI 10.1152/ajpheart.00526.2002; Mauban JRH, 2001, AM J PHYSIOL-HEART C, V280, pH2399, DOI 10.1152/ajpheart.2001.280.5.H2399; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Meyer C, 2002, J APPL PHYSIOL, V92, P888, DOI 10.1152/jappl.2002.92.2.888; Meyer MF, 2003, MICROVASC RES, V65, P88, DOI 10.1016/S0026-2862(02)00015-8; MOHAMED F, 1995, ARTERIOSCL THROM VAS, V15, P52, DOI 10.1161/01.ATV.15.1.52; Pasceri V, 2000, CIRCULATION, V102, P2165; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; Podgoreanu MV, 2002, ANESTHESIOLOGY, V97, P1110, DOI 10.1097/00000542-200211000-00012; Ridker PM, 2003, CIRCULATION, V108, P2292, DOI 10.1161/01.CIR.0000100688.17280.E6; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Sathish V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023662; Schindler TH, 2004, CIRCULATION, V110, P1069, DOI 10.1161/01.CIR.0000140264.56496.76; Soderstrom T, 2003, AM J PHYSIOL-HEART C, V284, pH1638, DOI 10.1152/ajpheart.00826.2000; Verma S, 2004, EUR HEART J, V25, P1754, DOI 10.1016/j.ehj.2004.06.039; Watanabe S, 2013, CIRC J, V77, P1018, DOI 10.1253/circj.CJ-12-1043; Yan GJ, 2008, CIRC RES, V103, P591, DOI 10.1161/CIRCRESAHA.108.173963	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110013	10.1371/journal.pone.0110013	http://dx.doi.org/10.1371/journal.pone.0110013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299643	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200096
J	Wensink, MJ; Wrycza, TF; Baudisch, A				Wensink, Maarten J.; Wrycza, Tomasz F.; Baudisch, Annette			Interaction Mortality: Senescence May Have Evolved because It Increases Lifespan	PLOS ONE			English	Article							EVOLUTION; AGE; RATES	Given an extrinsic challenge, an organism may die or not depending on how the threat interacts with the organism's physiological state. To date, such interaction mortality has been only a minor factor in theoretical modeling of senescence. We describe a model of interaction mortality that does not involve specific functions, making only modest assumptions. Our model distinguishes explicitly between the physiological state of an organism and potential extrinsic, age-independent threats. The resulting mortality may change with age, depending on whether the organism's state changes with age. We find that depending on the physiological constraints, any outcome, be it 'no senescence' or 'high rate of senescence', can be found in any environment; that the highest optimal rate of senescence emerges for an intermediate physiological constraint, i.e. intermediate strength of trade-off; and that the optimal rate of senescence as a function of the environment is driven by the way the environment changes the effect of the organism's state on mortality. We conclude that knowledge about the environment, physiology and their interaction is necessary before reasonable predictions about the evolution of senescence can be made.	[Wensink, Maarten J.; Wrycza, Tomasz F.; Baudisch, Annette] Max Planck Inst Demog Res, Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany; [Wensink, Maarten J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Baudisch, Annette] Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark	Max Planck Society; University of Southern Denmark	Wensink, MJ (corresponding author), Max Planck Inst Demog Res, Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany.	wensink@demogr.mpg.de	Andersen, Mette Adalheidur/D-5608-2017; Baudisch, Annette/ABA-2290-2020	Baudisch, Annette/0000-0002-4202-089X				ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; ARTHUR WB, 1984, DEMOGRAPHY, V21, P109, DOI 10.2307/2061031; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Baudisch A, 2012, GERONTOLOGY, V58, P481, DOI 10.1159/000341861; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Bonsall MB, 2006, PHILOS T R SOC B, V361, P119, DOI 10.1098/rstb.2005.1738; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2007, TRENDS ECOL EVOL, V22, P173, DOI 10.1016/j.tree.2007.01.006; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Chen HY, 2012, CURR BIOL, V22, P2140, DOI 10.1016/j.cub.2012.09.021; Drenos F, 2005, MECH AGEING DEV, V126, P99, DOI 10.1016/j.mad.2004.09.026; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Lenart A, 2014, SCAND ACTUAR J, V2014, P255, DOI 10.1080/03461238.2012.687697; Lotka AJ, 1924, ELEMENTS MATH BIOL; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Medawar P., 1952, UNSOLVED PROBLEM BIO; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Moorad JA, 2010, CURR BIOL, V20, pR406, DOI 10.1016/j.cub.2010.03.016; Rozing MP, 2008, AGING CELL, V7, P924, DOI 10.1111/j.1474-9726.2008.00437.x; Sozou PD, 2004, P ROY SOC B-BIOL SCI, V271, P457, DOI 10.1098/rspb.2003.2614; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Wensink M, 2014, ECOL EVOL, V4, P1924, DOI 10.1002/ece3.1074; Wensink M, 2013, BIOGERONTOLOGY, V14, P99, DOI 10.1007/s10522-012-9410-7; Wensink MJ, 2014, J THEOR BIOL, V347, P176, DOI 10.1016/j.jtbi.2013.11.016; Wensink MJ, 2012, BIOGERONTOLOGY, V13, P197, DOI 10.1007/s10522-011-9362-3; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2003, EVOLUTION, V57, P1478	32	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109638	10.1371/journal.pone.0109638	http://dx.doi.org/10.1371/journal.pone.0109638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299047	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200066
J	Yang, H; Wang, B; Wang, T; Xu, LJ; He, CY; Wen, HY; Yan, J; Su, HH; Zhu, XM				Yang, Huan; Wang, Bo; Wang, Tao; Xu, Longjiang; He, Chunyan; Wen, Huiyan; Yan, Jie; Su, Honghong; Zhu, Xueming			Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis	PLOS ONE			English	Article							DENDRITIC CELLS; EXPRESSION; TLR4; ACTIVATION; CARCINOMA; TUMOR; RECOGNITION; INVOLVEMENT; SURVIVAL; INVASION	Toll-like receptor (TLR)4-mediated signaling has been implicated in tumor cell invasion, survival, and metastasis in a variety of cancers. This study investigated the expression and biological role of TLR4 in human breast cancer metastasis. MCF-7 and MDA-MB-231 are human breast cancer cell lines with low and high metastatic potential, respectively. Using lipopolysaccharide (LPS) to stimulate MCF-7 and MDA-MB-231 cells, expression of TLR4 mRNA and protein increased compared with that in control cells. TLR4 activation notably up-regulated expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor(VEGF) mRNA and their secretion in the supernatants of both cell lines. LPS enhanced invasion of MDA-MB-231 cells by transwell assay and MCF-7 cells by wound healing assay. LPS triggered increased expression of TLR4 downstream signaling pathway protein myeloid differentiation factor 88(MyD88) and resulted in interleukin (IL)-6 and IL-10 higher production by human breast cancer cells. Stimulation of TLR4 with LPS promoted tumorigenesis and formed metastatic lesions in liver of nude mice. Moreover, expression of TLR4 and MyD88 as well as invasiveness and migration of the cells could be blocked by TLR4 antagonist. Combined with clinicopathological parameters, TLR4 was overexpressed in human breast cancer tissue and correlated with lymph node metastasis. These findings indicated that TLR4 may participate in the progression and metastasis of human breast cancer and provide a new therapeutic target.	[Yang, Huan; Wang, Tao; He, Chunyan; Wen, Huiyan; Yan, Jie; Su, Honghong; Zhu, Xueming] Soochow Univ, Affiliated Hosp 2, Dept Clin Lab, Suzhou, Jiangsu, Peoples R China; [Wang, Bo] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Jiangsu, Peoples R China; [Xu, Longjiang] Soochow Univ, Affiliated Hosp 2, Dept Pathol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zhu, XM (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Clin Lab, Suzhou, Jiangsu, Peoples R China.	zjyhcherry@126.com			Natural Science Foundation of the Jiangsu Province [BK2012609]; Foundation of Academic Excellent Member of the Second affiliated Hospital of Soochow University	Natural Science Foundation of the Jiangsu Province(Natural Science Foundation of Jiangsu Province); Foundation of Academic Excellent Member of the Second affiliated Hospital of Soochow University	This work was supported by the Natural Science Foundation of the Jiangsu Province, grant no. BK2012609, and the Foundation of Academic Excellent Member of the Second affiliated Hospital of Soochow University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, ANN SURG ONCOL, V1, P1; Ahmed A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22945; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Binns C, 2013, ASIA-PAC J PUBLIC HE, V25, P364, DOI 10.1177/1010539513505050; Di Domenico M, 2011, J BIOMED BIOTECHNOL, V2011; Ehsan N, 2013, TUMOR BIOL, V34, P1053, DOI 10.1007/s13277-013-0645-y; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hua D, 2009, MOL IMMUNOL, V46, P2876, DOI 10.1016/j.molimm.2009.06.016; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim SH, 2006, J SURG ONCOL, V93, P330, DOI 10.1002/jso.20461; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Petricevic B, 2012, MED ONCOL, V29, P486, DOI 10.1007/s12032-011-9885-0; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wang G, 2013, CANCER BIOMARK, V13, P21, DOI 10.3233/CBM-130332; Wang L., 2012, CANCER, V119, P782; Wang SQ, 2006, BLOOD, V107, P2432, DOI 10.1182/blood-2005-06-2486; Wang XX, 2013, ASIAN PAC J CANCER P, V14, P2295, DOI 10.7314/APJCP.2013.14.4.2295; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Zhang JJ, 2010, WORLD J GASTROENTERO, V16, P2881, DOI 10.3748/wjg.v16.i23.2881; Zuo YF, 2006, BIOCHEM BIOPH RES CO, V351, P361, DOI 10.1016/j.bbrc.2006.10.043	34	94	99	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109980	10.1371/journal.pone.0109980	http://dx.doi.org/10.1371/journal.pone.0109980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299052	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200090
J	Bandyopadhyay, S; Long, ME; Allent, LAH				Bandyopadhyay, Sarmistha; Long, Matthew E.; Allent, Lee-Ann H.			Differential Expression of microRNAs in Francisella tularensis-Infected Human Macrophages: miR-155-Dependent Downregulation of MyD88 Inhibits the Inflammatory Response	PLOS ONE			English	Article							LIVE VACCINE STRAIN; IN-VIVO; HELICOBACTER-PYLORI; DEPENDENT INDUCTION; MURINE MACROPHAGES; SIGNALING PATHWAYS; RESPIRATORY BURST; CYTOKINE RESPONSE; HUMAN NEUTROPHILS; IMMUNE-RESPONSE	Francisella tularensis is a Gram-negative, facultative intracellular pathogen that replicates in the cytosol of macrophages and is the causative agent of the potentially fatal disease tularemia. A characteristic feature of F. tularensis is its limited proinflammatory capacity, but the mechanisms that underlie the diminished host response to this organism are only partially defined. Recently, microRNAs have emerged as important regulators of immunity and inflammation. In the present study we investigated the microRNA response of primary human monocyte-derived macrophages (MDMs) to F. tularensis and identified 10 microRNAs that were significantly differentially expressed after infection with the live vaccine strain (LVS), as judged by Taqman Low Density Array profiling. Among the microRNAs identified, miR-155 is of particular interest as its established direct targets include components of the Toll-like receptor (TLR) pathway, which is essential for innate defense and proinflammatory cytokine production. Additional studies demonstrated that miR-155 acted by translational repression to downregulate the TLR adapter protein MyD88 and the inositol 5'-phosphatase SHIP-1 in MDMs infected with F. tularensis LVS or the fully virulent strain Schu S4. Kinetic analyses indicated that miR-155 increased progressively 3-18 hours after infection with LVS or Schu S4, and target proteins disappeared after 1218 hours. Dynamic modulation of MyD88 and SHIP-1 was confirmed using specific pre-miRs and anti-miRs to increase and decrease miR-155 levels, respectively. Of note, miR-155 did not contribute to the attenuated cytokine response triggered by F. tularensis phagocytosis. Instead, this microRNA was required for the ability of LVS-infected cells to inhibit endotoxin-stimulated TNF alpha secretion 1824 hours after infection. Thus, our data are consistent with the ability of miR-155 to act as a global negative regulator of the inflammatory response in F. tularensis-infected human macrophages.	[Bandyopadhyay, Sarmistha; Long, Matthew E.; Allent, Lee-Ann H.] Univ Iowa, Inflammat Program, Coralville, IA 52241 USA; [Bandyopadhyay, Sarmistha; Allent, Lee-Ann H.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Long, Matthew E.; Allent, Lee-Ann H.] Univ Iowa, Grad Training Program Mol & Cellular Biol, Iowa City, IA USA; [Allent, Lee-Ann H.] Vet Adm Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Allent, LAH (corresponding author), Univ Iowa, Inflammat Program, Coralville, IA 52241 USA.	lee-ann-allen@uiowa.edu		Allen, Lee-Ann/0000-0001-8929-6968; Long, Matthew/0000-0003-4485-019X	National Institutes of Health; National Institute of Allergy and Infectious Diseases [P01 AI044642, U54 AI057160]; Veteran's Administration (Veteran's Administration Merit Review) [I01 BX002108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044642, U54AI057160] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veteran's Administration (Veteran's Administration Merit Review); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by funds from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grants P01 AI044642 and U54 AI057160), and the Veteran's Administration (Veteran's Administration Merit Review grant I01 BX002108) all awarded to LAHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J INFECT DIS, V187, pS356, DOI 10.1086/374749; Allen LAH, 2005, J LEUKOCYTE BIOL, V78, P220, DOI 10.1189/jlb.0205091; Allen LAH, 2013, J LEUKOCYTE BIOL, V93, P641, DOI 10.1189/jlb.1212661; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barker JH, 2006, INFECT IMMUN, V74, P3277, DOI 10.1128/IAI.02011-05; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Cao JZ, 2013, CANCER RES, V73, P3326, DOI 10.1158/0008-5472.CAN-12-3055; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; Crane DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033349; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dai SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003114; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Ghorpade DS, 2013, MOL CELL BIOL, V33, P543, DOI 10.1128/MCB.01108-12; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; GREISMAN SE, 1963, J CLIN INVEST, V42, P1064, DOI 10.1172/JCI104792; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Kunkeaw N, 2013, ONCOGENE, V32, P3722, DOI 10.1038/onc.2012.382; Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#; Likhite Neah, 2011, J Biomol Tech, V22, P37; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long ME, 2013, INFECT IMMUN, V81, P850, DOI 10.1128/IAI.00822-12; Loof TG, 2010, AM J PATHOL, V176, P754, DOI 10.2353/ajpath.2010.090422; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; McCaffrey RL, 2010, J LEUKOCYTE BIOL, V88, P791, DOI 10.1189/jlb.1209811; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Medina EA, 2010, J IMMUNOL, V185, P7562, DOI 10.4049/jimmunol.0903790; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062232; Quinn EM, 2012, J LEUKOCYTE BIOL, V91, P721, DOI 10.1189/jlb.1111571; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Russo BC, 2013, AM J PATHOL, V183, P1223, DOI 10.1016/j.ajpath.2013.06.013; Schnitger AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027435; Scholz G, 2000, J BIOL CHEM, V275, P14615, DOI 10.1074/jbc.275.19.14615; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Schwartz JT, 2012, J IMMUNOL, V189, P3064, DOI 10.4049/jimmunol.1200816; Schwartz JT, 2012, J IMMUNOL, V188, P3351, DOI 10.4049/jimmunol.1102863; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058513; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thompson RC, 2011, J BIOL CHEM, V286, P1675, DOI 10.1074/jbc.M110.177063; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	81	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109525	10.1371/journal.pone.0109525	http://dx.doi.org/10.1371/journal.pone.0109525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295729	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000077
J	Dembek, KA; Hurcombe, SD; Frazer, ML; Morresey, PR; Toribio, RE				Dembek, Katarzyna A.; Hurcombe, Samuel D.; Frazer, Michele L.; Morresey, Peter R.; Toribio, Ramiro E.			Development of a Likelihood of Survival Scoring System for Hospitalized Equine Neonates Using Generalized Boosted Regression Modeling	PLOS ONE			English	Article							LACTATE CONCENTRATION; PERIPHERAL PERFUSION; FOALS; SEVERITY; SEPSIS; ASSOCIATION; PROGNOSIS	Background: Medical management of critically ill equine neonates (foals) can be expensive and labor intensive. Predicting the odds of foal survival using clinical information could facilitate the decision-making process for owners and clinicians. Numerous prognostic indicators and mathematical models to predict outcome in foals have been published; however, a validated scoring method to predict survival in sick foals has not been reported. The goal of this study was to develop and validate a scoring system that can be used by clinicians to predict likelihood of survival of equine neonates based on clinical data obtained on admission. Methods and Results: Data from 339 hospitalized foals of less than four days of age admitted to three equine hospitals were included to develop the model. Thirty seven variables including historical information, physical examination and laboratory findings were analyzed by generalized boosted regression modeling (GBM) to determine which ones would be included in the survival score. Of these, six variables were retained in the final model. The weight for each variable was calculated using a generalized linear model and the probability of survival for each total score was determined. The highest (7) and the lowest (0) scores represented 97% and 3% probability of survival, respectively. Accuracy of this survival score was validated in a prospective study on data from 283 hospitalized foals from the same three hospitals. Sensitivity, specificity, positive and negative predictive values for the survival score in the prospective population were 96%, 71%, 91%, and 85%, respectively. Conclusions: The survival score developed in our study was validated in a large number of foals with a wide range of diseases and can be easily implemented using data available in most equine hospitals. GBM was a useful tool to develop the survival score. Further evaluations of this scoring system in field conditions are needed.	[Dembek, Katarzyna A.; Hurcombe, Samuel D.; Toribio, Ramiro E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Frazer, Michele L.] Hagyard Equine Med Inst, Lexington, KY USA; [Morresey, Peter R.] Rood & Riddle Equine Hosp, Lexington, KY USA	University System of Ohio; Ohio State University	Toribio, RE (corresponding author), Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA.	toribio.1@osu.edu	Toribio, Ramiro/H-7838-2013	Toribio, Ramiro/0000-0002-9063-540X	Morris Animal Foundation [D14EQ-407]; Equine Research Funds at The Ohio State University; Grayson-Jockey Club Research Foundation	Morris Animal Foundation; Equine Research Funds at The Ohio State University; Grayson-Jockey Club Research Foundation	This work was supported by Morris Animal Foundation, Grant#: D14EQ-407, Equine Research Funds at The Ohio State University and Grayson-Jockey Club Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsnick RJIM, 2011, J VET INTERN MED, V25, P123, DOI 10.1111/j.1939-1676.2010.0636.x; Bouch C, 2008, CONTINUING ED ANAEST, V8, P181; Breiman L., 1983, CART CLASSIFICATION, P156; Breslow MJ, 2012, CHEST, V141, P245, DOI 10.1378/chest.11-0330; BREWER BD, 1988, EQUINE VET J, V20, P18, DOI 10.1111/j.2042-3306.1988.tb01445.x; Castagnetti C, 2010, THERIOGENOLOGY, V73, P343, DOI 10.1016/j.theriogenology.2009.09.018; Corley KTT, 2005, EQUINE VET J, V37, P53, DOI 10.2746/0425164054406856; Dembek KA, 2013, J VET INTERN MED, V27, P331, DOI 10.1111/jvim.12043; Dicken M, 2012, NEW ZEAL VET J, V60, P42, DOI 10.1080/00480169.2011.632340; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Furr M, 1997, J VET INTERN MED, V11, P183, DOI 10.1111/j.1939-1676.1997.tb00088.x; Gartman EJ, 2009, CURR OPIN CRIT CARE, V15, P578, DOI 10.1097/MCC.0b013e328332f50c; Gayle JM, 1998, J VET INTERN MED, V12, P140, DOI 10.1111/j.1939-1676.1998.tb02109.x; HOFFMAN AM, 1992, J VET INTERN MED, V6, P89, DOI 10.1111/j.1939-1676.1992.tb03157.x; Hurcombe SDA, 2008, J VET INTERN MED, V22, P639, DOI 10.1111/j.1939-1676.2008.0090.x; International Business Machines Corporation, 2012, IBM SPSS STAT 21, V21; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lima A, 2009, CRIT CARE MED, V37, P934, DOI 10.1097/CCM.0b013e31819869db; R Core Team, 2012, R LANG ENV STAT COMP; Rohrbach BW, 2006, JAVMA-J AM VET MED A, V228, P1748, DOI 10.2460/javma.228.11.1748; Roy MF, 2004, VET CLIN N AM-EQUINE, V20, P41, DOI 10.1016/j.cveq.2003.12.005; Sanchez LC, 2008, JAVMA-J AM VET MED A, V233, P1446, DOI 10.2460/javma.233.9.1446; Sanchez LC, 2005, VET CLIN N AM-EQUINE, V21, P273, DOI 10.1016/j.cveq.2005.04.007; Steel CM, 1999, J AM VET MED ASSOC, V215, P973; van Genderen ME, 2012, CURR OPIN CRIT CARE, V18, P273, DOI 10.1097/MCC.0b013e3283533924; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wotman K, 2009, J VET INTERN MED, V23, P598, DOI 10.1111/j.1939-1676.2009.0277.x	29	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109212	10.1371/journal.pone.0109212	http://dx.doi.org/10.1371/journal.pone.0109212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295600	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204000048
J	McCormick, ME; Rojas, M; Moser-Katz, T; Tzima, E; Reader, JS				McCormick, Margaret E.; Rojas, Mauricio; Moser-Katz, Tyler; Tzima, Ellie; Reader, John S.			Natural Aminoacyl tRNA Synthetase Fragment Enhances Cardiac Function after Myocardial Infarction	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; HEART-FAILURE; PROGENITOR CELLS; IN-VIVO; ANGIOGENESIS; HYPERTROPHY; ACTIVATION; SURVIVAL	A naturally-occurring fragment of tyrosyl-tRNA synthetase (TyrRS) has been shown in higher eukaryotes to 'moonlight' as a pro-angiogenic cytokine in addition to its primary role in protein translation. Pro-angiogenic cytokines have previously been proposed to be promising therapeutic mechanisms for the treatment of myocardial infarction. Here, we show that systemic delivery of the natural fragment of TyRS, mini-TyrRS, improves heart function in mice after myocardial infarction. This improvement is associated with reduced formation of scar tissue, increased angiogenesis of cardiac capillaries, recruitment of c-kit(pos) cells and proliferation of myocardial fibroblasts. This work demonstrates that mini-TyrRS has beneficial effects on cardiac repair and regeneration and offers support for the notion that elucidation of the ever expanding repertoire of noncanonical functions of aminoacyl tRNA synthetases offers unique opportunities for development of novel therapeutics.	[McCormick, Margaret E.; Moser-Katz, Tyler; Tzima, Ellie; Reader, John S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Rojas, Mauricio; Tzima, Ellie] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Reader, JS (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	jreader@med.unc.edu	Tzima, Ellie/L-9256-2017; , Histology Research Core Facility/ABF-6317-2021; Ariel, Pablo/AGJ-4118-2022	Tzima, Ellie/0000-0002-3437-0902; 	UNC NC TraCS grant	UNC NC TraCS grant	This work was supported by a UNC NC TraCS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero F, 2011, CIRC RES, V109, P272, DOI 10.1161/CIRCRESAHA.111.240820; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bolli R, 2006, CIRCULATION, V114, P239; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cheng G, 2008, AM J PHYSL REGUL INT; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Depre C, 2005, TRENDS CARDIOVAS MED, V15, P101, DOI 10.1016/j.tcm.2005.04.006; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Greenberg Y, 2008, FASEB J, V22, P1597, DOI 10.1096/fj.07-9973com; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; House SL, 2005, AM J PHYSIOL-HEART C, V289, pH2167, DOI 10.1152/ajpheart.00392.2005; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Loughran JH, 2012, CURR ATHEROSCLER REP, V14, P491, DOI 10.1007/s11883-012-0273-9; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Shinde AV, 2013, J MOL CELL CARDIOL; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407; Smart N, 2013, VASC PHARMACOL, V58, P164, DOI 10.1016/j.vph.2012.08.001; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, AM J PHYSIOL-HEART C, V296, pH997, DOI 10.1152/ajpheart.00660.2008; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yang XL, 2007, CHEM BIOL, V14, P1323, DOI 10.1016/j.chembiol.2007.10.016; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zeng R, 2011, HEART VESSELS, V26, P69, DOI 10.1007/s00380-010-0032-1; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013	44	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109325	10.1371/journal.pone.0109325	http://dx.doi.org/10.1371/journal.pone.0109325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296172	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000059
J	Tudor-Locke, C; Schuna, JM; Katzmarzyk, PT; Liu, W; Hamrick, KS; Johnson, WD				Tudor-Locke, Catrine; Schuna, John M., Jr.; Katzmarzyk, Peter T.; Liu, Wei; Hamrick, Karen S.; Johnson, William D.			Body Mass Index: Accounting for Full Time Sedentary Occupation and 24-Hr Self-Reported Time Use	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OBESITY; WEIGHT; OVERWEIGHT; VALIDITY; HEALTH; ACCELEROMETER; ADULTS	Objectives: We used linked existing data from the 2006-2008 American Time Use Survey (ATUS), the Current Population Survey (CPS, a federal survey that provides on-going U. S. vital statistics, including employment rates) and self-reported body mass index (BMI) to answer: How does BMI vary across full time occupations dichotomized as sedentary/non-sedentary, accounting for time spent in sleep, other sedentary behaviors, and light, moderate, and vigorous intensity activities? Methods: We classified time spent engaged at a primary job (sedentary or non-sedentary), sleep, and other non-work, non-sleep intensity-defined behaviors, specifically, sedentary behavior, light, moderate, and vigorous intensity activities. Age groups were defined by 20-29, 30-39, 40-49, and 50-64 years. BMI groups were defined by 18.5-24.9, 25.0-27.4, 27.5-29.9, 30.0-34.9, and >= 35.0 kg/m(2). Logistic and linear regression were used to examine the association between BMI and employment in a sedentary occupation, considering time spent in sleep, other non-work time spent in sedentary behaviors, and light, moderate, and vigorous intensity activities, sex, age race/ethnicity, and household income. Results: The analysis data set comprised 4,092 non-pregnant, non-underweight individuals 20-64 years of age who also reported working more than 7 hours at their primary jobs on their designated time use reporting day. Logistic and linear regression analyses failed to reveal any associations between BMI and the sedentary/non-sedentary occupation dichotomy considering time spent in sleep, other non-work time spent in sedentary behaviors, and light, moderate, and vigorous intensity activities, sex, age, race/ethnicity, and household income. Conclusions: We found no evidence of a relationship between self-reported full time sedentary occupation classification and BMI after accounting for sex, age, race/ethnicity, and household income and 24-hours of time use including non-work related physical activity and sedentary behaviors. The various sources of error associated with self-report methods and assignment of generalized activity and occupational intensity categories could compound to obscure any real relationships.	[Tudor-Locke, Catrine; Schuna, John M., Jr.; Katzmarzyk, Peter T.; Liu, Wei; Johnson, William D.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Hamrick, Karen S.] US Dept Agr Econ Res Serv, Washington, DC USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Tudor-Locke, C (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Tudor-Locke@pbrc.edu	Tudor-Locke, Catrine/AAC-2829-2021; Katzmarzyk, Peter T/N-1974-2017; Johnson, William/N-1972-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Johnson, William/0000-0002-3823-4094	USDA Economic Research Service [REE 58-4000-2-0082]; National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center [1 U54 GM104940]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	USDA Economic Research Service(United States Department of Agriculture (USDA)); National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided in part by 1) cooperative agreement REE 58-4000-2-0082 with USDA Economic Research Service, and 2) by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman-Farinelli MA, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-14; [Anonymous], 2008, PHYS ACT GUID REP; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Gillum RF, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-27; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; Kaleta Dorota, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P9, DOI 10.2478/v10001-007-0009-1; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; Monda KL, 2008, EUR J CLIN NUTR, V62, P1318, DOI 10.1038/sj.ejcn.1602849; Mummery WK, 2005, AM J PREV MED, V29, P91, DOI 10.1016/j.amepre.2005.04.003; Ogden CL, 2010, NATL VITAL STAT REPO, V6, P1; Owen N, 2000, Exerc Sport Sci Rev, V28, P153; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2011, J PHYS ACTIVITY HLTH, V8; Tudor-Locke C, 2011, J OCCUP ENVIRON MED, V53, P1382, DOI 10.1097/JOM.0b013e31823c1402; Tudor-Locke C, 2011, J PHYS ACT HEALTH, V8, P693, DOI 10.1123/jpah.8.5.693; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P347, DOI 10.1123/jpah.6.3.347; van der Ploeg HP, 2010, AM J EPIDEMIOL, V172, P1199, DOI 10.1093/aje/kwq265; Van Domelen DR, 2011, AM J PREV MED, V41, P136, DOI 10.1016/j.amepre.2011.03.019; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Zick CD, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-84	22	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109051	10.1371/journal.pone.0109051	http://dx.doi.org/10.1371/journal.pone.0109051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295601	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000034
J	Arokium, H; Kamata, M; Kim, S; Kim, N; Liang, M; Presson, AP; Chen, IS				Arokium, Hubert; Kamata, Masakazu; Kim, Sanggu; Kim, Namshin; Liang, Min; Presson, Angela P.; Chen, Irvin S.			Deep Sequencing Reveals Low Incidence of Endogenous LINE-1 Retrotransposition in Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							L1 RETROTRANSPOSITION; SOMATIC RETROTRANSPOSITION; EPIGENETIC MEMORY; IPS CELLS; ELEMENT; LANDSCAPE; INSERTION	Long interspersed element-1 (LINE-1 or L1) retrotransposition induces insertional mutations that can result in diseases. It was recently shown that the copy number of L1 and other retroelements is stable in induced pluripotent stem cells (iPSCs). However, by using an engineered reporter construct over-expressing L1, another study suggests that reprogramming activates L1 mobility in iPSCs. Given the potential of human iPSCs in therapeutic applications, it is important to clarify whether these cells harbor somatic insertions resulting from endogenous L1 retrotransposition. Here, we verified L1 expression during and after reprogramming as well as potential somatic insertions driven by the most active human endogenous L1 subfamily (L1Hs). Our results indicate that L1 over-expression is initiated during the reprogramming process and is subsequently sustained in isolated clones. To detect potential somatic insertions in iPSCs caused by L1Hs retotransposition, we used a novel sequencing strategy. As opposed to conventional sequencing direction, we sequenced from the 3' end of L1Hs to the genomic DNA, thus enabling the direct detection of the polyA tail signature of retrotransposition for verification of true insertions. Deep coverage sequencing thus allowed us to detect seven potential somatic insertions with low read counts from two iPSC clones. Negative PCR amplification in parental cells, presence of a polyA tail and absence from seven L1 germline insertion databases highly suggested true somatic insertions in iPSCs. Furthermore, these insertions could not be detected in iPSCs by PCR, likely due to low abundance. We conclude that L1Hs retrotransposes at low levels in iPSCs and therefore warrants careful analyses for genotoxic effects.	[Arokium, Hubert; Kamata, Masakazu; Kim, Sanggu; Liang, Min; Chen, Irvin S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Presson, Angela P.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California Los Angeles	Chen, IS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017; Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Chen, Irvin/0000-0003-1199-2415; Kamata, Masakazu/0000-0003-0323-3742	UCLA AIDS Institute (UCLA CFAR) [5P30 AI028697]; National Research Foundation of Korea - MSIP of the Korea government [20110030770]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008019, PJ008068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL116234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	UCLA AIDS Institute (UCLA CFAR); National Research Foundation of Korea - MSIP of the Korea government; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the UCLA AIDS Institute (UCLA CFAR Grant 5P30 AI028697), the National Research Foundation of Korea (grant No. 20110030770 funded by the MSIP of the Korea government) and the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (grants No. PJ008019 & PJ008068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Boissinot S, 2005, CYTOGENET GENOME RES, V110, P402, DOI 10.1159/000084972; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kamata M, 2010, HUM GENE THER, V21, P1555, DOI 10.1089/hum.2010.050; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2010, NAT PROTOC, V5, P963, DOI 10.1038/nprot.2010.61	46	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108682	10.1371/journal.pone.0108682	http://dx.doi.org/10.1371/journal.pone.0108682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289675	Green Published, gold			2022-12-27	WOS:000342798000022
J	Borreani, C; Bianchi, E; Pietrolongo, E; Rossi, I; Cilia, S; Giuntoli, M; Giordano, A; Confalonieri, P; Lugaresi, A; Patti, F; Grasso, MG; de Carvalho, LL; Palmisano, L; Zaratin, P; Battaglia, MA; Solari, A				Borreani, Claudia; Bianchi, Elisabetta; Pietrolongo, Erika; Rossi, Ilaria; Cilia, Sabina; Giuntoli, Miranda; Giordano, Andrea; Confalonieri, Paolo; Lugaresi, Alessandra; Patti, Francesco; Grasso, Maria Grazia; de Carvalho, Laura Lopes; Palmisano, Lucia; Zaratin, Paola; Battaglia, Mario Alberto; Solari, Alessandra		PeNSAMI Project	Unmet Needs of People with Severe Multiple Sclerosis and Their Carers: Qualitative Findings for a Home-Based Intervention	PLOS ONE			English	Article							PALLIATIVE CARE; OF-LIFE; EXPERIENCES	Background: Few data on services for people with severe multiple sclerosis (MS) are available. The Palliative Network for Severely Affected Adults with MS in Italy (PeNSAMI) developed a home palliative care program for MS patients and carers, preceded by a literature review and qualitative study (here reported). Objective: To identify unmet needs of people with severe MS living at home by qualitative research involving key stakeholders, and theorize broad areas of intervention to meet those needs. Method: Data were collected from: at least 10 personal interviews with adults with severe MS (primary/secondary progressive, EDSS >= 8.0); three focus group meetings (FGs) of carers of people with severe MS; and two FGs of health professionals (HPs). Grounded theory guided the analysis of interview and FG transcripts, from which the areas of intervention were theorized. Results: Between October 2012 and May 2013, 22 MS patients, 30 carers and 18 HPs participated. Forty-eight needs themes were identified, grouped into 14 categories and four domains. Seven, highly interdependent intervention areas were theorized. Patients had difficulties expressing needs; experiences of burden and loneliness were prominent, chiefly in dysfunctional, less affluent families, and among parent carers. Needs differed across Italy with requirements for information and access to services highest in the South. All participants voiced a strong need for qualified personnel and care coordination in day-to-day home care. Personal hygiene emerged as crucial, as did the need for a supportive network and preservation of patient/carer roles within family and community. Conclusions: Unmet needs transcended medical issues and embraced organizational and psychosocial themes, as well as health policies. The high interdependence of the seven intervention areas theorized is in line with the multifaceted approach of palliative care. At variance with typical palliative contexts, coping with disability rather than end-of-life was a major concern of patients and carers.	[Borreani, Claudia; Bianchi, Elisabetta] Fdn IRCCS Ist Nazl Cura Tumori, Unit Psychol, Milan, Italy; [Pietrolongo, Erika; Lugaresi, Alessandra] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Rossi, Ilaria; Grasso, Maria Grazia] Fdn IRCCS S Lucia Rehabil Hosp, Multiple Sclerosis Unit, Rome, Italy; [Cilia, Sabina; Patti, Francesco] Univ Hosp Policlin Vittorio Emanuele, MS Ctr, Neurol Clin, Catania, Italy; [Giuntoli, Miranda] AISM Liguria Reg Rehabil Serv, Genoa, Italy; [Giordano, Andrea; Solari, Alessandra] Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy; [Confalonieri, Paolo] Fdn IRCCS Neurol Inst C Besta, Unit Neuroimmunol, Milan, Italy; [Palmisano, Lucia] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Zaratin, Paola; Battaglia, Mario Alberto] Italian Multiple Sclerosis Fdn, Sci Res Dept, Genoa, Italy	G d'Annunzio University of Chieti-Pescara; IRCCS Santa Lucia; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania; Istituto Superiore di Sanita (ISS)	Solari, A (corresponding author), Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy.	solari@istituto-besta.it	Lugaresi, Alessandra/C-7743-2012; Solari, Alessandra/AAO-1741-2021; pietrolongo, erika/AAC-5694-2020; Giordano, Andrea/AAN-3738-2021; Fittipaldo, Andrea/ABF-9745-2020; Bianchi, Elisabetta/B-9406-2017; Fusco, Augusto/K-5794-2012; Campanella, Angela/AAP-4204-2021; Confalonieri, Paolo/AAS-8513-2021; Borreani, Claudia/E-6437-2017; Morone, Giovanni/A-9561-2013; pucci, eugenio/I-1039-2014; Torri Clerici, Valentina/AAR-5856-2021	Lugaresi, Alessandra/0000-0003-2902-5589; Solari, Alessandra/0000-0001-9930-7579; pietrolongo, erika/0000-0002-6311-5994; Giordano, Andrea/0000-0003-4466-9788; Fittipaldo, Andrea/0000-0002-2832-9241; Bianchi, Elisabetta/0000-0001-8085-3545; Fusco, Augusto/0000-0002-8528-7834; Campanella, Angela/0000-0001-8578-0920; Confalonieri, Paolo/0000-0001-8030-5725; Borreani, Claudia/0000-0002-7447-4626; troisi, elio/0000-0002-5171-0243; Morone, Giovanni/0000-0003-3602-4197; Veronese, Simone/0000-0002-9555-7252; patti, francesco/0000-0002-6923-0846; grasso, maria grazia/0000-0003-1582-5534; pucci, eugenio/0000-0001-7606-7330; Torri Clerici, Valentina/0000-0002-7336-6340	Fondazione Italiana Sclerosi Multipla (FISM) [2012/S/1]	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM))	This study was supported by the Fondazione Italiana Sclerosi Multipla (FISM, www.aism.it, grant No. 2012/S/1 to AS). The funding sources had no role in study design, data collection, data analysis, data interpretation, or report writing.	Barazzetti Gaia, 2010, BMC Palliat Care, V9, P1, DOI 10.1186/1472-684X-9-1; Ben-Zacharia AB, 2001, NEUROL CLIN, V19, P801, DOI 10.1016/S0733-8619(05)70048-7; Bluff R., 2005, QUALITATIVE RES HLTH, P147; Burt RS, 2005, BROKERAGE CLOSURE IN; Campbell CW, 2010, CLIN MED, V10, P290, DOI 10.7861/clinmedicine.10-3-290; Cote L, 2005, MED TEACH, V27, P71, DOI 10.1080/01421590400016308; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Denzin N.K., 2013, LANDSCAPE QUALITATIV; Edmonds P, 2007, MULT SCLER J, V13, P660, DOI 10.1177/1352458506071789; Edmonds P, 2007, PALLIATIVE MED, V21, P101, DOI 10.1177/0269216307076333; Edmonds P, 2010, MULT SCLER J, V16, P627, DOI 10.1177/1352458510364632; Galushko M, 2014, J PALLIAT MED, V17, P274, DOI 10.1089/jpm.2013.0497; Giordano A, 2012, EUR J NEUROL, V19, P847, DOI 10.1111/j.1468-1331.2011.03638.x; Glaser B.G., 1968, DISCOV GROUNDED THEO; Golla H, 2012, PALLIATIVE MED, V26, P139, DOI 10.1177/0269216311401465; GOMES B, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD007760.PUB2; Gruenewald DA, 2004, MULT SCLER J, V10, P690, DOI 10.1191/1352458504ms1116rr; Higginson IJ, 2006, J PALLIATIVE CARE, V22, P158, DOI 10.1177/082585970602200306; Higginson IJ, 2009, J PAIN SYMPTOM MANAG, V38, P816, DOI 10.1016/j.jpainsymman.2009.07.002; Humphries C, 2012, NATURE, V484, pS10, DOI 10.1038/nature11108; Khan F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006036.pub2; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Kristjanson LJ, 2006, INT J PALLIAT NURS, V12, P368, DOI 10.12968/ijpn.2006.12.8.368; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; National Institute for Health and Clinical Excellence, 2003, MAN MULT SCLER PRIM; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Runia TF, 2012, CNS NEUROL DISORD-DR, V11, P497; Sleeman KE, 2013, J PAIN SYMPTOM MANAG, V46, P406, DOI 10.1016/j.jpainsymman.2012.08.007; Solari A, 2006, J NEUROL SCI, V243, P13, DOI 10.1016/j.jns.2005.11.005; Stjernsward J, 2007, J PAIN SYMPTOM MANAG, V33, P486, DOI 10.1016/j.jpainsymman.2007.02.016; Strauss A., 1998, BASICS QUALITATIVE R; Turner-Stokes L, 2007, CLIN MED, V7, P129, DOI 10.7861/clinmedicine.7-2-129; Veronese S, 2013, PALLIATIVE CARE PEOP; Voltz R, 2010, MULT SCLER J, V16, P515, DOI 10.1177/1352458510367466	35	49	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109679	10.1371/journal.pone.0109679	http://dx.doi.org/10.1371/journal.pone.0109679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286321	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700084
J	Chan, K; Shah, K; Lien, K; Coyle, D; Lam, H; Ko, YJ				Chan, Kelvin; Shah, Keya; Lien, Kelly; Coyle, Doug; Lam, Henry; Ko, Yoo-Joung			A Bayesian Meta-Analysis of Multiple Treatment Comparisons of Systemic Regimens for Advanced Pancreatic Cancer	PLOS ONE			English	Article							RANDOMIZED PHASE-III; ONCOLOGY-GROUP; GEMCITABINE; TRIAL; COMBINATION; CAPECITABINE; OXALIPLATIN; MULTICENTER; CARCINOMA; CISPLATIN	Background: For advanced pancreatic cancer, many regimens have been compared with gemcitabine (G) as the standard arm in randomized controlled trials. Few regimens have been directly compared with each other in randomized controlled trials and the relative efficacy and safety among them remains unclear. Methods: A systematic review was performed through MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and ASCO meeting abstracts up to May 2013 to identify randomized controlled trials that included advanced pancreatic cancer comparing the following regimens: G, G+5-fluorouracil, G+ capecitabine, G+S1, G+ cisplatin, G+oxaliplatin, G+ erlotinib, G+ nab-paclitaxel, and FOLFIRINOX. Overall survival and progression-free survival with 95% credible regions were extracted using the Parmar method. A Bayesian multiple treatment comparisons was performed to compare all regimens simultaneously. Results: Twenty-two studies were identified and 16 were included in the meta-analysis. Median overall survival, progression free survival, and response rates for G arms from all trials were similar, suggesting no significant clinical heterogeneity. For overall survival, the mixed treatment comparisons found that the probability that FOLFIRINOX was the best regimen was 83%, while it was 11% for G+ nab-paclitaxel and 3% for G+S1 and G+ erlotinib, respectively. The overall survival hazard ratio for FOLFIRINOX versus G+ nab-paclitaxel was 0.79 [0.50-1.24], with no obvious difference in toxicities. The hazard ratios from direct pairwise comparisons were consistent with the mixed treatment comparisons results. Conclusions: FOLFIRINOX appeared to be the best regimen for advanced pancreatic cancer probabilistically, with a trend towards improvement in survival when compared with other regimens by indirect comparisons.	[Chan, Kelvin; Shah, Keya; Lien, Kelly; Lam, Henry; Ko, Yoo-Joung] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Chan, Kelvin] Univ Toronto, Div Biostat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Coyle, Doug] Univ Ottawa, Ottawa, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Ottawa	Chan, K (corresponding author), Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada.	kelvin.chan@sunnybrook.ca		Lien, Kelly/0000-0002-9494-3776; Coyle, Doug/0000-0003-3492-2268				Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; American Cancer Society, 2013, CANC FACTS FIG 2013; [Anonymous], 2008, ERL TREATM NONSM CEL; Berlin JD, 2002, J CLIN ONCOL, V20, P3270, DOI 10.1200/JCO.2002.11.149; Boeck S, 2008, ANN ONCOL, V19, P340, DOI 10.1093/annonc/mdm467; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Colucci G, 2002, CANCER, V94, P902, DOI 10.1002/cncr.10323.abs; Colucci G, 2010, J CLIN ONCOL, V28, P1645, DOI 10.1200/JCO.2009.25.4433; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Di Costanzo F, 2005, BRIT J CANCER, V93, P185, DOI 10.1038/sj.bjc.6602640; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Herrmann R, 2007, J CLIN ONCOL, V25, P2212, DOI 10.1200/JCO.2006.09.0886; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Kulke MH, 2009, J CLIN ONCOL, V27, P5506, DOI 10.1200/JCO.2009.22.1309; Li CP, 2004, J CLIN ONCOL, V22, p349S; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakai Y, 2012, BRIT J CANCER, V106, P1934, DOI 10.1038/bjc.2012.183; Ntzoufras I., 2009, BAYESIAN MODELING US; Office for National Statistics, 2011, CANC SURV ENGL PAT D; Ozaka M, 2012, CANCER CHEMOTH PHARM, V69, P1197, DOI 10.1007/s00280-012-1822-1; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peddi PF, 2012, J PANCREAS, V13, P497, DOI 10.6092/1590-8577/913; Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Poplin E, 2009, J CLIN ONCOL, V27, P3778, DOI 10.1200/JCO.2008.20.9007; Riess A, 2005, J CLIN ONCOL, V23; Scheithauer W, 2003, ANN ONCOL, V14, P97, DOI 10.1093/annonc/mdg029; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Viret F, 2004, J CLIN ONCOL, V22, p342S; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Von Hoff DD, 2012, J CLIN ONCOL S, V34; Wang Xingyuan, 2002, Zhonghua Zhongliu Zazhi, V24, P404; Warsame R, 2012, EXPERT REV ANTICANC, V12, P1327, DOI [10.1586/ERA.12.115, 10.1586/era.12.115]; Wells GA, 2009, INDIRECT EVIDENCE IN	40	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108749	10.1371/journal.pone.0108749	http://dx.doi.org/10.1371/journal.pone.0108749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286060	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700033
J	Horste, GMZ; Cordes, S; Mausberg, AK; Zozulya, AL; Wessig, C; Sparwasser, T; Mathys, C; Wiendl, H; Hartung, HP; Kieseier, BC				Hoerste, Gerd Meyer Zu; Cordes, Steffen; Mausberg, Anne K.; Zozulya, Alla L.; Wessig, Carsten; Sparwasser, Tim; Mathys, Christian; Wiendl, Heinz; Hartung, Hans-Peter; Kieseier, Bernd C.			FoxP3+Regulatory T Cells Determine Disease Severity in Rodent Models of Inflammatory Neuropathies	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE NEURITIS; REGULATORY CELLS; CYTOKINES; PATHOGENESIS; ENTEROPATHY; PEPTIDE; TOXIN; TH17; P0	Inflammatory neuropathies represent disabling human autoimmune disorders with considerable disease variability. Animal models provide insights into defined aspects of their disease pathogenesis. Forkhead box P3 (FoxP3)+ regulatory T lymphocytes (Treg) are anti-inflammatory cells that maintain immune tolerance and counteract tissue damage in a variety of immune-mediated disorders. Dysfunction or a reduced frequency of Tregs have been associated with different human autoimmune disorders. We here analyzed the functional relevance of Tregs in determining disease manifestation and severity in murine models of autoimmune neuropathies. We took advantage of the DEREG mouse system allowing depletion of Treg with high specificity as well as anti-CD25 directed antibodies to deplete Tregs in mice in actively induced experimental autoimmune neuritis (EAN). Furthermore antibody-depletion was performed in an adoptive transfer model of chronic neuritis. Early Treg depletion increased clinical EAN severity both in active and adoptive transfer chronic neuritis. This was accompanied by increased proliferation of myelin specific T cells and histological signs of peripheral nerve inflammation. Late stage Treg depletion after initial disease manifestation however did not exacerbate inflammatory neuropathy symptoms further. We conclude that Tregs determine disease severity in experimental autoimmune neuropathies during the initial priming phase, but have no major disease modifying function after disease manifestation. Potential future therapeutic approaches targeting Tregs should thus be performed early in inflammatory neuropathies.	[Hoerste, Gerd Meyer Zu; Cordes, Steffen; Mausberg, Anne K.; Hartung, Hans-Peter; Kieseier, Bernd C.] Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany; [Zozulya, Alla L.; Wessig, Carsten] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Hannover, Germany; [Mathys, Christian] Univ Dusseldorf, Dept Diagnost & Intervent Radiol, Fac Med, Dusseldorf, Germany; [Wiendl, Heinz] Univ Munster, Dept Neurol, D-48149 Munster, Germany	Heinrich Heine University Dusseldorf; University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Heinrich Heine University Dusseldorf; University of Munster	Horste, GMZ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	gerd.mzh@uni-duesseldorf.de	Horste, Gerd Meyer zu/O-9549-2016; Sparwasser, Tim D/AAA-4306-2022; Sparwasser, Tim/AAF-7085-2019; Wiendl, Heinz/AAX-6041-2021	Horste, Gerd Meyer zu/0000-0002-4341-4719; Sparwasser, Tim/0000-0001-5645-902X; Wiendl, Heinz/0000-0003-4310-3432; Mathys, Christian/0000-0002-5245-4958	Fritz-Thyssen foundation; Peripheral Nerve Society; Deutsche Forschungsgemeinschaft [ME-4050/1-1]; Forschungskommission of the Heinrich-Heine University	Fritz-Thyssen foundation; Peripheral Nerve Society; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission of the Heinrich-Heine University	This study was funded in part by grants from the Fritz-Thyssen foundation (www.fritz-thyssen-stiftung.de), the Peripheral Nerve Society (www.pnsociety.com), the Deutsche Forschungsgemeinschaft (www.dfg.de; grant number ME-4050/1-1), and the Forschungskommission of the Heinrich-Heine University (www.medizin.hhu.de); all to GMzH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Chi LJ, 2008, J PERIPHER NERV SYST, V13, P54, DOI 10.1111/j.1529-8027.2008.00158.x; Chi L, 2007, J NEUROIMMUNOL, V192, P206, DOI 10.1016/j.jneuroim.2007.09.034; Harness J, 2008, J CLIN NEUROSCI, V15, P1031, DOI 10.1016/j.jocn.2007.09.016; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Horste GMZ, 2010, J IMMUNOL METHODS, V354, P80, DOI 10.1016/j.jim.2010.01.012; Hughes RAC, 2006, J PERIPHER NERV SYST, V11, P30, DOI 10.1111/j.1085-9489.2006.00061.x; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Jung S, 1995, NEUROSCI LETT, V200, P167, DOI 10.1016/0304-3940(95)12115-K; Kieseier BC, 2000, J NEUROIMMUNOL, V110, P121, DOI 10.1016/S0165-5728(00)00323-4; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koller H, 2005, NEW ENGL J MED, V352, P1343, DOI 10.1056/nejmra041347; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Li XL, 2011, CELL IMMUNOL, V271, P455, DOI 10.1016/j.cellimm.2011.08.015; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Maurer M, 2002, CURR OPIN NEUROL, V15, P617, DOI 10.1097/00019052-200210000-00013; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Meyer Zu Horste G, 2014, J IMMUNOL; Meyer Zu Horste G, 2014, J IMMUNOL IN PRESS; Horste GMZ, 2007, ANN NEUROL, V61, P61, DOI 10.1002/ana.21026; Miletic H, 2005, J NEUROPATH EXP NEUR, V64, P66, DOI 10.1093/jnen/64.1.66; Picca CC, 2011, P NATL ACAD SCI USA, V108, P14890, DOI 10.1073/pnas.1103810108; Pritchard J, 2007, J NEUROIMMUNOL, V183, P232, DOI 10.1016/j.jneuroim.2006.12.002; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Sanvito L, 2009, J NEUROL NEUROSUR PS, V80, P333, DOI 10.1136/jnnp.2008.159798; Sanvito L, 2009, AUTOIMMUNITY, V42, P667, DOI 10.3109/08916930903140907; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Stephens LA, 2005, P NATL ACAD SCI USA, V102, P17418, DOI 10.1073/pnas.0507454102; Vallat JM, 2010, LANCET NEUROL, V9, P402, DOI 10.1016/S1474-4422(10)70041-7; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; Wang X, 2014, SCAND J IMMUNOL, V80, P180, DOI 10.1111/sji.12201; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Xia RH, 2010, J NEUROIMMUNOL, V219, P54, DOI 10.1016/j.jneuroim.2009.11.019; Xu H, 2014, J NEUROIMMUNOL, V269, P28, DOI 10.1016/j.jneuroim.2014.02.002; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zhang Z, 2009, EXP NEUROL, V216, P75, DOI 10.1016/j.expneurol.2008.11.014; Zou LP, 2000, J NEUROSCI RES, V62, P717, DOI 10.1002/1097-4547(20001201)62:5<717::AID-JNR11>3.0.CO;2-P	39	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108756	10.1371/journal.pone.0108756	http://dx.doi.org/10.1371/journal.pone.0108756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286182	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700034
J	Malik, R; Khan, M; Munir, A; Khan, WA				Malik, Rabia; Khan, Masood; Munir, Asif; Khan, Waqar Azeem			Flow and Heat Transfer in Sisko Fluid with Convective Boundary Condition	PLOS ONE			English	Article							STAGNATION-POINT FLOW; STEADY FLOW; STRETCHING SHEET; MOVING SURFACE	In this article, we have studied the flow and heat transfer in Sisko fluid with convective boundary condition over a non-isothermal stretching sheet. The flow is influenced by non-linearly stretching sheet in the presence of a uniform transverse magnetic field. The partial differential equations governing the problem have been reduced by similarity transformations into the ordinary differential equations. The transformed coupled ordinary differential equations are then solved analytically by using the homotopy analysis method (HAM) and numerically by the shooting method. Effects of different parameters like power-law index n, magnetic parameter M, stretching parameter s, generalized Prandtl number Pr and generalized Biot number gamma are presented graphically. It is found that temperature profile increases with the increasing value of M and gamma whereas it decreases for Pr. Numerical values of the skin-friction coefficient and local Nusselt number are tabulated at various physical situations. In addition, a comparison between the HAM and exact solutions is also made as a special case and excellent agreement between results enhance a confidence in the HAM results.	[Malik, Rabia; Khan, Masood; Munir, Asif; Khan, Waqar Azeem] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan	Quaid I Azam University	Malik, R (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	rabiamalik.qau@gmail.com	Khan, Dr. Waqar Azeem/AAZ-9625-2021; KHAN, Masood/AAA-7384-2020; khan, Masood/F-7143-2015	KHAN, Masood/0000-0003-4404-1456; 				[Anonymous], 2014, J KING SAUD UNIV SCI, DOI DOI 10.1016/j.jksus.2013.08.004; Arnold JC, 2010, INT J HEAT MASS TRAN, V53, P1112, DOI 10.1016/j.ijheatmasstransfer.2009.10.046; Bachok N, 2012, INT J HEAT MASS TRAN, V55, P8122, DOI 10.1016/j.ijheatmasstransfer.2012.08.051; Bhattacharyya K, 2013, AIN SHAMS ENG J, V4, P259, DOI 10.1016/j.asej.2012.07.002; Bataller RC, 2008, APPL MATH COMPUT, V206, P832, DOI 10.1016/j.amc.2008.10.001; Hakeem AKA, 2014, AIN SHAMS ENG J; Hamad MAA, 2012, NUCL ENG DES, V242, P194, DOI 10.1016/j.nucengdes.2011.09.005; Hayat T, 2013, COMPUT FLUIDS, V86, P103, DOI 10.1016/j.compfluid.2013.07.003; Hayat T, 2012, NUCL ENG DES, V252, P242, DOI 10.1016/j.nucengdes.2012.07.012; Hayat T, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4006897; Hayat T, 2012, INT J HEAT MASS TRAN, V55, P1817, DOI 10.1016/j.ijheatmasstransfer.2011.10.046; Ibrahim W, 2013, INT J HEAT MASS TRAN, V56, P1, DOI 10.1016/j.ijheatmasstransfer.2012.08.034; Khan M, 2012, INT J NUMER METH FL, V69, P1907, DOI 10.1002/fld.2673; Khan M, 2010, INT J HEAT MASS TRAN, V53, P1290, DOI 10.1016/j.ijheatmasstransfer.2009.12.037; Khan M, 2013, QUAEST MATH, V36, P137, DOI 10.2989/16073606.2013.779971; Khan M, 2010, J POROUS MEDIA, V13, P287, DOI 10.1615/JPorMedia.v13.i3.80; Liao S., 2012, HOMOTOPY ANAL METHOD; Makinde OD, 2009, APPL THERM ENG, V29, P1773, DOI 10.1016/j.applthermaleng.2008.08.012; Molati M, 2009, NONLINEAR ANAL-REAL, V10, P3428, DOI 10.1016/j.nonrwa.2008.09.023; Nandeppanavar MM, 2011, INT J HEAT MASS TRAN, V54, P4960, DOI 10.1016/j.ijheatmasstransfer.2011.07.009; Sarif NM, 2013, PROCEDIA ENGINEER, V53, P542, DOI 10.1016/j.proeng.2013.02.070; Shehzad SA, 2012, INT J HEAT MASS TRAN, V55, P3971, DOI 10.1016/j.ijheatmasstransfer.2012.03.027; Srinivas S, 2014, J KING SAUD U ENG SC; Vajravelu K, 2013, NONLINEAR ANAL-REAL, V14, P455, DOI 10.1016/j.nonrwa.2012.07.008; Yao SS, 2011, COMMUN NONLINEAR SCI, V16, P752, DOI 10.1016/j.cnsns.2010.05.028	25	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e107989	10.1371/journal.pone.0107989	http://dx.doi.org/10.1371/journal.pone.0107989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285822	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700011
J	Marringa, WJ; Krueger, MJ; Burritt, NL; Burritt, JB				Marringa, William J.; Krueger, Michael J.; Burritt, Nancy L.; Burritt, James B.			Honey Bee Hemocyte Profiling by Flow Cytometry	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; LARVAL CIRCULATING HEMOCYTES; APIS-MELLIFERA; INNATE IMMUNE; VARROA-DESTRUCTOR; FOREIGN TARGETS; INSECT; SILKWORM; CLASSIFICATION; MICROSPORIDIA	Multiple stress factors in honey bees are causing loss of bee colonies worldwide. Several infectious agents of bees are believed to contribute to this problem. The mechanisms of honey bee immunity are not completely understood, in part due to limited information about the types and abundances of hemocytes that help bees resist disease. Our study utilized flow cytometry and microscopy to examine populations of hemolymph particulates in honey bees. We found bee hemolymph includes permeabilized cells, plasmatocytes, and acellular objects that resemble microparticles, listed in order of increasing abundance. The permeabilized cells and plasmatocytes showed unexpected differences with respect to properties of the plasma membrane and labeling with annexin V. Both permeabilized cells and plasmatocytes failed to show measurable mitochondrial membrane potential by flow cytometry using the JC-1 probe. Our results suggest hemolymph particulate populations are dynamic, revealing significant differences when comparing individual hive members, and when comparing colonies exposed to diverse conditions. Shifts in hemocyte populations in bees likely represent changing conditions or metabolic differences of colony members. A better understanding of hemocyte profiles may provide insight into physiological responses of honey bees to stress factors, some of which may be related to colony failure.	[Marringa, William J.; Krueger, Michael J.; Burritt, Nancy L.; Burritt, James B.] Univ Wisconsin Stout, Dept Biol, Menomonie, WI 54751 USA	University of Wisconsin System; University of Wisconsin Stout	Burritt, JB (corresponding author), Univ Wisconsin Stout, Dept Biol, Menomonie, WI 54751 USA.	burrittj@uwstout.edu			Honey Bee Health Task Force of the North American Pollinator Protection Campaign (NAPPC); University of Wisconsin; Stout University Foundation	Honey Bee Health Task Force of the North American Pollinator Protection Campaign (NAPPC); University of Wisconsin; Stout University Foundation	The authors wish to acknowledge funding from the Honey Bee Health Task Force of the North American Pollinator Protection Campaign (NAPPC). The authors also acknowledge an internal Student Research Grant from the University of Wisconsin-Stout Access to Learning Program and a grant from the Stout University Foundation. The opinions expressed are those of the authors and do not necessarily reflect the views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bull JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003083; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cossarizza A, 2001, CURR PROTOC CYTOM; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, ENV MICROBIOL REP, V4, P123, DOI 10.1111/j.1758-2229.2011.00312.x; de Barros CM, 2014, NITRIC OXIDE-BIOL CH, V38, P26, DOI 10.1016/j.niox.2014.02.007; de Graaf DC, 2002, APIDOLOGIE, V33, P571, DOI 10.1051/apido:2002041; Di PG, 2013, PLOS ONE, V8; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evans J, 2010, PARLIAMENT AFF, V63, P1, DOI 10.1093/pa/gsp042; Fan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071600; Flenniken ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077263; Foley K, 2012, J INVERTEBR PATHOL, V111, P68, DOI 10.1016/j.jip.2012.06.006; Ford J, 2013, INT J LAB HEMATOL, V35, P351, DOI 10.1111/ijlh.12082; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Gatschenberger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066415; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; GILLIAM M, 1967, J INVERTEBR PATHOL, V9, P387, DOI 10.1016/0022-2011(67)90074-2; Harpur BA, 2013, MOL BIOL EVOL, V30, P1665, DOI 10.1093/molbev/mst061; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Jefferson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054097; Jy W, 2010, SEMIN THROMB HEMOST, V36, P876, DOI 10.1055/s-0030-1267041; Kanbar G, 2003, PARASITOL RES, V90, P349, DOI 10.1007/s00436-003-0827-4; Kuhn-Nentwig L, 2014, DEV COMP IMMUNOL, V43, P59, DOI 10.1016/j.dci.2013.10.008; Lavine MD, 2001, J INSECT PHYSIOL, V47, P965, DOI 10.1016/S0022-1910(01)00071-3; Ling E, 2005, TISSUE CELL, V37, P101, DOI 10.1016/j.tice.2004.10.007; Ling E, 2003, HISTOCHEM CELL BIOL, V120, P505, DOI 10.1007/s00418-003-0592-6; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; McMullan JB, 2009, EXP APPL ACAROL, V47, P225, DOI 10.1007/s10493-008-9213-3; Mizerska-Dudka M, 2014, J BASIC MICROB, V54, P232, DOI 10.1002/jobm.201200273; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Nakahara Y, 2009, DEV COMP IMMUNOL, V33, P439, DOI 10.1016/j.dci.2008.09.005; Niu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072988; Oliver JD, 2011, J INVERTEBR PATHOL, V108, P126, DOI 10.1016/j.jip.2011.07.004; Pech LL, 1996, J CELL SCI, V109, P2053; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pirk CWW, 2014, J APICULT RES, V53, P35, DOI 10.3896/IBRA.1.53.1.03; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Amaral IMR, 2010, MICRON, V41, P123, DOI 10.1016/j.micron.2009.10.003; Roseblade A, 2013, J PHARM PHARM SCI, V16, P238, DOI 10.18433/J3989X; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shi XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091794; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Suderman RJ, 2008, J GEN VIROL, V89, P1411, DOI 10.1099/vir.0.2008/000307-0; Theopold U, 1997, J INSECT PHYSIOL, V43, P667, DOI 10.1016/S0022-1910(97)00013-9; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vilmos P, 1998, IMMUNOL LETT, V62, P59, DOI 10.1016/S0165-2478(98)00023-6; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue F, 2014, FISH SHELLFISH IMMUN	70	22	22	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108486	10.1371/journal.pone.0108486	http://dx.doi.org/10.1371/journal.pone.0108486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285798	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700021
J	Singh, RS; Kaur, HP; Singh, J				Singh, Ram Sarup; Kaur, Hemant Preet; Singh, Jatinder			Purification and Characterization of a Mucin Specific Mycelial Lectin from Aspergillus gorakhpurensis: Application for Mitogenic and Antimicrobial Activity	PLOS ONE			English	Article							ACID-SPECIFIC LECTIN; ANTIPROLIFERATIVE ACTIVITY; BINDING-SPECIFICITY; MUSHROOM; CARBOHYDRATE; FUCOSE	Background: Lectins are carbohydrate binding proteins or glycoproteins that bind reversibly to specific carbohydrates present on the apposing cells, which are responsible for their ability to agglutinate red blood cells, lymphocytes, fibroblasts, etc. Interest in lectins has been intensified due to their carbohydrate specificity as they can be valuable reagents for the investigation of cell surface sugars, purification and characterization of glycoproteins. The present study reports the purification, characterization and evaluation of mitogenic and antimicrobial potential of a mycelial lectin from Aspergillus gorakhpurensis. Methods: Affinity chromatography on mucin-sepharose column was carried out for purification of Aspergillus gorakhpurensis lectin. The lectin was characterized for physico-chemical parameters. Mitogenic potential of the lectin was evaluated against splenocytes of Swiss albino mice by MTT assay. Antimicrobial activity of the purified lectin has also been evaluated by disc diffusion assay. Results: Single-step affinity purification resulted in 18.6-fold purification of the mycelial lectin. The molecular mass of the lectin was found to be 70 kDa and it was composed of two subunits of 34.8 kDa as determined by gel filtration chromatography, SDS-PAGE and MALDI-TOF analysis. pH optima of the lectin was found to be 6.5-9.5, while optimum temperature for lectin activity was 20-30 degrees C. Lectin was stable within a pH range of 7.0-10.5 and showed fair thermostability. EDTA did not affect lectin activity whereas it was found susceptible to the denaturants tested. MTT assay revealed strong mitogenic potential of A. gorakhpurensis lectin at a concentration upto 150 mu g/mL. Antimicrobial activity assay showed its potent antibacterial activity against Bacillus cereus, Staphylococcous aureus and Escherichia coli and marginal antifungal activity against Saccharomyces cerevisiae. Conclusion: This is the first report on the mitogenic and antimicrobial potential of Aspergillus gorakhpurensis lectin. The results will provide useful guidelines for further research in clinical applications of this lectin.	[Singh, Ram Sarup; Kaur, Hemant Preet] Punjabi Univ, Carbohydrate & Prot Biotechnol Lab, Dept Biotechnol, Patiala, Punjab, India; [Singh, Jatinder] Guru Nanak Dev Univ, Dept Mol Biol & Biochem, Amritsar, Punjab, India	Punjabi University; Guru Nanak Dev University	Singh, RS (corresponding author), Punjabi Univ, Carbohydrate & Prot Biotechnol Lab, Dept Biotechnol, Patiala, Punjab, India.	rssingh11@lycos.com	Singh, Ram Sarup/T-2262-2019					Albores S, 2013, J BASIC MICROB, V53, P1; Albores S, 2014, APPL BIOCHEM BIOTECH, V172, P2081, DOI 10.1007/s12010-013-0665-5; Bains JS, 2005, BBA-GEN SUBJECTS, V1723, P163, DOI 10.1016/j.bbagen.2005.02.006; Candy L, 2003, BIOCHEM BIOPH RES CO, V308, P396, DOI 10.1016/S0006-291X(03)01406-2; Chumkhunthod P, 2006, BBA-GEN SUBJECTS, V1760, P326, DOI 10.1016/j.bbagen.2006.01.015; Feroz Khan, 2011, International Journal of Biological Chemistry, V5, P1, DOI 10.3923/ijbc.2011.1.20; Gauto DF, 2011, CARBOHYD RES, V346, P939, DOI 10.1016/j.carres.2011.02.016; Hedge J., 1962, CARBOHYDRATE CHEM, P163; Jiang S, 2012, BIOCHEM J, V443, P369, DOI 10.1042/BJ20112061; Jung EC, 2007, BBA-GEN SUBJECTS, V1770, P833, DOI 10.1016/j.bbagen.2007.01.005; Karnchanatat A., 2012, ANTIMICROBIAL AGENTS, P145; Khan F, 2007, ARCH BIOCHEM BIOPHYS, V457, P243, DOI 10.1016/j.abb.2006.10.019; Kobayashi Y, 2004, J BIOL CHEM, V279, P53048, DOI 10.1074/jbc.M407997200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu QH, 2004, PEPTIDES, V25, P7, DOI 10.1016/j.peptides.2003.11.013; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Nagre NN, 2010, GLYCOCONJUGATE J, V27, P375, DOI 10.1007/s10719-010-9285-2; Ngai PHK, 2004, BIOCHEM BIOPH RES CO, V314, P988, DOI 10.1016/j.bbrc.2003.12.196; Oda Y, 2003, J BIOL CHEM, V278, P32439, DOI 10.1074/jbc.M305181200; Pohleven J, 2012, AFFINITY CHROMATOGRAPHY, P49; Pohleven J, 2011, APPL MICROBIOL BIOT, V91, P1141, DOI 10.1007/s00253-011-3236-0; ROBERTS DD, 1984, J BIOL CHEM, V259, P903; ROSEN S, 1992, J GEN MICROBIOL, V138, P2663, DOI 10.1099/00221287-138-12-2663; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Singh RS, 2013, INDIAN J EXP BIOL, V51, P984; Singh RS, 2014, BIOLOGIA, V69, P15, DOI 10.2478/s11756-013-0293-0; Singh RS, 2013, BIOLOGIA, V68, P1034, DOI 10.2478/s11756-013-0273-4; Singh RS, 2008, J BASIC MICROB, V48, P112, DOI 10.1002/jobm.200700314; Singh RS, 2015, CRIT REV MICROBIOL, V41, P77, DOI 10.3109/1040841X.2013.798780; Singh RS, 2014, CRIT REV MICROBIOL, V40, P329, DOI 10.3109/1040841X.2012.733680; Singh RS, 2011, CRIT REV BIOTECHNOL, V31, P193, DOI 10.3109/07388551.2010.505911; Singh RS, 2011, WORLD J MICROB BIOT, V27, P547, DOI 10.1007/s11274-010-0488-2; Singh RS, 2010, APPL BIOCHEM BIOTECH, V162, P1339, DOI 10.1007/s12010-009-8906-3; Singh RS, 2010, CRIT REV BIOTECHNOL, V30, P99, DOI 10.3109/07388550903365048; Sze KL, 2011, APPL MICROBIOL BIOT, V89, P45, DOI 10.1007/s00253-010-2892-9; Tronchin G, 2002, INFECT IMMUN, V70, P6891, DOI 10.1128/IAI.70.12.6891-6895.2002; Xiong CN, 2006, COMP BIOCHEM PHYS C, V143, P9, DOI 10.1016/j.cbpc.2005.11.008	38	59	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109265	10.1371/journal.pone.0109265	http://dx.doi.org/10.1371/journal.pone.0109265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286160	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700054
J	Zhang, L; Wu, CY; Zhang, Y; Liu, F; Wang, XE; Zhao, M; Hoffman, RM				Zhang, Lei; Wu, Chengyu; Zhang, Yong; Liu, Fang; Wang, Xiaoen; Zhao, Ming; Hoffman, Robert M.			Comparison of Efficacy and Toxicity of Traditional Chinese Medicine (TCM) Herbal Mixture LQ and Conventional Chemotherapy on Lung Cancer Metastasis and Survival in Mouse Models	PLOS ONE			English	Article							FLUORESCENT-PROTEIN EXPRESSION; NUDE-MOUSE; CELLULAR-DYNAMICS; PANCREATIC-CANCER; BREAST-CANCER; IN-VIVO; CELLS; MICE; CARCINOMA; ADENOCARCINOMA	Unlike Western medicine that generally uses purified compounds and aims to target a single molecule or pathway, traditional Chinese medicine (TCM) compositions usually comprise multiple herbs and components that are necessary for efficacy. Despite the very long-time and wide-spread use of TCM, there are very few direct comparisons of TCM and standard cytotoxic chemotherapy. In the present report, we compared the efficacy of the TCM herbal mixture LQ against lung cancer in mouse models with doxorubicin (DOX) and cyclophosphamide (CTX). LQ inhibited tumor size and weight measured directly as well as by fluorescent-protein imaging in subcutaneous, orthotopic, spontaneous experimental metastasis and angiogenesis mouse models of lung cancer. LQ was efficacious against primary and metastatic lung cancer without weight loss and organ toxicity. In contrast, CTX and DOX, although efficacious in the lung cancer models caused significant weight loss, and organ toxicity. LQ also had anti-angiogenic activity as observed in lung tumors growing in nestin-driven green fluorescent protein (ND-GFP) transgenic nude mice, which selectively express GFP in nascent blood vessels. Survival of tumor-bearing mice was also prolonged by LQ, comparable to DOX. In vitro, lung cancer cells were killed by LQ as observed by time-lapse imaging, comparable to cisplatinum. LQ was more potent to induce cell death on cancer cell lines than normal cell lines unlike cytotoxic chemotherapy. The results indicate that LQ has non-toxic efficacy against metastatic lung cancer.	[Zhang, Lei; Zhang, Yong; Liu, Fang; Wang, Xiaoen; Zhao, Ming; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Wu, Chengyu] Nanjing Univ Chinese Med, Dept Tradit Chinese Med Diagnost, Nanjing, Jiangsu, Peoples R China; [Zhang, Lei; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Liu, Fang] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China	Anti Cancer Inc; Nanjing University of Chinese Medicine; University of California System; University of California San Diego; Naval Medical University	Wu, CY (corresponding author), Nanjing Univ Chinese Med, Dept Tradit Chinese Med Diagnost, Nanjing, Jiangsu, Peoples R China.	chengyu720@163.com; all@anticancer.com			National Cancer Institute [CA132971]; Jiangsu Science and Technology Achievements Transformation Thematic Special Funds, China [BA2011019]; NATIONAL CANCER INSTITUTE [R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jiangsu Science and Technology Achievements Transformation Thematic Special Funds, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grant CA132971 and grant BA2011019 from the Jiangsu Science and Technology Achievements Transformation Thematic Special Funds, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2004, P NATL ACAD SCI USA, V101, P13291, DOI 10.1073/pnas.0405250101; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; ASTOUL P, 1994, J CELL BIOCHEM, V56, P9, DOI 10.1002/jcb.240560104; ASTOUL P, 1994, ANTICANCER RES, V14, P85; ASTOUL P, 1993, ANTICANCER RES, V13, P1999; Gai RY, 2008, DRUG DISCOV THER, V2, P2; Hayashi K, 2009, CELL PROLIFERAT, V42, P75, DOI 10.1111/j.1365-2184.2008.00574.x; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Hu MX, 2012, ANTICANCER RES, V32, P2509; Jiang P, 2006, CELL CYCLE, V5, P1198, DOI 10.4161/cc.5.11.2795; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Kimura H, 2010, J CELL BIOCHEM, V109, P58, DOI 10.1002/jcb.22379; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2010, CELL CYCLE, V9, P4518, DOI 10.4161/cc.9.22.13744; Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Rashidi B, 2000, CLIN EXP METASTAS, V18, P57, DOI 10.1023/A:1026596131504; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Unger RE, 2014, BIOMATERIALS, DOI [10.1016/j.biomaterials.2013.12.059, DOI 10.1016/J.BIOMATERIALS.2013.12.059.]; Wang MR, 2012, ANTICANCER RES, V32, P1213; WANG XE, 1992, ANTICANCER RES, V12, P1399; Wong R, 2001, CANCER TREAT REV, V27, P235, DOI 10.1053/ctrv.2001.0227; Yamamoto N, 2004, CANCER RES, V64, P4251, DOI 10.1158/0008-5472.CAN-04-0643; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yang M, 1998, CANCER RES, V58, P4217; Zhang L, 2013, J CELL BIOCHEM, V114, P2131, DOI 10.1002/jcb.24561; Zhang Qing-yuan, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P1074; Zhao M, 2012, CELL CYCLE, V11, P187, DOI 10.4161/cc.11.1.18667; Zou Yu-he, 2003, Zhongguo Zhong Xi Yi Jie He Za Zhi, V23, P733	35	25	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109814	10.1371/journal.pone.0109814	http://dx.doi.org/10.1371/journal.pone.0109814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286158	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700093
J	Chiu, CH; Wen, TH; Chien, LC; Yu, HL				Chiu, Chuan-Hung; Wen, Tzai-Hung; Chien, Lung-Chang; Yu, Hwa-Lung			A Probabilistic Spatial Dengue Fever Risk Assessment by a Threshold-Based-Quantile Regression Method	PLOS ONE			English	Article							SOCIOECONOMIC VULNERABILITY; AEDES-ALBOPICTUS; DISEASE; EPIDEMICS; MORTALITY; MOSQUITOS; DYNAMICS; PATTERNS; AEGYPTI; CALI	Understanding the spatial characteristics of dengue fever (DF) incidences is crucial for governmental agencies to implement effective disease control strategies. We investigated the associations between environmental and socioeconomic factors and DF geographic distribution, are proposed a probabilistic risk assessment approach that uses threshold-based quantile regression to identify the significant risk factors for DF transmission and estimate the spatial distribution of DF risk regarding full probability distributions. To interpret risk, return period was also included to characterize the frequency pattern of DF geographic occurrences. The study area included old Kaohsiung City and Fongshan District, two areas in Taiwan that have been affected by severe DF infections in recent decades. Results indicated that water-related facilities, including canals and ditches, and various types of residential area, as well as the interactions between them, were significant factors that elevated DF risk. By contrast, the increase of per capita income and its associated interactions with residential areas mitigated the DF risk in the study area. Nonlinear associations between these factors and DF risk were present in various quantiles, implying that water-related factors characterized the underlying spatial patterns of DF, and high-density residential areas indicated the potential for high DF incidence (e.g., clustered infections). The spatial distributions of DF risks were assessed in terms of three distinct map presentations: expected incidence rates, incidence rates in various return periods, and return periods at distinct incidence rates. These probability-based spatial risk maps exhibited distinct DF risks associated with environmental factors, expressed as various DF magnitudes and occurrence probabilities across Kaohsiung, and can serve as a reference for local governmental agencies.	[Chiu, Chuan-Hung; Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Wen, Tzai-Hung] Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan; [Chien, Lung-Chang] Univ Texas San Antonio, Div Biostat, Sch Publ Hlth, San Antonio, TX USA; [Chien, Lung-Chang] Univ Texas Hlth Sci Ctr San Antonio, Res Adv Community Hlth Ctr, San Antonio, TX 78229 USA	National Taiwan University; National Taiwan University; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Yu, HL (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	hlyu@ntu.edu.tw	Wen, Tzai-Hung/H-2635-2018	Wen, Tzai-Hung/0000-0002-9151-8336; Yu, Hwa Lung/0000-0001-9558-2100	Taiwan Ministry of Science and Technology [MOST 101-2628-E-002-017-MY3, MOST 102-2221-E-002-140-MY3]; Centers for Disease Control in Taiwan [DOH102-DC-1203]	Taiwan Ministry of Science and Technology; Centers for Disease Control in Taiwan	This study was supported by funds from Taiwan Ministry of Science and Technology (MOST 101-2628-E-002-017-MY3 and MOST 102-2221-E-002-140-MY3), and Centers for Disease Control in Taiwan (DOH102-DC-1203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Aldstadt J, 2007, STOCH ENV RES RISK A, V21, P487, DOI 10.1007/s00477-007-0132-3; Bari RA, 2003, PROBABILISTIC RISK A; Benjamin J., 1970, PROBABILITY STAT DEC; Bhandari KP, 2008, INT ARCH PHOTOGRAM R, V37, P165; Bhatt S, 2013, NATURE; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021; Chang SF, 2012, J FORMOS MED ASSOC, V111, P297, DOI 10.1016/j.jfma.2011.12.001; Daniels MJ, 2000, AM J EPIDEMIOL, V152, P397, DOI 10.1093/aje/152.5.397; Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2; Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Hiscox A, 2013, AM J TROP MED HYG, V88, P1070, DOI 10.4269/ajtmh.12-0623; Kienberger S, 2013, GEOSPATIAL HEALTH, V8, P313, DOI 10.4081/gh.2013.76; Kim SY, 2004, ENVIRON RES, V94, P113, DOI 10.1016/j.envres.2003.09.006; Knerer G, 2013, HLTH CARE MANAGEMENT, P1; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R, 2013, PACKAGE QUANTREG; KOZLOWSKI J, 1985, EKISTICS, V52, P146; KOZLOWSKI J, 1988, LANDSCAPE URBAN PLAN, V15, P327, DOI 10.1016/0169-2046(88)90056-4; Kumamoto H, 1996, PROBABILISTIC RISK A, Vxvii; Lei HuanYao, 2002, Dengue Bulletin, V26, P14; Lifson AR, 1996, LANCET, V347, P1201, DOI 10.1016/S0140-6736(96)90730-8; Maidana NA, 2008, MATH BIOSCI, V215, P64, DOI 10.1016/j.mbs.2008.05.008; Mata J, 1996, EUR ECON REV, V40, P1305, DOI 10.1016/0014-2921(95)00034-8; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Montgomery D.C., 2012, INTRO LINEAR REGRESS, Vfifith; [National Land Surveying and Mapping Center National Land Surveying and Mapping Center], 2012, LAND US CLASS SYST D; [National Land Surveying and Mapping Center Center NLSaM], 2007, LAND INV TAIW; NLSC, 2013, LAND US INV TAIW; Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415; O'Hagan A, 2006, UNCERTAIN JUDGEMENTS, Vxiii; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Rotela C, 2007, ACTA TROP, V103, P1, DOI 10.1016/j.actatropica.2007.05.003; Saifur RGM, 2013, J AM MOSQUITO CONTR, V29, P33, DOI 10.2987/12-6228R.1; Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775; Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478; [Taiwan CDC Welfare MoHa], 2013, GOVT DATA TAIPEI; Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2; Tuan Y-C, 2009, TAIWAN EPIDEMIOLOGY, V25, P462; Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; Vanwambeke SO, 2007, J MED ENTOMOL, V44, P133, DOI 10.1603/0022-2585(2007)44[133:LALCFI]2.0.CO;2; Vanwambeke SO, 2011, TROP MED INT HEALTH, V16, P174, DOI 10.1111/j.1365-3156.2010.02671.x; VESELY WE, 2011, PROBABILISTIC RISK A, P253; Wen TH, 2006, SCI TOTAL ENVIRON, V367, P631, DOI 10.1016/j.scitotenv.2006.02.009; Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019; WHO, 1997, DENG HAEM FEV DIAGN; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034; Yu HL, 2011, STOCH ENV RES RISK A, V25, P485, DOI 10.1007/s00477-010-0417-9	58	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e106334	10.1371/journal.pone.0106334	http://dx.doi.org/10.1371/journal.pone.0106334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25302582	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400002
J	Holt, V; Caplan, AI; Haynesworth, SE				Holt, Vance; Caplan, Arnold I.; Haynesworth, Stephen E.			Identification of a Subpopulation of Marrow MSC-Derived Medullary Adipocytes That Express Osteoclast-Regulating Molecules: Marrow Adipocytes Express Osteoclast Mediators	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; ADIPOSE-TISSUE; IN-VITRO; CULTURED PREADIPOCYTES; ADIPOGENESIS PROGRAM; MONOCLONAL-ANTIBODY; OSTEOBLAST LINEAGE; RANKL EXPRESSION; PROGENITOR CELLS	Increased marrow medullary adipogenesis and an associated decrease in bone mineral density, usually observed in elderly individuals, is a common characteristic in senile osteoporosis. In this study we investigated whether cells of the medullary adipocyte lineage have the potential to directly support the formation of osteoclasts, whose activity in bone leads to bone degradation. An in vitro mesenchymal stem cell (MSC)-derived medullary adipocyte lineage culture model was used to study the expression of the important osteoclast mediators RANKL, M-CSF, SDF-1, and OPG. We further assessed whether adipocytes at a specific developmental stage were capable of supporting osteoclast-like cell formation in culture. In vitro MSC-derived medullary adipocytes showed an mRNA and protein expression profile of M-CSF, RANKL, and OPG that was dependent on its developmental/metabolic stage. Furthermore, RANKL expression was observed in MSC-derived adipocytes that were at a distinct lineage stage and these cells were also capable of supporting osteoclast-like cell formation in co-cultures with peripheral blood mononuclear cells. These results suggest a connection between medullary adipocytes and osteoclast formation in vivo and may have major significance in regards to the mechanisms of decreased bone density in senile osteoporosis.	[Holt, Vance; Caplan, Arnold I.; Haynesworth, Stephen E.] Case Western Reserve Univ, Coll Arts & Sci, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Holt, V (corresponding author), Case Western Reserve Univ, Coll Arts & Sci, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44106 USA.	vxh18@case.edu; seh5@case.edu		Caplan, Arnold/0000-0002-8677-6621	L. David and E. Virginia Baldwin Fund; National Institutes of Health - A Window into the Aging Process [R01 AG021542]; NATIONAL INSTITUTE ON AGING [R01AG021542] Funding Source: NIH RePORTER	L. David and E. Virginia Baldwin Fund; National Institutes of Health - A Window into the Aging Process; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from L. David and E. Virginia Baldwin Fund and the National Institutes of Health - A Window into the Aging Process, Grant number: R01 AG021542. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Chowdhury A, 2011, PROSTAG OTH LIPID M, V95, P53, DOI 10.1016/j.prostaglandins.2011.06.002; Chu XQ, 2009, BBA-MOL CELL BIOL L, V1791, P273, DOI 10.1016/j.bbalip.2009.01.022; Cook A, 2009, STEMBOOK, P1; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; CRISTY M, 1981, PHYS MED BIOL, V26, P389, DOI 10.1088/0031-9155/26/3/003; DORHEIM MA, 1993, J CELL PHYSIOL, V154, P317, DOI 10.1002/jcp.1041540215; Fleming JE, 1998, DEV DYNAM, V212, P119, DOI 10.1002/(SICI)1097-0177(199805)212:1<119::AID-AJA11>3.3.CO;2-6; Gagnon A, 2004, HORM METAB RES, V36, P728, DOI 10.1055/s-2004-826023; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Goto H, 2011, BIOMED RES-TOKYO, V32, P37, DOI 10.2220/biomedres.32.37; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Higashio K, 2008, SOCIETY, V141, P3478; Hozumi A, 2009, BIOCHEM BIOPH RES CO, V382, P780, DOI 10.1016/j.bbrc.2009.03.111; HUDSON G, 1965, BRIT J HAEMATOL, V11, P446, DOI 10.1111/j.1365-2141.1965.tb06607.x; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kawai M, 2009, BONE, P216, DOI [10.1007/s12018-009-9050-x, DOI 10.1007/S12018-009-9050-X]; Kawai M, 2010, AM J PHYSIOL-ENDOC M, V299, pE3, DOI 10.1152/ajpendo.00157.2010; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2092, DOI 10.1210/en.139.4.2092; Kim JY, 2005, AM J PHYSIOL-ENDOC M, V288, P267, DOI [10.1152/ajpendo.00265.2004, DOI 10.1152/AJPENDO.00265.2004]; Kim S, 2000, J NUTR, V130, p3110S; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; Lin YF, 2008, CELL PROLIFERAT, V41, P803, DOI 10.1111/j.1365-2184.2008.00542.x; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Mackay DL, 2006, J CELL PHYSIOL, V207, P722, DOI 10.1002/jcp.20617; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Mori K, 2014, BIOMED RES-TOKYO, V35, P153, DOI 10.2220/biomedres.35.153; Motyl KJ, 2011, DISCOV MED, V11, P179; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pachon-Pena G, 2010, J CELL PHYSL, P843; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Riggs BL, 2009, SOCIETY, V141, P4768; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rosen CJ, 2009, AM J MED, V122, P409, DOI 10.1016/j.amjmed.2008.11.027; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Sugihara H, 1987, CULTURE, V28; Sul HS, 2000, INT J OBESITY, V24, pS15, DOI 10.1038/sj.ijo.0801494; Takagi K, 2008, J BONE MINER METAB, V26, P13, DOI 10.1007/s00774-007-0787-3; Takeshita S, 2014, J BIOL CHEM, V289, P16699, DOI 10.1074/jbc.M114.547919; Tang W, 2008, SCIENCE, P30; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451; Travlos GS, 2006, TOXICOL PATHOL, V34, P566, DOI 10.1080/01926230600964706; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813	72	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108920	10.1371/journal.pone.0108920	http://dx.doi.org/10.1371/journal.pone.0108920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302610	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400035
J	Korr, H; Angstman, NB; Born, TB; Bosse, K; Brauns, B; Demmler, M; Fueller, K; Kantor, O; Kever, BM; Rahimyar, N; Salimi, S; Silny, J; Schmitz, C				Korr, Hubert; Angstman, Nicholas B.; Born, Tatjana B.; Bosse, Kerstin; Brauns, Birka; Demmler, Martin; Fueller, Katja; Kantor, Orsolya; Kever, Barbara M.; Rahimyar, Navida; Salimi, Sepideh; Silny, Jiri; Schmitz, Christoph			No Evidence of Persisting Unrepaired Nuclear DNA Single Strand Breaks in Distinct Types of Cells in the Brain, Kidney, and Liver of Adult Mice after Continuous Eight-Week 50 Hz Magnetic Field Exposure with Flux Density of 0.1 mT or 1.0 mT	PLOS ONE			English	Article							GRAIN COUNT CORRECTIONS; THYMIDINE KINASE; NEURON LOSS; REPAIR; IRON; TRANSPORT; DAMAGE	Background: It has been hypothesized in the literature that exposure to extremely low frequency electromagnetic fields (50 or 60 Hz) may lead to human health effects such as childhood leukemia or brain tumors. In a previous study investigating multiple types of cells from brain and kidney of the mouse (Acta Neuropathologica 2004; 107: 257-264), we found increased unrepaired nuclear DNA single strand breaks (nDNA SSB) only in epithelial cells of the choroid plexus in the brain using autoradiographic methods after a continuous eight-week 50 Hz magnetic field (MF) exposure of adult mice with flux density of 1.5 mT. Methods: In the present study we tested the hypothesis that MF exposure with lower flux densities (0.1 mT, i.e., the actual exposure limit for the population in most European countries, and 1.0 mT) shows similar results to those in the previous study. Experiments and data analysis were carried out in a similar way as in our previous study. Results: Continuous eight-week 50 Hz MF exposure with 0.1 mT or 1.0 mT did not result in increased persisting unrepaired nDNA SSB in distinct types of cells in the brain, kidney, and liver of adult mice. MF exposure with 1.0 mT led to reduced unscheduled DNA synthesis (UDS) in epithelial cells in the choroid plexus of the fourth ventricle in the brain (EC-CP) and epithelial cells of the cortical collecting duct in the kidney, as well as to reduced mtDNA synthesis in neurons of the caudate nucleus in the brain and in EC-CP. Conclusion: No evidence was found for increased persisting unrepaired nDNA SSB in distinct types of cells in the brain, kidney, and liver of adult mice after continuous eight-week 50 Hz magnetic field exposure with flux density of 0.1 mT or 1.0 mT.	[Korr, Hubert; Born, Tatjana B.; Bosse, Kerstin; Brauns, Birka; Demmler, Martin; Fueller, Katja; Kantor, Orsolya; Kever, Barbara M.; Rahimyar, Navida; Schmitz, Christoph] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Aachen, Germany; [Angstman, Nicholas B.; Schmitz, Christoph] Univ Munich, Dept Neuroanat, Munich, Germany; [Kantor, Orsolya] Semmelweis Univ, Dept Anat Histol & Embryol, H-1085 Budapest, Hungary; [Silny, Jiri] Rhein Westfal TH Aachen, Inst Occupat & Social Med, Femu, Aachen, Germany	RWTH Aachen University; University of Munich; Semmelweis University; RWTH Aachen University	Schmitz, C (corresponding author), Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Aachen, Germany.	christoph_schmitz@med.uni-muenchen.de						Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0; BASSUKAS ID, 1987, CELL TISSUE KINET, V20, P527, DOI 10.1111/j.1365-2184.1987.tb01362.x; *BIOINITIATIVE WOR, 2012, BIOINITIATIVE REPORT; Bradbury MWB, 1997, J NEUROCHEM, V69, P443; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; CAVANAGH JB, 1969, J ANAT, V104, P341; Decker M, 1994, THESIS; FEINENDEGEN LE, 1984, INT J RADIAT BIOL, V45, P205, DOI 10.1080/09553008414550301; FEINENDEGEN LE, 1985, INT J RADIAT BIOL, V47, P723, DOI 10.1080/09553008514550961; HENDERSON C, 1989, J HISTOTECHNOL, V12, P123; HOHNELKARIM K, 1990, INT J RADIAT BIOL, V58, P97, DOI 10.1080/09553009014551461; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Korr H, 1997, ACTA NEUROPATHOL, V94, P557, DOI 10.1007/s004010050750; KORR H, 1989, RADIAT ENVIRON BIOPH, V28, P13, DOI 10.1007/BF01209719; Korr H, 2001, INT J RADIAT BIOL, V77, P567, DOI 10.1080/09553000010028467; Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012; KORR H, 1981, TECHNIQUES NEUROANAT, P218; Lai H, 2004, ENVIRON HEALTH PERSP, V112, P687, DOI 10.1289/ehp.6355; Lai H, 1997, BIOELECTROMAGNETICS, V18, P156, DOI 10.1002/(SICI)1521-186X(1997)18:2<156::AID-BEM8>3.0.CO;2-1; Lai H, 1997, J PINEAL RES, V22, P152, DOI 10.1111/j.1600-079X.1997.tb00317.x; Martin IV, 2002, GENOME BIOL, V3; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; PERA F, 1975, BEITR PATHOL, V156, P145; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; Schmitz C, 2004, ACTA NEUROPATHOL, V107, P257, DOI 10.1007/s00401-003-0799-6; Schmitz C, 1999, ACTA NEUROPATHOL, V97, P71, DOI 10.1007/s004010050957; Schmitz C, 1994, THESIS; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Smith Q, 1997, METALS OXIDATIVE DAM, P113; Stam R, 2011, COMPARISON OF INTERN; STILLSTR.J, 1965, INT J APPL RADIAT IS, V16, P357, DOI 10.1016/0020-708X(65)90019-0; STILLSTROM J, 1963, INT J APPL RADIAT IS, V14, P113, DOI 10.1016/0020-708X(63)90104-2; STUMPF WE, 1981, J HISTOCHEM CYTOCHEM, V29, P201, DOI 10.1177/29.1A_Suppl.7288156; WANG RY, 1995, INT J ONCOL, V6, P51; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109774	10.1371/journal.pone.0109774	http://dx.doi.org/10.1371/journal.pone.0109774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302592	Green Published, gold			2022-12-27	WOS:000343730400079
J	Amo, L; Tomas, G; Parejo, D; Aviles, JM				Amo, Luisa; Tomas, Gustavo; Parejo, Deseada; Miguel Aviles, Jesus			Are Female Starlings Able to Recognize the Scent of Their Offspring?	PLOS ONE			English	Article							PREEN GLAND-FUNCTION; INDIVIDUAL RECOGNITION; KIN RECOGNITION; LAYER FOWLS; ALCA-TORDA; BIRDS; VOLATILES; FINCH; DISCRIMINATION; PREFERENCES	Background: Although there is growing evidence that birds may have individual chemical profiles that can function in several social contexts, offspring recognition based on olfactory cues has never been explored. This ability should be more likely evolved in colonial birds and/or species suffering brood parasitism, in which the risk of being engaged in costly misdirected parental care is high. Methodology/Principal Findings: We performed a choice experiment to examine whether females of the spotless starling, Sturnus unicolor, a species that is colonial, and where a fraction of the population is exposed to intraspecific brood parasitism, can discriminate between the scent of their offspring and that of unrelated nestlings. We also explored whether the development of the uropygial gland secretion may play a role in such olfactory discrimination by performing the choice experiments to females rearing nestlings of two different ages, that is, without and with developed uropygial glands. Results showed that female starlings did not preferentially choose the scent of their offspring, independently of whether the gland of nestlings was developed or not. Conclusions/Significance: Our results suggest that female starlings do not have or do not show the ability to distinguish their offspring based on olfaction, at least up to 12-14 days of nestling age. Further research is needed to examine whether odour-based discrimination may function when fledgling starlings leave the nest and the risk of costly misidentification is likely to increase.	[Amo, Luisa; Tomas, Gustavo; Parejo, Deseada; Miguel Aviles, Jesus] CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Amo, L (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain.	luisa.amo@mncn.csic.es	Amo, Luisa/K-5960-2014; Parejo, Deseada/L-3953-2014; Avilés, Jesús/K-3332-2014; Tomas, Gustavo/J-7559-2012	Amo, Luisa/0000-0003-4621-3493; Parejo, Deseada/0000-0002-7368-2378; Avilés, Jesús/0000-0002-1463-8393; Tomas, Gustavo/0000-0001-6701-2055	Spanish Ministry of Education and Science/FEDER [CGL2008-00718, CGL2011-27561/BOS];  [CGL2010-19233-C03-01]	Spanish Ministry of Education and Science/FEDER(Spanish Government); 	LA and GT were supported by the Juan de la Cierva programme while performing the experiment and LA was supported by the Ramon y Cajal programme while writing. This research was funded by the Spanish Ministry of Education and Science/FEDER (CGL2008-00718 and CGL2011-27561/BOS) to JMA and DP and by CGL2010-19233-C03-01 to J. J. Soler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2012, ANIM BEHAV, V84, P1483, DOI 10.1016/j.anbehav.2012.09.021; Amo L, 2012, J ANIM ECOL, V81, P605, DOI 10.1111/j.1365-2656.2011.01940.x; Aviles JM, 2013, OECOLOGIA, V173, P399, DOI 10.1007/s00442-013-2625-8; BEECHER MD, 1981, ANIM BEHAV, V29, P95, DOI 10.1016/S0003-3472(81)80156-X; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; Beecher MD, 1990, CONT ISSUES COMP PSY, P360; Bonadonna F, 2004, ANIM BEHAV, V67, P893, DOI 10.1016/j.anbehav.2003.08.013; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Calvo JM, 2000, BIRD STUDY, V47, P285, DOI 10.1080/00063650009461188; Campagna S, 2012, CHEM SENSES, V37, P3, DOI 10.1093/chemse/bjr067; Caro SP, 2010, J COMP PHYSIOL A, V196, P751, DOI 10.1007/s00359-010-0534-4; Caspers BA, 2013, ANIM BEHAV, V86, P85, DOI 10.1016/j.anbehav.2013.04.015; Caspers BA, 2011, BIOL LETTERS, V7, P184, DOI 10.1098/rsbl.2010.0775; CHAIKEN M, 1992, BEHAVIOUR, V120, P139, DOI 10.1163/156853992X00255; CLARK L, 1987, ANIM BEHAV, V35, P227, DOI 10.1016/S0003-3472(87)80228-2; Coffin HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025002; Davies JJF, 1962, AUST J ZOOL, V10, P171; De Leon A, 2003, BEHAVIOUR, V140, P925, DOI 10.1163/156853903770238382; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; Hagelin Julie C., 2007, P75; Holmes W.G., 1990, P441; INGOLD P, 1973, BEHAVIOUR, V45, P154, DOI 10.1163/156853974X00633; Insley SJ, 2003, J EXP BIOL, V206, P25, DOI 10.1242/jeb.00072; Jacot A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1515, DOI 10.1007/s00265-010-0965-5; Jourdie V, 2004, NATURE, V431, P262, DOI 10.1038/431262a; KNUDSEN B, 1986, ANIM BEHAV, V34, P77, DOI 10.1016/0003-3472(86)90008-4; Krause ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036615; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Leclaire S, 2012, P ROY SOC B-BIOL SCI, V279, P1185, DOI 10.1098/rspb.2011.1611; Leclaire S, 2011, NATURWISSENSCHAFTEN, V98, P615, DOI 10.1007/s00114-011-0809-9; Lefevre K, 1998, ANIM BEHAV, V55, P925, DOI 10.1006/anbe.1997.0626; Levrero F, 2009, CR BIOL, V332, P579, DOI 10.1016/j.crvi.2009.02.006; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Mardon J, 2010, CHEM SENSES, V35, P309, DOI 10.1093/chemse/bjq021; O'Dwyer TW, 2008, J EXP BIOL, V211, P337, DOI 10.1242/jeb.010512; Parejo D, 2012, BIOL LETTERS, V8, P502, DOI 10.1098/rsbl.2012.0124; R Development Core Team, 2012, R LANG ENV STAT COMP; Reers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018466; RISKA DE, 1984, AUK, V101, P605, DOI 10.1093/auk/101.3.605; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Sandilands V, 2004, BRIT POULTRY SCI, V45, P109, DOI 10.1080/00071660410001668932; Sandilands V, 2004, COMP BIOCHEM PHYS A, V137, P217, DOI 10.1016/j.cbpb.2003.10.004; Shizuka D, 2010, NATURE, V463, P223, DOI 10.1038/nature08655; Soini HA, 2013, J CHROMATOGR A, V1317, P186, DOI 10.1016/j.chroma.2013.08.006; VANELSACKER L, 1988, BEHAVIOUR, V107, P122, DOI 10.1163/156853988X00232; Veiga JP, 2002, ENCICLOPEDIA VIRTUAL; WALLRAFF HG, 1995, CONDOR, V97, P20, DOI 10.2307/1368979; Whelan RJ, 2010, COMP BIOCHEM PHYS B, V156, P183, DOI 10.1016/j.cbpb.2010.03.005; Whittaker DJ, 2013, ANIM BEHAV, V86, P697, DOI 10.1016/j.anbehav.2013.07.025; Whittaker DJ, 2011, BEHAV ECOL, V22, P1256, DOI 10.1093/beheco/arr122; Whittaker DJ, 2010, BEHAV ECOL, V21, P608, DOI 10.1093/beheco/arq033; Zhang JX, 2010, CHEM SENSES, V35, P375, DOI 10.1093/chemse/bjq025; Zhang YH, 2013, BEHAV ECOL, V24, P1271, DOI 10.1093/beheco/art068	54	11	11	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109505	10.1371/journal.pone.0109505	http://dx.doi.org/10.1371/journal.pone.0109505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299305	Green Submitted, gold, Green Published			2022-12-27	WOS:000343941200053
J	Rahman, LF; Reaz, MBI; Yin, CC; Ali, MAM; Marufuzzaman, M				Rahman, Labonnah Farzana; Reaz, Mamun Bin Ibne; Yin, Chia Chieu; Ali, Mohammad Alauddin Mohammad; Marufuzzaman, Mohammad			Design of High Speed and Low Offset Dynamic Latch Comparator in 0.18 mu m CMOS Process	PLOS ONE			English	Article								The cross-coupled circuit mechanism based dynamic latch comparator is presented in this research. The comparator is designed using differential input stages with regenerative S-R latch to achieve lower offset, lower power, higher speed and higher resolution. In order to decrease circuit complexity, a comparator should maintain power, speed, resolution and offset-voltage properly. Simulations show that this novel dynamic latch comparator designed in 0.18 mu m CMOS technology achieves 3.44 mV resolution with 8 bit precision at a frequency of 50 MHz while dissipating 158.5 mu W from 1.8 V supply and 88.05 mu A average current. Moreover, the proposed design propagates as fast as 4.2 nS with energy efficiency of 0.7 fJ/ conversion-step. Additionally, the core circuit layout only occupies 0.008 mm(2).	[Rahman, Labonnah Farzana; Reaz, Mamun Bin Ibne; Ali, Mohammad Alauddin Mohammad; Marufuzzaman, Mohammad] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia; [Yin, Chia Chieu] Technol Pk Malaysia, MIMOS Berhad, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; MIMOS Berhad	Rahman, LF (corresponding author), Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia.	labonnah.deep@gmail.com	Rahman, Labonnah Farzana/AAF-6437-2021; Marufuzzaman, Mohammad/B-9183-2013; Marufuzzaman, Mohammad/HDN-1010-2022; Bin Ibne Reaz, Mamun/E-7221-2010	Rahman, Labonnah Farzana/0000-0001-6707-6454; Marufuzzaman, Mohammad/0000-0002-0159-1768; Bin Ibne Reaz, Mamun/0000-0002-0459-0365	MIMOS Berhad; Universiti Kebangsaan Malaysia; research university [DLP-2013-016, UKM-AP-ICT-20-2010]	MIMOS Berhad; Universiti Kebangsaan Malaysia; research university	The authors would like to express sincere gratitude to the MIMOS Berhad and Universiti Kebangsaan Malaysia for the collaborative research grant eScienceFund and the research university grant DLP-2013-016 and UKM-AP-ICT-20-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achigui HJ, 2011, MICROELECTRON J, V42, P785, DOI 10.1016/j.mejo.2011.01.006; [Anonymous], [No title captured]; CHO TB, 1994, PROCEEDINGS OF THE IEEE 1994 CUSTOM INTEGRATED CIRCUITS CONFERENCE, P499, DOI 10.1109/CICC.1994.379674; Fayomi CJB, 2000, ISCAS 2000: IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS - PROCEEDINGS, VOL V, P653, DOI 10.1109/ISCAS.2000.857549; Figueiredo PM, 2006, IEEE T CIRCUITS-II, V53, P541, DOI 10.1109/TCSII.2006.875308; Furth PM, 2010, MIDWEST SYMP CIRCUIT, P1077, DOI 10.1109/MWSCAS.2010.5548836; Graupner A., 2006, DESIGNERS GUIDE COMM, V1, P1; Gray P.R., 1993, ANAL DESIGN ANALOG I; Hoi Lee, 2009, 2009 16th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2009), P371, DOI 10.1109/ICECS.2009.5410915; Hong HC, 2007, IEEE J SOLID-ST CIRC, V42, P2161, DOI 10.1109/JSSC.2007.905237; Jeon H, 2012, ANALOG INTEGR CIRC S, V70, P337, DOI 10.1007/s10470-011-9687-5; KOBAYASHI T, 1993, IEEE J SOLID-ST CIRC, V28, P523, DOI 10.1109/4.210039; Miyahara M, 2008, IEEE ASIAN SOLID STA, P269, DOI 10.1109/ASSCC.2008.4708780; Rahman LF., 2010, P KAL INT INN FUT NE, P209; RAZAVI B, 1992, IEEE J SOLID-ST CIRC, V27, P1916, DOI 10.1109/4.173122; Sadeghipour KD, 2011, ANALOG INTEGR CIRC S, V66, P205, DOI 10.1007/s10470-010-9509-1; Samid L, 2004, 2004 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL 1, PROCEEDINGS, P181; Sandeep K, 2011, P INT C ADV COMP COM, P1248; Schinkel D., 2007, 2007 IEEE International Solid-State Circuits Conference (IEEE Cat. No.07CH37858), P314, DOI 10.1109/ISSCC.2007.373420; Solis CJ, 2010, MIDWEST SYMP CIRCUIT, P1045, DOI 10.1109/MWSCAS.2010.5548824; Van Elzakker M, 2008, P IEEE INT SOL STAT, V244, P610; Verma N, 2007, IEEE J SOLID-ST CIRC, V42, P1196, DOI 10.1109/JSSC.2007.897157; Wicht B, 2004, IEEE J SOLID-ST CIRC, V39, P1148, DOI 10.1109/JSSC.2004.829399; Xu Y., 2013, P 2013 NORCHIP VILN, P1, DOI [10.1109/norchip.2013.6702020, DOI 10.1109/NORCHIP.2013.6702020]	24	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108634	10.1371/journal.pone.0108634	http://dx.doi.org/10.1371/journal.pone.0108634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299266	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200020
J	Torrente, MP; Castellano, LM; Shorter, J				Torrente, Mariana P.; Castellano, Laura M.; Shorter, James			Suramin Inhibits Hsp104 ATPase and Disaggregase Activity	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE HSP104; AGENT GUANIDINIUM CHLORIDE; PROTEIN DISAGGREGATION; PROMISCUOUS INHIBITORS; NUCLEOTIDE-BINDING; AGGREGATED PROTEINS; FIREFLY LUCIFERASE; PRION PROPAGATION; COMMON MECHANISM; MIDDLE DOMAIN	Hsp104 is a hexameric AAA+ protein that utilizes energy from ATP hydrolysis to dissolve disordered protein aggregates as well as amyloid fibers. Interestingly, Hsp104 orthologues are found in all kingdoms of life except animals. Thus, Hsp104 could represent an interesting drug target. Specific inhibition of Hsp104 activity might antagonize non-metazoan parasites that depend on a potent heat shock response, while producing little or no side effects to the host. However, no small molecule inhibitors of Hsp104 are known except guanidinium chloride. Here, we screen over 16,000 small molecules and identify 16 novel inhibitors of Hsp104 ATPase activity. Excluding compounds that inhibited Hsp104 activity by non-specific colloidal effects, we defined Suramin as an inhibitor of Hsp104 ATPase activity. Suramin is a polysulphonated naphthylurea and is used as an antiprotozoal drug for African Trypanosomiasis. Suramin also interfered with Hsp104 disaggregase, unfoldase, and translocase activities, and the inhibitory effect of Suramin was not rescued by Hsp70 and Hsp40. Suramin does not disrupt Hsp104 hexamers and does not effectively inhibit ClpB, the E. coli homolog of Hsp104, establishing yet another key difference between Hsp104 and ClpB behavior. Intriguingly, a potentiated Hsp104 variant, Hsp104 A503V, is more sensitive to Suramin than wild-type Hsp104. By contrast, Hsp104 variants bearing inactivating sensor-1 mutations in nucleotide-binding domain (NBD) 1 or 2 are more resistant to Suramin. Thus, Suramin depends upon ATPase events at both NBDs to exert its maximal effect. Suramin could develop into an important mechanistic probe to study Hsp104 structure and function.	[Torrente, Mariana P.; Castellano, Laura M.; Shorter, James] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Castellano, Laura M.; Shorter, James] Univ Penn, Perelman Sch Med, Pharmacol Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Shorter, J (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Stong, Laura/0000-0001-7964-0761	PENN-PORT postdoctoral fellowship [K12GM081259]; NSF graduate research fellowship [DGE-0822];  [R01GM099836]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099836, K12GM081259] Funding Source: NIH RePORTER	PENN-PORT postdoctoral fellowship; NSF graduate research fellowship(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MPT is supported by a PENN-PORT postdoctoral fellowship (K12GM081259). LMC is supported by an NSF graduate research fellowship DGE-0822. JS is supported by grant: R01GM099836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babokhov P, 2013, PATHOG GLOB HEALTH, V107, P242, DOI 10.1179/2047773213Y.0000000105; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Borges S, 2014, BREAST CANCER RES TR, V144, P79, DOI 10.1007/s10549-014-2857-2; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; DeSantis ME, 2014, J BIOL CHEM, V289, P848, DOI 10.1074/jbc.M113.520759; DeSantis ME, 2012, CHEM BIOL, V19, P1400, DOI 10.1016/j.chembiol.2012.09.013; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Galam L, 2007, BIOORGAN MED CHEM, V15, P1939, DOI 10.1016/j.bmc.2007.01.004; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Halbeisen RE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000105; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Heallen TR, 2008, DEV CELL, V15, P603, DOI 10.1016/j.devcel.2008.08.005; Ivanov AI, 1998, J BIOL CHEM, V273, P14721, DOI 10.1074/jbc.273.24.14721; Izikki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077073; Jackrel ME, 2014, DIS MODEL MECH, V7, P1175, DOI 10.1242/dmm.016113; Jackrel ME, 2014, CELL CYCLE, V13, P1379, DOI 10.4161/cc.28709; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Kummer E, 2013, FEBS LETT, V587, P810, DOI 10.1016/j.febslet.2013.02.011; Liu N, 2011, CURR CLIN PHARMACOL, V6, P137, DOI 10.2174/157488411796151174; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Maccio A, 2013, EXPERT OPIN PHARMACO, V14, P1839, DOI 10.1517/14656566.2013.813934; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Martin I, 2013, J MED CHEM, V56, P7177, DOI 10.1021/jm400499k; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Naviaux JC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.33; Naviaux RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057380; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Shorter J, 2005, NAT STRUCT MOL BIOL, V12, P4, DOI 10.1038/nsmb0105-4; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; STEIN CA, 1993, CANCER RES, V53, P2239; Sweeny EA, 2011, JOVE-J VIS EXP, V55, pe3190; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Torrente MP, 2013, PRION, V7, P457, DOI 10.4161/pri.27531; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wigle TJ, 2007, BIOORG MED CHEM LETT, V17, P3249, DOI 10.1016/j.bmcl.2007.04.013; Zeymer C, 2013, J BIOL CHEM, V288, P7065, DOI 10.1074/jbc.M112.432583; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899	84	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110115	10.1371/journal.pone.0110115	http://dx.doi.org/10.1371/journal.pone.0110115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299406	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200102
J	Arnett, MT; Herman, DH; Mcgee, AW				Arnett, Megan T.; Herman, David H.; McGee, Aaron W.			Deficits in Tactile Learning in a Mouse Model of Fragile X Syndrome	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; FUNCTIONAL ARCHITECTURE; SYNAPTIC PLASTICITY; INTRINSIC SIGNAL; MICE; HYPEREXCITABILITY; TRANSLATION; INHIBITION; PHENOTYPE; AMYGDALA	The fragile X mental retardation 1 mutant mouse (Fmr1 KO) recapitulates several of the neurologic deficits associated with Fragile X syndrome (FXS). As tactile hypersensitivity is a hallmark of FXS, we examined the sensory representation of individual whiskers in somatosensory barrel cortex of Fmr1 KO and wild-type (WT) mice and compared their performance in a whisker-dependent learning paradigm, the gap cross assay. Fmr1 KO mice exhibited elevated responses to stimulation of individual whiskers as measured by optical imaging of intrinsic signals. In the gap cross task, initial performance of Fmr1 KO mice was indistinguishable from WT controls. However, while WT mice improved significantly with experience at all gap distances, Fmr1 KO mice displayed significant and specific deficits in improvement at longer distances which rely solely on tactile information from whiskers. Thus, Fmr1 KO mice possess altered cortical responses to sensory input that correlates with a deficit in tactile learning.	[Arnett, Megan T.; McGee, Aaron W.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles,Saban Res Inst, Dept Pediat,Dev Neurosci Program, Los Angeles, CA 90033 USA; [Herman, David H.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California	Mcgee, AW (corresponding author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles,Saban Res Inst, Dept Pediat,Dev Neurosci Program, Los Angeles, CA 90033 USA.	amcgee@usc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE to AWM; The Saban Research Institute; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077288] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE to AWM; The Saban Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded in part by grant 1R21N5077288 from the NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE to AWM. AWM is a recipient of a Research Development Career Award from The Saban Research Institute and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brennan FX, 2006, GENES BRAIN BEHAV, V5, P467, DOI 10.1111/j.1601-183X.2005.00183.x; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Goncalves JT, 2013, NAT NEUROSCI, V16, P903, DOI 10.1038/nn.3415; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HAGERMAN RJ, 1991, AM J MED GENET, V38, P283, DOI 10.1002/ajmg.1320380223; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Padmashri R, 2013, J NEUROSCI, V33, P19715, DOI 10.1523/JNEUROSCI.2514-13.2013; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Patel AB, 2014, J NEUROSCI, V34, P3413, DOI 10.1523/JNEUROSCI.2921-13.2014; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Selby L, 2007, NEUROSCI LETT, V412, P227, DOI 10.1016/j.neulet.2006.11.062; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Till SM, 2012, HUM MOL GENET, V21, P2143, DOI 10.1093/hmg/dds030; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008	47	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109116	10.1371/journal.pone.0109116	http://dx.doi.org/10.1371/journal.pone.0109116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296296	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000039
J	Cooper, LN; Seiffert, ER; Clementz, M; Madars, SI; Bajpai, S; Hussain, ST; Thewissen, JGM				Cooper, Lisa Noelle; Seiffert, Erik R.; Clementz, Mark; Madars, Sandra I.; Bajpai, Sunil; Hussain, S. Taseer; Thewissen, J. G. M.			Anthracobunids from the Middle Eocene of India and Pakistan Are Stem Perissodactyls	PLOS ONE			English	Article							ELEPHANT-SHREWS; MAMMALIA; RADIATION; ORIGIN; CARBON; MACROSCELIDEA; ISOTOPES; BIOGEOCHEMISTRY; DISCRIMINATION; ARTIODACTYLS	Anthracobunidae is an Eocene family of large mammals from south Asia that is commonly considered to be part of the radiation that gave rise to elephants (proboscideans) and sea cows (sirenians). We describe a new collection of anthracobunid fossils from Middle Eocene rocks of Indo-Pakistan that more than doubles the number of known anthracobunid fossils and challenges their putative relationships, instead implying that they are stem perissodactyls. Cranial, dental, and postcranial elements allow a revision of species and the recognition of a new anthracobunid genus. Analyses of stable isotopes and long bone geometry together suggest that most anthracobunids fed on land, but spent a considerable amount of time near water. This new evidence expands our understanding of stem perissodactyl diversity and sheds new light on perissodactyl origins.	[Cooper, Lisa Noelle; Thewissen, J. G. M.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Cooper, Lisa Noelle; Thewissen, J. G. M.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Clementz, Mark] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [Madars, Sandra I.] Hiram Univ, Dept Biol, Hiram, OH USA; [Bajpai, Sunil] Indian Inst Technol, Dept Earth Sci, Roorkee, Uttar Pradesh, India; [Hussain, S. Taseer] Howard Univ, Coll Med, Dept Anat, Washington, DC USA	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wyoming; Hiram College; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Howard University	Cooper, LN (corresponding author), Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA.	lcooper@neomed.edu		Thewissen, J. G. M./0000-0002-0973-4137	National Science Foundation [EAR-0847413, BCS-0819186, BCS-0416164, EAR-0207370]; Department of Science and Technology, Government of India; Division Of Behavioral and Cognitive Sci [1231288] Funding Source: National Science Foundation; Division Of Earth Sciences [0847413] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The National Science Foundation is acknowledged for support to M. T. C. (EAR-0847413), E. R. S. (BCS-0819186 and BCS-0416164), and J. G. M. T. (EAR-0207370). Also, S. B. acknowledges financial support received from the Department of Science and Technology, Government of India for field work in the Eocene sections of Gujarat. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P225, DOI 10.1016/S1055-7903(03)00118-0; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; Aslan A, 1994, PALEOVERTEBRATA, V25, P261; Bajpai Sunil, 2006, Journal of the Palaeontological Society of India, V51, P101; Barrow E, 2010, J SYST PALAEONTOL, V8, P213, DOI 10.1080/14772010903450407; Barrow EC, 2012, J VERTEBR PALEONTOL, V32, P166, DOI 10.1080/02724634.2012.635735; Benoit J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054307; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Cerling TE, 2008, J ZOOL, V276, P204, DOI 10.1111/j.1469-7998.2008.00450.x; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Clementz M, 2011, GEOLOGY, V39, P15, DOI 10.1130/G31585.1; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Clementz MT, 2012, J MAMMAL, V93, P368, DOI 10.1644/11-MAMM-S-179.1; Clementz MT, 2003, PALEOBIOLOGY, V29, P506, DOI 10.1666/0094-8373(2003)029<0506:APPTHA>2.0.CO;2; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Cobbett A, 2007, SYST BIOL, V56, P753, DOI 10.1080/10635150701627296; Cogne JP, 2013, GEOPHYS J INT, V192, P1000, DOI 10.1093/gji/ggs104; COOMBS WP, 1979, ZOOL J LINN SOC-LOND, V65, P185, DOI 10.1111/j.1096-3642.1979.tb01090.x; Cooper LN, 2009, J VERTEBR PALEONTOL, V29, P1289, DOI 10.1671/039.029.0423; de Buffrenil V, 2010, J MAMM EVOL, V17, P101, DOI 10.1007/s10914-010-9130-1; Dehm R., 1958, Abhandlungen der Bayerischen Akademie der Wissenschaften NF, VNo. 91, P1; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Domning DP, 2007, J VERTEBR PALEONTOL, V27, P748, DOI 10.1671/0272-4634(2007)27[748:ANNFTS]2.0.CO;2; Domning DP., 1986, SMITHSON CONTRIB PAL, DOI [10.5479/si.00810266.59.1, DOI 10.5479/SI.00810266.59.1]; Ducrocq S, 2000, CR ACAD SCI II A, V330, P725, DOI 10.1016/S1251-8050(00)00187-7; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fischer MS, 1993, MAMMAL PHYLOGENY, P217; Franzen J.L., 1986, Palaeovertebrata (Montpellier), V16, P35; FRANZEN J L, 1990, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V60, P175; Froehlich DJ, 1999, J VERTEBR PALEONTOL, V19, P140, DOI 10.1080/02724634.1999.10011129; Gheerbrant E, 2005, GEODIVERSITAS, V27, P239; Gheerbrant E, 1998, GEOBIOS-LYON, V31, P247, DOI 10.1016/S0016-6995(98)80041-7; Gheerbrant E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089739; Gheerbrant E, 2009, P NATL ACAD SCI USA, V106, P10717, DOI 10.1073/pnas.0900251106; GINGERICH P D, 1990, Contributions from the Museum of Paleontology University of Michigan, V28, P71; GINGERICH P D, 1977, Contributions from the Museum of Paleontology University of Michigan, V24, P190; GINGERICH P D, 1981, Contributions from the Museum of Paleontology University of Michigan, V25, P235; Gingerich PD, 1997, J VERTEBR PALEONTOL, V17, P629, DOI 10.1080/02724634.1997.10011012; Ginsburg L, 1999, CR ACAD SCI II A, V328, P209, DOI 10.1016/S1251-8050(99)80098-6; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; Godinot Marc, 1996, Palaeovertebrata (Montpellier), V25, P225; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Holbrook LT, 2004, J VERTEBR PALEONTOL, V24, P951, DOI 10.1671/0272-4634(2004)024[0951:SOTEPM]2.0.CO;2; Hooker JJ, 2012, ZOOL J LINN SOC-LOND, V164, P856, DOI 10.1111/j.1096-3642.2011.00787.x; Hooker JJ, 2004, PALAEONTOLOGY, V47, P1363, DOI 10.1111/j.0031-0239.2004.00421.x; HUI CA, 1981, PHYSIOL ZOOL, V54, P430, DOI 10.1086/physzool.54.4.30155836; Ijiri S., 1961, Earth Science Tokyo, V53, P1; Inuzuka N., 2005, B ASHORO MUSEUM PALE, V3, P3; Inuzuka Norihisa, 2000, Bulletin of Ashoro Museum of Paleontology, V1, P91; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kriloff A, 2008, J EVOLUTION BIOL, V21, P807, DOI 10.1111/j.1420-9101.2008.01512.x; KUMAR K, 1991, GEOBIOS-LYON, V24, P221, DOI 10.1016/S0016-6995(91)80010-W; Kumar K, 2010, J VERTEBR PALEONTOL, V30, P1245, DOI 10.1080/02724634.2010.483605; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Liu AGSC, 2008, P NATL ACAD SCI USA, V105, P5786, DOI 10.1073/pnas.0800884105; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUZ B, 1985, EARTH PLANET SC LETT, V75, P29, DOI 10.1016/0012-821X(85)90047-0; Maas M.C., 1998, Bulletin of Carnegie Museum of Natural History, V34, P286; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; McKenna M. C., 1989, EVOLUTION PERISSODAC, P24; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Missiaen P, 2012, ACTA PALAEONTOL POL, V57, P21, DOI 10.4202/app.2010.0093; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Nowak R.M., 1983, P1; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Pickford Martin, 2008, Geological Survey of Namibia Memoir, V20, P465; Pilgrim GE, 1940, P ZOOL SOC LOND B-SY, V110, P127; RADINSKY LB, 1966, EVOLUTION, V20, P408, DOI 10.1111/j.1558-5646.1966.tb03375.x; Radinsky LB, 1963, B PEABODY MUSEUM NAT, V17; RADINSKY LEONARD B., 1965, BULL MUS COMP ZOOL HARVARD UNIV, V134, P69; RAZA SM, 2001, GEOLOGICAL B U PESHA, V34, P83; Robinson TJ, 2004, CURR TOP DEV BIOL, V63, P37, DOI 10.1016/S0070-2153(04)63002-X; Rose KD, 2006, J VERTEBR PALEONTOL, V26, P219, DOI 10.1671/0272-4634(2006)26[219:EEYCVA]2.0.CO;2; Rose Kenneth D., 1996, Palaeovertebrata (Montpellier), V25, P243; RUSSELL D E, 1987, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V52, P1; SAHNI A, 1980, CURR SCI INDIA, V49, P270; Sahni A., 1980, J PALAEONTOLOGICAL S, P23; Samant Bandana, 2005, Journal of the Palaeontological Society of India, V50, P169; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; Seiffert ER, 2012, NATURWISSENSCHAFTEN, V99, P133, DOI 10.1007/s00114-011-0878-9; SEN S, 1979, Annales de Paleontologie Vertebres, V65, P73; Shikama T., 1966, PALEONTOL SOC JPN SP, V12, P1; Shikama T, 1968, SCI REPORTS YOKOHAMA, V2, P21; Shoshani Jeheskel, 1996, P57; Smit HA, 2011, J ZOOL, V284, P133, DOI 10.1111/j.1469-7998.2011.00790.x; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tabuce R, 2006, ACTA PALAEONTOL POL, V51, P37; Tabuce R, 2001, J VERTEBR PALEONTOL, V21, P535, DOI 10.1671/0272-4634(2001)021[0535:ANGOMM]2.0.CO;2; Tabuce R, 2007, P ROY SOC B-BIOL SCI, V274, P1159, DOI 10.1098/rspb.2006.0229; Tabuce R, 2012, PALAEONTOLOGY, V55, P945, DOI 10.1111/j.1475-4983.2012.01163.x; Tassy P., 1988, Systematics Association Special Volume Series, P283; Tassy Pascal, 1996, P39; Teeling EC, 2013, MOL BIOL EVOLUTION; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Thewissen J.G.M., 1992, Journal of Vertebrate Paleontology, V12, P494; THEWISSEN JGM, 1983, P K NED AKAD B PHYS, V86, P153; THEWISSEN JGM, 1990, ANAT HISTOL EMBRYOL, V19, P37, DOI 10.1111/j.1439-0264.1990.tb00876.x; Thewissen JGM, 1998, P 3 GEOSAS WORKSH HE, P19; Tipple BJ, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001851; VANVALEN L, 1978, EVOL THEORY, V4, P103; WELLS N A, 1983, Contributions from the Museum of Paleontology University of Michigan, V26, P117; WEST R M, 1983, Annals of Carnegie Museum, V52, P359; West R.M., 1985, Memoires de la Societe Geologique de France, P183; WEST RM, 1980, J PALEONTOL, V54, P508; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Wilkinson M, 2003, J VERTEBR PALEONTOL, V23, P311, DOI 10.1671/0272-4634(2003)023[0311:MEAMTI]2.0.CO;2; Williamson T. E., 1992, B NEW MEXICO MUSEUM, V1, P1; Zack SP, 2005, NATURE, V434, P497, DOI 10.1038/nature03351; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3; Zazzo A, 2000, PALEOBIOLOGY, V26, P294, DOI 10.1666/0094-8373(2000)026<0294:HPAPCI>2.0.CO;2	120	50	52	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109232	10.1371/journal.pone.0109232	http://dx.doi.org/10.1371/journal.pone.0109232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295875	gold, Green Published			2022-12-27	WOS:000345204000050
J	Cotton, JA; Motta, JP; Schenck, LP; Hirota, SA; Beck, PL; Buret, AG				Cotton, James A.; Motta, Jean-Paul; Schenck, L. Patrick; Hirota, Simon A.; Beck, Paul L.; Buret, Andre G.			Giardia duodenalis Infection Reduces Granulocyte Infiltration in an In Vivo Model of Bacterial Toxin-Induced Colitis and Attenuates Inflammation in Human Intestinal Tissue	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; NEUTROPHIL TRANSEPITHELIAL MIGRATION; CLOSTRIDIUM-DIFFICILE TOXIN; HUMAN DENDRITIC CELLS; G-CSF; LAMBLIA INFECTIONS; ION-TRANSPORT; MICE; EXPRESSION; CHILDREN	Giardia duodenalis (syn. G. intestinalis, G. lamblia) is a predominant cause of waterborne diarrheal disease that may lead to post-infectious functional gastrointestinal disorders. Although Giardia-infected individuals could carry as much as 10(6) trophozoites per centimetre of gut, their intestinal mucosa is devoid of overt signs of inflammation. Recent studies have shown that in endemic countries where bacterial infectious diseases are common, Giardia infections can protect against the development of diarrheal disease and fever. Conversely, separate observations have indicated Giardia infections may enhance the severity of diarrheal disease from a co-infecting pathogen. Polymorphonuclear leukocytes or neutrophils (PMNs) are granulocytic, innate immune cells characteristic of acute intestinal inflammatory responses against bacterial pathogens that contribute to the development of diarrheal disease following recruitment into intestinal tissues. Giardia cathepsin B cysteine proteases have been shown to attenuate PMN chemotaxis towards IL-8/CXCL8, suggesting Giardia targets PMN accumulation. However, the ability of Giardia infections to attenuate PMN accumulation in vivo and how in turn this effect may alter the host inflammatory response in the intestine has yet to be demonstrated. Herein, we report that Giardia infection attenuates granulocyte tissue infiltration induced by intra-rectal instillation of Clostridium difficile toxin A and B in an isolate-dependent manner. This attenuation of granulocyte infiltration into colonic tissues paralled decreased expression of several cytokines associated with the recruitment of PMNs. Giardia trophozoite isolates that attenuated granulocyte infiltration in vivo also decreased protein expression of cytokines released from inflamed mucosal biopsy tissues collected from patients with active Crohn's disease, including several cytokines associated with PMN recruitment. These results demonstrate for the first time that certain Giardia infections may attenuate PMN accumulation by decreasing the expression of the mediators responsible for their recruitment.	[Cotton, James A.; Motta, Jean-Paul; Buret, Andre G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Cotton, James A.; Motta, Jean-Paul; Buret, Andre G.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [Cotton, James A.; Motta, Jean-Paul; Buret, Andre G.] Univ Calgary, Calgary, AB, Canada; [Schenck, L. Patrick] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Schenck, L. Patrick; Beck, Paul L.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hirota, Simon A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Hirota, Simon A.] Univ Calgary, Dept Immunol Microbiol & Infect Dis, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Buret, AG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	aburet@ucalgary.ca	Motta, Jean-Paul/A-8844-2014	Motta, Jean-Paul/0000-0002-9464-0695	NSERC [RT 690446]; Alberta Innovates Health Solutions (AIHS); Crohn's and colitis foundation of Canada (CCFC) [10000008]; Alberta Innovates [201400554] Funding Source: researchfish	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Health Solutions (AIHS); Crohn's and colitis foundation of Canada (CCFC); Alberta Innovates	JA Cotton is a recipient of NSERC Alexander Graham Bell Scholarship graduate student scholarship and a joint IBD studentship from Alberta Innovates Health Solutions (AIHS) and the Crohn's and colitis foundation of Canada (CCFC). Research in AG Buret's lab is funded by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) RT 690446, and the CCFC 10000008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL A, 1989, MOL BIOCHEM PARASIT, V32, P39, DOI 10.1016/0166-6851(89)90127-8; Al-Sadi R, 2013, J IMMUNOL, V190, P6596, DOI 10.4049/jimmunol.1201876; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; ARNDT H, 1992, INFLAMMATION, V16, P549, DOI 10.1007/BF00918979; Banik S, 2013, INFECT IMMUN, V81, P2309, DOI 10.1128/IAI.00004-13; Bartelt LA, 2013, J CLIN INVEST, V123, P2672, DOI 10.1172/JCI67294; Bertelsen LS, 2004, AM J PHYSIOL-GASTR L, V286, pG157, DOI 10.1152/ajpgi.00227.2003; Bhavnani D, 2012, AM J EPIDEMIOL, V176, P387, DOI 10.1093/aje/kws220; Bilenko N, 2004, EUR J EPIDEMIOL, V19, P877, DOI 10.1023/B:EJEP.0000040533.75646.9c; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; CEVALLOS AM, 1995, GASTROENTEROLOGY, V109, P766, DOI 10.1016/0016-5085(95)90383-6; Chen TL, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-26; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Chin AC, 2007, ANNU REV PATHOL-MECH, V2, P111, DOI 10.1146/annurev.pathol.2.010506.091944; Chin AC, 2006, ANN NY ACAD SCI, V1072, P276, DOI 10.1196/annals.1326.018; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Cotton JA, 2014, INFECT IMMUN; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Fisher BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081104; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Hagel I, 2011, ACTA TROP, V117, P189, DOI 10.1016/j.actatropica.2010.12.001; Halliez MCM, 2013, WORLD J GASTROENTERO, V19, P8974, DOI 10.3748/wjg.v19.i47.8974; Hanevik K, 2007, J INFECTION, V55, P524, DOI 10.1016/j.jinf.2007.09.004; Hirota SA, 2012, INFECT IMMUN, V80, P4474, DOI 10.1128/IAI.00933-12; Hirota SA, 2010, GASTROENTEROLOGY, V139, P259, DOI 10.1053/j.gastro.2010.03.045; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jerlstrom-Hultqvist J, 2010, GUT MICROBES, V1, P379, DOI 10.4161/gmic.1.6.13608; Kamda JD, 2009, INFECT IMMUN, V77, P685, DOI 10.1128/IAI.00718-08; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; KELLY CP, 1994, J CLIN INVEST, V93, P1257, DOI 10.1172/JCI117080; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; KOSTMANN R, 1975, ACTA PAEDIATR SCAND, V64, P362, DOI 10.1111/j.1651-2227.1975.tb03847.x; Kuijpers T, 2012, CELL MOL LIFE SCI, V69, P7, DOI 10.1007/s00018-011-0834-z; KUMAR NB, 1982, AM J SURG PATHOL, V6, P523, DOI 10.1097/00000478-198209000-00004; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lee HY, 2012, PARASITE IMMUNOL, V34, P183, DOI 10.1111/j.1365-3024.2012.01354.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; MAYER P, 1993, BLOOD, V81, P3226; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Monis PT, 1999, MOL BIOL EVOL, V16, P1135, DOI 10.1093/oxfordjournals.molbev.a026204; Mukherjee AK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/786480; Obendorf J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-317; Oberhelman RA, 2001, PEDIATR INFECT DIS J, V20, P792, DOI 10.1097/00006454-200108000-00014; Oberhuber G, 1997, SCAND J GASTROENTERO, V32, P48, DOI 10.3109/00365529709025062; Panaro MA, 2007, FEMS IMMUNOL MED MIC, V51, P302, DOI 10.1111/j.1574-695X.2007.00304.x; Paul G, 2012, J BIOL CHEM, V287, P2144, DOI 10.1074/jbc.M111.318139; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Ranganathan P, 2013, AM J PHYSIOL-RENAL, V305, pF1422, DOI 10.1152/ajprenal.00319.2013; Ringqvist E, 2008, MOL BIOCHEM PARASIT, V159, P85, DOI 10.1016/j.molbiopara.2008.02.005; Roxstrom-Lindquist K, 2005, INFECT IMMUN, V73, P8204, DOI 10.1128/IAI.73.12.8204-8208.2005; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Scott KGE, 2000, INFECT IMMUN, V68, P3412, DOI 10.1128/IAI.68.6.3412-3418.2000; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Singer SM, 2000, J INFECT DIS, V181, P1510, DOI 10.1086/315409; Solaymani-Mohammadi S, 2011, J IMMUNOL, V187, P3769, DOI 10.4049/jimmunol.1100606; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Stadelmann B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-256; Stadelmann B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045325; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Szabady RL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00220; Teoh DA, 2000, J PARASITOL, V86, P800; Troeger H, 2007, GUT, V56, P328, DOI 10.1136/gut.2006.100198; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Veenemans J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001158; Wampfler PB, 2014, INT J PARASITOL, V44, P497, DOI 10.1016/j.ijpara.2014.03.008; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Wensaas KA, 2012, GUT, V61, P214, DOI 10.1136/gutjnl-2011-300220; Zeidler C, 2009, BRIT J HAEMATOL, V144, P459, DOI 10.1111/j.1365-2141.2008.07425.x; Zhou P, 2003, INFECT IMMUN, V71, P1566, DOI 10.1128/IAI.71.3.1566-1568.2003	85	46	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109087	10.1371/journal.pone.0109087	http://dx.doi.org/10.1371/journal.pone.0109087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289678	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000034
J	Gazzoni, M; Celadon, N; Mastrapasqua, D; Paleari, M; Margaria, V; Ariano, P				Gazzoni, Marco; Celadon, Nicolo; Mastrapasqua, Davide; Paleari, Marco; Margaria, Valentina; Ariano, Paolo			Quantifying Forearm Muscle Activity during Wrist and Finger Movements by Means of Multi-Channel Electromyography	PLOS ONE			English	Article							SURFACE EMG; FORCE; CROSSTALK; ROBUST; INDEPENDENCE; RECORDINGS; SYNERGIES; STRATEGY; SIGNALS	The study of hand and finger movement is an important topic with applications in prosthetics, rehabilitation, and ergonomics. Surface electromyography (sEMG) is the gold standard for the analysis of muscle activation. Previous studies investigated the optimal electrode number and positioning on the forearm to obtain information representative of muscle activation and robust to movements. However, the sEMG spatial distribution on the forearm during hand and finger movements and its changes due to different hand positions has never been quantified. The aim of this work is to quantify 1) the spatial localization of surface EMG activity of distinct forearm muscles during dynamic free movements of wrist and single fingers and 2) the effect of hand position on sEMG activity distribution. The subjects performed cyclic dynamic tasks involving the wrist and the fingers. The wrist tasks and the hand opening/closing task were performed with the hand in prone and neutral positions. A sensorized glove was used for kinematics recording. sEMG signals were acquired from the forearm muscles using a grid of 112 electrodes integrated into a stretchable textile sleeve. The areas of sEMG activity have been identified by a segmentation technique after a data dimensionality reduction step based on Non Negative Matrix Factorization applied to the EMG envelopes. The results show that 1) it is possible to identify distinct areas of sEMG activity on the forearm for different fingers; 2) hand position influences sEMG activity level and spatial distribution. This work gives new quantitative information about sEMG activity distribution on the forearm in healthy subjects and provides a basis for future works on the identification of optimal electrode configuration for sEMG based control of prostheses, exoskeletons, or orthoses. An example of use of this information for the optimization of the detection system for the estimation of joint kinematics from sEMG is reported.	[Gazzoni, Marco; Celadon, Nicolo; Mastrapasqua, Davide] Politecn Torino, Dept Elect & Telecommun, LISiN, Turin, Italy; [Celadon, Nicolo; Paleari, Marco; Margaria, Valentina; Ariano, Paolo] Ist Italiano Tecnol, Ctr Space Human Robot, Turin, Italy	Polytechnic University of Turin; Istituto Italiano di Tecnologia - IIT	Gazzoni, M (corresponding author), Politecn Torino, Dept Elect & Telecommun, LISiN, Turin, Italy.	marco.gazzoni@polito.it; paolo.ariano@iit.it	Gazzoni, Marco/G-3967-2012; Ariano, Paolo/B-9026-2008	Gazzoni, Marco/0000-0001-5939-6212; Ariano, Paolo/0000-0002-7957-8635; margaria, valentina/0000-0001-6125-4926; Paleari, Marco/0000-0002-8387-6678	Compagnia di San Paolo; Fondazione Cassa di Risparmio di Torino	Compagnia di San Paolo(Compagnia di San Paolo); Fondazione Cassa di Risparmio di Torino(Fondazione CRT)	This study was financially supported by the Compagnia di San Paolo and the Fondazione Cassa di Risparmio di Torino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boschmann A, 2012, IEEE ENG MED BIO, P4324, DOI 10.1109/EMBC.2012.6346923; Castellini C, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-41; Castellini C, 2009, BIOL CYBERN, V100, P35, DOI 10.1007/s00422-008-0278-1; Cipriani C, 2011, IEEE T NEUR SYS REH, V19, P260, DOI 10.1109/TNSRE.2011.2108667; Daley H, 2010, J PROSTHET ORTHOT, V22, P244, DOI DOI 10.1097/JP0.0B013E3181F989C2; Daley H, 2012, J ELECTROMYOGR KINES, V22, P478, DOI 10.1016/j.jelekin.2011.12.012; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Farina D, 2004, METHOD INFORM MED, V43, P30; Farina D, 2010, IEEE ENG MED BIO, P3591, DOI 10.1109/IEMBS.2010.5627455; Fougner A, 2011, IEEE T NEUR SYS REH, V19, P644, DOI 10.1109/TNSRE.2011.2163529; Geng Y, 2011, J NEUROENG REHABIL, V5, P9; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Hargrove L, 2008, BIOMED SIGNAL PROCES, V3, P175, DOI 10.1016/j.bspc.2007.11.005; Huang H, 2008, IEEE T NEUR SYS REH, V16, P37, DOI 10.1109/TNSRE.2007.910282; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Kamper DG, 2002, J BIOMECH, V35, P1581, DOI 10.1016/S0021-9290(02)00229-4; Keen DA, 2004, J NEUROPHYSIOL, V91, P2515, DOI 10.1152/jn.01178.2003; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Leijnse JNAL, 2008, J NEUROPHYSIOL, V100, P64, DOI 10.1152/jn.00706.2007; Leijnse JNAL, 2008, J NEUROPHYSIOL, V100, P3225, DOI 10.1152/jn.90570.2008; Li GL, 2010, IEEE T NEUR SYS REH, V18, P185, DOI 10.1109/TNSRE.2009.2039619; Li ZM, 2004, MOTOR CONTROL, V8, P1; Liu J, 2013, IEEE T NEUR SYS REH, V21, P96, DOI 10.1109/TNSRE.2012.2218832; Lucas MF, 2008, BIOMED SIGNAL PROCES, V3, P169, DOI 10.1016/j.bspc.2007.09.002; Mananas MA, 2005, P ANN INT IEEE EMBS, P5824, DOI 10.1109/IEMBS.2005.1615813; Marateb HR, 2012, MED BIOL ENG COMPUT, V50, P79, DOI 10.1007/s11517-011-0790-7; Mewett DT, 2004, MED BIOL ENG COMPUT, V42, P524, DOI 10.1007/BF02350994; Mogk JPM, 2003, J ELECTROMYOGR KINES, V13, P63, DOI 10.1016/S1050-6411(02)00071-8; Muceli S, 2014, IEEE T NEUR SYS REH, V22, P623, DOI 10.1109/TNSRE.2013.2282898; Muceli S, 2010, IEEE ENG MED BIO, P6066, DOI 10.1109/IEMBS.2010.5627622; Nielsen JLG, 2011, IEEE T BIO-MED ENG, V58, P681, DOI 10.1109/TBME.2010.2068298; Parker P, 2006, J ELECTROMYOGR KINES, V16, P541, DOI 10.1016/j.jelekin.2006.08.006; Peerdeman B, 2011, J REHABIL RES DEV, V48, P719, DOI 10.1682/JRRD.2010.08.0161; Rearick MP, 2003, J NEUROPHYSIOL, V89, P1317, DOI 10.1152/jn.00581.2002; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; SCHIEBER MH, 1995, J NEUROSCI, V15, P284; Tenore FVG, 2009, IEEE T BIO-MED ENG, V56, P1427, DOI 10.1109/TBME.2008.2005485; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; van Vugt JPP, 2001, CLIN NEUROPHYSIOL, V112, P583, DOI 10.1016/S1388-2457(01)00482-5; Vieira TMM, 2010, J BIOMECH, V43, P2149, DOI 10.1016/j.jbiomech.2010.03.049; Zhou P, 2007, J NEUROPHYSIOL, V98, P2974, DOI 10.1152/jn.00178.2007	43	55	57	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109943	10.1371/journal.pone.0109943	http://dx.doi.org/10.1371/journal.pone.0109943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289669	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000099
J	Greig, AM; Briggs, AM; Bennell, KL; Hodges, PW				Greig, Alison M.; Briggs, Andrew M.; Bennell, Kim L.; Hodges, Paul W.			Trunk Muscle Activity Is Modified in Osteoporotic Vertebral Fracture and Thoracic Kyphosis with Potential Consequences for Vertebral Health	PLOS ONE			English	Article							LOW-BACK-PAIN; UPPER-LIMB MOVEMENT; POSTURAL RESPONSES; LUMBAR SPINE; TRANSVERSUS ABDOMINIS; BALANCE IMPAIRMENT; ARM MOVEMENTS; ADJUSTMENTS; WOMEN; INDIVIDUALS	This study explored inter-relationships between vertebral fracture, thoracic kyphosis and trunk muscle control in elderly people with osteoporosis. Osteoporotic vertebral fractures are associated with increased risk of further vertebral fractures; but underlying mechanisms remain unclear. Several factors may explain this association, including changes in postural alignment (thoracic kyphosis) and altered trunk muscle contraction patterns. Both factors may increase risk of further fracture because of increased vertebral loading and impaired balance, which may increase falls risk. This study compared postural adjustments in 24 individuals with osteoporosis with and without vertebral fracture and with varying degrees of thoracic kyphosis. Trunk muscle electromyographic activity (EMG) associated with voluntary arm movements was recorded and compared between individuals with and without vertebral fracture, and between those with low and high thoracic kyphosis. Overall, elderly participants in the study demonstrated co-contraction of the trunk flexor and extensor muscles during forwards arm movements, but those with vertebral fractures demonstrated a more pronounced co-contraction than those without fracture. Individuals with high thoracic kyphosis demonstrated more pronounced alternating flexor and extensor EMG bursts than those with less kyphosis. Co-contraction of trunk flexor and extensor muscles in older individuals contrasts the alternating bursts of antagonist muscle activity in previous studies of young individuals. This may have several consequences, including altered balance efficacy and the potential for increased compressive loads through the spine. Both of these outcomes may have consequences in a population with fragile vertebrae who are susceptible to fracture.	[Greig, Alison M.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Briggs, Andrew M.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia; [Briggs, Andrew M.] Arthrit & Osteoporosis Victoria, Melbourne, Vic, Australia; [Bennell, Kim L.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Hodges, Paul W.] Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	University of British Columbia; Curtin University; University of Melbourne; University of Queensland	Hodges, PW (corresponding author), Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	p.hodges@uq.edu.au	Hodges, Paul W/B-6578-2008; Bennell, Kim/C-7022-2014	Hodges, Paul W/0000-0002-1206-9107; Bennell, Kim/0000-0003-4982-5639	National Health and Medical Research Council (NHMRC) of Australia; NHMRC [APP1002190]; Australian Research Council (ARC)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This study was supported by a Program Grant from the National Health and Medical Research Council (NHMRC) of Australia. PH was supported by a Senior Principal Research Fellowship (APP1002190) from the NHMRC. KB was supported by a Future Fellowship from the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUIN AS, 1995, EXP BRAIN RES, V103, P323; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; BOUISSET S, 1981, NEUROSCI LETT, V22, P263, DOI 10.1016/0304-3940(81)90117-8; Briggs AM, 2007, SKELETAL RADIOL, V36, P761, DOI 10.1007/s00256-007-0284-8; Briggs AM, 2007, OSTEOPOROSIS INT, V18, P575, DOI 10.1007/s00198-006-0304-x; Briggs AM, 2007, EUR SPINE J, V16, P1137, DOI 10.1007/s00586-006-0276-8; Briggs AM, 2006, EUR SPINE J, V15, P1785, DOI 10.1007/s00586-006-0158-0; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Cook C, 2002, PHYS OCCUP THER GERI, V20, P37; Ensrud KE, 1997, J AM GERIATR SOC, V45, P682, DOI 10.1111/j.1532-5415.1997.tb01470.x; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; Genant HK, 1996, J BONE MINER RES, V11, P984; Goh S, 2000, RHEUMATOLOGY, V39, P310, DOI 10.1093/rheumatology/39.3.310; Greig AM, 2007, OSTEOPOROSIS INT, V18, P543, DOI 10.1007/s00198-006-0277-9; Gruneberg C, 2004, EXP BRAIN RES, V157, P472, DOI 10.1007/s00221-004-1861-x; Harrison DE, 2000, SPINE, V25, P2072, DOI 10.1097/00007632-200008150-00011; Hodges P, 1999, EXP BRAIN RES, V124, P69, DOI 10.1007/s002210050601; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Hodges PW, 2000, GAIT POSTURE, V11, P92, DOI 10.1016/S0966-6362(99)00055-7; Hodges PW, 2003, EXP BRAIN RES, V151, P262, DOI 10.1007/s00221-003-1457-x; Hodges PW, 1999, NEUROSCI LETT, V265, P91, DOI 10.1016/S0304-3940(99)00216-5; Hodges PW, 1996, SPINE, V21, P2640, DOI 10.1097/00007632-199611150-00014; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Lee LJ, 2009, J ELECTROMYOGR KINES, V19, P46, DOI 10.1016/j.jelekin.2007.06.015; Lynn SG, 1997, ARCH PHYS MED REHAB, V78, P273, DOI 10.1016/S0003-9993(97)90033-2; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Marras WS, 2001, SPINE, V26, P2566, DOI 10.1097/00007632-200112010-00009; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; Mok NW, 2007, SPINE, V32, pE537, DOI 10.1097/BRS.0b013e31814541a2; Mok NW, 2011, SPINE, V36, pE45, DOI 10.1097/BRS.0b013e3181dfce83; Moseley GL, 2004, EXP BRAIN RES, V156, P64, DOI 10.1007/s00221-003-1766-0; Ng JK, 1998, ELECTROMYOGR CLIN NE, V38, P51; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Robinovitch SN, 1999, J GERONTOL A-BIOL, V54, pB124, DOI 10.1093/gerona/54.3.B124; SCHULTZ A, 1982, SPINE, V7, P390, DOI 10.1097/00007632-198207000-00009; SINAKI M, 1993, OSTEOPOROSIS INT, V3, P8, DOI 10.1007/BF01623170; Smith MD, 2007, INT UROGYNECOL J, V18, P901, DOI 10.1007/s00192-006-0259-7; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; van der Fits IBM, 1998, EXP BRAIN RES, V120, P202, DOI 10.1007/s002210050394; van Dieen JH, 2003, SPINE, V28, P834, DOI 10.1097/00007632-200304150-00018; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	46	22	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109515	10.1371/journal.pone.0109515	http://dx.doi.org/10.1371/journal.pone.0109515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285908	Green Submitted, gold, Green Published			2022-12-27	WOS:000345743700071
J	Keranen, H; Gutierrez-de-Teran, H; Aqvist, J				Keranen, Henrik; Gutierrez-de-Teran, Hugo; Aqvist, Johan			Structural and Energetic Effects of A(2A) Adenosine Receptor Mutations on Agonist and Antagonist Binding	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-COUPLED RECEPTORS; LIGAND-BINDING; CRYSTAL-STRUCTURE; FORCE-FIELD; DERIVATIVES; DISCOVERY; SITE; IDENTIFICATION; RECOGNITION	To predict structural and energetic effects of point mutations on ligand binding is of considerable interest in biochemistry and pharmacology. This is not only useful in connection with site-directed mutagenesis experiments, but could also allow interpretation and prediction of individual responses to drug treatment. For G-protein coupled receptors systematic mutagenesis has provided the major part of functional data as structural information until recently has been very limited. For the pharmacologically important A(2A) adenosine receptor, extensive site-directed mutagenesis data on agonist and antagonist binding is available and crystal structures of both types of complexes have been determined. Here, we employ a computational strategy, based on molecular dynamics free energy simulations, to rationalize and interpret available alanine-scanning experiments for both agonist and antagonist binding to this receptor. These computer simulations show excellent agreement with the experimental data and, most importantly, reveal the molecular details behind the observed effects which are often not immediately evident from the crystal structures. The work further provides a distinct validation of the computational strategy used to assess effects of point-mutations on ligand binding. It also highlights the importance of considering not only protein-ligand interactions but also those mediated by solvent water molecules, in ligand design projects.	[Keranen, Henrik; Gutierrez-de-Teran, Hugo; Aqvist, Johan] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden	Uppsala University	Aqvist, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden.	aqvist@xray.bmc.uu.se	Gutiérrez de Terán, Hugo/E-1391-2011; de Terán, Hugo Gutiérrez/AAX-2756-2020	Gutiérrez de Terán, Hugo/0000-0003-0459-3491; de Terán, Hugo Gutiérrez/0000-0003-0459-3491	Swedish Research Council [VR-M 2011-2438]; eSSENCE e-science initiative; Swedish National Infrastructure for Computing (SNIC)	Swedish Research Council(Swedish Research CouncilEuropean Commission); eSSENCE e-science initiative; Swedish National Infrastructure for Computing (SNIC)	This work was supported by the Swedish Research Council, grant number VR-M 2011-2438 (to JA)(www.vr.se); The eSSENCE e-science initiative (http://essenceofescience.se/); The Swedish National Infrastructure for Computing (SNIC); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2001, EUR J PHARMACOL, V411, P205, DOI 10.1016/S0014-2999(00)00899-2; [Anonymous], 2011, FFLD SERV; Bacilieri M, 2013, J CHEM INF MODEL, V53, P1620, DOI 10.1021/ci300615u; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bortolato A, 2013, J CHEM INF MODEL, V53, P1700, DOI 10.1021/ci4001458; Boukharta L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003585; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Chen D, 2013, J CHEM INF MODEL, V53, P2701, DOI 10.1021/ci4003156; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; DANG LX, 1989, J AM CHEM SOC, V111, P8505, DOI 10.1021/ja00204a027; Deflorian F, 2012, J MED CHEM, V55, P538, DOI 10.1021/jm201461q; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Gutierrez-de-Teran H, 2014, FUTURE MED CHEM, V6, P251, DOI 10.4155/fmc.13.209; Gutierrez-de-Teran H, 2013, STRUCTURE, V21, P2175, DOI 10.1016/j.str.2013.09.020; Gutierrez-de-Teran H, 2013, BIOCHEM SOC T, V41, P205, DOI 10.1042/BST20120287; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Higgs C, 2010, ACS MED CHEM LETT, V1, P160, DOI 10.1021/ml100008s; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jaakola VP, 2010, J BIOL CHEM, V285, P13032, DOI 10.1074/jbc.M109.096974; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Kim JH, 1996, MOL PHARMACOL, V49, P683; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; KING G, 1989, J CHEM PHYS, V91, P3647, DOI 10.1063/1.456845; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Langmead CJ, 2012, J MED CHEM, V55, P1904, DOI 10.1021/jm201455y; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; LEE FS, 1992, J CHEM PHYS, V97, P3100, DOI 10.1063/1.462997; Lee S, 2014, J PHYS CHEM B, V118, P3355, DOI 10.1021/jp411618h; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Marelius J, 1998, J MOL GRAPH MODEL, V16, P213, DOI 10.1016/S1093-3263(99)00012-1; Martinelli A, 2008, MED RES REV, V28, P247, DOI 10.1002/med.20106; Ng HW, 2013, J CHEM INF MODEL, V53, P1168, DOI 10.1021/ci300610w; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rodriguez D, 2011, BIOCHEMISTRY-US, V50, P4194, DOI 10.1021/bi200100t; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabbadin D, 2014, J CHEM INF MODEL, V54, P169, DOI 10.1021/ci400532b; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Tosh DK, 2012, J MED CHEM, V55, P4297, DOI 10.1021/jm300095s; van der Horst E, 2011, CHEMMEDCHEM, V6, P2302, DOI 10.1002/cmdc.201100369; VANDERWENDEN EM, 1995, J MED CHEM, V38, P4000, DOI 10.1021/jm00020a014; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vittori S, 2000, J MED CHEM, V43, P250, DOI 10.1021/jm9911231; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	53	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108492	10.1371/journal.pone.0108492	http://dx.doi.org/10.1371/journal.pone.0108492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285959	gold, Green Submitted, Green Published			2022-12-27	WOS:000345743700022
J	Yu, Q; Li, XT; Liu, C; Cui, WZ; Mu, ZM; Zhao, X; Liu, QX				Yu, Qi; Li, Xiao-Tong; Liu, Chun; Cui, Wei-Zheng; Mu, Zhi-Mei; Zhao, Xiao; Liu, Qing-Xin			Evolutionarily Conserved Repulsive Guidance Role of Slit in the Silkworm Bombyx mori	PLOS ONE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; PDGF ALPHA-RECEPTOR; NG2 PROTEOGLYCAN; ADULT-RAT; ELECTROCONVULSIVE SEIZURES; PREFRONTAL CORTEX; PROGENITOR CELLS; BRAIN-REGIONS; GLIAL-CELLS; HIPPOCAMPAL NEUROGENESIS	Axon guidance molecule Slit is critical for the axon repulsion in neural tissues, which is evolutionarily conserved from planarians to humans. However, the function of Slit in the silkworm Bombyx mori was unknown. Here we showed that the structure of Bombyx mori Slit (BmSlit) was different from that in most other species in its C-terminal sequence. BmSlit was localized in the midline glial cell, the neuropil, the tendon cell, the muscle and the silk gland and colocalized with BmRobo1 in the neuropil, the muscle and the silk gland. Knock-down of Bmslit by RNA interference (RNAi) resulted in abnormal development of axons and muscles. Our results suggest that BmSlit has a repulsive role in axon guidance and muscle migration. Moreover, the localization of BmSlit in the silk gland argues for its important function in the development of the silk gland.	[Yu, Qi; Li, Xiao-Tong; Cui, Wei-Zheng; Mu, Zhi-Mei; Zhao, Xiao; Liu, Qing-Xin] Shandong Agr Univ, Lab Dev Genet, Tai An, Shandong, Peoples R China; [Liu, Chun] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Shandong Agricultural University; Southwest University - China	Liu, QX (corresponding author), Shandong Agr Univ, Lab Dev Genet, Tai An, Shandong, Peoples R China.	liuqingxin@sdau.edu.cn	李, 晓童/AEL-7247-2022; yu, qi/Q-5819-2018; Li, xiaotong/GYV-4890-2022	李, 晓童/0000-0001-6890-2068; yu, qi/0000-0003-2605-5328; 	National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31240037, 31301951]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB114600) (http://www.973.gov.cn/English/Index.aspx) and National Natural Science Foundation of China (31240037, 31301951) (http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2000, GLIA, V31, P219, DOI 10.1002/1098-1136(200009)31:3<219::AID-GLIA30>3.0.CO;2-R; Asher RA, 2005, MOL CELL NEUROSCI, V29, P82, DOI 10.1016/j.mcn.2005.02.001; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Bay-Richter C, 2012, CYTOKINE, V60, P749, DOI 10.1016/j.cyto.2012.08.016; Bay-Richter C, 2011, BEHAV BRAIN RES, V222, P193, DOI 10.1016/j.bbr.2011.03.060; Beran O, 2009, EUR J CLIN MICROBIOL, V28, P793, DOI 10.1007/s10096-009-0708-6; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Buttini M, 1996, NEUROCHEM INT, V29, P25, DOI 10.1016/0197-0186(95)00141-7; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dunn AJ, 2005, PHARMACOL BIOCHEM BE, V81, P688, DOI 10.1016/j.pbb.2005.04.019; Edgar N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.34; Erhardt S, 2002, ACTA PHYSIOL SCAND, V175, P45, DOI 10.1046/j.1365-201X.2002.00962.x; Fujioka H, 2010, BRAIN RES, V1352, P35, DOI 10.1016/j.brainres.2010.07.032; Gallo V, 2008, J PHYSIOL-LONDON, V586, P3767, DOI 10.1113/jphysiol.2008.158436; Gao Q, 2010, NEUROSCIENCE, V165, P386, DOI 10.1016/j.neuroscience.2009.10.022; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Grako KA, 1999, J CELL SCI, V112, P905; Gregus A, 2005, BEHAV BRAIN RES, V156, P105, DOI 10.1016/j.bbr.2004.05.013; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Jansson L, 2009, PROG NEURO-PSYCHOPH, V33, P1119, DOI 10.1016/j.pnpbp.2009.06.007; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim SE, 2013, MOL MED REP, V7, P31, DOI 10.3892/mmr.2012.1160; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Larsson LC, 2000, SCAND J IMMUNOL, V52, P249; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Levine J, 1999, NEUROPSYCHOBIOLOGY, V40, P171, DOI 10.1159/000026615; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Madsen TM, 2005, NEUROPSYCHOPHARMACOL, V30, P27, DOI 10.1038/sj.npp.1300565; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Nielsen Henrietta M, 2013, Acta Neuropathol Commun, V1, P7, DOI 10.1186/2051-5960-1-7; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Nishiyama A, 1997, J NEUROSCI RES, V48, P299, DOI 10.1002/(SICI)1097-4547(19970515)48:4<299::AID-JNR2>3.0.CO;2-6; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Paintlia MK, 2008, J NEUROCHEM, V105, P956, DOI 10.1111/j.1471-4159.2007.05199.x; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; Russo I, 2011, CELL CYCLE, V10, P2568, DOI 10.4161/cc.10.15.15946; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sugama S, 2009, J NEUROIMMUNOL, V207, P24, DOI 10.1016/j.jneuroim.2008.11.007; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; Thomas AJ, 2005, AM J PSYCHIAT, V162, P175, DOI 10.1176/appi.ajp.162.1.175; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Uranova NA, 2004, SCHIZOPHR RES, V67, P269, DOI 10.1016/S0920-9964(03)00181-6; Wang A, 2009, NEUROL RES, V31, P144, DOI 10.1179/174313209X393555; Wennstrom M, 2006, BIOL PSYCHIAT, V59, P178, DOI 10.1016/j.biopsych.2005.08.032; Wennstrom M, 2004, BIOL PSYCHIAT, V55, P464, DOI 10.1016/j.biopsych.2003.11.011; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Wu JF, 2010, GLIA, V58, P410, DOI 10.1002/glia.20932; Yang C, 2013, MOL MED REP, V8, P887, DOI 10.3892/mmr.2013.1600; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; YAO JB, 1992, BRAIN RES, V591, P88, DOI 10.1016/0006-8993(92)90981-E	68	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109377	10.1371/journal.pone.0109377	http://dx.doi.org/10.1371/journal.pone.0109377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285792	Green Published, gold			2022-12-27	WOS:000345743700061
J	Wang, SS; Wang, JJ; Wang, PX; Chen, R				Wang, S-S; Wang, J-J; Wang, P-X; Chen, R.			Determinants of Fatigue after First-Ever Ischemic Stroke during Acute Phase (vol 9, e110037, 2014)	PLOS ONE			English	Correction									[Chen, R.] Wolverhampton Univ, Ctr Hlth & Social Care Improvement CHSCI, Wolverhampton WV1 1DJ, W Midlands, England	University of Wolverhampton			WANG, Jia Ji/E-9059-2015	Chen, Ruoling/0000-0002-3033-8753				Wang SS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110037, 10.1371/journal.pone.0116461]	1	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e116461	10.1371/journal.pone.0116461	http://dx.doi.org/10.1371/journal.pone.0116461			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25302807	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200061
J	Costa, J; Teixeira, PG; d'Avo, AF; Santos, C; Verissimo, A				Costa, Joana; Teixeira, Paulo Goncalves; d'Avo, Ana Filipa; Santos Junior, Celio; Verissimo, Antonio			Intragenic Recombination Has a Critical Role on the Evolution of Legionella pneumophila Virulence-Related Effector sidJ	PLOS ONE			English	Article							FALSE DISCOVERY RATE; POPULATION-STRUCTURE; MOLECULAR EVOLUTION; HYDROTHERMAL AREAS; DNA-SEQUENCES; DOTA GENE; PROTEIN; SEROGROUP; SELECTION; SECRETION	SidJ is a Dot/Icm effector involved in the trafficking or retention of ER-derived vesicles to Legionella pneumophila vacuoles whose mutation causes an observable growth defect, both in macrophage and amoeba hosts. Given the crucial role of this effector in L. pneumophila virulence we investigated the mechanisms shaping its molecular evolution. The alignment of SidJ sequences revealed several alleles with amino acid variations that may influence the protein properties. The identification of HGT events and the detection of balancing selection operating on sidJ evolution emerge as a clear result. Evidence suggests that intragenic recombination is an important strategy in the evolutionary adaptive process playing an active role on sidJ genetic plasticity. This pattern of evolution is in accordance with the life style of L. pneumophila as a broad host-range pathogen by preventing host-specialization and contributing to the resilience of the species.	[Costa, Joana; Verissimo, Antonio] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Costa, Joana; d'Avo, Ana Filipa; Verissimo, Antonio] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Teixeira, Paulo Goncalves] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Santos Junior, Celio] Univ Fed Sao Carlos, Dept Mol Biol & Evolutionary Genet, Sao Paulo, Brazil	Universidade de Coimbra; Universidade de Coimbra; Chalmers University of Technology; Universidade Federal de Sao Carlos	Verissimo, A (corresponding author), Univ Coimbra, Dept Life Sci, Coimbra, Portugal.	averiss@ci.uc.pt	Verissimo, Antonio/AAG-1159-2020; Costa, Joana/B-9176-2009; Santos-Júnior, Célio D./F-5580-2013; Veríssimo, António/AAE-6675-2020	Verissimo, Antonio/0000-0003-4996-3185; Costa, Joana/0000-0001-7028-2873; Santos-Júnior, Célio D./0000-0002-1974-1736; Goncalves Teixeira, Paulo/0000-0002-1102-8987	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal; EU-FEDER [PEst-C/SAU/LA0001/2011, PTDC/AGR-TEC/3789/2012]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); EU-FEDER(European Commission)	The research was funded by Fundacao para a Ciencia e a Tecnologia (FCT), Portugal and EU-FEDER through grants PEst-C/SAU/LA0001/2011 and PTDC/AGR-TEC/3789/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Allombert J, 2013, MICROBES INFECT, V15, P981, DOI 10.1016/j.micinf.2013.09.007; Amaro F, 2012, J BACTERIOL, V194, P1613, DOI 10.1128/JB.06626-11; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BISSETT ML, 1983, J CLIN MICROBIOL, V17, P887, DOI 10.1128/JCM.17.5.887-891.1983; BOGARDT RA, 1980, J MOL EVOL, V15, P197, DOI 10.1007/BF01732948; BRENNER DJ, 1988, J CLIN MICROBIOL, V26, P1695, DOI 10.1128/JCM.26.9.1695-1703.1988; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Buchrieser C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00182; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cianciotto NP, 2014, CURR TOP MICROBIOL, V376, P81, DOI 10.1007/82_2013_339; Coscolla M, 2007, ENVIRON MICROBIOL, V9, P643, DOI 10.1111/j.1462-2920.2006.01184.x; Coscolla M, 2006, ENVIRON MICROBIOL, V8, P1056, DOI 10.1111/j.1462-2920.2006.00997.x; Coscolla M, 2009, INFECT GENET EVOL, V9, P882, DOI 10.1016/j.meegid.2009.05.013; Costa J, 2005, APPL ENVIRON MICROB, V71, P663, DOI 10.1128/AEM.71.2.663-671.2005; Costa J, 2012, ENVIRON MICROBIOL, V14, P2017, DOI 10.1111/j.1462-2920.2011.02646.x; Costa J, 2010, ENVIRON MICROBIOL, V12, P2711, DOI 10.1111/j.1462-2920.2010.02240.x; Costa J, 2010, RES MICROBIOL, V161, P18, DOI 10.1016/j.resmic.2009.10.005; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Edwards MT, 2008, MICROBIOL-SGM, V154, P852, DOI 10.1099/mic.0.2007/012336-0; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Escoll P, 2014, CURR TOP MICROBIOL, V376, P1, DOI 10.1007/82_2013_351; FIELDS BS, 2008, INFEC AGENT, P85; Fu YX, 1997, GENETICS, V147, P915; FU YX, 1993, GENETICS, V134, P1261; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrison TG, 2007, CLIN MICROBIOL INFEC, V13, P78, DOI 10.1111/j.1469-0691.2006.01558.x; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hookey JV, 1996, INT J SYST BACTERIOL, V46, P526, DOI 10.1099/00207713-46-2-526; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JUKES T H, 1969, P21; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Khan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067298; Kimura M., 1983, NEUTRAL THEORY MOL E; Ko KS, 2002, J BACTERIOL, V184, P2123, DOI 10.1128/JB.184.8.2123-2130.2002; Kozak NA, 2009, J CLIN MICROBIOL, V47, P2525, DOI 10.1128/JCM.02410-08; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Ma J, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00320-13; MARRAO G, 1993, FEMS MICROBIOL ECOL, V12, P25, DOI 10.1016/0168-6496(93)90021-X; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MCKINNEY RM, 1980, J CLIN MICROBIOL, V12, P395, DOI 10.1128/JCM.12.3.395-401.1980; MCKINNEY RM, 1979, ANN INTERN MED, V90, P621, DOI 10.7326/0003-4819-90-4-621; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Molmeret M, 2004, MICROBES INFECT, V6, P129, DOI 10.1016/j.micinf.2003.11.004; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; NEI M, 1986, MOL BIOL EVOL, V3, P418; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Nora T, 2009, FUTURE MICROBIOL, V4, P691, DOI 10.2217/FMB.09.47; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reed FA, 2006, GENETICS, V172, P2011, DOI 10.1534/genetics.105.052183; Richards AM, 2013, VIRULENCE, V4, P307, DOI 10.4161/viru.24290; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH JM, 1992, J MOL EVOL, V34, P126; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao LL, 2013, INFECT IMMUN, V81, P3077, DOI 10.1128/IAI.00252-13; THACKER WL, 1986, J CLIN MICROBIOL, V23, P1146, DOI 10.1128/JCM.23.6.1146-1147.1986; Thomas V, 2010, INTERVIROLOGY, V53, P254, DOI 10.1159/000312910; VERISSIMO A, 1990, J HOSP INFECT, V15, P255, DOI 10.1016/0195-6701(90)90033-K; VERISSIMO A, 1991, APPL ENVIRON MICROB, V57, P2921; Verissimo A, 1996, INT J SYST BACTERIOL, V46, P41, DOI 10.1099/00207713-46-1-41; Yang ZH, 2000, GENETICS, V155, P431	98	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109840	10.1371/journal.pone.0109840	http://dx.doi.org/10.1371/journal.pone.0109840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299187	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200076
J	Schundeln, MM; Goretzki, SC; Hauffa, PK; Wieland, R; Bauer, J; Baeder, L; Eggert, A; Hauffa, BP; Grasemann, C				Schuendeln, Michael M.; Goretzki, Sarah C.; Hauffa, Pia K.; Wieland, Regina; Bauer, Jens; Baeder, Lena; Eggert, Angelika; Hauffa, Berthold P.; Grasemann, Corinna			Impairment of Bone Health in Pediatric Patients with Hemolytic Anemia	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; SICKLE-CELL-DISEASE; MINERAL DENSITY; CHRONIC PAIN; CHILDREN; ADOLESCENTS; MASS	Introduction: Sickle cell anemia and thalassemia result in impaired bone health in both adults and youths. Children with other types of chronic hemolytic anemia may also display impaired bone health. Study Design: To assess bone health in pediatric patients with chronic hemolytic anemia, a cross-sectional study was conducted involving 45 patients with different forms of hemolytic anemia (i.e., 17 homozygous sickle cell disease and 14 hereditary spherocytosis patients). Biochemical, radiographic and anamnestic parameters of bone health were assessed. Results: Vitamin D deficiency with 25 OH-vitamin D serum levels below 20 ng/ml was a common finding (80.5%) in this cohort. Bone pain was present in 31% of patients. Analysis of RANKL, osteoprotegerin (OPG) and osteocalcin levels indicated an alteration in bone modeling with significantly elevated RANKL/OPG ratios (control: 0.08+0.07; patients: 0.26+0.2, P = 0.0007). Osteocalcin levels were found to be lower in patients compared with healthy controls (68.5+39.0 ng/ml vs. 118.0+36.6 ng/ml, P = 0.0001). Multiple stepwise regression analysis revealed a significant (P,<0.025) influence of LDH (partial r(2) = 0.29), diagnosis of hemolytic anemia (partial r(2) = 0.05) and age (partial r(2) = 0.03) on osteocalcin levels. Patients with homozygous sickle cell anemia were more frequently and more severely affected by impaired bone health than patients with hereditary spherocytosis. Conclusion: Bone health is impaired in pediatric patients with hemolytic anemia. In addition to endocrine alterations, an imbalance in the RANKL/OPG system and low levels of osteocalcin may contribute to this impairment.	[Schuendeln, Michael M.; Goretzki, Sarah C.; Hauffa, Pia K.; Wieland, Regina] Univ Klinikum Essen, Dept Pediat Hematol & Oncol, Kinderklin 3, Essen, Germany; [Schuendeln, Michael M.; Goretzki, Sarah C.; Hauffa, Pia K.; Wieland, Regina; Bauer, Jens; Baeder, Lena; Hauffa, Berthold P.; Grasemann, Corinna] Univ Duisburg Essen, Essen, Germany; [Bauer, Jens; Baeder, Lena; Hauffa, Berthold P.; Grasemann, Corinna] Univ Klinikum Essen, Dept Pediat Endocrinol & Diabetol, Kinderklin 3, Essen, Germany; [Eggert, Angelika] Charite, Dept Pediat, Div Hematol & Oncol, D-13353 Berlin, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schundeln, MM (corresponding author), Univ Klinikum Essen, Dept Pediat Hematol & Oncol, Kinderklin 3, Essen, Germany.	michael.schuendeln@uk-essen.de	Grasemann, Corinna/AAG-3861-2021; Eggert, Angelika/AAE-6907-2022; Schündeln, Michael M/W-3455-2018	Eggert, Angelika/0000-0003-3476-8184; Schündeln, Michael M/0000-0001-7495-9060; Grasemann, Corinna/0000-0003-1793-4603	Essen University Hospital Foundation; Faculty of Medicine, University of Duisburg-Essen	Essen University Hospital Foundation; Faculty of Medicine, University of Duisburg-Essen	JB was supported by the Essen University Hospital Foundation 'Stiftung Universitatsmedizin'. MS and CG were supported by an IFORES stipend from the 'Faculty of Medicine, University of Duisburg-Essen'. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; Buison AM, 2005, PEDIATRICS, V116, P943, DOI 10.1542/peds.2004-2582; Chapelon E, 2009, EUR J HAEMATOL, V83, P572, DOI 10.1111/j.1600-0609.2009.01333.x; Dhaliwal G, 2004, AM FAM PHYSICIAN, V69, P2599; Ellis KJ, 2001, J BONE MINER RES, V16, P1658, DOI 10.1359/jbmr.2001.16.9.1658; Elmadfa I, 2011, GROSSE GU NAHRWERT K; GOLDING J S, 1956, Ann R Coll Surg Engl, V19, P296; Goodman B, 2010, PREVALENCE VITAMIN D; Guntur Anyonya R, 2013, Bonekey Rep, V2, P437, DOI 10.1038/bonekey.2013.171; HESEKER B, 2007, NAHRSTOFFE LEBENSMIT; KROMEYERHAUSCHI.K, 2001, PERZENTILE BODY MASS, P807; Lal A, 2006, PEDIATR BLOOD CANCER, V47, P901, DOI 10.1002/pbc.20681; Mahachoklertwattana P, 2003, CLIN ENDOCRINOL, V58, P273, DOI 10.1046/j.1365-2265.2003.01707.x; Morabito N, 2004, J BONE MINER RES, V19, P722, DOI 10.1359/JBMR.040113; Moreau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046101; Nouraie M, 2011, HAEMATOL-HEMATOL J, V96, P1092, DOI 10.3324/haematol.2011.042499; Osunkwo I, 2012, BRIT J HAEMATOL, V159, P211, DOI 10.1111/bjh.12019; Osunkwo I, 2011, BRIT J HAEMATOL, V153, P538, DOI 10.1111/j.1365-2141.2010.08458.x; Perisano C, 2012, ANEMIA, V2012, DOI 10.1155/2012/320737; Salama OS, 2006, HEMATOLOGY, V11, P197, DOI 10.1080/10245330600702851; Sarrai M, 2007, BRIT J HAEMATOL, V136, P666, DOI 10.1111/j.1365-2141.2006.06487.x; Soliman AT, 1998, J TROP PEDIATRICS, V44, P194, DOI 10.1093/tropej/44.4.194; Voskaridou E, 2006, HAEMATOLOGICA, V91, P813	23	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108400	10.1371/journal.pone.0108400	http://dx.doi.org/10.1371/journal.pone.0108400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299063	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200018
J	Thompson, DD; Murray, GD; Sudlow, CLM; Dennis, M; Whiteley, WN				Thompson, Douglas D.; Murray, Gordon D.; Sudlow, Cathie L. M.; Dennis, Martin; Whiteley, William N.			Comparison of Statistical and Clinical Predictions of Functional Outcome after Ischemic Stroke	PLOS ONE			English	Article							EXTERNAL VALIDATION; SCORE; MODELS; REGRESSION; MORTALITY	Background: To determine whether the predictions of functional outcome after ischemic stroke made at the bedside using a doctor's clinical experience were more or less accurate than the predictions made by clinical prediction models (CPMs). Methods and Findings: A prospective cohort study of nine hundred and thirty one ischemic stroke patients recruited consecutively at the outpatient, inpatient and emergency departments of the Western General Hospital, Edinburgh between 2002 and 2005. Doctors made informal predictions of six month functional outcome on the Oxford Handicap Scale (OHS). Patients were followed up at six months with a validated postal questionnaire. For each patient we calculated the absolute predicted risk of death or dependence (OHS >= 3) using five previously described CPMs. The specificity of a doctor's informal predictions of OHS >= 3 at six months was good 0.96 (95% CI: 0.94 to 0.97) and similar to CPMs (range 0.94 to 0.96); however the sensitivity of both informal clinical predictions 0.44 (95% CI: 0.39 to 0.49) and clinical prediction models (range 0.38 to 0.45) was poor. The prediction of the level of disability after stroke was similar for informal clinical predictions (ordinal c-statistic 0.74 with 95% CI 0.72 to 0.76) and CPMs (range 0.69 to 0.75). No patient or clinician characteristic affected the accuracy of informal predictions, though predictions were more accurate in outpatients. Conclusions: CPMs are at least as good as informal clinical predictions in discriminating between good and bad functional outcome after ischemic stroke. The place of these models in clinical practice has yet to be determined.	[Thompson, Douglas D.; Murray, Gordon D.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Sudlow, Cathie L. M.; Dennis, Martin; Whiteley, William N.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Thompson, DD (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	D.Thompson-3@sms.ed.ac.uk		Whiteley, William/0000-0002-4816-8991; Sudlow, Cathie/0000-0002-7725-7520	MRC HTMR [G0800803]; MRC Clinician Scientist Fellowship [G0902303]; MRC [G0902303, G0800803] Funding Source: UKRI; Medical Research Council [G0902303, G0800803] Funding Source: researchfish	MRC HTMR(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DDT is supported by an MRC HTMR grant (G0800803). WNW is supported by an MRC Clinician Scientist Fellowship G0902303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, Stroke, V16, P397; Appelros P, 2003, STROKE, V34, P122, DOI 10.1161/01.STR.0000047852.05842.3C; Biesheuvel CJ, 2008, J CLIN EPIDEMIOL, V61, P125, DOI 10.1016/j.jclinepi.2007.03.002; Collins G, 2013, ANESTHESIOLOGY, V118, P1252, DOI 10.1097/ALN.0b013e31828e13e9; Counsell C, 2004, J NEUROL NEUROSUR PS, V75, P401, DOI 10.1136/jnnp.2003.018085; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Goldie FC, 2014, INT J STROKE, V9, P328, DOI 10.1111/ijs.12178; Jackson C, 2008, QJM-INT J MED, V101, P281, DOI 10.1093/qjmed/hcm152; Jackson CA, 2009, STROKE, V40, P3679, DOI 10.1161/STROKEAHA.109.558221; Kahneman D., 2011, THINKING FAST SLOW; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Lee YS, 2009, ARCH GERONTOL GERIAT, V49, pS26, DOI 10.1016/S0167-4943(09)70009-3; Muscari A, 2011, ACTA NEUROL SCAND, V124, P334, DOI 10.1111/j.1600-0404.2010.01479.x; Ntaios G, 2012, NEUROLOGY, V78, P1916, DOI 10.1212/WNL.0b013e318259e221; Papavasileiou V, 2013, STROKE, V44, P1616, DOI 10.1161/STROKEAHA.113.001047; Reid JM, 2010, AGE AGEING, V39, P360, DOI 10.1093/ageing/afq027; Saposnik G, 2013, NEUROLOGY, V81, P448, DOI 10.1212/WNL.0b013e31829d874e; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Van Calster B, 2012, BIOMETRICAL J, V54, P674, DOI 10.1002/bimj.201200026; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Zhang N, 2013, STROKE, V44, P1924, DOI 10.1161/STROKEAHA.111.000172; Zhou XH, 2008, PHILOS T R SOC A, V366, P2405, DOI 10.1098/rsta.2008.0037	25	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110189	10.1371/journal.pone.0110189	http://dx.doi.org/10.1371/journal.pone.0110189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299053	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200106
J	Galimberti, A; De Mattia, F; Bruni, I; Scaccabarozzi, D; Sandionigi, A; Barbuto, M; Casiraghi, M; Labra, M				Galimberti, Andrea; De Mattia, Fabrizio; Bruni, Ilaria; Scaccabarozzi, Daniela; Sandionigi, Anna; Barbuto, Michela; Casiraghi, Maurizio; Labra, Massimo			A DNA Barcoding Approach to Characterize Pollen Collected by Honeybees	PLOS ONE			English	Article							QUALITY-CONTROL METHODS; BEE POLLEN; SPECIES IDENTIFICATION; CHEMICAL-COMPOSITION; CHEMOMETRICS; POLLINATION; MORPHOLOGY; SEQUENCES; TIME; IRAN	In the present study, we investigated DNA barcoding effectiveness to characterize honeybee pollen pellets, a food supplement largely used for human nutrition due to its therapeutic properties. We collected pollen pellets using modified beehives placed in three zones within an alpine protected area (Grigna Settentrionale Regional Park, Italy). A DNA barcoding reference database, including rbcL and trnH-psbA sequences from 693 plant species (104 sequenced in this study) was assembled. The database was used to identify pollen collected from the hives. Fifty-two plant species were identified at the molecular level. Results suggested rbcL alone could not distinguish among congeneric plants; however, psbA-trnH identified most of the pollen samples at the species level. Substantial variability in pollen composition was observed between the highest elevation locality (Alpe Moconodeno), characterized by arid grasslands and a rocky substrate, and the other two sites (Cornisella and Ortanella) at lower altitudes. Pollen from Ortanella and Cornisella showed the presence of typical deciduous forest species; however in samples collected at Ortanella, pollen of the invasive Lonicera japonica, and the ornamental Pelargonium x hortorum were observed. Our results indicated pollen composition was largely influenced by floristic local biodiversity, plant phenology, and the presence of alien flowering species. Therefore, pollen molecular characterization based on DNA barcoding might serve useful to beekeepers in obtaining honeybee products with specific nutritional or therapeutic characteristics desired by food market demands.	[Galimberti, Andrea; De Mattia, Fabrizio; Bruni, Ilaria; Sandionigi, Anna; Barbuto, Michela; Casiraghi, Maurizio; Labra, Massimo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlantLab, Milan, Italy; [Scaccabarozzi, Daniela] Parco Reg Grigna Settentrionale, Barzio, Italy	University of Milano-Bicocca	Labra, M (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlantLab, Milan, Italy.	massimo.labra@unimib.it	Sandionigi, Anna/H-8815-2016; Galimberti, Andrea/ABF-7019-2020; Scaccabarozzi, Daniela/AAK-8101-2021; Casiraghi, Maurizio/E-7273-2011	Sandionigi, Anna/0000-0002-5257-0027; Galimberti, Andrea/0000-0003-3140-3024; Casiraghi, Maurizio/0000-0002-2733-2094; Bruni, Ilaria/0000-0002-9947-0963	Fondazione Cariplo [C91H09000010003]	Fondazione Cariplo(Fondazione Cariplo)	This work was supported by Fondazione Cariplo grant C91H09000010003 with the project entitled "Insetti Pronubi: mezzi di connessione e diffusione di specie vegetali rare ed endemiche del parco regionale della Grigna Settentrionale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Muradian LB, 2005, J FOOD COMPOS ANAL, V18, P105, DOI 10.1016/j.jfca.2003.10.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aronne G, 2012, FUNCT ECOL, V26, P1186, DOI 10.1111/j.1365-2435.2012.02017.x; Arvanitoyannis IS, 2005, CRIT REV FOOD SCI, V45, P193, DOI 10.1080/10408690590956369; BEATTIE AJ, 1971, PAN-PAC ENTOMOL, V47, P82; Bennett KD, 2006, HOLOCENE, V16, P1031, DOI 10.1177/0959683606069383; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Bruni I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043256; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Campos MGR, 2008, J APICULT RES, V47, P154, DOI 10.3896/IBRA.1.47.2.12; Ceksteryte V, 2008, BIOLOGIJA, V54, P25; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Conti F., 2005, ANNOTATED CHECKLIST; Cotte JF, 2003, J CHROMATOGR A, V1021, P145, DOI 10.1016/j.chroma.2003.09.005; De Mattia F, 2012, BOT J LINN SOC, V169, P518, DOI 10.1111/j.1095-8339.2012.01251.x; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Estevinho LM, 2012, INT J FOOD SCI TECH, V47, P429, DOI 10.1111/j.1365-2621.2011.02859.x; Fay MF, 1998, TAXON, V47, P43, DOI 10.2307/1224017; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Friedman J, 2009, ANN BOT-LONDON, V103, P1515, DOI 10.1093/aob/mcp035; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Giovanetti M, 2011, B INSECTOL, V64, P77; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanner R., 2009, DATA STANDARDS BARCO; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Khansari E, 2012, FLORA, V207, P203, DOI 10.1016/j.flora.2012.01.006; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linskens HF, 1997, ECON BOT, V51, P78, DOI 10.1007/BF02910407; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; MATSUI K, 1991, Plant Species Biology, V6, P117, DOI 10.1111/j.1442-1984.1991.tb00218.x; Matsuki Y, 2007, MOL ECOL NOTES, V7, P194, DOI 10.1111/j.1471-8286.2006.01588.x; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; Naciri Y, 2010, MOL ECOL RESOUR, V10, P728, DOI 10.1111/j.1755-0998.2009.02816.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nogueira C, 2012, INT J MOL SCI, V13, P11173, DOI 10.3390/ijms130911173; PAN, 2011, PAN; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Park JY, 2012, BIOCHIP J, V6, P354, DOI 10.1007/s13206-012-6407-x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rossi P, 2005, FLORA GRUPPO GRIGNE; Salmaki Y, 2008, FLORA, V203, P627, DOI 10.1016/j.flora.2007.10.005; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Szczesna T, 2006, J APIC SCI, V50, P81, DOI DOI 10.1016/J.SJBS.2017.06.003; Szczesna T, 2006, J APIC SCI, V50, P65; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tzouros NE, 2001, CRIT REV FOOD SCI, V41, P287, DOI 10.1080/20014091091823; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; Yang K, 2013, J AGR FOOD CHEM, V61, P708, DOI 10.1021/jf304056b; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Zhou LJ, 2007, AM J BOT, V94, P477, DOI 10.3732/ajb.94.3.477	58	76	80	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109363	10.1371/journal.pone.0109363	http://dx.doi.org/10.1371/journal.pone.0109363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296114	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000066
J	Goode, KJ; Poon, IKH; Phipps, S; Hulett, MD				Goode, Katharine J.; Poon, Ivan K. H.; Phipps, Simon; Hulett, Mark D.			Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; MAMMALIAN HEPARANASE; DEGRADING ENZYME; CELL-MIGRATION; LUNG INJURY; T-CELLS; LIPOPOLYSACCHARIDE; EXPRESSION; ADHESION; ROLES	Heparanase is a beta-D-endoglucuronidase that cleaves heparan sulfate (HS), facilitating degradation of the extracellular matrix (ECM) and the release of HS-bound biomolecules including cytokines. The remodeling of the ECM by heparanase is important for various physiological and pathological processes, including inflammation, wound healing, tumour angiogenesis and metastasis. Although heparanase has been proposed to facilitate leukocyte migration through degradation of the ECM, its role in inflammation by regulating the expression and release of cytokines has not been fully defined. In this study, the role of heparanase in regulating the expression and release of cytokines from human and murine immune cells was examined. Human peripheral blood mononuclear cells treated ex vivo with heparanase resulted in the release of a range of pro-inflammatory cytokines including IL-1 beta, IL-6, IL-8, IL-10 and TNF. In addition, mouse splenocytes treated ex vivo with heparanase resulted in the release of IL-6, MCP-1 and TNF. A similar pattern of cytokine release was also observed when cells were treated with soluble HS. Furthermore, heparanase-induced cytokine release was abolished by enzymatic-inhibitors of heparanase, suggesting this process is mediated via the enzymatic release of cell surface HS fragments. As soluble HS can signal through the Toll-like receptor (TLR) pathway, heparanase may promote the upregulation of cytokines through the generation of heparanase-cleaved fragments of HS. In support of this hypothesis, mouse spleen cells lacking the key TLR adaptor molecule MyD88 demonstrated an abolition of cytokine release after heparanase stimulation. Furthermore, TLR4-deficient spleen cells showed reduced cytokine release in response to heparanase treatment, suggesting that TLR4 is involved in this response. Consistent with these observations, the pathway involved in cytokine upregulation was identified as being NF-kappa beta-dependent. These data identify a new mechanism for heparanase in promoting the release of pro-inflammatory cytokines that is likely to be important in regulating cell migration and inflammation.	[Goode, Katharine J.; Poon, Ivan K. H.; Hulett, Mark D.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia; [Goode, Katharine J.] Cooperat Res Ctr Biomarker Translat, Melbourne, Vic, Australia; [Phipps, Simon] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	La Trobe University; University of Queensland	Hulett, MD (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia.	m.hulett@latrobe.edu.au	Phipps, Simon/F-9170-2010	Phipps, Simon/0000-0002-7388-3612; Hulett, Mark/0000-0003-2072-5968; Poon, Ivan/0000-0002-9119-7173; Goodall, Katharine/0000-0001-5812-8515	Australian National Health and Medical Research Council (NHMRC) [APP418008]; NHMRC [APP1013584]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian National Health and Medical Research Council (NHMRC) Research Grant [APP418008], and Ivan Poon is supported by a NHMRC Training Fellowship [APP1013584]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akbarshahi H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-219; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Arvatz G, 2011, CANCER METAST REV, V30, P253, DOI 10.1007/s10555-011-9288-x; Baker AB, 2010, ATHEROSCLEROSIS, V213, P436, DOI 10.1016/j.atherosclerosis.2010.09.003; Bitan M, 2010, MOL IMMUNOL, V47, P1890, DOI 10.1016/j.molimm.2010.03.014; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Campo GM, 2009, ARCH BIOCHEM BIOPHYS, V491, P7, DOI 10.1016/j.abb.2009.09.017; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Courtney SM, 2005, BIOORG MED CHEM LETT, V15, P2295, DOI 10.1016/j.bmcl.2005.03.014; Davis DAS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00470; de Mestre AM, 2007, J LEUKOCYTE BIOL, V82, P1289, DOI 10.1189/jlb.0507315; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goldberg R, 2013, MATRIX BIOL, V32, P234, DOI 10.1016/j.matbio.2013.02.008; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HERSHKOVIZ R, 1995, J AUTOIMMUN, V8, P741, DOI 10.1006/jaut.1995.0055; Holmdahl R, 2014, EUR J IMMUNOL, V44, P1593, DOI 10.1002/eji.201444486; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Irie F, 2008, P NATL ACAD SCI USA, V105, P12307, DOI 10.1073/pnas.0801302105; Irony-Tur-Sinai M, 2003, J NEUROL SCI, V206, P49, DOI 10.1016/S0022-510X(02)00318-0; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Konno S, 2005, J INTERF CYTOK RES, V25, P277, DOI 10.1089/jir.2005.25.277; Korpos E, 2010, CELL TISSUE RES, V339, P47, DOI 10.1007/s00441-009-0853-3; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lerner A, 2011, MED HYPOTHESES, V77, P1, DOI 10.1016/j.mehy.2011.04.033; Li RW, 2008, ARTHRITIS RHEUM, V58, P1590, DOI 10.1002/art.23489; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038659; Lygizos MI, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.153; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Mitchell MD, 2004, J CLIN ENDOCR METAB, V89, P4149, DOI 10.1210/jc.2004-0373; Mora Carmen, 2006, Curr Diab Rep, V6, P463, DOI 10.1007/s11892-006-0080-1; NAPARSTEK E, 1993, BONE MARROW TRANSPL, V12, P185; Nasser NJ, 2008, CELL MOL LIFE SCI, V65, P1706, DOI 10.1007/s00018-008-7584-6; Novick D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085944; Parish CR, 2013, MATRIX BIOL, V32, P228, DOI 10.1016/j.matbio.2013.02.007; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Poon IKH, 2014, EUR J IMMUNOL, V44, P1016, DOI 10.1002/eji.201343645; Poon IKH, 2010, BLOOD, V115, P2473, DOI 10.1182/blood-2009-07-234013; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Sciumbata T, 1996, INVAS METAST, V16, P132; Sharif MN, 2004, J IMMUNOL, V172, P6476, DOI 10.4049/jimmunol.172.10.6476; Simeonovic CJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00471; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Vanlandschoot P, 2005, J GEN VIROL, V86, P323, DOI 10.1099/vir.0.80605-0; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2013, MATRIX BIOL, V32, P241, DOI 10.1016/j.matbio.2013.03.002; Waterman M, 2007, MODERN PATHOL, V20, P8, DOI 10.1038/modpathol.3800710; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wood RJ, 2008, J BIOL CHEM, V283, P4165, DOI 10.1074/jbc.M708723200; Zcharia E, 2005, FASEB J, V19, P211, DOI 10.1096/fj.04-1970com; Zhang Z, 2014, MOL MED REP, V10, P101, DOI 10.3892/mmr.2014.2226	65	133	139	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109596	10.1371/journal.pone.0109596	http://dx.doi.org/10.1371/journal.pone.0109596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295599	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000083
J	Mercer, KL; Emry, DJ; Snow, AA; Kost, MA; Pace, BA; Alexander, HM				Mercer, Kristin L.; Emry, D. Jason; Snow, Allison A.; Kost, Matthew A.; Pace, Brian A.; Alexander, Helen M.			Fitness of Crop-Wild Hybrid Sunflower under Competitive Conditions: Implications for Crop-to-Wild Introgression	PLOS ONE			English	Article							GENE FLOW; HELIANTHUS-ANNUUS; RISK-ASSESSMENT; LIFE-HISTORY; SEED SIZE; FECUNDITY; PLANT; POPULATIONS; SELECTION; TRANSGENES	Understanding the likelihood and extent of introgression of novel alleles in hybrid zones requires comparison of lifetime fitness of parents and hybrid progeny. However, fitness differences among cross types can vary depending on biotic conditions, thereby influencing introgression patterns. Based on past work, we predicted that increased competition would enhance introgression between cultivated and wild sunflower (Helianthus annuus) by reducing fitness advantages of wild plants. To test this prediction, we established a factorial field experiment in Kansas, USA where we monitored the fitness of four cross types (Wild, F-1, F-2, and BCw hybrids) under different levels of interspecific and intraspecific competition. Intraspecific manipulations consisted both of density of competitors and of frequency of crop-wild hybrids. We recorded emergence of overwintered seeds, survival to reproduction, and numbers of seeds produced per reproductive plant. We also calculated two compound fitness measures: seeds produced per emerged seedling and seeds produced per planted seed. Cross type and intraspecific competition affected emergence and survival to reproduction, respectively. Further, cross type interacted with competitive treatments to influence all other fitness traits. More intense competition treatments, especially related to density of intraspecific competitors, repeatedly reduced the fitness advantage of wild plants when considering seeds produced per reproductive plant and per emerged seedling, and F-2 plants often became indistinguishable from the wilds. Wild fitness remained superior when seedling emergence was also considered as part of fitness, but the fitness of F-2 hybrids relative to wild plants more than quadrupled with the addition of interspecific competitors and high densities of intraspecific competitors. Meanwhile, contrary to prediction, lower hybrid frequency reduced wild fitness advantage. These results emphasize the importance of taking a full life cycle perspective. Additionally, due to effects of exogenous selection, a given hybrid generation may be especially well-suited to hastening introgression under particular environmental conditions.	[Mercer, Kristin L.; Kost, Matthew A.; Pace, Brian A.] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Emry, D. Jason; Alexander, Helen M.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Emry, D. Jason] Washburn Univ, Topeka, KS 66621 USA; [Snow, Allison A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Kansas; Washburn University; University System of Ohio; Ohio State University	Mercer, KL (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.	mercer.97@osu.edu	Mercer, Kristin/K-2000-2012		University of Kansas Field Station; research unit of the Kansas Biological Survey; University of Kansas; Biotechnology Risk Assessment Grant Program [2006-39454-17438]; State and Federal funds	University of Kansas Field Station; research unit of the Kansas Biological Survey; University of Kansas; Biotechnology Risk Assessment Grant Program; State and Federal funds	The study was conducted at and partially supported by the University of Kansas Field Station, a research unit of the Kansas Biological Survey and the University of Kansas. It was also supported by Biotechnology Risk Assessment Grant Program competitive grant no. 2006-39454-17438 to AAS, KLM, and HMA from the United States Department of Agriculture, National Institute of Food and Agriculture; www.nifa.usda.gov. Salaries and research support also provided by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, Ohio State University: manuscript no. HCS-14-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HM, 2014, AM J BOT, V101, P1176, DOI 10.3732/ajb.1400088; Alexander HM, 2012, J ECOL, V100, P88, DOI 10.1111/j.1365-2745.2011.01917.x; Allainguillaume J, 2009, NEW PHYTOL, V183, P1201, DOI 10.1111/j.1469-8137.2009.02877.x; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; ARIAS DM, 1994, THEOR APPL GENET, V89, P655, DOI 10.1007/BF00223700; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Burke JM, 2002, AM J BOT, V89, P1550, DOI 10.3732/ajb.89.9.1550; Campbell DR, 2007, AM NAT, V169, P298, DOI 10.1086/510758; Campbell LG, 2007, NEW PHYTOL, V173, P648, DOI 10.1111/j.1469-8137.2006.01941.x; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Cummings CL, 2002, OECOLOGIA, V130, P274, DOI 10.1007/s004420100806; Dechaine JM, 2009, NEW PHYTOL, V184, P828, DOI 10.1111/j.1469-8137.2009.02964.x; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Hails RS, 2005, TRENDS ECOL EVOL, V20, P245, DOI 10.1016/j.tree.2005.02.006; Hauser TP, 2003, AM J BOT, V90, P571, DOI 10.3732/ajb.90.4.571; Heino M, 1998, TRENDS ECOL EVOL, V13, P367, DOI 10.1016/S0169-5347(98)01380-9; Hooftman DAP, 2005, J APPL ECOL, V42, P1086, DOI 10.1111/j.1365-2664.2005.01086.x; Hovick SM, 2012, AM NAT, V179, P192, DOI 10.1086/663684; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kimball S, 2008, J ECOL, V96, P1306, DOI 10.1111/j.1365-2745.2008.01432.x; Laughlin KD, 2009, ECOL APPL, V19, P1091, DOI 10.1890/08-0105.1; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; Mercer KL, 2007, ECOL LETT, V10, P383, DOI 10.1111/j.1461-0248.2007.01029.x; Mercer KL, 2006, EVOLUTION, V60, P2044, DOI 10.1111/j.0014-3820.2006.tb01842.x; Mercer KL, 2011, AM J BOT, V98, P975, DOI 10.3732/ajb.1000408; Nagy ES, 1997, EVOLUTION, V51, P1469, DOI [10.1111/j.1558-5646.1997.tb01470.x, 10.2307/2411199]; Pace BA, 2012, THESIS OHIO STATE U; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rieseberg LH, 2001, TAXON, V50, P47, DOI 10.2307/1224511; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Snow AA, 1997, BIOSCIENCE, V47, P86, DOI 10.2307/1313019; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; Snow AA, 1998, AM J BOT, V85, P794, DOI 10.2307/2446414; STANTON ML, 1984, ECOLOGY, V65, P1105, DOI 10.2307/1938318; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; TILMAN D, 1988; Vacher C, 2004, THEOR APPL GENET, V109, P806, DOI 10.1007/s00122-004-1696-7; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Weiss AN, 2013, SEED SCI RES, V23, P241, DOI 10.1017/S0960258513000226; Whitton J, 1997, THEOR APPL GENET, V95, P33, DOI 10.1007/s001220050529; WULFF RD, 1986, J ECOL, V74, P115, DOI 10.2307/2260352; Xiao ZS, 2010, BEHAV ECOL, V21, P169, DOI 10.1093/beheco/arp169; Yang X, 2011, EVOL APPL, V4, P672, DOI 10.1111/j.1752-4571.2011.00190.x	49	21	22	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109001	10.1371/journal.pone.0109001	http://dx.doi.org/10.1371/journal.pone.0109001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295859	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000029
J	Tait, J; Perotto-Baldivieso, HL; McKeown, A; Westcott, DA				Tait, Jessica; Perotto-Baldivieso, Humberto L.; McKeown, Adam; Westcott, David A.			Are Flying-Foxes Coming to Town? Urbanisation of the Spectacled Flying-Fox (Pteropus conspicillatus) in Australia	PLOS ONE			English	Article							NEW-SOUTH-WALES; FRUIT BATS; POLIOCEPHALUS; LANDSCAPE; WILDLIFE; PTEROPODIDAE; ECOLOGY; BIRDS; AVAILABILITY; CONNECTIVITY	Urbanisation of wildlife populations is a process with significant conservation and management implications. While urban areas can provide habitat for wildlife, some urbanised species eventually come into conflict with humans. Understanding the process and drivers of wildlife urbanisation is fundamental to developing effective management responses to this phenomenon. In Australia, flying-foxes (Pteropodidae) are a common feature of urban environments, sometimes roosting in groups of tens of thousands of individuals. Flying-foxes appear to be becoming increasingly urbanised and are coming into increased contact and conflict with humans. Flying-fox management is now a highly contentious issue. In this study we used monitoring data collected over a 15 year period (1998-2012) to examine the spatial and temporal patterns of association of spectacled flying-fox (Pteropus conspicillatus) roost sites (camps) with urban areas. We asked whether spectacled flying-foxes are becoming more urbanised and test the hypothesis that such changes are associated with anthropogenic changes to landscape structure. Our results indicate that spectacled flying-foxes were more likely to roost near humans than might be expected by chance, that over the period of the study the proportion of the flying-foxes in urban-associated camps increased, as did the number of urban camps. Increased urbanisation of spectacled flying-foxes was not related to changes in landscape structure or to the encroachment of urban areas on camps. Overall, camps tended to be found in areas that were more fragmented, closer to human habitation and with more urban land cover than the surrounding landscape. This suggests that urbanisation is a behavioural response rather than driven by habitat loss.	[Tait, Jessica; Perotto-Baldivieso, Humberto L.] Cranfield Univ, Sch Energy Environm & Agrifood, Cranfield MK43 0AL, Beds, England; [McKeown, Adam] CSIRO, Sustainable Land & Water, Smithfield, Qld, Australia; [Tait, Jessica; Westcott, David A.] CSIRO, Sustainable Land & Water, Atherton, Qld, Australia	Cranfield University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Westcott, DA (corresponding author), CSIRO, Sustainable Land & Water, Atherton, Qld, Australia.	David.Westcott@csiro.au	Perotto-Baldivieso, Humberto/M-1123-2019; Westcott, David A/G-5559-2010; McKeown, Adam/D-3170-2011	Perotto-Baldivieso, Humberto/0000-0001-7700-7110; 	Bat Conservation International; Commonwealth of Australia's Department of the Environment; National Environmental Research Program; Rural Industries Research Development Corporation (through Commonwealth of Australia); Rural Industries Research Development Corporation (through State of New South Wales); Rural Industries Research Development Corporation (through State of Queensland under the National Hendra Virus Research Program)	Bat Conservation International; Commonwealth of Australia's Department of the Environment; National Environmental Research Program; Rural Industries Research Development Corporation (through Commonwealth of Australia); Rural Industries Research Development Corporation (through State of New South Wales); Rural Industries Research Development Corporation (through State of Queensland under the National Hendra Virus Research Program)	This research was supported by a grant from Bat Conservation International to JT and funding to DAW from the Commonwealth of Australia's Department of the Environment, the National Environmental Research Program and the Rural Industries Research Development Corporation (through funding from the Commonwealth of Australia, the State of New South Wales and the State of Queensland under the National Hendra Virus Research Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; CRAIG P, 1994, BIOL CONSERV, V69, P261, DOI 10.1016/0006-3207(94)90425-1; Curtis Paul D., 2010, P201; Davis A, 2012, LANDSCAPE URBAN PLAN, V106, P191, DOI 10.1016/j.landurbplan.2012.03.005; Davis A, 2011, LANDSCAPE URBAN PLAN, V100, P295, DOI 10.1016/j.landurbplan.2010.12.017; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547; Eby Peggy, 1999, Australian Zoologist, V31, P240; Esselstyn JA, 2006, PAC SCI, V60, P531, DOI 10.1353/psc.2006.0027; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Garnett Stephen, 1999, Australian Zoologist, V31, P38; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Jenkins RKB, 2007, ORYX, V41, P263, DOI 10.1017/S0030605307001883; Johnston Richard F., 2001, P49; Jokimaki J, 2011, LANDSCAPE URBAN PLAN, V100, P383, DOI 10.1016/j.landurbplan.2011.02.001; Lunney D., 1997, AUSTR EVER CHANGING, P247; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Mahmood-ul-Hassan M, 2010, ACTA CHIROPTEROL, V12, P341, DOI 10.3161/150811010X537927; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; McGarigal K., 2012, TECH REP; McKeown A, 2012, AUSTRAL ECOL, V37, P295, DOI 10.1111/j.1442-9993.2011.02276.x; McKinney RA, 2013, URBAN ECOSYST, V16, P411, DOI 10.1007/s11252-012-0274-z; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Nakamoto A, 2007, ACTA CHIROPTEROL, V9, P237, DOI 10.3161/1733-5329(2007)9[237:FHOOFP]2.0.CO;2; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; Parry-Jones KA, 2001, AUSTRAL ECOL, V26, P47, DOI 10.1046/j.1442-9993.2001.01072.x; Parsons JG, 2009, J WILDLIFE MANAGE, V73, P526, DOI 10.2193/2008-268; Perotto-Baldivieso HL, 2009, BIODIVERS CONSERV, V18, P905, DOI 10.1007/s10531-008-9520-3; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Puth LM, 2009, DIVERS DISTRIB, V15, P12, DOI 10.1111/j.1472-4642.2008.00499.x; Queensland Department of Environment and Resource Management, 2010, NAT REC PLAN SPECT F; Queensland Treasury and Trade, 2012, POP DWELL PROF FAR N; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Roberts BJ, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P277; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shilton LA, 2008, AUSTRAL ECOL, V33, P549, DOI 10.1111/j.1442-9993.2008.01910.x; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Stork N., 2009, LIVING DYNAMIC TROPI; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Urbanek RE, 2011, WILDLIFE SOC B, V35, P310, DOI 10.1002/wsb.37; van der Ree R, 2006, J ZOOL, V268, P177, DOI 10.1111/j.1469-7998.2005.00005.x; Westcott D. A., 2001, SPECTACLED FLYING FO; Williams NSG, 2006, AUSTRAL ECOL, V31, P190, DOI 10.1111/j.1442-9993.2006.01590.x; Zuckerberg B, 2011, J ANIM ECOL, V80, P403, DOI 10.1111/j.1365-2656.2010.01780.x	49	44	46	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109810	10.1371/journal.pone.0109810	http://dx.doi.org/10.1371/journal.pone.0109810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295724	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000098
J	Zhu, CP; Pan, FY; Ge, LP; Zhou, J; Chen, LLL; Zhou, T; Zong, RR; Xiao, XY; Dong, N; Yang, MM; Ma, JX; Liu, ZG; Zhou, YP				Zhu, Chengpeng; Pan, Fangyu; Ge, Lianping; Zhou, Jing; Chen, Longlong; Zhou, Tong; Zong, Rongrong; Xiao, Xinye; Dong, Nuo; Yang, Maomin; Ma, Jian-xing; Liu, Zuguo; Zhou, Yueping			SERPINA3K Plays Antioxidant Roles in Cultured Pterygial Epithelial Cells through Regulating ROS System	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; EXPRESSION; PATHWAY; PROLIFERATION; LOCALIZATION; PATHOGENESIS; BEVACIZUMAB; ACTIVATION; MECHANISMS	We recently demonstrated that SERPINA3K, a serine proteinase inhibitor, has antioxidant activity in the cornea. Here we investigated the antioxidant effects of SERPINA3K on the pterygial, which is partially caused by oxidative stress in pathogenesis. The head part of primary pterygial tissue was dissected and then cultured in keratinocyte serum-free defined medium (KSFM). The cultured pterygial epithelial cells (PECs) were treated with SERPINA3K. The cell proliferation and migration of PECs were measured and analyzed. Western blot and quantitative real-time polymerase chain reaction (PCR) assay were performed. It showed that SERPINA3K significantly suppressed the cell proliferation of PECs in a concentration-dependent manner, compared with cultured human conjunctival epithelial cells. SERPINA3K also inhibited the cell migration of PECs. Towards its underlying mechanism, SERPINA3K had antioxidant activities on the PECs by significantly inhibiting NADPH oxidase 4 (NOX4), which is an important enzyme of ROS generation, and by elevating the levels of key antioxidant factors of ROS: such as NAD(P) H dehydrogenase (quinone 1) (NQO1), NF-E2-related factor-2 (NRF2) and superoxide dismutases (SOD2). Meanwhile, SERPINA3K down-regulated the key effectors of Wnt signaling pathway: beta-catenin, nonphospho-beta-catenin, and low-density lipoprotein receptor-related protein 6 (LRP6). We provided novel evidence that SERPINA3K had inhibitory effects on pterygium and SERPINA3K played antioxidant role via regulating the ROS system and antioxidants.	[Zhu, Chengpeng; Pan, Fangyu; Ge, Lianping; Zhou, Jing; Chen, Longlong; Zhou, Tong; Zong, Rongrong; Xiao, Xinye; Liu, Zuguo; Zhou, Yueping] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Inst Eye, Xiamen, Fujian, Peoples R China; [Dong, Nuo; Liu, Zuguo] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Yang, Maomin] Xiamen Kehong Eye Hosp, Xiamen, Fujian, Peoples R China; [Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA	Xiamen University; Xiamen University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhou, YP (corresponding author), Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Inst Eye, Xiamen, Fujian, Peoples R China.	ypzhou@yahoo.com			Natural Science Foundation of China [81170818]; National High Technology Research and Development Program of China [2012AA020507]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This project was supported by a grant from Natural Science Foundation of China (grant No. 81170818) and by a grant from National High Technology Research and Development Program of China (grant No. 2012AA020507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balci M, 2011, MOL VIS, V17, P443; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; CHAI KX, 1991, J BIOL CHEM, V266, P16029; Chowers I, 2001, OPHTHALMOLOGY, V108, P985, DOI 10.1016/S0161-6420(00)00651-5; Chui J, 2011, AM J PATHOL, V178, P817, DOI 10.1016/j.ajpath.2010.10.037; Cimpean AM, 2013, MOL VIS, V19, P348; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Kase S, 2007, BRIT J OPHTHALMOL, V91, P958, DOI 10.1136/bjo.2006.110387; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kato N, 2007, INVEST OPHTH VIS SCI, V48, P1511, DOI 10.1167/iovs.06-1060; Khandhadia S, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000164X; Kietzmann T, 2010, ANTIOXID REDOX SIGN, V13, P395, DOI 10.1089/ars.2009.3001; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liang K, 2011, MOL VIS, V17, P1687; Liu XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016712; Nakasato H, 2012, CORNEA, V31, P1339, DOI 10.1097/ICO.0b013e3182408bc7; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ozgurhan EB, 2013, CORNEA, V32, P835, DOI 10.1097/ICO.0b013e3182772d4e; Perra MT, 2006, MOL VIS, V12, P1136; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Schelonka LP, 2000, INVEST OPHTH VIS SCI, V41, P1617; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Tsai YY, 2005, MOL VIS, V11, P71; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xu K, 2013, MOL VIS, V19, P604; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zhou T, 2011, DIABETOLOGIA, V54, P459, DOI 10.1007/s00125-010-1943-1; Zhou T, 2012, INVEST OPHTH VIS SCI, V53, P5033, DOI 10.1167/iovs.12-9729	32	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108859	10.1371/journal.pone.0108859	http://dx.doi.org/10.1371/journal.pone.0108859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296038	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000023
J	Bose, AS; Jafari, H; Sosler, S; Narula, APS; Kulkarni, VM; Ramamurty, N; Oommen, J; Jadi, RS; Banpel, RV; Henao-Restrepo, AM				Bose, Anindya Sekhar; Jafari, Hamid; Sosler, Stephen; Narula, Arvinder Pal Singh; Kulkarni, V. M.; Ramamurty, Nalini; Oommen, John; Jadi, Ramesh S.; Banpel, R. V.; Henao-Restrepo, Ana Maria			Case Based Measles Surveillance in Pune: Evidence to Guide Current and Future Measles Control and Elimination Efforts in India	PLOS ONE			English	Article							MORTALITY; AMERICA; VACCINE	Background: According to WHO estimates, 35% of global measles deaths in 2011 occurred in India. In 2013, India committed to a goal of measles elimination by 2020. Laboratory supported case based measles surveillance is an essential component of measles elimination strategies. Results from a case-based measles surveillance system in Pune district (November 2009 through December 2011) are reported here with wider implications for measles elimination efforts in India. Methods: Standard protocols were followed for case identification, investigation and classification. Suspected measles cases were confirmed through serology (IgM) or epidemiological linkage or clinical presentation. Data regarding age, sex, vaccination status were collected and annualized incidence rates for measles and rubella cases calculated. Results: Of the 1011 suspected measles cases reported to the surveillance system, 76% were confirmed measles, 6% were confirmed rubella, and 17% were non-measles, non-rubella cases. Of the confirmed measles cases, 95% were less than 15 years of age. Annual measles incidence rate was more than 250 per million persons and nearly half were associated with outbreaks. Thirty-nine per cent of the confirmed measles cases were vaccinated with one dose of measles vaccine (MCV1). Conclusion: Surveillance demonstrated high measles incidence and frequent outbreaks in Pune where MCV1 coverage in infants was above 90%. Results indicate that even high coverage with a single dose of measles vaccine was insufficient to provide population protection and prevent measles outbreaks. An effective measles and rubella surveillance system provides essential information to plan, implement and evaluate measles immunization strategies and monitor progress towards measles elimination.	[Bose, Anindya Sekhar; Jafari, Hamid; Sosler, Stephen; Narula, Arvinder Pal Singh; Banpel, R. V.] WHO, India Country Off, Natl Polio Surveillance Project, New Delhi, India; [Bose, Anindya Sekhar] Bill & Melinda Gates Fdn, New Delhi, India; [Jafari, Hamid; Henao-Restrepo, Ana Maria] WHO, CH-1211 Geneva, Switzerland; [Sosler, Stephen] GAVI, Vaccine Alliance, Geneva, Switzerland; [Kulkarni, V. M.] Govt Maharashtra, Dept Hlth & Family Welf, Pune, Maharashtra, India; [Ramamurty, Nalini; Oommen, John] WHO, South East Asia Reg Off, New Delhi, India; [Jadi, Ramesh S.] Indian Council Med Res, Natl Inst Virol, Pune, Maharashtra, India	World Health Organization; World Health Organization; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Bose, AS (corresponding author), WHO, India Country Off, Natl Polio Surveillance Project, New Delhi, India.	anindyasbose@gmail.com	Jadi, Ramesh/AAV-2059-2020; Oommen, B. John/P-6323-2017	Jadi, Ramesh/0000-0002-5710-4893; Oommen, B. John/0000-0002-5105-1575; John, Oommen/0000-0002-9008-1726; Bose, Anindya Sekhar/0000-0002-7657-8648	Measles Aerosol Vaccine Project; Bill and Melinda Gates Foundation	Measles Aerosol Vaccine Project; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	WHO-India Country Office received funds from the Measles Aerosol Vaccine Project to set up the surveillance system. World Health Organization Initiative for Vaccine Research (WHO/IVR) coordinated Measles Aerosol Vaccine Project (MAVP). The Centre for Disease Control and Prevention (CDC), USA and the American Red Cross (ARC) are partners in MAVP, which has received financial support from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Wkly Epidemiol Rec, V88, P29; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P490; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P349; [Anonymous], 2010, 63 HLTH ASS A63 18; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Clements C, 2004, GLOBAL EPIDEMIOLOGY, P75; deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224; GPEI, 2013, POL ER ENDG STRAG PL; Gupta SK, 2011, INDIAN PEDIATR, V48, P379, DOI 10.1007/s13312-011-0066-1; Guris D, 2004, J INFECT DIS, V189, pS177, DOI 10.1086/374606; Guris D, 2002, MODULE BEST PRACTICE; Hersh BS, 2000, LANCET, V355, P1943, DOI 10.1016/S0140-6736(00)02325-4; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Ministry Of Health And Family Welfare Goi New Delhi, 2005, MEAS MORT RED IND ST; MOHFW-GOI, 2009, NAT HLTH PROF 2008; [MOHFW-GOI Government Of India Dohfw], 2006, FIELD GUID MEASL SUR; Moss WJ, 2009, IMMUNOLOGICAL BASIS; Murhekar MV, 2011, J INFECT DIS, V204, pS427, DOI 10.1093/infdis/jir062; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Oum S, 2005, TROP MED INT HEALTH, V10, P689, DOI 10.1111/j.1365-3156.2005.01445.x; PAHO, 2005, MEAS EL FIELD GUID; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Singh J, 1999, Indian Pediatr, V36, P249; Singh Jagvir, 1994, Journal of Communicable Diseases, V26, P203; Sosler Stephen, 2011, Morbidity and Mortality Weekly Report, V60, P1315; Sudfeld CR, 2009, INDIAN PEDIATR, V46, P983; UNICEF-India, 2010, COV EV SURV 2009 ALL; WHO-NPSP, 2011, MONTHL MEASL SURV B; World Health Organisation, 2008, WHO REC STAND SURV S; World Health Organization, 2007, MAN LAB DIAGN MEAS R	30	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108786	10.1371/journal.pone.0108786	http://dx.doi.org/10.1371/journal.pone.0108786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290339	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000026
J	Pau, S; Still, CJ				Pau, Stephanie; Still, Christopher J.			Phenology and Productivity of C-3 and C-4 Grasslands in Hawaii	PLOS ONE			English	Article							GREAT-PLAINS; ECOLOGICAL DISTRIBUTION; TALLGRASS PRAIRIE; GRASSES; PHOTOSYNTHESIS; VARIABILITY; PHYLOGENY; CLIMATE; PLANTS; NICHE	Grasslands account for a large proportion of global terrestrial productivity and play a critical role in carbon and water cycling. Within grasslands, photosynthetic pathway is an important functional trait yielding different rates of productivity along environmental gradients. Recently, C-3-C-4 sorting along spatial environmental gradients has been reassessed by controlling for confounding traits in phylogenetically structured comparisons. C-3 and C-4 grasses should sort along temporal environmental gradients as well, resulting in differing phenologies and growing season lengths. Here we use 10 years of satellite data (NDVI) to examine the phenology and greenness (as a proxy for productivity) of C-3 and C-4 grass habitats, which reflect differences in both environment and plant physiology. We perform phylogenetically structured comparisons based on 3,595 digitized herbarium collections of 152 grass species across the Hawaiian Islands. Our results show that the clade identity of grasses captures differences in their habitats better than photosynthetic pathway. Growing season length (GSL) and associated productivity (GSP) were not significantly different when considering photosynthetic type alone, but were indeed different when considering photosynthetic type nested within clade. The relationship between GSL and GSP differed most strongly between C-3 clade habitats, and not between C-3-C-4 habitats. Our results suggest that accounting for the interaction between phylogeny and photosynthetic pathway can help improve predictions of productivity, as commonly used C-3-C-4 classifications are very broad and appear to mask important diversity in grassland ecosystem functions.	[Pau, Stephanie] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA; [Still, Christopher J.] Oregon State Univ, Corvallis, OR 97331 USA	State University System of Florida; Florida State University; Oregon State University	Pau, S (corresponding author), Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA.	spau@fsu.edu		Still, Christopher/0000-0002-8295-4494	NSF [EF-0553768]; University of California, Santa Barbara; State of California; Florida State University's Committee on Faculty Research Support (COFRS) Award; NASA New Investigator Program award	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Florida State University's Committee on Faculty Research Support (COFRS) Award; NASA New Investigator Program award	This work was initiated while SP was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. SP completed revisions with the support of Florida State University's Committee on Faculty Research Support (COFRS) Award. CJS acknowledges the support of a NASA New Investigator Program award that initially supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Angelo CL, 2013, ECOGRAPHY, V36, P551, DOI 10.1111/j.1600-0587.2012.07754.x; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Burnham K.P., 2010, MODEL SELECTION MULT; Cabido M, 2007, J BIOGEOGR, V24, P197; CAVAGNARO JB, 1988, OECOLOGIA, V76, P273, DOI 10.1007/BF00379962; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; CHAZDON RL, 1978, BIOTROPICA, V10, P265, DOI 10.2307/2387678; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Davidson A, 2003, REMOTE SENS ENVIRON, V86, P70, DOI 10.1016/S0034-4257(03)00069-5; Dunn AL, 2007, GLOBAL CHANGE BIOL, V13, P577, DOI 10.1111/j.1365-2486.2006.01221.x; Edwards EJ, 2008, ECOL LETT, V11, P266, DOI 10.1111/j.1461-0248.2007.01144.x; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Epstein HE, 1997, ECOLOGY, V78, P722; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Foody GM, 2007, ECOL INFORM, V2, P89, DOI 10.1016/j.ecoinf.2007.03.009; Foody GM, 2010, INT J REMOTE SENS, V31, P351, DOI 10.1080/01431160902887339; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Goodin DG, 1997, REMOTE SENS ENVIRON, V61, P270, DOI 10.1016/S0034-4257(97)00043-6; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Hu J, 2010, GLOBAL CHANGE BIOL, V16, P771, DOI 10.1111/j.1365-2486.2009.01967.x; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; KEMP PR, 1980, ECOLOGY, V61, P846, DOI 10.2307/1936755; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mooney H. A., 1972, Annual Review of Ecology and Systematics, V3, P315, DOI 10.1146/annurev.es.03.110172.001531; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Newell C, 1968, PHYTOSOCIOLOGICAL ST; Nippert JB, 2012, PLANT SOIL, V355, P385, DOI 10.1007/s11104-011-1112-4; ODE DJ, 1980, ECOLOGY, V61, P1304, DOI 10.2307/1939038; Osborne CP, 2009, P ROY SOC B-BIOL SCI, V276, P1753, DOI 10.1098/rspb.2008.1762; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Powell RL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00162.1; Reed BC, 2009, INFORM SYST, V5, P703; REICH PB, 1991, OECOLOGIA, V86, P16, DOI 10.1007/BF00317383; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Richardson AD, 2012, GLOBAL CHANGE BIOL, V18, P566, DOI 10.1111/j.1365-2486.2011.02562.x; RUNDEL PW, 1980, OECOLOGIA, V45, P354, DOI 10.1007/BF00540205; Sage RF, 1999, C4 PLANT BIOL; Saugier B., 2001, TERRESTRIAL GLOBAL P, P543, DOI [10.1016/B978-0-12-505290-0.X5000-5, DOI 10.1016/B978-012505290-0/50024-7]; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Still CJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P286, DOI 10.1111/geb.12121; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Still CJ, 2003, OECOLOGIA, V136, P347, DOI 10.1007/s00442-003-1274-8; Taylor G, 2008, GLOBAL CHANGE BIOL, V14, P264, DOI 10.1111/j.1365-2486.2007.01473.x; Taylor SH, 2010, NEW PHYTOL, V185, P780, DOI 10.1111/j.1469-8137.2009.03102.x; TIESZEN LL, 1979, OECOLOGIA, V37, P337, DOI 10.1007/BF00347910; Tieszen LL, 1997, ECOL APPL, V7, P59, DOI 10.2307/2269407; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; Wang CZ, 2010, REMOTE SENS ENVIRON, V114, P531, DOI 10.1016/j.rse.2009.10.010; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	58	11	11	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107396	10.1371/journal.pone.0107396	http://dx.doi.org/10.1371/journal.pone.0107396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290341	gold, Green Published			2022-12-27	WOS:000342798000004
J	Qing, J; Yan, D; Zhou, Y; Liu, Q; Wu, WJ; Xiao, Z; Liu, YY; Liu, J; Du, LL; Xie, DH; Liu, XZ				Qing, Jie; Yan, Denise; Zhou, Yuan; Liu, Qiong; Wu, Weijing; Xiao, Zian; Liu, Yuyuan; Liu, Jia; Du, Lilin; Xie, Dinghua; Liu, Xue Zhong			Whole-Exome Sequencing to Decipher the Genetic Heterogeneity of Hearing Loss in a Chinese Family with Deaf by Deaf Mating	PLOS ONE			English	Article							RIBOSOMAL-RNA MUTATION; DOMINANT OPTIC ATROPHY; WOLFRAM-SYNDROME; WFS1 GENE; MISSENSE MUTATION; TRANSMEMBRANE PROTEIN; DIABETES-MELLITUS; NOVO MUTATIONS; IMPAIRMENT; PHENOTYPE	Inherited deafness has been shown to have high genetic heterogeneity. For many decades, linkage analysis and candidate gene approaches have been the main tools to elucidate the genetics of hearing loss. However, this associated study design is costly, time-consuming, and unsuitable for small families. This is mainly due to the inadequate numbers of available affected individuals, locus heterogeneity, and assortative mating. Exome sequencing has now become technically feasible and a cost-effective method for detection of disease variants underlying Mendelian disorders due to the recent advances in next-generation sequencing (NGS) technologies. In the present study, we have combined both the Deafness Gene Mutation Detection Array and exome sequencing to identify deafness causative variants in a large Chinese composite family with deaf by deaf mating. The simultaneous screening of the 9 common deafness mutations using the allele-specific PCR based universal array, resulted in the identification of the 1555A>G in the mitochondrial DNA (mtDNA) 12S rRNA in affected individuals in one branch of the family. We then subjected the mutation-negative cases to exome sequencing and identified novel causative variants in the MYH14 and WFS1 genes. This report confirms the effective use of a NGS technique to detect pathogenic mutations in affected individuals who were not candidates for classical genetic studies.	[Qing, Jie; Zhou, Yuan; Wu, Weijing; Xiao, Zian; Liu, Yuyuan; Liu, Jia; Xie, Dinghua; Liu, Xue Zhong] Cent S Univ, Xiangya Hosp 2, Inst Otol, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Qing, Jie; Yan, Denise; Liu, Qiong; Du, Lilin; Liu, Xue Zhong] Univ Miami, Leonard M Miller Sch Med, Dept Otolaryngol, Miami, FL USA; [Qing, Jie; Yan, Denise; Liu, Qiong; Du, Lilin; Liu, Xue Zhong] Univ Miami, Leonard M Miller Sch Med, Dept Head & Neck Surg, Miami, FL USA	Central South University; University of Miami; University of Miami	Xie, DH (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Otol, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China.	dhuaxie@163.com; xliu@med.Miami.edu			Cochlear Implantation Program of Hunan, China; National Basic Research Program of China (973) [2012CB967900, 2012CB967904]; National Institutes of Health (NIH) [R01DC005575, R01DC012546, R01DC012115]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012115, R01DC005575, R01DC012546] Funding Source: NIH RePORTER	Cochlear Implantation Program of Hunan, China; National Basic Research Program of China (973)(National Basic Research Program of China); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants from the Cochlear Implantation Program of Hunan, China, and National Basic Research Program of China (973) (grants 2012CB967900 and 2012CB967904). This work also was supported by National Institutes of Health (NIH) (grant R01DC005575, R01DC012546 and R01DC012115) to XZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bae JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042463; Bespalova IN, 2001, HUM MOL GENET, V10, P2501, DOI 10.1093/hmg/10.22.2501; Bom SJH, 1999, BRIT J AUDIOL, V33, P335, DOI 10.3109/03005369909090117; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; Chistiakov Dimitry A, 2010, Rev Diabet Stud, V7, P285, DOI 10.1900/RDS.2010.7.285; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Cryns K, 2002, HUM GENET, V110, P389, DOI 10.1007/s00439-002-0719-1; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892; Fuchs SA, 2012, METALLOMICS, V4, P606, DOI 10.1039/c2mt20034a; Fujikawa T, 2010, LARYNGOSCOPE, V120, P166, DOI 10.1002/lary.20691; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Goncalves AC, 2014, GENE, V538, P288, DOI 10.1016/j.gene.2014.01.040; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Gurtler N, 2004, J MOL MED, V82, P775, DOI 10.1007/s00109-004-0597-1; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Hogewind BFT, 2010, MOL VIS, V16, P26; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Khanim F, 2001, HUM MUTAT, V17, P357, DOI 10.1002/humu.1110.abs; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Kunz J, 2003, MUTAT RES-FUND MOL M, V525, P121, DOI 10.1016/S0027-5107(02)00265-8; Lalwani AK, 1998, ARCH OTOLARYNGOL, V124, P699, DOI 10.1001/archotol.124.6.699; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lesperance MM, 2003, ARCH OTOLARYNGOL, V129, P411, DOI 10.1001/archotol.129.4.411; LESPERANCE MM, 1995, HUM MOL GENET, V4, P1967, DOI 10.1093/hmg/4.10.1967; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Middle F, 2000, AM J MED GENET, V96, P154, DOI 10.1002/(SICI)1096-8628(20000403)96:2<154::AID-AJMG5>3.0.CO;2-F; Pennings RJE, 2003, ARCH OTOLARYNGOL, V129, P421, DOI 10.1001/archotol.129.4.421; Podoly E, 2010, CHEM-BIOL INTERACT, V187, P64, DOI 10.1016/j.cbi.2010.01.003; Rendtorff ND, 2011, AM J MED GENET A, V155A, P1298, DOI 10.1002/ajmg.a.33970; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Shearer AE, 2011, HEARING RES, V282, P1, DOI 10.1016/j.heares.2011.10.001; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Tranebjaerg L, 2004, MOL BIOL HEAR DEAFN; Wasson J, 2008, DIABETOLOGIA, V51, P391, DOI 10.1007/s00125-007-0920-9; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yan D, 2013, GENET TEST MOL BIOMA, V17, P581, DOI 10.1089/gtmb.2012.0464; Yang Rong, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P259, DOI [10.3760/cma.j.issn.1003-940.2010.03.005, 10.3760/cma.j.issn.1003-9406.2010.0.005]; Yang T, 2005, AM J MED GENET A, V139A, P9, DOI 10.1002/ajmg.a.30989; Young TL, 2001, HUM MOL GENET, V10, P2509, DOI 10.1093/hmg/10.22.2509	45	12	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109178	10.1371/journal.pone.0109178	http://dx.doi.org/10.1371/journal.pone.0109178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289672	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000045
J	Shen, L; Wang, P; Yang, JL; Li, XT				Shen, Lei; Wang, Peng; Yang, Jili; Li, Xiaotao			MicroRNA-217 Regulates WASF3 Expression and Suppresses Tumor Growth and Metastasis in Osteosarcoma	PLOS ONE			English	Article							CELL-PROLIFERATION; DOWN-REGULATION; CANCER CELLS; IN-VITRO; MIGRATION; GENE; INACTIVATION; INVASION; PATHWAY; MIRNAS	Osteosarcoma is the most common type of primary tumor of bone which mainly affects adolescents and young adults. Osteosarcoma causes large number of deaths because of its complex pathogenesis and resistance to conventional treatment. MicroRNAs are a class of small noncoding RNAs that function as critical gene regulators through targeting mRNAs, causing translational repression or degradation. In this study, we showed that miR-217 was down-regulated in osteosarcoma cell lines and tissues in comparison to that in normal bone cells or tissues. Meanwhile, the lower level of miR-217 was associated with metastasis in clinical osteosarcoma patients. Furthermore, we found that overexpession of miR-217 markedly suppressed cell proliferation, migration, and invasion of osteosarcoma cells. Conversely, the inhibition of miR-217 expression significantly accelerated the cell proliferation, migration, and invasion. Moreover, we identified WASF3 as a novel functional downstream target of miR-217. The ectopic expression of WASF3 can partially reverse the inhibition of cell proliferation and invasion caused by miR-217. Take together, our results demonstrate that miR-217 functions as a tumor-suppressive miRNA and inhibits the osteosarcoma tumorigenesis through targeting WASF3.	[Shen, Lei] Qiqihar Med Sch, Dept Anat, Qiqihar, Heilongjiang, Peoples R China; [Wang, Peng] Harbin Med Univ, Hosp 4, Dept Orthoped, Harbin, Heilongjiang, Peoples R China; [Yang, Jili] Jilin Prov Tumor Hosp, Dept TCM, Changchun, Jilin, Peoples R China; [Li, Xiaotao] Jiamusi Univ, Affiliated Hosp 1, Dept Orthoped, Jiamusi, Heilongjiang, Peoples R China	Harbin Medical University; Jiamusi University	Li, XT (corresponding author), Jiamusi Univ, Affiliated Hosp 1, Dept Orthoped, Jiamusi, Heilongjiang, Peoples R China.	hljjmsxt@126.com			Natural Science Foundation of Heilongjiang Province of China [H201359]	Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This study is supported by Natural Science Foundation of Heilongjiang Province of China (Grant No. H201359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2013, FEBS LETT, V587, P1366, DOI 10.1016/j.febslet.2013.03.007; Dai N, 2013, NEOPLASMA, V60, P384, DOI 10.4149/neo_2013_050; Ghoshal P, 2012, INT J CANCER, V131, pE905, DOI 10.1002/ijc.27631; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Ji F, 2013, BONE, V56, P220, DOI 10.1016/j.bone.2013.05.020; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kobayashi Eisuke, 2012, Sarcoma, V2012, P359739, DOI 10.1155/2012/359739; Li H, 2013, NEOPLASMA, V60, P511, DOI 10.4149/neo_2013_066; Li Z., 2014, GASTRIC CANC; Liang WQ, 2013, FRONT BIOSCI-LANDMRK, V18, P788, DOI 10.2741/4142; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Miao J, 2013, TUMOUR BIOL; Ouyang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0340-7; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Rottiers V, 2011, COLD SH Q B, V76, P225, DOI 10.1101/sqb.2011.76.011049; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Schotte D, 2012, LEUKEMIA, V26, P1, DOI 10.1038/leu.2011.151; Song B, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001663; Song L, 2013, ARCH BIOCHEM BIOPHYS, V535, P128, DOI 10.1016/j.abb.2013.04.001; Suzuki H, 2012, MOL ONCOL; Tang JT, 2009, MINI-REV MED CHEM, V9, P921, DOI 10.2174/138955709788681672; Teng Y, 2014, ONCOGENE, V33, P203, DOI 10.1038/onc.2012.565; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2013, CARCINOGENESIS, V34, P1994, DOI 10.1093/carcin/bgt167; Teng Y, 2011, INT J CANCER, V129, P2825, DOI 10.1002/ijc.25964; Van Wynsberghe PM, 2011, METHOD CELL BIOL, V106, P219, DOI 10.1016/B978-0-12-544172-8.00008-6; Won KY, 2013, HUM PATHOL, V44, P1648, DOI 10.1016/j.humpath.2013.01.016; Wu XY, 2013, INT J MED SCI, V10, P676, DOI 10.7150/ijms.5528; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zhao HE, 2012, INT J MOL MED, V30, P1013, DOI 10.3892/ijmm.2012.1111; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023	35	56	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109138	10.1371/journal.pone.0109138	http://dx.doi.org/10.1371/journal.pone.0109138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289936	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000036
J	de Waal, PW; Sunden, KF; Furge, LL				de Waal, Parker W.; Sunden, Kyle F.; Furge, Laura Lowe			Molecular Dynamics of CYP2D6 Polymorphisms in the Absence and Presence of a Mechanism-Based Inactivator Reveals Changes in Local Flexibility and Dominant Substrate Access Channels	PLOS ONE			English	Article							HUMAN CYTOCHROME-P450 2D6; CRYSTAL-STRUCTURE; EXPLICIT SOLVENT; BINDING; LIGAND; P450; VARIANTS; INSIGHT; AMBER; PLASTICITY	Cytochrome P450 enzymes (CYPs) represent an important enzyme superfamily involved in metabolism of many endogenous and exogenous small molecules. CYP2D6 is responsible for similar to 15% of CYP-mediated drug metabolism and exhibits large phenotypic diversity within CYPs with over 100 different allelic variants. Many of these variants lead to functional changes in enzyme activity and substrate selectivity. Herein, a molecular dynamics comparative analysis of four different variants of CYP2D6 was performed. The comparative analysis included simulations with and without SCH 66712, a ligand that is also a mechanism-based inactivator, in order to investigate the possible structural basis of CYP2D6 inactivation. Analysis of protein stability highlighted significantly altered flexibility in both proximal and distal residues from the variant residues. In the absence of SCH 66712, *34, *17-2, and *17-3 displayed more flexibility than *1, and *53 displayed more rigidity. SCH 66712 binding reversed flexibility in *17-2 and *17-3, through *53 remained largely rigid. Throughout simulations with docked SCH 66712, ligand orientation within the heme-binding pocket was consistent with previously identified sites of metabolism and measured binding energies. Subsequent tunnel analysis of substrate access, egress, and solvent channels displayed varied bottle-neck radii. Taken together, our results indicate that SCH 66712 should inactivate these allelic variants, although varied flexibility and substrate binding-pocket accessibility may alter its interaction abilities.	[de Waal, Parker W.; Sunden, Kyle F.; Furge, Laura Lowe] Kalamazoo Coll, Dept Chem, Kalamazoo, MI 49007 USA	Kalamazoo College	Furge, LL (corresponding author), Kalamazoo Coll, Dept Chem, Kalamazoo, MI 49007 USA.	Laura.Furge@kzoo.edu	; de Waal, Parker/M-1138-2017	Furge, Laura/0000-0003-3593-4770; Sunden, Kyle/0000-0001-6167-8059; de Waal, Parker/0000-0001-6922-9768	National Institutes of Health [1R15GM086767-02]; National Science Foundation [OCI-1053575, MCB130144]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM086767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant 1R15GM086767-02 (to L.L.F.) and the National Science Foundation grant OCI-1053575 to the Extreme Science and Engineering Discovery Environment (project allocation MCB130144 to L.L.F.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Berka K, 2012, J INORG BIOCHEM, V110, P46, DOI 10.1016/j.jinorgbio.2012.02.010; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2012, AMBER 12; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cui YL, 2013, J CHEM INF MODEL, V53, P3308, DOI 10.1021/ci400553w; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fu G, 2012, J PHYS CHEM B, V116, P9580, DOI 10.1021/jp301456j; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Handa K, 2014, DRUG METAB PHARMACOK, V29, P52, DOI 10.2133/dmpk.DMPK-13-RG-044; Hendrychova T, 2012, CURR DRUG METAB, V13, P177, DOI 10.2174/138920012798918408; Hollenberg PF, 2008, CHEM RES TOXICOL, V21, P189, DOI 10.1021/tx7002504; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hritz J, 2008, J MED CHEM, V51, P7469, DOI 10.1021/jm801005m; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Jang HH, 2014, ARCH BIOCHEM BIOPHYS, V545, P100, DOI 10.1016/j.abb.2014.01.008; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Kar P, 2012, J PHYS CHEM B, V116, P6137, DOI 10.1021/jp3022612; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; Lertkiatmongkol P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074053; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Livezey Mara, 2012, Drug Metab Lett, V6, P7; Marechal JD, 2008, BRIT J PHARMACOL, V153, pS82, DOI 10.1038/sj.bjp.0707570; Marez D, 1997, PHARMACOGENETICS, V7, P193, DOI 10.1097/00008571-199706000-00004; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Nagy LD, 2011, DRUG METAB DISPOS, V39, P974, DOI 10.1124/dmd.110.037630; Niwa T, 2011, CURR DRUG METAB, V12, P412, DOI 10.2174/138920011795495286; Oscarson M, 1997, MOL PHARMACOL, V52, P1034, DOI 10.1124/mol.52.6.1034; Otyepka M, 2012, CURR DRUG METAB, V13, P130, DOI 10.2174/138920012798918372; Peric-Hassler L, 2013, INT J MOL SCI, V14, P24514, DOI 10.3390/ijms141224514; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robarge J, 2007, CLIN PHARMACOL THER, V82, P244, DOI 10.1038/sj.clpt.6100284; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sakuyama K, 2008, DRUG METAB DISPOS, V36, P2460, DOI 10.1124/dmd.108.023242; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sano E, 2010, J COMPUT CHEM, V31, P2746, DOI 10.1002/jcc.21568; Shahrokh K, 2012, J COMPUT CHEM, V33, P119, DOI 10.1002/jcc.21922; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Sridar C, 2011, DRUG METAB DISPOS, V39, P782, DOI 10.1124/dmd.110.036707; Tan CH, 2006, J PHYS CHEM B, V110, P18680, DOI 10.1021/jp063479b; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wang B, 2009, DRUG METAB REV, V41, P573, DOI 10.1080/03602530903118729; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Yu AM, 2002, J PHARMACOL EXP THER, V303, P1291, DOI 10.1124/jpet.102.039891; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074; Zhang HM, 2013, BIOCHEMISTRY-US, V52, P355, DOI 10.1021/bi301567z; Zhang T, 2011, J CHEM INF MODEL, V51, P1336, DOI 10.1021/ci200112b; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zheng YM, 1998, BIOCHEMISTRY-US, V37, P12847, DOI 10.1021/bi981280m; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P761, DOI 10.2165/11318070-000000000-00000; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000; Zou HJ, 2007, J PHYS CHEM B, V111, P9104, DOI 10.1021/jp0713763	58	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108607	10.1371/journal.pone.0108607	http://dx.doi.org/10.1371/journal.pone.0108607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286176	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700024
J	Yu, GH; Jiang, LL; Ma, XF; Xu, ZS; Liu, MM; Shan, SG; Cheng, XG				Yu, Guo-Hong; Jiang, Lin-Lin; Ma, Xue-Feng; Xu, Zhao-Shi; Liu, Meng-Meng; Shan, Shu-Guang; Cheng, Xian-Guo			A Soybean C2H2-Type Zinc Finger Gene GmZF1 Enhanced Cold Tolerance in Transgenic Arabidopsis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GENE; ABIOTIC STRESS; DROUGHT TOLERANCE; SALT TOLERANCE; ABSCISIC-ACID; PROTEIN GENE; INDUCIBLE GENES; EXPRESSION; FAMILY; PETUNIA	Zinc finger proteins were involved in response to different environmental stresses in plant species. A typical Cys2/His2-type (C2H2-type) zinc finger gene GmZF1 from soybean was isolated and was composed of 172 amino acids containing two conserved C2H2-type zinc finger domains. Phylogenetic analysis showed that GmZF1 was clustered on the same branch with six C2H2-type ZFPs from dicotyledonous plants excepting for GsZFP1, and distinguished those from monocotyledon species. The GmZF1 protein was localized at the nucleus, and has specific binding activity with EP1S core sequence, and nucleotide mutation in the core sequence of EPSPS promoter changed the binding ability between GmZF1 protein and core DNA element, implying that two amino acid residues, G and C boxed in core sequence TGACAGTGTCA possibly play positive regulation role in recognizing DNA-binding sites in GmZF1 proteins. High accumulation of GmZF1 mRNA induced by exogenous ABA suggested that GmZF1 was involved in an ABA-dependent signal transduction pathway. Over-expression of GmZF1 significantly improved the contents of proline and soluble sugar and decreased the MDA contents in the transgenic lines exposed to cold stress, indicating that transgenic Arabidopsis carrying GmZF1 gene have adaptive mechanisms to cold stress. Over-expression of GmZF1 also increased the expression of cold-regulated cor6.6 gene by probably recognizing protein-DNA binding sites, suggesting that GmZF1 from soybean could enhance the tolerance of Arabidopsis to cold stress by regulating expression of cold-regulation gene in the transgenic Arabidopsis.	[Yu, Guo-Hong; Jiang, Lin-Lin; Ma, Xue-Feng; Liu, Meng-Meng; Shan, Shu-Guang; Cheng, Xian-Guo] Chinese Acad Agr Sci, Key Lab Plant Nutr & Fertilizer, Inst Agr Resources & Reg Planning, Minist Agr, Beijing 100193, Peoples R China; [Ma, Xue-Feng] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China; [Xu, Zhao-Shi] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Cheng, XG (corresponding author), Chinese Acad Agr Sci, Key Lab Plant Nutr & Fertilizer, Inst Agr Resources & Reg Planning, Minist Agr, Beijing 100193, Peoples R China.	chengxianguo@caas.cn			National Key Project for Cultivation of New Varieties of Genetically Modified Organisms [2013ZX08002-005]	National Key Project for Cultivation of New Varieties of Genetically Modified Organisms	This work was supported by the National Key Project for Cultivation of New Varieties of Genetically Modified Organisms (2013ZX08002-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai L, 2008, J AGRON CROP SCI, V194, P360, DOI 10.1111/j.1439-037X.2008.00325.x; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Chen M, 2009, J EXP BOT, V60, P121, DOI 10.1093/jxb/ern269; Chen Y, 2014, PLANT MOL BIOL, V84, P621, DOI 10.1007/s11103-013-0158-5; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Giannakoula A, 2012, ENVIRON EXP BOT, V67, P487; Giannakoula A, 2008, J PLANT PHYSIOL, V165, P385, DOI 10.1016/j.jplph.2007.01.014; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Han MJ, 2006, PLANT CELL PHYSIOL, V47, P1457, DOI 10.1093/pcp/pcl013; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601; Jain D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005154; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Kubo K, 1998, NUCLEIC ACIDS RES, V26, P608, DOI 10.1093/nar/26.2.608; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Lippuner V, 1996, J BIOL CHEM, V271, P12859, DOI 10.1074/jbc.271.22.12859; Liu P, 2013, J EXP BOT, V64, P2915, DOI 10.1093/jxb/ert133; Liu XM, 2013, BIOCHEM BIOPH RES CO, V430, P1054, DOI 10.1016/j.bbrc.2012.12.039; Lu XD, 2012, J EXP BOT, V63, P5935, DOI 10.1093/jxb/ers243; Luo X, 2012, PLANTA, V235, P1141, DOI 10.1007/s00425-011-1563-0; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Nakai Y, 2013, PLANT J, V73, P761, DOI 10.1111/tpj.12069; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Ramel F, 2009, ANN BOT-LONDON, V104, P1323, DOI 10.1093/aob/mcp243; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Sperdouli I, 2012, J PLANT PHYSIOL, V169, P577, DOI 10.1016/j.jplph.2011.12.015; Sugano S, 2003, PLANT J, V36, P830, DOI 10.1046/j.1365-313X.2003.01924.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TAKATSUJI H, 1992, EMBO J, V11, P241, DOI 10.1002/j.1460-2075.1992.tb05047.x; TAKATSUJI H, 1994, PLANT CELL, V6, P947, DOI 10.1105/tpc.6.7.947; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tian ZD, 2010, PLANT BIOLOGY, V12, P689, DOI 10.1111/j.1438-8677.2009.00276.x; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; van der Krol AR, 1999, PLANT PHYSIOL, V121, P1153, DOI 10.1104/pp.121.4.1153; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu SM, 2007, PLANT CELL REP, V26, P497, DOI 10.1007/s00299-006-0248-9; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yue YS, 2012, J EXP BOT, V63, P3741, DOI 10.1093/jxb/ers069; Zhan XQ, 2012, P NATL ACAD SCI USA, V109, P18198, DOI 10.1073/pnas.1216199109; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	51	31	42	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109399	10.1371/journal.pone.0109399	http://dx.doi.org/10.1371/journal.pone.0109399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286048	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700062
J	Gu, N; Ma, XW; Zhang, JQ; Dong, AM; Jin, MM; Feng, N; Zhang, H; Guo, XH				Gu, Nan; Ma, Xiaowei; Zhang, Junqing; Dong, Aimei; Jin, Mengmeng; Feng, Nan; Zhang, Hong; Guo, Xiaohui			Obesity Has an Interactive Effect with Genetic Variation in the Activating Transcription Factor 6 Gene on the Risk of Pre-Diabetes in Individuals of Chinese Han Descent	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; POLYMORPHISMS; GLUCOSE; ASSOCIATION; HOMEOSTASIS; ATF6	Endoplasmic reticulum (ER) stress is one of the contributing factors to the development of b-cell failure in type 2 diabetes. ER stress response through ATF6 has been shown to play an important role in insulin resistance and pancreatic beta-cell function. We investigated whether genetic polymorphisms in ATF6 were associated with the risk of pre-diabetes in a Chinese Han population, and whether they had a synergistic effect with obesity. Our samples included 828 individuals who were diagnosed as pre-diabetic, and 620 controls. The minor allele A at rs2340721 was associated with increased risk for pre-diabetes(p = 0.013), and this association was still significant after adjusting for gender, age, body mass index (BMI), and waist-hip ratio (p' = 0.011). BMI, treated as a continuous variable, and rs2340721 had an interactive effect on pre-diabetic risk(p for interaction = 0.003, beta = 0.106). Carriers of GG at rs7522210 were also at a higher risk compared to non-carriers (OR = 1.390, 95%CI:1.2061.818, p = 0.013, adjusted OR' = 1.516, 95%CI:1.1012.006, p' = 0.006). GG homozygotes had increased fasting blood glucose (FBG) levels(GG vs CX: 5.6 +/- 0.52 vs 5.5 +/- 0.57 mmol/L, p = 0.016), lower insulin levels (0,30,120 minutes after glucose load) (p<0.05), and reduced areas under the insulin curve than non-carriers(GG vs CX:67.3(44.2102.3) vs 73.1(49.4111.4), p = 0.014). rs10918270 was associated with FBG, and rs4657103 with 2 hour glucose levels after a 75 g glucose load. We also identified a haplotype of TTAG composed of rs4657103, rs2134697, rs2340721, and rs12079579, which was associated with pre-diabetes. The genetic variation in ATF6 is associated with pre-diabetes and has interactive effects with BMI on pre-diabetes in the Chinese Han population.	[Gu, Nan; Ma, Xiaowei; Zhang, Junqing; Dong, Aimei; Jin, Mengmeng; Feng, Nan; Zhang, Hong; Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China	Peking University	Ma, XW (corresponding author), Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China.	mxiaowei@yahoo.com	FENG, NAN/HGD-3255-2022	Gu, Nan/0000-0001-9852-0060	National Natural Science Foundation of China [NSFC 30771033]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110001120047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (NSFC 30771033) and by Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110001120047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chu WS, 2007, DIABETES, V56, P856, DOI 10.2337/db06-1305; Das SK, 2006, DIABETES, V55, P2631, DOI 10.2337/db05-1369; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Hu C, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-3; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Meex SJR, 2007, J CLIN ENDOCR METAB, V92, P2720, DOI 10.1210/jc.2006-2280; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Teodoro T, 2012, AM J PHYSIOL-CELL PH, V302, pC992, DOI 10.1152/ajpcell.00160.2011; Thameem F, 2006, DIABETES, V55, P839, DOI 10.2337/diabetes.55.03.06.db05-1002; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	21	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109805	10.1371/journal.pone.0109805	http://dx.doi.org/10.1371/journal.pone.0109805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302688	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400080
J	Hussanan, A; Salleh, MZ; Tahar, RM; Khan, I				Hussanan, Abid; Salleh, Mohd Zuki; Tahar, Razman Mat; Khan, Ilyas			Unsteady Boundary Layer Flow and Heat Transfer of a Casson Fluid past an Oscillating Vertical Plate with Newtonian Heating	PLOS ONE			English	Article							SURFACE	In this paper, the heat transfer effect on the unsteady boundary layer flow of a Casson fluid past an infinite oscillating vertical plate with Newtonian heating is investigated. The governing equations are transformed to a systems of linear partial differential equations using appropriate non-dimensional variables. The resulting equations are solved analytically by using the Laplace transform method and the expressions for velocity and temperature are obtained. They satisfy all imposed initial and boundary conditions and reduce to some well-known solutions for Newtonian fluids. Numerical results for velocity, temperature, skin friction and Nusselt number are shown in various graphs and discussed for embedded flow parameters. It is found that velocity decreases as Casson parameters increases and thermal boundary layer thickness increases with increasing Newtonian heating parameter.	[Hussanan, Abid; Salleh, Mohd Zuki] Univ Malaysia Pahang, Fac Ind Sci & Technol, Futures & Trends Res Grp, Kuantan, Pahang, Malaysia; [Tahar, Razman Mat] Univ Malaysia Pahang, Fac Ind Management, Kuantan, Pahang, Malaysia; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia	Universiti Malaysia Pahang; Universiti Malaysia Pahang; Majmaah University	Khan, I (corresponding author), Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia.	ilyaskhanqau@yahoo.com	Hussanan, Abid/J-1817-2019; SALLEH, MOHD ZUKI/F-5440-2012; Khan, Ilyas/C-8770-2019	Hussanan, Abid/0000-0003-4545-3110; SALLEH, MOHD ZUKI/0000-0001-9732-9280; Khan, Ilyas/0000-0002-2056-9371	Universiti Malaysia Pahang, Malaysia [RDU121302, RDU131405]; Majmaah University Saudi Arabia	Universiti Malaysia Pahang, Malaysia; Majmaah University Saudi Arabia	The authors gratefully acknowledge the financial supports received from the Universiti Malaysia Pahang, Malaysia, through vote numbers RDU121302 and RDU131405. The corresponding author is also grateful to Majmaah University Saudi Arabia for the financial support through research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg OA., 2013, HEAT TRANSFER ASIAN, V2013, P1; Casson N., 1959, RHEOL DISPERSE SYST, P84; Chaudhary R. C., 2006, Romanian Journal of Physics, V51, P911; Das S., 2012, INT J COMPUTER APPL, V41, P36, DOI [10.5120/5605-7864, DOI 10.5120/5605-7864]; Ganesh S, 2014, INDIAN J RES, V2, P101; Hassan MA, 2013, J HEAT TRANSFER; Hayat T, 2008, J POROUS MEDIA, V11, P389, DOI 10.1615/JPorMedia.v11.i4.50; Hussanan A., 2013, J APPL MATH, V12, P1; Hussanan A, 2014, HEAT TRANSF RES, V45, P119, DOI 10.1615/HeatTransRes.2013006385; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; Jain Anjali, 2014, International Conference on Recent Advances and Innovations in Engineering (ICRAIE-2014), DOI 10.1109/ICRAIE.2014.6909144; Kasim A. R. M., 2012, WORLD ACAD SCI ENG T, V64, P628, DOI DOI 10.5281/ZENODO.1328964; Khan I, 2012, SPEC TOP REV POROUS, V3, P89, DOI 10.1615/SpecialTopicsRevPorousMedia.v3.i1.80; Khan I, 2014, B MALAYS MATH SCI SO, V37, P437; Khan I, 2013, Z NATURFORSCH A, V68, P635, DOI 10.5560/ZNA.2013-0040; KLEPPE J, 1972, J HEAT TRANSF, V94, P371, DOI 10.1115/1.3449954; Malik MY, 2014, APPL NANOSCI, V4, P869, DOI 10.1007/s13204-013-0267-0; Mebine P, 2009, TURK J PHYS, V33, P109, DOI 10.3906/fiz-0809-2; MERKIN JH, 1994, INT J HEAT FLUID FL, V15, P392, DOI 10.1016/0142-727X(94)90053-1; Mukhopadhyay S, 2014, CHINESE PHYS B; Mukhopadhyay S, 2013, CHINESE PHYS B; Mustafa M, 2011, HEAT TRANSFER ASIAN, P553; Narahari M., 2011, Journal of Applied Sciences, V11, P1096, DOI 10.3923/jas.2011.1096.1104; Olajuwon B.I., 2009, INT J NONLIN SCI NUM, V7, P50; Pramanik S, 2014, AIN SHAMS ENG J, V5, P205, DOI 10.1016/j.asej.2013.05.003; Qasim M, 2013, ALEX ENG J, V52, P571, DOI 10.1016/j.aej.2013.08.004; Qasim M, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14007-5; Salleh MZ, 2011, J ENG MATH, V69, P101, DOI 10.1007/s10665-010-9408-6; Salleh MZ, 2010, J TAIWAN INST CHEM E, V41, P651, DOI 10.1016/j.jtice.2010.01.013; Shehzad SA, 2013, BRAZ J CHEM ENG, V30, P187, DOI 10.1590/S0104-66322013000100020; Venkatesan J, 2013, J APPL MATH, DOI 10.1155/2013/583809; WANG CY, 1989, INT J HEAT FLUID FL, V10, P160, DOI 10.1016/0142-727X(89)90011-8; Zakaria MN, 2013, J TEKNOL, V62	33	72	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108763	10.1371/journal.pone.0108763	http://dx.doi.org/10.1371/journal.pone.0108763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302782	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400026
J	Lee, YK; Lee, HW; Choi, KH; Kim, BS				Lee, Yong Kyu; Lee, Hae Won; Choi, Kyu Hun; Kim, Beom Seok			Ability of Nafamostat Mesilate to Prolong Filter Patency during Continuous Renal Replacement Therapy in Patients at High Risk of Bleeding: A Randomized Controlled Study	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMOFILTRATION; REGIONAL CITRATE ANTICOAGULATION; MOLECULAR-WEIGHT HEPARIN; PROTEASE INHIBITOR; SYSTEMIC HEPARIN; HEMODIALYSIS; PHARMACOKINETICS; COAGULATION; MECHANISMS; PROTAMINE	Continuous renal replacement therapy (CRRT) is considered as an effective modality for renal replacement therapy in hemodynamically unstable patients within intensive care units (ICUs). However, the role of heparin anticoagulation, which is used to maintain circuit patency, is equivocal due to the risk of bleeding and morbidity. Among various alternative anticoagulants, nafamostat mesilate has been shown to be an effective anticoagulant in patients prone to bleeding. Hence, we conducted a prospective, randomized controlled study investigating the effect of nafamostat mesilate on mortality, CRRT filter life span and adverse events in patients with bleeding tendency. Seventy-three Patients were randomized into either the futhan or no-anticoagulation group. Thirty-six subjects in the futhan group received nafamostat mesilate, while thirty seven subjects in the no-anticoagulation group received no anticoagulants. Baseline characteristics and appropriate laboratory tests were taken from each group. The mortality between the two groups was not significantly different. Nevertheless, between the futhan group and the no-anticoagulation group, the overall number of filters used during CRRT (2.71 +/- 2.12 vs. 4.50 +/- 3.25; p = 0.042) and the number of filters changed due to clots per 24 hours (1.15 +/- 0.81 vs. 1.74 +/- 1.62; p = 0.040) were significantly different. When filter life span was subdivided into below and over 12 hours, the number of filters functioning over 12 hours was significantly higher in the futhan group than in the no-anticoagulation group (p = 0.037, odds ratio 1.84). There were no significant differences in transfusion, mortality, or survival between the two groups, and no adverse events related to nafamostat mesilate were noted. Hence, nafamostat mesilate may be used as an effective and safe anticoagulant, without increasing the risk of major bleeding complications, in patients prone to bleeding.	[Lee, Yong Kyu] Ilsan Hosp, Natl Hlth Inst Corp, Dept Internal Med, Div Nephrol, Goyang, South Korea; [Lee, Hae Won; Choi, Kyu Hun; Kim, Beom Seok] Yonsei Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea	NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System	Kim, BS (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea.	docbsk@yuhs.ac		Kim, Beom Seok/0000-0002-5732-2583; Choi, Kyu Hun/0000-0003-0095-9011	SK chemical, Seoul, Republic of Korea [NCT01761994]; faculty research grant of Yonsei University College of Medicine [2012(6-2012-0161)]	SK chemical, Seoul, Republic of Korea; faculty research grant of Yonsei University College of Medicine	This work was financially supported by SK chemical, Seoul, Republic of Korea (NCT01761994) and faculty research grant of Yonsei University College of Medicine for 2012(6-2012-0161). However, SK chemical and Yonsei University College of Medicine had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIZAWA T, 1993, NEPHRON, V64, P376, DOI 10.1159/000187357; Baek NN, 2012, RENAL FAILURE, V34, P279, DOI 10.3109/0886022X.2011.647293; Hetzel GR, 2011, NEPHROL DIAL TRANSPL, V26, P232, DOI 10.1093/ndt/gfq575; Higuchi N, 2000, NEPHRON, V86, P400, DOI 10.1159/000045822; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; HITOMI Y, 1985, HAEMOSTASIS, V15, P164; HORROW JC, 1985, ANESTH ANALG, V64, P348; Hwang SD, 2013, INT J ARTIF ORGANS, V36, P208, DOI [10.5301/ijao.5000191, 10.5301/IJAO.5000191]; JOURNOIS D, 1990, ANN FR ANESTH, V9, P331, DOI 10.1016/S0750-7658(05)80244-8; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kutsogiannis DJ, 2005, KIDNEY INT, V67, P2361, DOI 10.1111/j.1523-1755.2005.00342.x; Lindquist M, 2000, DRUG SAFETY, V23, P533, DOI 10.2165/00002018-200023060-00004; Maruyama Y, 2011, INT J ARTIF ORGANS, V34, P571, DOI 10.5301/IJAO.2011.8535; Meier-Kriesche H U, 1999, Am J Kidney Dis, V33, pe8, DOI 10.1016/S0272-6386(99)70249-0; Meier-Kriesche HU, 2001, CRIT CARE MED, V29, P748, DOI 10.1097/00003246-200104000-00010; Monchi M, 2004, INTENS CARE MED, V30, P260, DOI 10.1007/s00134-003-2047-x; Morabito S, 2012, CRIT CARE, V16, DOI 10.1186/cc11403; Nakae H, 2003, THER APHER DIAL, V7, P483, DOI 10.1046/j.1526-0968.2003.00088.x; National Cancer Institute NIoH, US DEP HLTH HUM SERV; OHTAKE Y, 1991, CONTRIB NEPHROL, V93, P215; OKADA H, 1992, NEPHROL DIAL TRANSPL, V7, P980, DOI 10.1093/ndt/7.9.980a; Ookawara S, 1996, EUR J CLIN PHARMACOL, V51, P149, DOI 10.1007/s002280050176; Oudemans-van Straaten HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11645; Oudemans-van Straaten HM, 2009, CRIT CARE MED, V37, P545, DOI 10.1097/CCM.0b013e3181953c5e; Reeves JH, 1999, CRIT CARE MED, V27, P2224, DOI 10.1097/00003246-199910000-00026; SCHETZ M, 1989, INTENS CARE MED, V15, P349; Tolwani A, 2012, AM J KIDNEY DIS, V59, P745, DOI 10.1053/j.ajkd.2012.03.003; Tolwani AJ, 2009, SEMIN DIALYSIS, V22, P141, DOI 10.1111/j.1525-139X.2008.00545.x; van der Voort PHJ, 2005, BLOOD PURIFICAT, V23, P175, DOI 10.1159/000083938; vandeWetering J, 1996, J AM SOC NEPHROL, V7, P145; Wu MY, 2012, AM J KIDNEY DIS, V59, P810, DOI 10.1053/j.ajkd.2011.11.030	31	26	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108737	10.1371/journal.pone.0108737	http://dx.doi.org/10.1371/journal.pone.0108737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302581	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400024
J	Frahm, GE; Smith, DGS; Kane, A; Lorbetskie, B; Cyr, TD; Girard, M; Johnston, MJW				Frahm, Grant E.; Smith, Daryl G. S.; Kane, Anita; Lorbetskie, Barry; Cyr, Terry D.; Girard, Michel; Johnston, Michael J. W.			Determination of Supplier-to-Supplier and Lot-to-Lot Variability in Glycation of Recombinant Human Serum Albumin Expressed in Oryza sativa	PLOS ONE			English	Article							FATTY-ACIDS; IN-VITRO; THERMAL-STABILITY; CRYSTAL-STRUCTURE; STABILIZATION; FLUORESCENCE; TRANSITIONS; LIPOSOMES; CHAIN	The use of different expression systems to produce the same recombinant human protein can result in expression-dependent chemical modifications (CMs) leading to variability of structure, stability and immunogenicity. Of particular interest are recombinant human proteins expressed in plant-based systems, which have shown particularly high CM variability. In studies presented here, recombinant human serum albumins (rHSA) produced in Oryza sativa (Asian rice) (OsrHSA) from a number of suppliers have been extensively characterized and compared to plasma-derived HSA (pHSA) and rHSA expressed in yeast (Pichia pastoris and Saccharomyces cerevisiae). The heterogeneity of each sample was evaluated using size exclusion chromatography (SEC), reversed-phase high-performance liquid chromatography (RP-HPLC) and capillary electrophoresis (CE). Modifications of the samples were identified by liquid chromatography-mass spectrometry (LC-MS). The secondary and tertiary structure of the albumin samples were assessed with far U/V circular dichroism spectropolarimetry (far U/V CD) and fluorescence spectroscopy, respectively. Far U/V CD and fluorescence analyses were also used to assess thermal stability and drug binding. High molecular weight aggregates in OsrHSA samples were detected with SEC and supplier-to-supplier variability and, more critically, lot-to-lot variability in one manufactures supplied products were identified. LC-MS analysis identified a greater number of hexose-glycated arginine and lysine residues on OsrHSA compared to pHSA or rHSA expressed in yeast. This analysis also showed supplier-to-supplier and lot-to-lot variability in the degree of glycation at specific lysine and arginine residues for OsrHSA. Both the number of glycated residues and the degree of glycation correlated positively with the quantity of non-monomeric species and the chromatographic profiles of the samples. Tertiary structural changes were observed for most OsrHSA samples which correlated well with the degree of arginine/lysine glycation. The extensive glycation of OsrHSA from multiple suppliers may have further implications for the use of OsrHSA as a therapeutic product.	[Frahm, Grant E.; Smith, Daryl G. S.; Kane, Anita; Lorbetskie, Barry; Cyr, Terry D.; Girard, Michel; Johnston, Michael J. W.] Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada	Health Canada	Johnston, MJW (corresponding author), Hlth Canada, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada.	michael.johnston@hc-sc.gc.ca			Government of Canada	Government of Canada(CGIAR)	This research is supported by the Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Anraku M, 2004, BBA-PROTEINS PROTEOM, V1702, P9, DOI 10.1016/j.bbapap.2004.07.002; Anraku M, 2001, PHARMACEUT RES, V18, P632, DOI 10.1023/A:1011029226072; Baraka-Vidot J, 2012, BIOCHIMIE, V94, P1960, DOI 10.1016/j.biochi.2012.05.017; Bechtold U, 2009, PLANT J, V59, P661, DOI 10.1111/j.1365-313X.2009.03898.x; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; Bojko B, 2008, INT J BIOL MACROMOL, V42, P314, DOI 10.1016/j.ijbiomac.2007.11.002; Cha SS, 1998, J BIOL CHEM, V273, P2153, DOI 10.1074/jbc.273.4.2153; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Chen Z, BIOCH BIOPHYSICA ACT; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; Digel I, 2006, BIOPHYS J, V91, P3014, DOI 10.1529/biophysj.106.087809; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Frahm GE, 2013, J LIPOSOME RES, V23, P101, DOI 10.3109/08982104.2012.747535; Frahm GE, 2012, J PHYS CHEM B, V116, P4661, DOI 10.1021/jp2125729; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Girard M, 1999, CHROMATOGRAPHIA, V49, pS21, DOI 10.1007/BF02468972; Girard M, 1997, J CHROMATOGR A, V772, P235, DOI 10.1016/S0021-9673(97)00099-X; Girard M., 1998, Biomedical Chromatography, V12, P183, DOI 10.1002/(SICI)1099-0801(199805/06)12:3<183::AID-BMC804>3.0.CO;2-X; GLATZ JFC, 1983, J BIOCHEM BIOPH METH, V8, P57, DOI 10.1016/0165-022X(83)90021-0; Hawe A, 2007, J PHARM SCI-US, V96, P2987, DOI 10.1002/jps.20909; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Hioki A, 2010, BIOL PHARM BULL, V33, P1466, DOI 10.1248/bpb.33.1466; InVitria, 2010, CELL PROD SPEC; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Johnston MJW, 2011, PHARM RES-DORDR, V28, P1661, DOI 10.1007/s11095-011-0402-0; Kang HA, 2000, APPL MICROBIOL BIOT, V53, P575, DOI 10.1007/s002530051659; Kessler M, 2006, NEPHROL DIAL TRANSPL, V21, P9, DOI 10.1093/ndt/gfl476; Kobayashi K, 2006, BIOLOGICALS, V34, P55, DOI 10.1016/j.biologicals.2005.08.021; Kobayashi K, 2000, J BIOSCI BIOENG, V89, P55, DOI 10.1016/S1389-1723(00)88050-0; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kuhlmann M, 2006, NEPHROL DIAL TRANSPL, V21, P4, DOI 10.1093/ndt/gfl474; Kuo YC, 2013, INT J MOL SCI, V14, P8719, DOI 10.3390/ijms14058719; Lautenslager GT, 2011, METABOLISM, V60, P1683, DOI 10.1016/j.metabol.2011.03.022; Leggio C, 2009, J PHYS CHEM B, V113, P12590, DOI 10.1021/jp904330v; Liu KS, 2011, J FOOD SCI, V76, pC334, DOI 10.1111/j.1750-3841.2010.02038.x; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Moriyama Y, 2003, J COLLOID INTERF SCI, V257, P41, DOI 10.1016/S0021-9797(02)00017-6; Moriyama Y, 2008, J PHYS CHEM B, V112, P16585, DOI 10.1021/jp8067624; Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338; Nakajou K, 2003, BBA-GEN SUBJECTS, V1623, P88, DOI 10.1016/j.bbagen.2003.08.001; OKABE N, 1994, BIOL PHARM BULL, V17, P16; Petrelli F, 2010, EXPERT OPIN PHARMACO, V11, P1413, DOI 10.1517/14656561003796562; Povey JF, 2008, J STRUCT BIOL, V161, P151, DOI 10.1016/j.jsb.2007.10.004; Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Shrake A, 2006, BIOPOLYMERS, V81, P235, DOI 10.1002/bip.20406; SPECTOR AA, 1968, ARCH BIOCHEM BIOPHYS, V127, P65, DOI 10.1016/0003-9861(68)90202-6; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; Steere AN, 2012, J INORG BIOCHEM, V116, P37, DOI 10.1016/j.jinorgbio.2012.07.005; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Vetter SW, 2011, CLIN CHIM ACTA, V412, P2105, DOI 10.1016/j.cca.2011.07.022; Webster DE, 2012, BIOTECHNOL ADV, V30, P410, DOI 10.1016/j.biotechadv.2011.07.015; Willuda J, 1999, CANCER RES, V59, P5758; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795; Yoshida S., 1981, FUNDAMENTALS RICE CR, P1; Zhu C, 2006, RUSS J PLANT PHYSL+, V53, P198, DOI 10.1134/S1021443706020087	59	9	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109893	10.1371/journal.pone.0109893	http://dx.doi.org/10.1371/journal.pone.0109893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299339	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200085
J	Luo, JM; Bai, YH; Liang, JS; Qu, JH				Luo, Jinming; Bai, Yaohui; Liang, Jinsong; Qu, Jiuhui			Metagenomic Approach Reveals Variation of Microbes with Arsenic and Antimony Metabolism Genes from Highly Contaminated Soil	PLOS ONE			English	Article							ACTIVATED-SLUDGE; OXIDATION; REDUCTION; BACTERIA; INSIGHTS; DETOXIFICATION; FERRIHYDRITE; DIVERSITY	Microbes have great potential for arsenic (As) and antimony (Sb) bioremediation in heavily contaminated soil because they have the ability to biotransform As and Sb to species that have less toxicity or are more easily removed. In this study, we integrated a metagenomic method with physicochemical characterization to elucidate the composition of microbial community and functional genes (related to As and Sb) in a high As (range from 34.11 to 821.23 mg kg(-1)) and Sb (range from 226.67 to 3923.07 mg kg(-1)) contaminated mine field. Metagenomic analysis revealed that microbes from 18 phyla were present in the 5 samples of soil contaminated with high As and Sb. Moreover, redundancy analysis (RDA) of the relationship between the 18 phyla and the concentration of As and Sb demonstrated that 5 phyla of microbes, i.e. Actinobacteria, Firmicutes, Nitrospirae, Tenericutes and Gemmatimonadetes were positively correlated with As and Sb concentration. The distribution, diversity and abundance of functional genes (including arsC, arrA, aioA, arsB and ACR3) were much higher for the samples containing higher As and Sb concentrations. Based on correlation analysis, the results showed a positive relationship between arsC-like (R-2 = 0.871) and aioA-like (R-2 = 0.675) gene abundance and As concentration, and indicated that intracellular As(V) reduction and As(III) oxidation could be the dominant As detoxification mechanism enabling the microbes to survive in the environment. This study provides a direct and reliable reference on the diversity of microbial community and functional genes in an extremely high concentration As- and Sb-contaminated environment.	[Luo, Jinming; Bai, Yaohui; Liang, Jinsong; Qu, Jiuhui] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Key Lab Drinking Water Sci & Technol, Beijing, Peoples R China; [Luo, Jinming; Liang, Jinsong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Qu, JH (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Key Lab Drinking Water Sci & Technol, POB 934, Beijing, Peoples R China.	jhqu@rcees.ac.cn	Luo, Jinming/AAH-1577-2020; Wenxiang, HE/V-6488-2017; liang, jinsong/AAP-5012-2021	Luo, Jinming/0000-0001-8698-7624; 	Major Program of the National Natural Science Foundation of China [51290282]; National High Technology Research and Development Program of China [2012AA062604]	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is financially supported by the Major Program of the National Natural Science Foundation of China (No. 51290282) and National High Technology Research and Development Program of China (No. 2012AA062604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Bertin PN, 2011, ISME J, V5, P1735, DOI 10.1038/ismej.2011.51; Cai L, 2013, APPL MICROBIOL BIOT, V97, P9579, DOI 10.1007/s00253-012-4678-8; Cavalca L, 2013, FUTURE MICROBIOL, V8, P753, DOI [10.2217/FMB.13.38, 10.2217/fmb.13.38]; Chen J, 2013, APPL ENVIRON MICROB, V79, P4493, DOI 10.1128/AEM.01133-13; China SEPAo, 1989, MON AN METH WAT WAST; Cutter GA, 2001, DEEP-SEA RES PT II, V48, P2895, DOI 10.1016/S0967-0645(01)00023-6; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Filella M, 2007, EARTH-SCI REV, V80, P195, DOI 10.1016/j.earscirev.2006.09.003; Flynn HC, 2003, ENVIRON POLLUT, V124, P93, DOI 10.1016/S0269-7491(02)00411-6; GREEN H. H., 1919, Union S. Africa Dept. Agrie. 5th and 6th Repts. Direc. Vet. Research, April 1918., P595; Handley KM, 2009, ENVIRON MICROBIOL, V11, P1601, DOI 10.1111/j.1462-2920.2009.01890.x; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Ito A, 2012, WATER RES, V46, P4825, DOI 10.1016/j.watres.2012.06.013; Jackson CR, 2005, SOIL BIOL BIOCHEM, V37, P2319, DOI 10.1016/j.soilbio.2005.04.010; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Lehr CR, 2007, APPL ENVIRON MICROB, V73, P2386, DOI 10.1128/AEM.02789-06; Leps J, 2003, MULTIVARIATE ANAL EC; Li J, 2013, INT BIODETER BIODEGR, V76, P76, DOI 10.1016/j.ibiod.2012.06.009; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Marcovecchio J.E., 2007, HDB WATER ANAL, V2, P275; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Plewniak F, 2013, MOL ECOL, V22, P4870, DOI 10.1111/mec.12432; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Raven KP, 1998, ENVIRON SCI TECHNOL, V32, P344, DOI 10.1021/es970421p; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Wang QS, 2011, ECOTOXICOLOGY, V20, P9, DOI 10.1007/s10646-010-0551-7; Wang X, 2012, ENVIRON SCI TECHNOL, V46, P11259, DOI 10.1021/es300454b; WAYCHUNAS GA, 1993, GEOCHIM COSMOCHIM AC, V57, P2251, DOI 10.1016/0016-7037(93)90567-G; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Yin XX, 2011, PLANT PHYSIOL, V156, P1631, DOI 10.1104/pp.111.178947; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200; Zobrist J, 2000, ENVIRON SCI TECHNOL, V34, P4747, DOI 10.1021/es001068h	49	126	135	5	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108185	10.1371/journal.pone.0108185	http://dx.doi.org/10.1371/journal.pone.0108185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299175	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200011
J	Pierdominici-Sottile, G; Perez, RC; Galindo, JF; Palma, J				Pierdominici-Sottile, Gustavo; Cossio Perez, Rodrigo; Galindo, Johan F.; Palma, Juliana			QM/MM Molecular Dynamics Study of the Galactopyranose -> Galactofuranose Reaction Catalysed by Trypanosoma cruzi UDP-Galactopyranose Mutase	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; POLYSACCHARIDE CHAIN; REACTION-MECHANISM; CHAGAS-DISEASE; BIOSYNTHESIS; ANTIGEN; BINDING; INTERMEDIATE; METABOLISM; SIMULATION	The enzyme UDP-Galactopyranose Mutase (UGM) catalyses the conversion of galactopyranose into galactofuranose. It is known to be critical for the survival and proliferation of several pathogenic agents, both prokaryotic and eukaryotic. Among them is Trypanosoma cruzi, the parasite responsible for Chagas' disease. Since the enzyme is not present in mammals, it appears as a promising target for the design of drugs to treat this illness. A precise knowledge of the mechanism of the catalysed reaction would be crucial to assist in such design. In this article we present a detailed study of all the putative steps of the mechanism. The study is based on QM/MM free energy calculations along properly selected reaction coordinates, and on the analysis of the main structural changes and interactions taking place at every step. The results are discussed in connection with the experimental evidence and previous theoretical studies.	[Pierdominici-Sottile, Gustavo; Cossio Perez, Rodrigo; Palma, Juliana] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Bernal, Argentina; [Galindo, Johan F.] Univ Nacl Colombia, Dept Quim, Quantum & Computat Chem Grp, Bogota, Colombia	Universidad Nacional de Colombia	Pierdominici-Sottile, G (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, Bernal, Argentina.	gsottile@unq.edu.ar	Palma, Juliana/J-4386-2019; Palma, Juliana/AAG-4492-2020	Palma, Juliana/0000-0002-0761-0253; Galindo, Johan/0000-0001-9968-362X; Pierdominici-Sottile, Gustavo/0000-0003-3792-4509; Cossio-Perez, Rodrigo/0000-0002-4407-7179	CONICET; Universidad de Quilmes; Agencia Nacional de Promocion Cientifica y Tecnologica for the University of Quilmes [2597]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Quilmes; Agencia Nacional de Promocion Cientifica y Tecnologica for the University of Quilmes	This work was mainly supported by CONICET and Universidad de Quilmes. A part of this work was supported by the grant pict 2010-#2597 of the Agencia Nacional de Promocion Cientifica y Tecnologica for the University of Quilmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED Z, 1993, PHYS REV A, V47, P4761, DOI 10.1103/PhysRevA.47.4761; ALMEIDA IC, 1994, BRAZ J MED BIOL RES, V27, P443; Barlow JN, 1999, J AM CHEM SOC, V121, P6968, DOI 10.1021/ja991582r; Barnett CB, 2010, J PHYS CHEM B, V114, P17142, DOI 10.1021/jp107620h; Beis K, 2005, J MOL BIOL, V348, P971, DOI 10.1016/j.jmb.2005.02.057; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; BERST M, 1969, EUR J BIOCHEM, V11, P353, DOI 10.1111/j.1432-1033.1969.tb00779.x; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Biarnes X, 2007, J AM CHEM SOC, V129, P10686, DOI 10.1021/ja068411o; Boechi L, 2013, PROTEIN SCI, V22, P1490, DOI 10.1002/pro.2332; Case DA, 2012, AMBER 12, V12, P142; Chad JM, 2007, BIOCHEMISTRY-US, V46, P6723, DOI 10.1021/bi7002795; Chatfield DC, 1998, THEOCHEM-J MOL STRUC, V423, P79, DOI 10.1016/S0166-1280(96)04875-0; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Cunningham MA, 1997, BIOCHEMISTRY-US, V36, P4800, DOI 10.1021/bi962734n; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; DAVENPORT RC, 1991, BIOCHEMISTRY-US, V30, P5821, DOI 10.1021/bi00238a002; Dhatwalia R, 2012, BIOCHEMISTRY-US, V51, P4968, DOI 10.1021/bi300498c; Dhatwalia R, 2012, J BIOL CHEM, V287, P9041, DOI 10.1074/jbc.M111.327536; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; DMITRIEV BA, 1977, CARBOHYD RES, V56, P207, DOI 10.1016/S0008-6215(00)84257-3; Dykhuizen EC, 2008, J AM CHEM SOC, V130, P6706, DOI 10.1021/ja8018687; Ferguson MAJ, 1997, PHILOS T ROY SOC B, V352, P1295, DOI 10.1098/rstb.1997.0113; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; Hensen C, 2004, J MED CHEM, V47, P6673, DOI 10.1021/jm0497343; Himo F, 2006, THEOR CHEM ACC, V116, P232, DOI 10.1007/s00214-005-0012-1; Huang WJ, 2012, J PHYS CHEM B, V116, P14040, DOI 10.1021/jp310952c; Huang ZH, 2003, BIOORG CHEM, V31, P494, DOI 10.1016/j.bioorg.2003.08.002; Issa VS, 2010, LANCET, V376, P768, DOI 10.1016/S0140-6736(10)61372-4; JANN B, 1994, CARBOHYD RES, V264, P305, DOI 10.1016/S0008-6215(05)80014-X; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kizjakina K, 2013, CURR PHARM DESIGN, V19, P2561, DOI 10.2174/1381612811319140007; KOL O, 1991, CARBOHYD RES, V217, P117, DOI 10.1016/0008-6215(91)84122-U; Kruger T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1871913; Kruger T, 2005, J CHEM PHYS, V122; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEE FS, 1992, PROTEIN ENG, V5, P215, DOI 10.1093/protein/5.3.215; Lin YL, 2010, BIOCHEMISTRY-US, V49, P84, DOI 10.1021/bi901790e; MacRae JI, 2006, MOL BIOCHEM PARASIT, V147, P126, DOI 10.1016/j.molbiopara.2006.02.011; Major DT, 2006, J AM CHEM SOC, V128, P16345, DOI 10.1021/ja066334r; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; NIKAIDO H, 1971, J BACTERIOL, V105, P1073, DOI 10.1128/JB.105.3.1073-1082.1971; Oppenheimer M, 2011, ENZYME RES, V2011; Oppenheimer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032918; Partha SK, 2010, J MOL BIOL, V403, P578, DOI 10.1016/j.jmb.2010.08.053; Partha SK, 2009, J MOL BIOL, V394, P864, DOI 10.1016/j.jmb.2009.10.013; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Pierdominici-Sottile G, 2008, CHEM PHYS LETT, V456, P243, DOI 10.1016/j.cplett.2008.03.023; Pierdominici-Sottile G, 2014, PROTEINS, V82, P424, DOI 10.1002/prot.24408; RALTON JE, 1993, J BIOL CHEM, V268, P24183; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Sun HG, 2012, J BIOL CHEM, V287, P4602, DOI 10.1074/jbc.M111.312538; Tanner JJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P128, DOI 10.1016/j.abb.2013.09.017; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; TEIXEIRA ARL, 1990, AM J TROP MED HYG, V43, P146, DOI 10.4269/ajtmh.1990.43.146; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; TURCO SJ, 1989, J BIOL CHEM, V264, P6711; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; van Straaten KE, 2012, ACTA CRYSTALLOGR F, V68, P455, DOI 10.1107/S1744309112006914; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Woodcock HL, 2007, J PHYS CHEM A, V111, P5720, DOI 10.1021/jp0714217; Yuan Y, 2008, J AM CHEM SOC, V130, P3157, DOI 10.1021/ja7104152	69	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109559	10.1371/journal.pone.0109559	http://dx.doi.org/10.1371/journal.pone.0109559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299056	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200058
J	Jonker, JL; Abram, F; Pires, E; Coelho, AV; Grunwald, I; Power, AM				Jonker, Jaimie-Leigh; Abram, Florence; Pires, Elisabete; Coelho, Ana Varela; Grunwald, Ingo; Power, Anne Marie			Adhesive Proteins of Stalked and Acorn Barnacles Display Homology with Low Sequence Similarities	PLOS ONE			English	Article							CEMENT PROTEINS; LEPAS-ANATIFERA; MUSSEL; SPECTROSCOPY; PLAQUE; DOPA; EXPRESSION; BONDS; GENE	Barnacle adhesion underwater is an important phenomenon to understand for the prevention of biofouling and potential biotechnological innovations, yet so far, identifying what makes barnacle glue proteins 'sticky' has proved elusive. Examination of a broad range of species within the barnacles may be instructive to identify conserved adhesive domains. We add to extensive information from the acorn barnacles (order Sessilia) by providing the first protein analysis of a stalked barnacle adhesive, Lepas anatifera (order Lepadiformes). It was possible to separate the L. anatifera adhesive into at least 10 protein bands using SDS-PAGE. Intense bands were present at approximately 30, 70, 90 and 110 kilodaltons (kDa). Mass spectrometry for protein identification was followed by de novo sequencing which detected 52 peptides of 7-16 amino acids in length. None of the peptides matched published or unpublished transcriptome sequences, but some amino acid sequence similarity was apparent between L. anatifera and closely-related Dosima fascicularis. Antibodies against two acorn barnacle proteins (ab-cp-52k and ab-cp-68k) showed cross-reactivity in the adhesive glands of L. anatifera. We also analysed the similarity of adhesive proteins across several barnacle taxa, including Pollicipes pollicipes (a stalked barnacle in the order Scalpelliformes). Sequence alignment of published expressed sequence tags clearly indicated that P. pollicipes possesses homologues for the 19 kDa and 100 kDa proteins in acorn barnacles. Homology aside, sequence similarity in amino acid and gene sequences tended to decline as taxonomic distance increased, with minimum similarities of 18-26%, depending on the gene. The results indicate that some adhesive proteins (e. g. 100 kDa) are more conserved within barnacles than others (20 kDa).	[Jonker, Jaimie-Leigh; Abram, Florence; Power, Anne Marie] Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland; [Pires, Elisabete; Coelho, Ana Varela] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Grunwald, Ingo] Fraunhofer Inst Mfg Technol & Adv Mat, Dept Adhes Bonding & Surfaces, Bremen, Germany	Ollscoil na Gaillimhe-University of Galway; Universidade Nova de Lisboa; Fraunhofer Gesellschaft	Power, AM (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland.	annemarie.power@nuigalway.ie	abram, florence/K-6639-2015; Coelho, Ana V/H-8885-2012; Coelho, Ana V Varela/O-3977-2014; Grunwald, Ingo/C-5662-2012	abram, florence/0000-0001-7522-9158; Coelho, Ana V/0000-0002-6143-4203; Coelho, Ana V Varela/0000-0002-6143-4203; Pires, Elisabete/0000-0001-8646-062X; Power, Anne Marie/0000-0001-7351-2451	Science Foundation Ireland [09RFPMTR2311]; Department of Communications, Marine and Natural Resources, Government of Ireland; European Cooperation in the field of Scientific and Technical Research [TD0906]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Communications, Marine and Natural Resources, Government of Ireland; European Cooperation in the field of Scientific and Technical Research(European Cooperation in Science and Technology (COST))	Funding was provided by Science Foundation Ireland Contract grant number 09RFPMTR2311 awarded to AMP (http://www.sfi.ie/), and Beaufort Marine Research Awards grant-aided by the Department of Communications, Marine and Natural Resources, Government of Ireland, awarded to AMP and co-Pls. Work was also supported by European Cooperation in the field of Scientific and Technical Research (COST Action TD0906). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson KE, 1998, BIOL BULL, V194, P150, DOI 10.2307/1543045; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; BAINBRIDGE V., 1966, P67; Barlow DE, 2012, ANNU REV ANAL CHEM, V5, P229, DOI 10.1146/annurev-anchem-061010-113844; BARNES H, 1976, J EXP MAR BIOL ECOL, V25, P263, DOI 10.1016/0022-0981(76)90128-3; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Benaziz L, 2001, J COLLOID INTERF SCI, V238, P48, DOI 10.1006/jcis.2001.7450; Berglin M, 2003, COLLOID SURFACE B, V28, P107, DOI 10.1016/S0927-7765(02)00149-2; Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Endrizzi BJ, 2009, J ADHESION, V85, P546, DOI 10.1080/00218460902996457; Flammang P, 2006, BIOL ADHEISVES; Flammang P, 2009, J ADHESION, V85, P447, DOI 10.1080/00218460902996358; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; He LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064130; Holowka EP, 2010, MACROMOL BIOSCI, V10, P496, DOI 10.1002/mabi.200900390; Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028; Hwang DS, 2007, J BIOTECHNOL, V127, P727, DOI 10.1016/j.jbiotec.2006.08.005; Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039; INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698; Jonker J-L, 2013, NATURAL ADHESIVE GOO; Jonker JL, 2012, J MORPHOL, V273, P1377, DOI 10.1002/jmor.20067; Kamino K, 1998, NEW DEVELOPMENTS IN MARINE BIOTECHNOLOGY, P77; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 1996, BIOL BULL, V190, P403, DOI 10.2307/1543033; Kamino K., 2013, STRUCTURAL INTERFACE, P175, DOI [DOI 10.1007/978-1-4614-3317-0_9, 10.1007/978-1-4614-3317-0_9]; Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3; Kamino K, 2006, BIOLOGICAL ADHESIVES, P145, DOI 10.1007/978-3-540-31049-5_8; Kamino K, 2012, FEBS J, V279, P1750, DOI 10.1111/j.1742-4658.2012.08552.x; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Lin HC, 2013, BIOFOULING; Lin HC, 2014, BIOFOULING, V30, P169, DOI 10.1080/08927014.2013.853051; McEvilly P, 2011, LEPAS ANATIFERA CONC; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mori Y, 2007, FEBS J, V274, P6436, DOI 10.1111/j.1742-4658.2007.06161.x; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; NALDRETT MJ, 1993, J MAR BIOL ASSOC UK, V73, P689, DOI 10.1017/S0025315400033221; Naldrett MJ, 1997, MAR BIOL, V127, P629, DOI 10.1007/s002270050053; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ohkawa K, 2009, J ADHESION, V85, P770, DOI 10.1080/00218460903291353; PARKER JH, 1967, PHYS REV, V155, P712, DOI 10.1103/PhysRev.155.712; Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458; Perez-Losada M, 2008, MOL PHYLOGENET EVOL, V46, P328, DOI 10.1016/j.ympev.2007.10.004; Pilson M.E.Q., 2013, INTRO CHEM SEA, Vsecond, P248, DOI [10.5670/oceanog.2014.31, DOI 10.5670/OCEANOG.2014.31]; Power AM, 2001, ESTUAR COAST SHELF S, V52, P349, DOI 10.1006/ecss.2000.0711; Power AM, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P153, DOI 10.1007/978-3-7091-0286-2_9; Raman S, 2013, INT J ADHES ADHES, V41, P140, DOI 10.1016/j.ijadhadh.2012.11.003; Schweitzer-Stenner R, 2001, J RAMAN SPECTROSC, V32, P711, DOI 10.1002/jrs.757; SNELI JA, 1983, CRUSTACEANA, V45, P306, DOI 10.1163/156854083X00352; Stewart RJ, 2004, J EXP BIOL, V207, P4727, DOI 10.1242/jeb.01330; Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d; Suzuki R, 2005, J BIOMOL NMR, V32, P257, DOI 10.1007/s10858-005-7029-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s; Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; WALKER G, 1987, SYNTHETIC ADHESIVES, P112; Wiegemann M, 2006, MAR BIOL, V149, P241, DOI 10.1007/s00227-005-0219-7; Wolpert M, 2006, SPECTROCHIM ACTA A, V64, P987, DOI 10.1016/j.saa.2005.08.025; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200; Zheden V, 2014, BIOFOULING; Zheden V, 2012, BIOL BULL-US, V223, P192, DOI 10.1086/BBLv223n2p192	65	18	18	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108902	10.1371/journal.pone.0108902	http://dx.doi.org/10.1371/journal.pone.0108902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295513	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000026
J	Spitz, A; Horvat, EA				Spitz, Andreas; Horvat, Emoeke-Agnes			Measuring Long-Term Impact Based on Network Centrality: Unraveling Cinematic Citations	PLOS ONE			English	Article							SOCIAL NETWORK; EVOLUTION; DYNAMICS; EMERGENCE; ART	Traditional measures of success for film, such as box-office revenue and critical acclaim, lack the ability to quantify long-lasting impact and depend on factors that are largely external to the craft itself. With the growing number of films that are being created and large-scale data becoming available through crowd-sourced online platforms, an endogenous measure of success that is not reliant on manual appraisal is of increasing importance. In this article we propose such a ranking method based on a combination of centrality indices. We apply the method to a network that contains several types of citations between more than 40,000 international feature films. From this network we derive a list of milestone films, which can be considered to constitute the foundations of cinema. In a comparison to various existing lists of 'greatest' films, such as personal favourite lists, voting lists, lists of individual experts, and lists deduced from expert polls, the selection of milestone films is more diverse in terms of genres, actors, and main creators. Our results shed light on the potential of a systematic quantitative investigation based on cinematic influences in identifying the most inspiring creations in world cinema. In a broader perspective, we introduce a novel research question to large-scale citation analysis, one of the most intriguing topics that have been at the forefront of scientific enquiries for the past fifty years and have led to the development of various network analytic methods. In doing so, we transfer widely studied approaches from citation analysis to the the newly emerging field of quantification efforts in the arts. The specific contribution of this paper consists in modelling the multidimensional cinematic references as a growing multiplex network and in developing a methodology for the identification of central films in this network.	[Spitz, Andreas; Horvat, Emoeke-Agnes] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Horvat, Emoeke-Agnes] Northwestern Univ, NICO, Evanston, IL USA	Ruprecht Karls University Heidelberg; Northwestern University	Horvat, EA (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany.	a-horvat@northwestern.edu			MFG Stiftung Baden-Wuerttemberg, Germany; Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany - German Excellence Initiative [GSC 220]; Northwestern Institute on Complex Systems	MFG Stiftung Baden-Wuerttemberg, Germany; Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany - German Excellence Initiative; Northwestern Institute on Complex Systems	This research was funded by the MFG Stiftung Baden-Wuerttemberg, Germany through a Karl Steinbuch Scholarship. The publication fee was covered by the Northwestern Institute on Complex Systems. EAH was supported by the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, University of Heidelberg, Germany, which is funded by the German Excellence Initiative (GSC 220), and by the Northwestern Institute on Complex Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Atkinson M, 2012, LISTOMANIA SIGHT SOU; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baxandall Michael., 1985, PATTERNS INTENTION H, P77; Boatwright P, 2007, QME-QUANT MARK ECON, V5, P401, DOI 10.1007/s11129-007-9029-1; Bordwell David, 1997, HIST FILM STYLE; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; Csardi G, 2007, PHYSICA A, V374, P783, DOI 10.1016/j.physa.2006.08.022; Davis DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022670; De Vany A, 2011, HOLLYWOOD EC EXTREME; Doshi L, 2010, PROCD SOC BEHV, V2, P6423, DOI 10.1016/j.sbspro.2010.04.052; Egghe L, 1990, INTRO INFORM, P203; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Fowler JH, 2008, SOC NETWORKS, V30, P16, DOI 10.1016/j.socnet.2007.05.001; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Gemser G, 2007, J CULT ECON, V31, P43, DOI 10.1007/s10824-006-9025-4; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Grindrod P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046120; Hidalgo CA, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/4/052; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Holbrook MB, 1999, J CONSUM RES, V26, P144, DOI 10.1086/209556; Holbrook MB, 2008, J CULT ECON, V32, P87, DOI 10.1007/s10824-007-9059-2; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Leicht EA, 2007, EUR PHYS J B, V59, P75, DOI 10.1140/epjb/e2007-00271-7; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Magnani M, 2011, 2011 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2011), P5, DOI 10.1109/ASONAM.2011.114; McCusker JJ, 1992, MUCH IS REAL MONEY H; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Neville J., P 9 ACM SIGKDD INT C, P625; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; PADGETT JF, 1993, AM J SOCIOL, V98, P1259, DOI 10.1086/230190; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pardoe I, 2008, J R STAT SOC A STAT, V171, P375, DOI 10.1111/j.1467-985X.2007.00518.x; Peterson GJ, 2010, P NATL ACAD SCI USA, V107, P16023, DOI 10.1073/pnas.1010757107; PRICE DJD, 1965, SCIENCE, V149, P510; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2012, UNDERST COMPLEX SYST, P233, DOI 10.1007/978-3-642-23068-4_7; See L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069958; Sreenivasan S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02758; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; The Internet Movie Database (IMDb), ALT INT; Thompson K., 2019, FILM HIST INTRO; Trajtenberg, 2002, PATENTS CITATIONS IN, DOI 10.7551/mitpress/5263.001.0001; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wasserman M, 2014, J ASS INFORM SCI TEC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	56	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108857	10.1371/journal.pone.0108857	http://dx.doi.org/10.1371/journal.pone.0108857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295877	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000022
J	Fortunato, TM; Vara, DS; Wheeler-Jones, CP; Pula, G				Fortunato, Tiago M.; Vara, Dina S.; Wheeler-Jones, Caroline P.; Pula, Giordano			Expression of Protease-Activated Receptor 1 and 2 and Anti-Tubulogenic Activity of Protease-Activated Receptor 1 in Human Endothelial Colony-Forming Cells	PLOS ONE			English	Article							PROGENITOR CELLS; UP-REGULATION; MOLECULAR-CLONING; PAR-1 ACTIVATION; GENE-EXPRESSION; IN-VITRO; THROMBIN; VASCULOGENESIS; ANGIOGENESIS; INCREASES	Endothelial colony-forming cells (ECFCs) are obtained from the culture of human peripheral blood mononuclear cell (hPBMNC) fractions and are characterised by high proliferative and pro-vasculogenic potential, which makes them of great interest for cell therapy. Here, we describe the detection of protease-activated receptor (PAR) 1 and 2 amongst the surface proteins expressed in ECFCs. Both receptors are functionally coupled to extracellular signal-regulated kinase (ERK) 1 and 2, which become activated and phosphorylated in response to selective PAR1- or PAR2-activating peptides. Specific stimulation of PAR1, but not PAR2, significantly inhibits capillary-like tube formation by ECFCs in vitro, suggesting that tubulogenesis is negatively regulated by proteases able to stimulate PAR1 (e.g. thrombin). The activation of ERKs is not involved in the regulation of tubulogenesis in vitro, as suggested by use of the MEK inhibitor PD98059 and by the fact that PAR2 stimulation activates ERKs without affecting capillary tube formation. Both qPCR and immunoblotting showed a significant downregulation of vascular endothelial growth factor 2 (VEGFR2) in response to PAR1 stimulation. Moreover, the addition of VEGF (50-100 ng/ml) but not basic Fibroblast Growth Factor (FGF) (25-100 ng/ml) rescued tube formation by ECFCs treated with PAR1-activating peptide. Therefore, we propose that reduction of VEGF responsiveness resulting from down-regulation of VEGFR2 is underlying the anti-tubulogenic effect of PAR1 activation. Although the role of PAR2 remains elusive, this study sheds new light on the regulation of the vasculogenic activity of ECFCs and suggests a potential link between adult vasculogenesis and the coagulation cascade.	[Fortunato, Tiago M.; Vara, Dina S.; Pula, Giordano] Univ Bath, Dept Pharm & Pharmacol, Bath Spa, England; [Wheeler-Jones, Caroline P.] Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, London, England	University of Bath; University of London; University of London Royal Veterinary College	Pula, G (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath Spa, England.	G.Pula@bath.ac.uk	Vara, Dina/W-6349-2019; Pula, Giordano/ABE-8596-2020	Vara, Dina/0000-0002-3099-6748	Royal Society [RG120494]; BBSRC [BB/J002690/1]; Biotechnology and Biological Sciences Research Council [BB/J002690/1] Funding Source: researchfish	Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Royal Society provided funds for the reagents utilized for this study (grant number RG120494), whereas BBSRC provided funds for the salary of DV (grant number BB/J002690/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2012, N-S ARCH PHARMACOL, V385, P861, DOI 10.1007/s00210-012-0783-6; Banfi C, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2008.03204.x; Bennis Y, 2012, J THROMB HAEMOST, V10, P1914, DOI 10.1111/j.1538-7836.2012.04835.x; Benslimane-Ahmim Z, 2011, J THROMB HAEMOST, V9, P834, DOI 10.1111/j.1538-7836.2011.04207.x; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Camerer E, 1996, J BIOL CHEM, V271, P29034, DOI 10.1074/jbc.271.46.29034; Camerer E, 2002, J BIOL CHEM, V277, P16081, DOI 10.1074/jbc.M108555200; Chan B, 2003, MICROVASC RES, V66, P1, DOI 10.1016/S0026-2862(03)00037-2; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Critser PJ, 2010, CURR OPIN ORGAN TRAN, V15, P68, DOI 10.1097/MOT.0b013e32833454b5; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; Drake CJ, 2000, DEV BIOL, V224, P178, DOI 10.1006/dbio.2000.9744; Evrard SM, 2012, J THROMB HAEMOST, V10, P670, DOI 10.1111/j.1538-7836.2012.04644.x; Hamilton JR, 2001, J CARDIOVASC PHARM, V38, P108, DOI 10.1097/00005344-200107000-00012; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Ritchie E, 2007, BRIT J PHARMACOL, V150, P1044, DOI 10.1038/sj.bjp.0707150; Sbaa E, 2006, CIRC RES, V98, P1219, DOI 10.1161/01.RES.0000220648.80170.8b; Smadja DM, 2007, J CELL MOL MED, V11, P1149, DOI 10.1111/j.1582-4934.2007.00090.x; Smadja DM, 2011, ANGIOGENESIS, V14, P17, DOI 10.1007/s10456-010-9192-y; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Smadja DM, 2009, J CELL MOL MED, V13, P2534, DOI 10.1111/j.1582-4934.2008.00429.x; Smadja DM, 2005, ARTERIOSCL THROM VAS, V25, P2321, DOI 10.1161/01.ATV.0000184762.63888.bd; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Tarzami ST, 2006, J THROMB HAEMOST, V4, P656, DOI 10.1111/j.1538-7836.2006.01788.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Zhou Z, 2007, MOL CANCER RES, V5, P1125, DOI 10.1158/1541-7786.MCR-07-0174	38	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109375	10.1371/journal.pone.0109375	http://dx.doi.org/10.1371/journal.pone.0109375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289673	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000342798000056
J	Jackson, AR; Shah, A; Kumar, A				Jackson, Austin R.; Shah, Ankit; Kumar, Anil			Methamphetamine Alters the Normal Progression by Inducing Cell Cycle Arrest in Astrocytes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GP120 TRANSGENIC MICE; HIV-1 GP120; DNA-DAMAGE; OXIDATIVE STRESS; BRAIN; ASTROGLIOSIS; INFECTION; APOPTOSIS; STRIATUM	Methamphetamine (MA) is a potent psychostimulant with a high addictive capacity, which induces many deleterious effects on the brain. Chronic MA abuse leads to cognitive dysfunction and motor impairment. MA affects many cells in the brain, but the effects on astrocytes of repeated MA exposure is not well understood. In this report, we used Gene chip array to analyze the changes in the gene expression profile of primary human astrocytes treated with MA for 3 days. Range of genes were found to be differentially regulated, with a large number of genes significantly downregulated, including NEK2, TTK, TOP2A, and CCNE2. Gene ontology and pathway analysis showed a highly significant clustering of genes involved in cell cycle progression and DNA replication. Further pathway analysis showed that the genes downregulated by multiple MA treatment were critical for G2/M phase progression and G1/S transition. Cell cycle analysis of SVG astrocytes showed a significant reduction in the percentage of cell in the G2/M phase with a concomitant increase in G1 percentage. This was consistent with the gene array and validation data, which showed that repeated MA treatment downregulated the genes associated with cell cycle regulation. This is a novel finding, which explains the effect of MA treatment on astrocytes and has clear implication in neuroinflammation among the drug abusers.	[Jackson, Austin R.; Shah, Ankit; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Kumar, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	kumaran@umkc.edu	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022		National Institute on Drug Abuse [DA025528, DA025011]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025011, R01DA025528] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institute on Drug Abuse (DA025528 and DA025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Muneer PM, 2011, PLOS ONE, V6; Ando H, 2013, BRAIN, V136, P2876, DOI 10.1093/brain/awt183; Atmaca HT, 2014, NEUROSCIENCE, V269, P184, DOI 10.1016/j.neuroscience.2014.03.049; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bento AR, 2011, REJUV RES, V14, P205, DOI 10.1089/rej.2010.1109; Broderick R, 2009, BIOCHEM SOC T, V37, P926, DOI 10.1042/BST0370926; Cadet JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-545; Cekanaviciute E, 2014, J IMMUNOL; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Cisneros IE, 2014, NEUROPHARMACOLOGY; Cisneros IE, 2012, CURR HIV RES, V10, P392, DOI 10.2174/157016212802138832; Cooley ID, 2014, GLIA, V62, P818, DOI 10.1002/glia.22644; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; Friend DM, 2013, J NEUROCHEM, V125, P566, DOI 10.1111/jnc.12201; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Goncalves J., 2014, NEUROPHARMACOLOGY; Granado N, 2011, GLIA, V59, P1850, DOI 10.1002/glia.21229; Guillot TS, 2008, J NEUROCHEM, V106, P2205, DOI 10.1111/j.1471-4159.2008.05568.x; Guo M-F, 2014, J NEUROL SCI; Hadlock GC, 2010, J PHARMACOL EXP THER, V335, P207, DOI 10.1124/jpet.110.166660; Helmuth L, 2001, SCIENCE, V291, P569; Henry BL, 2014, BEHAV PHARMACOL, V25, P12, DOI 10.1097/FBP.0000000000000012; Henry BL, 2013, BEHAV BRAIN RES, V236, P210, DOI 10.1016/j.bbr.2012.08.037; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hostenbach S, 2014, NEUROSCI LETT, V565, P39, DOI 10.1016/j.neulet.2013.10.012; Hu C.-M., 2014, ONCOGENE; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim YH, 2002, BIOCHEM BIOPH RES CO, V290, P730, DOI 10.1006/bbrc.2001.6212; Lang AJ, 1998, GENE, V221, P255, DOI 10.1016/S0378-1119(98)00468-5; Liu X, 2014, ONCOL REP, V31, P745, DOI 10.3892/or.2013.2910; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033822; Ma YF, 2013, BIOCHEM BIOPH RES CO, V441, P958, DOI 10.1016/j.bbrc.2013.11.010; Mandyam CD, 2008, BIOL PSYCHIAT, V64, P958, DOI 10.1016/j.biopsych.2008.04.010; Marshall JF, 2012, TRENDS NEUROSCI, V35, P536, DOI 10.1016/j.tins.2012.05.006; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Pendyala G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037604; Pereira FC, 2012, NEUROTOXICOL TERATOL, V34, P522, DOI 10.1016/j.ntt.2012.07.005; POCH O, 1994, MOL GEN GENET, V243, P641, DOI 10.1007/BF00279573; Quinton MS, 2006, AAPS J, V8, pE337, DOI 10.1208/aapsj080238; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Robson MJ, 2014, EXP NEUROL, V254, P180, DOI 10.1016/j.expneurol.2014.01.020; Shah A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.374; Shah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052060; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Sharma A, 2011, J NEUROIMMUNE PHARM, V6, P597, DOI 10.1007/s11481-011-9295-2; Shin OS, 2014, VIRAL IMMUNOL; Silverstein PS, 2012, CURR HIV RES, V10, P369, DOI 10.2174/157016212802138724; Silverstein PS, 2011, J NEUROVIROL, V17, P401, DOI 10.1007/s13365-011-0043-4; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Wang JQ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00367; Wu CW, 2007, TOXICOL APPL PHARM, V220, P243, DOI 10.1016/j.taap.2007.01.011; Yamanaka S, 2012, CELL CYCLE, V11, P2729, DOI 10.4161/cc.21105; Yeh YH, 2009, ONCOGENE, V28, P1366, DOI 10.1038/onc.2008.477; Yu HS, 2014, ONCOL LETT, V7, P799, DOI 10.3892/ol.2013.1754; Yuan CJ, 2011, PHARMACOL BIOCHEM BE, V100, P98, DOI 10.1016/j.pbb.2011.08.004	59	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109603	10.1371/journal.pone.0109603	http://dx.doi.org/10.1371/journal.pone.0109603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290377	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000071
J	Huergo-Zapico, L; Acebes-Huerta, A; Gonzalez-Rodriguez, AP; Contesti, J; Gonzalez-Garcia, E; Payer, AR; Villa-Alvarez, M; Fernandez-Guizan, A; Lopez-Soto, A; Gonzalez, S				Huergo-Zapico, Leticia; Acebes-Huerta, Andrea; Pilar Gonzalez-Rodriguez, Ana; Contesti, Juan; Gonzalez-Garcia, Esther; Payer, Angel R.; Villa-Alvarez, Monica; Fernandez-Guizan, Azahara; Lopez-Soto, Alejandro; Gonzalez, Segundo			Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease	PLOS ONE			English	Article							PREDICTS SUPERIOR SURVIVAL; NEWLY-DIAGNOSED PATIENTS; T-CELLS; PROGNOSTIC-SIGNIFICANCE; MULTIPLE-MYELOMA; LIGANDS; COUNT; MUTATIONS; RECOVERY; RECEPTOR	The immune system may mediate anti-tumor responses in chronic lymphocytic leukemia (CLL) which may affect disease progression and survival. In this study, we analyzed the immune characteristics of 99 consecutive previously diagnosed CLL patients and 50 healthy controls. The distribution of lymphocyte subsets at diagnosis was retrospectively analyzed. Compared with controls, leukemia patients showed an expansion of NK and CD8 T cells at diagnosis. The relative number of CD8 T cells at diagnosis was associated with time to treatment, suggesting that CD8 T cells may modify disease progression. The distribution of lymphocyte subsets was analyzed again when patients were enrolled in this study. The median time since these patients were diagnosed was 277 weeks. Compared with diagnosis, the absolute number of CD8 T cells significantly decreased in these patients, reaching similar values to healthy controls; however NK cells kept significantly elevated overtime. Nevertheless, NK cells showed an impaired expression of NKG2D receptor and a defective cytotoxic activity. This down-regulation of NKG2D expression was further enhanced in patients with advanced and progressive disease. Additionally, membrane NKG2D levels significantly decreased on CD8 T cells, but a significant increase of NKG2D+ CD4+ T cells was observed in CLL patients. The cytotoxic activity of NK cells was diminished in CLL patients; however the treatments with IL-2, IL-15, IL-21 and lenalidomide were able to restore their activity. The effect of IL-2 and IL-15 was associated with the increase of NKG2D expression on immune cells, but the effect of IL-21 and lenalidomide was not due to NKG2D up-regulation. The expansion of NK cells and the reversibility of NK cell defects provide new opportunities for the immunotherapeutic intervention in CLL.	[Huergo-Zapico, Leticia; Acebes-Huerta, Andrea; Villa-Alvarez, Monica; Fernandez-Guizan, Azahara; Lopez-Soto, Alejandro; Gonzalez, Segundo] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Huergo-Zapico, Leticia; Acebes-Huerta, Andrea; Villa-Alvarez, Monica; Fernandez-Guizan, Azahara; Lopez-Soto, Alejandro; Gonzalez, Segundo] Univ Oviedo, IUOPA, Oviedo, Spain; [Pilar Gonzalez-Rodriguez, Ana; Payer, Angel R.] Hosp Univ Cent Asturias, Dept Hematol, Oviedo, Spain; [Contesti, Juan; Gonzalez-Garcia, Esther] Hosp Cabuenes, Dept Hematol, Gijon, Spain	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; Hospital de Cabuenes	Gonzalez, S (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Spain.	segundog@uniovi.es	Gonzalez-Rodriguez, Ana Pilar/AAC-6242-2021; , anapilar/HHS-1278-2022; Gonzalez, Segundo/AAK-8719-2021; Acebes-Huerta, Andrea/AAA-8004-2020; López-Soto, Alejandro/A-9779-2018; Huergo-Zapico, Leticia/S-5863-2018	Gonzalez-Rodriguez, Ana Pilar/0000-0002-0565-9133; Gonzalez, Segundo/0000-0003-4631-9255; Acebes-Huerta, Andrea/0000-0002-7106-3063; López-Soto, Alejandro/0000-0002-6360-5205; Huergo-Zapico, Leticia/0000-0001-9942-1144	Spanish grants of Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III) [PI12/01280]; Sara Borrell grant [ISCIII/CD1300412]; Severo Ochoa grant [BP09-144]	Spanish grants of Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III); Sara Borrell grant; Severo Ochoa grant(Spanish Government)	This work was supported by the Spanish grants of Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III) PI12/01280. http://www.isciii.es/. ALS holds a Sara Borrell grant (ISCIII/CD1300412); (http://www.isciii.es/). LHZ holds a Severo Ochoa grant (BP09-144); (www.Ficyt.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Awan FT, 2010, LEUKEMIA LYMPHOMA, V51, P27, DOI 10.3109/10428190903350405; Behl D, 2006, LEUKEMIA, V20, P29, DOI 10.1038/sj.leu.2404032; Cox MC, 2008, LEUKEMIA LYMPHOMA, V49, P1745, DOI 10.1080/10428190802226425; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Ege H, 2008, BRIT J HAEMATOL, V141, P792, DOI 10.1111/j.1365-2141.2008.07123.x; Eskelund CW, 2011, LEUKEMIA RES, V35, P914, DOI 10.1016/j.leukres.2011.02.006; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez-Rodriguez AP, 2010, LEUKEMIA LYMPHOMA, V51, P1829, DOI 10.3109/10428194.2010.503820; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Hamblin AD, 2008, BRIT MED BULL, V87, P49, DOI 10.1093/bmb/ldn034; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Herishanu Y, 2013, HEMATOL ONCOL CLIN N, V27, P173, DOI 10.1016/j.hoc.2013.01.002; Huergo-Zapico L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00106; Huergo-Zapico L, 2012, CANCER IMMUNOL IMMUN, V61, P1201, DOI 10.1007/s00262-011-1195-z; KAY NE, 1984, BLOOD, V63, P305; Lopez-Soto A, 2015, INT J CANCER, V136, P1741, DOI 10.1002/ijc.28775; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Palmer S, 2008, BRIT J HAEMATOL, V141, P607, DOI 10.1111/j.1365-2141.2008.07070.x; Plonquet A, 2007, ANN ONCOL, V18, P1209, DOI 10.1093/annonc/mdm110; Poggi A, 2004, CANCER RES, V64, P9172, DOI 10.1158/0008-5472.CAN-04-2417; Porrata LF, 2001, BLOOD, V98, P579, DOI 10.1182/blood.V98.3.579; Porrata LF, 2009, AM J HEMATOL, V84, P93, DOI 10.1002/ajh.21337; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Reiners KS, 2013, BLOOD, V121, P3658, DOI 10.1182/blood-2013-01-476606; Siddiqui M, 2006, BRIT J HAEMATOL, V134, P596, DOI 10.1111/j.1365-2141.2006.06232.x; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Sutherland CL, 2006, BLOOD, V108, P1313, DOI 10.1182/blood-2005-11-011320; Takaki R, 2005, J IMMUNOL, V175, P2167, DOI 10.4049/jimmunol.175.4.2167; te Raa GD, 2012, LEUKEMIA LYMPHOMA, V53, P2321, DOI 10.3109/10428194.2012.698277; Veuillen C, 2012, J CLIN IMMUNOL, V32, P632, DOI 10.1007/s10875-011-9624-5	34	59	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108326	10.1371/journal.pone.0108326	http://dx.doi.org/10.1371/journal.pone.0108326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286418	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700017
J	Wong, CW; Olafsson, V; Plank, M; Snider, J; Halgren, E; Poizner, H; Liu, TT				Wong, Chi Wah; Olafsson, Valur; Plank, Markus; Snider, Joseph; Halgren, Eric; Poizner, Howard; Liu, Thomas T.			Resting-State fMRI Activity Predicts Unsupervised Learning and Memory in an Immersive Virtual Reality Environment	PLOS ONE			English	Article							LOW-FREQUENCY FLUCTUATION; SCALE-FREE DYNAMICS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; DECISION-MAKING; BASAL GANGLIA; HIPPOCAMPAL SYNAPSES; SELECTIVE ATTENTION; SIGNAL VARIABILITY; PREFRONTAL CORTEX	In the real world, learning often proceeds in an unsupervised manner without explicit instructions or feedback. In this study, we employed an experimental paradigm in which subjects explored an immersive virtual reality environment on each of two days. On day 1, subjects implicitly learned the location of 39 objects in an unsupervised fashion. On day 2, the locations of some of the objects were changed, and object location recall performance was assessed and found to vary across subjects. As prior work had shown that functional magnetic resonance imaging (fMRI) measures of resting-state brain activity can predict various measures of brain performance across individuals, we examined whether resting-state fMRI measures could be used to predict object location recall performance. We found a significant correlation between performance and the variability of the resting-state fMRI signal in the basal ganglia, hippocampus, amygdala, thalamus, insula, and regions in the frontal and temporal lobes, regions important for spatial exploration, learning, memory, and decision making. In addition, performance was significantly correlated with resting-state fMRI connectivity between the left caudate and the right fusiform gyrus, lateral occipital complex, and superior temporal gyrus. Given the basal ganglia's role in exploration, these findings suggest that tighter integration of the brain systems responsible for exploration and visuospatial processing may be critical for learning in a complex environment.	[Wong, Chi Wah; Liu, Thomas T.] Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA; [Wong, Chi Wah; Halgren, Eric; Liu, Thomas T.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Liu, Thomas T.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Plank, Markus; Snider, Joseph; Poizner, Howard] Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA; [Halgren, Eric] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Halgren, Eric] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Halgren, Eric; Poizner, Howard] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Olafsson, Valur] Univ Pittsburgh, Neurosci Imaging Ctr, Pittsburgh, PA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wong, CW (corresponding author), Univ Calif San Diego, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA.	cwwong@ieee.org; vto77@pitt.edu; ttliu@ucsd.edu	Wong, Chi Wah/AAQ-6381-2021; Olafsson, Valur Thor/I-6792-2019	Wong, Chi Wah/0000-0002-2833-979X; Olafsson, Valur Thor/0000-0003-3854-6159; Snider, Joseph/0000-0002-0176-5107; Liu, Thomas/0000-0002-1978-7486	ONR MURI [N00014-10-1-0072]; NIH [R01NS051661, R21MH096495]; NSF [SMA-1041755]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH096495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051661] Funding Source: NIH RePORTER	ONR MURI(MURIOffice of Naval Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by ONR MURI Award No. N00014-10-1-0072 (www.onr.navy.mil), NIH Grants R01NS051661 and R21MH096495 (www.nih.gov), and NSF grant SMA-1041755 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Amorapanth PX, 2010, J COGNITIVE NEUROSCI, V22, P1739, DOI 10.1162/jocn.2009.21322; Ashby FG, 2010, TRENDS COGN SCI, V14, P208, DOI 10.1016/j.tics.2010.02.001; Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Chen LY, 2010, J NEUROSCI, V30, P15097, DOI 10.1523/JNEUROSCI.3549-10.2010; Chen LY, 2010, P NATL ACAD SCI USA, V107, P7030, DOI 10.1073/pnas.0912973107; Ciuciu P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00186; Ciuciu P, 2014, NEUROIMAGE, V95, P248, DOI 10.1016/j.neuroimage.2014.03.047; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Cox CD, 2014, J NEUROSCI, V34, P3033, DOI 10.1523/JNEUROSCI.4159-13.2014; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Eke A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00417; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fessler JA, 2005, IEEE T SIGNAL PROCES, V53, P3393, DOI 10.1109/TSP.2005.853152; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Garrett DD, 2013, CEREB CORTE IN PRESS; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Hotting K, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-73; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Humphries MD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00009; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Iaria G, 2008, EUR J NEUROSCI, V27, P1017, DOI 10.1111/j.1460-9568.2008.06060.x; Jao T, 2013, NEUROIMAGE, V69, P21, DOI 10.1016/j.neuroimage.2012.12.007; Kalva SK, 2012, NEURAL NETWORKS, V32, P65, DOI 10.1016/j.neunet.2012.02.031; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Molnar-Szakacs I, 2005, CEREB CORTEX, V15, P986, DOI 10.1093/cercor/bhh199; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Pennartz CMA, 2011, TRENDS NEUROSCI, V34, P548, DOI 10.1016/j.tins.2011.08.001; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reas Emilie T, 2011, Front Hum Neurosci, V5, P112, DOI 10.3389/fnhum.2011.00112; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Shen LM, 1999, HUM BRAIN MAPP, V8, P60, DOI 10.1002/(SICI)1097-0193(1999)8:1<60::AID-HBM5>3.0.CO;2-6; Sheth SA, 2011, J NEUROSCI, V31, P4878, DOI 10.1523/JNEUROSCI.3658-10.2011; Shimizu Y, 2004, NEUROIMAGE, V22, P1195, DOI 10.1016/j.neuroimage.2004.03.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snider J, 2013, IEEE T BIOMED CIRC S, V7, P713, DOI 10.1109/TBCAS.2012.2236089; Snider J, 2013, J NEUROSCI, V33, P15056, DOI 10.1523/JNEUROSCI.0268-13.2013; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; Vo LTK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016093; Wink AM, 2008, HUM BRAIN MAPP, V29, P791, DOI 10.1002/hbm.20593; Wong CW, 2013, NEUROIMAGE, V83, P983, DOI 10.1016/j.neuroimage.2013.07.057; Wong CW, 2012, NEUROIMAGE, V63, P356, DOI 10.1016/j.neuroimage.2012.06.035; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yang GJ, 2014, P NATL ACAD SCI US; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zhu Q, 2011, J NEUROSCI, V31, P10323, DOI 10.1523/JNEUROSCI.0873-11.2011; Zilber N, 2013, I S BIOMED IMAGING, P998; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136	88	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109622	10.1371/journal.pone.0109622	http://dx.doi.org/10.1371/journal.pone.0109622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286145	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000345743700073
J	Xia, H; Zheng, XG; Chen, L; Gao, H; Yang, H; Long, P; Rong, J; Lu, BR; Li, JJ; Luo, LJ				Xia, Hui; Zheng, Xiaoguo; Chen, Liang; Gao, Huan; Yang, Hua; Long, Ping; Rong, Jun; Lu, Baorong; Li, Jiajia; Luo, Lijun			Genetic Differentiation Revealed by Selective Loci of Drought-Responding EST-SSRs between Upland and Lowland Rice in China	PLOS ONE			English	Article							GENIC MICROSATELLITE MARKERS; F-ST; ADAPTATION; RESISTANCE; IDENTIFY; POPULATIONS; EXPRESSION; DIVERSITY; ALLELE; PLANTS	Upland and lowland rice (Oryza sativa L.) represent two of the most important rice ecotypes adapted to ago/ecosystems with contrasting soil-water conditions. Upland rice, domesticated in the water-limited environment, contains valuable drought-resistant characters that can be used in water-saving breeding. Knowledge about the divergence between upland and lowland rice will provide valuable cues for the evolution of drought-resistance in rice. Genetic differentiation between upland and lowland rice was explored by 47 Simple Sequence Repeats (SSRs) located in drought responding expressed sequence tags (ESTs) among 377 rice landraces. The morphological traits of drought-resistance were evaluated in the field experiments. Different outlier loci were detected in the japonica and indica subspecies, respectively. Considerable genetic differentiation between upland and lowland rice on these outlier loci was estimated in japonica (Fst = 0.258) and indica (Fst = 0.127). Furthermore, populations of the upland and lowland ecotypes were clustered separately on these outlier loci. A significant correlation between genetic distance matrices and the dissimilarity matrices of drought-resistant traits was determined, indicating a certain relationship between the upland-lowland rice differentiation and the drought-resistance. Divergent selections occur between upland and lowland rice on the drought-resistance as the Qsts of some drought-resistant traits are significantly higher than the neutral Fst. In addition, the upland-and lowland-preferable alleles responded differently among ecotypes or allelic types under osmotic stress. This shows the evolutionary signature of drought resistance at the gene expression level. The findings of this study can strengthen our understanding of the evolution of drought-resistance in rice with significant implications in the improvement of rice drought-resistance.	[Xia, Hui; Zheng, Xiaoguo; Chen, Liang; Gao, Huan; Yang, Hua; Long, Ping; Li, Jiajia; Luo, Lijun] Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China; [Rong, Jun] Nanchang Univ, Minist Educ, Ctr Watershed Ecol, Inst Life Sci, Nanchang, Peoples R China; [Rong, Jun] Nanchang Univ, Minist Educ, Key Lab Poyang Lake Environm & Resource Utilizat, Nanchang, Peoples R China; [Lu, Baorong] Fudan Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Shanghai 200433, Peoples R China	Nanchang University; Nanchang University; Fudan University	Luo, LJ (corresponding author), Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China.	lijun@sagc.org.cn	Xia, Hui/L-7129-2019; Lu, Bao-Rong/C-3130-2009; li, jia/GVT-7587-2022; Rong, Jun/B-6037-2008	Xia, Hui/0000-0003-2446-5171; Lu, Bao-Rong/0000-0002-0214-2390; Rong, Jun/0000-0003-1408-2898	Natural Science Foundation of China [31200279]; Postdoctoral Science Foundation, Shanghai [12R21421300]; National Basic Research Program [2012CB114305]; Shanghai "Phosphor" Science Foundation [11QA1405900]; National High-Tech Research and Development Program of China (863 Plan) [2012AA101102, 02014AA10A603]; Shanghai Seed projects [2014.01]; Talented Person Project [2010CI120]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation, Shanghai; National Basic Research Program(National Basic Research Program of China); Shanghai "Phosphor" Science Foundation; National High-Tech Research and Development Program of China (863 Plan)(National High Technology Research and Development Program of China); Shanghai Seed projects; Talented Person Project	The work was supported by the following: Natural Science Foundation of China (Grant no. 31200279); Postdoctoral Science Foundation, Shanghai (No. 12R21421300); National Basic Research Program (Grant no. 2012CB114305); Shanghai "Phosphor" Science Foundation (Grant no. 11QA1405900); the National High-Tech Research and Development Program of China (863 Plan)(Grant No. 2012AA101102; 2014AA10A603); Shanghai Seed projects (2014.01); and Talented Person Project (2010CI120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, ACTA AGR BOREALI SIN; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bernier J, 2008, J SCI FOOD AGR, V88, P927, DOI 10.1002/jsfa.3153; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farooq M, 2009, CRIT REV PLANT SCI, V28, P199, DOI 10.1080/07352680902952173; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gholizadeh A, 2011, PROTEIN J, V30, P351, DOI 10.1007/s10930-011-9338-9; Huang Ji-Yue, 2010, Yichuan, V32, P1281, DOI 10.3724/SP.J.1005.2010.01281; Huber S, 2009, MOL ECOL, V18, P1523, DOI 10.1111/j.1365-294X.2009.04106.x; Ichitani K, 2007, THEOR APPL GENET, V114, P1407, DOI 10.1007/s00122-007-0526-0; IRRI (International Rice Research Institute), 1986, UPL RIC GLOB PERSP; ISHIKAWA R, 1992, JPN J BREED, V42, P737; Knight CA, 2006, MOL ECOL, V15, P1229, DOI 10.1111/j.1365-294X.2006.02818.x; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; Lyu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3138; Martin MA, 2010, TREE GENET GENOMES, V6, P735, DOI 10.1007/s11295-010-0287-9; Miller JR, 2008, GENETICS, V180, P1023, DOI 10.1534/genetics.108.092031; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Shikano T, 2010, MOL BIOL EVOL, V27, P2775, DOI 10.1093/molbev/msq167; Steele KA, 2004, THEOR APPL GENET, V109, P1247, DOI 10.1007/s00122-004-1732-7; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vitalis R, 2003, J HERED, V94, P429, DOI 10.1093/jhered/esg083; Whitehead A, 2010, MOL ECOL, V19, P5186, DOI 10.1111/j.1365-294X.2010.04829.x; Xia H, 2010, MOL ECOL, V19, P4144, DOI 10.1111/j.1365-294X.2010.04762.x; Yang HP, 1999, P NATL ACAD SCI USA, V96, P13560, DOI 10.1073/pnas.96.23.13560; YU LX, 1994, THEOR APPL GENET, V87, P668, DOI 10.1007/BF00222891; Zhang DL, 2009, THEOR APPL GENET, V119, P1105, DOI 10.1007/s00122-009-1112-4; Zhang HY, 2011, GENE, V478, P28, DOI 10.1016/j.gene.2011.01.011	29	23	26	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e106352	10.1371/journal.pone.0106352	http://dx.doi.org/10.1371/journal.pone.0106352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286109	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700004
J	Furstenberg-Hagg, J; Zagrobelny, M; Jorgensen, K; Vogel, H; Moller, BL; Bak, S				Furstenberg-Hagg, Joel; Zagrobelny, Mika; Jorgensen, Kirsten; Vogel, Heiko; Moller, Birger Lindberg; Bak, Soren			Chemical Defense Balanced by Sequestration and De Novo Biosynthesis in a Lepidopteran Specialist	PLOS ONE			English	Article							ZYGAENA-FILIPENDULAE LEPIDOPTERA; UDP-GLUCOSYLTRANSFERASE ACTIVITY; CYANOGENIC GLUCOSIDES; LEAF BEETLES; IRIDOID BIOSYNTHESIS; LOTUS-CORNICULATUS; PLANT DEFENSE; LARVAE; LOTAUSTRALIN; LINAMARIN	The evolution of sequestration (uptake and accumulation) relative to de novo biosynthesis of chemical defense compounds is poorly understood, as is the interplay between these two strategies. The Burnet moth Zygaena filipendulae (Lepidoptera) and its food-plant Lotus corniculatus (Fabaceae) poses an exemplary case study of these questions, as Z. filipendulae belongs to the only insect family known to both de novo biosynthesize and sequester the same defense compounds directly from its food-plant. Z. filipendulae and L. corniculatus both contain the two cyanogenic glucosides linamarin and lotaustralin, which are defense compounds that can be hydrolyzed to liberate toxic hydrogen cyanide. The overall amounts and ratios of linamarin and lotaustralin in Z. filipendulae are tightly regulated, and only to a low extent reflect the ratio in the ingested food-plant. We demonstrate that Z. filipendulae adjusts the de novo biosynthesis of CNglcs by regulation at both the transcriptional and protein level depending on food plant composition. Ultimately this ensures that the larva saves energy and nitrogen while maintaining an effective defense system to fend off predators. By using in situ PCR and immunolocalization, the biosynthetic pathway was resolved to the larval fat body and integument, which infers rapid replenishment of defense compounds following an encounter with a predator. Our study supports the hypothesis that de novo biosynthesis of CNglcs in Z. filipendulae preceded the ability to sequester, and facilitated a food-plant switch to cyanogenic plants, after which sequestration could evolve. Preservation of de novo biosynthesis allows fine-tuning of the amount and composition of CNglcs in Z. filipendulae.	[Furstenberg-Hagg, Joel; Zagrobelny, Mika; Jorgensen, Kirsten; Moller, Birger Lindberg; Bak, Soren] Univ Copenhagen, Copenhagen Plant Sci Ctr, Dept Plant & Environm Sci, Plant Biochem Lab, Copenhagen, Denmark; [Furstenberg-Hagg, Joel; Zagrobelny, Mika; Jorgensen, Kirsten; Moller, Birger Lindberg; Bak, Soren] Univ Copenhagen, VILLUM Res Ctr Plant Plast, Dept Plant & Environm Sci, Copenhagen, Denmark; [Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	University of Copenhagen; University of Copenhagen; Max Planck Society	Bak, S (corresponding author), Univ Copenhagen, Copenhagen Plant Sci Ctr, Dept Plant & Environm Sci, Plant Biochem Lab, Copenhagen, Denmark.	bak@plen.ku.dk	Zagrobelny, Mika/L-8679-2015; Bak, Soren/H-4404-2014; Møller, Birger Lindberg/GQI-1792-2022; Møller, Birger Lindberg/H-2657-2014; jorgensen, kirsten/H-4346-2014	Zagrobelny, Mika/0000-0001-5574-2894; Bak, Soren/0000-0003-4100-115X; Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119; jorgensen, kirsten/0000-0003-2855-7735	VILLUM Research Center "Proactive-Plants" and "Plant Plasticity"; Danish Council for Independent Research [DFF - 1323-00088]; Villum Fonden [00007523] Funding Source: researchfish	VILLUM Research Center "Proactive-Plants" and "Plant Plasticity"; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	Funding provided by VILLUM Research Center "Proactive-Plants" and "Plant Plasticity" (http://villumfoundation.dk/) to JF-H, MZ, KJ, BLM and SB and the Danish Council for Independent Research (grant # DFF - 1323-00088) (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research) to BLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RJ, 1977, HEREDITY, V38, P397, DOI 10.1038/hdy.1977.103; AHMAD SA, 1993, COMP BIOCHEM PHYS B, V104, P515, DOI 10.1016/0305-0491(93)90276-B; AHMAD SA, 1992, ARCH INSECT BIOCHEM, V21, P207, DOI 10.1002/arch.940210305; Ahn SJ, 2012, INSECT BIOCHEM MOLEC, V42, P133, DOI 10.1016/j.ibmb.2011.11.006; Armstrong HE, 1913, P R SOC LOND B-CONTA, V86, P262, DOI 10.1098/rspb.1913.0021; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Ballhorn DJ, 2010, ENTOMOL EXP APPL, V134, P245, DOI 10.1111/j.1570-7458.2009.00961.x; Bock KW, 2003, BIOCHEM PHARMACOL, V66, P691, DOI 10.1016/S0006-2952(03)00296-X; Burse A, 2008, INSECT BIOCHEM MOLEC, V38, P76, DOI 10.1016/j.ibmb.2007.09.006; Burse A, 2007, INSECT BIOCHEM MOLEC, V37, P255, DOI 10.1016/j.ibmb.2006.11.011; Burse A, 2009, PHYTOCHEMISTRY, V70, P1899, DOI 10.1016/j.phytochem.2009.08.002; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Celorio-Mancera MD, 2012, ENTOMOL EXP APPL, V144, P123, DOI 10.1111/j.1570-7458.2012.01249.x; Corkill L., 1942, NZ J SCI TECHNOL   B, V23, P178; DAVIS RH, 1979, COMP BIOCHEM PHYS B, V64, P395, DOI 10.1016/0305-0491(79)90289-X; DAVIS RH, 1982, COMP BIOCHEM PHYS B, V71, P329, DOI 10.1016/0305-0491(82)90266-8; Davis RH, 1985, COMPREHENSIVE INSECT, V11, P635, DOI DOI 10.1016/B978-0-08-030812-8.50020-4; Discher S, 2009, CHEMBIOCHEM, V10, P2223, DOI 10.1002/cbic.200900226; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Engler-Chaouat HS, 2007, J CHEM ECOL, V33, P25, DOI 10.1007/s10886-006-9207-8; FRANZL S, 1986, J INSECT PHYSIOL, V32, P705, DOI 10.1016/0022-1910(86)90112-5; FRANZL S, 1985, TISSUE CELL, V17, P267, DOI 10.1016/0040-8166(85)90093-X; FRANZL S, 1988, ZOOMORPHOLOGY, V108, P183, DOI 10.1007/BF00363935; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gebrehiwot L, 2001, AGRON J, V93, P603, DOI 10.2134/agronj2001.933603x; Gleadow RM, 2002, J CHEM ECOL, V28, P1301, DOI 10.1023/A:1016298100201; Gleadow RM, 2009, J CHEM ECOL, V35, P476, DOI 10.1007/s10886-009-9617-5; Jensen NB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1271; JONES DA, 1988, CIBA F SYMP, V140, P151; Jorgensen K, 2005, PLANT PHYSIOL, V139, P363, DOI 10.1104/pp.105.065904; Kahn RA, 1999, ARCH BIOCHEM BIOPHYS, V363, P9, DOI 10.1006/abbi.1998.1068; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KEYMER R, 1978, HEREDITY, V40, P189, DOI 10.1038/hdy.1978.21; Kuhn J, 2004, P NATL ACAD SCI USA, V101, P13808, DOI 10.1073/pnas.0402576101; Kunert M, 2008, INSECT BIOCHEM MOLEC, V38, P895, DOI 10.1016/j.ibmb.2008.06.005; Lechtenberg M, 2011, ELS, DOI 10.1002/9780470015902.a0001921.pub2; Luque T, 2002, EUR J BIOCHEM, V269, P819, DOI 10.1046/j.0014-2956.2001.02723.x; MORELLO A, 1979, BIOCHEM J, V177, P809, DOI 10.1042/bj1770809; NAHRSTEDT A, 1986, PHYTOCHEMISTRY, V25, P2299, DOI 10.1016/S0031-9422(00)81683-0; NAHRSTEDT A, 1985, COMP BIOCHEM PHYS B, V82, P745, DOI 10.1016/0305-0491(85)90519-X; Naumann CM, 1999, W PALAEARCTIC ZYGAEN; Niehuis O, 2007, BIOL J LINN SOC, V92, P501, DOI 10.1111/j.1095-8312.2007.00858.x; Oldham NJ, 1996, NATURWISSENSCHAFTEN, V83, P470; Olsen KM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0347; Pasteels JM, 2003, J CHEM ECOL, V29, P337, DOI 10.1023/A:1022629911304; Pentzold S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091337; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rammert U., 1985, UNTERSUCHUNGEN WIRKS; Rammert U., 1992, P 4 S ZYG NANT 11 13, P38; REAL MD, 1991, ANAL BIOCHEM, V194, P349, DOI 10.1016/0003-2697(91)90239-P; ROWELLRAHIER M, 1986, J CHEM ECOL, V12, P1189, DOI 10.1007/BF01639004; Sanchez-Perez R, 2009, PLANT J, V60, P894, DOI 10.1111/j.1365-313X.2009.03997.x; Schappert PJ, 1999, ECOSCIENCE, V6, P511, DOI 10.1080/11956860.1999.11682560; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; WIKLUND C, 1982, EVOLUTION, V36, P998, DOI 10.1111/j.1558-5646.1982.tb05468.x; WRAY V, 1983, Z NATURFORSCH C, V38, P583; Zagrobelny M, 2004, PHYTOCHEMISTRY, V65, P293, DOI 10.1016/j.phytochem.2003.10.016; Zagrobelny M, 2007, INSECT BIOCHEM MOLEC, V37, P1189, DOI 10.1016/j.ibmb.2007.07.008; Zagrobelny M, 2007, INSECT BIOCHEM MOLEC, V37, P10, DOI 10.1016/j.ibmb.2006.09.008; Zagrobelny M, 2014, INSECT BIOCHEM MOLEC, V44, P44, DOI 10.1016/j.ibmb.2013.11.003; Zagrobelny M, 2011, PHYTOCHEMISTRY, V72, P1585, DOI 10.1016/j.phytochem.2011.02.023; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574	67	14	14	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108745	10.1371/journal.pone.0108745	http://dx.doi.org/10.1371/journal.pone.0108745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299618	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200023
J	He, LJ; Tian, XY; Zhang, H; Hu, TY; Huang, XZ; Zhang, LB; Wang, Z; Zhou, B				He, Lingjuan; Tian, Xueying; Zhang, Hui; Hu, Tianyuan; Huang, Xiuzhen; Zhang, Libo; Wang, Zhong; Zhou, Bin			BAF200 Is Required for Heart Morphogenesis and Coronary Artery Development	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEXES; VASCULATURE; MECHANISMS; EXPRESSION; SUBUNIT; LINEAGE; BAF180; CELLS; FORM	ATP-dependent SWI/SNF chromatin remodeling complexes utilize ATP hydrolysis to non-covalently change nucleosome-DNA interactions and are essential in stem cell development, organogenesis, and tumorigenesis. Biochemical studies show that SWI/SNF in mammalian cells can be divided into two subcomplexes BAF and PBAF based on the subunit composition. ARID2 or BAF200 has been defined as an intrinsic subunit of PBAF complex. However, the function of BAF200 in vivo is not clear. To dissect the possible role of BAF200 in regulating embryogenesis and organ development, we generated BAF200 mutant mice and found they were embryonic lethal. BAF200 mutant embryos exhibited multiple cardiac defects including thin myocardium, ventricular septum defect, common atrioventricular valve, and double outlet right ventricle around E14.5. Moreover, we also detected reduced intramyocardial coronary arteries in BAF200 mutants, suggesting that BAF200 is required for proper migration and differentiation of subepicardial venous cells into arterial endothelial cells. Our work revealed that PBAF complex plays a critical role in heart morphogenesis and coronary artery angiogenesis.	[He, Lingjuan; Tian, Xueying; Zhang, Hui; Hu, Tianyuan; Huang, Xiuzhen; Zhang, Libo; Zhou, Bin] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China; [Wang, Zhong] Univ Michigan, Cardiovasc Res Ctr, Dept Cardiac Surg, Ann Arbor, MI 48109 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Michigan System; University of Michigan	Zhou, B (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China.	zhoubin@sibs.ac.cn		Zhou, Bin/0000-0001-5278-5522	Ministry of Science and Technology [2012CB945102, 2013CB945302]; National Science Foundation of China [91339104, 31271552, 31222038, 31301188]; Chinese Academy of Sciences [KSCX2-EW-R-09]; Organization Department of the CPC Central Committee Bajian Talents Program, Shanghai Pujiang Program [11PJ1411400]; Basic Research Key Project [14JC1407400]; AstraZeneca; Sanofi-Shanghai Institutes for Biological Sciences (SIBS) Fellowship; SIBS Postdoc Fund [2013KIP311]; China Postdoc Fund [2013M541561]; National Institutes of Health [HL109054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Organization Department of the CPC Central Committee Bajian Talents Program, Shanghai Pujiang Program; Basic Research Key Project; AstraZeneca(AstraZeneca); Sanofi-Shanghai Institutes for Biological Sciences (SIBS) Fellowship; SIBS Postdoc Fund; China Postdoc Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Ministry of Science and Technology (2012CB945102 and 2013CB945302), National Science Foundation of China (91339104, 31271552, 31222038, 31301188), Chinese Academy of Sciences (Hundred Talents Program and KSCX2-EW-R-09), Organization Department of the CPC Central Committee Bajian Talents Program, Shanghai Pujiang Program (11PJ1411400) and Basic Research Key Project (14JC1407400), AstraZeneca, Sanofi-Shanghai Institutes for Biological Sciences (SIBS) Fellowship, SIBS Postdoc Fund 2013KIP311, China Postdoc Fund 2013M541561, National Institutes of Health (HL109054, WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Huang XL, 2008, DEV BIOL, V319, P258, DOI 10.1016/j.ydbio.2008.04.020; Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Nie ZQ, 2003, MOL CELL BIOL, V23, P2942, DOI 10.1128/MCB.23.8.2942-2952.2003; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Xiong Y, 2013, DEV CELL; Xu F, 2011, J BIOL CHEM; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; YANG JT, 1995, DEVELOPMENT, V121, P549; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723	28	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109493	10.1371/journal.pone.0109493	http://dx.doi.org/10.1371/journal.pone.0109493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299188	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200052
J	Jin, S; Deng, Y; Hao, JW; Li, Y; Liu, B; Yu, Y; Shi, FD; Zhou, QH				Jin, Shi; Deng, Yi; Hao, Jun-Wei; Li, Yang; Liu, Bin; Yu, Yan; Shi, Fu-Dong; Zhou, Qing-Hua			NK Cell Phenotypic Modulation in Lung Cancer Environment	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MOLONEY LEUKEMIA-CELLS; PROGNOSTIC-SIGNIFICANCE; IMMUNE SURVEILLANCE; CYTOTOXIC-CELLS; T-CELLS; STATISTICS; NKG2D; SPECIFICITY; RECEPTORS	Background: Nature killer (NK) cells play an important role in anti-tumor immunotherapy. But it indicated that tumor cells impacted possibly on NK cell normal functions through some molecules mechanisms in tumor microenvironment. Materials and methods: Our study analyzed the change about NK cells surface markers (NK cells receptors) through immunofluorescence, flow cytometry and real-time PCR, the killed function from mouse spleen NK cell and human high/low lung cancer cell line by co-culture. Furthermore we certificated the above result on the lung cancer model of SCID mouse. Results: We showed that the infiltration of NK cells in tumor periphery was related with lung cancer patients' prognosis. And the number of NK cell infiltrating in lung cancer tissue is closely related to the pathological types, size of the primary cancer, smoking history and prognosis of the patients with lung cancer. The expression of NK cells inhibitor receptors increased remarkably in tumor micro-environment, in opposite, the expression of NK cells activated receptors decrease magnificently. Conclusions: The survival time of lung cancer patient was positively related to NK cell infiltration degree in lung cancer. Thus, the down-regulation of NKG2D, Ly49I and the up-regulation of NKG2A may indicate immune tolerance mechanism and facilitate metastasis in tumor environment. Our research will offer more theory for clinical strategy about tumor immunotherapy.	[Jin, Shi; Deng, Yi; Li, Yang; Liu, Bin; Zhou, Qing-Hua] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Jin, Shi; Yu, Yan] Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Peoples R China; [Deng, Yi] Third Mil Med Univ, Res Inst Surg & Daping Hosp, Ctr Canc, Chongqing, Peoples R China; [Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University; Harbin Medical University; Army Medical University; Tianjin Medical University	Zhou, QH (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.	zhouqh135@163.com		Hao, Junwei/0000-0002-3075-5434	Young People Research Fund from the National Eleventh-Five-Year Key Task Projects of China [2006BAI02A01]; National 973 Program [2010CB529405]; Tianjin Scientific Innovation System Program [07SYSYSF05000, 07SYSYJC27900]; China-Sweden Cooperative Foundation [09ZCZDSF04100]; grant National Natural Scientific Foundation of China [81201828]; Young People Foundation of Heilongjiang Provincial of China [QC2012C013]; Health Department of Heilongjiang Provincial of China [2011-124]; Harbin Medical University Cancer Hospital major project Foundation [JJZ-2010-01]	Young People Research Fund from the National Eleventh-Five-Year Key Task Projects of China; National 973 Program(National Basic Research Program of China); Tianjin Scientific Innovation System Program; China-Sweden Cooperative Foundation; grant National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Young People Foundation of Heilongjiang Provincial of China; Health Department of Heilongjiang Provincial of China; Harbin Medical University Cancer Hospital major project Foundation	This work was supported by Young People Research Fund from the grants the National Eleventh-Five-Year Key Task Projects of China (No. 2006BAI02A01), the National 973 Program (No. 2010CB529405), Tianjin Scientific Innovation System Program (No. 07SYSYSF05000, 07SYSYJC27900), the China-Sweden Cooperative Foundation (No. 09ZCZDSF04100), the grant National Natural Scientific Foundation of China (No 81201828), Young People Foundation of Heilongjiang Provincial of China (No QC2012C013), Health Department of Heilongjiang Provincial of China (No 2011-124) and Harbin Medical University Cancer Hospital major project Foundation (No: JJZ-2010-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campoli M, 2008, TISSUE ANTIGENS, V72, P321, DOI 10.1111/j.1399-0039.2008.01106.x; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dasgupta S, 2005, J IMMUNOL, V175, P5541, DOI 10.4049/jimmunol.175.8.5541; Esendagli G, 2008, LUNG CANCER, V59, P32, DOI 10.1016/j.lungcan.2007.07.022; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Ishigami S, 2000, CANCER LETT, V159, P103, DOI 10.1016/S0304-3835(00)00542-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Levy EM, 2008, INT J ONCOL, V32, P633, DOI 10.3892/ijo.32.3.633; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng Hong, 2011, Zhongguo Fei Ai Za Zhi, V14, P362, DOI 10.3779/j.issn.1009-3419.2011.04.11; Peng YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083913; Ren Yuanrong, 2008, Zhongguo Fei Ai Za Zhi, V11, P321, DOI 10.3779/j.issn.1009-3419.2008.03.012; Richards JO, 2006, BLOOD, V108, P246, DOI 10.1182/blood-2005-11-4535; Salazar-Onfray F, 2007, CYTOKINE GROWTH F R, V18, P171, DOI 10.1016/j.cytogfr.2007.01.015; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Schleypen JS, 2003, INT J CANCER, V106, P905, DOI 10.1002/ijc.11321; Urosevic M, 2008, CANCER RES, V68, P627, DOI 10.1158/0008-5472.CAN-07-2704; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Yang L, 2005, EUR J CANCER PREV, V14, P329, DOI 10.1097/00008469-200508000-00004; Yoshimi I, 2004, JPN J CLIN ONCOL, V34, P759, DOI 10.1093/jjco/hyh144; Zhou Qinghua, 2003, Zhongguo Fei Ai Za Zhi, V6, P464, DOI 10.3779/j.issn.1009-3419.2003.06.13; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	36	49	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109976	10.1371/journal.pone.0109976	http://dx.doi.org/10.1371/journal.pone.0109976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299645	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200088
J	Wang, C; Lei, AP; Zhou, K; Hu, ZY; Hao, WL; Yang, JD				Wang, Chao; Lei, Anping; Zhou, Kai; Hu, Zhengyu; Hao, Wenlong; Yang, Junda			Growth and Nitrogen Uptake Characteristics Reveal Outbreak Mechanism of the Opportunistic Macroalga Gracilaria tenuistipitata	PLOS ONE			English	Article							NITRATE UPTAKE; INORGANIC NITROGEN; COASTAL WATERS; ULVA-LACTUCA; INTERTIDAL SEAWEEDS; NUTRIENT CONTROL; AMMONIUM UPTAKE; UPTAKE KINETICS; AGAR YIELD; J. AGARDH	Macroalgae has bloomed in the brackish lake of Shenzhen Bay, China continuously from 2010 to 2014. Gracilaria tenuistipitata was identified as the causative macroalgal species. The aim of this study was to explore the outbreak mechanism of G. tenuistipitata, by studying the effects of salinity and nitrogen sources on growth, and the different nitrogen sources uptake characteristic. Our experimental design was based on environmental conditions observed in the bloom areas, and these main factors were simulated in the laboratory. Results showed that salinity 12 to 20 % was suitable for G. tenuistipitata growth. When the nitrogen sources' (NH4+, NO3+) concentrations reached 40 mu M or above, the growth rate of G. tenuistipitata was significantly higher. Algal biomass was higher (approximately 1.4 times) when cultured with NH4+ than that with NO3+ addition. Coincidentally, macroalgal bloom formed during times of moderate salinity (similar to 12 %) and high nitrogen conditions. The NH4+ and NO3+ uptake characteristic was studied to understand the potential mechanism of G. tenuistipitata bloom. NH4+ uptake was best described by a linear, rate-unsaturated response, with the slope decreasing with time intervals. In contrast, NO3+ uptake followed a rate-saturating mechanism best described by the Michaelis-Menten model, with kinetic parameters V-max = 37.2 mu M g(-1) DM h(-1) and K-s = 61.5 mu M. Further, based on the isotope N-15 tracer method, we found that N-15 from NH4+ accumulated faster and reached an atom% twice than that of N-15 from NO3+, suggesting when both NH4+ and NO3+ were available, NH4+ was assimilated more rapidly. The results of the present study indicate that in the estuarine environment, the combination of moderate salinity with high ammonium may stimulate bloom formation.	[Wang, Chao; Lei, Anping; Hao, Wenlong; Yang, Junda] Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China; [Wang, Chao; Hu, Zhengyu] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Zhou, Kai] Shenzhen Marine Environm & Resources Monitoring C, Shenzhen, Peoples R China	Shenzhen University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Lei, AP (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China.	aplei@szu.edu.cn; kzhou@tom.com			National Natural Science Foundation of China [31170491]; Shenzhen Municipal Basic research program [JCYJ20130329114940668]; Shenzhen Marine Environment and Resources Monitoring Center [HHZB11025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Basic research program; Shenzhen Marine Environment and Resources Monitoring Center	This work was supported by National Natural Science Foundation of China (31170491), Shenzhen Municipal Basic research program (JCYJ20130329114940668) and a project from Shenzhen Marine Environment and Resources Monitoring Center(HHZB11025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MH, 2011, J EXP MAR BIOL ECOL, V407, P190, DOI 10.1016/j.jembe.2011.06.034; BJORNSATER BR, 1990, J PHYCOL, V26, P603, DOI 10.1111/j.0022-3646.1990.00603.x; Bunsom C, 2012, PHYCOL RES, V60, P169, DOI 10.1111/j.1440-1835.2012.00648.x; Carneiro MAA, 2011, REV BRAS FARMACOGN, V21, P329, DOI 10.1590/S0102-695X2011005000074; Chan TU, 2001, MAR FRESHWATER RES, V52, P869, DOI 10.1071/MF00088; Choi HG, 2006, J APPL PHYCOL, V18, P269, DOI 10.1007/s10811-006-9033-y; CLOERN JE, 1987, CONT SHELF RES, V7, P1367, DOI 10.1016/0278-4343(87)90042-2; DELIA CF, 1978, J PHYCOL, V14, P266, DOI 10.1111/j.1529-8817.1978.tb00297.x; DOWD JE, 1965, J BIOL CHEM, V240, P863; ECOHAB, 1995, EC OC HARM ALG BLOOM; EKMAN P, 1991, BRIT PHYCOL J, V26, P123, DOI 10.1080/00071619100650091; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; FONG P, 1994, MAR ECOL PROG SER, V106, P273, DOI 10.3354/meps106273; Franz DR, 2002, J EXP MAR BIOL ECOL, V271, P209, DOI 10.1016/S0022-0981(02)00045-X; GORDON DM, 1981, BOT MAR, V24, P93, DOI 10.1515/botm.1981.24.2.93; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HAINES KC, 1978, J PHYCOL, V14, P319, DOI 10.1111/j.1529-8817.1978.tb00305.x; HANISAK MD, 1978, J PHYCOL, V14, P450, DOI 10.1111/j.1529-8817.1978.tb02467.x; Harrison PJ, 2001, CAH BIOL MAR, V42, P71; He Li-Hong, 2002, Chinese Journal of Oceanology and Limnology, V20, P365; Hernandez I, 1997, J PHYCOL, V33, P764, DOI 10.1111/j.0022-3646.1997.00764.x; HURD CL, 1995, J PHYCOL, V31, P835, DOI 10.1111/j.0022-3646.1995.00835.x; Israel A, 1999, J APPL PHYCOL, V11, P543, DOI 10.1023/A:1008141906299; Kim JK, 2007, J APPL PHYCOL, V19, P431, DOI 10.1007/s10811-006-9150-7; Kirst GO, 1995, ALGAE ENV HUMAN AFFA, P123; Li Juan, 2007, Xiamen Daxue Xuebao (Ziran Kexue Ban), V46, P221; Liu G, 2013, JING NEWSPAPER; Lotze HK, 2000, J PHYCOL, V36, P287, DOI 10.1046/j.1529-8817.2000.99109.x; Luo MB, 2012, AQUAT BOT, V100, P18, DOI 10.1016/j.aquabot.2012.03.006; Marinho-Soriano E, 2009, BIORESOURCE TECHNOL, V100, P6192, DOI 10.1016/j.biortech.2009.06.102; McClelland JW, 1998, MAR ECOL PROG SER, V168, P259, DOI 10.3354/meps168259; McGlathery KJ, 2001, J PHYCOL, V37, P453, DOI 10.1046/j.1529-8817.2001.037004453.x; McGlathery KJ, 1996, J PHYCOL, V32, P393, DOI 10.1111/j.0022-3646.1996.00393.x; Naldi M, 2002, J PHYCOL, V38, P135, DOI 10.1046/j.1529-8817.2002.01070.x; Nelson TA, 2001, AQUAT BOT, V71, P149, DOI 10.1016/S0304-3770(01)00183-8; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Pedersen MF, 1996, MAR ECOL PROG SER, V142, P261, DOI 10.3354/meps142261; PEDERSEN MF, 1994, J PHYCOL, V30, P980, DOI 10.1111/j.0022-3646.1994.00980.x; Pedersen MF, 1997, MAR ECOL PROG SER, V161, P155, DOI 10.3354/meps161155; Phillips JC, 2004, J PHYCOL, V40, P534, DOI 10.1111/j.1529-8817.2004.03157.x; Pinchetti JLG, 1998, J APPL PHYCOL, V10, P383, DOI 10.1023/A:1008008912991; Raffaelli D, 1999, AQUAT CONSERV, V9, P219, DOI 10.1002/(SICI)1099-0755(199903/04)9:2<219::AID-AQC334>3.0.CO;2-P; Randall DJ, 2002, MAR POLLUT BULL, V45, P17, DOI 10.1016/S0025-326X(02)00227-8; ROSENBERG G, 1984, AQUAT BOT, V19, P65, DOI 10.1016/0304-3770(84)90008-1; Runcie JW, 2003, AQUAT BOT, V76, P155, DOI 10.1016/S0304-3770(03)00037-8; Smit AJ, 2002, BOT MAR, V45, P196, DOI 10.1515/BOT.2002.019; Smith SL, 2009, MAR ECOL PROG SER, V384, P1, DOI 10.3354/meps08022; THOMAS TE, 1987, J EXP MAR BIOL ECOL, V107, P1, DOI 10.1016/0022-0981(87)90118-3; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P133, DOI 10.1016/S0022-0981(00)00195-7; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; VALIELA I, 1992, ESTUARIES, V15, P443, DOI 10.2307/1352389; WAITE TD, 1972, J SANIT ENG DIV ASCE, V98, P763; Wang C, 2012, HARMFUL ALGAE, V16, P12, DOI 10.1016/j.hal.2011.12.007; Wang C, 2011, CHIN J OCEANOL LIMN, V29, P541, DOI 10.1007/s00343-011-0126-3; Wen SS, 2008, J FISHERIES CHINA, V32, P754; Xu D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033648, 10.1371/journal.pone.0042243]; Yang YF, 2006, AQUACULTURE, V254, P248, DOI 10.1016/j.aquaculture.2005.08.029; [张静 Zhang Jing], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P253; Zhou MJ, 2006, ADV EARTH SCI, V7, P673	59	21	21	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108980	10.1371/journal.pone.0108980	http://dx.doi.org/10.1371/journal.pone.0108980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299123	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200027
J	Zhang, XL; Reed, JL				Zhang, Xiaolin; Reed, Jennifer L.			Adaptive Evolution of Synthetic Cooperating Communities Improves Growth Performance	PLOS ONE			English	Article							ESCHERICHIA-COLI; DYNAMICS; MECHANISMS; CONSORTIA	Symbiotic interactions between organisms are important for human health and biotechnological applications. Microbial mutualism is a widespread phenomenon and is important in maintaining natural microbial communities. Although cooperative interactions are prevalent in nature, little is known about the processes that allow their initial establishment, govern population dynamics and affect evolutionary processes. To investigate cooperative interactions between bacteria, we constructed, characterized, and adaptively evolved a synthetic community comprised of leucine and lysine Escherichia coli auxotrophs. The co-culture can grow in glucose minimal medium only if the two auxotrophs exchange essential metabolites - lysine and leucine (or its precursors). Our experiments showed that a viable co-culture using these two auxotrophs could be established and adaptively evolved to increase growth rates (by similar to 3 fold) and optical densities. While independently evolved co-cultures achieved similar improvements in growth, they took different evolutionary trajectories leading to different community compositions. Experiments with individual isolates from these evolved co-cultures showed that changes in both the leucine and lysine auxotrophs improved growth of the co-culture. Interestingly, while evolved isolates increased growth of co-cultures, they exhibited decreased growth in mono-culture (in the presence of leucine or lysine). A genome-scale metabolic model of the co-culture was also constructed and used to investigate the effects of amino acid (leucine or lysine) release and uptake rates on growth and composition of the co-culture. When the metabolic model was constrained by the estimated leucine and lysine release rates, the model predictions agreed well with experimental growth rates and composition measurements. While this study and others have focused on cooperative interactions amongst community members, the adaptive evolution of communities with other types of interactions (e. g., commensalism, ammensalism or parasitism) would also be of interest.	[Zhang, Xiaolin] Univ Wisconsin, Madison, WI USA; [Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Reed, JL (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	reed@engr.wisc.edu	Reed, Jennifer L/E-5137-2011; Zhang, Xiaolin/N-7139-2017	Reed, Jennifer L/0000-0001-7854-6220; Zhang, Xiaolin/0000-0003-4745-0810	U.S. Department of Energy Genomics: GTL and SciDAC Programs [DE-FG02-04ER25627]; University of WisconsinMadison Graduate School	U.S. Department of Energy Genomics: GTL and SciDAC Programs; University of WisconsinMadison Graduate School	This work was funded by the U.S. Department of Energy Genomics: GTL and SciDAC Programs (DE-FG02-04ER25627) and the University of WisconsinMadison Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baumler DJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-182; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Bull JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004115; Casida L, 1956, U.S. Patent, Patent No. [2771396A, 2771396]; Charusanti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033727; Christensen JE, 2003, J BACTERIOL, V185, P3297, DOI 10.1128/JB.185.11.3297-3306.2003; CONNOR RC, 1995, BIOL REV, V70, P427, DOI 10.1111/j.1469-185X.1995.tb01196.x; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS BD, 1952, NATURE, V169, P534, DOI 10.1038/169534a0; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Harris D.C., 2003, QUANTITATIVE CHEM AN, P80; Higgins BT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096807; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Hosoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017105; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kerner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034032; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Minty JJ, 2013, P NATL ACAD SCI USA, V110, P14592, DOI 10.1073/pnas.1218447110; Mongold JA, 1996, EVOLUTION, V50, P35, DOI 10.1111/j.1558-5646.1996.tb04470.x; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nagarajan H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3809; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pande S, 2014, ISME J, V8, P953, DOI 10.1038/ismej.2013.211; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Salimi F, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-95; Shin CS, 1998, BIOTECHNOL BIOENG, V59, P576, DOI 10.1002/(SICI)1097-0290(19980905)59:5<576::AID-BIT7>3.0.CO;2-7; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; STERNBERG N, 1983, ANNU REV GENET, V17, P123, DOI 10.1146/annurev.ge.17.120183.001011; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Waks Z, 2009, APPL ENVIRON MICROB, V75, P1867, DOI 10.1128/AEM.02009-08; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363	46	28	29	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108297	10.1371/journal.pone.0108297	http://dx.doi.org/10.1371/journal.pone.0108297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299364	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200013
J	Uthicke, S; Furnas, M; Lonborg, C				Uthicke, Sven; Furnas, Miles; Lonborg, Christian			Coral Reefs on the Edge? Carbon Chemistry on Inshore Reefs of the Great Barrier Reef	PLOS ONE			English	Article							WATER COLUMN NUTRIENTS; OCEAN ACIDIFICATION; BENTHIC FORAMINIFERA; PARTIAL-PRESSURE; CLIMATE-CHANGE; CO2; QUALITY; CALCIFICATION; PRODUCTIVITY; TEMPERATURE	While increasing atmospheric carbon dioxide (CO2) concentration alters global water chemistry (Ocean Acidification; OA), the degree of changes vary on local and regional spatial scales. Inshore fringing coral reefs of the Great Barrier Reef (GBR) are subjected to a variety of local pressures, and some sites may already be marginal habitats for corals. The spatial and temporal variation in directly measured parameters: Total Alkalinity (TA) and dissolved inorganic carbon (DIC) concentration, and derived parameters: partial pressure of CO2 (pCO(2)); pH and aragonite saturation state (Omega(ar)) were measured at 14 inshore reefs over a two year period in the GBR region. Total Alkalinity varied between 2069 and 2364 mu mol kg(-1) and DIC concentrations ranged from 1846 to 2099 mu mol kg(-1). This resulted in pCO(2) concentrations from 340 to 554 mu atm, with higher values during the wet seasons and pCO(2) on inshore reefs distinctly above atmospheric values. However, due to temperature effects, Omega(ar) was not further reduced in the wet season. Aragonite saturation on inshore reefs was consistently lower and pCO(2) higher than on GBR reefs further offshore. Thermodynamic effects contribute to this, and anthropogenic runoff may also contribute by altering productivity (P), respiration (R) and P/R ratios. Compared to surveys 18 and 30 years ago, pCO(2) on GBR mid-and outer-shelf reefs has risen at the same rate as atmospheric values (similar to 1.7 mu atm yr(-1)) over 30 years. By contrast, values on inshore reefs have increased at 2.5 to 3 times higher rates. Thus, pCO(2) levels on inshore reefs have disproportionately increased compared to atmospheric levels. Our study suggests that inshore GBR reefs are more vulnerable to OA and have less buffering capacity compared to offshore reefs. This may be caused by anthropogenically induced trophic changes in the water column and benthos of inshore reefs subjected to land runoff.	[Uthicke, Sven; Furnas, Miles; Lonborg, Christian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Uthicke, S (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	Suthicke@aims.gov.au	Uthicke, Sven/F-1810-2010; Lønborg, Christian/M-4456-2013	Uthicke, Sven/0000-0002-3476-6595; Lønborg, Christian/0000-0001-8380-0238	Australian Government's National Environmental Research Program	Australian Government's National Environmental Research Program(Australian Government)	This work was conducted with the support of funding from the Australian Government's National Environmental Research Program NERP 5.2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2005, ENVIRONM SCI, P187; Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Anthony K, 2011, GLOBAL CHANGE BIOL; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; BARNES DJ, 1983, J EXP MAR BIOL ECOL, V66, P149, DOI 10.1016/0022-0981(83)90036-9; BARNES DJ, 1984, J EXP MAR BIOL ECOL, V79, P213, DOI 10.1016/0022-0981(84)90196-5; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cyronak T, 2014, GEOPHYS RES LETT; Cyronak T, 2013, LIMNOL OCEANOGR, V58, P131, DOI 10.4319/lo.2013.58.1.0131; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Duarte C.M., 2013, ESTUAR COAST, P1; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2008, ECOLOGY, V89, P3163, DOI 10.1890/08-0005.1; Fabricius KE, 2012, MAR POLLUT BULL, V65, P320, DOI 10.1016/j.marpolbul.2011.09.004; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; Friis K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015898; Hintze J., 2001, NCSS PASS NUMBER CRU; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Kawahata H, 2000, MAR CHEM, V72, P257, DOI 10.1016/S0304-4203(00)00085-2; Khatiwala S, 2013, BIOGEOSCIENCES, V10, P2169, DOI 10.5194/bg-10-2169-2013; Kleypas JA, 2011, GLOBAL CHANGE BIOL; KROEKER KJ, 2013, GLOBAL CHANGE BIOL; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; McKinnon AD, 2013, LIMNOL OCEANOGR, V58, P1227, DOI 10.4319/lo.2013.58.4.1227; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nobes K, 2008, J EXP MAR BIOL ECOL, V363, P48, DOI 10.1016/j.jembe.2008.06.015; R Development Core Team, 2012, R LANG ENV STAT COMP; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Robbins PE, 2001, J GEOPHYS RES-OCEANS, V106, P30939, DOI 10.1029/2000JC000451; Russell BD, 2013, MAR POLLUT BULL, V73, P463, DOI 10.1016/j.marpolbul.2013.01.031; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Schaffelke B, 2005, MAR POLLUT BULL, V51, P279, DOI 10.1016/j.marpolbul.2004.10.025; Schaffelke B., 2011, REEF RESCUE MARINE M; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Shaw EC, 2014, MAR CHEM, V158, P49, DOI 10.1016/j.marchem.2013.11.007; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Suzuki A, 2003, TELLUS B, V55, P428, DOI 10.3402/tellusb.v55i2.16761; Suzuki A, 2001, GEOPHYS RES LETT, V28, P1243, DOI 10.1029/2000GL011875; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; TAKAHASHI T, 1993, GLOBAL BIOGEOCHEM CY, V7, P843, DOI 10.1029/93GB02263; Thomas H, 2005, BIOGEOSCIENCES, V2, P323, DOI 10.5194/bg-2-323-2005; Tyrrell T, 2011, PHILOS T R SOC A, V369, P887, DOI [10.1098/rsta.2010.0334, 10.1098/rsta.2010.0331]; Uthicke S, 2014, CORAL REEFS, V33, P831, DOI 10.1007/s00338-014-1165-y; Uthicke S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01769; Uthicke S, 2008, ESTUAR COAST SHELF S, V78, P763, DOI 10.1016/j.ecss.2008.02.014; Uthicke S, 2010, LIMNOL OCEANOGR, V55, P1681, DOI 10.4319/lo.2010.55.4.1681; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Wallace D, 2006, MS EXCEL PROGRAM DEV	55	32	33	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109092	10.1371/journal.pone.0109092	http://dx.doi.org/10.1371/journal.pone.0109092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295864	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000036
J	Begus, K; Gliga, T; Southgate, V				Begus, Katarina; Gliga, Teodora; Southgate, Victoria			Infants Learn What They Want to Learn: Responding to Infant Pointing Leads to Superior Learning	PLOS ONE			English	Article							CURIOSITY; MOTHERS; GAZE	The majority of current developmental models prioritise a pedagogical approach to knowledge acquisition in infancy, in which infants play a relatively passive role as recipients of information. In view of recent evidence, demonstrating that infants use pointing to express interest and solicit information from adults, we set out to test whether giving the child the leading role in deciding what information to receive leads to better learning. Sixteen-month-olds were introduced to pairs of novel objects and, once they had pointed to an object, were shown a function for either the object they had chosen, or the object they had ignored. Ten minutes later, infants replicated the functions of chosen objects significantly more than those of un-chosen objects, despite having been equally visually attentive during demonstrations on both types of objects. These results show that offering information in response to infants' communicative gestures leads to superior learning (Experiment 1) and that this difference in performance is due to learning being facilitated when infants' pointing was responded to, not hindered when their pointing was ignored (Experiment 2), highlighting the importance of infants' own active engagement in acquiring information.	[Begus, Katarina; Gliga, Teodora; Southgate, Victoria] Univ London Birkbeck Coll, Ctr Brain & Cognit Dev, London WC1E 7HX, England	University of London; Birkbeck University London	Begus, K (corresponding author), Univ London Birkbeck Coll, Ctr Brain & Cognit Dev, London WC1E 7HX, England.	k.begus@bbk.ac.uk		Gliga, Teodora/0000-0001-8053-7286; Southgate, Victoria/0000-0001-9328-3019	MRC [G0701484, MR/K021389/1] Funding Source: UKRI; Medical Research Council [MR/K021389/1, G0701484] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BATES E, 1975, MERRILL PALMER QUART, V21, P205; Begus K, 2012, DEVELOPMENTAL SCI, V15, P611, DOI 10.1111/j.1467-7687.2012.01160.x; Bonawitz E, 2011, COGNITION, V120, P322, DOI 10.1016/j.cognition.2010.10.001; Brooks R, 2008, J CHILD LANG, V35, P207, DOI 10.1017/S030500090700829X; Chow V, 2008, DEVELOPMENTAL SCI, V11, P761, DOI 10.1111/j.1467-7687.2008.00726.x; CSIBRA G, 2010, MIND LANG, V25, P141, DOI DOI 10.1111/J.1468-0017.2009.01384.X; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Goldin-Meadow S, 2007, DEVELOPMENTAL SCI, V10, P778, DOI 10.1111/j.1467-7687.2007.00636.x; Goldstein MH, 2010, INFANCY, V15, P362, DOI 10.1111/j.1532-7078.2009.00020.x; Gruber MJ, 2010, J NEUROSCI, V30, P9793, DOI 10.1523/JNEUROSCI.0915-10.2010; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Kang MJ, 2009, PSYCHOL SCI, V20, P963, DOI 10.1111/j.1467-9280.2009.02402.x; Kishimoto T, 2007, INFANT BEHAV DEV, V30, P562, DOI 10.1016/j.infbeh.2007.04.001; Lyons DE, 2007, P NATL ACAD SCI USA, V104, P19751, DOI 10.1073/pnas.0704452104; McGillion ML, 2013, IEEE T AUTON MENT DE, V5, P240, DOI 10.1109/TAMD.2013.2275949; PERLMUTER L C, 1980, Motivation and Emotion, V4, P35, DOI 10.1007/BF00995928; Smith LB, 2011, DEVELOPMENTAL SCI, V14, P9, DOI 10.1111/j.1467-7687.2009.00947.x; Tomasello M, 2007, CHILD DEV, V78, P705, DOI 10.1111/j.1467-8624.2007.01025.x; von Stumm S, 2011, PERSPECT PSYCHOL SCI, V6, P574, DOI 10.1177/1745691611421204; Wu Z, 2014, J CHILD LANG; Zmyj N, 2010, J EXP CHILD PSYCHOL, V106, P208, DOI 10.1016/j.jecp.2010.03.002	21	51	52	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108817	10.1371/journal.pone.0108817	http://dx.doi.org/10.1371/journal.pone.0108817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ4VK	25290444	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000342798000027
J	Chen, H; Zhao, YJ; Li, HT; Zhang, DY; Huang, YZ; Shen, Q; Van Duyne, R; Kashanchi, F; Zeng, C; Liu, SY				Chen, Hao; Zhao, Yunjie; Li, Haotian; Zhang, Dongyan; Huang, Yanzhao; Shen, Qi; Van Duyne, Rachel; Kashanchi, Fatah; Zeng, Chen; Liu, Shiyong			Break CDK2/Cyclin E1 Interface Allosterically with Small Peptides	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; CYCLIN-DEPENDENT KINASE-2; MOLECULAR-DYNAMICS; COMPUTATIONAL DESIGN; STRUCTURAL BASIS; BINDING; ACTIVATION; INHIBITORS; MDM2; P53	Most inhibitors of Cyclin-dependent kinase 2 (CDK2) target its ATP-binding pocket. It is difficult, however, to use this pocket to design very specific inhibitors because this catalytic pocket is highly conserved in the protein family of CDKs. Here we report some short peptides targeting a noncatalytic pocket near the interface of the CDK2/Cyclin complex. Docking and molecular dynamics simulations were used to select the peptides, and detailed dynamical network analysis revealed that these peptides weaken the complex formation via allosteric interactions. Our experiments showed that upon binding to the noncatalytic pocket, these peptides break the CDK2/Cyclin complex partially and diminish its kinase activity in vitro. The binding affinity of these peptides measured by Surface Plasmon Resonance can reach as low as 0.5 mu M.	[Li, Haotian; Zhang, Dongyan; Huang, Yanzhao; Zeng, Chen; Liu, Shiyong] Huazhong Univ Sci & Technol, Dept Phys, Wuhan 430074, Hubei, Peoples R China; [Chen, Hao; Zhao, Yunjie; Zeng, Chen] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Shen, Qi] Peking Univ, Ctr Quantitat Biol, BNLMS, Beijing 100871, Peoples R China; [Van Duyne, Rachel; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA; [Van Duyne, Rachel] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA	Huazhong University of Science & Technology; George Washington University; Chinese Academy of Sciences; Peking University; George Mason University; George Washington University	Liu, SY (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Wuhan 430074, Hubei, Peoples R China.	liushiyong@gmail.com	Van Duyne, Rachel/ABI-2429-2020; Liu, Shiyong/P-1086-2019; liu, shiyong/A-9370-2011; Van Duyne, Rachel/I-7365-2019	Van Duyne, Rachel/0000-0003-2914-6874; Liu, Shiyong/0000-0001-7986-5178; liu, shiyong/0000-0001-7986-5178; 	National Natural Science Foundation of China [31100522]; National High Technology Research and Development Program of China [2012AA020402]; Specialized Research Fund for the Doctoral Program of Higher Education [20110142120038]; Fundamental Research Funds for the Central Universities, [HUST: 2013QN019]; NSFC [11174093]; George Mason University funds; NIH [AI043894]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043894] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities,(Fundamental Research Funds for the Central Universities); NSFC(National Natural Science Foundation of China (NSFC)); George Mason University funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SYL is supported by the National Natural Science Foundation of China [31100522]; and the National High Technology Research and Development Program of China [2012AA020402]; and Specialized Research Fund for the Doctoral Program of Higher Education [20110142120038]; and the Fundamental Research Funds for the Central Universities, HUST: 2013QN019. YZH is supported by NSFC [11174093]. FK is supported by George Mason University funds and NIH grant AI043894. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbottah E, 2006, VIROLOGY, V345, P373, DOI 10.1016/j.virol.2005.09.062; Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Arkin M, 2005, CURR OPIN CHEM BIOL, V9, P317, DOI 10.1016/j.cbpa.2005.03.001; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arris CE, 2000, J MED CHEM, V43, P2797, DOI 10.1021/jm990628o; Barrett CP, 2005, J BIOL CHEM, V280, P13993, DOI 10.1074/jbc.M407371200; Bartova I, 2004, PROTEIN SCI, V13, P1449, DOI 10.1110/ps.03578504; Bartova I, 2008, PROTEIN SCI, V17, P22, DOI 10.1110/ps.072951208; Betzi S, 2011, ACS CHEM BIOL, V6, P492, DOI 10.1021/cb100410m; Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; Chen H, 2009, PROTEINS, V74, P122, DOI 10.1002/prot.22136; Dagliyan O, 2011, STRUCTURE, V19, P1837, DOI 10.1016/j.str.2011.09.014; Easley R, 2010, J VIROL, V84, P4755, DOI 10.1128/JVI.00851-09; Echalier A, 2010, BBA-PROTEINS PROTEOM, V1804, P511, DOI 10.1016/j.bbapap.2009.10.002; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fu XR, 2007, J MOL BIOL, V371, P1099, DOI 10.1016/j.jmb.2007.04.069; Futamura M, 2005, J BIOL CHEM, V280, P5414, DOI 10.1074/jbc.M411719200; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gondeau C, 2005, J BIOL CHEM, V280, P13793, DOI 10.1074/jbc.M413690200; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang L, 2002, PROTEINS, V46, P190, DOI 10.1002/prot.10031; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; London N, 2013, CURR OPIN STRUC BIOL, V23, P894, DOI 10.1016/j.sbi.2013.07.006; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Liu S, 2007, P NATL ACAD SCI USA, V104, P5330, DOI 10.1073/pnas.0606198104; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Slivka PF, 2009, CHEMBIOCHEM, V10, P645, DOI 10.1002/cbic.200800769; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Trellet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058769; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Duyne R, 2008, VIROLOGY, V376, P308, DOI 10.1016/j.virol.2008.02.036; Vanhee P, 2011, TRENDS BIOTECHNOL, V29, P231, DOI 10.1016/j.tibtech.2011.01.004; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verschueren E, 2013, STRUCTURE, V21, P789, DOI 10.1016/j.str.2013.02.023; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Winter A, 2012, Q REV BIOPHYS, P1; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wu KL, 2004, J BIOL CHEM, V279, P495, DOI 10.1074/jbc.M310069200; Zacharias M, 2012, PROTEINS; Zhang CS, 2013, ANGEW CHEM INT EDIT, V52, P11059, DOI 10.1002/anie.201305963	55	16	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109154	10.1371/journal.pone.0109154	http://dx.doi.org/10.1371/journal.pone.0109154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290691	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000040
J	Lorente, L; Martin, MM; Gonzalez-Rivero, AF; Ferreres, J; Sole-Violan, J; Labarta, L; Diaz, C; Jimenez, A; Borreguero-Leon, JM				Lorente, Leonardo; Martin, Maria M.; Gonzalez-Rivero, Agustin F.; Ferreres, Jose; Sole-Violan, Jordi; Labarta, Lorenzo; Diaz, Cesar; Jimenez, Alejandro; Borreguero-Leon, Juan M.			Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study	PLOS ONE			English	Article							THERAPEUTIC TARGET; SEVERE SEPSIS; APOPTOSIS; SURVIVAL; BIOMARKERS; FRAGMENTS; IMPROVES; LIVER	Objective: Apoptosis is increased in sepsis. Cytokeratin 18 (CK-18), a protein of the intermediate filament group present in most epithelial and parenchymal cells, is cleaved by the action of caspases and released into the blood as caspase-cleaved CK (CCCK)-18 during apoptosis. Circulating levels of CCCK-18 have scarcely been explored in septic patients. In one study with 101 severe septic patients, the authors reported higher serum CCCK-18 levels in non-survivors than in survivors; however, the sample size was too small to demonstrate an association between serum CCCK-18 levels and early mortality and whether they could be used as a biomarker to predict outcomes in septic patients. Thus, these were the objectives of this study with a large series of patients. Methods: We performed a prospective, multicenter, observational study in six Spanish Intensive Care Units with 224 severe septic patients. Blood samples were collected at the time that severe sepsis was diagnosed to determine serum levels of CCCK-18, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6 and IL-10. The end point was 30-day mortality. Results: Non-surviving patients (n = 80) showed higher serum CCCK-18 levels (P<0.001) than survivors (n = 144). Multiple logistic regression analysis showed that serum CCCK-18 levels>391 u/L were associated with 30-day survival (Odds ratio = 2.687; 95% confidence interval = 1.449-4.983; P = 0.002), controlling for SOFA score, serum lactic acid levels and age. Kaplan-Meier survival analysis showed that the risk of death in septic patients with serum CCCK-18 levels >391 u/L was higher than in patients with lower values (Hazard Ratio = 3.1; 95% CI = 1.96-4.84; P<0.001). Serum CCCK-18 levels were positively associated with serum levels of IL-6 and lactic acid, and with SOFA and APACHE scores. Conclusions: The major novel finding of our study, the largest cohort of septic patients providing data on circulating CCCK-18 levels, was that serum CCCK-18 levels are associated with mortality in severe septic patients.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Tenerife, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Tenerife, Spain; [Gonzalez-Rivero, Agustin F.; Borreguero-Leon, Juan M.] Hosp Univ Canarias, Dept Lab, Tenerife, Spain; [Ferreres, Jose] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Labarta, Lorenzo] Hosp San Jorge, Intens Care Unit, Huesca, Spain; [Diaz, Cesar] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; Hospital Clinic Universitari de Valencia; Hospital Universidad San Jorge; Universidad de la Laguna	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Tenerife, Spain.	lorentemartin@msn.com	Borreguero León, Juan María/ABQ-2161-2022; Martín, María/HDL-9512-2022	Borreguero León, Juan María/0000-0001-7414-5278; 	Instituto de Salud Carlos III (Madrid, Spain) [FIS-PI-10-01572, I3SNS-INT-11-063, I3SNS-INT-12-087]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This study was supported in part by grants from Instituto de Salud Carlos III (FIS-PI-10-01572, I3SNS-INT-11-063, and I3SNS-INT-12-087) (Madrid, Spain) and co-financed by Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Chung CS, 2003, J LEUKOCYTE BIOL, V74, P344, DOI 10.1189/jlb.0102006; Fischer U, 2005, CELL DEATH DIFFER, V12, P942, DOI 10.1038/sj.cdd.4401556; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Hagg M, 2002, INVEST NEW DRUG, V20, P253, DOI 10.1023/A:1016249728664; Harjai M, 2013, ANAESTH INTENS CARE, V41, P175, DOI 10.1177/0310057X1304100207; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Huttunen R, 2011, J INFECTION, V63, P407, DOI 10.1016/j.jinf.2011.08.004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Luft T, 2007, BLOOD, V110, P4535, DOI 10.1182/blood-2006-10-049817; Moore DJ, 2012, CLIN DRUG INVEST, V32, P179, DOI 10.2165/11598610-000000000-00000; Parfieniuk-Kowerda A, 2014, LIVER INT, V34, P544, DOI 10.1111/liv.12297; Roth GA, 2004, SHOCK, V22, P218, DOI 10.1097/01.shk.0000136098.49672.0e; Sgier C, 2010, J VIRAL HEPATITIS, V17, P845, DOI 10.1111/j.1365-2893.2009.01251.x; Sumer S, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10106; Ueno T, 2003, EUR J CANCER, V39, P769, DOI 10.1016/S0959-8049(02)00865-1; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764	26	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109618	10.1371/journal.pone.0109618	http://dx.doi.org/10.1371/journal.pone.0109618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290885	Green Published, gold			2022-12-27	WOS:000342798000073
J	Zhou, Q; Wang, CC; Wang, XF; Wu, XY; Zhu, ZG; Liu, BY; Su, LP				Zhou, Quan; Wang, Chenchen; Wang, Xiaofeng; Wu, Xiongyan; Zhu, Zhenggang; Liu, Bingya; Su, Liping			Association between TLR4 (+896A/G and+1196C/T) Polymorphisms and Gastric Cancer Risk: An Updated Meta-Analysis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; HELICOBACTER-PYLORI; GENE POLYMORPHISMS; THR399ILE POLYMORPHISMS; SUSCEPTIBILITY; POPULATION; VARIANTS; PATTERNS; LESIONS	Background: Toll-like receptor 4 (TLR4) is a receptor of lipopolysaccharide in the signaling transduction of gastric epithelial cell. It plays a pivotal role in activation of innate immunity and pathogen recognition and thus acts as a modulator in the development and progression of gastric cancer. Growing studies explored the association of polymorphisms in TLR4 with susceptibility to gastric cancer, but the results have remained controversial and conflicting. To investigate the effect of two selected TLR4 (+896A/G and +1196C/T) polymorphisms on gastric cancer, we performed a meta-analysis. Methods: A comprehensive search was conducted to identify all eligible case-control publications investigating the association between TLR4 polymorphisms and gastric cancer risk. Odds ratios (OR) and corresponding 95% confidence intervals (CI) were used to assess such association. Results: Up to March 26 2014, 10 published case-control studies from PubMed and EMBase were available, involving a total of 1888 gastric cancer patients and 3433 control subjects. In the overall meta-analyses, a significantly increased gastric cancer risk was detected in TLR4 +896A/G polymorphism (heterozygous model, AG vs. AA: OR = 1.67, 95% CI, 1.39-2.01; additive model, G vs. A: OR = 1.64, 95% CI, 1.37-1.95) and TLR4 +1196C/T polymorphism (heterozygous model, CT vs. CC: OR = 1.42, 95% CI, 1.11-1.81; additive model, T vs. C: OR = 1.36, 95% CI, 1.08-1.72), similar results were obtained in the subgroup analyses of Caucasian, whereas no associations were detected in any genetic models of non-Caucasian. Conclusions: The overall results suggest that TLR4 polymorphisms (+896A/G and +1196C/T) may be associated with a significantly increased gastric cancer risk in Caucasian.	[Zhou, Quan; Wang, Chenchen; Wang, Xiaofeng; Wu, Xiongyan; Zhu, Zhenggang; Liu, Bingya; Su, Liping] Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Dept Surg,Sch Med,Shanghai Key Lab Gastr Neoplasm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Dept Surg,Sch Med,Shanghai Key Lab Gastr Neoplasm, Shanghai 200030, Peoples R China.	byliu@sjtu.edu.cn; franesulp@hotmail.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China (NSFC) [81272749, 91229106]; Science and Technology Commission of Shanghai Municipality [11jc1407602, 14DZ2272200]; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine [BXJ201318]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine	This work was supported by National Natural Science Foundation of China (NSFC) - No. 81272749 [LPS] http://www.nsfc.gov.cn/; Science and Technology Commission of Shanghai Municipality (No. 11jc1407602). [LPS] http://www.stcsm.gov.cn/; National Natural Science Foundation of China (NSFC) No. 91229106 [BYL] http://www.nsfc.gov.cn/; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ201318). [QZ] http://yjsy.shsmu.edu.cn/; Science and Technology Commission of Shanghai Municipality (No. 14DZ2272200) [ZGZ] http://www.stcsm.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2007, HUM IMMUNOL, V68, P901, DOI 10.1016/j.humimm.2007.10.006; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Armant MA, 2002, GENOME BIOL, V3; Bagheri N, 2014, CLIN RES HEPATOL GAS, V38, P366, DOI 10.1016/j.clinre.2013.12.004; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bornschein J, 2011, LANGENBECK ARCH SURG, V396, P729, DOI 10.1007/s00423-011-0810-y; Chen J, 2013, CANCER BIOTHER RADIO, V28, P674, DOI 10.1089/cbr.2012.1395; Cole SW, 2009, J CLIN ONCOL, V27, P3418, DOI 10.1200/JCO.2009.21.9782; Companioni O, 2014, INT J CANCER, V134, P92, DOI 10.1002/ijc.28357; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; de Oliveira JG, 2013, DIGEST DIS SCI, V58, P978, DOI 10.1007/s10620-012-2460-5; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Fan YF, 2014, HUM IMMUNOL, V75, P176, DOI 10.1016/j.humimm.2013.11.002; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; Hamajima Nobuyuki, 2003, Nagoya J Med Sci, V66, P103; He CY, 2014, MUTAT RES-REV MUTAT, V759, P14, DOI 10.1016/j.mrrev.2013.09.002; Hishida A, 2010, WORLD J GASTRO ONCOL, V2, P369, DOI 10.4251/wjgo.v2.i10.369; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Jing JJ, 2012, GENE, V499, P237, DOI 10.1016/j.gene.2012.03.045; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kato I, 2007, DIGEST DIS SCI, V52, P254, DOI 10.1007/s10620-006-9303-1; Kazma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051680; Kutikhin AG, 2014, TUMOR BIOL, V35, P4821, DOI 10.1007/s13277-014-1633-6; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Qadri Q, 2014, IMMUNOL INVEST, V43, P324, DOI 10.3109/08820139.2013.854378; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Trejo-de la O A, 2008, CLIN IMMUNOL, V129, P333, DOI 10.1016/j.clim.2008.07.009; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016; Ward R, 2014, BIOSTATISTICS, V15, P74, DOI 10.1093/biostatistics/kxt028; WHO: World Health Organization: stomach cancer, 2014, EST INC MORT PREV WO; Zhang K, 2013, EUR J CANCER, V49, P946, DOI 10.1016/j.ejca.2012.09.022; Zhu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102443; Zou TH, 2013, TUMOR BIOL, V34, P2441, DOI 10.1007/s13277-013-0795-y	46	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109605	10.1371/journal.pone.0109605	http://dx.doi.org/10.1371/journal.pone.0109605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290654	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000072
J	Bienick, MS; Young, KW; Klesmith, JR; Detwiler, EE; Tomek, KJ; Whitehead, TA				Bienick, Matthew S.; Young, Katherine W.; Klesmith, Justin R.; Detwiler, Emily E.; Tomek, Kyle J.; Whitehead, Timothy A.			The Interrelationship between Promoter Strength, Gene Expression, and Growth Rate	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; PLASMIDS; COST	In exponentially growing bacteria, expression of heterologous protein impedes cellular growth rates. Quantitative understanding of the relationship between expression and growth rate will advance our ability to forward engineer bacteria, important for metabolic engineering and synthetic biology applications. Recently, a work described a scaling model based on optimal allocation of ribosomes for protein translation. This model quantitatively predicts a linear relationship between microbial growth rate and heterologous protein expression with no free parameters. With the aim of validating this model, we have rigorously quantified the fitness cost of gene expression by using a library of synthetic constitutive promoters to drive expression of two separate proteins (eGFP and amiE) in E. coli in different strains and growth media. In all cases, we demonstrate that the fitness cost is consistent with the previous findings. We expand upon the previous theory by introducing a simple promoter activity model to quantitatively predict how basal promoter strength relates to growth rate and protein expression. We then estimate the amount of protein expression needed to support high flux through a heterologous metabolic pathway and predict the sizable fitness cost associated with enzyme production. This work has broad implications across applied biological sciences because it allows for prediction of the interplay between promoter strength, protein expression, and the resulting cost to microbial growth rates.	[Bienick, Matthew S.; Young, Katherine W.; Detwiler, Emily E.; Tomek, Kyle J.; Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Young, Katherine W.] Michigan State Univ, High Sch Honors Sci Math Engn Program, E Lansing, MI 48824 USA; [Klesmith, Justin R.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Whitehead, TA (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.	taw@msu.edu		Young, Katherine/0000-0003-1808-5658; Whitehead, Timothy/0000-0003-3177-1361; Klesmith, Justin/0000-0003-2908-9355; Wrenbeck, Emily/0000-0003-0096-0768	National Science Foundation [CBET -1254238]; Directorate For Engineering [1254238] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding for this work was supplied by a National Science Foundation CAREER award to TAW (CBET -1254238; www.nsf.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MK, 2009, METAB ENG, V11, P139, DOI 10.1016/j.ymben.2009.01.002; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Andrade J, 2007, J BIOL CHEM, V282, P19598, DOI 10.1074/jbc.M701039200; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Blanch HW, 1996, BIOCH ENG, Vxii; Bremer H, 1996, ESCHERICHIA COLI SAL; Cardinale S, 2013, CELL REP, V4, P231, DOI 10.1016/j.celrep.2013.06.023; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Green MR, 2012, MOL CLONING LAB MANU, V1; HELLMUTH K, 1994, J BIOTECHNOL, V32, P289, DOI 10.1016/0168-1656(94)90215-1; Hintsche M, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-22; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Karpinets TV, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-30; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; Klumpp S, 2013, P NATL ACAD SCI USA, V110, P16754, DOI 10.1073/pnas.1310377110; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lee ME, 2013, NUCLEIC ACIDS RES, V41, P10668, DOI 10.1093/nar/gkt809; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Marbach A, 2012, J BIOTECHNOL, V157, P82, DOI 10.1016/j.jbiotec.2011.10.009; Milo R, 2012, SCIENCE, V336, P1663, DOI 10.1126/science.1217665; Mosier AC, 2013, MBIO, V4, DOI 10.1128/mBio.00484-12; Olson EJ, 2014, NAT METHODS, V11, P449, DOI 10.1038/nmeth.2884; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Plata G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r98; Rang C, 2003, CAN J MICROBIOL, V49, P531, DOI 10.1139/w03-072; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; SEARLE PL, 1984, ANALYST, V109, P549, DOI 10.1039/an9840900549; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tran NP, 2008, J BACTERIOL, V190, P3213, DOI 10.1128/JB.01936-07; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x	42	55	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109105	10.1371/journal.pone.0109105	http://dx.doi.org/10.1371/journal.pone.0109105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286161	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700044
J	Han, YL; Shi, LL; Meng, J; Yu, HB; Zhang, XY				Han, Yuling; Shi, Lili; Meng, Jing; Yu, Hongbo; Zhang, Xiaoyu			Azo Dye Biodecolorization Enhanced by Echinodontium taxodii Cultured with Lignin	PLOS ONE			English	Article							WHITE-ROT FUNGI; LACCASE-CATALYZED MODIFICATION; ENZYMATIC-HYDROLYSIS; PHANEROCHAETE-CHRYSOSPORIUM; BIOLOGICAL PRETREATMENT; MICROBIAL-DEGRADATION; NATURAL MEDIATORS; CRYSTAL VIOLET; DECOLORIZATION; PLEUROTUS	Lignocellulose facilitates the fungal oxidization of recalcitrant organic pollutants through the extracellular ligninolytic enzymes induced by lignin in wood or other plant tissues. However, available information on this phenomenon is insufficient. Free radical chain reactions during lignin metabolism are important in xenobiotic removal. Thus, the effect of lignin on azo dye decolorization in vivo by Echinodontium taxodii was evaluated. In the presence of lignin, optimum decolorization percentages for Remazol Brilliant Violet 5R, Direct Red 5B, Direct Black 38, and Direct Black 22 were 91.75% (control, 65.96%), 76.89% (control, 43.78%), 43.44% (control, 17.02%), and 44.75% (control, 12.16%), respectively, in the submerged cultures. Laccase was the most important enzyme during biodecolorization. Aside from the stimulating of laccase activity, lignin might be degraded by E. taxodii, and then these degraded low-molecular-weight metabolites could act as redox mediators promoting decolorization of azo dyes. The relationship between laccase and lignin degradation was investigated through decolorization tests in vitro with purified enzyme and dozens of aromatics, which can be derivatives of lignin and can function as laccase mediators or inducers. Dyes were decolorized at triple or even higher rates in certain laccase-aromatic systems at chemical concentrations as low as 10 mu M.	[Han, Yuling; Shi, Lili; Meng, Jing; Yu, Hongbo; Zhang, Xiaoyu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhang, XY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	xyzhang.imer@gmail.com	Zhang, xiaoyu/GXA-3206-2022; Zhang, xiaoyu/A-6515-2015; Yu, Hongbo/B-5696-2009	Yu, Hongbo/0000-0002-7482-7292	National Natural Science Foundation of China [31170104/C010501]; National High Technology Research and Development Program of China (863 Program) [2012AA101805]; Cooperation Project in Industry, Education and Research of Guangdong Province; Ministry of Education of P.R. China [2008B090500217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Cooperation Project in Industry, Education and Research of Guangdong Province; Ministry of Education of P.R. China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (Grant No. 31170104/C010501), National High Technology Research and Development Program of China (863 Program) (No. 2012AA101805), and the Cooperation Project in Industry, Education and Research of Guangdong Province and Ministry of Education of P.R. China, 2008B090500217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgher M, 2008, BIODEGRADATION, V19, P771, DOI 10.1007/s10532-008-9185-3; Binupriya AR, 2008, BIORESOURCE TECHNOL, V99, P1080, DOI 10.1016/j.biortech.2007.02.022; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Burkinshaw SM, 2013, DYES PIGMENTS, V99, P548, DOI 10.1016/j.dyepig.2013.06.006; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Camarero S, 2008, ENVIRON SCI TECHNOL, V42, P6703, DOI 10.1021/es8008979; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; CHEN CL, 1983, J WOOD CHEM TECHNOL, V3, P35, DOI 10.1080/02773818308085150; de Souza SMAGU, 2007, J HAZARD MATER, V147, P1073, DOI 10.1016/j.jhazmat.2007.06.003; Erkurt EA, 2010, HANDB ENVIRON CHEM, V9, P157, DOI 10.1007/698_2009_48; Gao DW, 2010, CRIT REV BIOTECHNOL, V30, P70, DOI 10.3109/07388550903427272; de Souza SMDGU, 2010, J HAZARD MATER, V179, P35, DOI 10.1016/j.jhazmat.2010.02.053; GUTIERREZ A, 1994, APPL ENVIRON MICROB, V60, P1783; Ibrahim V, 2013, J MOL CATAL B-ENZYM, V97, P45, DOI 10.1016/j.molcatb.2013.07.014; Isik M, 2007, ENZYME MICROB TECH, V40, P934, DOI 10.1016/j.enzmictec.2006.07.032; Johannes C, 2000, APPL ENVIRON MICROB, V66, P524, DOI 10.1128/AEM.66.2.524-528.2000; Kaushik P, 2009, ENVIRON INT, V35, P127, DOI 10.1016/j.envint.2008.05.010; Kudlich M, 1997, APPL ENVIRON MICROB, V63, P3691, DOI 10.1128/AEM.63.9.3691-3694.1997; Lin YH, 2011, J ENVIRON SCI, V23, P2055, DOI 10.1016/S1001-0742(10)60643-2; Liu JY, 2012, B ENVIRON CONTAM TOX, V89, P269, DOI 10.1007/s00128-012-0678-8; Ma FY, 2010, BIORESOURCE TECHNOL, V101, P9600, DOI 10.1016/j.biortech.2010.07.084; Moilanen U, 2011, ENZYME MICROB TECH, V49, P492, DOI 10.1016/j.enzmictec.2011.09.012; Ozmen N, 2012, BIORESOURCES, V7, P1656; Parshetti GK, 2010, J HAZARD MATER, V176, P503, DOI 10.1016/j.jhazmat.2009.11.058; Piccolo A, 2002, ADV AGRON, V75, P57, DOI 10.1016/S0065-2113(02)75003-7; Puvaneswari N., 2006, Indian Journal of Experimental Biology, V44, P618; Rencoret J, 2014, BIOCHEM ENG J, V86, P16, DOI 10.1016/j.bej.2014.02.013; ROGALSKI J, 1991, PHYTOCHEMISTRY, V30, P2869, DOI 10.1016/S0031-9422(00)98215-3; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; TIEN M, 1988, METHOD ENZYMOL, V161, P238; Tinoco R, 2011, J IND MICROBIOL BIOT, V38, P531, DOI 10.1007/s10295-010-0797-3; Tychanowicz GK, 2004, PROCESS BIOCHEM, V39, P855, DOI 10.1016/S0032-9592(03)00194-8; Verma P, 2002, APPL BIOCHEM BIOTECH, V102, P109, DOI 10.1385/ABAB:102-103:1-6:109; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; WOLFENDEN BS, 1982, J CHEM SOC PERK T 2, P805, DOI 10.1039/p29820000805; Yan KL, 2009, J BIOSCI BIOENG, V108, P421, DOI 10.1016/j.jbiosc.2009.05.001; Yan KL, 2009, J MICROBIOL BIOTECHN, V19, P1421, DOI 10.4014/jmb.0901.0033; Yang XW, 2010, BIORESOURCE TECHNOL, V101, P5475, DOI 10.1016/j.biortech.2010.01.129; Yu HB, 2010, J BIOSCI BIOENG, V110, P660, DOI 10.1016/j.jbiosc.2010.08.002; Yu HB, 2009, BIORESOURCE TECHNOL, V100, P5170, DOI 10.1016/j.biortech.2009.05.049; Zhang XY, 2007, INT BIODETER BIODEGR, V60, P159, DOI 10.1016/j.ibiod.2007.02.003	41	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109786	10.1371/journal.pone.0109786	http://dx.doi.org/10.1371/journal.pone.0109786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285777	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700090
J	Joly, M; Ammersdorfer, S; Schmidtke, D; Zimmermann, E				Joly, Marine; Ammersdoerfer, Sandra; Schmidtke, Daniel; Zimmermann, Elke			Touchscreen-Based Cognitive Tasks Reveal Age-Related Impairment in a Primate Aging Model, the Grey Mouse Lemur (Microcebus murinus)	PLOS ONE			English	Article							OPERANT PLATFORM; NONHUMAN PRIMATE; SLEEPING SITES; TAU-PROTEINS; MEMORY; REVERSAL; RATS; DISCRIMINATION; ACQUISITION; PERFORMANCE	Mouse lemurs are suggested to represent promising novel non-human primate models for aging research. However, standardized and cross-taxa cognitive testing methods are still lacking. Touchscreen-based testing procedures have proven high stimulus control and reliability in humans and rodents. The aim of this study was to adapt these procedures to mouse lemurs, thereby exploring the effect of age. We measured appetitive learning and cognitive flexibility of two age groups by applying pairwise visual discrimination (PD) and reversal learning (PDR) tasks. On average, mouse lemurs needed 24 days of training before starting with the PD task. Individual performances in PD and PDR tasks correlate significantly, suggesting that individual learning performance is unrelated to the respective task. Compared to the young, aged mouse lemurs showed impairments in both PD and PDR tasks. They needed significantly more trials to reach the task criteria. A much higher inter-individual variation in old than in young adults was revealed. Furthermore, in the PDR task, we found a significantly higher perseverance in aged compared to young adults, indicating an age-related deficit in cognitive flexibility. This study presents the first touchscreen-based data on the cognitive skills and age-related dysfunction in mouse lemurs and provides a unique basis to study mechanisms of inter-individual variation. It furthermore opens exciting perspectives for comparative approaches in aging, personality, and evolutionary research.	[Joly, Marine; Ammersdoerfer, Sandra; Schmidtke, Daniel; Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Zimmermann, E (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Germany.	elke.zimmermann@tiho-hannover.de	Joly, Marine/P-5990-2014	Joly, Marine/0000-0002-0784-5167	European Community's 7th Framework Programme [278486]	European Community's 7th Framework Programme	This study is part of a project which has received funding from the European Community's 7th Framework Programme (FP7/2007-2013) under grant agreement no 278486 acronym "DEVELAGE" (http://www.develage.eu/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barense MD, 2002, LEARN MEMORY, V9, P191, DOI 10.1101/lm.48602; Bons N, 2006, GENES BRAIN BEHAV, V5, P120, DOI 10.1111/j.1601-183X.2005.00149.x; BONS N, 1995, CR ACAD SCI III-VIE, V318, P741; Boutet I, 2007, J COMP PSYCHOL, V121, P270, DOI 10.1037/0735-7036.121.3.270; Brushfield AM, 2008, BEHAV NEUROSCI, V122, P54, DOI 10.1037/0735-7044.122.1.54; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P957, DOI 10.1037/0735-7044.115.4.957; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; DELACOURTE A, 1995, CR ACAD SCI III-VIE, V318, P85; Dhenain M, 2000, NEUROBIOL AGING, V21, P81, DOI 10.1016/S0197-4580(00)00098-1; Dhenain M, 2003, MAGNET RESON MED, V50, P984, DOI 10.1002/mrm.10612; Dhenain M, 1998, NEUROBIOL AGING, V19, P65, DOI 10.1016/S0197-4580(98)00005-0; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dkhissi-Benyahya O, 2001, J COMP NEUROL, V438, P490, DOI 10.1002/cne.1330; Dubicanac M, 2013, 13 C GES PRIM HAMB 6, P52; Herndon JG, 1997, BEHAV BRAIN RES, V87, P25, DOI 10.1016/S0166-4328(96)02256-5; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Joly M, 2006, NEUROBIOL AGING, V27, P1045, DOI 10.1016/j.neurobiolaging.2005.05.001; Joly M, 2011, BIOL LETTERS, V7, P638, DOI 10.1098/rsbl.2011.0258; Lacreuse A, 2014, NEUROBIOL AGING, V35, P623, DOI 10.1016/j.neurobiolaging.2013.08.036; LAI ZC, 1995, NEUROBIOL AGING, V16, P947, DOI 10.1016/0197-4580(95)02014-4; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Mar AC, 2013, NAT PROTOC, V8, P1985, DOI 10.1038/nprot.2013.123; Nagahara AH, 2010, NEUROBIOL AGING, V31, P1020, DOI 10.1016/j.neurobiolaging.2008.07.007; Oomen CA, 2013, NAT PROTOC, V8, P2006, DOI 10.1038/nprot.2013.124; Perret M, 1997, J BIOL RHYTHM, V12, P136, DOI 10.1177/074873049701200205; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; Radespiel U, 1998, AM J PRIMATOL, V46, P77, DOI 10.1002/(SICI)1098-2345(1998)46:1<77::AID-AJP6>3.3.CO;2-#; Radespiel U, 2000, AM J PRIMATOL, V51, P21, DOI 10.1002/(SICI)1098-2345(200005)51:1<21::AID-AJP3>3.0.CO;2-C; Radespiel U, 2003, AM J PRIMATOL, V59, P139, DOI 10.1002/ajp.10071; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Romberg C, 2013, NEUROBIOL AGING, V34, P731, DOI 10.1016/j.neurobiolaging.2012.08.006; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Schmid J, 1998, BEHAV ECOL SOCIOBIOL, V43, P125, DOI 10.1007/s002650050474; Schoenbaum G, 2006, J NEUROPHYSIOL, V95, P1509, DOI 10.1152/jn.01052.2005; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Spinelli S, 2003, J PSYCHOPHARMACOL, V17, pA60; Trouche SG, 2010, NEUROBIOL LEARN MEM, V94, P100, DOI 10.1016/j.nlm.2010.04.006; Voytko ML, 1999, NEUROBIOL AGING, V20, P617, DOI 10.1016/S0197-4580(99)00097-4; Weed MR, 1999, COGNITIVE BRAIN RES, V8, P185, DOI 10.1016/S0926-6410(99)00020-8; Weiler JA, 2008, LEARN MEMORY, V15, P190, DOI 10.1101/lm.890408; Winters BD, 2010, NEUROBIOL LEARN MEM, V93, P221, DOI 10.1016/j.nlm.2009.10.002; Wrogemann D, 2001, INT J PRIMATOL, V22, P91, DOI 10.1023/A:1026418132281; Zimmermann E, 1998, FOLIA PRIMATOL, V69, P106, DOI 10.1159/000021571; Zimmermann E, DWARF MOUSE LEMURS M; Zimmermann Elke, 2007, P1163, DOI 10.1007/978-3-540-33761-4_38; Zurcher NR, 2010, J NEUROSCI METH, V188, P219, DOI 10.1016/j.jneumeth.2010.02.011	50	49	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109393	10.1371/journal.pone.0109393	http://dx.doi.org/10.1371/journal.pone.0109393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299046	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200050
J	Kazi, AM; Warraich, GJ; Qureshi, S; Khan, MMA; Khan, MMA; Zaidi, AKM				Kazi, Abdul Momin; Warraich, Gohar Javed; Qureshi, Shahida; Qureshi, Huma; Khan, Muhammad Mubashir Ahmad; Zaidi, Anita Kaniz Mehdi		Pakistan Rotavirus Study Grp	Sentinel Hospital-Based Surveillance for Assessment of Burden of Rotavirus Gastroenteritis in Children in Pakistan	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; CHILDHOOD DIARRHEA; STRAIN DIVERSITY; VACCINE; DISEASE; EPIDEMIOLOGY; MULTICENTER; BANGLADESH; MORTALITY; ETIOLOGY	Objectives: To determine the burden and molecular epidemiology of rotavirus gastroenteritis in children hospitalized with severe acute watery diarrhea in Pakistan prior to introduction of rotavirus vaccine. Methods: A cross-sectional study was carried out over a period of two years from 2006 - 2008 at five sentinel hospitals in the cities of Karachi, Lahore, Rawalpindi, and Peshawar. Stool samples collected from children under five years of age hospitalized with severe acute watery diarrhea were tested for rotavirus antigen via enzyme immunoassay (EIA) (IDEA REF K6020 Oxoid Ltd (Ely), Cambridge, United Kingdom). A subset of EIA positive stool samples were further processed for genotyping. Results: 6679 children were enrolled and stool specimens of 2039 (30.5%) were positive for rotavirus. Rotavirus positivity ranged from 16.3% to 39.4% in the 5 hospitals with highest positivity in Lahore. 1241 (61%) of all rotavirus cases were in infants under one year of age. Among the strains examined for G-serotypes, the occurrence of G1, G2, G9 and G4 strains was found to be 28%, 24%, 14% and 13%, respectively. Among P-types, the most commonly occurring strains were P6 (31.5%) followed by P8 (20%) and P4 (12%). Prevalent rotavirus genotype in hospitalized children of severe diarrhea were G1P[8] 11.6% (69/593), followed by G2P[4] 10.4% (62/593), and G4P[6] 10.1% (60/593). Conclusions: Approximately one third of children hospitalized with severe gastroenteritis in urban centers in Pakistan have rotavirus. Introduction of rotavirus vaccine in Pakistan's national immunization program could prevent many severe episodes and diarrheal deaths.	[Kazi, Abdul Momin; Warraich, Gohar Javed; Qureshi, Shahida; Zaidi, Anita Kaniz Mehdi] Aga Khan Univ, Karachi, Pakistan; [Qureshi, Huma; Khan, Muhammad Mubashir Ahmad] Pakistan Med Res Council, Islamabad, Pakistan	Aga Khan University; Pakistan Medical Research Council	Zaidi, AKM (corresponding author), Aga Khan Univ, Karachi, Pakistan.	anita.zaidi@aku.edu			Program for Appropriate Technology in Health (PATH), USA; Fogarty International Center, National Institute of Health, USA [ID43 TW0075 85-01]	Program for Appropriate Technology in Health (PATH), USA; Fogarty International Center, National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant from the Program for Appropriate Technology in Health (PATH), USA. AMK received partial training support from the Fogarty International Center, National Institute of Health, USA (Grant number: ID43 TW0075 85-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agboatwalla Mubina, 1995, Indian Journal of Pediatrics, V62, P345, DOI 10.1007/BF02753600; Alam MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067998; [Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P533; Assis ASF, 2013, J PEDIAT-BRAZIL, V89, P470, DOI 10.1016/j.jped.2013.02.019; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Bass ES, 2007, PEDIATR REV, V28, P183, DOI 10.1542/pir.28-5-183; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Ehlken B, 2002, ACTA PAEDIATR, V91, P769, DOI 10.1080/08035250213227; FEIGIN RD, 2003, TXB PEDIAT INFECT DI; Fruhwirth M, 2000, J CLIN MICROBIOL, V38, P1804; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; HUILAN S, 1991, B WORLD HEALTH ORGAN, V69, P549; Iftikhar T, 2012, J MED VIROL, V84, P2003, DOI 10.1002/jmv.23402; Kawai K., 2011, VACCINE; KHALIL K, 1993, ACTA PAEDIATR, V82, P87, DOI 10.1111/j.1651-2227.1993.tb12909.x; KHAN M M A, 1988, Journal of Diarrhoeal Diseases Research, V6, P228; Kilgore A, 2013, VACCINE, V31, P4164, DOI 10.1016/j.vaccine.2013.06.085; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Miles MG, 2012, VACCINE, V30, pA131, DOI 10.1016/j.vaccine.2011.10.002; Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008; Mubashir M, 1990, J Gastroenterol Hepatol, V5, P264; Nakagomi T, 2005, J INFECT DIS, V192, pS106, DOI 10.1086/431503; Ngo TC, 2009, VACCINE, V27, pF75, DOI 10.1016/j.vaccine.2009.08.074; Nyambat B, 2009, VACCINE, V27, pF81, DOI 10.1016/j.vaccine.2009.08.085; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Qazi R, 2009, VACCINE, V27, pF25, DOI 10.1016/j.vaccine.2009.08.064; Richardson V, 2011, NEW ENGL J MED, V365, P772, DOI 10.1056/NEJMc1100062; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO, 2005, HDB IMCI INT MAN CHI; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zaman K, 2009, VACCINE, V27, pF31, DOI 10.1016/j.vaccine.2009.08.063	39	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108221	10.1371/journal.pone.0108221	http://dx.doi.org/10.1371/journal.pone.0108221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295613	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000013
J	Smith, AN; Belk, MC; Creighton, JC				Smith, Ashlee N.; Belk, Mark C.; Creighton, J. Curtis			Residency Time as an Indicator of Reproductive Restraint in Male Burying Beetles	PLOS ONE			English	Article							NICROPHORUS-VESPILLOIDES COLEOPTERA; MALE PARENTAL CARE; PATERNAL CARE; BROOD SIZE; TERMINAL INVESTMENT; BODY-SIZE; DURATION; SUCCESS; EVOLUTION; INFANTICIDE	The cost of reproduction theory posits that there are trade-offs between current and future reproduction because resources that are allocated to current offspring cannot be used for future reproductive opportunities. Two adaptive reproductive strategies have been hypothesized to offset the costs of reproduction and maximize lifetime fitness. The terminal investment hypothesis predicts that as individuals age they will allocate more resources to current reproduction as a response to decreasing residual reproductive value. The reproductive restraint hypotheses predicts that as individuals age they will allocate fewer resources to current reproduction to increase the chance of surviving for an additional reproductive opportunity. In this study, we test for adaptive responses to advancing age in male burying beetles, Nicrophorus orbicollis. Burying beetles use facultative biparental care, but the male typically abandons the brood before the female. Previous work in male burying beetles has suggested several factors to explain variation in male residency time, but no study has observed male behavior throughout their entire reproductive lifetimes to determine whether males change residency time in an adaptive way with age. We compared residency time of males that reproduced biparentally, uniparentally, and on differentsized carcasses to determine if they used an adaptive reproductive strategy. Males did not increase residency time as they aged when reproducing biparentally, but decreased residency time with age when reproducing uniparentally. A decrease in parental care with age is consistent with a reproductive restraint strategy. When female age increased over time, males did not increase their residency time to compensate for deteriorating female condition. To our knowledge, this is the first test of adaptive reproductive allocation strategies in male burying beetles.	[Smith, Ashlee N.; Creighton, J. Curtis] Purdue Univ Calumet, Dept Biol Sci, Hammond, IN USA; [Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Purdue University System; Purdue University; Brigham Young University	Smith, AN (corresponding author), Brigham Young Univ, Provo, UT 84602 USA.	ashlee.n.smith@gmail.com		Smith, Ashlee/0000-0001-8941-8574	Purdue University Graduate Studies Department	Purdue University Graduate Studies Department	Funding for this research was provided by the Purdue University Graduate Studies Department through a Graduate Research Grant (http://webs.purduecal.edu/gradschool/graduate-research-awards/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V23, P297, DOI 10.1007/BF00300576; BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V22, P429, DOI 10.1007/BF00294981; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Creighton JC, 2009, AM NAT, V174, P673, DOI 10.1086/605963; Creighton JC, 2005, BEHAV ECOL, V16, P1031, DOI 10.1093/beheco/ari084; Eggert Anne-Katrin, 1997, P216; FETHERSTON IA, 1994, ANIM BEHAV, V47, P777, DOI 10.1006/anbe.1994.1110; FETHERSTON IA, 1990, ETHOLOGY, V85, P177, DOI 10.1111/j.1439-0310.1990.tb00398.x; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Koulianos S, 2000, ANN ENTOMOL SOC AM, V93, P836, DOI 10.1603/0013-8746(2000)093[0836:POIAIE]2.0.CO;2; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Muller JK, 1998, ECOL ENTOMOL, V23, P195, DOI 10.1046/j.1365-2311.1998.00119.x; MULLER JK, 1990, ANIM BEHAV, V40, P491, DOI 10.1016/S0003-3472(05)80529-9; Otronen M, 1988, EFFECT BODY SIZE OUT; Rauter CM, 2004, ANIM BEHAV, V68, P695, DOI 10.1016/j.anbehav.2003.09.018; Rauter CM, 1999, P ROY SOC B-BIOL SCI, V266, P1691, DOI 10.1098/rspb.1999.0833; REID ML, 1995, CAN J ZOOL, V73, P1396, DOI 10.1139/z95-164; Robertson IC, 1998, BEHAV ECOL SOCIOBIOL, V43, P379, DOI 10.1007/s002650050505; ROBERTSON IC, 1993, J ZOOL, V231, P583, DOI 10.1111/j.1469-7998.1993.tb01940.x; Roff Derek A., 1992; Safryn SA, 2000, J INSECT BEHAV, V13, P291, DOI 10.1023/A:1007700601095; SCOTT MP, 1993, EVOL ECOL, V7, P362, DOI 10.1007/BF01237868; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SCOTT MP, 1990, ANIM BEHAV, V39, P274, DOI 10.1016/S0003-3472(05)80871-1; SCOTT MP, 1989, J INSECT BEHAV, V2, P133, DOI 10.1007/BF01053623; SCOTT MP, 1990, BEHAV ECOL SOCIOBIOL, V26, P31, DOI 10.1007/BF00174022; Stearns S.C., 1992, pi; Steiger S, 2012, BEHAV ECOL, V23, P1126, DOI 10.1093/beheco/ars082; Suzuki S, 2009, ETHOLOGY, V115, P1, DOI 10.1111/j.1439-0310.2008.01598.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRUMBO ST, 1991, BEHAVIOUR, V117, P82, DOI 10.1163/156853991X00139; TRUMBO ST, 1992, ECOL ENTOMOL, V17, P289, DOI 10.1111/j.1365-2311.1992.tb01060.x; TRUMBO ST, 1994, OIKOS, V69, P241, DOI 10.2307/3546144; Trumbo ST, 2006, ANIM BEHAV, V72, P1159, DOI 10.1016/j.anbehav.2006.05.004; Ward RJS, 2009, BEHAV ECOL, V20, P1274, DOI 10.1093/beheco/arp132; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WILSON DS, 1984, ECOL ENTOMOL, V9, P195, DOI 10.1111/j.1365-2311.1984.tb00715.x	39	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109165	10.1371/journal.pone.0109165	http://dx.doi.org/10.1371/journal.pone.0109165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295755	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000042
J	Wojdylo, K; Baumann, N; Fischbach, L; Engeser, S				Wojdylo, Kamila; Baumann, Nicola; Fischbach, Lis; Engeser, Stefan			Live to Work or Love to Work: Work Craving and Work Engagement	PLOS ONE			English	Article							WORKAHOLISM; DEMANDS; BURNOUT; HEALTH; ORIENTATION; EMPLOYEES	Objective: According to the theory of work craving, a workaholic has a craving for self-worth compensatory incentives and an expectation of relief from negative affect experienced through neurotic perfectionism and an obsessive-compulsive style of working. Research has shown that workaholism and work engagement should be considered as two distinct work styles with different health consequences. However, the mechanisms underlying the adoption of these work styles have been neglected. The present study proposes that work craving and work engagement are differentially associated with self-regulatory competencies and health. In particular, we expected that the working styles mediate the relationships between emotional self-regulation and health. Methods: In the cross-sectional study, 469 teachers from German schools completed online administered questionnaires. By means of structural equation modeling, we tested two indirect paths: a) from self-relaxation deficits via work craving to poor health and b) from self-motivation competencies via work engagement to good health. Results: As expected, we found evidence that a) the negative relationship of self-relaxation deficits on health was partially mediated by work craving and b) the positive relationship of self-motivation competencies on health was partially mediated by work engagement. Conclusions: The present study emphasizes the importance of self-regulation competencies for healthy or unhealthy work styles. Whereas work craving was associated with a low ability to down-regulate negative emotions and poor health, work engagement was associated with a high ability to up-regulate positive emotions and good health.	[Wojdylo, Kamila] Polish Acad Sci, Inst Psychol, Warsaw, Poland; [Baumann, Nicola; Fischbach, Lis; Engeser, Stefan] Univ Trier, Dept Psychol, Trier, Germany	Polish Academy of Sciences; Institute of Psychology of the Polish Academy of Sciences; Universitat Trier	Wojdylo, K (corresponding author), Polish Acad Sci, Inst Psychol, Warsaw, Poland.	kamila.wojdylo@psych.pan.pl; nicola.baumann@uni-trier.de	Baumann, Nicola/F-9899-2018; Jansik, Attila/AAG-8335-2019	Baumann, Nicola/0000-0002-4713-6664; Wojdylo, Kamila/0000-0002-0164-1972	Polish National Science Centre [DEC/2011/01/M/H56/02567]	Polish National Science Centre	This project was supported by Polish National Science Centre Grant (DEC/2011/01/M/H56/02567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AB, 2009, J OCCUP HEALTH PSYCH, V14, P23, DOI 10.1037/a0013290; Bauer J, 2007, INT ARCH OCC ENV HEA, V80, P442, DOI 10.1007/s00420-007-0170-7; Baumann N, 2005, J PERS SOC PSYCHOL, V89, P781, DOI 10.1037/0022-3514.89.5.781; Baumann N, 2003, PERS SOC PSYCHOL B, V29, P487, DOI 10.1177/0146167202250916; Baumann N, 2006, Z GESUNDHEITSPSYCHOL, V14, P46, DOI [10.1026/0943-8149.14.2.46, DOI 10.1026/0943-8149.14.2.46]; Baumann N, 2007, J RES PERS, V41, P239, DOI 10.1016/j.jrp.2006.05.002; Beckmann J., 1994, VOLITION PERSONALITY, P391; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Biebrich R, 2004, Z DIFFERENTIELLE DIA, V25, P57, DOI [10.1024/0170-1789.25.2.57, DOI 10.1024/0170-1789.25.2.57]; Bledow R, 2011, J APPL PSYCHOL, V96, P1246, DOI 10.1037/a0024532; Bonebright CA, 2000, J COUNS PSYCHOL, V47, P469, DOI 10.1037/0022-0167.47.4.469; Brunstein JC., 2001, Z DIFFERENTIELLE DIA, V22, P1, DOI [10.1024//0170-1789.22.1.1, DOI 10.1024//0170-1789.22.1.1]; Buelens M, 2004, J ORGAN CHANGE MANAG, V17, P440, DOI 10.1108/09534810410554470; Burke R., 2004, WOMEN MANAGEMENT REV, V19, DOI [10.1108/09649420410545971, DOI 10.1108/09649420410545971]; Burke RJ, 2000, ANXIETY STRESS COPIN, V13, P53, DOI 10.1080/10615800008248333; Demerouti E, 2001, SCAND J WORK ENV HEA, V27, P279, DOI 10.5271/sjweh.615; Diefendorff JM, 2000, J APPL PSYCHOL, V85, P250, DOI 10.1037/0021-9010.85.2.250; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Greenberg LS, 2004, CLIN PSYCHOL PSYCHOT, V11, P3, DOI 10.1002/cpp.388; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Koole SL, 2004, J PERS SOC PSYCHOL, V87, P974, DOI 10.1037/0022-3514.87.6.974; Kuhl J, 2001, MOTIVATION PERSONLIC; Kuhl J., 1994, VOLITION PERSONALITY, P47; Kuhl J., 2000, HDB SELF REGULATION, P111, DOI [DOI 10.1016/B978-012109890-2/50034-2, 10.1016/B978-012109890-2/50034-2]; Kuhl J., 1994, VOLITION PERSONALITY; Kuhl J., 1994, VOLITION PERSONALITY, P375; Mathieu JE, 2006, J ORGAN BEHAV, V27, P1031, DOI 10.1002/job.406; McMillan LHW, 2004, J ORGAN CHANGE MANAG, V17, P509, DOI 10.1108/09534810410554515; Muthen LK., 2017, MPLUS, VEight; Porter G, 1996, J Occup Health Psychol, V1, P70, DOI 10.1037/1076-8998.1.1.70; Robinson BE, 2007, CHAINED DESK GUIDEBO; Schaufeli W., 1998, BURNOUT COMPANION ST; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Schaufeli WB, 2006, WORK HOURS WORK ADDI, P193; Schaufeli WB, 2006, NEW HORIZ MANAG, P193; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Shimazu A, 2012, IND HEALTH, V50, P316, DOI 10.2486/indhealth.MS1355; Shimazu A, 2010, INT J BEHAV MED, V17, P154, DOI 10.1007/s12529-010-9077-x; Shimazu A, 2009, IND HEALTH, V47, P495, DOI 10.2486/indhealth.47.495; Snir R, 2008, APPL PSYCHOL-INT REV, V57, P109, DOI 10.1111/j.1464-0597.2006.00270.x; Taris TW, 2008, WORK STRESS, V22, P153, DOI 10.1080/02678370701758074; Taris TW, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P39; van Beek I, 2012, APPL PSYCHOL-INT REV, V61, P30, DOI 10.1111/j.1464-0597.2011.00454.x; van Beek I, 2011, J OCCUP HEALTH PSYCH, V16, P468, DOI 10.1037/a0024392; Van den Broeck A, 2011, APPL PSYCHOL-INT REV, V60, P600, DOI 10.1111/j.1464-0597.2011.00449.x; Wagner AC, 2011, GELASSENHEIT DURCH A; Wojdylo K, 2013, NAUKA, V3, P87; Wojdylo K, 2009, PRZEGLAD PSYCHOLOGIC, V52, P453; Wojdylo K, 2013, BASIC APPL SOC PSYCH, V35, P547, DOI 10.1080/01973533.2013.840631; Young J. E. S., 1994, COGNITIVE THERAPY PE	52	23	23	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e106379	10.1371/journal.pone.0106379	http://dx.doi.org/10.1371/journal.pone.0106379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296091	Green Published, gold			2022-12-27	WOS:000345204000003
J	Mead, B; Logan, A; Berry, M; Leadbeater, W; Scheven, BA				Mead, Ben; Logan, Ann; Berry, Martin; Leadbeater, Wendy; Scheven, Ben A.			Paracrine-Mediated Neuroprotection and Neuritogenesis of Axotomised Retinal Ganglion Cells by Human Dental Pulp Stem Cells: Comparison with Human Bone Marrow and Adipose-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; AXON REGENERATION; SPINAL-CORD; BRAIN; TRANSPLANTATION; SURVIVAL; PROMOTE; DEATH; INTERLEUKIN-6; CONTRIBUTES	We have investigated and compared the neurotrophic activity of human dental pulp stem cells (hDPSC), human bone marrow-derived mesenchymal stem cells (hBMSC) and human adipose-derived stem cells (hAMSC) on axotomised adult rat retinal ganglion cells (RGC) in vitro in order to evaluate their therapeutic potential for neurodegenerative conditions of RGC. Using the transwell system, RGC survival and length/number of neurites were quantified in coculture with stem cells in the presence or absence of specific Fc-receptor inhibitors to determine the role of NGF, BDNF, NT-3, VEGF, GDNF, PDGF-AA and PDGF-AB/BB in stem cell-mediated RGC neuroprotection and neuritogenesis. Conditioned media, collected from cultured hDPSC/hBMSC/hAMSC, were assayed for the secreted growth factors detailed above using ELISA. PCR array determined the hDPSC, hBMSC and hAMSC expression of genes encoding 84 growth factors and receptors. The results demonstrated that hDPSC promoted significantly more neuroprotection and neuritogenesis of axotomised RGC than either hBMSC or hAMSC, an effect that was neutralized after the addition of specific Fc-receptor inhibitors. hDPSC secreted greater levels of various growth factors including NGF, BDNF and VEGF compared with hBMSC/hAMSC. The PCR array confirmed these findings and identified VGF as a novel potentially therapeutic hDPSC-derived neurotrophic factor (NTF) with significant RGC neuroprotective properties after coculture with axotomised RGC. In conclusion, hDPSC promoted significant multi-factorial paracrine-mediated RGC survival and neurite outgrowth and may be considered a potent and advantageous cell therapy for retinal nerve repair.	[Mead, Ben; Logan, Ann; Berry, Martin; Leadbeater, Wendy] Univ Birmingham, Sch Clin & Expt Med, Neurobiol Sect, Neurotrauma Res Grp, Birmingham, W Midlands, England; [Mead, Ben; Scheven, Ben A.] Univ Birmingham, Sch Dent, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Mead, B (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Neurobiol Sect, Neurotrauma Res Grp, Birmingham, W Midlands, England.	BXM813@bham.ac.uk		Logan, Ann/0000-0003-3215-5042; Mead, Ben/0000-0001-5855-0097	Rosetrees trust; Biotechnology and Biological Sciences Research Council (BBSRC) studentship;  [BB/F017553/1]; Biotechnology and Biological Sciences Research Council [1090357] Funding Source: researchfish; Rosetrees Trust [M306] Funding Source: researchfish	Rosetrees trust(Rosetrees Trust); Biotechnology and Biological Sciences Research Council (BBSRC) studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rosetrees Trust(Rosetrees Trust)	This work was funded by the Rosetrees trust and a Biotechnology and Biological Sciences Research Council (BBSRC) studentship; BM BAS. Grant number BB/F017553/1 (http://www.rosetreestrust.co.uk) (http://www.bbsrc.ac.uk/home/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Berry M, 2008, RESTOR NEUROL NEUROS, V26, P147; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Dormady SP, 2001, J HEMATOTH STEM CELL, V10, P125, DOI 10.1089/152581601750098372; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; Duarte PC, 2012, EXP NEUROL, V234, P466, DOI 10.1016/j.expneurol.2012.01.021; Gale Z, 2011, J DENT RES, V90, P1240, DOI 10.1177/0022034511417443; Hutchinson AJ, 2009, NEUROCHEM INT, V54, P439, DOI 10.1016/j.neuint.2009.01.018; JIANG LQ, 1991, INVEST OPHTH VIS SCI, V32, P224; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Johnson TV, 2013, BRAIN; Johnson TV, 2012, CURR OPIN PHARM; Jung JE, 2011, STROKE, V42, P3574, DOI 10.1161/STROKEAHA.111.626648; Kalbermatten DF, 2011, CELL TISSUE RES, V344, P251, DOI 10.1007/s00441-011-1142-5; Kanda N, 2005, J PHARMACOL EXP THER, V315, P796, DOI 10.1124/jpet.105.091645; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kinkl N, 2003, MOL CELL NEUROSCI, V23, P39, DOI 10.1016/S1044-7431(03)00070-8; Ko ML, 2000, INVEST OPHTH VIS SCI, V41, P2967; Ko ML, 2001, NEUROSCI LETT, V305, P139, DOI 10.1016/S0304-3940(01)01830-4; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310; Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706; Lorber B, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-56; Martens CR, 2013, FASEB J, V27; Mead B, 2014, NEURAL REGEN RES, V9, P577, DOI 10.4103/1673-5374.130089; Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045; Nosrat CA, 1997, CELL TISSUE RES, V290, P569, DOI 10.1007/s004410050962; Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Shimazawa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015307; Suggate EL, 2009, MOL CELL NEUROSCI, V40, P451, DOI 10.1016/j.mcn.2009.01.004; Sugitani S, 2013, EXP EYE RES, V116, P254, DOI 10.1016/j.exer.2013.09.013; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Tsuruma K, 2014, STEM CELL TRANSL MED, V3, P42, DOI 10.5966/sctm.2013-0020; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Zhou Z, 2013, CYTOTHERAPY	45	152	157	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109305	10.1371/journal.pone.0109305	http://dx.doi.org/10.1371/journal.pone.0109305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290916	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000052
J	Rouse, R; Zhang, LS; Shea, K; Zhou, HF; Xu, L; Stewart, S; Rosenzweig, B; Zhang, J				Rouse, Rodney; Zhang, Leshuai; Shea, Katherine; Zhou, Hongfei; Xu, Lin; Stewart, Sharron; Rosenzweig, Barry; Zhang, Jun			Extended Exenatide Administration Enhances Lipid Metabolism and Exacerbates Pancreatic Injury in Mice on a High Fat, High Carbohydrate Diet	PLOS ONE			English	Article							CELL-SPECIFIC TRANSCRIPTION; PEPTIDE-1 RECEPTOR AGONIST; NUCLEAR FACTOR 3-BETA; ACINAR-CELLS; OXIDATIVE STRESS; PDX-1 GENE; BETA; RATS; ACTIVATION; EXENDIN-4	This study expanded upon a previous study in mice reporting a link between exenatide treatment and exocrine pancreatic injury by demonstrating temporal and dose responses and providing an initial mechanistic hypothesis. The design of the present study included varying lengths of exenatide exposure (3, 6 weeks to 12 weeks) at multiple concentrations (3, 10, or 30 mu g/kg) with multiple endpoints (histopathology evaluations, immunoassay for cytokines, immunostaining of the pancreas, serum chemistries and measurement of trypsin, amylase, and, lipase, and gene expression profiles). Time- and dose-dependent exocrine pancreatic injury was observed in mice on a high fat diet treated with exenatide. The morphological changes identified in the pancreas involved acinar cell injury and death (autophagy, apoptosis, necrosis, and atrophy), cell adaptations (hypertrophy and hyperplasia), and cell survival (proliferation/regeneration) accompanied by varying degrees of inflammatory response leading to secondary injury in pancreatic blood vessels, ducts, and adipose tissues. Gene expression profiles indicated increased signaling for cell survival and altered lipid metabolism in exenatide treated mice. Immunohistochemistry supported gene expression findings that exenatide caused and/or exacerbated pancreatic injury in a high fat diet environment potentially by further increasing high fat diet exacerbated lipid metabolism and resulting oxidative stress. Further investigation is required to confirm these findings and determine their relevance to human disease.	[Rouse, Rodney; Zhang, Leshuai; Shea, Katherine; Zhou, Hongfei; Xu, Lin; Stewart, Sharron; Rosenzweig, Barry; Zhang, Jun] US FDA, Div Appl Regulatory Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Rouse, R (corresponding author), US FDA, Div Appl Regulatory Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	rodney.rouse@fda.hhs.gov	Zhang, Leshuai/C-8077-2012		U.S. Food and Drug Administration	U.S. Food and Drug Administration	All funding originated from U.S. congressional appropriation to fund the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SR, 2008, NEW ENGL J MED, V358, P1970; Bastien-Dionne PO, 2011, DIABETES, V60, P3217, DOI 10.2337/db11-0101; Bulchandani D, 2009, ENDOCRINOLOGIST, V19, P114, DOI 10.1097/TEN.0b013e3181a48938; Bulter AE, 2013, DIABETES, V62, P2595; Chvanov M, 2005, PHILOS T R SOC B, V360, P2273, DOI 10.1098/rstb.2005.1757; De Leon DD, 2006, PHYSL GENETICS, V4, P233; Ellenbroek JH, 2013, DIABETOLOGIA, V56, P1980, DOI 10.1007/s00125-013-2957-2; Fatehi-Hassanabad Zahra, 2005, Nutr Metab (Lond), V2, P1, DOI 10.1186/1743-7075-2-1; Feng WH, 2013, FOLIA BIOL-PRAGUE, V59, P217; Fisher WE, 2009, SCHWARTZS PRINCIPLES, P1167; Fujimori N, 2011, PEPTIDES, V32, P2067, DOI 10.1016/j.peptides.2011.08.027; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Ghanaat-Pour H, 2011, METABOLOMICS, V1, P102, DOI DOI 10.4172/2153-0769.1000102; Ghanaat-Pour H, 2009, DIABETES-METAB RES, V25, P163, DOI 10.1002/dmrr.896; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Goodwin D, 2014, BIOMAKERS, V25, P1; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Kawasaki Y, 2010, HORM METAB RES, V42, P311, DOI 10.1055/s-0030-1249035; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Koehler JA, 2009, DIABETES, V58, P2148, DOI 10.2337/db09-0626; Kota Sunil K, 2012, Indian J Endocrinol Metab, V16, P141, DOI 10.4103/2230-8210.91211; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031394; Matveyenko AV, 2009, DIABETES, V58, P1604, DOI 10.2337/db09-0058; Nachnani JS, 2010, DIABETOLOGIA, V53, P153, DOI 10.1007/s00125-009-1515-4; Niederau C, 1996, FREE RADICAL BIO MED, V20, P877, DOI 10.1016/0891-5849(95)02153-1; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rouse R, 2014, TOXICOL APPL PHARM, V276, P104, DOI 10.1016/j.taap.2014.01.021; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Seo JY, 2009, ANN NY ACAD SCI, V1171, P570, DOI 10.1111/j.1749-6632.2009.04712.x; Siech M, 2009, AM J PHYSIOL-GASTR L, V297, pG1163, DOI 10.1152/ajpgi.90468.2008; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Tanaka K, 2014, WORLD J GASTROENTERO, V20, P2653, DOI 10.3748/wjg.v20.i10.2653; Weber H, 2005, BIOCHEM PHARMACOL, V70, P1241, DOI 10.1016/j.bcp.2005.06.028; Wei Q, 2012, PEPTIDES, V37, P18, DOI 10.1016/j.peptides.2012.06.018; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yang HP, 2012, ACTA PHARM SIN B, V2, P396, DOI 10.1016/j.apsb.2012.05.003; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhang J, 1999, TOXICOL PATHOL, V27, P427; Zhang J, 2014, HISTOL HISTOPATHOL, V29, P1135, DOI 10.14670/HH-29.1135; Zhang LS, 2014, TOXICOL PATHOL, V42, P435, DOI 10.1177/0192623313486967; Zhou J, 2002, J CELL PHYSIOL, V192, P304, DOI 10.1002/jcp.10143	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109477	10.1371/journal.pone.0109477	http://dx.doi.org/10.1371/journal.pone.0109477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291183	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000064
J	Stuckey, EM; Stevenson, J; Galactionova, K; Baidjoe, AY; Bousema, T; Odongo, W; Kariuki, S; Drakeley, C; Smith, TA; Cox, J; Chitnis, N				Stuckey, Erin M.; Stevenson, Jennifer; Galactionova, Katya; Baidjoe, Amrish Y.; Bousema, Teun; Odongo, Wycliffe; Kariuki, Simon; Drakeley, Chris; Smith, Thomas A.; Cox, Jonathan; Chitnis, Nakul			Modeling the Cost Effectiveness of Malaria Control Interventions in the Highlands of Western Kenya	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; PLASMODIUM-FALCIPARUM MALARIA; HEALTH SYSTEM; IMPACT; TRANSMISSION; PREVENTION	Introduction: Tools that allow for in silico optimization of available malaria control strategies can assist the decision-making process for prioritizing interventions. The OpenMalaria stochastic simulation modeling platform can be applied to simulate the impact of interventions singly and in combination as implemented in Rachuonyo South District, western Kenya, to support this goal. Methods: Combinations of malaria interventions were simulated using a previously-published, validated model of malaria epidemiology and control in the study area. An economic model of the costs of case management and malaria control interventions in Kenya was applied to simulation results and cost-effectiveness of each intervention combination compared to the corresponding simulated outputs of a scenario without interventions. Uncertainty was evaluated by varying health system and intervention delivery parameters. Results: The intervention strategy with the greatest simulated health impact employed long lasting insecticide treated net (LLIN) use by 80% of the population, 90% of households covered by indoor residual spraying (IRS) with deployment starting in April, and intermittent screen and treat (IST) of school children using Artemether lumefantrine (AL) with 80% coverage twice per term. However, the current malaria control strategy in the study area including LLIN use of 56% and IRS coverage of 70% was the most cost effective at reducing disability-adjusted life years (DALYs) over a five year period. Conclusions: All the simulated intervention combinations can be considered cost effective in the context of available resources for health in Kenya. Increasing coverage of vector control interventions has a larger simulated impact compared to adding IST to the current implementation strategy, suggesting that transmission in the study area is not at a level to warrant replacing vector control to a school-based screen and treat program. These results have the potential to assist malaria control program managers in the study area in adding new or changing implementation of current interventions.	[Stuckey, Erin M.; Galactionova, Katya; Smith, Thomas A.; Chitnis, Nakul] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Stuckey, Erin M.; Galactionova, Katya; Smith, Thomas A.; Chitnis, Nakul] Univ Basel, Basel, Switzerland; [Stevenson, Jennifer; Bousema, Teun; Drakeley, Chris; Cox, Jonathan] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Stevenson, Jennifer; Odongo, Wycliffe; Kariuki, Simon] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent, Ctr Global Hlth Res, Kisumu, Kenya; [Stevenson, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Baidjoe, Amrish Y.; Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Radboud University Nijmegen	Stuckey, EM (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	erin.stuckey@unibas.ch	Chitnis, Nakul/B-3105-2013; Kariuki, Simon/AFT-6596-2022; Smith, Thomas/B-5569-2015; Bousema, Teun/N-3574-2014	Smith, Thomas/0000-0002-3650-9381; Bousema, Teun/0000-0003-2666-094X; Baidjoe, Amrish/0000-0001-5295-5085; Chitnis, Nakul/0000-0002-1103-9141; Galactionova, Katya/0000-0002-5743-7647	Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium [45114, 1032350]; Grand Challenge Grant [OPP1024438]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science & Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health, USA; Wellcome Trust [091924]	Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium; Grand Challenge Grant; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science & Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health, USA; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium [grants number 45114 and 1032350] and Grand Challenge Grant [grant number OPP1024438]. NC also acknowledges support from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science & Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health, USA. CD is supported by the Wellcome Trust [grant number 091924]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazili J., 2007, AFR J HLTH SCI, V14, P70; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Batwala V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-372; Bousema T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-36; Brooker S, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-93; Chitnis N, 2012, B MATH BIOL, V74, P1098, DOI 10.1007/s11538-011-9710-0; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; Chuma J, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-22; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; Department of Malaria Control Kenya National Bureau of Statistics ICF Macro, 2011, 2010 KEN MAL IND SUR; Drake TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-273; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Galactionova K, 2013, 9 WORLD C HLTH EC CE; Global Fund to fight AIDS TB and Malaria, 2013, PRIC QUAL REP TOOL; Goodman C, 2000, EC ANAL MALARIA CONT; Government of Kenya, 2013, COMPR PUBL EXP REV 2; Guyatt HL, 2002, HEALTH POLICY PLANN, V17, P144, DOI 10.1093/heapol/17.2.144; Halliday KE, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001594; INDEPTH Network, 2004, MOD LIF TABL SUBS AF; International Association for Impact Assessment, 2006, HLTH IMP ASS INT BES; Kenya Division of Malaria Control, 2006, NAT GUID DIAGN TREAT; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Kirigia JM, 1998, TROP MED INT HEALTH, V3, P145, DOI 10.1046/j.1365-3156.1998.00204.x; Kolaczinski J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-37; Kristan M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-231; Mabaso MLH, 2007, AM J TROP MED HYG, V76, P33, DOI 10.4269/ajtmh.2007.76.33; Malaria Vaccine Initiative, 2012, EST EC BURD MAL NIG; Management Sciences for Health, 2011, INT DRUG PRIC IND GU; Mikkelsen-Lopez I, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-13; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Oanda, 2013, HIST EXCH RAT; OpenMalaria, 2010, OPENMALARIA; RTI International, 2013, 1 RTI INT; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001157; Stevenson J, 2012, EMERG INFECT DIS; Stevenson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077641; Stuckey EM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-357; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; UNITAID, 2013, MAL VECT CONTR COMM; Watsierah CA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-295; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO-CHOICE, 2005, AFR E COST EFF RES T; WHO-CHOICE, 2005, ARE E COST EFF RES M; WHO-CHOICE, 2005, AFR E COST EFF RES H; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; World Bank, 2013, IMPL PRIC DEFL GROSS; World Health Organization, 2011, CHOOSING INT AR COST; World Health Organization, 2014, GLOB BURD DIS 2012	56	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107700	10.1371/journal.pone.0107700	http://dx.doi.org/10.1371/journal.pone.0107700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290939	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000342798000007
J	Peng, JZ; Fang, Y; Tao, Y; Li, KK; Su, T; Nong, YC; Xie, F; Lai, MY				Peng, Jinzhen; Fang, Ye; Tao, Yong; Li, Keke; Su, Ting; Nong, Yuncui; Xie, Fang; Lai, Mingyu			Mechanisms of GOLPH3 Associated with the Progression of Gastric Cancer: A Preliminary Study	PLOS ONE			English	Article							PI3K/AKT/MTOR PATHWAY; THERAPEUTIC TARGET; TUMOR PROGRESSION; POOR-PROGNOSIS; GOLGI; MTOR; OVEREXPRESSION; ACTIVATION; PATTERNS; GMX33	Study Design: To investigate the specific mechanisms by which Golgi phosphoprotein 3 (GOLPH3) affects the progression of gastric cancer and to explore its clinical significance. Methods: Immunohistochemical analysis was used to evaluate the correlations between GOLPH3, phosphorylated mTOR (p-mTOR), phosphorylated Akt (p-Akt), phosphorylated p70S6 (p-p70S6), phosphorylated 4E-BP1 (p-4E-BP1) and the clinicopathological features of gastric cancer. The mRNA expression levels of GOLPH3, mTOR, Akt, p70S6 and 4E-BP1 in gastric cancer, carcinoma-adjacent and paired normal tissue were analyzed using RT-PCR. Western blotting was used to determine the protein expression of GOLPH3, p-mTOR, p-Akt, p-p70S6 and p-4E-BP1 in tissues. Results: High expression protein levels of GOLPH3, p-AKT, p-mTOR, p70S6, p-4E-BP1 were positively associated with histological grade (p<0.05), depth of invasion (p<0.05), distant metastasis (p<0.05) and lymph node involvement (p<0.05). Compared with carcinoma-adjacent and paired normal tissues, the mRNA expression levels of GOLPH3, AKT, mTOR, p70S6 and 4EBP1 in gastric cancer tissues were significantly higher. The protein expression levels of GOLPH3, p-AKT, p-mTOR, p-p70S6 and p-4E-BP1 in gastric cancer tissues were also significantly higher than in carcinoma-adjacent and paired normal tissues. A strong positive correlation was observed between GOLPH3, p-mTOR, p-p70S6 and p-4EBP1 expression (r = 0.410, 0.303 and 0.276, respectively, p<0.05), but no significant correlation between the expression of GOLPH3 and p-Akt was observed. Conclusions: The GOPLH3 expression level is highly correlated with Akt/mTOR signaling in human gastric cancer samples. GOLPH3 combined with Akt/mTOR signaling activation may play an important role in the development, differentiation, invasion and metastasis of gastric cancer.	[Peng, Jinzhen; Su, Ting; Nong, Yuncui; Xie, Fang; Lai, Mingyu] Guangxi Med Univ, Dept Geriatr Gastroenterol, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Fang, Ye; Tao, Yong; Li, Keke] Guangxi Med Univ, Dept Spine Osteopathia, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Lai, MY (corresponding author), Guangxi Med Univ, Dept Geriatr Gastroenterol, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	laimingyu14@sina.com			Research Foundation of Guangxi Health Appropriate Technology and Development Project [S201415-01]	Research Foundation of Guangxi Health Appropriate Technology and Development Project	This study was supported by the Research Foundation of Guangxi Health Appropriate Technology and Development Project (Grant number: S201415-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2009, PIGM CELL MELANOMA R, V22, P378, DOI 10.1111/j.1755-148X.2009.00596.x; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Fujiyoshi M, 2011, J HEPATO-BIL-PAN SCI, V18, P13, DOI 10.1007/s00534-010-0304-2; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hu BS, 2013, TUMOR BIOL, V34, P515, DOI 10.1007/s13277-012-0576-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Komori Y, 2014, J HEPATO-BIL-PAN SCI, V21, P288, DOI 10.1002/jhbp.26; Li H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-168; Ma YC, 2014, VIRCHOWS ARCH, V464, P443, DOI 10.1007/s00428-014-1536-3; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; No JH, 2011, GYNECOL ONCOL, V121, P8, DOI 10.1016/j.ygyno.2010.12.364; Pocza T, 2014, PATHOLOGY O IN PRESS; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Sun CH, 2011, HISTOPATHOLOGY, V58, P1054, DOI 10.1111/j.1365-2559.2011.03856.x; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Xue Y, 2014, BRIT J CANCER, V110, P2250, DOI 10.1038/bjc.2014.124; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9	29	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e107362	10.1371/journal.pone.0107362	http://dx.doi.org/10.1371/journal.pone.0107362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286393	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700007
J	Zhao, XF; Chen, YD; Zhu, Q; Huang, H; Teng, P; Zheng, K; Hu, XM; Xie, BH; Zhang, ZY; Sander, M; Qiu, MS				Zhao, Xiaofeng; Chen, Yidan; Zhu, Qiang; Huang, Hao; Teng, Peng; Zheng, Kang; Hu, Xuemei; Xie, Binghua; Zhang, Zunyi; Sander, Maike; Qiu, Mengsheng			Control of Astrocyte Progenitor Specification, Migration and Maturation by Nkx6.1 Homeodomain Transcription Factor	PLOS ONE			English	Article							SPINAL-CORD; OLIGODENDROCYTE PROGENITORS; SELECTIVE EXPRESSION; GENE-EXPRESSION; PRECURSOR CELLS; VERTEBRATE CNS; MOTOR-NEURON; RADIAL GLIA; DOMAINS; OLIG2	Although astrocytes are the most abundant cell type in the central nervous system (CNS), little is known about their molecular specification and differentiation. It has previously been reported that transcription factor Nkx6.1 is expressed in neuroepithelial cells that give rise to astrocyte precursors in the ventral spinal cord. In the present study, we systematically investigated the function of Nkx6.1 in astrocyte development using both conventional and conditional Nkx6.1 mutant mice. At early postnatal stages, Nkx6.1 was expressed in a subpopulation of astrocytes in the ventral spinal cord. In the conventional Nkx6.1KO spinal cord, the initial specification of astrocyte progenitors was affected by the mutation, and subsequent migration and differentiation were disrupted in newborn mice. In addition, the development of VA2 subtype astrocytes was also inhibited in the white matter. Further studies with Nkx6.1 conditional mutants revealed significantly delayed differentiation and disorganized arrangement of fibrous astrocytes in the ventral white matter. Together, our studies indicate that Nkx6.1 plays a vital role in astrocyte specification and differentiation in the ventral spinal cord.	[Zhao, Xiaofeng; Chen, Yidan; Huang, Hao; Teng, Peng; Zheng, Kang; Xie, Binghua; Zhang, Zunyi; Qiu, Mengsheng] Hangzhou Normal Univ, Inst Dev & Regenerat Biol, Zhejiang Key Lab Organ Dev & Regenerat, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Zhao, Xiaofeng; Zhu, Qiang; Hu, Xuemei; Qiu, Mengsheng] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Sander, Maike] Univ Calif San Diego, Dept Pediat, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA; [Sander, Maike] Univ Calif San Diego, Dept Cellular & Mol Med, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA	Hangzhou Normal University; University of Louisville; University of California System; University of California San Diego; University of California System; University of California San Diego	Qiu, MS (corresponding author), Hangzhou Normal Univ, Inst Dev & Regenerat Biol, Zhejiang Key Lab Organ Dev & Regenerat, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	m0qiu001@yahoo.com	Huang, Hao/O-8809-2017; Huang, Hao/M-6127-2019; Sander, Maike/N-6615-2016	Huang, Hao/0000-0001-7346-7056; Huang, Hao/0000-0001-7346-7056; Sander, Maike/0000-0001-5308-7785; Zhu, Qiang/0000-0002-6190-7023	Kentucky The National Key Basic Research Program of China [2013CB531300]; National Natural Sciences Foundation of China [31372150]; Spinal Cord and Head Injury Trust [13-9A]; Zhejiang Provincial Natural Science Foundation of China [Z2100730]; Major Project of Science and Technology Department of Zhejiang Province [2011C13030]; NIH [R01NS37717]	Kentucky The National Key Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Spinal Cord and Head Injury Trust; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Major Project of Science and Technology Department of Zhejiang Province; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by Kentucky The National Key Basic Research Program of China (2013CB531300); National Natural Sciences Foundation of China (31372150), Spinal Cord and Head Injury Trust (#13-9A), Zhejiang Provincial Natural Science Foundation of China (Z2100730), Major Project of Science and Technology Department of Zhejiang Province (2011C13030) and NIH (R01NS37717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry D, 2005, GLIA, V50, P187, DOI 10.1002/glia.20166; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Fu H, 2002, DEVELOPMENT, V129, P681; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Hong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086851; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Liu RG, 2003, DEVELOPMENT, V130, P6221, DOI 10.1242/dev.00868; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Miller G, 2005, SCIENCE, V308, P778, DOI 10.1126/science.308.5723.778; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Ogawa Y, 2005, DEV NEUROSCI-BASEL, V27, P364, DOI 10.1159/000088452; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Pabst O, 1998, MECH DEVELOP, V73, P85, DOI 10.1016/S0925-4773(98)00035-5; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schaffer AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003274; Shibata T, 1997, J NEUROSCI, V17, P9212; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stanimirovic DB, 1999, INT J DEV NEUROSCI, V17, P173, DOI 10.1016/S0736-5748(99)00028-3; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Xu XH, 2000, MOL CELL NEUROSCI, V16, P740, DOI 10.1006/mcne.2000.0916; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976; Zhao SF, 2007, DEV DYNAM, V236, P2708, DOI 10.1002/dvdy.21283; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	34	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109171	10.1371/journal.pone.0109171	http://dx.doi.org/10.1371/journal.pone.0109171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285789	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700051
J	Davies, K; Kingston, A; Robinson, L; Hughes, J; Hunt, JM; Barker, SAH; Edwards, J; Collerton, J; Jagger, C; Kirkwood, TBL				Davies, Karen; Kingston, Andrew; Robinson, Louise; Hughes, Joan; Hunt, Judith M.; Barker, Sally A. H.; Edwards, June; Collerton, Joanna; Jagger, Carol; Kirkwood, Thomas B. L.			Improving Retention of Very Old Participants in Longitudinal Research: Experiences from the Newcastle 85+Study	PLOS ONE			English	Article							COGNITIVE FUNCTION; CLINICAL-RESEARCH; FOLLOW-UP; ATTRITION; HEALTH; RECRUITMENT; LIFE; PREDICTORS; LESSONS; COHORT	Background: People aged 85 and over are often excluded from research on the grounds of being difficult to recruit and problematic to retain. The Newcastle 85+ study successfully recruited a cohort of 854 85-year-olds to detailed health assessment at baseline and followed them up over 3 phases spanning 5 years. This paper describes the effectiveness of its retention strategies. Methods: Primary retention strategies involved meticulous management of contact information and active maintenance of contact with participants between research visits and between phases of the study. For statistical analysis, data on post-inclusion attrition over the 3 follow-up phases was separated into 'death' and 'withdrawal' categories, with sub-categories 'health' and 'non-health' reasons created for 'withdrawal'. Multinomial logistic regression was used to determine if particular socio-demographic and health characteristics were associated with post-inclusion attrition due to withdrawal at each of the 3 phase-to-phase transition points. Results: For both sexes, at successive follow-up phases there was a decrease in attrition due to withdrawal and an increase due to death. Withdrawal was most prevalent between baseline and phase 2. Across the 5 years of the study total post-inclusion (post-baseline) attrition due to death accounted for a 40% (344/854) loss to cohort and total post-inclusion attrition due to withdraw a 19% (166/854) loss to cohort, with health reasons for withdrawal becoming more dominant over time. Adjusting for sex, parsimonious modelling showed only occupational class (National Statistics Socio-economic Classification) to be associated with withdrawal and only between baseline and phase 2 (routine/manual compared to managerial (OR 3.41; 95% CI [1.23 to 9.44]). Conclusion: Following successful recruitment, we retained a high proportion of participants from a very old age group over 5 years of longitudinal research. No strong predictors of post-inclusion attrition due to withdrawal were found, suggesting the general effectiveness of our retention strategies.	[Davies, Karen; Kingston, Andrew; Robinson, Louise; Hughes, Joan; Hunt, Judith M.; Barker, Sally A. H.; Edwards, June; Collerton, Joanna; Jagger, Carol; Kirkwood, Thomas B. L.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Davies, Karen; Kingston, Andrew; Robinson, Louise; Collerton, Joanna; Jagger, Carol] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kirkwood, Thomas B. L.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Davies, K (corresponding author), Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Karen.davies@ncl.ac.uk		Davies, Karen/0000-0002-2820-9397; Kingston, Andrew/0000-0003-4211-7007; Jagger, Carol/0000-0002-6377-9926; Robinson, Louise/0000-0003-0209-2503	Medical Research Council; Biotechnology and Biological Sciences Research Council [G0500997]; Newcastle Healthcare Charity; Dunhill Medical Trust; Medical Research Council [MR/J50001X/1, G0500997] Funding Source: researchfish; MRC [MR/J50001X/1, G0500997] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle Healthcare Charity; Dunhill Medical Trust(Dunhill Medical Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Newcastle 85+ Study was supported by a combined grant from the Medical Research Council and Biotechnology and Biological Sciences Research Council (reference G0500997), and a grant from the Newcastle Healthcare Charity and the Dunhill Medical Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Ranberg K, 1999, AGE AGEING, V28, P373, DOI 10.1093/ageing/28.4.373; Blanton S, 2006, PHYS THER, V86, P1520, DOI 10.2522/ptj.20060091; Bonk J, 2010, J AM GERIATR SOC, V58, pS303, DOI 10.1111/j.1532-5415.2010.02937.x; Bower P, 2009, FAM PRACT, V26, P391, DOI 10.1093/fampra/cmp037; Brayne C, 2006, INT J EPIDEMIOL, V35, P1140, DOI 10.1093/ije/dyl199; Bronnum-Hansen H, 2009, AGE AGEING, V38, P47, DOI 10.1093/ageing/afn239; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Cotter RB, 2002, J CHILD FAM STUD, V11, P458; Cunliffe AL, 2009, HE SAGE HDB MANAGEME; Dapp U, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-35; Davies K, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-64; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9; Doyle S, 2013, QUAL HEALTH RES, V23, P248, DOI 10.1177/1049732312467854; Ejiogu N, 2011, GERONTOLOGIST, V51, pS33, DOI 10.1093/geront/gnr027; FLICK SN, 1988, CLIN PSYCHOL REV, V8, P499, DOI 10.1016/0272-7358(88)90076-1; Gustavson K, 2012, J POSIT PSYCHOL, V7, P188, DOI 10.1080/17439760.2012.671346; Hayman KJ, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-33; Helliwell B, 2001, INT PSYCHOGERIATR, V13, P49, DOI 10.1017/S1041610202007986; Jacomb PA, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-4; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Jefferys M, 1989, GROWING OLD 20 CENTU, P1; Kingston A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088016; Marmot M, 2003, BR MED J; Matthews FE, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-12; McMurdo MET, 2011, AGE AGEING, V40, P659, DOI 10.1093/ageing/afr115; Mein G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-164; Mihelic AH, 1997, J GERONTOL B-PSYCHOL, V52, pS37, DOI 10.1093/geronb/52B.1.S37; Morris G, 2014, AGE WONDERS STORY NE; National institute of Mental Health (NIoMH), 2005, POINTS CONS RECR RET; Office for National Statistics, 2010, NAT STAT SOC CLASS N; Office of the deputy Prime Minsiter, 2004, ENGL IND DEPR; Olshansky S.J., 1991, J AGING HEALTH, V3, P194, DOI DOI 10.1177/089826439100300205; Orwig D, 2011, AM J GERIATR PHARMAC, V9, P173, DOI 10.1016/j.amjopharm.2011.04.008; Patel M.X., 2003, ADV PSYCHIAT TREAT, V9, P229, DOI [10.1192/apt.9.3.229, DOI 10.1192/APT.9.3.229]; Schaffer RH, 1996, SOCIAL DEV; Tesch-Romer, 2006, NEW DYNAMICS OLD AGE, P127; Tinker A, 2009, RES ETHICS REV, V5, P71; Van Beijsterveldt CEM, 2002, J CLIN EPIDEMIOL, V55, P216, DOI 10.1016/S0895-4356(01)00473-5; Wanless, 2002, SECURING OUR FUTURE; Weverling-Rijnsburger AWE, 1997, LANCET, V350, P1119; Witham MD, 2014, QJM-INT J MED, V107, P15, DOI 10.1093/qjmed/hct178; Zebracki K, 2003, J PEDIATR PSYCHOL, V28, P519, DOI 10.1093/jpepsy/jsg042; Zunzunegui MV, 2001, J CLIN EPIDEMIOL, V54, P501, DOI 10.1016/S0895-4356(00)00325-5	44	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108370	10.1371/journal.pone.0108370	http://dx.doi.org/10.1371/journal.pone.0108370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25302500	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400012
J	Tang, LL; Guo, R; Zhou, GQ; Sun, Y; Liu, LZ; Lin, AH; Mai, HQ; Shao, JY; Li, L; Ma, J				Tang, Ling-Long; Guo, Rui; Zhou, Guanqun; Sun, Ying; Liu, Li-Zhi; Lin, Ai-Hua; Mai, Haiqiang; Shao, Jianyong; Li, Li; Ma, Jun			Prognostic Value and Staging Classification of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy	PLOS ONE			English	Article							GENE-EXPRESSION CLASSIFIER; HYPOXIC MODIFICATION; NECK-CANCER; HEAD; TOMOGRAPHY; PATTERNS; CT; CATEGORIES; DISEASE; SPREAD	Background: The development of intensity-modulated radiotherapy (IMRT) has revolutionized the management of nasopharyngeal carcinoma (NPC). The purpose of this study was to evaluate the prognostic value and classification of TNM stage system for retropharyngeal lymph node (RLN) metastasis in NPC in the IMRT era. Material and Methods: We retrospectively reviewed data from 749 patients with biopsy-proven, non-metastatic NPC. All patients received IMRT as the primary treatment. Chemotherapy was administered to 86.2% (424/492) of the patients with stage III or IV disease. Results: The incidence of RLN metastasis was 64.2% (481/749). Significant differences were observed in the 5-year disease-free survival (DFS; 70.6% vs. 85.4%, P<0.001) and distant metastasis-free survival (DMFS; 79.2% vs. 90.1%, P<0.001) rates of patients with and without RLN metastasis. In multivariate analysis, RLN metastasis was an independent prognostic factor for disease failure and distant failure (P = 0.005 and P = 0.026, respectively), but not for locoregional recurrence. Necrotic RLN metastases have a negative effect on disease failure, distant failure and locoregional recurrence in NPC with RLN metastasis (P = 0.003, P = 0.018 and P = 0.005, respectively). Survival curves demonstrated a significant difference in DFS between patients with N0 disease and N1 disease with only RLN metastasis (P = 0.020), and marginally statistically significant differences in DMFS and DFS between N1 disease with only RLN metastasis and other N1 disease (P = 0.058 and P = 0.091, respectively). In N1 disease, no significant differences in DFS were observed between unilateral and bilateral RLN metastasis (P = 0.994). Conclusions: In the IMRT era, RLN metastasis remains an independent prognostic factor for DFS and DMFS in NPC. It is still reasonable for RLN metastasis to be classified in the N1 disease, regardless of laterality. However, there is a need to investigate the feasibility of classifying RLN metastasis as N1a disease in future by a larger cohort study.	[Tang, Ling-Long; Guo, Rui; Zhou, Guanqun; Sun, Ying; Ma, Jun] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Ling-Long; Guo, Rui; Zhou, Guanqun; Sun, Ying; Ma, Jun] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Tang, Ling-Long; Guo, Rui; Zhou, Guanqun; Sun, Ying; Ma, Jun] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Liu, Li-Zhi; Li, Li] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Imaging Diag & Intervent Ctr,State Key Lab Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Mai, Haiqiang] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Shao, Jianyong] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Mol Diagnost, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	majun2@mail.sysu.edu.cn			China Scholarship Council [201308440052]; National Natural Science Foundation of China [81101695, 81071836]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Ministry of Education [IRT1297]	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Ministry of Education	This work was supported by grants from the China Scholarship Council (No. 201308440052, the National Natural Science Foundation of China (No. 81101695 and No. 81071836), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2010), and the Innovation Team Development Plan of the Ministry of Education (IRT1297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COX DR, 1972, J R STAT SOC B, V34, P187; DON DM, 1995, LARYNGOSCOPE, V105, P669, DOI 10.1288/00005537-199507000-00001; Edge SB, 2010, AJCC CANC STAGING MA, P41, DOI [10.1007/978-0-387-88441-7_4, DOI 10.1007/978-0-387-88441-7_4]; Groome PA, 2001, HEAD NECK-J SCI SPEC, V23, P613, DOI 10.1002/hed.1087; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; King AD, 2004, EUR J RADIOL, V52, P264, DOI 10.1016/j.ejrad.2004.03.004; King AD, 2004, RADIOLOGY, V230, P720, DOI 10.1148/radiol.2303030157; King AD, 2000, HEAD NECK-J SCI SPEC, V22, P275; Kong FF, 2014, EUR ARCH OTO-RHINO-L, V271, P3283, DOI 10.1007/s00405-014-2900-2; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lam WWM, 1997, HEAD NECK-J SCI SPEC, V19, P176, DOI 10.1002/(SICI)1097-0347(199705)19:3<176::AID-HED2>3.0.CO;2-#; Liao XB, 2008, INT J RADIAT ONCOL, V72, P1368, DOI 10.1016/j.ijrobp.2008.03.017; Ma J, 2007, CLIN CANCER RES, V13, P1445, DOI 10.1158/1078-0432.CCR-06-2059; Ng SH, 2004, EUR J NUCL MED MOL I, V31, P1073, DOI 10.1007/s00259-004-1498-9; Ng SH, 1997, NEURORADIOLOGY, V39, P741, DOI 10.1007/s002340050499; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; OLMI P, 1995, INT J RADIAT ONCOL, V32, P795, DOI 10.1016/0360-3016(94)00535-S; Rischin D, 2006, J CLIN ONCOL, V24, P2098, DOI 10.1200/JCO.2005.05.2878; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; SOM PM, 1987, RADIOLOGY, V165, P593, DOI 10.1148/radiology.165.3.3317494; Tang LL, 2008, CANCER, V113, P347, DOI 10.1002/cncr.23555; Tang LL, 2009, CANCER-AM CANCER SOC, V115, P680, DOI 10.1002/cncr.24049; Toustrup K, 2012, RADIOTHER ONCOL, V102, P122, DOI 10.1016/j.radonc.2011.09.010; Toustrup K, 2011, CANCER RES, V71, P5923, DOI 10.1158/0008-5472.CAN-11-1182; VANDENBREKEL MWM, 1990, RADIOLOGY, V177, P379, DOI 10.1148/radiology.177.2.2217772; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X	26	28	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108375	10.1371/journal.pone.0108375	http://dx.doi.org/10.1371/journal.pone.0108375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302611	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400013
J	Belaganahalli, MN; Maan, S; Maan, NS; Pritchard, I; Kirkland, PD; Brownlie, J; Attoui, H; Mertens, PPC				Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Pritchard, Ian; Kirkland, Peter D.; Brownlie, Joe; Attoui, Houssam; Mertens, Peter P. C.			Full Genome Characterization of the Culicoides-Borne Marsupial Orbiviruses: Wallal Virus, Mudjinbarry Virus and Warrego Viruses	PLOS ONE			English	Article							EPIZOOTIC HEMORRHAGIC-DISEASE; BLUETONGUE-VIRUS; COMPLETE SEQUENCE; GENETIC-ANALYSIS; MOSQUITOS; ARBOVIRUSES; REOVIRIDAE; STRATEGIES; MIDGES; CELLS	Viruses belonging to the species Wallal virus and Warrego virus of the genus Orbivirus were identified as causative agents of blindness in marsupials in Australia during 1994/5. Recent comparisons of nucleotide (nt) and amino acid (aa) sequences have provided a basis for the grouping and classification of orbivirus isolates. However, full-genome sequence data are not available for representatives of all Orbivirus species. We report full-genome sequence data for three additional orbiviruses: Wallal virus (WALV); Mudjinabarry virus (MUDV) and Warrego virus (WARV). Comparisons of conserved polymerase (Pol), sub-core-shell 'T2' and core-surface 'T13' proteins show that these viruses group with other Culicoides borne orbiviruses, clustering with Eubenangee virus (EUBV), another orbivirus infecting marsupials. WARV shares <70% aa identity in all three conserved proteins (Pol, T2 and T13) with other orbiviruses, consistent with its classification within a distinct Orbivirus species. Although WALV and MUDV share,<72.86%/67.93% aa/nt identity with other orbiviruses in Pol, T2 and T13, they share >99%/90% aa/nt identities with each other (consistent with membership of the same virus species - Wallal virus). However, WALV and MUDV share, <68% aa identity in their larger outer capsid protein VP2(OC1), consistent with membership of different serotypes within the species - WALV-1 and WALV-2 respectively.	[Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Attoui, Houssam; Mertens, Peter P. C.] Inst Anim Hlth, Vector Borne Viral Dis Programme, Woking, Surrey, England; [Pritchard, Ian] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Kirkland, Peter D.] Elizabeth Macarthur Agr Inst, Camden, NSW, Australia; [Brownlie, Joe] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of London; University of London Royal Veterinary College	Mertens, PPC (corresponding author), Inst Anim Hlth, Vector Borne Viral Dis Programme, Woking, Surrey, England.	peter.mertens@pirbright.ac.uk	Kirkland, Peter/AAC-6731-2019; Belaganahalli, Manjunatha N/I-1688-2019	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Mertens, Peter/0000-0002-3438-3738; Attoui, Houssam/0000-0001-9639-9981	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/ 940/ 2002]; EMIDA [K1303206]; WildTech [222633-2.]; CSIRO; Dept of Agriculture, Fisheries and Forestry, Australian Government; NSW Department of Primary Industries; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001144, BB/I017259/1, BBS/E/I/00001446] Funding Source: researchfish; BBSRC [BBS/E/I/00001446, BB/I017259/1] Funding Source: UKRI	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); EMIDA; WildTech; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Dept of Agriculture, Fisheries and Forestry, Australian Government(Australian GovernmentDepartment of Agriculture and Water Resources); NSW Department of Primary Industries; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by the Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/) awarded to MB, partly by the Department for Environment, Food and Rural Affairs (Defra)(SE2617) awarded to SM. NSM, PCM and HA were funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the European Union (EU) (SANCO/ 940/ 2002; EMIDA grant OrbiNet - K1303206) and WildTech - Grant no. 222633-2. IP was part of this work, funded by CSIRO & Dept of Agriculture, Fisheries and Forestry, Australian Government. PK was funded by NSW Department of Primary Industries. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Vieira CDA, 2009, J GEN VIROL, V90, P2183, DOI 10.1099/vir.0.010165-0; Anthony SJ, 2011, VIROLOGY, V420, P164, DOI 10.1016/j.virol.2011.09.009; Anthony SJ, 2009, VIRUS RES, V145, P187, DOI 10.1016/j.virusres.2009.07.011; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; Anthony SJ, 2009, VIRUS RES, V145, P211, DOI 10.1016/j.virusres.2009.07.019; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H, 2012, REOVIRIDAE, P497; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Belaganahalli MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070779; Belaganahalli MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031911; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; BORDEN EC, 1971, J GEN VIROL, V13, P261, DOI 10.1099/0022-1317-13-2-261; BROWN SE, 1992, VET MICROBIOL, V32, P241, DOI 10.1016/0378-1135(92)90147-L; Curran G, 1997, EPIDEMIOL SANTE ANIM, V31-32, P1; DELLA-PORTA A J, 1985, P445; DOHERTY RL, 1973, T ROY SOC TROP MED H, V67, P536, DOI 10.1016/0035-9203(73)90084-9; DOHERTY RL, 1978, AUST J BIOL SCI, V31, P97, DOI 10.1071/BI9780097; DOHERTY RL, 1970, T ROY SOC TROP MED H, V64, P748, DOI 10.1016/0035-9203(70)90017-9; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Gorman B.M., 1983, P287; GORMAN BM, 1978, J GEN VIROL, V41, P333, DOI 10.1099/0022-1317-41-2-333; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hooper PT, 1999, AUST VET J, V77, P529, DOI 10.1111/j.1751-0813.1999.tb12127.x; Hooper PT, 1999, VET MICROBIOL, V68, P89, DOI 10.1016/S0378-1135(99)00064-4; Kapoor A, 2013, J GEN VIROL, V94, P1051, DOI 10.1099/vir.0.046748-0; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Martins LC, 2007, INT J EXP PATHOL, V88, P63, DOI 10.1111/j.1365-2613.2006.00516.x; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; Mertens PPC., 2005, VIRUS TAXONOMY, P466; MOORE DL, 1974, AM J VET RES, V35, P1109; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; PEDLEY S, 1988, VIRUS RES, V10, P381, DOI 10.1016/0168-1702(88)90078-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Rose K, 2012, AUST VET J, P90; Rose KA, 2000, P AAZV IAAAM JOINT C, P166; SATO M, 1977, ARCH VIROL, V53, P269, DOI 10.1007/BF01314672; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verwoerd D. W., 1979, Comprehensive virology, volume 14, P285; WALKER PJ, 1980, J VIROL, V34, P583, DOI 10.1128/JVI.34.3.583-591.1980; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yamakawa M, 1999, J GEN VIROL, V80, P937, DOI 10.1099/0022-1317-80-4-937	57	8	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108379	10.1371/journal.pone.0108379	http://dx.doi.org/10.1371/journal.pone.0108379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299687	Green Published, Green Accepted, gold			2022-12-27	WOS:000343941200017
J	Du, J; Ma, YY; Xiang, H; Li, YM				Du, Juan; Ma, Yan-Yan; Xiang, Ha; Li, You-Ming			Confluent Granulomas and Ulcers Lined by Epithelioid Histiocytes: New Ideal Method for Differentiation of ITB and CD? A Meta Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; INTESTINAL TUBERCULOSIS; ABDOMINAL TUBERCULOSIS; HISTOLOGICAL DIFFERENTIATIONS; DIAGNOSIS; PREVALENCE; EPIDEMIOLOGY; MANAGEMENT; BIAS	Background: There are few widely accepted criteria other than caseation, which has low sensitivity, for differentiating intestinal tuberculosis (ITB) and Crohn's disease (CD). Objective: We performed a meta-analysis to evaluate the use of confluent granulomas and ulcers lined by epithelioid histiocytes as histological methods for differentiating ITB and CD, compared with that of caseation. Methods: We searched PubMed, Medline, Embase, Web of Science, the Cochrane Library and Chinese Biomedicine Database for all relevant studies on the histological differentiation of ITB and CD. Sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated for each study. Study quality and heterogeneity were assessed. Meta-regression analysis and sensitivity analyses were performed. Results: Ten randomized trials involving 316 ITB and 376 CD patients were included. The results showed that analysis of caseation showed an overall weighted area under the curve (AUC) of 0.9966, overall sensitivity and specificity were 0.21 and 1.00, respectively, with a positive likelihood ratio (+LR) of 10.79, negative likelihood ratio(-LR) of 0.82 and DOR of 13.74. Confluent granulomas had a lower overall weighted AUC of 0.9381, sensitivity and specificity were 0.38 and 0.99, respectively, with a +LR of 16.29, -LR of 0.65 and DOR of 26.52. Overall weighted AUC for ulcers lined by epithelioid histiocytes was 0.9017, sensitivity and specificity were 0.41 and 0.94, respectively, with a +LR of 6.46, -LR of 0.54 and DOR of 13.17. Significant heterogeneity was noted for the studies. Meta-regression analysis showed that study source, publication year, size, design and quality did not affect heterogeneity. Conclusion: Confluent granulomas and ulcers lined by epithelioid histiocytes are helpful in distinguishing ITB from CD, which may provide a new method, other than caseating granulomas and acid-fast bacilli, to differentiate ITB and CD in mucosal biopsies.	[Du, Juan; Ma, Yan-Yan; Li, You-Ming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Xiang, Ha] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zlym@zju.edu.cn	MA, YAN/HHN-2912-2022	Ma, Han/0000-0001-9985-3035	Zhejiang Provincial Natural Science Foundation of China [LQ13H030002]; Medical and Healthy Science Foundation of Health Bureau of Zhejiang Province [2013KYB089]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Medical and Healthy Science Foundation of Health Bureau of Zhejiang Province	This study was supported by the Zhejiang Provincial Natural Science Foundation of China, No. LQ13H030002; Medical and Healthy Science Foundation of Health Bureau of Zhejiang Province, No. 2013KYB089. The funders contributed in study design, data collection and analysis, preparation of the manuscript.	Amarapurkar DN, 2008, WORLD J GASTROENTERO, V14, P741, DOI 10.3748/wjg.14.741; Chatzicostas Constantinos, 2002, BMC Gastroenterol, V2, P10, DOI 10.1186/1471-230X-2-10; Chinese Society of Gastroenterology Chinese Medical Association, 2001, CHINESE J INTERN MED, V40, P138; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x; GILINSKY NH, 1983, S AFR MED J, V64, P849; Gu Qing, 2009, Zhonghua Nei Ke Za Zhi, V48, P291; Kirsch R, 2006, J CLIN PATHOL, V59, P840, DOI 10.1136/jcp.2005.032383; Lee YJ, 2006, ENDOSCOPY, V38, P592, DOI 10.1055/s-2006-924996; Lee Yun Jung, 2004, Korean J Gastroenterol, V44, P153; Li XF, 2011, DIGEST DIS SCI, V56, P188, DOI 10.1007/s10620-010-1231-4; Li Y, 2012, J CROHNS COLITIS, V6, P317, DOI 10.1016/j.crohns.2011.09.002; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Makharia GK, 2006, J GASTROEN HEPATOL, V21, P929, DOI 10.1111/j.1440-1746.2006.04471.x; Makharia GK, 2010, AM J GASTROENTEROL, V105, P642, DOI 10.1038/ajg.2009.585; Miao YL, 2002, CHIN J DIG ENDOSC, V19, P9; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ouyang Q, 2008, J DIGEST DIS, V9, P52, DOI 10.1111/j.1443-9573.2007.00320x; Park Jong Beom, 2004, Korean J Gastroenterol, V43, P8; Petroianni A, 2002, PANMINERVA MED, V44, P155; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Pulimood AB, 2005, J GASTROEN HEPATOL, V20, P688, DOI 10.1111/j.1440-1746.2005.03814.x; Sahu MK, 2011, INDIAN J GASTROENTER, V30, P204, DOI 10.1007/s12664-011-0135-3; Sinhasan SP, 2011, SAUDI J GASTROENTERO, V17, P110, DOI 10.4103/1319-3767.77239; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Sood Ajit, 2007, Indian J Gastroenterol, V26, P285; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; XIA B, 1997, CHINA NATL J NEW GAS, V3, P119; Yu HS, 2012, DIGESTION, V85, P202, DOI 10.1159/000335431; Zhou ZY, 2006, INT J CLIN PRACT, V60, P212, DOI 10.1111/j.1742-1241.2006.00702.x	31	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e103303	10.1371/journal.pone.0103303	http://dx.doi.org/10.1371/journal.pone.0103303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299041	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200002
J	Lau, LCM; Ma, L; Young, AL; Rong, SS; Jhanji, V; Brelen, ME; Pang, CP; Chen, LJ				Lau, Lawrence C. M.; Ma, Li; Young, Alvin L.; Rong, Shi Song; Jhanji, Vishal; Brelen, Marten E.; Pang, Chi Pui; Chen, Li Jia			Association of Common Variants in TCF4 and PTPRG with Fuchs' Corneal Dystrophy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PENETRATING KERATOPLASTY; ENDOTHELIAL DYSTROPHY; GENOME BROWSER; UNITED-STATES; MUTATIONS; LOCUS; GENE; PROTEIN; ZEB1; POLYMORPHISMS	Topic: A meta-analysis of TCF4 and PTPRG gene variants in Fuchs' corneal dystrophy (FCD). Methods: MEDLINE and EMBASE were searched for eligible genetic studies on TCF4 and PTPRG in FCD. Odds ratios (OR) and 95% confidence intervals (CI) of each single-nucleotide polymorphism (SNP) in allelic, dominant and recessive models were estimated using fixed-effect model if r(2)<50% in the test for heterogeneity, otherwise the random effects model was used. Results: Thirty-three records were obtained, with 8 being suitable for meta-analysis, which included five SNPs in TCF4 and two in PTPRG. There were 1610 FCD patients and 1565 controls tested for TCF4 rs613872. This SNP was strongly associated with FCD in Caucasians (P = 5.0x10(-106)), with the risk allele G conferring an OR of 3.95 (95% CI: 3.49-4.46). A further 4 TCF4 SNPs (rs17595731, rs2286812, rs618869 and rs9954153) were also significantly associated with FCD in Caucasians (P<10(-8)). However, we found no SNP associated with FCD in Chinese. In addition, there was no significant association between FCD and PTPRG. Conclusion: TCF4 rs613872 is strongly associated with FCD in Caucasians but not in Chinese, which may suggest ethnic diversity in FCD SNP associations. SNPs in PTPRG were not associated with FCD in Caucasians or Chinese populations. Results of this meta-analysis indicate the need for larger-scale and multi-ethnic genetic studies on FCD to further explore the associated gene variants and their roles on the mechanism and genetic basis of FCD.	[Lau, Lawrence C. M.; Young, Alvin L.; Jhanji, Vishal; Brelen, Marten E.; Pang, Chi Pui; Chen, Li Jia] Prince Wales Hosp, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Lau, Lawrence C. M.; Ma, Li; Young, Alvin L.; Rong, Shi Song; Jhanji, Vishal; Brelen, Marten E.; Pang, Chi Pui; Chen, Li Jia] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong	Chen, LJ (corresponding author), Prince Wales Hosp, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China.	lijia_chen@cuhk.edu.hk	Rong, Shi Song/L-9735-2019; Lau, Lawrence C.M./AAJ-4908-2020; Chen, Li Jia/I-5078-2014; Jhanji, Vishal/I-5676-2014; Brelen, Marten E./D-1133-2016	Rong, Shi Song/0000-0001-8352-6363; Lau, Lawrence C.M./0000-0002-2245-9627; Chen, Li Jia/0000-0003-3500-5840; 	Health and Medical Research Fund (HMRF), Hong Kong [01122236, 11120801]; Endowment Fund for the Lim Por-Yen Eye Genetics Research Centre, Hong Kong	Health and Medical Research Fund (HMRF), Hong Kong; Endowment Fund for the Lim Por-Yen Eye Genetics Research Centre, Hong Kong	This study was supported in part by the Health and Medical Research Fund (HMRF, Ref: 01122236 & 11120801), Hong Kong, and by an Endowment Fund for the Lim Por-Yen Eye Genetics Research Centre, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Chen WL, 2001, CORNEA, V20, P141, DOI 10.1097/00003226-200103000-00004; Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247; Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010; FRISCH SM, 1994, J CELL BIOL, V127, P1085, DOI 10.1083/jcb.127.4.1085; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P4504, DOI 10.1167/iovs.05-0497; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Igo RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046742; Iliff BW, 2012, EXPERT REV OPHTHALMO, V7, P363, DOI 10.1586/EOP.12.39; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Kuot A, 2012, EUR J HUM GENET, V20, P632, DOI 10.1038/ejhg.2011.248; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; Liu J, 2012, INVEST OPHTH VIS SCI, V53, P3270, DOI 10.1167/iovs.11-8724; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; Musch DC, 2011, INVEST OPHTH VIS SCI, V52, P6959, DOI 10.1167/iovs.11-7771; Pan Q, 2012, CLIN EXP OPHTHALMOL, V40, P232, DOI 10.1111/j.1442-9071.2011.02598.x; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Riazuddin SA, 2013, AM J HUM GENET, V93, P758, DOI 10.1016/j.ajhg.2013.08.010; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2011, INVEST OPHTH VIS SCI, V52, P2825, DOI 10.1167/iovs.10-6497; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Stamler JF, 2013, OPHTHALMIC GENET, V34, P32, DOI 10.3109/13816810.2012.726396; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P140, DOI 10.1167/iovs.05-0578; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Terraz C, 2001, J BIOL CHEM, V276, P37011, DOI 10.1074/jbc.M104185200; Thalamuthu A, 2011, INVEST OPHTH VIS SCI, V52, P5573, DOI 10.1167/iovs.11-7568; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Wang KJ, 2013, OPHTHALMIC GENET; Wang X, 2012, GRAEF ARCH CLIN EXP, V250, P307, DOI 10.1007/s00417-010-1606-4	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109142	10.1371/journal.pone.0109142	http://dx.doi.org/10.1371/journal.pone.0109142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299301	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200037
J	Nzeyimana, I; Hartemink, AE; Geissen, V				Nzeyimana, Innocent; Hartemink, Alfred E.; Geissen, Violette			GIS-Based Multi-Criteria Analysis for Arabica Coffee Expansion in Rwanda	PLOS ONE			English	Article							SUITABILITY EVALUATION; SOIL PROPERTIES; LAND EVALUATION; PREDICTION; FRAMEWORK; QUALITY; YIELD; MODEL; CORN	The Government of Rwanda is implementing policies to increase the area of Arabica coffee production. Information on the suitable areas for sustainably growing Arabica coffee is still scarce. This study aimed to analyze suitable areas for Arabica coffee production. We analyzed the spatial distribution of actual and potential production zones for Arabica coffee, their productivity levels and predicted potential yields. We used a geographic information system (GIS) for a weighted overlay analysis to assess the major production zones of Arabica coffee and their qualitative productivity indices. Actual coffee yields were measured in the field and were used to assess potential productivity zones and yields using ordinary kriging with ArcGIS software. The production of coffee covers about 32 000 ha, or 2.3% of all cultivated land in the country. The major zones of production are the Kivu Lake Borders, Central Plateau, Eastern Plateau, and Mayaga agro-ecological zones, where coffee is mainly cultivated on moderate slopes. In the highlands, coffee is grown on steep slopes that can exceed 55%. About 21% percent of the country has a moderate yield potential, ranging between 1.0 and 1.6 t coffee ha(-1), and 70% has a low yield potential (< 1.0 t coffee ha(-1)). Only 9% of the country has a high yield potential of 1.6-2.4 t coffee ha(-1). Those areas are found near Lake Kivu where the dominant soil Orders are Inceptisols and Ultisols. Moderate yield potential is found in the Birunga (volcano), Congo-Nile watershed Divide, Impala and Imbo zones. Low-yield regions (< 1 t ha(-1)) occur in the eastern semi-dry lowlands, Central Plateau, Eastern Plateau, Buberuka Highlands, and Mayaga zones. The weighted overlay analysis and ordinary kriging indicated a large spatial variability of potential productivity indices. Increasing the area and productivity of coffee in Rwanda thus has considerable potential.	[Nzeyimana, Innocent; Geissen, Violette] Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands; [Hartemink, Alfred E.] Univ Wisconsin, Dept Soil Sci, FD Hole Soils Lab, Madison, WI 53706 USA	Wageningen University & Research; University of Wisconsin System; University of Wisconsin Madison	Nzeyimana, I (corresponding author), Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands.	innocent.nzeyimana@wur.nl	Hartemink, Alfred/G-1149-2011	Hartemink, Alfred/0000-0002-5797-6798	NUFFIC; NZEYIMANA at Wageningen University	NUFFIC; NZEYIMANA at Wageningen University	The authors acknowledge NUFFIC of the Netherlands for funding the PhD training of Innocent NZEYIMANA at Wageningen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birasa EC, 1990, SOLS RWANDA ME UNPUB; Boffa J.M., 2009, MOUNTAIN RES DEV, V25, P212; Bosselmann AS, 2009, AGR ECOSYST ENVIRON, V129, P253, DOI 10.1016/j.agee.2008.09.004; Changere A, 1997, J SUSTAIN AGR, V11, P5, DOI 10.1300/J064v11n01_03; Clay J, 2004, WORLD AGR ENV; Coleman A L, 2000, USING GIS AGR LAND U; DELAROSA D, 1992, SOIL USE MANAGE, V8, P89, DOI 10.1111/j.1475-2743.1992.tb00900.x; Descroix F, 2004, GUIDEBOOK GROWERS PR, P164; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; ESRI, 2001, ARCGIS SPAT AN ADV G; ESRI, 2011, ARCGIS DESKT REAL 10; FAO, 2014, FAOSTAT STAT DAT; Food and Agriculture Organization (FAO), 1976, FRAM LAND EV; Gabre-Madhin EZ, 2004, WORLD DEV, V32, P745, DOI 10.1016/j.worlddev.2003.11.004; Genton MG, 2000, MATH GEOLOGY, V32; Genton MG, 1998, MATH GEOLOGY, V30; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; JANSSEN R, 1990, GEOJ LIB, V17, P129; JOERIN F, 2001, INT J GEOGR INF SYST, V10, P321; Kravchenko AN, 2000, AGRON J, V92, P75, DOI 10.1007/s100870050010; Labouisse JP, 2008, GENET RESOUR CROP EV, V55, P1079, DOI 10.1007/s10722-008-9361-7; Li B, 2012, PEDOSPHERE, V22, P122, DOI 10.1016/S1002-0160(11)60198-7; Maji A. K., 1998, Journal of the Indian Society of Soil Science, V46, P260; Maji AK, 2001, INT J APPL EARTH OBS, V3, P69; Malczewski J, 1996, INT J GEOGR INF SYST, V10, P955, DOI 10.1080/026937996137675; Malczewski J, 2004, PROG PLANN, V62, P3, DOI 10.1016/j.progress.2003.09.002; McKinion JM, 2010, COMPUT ELECTRON AGR, V70, P187, DOI 10.1016/j.compag.2009.10.005; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Mueller TG, 2004, SOIL SCI SOC AM J, V68, P2042, DOI 10.2136/sssaj2004.2042; Nzeyimana I, 2013, OUTLOOK AGR, V42, P47, DOI 10.5367/oa.2013.0118; Park SJ, 2002, GEODERMA, V109, P117, DOI 10.1016/S0016-7061(02)00146-5; Ponte S, 2002, WORLD DEV, V30, P1099, DOI 10.1016/S0305-750X(02)00032-3; Rossiter DG, 1996, GEODERMA, V72, P165, DOI 10.1016/0016-7061(96)00031-6; Soltani A, 2013, EUR J AGRON, V48, P101, DOI 10.1016/j.eja.2013.02.010; van Asten PJA, 2011, AGR SYST, V104, P326, DOI 10.1016/j.agsy.2010.12.004; Van Oijen M, 2010, AGROFORESTRY SYSTEMS, P80; Verdoodt A., 2003, LAND EVALUATION AGR; Walke N, 2012, COMPUT GEOSCI-UK, V41, P108, DOI 10.1016/j.cageo.2011.08.020	38	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e107449	10.1371/journal.pone.0107449	http://dx.doi.org/10.1371/journal.pone.0107449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299459	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200006
J	Su, H; Han, B; Li, S; Na, B; Ma, W; Xu, TM				Su, Hong; Han, Bing; Li, Sa; Na, Bin; Ma, Wen; Xu, Tian-Min			Factors Predisposing to Maxillary Anchorage Loss: A Retrospective Study of 1403 Cases	PLOS ONE			English	Article							HEAD FILM MEASUREMENTS; CLASS-II MALOCCLUSION; PREMOLAR EXTRACTIONS; ORTHODONTIC TREATMENT; DIFFERENTIAL MOMENTS; SKELETAL ANCHORAGE; TREATMENT OUTCOMES; TOOTH MOVEMENT; IMPLANT; RELIABILITY	Anchorage loss is very disturbing for orthodontists and patients during orthodontic treatment, which usually results in bad treatment effects. Despite the same treatment strategy, different patients show different tendencies toward anchorage loss, which influences the treatment results and should preferably be predicted before the treatment is begun. However, relatively little research has been conducted on which patients are more likely to lose anchorage. The mesial tipping of the first molar marks the onset of anchorage loss, and changes in the angulation of the first molar are closely related to anchorage loss. This cross-sectional study aimed to determine how the mesiodistal angulation of the upper first molars changes during general orthodontic treatment and to identify the individual physiologic factors leading to these changes in a large sample of 1403 patients with malocclusion. The data indicate that the upper first molars tend to be tipped mesially during orthodontic treatment, and this constitutes a type of anchorage loss that orthodontists should consider carefully. Compared to treatment-related factors, patients' physiologic characteristics have a greater influence on changes in the angulation of the upper first molars during orthodontic treatment. The more distally tipped the upper first molars are before treatment, the more they will tip mesially during treatment. Mesial tipping of the upper first molars, and therefore, anchorage loss, is more likely to occur in adolescents, males, patients with class II malocclusion and patients who have undergone maxillary premolar extraction. This finding is of clinical significance to orthodontists who wish to prevent iatrogenic anchorage loss by tipping originally distally tipped upper molars forward, and provides a new perspective on anchorage during orthodontic treatment planning.	[Su, Hong; Han, Bing; Xu, Tian-Min] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China; [Li, Sa] Shenzhen Peoples Hosp, Dept Stomatol, Shenzhen, Peoples R China; [Na, Bin; Ma, Wen] Peking Univ, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Jinan University; Peking University	Xu, TM (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China.	tmxuortho@gmail.com			National Natural Science Foundation of China [NSFC81371192]; Beijing Municipal Science & Technology Commission [Z141107002514054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	The work was supported by National Natural Science Foundation of China (No. NSFC81371192) and Beijing Municipal Science & Technology Commission (No. Z141107002514054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS LF, 1972, AMER J ORTHODONTICS, V62, P296, DOI 10.1016/S0002-9416(72)90268-0; Arat ZM, 2005, ANGLE ORTHOD, V75, P69; BAKER RW, 1972, ANGLE ORTHOD, V42, P129; BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P111, DOI 10.1016/0002-9416(71)90028-5; BAUMRIND S, 1971, AMER J ORTHODONTICS, V60, P505, DOI 10.1016/0002-9416(71)90116-3; BAUMRIND S, 1976, AM J ORTHOD DENTOFAC, V70, P617, DOI 10.1016/0002-9416(76)90224-4; BJORK A, 1972, AMER J ORTHODONTICS, V62, P339, DOI 10.1016/S0002-9416(72)90277-1; Chen K, 2010, AM J ORTHOD DENTOFAC, V138, P770, DOI 10.1016/j.ajodo.2009.01.030; Chen S, 2013, CHIN J ORTHOD, V20, P26; Cho MY, 2010, AM J ORTHOD DENTOFAC, V138, P747, DOI 10.1016/j.ajodo.2008.11.033; DOWNS WB, 1952, AM J ORTHOD DENTOFAC, V38, P162, DOI 10.1016/0002-9416(52)90106-1; Fuziy A, 2006, AM J ORTHOD DENTOFAC, V130, P502, DOI 10.1016/j.ajodo.2004.12.031; Gu Y, 2008, ANGLE ORTHOD, V78, P967, DOI 10.2319/070107-301.1; HART A, 1992, AM J ORTHOD DENTOFAC, V102, P434, DOI 10.1016/S0889-5406(05)81190-4; Hilgers J J, 1992, J Clin Orthod, V26, P706; Iseri H, 1996, EUR J ORTHODONT, V18, P245; Keeling SD, 1998, AM J ORTHOD DENTOFAC, V113, P40, DOI 10.1016/S0889-5406(98)70275-6; Kim YE, 2002, AM J ORTHOD DENTOFAC, V121, P280, DOI 10.1067/mod.2002.119978; Lai EHH, 2008, AM J ORTHOD DENTOFAC, V134, P636, DOI 10.1016/j.ajodo.2007.05.017; Liao Chun-hui, 2010, Hua Xi Kou Qiang Yi Xue Za Zhi, V28, P374; Londhe S M, 2010, Med J Armed Forces India, V66, P220, DOI 10.1016/S0377-1237(10)80041-3; Martinelli FL, 2010, AM J ORTHOD DENTOFAC, V137, P775, DOI 10.1016/j.ajodo.2008.06.037; McKinney JR, 2001, AM J ORTHOD DENTOFAC, V120, P530, DOI 10.1067/mod.2001.118784; Nanda RS, 2006, SEMIN ORTHOD, V12, P25; Ong HB, 2001, ANGLE ORTHOD, V71, P90; Patel MP, 2009, AM J ORTHOD DENTOFAC, V135, P336, DOI 10.1016/j.ajodo.2007.01.035; Proffit W., 2000, CONT ORTHODONTICS; Rajcich MM, 1997, AM J ORTHOD DENTOFAC, V112, P441, DOI 10.1016/S0889-5406(97)70053-2; Roth R H, 1987, J Clin Orthod, V21, P632; Roth R H, 1981, J Clin Orthod, V15, P32; SCHWAB DT, 1971, AMER J ORTHODONTICS, V59, P126, DOI 10.1016/0002-9416(71)90045-5; Steyn CL, 1997, AM J ORTHOD DENTOFAC, V112, P480, DOI 10.1016/S0889-5406(97)70074-X; Su H, 2014, INT J ORAL SCI, V6, P175, DOI 10.1038/ijos.2014.15; Tsourakis AK, 2014, SEMIN ORTHOD, V20, P59, DOI 10.1053/j.sodo.2013.12.006; Upadhyay M, 2008, AM J ORTHOD DENTOFAC, V134, P803, DOI 10.1016/j.ajodo.2006.10.025; Xu TM, 2010, AM J ORTHOD DENTOFAC, V138, P544, DOI 10.1016/j.ajodo.2010.07.004; Yao CCJ, 2008, AM J ORTHOD DENTOFAC, V134, P615, DOI 10.1016/j.ajodo.2006.12.022; Zhang Y, 2008, CHIN J ORTHOD, V15, P162; [张晔 ZHANG Ye], 2007, [哈尔滨医科大学学报, The Journal of Harbin Medical College], V41, P375; ZIEGLER P, 1989, AM J ORTHOD DENTOFAC, V95, P99, DOI 10.1016/0889-5406(89)90388-0; 고신애, 2007, [The Korean Journal of Orthodontics, 대한치과교정학회지], V37, P407	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109561	10.1371/journal.pone.0109561	http://dx.doi.org/10.1371/journal.pone.0109561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299164	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200059
J	Banerjee, P; Mondal, RK; Nandi, M; Ghosh, S; Khatun, M; Chakraborty, N; Bhattacharya, S; RoyChoudhury, A; Banerjee, S; Santra, A; Sil, S; Chowdhury, A; Bhaumik, P; Datta, S				Banerjee, Priyanka; Mondal, Rajiv Kumar; Nandi, Madhuparna; Ghosh, Sumantra; Khatun, Mousumi; Chakraborty, Nabendu; Bhattacharya, Swatilekha; RoyChoudhury, Arindam; Banerjee, Soma; Santra, Amal; Sil, Samir; Chowdhury, Abhijit; Bhaumik, Pradip; Datta, Simanti			A Rare HBV Subgenotype D4 with Unique Genomic Signatures Identified in North-Eastern India -An Emerging Clinical Challenge?	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; BLOOD-DONORS; S GENE; GENOTYPES; MUTATIONS; INFECTION; PREVALENCE; MUTANTS; STRAINS; AFRICA	Background/Aims: HBV has been classified into ten genotypes (A-J) and multiple subgenotypes, some of which strongly influence disease outcome and their distribution also correlate with human migration. HBV infection is highly prevalent in India and its diverse population provides an excellent opportunity to study the distinctiveness of HBV, its evolution and disease biology in variegated ethnic groups. The North-East India, having international frontiers on three sides, is one of the most ethnically and linguistically diverse region of the country. Given the paucity of information on molecular epidemiology of HBV in this region, the study aimed to carry out an in-depth genetic characterization of HBV prevailing in North-East state of Tripura. Methods: From sera of chronically HBV infected patients biochemical/serological tests, HBV DNA quantification, PCR-amplification, sequencing of PreS/S or full-length HBV genomes were done. HBV genotype/subgenotype determination and sequence variability were assessed by MEGA5-software. The evolutionary divergence times of different HBV subgenotypes were estimated by DNAMLK/PHYLIP program while jpHMM method was used to detect any recombination event in HBV genomes. Results: HBV genotypes D (89.5%), C (6.6%) and A (3.9%) were detected among chronic carriers. While all HBV/A and HBV/C isolates belonged to subgenotype-A1 and C1 respectively, five subgenotypes of HBV/D (D1-D5) were identified including the first detection of rare D4. These non-recombinant Indian D4 (IndD4) formed a distinct phylogenetic clade, had 2.7% nucleotide divergence and recent evolutionary radiation than other global D4. Ten unique amino acids and 9 novel nucleotide substitutions were identified as IndD4 signatures. All IndD4 carried T-120 and R-129 in ORF-S that may cause immune/vaccine/diagnostic escape and N-128 in ORF-P, implicated as compensatory Lamivudine resistance mutation. Conclusions: IndD4 has potential to undermine vaccination programs or anti-viral therapy and its introduction to North-East India is believed to be linked with the settlement of ancient Tibeto-Burman migrants from East-Asia.	[Banerjee, Priyanka; Mondal, Rajiv Kumar; Nandi, Madhuparna; Ghosh, Sumantra; Khatun, Mousumi; Banerjee, Soma; Santra, Amal; Datta, Simanti] Inst Post Grad Med Educ & Res, Liver Res Ctr, Sch Digest & Liver Dis, Kolkata, India; [Chakraborty, Nabendu; Bhattacharya, Swatilekha; Bhaumik, Pradip] Agartala Govt Med Coll, Agartala, India; [RoyChoudhury, Arindam] Columbia Univ, New York, NY USA; [Sil, Samir] Tripura Univ, Agartala, India; [Chowdhury, Abhijit] Inst Post Grad Med Educ & Res, Sch Digest & Liver Dis, Dept Hepatol, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Columbia University; Tripura University; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Datta, S (corresponding author), Inst Post Grad Med Educ & Res, Liver Res Ctr, Sch Digest & Liver Dis, Kolkata, India.	seemdatt@gmail.com	Ghosh, Sumantra/H-8897-2015; Mondal, Rajiv Kumar/AAQ-9076-2021	Ghosh, Sumantra/0000-0002-8367-8620; Mondal, Rajiv Kumar/0000-0001-7850-1671	Indian Council of Medical Research [NER/2/2008-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, NER/2/2008-ECD-I [B]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Baha W, 2012, INFECT GENET EVOL, V12, P1157, DOI 10.1016/j.meegid.2012.04.026; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Bhowmik P, 2011, EUROASIAN J HEPATO G, V1, P39; Borkakoty BJ, 2008, INDIAN J MED RES, V127, P65; Borkar M, 2011, ANN HUM BIOL, V38, P736, DOI 10.3109/03014460.2011.617389; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Candotti D, 2006, J VIRAL HEPATITIS, V13, P715, DOI 10.1111/j.1365-2893.2006.00741.x; Datta S, 2006, EMERG INFECT DIS, V12, P1954; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; Deka M, 2010, WORLD J GASTROENTERO, V16, P4800, DOI 10.3748/wjg.v16.i38.4800; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Ghosh S, 2013, J VIRAL HEPATITIS, V20, P209, DOI 10.1111/j.1365-2893.2012.01655.x; GILLES PN, 1992, HEPATOLOGY, V16, P655, DOI 10.1002/hep.1840160308; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Kamili S, 2010, ANTIVIR THER, V15, P477, DOI 10.3851/IMP1520; Kumar C, 2009, SCHOLARS VOICE NEW W, V1, P64; Kwange SO, 2013, VIRUS GENES, V47, P448, DOI 10.1007/s11262-013-0976-1; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Osiowy C, 2011, J VIRAL HEPATITIS, V18, pe11, DOI 10.1111/j.1365-2893.2010.01356.x; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Pollicino T, 2009, ANTIVIR THER, V14, P649; Pugach I, 2013, P NATL ACAD SCI USA, V110, P1803, DOI 10.1073/pnas.1211927110; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Sugauchi F, 2001, J GEN VIROL, V82, P883, DOI 10.1099/0022-1317-82-4-883; Utsumi T, 2007, J MED VIROL, V79, P229, DOI 10.1002/jmv.20791; Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198	29	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109425	10.1371/journal.pone.0109425	http://dx.doi.org/10.1371/journal.pone.0109425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295865	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000071
J	Skrnjug, I; Guzman, CA; Ruecker, C				Skrnjug, Ivana; Guzman, Carlos Alberto; Ruecker, Christine			Cyclic GMP-AMP Displays Mucosal Adjuvant Activity in Mice	PLOS ONE			English	Article							C-DI-GMP; DNA SENSOR; 2ND-MESSENGER; DINUCLEOTIDE; MODULATION; EXPRESSION; SYNTHASE	The recently discovered mammalian enzyme cyclic GMP-AMP synthase produces cyclic GMP-AMP (cGAMP) after being activated by pathogen-derived cytosolic double stranded DNA. The product can stimulate STING-dependent interferon type I signaling. Here, we explore the efficacy of cGAMP as a mucosal adjuvant in mice. We show that cGAMP can enhance the adaptive immune response to the model antigen ovalbumin. It promotes antigen specific IgG and a balanced Th1/Th2 lymphocyte response in immunized mice. A characteristic of the cGAMP-induced immune response is the slightly reduced induction of interleukin-17 as a hallmark of Th17 activity - a distinct feature that is not observed with other cyclic dinucleotide adjuvants. We further characterize the innate immune stimulation activity in vitro on murine bone marrow-derived dendritic cells and human dendritic cells. The observed results suggest the consideration of cGAMP as a candidate mucosal adjuvant for human vaccines.	[Skrnjug, Ivana; Guzman, Carlos Alberto; Ruecker, Christine] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Ruecker, C (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	christine.rueckert@helmholtz-hzi.de			EU (PANFLUVAC); BMBF; Helmholtz Association (IG-SCID)	EU (PANFLUVAC); BMBF(Federal Ministry of Education & Research (BMBF)); Helmholtz Association (IG-SCID)	This work was supported in part by grants from the EU (PANFLUVAC); BMBF in the context of the programs Gerontosys 2 (Gerontoshield), EuroNanoMed (HCVAX) and ERANetRUS (HCRUS), and the Helmholtz Association (IG-SCID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Burchill MA, 2003, INFECT IMMUN, V71, P3437, DOI 10.1128/IAI.71.6.3437-3442.2003; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Harandi AM, 2010, CURR HIV RES, V8, P330, DOI 10.2174/157016210791208695; Kang Suk-Jo, 2009, F1000 Biol Rep, V1, P15, DOI 10.3410/B1-15; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Libanova R, 2012, MICROB BIOTECHNOL, V5, P168, DOI 10.1111/j.1751-7915.2011.00306.x; Libanova R, 2010, VACCINE, V28, P2249, DOI 10.1016/j.vaccine.2009.12.045; Malefyt RD, 2009, IMMUNITY, V31, P700, DOI 10.1016/j.immuni.2009.11.002; Medina E, 2000, EUR J IMMUNOL, V30, P768, DOI 10.1002/1521-4141(200003)30:3<768::AID-IMMU768>3.3.CO;2-D; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Montomoli E, 2011, EXPERT REV VACCINES, V10, P1053, DOI [10.1586/erv.11.48, 10.1586/ERV.11.48]; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Rueckert C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003001; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	30	33	41	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110150	10.1371/journal.pone.0110150	http://dx.doi.org/10.1371/journal.pone.0110150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295996	Green Published, gold			2022-12-27	WOS:000345204000114
J	Wallace, RM; Gilbert, A; Slate, D; Chipman, R; Singh, A; Wedd, C; Blanton, JD				Wallace, Ryan M.; Gilbert, Amy; Slate, Dennis; Chipman, Richard; Singh, Amber; Wedd, Cassie; Blanton, Jesse D.			Right Place, Wrong Species: A 20-Year Review of Rabies Virus Cross Species Transmission among Terrestrial Mammals in the United States	PLOS ONE			English	Article							RACCOONS PROCYON-LOTOR; SKUNKS MEPHITIS-MEPHITIS; DENSITY; HOST; EPIDEMIOLOGY; SURVEILLANCE; INJURIES; DYNAMICS; COYOTES; DISEASE	Introduction: In the continental US, four terrestrial mammalian species are reservoirs for seven antigenic rabies virus variants. Cross species transmission (CST) occurs when a rabies virus variant causes disease in non-reservoir species. Methods: This study analyzed national surveillance data for rabies in terrestrial mammals. The CST rate was defined as: number of rabid non-reservoir animals/number of rabid reservoir animals. CST rates were analyzed for trend. Clusters of high CST rate counties were evaluated using space-time scanning statistics. Results: The number of counties reporting a raccoon variant CST rate >1.0 increased from 75 in 1992 to 187 in 2011; counties with skunk variant CST rates >1.0 remained unchanged during the same period. As of 2011, for every rabid raccoon reported within the raccoon variant region, there were 0.73 cases of this variant reported in non-reservoir animals. Skunks were the most common non-reservoir animal reported with the raccoon rabies variant. Domestic animals were the most common non-reservoir animal diagnosed with a skunk rabies virus variant (n = 1,601). Cross species transmission rates increased fastest among domestic animals. Conclusions: Cross species transmission of rabies virus variants into non-reservoir animals increases the risk of human exposures and threatens current advances toward rabies control. Cross species transmission in raccoon rabies enzootic regions increased dramatically during the study period. Pet owners should vaccinate their dogs and cats to ensure against CST, particularly in regions with active foci of rabies circulation. Clusters of high CST activity represent areas for further study to better understand interspecies disease transmission dynamics. Each CST event has the potential to result in a rabies virus adapted for sustained transmission in a new species; therefore further understanding of the dynamics of CST may help in early detection or prevention of the emergence of new terrestrial rabies virus variants.	[Wallace, Ryan M.; Singh, Amber; Wedd, Cassie; Blanton, Jesse D.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [Gilbert, Amy] USDA, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Slate, Dennis; Chipman, Richard] USDA, Wildlife Serv, Concord, NH USA	Centers for Disease Control & Prevention - USA; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Wallace, RM (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	euk5@cdc.gov		Gilbert, Amy T./0000-0002-8256-0081; Blanton, Jesse/0000-0002-2634-355X				ANDERSON RM, 1981, NATURE, V289, P765, DOI 10.1038/289765a0; Blanton JD, 2011, JAVMA, V239, P11; Blanton JD, 2012, JAVMA-J AM VET MED A, V241, P712, DOI 10.2460/javma.241.6.712; Borucki MK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002555; Bowen-Davies J, 2000, IN PRACTICE, V22, P118, DOI 10.1136/inpract.22.3.118; Breed MD, 2012, ANIMAL BEHAV AMSTERD, Vxiii; Broadfoot JD, 2001, ECOL APPL, V11, P295, DOI 10.1890/1051-0761(2001)011[0295:RASPMF]2.0.CO;2; Bureau USC, 2011, 2010 CENS XUMM FIL 1; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P31; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; CLARK KA, 1994, J AM VET MED ASSOC, V204, P536; Constantine D.G., 2009, BAT RABIES OTHER LYS, P1329; Dyer JL, 2013, JAVMA-J AM VET MED A, V243, P805, DOI 10.2460/javma.243.6.805; ESRI, 2011, ARCGIS DESK REL 10; Fascione N, 2004, PEOPLE PREDATORS CON; Feldhamer G.A., 2003, WILD MAMMALS N AM BI; Freer L, 2004, EMERG MED CLIN N AM, V22, P445, DOI 10.1016/j.emc.2004.01.008; Gordon ER, 2004, EPIDEMIOL INFECT, V132, P515, DOI 10.1017/S0950268804002067; Guerra MA, 2003, EMERG INFECT DIS, V9, P1143; Henner CM, 2004, J WILDLIFE MANAGE, V68, P179, DOI 10.2193/0022-541X(2004)068[0179:AMAORD]2.0.CO;2; HILL RE, 1992, J WILDLIFE DIS, V28, P51, DOI 10.7589/0090-3558-28.1.51; HILL RE, 1993, J WILDLIFE DIS, V29, P475, DOI 10.7589/0090-3558-29.3.475; Hirsch BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075830; Houle M, 2011, CAN J ZOOL, V89, P1107, DOI [10.1139/Z11-085, 10.1139/z11-085]; KAPPUS K D, 1970, Journal of Wildlife Diseases, V6, P507; Kim BI, 2013, CONCEPTUAL MODEL IMP; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KIZER KW, 1979, JACEP-J AM COLL EMER, V8, P134, DOI 10.1016/S0361-1124(79)80339-1; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kuzmin IV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002786; Kuzmina NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082348; McQuiston JH, 2001, J AM VET MED ASSOC, V218, P1939, DOI 10.2460/javma.2001.218.1939; NETTLES VF, 1979, AM J PUBLIC HEALTH, V69, P601, DOI 10.2105/AJPH.69.6.601; Oertli EH, 2009, JAVMA-J AM VET MED A, V234, P616, DOI 10.2460/javma.234.5.616; Page LK, 1999, J WILDLIFE DIS, V35, P474, DOI 10.7589/0090-3558-35.3.474; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Riley SPD, 1998, CAN J ZOOL, V76, P1153, DOI 10.1139/cjz-76-6-1153; RIVEST P, 1981, CAN J ZOOL, V59, P1755, DOI 10.1139/z81-241; Rosatte RC, 1992, DENSITY DISPERSION M, P932; Shirer HW FH, 1970, J MAMMAL, V51, P13; Sidwa TJ, 2005, JAVMA-J AM VET MED A, V227, P785, DOI 10.2460/javma.2005.227.785; Slate D, 2008, DEV BIOLOGICALS, V131, P439; Smith HT, 2002, CAN FIELD NAT, V116, P636; Smith JS, 1996, CLIN MICROBIOL REV, V9, P166, DOI 10.1128/CMR.9.2.166; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Totton SC, 2002, J WILDLIFE DIS, V38, P313, DOI 10.7589/0090-3558-38.2.313; Velasco-Villa A, 2008, EMERG INFECT DIS, V14, P1849, DOI 10.3201/eid1412.080876; Weissinger MD, 2009, J WILDLIFE DIS, V45, P388, DOI 10.7589/0090-3558-45.2.388; WINKLER W G, 1972, Journal of Wildlife Diseases, V8, P99	49	51	51	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107539	10.1371/journal.pone.0107539	http://dx.doi.org/10.1371/journal.pone.0107539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295750	Green Published, gold			2022-12-27	WOS:000345204000007
J	Abdi, AI; Muthui, M; Kiragu, E; Bull, PC				Abdi, Abdirahman I.; Muthui, Michelle; Kiragu, Esther; Bull, Peter C.			Measuring Soluble ICAM-1 in African Populations	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; SEVERE MALARIA; ENDOTHELIAL ACTIVATION; GENE; ATHEROSCLEROSIS; POLYMORPHISMS; ASSOCIATION; BIOMARKERS; CHILDREN; RECEPTOR	The level of plasma soluble ICAM-1 (sICAM-1) has been associated with the pathogenesis of several diseases. Previously, a commercial antibody was reported not to recognize an ICAM-1 allele known as ICAM-1(kilifi) prevalent among African populations. However, that study was based on 19 samples from African Americans of whom 13 had the wild type allele, five heterozygotes and one homozygote. Here, we compare plasma sICAM-1 measures using three different commercial antibodies in samples from Kenyan children genotyped for ICAM-1(kilifi) allele. We show that two of these antibodies have some degree of deficiency in detecting the ICAM-1(kilifi) allele. Consideration of the antibody used to measure sICAM-1 is important as up to 30% of the populations in Africa harbour this allele.	[Abdi, Abdirahman I.; Muthui, Michelle; Kiragu, Esther; Bull, Peter C.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Bull, Peter C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Abdi, Abdirahman I.] Pwani Univ, Dept Biochem & Chem, Kilifi, Kenya	University of Oxford; Pwani University	Abdi, AI (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	aabdi@kemri-wellcome.org		Abdi, Abdirahman/0000-0001-7989-2125; Bull, Peter/0000-0002-7674-6752	Wellcome Trust [084535, 077092, 084538/Z/07/B];  [076030]	Wellcome Trust(Wellcome TrustEuropean Commission); 	This work was supported by Wellcome Trust Programme Grants (084535 and 077092 to PCB and Prof Kevin Marsh (KM)) and Project Grant (076030 to PCB and KM). AA was also supported by the Wellcome Trust strategic grant (084538/Z/07/B). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Published with the permission of the director of KEMRI.	Adukpo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084181; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; Bielinski SJ, 2008, ATHEROSCLEROSIS, V201, P339, DOI 10.1016/j.atherosclerosis.2008.02.031; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Chen Q, 2009, MICROCIRCULATION, V16, P143, DOI 10.1080/10739680802353850; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Cserti-Gazdewich CM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-233; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; El-Deek SE, 2013, MED PRIN PRACT, V22, P469, DOI 10.1159/000349934; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fisher DT, 2010, IMMUNOL RES, V46, P177, DOI 10.1007/s12026-009-8122-9; Fry AE, 2008, GENES IMMUN, V9, P462, DOI 10.1038/gene.2008.38; Gross MD, 2012, CLIN CHEM, V58, P411, DOI 10.1373/clinchem.2011.168559; Jenkins NE, 2005, CLIN INFECT DIS, V41, P1817, DOI 10.1086/498156; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Mita-Mendoza NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054481; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Park GS, 2012, J PEDIATR INFECT DIS, V1, P16, DOI [10.1093/JPIDS/PIS010, 10.1093/jpids/pis010]; Register TC, 2004, CLIN CHEM, V50, P2185, DOI 10.1373/clinchem.2004.036806; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108956	10.1371/journal.pone.0108956	http://dx.doi.org/10.1371/journal.pone.0108956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289635	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000032
J	Ai, CQ; Zhang, QX; Ren, CC; Wang, G; Liu, XM; Tian, FW; Zhao, JX; Zhang, H; Chen, YQ; Chen, W				Ai, Chunqing; Zhang, Qiuxiang; Ren, Chengcheng; Wang, Gang; Liu, Xiaoming; Tian, Fengwei; Zhao, Jianxin; Zhang, Hao; Chen, Yong Q.; Chen, Wei			Genetically Engineered Lactococcus lactis Protect against House Dust Mite Allergy in a BALB/c Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; ACID BACTERIA; IMMUNOMODULATORY PROPERTIES; LACTOBACILLUS-PLANTARUM; INTESTINAL HOMEOSTASIS; CYTOKINE PRODUCTION; EGG ALLERGY; ASTHMA; IMMUNOTHERAPY; ANTIGEN	Background: Mucosal vaccine based on lactic acid bacteria is an attractive concept for the prevention and treatment of allergic diseases, but their mechanisms of action in vivo are poorly understood. Therefore, we sought to investigate how recombinant major dust mite allergen Der p2-expressing Lactococcus lactis as a mucosal vaccine induced the immune tolerance against house dust mite allergy in a mouse model. Methods: Three strains of recombinant L. lactis producing Der p2 in different cell components (extracellular, intracellular and cell wall) were firstly constructed. Their prophylactic potential was evaluated in a Der p2-sensitised mouse model, and immunomodulation properties at the cellular level were determined by measuring cytokine production in vitro. Results: Der p2 expressed in the different recombinant L. lactis strains was recognized by a polyclonal anti-Der p2 antibody. Oral treatment with the recombinant L. lactis prior sensitization significantly prevented the development of airway inflammation in the Der p2-sensitized mice, as determined by the attenuation of inflammatory cells infiltration in the lung tissues and decrease of Th2 cytokines IL-4 and IL-5 levels in bronchoalveolar lavage. In addition, the serum allergen-specific IgE levels were significantly reduced, and the levels of IL-4 in the spleen and mesenteric lymph nodes cell cultures were also markedly decreased upon allergen stimulation in the mice fed with the recombinant L. lactis strains. These protective effects correlated with a significant up-regulation of regulatory T cells in the mesenteric lymph nodes. Conclusion: Oral pretreatment with live recombinant L. lactis prevented the development of allergen-induced airway inflammation primarily by the induction of specific mucosal immune tolerance.	[Ai, Chunqing; Zhang, Qiuxiang; Ren, Chengcheng; Wang, Gang; Liu, Xiaoming; Tian, Fengwei; Zhao, Jianxin; Zhang, Hao; Chen, Yong Q.; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Chen, Yong Q.; Chen, Wei] Jiangnan Univ, Synergist Innovat Ctr Food Safety & Nutr, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University	Zhang, QX (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	zhangqx@jiangnan.edu.cn; chenwei66@jiangnan.edu.cn	Zhang, Hao/HHM-1940-2022; Chen, Wei/GZK-7348-2022; Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708; Wang, Gang/0000-0003-2007-2143	National Natural Science Foundation of China [31200691]; National Science Fund for Distinguished Young Scholars [31125021]; 111 project [B07029, IRT124]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 111 project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (No. 31200691), the National Science Fund for Distinguished Young Scholars (No. 31125021), the 111 project B07029, IRT124, and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2005, J ALLERGY CLIN IMMUN, V116, P961, DOI 10.1016/j.jaci.2005.09.004; Ando H, 2008, J ALLERGY CLIN IMMUN, V122, P583, DOI 10.1016/j.jaci.2008.06.016; AVERSA G, 1993, J EXP MED, V178, P2213, DOI 10.1084/jem.178.6.2213; Bermudez-Humaran LG, 2004, J MED MICROBIOL, V53, P427, DOI 10.1099/jmm.0.05472-0; Bermudez-Humaran LG, 2003, INFECT IMMUN, V71, P1887, DOI 10.1128/IAI.71.4.1887-1896.2003; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Daniel C, 2006, ALLERGY, V61, P812, DOI 10.1111/j.1398-9995.2006.01071.x; Daniel C, 2011, TRENDS BIOTECHNOL, V29, P499, DOI 10.1016/j.tibtech.2011.05.002; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Eyles JE, 2001, VACCINE, V19, P4732, DOI 10.1016/S0264-410X(01)00220-1; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hage-Hamsten V, 2002, ALLERGY, V57, P375; Huibregtse IL, 2007, GASTROENTEROLOGY, V133, P517, DOI 10.1053/j.gastro.2007.04.073; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kandane-Rathnayake RK, 2009, THORAX, V64, P1025, DOI 10.1136/thx.2009.118430; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Larche M, 2007, CHEST, V132, P1007, DOI 10.1378/chest.06-2434; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; Lee CC, 2011, CELL MOL IMMUNOL, V8, P404, DOI 10.1038/cmi.2011.13; Lee P, 2009, MICROBES INFECT, V11, P20, DOI 10.1016/j.micinf.2008.10.002; Lim SHE, 2010, LETT APPL MICROBIOL, V51, P658, DOI 10.1111/j.1472-765X.2010.02950.x; Liu Xiao-yu, 2009, Chinese Journal of Zoonoses, V25, P764; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Martinez HQ, 2009, YEARB INTENSIVE CARE, P372; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nandakumar MP, 2003, J PROTEOME RES, V2, P89, DOI 10.1021/pr025541x; Nelson RP, 1996, J ALLERGY CLIN IMMUN, V98, P258, DOI 10.1016/S0091-6749(96)70148-3; NONAKA M, 1995, J IMMUNOL, V155, P3234; Norton PM, 1996, FEMS IMMUNOL MED MIC, V14, P167, DOI 10.1111/j.1574-695X.1996.tb00284.x; Nouaille Sebastien, 2003, Genet Mol Res, V2, P102; Pauli G, 2006, CLIN EXP ALLERGY, V36, P1206; Piard JC, 1997, J BACTERIOL, V179, P3068, DOI 10.1128/jb.179.9.3068-3072.1997; Pretolani M, 1999, CLIN EXP ALLERGY, V29, P1164, DOI 10.1046/j.1365-2222.1999.00456.x; Rigaux P, 2009, ALLERGY, V64, P406, DOI 10.1111/j.1398-9995.2008.01825.x; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Schabussova I, 2008, CURR OPIN ALLERGY CL, V8, P557, DOI 10.1097/ACI.0b013e328317b88b; Schwarzer M, 2011, ALLERGY, V66, P368, DOI 10.1111/j.1398-9995.2010.02488.x; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; Valenta R, 2002, NAT REV IMMUNOL, V2, P446, DOI 10.1038/nri824; van Scott MR, 2000, AM J PHYSIOL-LUNG C, V278, pL667, DOI 10.1152/ajplung.2000.278.4.L667; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840	49	25	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109461	10.1371/journal.pone.0109461	http://dx.doi.org/10.1371/journal.pone.0109461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290938	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000063
J	Bertolde, FZ; Almeida, AAF; Pirovani, CP				Bertolde, Fabiana Z.; Almeida, Alex-Alan F.; Pirovani, Carlos P.			Analysis of Gene Expression and Proteomic Profiles of Clonal Genotypes from Theobroma cacao Subjected to Soil Flooding	PLOS ONE			English	Article							ORYZA-SATIVA L; WATERLOGGING TOLERANCE; ETHANOLIC FERMENTATION; DEHYDROASCORBATE REDUCTASE; MONILIOPHTHORA-PERNICIOSA; LACTATE-DEHYDROGENASE; PROTEIN EXTRACTION; TRYPSIN-INHIBITOR; ANOXIA TOLERANCE; OXYGEN	Soil flooding causes changes in gene transcription, synthesis and degradation of proteins and cell metabolism. The main objective of this study was to understand the biological events of Theobroma cacao during soil flooding-induced stress, using the analyses of gene expression and activity of key enzymes involved in fermentation, as well as the identification of differentially expressed proteins by mass spectrometry in two contrasting genotypes for flooding tolerance (tolerant - TSA-792 and susceptible - TSH-774). Soil anoxia caused by flooding has led to changes in the expression pattern of genes associated with the biosynthesis of alcohol dehydrogenase (ADH), pyruvate decarboxylase (PDC) and lactate dehydrogenase (LDH) in leaves and roots of the two evaluated genotypes. Significant differences were observed between the enzyme activities of the two genotypes. Leaves and roots of the TSA-792 genotype showed higher ADH activity as compared to the TSH-774 genotype, whereas the activities of PDC and LDH have varied over the 96 h of soil flooding, being higher for TSA-792 genotype, at the initial stage, and TSH-774 genotype, at the final stage. Some of the identified proteins are those typical of the anaerobic metabolism-involved in glycolysis and alcoholic fermentation-and different proteins associated with photosynthesis, protein metabolism and oxidative stress. The ability to maintain glycolysis and induce fermentation was observed to play an important role in anoxia tolerance in cacao and may also serve to distinguish tolerant and susceptible genotypes in relation to this stressor.	[Bertolde, Fabiana Z.] Inst Fed Educ Ciencia & Tecnol, Eunapolis, BA, Brazil; [Almeida, Alex-Alan F.; Pirovani, Carlos P.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil	Instituto Federal do Sertao Pernambucano; Universidade Estadual de Santa Cruz	Bertolde, FZ (corresponding author), Inst Fed Educ Ciencia & Tecnol, Campus Eunapolis, Eunapolis, BA, Brazil.	fzbertolde@yahoo.com.br	Pirovani, Carlos Priminho/N-1153-2019; Almeida, Alex-Alan/AAL-9505-2021; Pirovani, Carlos P/J-3426-2017	Pirovani, Carlos Priminho/0000-0002-6176-4069; Almeida, Alex-Alan/0000-0001-5313-0608; Pirovani, Carlos P/0000-0002-6176-4069	Fundacao de Amparo a Pesquisa da Bahia (FAPESB); Universidade Estadual de Santa Cruz (UESC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Universidade Estadual de Santa Cruz (UESC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by Fundacao de Amparo a Pesquisa da Bahia (FAPESB), Universidade Estadual de Santa Cruz (UESC), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2007, PLANT SOIL, V295, P37, DOI 10.1007/s11104-007-9258-9; Alam I, 2010, J BIOSCIENCES, V35, P49, DOI 10.1007/s12038-010-0007-5; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bartley BGD, 2005, GENETIC DIVERSITY OF CACAO AND ITS UTILIZATION: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996196.0000; Benz BR, 2007, AM J BOT, V94, P542, DOI 10.3732/ajb.94.4.542; Bertolde FZ, 2014, GENET MOL RES, V13, P5036, DOI 10.4238/2014.July.4.19; Bertolde FZ, 2012, PHOTOSYNTHETICA, V50, P447, DOI 10.1007/s11099-012-0052-4; Bertolde FZ, 2010, TREE PHYSIOL, V30, P56, DOI 10.1093/treephys/tpp101; Branco-Price C, 2005, ANN BOT-LONDON, V96, P647, DOI 10.1093/aob/mci217; BUCHER M, 1993, PLANT PHYSIOL, V103, P441, DOI 10.1104/pp.103.2.441; Chang WWP, 2000, PLANT PHYSIOL, V122, P295, DOI 10.1104/pp.122.2.295; Chen H, 2003, ENVIRON EXP BOT, V50, P9; CRAWFORD RMM, 1992, ADV ECOL RES, V23, P93, DOI 10.1016/S0065-2504(08)60147-6; DAVIES DD, 1974, PLANTA, V118, P297, DOI 10.1007/BF00385580; de Almeida AAF, 2010, AGR ISSUES POLICIES, P37; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P425, DOI 10.1590/S1677-04202007000400011; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Dubey H, 2003, CURR SCI INDIA, V84, P83; Ellis MH, 2000, AUST J PLANT PHYSIOL, V27, P1041, DOI 10.1071/PP00052; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; Geigenberger P, 2000, BIOL CHEM, V381, P723, DOI 10.1515/BC.2000.093; GOMES ARS, 1986, J HORTIC SCI BIOTECH, V61, P265, DOI 10.1080/14620316.1986.11515700; HOFFMAN NE, 1986, PLANT PHYSIOL, V82, P658, DOI 10.1104/pp.82.3.658; Hou WC, 1997, PLANT SCI, V128, P151, DOI 10.1016/S0168-9452(97)00153-2; Hou WC, 2000, J EXP BOT, V51, P713, DOI 10.1093/jexbot/51.345.713; Huang SB, 2005, ANN BOT-LONDON, V96, P703, DOI 10.1093/aob/mci222; Hunt PW, 2002, P NATL ACAD SCI USA, V99, P17197, DOI 10.1073/pnas.212648799; Jaeger C, 2009, J EXP BOT, V60, P4335, DOI 10.1093/jxb/erp268; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Kato-Noguchi H, 2000, PHYSIOL PLANTARUM, V109, P28, DOI 10.1034/j.1399-3054.2000.100105.x; Kato-Noguchi H, 2007, J PLANT PHYSIOL, V164, P168, DOI 10.1016/j.jplph.2005.09.017; KatoNoguchi H, 1997, J AM SOC HORTIC SCI, V122, P107, DOI 10.21273/JASHS.122.1.107; Klok EJ, 2002, PLANT CELL, V14, P2481, DOI 10.1105/tpc.004747; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Komatsu S, 2010, AMINO ACIDS, V38, P729, DOI 10.1007/s00726-009-0277-0; Kutter S, 2009, J BIOL CHEM, V284, P12136, DOI 10.1074/jbc.M806228200; Lin KHR, 2004, PLANT SCI, V167, P355, DOI 10.1016/j.plantsci.2004.04.004; Lin KH, 2010, PLANT MOL BIOL REP, V28, P212, DOI 10.1007/s11105-009-0142-z; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MUCKE U, 1995, BIOL CHEM H-S, V376, P111, DOI 10.1515/bchm3.1995.376.2.111; Mustroph A, 2005, ANN BOT-LONDON, V96, P717, DOI 10.1093/aob/mci223; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pechanova O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-674; Pena-Fronteras JT, 2009, ANN BOT-LONDON, V103, P295, DOI 10.1093/aob/mcn085; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; RATCLIFFE RG, 1995, ENV PLANT B, P111; RIVOAL J, 1991, PLANT PHYSIOL, V95, P682, DOI 10.1104/pp.95.3.682; ROBERTS JKM, 1985, PLANT PHYSIOL, V77, P492, DOI 10.1104/pp.77.2.492; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; SACHS MM, 1980, CELL, V20, P761, DOI 10.1016/0092-8674(80)90322-0; Sairam RK, 2008, BIOL PLANTARUM, V52, P401, DOI 10.1007/s10535-008-0084-6; Sairam RK, 2009, J PLANT PHYSIOL, V166, P602, DOI 10.1016/j.jplph.2008.09.005; Shi F, 2008, PHYTOCHEMISTRY, V69, P1295, DOI 10.1016/j.phytochem.2008.01.007; Silva FAC, 2013, GENET MOL RES, V12, P4855, DOI 10.4238/2013.October.22.5; SMITH AM, 1979, PLANTA, V146, P327, DOI 10.1007/BF00387805; Souza Jr JO, 2007, THESIS U SAO PAULO S, P125; Subbaiah CC, 2003, ANN BOT-LONDON, V91, P119, DOI 10.1093/aob/mcf210; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; TASHIRO M, 1978, AGR BIOL CHEM TOKYO, V42, P1119, DOI 10.1080/00021369.1978.10863122; UMEDA M, 1994, PLANT PHYSIOL, V106, P1015, DOI 10.1104/pp.106.3.1015; Villela-Dias C, 2014, PHYSIOL PLANTARUM, V150, P1, DOI 10.1111/ppl.12061; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200; Zou X, 2010, BMC PLANT BIOL, V10, P1471	67	21	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108705	10.1371/journal.pone.0108705	http://dx.doi.org/10.1371/journal.pone.0108705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289700	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000023
J	Tabatabai, J; Prifert, C; Pfeil, J; Grulich-Henn, J; Schnitzler, P				Tabatabai, Julia; Prifert, Christiane; Pfeil, Johannes; Grulich-Henn, Juergen; Schnitzler, Paul			Novel Respiratory Syncytial Virus (RSV) Genotype ON1 Predominates in Germany during Winter Season 2012-13	PLOS ONE			English	Article							GROUP-A; GENETIC-VARIABILITY; SUBGROUP-B; MOLECULAR CHARACTERIZATION; ATTACHMENT GLYCOPROTEIN; PHYLOGENETIC ANALYSIS; CIRCULATION PATTERNS; SOUTH-AFRICA; STRAINS; IDENTIFICATION	Respiratory syncytial virus (RSV) is the leading cause of hospitalization especially in young children with respiratory tract infections (RTI). Patterns of circulating RSV genotypes can provide a better understanding of the molecular epidemiology of RSV infection. We retrospectively analyzed the genetic diversity of RSV infection in hospitalized children with acute RTI admitted to University Hospital Heidelberg/Germany between October 2012 and April 2013. Nasopharyngeal aspirates (NPA) were routinely obtained in 240 children younger than 2 years of age who presented with clinical symptoms of upper or lower RTI. We analyzed NPAs via PCR and sequence analysis of the second variable region of the RSV G gene coding for the attachment glycoprotein. We obtained medical records reviewing routine clinical data. RSV was detected in 134/240 children. In RSV-positive patients the most common diagnosis was bronchitis/bronchiolitis (75.4%). The mean duration of hospitalization was longer in RSV-positive compared to RSV-negative patients (3.5 vs. 5.1 days; p < 0.01). RSV-A was detected in 82.1%, RSV-B in 17.9% of all samples. Phylogenetic analysis of 112 isolates revealed that the majority of RSV-A strains (65%) belonged to the novel ON1 genotype containing a 72-nucleotide duplication. However, genotype ON1 was not associated with a more severe course of illness when taking basic clinical/laboratory parameters into account. Molecular characterization of RSV confirms the co-circulation of multiple genotypes of subtype RSV-A and RSV-B. The duplication in the G gene of genotype ON1 might have an effect on the rapid spread of this emerging RSV strain.	[Tabatabai, Julia; Schnitzler, Paul] Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany; [Tabatabai, Julia] London Sch Hyg & Trop Med, London WC1, England; [Prifert, Christiane] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Pfeil, Johannes; Grulich-Henn, Juergen] Heidelberg Univ, Dept Pediat, Heidelberg, Germany; [Pfeil, Johannes] German Ctr Infect Dis DZIF, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of London; London School of Hygiene & Tropical Medicine; University of Wurzburg; Ruprecht Karls University Heidelberg; German Center for Infection Research	Schnitzler, P (corresponding author), Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany.	Paul_Schnitzler@med.uni-heidelberg.de	Tabatabai, Julia/AFQ-1931-2022	Pfeil, Johannes/0000-0003-0104-8375				Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Berner R, 2001, EUR J PEDIATR, V160, P541, DOI 10.1007/s004310100801; Blanc A, 2005, ARCH VIROL, V150, P603, DOI 10.1007/s00705-004-0412-x; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Cui GL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.19; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; GARCIA O, 1994, J VIROL, V68, P5448; Geis S, 2013, J CLIN MICROBIOL, V51, P155, DOI 10.1128/JCM.02151-12; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Gupta R., 2004, RESEARCHGATE; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pierangeli A, 2014, EURO SURVEILL, V19; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; STORCH GA, 1991, J INFECT DIS, V163, P858, DOI 10.1093/infdis/163.4.858; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; WERTZ GW, 1989, J VIROL, V63, P4767, DOI 10.1128/JVI.63.11.4767-4776.1989	40	73	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109191	10.1371/journal.pone.0109191	http://dx.doi.org/10.1371/journal.pone.0109191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290155	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000048
J	Zhang, Y; Dong, SW; Zuo, JH; Hu, XQ; Zhang, H; Zhao, Y				Zhang, Yan; Dong, Shengwen; Zuo, Jianhua; Hu, Xiangqin; Zhang, Hua; Zhao, Yue			Physical Activity Level of Urban Pregnant Women in Tianjin, China: A Cross-Sectional Study	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; EXERCISE; BELIEFS; POSTPARTUM; IMPACT; DIET	Objective: To determine the physical activity level and factors influencing physical activity among pregnant urban Chinese women. Methods: This prospective cross-sectional study enrolled 1056 pregnant women (18-44 years of age) in Tianjin, China. Their socio-demographic characteristics were recorded, and the Pregnancy Physical Activity Questionnaire was used to assess their physical activity during pregnancy. The data were analyzed by multinomial logistic regression with adjustment for potential confounders. Results: Median total energy expenditure of pregnant women in each of the three trimesters ranged from 18.50 to 21.90 metabolic equivalents of task (METs) h/day. They expended 1.76-1.85 MET h/day on moderate and vigorous activities and 0.11 MET h/day on exercise. Only 117 of the women (11.1%) met the international guideline for physical activity in pregnancy (>= 150 min moderate intensity exercise per week). The most frequent reason given for not being more physically active was the fear of miscarriage. Higher education level (OR: 4.11, 95% CI: 1.59-10.62), habitual exercise before pregnancy (OR: 2.14, 95% CI: 1.39-3.28), and husbands who exercised regularly (OR: 2.21, 95% CI: 1.33-3.67) significantly increased the odds of meeting the guideline (p<0.001). A low pre gravid body mass index (OR: 0.42, 95% CI: 0.20-0.87) significantly decreased the odds (p<0.001). Conclusions: Few urban Chinese pregnant women met the recommended physical activity guideline. They also expended little energy exercising. Future interventions should be based on the clinic environment and targeting family members as well as the subjects. All pregnant women should be targeted, not just those in high-risk groups.	[Zhang, Yan; Dong, Shengwen; Zhang, Hua; Zhao, Yue] Tianjin Med Univ, Sch Nursing, Tianjin, Peoples R China; [Zuo, Jianhua] Wangdingdi Hosp, Dept Obstet & Gynecol, Tianjin, Peoples R China; [Hu, Xiangqin] Tianjin Cent Hosp Gynecol & Obstet, Tianjin, Peoples R China	Tianjin Medical University	Zhao, Y (corresponding author), Tianjin Med Univ, Sch Nursing, Tianjin, Peoples R China.	yuezhao35@hotmail.com			Scientific Research Program of the Health Department of Tianjin, China [2013KZ085]	Scientific Research Program of the Health Department of Tianjin, China	This study was supported by the Scientific Research Program of the Health Department of Tianjin, China (grant No. 2013KZ085). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee Obstetric Practice, 2002, Obstet Gynecol, V99, P171; Bell R, 2013, EUR J OBSTET GYN R B, V170, P90, DOI 10.1016/j.ejogrb.2013.05.018; Chandonnet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038818; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Clarke PE, 2004, MIDWIFERY, V20, P133, DOI 10.1016/j.midw.2003.11.003; Ding D, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-37; Duncombe D, 2009, MIDWIFERY, V25, P430, DOI 10.1016/j.midw.2007.03.002; Evenson KR, 2010, PREV MED, V50, P123, DOI 10.1016/j.ypmed.2009.12.015; Evenson KR, 2010, PATIENT EDUC COUNS, V79, P124, DOI 10.1016/j.pec.2009.07.028; Fell DB, 2009, MATERN CHILD HLTH J, V13, P597, DOI 10.1007/s10995-008-0404-7; Foxcroft KF, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-4; Gao HY, 2013, NUTRIENTS, V5, P2933, DOI 10.3390/nu5082933; Gjestland K, 2013, BRIT J SPORT MED, V47, P515, DOI 10.1136/bjsports-2012-091344; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Huang Tzu-Ting, 2007, J Nurs Res, V15, P11; Huang TT, 2011, MIDWIFERY, V27, P257, DOI 10.1016/j.midw.2009.06.009; Jiang H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-12; Krans Elizabeth E, 2005, J Miss State Med Assoc, V46, P67; Lee DTS, 2009, MIDWIFERY, V25, P104, DOI 10.1016/j.midw.2007.01.008; Li Q, 2014, PUBLIC HEALTH NUTR, V17, P1850, DOI 10.1017/S1368980013001882; Liu JH, 2011, EUR J EPIDEMIOL, V26, P237, DOI 10.1007/s10654-010-9538-1; Matsuzaki M, 2010, BIOSCI TRENDS, V4, P170; Ota Erika, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P562; Pearce EE, 2013, AM J LIFESTYLE MED, V7, P38, DOI 10.1177/1559827612446416; Pivarnik JM, 2006, MED SCI SPORT EXER, V38, P989, DOI 10.1249/01.mss.0000218147.51025.8a; Raven Joanna H, 2007, BMC Pregnancy Childbirth, V7, P8, DOI 10.1186/1471-2393-7-8; Ribeiro CP, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-31; Schmidt MD, 2006, J WOMENS HEALTH, V15, P909, DOI 10.1089/jwh.2006.15.909; Smith KM, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/165617; Thornton PL, 2006, MATERN CHILD HLTH J, V10, P95, DOI 10.1007/s10995-005-0025-3; Walsh JM, 2011, INT J GYNECOL OBSTET, V114, P154, DOI 10.1016/j.ijgo.2011.02.016; [张燕 Zhang Yan], 2013, [中华护理杂志, Chinese Journal of Nursing], V48, P825	32	35	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109624	10.1371/journal.pone.0109624	http://dx.doi.org/10.1371/journal.pone.0109624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XC	25286237	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700074
J	Ding, XY; Yang, Z; Han, YW; Yu, H				Ding, Xiaoyan; Yang, Zi; Han, Yiwei; Yu, Huan			Fatty Acid Oxidation Changes and the Correlation with Oxidative Stress in Different Preeclampsia-Like Mouse Models	PLOS ONE			English	Article							PREGNANT RATS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; LIVER-DISEASE; L-NAME; TRIGLYCERIDE; ANTIBODIES; WOMEN; MICE	Background: Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) expression is decreased in placenta of some cases of preeclampsia (PE) which may result in free fatty acid (FFA) increased. High FFA level will induce oxidative stress, so abnormal long-chain fatty acid-oxidation may participate in the pathogenesis of PE through oxidative stress pathway. Methods: PE-like groups were ApoC3 transgenic mice with abnormal fatty acid metabolism, classical PE-like models with injection of Nw-nitro-L-arginine-methyl ester (L-NA) or lipopolysaccharide (LPS) and the antiphospholipid syndrome (APS) mouse model with beta GPI injection (ApoC3+NS, ApoC3+L-NA, L-NA, LPS and beta GPI groups). The control group was wild-type mice with normal saline injection. Except for beta 2GPI mice, the other mice were subdivided into pre-implantation (Pre) and mid-pregnancy (Mid) subgroups by injection time. Results: All PE-like groups showed hypertension and proteinuria except ApoC3+NS mice only showed hypertension. Serum FFA levels increased significantly except in LPS group compared to controls (P<0.05). LCHAD mRNA and protein expression in the liver and placenta was significantly higher for ApoC3+NS, ApoC3+L-NA and beta 2GPI mice and lower for L-NA mice than controls (P<0.05) but did not differ between LPS mice and controls. P47phox mRNA and protein expression in the liver significantly increased in all PE-like groups except LPS group, while P47phox expression in the placenta only significantly increased in L-NA and beta 2GPI groups. Conclusions: Abnormal long-chain fatty acid-oxidation may play a different role in different PE-like models and in some cases participate in the pathogenesis of PE through oxidative stress pathway.	[Ding, Xiaoyan; Yang, Zi; Han, Yiwei; Yu, Huan] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100871, Peoples R China	Peking University	Yang, Z (corresponding author), Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	zi_yang@email.com			National Natural Science Foundation of China [81370723]; Beijing Municipal Natural Science Foundation [7132215]; Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education of China [20130001110111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants to ZY from the National Natural Science Foundation of China (No. 81370723; http://www.nsfc.gov.cn/), Beijing Municipal Natural Science Foundation (No. 7132215; http://www.bjnsf.org/) and the Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education of China (No. 20130001110111; http://www.cutech.edu.cn/cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha JL, 2012, PLACENTA, V33, P132, DOI 10.1016/j.placenta.2011.11.027; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; Chen CW, 2014, CARDIOVASC RES, V101, P579, DOI 10.1093/cvr/cvu018; Ding X, 2014, PLACENTA; do Prado AD, 2010, OBSTET GYNECOL, V116, P1433, DOI 10.1097/AOG.0b013e3181fe02ec; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; Gallos ID, 2013, BJOG-INT J OBSTET GY, V120, P1321, DOI 10.1111/1471-0528.12375; Gilbert J, 2007, AM J HYPERTENS, V20, P686, DOI 10.1016/j.amjhyper.2006.12.016; Gupta S, 2005, OBSTET GYNECOL SURV, V60, P807, DOI 10.1097/01.ogx.0000193879.79268.59; Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204; Jing Xin-yan, 2013, Chinese Medical Sciences Journal, V28, P233; Kajiwara T, 2007, J AUTOIMMUN, V29, P164, DOI 10.1016/j.jaut.2007.07.003; Khedara A, 1996, J NUTR, V126, P2563, DOI 10.1093/jn/126.10.2563; Lin F, 2012, REPROD TOXICOL, V34, P677, DOI 10.1016/j.reprotox.2012.09.009; Ma RQ, 2011, CHINESE MED J-PEKING, V124, P3141, DOI 10.3760/cma.j.issn.0366-6999.2011.19.033; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Richer C, 1996, BRIT J PHARMACOL, V119, P1642, DOI 10.1111/j.1476-5381.1996.tb16084.x; Robinson NJ, 2009, J HYPERTENS, V27, P1293, DOI 10.1097/HJH.0b013e328329fbfe; Rolfo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013288; Sharp GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070180; Sun Xiao-le, 2011, Zhonghua Yi Xue Za Zhi, V91, P2026; Sunderland N, 2011, AM J REPROD IMMUNOL, V65, P533, DOI 10.1111/j.1600-0897.2010.00929.x; Tonin AM, 2010, NEUROCHEM INT, V56, P930, DOI 10.1016/j.neuint.2010.03.025; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; Wang Jia-lue, 2008, Zhonghua Yi Xue Za Zhi, V88, P1471; WILCKEN B, 1993, LANCET, V341, P407, DOI 10.1016/0140-6736(93)92993-4; Xie WD, 2011, INT IMMUNOPHARMACOL, V11, P136, DOI 10.1016/j.intimp.2010.10.018; Yang Z, 2002, JAMA-J AM MED ASSOC, V288, P2163, DOI 10.1001/jama.288.17.2163; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70; Zhou QJ, 2013, HYPERTENS PREGNANCY, V32, P422, DOI 10.3109/10641955.2013.824978	30	14	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109554	10.1371/journal.pone.0109554	http://dx.doi.org/10.1371/journal.pone.0109554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302499	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400067
J	Martin-Vilchez, S; Rodriguez-Munoz, Y; Lopez-Rodriguez, R; Hernandez-Bartolome, A; Borque-Inurrita, MJ; Molina-Jimenez, F; Garcia-Buey, L; Moreno-Otero, R; Sanz-Cameno, P				Martin-Vilchez, Samuel; Rodriguez-Munoz, Yolanda; Lopez-Rodriguez, Rosario; Hernandez-Bartolome, Angel; Jesus Borque-Inurrita, Maria; Molina-Jimenez, Francisca; Garcia-Buey, Luisa; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma			Inhibition of Tyrosine Kinase Receptor Tie2 Reverts HCV-Induced Hepatic Stellate Cell Activation	PLOS ONE			English	Article							C VIRUS-CORE; ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCED VEGF; ANGIOPOIETIN-2 EXPRESSION; PROANGIOGENIC CYTOKINES; LIVER FIBROGENESIS; UP-REGULATION; ANGIOGENESIS; MIGRATION; MECHANISMS	Background: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease (CLD) and is frequently linked to intrahepatic microvascular disorders. Activation of hepatic stellate cells (HSC) is a central event in liver damage, due to their contribution to hepatic renewal and to the development of fibrosis and hepatocarcinoma. During the progression of CLDs, HSC attempt to restore injured tissue by stimulating repair processes, such as fibrosis and angiogenesis. Because HSC express the key vascular receptor Tie2, among other angiogenic receptors and mediators, we analyzed its involvement in the development of CLD. Methods: Tie2 expression was monitored in HSC cultures that were exposed to media from HCV-expressing cells (replicons). The effects of Tie2 blockade on HSC activation by either neutralizing antibody or specific signaling inhibitors were also examined. Results: Media from HCV-replicons enhanced HSC activation and invasion and upregulated Tie2 expression. Notably, the blockade of Tie2 receptor (by a specific neutralizing antibody) or signaling (by selective AKT and MAPK inhibitors) significantly reduced alpha-smooth muscle actin (alpha-SMA) expression and the invasive potential of HCV-conditioned HSC. Conclusions: These findings ascribe a novel profibrogenic function to Tie2 receptor in the progression of chronic hepatitis C, highlighting the significance of its dysregulation in the evolution of CLDs and its potential as a novel therapeutic target.	[Martin-Vilchez, Samuel] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Rodriguez-Munoz, Yolanda; Lopez-Rodriguez, Rosario; Hernandez-Bartolome, Angel; Garcia-Buey, Luisa; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IIS IP, Unidad Hepatol, Madrid, Spain; [Rodriguez-Munoz, Yolanda; Lopez-Rodriguez, Rosario; Garcia-Buey, Luisa; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Jesus Borque-Inurrita, Maria; Molina-Jimenez, Francisca] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IIS IP, Unidad Biol Mol, Madrid, Spain	University of Virginia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Sanz-Cameno, P (corresponding author), Hosp Univ Princesa, Inst Invest Sanitaria Princesa IIS IP, Unidad Hepatol, Madrid, Spain.	paloma_march@hotmail.com	Sanz, Paloma/C-7799-2014; Lopez-Rodriguez, Rosario/M-3381-2014; Chaparro, María/I-2500-2016; Martin-Vilchez, Samuel/AFV-2112-2022; López-Rodríguez, Rosario/AAB-2290-2022	Lopez-Rodriguez, Rosario/0000-0002-4713-0633; Chaparro, María/0000-0002-9275-4242; Martin-Vilchez, Samuel/0000-0003-0557-7653; López-Rodríguez, Rosario/0000-0002-4713-0633	CIBER-ehd; Ministerio de Ciencia e Innovacion [SAF2010/21805]; AIO Asociacion Espanola Contra el Cancer; Mutua Madrilena	CIBER-ehd; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); AIO Asociacion Espanola Contra el Cancer; Mutua Madrilena	This work was supported in part by grants: 1) CIBER-ehd to Dr. R. Moreno-Otero, 2) SAF2010/21805 from Ministerio de Ciencia e Innovacion to RM-O, 3) AIO Asociacion Espanola Contra el Cancer to PS-C, 4) Mutua Madrilena to RM-O, and 5) Mutua Madrilena to PS-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MY, 2005, J MED VIROL, V76, P489, DOI 10.1002/jmv.20388; Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122; Ankoma-Sey V, 1998, ONCOGENE, V17, P115, DOI 10.1038/sj.onc.1201912; Bartenschlager R, 2005, J HEPATOL, V43, P210, DOI 10.1016/j.jhep.2005.05.013; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Cho YJ, 2011, RESPIROLOGY, V16, P284, DOI 10.1111/j.1440-1843.2010.01915.x; Chu VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028551; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; di Bonzo LV, 2009, HISTOL HISTOPATHOL, V24, P1323, DOI 10.14670/HH-24.1323; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Eleuteri E, 2011, EUR J CARDIOV PREV R, V18, P607, DOI 10.1177/1741826710389410; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Forbes SJ, 2011, BEST PRACT RES CL GA, V25, P207, DOI 10.1016/j.bpg.2011.02.006; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Friedman SL, 2004, HEPATOLOGY, V40, P1041, DOI 10.1002/hep.20476; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2009, EXP MOL MED, V41, P133, DOI 10.3858/emm.2009.41.3.016; Hernandez-Bartolome A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066143; Hsieh MJ, 2011, J CELL BIOCHEM, V112, P233, DOI 10.1002/jcb.22926; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li YM, 2010, HEPATOL RES, V40, P1022, DOI 10.1111/j.1872-034X.2010.00712.x; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Martin-Vilchez S, 2008, HEPATOLOGY, V47, P1872, DOI 10.1002/hep.22265; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; Medina J, 2003, J HEPATOL, V38, P660, DOI 10.1016/S0168-8278(03)00053-9; Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887; Novo E, 2009, INT J BIOCHEM CELL B, V41, P2089, DOI 10.1016/j.biocel.2009.03.010; Parola M, 2008, MOL ASPECTS MED, V29, P58, DOI 10.1016/j.mam.2007.09.002; Phelps ED, 2006, AM J PHYSIOL-CELL PH, V290, pC352, DOI 10.1152/ajpcell.00050.2005; Pietila R, 2012, J CELL SCI, V125, P2212, DOI 10.1242/jcs.098020; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Poynard T, 2000, BEST PRACT RES CL GA, V14, P211, DOI 10.1053/bega.1999.0071; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Salcedo X, 2005, HEPATOLOGY, V42, P696, DOI 10.1002/hep.20828; Salcedo X, 2005, ALIMENT PHARM THER, V22, P23, DOI 10.1111/j.1365-2036.2005.02532.x; Sancho-Bru P, 2010, LIVER INT, V30, P31, DOI 10.1111/j.1478-3231.2009.02161.x; Sanz-Cameno P, 2006, AM J PATHOL, V169, P1215, DOI 10.2353/ajpath.2006.051246; Sanz-Cameno P, 2010, J ONCOL, V2010, DOI 10.1155/2010/272170; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Shin Ju Yeop, 2003, Korean J Gastroenterol, V42, P400; Shin JY, 2005, EXP MOL MED, V37, P138, DOI 10.1038/emm.2005.19; Singh H, 2009, CELL SIGNAL, V21, P1346, DOI 10.1016/j.cellsig.2009.04.002; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V317, P358, DOI 10.1016/j.bbrc.2004.03.050; Watanabe N, 2011, BIOCHEM BIOPH RES CO, V407, P135, DOI 10.1016/j.bbrc.2011.02.125; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347	70	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e106958	10.1371/journal.pone.0106958	http://dx.doi.org/10.1371/journal.pone.0106958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302785	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400004
J	Sheng-Fowler, L; Tu, W; Fu, HQ; Murata, H; Lanning, L; Foseh, G; Macauley, J; Blair, D; Hughes, SH; Coffin, JM; Lewis, AM; Peden, K				Sheng-Fowler, Li; Tu, Wei; Fu, Haiqing; Murata, Haruhiko; Lanning, Lynda; Foseh, Gideon; Macauley, Juliete; Blair, Donald; Hughes, Stephen H.; Coffin, John M.; Lewis, Andrew M., Jr.; Peden, Keith			A Mouse Strain Defective in Both T Cells and NK Cells Has Enhanced Sensitivity to Tumor Induction by Plasmid DNA Expressing Both Activated H-Ras and c-Myc	PLOS ONE			English	Article							BLADDER-CARCINOMA CELLS; TRANSFORMING GENE; IN-VIVO; TUMORIGENIC CONVERSION; PAPILLOMAVIRUS DNA; POLYOMA-VIRUS; LINES; CANCER; MICE; ONCOGENES	As part of safety studies to evaluate the risk of residual cellular DNA in vaccines manufactured in tumorigenic cells, we have been developing in vivo assays to detect and quantify the oncogenic activity of DNA. We generated a plasmid expressing both an activated human H-ras gene and murine c-myc gene and showed that 1 mu g of this plasmid, pMSV-T24-H-ras/MSV-c-myc, was capable of inducing tumors in newborn NIH Swiss mice. However, to be able to detect the oncogenicity of dominant activated oncogenes in cellular DNA, a more sensitive system was needed. In this paper, we demonstrate that the newborn CD3 epsilon transgenic mouse, which is defective in both T-cell and NK-cell functions, can detect the oncogenic activity of 25 ng of the circular form of pMSV-T24-H-ras/MSV-c-myc. When this plasmid was inoculated as linear DNA, amounts of DNA as low as 800 pg were capable of inducing tumors. Animals were found that had multiple tumors, and these tumors were independent and likely clonal. These results demonstrate that the newborn CD3 epsilon mouse is highly sensitive for the detection of oncogenic activity of DNA. To determine whether it can detect the oncogenic activity of cellular DNA derived from four human tumor-cell lines (HeLa, A549, HT-1080, and CEM), DNA (100 mu g) was inoculated into newborn CD3 epsilon mice both in the presence of 1 mu g of linear pMSV-T24-H-ras/MSV-c-myc as positive control and in its absence. While tumors were induced in 100% of mice with the positive-control plasmid, no tumors were induced in mice receiving any of the tumor DNAs alone. These results demonstrate that detection of oncogenes in cellular DNA derived from four human tumor-derived cell lines in this mouse system was not possible; the results also show the importance of including a positive-control plasmid to detect inhibitory effects of the cellular DNA.	[Sheng-Fowler, Li; Tu, Wei; Fu, Haiqing; Murata, Haruhiko; Foseh, Gideon; Macauley, Juliete; Lewis, Andrew M., Jr.; Peden, Keith] US FDA, Off Vaccines Res & Review, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Lanning, Lynda] Natl Inst Allergy & Infect Dis, Rockville, MD USA; [Blair, Donald] Natl Canc Inst, Rockville, MD USA; [Hughes, Stephen H.; Coffin, John M.] Natl Canc Inst, Frederick Canc Res Facil, Frederick, MD USA; [Coffin, John M.] Tufts Univ, Boston, MA 02111 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University	Peden, K (corresponding author), US FDA, Off Vaccines Res & Review, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	keith.peden@fda.hhs.gov			Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases; CBER/FDA [YI-AI-4893-02NIAID]; National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research; NCI, NIH [HHSN26120080001E]	Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CBER/FDA; National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a contract from the Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases through an Interagency Agreement with CBER/FDA (contract number YI-AI-4893-02NIAID), program officer Sonnie Kim-Grossman. SHH is supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research, and in part with funds from the NCI, NIH, under contract HHSN26120080001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR DG, 1982, SCIENCE, V218, P1122, DOI 10.1126/science.6293052; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; BOUCHARD L, 1984, VIROLOGY, V135, P53, DOI 10.1016/0042-6822(84)90116-8; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; Chang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021097; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Cupillard L, 2005, VACCINE, V23, P1910, DOI 10.1016/j.vaccine.2004.10.018; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FOLEY GE, 1965, CANCER RES, V25, P1254; GEY G O, 1954, Harvey Lect, V50, P154; GEY G O, 1954, Ann N Y Acad Sci, V58, P976, DOI 10.1111/j.1749-6632.1954.tb45886.x; GEY GO, 1952, CANCER RES, V12, P264; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; Hesketh R., 1997, ONCOGENE TUMOUR SUPP; HILL RP, 1980, BRIT J CANCER, V41, P230; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; ISRAEL MA, 1979, J VIROL, V29, P990, DOI 10.1128/JVI.29.3.990-996.1979; ISRAEL MA, 1979, P NATL ACAD SCI USA, V76, P3713, DOI 10.1073/pnas.76.8.3713; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lewis A M Jr, 2001, Dev Biol (Basel), V106, P513; Lewis AM, 1999, J VIROL METHODS, V79, P41, DOI 10.1016/S0166-0934(98)00182-7; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Liu CZ, 2010, J HEPATOL, V53, P98, DOI 10.1016/j.jhep.2010.02.021; Macville M, 1999, CANCER RES, V59, P141; MARSHALL CJ, 1982, NATURE, V299, P171, DOI 10.1038/299171a0; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; MERL S, 1984, BLOOD, V64, P967; Mortimer I, 1999, GENE THER, V6, P403, DOI 10.1038/sj.gt.3300837; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; Petricciani J, 2001, Dev Biol (Basel), V106, P275; PETRICCIANI JC, 1995, BIOLOGICALS, V23, P233, DOI 10.1006/biol.1995.0039; Pillai VB, 2008, VACCINE, V26, P1136, DOI 10.1016/j.vaccine.2007.10.023; PULCIANI S, 1982, P NATL ACAD SCI-BIOL, V79, P2845, DOI 10.1073/pnas.79.9.2845; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Routes JM, 2000, VIROLOGY, V277, P48, DOI 10.1006/viro.2000.0571; SANTOS E, 1984, FED PROC, V43, P2280; Sheng L, 2008, BIOLOGICALS, V36, P184, DOI 10.1016/j.biologicals.2007.11.003; Sheng-Fowler L, 2010, INT J BIOL SCI, V6, P151; Sheng-Fowler L, 2009, BIOLOGICALS, V37, P259, DOI 10.1016/j.biologicals.2009.04.002; Sheng-Fowler L, 2009, BIOLOGICALS, V37, P190, DOI 10.1016/j.biologicals.2009.02.015; SMALL MB, 1987, MOL CELL BIOL, V7, P1638, DOI 10.1128/MCB.7.5.1638; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; ZERLIN M, 1987, ONCOGENE, V1, P19; ZIETMAN AL, 1988, CANCER RES, V48, P6510	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108926	10.1371/journal.pone.0108926	http://dx.doi.org/10.1371/journal.pone.0108926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302710	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400036
J	Kim, HS; Choi, SI; Jeung, EB; Yoo, YM				Kim, Han Sung; Choi, Seung-Il; Jeung, Eui-Bae; Yoo, Yeong-Min			Cyclosporine A Induces Apoptotic and Autophagic Cell Death in Rat Pituitary GH3 Cells	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; MALIGNANT GLIOMA-CELLS; RENAL TUBULAR CELLS; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISM; MESANGIAL CELLS; IN-VITRO; STRESS; MITOCHONDRIA; NEPHROPATHY	Cyclosporine A (CsA) is a powerful immunosuppressive drug with side effects including the development of chronic nephrotoxicity. In this study, we investigated CsA treatment induced apoptotic and autophagic cell death in pituitary GH3 cells. CsA treatment (0.1 to 10 mu M) decreased survival of GH3 cells in a dose-dependent manner. Cell viability decreased significantly with increasing CsA concentrations largely due to an increase in apoptosis, while cell death rates due to autophagy altered only slightly. Several molecular and morphological features correlated with cell death through these distinct pathways. At concentrations ranging from 1.0 to 10 mu M, CsA induced a dose-dependent increase in expression of the autophagy markers LC3-I and LC3-II. Immunofluorescence staining revealed markedly increased levels of both LC3 and lysosomal-associated membrane protein 2 (Lamp2), indicating increases in autophagosomes. At the same CsA doses, apoptotic cell death was apparent as indicated by nuclear and DNA fragmentation and increased p53 expression. In apoptotic or autophagic cells, p-ERK levels were highest at 1.0 mu M CsA compared to control or other doses. In contrast, Bax levels in both types of cell death were increased in a dose-dependent manner, while Bcl-2 levels showed dose-dependent augmentation in autophagy and were decreased in apoptosis. Manganese superoxide dismutase (Mn-SOD) showed a similar dose-dependent reduction in cells undergoing apoptosis, while levels of the intracellular calcium ion exchange maker calbindin-D9k were decreased in apoptosis (1.0 to 5 mu M CsA), but unchanged in autophagy. In conclusion, these results suggest that CsA induction of apoptotic or autophagic cell death in rat pituitary GH3 cells depends on the relative expression of factors and correlates with Bcl-2 and Mn-SOD levels.	[Kim, Han Sung; Yoo, Yeong-Min] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, Gangwon Do, South Korea; [Choi, Seung-Il] Yonsei Univ, Coll Med, Cornea Dystrophy Res Inst, Seoul, South Korea; [Choi, Seung-Il] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Jeung, Eui-Bae] Chungbuk Natl Univ, Coll Vet Med, Lab Vet Biochem & Mol Biol, Cheongju, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungbuk National University	Jeung, EB (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Lab Vet Biochem & Mol Biol, Cheongju, South Korea.	ebjeung@cbu.ac.kr; yyeongm@hanmail.net		choi, seung-il/0000-0001-7168-8795	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2010-00757]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00956301]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2010-00757) and by a grant from the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (No. PJ00956301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulares AH, 2002, J BIOL CHEM, V277, P372, DOI 10.1074/jbc.M107738200; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Buetler TM, 2000, TRENDS PHARMACOL SCI, V21, P288, DOI 10.1016/S0165-6147(00)01508-X; Cardenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735; Cecka JM, 1991, CLIN TRANSPL, V1991, P1; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Choi KC, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-66; Choi KC, 2008, J CELL MOL MED, V12, P409, DOI 10.1111/j.1582-4934.2007.00209.x; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; Daly PJ, 2009, BJU INT, V103, P254, DOI 10.1111/j.1464-410X.2008.08010.x; de Lema GP, 1998, LIFE SCI, V62, P1745, DOI 10.1016/S0024-3205(98)00136-2; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Galletti P, 2005, NEPHROL DIAL TRANSPL, V20, P1551, DOI 10.1093/ndt/gfh846; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Han SY, 2006, TRANSPLANT P, V38, P2244, DOI 10.1016/j.transproceed.2006.06.029; Han SW, 2008, AM J NEPHROL, V28, P707, DOI 10.1159/000127432; Ito H, 2005, INT J ONCOL, V26, P1401; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; KERR JFR, 1965, J PATHOL BACTERIOL, V90, P419, DOI 10.1002/path.1700900210; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee GS, 2003, CLIN BIOCHEM, V36, P255, DOI 10.1016/S0009-9120(03)00010-9; Lim SW, 2012, TRANSPLANTATION, V94, P218, DOI 10.1097/TP.0b013e31825ace5c; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Longoni B, 2002, FREE RADICAL RES, V36, P357, DOI 10.1080/10715760290019381; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Nguyen TH, 2005, MOL BRAIN RES, V141, P166, DOI 10.1016/j.molbrainres.2005.09.008; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Oakes SA, 2003, BIOCHEM PHARMACOL, V66, P1335, DOI 10.1016/S0006-2952(03)00482-9; Olyaei A J, 2001, Curr Opin Crit Care, V7, P384, DOI 10.1097/00075198-200112000-00003; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pallet N, 2009, KIDNEY INT, V75, P118, DOI 10.1038/ki.2008.537; Pyrzynska B, 2002, J BIOL CHEM, V277, P14102, DOI 10.1074/jbc.M104443200; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sarro E, 2008, KIDNEY INT, V73, P77, DOI 10.1038/sj.ki.5002638; Shihab FS, 1999, KIDNEY INT, V56, P2147, DOI 10.1046/j.1523-1755.1999.00794.x; Smaili SS, 2003, BRAZ J MED BIOL RES, V36, P183, DOI 10.1590/S0100-879X2003000200004; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; Tinnanooru P, 2008, MOL CELL ENDOCRINOL, V285, P26, DOI 10.1016/j.mce.2008.01.011; Wolf A, 1997, J PHARMACOL EXP THER, V280, P1328; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yanagisawa H, 2003, CELL DEATH DIFFER, V10, P798, DOI 10.1038/sj.cdd.4401246; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81	47	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108981	10.1371/journal.pone.0108981	http://dx.doi.org/10.1371/journal.pone.0108981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299210	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200028
J	Li, W; Gong, XY; Sun, MY; Zhao, XL; Gong, BF; Wei, H; Mi, YC; Wang, JX				Li, Wei; Gong, Xiaoyuan; Sun, Mingyuan; Zhao, Xingli; Gong, Benfa; Wei, Hui; Mi, Yingchang; Wang, Jianxiang			High-Dose Cytarabine in Acute Myeloid Leukemia Treatment: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; AML-COOPERATIVE-GROUP; POSTREMISSION THERAPY; 1ST REMISSION; CONSOLIDATION CHEMOTHERAPY; RANDOMIZED-TRIAL; INTENSIVE CONSOLIDATION; PROLONGED MAINTENANCE	The optimal dose, scheme, and clinical setting for Ara-C in acute myeloid leukemia (AML) treatment remain uncertain. In this study, we performed a meta-analysis to systematically assess the impact of high-dose cytarabine (HDAC) on AML therapy during the induction and consolidation stages. Twenty-two trials with a total of 5,945 de novo AML patients were included in the meta-analysis. Only patients less than 60 year-old were included in the study. Using HDAC in induction therapy was beneficial for RFS (HR = 0.57; 95% CI, 0.35-0.93; P = 0.02) but not so for CR rate (HR = 1.01; 95% CI, 0.93-1.09; P = 0.88) and OS (HR = 0.83; 95% CI, 0.66-1.03; P = 0.1). In consolidation therapy, HDAC showed significant RFS benefits (HR = 0.67; 95% CI, 0.49-0.9; P = 0.008) especially for the favorable-risk group (HR = 0.38; 95% CI, 0.21-0.69; P = 0.001) compared with SDAC (standard dose cytarabine), although no OS advantage was observed (HR = 0.84; 95% CI, 0.55-1.27; P = 0.41). HDAC treatment seemed less effective than auto-BMT/allo-BMT treatment (HR = 1.66, 95% CI, 1.3-2.14; P<0.0001) with similar OS. HDAC treatment led to lower relapse rate in induction and consolidation therapy than SDAC treatment, especially for the favorable-risk group. Auto-BMT/allo-BMT was more beneficial in prolonging RFS than HDAC.	[Li, Wei; Gong, Xiaoyuan; Sun, Mingyuan; Zhao, Xingli; Gong, Benfa; Wei, Hui; Mi, Yingchang; Wang, Jianxiang] Chinese Acad Med Sci, Inst Hematol, Leukemia Diag & Treatment Ctr, Tianjin, Peoples R China; [Li, Wei; Gong, Xiaoyuan; Sun, Mingyuan; Zhao, Xingli; Gong, Benfa; Wei, Hui; Mi, Yingchang; Wang, Jianxiang] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Li, Wei; Gong, Xiaoyuan; Sun, Mingyuan; Zhao, Xingli; Gong, Benfa; Wei, Hui; Mi, Yingchang; Wang, Jianxiang] Peking Union Med Coll, Tianjin, Peoples R China; [Wang, Jianxiang] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS	Wang, JX (corresponding author), Chinese Acad Med Sci, Inst Hematol, Leukemia Diag & Treatment Ctr, Tianjin, Peoples R China.	wangjx@ihcams.ac.cn			National Natural Science Foundation [81270635]; National Public Health Grand Research Foundation [201202017]; National Science & Technology Major Projects of China [201 1ZX09302-007-04]; Tianjin Major Science and Technology Project [12ZCDZSY17500]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation; National Science & Technology Major Projects of China; Tianjin Major Science and Technology Project	This study was supported by National Natural Science Foundation (81270635), National Public Health Grand Research Foundation (201202017), National Science & Technology Major Projects (201 1ZX09302-007-04) of China and Tianjin Major Science and Technology Project (12ZCDZSY17500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassan R, 1998, HAEMATOLOGICA, V83, P627; Bishop JF, 1996, BLOOD, V87, P1710, DOI 10.1182/blood.V87.5.1710.bloodjournal8751710; Bloomfield CD, 1998, CANCER RES, V58, P4173; Bradstock KF, 2005, BLOOD, V105, P481, DOI 10.1182/blood-2004-01-0326; Brunet S, 2004, HAEMATOLOGICA, V89, P940; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Buchner T, 1999, BLOOD, V93, P4116; Buchner T, 2003, J CLIN ONCOL, V21, P4496, DOI 10.1200/JCO.2003.02.133; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Cassileth PA, 1998, NEW ENGL J MED, V339, P1649, DOI 10.1056/NEJM199812033392301; CASSILETH PA, 1992, BLOOD, V79, P1924; Farag SS, 2005, J CLIN ONCOL, V23, P482, DOI 10.1200/JCO.2005.06.090; Fopp M, 1997, ANN ONCOL, V8, P251, DOI 10.1023/A:1008267904952; HAROUSSEAU JL, 1991, J CLIN ONCOL, V9, P1432, DOI 10.1200/JCO.1991.9.8.1432; Harousseau JL, 1997, BLOOD, V90, P2978; Kern W, 2006, CANCER-AM CANCER SOC, V107, P116, DOI 10.1002/cncr.21543; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lowenberg B, 2013, BLOOD, V121, P26, DOI 10.1182/blood-2012-07-444851; Lowenberg B, 2011, NEW ENGL J MED, V364, P1027, DOI 10.1056/NEJMoa1010222; Matthews JP, 2001, BRIT J HAEMATOL, V113, P727, DOI 10.1046/j.1365-2141.2001.02756.x; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Miyawaki S, 2011, BLOOD, V117, P2366, DOI 10.1182/blood-2010-07-295279; Moore JO, 2005, BLOOD, V105, P3420, DOI 10.1182/blood-2004-08-2977; Ohtake S, 2011, BLOOD, V117, P2358, DOI 10.1182/blood-2010-03-273243; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; SCHILLER GJ, 1992, J CLIN ONCOL, V10, P41, DOI 10.1200/JCO.1992.10.1.41; Schoch C, 2001, BRIT J HAEMATOL, V112, P118, DOI 10.1046/j.1365-2141.2001.02511.x; Thomas X, 2011, BLOOD, V118, P1754, DOI 10.1182/blood-2011-04-349258; Tsimberidou AM, 2003, CANCER-AM CANCER SOC, V97, P1721, DOI 10.1002/cncr.11240; Weick JK, 1996, BLOOD, V88, P2841, DOI 10.1182/blood.V88.8.2841.bloodjournal8882841; ZITTOUN RA, 1995, NEW ENGL J MED, V332, P217, DOI 10.1056/NEJM199501263320403	31	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110153	10.1371/journal.pone.0110153	http://dx.doi.org/10.1371/journal.pone.0110153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299623	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200104
J	Lopes-Pacheco, M; Ventura, TG; de Oliveira, HD; Moncao-Riberio, LC; Gutfilen, B; de Souza, SAL; Rocco, PRM; Borojevic, R; Morales, MM; Takiya, CM				Lopes-Pacheco, Miqueias; Ventura, Tulio G.; de Oliveira, Helena D'Anunciacao; Moncao-Riberio, Leonardo C.; Gutfilen, Bianca; de Souza, Sergio A. L.; Rocco, Patricia R. M.; Borojevic, Radovan; Morales, Marcelo M.; Takiya, Christina M.			Infusion of Bone Marrow Mononuclear Cells Reduces Lung Fibrosis but Not Inflammation in the Late Stages of Murine Silicosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; STEM-CELLS; TGF-BETA; LIVER FIBROSIS; NITRIC-OXIDE; APOPTOSIS; THERAPY; MACROPHAGES; ACTIVATION; SECRETION	We hypothesized that infusion of bone marrow mononuclear cells (BMMCs) in the late stages of silica- induced damage would reduce the remodelling process in a murine model of silicosis. C57BL/6 mice were assigned to 2 groups. In the SIL group, mice were instilled with a silica particle suspension intratracheally. Control (C) mice received saline under the same protocol. On the 40th day, some of the animals from both groups were killed. The others were treated with either saline or BMMCs (1x10(6) cells) intravenously (C+BMMC and SIL+BMMC), and the mice were killed 70 days after the start of the protocol. In the mice in the SIL+BMMC group, collagen deposition, the presence of silica particles inside nodules, the presence of macrophages and cells reactive for inducible nitric oxide synthase were reduced. Lung parameters also improved. Beyond that, the total and differential cellularity of bronchoalveolar lavage fluid, immunoexpression of transforming growth factor-beta, the number of T regulatory cells and apoptosis were increased. However, the presence of male donor cells in lung tissue was not observed using GFP+cells (40d) or Y chromosome DNA (70d). Therefore, BMMC therapy in the late stages of experimental silicosis improved lung function by diminishing fibrosis but inflammatory cells persisted, which could be related to expansion of T regulatory cells, responsible for the beneficial effects of cell therapy.	[Lopes-Pacheco, Miqueias; Ventura, Tulio G.; Borojevic, Radovan; Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Cellular Pathol, Rio De Janeiro, Brazil; [Lopes-Pacheco, Miqueias; de Oliveira, Helena D'Anunciacao; Morales, Marcelo M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Cellular & Mol Physiol, Rio De Janeiro, Brazil; [Lopes-Pacheco, Miqueias; Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Pulm Invest, Rio De Janeiro, Brazil; [Gutfilen, Bianca; de Souza, Sergio A. L.] Univ Fed Rio de Janeiro, Sch Med, Dept Radiol, Rio De Janeiro, Brazil; [Borojevic, Radovan] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Cellular Proliferat & Differentiat, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Morales, MM (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Cellular & Mol Physiol, Rio De Janeiro, Brazil.	mmorales@biof.ufrj.br	Lopes-Pacheco, Miquéias/I-1290-2017; Gutfilen, Bianca/C-3116-2013; Takiya, Christina/AAU-5959-2021; Rocco, Patricia/I-7460-2012; Borojevic, Radovan/V-8500-2019; de Souza, Sergio Augusto Lopes/A-9431-2013; Oliveira, Helena/AAR-6862-2020; Lopes-Pacheco, Miquéias/AAM-7432-2020	Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Takiya, Christina/0000-0002-8019-628X; Rocco, Patricia/0000-0003-1412-7136; Borojevic, Radovan/0000-0002-2393-7280; de Souza, Sergio Augusto Lopes/0000-0002-7901-4805; Lopes-Pacheco, Miquéias/0000-0002-7444-9359; de Oliveira, Helena/0000-0003-2744-3496	FAPERJ; CAPES; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants of FAPERJ, CAPES and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES JHT, 1985, J APPL PHYSIOL, V59, P732, DOI 10.1152/jappl.1985.59.3.732; Castelo-Branco MTL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033360; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Davis Gerald S., 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P99; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Gossart S, 1996, J IMMUNOL, V156, P1540; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Hisanaga T, 2011, CELL TISSUE RES, V346, P79, DOI 10.1007/s00441-011-1236-0; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Kong QF, 2009, J NEUROIMMUNOL, V207, P83, DOI 10.1016/j.jneuroim.2008.12.005; Kumamoto M, 2009, EUR RESPIR J, V34, P740, DOI 10.1183/09031936.00128508; Lassance RM, 2009, RESP PHYSIOL NEUROBI, V169, P227, DOI 10.1016/j.resp.2009.09.004; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Lopes-Pacheco M, 2013, CELL PHYSIOL BIOCHEM, V32, P1681, DOI 10.1159/000356603; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Maron-Gutierrez T, 2011, EUR RESPIR J, V37, P1217, DOI 10.1183/09031936.00205009; MCDONALD JW, 1995, ARCH PATHOL LAB MED, V119, P242; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Ornellas DS, 2011, RESP PHYSIOL NEUROBI, V178, P304, DOI 10.1016/j.resp.2011.06.029; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Porter DW, 2006, TOXICOL SCI, V90, P188, DOI 10.1093/toxsci/kfj075; Prota LFM, 2010, CELL TRANSPLANT, V19, P965, DOI 10.3727/096368910X506845; Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386; Rejman J, 2009, MOL THER, V17, P1257, DOI 10.1038/mt.2009.96; Rimal B, 2005, CURR OPIN PULM MED, V11, P169, DOI 10.1097/01.mcp.0000152998.11335.24; Semedo P, 2010, LAB INVEST, V90, P685, DOI 10.1038/labinvest.2010.45; Shen HM, 2001, AM J PHYSIOL-LUNG C, V280, pL10, DOI 10.1152/ajplung.2001.280.1.L10; Srivastava KD, 2002, AM J RESP CRIT CARE, V165, P527, DOI 10.1164/ajrccm.165.4.2106009; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Thakur SA, 2009, TOXICOL SCI, V108, P462, DOI 10.1093/toxsci/kfp011; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Vasconcelos-dos-Santos A, 2012, STEM CELL RES, V9, P1, DOI 10.1016/j.scr.2012.02.002; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yang ZQ, 2009, AM J RESP CELL MOL, V40, P375, DOI 10.1165/rcmb.2008-0300OC; Zhen GH, 2008, FRONT BIOSCI, V13, P3415; Zhen GH, 2010, CYTOTHERAPY, V12, P605, DOI 10.3109/14653241003745888	48	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109982	10.1371/journal.pone.0109982	http://dx.doi.org/10.1371/journal.pone.0109982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299237	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200092
J	Booiman, T; Jimenez, VC; van Dort, KA; van't Wout, AB; Kootstra, NA				Booiman, Thijs; Jimenez, Viviana Cobos; van Dort, Karel A.; van't Wout, Angelique B.; Kootstra, Neeltje A.			Phosphodiesterase 8a Supports HIV-1 Replication in Macrophages at the Level of Reverse Transcription	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; PRODUCTIVE INFECTION; TYPE-1 REPLICATION; CCR5 EXPRESSION; LYMPHOID-TISSUE; T-CELLS; TRANSMISSION; SAMHD1; PERSISTENCE	Background: HIV-1 infected macrophages play a key role in HIV-1 infection. Even during anti-retroviral treatment, macrophages keep producing virus due to suboptimal tissue penetration and reduced efficacy of antiretrovirals. It is therefore of major importance to understand which host factors are involved in HIV-1 replication in macrophages. Previously, we have shown that genetic polymorphisms in phosphodiesterase 8a (PDE8A) are strongly associated with HIV-1 replication in these cells. Here we analyzed the mechanism and regulation of PDE8A in HIV-1 replication in macrophages. Results: PDE8A mRNA expression strongly increases upon differentiation of monocytes into macrophages, which corresponds to the increased susceptibility of mature macrophages to HIV-1. In parallel, expression of microRNA miR-1455p, predicted to target PDE8A mRNA, strongly decreased. The interaction of miR-145-5p with the 39 UTR of PDE8A mRNA could be experimentally validated, suggesting that indeed miR-145-5p can regulate PDE8A expression levels. Knockdown of PDE8A in macrophages resulted in a decrease in total HIV-1 replication and proviral DNA levels. These observations confirm that PDE8A regulates HIV-1 replication in macrophages and that this effect is mediated through early steps in the viral replication cycle. Conclusions: PDE8A is highly expressed in macrophages, and its expression is regulated by miR-145-5p. Our findings strongly suggest that PDE8A supports HIV-1 replication in macrophages and that this effect is mediated at the level of reverse transcription.	[Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab,Sanquin Res, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab,Sanquin Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.a.kootstra@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754	Academic Medical Center of the University of Amsterdam; Landsteiner Foundation of Blood Research [0526]	Academic Medical Center of the University of Amsterdam; Landsteiner Foundation of Blood Research	This work was supported by the Academic Medical Center of the University of Amsterdam and the Landsteiner Foundation of Blood Research (registration number 0526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouch A, 2013, P NATL ACAD SCI USA, V110, pE3997, DOI 10.1073/pnas.1306719110; Bol SM, 2011, VIROLOGY, V420, P32, DOI 10.1016/j.virol.2011.08.013; Bol SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017190; Brown KM, 2013, P NATL ACAD SCI USA, V110, pE1533, DOI 10.1073/pnas.1303004110; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Cassol E, 2010, J LEUKOCYTE BIOL, V87, P599, DOI 10.1189/jlb.1009673; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Crowe SM, 2010, J LEUKOCYTE BIOL, V87, P589, DOI 10.1189/jlb.0809580; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fisher DA, 1998, BIOCHEM BIOPH RES CO, V246, P570, DOI 10.1006/bbrc.1998.8684; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; HO DD, 1985, NEW ENGL J MED, V313, P1493, DOI 10.1056/NEJM198512123132401; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Huysentruyt LC, 2010, J LEUKOCYTE BIOL, V87, P627, DOI 10.1189/jlb.0809564; Jimenez VC, 2014, PHYSIOL GENOMICS, V46, P91, DOI 10.1152/physiolgenomics.00140.2013; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Kootstra NA, 1999, VIROLOGY, V253, P170, DOI 10.1006/viro.1998.9482; KOOTSTRA NA, 1994, J VIROL, V68, P6967, DOI 10.1128/JVI.68.11.6967-6975.1994; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lambotte O, 2005, AIDS, V19, P217, DOI 10.1097/00002030-200501280-00018; MANN DL, 1990, J IMMUNOL, V144, P2152; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; Montaner LJ, 1999, J IMMUNOL, V162, P4606; MONTANER LJ, 1994, J GEN VIROL, V75, P3393, DOI 10.1099/0022-1317-75-12-3393; Montaner LJ, 1997, J LEUKOCYTE BIOL, V62, P126, DOI 10.1002/jlb.62.1.126; Moreno-Fernandez ME, 2012, AIDS RES HUM RETROV, V28, P49, DOI [10.1089/aid.2011.0265, 10.1089/AID.2011.0265]; NAIF H, 1994, J LEUKOCYTE BIOL, V56, P335, DOI 10.1002/jlb.56.3.335; Naif HM, 1998, J VIROL, V72, P830, DOI 10.1128/JVI.72.1.830-836.1998; NICHOLSON JKA, 1986, J IMMUNOL, V137, P323; Olivetta E, 2006, EXP CELL RES, V312, P890, DOI 10.1016/j.yexcr.2005.12.003; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; RICH EA, 1992, J CLIN INVEST, V89, P176, DOI 10.1172/JCI115559; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; SCHUITEMAKER H, 1992, J CLIN INVEST, V89, P1154, DOI 10.1172/JCI115697; Schwartz BG, 2010, CIRCULATION, V122, P88, DOI 10.1161/CIRCULATIONAHA.110.944603; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Thivierge M, 1998, BLOOD, V92, P40, DOI 10.1182/blood.V92.1.40.413k43_40_45; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhang HT, 2009, CURR PHARM DESIGN, V15, P1688, DOI 10.2174/138161209788168092; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	63	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109673	10.1371/journal.pone.0109673	http://dx.doi.org/10.1371/journal.pone.0109673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295610	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000090
J	Hochman-Mendez, C; Cantini, M; Moratal, D; Salmeron-Sanchez, M; Coelho-Sampaio, T				Hochman-Mendez, Camila; Cantini, Marco; Moratal, David; Salmeron-Sanchez, Manuel; Coelho-Sampaio, Tatiana			A Fractal Nature for Polymerized Laminin	PLOS ONE			English	Article							BASEMENT-MEMBRANE; POLYLAMININ; NICHE; EXPRESSION; STABILITY; DIMENSION; PATTERNS	Polylaminin (polyLM) is a non-covalent acid-induced nano- and micro-structured polymer of the protein laminin displaying distinguished biological properties. Polylaminin stimulates neuritogenesis beyond the levels achieved by ordinary laminin and has been shown to promote axonal regeneration in animal models of spinal cord injury. Here we used confocal fluorescence microscopy (CFM), scanning electron microscopy (SEM) and atomic force microscopy (AFM) to characterize its three-dimensional structure. Renderization of confocal optical slices of immunostained polyLM revealed the aspect of a loose flocculated meshwork, which was homogeneously stained by the antibody. On the other hand, an ordinary matrix obtained upon adsorption of laminin in neutral pH (LM) was constituted of bulky protein aggregates whose interior was not accessible to the same anti-laminin antibody. SEM and AFM analyses revealed that the seed unit of polyLM was a flat polygon formed in solution whereas the seed structure of LM was highly heterogeneous, intercalating rod-like, spherical and thin spread lamellar deposits. As polyLM was visualized at progressively increasing magnifications, we observed that the morphology of the polymer was alike independently of the magnification used for the observation. A search for the Hausdorff dimension in images of the two matrices showed that polyLM, but not LM, presented fractal dimensions of 1.55, 1.62 and 1.70 after 1, 8 and 12 hours of adsorption, respectively. Data in the present work suggest that the intrinsic fractal nature of polymerized laminin can be the structural basis for the fractal-like organization of basement membranes in the neurogenic niches of the central nervous system.	[Hochman-Mendez, Camila] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Hochman-Mendez, Camila; Coelho-Sampaio, Tatiana] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Cantini, Marco; Salmeron-Sanchez, Manuel] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland; [Moratal, David] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of Glasgow; Universitat Politecnica de Valencia	Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.	tcsampaio@histo.ufrj.br	Salmeron-Sanchez, Manuel/E-4680-2010; Moratal, David/D-1853-2010	Salmeron-Sanchez, Manuel/0000-0002-8112-2100; Moratal, David/0000-0002-2825-3646; Hochman-Mendez, Camila/0000-0002-1425-594X; Cantini, Marco/0000-0003-0326-1508	Brazilian National Research Council (CNPq) [476772/2008-7]; European Research Council [ERC - 306990]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by a grant from the Brazilian National Research Council (CNPq; 476772/2008-7) to TCS. MSS acknowledges support from the European Research Council through ERC - 306990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Hernandez JCR, 2007, BIOPHYS J, V93, P202, DOI 10.1529/biophysj.106.102491; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Chyba M, 2011, J MATH IND, V3, P79; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Douet V, 2013, CELL PROLIFERAT, V46, P137, DOI 10.1111/cpr.12023; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276; Freire E, 2002, J CELL SCI, V115, P4867, DOI 10.1242/jcs.00173; Freire E, 2000, J BIOL CHEM, V275, P817, DOI 10.1074/jbc.275.2.817; Freire E, 2012, MACROMOL BIOSCI, V12, P67, DOI 10.1002/mabi.201100125; Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916; GARCIAABREU J, 1995, NEUROREPORT, V6, P761, DOI 10.1097/00001756-199503270-00014; Hausdorff F, 1919, MATH ANN, V79, P157; Hediyeh I, 2012, J PHIS CHEM B, V116, P1951; Hochman-Mendez C, 2014, J NEUROSCI RES, V92, P24, DOI 10.1002/jnr.23298; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Kanatsu-Shinohara M, 2013, ANNU REV CELL DEV BI, V29, P163, DOI 10.1146/annurev-cellbio-101512-122353; Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970; Lander AD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-19; LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628; Mercier F, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P109, DOI 10.1007/978-4-431-53933-9_4; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palmero CY, 2013, MOL CELL ENDOCRINOL, V376, P12, DOI 10.1016/j.mce.2013.05.020; Qu HT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-135; Barroso MMS, 2008, J BIOL CHEM, V283, P11714, DOI 10.1074/jbc.M709301200; Soille P, 1996, J VIS COMMUN IMAGE R, V7, P217, DOI 10.1006/jvci.1996.0020; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I	38	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109388	10.1371/journal.pone.0109388	http://dx.doi.org/10.1371/journal.pone.0109388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296244	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000345204000067
J	Miller, SH; Zarate, S; Smith, EH; Gaylord, B; Hosfelt, JD; Hill, TM				Miller, Seth H.; Zarate, Sonia; Smith, Edmund H.; Gaylord, Brian; Hosfelt, Jessica D.; Hill, Tessa M.			Effect of Elevated pCO(2) on Metabolic Responses of Porcelain Crab (Petrolisthes cinctipes) Larvae Exposed to Subsequent Salinity Stress	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; LIFE-HISTORY; CO2 LEVELS; IMPACTS; BEHAVIOR; ANOMURA; RECRUITMENT; CRUSTACEANS; SETTLEMENT	Future climate change is predicted to alter the physical characteristics of oceans and estuaries, including pH, temperature, oxygen, and salinity. Investigating how species react to the influence of such multiple stressors is crucial for assessing how future environmental change will alter marine ecosystems. The timing of multiple stressors can also be important, since in some cases stressors arise simultaneously, while in others they occur in rapid succession. In this study, we investigated the effects of elevated pCO(2) on oxygen consumption by larvae of the intertidal porcelain crab Petrolisthes cinctipes when exposed to subsequent salinity stress. Such an exposure mimics how larvae under future acidified conditions will likely experience sudden runoff events such as those that occur seasonally along portions of the west coast of the U.S. and in other temperate systems, or how larvae encounter hypersaline waters when crossing density gradients via directed swimming. We raised larvae in the laboratory under ambient and predicted future pCO(2) levels (385 and 1000 mu atm) for 10 days, and then moved them to seawater at ambient pCO(2) but with decreased, ambient, or elevated salinity, to monitor their respiration. While larvae raised under elevated pCO(2) or exposed to stressful salinity conditions alone did not exhibit higher respiration rates than larvae held in ambient conditions, larvae exposed to elevated pCO(2) followed by stressful salinity conditions consumed more oxygen. These results show that even when multiple stressors act sequentially rather than simultaneously, they can retain their capacity to detrimentally affect organisms.	[Miller, Seth H.; Zarate, Sonia; Smith, Edmund H.; Gaylord, Brian; Hosfelt, Jessica D.; Hill, Tessa M.] Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA; [Gaylord, Brian] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Hosfelt, Jessica D.; Hill, Tessa M.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Miller, SH (corresponding author), Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA.	shmiller@ucdavis.edu	Hill, Tessa Michelle/P-3401-2019	Hill, Tessa Michelle/0000-0003-4159-9104	UC Multicampus Programs & Initiatives Grant; National Science Foundation [OCE-0927255, OCE-1041089]	UC Multicampus Programs & Initiatives Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by a UC Multicampus Programs & Initiatives Grant (http://www.ucop.edu/research-grants-program/programs/multi-campus-research-programs-and-initiatives.html) and the National Science Foundation (grants OCE-0927255 and OCE-1041089) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess SC, 2012, ECOLOGY, V93, P1378; Burgess SC, 2011, J ANIM ECOL, V80, P681, DOI 10.1111/j.1365-2656.2010.01802.x; Byrne M, 2013, INTEGR COMP BIOL, V53, P582, DOI 10.1093/icb/ict049; Carter HA, 2013, J EXP BIOL, V216, P1412, DOI 10.1242/jeb.078162; Ceballos-Osuna L, 2013, J EXP BIOL, V216, P1405, DOI 10.1242/jeb.078154; de la Haye KL, 2011, ANIM BEHAV, V82, P495, DOI 10.1016/j.anbehav.2011.05.030; de la Haye KL, 2012, J EXP MAR BIOL ECOL, V412, P134, DOI 10.1016/j.jembe.2011.11.013; Di Lorenzo E, 2005, J PHYS OCEANOGR, V35, P336, DOI 10.1175/JPO-2690.1; Dickinson GH, 2013, J EXP BIOL, V216, P2607, DOI 10.1242/jeb.082909; Dickinson GH, 2012, J EXP BIOL, V215, P29, DOI 10.1242/jeb.061481; Dickson A. G., 2007, PICES SPEC PUB, V3, P1, DOI DOI 10.1159/000331784; Diffenbaugh NS, 2004, P NATL ACAD SCI USA, V101, P27, DOI 10.1073/pnas.0305746101; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donohue PJC, 2012, AQUAT BIOL, V15, P73, DOI 10.3354/ab00408; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hollebone AL, 2007, MAR ECOL PROG SER, V336, P211, DOI 10.3354/meps336211; Intergovernmental Panel on Climate Change (IPCC), 2014, CLIMATE CHANGE 201 A; IPCC, 2007, CLIM CHANG 2004 PHYS; JENSEN GC, 1989, J EXP MAR BIOL ECOL, V131, P223, DOI 10.1016/0022-0981(89)90114-7; JENSEN GC, 1991, MAR ECOL PROG SER, V73, P47, DOI 10.3354/meps073047; JENSEN GC, 1991, J EXP MAR BIOL ECOL, V153, P49, DOI 10.1016/S0022-0981(05)80005-X; Kaldy JE, 2013, BOT MAR, V56, P75, DOI 10.1515/bot-2012-0144; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Lagos ME, 2011, SCI MAR, V75, P273, DOI 10.3989/scimar.2011.75n2273; Long WC, 2013, MAR POLLUT BULL, V69, P38, DOI 10.1016/j.marpolbul.2013.01.011; Masunari Setuko, 1998, Revista Brasileira de Zoologia, V15, P219; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; Micheletti-Flores C. V., 1999, Revista Brasileira de Biologia, V59, P63; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Morgan SG, 2009, ECOLOGY, V90, P3489, DOI 10.1890/08-1550.1; Morris R.H., 1980, INTERTIDAL INVERTEBR; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Pansch C, 2013, MAR BIOL, V160, P2023, DOI 10.1007/s00227-012-2069-4; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PELLEGRINO CR, 1984, CRUSTACEANA, V47, P251, DOI 10.1163/156854084X00513; Shanks AL, 2005, ECOL MONOGR, V75, P505, DOI 10.1890/05-0309; Smith SV, 1997, ECOL MONOGR, V67, P509, DOI 10.1890/0012-9615(1997)067[0509:ACAIVO]2.0.CO;2; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Stillman JH, 1996, J EXP BIOL, V199, P1845; Stillman JH, 2009, MOL ECOL, V18, P4206, DOI 10.1111/j.1365-294X.2009.04354.x; Strathmann MF, 1987, REPROD DEV MARINE IN; Styf HK, 2013, ECOL EVOL, V3, P5055, DOI 10.1002/ece3.860; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Yaikin J, 2002, J CRUSTACEAN BIOL, V22, P345, DOI 10.1651/0278-0372(2002)022[0345:ARRAAE]2.0.CO;2; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	56	7	7	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109167	10.1371/journal.pone.0109167	http://dx.doi.org/10.1371/journal.pone.0109167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295878	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000043
J	Nakamura, K; Chung, SW; Kono, Y; Ho, MJ; Hsu, TC; Peng, CI				Nakamura, Koh; Chung, Shih-Wen; Kono, Yoshiko; Ho, Meng-Jung; Hsu, Tian-Chuan; Peng, Ching-I			Ixeridium calcicola (Compositae), a New Limestone Endemic from Taiwan, with Notes on Its Atypical Basic Chromosome Number, Phylogenetic Affinities, and a Limestone Refugium Hypothesis	PLOS ONE			English	Article							YOUNGIA ASTERACEAE; SEQUENCE ALIGNMENT; EVOLUTION; CICHORIEAE; GENUS; DELIMITATION; DIVERGENCE; INFERENCE; MODELS; SPACER	A new species Ixeridium calcicola (Compositae) endemic to middle altitude (ca 1,000-2,000 m asl) limestone mountains of eastcentral Taiwan is described based on morphological and chromosome cytological observations and molecular phylogenetic analyses. Ixeridium calcicola resembles Ixeridium transnokoense, endemic to upper montane and alpine ranges (2,600-3,500 m asl) of Taiwan, in the dwarf habit, but differs in the oblong to lanceolate leaf blades (vs. linear to linear-lanceolate), the presence of mucronulate teeth on the leaf margin and petiole (vs. smooth to very sparse), the dark purple lower leaf surface (vs. greenish), the capitulum with 10 to 12 florets (vs. 5 to 7) and 8 to 10 inner phyllaries (vs. 5, rarely to 7). The basic chromosome number in Ixeridium was known as X = 7. However, the new species has a basic chromosome number of X = 8, as recorded also in the closely related Ixeris. Molecular phylogenetic analyses with the expanded sampling of Ixeridium and Ixeris including both type species supported the monophyly of each of the genera and the placement of the new species in Ixeridium. The result of the phylogenetic analyses and detailed observation of the chromosome morphology revealed that X = 8 in Ixeridium calcicola is derived from centric fission in an ancestral karyomorphotype with X = 7 in Ixeridium. Ixeridium calcicola and Ixeridium transnokoense formed a Taiwan endemic lineage and their estimated divergence time was in the middle Pleistocene. Their common ancestral lineage may have experienced altitudinal distribution shifts in response to glacial-interglacial temperature fluctuation, and a lineage which had not retreated to alpine ranges in an interglacial period likely survived in a limestone refugium, where ordinary plant species did not grow, leading to allopatric speciation.	[Nakamura, Koh; Kono, Yoshiko; Ho, Meng-Jung; Peng, Ching-I] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chung, Shih-Wen; Hsu, Tian-Chuan] Taiwan Forestry Res Inst, Bot Garden Div, Taipei, Taiwan	Academia Sinica - Taiwan	Peng, CI (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	bopeng@sinica.edu.tw			Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This study was supported in part by a postdoctoral fellowship from Academia Sinica to KN, and a research grant from Academia Sinica to CIP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN BG, 1993, AM J BOT, V80, P222, DOI 10.2307/2445043; Chung KF, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-1; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Enke N, 2008, TAXON, V57, P756, DOI 10.1002/tax.573008; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goertzen LR, 2003, MOL PHYLOGENET EVOL, V29, P216, DOI 10.1016/S1055-7903(03)00094-0; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho C.-S., 1982, TECTONIC EVOLUTION T; HSIEH CF, 1994, FLORA TAIWAN, V1, P1; Jones K, 1998, BOT REV, V64, P273, DOI 10.1007/BF02856567; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kilian N., 2009, SYSTEMATICS, P343; Kokubugata G, 2010, MOL PHYLOGENET EVOL, V54, P657, DOI 10.1016/j.ympev.2009.09.004; Korea National Arboretum Plant Taxonomic Society of Korea National Plant List Committee and Cultivated Plant List Committee, 2004, KOR PLANT NAM IND; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lu CT, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-57; Mamgain S. K., 1998, Taiwania, V43, P155; Mitsui Y, 2008, ANN BOT-LONDON, V101, P111, DOI 10.1093/aob/mcm267; Nakamura K, 2006, J PLANT RES, V119, P657, DOI 10.1007/s10265-006-0017-4; Nakamura K, 2013, SYST BOT, V38, P507, DOI 10.1600/036364413X666769; Nakamura K, 2012, MOL PHYLOGENET EVOL, V63, P486, DOI 10.1016/j.ympev.2012.01.023; PAK J-H, 1990, Cytologia (Tokyo), V55, P553; PAK J-H, 1990, Acta Phytotaxonomica et Geobotanica, V41, P43; Pak Jae-Hong, 1992, Memoirs of the Faculty of Science Kyoto University Series of Biology, V15, P29; Pelser P.B., 2011, COS DIGITAL FLORA PH; Peng CI, 1999, BOT BULL ACAD SINICA, V40, P53; Peng CI, 1998, FLORA TAIWAN, P995; Peng CI, 1998, FLORA TAIWAN, V4, P993; Peng YL, 2014, PHYTOTAXA, V159, P241, DOI 10.11646/phytotaxa.159.4.1; Petley DN, 1999, GEOL SOC SPEC PUBL, V162, P169, DOI 10.1144/GSL.SP.1999.162.01.14; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Samuel R, 2003, AM J BOT, V90, P496, DOI 10.3732/ajb.90.3.496; Shaw C.L, 1996, ANN REP NATL TAIWAN, V39, P429; Shi C, 2011, FLORA CHINA, V20-21, P328; Shih C, 2011, FLORA CHINA, V20-21, P331; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tremetsberger K, 2013, ORG DIVERS EVOL, V13, P1, DOI 10.1007/s13127-012-0094-2; TSUKADA M, 1966, P NATL ACAD SCI USA, V55, P543, DOI 10.1073/pnas.55.3.543; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yahara Y, 1995, FLORA JAPAN B, VIII, P15	51	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109797	10.1371/journal.pone.0109797	http://dx.doi.org/10.1371/journal.pone.0109797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295587	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000097
J	Bhargava, M; Becker, TL; Viken, KJ; Jagtap, PD; Dey, S; Steinbach, MS; Wu, BL; Kumar, V; Bitterman, PB; Ingbar, DH; Wendt, CH				Bhargava, Maneesh; Becker, Trisha L.; Viken, Kevin J.; Jagtap, Pratik D.; Dey, Sanjoy; Steinbach, Michael S.; Wu, Baolin; Kumar, Vipin; Bitterman, Peter B.; Ingbar, David H.; Wendt, Christine H.			Proteomic Profiles in Acute Respiratory Distress Syndrome Differentiates Survivors from Non-Survivors	PLOS ONE			English	Article							ACUTE LUNG INJURY; BRONCHOALVEOLAR LAVAGE FLUID; MOESIN-DEFICIENT MICE; PULMONARY-EDEMA FLUID; CLARA CELL PROTEIN; CLINICAL-OUTCOMES; ERM PROTEINS; PLASMA; MORTALITY; ADHESION	Acute Respiratory Distress Syndrome (ARDS) continues to have a high mortality. Currently, there are no biomarkers that provide reliable prognostic information to guide clinical management or stratify risk among clinical trial participants. The objective of this study was to probe the bronchoalveolar lavage fluid (BALF) proteome to identify proteins that differentiate survivors from non-survivors of ARDS. Patients were divided into early-phase (1 to 7 days) and late-phase (8 to 35 days) groups based on time after initiation of mechanical ventilation for ARDS (Day 1). Isobaric tags for absolute and relative quantitation (iTRAQ) with LC MS/MS was performed on pooled BALF enriched for medium and low abundance proteins from early-phase survivors (n = 7), early-phase non-survivors (n = 8), and late-phase survivors (n = 7). Of the 724 proteins identified at a global false discovery rate of 1%, quantitative information was available for 499. In early-phase ARDS, proteins more abundant in survivors mapped to ontologies indicating a coordinated compensatory response to injury and stress. These included coagulation and fibrinolysis; immune system activation; and cation and iron homeostasis. Proteins more abundant in early-phase non-survivors participate in carbohydrate catabolism and collagen synthesis, with no activation of compensatory responses. The compensatory immune activation and ion homeostatic response seen in early-phase survivors transitioned to cell migration and actin filament based processes in late-phase survivors, revealing dynamic changes in the BALF proteome as the lung heals. Early phase proteins differentiating survivors from non-survivors are candidate biomarkers for predicting survival in ARDS.	[Bhargava, Maneesh; Becker, Trisha L.; Viken, Kevin J.; Bitterman, Peter B.; Ingbar, David H.; Wendt, Christine H.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Jagtap, Pratik D.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN 55455 USA; [Dey, Sanjoy; Steinbach, Michael S.; Kumar, Vipin] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Wu, Baolin] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Wendt, Christine H.] Univ Minnesota, Minneapolis VA Med Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Bhargava, M (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	bharg005@umn.edu		Viken, Kevin/0000-0003-3822-2269; Steinbach, Michael/0000-0002-7309-6395; WU, BAOLIN/0000-0001-6676-0422; BITTERMAN, PETER/0000-0002-7995-7117; Bhargava, Maneesh/0000-0002-1294-6181; Ingbar, David H./0000-0003-1695-4493; Jagtap, Pratik/0000-0003-0984-0973	American Heart Association Scientist Development Grant [12SDG8160000]; UMN KL2 Scholars Award [1UL1RR033183-01, 8UL1TR000114-02]; Minnesota Medical Foundation Research Grant [MFN MED FDN/3899-9238-09]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002492, KL2TR000113, UL1TR000114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033183] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); UMN KL2 Scholars Award; Minnesota Medical Foundation Research Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	12SDG8160000 American Heart Association Scientist Development Grant (MB PI). 1UL1RR033183-01 and 8UL1TR000114-02 UMN KL2 Scholars Award (MB, Blarzar-PI). MFN MED FDN/3899-9238-09 Minnesota Medical Foundation Research Grant (MB PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; ASHBAUGH DG, 1967, LANCET, V2, P319; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bersten AD, 2001, AM J RESP CRIT CARE, V164, P648, DOI 10.1164/ajrccm.164.4.2010111; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Calfee CS, 2012, CRIT CARE MED, V40, P1731, DOI 10.1097/CCM.0b013e3182451c87; Calfee CS, 2011, CRIT CARE MED, V39, P711, DOI 10.1097/CCM.0b013e318207ec3c; Calfee C, 2009, INTENS CARE MED, V35, P248, DOI 10.1007/s00134-008-1235-0; Chang DW, 2008, AM J RESP CRIT CARE, V178, P701, DOI 10.1164/rccm.200712-1895OC; Cheng IW, 2003, CRIT CARE MED, V31, P20, DOI 10.1097/00003246-200301000-00003; CLARK JG, 1995, ANN INTERN MED, V122, P17, DOI 10.7326/0003-4819-122-1-199501010-00003; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Connelly KG, 1997, AM J RESP CRIT CARE, V155, P21, DOI 10.1164/ajrccm.155.1.9001283; Cribbs SK, 2008, CRIT CARE MED, V36, P2457, DOI 10.1097/CCM.0b013e318181052a; Determann Rogier M, 2009, BMC Pulm Med, V9, P49, DOI 10.1186/1471-2466-9-49; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; FARJANEL J, 1993, AM REV RESPIR DIS, V147, P1091, DOI 10.1164/ajrccm/147.5.1091; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Gallagher DC, 2008, SHOCK, V29, P656, DOI 10.1097/SHK.0b013e31815dd92f; Gharib SA, 2010, EUR RESPIR J, V35, P1388, DOI 10.1183/09031936.00089409; Ghio AJ, 2003, CRIT CARE MED, V31, P395, DOI 10.1097/01.CCM.0000050284.35609.97; Griffin T, 2013, GALAXY P TRANSFORMIN; Guerin C, 2013, NEW ENGLAND J MED; Hashimoto S, 2008, AM J PHYSIOL-LUNG C, V295, pL566, DOI 10.1152/ajplung.90250.2008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240; Katayama M, 2010, INTENS CARE MED, V36, P479, DOI 10.1007/s00134-009-1719-6; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koeppen M, 2013, MUCOSAL IMMUNOL, V6, P762, DOI 10.1038/mi.2012.114; Kong MYF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022596; Kosanam H, 2012, CLIN BIOCHEM, V45, P223, DOI 10.1016/j.clinbiochem.2011.11.015; Kropski JA, 2009, CHEST, V135, P1440, DOI 10.1378/chest.08-2465; Lagan AL, 2008, CHEST, V133, P1302, DOI 10.1378/chest.07-1117; Lesur O, 2006, INTENS CARE MED, V32, P1167, DOI 10.1007/s00134-006-0235-1; Magi B, 2002, ELECTROPHORESIS, V23, P3434, DOI 10.1002/1522-2683(200210)23:19<3434::AID-ELPS3434>3.0.CO;2-R; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; McClintock DE, 2006, AM J PHYSIOL-LUNG C, V291, pL566, DOI 10.1152/ajplung.00457.2005; Merkel D, 2005, PROTEOMICS, V5, P2972, DOI 10.1002/pmic.200401180; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Okayama T, 2008, BBA-MOL BASIS DIS, V1782, P542, DOI 10.1016/j.bbadis.2008.06.006; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Parsons PE, 2005, AM J PHYSIOL-LUNG C, V288, pL426, DOI 10.1152/ajplung.00302.2004; Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002; Quinlan GJ, 2001, CLIN SCI, V100, P169, DOI 10.1042/CS20000155; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suratt BT, 2006, CLIN CHEST MED, V27, P579, DOI 10.1016/j.ccm.2006.06.005; Suratt BT, 2009, CRIT CARE MED, V37, P1322, DOI 10.1097/CCM.0b013e31819c14fa; The Acute Respiratory Distress Syndrome Network, 2000, NEW ENGLAND J MED, V342, P1301; Torii K, 1997, AM J RESP CRIT CARE, V155, P43, DOI 10.1164/ajrccm.155.1.9001287; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Ware LB, 2010, EUR RESPIR J, V35, P331, DOI 10.1183/09031936.00098709; Ware LB, 2003, AM J PHYSIOL-LUNG C, V285, pL514, DOI 10.1152/ajplung.00442.2002; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC; Ware LB, 2007, CRIT CARE MED, V35, P1821, DOI 10.1097/01.CCM.0000275386.95968.5F; Ware Lorraine B., 2005, Keio Journal of Medicine, V54, P142, DOI 10.2302/kjm.54.142; Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wu J, 2005, MOL CELL PROTEOMICS, V4, P1251, DOI 10.1074/mcp.M500041-MCP200; Zhang Y, 2006, PROTEOMICS, V6, P1001, DOI 10.1002/pmic.200500105	63	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109713	10.1371/journal.pone.0109713	http://dx.doi.org/10.1371/journal.pone.0109713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290099	Green Submitted, gold, Green Published			2022-12-27	WOS:000342798000080
J	Bischoff, JM; Ringsted, TK; Petersen, M; Sommer, C; Uceyler, N; Werner, MU				Bischoff, Joakim M.; Ringsted, Thomas K.; Petersen, Marian; Sommer, Claudia; Uceyler, Nurcan; Werner, Mads U.			A Capsaicin (8%) Patch in the Treatment of Severe Persistent Inguinal Postherniorrhaphy Pain: A Randomized, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							LONG-TERM PAIN; RISK-FACTORS; POSTHERPETIC NEURALGIA; CUTANEOUS PATCH; HERNIA REPAIR; INTERFERENCE; MANAGEMENT; NGX-4010; SCALE	Background: Persistent pain after inguinal herniorrhaphy is a disabling condition with a lack of evidence-based pharmacological treatment options. This randomized placebo-controlled trial investigated the efficacy of a capsaicin 8% cutaneous patch in the treatment of severe persistent inguinal postherniorrhaphy pain. Methods: Forty-six patients with persistent inguinal postherniorrhaphy pain were randomized to receive either a capsaicin 8% patch or a placebo patch. Pain intensity (Numerical Rating Scale [NRS 0-10]) was evaluated under standardized conditions (at rest, during movement, and during pressure) at baseline and at 1, 2 and 3 months after patch application. Skin punch biopsies for intraepidermal nerve fiber density (IENFD) measurements were taken at baseline and 1 month after patch application. Quantitative sensory testing was performed at baseline and at 1, 2, and 3 months after patch application. The primary outcome was comparisons of summed pain intensity differences (SPIDs) between capsaicin and placebo treatments at 1, 2 and 3 months after patch application (significance level P<0.01). Results: The maximum difference in SPID, between capsaicin and placebo treatments, was observed at 1 month after patch application, but the pain reduction was not significant (NRS, mean difference [95% CI]: 5.0 [0.09 to 9.9]; P=0.046). No differences in SPID between treatments were observed at 2 and 3 months after patch application. Changes in IENFD on the pain side, from baseline to 1 month after patch application, did not differ between capsaicin and placebo treatment: 1.9 [-0.1 to 3.9] and 0.6 [-1.2 to 2.5] fibers/mm, respectively (P=0.32). No significant changes in sensory function, sleep quality or psychological factors were associated with capsaicin patch treatment. Conclusions: The study did not demonstrate significant differences in pain relief between capsaicin and placebo treatment, although a trend toward pain improvement in capsaicin treated patients was observed 1 month after patch application.	[Bischoff, Joakim M.; Ringsted, Thomas K.; Petersen, Marian; Werner, Mads U.] Univ Copenhagen, Rigshosp, Ctr Neurosci, Multidisciplinary Pain Ctr 7612, DK-2100 Copenhagen, Denmark; [Sommer, Claudia; Uceyler, Nurcan] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany	Rigshospitalet; University of Copenhagen; University of Wurzburg	Bischoff, JM (corresponding author), Univ Copenhagen, Rigshosp, Ctr Neurosci, Multidisciplinary Pain Ctr 7612, DK-2100 Copenhagen, Denmark.	jomutahi@hotmail.com	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002; Uceyler, Nurcan/0000-0001-6973-6428; Werner, Mads/0000-0003-1540-8845	Astellas Pharma a/s, Kastrup, Denmark	Astellas Pharma a/s, Kastrup, Denmark	The study was supported by an unrestricted research grant from Astellas Pharma a/s, Kastrup, Denmark (http://www.astellas.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasvang EK, 2008, ANESTH ANALG, V107, P282, DOI 10.1213/ane.0b013e31816b94c9; Aasvang EK, 2010, PAIN, V150, P237, DOI 10.1016/j.pain.2010.03.025; Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Backonja M, 2008, LANCET NEUROL, V7, P1106, DOI 10.1016/S1474-4422(08)70228-X; Bennett MI, 2005, J PAIN, V6, P149, DOI 10.1016/j.jpain.2004.11.007; Bischoff JM, 2013, HERNIA, V17, P339, DOI 10.1007/s10029-013-1073-z; Bischoff JM, 2013, ANESTHESIOLOGY, V119, P1444, DOI 10.1097/ALN.0b013e3182a2a243; Bischoff JM, 2012, ANESTH ANALG, V114, P1323, DOI 10.1213/ANE.0b013e31824d6168; Chen DC, 2013, JAMA SURG, V148, P962, DOI 10.1001/jamasurg.2013.3189; DERRY S, 2013, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD007393.PUB3, 10.1002/14651858.CD007393.pub3]; Franneby U, 2006, ANN SURG, V244, P212, DOI 10.1097/01.sla.0000218081.53940.01; Irving GA, 2011, PAIN MED, V12, P99, DOI 10.1111/j.1526-4637.2010.01004.x; Kalliomaki ML, 2008, EUR J PAIN, V12, P214, DOI 10.1016/j.ejpain.2007.05.006; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kennedy WR, 2010, J PAIN, V11, P579, DOI 10.1016/j.jpain.2009.09.019; Knolle E, 2013, PAIN, V154, P2729, DOI 10.1016/j.pain.2013.08.001; Maihofner C, 2013, CURR MED RES OPIN, V29, P673, DOI 10.1185/03007995.2013.792246; Malmberg AB, 2004, PAIN, V111, P360, DOI 10.1016/j.pain.2004.07.017; Mikkelsen T, 2004, ANESTH ANALG, V99, P146, DOI 10.1213/01.ANE.0000115147.14626.C5; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moller AT, 2009, PAIN, V145, P237, DOI 10.1016/j.pain.2009.06.032; Rage M, 2010, CLIN NEUROPHYSIOL, V121, P1256, DOI 10.1016/j.clinph.2010.02.159; Ringkamp M., 2013, WALL MELZACKS TXB PA, P1; Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Treede RD, 2013, CURR MED RES OPIN, V29, P527, DOI 10.1185/03007995.2013.781019; Vernon MK, 2008, J PAIN SYMPTOM MANAG, V36, P54, DOI 10.1016/j.jpainsymman.2007.09.016; Webster LR, 2010, J PAIN, V11, P972, DOI 10.1016/j.jpain.2010.01.270; Webster LR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-92; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109144	10.1371/journal.pone.0109144	http://dx.doi.org/10.1371/journal.pone.0109144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290151	Green Published, gold			2022-12-27	WOS:000342798000037
J	Bishop, MJ; Connolly, A; Plank, G				Bishop, Martin J.; Connolly, Adam; Plank, Gernot			Structural Heterogeneity Modulates Effective Refractory Period: A Mechanism of Focal Arrhythmia Initiation	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; IMPULSE PROPAGATION; ACTIVATION SEQUENCE; REPOLARIZATION; DYNAMICS; GEOMETRY; IMPACT; SPREAD; TOOLS; MODEL	Reductions in electrotonic loading around regions of structural and electrophysiological heterogeneity may facilitate capture of focal triggered activity, initiating reentrant arrhythmias. How electrotonic loading, refractoriness and capture of focal ectopics depend upon the intricate nature of physiological structural anatomy, as well as pathological tissue remodelling, however, is not well understood. In this study, we performed computational bidomain simulations with anatomically-detailed models representing the rabbit left ventricle. We used these models to quantify the relationship between local structural anatomy and spatial heterogeneity in action potential (AP) characteristics, electrotonic currents and effective refractory periods (ERPs) under pacing and restitution protocols. Regions surrounding vessel cavities, in addition to tissue surfaces, had significantly lower peak downstream electrotonic currents than well coupled myocardium (72.6 vs 220.4 mu A/cm(2)), with faster maximum AP upstroke velocities (257.3 vs 147.3 mV/ms), although noticeably very similar APDs (167.7 vs 168.4 ms) and AP restitution properties. Despite similarities in APDs, ERPs in regions of low electrotonic load in the vicinity of surfaces, intramural vessel cavities and endocardial structures were up to 40 ms shorter compared to neighbouring well-coupled tissue, leading to regions of sharp ERP gradients. Consequently, focal extra-stimuli timed within this window of ERP heterogeneity between neighbouring regions readily induced uni-directional block, inducing reentry. Most effective induction sites were within channels of low ERPs between large vessels and epicardium. Significant differences in ERP driven by reductions in electrotonic loading due to fine-scale physiological structural heterogeneity provides an important mechanism of capture of focal activity and reentry induction. Application to pathological ventricles, particularly myocardial infarction, will have important implications in anti-arrhythmia therapy.	[Bishop, Martin J.; Connolly, Adam] Kings Coll London, Div Imaging Sci & Biomed Engn, Dept Biomed Engn, London, England; [Plank, Gernot] Med Univ Graz, Inst Biophys, Graz, Austria; [Plank, Gernot] Univ Oxford, Oxford eRes Ctr, Oxford, England	University of London; King's College London; Medical University of Graz; University of Oxford	Bishop, MJ (corresponding author), Kings Coll London, Div Imaging Sci & Biomed Engn, Dept Biomed Engn, London, England.	martin.bishop@kcl.ac.uk	Plank, Gernot/O-3791-2019; Plank, Gernot/C-9498-2011	Plank, Gernot/0000-0002-7380-6908; Plank, Gernot/0000-0002-7380-6908; Bishop, Martin/0000-0002-6237-1902	United Kingdom Engineering and Physical Sciences Research Council (EPSRC) [EP/K034367/1]; National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Centre of Excellence in Medical Engineering - Wellcome Trust and EPSRC [WT 088641/Z/09/Z]; Austrian Science Fund [F3210-N18]; National Heart, Lung, and Blood Institute [RO1-HL-10119601]; Austrian Science Fund (FWF) [F 3201] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K034367/1] Funding Source: researchfish; EPSRC [EP/K034367/1] Funding Source: UKRI	United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London; Centre of Excellence in Medical Engineering - Wellcome Trust and EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Austrian Science Fund(Austrian Science Fund (FWF)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an United Kingdom Engineering and Physical Sciences Research Council (EPSRC) First Grant Award to MJB (EP/K034367/1). MJB \& AC acknowledge the support of the National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London and support from the Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC (Grant WT 088641/Z/09/Z). GP acknowledges Austrian Science Fund Grant F3210-N18 and National Heart, Lung, and Blood Institute Grant RO1-HL-10119601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2001, AM J PHYSIOL-HEART C, V281, pH533, DOI 10.1152/ajpheart.2001.281.2.H533; Bishop MJ, 2011, BIOPHYS J, V101, P2871, DOI 10.1016/j.bpj.2011.10.052; Bishop MJ, 2011, IEEE T BIO-MED ENG, V58, P1066, DOI 10.1109/TBME.2010.2096425; Bishop MJ, 2010, IEEE T BIO-MED ENG, V57, P2335, DOI 10.1109/TBME.2010.2051227; Bishop MJ, 2010, AM J PHYSIOL-HEART C, V298, pH699, DOI 10.1152/ajpheart.00606.2009; Cherry EM, 2011, J THEOR BIOL, V285, P164, DOI 10.1016/j.jtbi.2011.06.039; CLERC L, 1976, J PHYSIOL-LONDON, V255, P335, DOI 10.1113/jphysiol.1976.sp011283; Colli-Franzone P, 2006, MATH BIOSCI, V204, P132, DOI 10.1016/j.mbs.2006.06.002; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; FAST VG, 1995, CARDIOVASC RES, V30, P449, DOI 10.1016/0008-6363(95)00071-2; Fast VG, 1997, CARDIOVASC RES, V33, P258, DOI 10.1016/S0008-6363(96)00216-7; Gibb M, 2009, LECT NOTES COMPUT SC, V5528, P268, DOI 10.1007/978-3-642-01932-6_29; Hanson B, 2009, CIRC-ARRHYTHMIA ELEC, V2, P162, DOI 10.1161/CIRCEP.108.785352; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Kelly A, 2013, CIRC-ARRHYTHMIA ELEC, V6, P809, DOI 10.1161/CIRCEP.113.000334; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Myles RC, 2010, AM J PHYSIOL-HEART C, V299, pH1812, DOI 10.1152/ajpheart.00518.2010; Nguyen TP, 2013, J AMBIENT INTELLIGEN, P1; Plank G, 2009, PHILOS T R SOC A, V367, P2257, DOI 10.1098/rsta.2009.0056; POLLARD AE, 1992, CRIT REV BIOMED ENG, V20, P171; Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943; Sampson KJ, 2005, AM J PHYSIOL-HEART C, V289, pH350, DOI 10.1152/ajpheart.00507.2004; SPACH MS, 1985, IEEE T BIO-MED ENG, V32, P743, DOI 10.1109/TBME.1985.325489; STEVENSON WG, 1995, J CARDIOVASC ELECTR, V6, P942, DOI 10.1111/j.1540-8167.1995.tb00370.x; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Walton RD, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00281; Wilders R, 2000, PFLUG ARCH EUR J PHY, V441, P301, DOI 10.1007/s004240000413; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109754	10.1371/journal.pone.0109754	http://dx.doi.org/10.1371/journal.pone.0109754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291380	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000086
J	Geir, P; Selsbakk, JM; Theresa, W; Sigmund, K				Geir, Pedersen; Selsbakk, Johansen Merete; Theresa, Wilberg; Sigmund, Karterud			Testing Different Versions of the Affective Neuroscience Personality Scales in a Clinical Sample	PLOS ONE			English	Article							FIT; COEFFICIENT; VALIDATION; FORM	Background: As a tool to investigate the experiences of six primary emotions, Davis, Panksepp, and Normansell [1] developed the Affective Neuroscience Personality Scales (ANPS). However, the psychometric properties of the ANPS have been questioned, and in particular the factor structure. This study replicates earlier psychometric studies on ANPS in a sample of (546) personality disordered patients, and also includes ANPS-S, a recent short version of ANPS by Pingault and colleagues [2], and a truncated version of BANPS by Barrett and colleagues [3]. Methodology/Principal Findings: The study of the full ANPS revealed acceptable internal consistencies of the primary emotion subscales, ranging from 0.74-0.87. However, factor analyses revealed poor to mediocre fit for a six factor solution. Correlational analyses, in addition, revealed too high correlations between PLAY and SEEK, and between SADNESS and FEAR. The two short versions displayed better psychometric properties. The range of internal consistency was 0.61-0.80 for the BANPS scales and 0.65-84 for the ANPS-S. Backward Cronbach Alpha Curves indicated potentials for improvement on all three versions of the questionnaire. Items retained in the short versions did not systematically cover the full theoretical content of the long scales, in particular for CARE and SADNESS in the BANPS. The major problems seem to reside in the operationalization of the CARE and SADNESS subscales of ANPS. Conclusions/Significance: Further work needs to be done in order to realize a psychometrically sound instrument for the assessment of primary emotional experiences.	[Geir, Pedersen; Selsbakk, Johansen Merete] Oslo Univ Hosp, Clin Mental Hlth & Addict, Dept Personal Psychiat, Oslo, Norway; [Theresa, Wilberg] Oslo Univ Hosp, Dept Res & Dev, Clin Mental Hlth & Addict, Oslo, Norway; [Sigmund, Karterud] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Geir, P (corresponding author), Oslo Univ Hosp, Clin Mental Hlth & Addict, Dept Personal Psychiat, Oslo, Norway.	geir.pedersen@medisin.uio.no		Rudolfsen, Geir/0000-0001-7984-8458				Abella V, 2011, SPAN J PSYCHOL, V14, P926, DOI 10.5209/rev_SJOP.2011.v14.n2.38; Barrett FS, 2013, PSYCHOL ASSESSMENT, V25, P826, DOI 10.1037/a0032576; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Cameletti M, 2013, ANN ISUP I STAT U PA, V57, P59; CERNY BA, 1977, MULTIVAR BEHAV RES, V12, P43, DOI 10.1207/s15327906mbr1201_3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa PT, 2007, REVISED NEO PERSONAL; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Curt F, 1997, Laterality, V2, P137, DOI 10.1080/713754262; Damasio A.R., 2000, FEELING WHAT HAPPENS; Darwin C., 1872, P374; Davis KL, 2011, NEUROSCI BIOBEHAV R, V35, P1946, DOI 10.1016/j.neubiorev.2011.04.004; Davis KL., 2003, NEUROPSYCHOANALYSIS, V5, P57, DOI [DOI 10.1080/15294145.2003.10773410, 10.1080/15294145.2003.10773410]; DZIUBAN CD, 1974, PSYCHOL BULL, V81, P358, DOI 10.1037/h0036316; First M. B., 1997, STRUCTURED CLIN INTE; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Hambleton RK, 2005, ADAPTING EDUCATIONAL AND PSYCHOLOGICAL TESTS FOR CROSS- CULTURAL ASSESSMENT, P3; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; IBM Corp, 2010, IBM SPSS STAT WIND V; Jang KL, 1998, J PERS SOC PSYCHOL, V74, P1556, DOI 10.1037/0022-3514.74.6.1556; Joreskog KG, 2013, LISREL 9 10 WINDOWS; Karterud S, 2003, J PERS DISORD, V17, P173, DOI DOI 10.1521/pedi.17.3.243.22151; Kendler KS, 2003, AM J PSYCHIAT, V160, P496, DOI 10.1176/appi.ajp.160.3.496; Kenny DA, 2003, STRUCT EQU MODELING, V10, P333, DOI 10.1207/S15328007SEM1003_1; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Mesbah M., 2010, METHODS APPL STAT LI, P839; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Pahlavan F, 2008, EUR REV APPL PSYCHOL, V58, P155, DOI 10.1016/j.erap.2007.08.004; Panksepp J, 2004, NEBR SYM MOTIV, V50, P85; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J., 2012, ARCHAEOLOGY MIND NEU; Panksepp J, 2007, COGNITION EMOTION, V21, P1819, DOI 10.1080/02699930701334302; Panksepp J, 2012, MOTIV EMOTION, V36, P4, DOI 10.1007/s11031-011-9232-y; Pedersen G, 2013, PERSONAL MENT HEALTH, V7, P277, DOI 10.1002/pmh.1234; Pedersen G, 2007, NORD J PSYCHIAT, V61, P271, DOI 10.1080/08039480701414999; Pingault JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041489; Pingault JB, 2012, PSYCHOL ASSESSMENT, V24, P375, DOI 10.1037/a0025692; R Core Team, 2021, R LANGUAGE ENV STAT; Reichborn-Kjennerud T, 2008, PSYCHIAT CLIN N AM, V31, P421, DOI 10.1016/j.psc.2008.03.012; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Spielberger C D, 1975, EMOTIONS THEIR PARAM; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tomkins, 1963, AFFECT IMAGERY CONSC, V2; Tomkins SS, 1962, AFFECT IMAGERY CONSC, V1; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Yu C.Y., 2002, EVALUATING CUTOFF CR	53	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109394	10.1371/journal.pone.0109394	http://dx.doi.org/10.1371/journal.pone.0109394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ4VK	25289939	gold, Green Published, Green Submitted			2022-12-27	WOS:000342798000058
J	Grover, V; Pantelidis, P; Soni, N; Takata, M; Shah, PL; Wells, AU; Henderson, DC; Kelleher, P; Singh, S				Grover, Vimal; Pantelidis, Panagiotis; Soni, Neil; Takata, Masao; Shah, Pallav L.; Wells, Athol U.; Henderson, Don C.; Kelleher, Peter; Singh, Suveer			A Biomarker Panel (Bioscore) Incorporating Monocytic Surface and Soluble TREM-1 Has High Discriminative Value for Ventilator-Associated Pneumonia: A Prospective Observational Study	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; MYELOID CELLS-1; EXPRESSION PATTERNS; ATTRIBUTABLE MORTALITY; CROSS-VALIDATION; DIAGNOSIS; LUNG; INFECTION; PATIENT; SEPSIS	Introduction: Ventilator-associated pneumonia (VAP) increases mortality in critical illness. However, clinical diagnostic uncertainty persists. We hypothesised that measuring cell-surface and soluble inflammatory markers, incorporating Triggering Receptor Expressed by Myeloid cells (TREM)-1, would improve diagnostic accuracy. Methods: A single centre prospective observational study, set in a University Hospital medical-surgical intensive Care unit, recruited 91 patients into 3 groups: 27 patients with VAP, 33 ventilated controls without evidence of pulmonary sepsis (non-VAP), and 31 non-ventilated controls (NVC), without clinical infection, attending for bronchoscopy. Paired samples of Bronchiolo-alveolar lavage fluid (BALF) and blood from each subject were analysed for putative biomarkers of infection: Cellular (TREM-1, CD11b and CD62L) and soluble (IL-1 beta, IL-6, IL-8, sTREM-1, Procalcitonin). Expression of cellular markers on monocytes and neutrophils were measured by flow cytometry. Soluble inflammatory markers were determined by ELISA. A biomarker panel ('Bioscore'), was constructed, tested and validated, using Fisher's discriminant function analysis, to assess its value in distinguishing VAP from non VAP. Results: The expression of TREM-1 on monocytes (mTREM-1) and neutrophils (nTREM-1) and concentrations of IL-1 beta, IL-8, and sTREM-1 in BALF were significantly higher in VAP compared with non-VAP and NVC (p<0.001). The BALF/blood mTREM-1 was significantly higher in VAP patients compared to non-VAP and NVC (0.8 v 0.4 v 0.3 p<0.001). A seven marker Bioscore (BALF/blood ratio mTREM-1 and mCD11b, BALF sTREM-1, IL-8 and IL-1 beta, and serum CRP and IL-6) correctly identified 88.9% of VAP cases and 100% of non-VAP cases. Conclusion: A 7-marker bioscore, incorporating cellular and soluble TREM-1, accurately discriminates VAP from non-pulmonary infection.	[Grover, Vimal; Soni, Neil; Singh, Suveer] Chelsea & Westminster Hosp Natl Hlth Serv Fdn Tru, Magill Dept Anaesthesia Crit Care & Pain, London, England; [Grover, Vimal; Pantelidis, Panagiotis; Henderson, Don C.; Kelleher, Peter] Univ London Imperial Coll Sci Technol & Med, Dept Med, Immunol Sect, London, England; [Grover, Vimal; Soni, Neil; Takata, Masao; Singh, Suveer] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Pantelidis, Panagiotis; Henderson, Don C.; Kelleher, Peter] Imperial Coll Healthcare Natl Hlth Serv Trust, Dept Immunol, London, England; [Shah, Pallav L.; Singh, Suveer] Chelsea & Westminster Hosp Natl Hlth Serv Fdn Tru, Dept Resp Med, London, England; [Shah, Pallav L.; Wells, Athol U.] Royal Brompton & Harefield Hosp Natl Hlth Serv Fd, Dept Resp Med, London, England	Imperial College London; Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Singh, S (corresponding author), Chelsea & Westminster Hosp Natl Hlth Serv Fdn Tru, Magill Dept Anaesthesia Crit Care & Pain, London, England.	suveer.singh@imperial.ac.uk	Shah, Pallav L/AAB-2758-2019	Shah, Pallav L/0000-0002-9052-4638	Chelsea and Westminster Health Charity; Westminster Medical School Research Trust [JRC 09/10 SG006]; National Institute of Academic Anaesthesia, UK	Chelsea and Westminster Health Charity; Westminster Medical School Research Trust; National Institute of Academic Anaesthesia, UK	This work was supported by Chelsea and Westminster Health Charity (http://www.cwhc.org.uk/), Westminster Medical School Research Trust (JRC 09/10 SG006), and National Institute of Academic Anaesthesia, UK (http://www.niaa.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Anand NJ, 2009, CHEST, V135, P641, DOI 10.1378/chest.08-1829; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Baselski V, 2013, J CLIN MICROBIOL, V51, P740, DOI 10.1128/JCM.03383-12; Beirne P, 2009, EUR RESPIR J, V34, P1376, DOI 10.1183/09031936.00028209; Bekaert M, 2011, AM J RESP CRIT CARE, V184, P1133, DOI 10.1164/rccm.201105-0867OC; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chastre J, 2010, CLIN INFECT DIS, V51, pS88, DOI 10.1086/653054; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Determann RM, 2005, INTENS CARE MED, V31, P1495, DOI 10.1007/s00134-005-2818-7; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Gibot S, 2005, INTENS CARE MED, V31, P594, DOI 10.1007/s00134-005-2572-x; Gibot S, 2005, CRIT CARE MED, V33, P1787, DOI 10.1097/01.CCM.0000172614.36571.75; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot S, 2007, SCAND J INFECT DIS, V39, P604, DOI 10.1080/00365540701199832; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Hartog CM, 2003, AM J RESP CRIT CARE, V167, P593, DOI 10.1164/rccm.200203-258OC; Huh JW, 2008, CRIT CARE, V12, DOI 10.1186/cc6770; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Knapp S, 2004, J IMMUNOL, V173, P7131, DOI 10.4049/jimmunol.173.12.7131; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kollef MH, 2012, INFECT CONT HOSP EP, V33, P250, DOI 10.1086/664049; Kollef MH, 2012, CRIT CARE MED, V40, P271, DOI 10.1097/CCM.0b013e318232e41d; Leone M, 2007, CRIT CARE MED, V35, P379, DOI 10.1097/01.CCM.0000253404.69418.AA; Lisboa T, 2008, CURR OPIN INFECT DIS, V21, P174, DOI 10.1097/QCO.0b013e3282f55dd1; Luna CM, 2003, CRIT CARE MED, V31, P676, DOI 10.1097/01.CCM.0000055380.86458.1E; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Millo JL, 2004, INTENS CARE MED, V30, P68, DOI 10.1007/s00134-003-2060-0; Morris AC, 2009, THORAX, V64, P516, DOI 10.1136/thx.2008.110239; Morris AC, 2010, THORAX, V65, P201, DOI 10.1136/thx.2009.122291; Oudhuis GJ, 2009, INTENS CARE MED, V35, P1265, DOI 10.1007/s00134-009-1463-y; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Ramirez P, 2011, CRIT CARE, V15, DOI 10.1186/cc10015; Rea-Neto A, 2008, CRIT CARE, V12, DOI 10.1186/cc6877; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Richeldi L, 2004, EUR RESPIR J, V24, P247, DOI 10.1183/09031936.04.00014204; Song YL, 2007, ANESTHESIOLOGY, V106, P252, DOI 10.1097/00000542-200702000-00012; Suetens C, 2002, Euro Surveill, V7, P127; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	43	26	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109686	10.1371/journal.pone.0109686	http://dx.doi.org/10.1371/journal.pone.0109686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289689	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000078
J	Janto, BA; Hiller, NL; Eutsey, RA; Dahlgren, ME; Earl, JP; Powell, E; Ahmed, A; Hu, FZ; Ehrlich, GD				Janto, Benjamin A.; Hiller, N. Luisa; Eutsey, Rory A.; Dahlgren, Margaret E.; Earl, Joshua P.; Powell, Evan; Ahmed, Azad; Hu, Fen Z.; Ehrlich, Garth D.			Development and Validation of an Haemophilus influenzae Supragenome Hybridization (SGH) Array for Transcriptomic Analyses	PLOS ONE			English	Article							MIDDLE-EAR MUCOSA; COMPARATIVE GENOMIC ANALYSES; CHINCHILLA-LANIGER MODEL; STREPTOCOCCUS-PNEUMONIAE; PAN-GENOME; VIRULENCE PHENOTYPES; BIOFILM FORMATION; INVASIVE DISEASE; OTITIS-MEDIA; EXPRESSION	We previously carried out the design and testing of a custom-built Haemophilus influenzae supragenome hybridization (SGH) array that contains probe sequences to 2,890 gene clusters identified by whole genome sequencing of 24 strains of H. influenzae. The array was originally designed as a tool to interrogate the gene content of large numbers of clinical isolates without the need for sequencing, however, the data obtained is quantitative and is thus suitable for transcriptomic analyses. In the current study RNA was extracted from H. influenzae strain CZ4126/02 (which was not included in the design of the array) converted to cDNA, and labelled and hybridized to the SGH arrays to assess the quality and reproducibility of data obtained from these custom-designed chips to serve as a tool for transcriptomics. Three types of experimental replicates were analyzed with all showing very high degrees of correlation, thus validating both the array and the methods used for RNA profiling. A custom filtering pipeline for two-condition unpaired data using five metrics was developed to minimize variability within replicates and to maximize the identification of the most significant true transcriptional differences between two samples. These methods can be extended to transcriptional analysis of other bacterial species utilizing supragenome-based arrays.	[Janto, Benjamin A.; Hiller, N. Luisa; Eutsey, Rory A.; Dahlgren, Margaret E.; Earl, Joshua P.; Powell, Evan; Ahmed, Azad; Hu, Fen Z.; Ehrlich, Garth D.] Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Janto, Benjamin A.; Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Pittsburgh, PA USA; [Hiller, N. Luisa] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA	Drexel University; Carnegie Mellon University; Drexel University	Hu, FZ (corresponding author), Allegheny Singer Res Inst, Ctr Genom Sci, 320 E N Ave, Pittsburgh, PA 15212 USA.	fhu168168@gmail.com; garth.ehrlich@drexelmed.edu	Janto, Benjamin/E-7459-2010; Hiller, N. Luisa/A-3739-2016	Janto, Benjamin/0000-0002-3841-4917; Hiller, N. Luisa/0000-0001-6572-1368; Ehrlich, Garth/0000-0003-1140-6594	Allegheny General Hospital; Allegheny-Singer Research Institute; National Institutes of Health [DC002148, DC02148 - 16S1, AI080935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002148] Funding Source: NIH RePORTER	Allegheny General Hospital(General Electric); Allegheny-Singer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Allegheny General Hospital, Allegheny-Singer Research Institute and National Institutes of Health grant numbers DC002148, DC02148 - 16S1, and AI080935 to GDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BLUESTONE CD, 1992, PEDIATR INFECT DIS J, V11, pS7, DOI 10.1097/00006454-199208001-00002; Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borneman AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-373; Buchinsky FJ, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-56; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Davie JJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-70; Dohar JE, 2005, LARYNGOSCOPE, V115, P1469, DOI 10.1097/01.mlg.0000172036.82897.d4; Dohar JE, 2009, CURR MED RES OPIN, V25, P287, DOI [10.1185/03007990802603072, 10.1185/03007990802603072 ]; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x; Ehrlich GD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-225; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Erwin AL, 2005, INFECT IMMUN, V73, P5853, DOI 10.1128/IAI.73.9.5853-5863.2005; Eutsey RA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-484; Forbes ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001969; Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hu FZ, 2008, FUTURE MICROBIOL, V3, P31, DOI 10.2217/17460913.3.1.31; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kelly L, 2011, J MED MICROBIOL, V60, P384, DOI 10.1099/jmm.0.026914-0; Ladhani S, 2010, EMERG INFECT DIS, V16, P455, DOI 10.3201/eid1603.090290; Murphy TF, 1999, J INFECT DIS, V180, P404, DOI 10.1086/314870; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Pereira M. Beatriz Rotta, 2004, J. Pediatr. (Rio J.), V80, P41, DOI 10.1590/S0021-75572004000100009; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shen K, 2005, INFECT IMMUN, V73, P3479, DOI 10.1128/IAI.73.6.3479-3491.2005; Shuel M, 2010, FEMS IMMUNOL MED MIC, V58, P277, DOI 10.1111/j.1574-695X.2009.00634.x; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	44	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e105493	10.1371/journal.pone.0105493	http://dx.doi.org/10.1371/journal.pone.0105493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290153	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000003
J	Khanal, S; Anex, RP; Anderson, CJ; Herzmann, DE				Khanal, Sami; Anex, Robert P.; Anderson, Christopher J.; Herzmann, Daryl E.			Streamflow Impacts of Biofuel Policy-Driven Landscape Change	PLOS ONE			English	Article							MISCANTHUS X GIGANTEUS; LAND-COVER CHANGE; BIOENERGY CROPS; CLIMATE-CHANGE; ENERGY; MODEL; WATER; IMPLEMENTATION; ELASTICITY; CYCLE	Likely changes in precipitation (P) and potential evapotranspiration (PET) resulting from policy-driven expansion of bioenergy crops in the United States are shown to create significant changes in streamflow volumes and increase water stress in the High Plains. Regional climate simulations for current and biofuel cropping system scenarios are evaluated using the same atmospheric forcing data over the period 1979-2004 using the Weather Research Forecast (WRF) model coupled to the NOAH land surface model. PET is projected to increase under the biofuel crop production scenario. The magnitude of the mean annual increase in PET is larger than the inter-annual variability of change in PET, indicating that PET increase is a forced response to the biofuel cropping system land use. Across the conterminous U.S., the change in mean streamflow volume under the biofuel scenario is estimated to range from negative 56% to positive 20% relative to a business-as-usual baseline scenario. In Kansas and Oklahoma, annual streamflow volume is reduced by an average of 20%, and this reduction in streamflow volume is due primarily to increased PET. Predicted increase in mean annual P under the biofuel crop production scenario is lower than its inter-annual variability, indicating that additional simulations would be necessary to determine conclusively whether predicted change in P is a response to biofuel crop production. Although estimated changes in streamflow volume include the influence of P change, sensitivity results show that PET change is the significantly dominant factor causing streamflow change. Higher PET and lower streamflow due to biofuel feedstock production are likely to increase water stress in the High Plains. When pursuing sustainable biofuels policy, decision-makers should consider the impacts of feedstock production on water scarcity.	[Khanal, Sami] Ohio State Univ, Sch Environm & Nat Resources, Wooster, OH 44691 USA; [Anex, Robert P.] Univ Wisconsin, Dept Biol Syst Engn, Madison, WI USA; [Anderson, Christopher J.; Herzmann, Daryl E.] Iowa State Univ, Dept Agron, Ames, IA USA	University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison; Iowa State University	Khanal, S (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Wooster, OH 44691 USA.	khanal.3@osu.edu; anex@wisc.edu			National Science Foundation [CBET-1137677]	National Science Foundation(National Science Foundation (NSF))	This work is supported by the National Science Foundation Grant CBET-1137677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2013, GEOPHYS RES LETT, V40, P1217, DOI 10.1002/grl.50179; Anderson CJ, 2012, CLIMATE CHANGE MIDWE; Arora VK, 2002, J HYDROL, V265, P164, DOI 10.1016/S0022-1694(02)00101-4; Bonan GB, 2001, J CLIMATE, V14, P2430, DOI 10.1175/1520-0442(2001)014&lt;2430:OEFROD&gt;2.0.CO;2; Braun M, 2012, J HYDROMETEOROL, V13, P443, DOI 10.1175/JHM-D-11-051.1; Budyko MI, 1963, EVAPORATION NATURAL; Carlisle DM, 2011, FRONT ECOL ENVIRON, V9, P264, DOI 10.1890/100053; Chen F, 2001, MON WEATHER REV, V129, P569, DOI 10.1175/1520-0493(2001)129<0569:CAALSH>2.0.CO;2; Chiew FHS, 2009, J HYDROL, V379, P172, DOI 10.1016/j.jhydrol.2009.10.004; Chiew FHS, 2006, HYDROLOG SCI J, V51, P613, DOI 10.1623/hysj.51.4.613; Costello C, 2009, ENVIRON SCI TECHNOL, V43, P7985, DOI 10.1021/es9011433; de Elia R, 2008, CLIM DYNAM, V30, P113, DOI 10.1007/s00382-007-0288-z; Dicks M. R., 2009, Journal of Agricultural and Applied Economics, V41, P435; Diffenbaugh NS, 2009, CLIM DYNAM, V33, P945, DOI 10.1007/s00382-009-0566-z; Donner SD, 2007, GLOBAL ENVIRON CHANG, V17, P105, DOI 10.1016/j.gloenvcha.2006.04.005; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; Georgescu M, 2011, P NATL ACAD SCI USA, V108, P4307, DOI 10.1073/pnas.1008779108; Guo G, 2007, J HYDROL, V355, P106; Hallgren W, 2013, GEOPHYS RES LETT, V40, P1624, DOI 10.1002/grl.50352; Hess JR, 2003, DOENEID11129; Hill J, 2007, AGRON SUSTAIN DEV, V27, P1, DOI 10.1051/agro:2007006; Hu Q, 2005, ENVIRON MODEL ASSESS, V10, P9, DOI 10.1007/s10666-004-4266-0; Khanal S, 2013, GCB BIOENERGY, V5, P713, DOI 10.1111/gcbb.12050; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Le PVV, 2011, P NATL ACAD SCI USA, V108, P15085, DOI 10.1073/pnas.1107177108; Marland G, 2003, CLIM POLICY, V3, P149, DOI 10.1016/S1469-3062(03)00028-7; Marshall E, 2011, AP054 ERS USDA; Miguez FE, 2012, GCB BIOENERGY, V4, P509, DOI 10.1111/j.1757-1707.2011.01150.x; Mishra V, 2010, INT J CLIMATOL, V30, P2025, DOI 10.1002/joc.2095; Mitchell R, 2012, SWITCHGRASS GREEN EN, P113, DOI DOI 10.1007/978-1-4471-2903-5_5; Ol'Dekop E, 1911, T MET OBS LUREVSKOGO, V4; Perlack R., 2011, US BILLION TON UPDAT; Pielke RA, 2007, TELLUS B, V59, P587, DOI 10.1111/j.1600-0889.2007.00251.x; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Pike J. G., 1964, J HYDROL, V2, P116, DOI [10.1016/0022-1694(64)90022-8, DOI 10.1016/0022-1694(64)90022-8]; RAY DE, 1976, AGR ECON RES, V28, P14; Rosero E, 2011, J HYDROMETEOROL, V12, P45, DOI 10.1175/2010JHM1228.1; Sankarasubramanian A, 2001, WATER RESOUR RES, V37, P1771, DOI 10.1029/2000WR900330; Schaake J. C., 1990, Climate change and US water resources., P177; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schnoor J, 2008, WATER IMPLICATIONS B; Schreiber P., 1904, Z METEOROL, V21, P441; Skamarock W C, 2008, DESCRIPTION ADV RES, P1, DOI [DOI 10.5065/D68S4MVH, 10.5065/D68S4MVH]; Skamarock WC, 2008, J COMPUT PHYS, V227, P3465, DOI 10.1016/j.jcp.2007.01.037; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steiner AL, 2009, CLIM DYNAM, V33, P869, DOI 10.1007/s00382-009-0543-6; Stone KC, 2010, BIORESOURCE TECHNOL, V101, P2014, DOI 10.1016/j.biortech.2009.10.037; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tu J, 2009, J HYDROL, V379, P268, DOI 10.1016/j.jhydrol.2009.10.009; TURC L., 1954, Annales Agronomiques, V5, P491; Twine TE, 2004, J HYDROMETEOROL, V5, P640, DOI 10.1175/1525-7541(2004)005<0640:EOLCCO>2.0.CO;2; Ugarte DGD, 2000, BIOMASS BIOENERG, V18, P291; Vanloocke A, 2010, GCB BIOENERGY, V2, P180, DOI 10.1111/j.1757-1707.2010.01053.x; Vogel RM, 1999, J IRRIG DRAIN ENG, V125, P148, DOI 10.1061/(ASCE)0733-9437(1999)125:3(148); Wu YP, 2012, BIOMASS BIOENERG, V36, P182, DOI 10.1016/j.biombioe.2011.10.030; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zheng HX, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006665	57	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109129	10.1371/journal.pone.0109129	http://dx.doi.org/10.1371/journal.pone.0109129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289698	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000035
J	Swales, C; Athanasou, NA; Knowles, HJ				Swales, Catherine; Athanasou, Nicholas A.; Knowles, Helen J.			Angiopoietin-Like 4 Is Over-Expressed in Rheumatoid Arthritis Patients: Association with Pathological Bone Resorption	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; GENE-EXPRESSION; SYNOVIUM; JOINT; CHONDROCLASTS; MACROPHAGES; ACTIVATION; EROSION; TARGET	Introduction: Osteoclasts are responsible for the bone loss associated with rheumatoid arthritis (RA). The secreted adipokine angiopoietin-like 4 (ANGPTL4) specifically increases osteoclast-mediated bone resorption. We have investigated expression of ANGPTL4 and its regulatory transcription factor, hypoxia-inducible factor-1 alpha (HIF-1 alpha), in osteoclasts and other cells within rheumatoid synovium. We have also examined whether circulating levels of ANGPTL4 differ in RA patients compared with that in normal controls or patients with osteoarthritis (OA). Results: Immunohistochemical analysis revealed that bone-apposing osteoclasts within the rheumatoid synovium express both ANGPTL4 and HIF-1 alpha. ANGPTL4 was also strongly expressed in synovial lining cells, endothelial cells, stromal cells, CD68+ macrophages and plasma cells within RA synovium. Little ANGPTL4 was evident in normal synovial tissue. This reflected the over-expression of HIF-1 alpha in rheumatoid versus normal synovial tissue. The concentration of ANGPTL4 was higher in both the serum and the synovial fluid of RA patients than in patients with OA or normal controls. High serum ANGPTL4 associated with elevated levels of the serum marker of bone resorption, receptor activator for nuclear factor kappa B ligand (RANKL). Conclusions: Over-expression of ANGPTL4 in multiple cell types within the rheumatoid synovium potentially provides a local pool of ANGPTL4 to stimulate osteoclast-mediated bone resorption in RA. Additionally, correlation of high serum ANGPTL4 with circulating RANKL suggests that ANGPTL4 may represent a novel marker for bone destruction in RA.	[Swales, Catherine; Knowles, Helen J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England; [Athanasou, Nicholas A.] Univ Oxford, Dept Pathol, Nuffield Orthopaed Ctr, Oxford, England	University of Oxford; Nuffield Orthopaedic Centre; University of Oxford	Knowles, HJ (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England.	helen.knowles@ndorms.ox.ac.uk	Knowles, Helen/F-3857-2018	Knowles, Helen/0000-0002-9575-6067	Arthritis Research UK [MP/19200]; Oxford National Institute for Health Research (NIHR) Biomedical Research Unit; Versus Arthritis [19200] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Oxford National Institute for Health Research (NIHR) Biomedical Research Unit; Versus Arthritis(Versus Arthritis)	This work was supported by an Arthritis Research UK grant to HJK, grant number MP/19200 (www.arthritisresearchuk.org). Additional support was received from the Oxford National Institute for Health Research (NIHR) Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P968, DOI 10.1002/art.1780270902; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Corisdeo S, 2001, BIOCHEM BIOPH RES CO, V285, P335, DOI 10.1006/bbrc.2001.5127; Fujikawa Y, 1996, ANN RHEUM DIS, V55, P816, DOI 10.1136/ard.55.11.816; Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641; Giatromanolaki A, 2003, ARTHRITIS RES THER, V5, pR193, DOI 10.1186/ar756; Gough A, 1998, J RHEUMATOL, V25, P1282; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Hashimoto A, 2007, ARTHRITIS RHEUM, V56, P1094, DOI 10.1002/art.22450; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Hummel KM, 1998, J RHEUMATOL, V25, P1887; KAARELA K, 1985, SCAND J RHEUMATOL, P5; Kim YG, 2010, ARTHRITIS RHEUM-US, V62, P515, DOI 10.1002/art.27197; Knowles HJ, 2012, VIRCHOWS ARCH, V461, P205, DOI 10.1007/s00428-012-1274-3; Knowles HJ, 2010, FASEB J, V24, P4648, DOI 10.1096/fj.10-162230; Knowles HJ, 2009, J PATHOL, V218, P256, DOI 10.1002/path.2534; Lanfant-Weybel K, 2012, JOINT BONE SPINE, V79, P574, DOI 10.1016/j.jbspin.2011.11.006; Larsen H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3934; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Morten KJ, 2013, J PATHOL, V229, P755, DOI 10.1002/path.4159; Murata M, 2009, J ORTHOP RES, V27, P50, DOI 10.1002/jor.20703; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Sivakumar B, 2008, J HAND SURG-AM, V33A, P49, DOI 10.1016/j.jhsa.2007.09.002; Tanaka S, 2013, WORLD J ORTHOP, V4, P1, DOI 10.5312/wjo.v4.i1.1; Trebec-Reynolds DP, 2010, J CELL BIOCHEM, V110, P343, DOI 10.1002/jcb.22542; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Troen BR, 2003, EXP GERONTOL, V38, P605, DOI 10.1016/S0531-5565(03)00069-X; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhao XL, 2013, CURR DRUG TARGETS, V14, P700, DOI 10.2174/1389450111314060010	36	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109524	10.1371/journal.pone.0109524	http://dx.doi.org/10.1371/journal.pone.0109524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289668	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000066
J	Bahl, V; Jacob, P; Havel, C; Schick, SF; Talbot, P				Bahl, Vasundhra; Jacob, Peyton, III; Havel, Christopher; Schick, Suzaynn F.; Talbot, Prue			Thirdhand Cigarette Smoke: Factors Affecting Exposure and Remediation	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; NICOTINE EXPOSURE; EMISSION FACTORS; MAINSTREAM	Thirdhand smoke (THS) refers to components of secondhand smoke that stick to indoor surfaces and persist in the environment. Little is known about exposure levels and possible remediation measures to reduce potential exposure in contaminated areas. This study deals with the effect of aging on THS components and evaluates possible exposure levels and remediation measures. We investigated the concentration of nicotine, five nicotine related alkaloids, and three tobacco specific nitrosamines (TSNAs) in smoke exposed fabrics. Two different extraction methods were used. Cotton terry cloth and polyester fleece were exposed to smoke in controlled laboratory conditions and aged before extraction. Liquid chromatography-tandem mass spectrometry was used for chemical analysis. Fabrics aged for 19 months after smoke exposure retained significant amounts of THS chemicals. During aqueous extraction, cotton cloth released about 41 times as much nicotine and about 78 times the amount of tobacco specific nitrosamines (TSNAs) as polyester after one hour of aqueous extraction. Concentrations of nicotine and TSNAs in extracts of terry cloth exposed to smoke were used to estimate infant/toddler oral exposure and adult dermal exposure to THS. Nicotine exposure from THS residue can be 6.8 times higher in toddlers and 24 times higher in adults and TSNA exposure can be 16 times higher in toddlers and 56 times higher in adults than what would be inhaled by a passive smoker. In addition to providing exposure estimates, our data could be useful in developing remediation strategies and in framing public health policies for indoor environments with THS.	[Bahl, Vasundhra; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Bahl, Vasundhra] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Jacob, Peyton, III; Havel, Christopher] Univ Calif San Francisco, Dept Clin Pharmacol, San Francisco, CA 94143 USA; [Schick, Suzaynn F.] Univ Calif San Francisco, Dept Med, Div Occupat & Environm Med, San Francisco, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	talbot@ucr.edu	Bahl, Vasundhra/AAB-6958-2020; Talbot, Prue/AAY-3896-2021		California Consortium on Thirdhand Smoke; California Tobacco-Related Disease Research Program [20PT-0184, 21 ST-011]; National Institute on Drug Abuse [P30 DA012393]; National Center for Research Resources [S10 RR026437]; National Center for Advancing Translational Sciences, National Institutes of Health through UCSF-CTSI [UL1 TR000004]; Deans Pre-doctoral Fellowship; California Tobacco-Related Disease Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012393] Funding Source: NIH RePORTER	California Consortium on Thirdhand Smoke; California Tobacco-Related Disease Research Program(University of California System); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health through UCSF-CTSI; Deans Pre-doctoral Fellowship; California Tobacco-Related Disease Research Program(University of California System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the California Consortium on Thirdhand Smoke, California Tobacco-Related Disease Research Program (trdrp.org) grant 20PT-0184 and California Tobacco-Related Disease Research Program grant 21 ST-011, the National Institute on Drug Abuse P30 DA012393, the National Center for Research Resources S10 RR026437, the National Center for Advancing Translational Sciences, National Institutes of Health (nih.gov), through UCSF-CTSI Grant Number UL1 TR000004. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding agencies. VB was supported on a Deans Pre-doctoral Fellowship and a California Tobacco-Related Disease Research Program pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley DL, 2010, CANCER EPIDEM BIOMAR, V19, P1389, DOI 10.1158/1055-9965.EPI-10-0084; Bendak A., 1991, J ISLAM ACAD SCI, V4, P275; Brown Buddy G, 2003, Nonlinearity Biol Toxicol Med, V1, P179, DOI 10.1080/15401420391434324; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Centers for Disease Control and Prevention, 2014, SURG GEN REP HLTH CO; Daisey JM, 1998, J EXPO ANAL ENV EPID, V8, P313; DiCarlantonio G, 1999, BIOL REPROD, V61, P651, DOI 10.1095/biolreprod61.3.651; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Edderkaoui Mouad, 2013, J Cancer Ther, V4, P34; Fortmann AL, 2010, NICOTINE TOB RES, V12, P1029, DOI 10.1093/ntr/ntq144; Foulds J., 2008, HDB MED CONSEQUENCES, P423; Gieseke C, 2005, BIOL REPROD, V73, P443, DOI 10.1095/biolreprod.105.041152; Hammer TR, 2011, INT J HYG ENVIR HEAL, V214, P384, DOI 10.1016/j.ijheh.2011.04.007; Hang B, 2013, MUTAGENESIS, V28, P381, DOI 10.1093/mutage/get013; Hecht SS, 2004, TOB CONTROL, V13, P48, DOI 10.1136/tc.2002.002816; Hofhuis W, 2003, ARCH DIS CHILD, V88, P1086, DOI 10.1136/adc.88.12.1086; Jacob P, 2013, CHEM RES TOXICOL, V26, P1615, DOI 10.1021/tx400094y; Klepeis NE, 2003, AEROSOL SCI TECH, V37, P780, DOI 10.1080/02786820300914; Koh J, 2011, TEXTILE DYEING, P195; LEADERER BP, 1991, ENVIRON SCI TECHNOL, V25, P770, DOI 10.1021/es00016a023; Lehman-McKeeman LD, 2007, CASARETT DOULLS TOXI, P131; Martins-Green M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086391; Matt GE, 2013, TOB CONTROL, V0, P1, DOI [10.1136/tobaccocontrol-2012-05082, DOI 10.1136/T0BACC0C0NTR0L-2012-050824]; Matt GE, 2011, ENVIRON HEALTH PERSP, V119, P1218, DOI 10.1289/ehp.1103500; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Okoli CTC, 2007, ADDICT BEHAV, V32, P1977, DOI 10.1016/j.addbeh.2006.12.024; Pang XB, 2011, SCI TOTAL ENVIRON, V409, P5000, DOI 10.1016/j.scitotenv.2011.07.065; Petrick L, 2010, PHYS CHEM CHEM PHYS, V12, P10356, DOI 10.1039/c002643c; Petrick LM, 2011, ATMOS ENVIRON, V45, P4959, DOI 10.1016/j.atmosenv.2011.05.076; Rehan VK, 2011, AM J PHYSIOL-LUNG C, V301, pL1, DOI 10.1152/ajplung.00393.2010; Repace J., 2007, EXPOSURE ANAL, P201; Riveles K, 2007, HUM REPROD, V22, P346, DOI 10.1093/humrep/del380; Sarker AH, PLOSONE IN PRESS; Schick SF, 2012, AEROSOL SCI TECH, V46, P1246, DOI 10.1080/02786826.2012.708947; Senthilkumar L, 2012, INT J QUANTUM CHEM, V112, P2787, DOI 10.1002/qua.23304; Sleiman M, 2010, P NATL ACAD SCI USA, V107, P6576, DOI 10.1073/pnas.0912820107; Talbot P, 2011, BIOL RES, V44, P189, DOI /S0716-97602011000200011; Yolton K, 2005, ENVIRON HEALTH PERSP, V113, P98, DOI 10.1289/ehp.7210	39	56	56	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108258	10.1371/journal.pone.0108258	http://dx.doi.org/10.1371/journal.pone.0108258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286392	Green Published, gold			2022-12-27	WOS:000345743700016
J	Liao, K; Yu, LL; Yang, K; Saren, GW; Wang, SY; Huang, B; Jiang, H				Liao, Kai; Yu, Lilei; Yang, Kang; Saren, Gaowa; Wang, Songyun; Huang, Bing; Jiang, Hong			Low-Level Carotid Baroreceptor Stimulation Suppresses Ventricular Arrhythmias during Acute Ischemia	PLOS ONE			English	Article							BAROREFLEX ACTIVATION THERAPY; SYMPATHETIC-NERVOUS-SYSTEM; MYOCARDIAL-ISCHEMIA; STELLATE GANGLION; BLOOD-PRESSURE; FIBRILLATION; HEART; REPOLARIZATION; INFARCTION	Background: The autonomic imbalance during acute ischemia is involved in the occurrence of life-threatening arrhythmias. Objective: To investigate the effect of autonomic nervous system (ANS) modulation by low-level carotid baroreceptor stimulation (LL-CBS) on ventricular ischemia arrhythmias. Methods: Anesthetized dogs were received either sham treatment (SHAM group, n = 10) or LL-CBS treatment (LL-CBS group, n = 10). The voltage lowering the blood pressure was used as the threshold for setting LL-CBS at 80% below the threshold. Treatment started 1 hour before left anterior descending coronary (LAD) occlusion, and continued until the end of experience. Ventricular effective refractory periods (ERP), monophasic action potential duration at 90% (APD(90)), ventricular arrhythmias, indices of heart rate variability, left stellate ganglion nerve activity (LSGNA) and infarct sizes were measured and analyzed. Results: Ventricular ischemia resulted in an acute reduction of blood pressure, which was not significantly affected by LL-CBS. After 1 hour of LL-CBS, there was a progressive and significant increase in ERP, increase in APD(90), and decrease in LSGNA vs the SHAM group (all P<0.05). LL-CBS apparently reduced premature ventricular contractions (PVC, 264 +/- 165 in the SHAM group vs 60 +/- 37 in the LL-CBS group; P<0.01) during LAD occlusion. Number of episodes of ventricular fibrillation (VF) was 8 in the Control group versus 3 in the LL-CBS group (80% versus 30%, P<0.05). LL-CBS obviously increased high frequency (HF) component (P<0.05) and decreased low frequency/high frequency ratio (P<0.05) compared with the SHAM group. Ischemic size was not affected by LL-CBS between the two groups. Conclusions: LL-CBS reduced the occurrences of ventricular arrhythmias during acute ischemia without affecting blood pressure. The procedure was associated with changes of electrophysiological characteristics, nerve activity and heart rate variability. Therefore, LL-CBS may protect from ventricular arrhythmias during acute ischemic events by modulating ANS.	[Liao, Kai; Yu, Lilei; Yang, Kang; Saren, Gaowa; Wang, Songyun; Huang, Bing; Jiang, Hong] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China	Wuhan University	Yu, LL (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	yulilei_wh@163.com; jianghong_wh@163.com		Yu, Lilei/0000-0001-9229-2829	National Natural Science Foundation of China [81270339, 81300182]; Natural Science Foundation of Hubei Province [2013CFB302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (81270339 and 81300182), the Natural Science Foundation of Hubei Province (2013CFB302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnima T, 2013, HYPERTENSION, V61, P1334, DOI 10.1161/HYPERTENSIONAHA.113.01159; Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; BLOMBERG S, 1988, ACTA ANAESTH SCAND, V32, P173, DOI 10.1111/j.1399-6576.1988.tb02710.x; Camm AJ, 1996, CIRCULATION, V93, P1043; CRIPPS TR, 1991, BRIT HEART J, V65, P14; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Han S, 2012, J AM COLL CARDIOL, V59, P954, DOI 10.1016/j.jacc.2011.11.030; Han Y, PLOS ONE, V7; He B, 2013, INT J CARDIOL, V168, P86, DOI 10.1016/j.ijcard.2012.09.067; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Kapa S, 2010, CARDIOL REV, V18, P275, DOI 10.1097/CRD.0b013e3181ebb152; KOLLER BS, 1995, CIRCULATION, V91, P2378, DOI 10.1161/01.CIR.91.9.2378; Liao K, J CARDIOVASC PHARM; Linz D, 2013, HEART RHYTHM, V10, P1525, DOI 10.1016/j.hrthm.2013.07.015; Linz D, 2013, J CARDIOVASC ELECTR, V24, P1028, DOI 10.1111/jce.12171; MINISI AJ, 1991, CIRCULATION, V84, P357, DOI 10.1161/01.CIR.84.1.357; Ng GA, 2007, CARDIOVASC RES, V73, P750, DOI 10.1016/j.cardiores.2006.12.001; Odenstedt J, 2011, HEART RHYTHM, V8, P892, DOI 10.1016/j.hrthm.2011.01.029; RANDALL WC, 1968, CIRC RES, V22, P315, DOI 10.1161/01.RES.22.3.315; Sabbah HN, 2011, CIRC-HEART FAIL, V4, P65, DOI 10.1161/CIRCHEARTFAILURE.110.955013; SCHOMIG A, 1990, CIRCULATION, V82, P13; Shinlapawittayatorn K, 2013, HEART RHYTHM, V10, P1700, DOI 10.1016/j.hrthm.2013.08.009; Swann MH, 2003, J CARDIOVASC ELECTR, V14, P873, DOI 10.1046/j.1540-8167.2003.03100.x; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; WAXMAN MB, 1989, CAN J PHYSIOL PHARM, V67, P801, DOI 10.1139/y89-127; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Zhou S, 2008, HEART RHYTHM, V5, P131, DOI 10.1016/j.hrthm.2007.09.007; Zipes Douglas P, 2008, Cleve Clin J Med, V75 Suppl 2, pS94; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	30	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109313	10.1371/journal.pone.0109313	http://dx.doi.org/10.1371/journal.pone.0109313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286406	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700057
J	Macfall, J; Robinette, P; Welch, D				Macfall, Janet; Robinette, Paul; Welch, David			Factors Influencing Bank Geomorphology and Erosion of the Haw River, a High Order River in North Carolina, since European Settlement	PLOS ONE			English	Article							WIDTH ADJUSTMENT; STREAMS; VARIABILITY; VEGETATION; DAMS	The Haw River, a high order river in the southeastern United States, is characterized by severe bank erosion and geomorphic change from historical conditions of clear waters and connected floodplains. In 2014 it was named one of the 10 most threatened rivers in the United States by American Rivers. Like many developed areas, the region has a history of disturbance including extensive upland soil loss from agriculture, dams, and upstream urbanization. The primary objective of this study was to identify the mechanisms controlling channel form and erosion of the Haw River. Field measurements including bank height, bankfull height, bank angle, root depth and density, riparian land cover and slope, surface protection, river width, and bank retreat were collected at 87 sites along 43.5 km of river. A Bank Erosion Hazard Index (BEHI) was calculated for each study site. Mean bank height was 11.8 m, mean width was 84.3 m, and bank retreat for 2005/2007-2011/2013 was 2.3 m. The greatest bank heights, BEHI values, and bank retreat were adjacent to riparian areas with low slope (<2). This is in contrast to previous studies which identify high slope as a risk factor for erosion. Most of the soils in low slope riparian areas were alluvial, suggesting sediment deposition from upland row crop agriculture and/or flooding. Bank retreat was not correlated to bank heights or BEHI values. Historical dams (1.2-3 m height) were not a significant factor. Erosion of the Haw River in the study section of the river (25% of the river length) contributed 205,320 m(3) of sediment and 3759 kg of P annually. Concentration of suspended solids in the river increased with discharge. In conclusion, the Haw River is an unstable system, with river bank erosion and geomodification potential influenced by riparian slope and varied flows.	[Macfall, Janet; Robinette, Paul; Welch, David] Elon Univ, Ctr Environm Studies, Elon, NC 27244 USA	Elon University	Macfall, J (corresponding author), Elon Univ, Ctr Environm Studies, Elon, NC 27244 USA.	macfallj@elon.edu			North Carolina Clean Water Management Trust Fund; Elon University	North Carolina Clean Water Management Trust Fund; Elon University	This work was supported by the North Carolina Clean Water Management Trust Fund (JM). Haw River Assembly was the grant recipient, with funds passed to JM through Elon University to financially support all of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B, 1998, GEOMORPHOLOGY, V23, P55, DOI 10.1016/S0169-555X(97)00089-5; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Anderson RJ, 2004, J AM WATER RESOUR AS, V40, P1159, DOI 10.1111/j.1752-1688.2004.tb01576.x; [Anonymous], WEB SOIL SURV; [Anonymous], 2011, CAPE FEAR RIVER BASI; [Anonymous], GEOLOGICAL SURVEY PR; Atkinson PM, 2003, GEOGR ANAL, V35, P58, DOI 10.1353/geo.2002.0028; Bennett HH, 1928, GEOGR REV, V18, P579, DOI 10.2307/207949; Beyer PJ, 2005, GEOMORPHOLOGY, V71, P1, DOI 10.1016/j.geomorph.2005.03.004; Bledsoe BP, 2012, J AM WATER RESOUR AS, V48, P788, DOI 10.1111/j.1752-1688.2012.00653.x; Cassebaum AM, 2011, DOWN LONG HAW HIST N; Chilton M, 2008, HIST ATLAS HAW RIVER; Cruise JF, 2010, J AM WATER RESOUR AS, V46, P1159, DOI 10.1111/j.1752-1688.2010.00483.x; Docker BB, 2008, GEOMORPHOLOGY, V100, P401, DOI 10.1016/j.geomorph.2008.01.009; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Florsheim JL, 2011, GEOMORPHOLOGY, V132, P272, DOI 10.1016/j.geomorph.2011.04.037; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Harman W. H., 1999, BANKFULL HYDRAULIC G; Hupp CR, 2013, GEOMORPHOLOGY, V180, P156, DOI 10.1016/j.geomorph.2012.10.007; Hupp CR, 2009, GEOL SOC AM SPEC PAP, V451, P97, DOI 10.1130/2009.2451(06); JACOBSON RB, 1986, AM J SCI, V286, P617, DOI 10.2475/ajs.286.8.617; Jennings G. D, 2001, MEASUREMENT STABILIZ; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Kessler AC, 2013, GEOMORPHOLOGY, V201, P312, DOI 10.1016/j.geomorph.2013.07.006; Knox JC, 2001, CATENA, V42, P193, DOI 10.1016/S0341-8162(00)00138-7; Kouli M, 2009, ENVIRON GEOL, V57, P483, DOI 10.1007/s00254-008-1318-9; Lawson J.M., 1925, ENG NEWS-REC, P327; Leopold L.B., 1994, VIEW RIVER; LIGON FK, 1995, BIOSCIENCE, V45, P183, DOI 10.2307/1312557; Parker C, 2008, GEOMORPHOLOGY, V101, P533, DOI 10.1016/j.geomorph.2008.02.007; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Petts GE, 2005, GEOMORPHOLOGY, V71, P27, DOI 10.1016/j.geomorph.2004.02.015; Pollen-Bankhead N, 2010, GEOMORPHOLOGY, V116, P353, DOI 10.1016/j.geomorph.2009.11.013; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Rosgen D., 1996, APPL RIVER MORPHOLOG; Rosgen D, 1996, FLUVIAL PROCESS SEDI, P381; Rosgen D.L., 2001, P 7 FED INT SED C, V2, P9, DOI DOI 10.1007/S13398-014-0173-7.2; Rosgen D.L., 2007, ROSG GEOM CHANN 654, P1; Sass CK, 2012, J AM WATER RESOUR AS, V48, P774, DOI 10.1111/j.1752-1688.2012.00644.x; Schenk ER, 2013, EARTH SURF PROC LAND, V38, P771, DOI 10.1002/esp.3314; Schenk ER, 2009, J AM WATER RESOUR AS, V45, P597, DOI 10.1111/j.1752-1688.2009.00308.x; Schturun A., 1986, INCISED CHANNELS MOR; Simon A, 1996, EARTH SURF PROCESSES, V21, P155, DOI 10.1002/(SICI)1096-9837(199602)21:2<155::AID-ESP610>3.0.CO;2-5; Simon A, 2007, J AM WATER RESOUR AS, V43, P1117, DOI 10.1111/j.1752-1688.2007.00091.x; Simon A., 1986, P 4 FEDERAL INTERAGE, V2, p5; Smith SV, 2002, SCI TOTAL ENVIRON, V299, P21, DOI 10.1016/S0048-9697(02)00222-X; Spoon WL, 1928, MAP ALAMANCE CO; Spoon WL, 1893, MAP ALAMANCE COUNTY; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; Thorne CR, 1998, J HYDRAUL ENG-ASCE, V124, P903; Thorne CR, 1998, J HYDRAUL ENG, V124, P881, DOI 10.1061/(ASCE)0733-9429(1998)124:9(881); TRIMBLE SW, 1975, USDA AGR RES SERVI S, V40, P142; Trimble SW, 2008, MAN INDUCED SOIL ERO; U.S. Dept. of Agriculture, 2009, USDA GEOGR AR SER 33; U.S. Dept. of Agriculture, 1952, US CENS AGR 1950 COU; U.S. Dept. of Agriculture, 1913, 13 CENS US TAK YEAR; U.S. Geological Survey, 2013, USGS WAT INF SYST; United States Army Corps of Engineers, 2013, NAT INV DAMS; University T&M, 2014, SOIL WAT ASS TOOL; Walter RC, 2008, SCIENCE, V319, P299, DOI 10.1126/science.1151716; Zaimes G, 2006, STREAM PROCESSES 1	61	12	12	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110170	10.1371/journal.pone.0110170	http://dx.doi.org/10.1371/journal.pone.0110170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302956	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400115
J	Vuorinen, M; Damangir, S; Niskanen, E; Miralbell, J; Rusanen, M; Spulber, G; Soininen, H; Kivipelto, M; Solomon, A				Vuorinen, Miika; Damangir, Soheil; Niskanen, Eini; Miralbell, Julia; Rusanen, Minna; Spulber, Gabriela; Soininen, Hilkka; Kivipelto, Miia; Solomon, Alina			Coronary Heart Disease and Cortical Thickness, Gray Matter and White Matter Lesion Volumes on MRI	PLOS ONE			English	Article							BLOOD-PRESSURE; ALZHEIMERS-DISEASE; ARTERY-DISEASE; RISK-FACTORS; BRAIN MORPHOLOGY; DEMENTIA; ADULTS; SEGMENTATION; METAANALYSIS; DIAGNOSIS	Coronary heart disease (CHD) has been linked with cognitive decline and dementia in several studies. CHD is strongly associated with blood pressure, but it is not clear how blood pressure levels or changes in blood pressure over time affect the relation between CHD and dementia-related pathology. The aim of this study was to investigate relations between CHD and cortical thickness, gray matter volume and white matter lesion (WML) volume on MRI, considering CHD duration and blood pressure levels from midlife to three decades later. The study population included 69 elderly at risk of dementia who participated in the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study. CAIDE participants were examined in midlife, re-examined 21 years later, and then after additionally 7 years (in total up to 30 years follow-up). MRIs from the second re-examination were used to calculate cortical thickness, gray matter and WML volume. CHD diagnoses were obtained from the Finnish Hospital Discharge Register. Linear regression analyses were adjusted for age, sex, follow-up time and scanner type, and additionally total intracranial volume in GM volume analyses. Adding diabetes, cholesterol or smoking to the models did not influence the results. CHD was associated with lower thickness in multiple regions, and lower total gray matter volume, particularly in people with longer disease duration (>10 years). Associations between CHD, cortical thickness and gray matter volume were strongest in people with CHD and hypertension in midlife, and those with CHD and declining blood pressure after midlife. No association was found between CHD and WML volumes. Based on these results, long-term CHD seems to have detrimental effects on brain gray matter tissue, and these effects are influenced by blood pressure levels and their changes over time.	[Vuorinen, Miika; Rusanen, Minna; Soininen, Hilkka; Kivipelto, Miia; Solomon, Alina] Univ Eastern Finland, Sch Med, Dept Neurol, Kuopio, Finland; [Damangir, Soheil; Spulber, Gabriela] Karolinska Inst, NVS, Div Clin Geriatr, Stockholm, Sweden; [Niskanen, Eini] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Miralbell, Julia] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Kivipelto, Miia; Solomon, Alina] Karolinska Inst, ADRC, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	University of Eastern Finland; Karolinska Institutet; University of Eastern Finland; University of Barcelona; Karolinska Institutet	Vuorinen, M (corresponding author), Univ Eastern Finland, Sch Med, Dept Neurol, Kuopio, Finland.	miika.vuorinen@uef.fi	Damangir, Soheil/S-3278-2016; Kivipelto, Miia/AAS-3557-2021	Damangir, Soheil/0000-0001-5425-5859; Spulber, Gabriela/0000-0002-0995-7138; Solomon, Alina/0000-0002-7166-9903; Kivipelto, Miia/0000-0003-0992-3875	Graduate School of Molecular Medicine at University of Eastern Finland; strategic funding of University of Eastern Finland for UEFBRAIN; National Graduate School of Clinical Investigation; Swedish Research Council for Medical Research (Vetenskapsradet); EU FP7 project LipiDiDiet [211696]; EVO grant (Finland) [5772720]; Academy of Finland grants [120676, 117458, 251645, 218037, 129395]; Saastamoinen Foundation (Finland); Instrumentarium Foundation (Finland); Maud Kuistila Memorial Foundation (Finland); Stiftelsen Ragnhild och Einar Lundstroms Minne Lindhe's Foundation (Sweden); Stohnes Stiftelse Foundation (Sweden); Gamla Tjanarinnor Foundation (Sweden); Alzheimerfonden (Sweden); Demensfondens Forskningsstipendier (Sweden); Stiftelsen Dementia (Sweden); Novo Nordisk Fonden [NNF12OC1016402, NNF11OC1014884] Funding Source: researchfish	Graduate School of Molecular Medicine at University of Eastern Finland; strategic funding of University of Eastern Finland for UEFBRAIN; National Graduate School of Clinical Investigation; Swedish Research Council for Medical Research (Vetenskapsradet)(Swedish Research Council); EU FP7 project LipiDiDiet; EVO grant (Finland); Academy of Finland grants(Academy of Finland); Saastamoinen Foundation (Finland); Instrumentarium Foundation (Finland); Maud Kuistila Memorial Foundation (Finland); Stiftelsen Ragnhild och Einar Lundstroms Minne Lindhe's Foundation (Sweden); Stohnes Stiftelse Foundation (Sweden); Gamla Tjanarinnor Foundation (Sweden); Alzheimerfonden (Sweden); Demensfondens Forskningsstipendier (Sweden); Stiftelsen Dementia (Sweden); Novo Nordisk Fonden(Novo Nordisk Foundation)	Support was provided by the Graduate School of Molecular Medicine at University of Eastern Finland; strategic funding of University of Eastern Finland for UEFBRAIN; the National Graduate School of Clinical Investigation; the Swedish Research Council for Medical Research (Vetenskapsradet); EU FP7 project LipiDiDiet 211696; EVO grant 5772720 (Finland); the Academy of Finland grants 120676, 117458, 251645, 218037, and 129395; Saastamoinen Foundation (Finland); Instrumentarium Foundation (Finland); Maud Kuistila Memorial Foundation (Finland); Stiftelsen Ragnhild och Einar Lundstroms Minne Lindhe's Foundation (Sweden); Stohnes Stiftelse Foundation (Sweden); Gamla Tjanarinnor Foundation (Sweden); Alzheimerfonden (Sweden); Demensfondens Forskningsstipendier (Sweden) and Stiftelsen Dementia (Sweden). The authors acknowledge the neuGRID infrastructure (www.neugrid4you.eu) for providing resources that were used for preprocessing the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2003, STROKE, V34, P2310, DOI 10.1161/01.STR.0000090125.28466.E2; Almeida OP, 2012, EUR HEART J, V33, P1769, DOI 10.1093/eurheartj/ehr467; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bangalore S, 2013, HEART, V99, P601, DOI 10.1136/heartjnl-2012-301968; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Beeri MS, 2006, NEUROLOGY, V66, P1399, DOI 10.1212/01.wnl.0000210447.19748.0b; Blain Jean-Francois, 2004, Expert Rev Neurother, V4, P823, DOI 10.1586/14737175.4.5.823; Bos D, 2011, ARTERIOSCL THROM VAS, V31, P2331, DOI 10.1161/ATVBAHA.111.232728; Damangir S, 2012, J NEUROL SCI, V322, P211, DOI 10.1016/j.jns.2012.07.064; DeCarli C, 1999, STROKE, V30, P1548, DOI 10.1161/01.STR.30.8.1548; DeCarli C, 1999, STROKE, V30, P529, DOI 10.1161/01.STR.30.3.529; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Geerlings MI, 2010, ATHEROSCLEROSIS, V210, P130, DOI 10.1016/j.atherosclerosis.2009.10.039; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Honig LS, 2005, NEUROLOGY, V64, P494, DOI 10.1212/01.WNL.0000150886.50187.30; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Ikram MA, 2008, STROKE, V39, P1421, DOI 10.1161/STROKEAHA.107.501106; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Jochemsen HM, 2013, JAMA NEUROL, V70, P1046, DOI 10.1001/jamaneurol.2013.217; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Morris MC, 2001, ARCH NEUROL-CHICAGO, V58, P1640, DOI 10.1001/archneur.58.10.1640; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Qiu CX, 2009, DEMENT GERIATR COGN, V28, P213, DOI 10.1159/000236913; Ross GW, 1999, NEUROLOGY, V53, P337, DOI 10.1212/WNL.53.2.337; Royall Donald R, 2008, Cleve Clin J Med, V75 Suppl 2, pS97; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SPARKS DL, 1990, NEUROBIOL AGING, V11, P601, DOI 10.1016/0197-4580(90)90024-T; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Tijms BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058921; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; Vidal JS, 2010, STROKE, V41, P891, DOI 10.1161/STROKEAHA.110.579581; Vuorinen M, 2013, NEUROBIOL AGING, V34, P100, DOI 10.1016/j.neurobiolaging.2012.07.014; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	48	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109250	10.1371/journal.pone.0109250	http://dx.doi.org/10.1371/journal.pone.0109250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302686	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400047
J	Zhang, YH; Xiao, YP; Wang, P; Liu, QH				Zhang, Yanhua; Xiao, Yaping; Wang, Pan; Liu, Quanhong			Compositions and Anti-Tumor Activity of Pyropolyporus fomentarius Petroleum Ether Fraction In Vitro and In Vivo	PLOS ONE			English	Article							FOMES-FOMENTARIUS; CANCER-CELLS; APOPTOSIS; EXTRACT; MUSHROOM; PATHWAY; FUNGI; DEATH; TUMOR; S180	The chemical compositions and anti-tumour activities of he petroleum ether fraction PE) from mushroom Pyropolyporus formentarius, were studied. Upon gas chromatography-mass spectrometry GC-MS analysis, nine major constituents were identified in the fraction. In vitro, the PE showed cytotoxic activity against murine sarcoma S180 (S180) cells in a dose- and time-dependent manner, and the cytotoxic effects were associated with apoptosis. The mitochondrial membrane potential loss and the intracellular ROS generation were greatly increased in the Pyropolyporus fomentarius PE treated group, suggesting cell apoptosis, induced by the PE in S180 cells, might be mitochondria dependent and ROS mediated. Consistent with in vitro findings, the in vivo study showed that the Pyropolyporus fomentarius PE was also effective in inhibiting the tumour growth induced by S180 cells and had lower immune organ toxicity. We found that the Pyropolyporus famentarius PE has significant anti-tumor activity and great potential in screening anti-tumor drugs.	[Zhang, Yanhua; Xiao, Yaping; Wang, Pan; Liu, Quanhong] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Key Lab Med Resources & Nat Pharmaceut Chem,Minis, Xian, Shaanxi, Peoples R China; [Zhang, Yanhua] Jiangsu Normal Univ, Coll Life Sci, Xuzhou, Jiangsu, Peoples R China	Shaanxi Normal University; Jiangsu Normal University	Liu, QH (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Key Lab Med Resources & Nat Pharmaceut Chem,Minis, Xian, Shaanxi, Peoples R China.	lshaof@snnu.edu.cn			National "Twelfth Five-Year" Plan for Science & Technology Support [2011BAI06B05]; Natural Science Foundation of Shaanxi Province, China [2014JM4137]	National "Twelfth Five-Year" Plan for Science & Technology Support; Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by National "Twelfth Five-Year" Plan for Science & Technology Support (2011BAI06B05) and Natural Science Foundation of Shaanxi Province, China (Grant No. 2014JM4137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel Aziz A, 2009, AUST J BASIC APPL SC, V3, P2754; Aikemu A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-157; AOKI M, 1993, BIOSCI BIOTECH BIOCH, V57, P278, DOI 10.1271/bbb.57.278; Bao XL, 2013, CARBOHYD POLYM, V98, P1236, DOI 10.1016/j.carbpol.2013.07.018; Beattie KD, 2011, MYCOLOGIA, V103, P458, DOI 10.3852/10-121; Bok JW, 1999, PHYTOCHEMISTRY, V51, P891, DOI 10.1016/S0031-9422(99)00128-4; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Chen W, 2008, FREE RADICAL BIO MED, V45, P60, DOI 10.1016/j.freeradbiomed.2008.03.013; Chen W, 2011, CARBOHYD POLYM, V85, P369, DOI 10.1016/j.carbpol.2011.02.035; Cheng XX, 2012, J ETHNOPHARMACOL, V143, P49, DOI 10.1016/j.jep.2012.05.054; CHIHARA G, 1969, Nature (London), V222, P687; Chung MJ, 2010, NUTR RES PRACT, V4, P177, DOI 10.4162/nrp.2010.4.3.177; Crazzolara R, 2009, CURR CANCER DRUG TAR, V9, P19, DOI 10.2174/156800909787314057; Dou XJ, 2014, CYTOTECHNOLOGY, V66, P107, DOI 10.1007/s10616-013-9543-9; [冯薇 Feng Wei], 2010, [中国药学杂志, Chinese Pharmaceutical Journal], V45, P1528; Ferreira ICFR, 2010, ANTI-CANCER AGENT ME, V10, P424; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada H, 2002, ANTICANCER RES, V22, P2587; Huang TianZi, 2012, Mycosystema, V31, P775; INDAP M A, 1986, Indian Journal of Physiology and Pharmacology, V30, P182; Jabbour E, 2011, HEMATOL ONCOL CLIN N, V25, P981, DOI 10.1016/j.hoc.2011.09.004; Judova J, 2012, FUNGAL BIOL-UK, V116, P155, DOI 10.1016/j.funbio.2011.10.010; Keawsa-ard S, 2012, NAT PROD COMMUN, V7, P955; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lee WY, 2005, B KOREAN CHEM SOC, V26, P1464; Li CF, 2014, BIOPHARM DRUG DISPOS, V35, P50, DOI 10.1002/bdd.1868; Magalhaes HIF, 2006, J PHARM PHARMACOL, V58, P235, DOI 10.1211/jpp.58.2.0011; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Petrova RD, 2008, ONCOL REP, V19, P299; Pezzuto J.M., 1991, METHODS PLANT BIOCH, P71; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; Roussel Bertrand, 2002, Rev Hist Pharm (Paris), V50, P599; SAAR M, 1991, J ETHNOPHARMACOL, V31, P175, DOI 10.1016/0378-8741(91)90003-V; Seniuk OF, 2011, INT J MED MUSHROOMS, V13, P7, DOI 10.1615/IntJMedMushr.v13.i1.20; Shaffer BC, 2012, DRUG RESIST UPDATE, V15, P62, DOI 10.1016/j.drup.2012.02.001; Smith DJ, 2008, IUBMB LIFE, V60, P383, DOI 10.1002/iub.44; STEBBING ARD, 1982, SCI TOTAL ENVIRON, V22, P213, DOI 10.1016/0048-9697(82)90066-3; Stewart B.W., 2003, WORLD CANC REPORT; Sun B, 2011, CANCER LETT, V301, P95, DOI 10.1016/j.canlet.2010.10.010; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; W.H.O. (WHO), 2013, GLOBOCAN 2012; Wang J, 2009, CANCER LETT, V283, P193, DOI 10.1016/j.canlet.2009.03.039; Wang X, 2013, AFR J TRADIT COMPLEM, V10, P475, DOI 10.4314/ajtcam.v10i3.14; World Health Organization, 2004, WORLD HLTH REP 2004; Yan H, 2014, HUM EXP TOXICOL, V33, P522, DOI 10.1177/0960327113497771; Yuan HM, 2011, J APPL PHYCOL, V23, P59, DOI 10.1007/s10811-010-9536-4; Zaidman BZ, 2005, APPL MICROBIOL BIOT, V67, P453, DOI 10.1007/s00253-004-1787-z; Zang Y, 2013, PHYTOCHEMISTRY, V92, P137, DOI 10.1016/j.phytochem.2013.05.003; Zhang JH, 2012, AM J CHINESE MED, V40, P861, DOI 10.1142/S0192415X12500644; Zhao YY, 2011, BIOCHIM BIOPHYS ACTA, V4, P384; Zhao YY, 2010, PLANTA MEDICAX, V26, P1464; Zhong JJ, 2009, ADV BIOCHEM ENG BIOT, V113, P79, DOI 10.1007/10_2008_26; Zhou BR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/513027	56	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109599	10.1371/journal.pone.0109599	http://dx.doi.org/10.1371/journal.pone.0109599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302783	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400070
J	Gagnon, C; Daly, RM; Carpentier, A; Lu, ZX; Shore-Lorenti, C; Sikaris, K; Jean, S; Ebeling, PR				Gagnon, Claudia; Daly, Robin M.; Carpentier, Andre; Lu, Zhong X.; Shore-Lorenti, Catherine; Sikaris, Ken; Jean, Sonia; Ebeling, Peter R.			Effects of Combined Calcium and Vitamin D Supplementation on Insulin Secretion, Insulin Sensitivity and beta-Cell Function in Multi-Ethnic Vitamin D-Deficient Adults at Risk for Type 2 Diabetes: A Pilot Randomized, Placebo-Controlled Trial	PLOS ONE			English	Article							FORTIFIED YOGURT DRINK; DOUBLE-BLIND; GLUCOSE-HOMEOSTASIS; 25-HYDROXYVITAMIN D; DIETARY CALCIUM; CLINICAL-TRIAL; RESISTANCE; WOMEN; ASSOCIATION; MELLITUS	Objectives: To examine whether combined vitamin D and calcium supplementation improves insulin sensitivity, insulin secretion, beta-cell function, inflammation and metabolic markers. Design: 6-month randomized, placebo-controlled trial. Participants: Ninety-five adults with serum 25-hydroxyvitamin D [25(OH)D] <= 55 nmol/L at risk of type 2 diabetes (with prediabetes or an AUSDRISK score >= 15) were randomized. Analyses included participants who completed the baseline and final visits (treatment n = 35; placebo n = 45). Intervention: Daily calcium carbonate (1,200 mg) and cholecalciferol [2,000-6,000 IU to target 25(OH)D >75 nmol/L] or matching placebos for 6 months. Measurements: Insulin sensitivity (HOMA2%S, Matsuda index), insulin secretion (insulinogenic index, area under the curve (AUC) for C-peptide) and beta-cell function (Matsuda index x AUC for C-peptide) derived from a 75 g 2-h OGTT; anthropometry; blood pressure; lipid profile; hs-CRP; TNF-alpha; IL-6; adiponectin; total and undercarboxylated osteocalcin. Results: Participants were middle-aged adults (mean age 54 years; 69% Europid) at risk of type 2 diabetes (48% with prediabetes). Compliance was >80% for calcium and vitamin D. Mean serum 25(OH)D concentration increased from 48 to 95 nmol/L in the treatment group (91% achieved >75 nmol/L), but remained unchanged in controls. There were no significant changes in insulin sensitivity, insulin secretion and b-cell function, or in inflammatory and metabolic markers between or within the groups, before or after adjustment for potential confounders including waist circumference and season of recruitment. In a post hoc analysis restricted to participants with prediabetes, a significant beneficial effect of vitamin D and calcium supplementation on insulin sensitivity (HOMA%S and Matsuda) was observed. Conclusions: Daily vitamin D and calcium supplementation for 6 months may not change OGTT-derived measures of insulin sensitivity, insulin secretion and beta-cell function in multi-ethnic adults with low vitamin D status at risk of type 2 diabetes. However, in participants with prediabetes, supplementation with vitamin D and calcium may improve insulin sensitivity.	[Gagnon, Claudia; Daly, Robin M.; Shore-Lorenti, Catherine; Ebeling, Peter R.] Univ Melbourne, Western Hlth, NorthWest Acad Ctr, Dept Med, Melbourne, Vic, Australia; [Carpentier, Andre] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Lu, Zhong X.; Sikaris, Ken] Melbourne Pathol, Melbourne, Vic, Australia; [Lu, Zhong X.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Jean, Sonia] Inst Natl Sante Publ Quebec, Dept Chron Dis Surveillance, Quebec City, PQ, Canada; [Jean, Sonia] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada	University of Melbourne; University of Sherbrooke; Monash University; Institut national de sante publique du Quebec (INSPQ); Laval University	Gagnon, C (corresponding author), Univ Laval, CHU Quebec Res Ctr, Quebec City, PQ, Canada.	claudia.gagnon@crchuq.ulaval.ca	Daly, Robin/AAN-2353-2020	Daly, Robin/0000-0002-9897-1598; Ebeling, Peter/0000-0002-2921-3742; Sikaris, Ken/0000-0002-3882-166X; Gagnon, Claudia/0000-0001-9623-962X	Diabetes Australia Research Trust; Department of Medicine, The University of Melbourne, Australia	Diabetes Australia Research Trust; Department of Medicine, The University of Melbourne, Australia	This study was supported by a grant from the Diabetes Australia Research Trust, no grant number assigned, http://www.diabetesaustralia.com.au/Research/DART/; PRE, RMD, CG. This study was also supported by funds from the Department of Medicine, The University of Melbourne, Australia. No grant number assigned or URL; PRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Ardabili HR, 2012, NUTR RES, V32, P195, DOI 10.1016/j.nutres.2012.02.001; Belenchia AM, 2013, AM J CLIN NUTR, V97, P774, DOI 10.3945/ajcn.112.050013; Breslavsky A, 2013, CLIN NUTR, V32, P970, DOI 10.1016/j.clnu.2013.01.020; Chen M, 2012, AM J CLIN NUTR, V96, P735, DOI 10.3945/ajcn.112.037119; Couture C, 2007, OBESITY, V15, pA186; Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204; Gagnon C, 2011, DIABETES CARE, V34, P1133, DOI 10.2337/dc10-2167; Grimnes G, 2011, DIABETES, V60, P2748, DOI 10.2337/db11-0650; Gundberg CM, 1998, J CLIN ENDOCR METAB, V83, P3258, DOI 10.1210/jc.83.9.3258; Harris SS, 2012, DIABETES OBES METAB, V14, P789, DOI 10.1111/j.1463-1326.2012.01605.x; Jain R, 2012, METABOLISM, V61, P293, DOI 10.1016/j.metabol.2011.06.018; Jenab M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5500; Jorde R, 2009, EUR J NUTR, V48, P349, DOI 10.1007/s00394-009-0020-3; Kayaniyil S, 2010, DIABETES CARE, V33, P1379, DOI 10.2337/dc09-2321; Kirii K, 2009, DIABETOLOGIA, V52, P2542, DOI 10.1007/s00125-009-1554-x; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Ma B, 2006, AM J EPIDEMIOL, V164, P449, DOI 10.1093/aje/kwj246; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Neyestani TR, 2013, DIABETES CARE, V36, P550, DOI 10.2337/dc12-0919; Neyestani TR, 2012, J CLIN ENDOCR METAB, V97, P2005, DOI 10.1210/jc.2011-3465; Nikooyeh B, 2011, AM J CLIN NUTR, V93, P764, DOI 10.3945/ajcn.110.007336; Oosterwerff MM, 2014, AM J CLIN NUTR, V100, P152, DOI 10.3945/ajcn.113.069260; Pasco JA, 2000, AUST NZ J MED, V30, P21, DOI 10.1111/j.1445-5994.2000.tb01049.x; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Ryu OH, 2014, ENDOCR J, V61, P167, DOI 10.1507/endocrj.EJ13-0356; Salehpour A, 2013, DIABETIC MED, V30, P1477, DOI 10.1111/dme.12273; Shab-Bidar S, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-125; Simha V, 2012, J INVEST MED, V60, P1214, DOI 10.2310/JIM.0b013e3182747c06; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Strobel F, 2014, HORM METAB RES, V46, P54, DOI 10.1055/s-0033-1358453; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; van Dam RM, 2006, DIABETES CARE, V29, P2238, DOI 10.2337/dc06-1014; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Wamberg L, 2013, EUR J INTERN MED, V24, P644, DOI 10.1016/j.ejim.2013.03.005; Witham MD, 2010, DIABETOLOGIA, V53, P2112, DOI 10.1007/s00125-010-1838-1; Wood AD, 2012, J CLIN ENDOCR METAB, V97, P3557, DOI 10.1210/jc.2012-2126; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zheng JS, 2014, CLIN CHEM, V60, P186, DOI 10.1373/clinchem.2013.215251; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	45	86	87	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109607	10.1371/journal.pone.0109607	http://dx.doi.org/10.1371/journal.pone.0109607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299668	gold, Green Published			2022-12-27	WOS:000343941200064
J	Kato, T				Kato, Tsukasa			Relationship between Coping with Interpersonal Stressors and Depressive Symptoms in the United States, Australia, and China: A Focus on Reassessing Coping	PLOS ONE			English	Article							PSYCHOLOGICAL HEALTH; GENDER-DIFFERENCES; FIT INDEXES; SCALE	Objective: Reassessing coping involves efforts to wait patiently for an appropriate opportunity to act or for a change or improvement in the situation, and can be observed in individuals encountering a stressful relationship event. It was hypothesized that reassessing coping would be negatively associated with depressive symptoms. Methods: A cross-sectional Web-based survey was conducted in order to test this hypothesis by examining relationships between coping strategies including reassessing coping, distancing coping and constructive coping for stressful relationship events and depressive symptoms. Participants were 1,500 individuals recruited from the general populations of the United States, Australia, and China. Results: Structural equation modeling analysis revealed that scores on coping strategies predicted depressive symptom scores in the samples from all three countries with medium or large effect sizes. Further, the beta values for reassessing coping scores were negative and significant in all samples, indicating that the hypothesis was supported for each of the population samples surveyed. In addition, distancing coping, which reflects strategies that attempt to actively damage, disrupt, and dissolve a stressful relationship, was associated with high levels of depressive symptoms. Conclusions: Reassessing coping for interpersonal stressors was be negatively associated with depressive symptoms in sample from general populations of the United States, Australia, and China.	Toyo Univ, Dept Social Psychol, Bunkyo Ku, Tokyo, Japan	Toyo University	Kato, T (corresponding author), Toyo Univ, Dept Social Psychol, Bunkyo Ku, Tokyo, Japan.	mtsukasa@hotmail.com	Kato, Tsukasa/C-2066-2014	Kato, Tsukasa/0000-0002-0827-0051	Japan Society for the Promotion of Science [C-25380948]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research C-25380948) and the founding of support is external to the authors' organization (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle JL, 2013, AMOS 16 0 COMPUTER S; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cohen J.E., 1988, STAT POWER ANAL BEHA; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hames JL, 2013, ANNU REV CLIN PSYCHO, V9, P355, DOI 10.1146/annurev-clinpsy-050212-185553; Hammen C, 2009, CURR DIR PSYCHOL SCI, V18, P200, DOI 10.1111/j.1467-8721.2009.01636.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joiner T, 1999, INTERACTIONAL NATURE OF DEPRESSION, P3, DOI 10.1037/10311-013; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kato T, 2014, BIPOLAR DISORD, V16, P18, DOI 10.1111/bdi.12186; Kato T., 2013, INT PERSPECTIVEPSY, V2, P100, DOI [10.1037/ipp0000002, DOI 10.1037/IPP0000002]; Kato T, 2014, PSYCHOL RES BEHAV MA, V7, P31, DOI 10.2147/PRBM.S57030; Kayser K, 1999, PSYCHOL WOMEN QUART, V23, P725, DOI 10.1111/j.1471-6402.1999.tb00394.x; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; KRAMER BJ, 1993, FAM RELAT, V42, P383, DOI 10.2307/585338; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lazarus R. S., 1988, MANUAL WAYS COPING Q; Lazarus R.S., 1999, STRESS EMOTION NEW S; Linehan M. M., 1993, DBT SKILLS TRAINING; Mayberry DJ, 2001, STRESS HEALTH, V17, P91, DOI 10.1002/smi.891; MCCALLUM J, 1995, J GERONTOL B-PSYCHOL, V50, pS182, DOI 10.1093/geronb/50B.3.S182; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raju NS, 2002, J APPL PSYCHOL, V87, P517, DOI 10.1037/0021-9010.87.3.517; Rudolph KD, 2009, HANDBOOK OF DEPRESSION IN ADOLESCENTS, P377; Rudolph KD, 2002, J ADOLESCENT HEALTH, V30, P3, DOI 10.1016/S1054-139X(01)00383-4; Segal Z. V., 2002, MINDFULNESS BASED CO; Seiffge-Krenke I, 2006, J YOUTH ADOLESCENCE, V35, P25, DOI 10.1007/s10964-005-9015-4; Shih JH, 2010, J SOC CLIN PSYCHOL, V29, P243, DOI 10.1521/jscp.2010.29.3.243; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; Thomas K, 1976, HDB IND ORG PSYCHOL, P889; Triandis HC, 1995, INDIVIDUALISM COLLEC; Van de Vliert E., 1997, COMPLEX INTERPERSONA; Viswesvaran C, 1999, J VOCAT BEHAV, V54, P314, DOI 10.1006/jvbe.1998.1661; Wells A., 2005, J RATIONAL EMOTIVE C, V23, P337, DOI [10.1007/s10942-005-0018-6, DOI 10.1007/S10942-005-0018-6]; WHO, 2001, WORLD HLTH REP MENT; Wong PTP, 2006, HDB MULTICULTURAL PE; Zhang BS, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-74	40	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109644	10.1371/journal.pone.0109644	http://dx.doi.org/10.1371/journal.pone.0109644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299135	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200067
J	Kumar, M; Duda, JT; Hwang, WT; Kenworthy, C; Ittyerah, R; Pickup, S; Brodkin, ES; Gee, JC; Abel, T; Poptani, H				Kumar, Manoj; Duda, Jeffery T.; Hwang, Wei-Ting; Kenworthy, Charles; Ittyerah, Ranjit; Pickup, Stephen; Brodkin, Edward S.; Gee, James C.; Abel, Ted; Poptani, Harish			High Resolution Magnetic Resonance Imaging for Characterization of the Neuroligin-3 Knock-in Mouse Model Associated with Autism Spectrum Disorder	PLOS ONE			English	Article							DIFFUSION; SOCIABILITY; BALB/CJ; MICE; CHILDREN; GENES; NLGN4; ABNORMALITIES; PHENOTYPES; C57BL/6J	Autism spectrum disorders (ASD) comprise an etiologically heterogeneous set of neurodevelopmental disorders. Neuroligin-3 (NL-3) is a cell adhesion protein that mediates synapse development and has been implicated in ASD. We performed ex-vivo high resolution magnetic resonance imaging (MRI), including diffusion tensor imaging (DTI) and behavioral (social approach and zero maze) tests at 3 different time points (30, 50 and 70 days-of-age) on NL-3 and wild-type littermates to assess developmental brain abnormalities in NL-3 mice. MRI data were segmented in 39 different gray and white matter regions. Volumetric measurements, along with DTI indices from these segmented regions were also performed. After controlling for age and gender, the NL-3 knock-in animals demonstrated significantly reduced sociability and lower anxiety-related behavior in comparison to their wild type littermates. Significantly reduced volume of several white and gray matter regions in the NL-3 knock-in mice were also observed after considering age, gender and time point as covariates. These findings suggest that structural changes in the brain of NL-3 mice are induced by the mutation in the NL-3 gene. No significant differences in DTI indices were observed, which suggests that the NL-3 mutation may not have a profound effect on water diffusion as detected by DTI. The volumetric and DTI studies aid in understanding the biology of disrupting function on an ASD risk model and may assist in the development of imaging biomarkers for ASD.	[Kumar, Manoj; Duda, Jeffery T.; Ittyerah, Ranjit; Pickup, Stephen; Gee, James C.; Poptani, Harish] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hwang, Wei-Ting] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Kenworthy, Charles; Abel, Ted] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Brodkin, Edward S.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Poptani, H (corresponding author), Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	Harish.Poptani@uphs.upenn.edu	Kumar, Manoj/AAU-5893-2020; Abel, Ted/AAX-2825-2021	Kumar, Manoj/0000-0002-2729-7049; Abel, Ted/0000-0003-2423-4592; Poptani, Harish/0000-0002-0593-3235	Pennsylvania Department of Health (SAP) [4100042728];  [R01MH080718];  [R21HD058237];  [1P50MH096891 - subproject 6773];  [5-T32-MH017168]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080718, P50MH096891, T32MH017168] Funding Source: NIH RePORTER	Pennsylvania Department of Health (SAP); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by R01MH080718 (ESB), R21HD058237 (HP), 1P50MH096891 -subproject 6773 (ESB and TA), 5-T32-MH017168 (TA) and the Pennsylvania Department of Health (SAP # 4100042728, TA and ESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bai J, 2012, MAGN RESON IMAGING, V30, P789, DOI 10.1016/j.mri.2012.02.010; Baribeau Danielle A, 2013, Front Psychiatry, V4, P175, DOI 10.3389/fpsyt.2013.00175; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Billeci L, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-148; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Cook PA, 2006, CAMINO OPEN SOURCE D, pP2759; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; El-Kordi A, 2013, BEHAV BRAIN RES, V251, P41, DOI 10.1016/j.bbr.2012.11.016; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; Ellegood Jacob, 2012, Front Psychiatry, V3, P37, DOI 10.3389/fpsyt.2012.00037; Ellegood J, 2011, AUTISM RES, V4, P368, DOI 10.1002/aur.215; Fairless AH, 2012, BEHAV BRAIN RES, V228, P299, DOI 10.1016/j.bbr.2011.12.001; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Kim S, 2012, NMR BIOMED, V25, P104, DOI 10.1002/nbm.1722; Kleinhans NM, 2012, BRAIN RES, V1479, P1, DOI 10.1016/j.brainres.2012.07.056; Koldewyn K, 2014, P NATL ACAD SCI USA, V111, P1981, DOI 10.1073/pnas.1324037111; Kumar M, 2012, BRAIN RES, V1455, P56, DOI 10.1016/j.brainres.2012.03.041; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Li XH, 2012, BRAIN RES BULL, V88, P543, DOI 10.1016/j.brainresbull.2012.05.017; Mori S, 1998, MAGNET RESON MED, V40, P511, DOI 10.1002/mrm.1910400403; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Scheel C, 2011, NEUROIMAGE, V58, P391, DOI 10.1016/j.neuroimage.2011.06.040; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Stein JM, 2006, J NEUROSCI, V26, P2184, DOI 10.1523/JNEUROSCI.4437-05.2006; Stigler KA, 2011, BRAIN RES, V1380, P146, DOI 10.1016/j.brainres.2010.11.076; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Travers BG, 2014, NEUROPSYCHOLOGIA, V53, P137, DOI 10.1016/j.neuropsychologia.2013.11.008; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Verhoeven JS, 2010, NEURORADIOLOGY, V52, P3, DOI 10.1007/s00234-009-0583-y; Walker L, 2012, BIOL PSYCHIAT, V72, P1043, DOI 10.1016/j.biopsych.2012.08.001; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027	44	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109872	10.1371/journal.pone.0109872	http://dx.doi.org/10.1371/journal.pone.0109872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299583	Green Submitted, gold, Green Published			2022-12-27	WOS:000343941200079
J	Lu, H; Zhao, Q; Jiang, H; Zhu, TG; Xia, P; Seffens, W; Aikhionbare, F; Wang, DM; Dou, Z; Yao, XB				Lu, Huan; Zhao, Qun; Jiang, Hao; Zhu, Tongge; Xia, Peng; Seffens, William; Aikhionbare, Felix; Wang, Dongmei; Dou, Zhen; Yao, Xuebiao			Characterization of Ring-Like F-Actin Structure as a Mechanical Partner for Spindle Positioning in Mitosis	PLOS ONE			English	Article							CENTROSOME SEPARATION; CORTICAL DYNEIN; CELL-DIVISION; CENP-E; CHROMOSOME; ORIENTATION; CHECKPOINT; MOVEMENT; MOESIN; PHOSPHORYLATION	Proper spindle positioning and orientation are essential for accurate mitosis which requires dynamic interactions between microtubule and actin filament (F-actin). Although mounting evidence demonstrates the role of F-actin in cortical cytoskeleton dynamics, it remains elusive as to the structure and function of F-actin-based networks in spindle geometry. Here we showed a ring-like F-actin structure surrounding the mitotic spindle which forms since metaphase and maintains in MG132-arrested metaphase HeLa cells. This cytoplasmic F-actin structure is relatively isotropic and less dynamic. Our computational modeling of spindle position process suggests a possible mechanism by which the ring-like F-actin structure can regulate astral microtubule dynamics and thus mitotic spindle orientation. We further demonstrated that inhibiting Plk1, Mps1 or Myosin, and disruption of microtubules or F-actin polymerization perturbs the formation of the ring-like F-actin structure and alters spindle position and symmetric division. These findings reveal a previously unrecognized but important link between mitotic spindle and ring-like F-actin network in accurate mitosis and enables the development of a method to theoretically illustrate the relationship between mitotic spindle and cytoplasmic F-actin.	[Lu, Huan; Jiang, Hao; Zhu, Tongge; Xia, Peng; Wang, Dongmei; Dou, Zhen; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Anhui, Peoples R China; [Zhu, Tongge; Seffens, William; Aikhionbare, Felix] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine	Yao, XB (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Anhui, Peoples R China.	yaoxb@ustc.edu.cn	DOU, ZHEN/N-2022-2013; Yao, Xuebiao/P-5771-2014	DOU, ZHEN/0000-0003-3303-9393; Xia, Peng/0000-0002-5419-7756	National Institutes of Health [DK56292, CA164133, G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB917204, 2014CB964800]; Anhui Province Key Project Grant [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [91313303, 91129714, 81270466, 90913016, 31000602, 31071184, 31171300, 31271439]; MOE [20113402130010, PCSIRT-CDCB, WK2060190018, WK2340000021]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project Grant; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); MOE(Ministry of Higher Education & Scientific Research (MHESR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, and G12RR03034. This project was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, and 2014CB964800; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 2009DFA31010; Chinese Natural Science Foundation Grants 91313303, 91129714, 81270466, 90913016, 31000602, 31071184, 31171300, 31271439; and MOE grants (20113402130010, PCSIRT-CDCB, WK2060190018, and WK2340000021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINKLEY BR, 1967, J ULTRA MOL STRUCT R, V19, P1, DOI 10.1016/S0022-5320(67)80057-1; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chew TG, 2012, CYTOSKELETON, V69, P1040, DOI 10.1002/cm.21062; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gundersen GG, 2003, SCIENCE, V300, P2040, DOI 10.1126/science.1084938; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Ma R, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013018; Maier B, 2013, CELL CYCLE, V12, P1457, DOI 10.4161/cc.24602; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Okada S, 2013, DEV CELL, V26, P148, DOI 10.1016/j.devcel.2013.06.015; Pavin N, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/105025; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Solinet S, 2013, J CELL BIOL, V202, P251, DOI 10.1083/jcb.201304052; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Vilmos P, 2009, EUR J CELL BIOL, V88, P609, DOI 10.1016/j.ejcb.2009.05.006; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Zheng Z, 2013, MOL BIOL CELL, V24, P901, DOI 10.1091/mbc.E12-06-0458; Zhu M, 2013, J CELL BIOL, V200, P773, DOI 10.1083/jcb.201207050	46	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e102547	10.1371/journal.pone.0102547	http://dx.doi.org/10.1371/journal.pone.0102547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299690	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200001
J	Nantarat, N; Wade, CM; Jeratthitikul, E; Sutcharit, C; Panha, S				Nantarat, Nattawadee; Wade, Christopher M.; Jeratthitikul, Ekgachai; Sutcharit, Chirasak; Panha, Somsak			Molecular Evidence for Cryptic Speciation in the Cyclophorus fulguratus (Pfeiffer, 1854) Species Complex (Caenogastropoda: Cyclophoridae) with Description of New Species	PLOS ONE			English	Article							LAND SNAILS; MAXIMUM-LIKELIHOOD; BAYESIAN-INFERENCE; SHELL SHAPE; PHYLOGENY; DELIMITATION; CONFIDENCE; EVOLUTION; MOLLUSCA	A high degree of intraspecific variation, both genetic and in shell morphology, of the operculate land snail Cyclophorus fulguratus (Pfeiffer, 1854) suggests that its classification as a single species warrants reconsideration. We sequenced two nuclear (18S and 28S) and two mitochondrial (16S and COI) genes of 46 C. fulguratus specimens and used them to estimate the phylogeny and to determine the validity of species boundaries. Molecular phylogenetic analyses revealed the presence of three lineages corresponding to three geographically disjunctive populations of C. fulguratus in Thailand. Likelihood tests of topologies significantly supported the non-monophyly of the C. fulguratus-complex and Bayesian species delimitation analysis significantly supported the potential representation as distinct species of these three lineages. Discriminant function analysis based on geometric-morphometrics of shell shape allowed for significant distinction of these three candidate species, although they revealed a considerable degree of overlap of shell shape reflecting their crypsis morphologically. The diagnostic characters are provided by color pattern, pattern of protoconch and pattern of jaw. In conclusion, the results support that the C. fulguratus s.l., as currently recognized, consists of three distinct species in Thailand: C. fulguratus s.s., C. rangunensis and C. abditus sp. nov., which are described herein.	[Nantarat, Nattawadee] Chulalongkorn Univ, Biol Sci Program, Fac Sci, Bangkok, Thailand; [Nantarat, Nattawadee; Jeratthitikul, Ekgachai; Sutcharit, Chirasak; Panha, Somsak] Chulalongkorn Univ, Fac Sci, Anim Systemat Res Unit, Dept Biol, Bangkok, Thailand; [Wade, Christopher M.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	Chulalongkorn University; Chulalongkorn University; University of Nottingham	Panha, S (corresponding author), Chulalongkorn Univ, Fac Sci, Anim Systemat Res Unit, Dept Biol, Bangkok, Thailand.	somsak.pan@chula.ac.th	Nantarat, Nattawadee/AAH-8297-2019	Jeratthitikul, Ekgachai/0000-0002-3477-9548; Wade, Christopher/0000-0002-1269-9694	Thailand Research Fund (TRF) under TRF-Senior Research Scholar Grant [RTA 5580001]; Royal Golden Jubilee Ph.D Program [PHD/0315/2550]; UNITAS Malacologica Student Research Awards	Thailand Research Fund (TRF) under TRF-Senior Research Scholar Grant(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D Program(Thailand Research Fund (TRF)); UNITAS Malacologica Student Research Awards	The main funding source for this project was from The Thailand Research Fund (TRF) to SP under TRF-Senior Research Scholar Grant RTA 5580001. TRF and Chulalongkorn University also jointly supported The Royal Golden Jubilee Ph.D Program (PHD/0315/2550) to SP and NN, and the UNITAS Malacologica Student Research Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; Blanford W. T., 1864, Annals & Magazine of Natural History, Vxiii, P441; Chiba S, 2004, J EVOLUTION BIOL, V17, P131, DOI 10.1046/j.1420-9101.2004.00639.x; CORNISHBOWDEN A, 1985, NUCLEIC ACIDS RES, V13, P3021, DOI 10.1093/nar/13.9.3021; Corporation MC, 2001, END WILDL PLANTS WOR; Davison A, 2005, PLOS BIOL, V3, P1559, DOI 10.1371/journal.pbio.0030282; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dryden IL, 1998, STAT SHAPE ANAL; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gude G. K., 1921, P1; Habe T, 1964, FAUNA FLORA RES SOC, V4, P111; Hanley SCT, 1870, CONCHOLOGIA INDICA I; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kameda YC, 2007, MOL PHYLOGENET EVOL, V45, P519, DOI 10.1016/j.ympev.2007.03.021; KASINATHAN R, 1975, Proceedings of the Malacological Society of London, V41, P379; Kessing B., 1989, SIMPLE FOOLS GUIDE P, P1; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kobelt W, 1907, SYSTEMATISCHES CONCH, V1, P401; Kobelt W, 1902, TIERREICH, V16, P1, DOI DOI 10.5962/BHL.TITLE.1227; Kongim B, 2006, INVERTEBR REPROD DEV, V49, P1, DOI 10.1080/07924259.2006.9652188; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; MINATO H, 1982, Venus the Japanese Journal of Malacology, V41, P124; Morgan JAT, 2002, MOL PHYLOGENET EVOL, V25, P477, DOI 10.1016/S1055-7903(02)00280-4; Nantarat N, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.411.7258; Nantarat N, 2014, MOL PHYLOGENET EVOL, V70, P99, DOI 10.1016/j.ympev.2013.09.013; Nevill G., 1878; Oakley KP, 1966, FRAMEWORKS DATING FO; Okusu A, 2003, ORG DIVERS EVOL, V3, P281, DOI 10.1078/1439-6092-00085; Paz V, 2004, SE ASIAN ARCHAEOLOGY; Pfeiffer L, 1854, P ZOOL SOC LOND, V20, P56; Pfeiffer L, 1853, SYSTEMATISCHES CONCH, V1, P229; Pfeiffer LGK, 1866, NOVITATES CONCHOLO 1, V3, P301; PILSBRY H. A., 1926, PROC ACAD NAT SCI PHILADELPHIA, V78, P453; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prasankok P, 2008, BIOCHEM SYST ECOL, V36, P900, DOI 10.1016/j.bse.2008.11.005; Rabett R, 2011, QUATERN INT, V239, P153, DOI 10.1016/j.quaint.2010.01.025; Rambaut A., 2009, TRACER MCMC TRACE AN; Reeve L, 1861, MONOGRAPH GENUS CYCL, V13; Rohlf F. J., 2012, TPSUTIL VERSION 1 49; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Rundell RJ, 2008, PHILOS T R SOC B, V363, P3401, DOI 10.1098/rstb.2008.0110; Serb JM, 2011, ZOOL J LINN SOC-LOND, V163, P571, DOI 10.1111/j.1096-3642.2011.00707.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Solem A, 1959, FIELDIANA ZOOLOGY, V43, P243; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teshima H, 2003, MOL ECOL, V12, P1869, DOI 10.1046/j.1365-294X.2003.01862.x; Thacker RW, 2000, MOL PHYLOGENET EVOL, V16, P263, DOI 10.1006/mpev.2000.0793; Tielecke H., 1940, ARCH NATURGESCH, V9, P317; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; van BENTHEM JUTTING W. S. S., 1949, BULL RAFFLES MUS, V19, P50; Van Benthem Jutting W. S. S., 1948, TREUBIA, V19, P539; Welber L, 1925, FAUNA ANAT CEYLAN, V2, P497; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	64	16	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109785	10.1371/journal.pone.0109785	http://dx.doi.org/10.1371/journal.pone.0109785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299674	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200073
J	Radosevic, M; Fargas, L; Alsina, B				Radosevic, Marija; Fargas, Laura; Alsina, Berta			The Role of her4 in Inner Ear Development and Its Relationship with Proneural Genes and Notch Signalling	PLOS ONE			English	Article							CRANIAL SENSORY GANGLIA; HAIR CELL-DEVELOPMENT; LATERAL INHIBITION; COCHLEAR DEVELOPMENT; MAMMALIAN COCHLEA; NEUROGENIC GENES; NERVOUS-SYSTEM; FATE CHOICES; ZEBRAFISH; EXPRESSION	The generation of sensory neurons and hair cells of the inner ear is under tight control. Different members of the Hairy and Enhancer of Split genes (HES) are expressed in the inner ear, their full array of functions still not being disclosed. We have previously shown that zebrafish her9 acts as a patterning gene to restrict otic neurogenesis to an anterior domain. Here, we disclose the role of another her gene, her4, a zebrafish ortholog of Hes5 that is expressed in the neurogenic and sensory domains of the inner ear. The expression of her4 is highly dynamic and spatiotemporally regulated. We demonstrate by loss of function experiments that in the neurogenic domain her4 expression is under the regulation of neurogenin1 (neurog1) and the Notch pathway. Moreover, her4 participates in lateral inhibition during otic neurogenesis since her4 knockdown results in overproduction of the number of neurog1 and deltaB-positive otic neurons. In contrast, during sensorigenesis her4 is initially Notch-independent and induced by atoh1b in a broad prosensory domain. At later stages her4 expression becomes Notch-dependent in the future sensory domains but loss of her4 does not result in hair cell overproduction, suggesting that there other her genes can compensate its function.	[Radosevic, Marija; Fargas, Laura; Alsina, Berta] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Pompeu Fabra University	Alsina, B (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Parc Recerca Biomed Barcelona, Barcelona, Spain.	berta.alsina@upf.edu	Radosevic, Marija/AAI-2432-2019; Alsina, Berta/A-2632-2010	Radosevic, Marija/0000-0002-8323-6160; Alsina, Berta/0000-0002-6997-1249	Ministerio de Ciencia e Innovacion [BFU2011-27006]; Ministerio de Ciencia e Innovacion; Agencia de gestio d'Ajuts Universitaris de Recerca	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia de gestio d'Ajuts Universitaris de Recerca	This work was supported by BFU2011-27006 from Ministerio de Ciencia e Innovacion (http://www.idi.mineco.gob.es/), MR was supported by FPI fellowship from Ministerio de Ciencia e Innovacion and LF was supported by FI from Agencia de gestio d'Ajuts Universitaris de Recerca(http://www10.gencat.cat/agaur_web/AppJava/catala/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello G, 2007, MECH DEVELOP, V124, P631, DOI 10.1016/j.mod.2007.04.002; Adam J, 1998, DEVELOPMENT, V125, P4645; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Chrysostomou E, 2012, DEVELOPMENT, V139, P3764, DOI 10.1242/dev.074476; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Gajewski M, 2006, DEV GENES EVOL, V216, P315, DOI 10.1007/s00427-006-0059-6; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Haddon C, 1998, DEVELOPMENT, V125, P359; Hartman BH, 2009, JARO-J ASSOC RES OTO, V10, P321, DOI 10.1007/s10162-009-0162-2; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jahan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030853; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Madelaine R, 2011, DEV BIOL, V350, P198, DOI 10.1016/j.ydbio.2010.10.025; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Pujades C, 2006, DEV BIOL, V292, P55, DOI 10.1016/j.ydbio.2006.01.001; Radosevic M, 2011, DEVELOPMENT, V138, P397, DOI 10.1242/dev.056093; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Sapede D, 2012, J NEUROSCI, V32, P16424, DOI 10.1523/JNEUROSCI.3686-12.2012; Satoh T, 2005, DEVELOPMENT, V132, P1687, DOI 10.1242/dev.01730; Scholpp S, 2009, P NATL ACAD SCI USA, V106, P19895, DOI 10.1073/pnas.0910894106; Shailam R, 1999, J NEUROCYTOL, V28, P809, DOI 10.1023/A:1007009803095; So JH, 2009, BIOCHEM BIOPH RES CO, V379, P22, DOI 10.1016/j.bbrc.2008.11.149; TAKEBAYASHI K, 1995, J BIOL CHEM, V270, P1342, DOI 10.1074/jbc.270.3.1342; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Takke C, 1999, DEVELOPMENT, V126, P1811; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	46	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109860	10.1371/journal.pone.0109860	http://dx.doi.org/10.1371/journal.pone.0109860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299450	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200078
J	Charest, H; Doualla-Bell, F; Cantin, R; Murphy, DG; Lemieux, L; Brenner, B; Hardy, I; Moisi, D; Lo, E; Baril, JG; Wainberg, MA; Roger, M; Tremblay, C				Charest, Hugues; Doualla-Bell, Florence; Cantin, Regis; Murphy, Donald G.; Lemieux, Linda; Brenner, Bluma; Hardy, Isabelle; Moisi, Daniela; Lo, Ernest; Baril, Jean-Guy; Wainberg, Mark A.; Roger, Michel; Tremblay, Cecile			A Significant Reduction in the Frequency of HIV-1 Drug Resistance in Quebec from 2001 to 2011 Is Associated with a Decrease in the Monitored Viral Load	PLOS ONE			English	Article							TRANSMISSION; PREVALENCE; EMTRICITABINE; LAMIVUDINE; INFECTION; VARIANTS; PROFILES; MUTATION; THERAPY; TRENDS	Background: HIV drug resistance represents a major threat for effective treatment. We assessed the trends in the frequency of drug resistance mutations and the monitored viral load (VL) in treatment-naive (TN) and treatment-experienced (TE) individuals infected with HIV-1 in Quebec, Canada, between 2001 and 2011. Methods and Findings: Resistance data were obtained from 4,105 and 5,086 genotypic tests performed on TN and TE patients, respectively. Concomitantly, 274,161 VL tests were carried out in the Province. Changes over time in drug resistance frequency and in different categories of VL were assessed using univariate logistic regression. Multiple logistic regression was used to evaluate associations between the rates of certain mutations and antiretroviral prescriptions. From 2001 to 2011, the proportion of undetectable VL test results continually increased, from 42.1% to 75.9%, while a significant decrease in the frequency of resistance mutations associated with protease inhibitors [PI (from 54% to 16%)], nucleoside [NRTI (from 78% to 37%) and non-nucleoside reverse transcriptase inhibitors [NNRTI (from 44% to 31%)I was observed in TE patients. In TN individuals, the overall frequency of transmitted drug resistance was 13.1%. A multiple logistic regression analysis indicated that the introduction of co-formulated emtricitabine/tenofovir or emtricitabine/tenofovir/efavirenz was positively associated with the decrease of the frequency of the M184I/V mutations observed overtime (p = 0.0004). Conclusions: We observed a significant decrease in the frequency of drug resistance mutations in TE patients, concomitant with a decrease in the proportion of patients with detectable viremia. These findings may be related to both the increased potencies and adherence to therapy associated with newer antiretroviral regimens. Nevertheless, our data demonstrate that broad use of antiretrovirals does not increase the level of circulating drug resistant variants.	[Charest, Hugues; Doualla-Bell, Florence; Cantin, Regis; Murphy, Donald G.; Lemieux, Linda; Lo, Ernest; Tremblay, Cecile] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Charest, Hugues; Roger, Michel; Tremblay, Cecile] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Doualla-Bell, Florence] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Brenner, Bluma; Moisi, Daniela; Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Hardy, Isabelle; Roger, Michel; Tremblay, Cecile] McGill Univ, Ctr Hosp, Montreal, PQ, Canada; [Lo, Ernest] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Baril, Jean-Guy] Clin Quartier Latin, Montreal, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University	Charest, H (corresponding author), Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.	hugues.charest@inspq.qc.ca	Brenner, Bluma/I-8714-2019		Ministry of Health (Ministere de la Sante et Services Sociaux du Quebec), Province of Quebec, Canada	Ministry of Health (Ministere de la Sante et Services Sociaux du Quebec), Province of Quebec, Canada	Data generated as part of the Quebec HIV-1 genotyping program was supported by the Ministry of Health (Ministere de la Sante et Services Sociaux du Quebec), Province of Quebec, Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Costagliola D, 2007, JAIDS-J ACQ IMM DEF, V46, P12; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Dieffenbach CW, 2012, CURR OPIN HIV AIDS, V7, P106, DOI 10.1097/COH.0b013e32834f3f13; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Frentz D, 2012, AIDS REV, V14, P17; Gianotti N, 2005, NEW MICROBIOL, V28, P319; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Marcelin AG, 2012, J ANTIMICROB CHEMOTH, V67, P1475, DOI 10.1093/jac/dks047; McColl DJ, 2011, HIV CLIN TRIALS, V12, P61, DOI 10.1310/hct1202-61; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; R Development Core Team, 2012, R LANG ENV STAT COMP; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Ruelle J, 2013, AIDS RES HUM RETROVI; Shafer Robert W, 2001, HIV Seq Compend, V2001, P1; Svicher V, 2010, JAIDS-J ACQ IMM DEF, V55, P336, DOI 10.1097/QAI.0b013e3181e6763f; Truong HHM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025281; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; von Wyl V, 2009, CLIN INFECT DIS, V48, P979, DOI 10.1086/597352; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109420	10.1371/journal.pone.0109420	http://dx.doi.org/10.1371/journal.pone.0109420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295725	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000070
J	Schonberg, A; Bergner, E; Helm, S; Agne, B; Duenschede, B; Schunemann, D; Schutkowski, M; Baginsky, S				Schoenberg, Anna; Bergner, Elena; Helm, Stefan; Agne, Birgit; Duenschede, Beatrix; Schuenemann, Danja; Schutkowski, Mike; Baginsky, Sacha			The Peptide Microarray "ChloroPhos1.0" Identifies New Phosphorylation Targets of Plastid Casein Kinase II (pCKII) in Arabidopsis thaliana	PLOS ONE			English	Article							PHOSPHOPROTEOME PROFILING REVEALS; CHLOROPLAST RNA-POLYMERASE; PROTEIN-KINASE; STRUCTURAL BASIS; STN7 KINASE; SPECIFICITY; SUBSTRATE; CK2; PROTEOMICS; NETWORKS	We report the development of a peptide microarray based on previously determined phosphorylation sites in chloroplast proteins. Altogether, 905 peptides were spotted as 15mers in nine replicates onto glass slides. We used the microarray for in vitro phosphorylation experiments and specifically assessed the peptide substrate spectrum of chloroplast casein kinase II (pCKII). To this end, native pCKII from Arabidopsis thaliana and Sinapis alba chloroplasts was enriched by Heparin-Sepharose chromatography and its activity on the microarray was compared to the activity of a recombinant Arabidopsis pCKII. All three kinase preparations phosphorylated a similar set of peptides that were clearly distinct from those phosphorylated by bovine heart protein kinase A (PKA) in control experiments. The majority of the pCKII phosphorylation targets are involved in plastid gene expression, supporting the earlier denomination of pCKII as plastid transcription kinase (PTK). In addition we identified Alb3 as pCKII substrate that is essential for the integration of light-harvesting complex subunits (LHC) into the thylakoid membrane. Plastid CKII phosphorylation activity was characterized in greater detail in vitro with recombinant wildtype Alb3 and phosphorylation site mutants as substrates, establishing S424 as the pCKII phosphorylation site. Our data show that the peptide microarray ChloroPhos1.0 is a suitable tool for the identification of new kinase downstream targets in vitro that can be validated subsequently by in vivo experiments.	[Schoenberg, Anna; Bergner, Elena; Helm, Stefan; Agne, Birgit; Schutkowski, Mike; Baginsky, Sacha] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06108 Halle, Germany; [Duenschede, Beatrix; Schuenemann, Danja] Ruhr Univ Bochum, Bochum, Germany; [Schutkowski, Mike] Steinbeis Forschungszentrum, Peptide Microarrays, Halle, Germany	Martin Luther University Halle Wittenberg; Ruhr University Bochum	Baginsky, S (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06108 Halle, Germany.	sacha.baginsky@biochemtech.uni-halle.de		Baginsky, Sacha/0000-0002-5440-3898; Schuenemann, Danja/0000-0001-8894-7685; Schutkowski, MIke/0000-0003-0919-7076	Deutsche Forschungsgemeinschaft (DFG) [BA1902/2-1, SCHU1163/5-1]; European Regional Development fund of the European Commission [W21004490]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Regional Development fund of the European Commission	This work was supported by financial support from the Deutsche Forschungsgemeinschaft (DFG) via grant BA1902/2-1 (AS) and from the European Regional Development fund of the European Commission via grant W21004490 "Land Sachsen-Anhalt" (SH) to SB. Furthermore, the authors are grateful for support from DFG grant SCHU1163/5-1. SB gratefully acknowledges DFG support for the acquisition of a Synapt G2-S mass spectrometer (INST 271/283-1 FUGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; Al Quobaili F, 2012, METABOLISM, V61, P1512, DOI 10.1016/j.metabol.2012.07.011; Baerenfaller K, 2011, INTEGR BIOL-UK, V3, P225, DOI 10.1039/c0ib00078g; Baginsky S, 1997, PLANT MOL BIOL, V34, P181, DOI 10.1023/A:1005802909902; Baginsky S, 1999, PLANT MOL BIOL, V39, P1013, DOI 10.1023/A:1006177807844; Bellafiore S, 2002, PLANT CELL, V14, P2303, DOI 10.1105/tpc.003442; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Fitzpatrick LM, 2001, PLANT J, V27, P59, DOI 10.1046/j.0960-7412.2001.01061.x; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Helm S, 2014, J PROTEOMICS, V98, P79, DOI 10.1016/j.jprot.2013.12.007; Huang YD, 2010, ANAL BIOCHEM, V402, P69, DOI 10.1016/j.ab.2010.03.028; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Ingelsson B, 2012, FEBS LETT, V586, P1265, DOI 10.1016/j.febslet.2012.03.061; Kanekatsu M, 1998, BIOCHEM MOL BIOL INT, V46, P99; KANEKATSU M, 1993, FEBS LETT, V335, P176, DOI 10.1016/0014-5793(93)80724-9; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Loza-Tavera H, 2006, BIOCHIMIE, V88, P1217, DOI 10.1016/j.biochi.2006.03.009; Mulekar JJ, 2012, PLANT SIGNAL BEHAV, V7, P292, DOI 10.4161/psb.18883; Ortelt J, 2014, METHODS MOL BIOL, V1132, P47, DOI 10.1007/978-1-62703-995-6_3; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; Pfalz J, 2013, TRENDS PLANT SCI, V18, P186, DOI 10.1016/j.tplants.2012.11.003; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Puthiyaveetil S, 2012, PLANT CELL ENVIRON, V35, P347, DOI 10.1111/j.1365-3040.2011.02349.x; Reiland S, 2011, P NATL ACAD SCI USA, V108, P12955, DOI 10.1073/pnas.1104734108; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Rochaix JD, 2013, ANTIOXID REDOX SIGN, V18, P2184, DOI 10.1089/ars.2012.5110; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P375, DOI 10.1016/j.bbabio.2010.11.010; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Schonberg A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00256; Schutkowski M, 2004, ANGEW CHEM INT EDIT, V43, P2671, DOI 10.1002/anie.200453900; Schweer J, 2010, PLANT J, V62, P192, DOI 10.1111/j.1365-313X.2010.04138.x; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Thiele A, 2009, METHODS MOL BIOL, V570, P203, DOI 10.1007/978-1-60327-394-7_9; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van Wijk KJ, 2011, PLANT PHYSIOL, V155, P1578, DOI 10.1104/pp.111.172932; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Zulawski M, 2013, NUCLEIC ACIDS RES, V41, pD1176, DOI 10.1093/nar/gks1081	45	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108344	10.1371/journal.pone.0108344	http://dx.doi.org/10.1371/journal.pone.0108344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295873	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000015
J	Julian, GS; de Oliveira, RW; Perry, JC; Tufik, S; Chagas, JR				Julian, Guilherme Silva; de Oliveira, Renato Watanabe; Perry, Juliana Cini; Tufik, Sergio; Chagas, Jair Ribeiro			Validation of Housekeeping Genes in the Brains of Rats Submitted to Chronic Intermittent Hypoxia, a Sleep Apnea Model	PLOS ONE			English	Article							RT-PCR; NORMALIZATION; EXPOSURE; CELLS; MICE; 18S	Obstructive sleep apnea (OSA) is a syndrome characterized by intermittent nocturnal hypoxia, sleep fragmentation, hypercapnia and respiratory effort, and it has been associated with several complications, such as diabetes, hypertension and obesity. Quantitative real-time PCR has been performed in previous OSA-related studies; however, these studies were not validated using proper reference genes. We have examined the effects of chronic intermittent hypoxia (CIH), which is an experimental model mainly of cardiovascular consequences of OSA, on reference genes, including beta-actin, beta-2-microglobulin, glyceraldehyde-3-phosphate dehydrogenase, hypoxanthine guanine phosphoribosyl transferase and eukaryotic 18S rRNA, in different areas of the brain. All stability analyses were performed using the geNorm, Normfinder and BestKeeper software programs. With exception of the 18S rRNA, all of the evaluated genes were shown to be stable following CIH exposure. However, gene stability rankings were dependent on the area of the brain that was analyzed and varied according to the software that was used. This study demonstrated that CIH affects various brain structures differently. With the exception of the 18S rRNA, all of the tested genes are suitable for use as housekeeping genes in expression analyses.	[Julian, Guilherme Silva; de Oliveira, Renato Watanabe; Perry, Juliana Cini; Tufik, Sergio; Chagas, Jair Ribeiro] Univ Fed Sao Paulo, Dept Psicobiol, UNIFESP, Sao Paulo, Brazil; [Chagas, Jair Ribeiro] Univ Fed Sao Paulo, Dept Biociencias, UNIFESP Baixada Santista, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Chagas, JR (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, UNIFESP, Sao Paulo, Brazil.	jchagas1@gmail.com	Chagas, Jair Ribeiro/AFV-6501-2022; Chagas, Jair R/A-1701-2012	Chagas, Jair Ribeiro/0000-0002-0357-8276; Chagas, Jair R/0000-0002-0357-8276; Julian, Guilherme/0000-0002-3487-2240	Associacao Fundo de Incentivo a Pesquisa (AFIP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/15060-4, 2011/16011-6]; CNPq [558924/2008-5]	Associacao Fundo de Incentivo a Pesquisa (AFIP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Associacao Fundo de Incentivo a Pesquisa (AFIP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/15060-4 to GSJ and 2011/16011-6 to RWO). JCP (#558924/2008-5), ST, and JRC are recipients of fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersen M.L., 2011, ANIMAL MODELS TOOLS, V1; Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Caradec J, 2010, BRIT J CANCER, V103, P591, DOI 10.1038/sj.bjc.6605755; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Carreras A, 2012, AM J PHYSIOL-REG I, V303, pR700, DOI 10.1152/ajpregu.00258.2012; Dumitrascu R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/234631; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Foster Russell G, 2007, Methods Mol Biol, V362, P3; Gilliland HE, 1997, CHOICE ANESTHETIC MA, DOI [10.1213/00000539-199712000-00039, DOI 10.1213/00000539-199712000-00039]; Goldbart A, 2003, NEUROSCIENCE, V122, P585, DOI 10.1016/j.neuroscience.2003.08.054; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Iyer S Ramnathan, 2012, J Assoc Physicians India, V60, P42; Kandel E., 2000, PRINCIPLES NEURAL SC; Lal C, 2012, CHEST, V141, P1601, DOI 10.1378/chest.11-2214; Lee KS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-45; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Moraes DJA, 2013, J NEUROSCI, V33, P19223, DOI 10.1523/JNEUROSCI.3041-13.2013; Nagelkerke A, 2010, BRIT J CANCER, V103, P590, DOI 10.1038/sj.bjc.6605754; Nieto F, 2000, MED ASS; Peppard P, 2000, NEW ENGL J; Perry JC, 2013, RESP PHYSIOL NEUROBI, P8; Perry JC, 2007, RESP PHYSIOL NEUROBI, V156, P250, DOI 10.1016/j.resp.2006.10.004; Perry JC, 2011, AUTON NEUROSCI-BASIC, V160, P32, DOI 10.1016/j.autneu.2010.11.006; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Punjabi N, 2002, AM J; Ramasamy S, 2013, ARCH BIOCHEM BIOPHYS, V534, P71, DOI 10.1016/j.abb.2013.02.004; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sunderram J., 2012, Critical Reviews in Biomedical Engineering, V40, P265; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Yao L, 2012, MOL BIOL REP, V39, P569, DOI 10.1007/s11033-011-0772-8; Zhao DJ, 2012, FEBS OPEN BIO, V2, P235, DOI 10.1016/j.fob.2012.08.001	36	32	32	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109902	10.1371/journal.pone.0109902	http://dx.doi.org/10.1371/journal.pone.0109902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289636	gold, Green Published, Green Submitted			2022-12-27	WOS:000342798000098
J	Wang, DY; Chen, S; Wang, ZM; Ji, CL; Xu, CM; Zhang, XF; Chauhan, BS				Wang, Danying; Chen, Song; Wang, Zaiman; Ji, Chenglin; Xu, Chunmei; Zhang, Xiufu; Chauhan, Bhagirath Singh			Optimizing Hill Seeding Density for High-Yielding Hybrid Rice in a Single Rice Cropping System in South China	PLOS ONE			English	Article							LEAF-AREA INDEX; GRAIN-YIELD; COMPONENTS; NITROGEN; GROWTH	Mechanical hill direct seeding of hybrid rice could be the way to solve the problems of high seeding rates and uneven plant establishment now faced in direct seeded rice; however, it is not clear what the optimum hill seeding density should be for high-yielding hybrid rice in the single-season rice production system. Experiments were conducted in 2010 and 2011 to determine the effects of hill seeding density (25 cm x 15 cm, 25 cm x 17 cm, 25 cm x 19 cm, 25 cm x 21 cm, and 25 cm x 23 cm; three to five seeds per hill) on plant growth and grain yield of a hybrid variety, Nei2you6, in two fields with different fertility (soil fertility 1 and 2). In addition, in 2012 and 2013, comparisons among mechanical hill seeding, broadcasting, and transplanting were conducted with three hybrid varieties to evaluate the optimum seeding density. With increases in seeding spacing from 25 cm x 15 cm to 25 cm x 23 cm, productive tillers per hill increased by 34.2% and 50.0% in soil fertility 1 and 2. Panicles per m(2) declined with increases in seeding spacing in soil fertility 1. In soil fertility 2, no difference in panicles per m 2 was found at spacing ranging from 25 cm x 17 cm to 25 cm x 23 cm, while decreases in the area of the top three leaves and aboveground dry weight per shoot at flowering were observed. Grain yield was the maximum at 25 cm x 17 cm spacing in both soil fertility fields. Our results suggest that a seeding density of 25 cm x 17 cm was suitable for high-yielding hybrid rice. These results were verified through on-farm demonstration experiments, in which mechanical hill-seeded rice at this density had equal or higher grain yield than transplanted rice.	[Wang, Danying; Chen, Song; Ji, Chenglin; Xu, Chunmei; Zhang, Xiufu] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Wang, Zaiman] South China Agr Univ, Key Lab Key Technol Agr Machine & Equipment, Guangzhou, Guangdong, Peoples R China; [Chauhan, Bhagirath Singh] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; South China Agricultural University; University of Queensland	Zhang, XF (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	chais.zju@gmail.com	wang, danying/GQY-7371-2022; Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668	National Rice Industry Technology System [CARS-01-04A]; 3 Nong 6 Fang Program; Five-twelfth National Science and Technology Support Program [2011BAD16B14]	National Rice Industry Technology System; 3 Nong 6 Fang Program; Five-twelfth National Science and Technology Support Program(Chinese Academy of Sciences)	The authors are grateful for grants from the National Rice Industry Technology System (CARS-01-04A), the 3 Nong 6 Fang Program, and the Five-twelfth National Science and Technology Support Program (2011BAD16B14). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baloch A.W., 2008, ASIAN J PLANT SCI, V1, P25, DOI DOI 10.3923/ajps.2002.25.27; Chauhan BS, 2012, ADV AGRON, V117, P315, DOI 10.1016/B978-0-12-394278-4.00007-6; Chen FB., 2011, CHINA RICE, V17, P1; Chen S, 2012, SCI WORLD J, DOI 10.1100/2012/279641; Chen Y, 1959, CHEN YK RICE CULTIVA, P1; [程建平 Cheng Jianping], 2010, [华中农业大学学报, Journal of Huazhong Agricultural University], V29, P1; COUNCE PA, 1989, CROP SCI, V29, P175, DOI 10.2135/cropsci1989.0011183X002900010038x; De Datta SK, 1981, PRINCIPLES PRACTICES, P220; Ding Y, 1961, CHINA RICE CULTIVATI, P53; Ekta Joshi, 2013, Plant Knowledge Journal, V2, P119; FAGADE SO, 1971, AGRON J, V63, P503, DOI 10.2134/agronj1971.00021962006300030047x; Farooq M, 2011, SOIL TILL RES, V111, P87, DOI 10.1016/j.still.2010.10.008; Gong ZiTong, 1999, Pedosphere, V9, P193; Gravios KA, 1982, AGRON J, V84, P1; Hanada K, 1993, SCI RICE PLANT, V1, P222; Horie T., 2003, Rice science: innovations and impact for livelihood. Proceedings of the International Rice Research Conference, Beijing, China, 16-19 September 2002, P117; Huang M, 2011, AGR SCI CHINA, V10, P1537, DOI 10.1016/S1671-2927(11)60149-1; Huang M, 2011, PLANT PROD SCI, V14, P331, DOI 10.1626/pps.14.331; ISLAM MF, 2008, INT J BIOL RES, V5, P60; Jiang P, 1987, CHINESE J RICE SCI, V1, P111; Kabir MH, 2008, INT J BIOL RES, V5, P42; Katsura K, 2007, FIELD CROP RES, V103, P170, DOI 10.1016/j.fcr.2007.06.001; Lei XiaoLong, 2013, Acta Agronomica Sinica, V39, P1814, DOI 10.3724/SP.J.1006.2013.01814; Lin Q, 1982, JIANGSU AGR SCI, V9, P1; Lin XQ, 2009, RICE SCI, V16, P138, DOI 10.1016/S1672-6308(08)60070-0; Ling Q H, 2000, CROP POPULATION QUAL, P42; MILLER BC, 1991, AGRON J, V83, P291, DOI 10.2134/agronj1991.00021962008300020006x; Mithrasena Y. J. P. K., 1986, International Rice Research Newsletter, V11, P20; Nuruzzaman M, 2000, SOIL SCI PLANT NUTR, V46, P381; Oziegbe M., 2007, International Journal of Botany, V3, P317; Pandey S., 2002, DIRECT SEEDING RES S, P3; Shu S, 2009, CHIN AGR SCI B, V25, P142; Chauhan BS, 2013, CROP PROT, V48, P51, DOI 10.1016/j.cropro.2013.02.015; Sittisuang P, 1995, CONSTRAINTS OPPORTUN, P1; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Uphoff N., 2003, International Journal of Agricultural Sustainability, V1, P38, DOI 10.3763/ijas.2003.0105; Wang D, 2010, ACTA AGR ZHEJIANG, V22, P330; Wang D, 2010, CHINA RICE, V16, P22; Wang ZaiMan, 2010, Journal of South China Agricultural University, V31, P91; Wu GW, 1998, AGRON J, V90, P317, DOI 10.2134/agronj1998.00021962009000030001x; Wu W, 2008, J IRON STEEL RES INT, V15, P15, DOI 10.1016/S1006-706X(08)60004-7; Yang ShiMin, 2009, Acta Agronomica Sinica, V35, P93, DOI 10.3724/SP.J.1006.2009.00093; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Yoshida S., 1970, Soil Science and Plant Nutrition, V16, P186, DOI 10.1080/00380768.1970.10432838; Yoshinaga S, 2005, JARQ-JPN AGR RES Q, V39, P147, DOI 10.6090/jarq.39.147; [曾山 Zeng Shan], 2014, [华中农业大学学报, Journal of Huazhong Agricultural University], V33, P12; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008; Zhong X, 2002, J AGR SCI, V138, P269, DOI 10.1017/S0021859601001903; Zhong XH, 2003, J PLANT NUTR, V26, P1203, DOI 10.1081/PLN-120020365; Zhu D, 2008, ANHUI AGR SCI B, V14, P133	50	27	31	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109417	10.1371/journal.pone.0109417	http://dx.doi.org/10.1371/journal.pone.0109417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290342	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000060
J	Al-Gumaei, YA; Noordin, KA; Reza, AW; Dimyati, K				Al-Gumaei, Yousef Ali; Noordin, Kamarul Ariffin; Reza, Ahmed Wasif; Dimyati, Kaharudin			A New SIR-Based Sigmoid Power Control Game in Cognitive Radio Networks	PLOS ONE			English	Article							CONTROL ALGORITHM; ALLOCATION	Interference resulting from Cognitive Radios (CRs) is the most important aspect of cognitive radio networks that leads to degradation in Quality of Service (QoS) in both primary and CR systems. Power control is one of the efficient techniques that can be used to reduce interference and satisfy the Signal-to-Interference Ratio (SIR) constraint among CRs. This paper proposes a new distributed power control algorithm based on game theory approach in cognitive radio networks. The proposal focuses on the channel status of cognitive radio users to improve system performance. A new cost function for SIR-based power control via a sigmoid weighting factor is introduced. The existence of Nash Equilibrium and convergence of the algorithm are also proved. The advantage of the proposed algorithm is the possibility to utilize and implement it in a distributed manner. Simulation results show considerable savings on Nash Equilibrium power compared to relevant algorithms while reduction in achieved SIR is insignificant.	[Al-Gumaei, Yousef Ali; Noordin, Kamarul Ariffin; Reza, Ahmed Wasif] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Dimyati, Kaharudin] Natl Def Univ Malaysia, Fac Engn, Dept Elect & Elect Engn, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Pertahanan Nasional Malaysia	Reza, AW (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.	wasif@um.edu.my	Noordin, Kamarul Ariffin/B-7751-2010; Al-Gumaei, Yousef Ali/B-4394-2017; Reza, Ahmed Wasif/ABE-5779-2020; Malekmohammadi, Amin/J-2973-2012; Dimyati, Kaharudin/AAU-2370-2021	Noordin, Kamarul Ariffin/0000-0003-4003-4793; Al-Gumaei, Yousef Ali/0000-0001-9920-3091; 	University of Malaya Research Grant (UMRG) [RG088/12ICT]; University of Malaya High Impact Research (HIR) Grant - Ministry of Higher Education (MOHE), Malaysia [UM.C/HIR/MOHE/ENG/51];  [FRGS/1/2012/TK06/UPNM/01/01]	University of Malaya Research Grant (UMRG); University of Malaya High Impact Research (HIR) Grant - Ministry of Higher Education (MOHE), Malaysia; 	Y. A. Al-Guamei and K. A. Noordin are supported by University of Malaya Research Grant (UMRG) No. RG088/12ICT, A. W. Reza is supported by University of Malaya High Impact Research (HIR) Grant (UM.C/HIR/MOHE/ENG/51) sponsored by the Ministry of Higher Education (MOHE), Malaysia, and K. Dimyati is supported by FRGS/1/2012/TK06/UPNM/01/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpcan T, 2002, WIREL NETW, V8, P659, DOI 10.1023/A:1020375225649; Bacci G, 2013, IEEE WIREL COMMUN LE, V2, P431, DOI 10.1109/WCL.2013.051513.130232; El-Osery A, 2000, IEEE ANTENN PROPAG M, V42, P152, DOI 10.1109/74.868061; FOSCHINI GJ, 1993, IEEE T VEH TECHNOL, V42, P641, DOI 10.1109/25.260747; Gajic Z, 2003, PROC SPIE, V5244, P115, DOI 10.1117/12.509266; Goodman D, 2000, IEEE PERS COMMUN, V7, P48, DOI 10.1109/98.839331; Grandhi S. A., 1994, Wireless Personal Communications, V1, P257, DOI 10.1007/BF01098870; Gunnarsson F, 2002, IFAC WORLD C; Gunnarsson F, 2000, THESIS; Haykin S, 2005, IEEE J SEL AREA COMM, V23, P201, DOI 10.1109/JSAC.2004.839380; Hong MY, 2013, IEEE T SIGNAL PROCES, V61, P3334, DOI 10.1109/TSP.2013.2253772; Hossain E, 2009, DYNAMIC SPECTRUM ACCESS AND MANAGEMENT IN COGNITIVE RADIO NETWORKS, P1, DOI 10.1017/CBO9780511609909; Jantti R, 2000, IEEE J SEL AREA COMM, V18, P447, DOI 10.1109/49.840203; Javan MR, 2013, IEEE T COMMUN, V61, P1708, DOI 10.1109/TCOMM.2013.031213.120316; Ji HB, 1998, WIREL NETW, V4, P233, DOI 10.1023/A:1019108223561; Kaiwang Lu, 2012, 2012 IEEE Global High Tech Congress on Electronics (GHTCE), P91, DOI 10.1109/GHTCE.2012.6490131; Kim S, 2011, IET COMMUN, V5, P2648, DOI 10.1049/iet-com.2011.0093; Koskie S, 2005, IEEE ACM T NETWORK, V13, P1017, DOI 10.1109/TNET.2005.857068; Lee MY, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P4225; Li F, 2011, IEEE T VEH TECHNOL, V60, P4384, DOI 10.1109/TVT.2011.2172474; Lv L, 2003, IEE P-COMMUN, V150, P134, DOI 10.1049/ip-com:20030173; Marcus M., 2002, FEDERAL COMMUNICATIO; Meshkati F, 2006, IEEE J SEL AREA COMM, V24, P1115, DOI 10.1109/JSAC.2005.864028; Nadkar T, 2012, IEEE T WIREL COMMUN, V11, P1576, DOI 10.1109/TWC.2012.020712.111502; Parsaeefard S, 2013, IEEE T MOBILE COMPUT, V12, P609, DOI 10.1109/TMC.2012.28; Pasandshanjani E, 2012, IET COMMUN, V6, P1212, DOI 10.1049/iet-com.2011.0224; PASANDSHANJANI E, 2011, 7 INT WIR COMM MOB C, P1147; Popescu DC, 2005, IEEE VTS VEH TECHNOL, P314; Rheinboldt W. C., 2000, ITERATIVE SOLUTION N, V30; Saraydar CU, 2002, IEEE T COMMUN, V50, P291, DOI 10.1109/26.983324; Sorooshyari S, 2012, IEEE ACM T NETWORK, V20, P878, DOI 10.1109/TNET.2011.2169986; Xiao MB, 2001, IEEE INFOCOM SER, P412, DOI 10.1109/INFCOM.2001.916724; Xingzhe Fan, 2004, Turkish Journal Electrical Engineering and Computer Sciences, Elektrik, V12, P139; Yang CG, 2010, IEEE T VEH TECHNOL, V59, P1696, DOI 10.1109/TVT.2009.2039502; YATES RD, 1995, IEEE J SEL AREA COMM, V13, P1341, DOI 10.1109/49.414651; Zheng L, 2013, IEEE J SEL AREA COMM, V31, P500, DOI 10.1109/JSAC.2013.130315; Zhou P, 2012, IEEE J SEL AREA COMM, V30, P54, DOI 10.1109/JSAC.2012.120106	37	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109077	10.1371/journal.pone.0109077	http://dx.doi.org/10.1371/journal.pone.0109077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286044	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700043
J	Guo, F; Han, XH; Zhang, JH; Zhao, XX; Lou, JC; Chen, H; Huang, XL				Guo, Feng; Han, Xiaohua; Zhang, Jinghui; Zhao, Xiuxiu; Lou, Jicheng; Chen, Hong; Huang, Xiaolin			Repetitive Transcranial Magnetic Stimulation Promotes Neural Stem Cell Proliferation via the Regulation of MiR-25 in a Rat Model of Focal Cerebral Ischemia	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; PARKINSONS-DISEASE; ARTERY OCCLUSION; PROGENITOR CELLS; CHRONIC STROKE; MOTOR CORTEX; NEUROGENESIS; MICRORNAS; RTMS; EXCITABILITY	Repetitive transcranial magnetic stimulation (rTMS) has increasingly been studied over the past decade to determine whether it has a therapeutic benefit on focal cerebral ischemia. However, the underlying mechanism of rTMS in this process remains unclear. In the current study, we investigated the effects of rTMS on the proliferation of adult neural stem cells (NSCs) and explored microRNAs (miRNAs) that were affected by rTMS. Our data showed that 10 Hz rTMS significantly increased the proliferation of adult NSCs after focal cerebral ischemia in the subventricular zone (SVZ), and the expression of miR-25 was obviously up-regulated in the ischemic cortex after rTMS. p57, an identified miR-25 target gene that regulates factors linked to NSC proliferation, was also evaluated, and it exhibited down-regulation. To further verify the role of miR-25, rats were injected with a single dose of antagomir-25 and were subjected to focal cerebral ischemia followed by rTMS treatment. The results confirmed that miR-25 could be repressed specifically and could drive the up-regulation of its target gene (p57), which resulted in the inhibition of adult NSC proliferation in the SVZ after rTMS. Thus, our studies strongly indicated that 10 Hz rTMS can promote the proliferation of adult NSCs in the SVZ after focal cerebral ischemia by regulating the miR-25/p57 pathway.	[Guo, Feng; Han, Xiaohua; Zhao, Xiuxiu; Chen, Hong; Huang, Xiaolin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rehabil Med, Wuhan 430074, Peoples R China; [Zhang, Jinghui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rehabil Med, Guangzhou 510275, Guangdong, Peoples R China; [Lou, Jicheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Sun Yat Sen University; Huazhong University of Science & Technology	Huang, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rehabil Med, Wuhan 430074, Peoples R China.	xiaolinh2006@126.com	Zhang, Jing/GWZ-7332-2022		National Natural Science Foundation of China [81071601, 81171858, 81070986]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Nos: 81071601, 81171858 and 81070986). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Carrion O, 2004, J NEUROSCI RES, V78, P16, DOI 10.1002/jnr.20235; Arias-Carrion Oscar, 2008, Int Arch Med, V1, P2, DOI 10.1186/1755-7682-1-2; Arnold CP, 2011, GENOME RES, V21, P798, DOI 10.1101/gr.111385.110; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Corti M, 2012, AM J PHYS MED REHAB, V91, P254, DOI 10.1097/PHM.0b013e318228bf0c; Deng ZD, 2014, CLIN NEUROPHYSIOL, V125, P1202, DOI 10.1016/j.clinph.2013.11.038; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dziennis S, 2011, METAB BRAIN DIS, V26, P123, DOI 10.1007/s11011-011-9241-2; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Feng SF, 2012, BEHAV BRAIN RES, V232, P245, DOI 10.1016/j.bbr.2012.04.019; Ferrarelli F, 2004, BRAIN RES BULL, V64, P103, DOI 10.1016/j.brainresbull.2004.04.020; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; Hiscock A, 2008, NEUROREHAB NEURAL RE, V22, P228, DOI 10.1177/1545968307307115; Hotermans C, 2007, STROKE, V38, P253, DOI 10.1161/01.STR.0000254446.14130.aa; ISAYAMA K, 1991, STROKE, V22, P1394, DOI 10.1161/01.STR.22.11.1394; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Khedr EM, 2006, MOVEMENT DISORD, V21, P2201, DOI 10.1002/mds.21089; Kim YH, 2006, STROKE, V37, P1471, DOI 10.1161/01.STR.0000221233.55497.51; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kwon TG, 2014, RESTOR NEUROL NEUROS, V32, P223, DOI 10.3233/RNN-130313; Lang N, 2006, CLIN NEUROPHYSIOL, V117, P2292, DOI 10.1016/j.clinph.2006.05.030; Le Q, 2014, AM J PHYS MED REHAB, V93, P422, DOI 10.1097/PHM.0000000000000027; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075561; Linden RD, 1999, J NEUROSURG, V91, P205, DOI 10.3171/spi.1999.91.2.0205; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032230; Lomarev MP, 2007, CLIN NEUROPHYSIOL, V118, P2072, DOI 10.1016/j.clinph.2007.06.016; Lomarev MP, 2006, MOVEMENT DISORD, V21, P325, DOI 10.1002/mds.20713; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Machado S, 2008, FUNCT NEUROL, V23, P113; Mally Judit, 2007, Expert Rev Neurother, V7, P165, DOI 10.1586/14737175.7.2.165; Peck B, 2011, AGING-US, V3, P329, DOI 10.18632/aging.100302; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rooke HM, 2001, PATHOLOGY, V33, P73; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sasaki N, 2013, J STROKE CEREBROVASC, V22, P413, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.004; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Ueyama E, 2011, PSYCHIAT CLIN NEUROS, V65, P77, DOI 10.1111/j.1440-1819.2010.02170.x; Wu XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078629; Xu XH, 2012, BIOCHEM BIOPH RES CO, V421, P640, DOI 10.1016/j.bbrc.2012.03.048; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yoon KJ, 2011, EXP BRAIN RES, V214, P549, DOI 10.1007/s00221-011-2853-2; Yozbatiran N, 2009, STROKE, V40, P309, DOI 10.1161/STROKEAHA.108.522144; Zhao ZN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045133	55	60	65	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109267	10.1371/journal.pone.0109267	http://dx.doi.org/10.1371/journal.pone.0109267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302788	gold, Green Submitted, Green Published			2022-12-27	WOS:000343730400048
J	Ohshima, D; Ichikawa, K				Ohshima, Daisuke; Ichikawa, Kazuhisa			Regulation of Nuclear NF-kappa B Oscillation by a Diffusion Coefficient and Its Biological Implications	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ACTIVATION; DYNAMICS; PORES; BETA; CELL; INFLAMMATION; MORPHOMETRY; PROGRESSION; PATHWAYS	The transcription factor NF-kappa B shuttles between the cytoplasm and the nucleus, and nuclear NF-kappa B is known to oscillate with a cycle of 1.5-2.5 h following the application of external stimuli. Oscillation pattern of NF-kappa B is implicated in regulation of the gene expression profile. In a previous report, we found that the oscillation pattern of nuclear NF-kappa B in a computational 3D spherical cell was regulated by spatial parameters such as nuclear to cytoplasmic volume ratio, nuclear transport, locus of protein synthesis, and diffusion coefficient. Here we report analyses and a biological implication for the regulation of oscillation pattern by diffusion coefficient. Our analyses show that the "reset" of nuclear NF-kappa B, defined as the return of nuclear NF-kappa B to the initial level or lower, was crucial for the oscillation; this was confirmed by the flux analysis. In addition, we found that the distant cytoplasmic location from the nucleus acted as a "reservoir" for storing newly synthesized Ian.. When the diffusion coefficient of proteins was large (>= 10(-11) m(2)/s), a larger amount of I kappa B alpha was stored in the "reservoir" with a large flux by diffusion. Subsequently, stored I kappa BB alpha diffused back to the nucleus, where nuclear NF-kappa B was "reset" to the initial state. This initiated the next oscillation cycle. When the diffusion coefficient was small (<= 10(-13) m(2)/s), oscillation of nuclear NF-kappa B was not observed because a smaller amount of lac( was stored in the "reservoir" and there was incomplete "reset" of nuclear NF-kappa B. If the diffusion coefficient for I kappa B alpha was increased to 10(-11) m(2)/5 keeping other proteins at 10(-13) m(2)/s, the oscillation was rescued confirming the "reset" and "reservoir" hypothesis. Finally, we showed altered effective value of diffusion coefficient by diffusion obstacles. Thus, organelle crowding seen in stressed cells possibly changes the oscillation pattern by controlling the effective diffusion coefficient.	[Ohshima, Daisuke; Ichikawa, Kazuhisa] Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo, Japan	University of Tokyo	Ichikawa, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo, Japan.	kichi@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22117008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Biteen JS, 2010, COLD SPRING HARVOR P; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; CZERNIAK B, 1984, CANCER RES, V44, P3752; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Dieteren CEJ, 2011, P NATL ACAD SCI USA, V108, P8657, DOI 10.1073/pnas.1017581108; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ichikawa K, 2005, NEUROINFORMATICS, V3, P49, DOI 10.1385/NI:3:1:049; Ichikawa K, 2001, BIOINFORMATICS, V17, P483, DOI 10.1093/bioinformatics/17.5.483; Ichikawa K, 2014, IET SYSTEMS IN PRESS; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; KATSOULIS M, 1995, BRIT J CANCER, V72, P958, DOI 10.1038/bjc.1995.441; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; KOONG AC, 1994, CANCER RES, V54, P1425; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin YC, 2013, CURR OPIN CHEM BIOL, V17, P663, DOI 10.1016/j.cbpa.2013.04.027; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Mazel T, 2009, BIOPHYS J, V96, P1691, DOI 10.1016/j.bpj.2008.10.066; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ohshima D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046911; Oliver KM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2575; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; PIENTA KJ, 1991, CANCER, V68, P2012, DOI 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C; SACKSWILNER R, 1990, ULTRASTRUCT PATHOL, V14, P311, DOI 10.3109/01913129009032246; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Staudt LM, 2010, COLD SPRING HARBOR P, V2; SUGIE S, 1994, CARCINOGENESIS, V15, P95, DOI 10.1093/carcin/15.1.95; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; SVEJDA J, 1975, NEOPLASMA, V22, P385; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Weigum SE, CANC PREV RES PHILA, V3, P518; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	58	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109895	10.1371/journal.pone.0109895	http://dx.doi.org/10.1371/journal.pone.0109895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302804	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400092
J	Auer, MK; Fuss, J; Hohne, N; Stalla, GK; Sievers, C				Auer, Matthias K.; Fuss, Johannes; Hoehne, Nina; Stalla, Guenter K.; Sievers, Caroline			Transgender Transitioning and Change of Self-Reported Sexual Orientation	PLOS ONE			English	Article							GENDER IDENTITY; TRANSSEXUALISM; BEHAVIOR; AUTOGYNEPHILIA; REASSIGNMENT; DIFFERENCE; TYPOLOGY; HEALTH; BRAIN	Objective: Sexual orientation is usually considered to be determined in early life and stable in the course of adulthood. In contrast, some transgender individuals report a change in sexual orientation. A common reason for this phenomenon is not known. Methods: We included 115 transsexual persons (70 male-to-female "MtF" and 45 female-to-male "FtM") patients from our endocrine outpatient clinic, who completed a questionnaire, retrospectively evaluating the history of their gender transition phase. The questionnaire focused on sexual orientation and recalled time points of changes in sexual orientation in the context of transition. Participants were further asked to provide a personal concept for a potential change in sexual orientation. Results: In total, 32.9% (n = 23) MtF reported a change in sexual orientation in contrast to 22.2% (n = 10) FtM transsexual persons (p = 0.132). Out of these patients, 39.1% (MtF) and 60% (FtM) reported a change in sexual orientation before having undergone any sex reassignment surgery. FtM that had initially been sexually oriented towards males (= androphilic), were significantly more likely to report on a change in sexual orientation than gynephilic, analloerotic or bisexual FtM (p = 0.012). Similarly, gynephilic MtF reported a change in sexual orientation more frequently than androphilic, analloerotic or bisexual MtF transsexual persons (p = 0.05). Conclusion: In line with earlier reports, we reveal that a change in self-reported sexual orientation is frequent and does not solely occur in the context of particular transition events. Transsexual persons that are attracted by individuals of the opposite biological sex are more likely to change sexual orientation. Qualitative reports suggest that the individual's biography, autogynephilic and autoandrophilic sexual arousal, confusion before and after transitioning, social and self-acceptance, as well as concept of sexual orientation itself may explain this phenomenon.	[Auer, Matthias K.; Stalla, Guenter K.; Sievers, Caroline] Max Planck Inst Psychiat, Dept Internal Med Endocrinol & Clin Chem, Munich, Germany; [Fuss, Johannes] Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Ctr Psychosocial Med, Hamburg, Germany; [Hoehne, Nina] Max Planck Inst Psychiat, Dept Mol Psychol, Munich, Germany	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society	Auer, MK (corresponding author), Max Planck Inst Psychiat, Dept Internal Med Endocrinol & Clin Chem, Munich, Germany.	mauer@mpipsykl.mpg.de	Auer, Matthias/AAI-5449-2021; Fuss, Johannes/AAI-6580-2021					APA, 2000, DIAGN STAT MAN MENT; APA (American Psychiatric Association), 2008, ANSW YOUR QUEST BETT; Auer MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078469; Auer MK, 2013, FERTIL STERIL, V100, P1103, DOI 10.1016/j.fertnstert.2013.05.047; Bailey JM, 2009, NEBRASKA S MOTIVATIO; BLANCHARD R, 1989, ARCH SEX BEHAV, V18, P315, DOI 10.1007/BF01541951; BLANCHARD R, 1989, J NERV MENT DIS, V177, P616, DOI 10.1097/00005053-198910000-00004; BLANCHARD R, 1985, ARCH SEX BEHAV, V14, P247, DOI 10.1007/BF01542107; Bockting W, 2009, ARCH SEX BEHAV, V38, P688, DOI 10.1007/s10508-009-9489-3; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Cohen-Kettenis PT, 1993, J PSYCHOL HUMAN SEX, V5, P55, DOI DOI 10.1300/J056V05N04_; Daskalos CT, 1998, ARCH SEX BEHAV, V27, P605, DOI 10.1023/A:1018725201811; De Cuypere G, 2005, ARCH SEX BEHAV, V34, P679, DOI 10.1007/s10508-005-7926-5; DEVOR H, 1993, J SEX RES, V30, P303, DOI 10.1080/00224499309551717; DOORN CD, 1994, ARCH SEX BEHAV, V23, P185, DOI 10.1007/BF01542098; Foucault Michel, 1998, HIST SEXUALITY 1 WIL, V1; FREUND K, 1993, BRIT J PSYCHIAT, V162, P558, DOI 10.1192/bjp.162.4.558; Fuss J, 2013, J PSYCHIATR RES, V47, P2015, DOI 10.1016/j.jpsychires.2013.08.023; Hirschfeld M, 1918, SEXUALPATHOLOGIE; Hirschfeld M., 1948, SEXUAL ANOMALIES ORI; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kinnish KK, 2005, ARCH SEX BEHAV, V34, P173, DOI 10.1007/s10508-005-1795-9; Lawrence AA, 2005, ARCH SEX BEHAV, V34, P147, DOI 10.1007/s10508-005-1793-y; Lawrence AA, 2005, ARCH SEX BEHAV, V34, P135, DOI 10.1007/s10508-005-1792-z; Lawrence AA., 2013, MEN TRAPPED MENS BOD, DOI [10.1007/978-1-4614-5182-2, DOI 10.1007/978-1-4614-5182-2]; Lever J., 1994, ADVOCATE, P16; LEVINE SB, 1981, J SEX MARITAL THER, V7, P85, DOI 10.1080/00926238108406096; Meier SC, 2013, ARCH SEX BEHAV, V42, P463, DOI 10.1007/s10508-012-0052-2; Moser C, 2010, J HOMOSEXUAL, V57, P790, DOI 10.1080/00918369.2010.486241; Nieder TO, 2011, J SEX MED, V8, P783, DOI 10.1111/j.1743-6109.2010.02142.x; Pathela P, 2006, ANN INTERN MED, V145, P416; PILLARD RC, 1995, PSYCHIAT CLIN N AM, V18, P71, DOI 10.1016/S0193-953X(18)30071-6; Rowniak S, 2013, ARCH SEX BEHAV, V42, P449, DOI 10.1007/s10508-012-0036-2; Schleifer D., 2006, SEXUALITIES, V9, P57, DOI [DOI 10.1177/1363460706058397, 10.1177/1363460706058397]; SEIL D, 1997, GENDER BLENDING, P137; Seil D., 1996, TXB HOMOSEXUALITY ME, P743; Seil D, 2004, TRANSGENDER SUBJECTI, P99, DOI DOI 10.1080/; Serano JM, 2010, INT J TRANSGENDERISM, V12, P176, DOI 10.1080/15532739.2010.514223; Sigal P, 2000, MOON GOODDESS VIGING; Smith YLS, 2005, PSYCHOL MED, V35, P89, DOI 10.1017/S0033291704002776; Swaab DF, 2007, BEST PRACT RES CL EN, V21, P431, DOI 10.1016/j.beem.2007.04.003; Thompson EM, 2008, DEV PSYCHOL, V44, P15, DOI 10.1037/0012-1649.44.1.15; vanKesteren PJ, 1996, ARCH SEX BEHAV, V25, P589, DOI 10.1007/BF02437841; WEINBERG TS, 1978, J HOMOSEXUAL, V4, P143; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0; Zucker KJ, 2012, J SEX MARITAL THER, V38, P151, DOI 10.1080/0092623X.2011.611219	47	48	48	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110016	10.1371/journal.pone.0110016	http://dx.doi.org/10.1371/journal.pone.0110016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299675	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200097
J	Da Silva, S; Moreira, B; Da Costa, N				Da Silva, Sergio; Moreira, Bruno; Da Costa, Newton, Jr.			Preschoolers and the Endowment Effect	PLOS ONE			English	Article							EMOTIONS; CHILDREN; RISK	We show that preschoolers exhibit the endowment effect as evidenced by experiments where children generally chose to keep their own toys rather than trading them for similar ones. Furthermore, we relate the emergence of this effect to children's innate psychobiological traits-emotional state, gender, handedness, and digit ratio. The trials were conducted with 141 children across 6 kindergartens. We also found support that children, like adults, exhibit a preference for physical possession as opposed to ownership. As with adults, emotions also seem to matter, as children who were described as quiet and calm were more likely to present the endowment effect. Also of note, right-handed children described as quiet were more likely to exhibit the phenomenon. Furthermore, female children were generally found to be calmer than males, while males tended to be more fearful than females. This result was also previously found in teenagers.	[Da Silva, Sergio; Da Costa, Newton, Jr.] Univ Fed Santa Catarina, Grad Program Econ, Florianopolis, SC, Brazil; [Moreira, Bruno] Fed Inst Minas Gerais, Formiga, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); Instituto Federal de Educacao, Ciencia e Tecnologia de Minas Gerais (IFMG)	Da Silva, S (corresponding author), Univ Fed Santa Catarina, Grad Program Econ, Florianopolis, SC, Brazil.	professorsergiodasilva@gmail.com	da Costa Jr., Newton C. A./AAZ-4155-2020; Da Silva, Sergio/A-2477-2008	da Costa Jr., Newton C. A./0000-0001-7723-2676; Da Silva, Sergio/0000-0002-7987-4098	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [304342/2009-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the following: BM, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) PhD scholarship http://www.capes.gov.br; NDC, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) http://www.cnpq.br Grant Number: 304342/2009-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2014, AM ECON REV, V104, P1793, DOI 10.1257/aer.104.6.1793; Da Silva S, 2013, APPL ECON, V45, P555, DOI 10.1080/00036846.2011.607133; Deb S, 2010, AUST J EDUC DEV PSYC, V10, P18; Gintis H, 2007, J ECON BEHAV ORGAN, V64, P1, DOI 10.1016/j.jebo.2006.02.002; HANEMANN WM, 1991, AM ECON REV, V81, P635; Harbaugh WT, 2001, ECON LETT, V70, P175, DOI 10.1016/S0165-1765(00)00359-1; Knutson B, 2008, NEURON, V58, P814, DOI 10.1016/j.neuron.2008.05.018; Lin CH, 2006, J ECON PSYCHOL, V27, P589, DOI 10.1016/j.joep.2005.10.001; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; Martinez LF, 2011, J ECON PSYCHOL, V32, P962, DOI 10.1016/j.joep.2011.08.006; Moreira B, 2010, J ECON PSYCHOL, V31, P794, DOI 10.1016/j.joep.2010.03.005; Reb J, 2007, JUDGM DECIS MAK, V2, P107; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Trepel C, 2005, COGNITIVE BRAIN RES, V23, P34, DOI 10.1016/j.cogbrainres.2005.01.016; Zhang Y, 2005, J CONSUM PSYCHOL, V15, P316, DOI 10.1207/s15327663jcp1504_6	16	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109520	10.1371/journal.pone.0109520	http://dx.doi.org/10.1371/journal.pone.0109520			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299430	Green Published, gold			2022-12-27	WOS:000343941200054
J	Joe, B; Nagaraju, A; Gowda, LR; Basrur, V; Lokesh, BR				Joe, Bina; Nagaraju, Anitha; Gowda, Lalitha R.; Basrur, Venkatesha; Lokesh, Belur R.			Mass-Spectrometric Identification of T-Kininogen I/Thiostatin as an Acute-Phase Inflammatory Protein Suppressed by Curcumin and Capsaicin	PLOS ONE			English	Article							RAT PERITONEAL-MACROPHAGES; MOLECULAR-MECHANISMS; LIPID-PEROXIDATION; FATTY-ACIDS; SERUM; INHIBITION; CELLS; LIVER; IRON; GLYCOPROTEIN	Curcumin and capsaicin are dietary xenobiotics with well-documented anti-inflammatory properties. Previously, the beneficial effect of these spice principles in lowering chronic inflammation was demonstrated using a rat experimental model for arthritis. The extent of lowering of arthritic index by the spice principles was associated with a significant shift in macrophage function favoring the reduction of pro-inflammatory molecules such as reactive oxygen species and production and release of anti-inflammatory metabolites of arachidonic acid. Beyond the cellular effects on macrophage function, oral administration of curcumin and capsaicin caused alterations in serum protein profiles of rats injected with adjuvant to develop arthritis. Specifically, a 72 kDa acidic glycoprotein, GpA72, which was elevated in pre-arthritic rats, was significantly lowered by feeding either curcumin or capsaicin to the rats. Employing the tandem mass spectrometric approach for direct sequencing of peptides, here we report the identification of GpA72 as T-kininogen I also known as Thiostatin. Since T-kininogen I is an early acute-phase protein, we additionally tested the efficiency of curcumin and capsaicin to mediate the inflammatory response in an acute phase model. The results demonstrate that curcumin and capsaicin lower the acute-phase inflammatory response, the molecular mechanism for which is, in part, mediated by pathways associated with the lowering of T-kininogen I.	[Joe, Bina; Basrur, Venkatesha] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43606 USA; [Nagaraju, Anitha; Lokesh, Belur R.] Cent Food Technol Res Inst, Dept Lipid Sci & Tradit Foods, Mysore 570013, Karnataka, India; [Gowda, Lalitha R.] Cent Food Technol Res Inst, Dept Prot Chem & Technol, Mysore 570013, Karnataka, India; [Basrur, Venkatesha] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University System of Ohio; University of Toledo; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); University of Michigan System; University of Michigan	Basrur, V (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.	vbasrur@med.umich.edu; belurlokesh821@gmail.com			Department of Science and Technology, New Delhi [SP/SO/B-27/98]; University of Toledo College of Medicine	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); University of Toledo College of Medicine	This work was supported by a grant from Department of Science and Technology, New Delhi (SP/SO/B-27/98). BJ and VB acknowledge support from the University of Toledo College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED M, 1995, REGUL PEPTIDES, V55, P85, DOI 10.1016/0167-0115(94)00095-F; Ahuja KDK, 2006, J AGR FOOD CHEM, V54, P6436, DOI 10.1021/jf061331j; Beltran J, 2007, J IMMUNOL, V178, P3260, DOI 10.4049/jimmunol.178.5.3260; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Cheppudira B, 2013, EXPERT OPIN INVESTIG; COLE T, 1985, FEBS LETT, V182, P57, DOI 10.1016/0014-5793(85)81153-4; Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Haanpaa M, 2012, EUR NEUROL, V68, P264, DOI 10.1159/000339944; HUSSAIN MS, 1994, INDIAN J BIOCHEM BIO, V31, P407; Jacob JN, 2013, NAT PROD COMMUN, V8, P359; JOE B, 1994, BBA-MOL CELL RES, V1224, P255, DOI 10.1016/0167-4889(94)90198-8; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Joe B, 1997, MOL CELL BIOCHEM, V169, P125, DOI 10.1023/A:1006877928703; Joe B, 1997, LIPIDS, V32, P1173, DOI 10.1007/s11745-997-0151-8; Joe B, 2000, MOL CELL BIOCHEM, V203, P153, DOI 10.1023/A:1007005605869; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Karaman M, 2012, ALLERGOL IMMUNOPATH, V40, P210, DOI 10.1016/j.aller.2011.04.006; Kempaiah RK, 2004, ANN NUTR METAB, V48, P314, DOI 10.1159/000081198; Khan MS, 2013, J FLUORESC, V23, P451, DOI 10.1007/s10895-013-1158-1; Kim G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062300; Kulac M, 2013, J MOL HISTOL, V44, P83, DOI 10.1007/s10735-012-9452-9; Maine GN, 2010, NAT PROTOC, V5, P1447, DOI 10.1038/nprot.2010.109; Marchiani A, 2013, CURR MED CHEM; MATUCCI CM, 1995, J RHEUMATOL, V22, P1447; Nevius E, 2012, MUCOSAL IMMUNOL, V5, P76, DOI 10.1038/mi.2011.50; Plytycz B, 2003, ARCH IMMUNOL THER EX, V51, P105; Pramanik KC, 2012, ANTIOXID REDOX SIGN, V17, P1417, DOI 10.1089/ars.2011.4369; Qiu JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033032; Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; REDDY ACP, 1994, MOL CELL BIOCHEM, V137, P1, DOI 10.1007/BF00926033; REDDY ACP, 1994, FOOD CHEM TOXICOL, V32, P279, DOI 10.1016/0278-6915(94)90201-1; REDDY ACP, 1992, MOL CELL BIOCHEM, V111, P117; Reddy ACP, 1999, LIPIDS, V34, P1025, DOI 10.1007/s11745-999-0453-x; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Shin YH, 2013, J DENT RES, V92, P547, DOI 10.1177/0022034513487376; Sinha D, 2012, CURR DRUG TARGETS, V13, P1799, DOI 10.2174/138945012804545632; Srinivasan K, 2013, FOOD FUNCT, V4, P503, DOI 10.1039/c2fo30249g; Teiten MH, 2013, MOL NUTR FOOD RES; URBAN J, 1979, J BIOL CHEM, V254, P565; Wiwanitkit V, 2012, NUTR CANCER, V64, P781, DOI 10.1080/01635581.2012.688913; Wu BS, 2013, DNA CELL BIOL, V32, P292, DOI 10.1089/dna.2013.2042; Yang CF, 2013, CURR PHARM DESIGN, V19, P1966; Yu JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055934, 10.1371/journal.pone.0057564]; Zingg JM, 2013, BIOFACTORS, V39, P101, DOI 10.1002/biof.1072	46	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e107565	10.1371/journal.pone.0107565	http://dx.doi.org/10.1371/journal.pone.0107565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299597	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200007
J	Lee, IP; Evans, AK; Yang, C; Works, MG; Kumar, V; De Miguel, Z; Manley, NC; Sapolsky, RM				Lee, I-Ping; Evans, Andrew K.; Yang, Cissy; Works, Melissa G.; Kumar, Vineet; De Miguel, Zurine; Manley, Nathan C.; Sapolsky, Robert M.			Toxoplasma gondii Is Dependent on Glutamine and Alters Migratory Profile of Infected Host Bone Marrow Derived Immune Cells through SNAT2 and CXCR4 Pathways	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; SYSTEM-A; ADAPTIVE REGULATION; MITOCHONDRIAL METABOLISM; CHEMOKINE RECEPTOR; DENDRITIC CELLS; INHIBITION; INNATE; MUSCLE; ROLES	The obligate intracellular parasite, Toxoplasma gondii, disseminates through its host inside infected immune cells. We hypothesize that parasite nutrient requirements lead to manipulation of migratory properties of the immune cell. We demonstrate that 1) T. gondii relies on glutamine for optimal infection, replication and viability, and 2) T. gondii-infected bone marrow-derived dendritic cells (DCs) display both "hypermotility" and "enhanced migration" to an elevated glutamine gradient in vitro. We show that glutamine uptake by the sodium-dependent neutral amino acid transporter 2 (SNAT2) is required for this enhanced migration. SNAT2 transport of glutamine is also a significant factor in the induction of migration by the small cytokine stromal cell-derived factor-1 (SDF-1) in uninfected DCs. Blocking both SNAT2 and C-X-C chemokine receptor 4 (CXCR4; the unique receptor for SDF-1) blocks hypermotility and the enhanced migration in T. gondii-infected DCs. Changes in host cell protein expression following T. gondii infection may explain the altered migratory phenotype; we observed an increase of CD80 and unchanged protein level of CXCR4 in both T. gondii-infected and lipopolysaccharide (LPS)-stimulated DCs. However, unlike activated DCs, SNAT2 expression in the cytosol of infected cells was also unchanged. Thus, our results suggest an important role of glutamine transport via SNAT2 in immune cell migration and a possible interaction between SNAT2 and CXCR4, by which T. gondii manipulates host cell motility.	[Lee, I-Ping; Evans, Andrew K.; Yang, Cissy; Works, Melissa G.; De Miguel, Zurine; Manley, Nathan C.; Sapolsky, Robert M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kumar, Vineet] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Manley, Nathan C.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Manley, Nathan C.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Stanford Stroke Ctr, Stanford, CA 94305 USA; [Manley, Nathan C.; Sapolsky, Robert M.] Stanford Univ, Sch Med, Stanford Inst Neuroinnovat & Translat Neurosci, Stanford, CA 94305 USA; [Sapolsky, Robert M.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University; Stanford University; Stanford University; Stanford University	Lee, IP (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ipinglee@stanford.edu	De Miguel, Zurine/AAH-9544-2019; evans, andrew k/A-7143-2012; Kumar, Vineet/H-3568-2013	De Miguel, Zurine/0000-0002-7006-1445; Evans, Andrew/0000-0003-2986-6476; Kumar, Vineet/0000-0003-2121-3964	Stanley Medical Research Institute [06R-1463]	Stanley Medical Research Institute	This work was supported by The Stanley Medical Research Institute (grant number: 06R-1463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2010, NEURON GLIA BIOL, V6, P263, DOI 10.1017/S1740925X11000093; Badillo AT, 2008, J PEDIATR SURG, V43, P1128, DOI 10.1016/j.jpedsurg.2008.02.043; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bougdour A, 2013, CELL MICROBIOL; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Darde Marie-Laure, 2004, Annali dell'Istituto Superiore di Sanita, V40, P57; Evans K, 2008, J AM SOC NEPHROL, V19, P2119, DOI 10.1681/ASN.2007101108; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fleckenstein MC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001358; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; Gazzola RF, 2001, FEBS LETT, V490, P11; Gupta R, 2013, AMINO ACIDS, V44, P757, DOI 10.1007/s00726-012-1400-1; Gupta R, 2009, AMINO ACIDS, V37, P359, DOI 10.1007/s00726-008-0162-2; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jones HN, 2006, REPRODUCTION, V131, P951, DOI 10.1530/rep.1.00808; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Kraemer BF, 2010, J MOL MED, V88, P1277, DOI 10.1007/s00109-010-0680-8; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; Lee JY, 2009, J LEUKOCYTE BIOL, V86, P1285, DOI 10.1189/jlb.0309214; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Ling R, 2001, BBA-BIOMEMBRANES, V1512, P15, DOI 10.1016/S0005-2736(01)00310-8; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Manley NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061789; MARONI BJ, 1986, AM J PHYSIOL, V251, pF74, DOI 10.1152/ajprenal.1986.251.1.F74; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Persat F, 2012, J LEUKOCYTE BIOL, V92, P1241, DOI 10.1189/jlb.1211600; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Sheiner L, 2013, CURR OPIN MICROBIOL, V16, P452, DOI 10.1016/j.mib.2013.07.003; Song C, 2011, CYTOTHERAPY, V13, P549, DOI 10.3109/14653249.2010.542457; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tanhoffer RA, 2007, J SPINAL CORD MED, V30, P140, DOI 10.1080/10790268.2007.11753925; Tjader I, 2007, CRIT CARE MED, V35, pS553, DOI 10.1097/01.CCM.0000278602.41352.0E; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2013, J EXP BIOL, V216, P120, DOI 10.1242/jeb.072983	53	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109803	10.1371/journal.pone.0109803	http://dx.doi.org/10.1371/journal.pone.0109803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299045	Green Published, gold			2022-12-27	WOS:000343941200074
J	Meury, M; Costa, M; Harder, D; Stauffer, M; Jeckelmann, JM; Bruhlmann, B; Rosell, A; Ilgu, H; Kovar, K; Palacin, M; Fotiadis, D				Meury, Marcel; Costa, Meritxell; Harder, Daniel; Stauffer, Mirko; Jeckelmann, Jean-Marc; Bruehlmann, Bela; Rosell, Albert; Ilgue, Hueseyin; Kovar, Karin; Palacin, Manuel; Fotiadis, Dimitrios			Detergent-Induced Stabilization and Improved 3D Map of the Human Heteromeric Amino Acid Transporter 4F2hc-LAT2	PLOS ONE			English	Article							MEMBRANE-PROTEINS; PICHIA-PASTORIS; LIGHT SUBUNIT; MECHANISM; ANTIPORTER; CYSTINE; SYSTEM; FAMILY; RBAT; MUTATIONS	Human heteromeric amino acid transporters (HATs) are membrane protein complexes that facilitate the transport of specific amino acids across cell membranes. Loss of function or overexpression of these transporters is implicated in several human diseases such as renal aminoacidurias and cancer. HATs are composed of two subunits, a heavy and a light subunit, that are covalently connected by a disulphide bridge. Light subunits catalyse amino acid transport and consist of twelve transmembrane alpha-helix domains. Heavy subunits are type II membrane N-glycoproteins with a large extracellular domain and are involved in the trafficking of the complex to the plasma membrane. Structural information on HATs is scarce because of the difficulty in heterologous overexpression. Recently, we had a major breakthrough with the overexpression of a recombinant HAT, 4F2hc-LAT2, in the methylotrophic yeast Pichia pastoris. Microgram amounts of purified protein made possible the reconstruction of the first 3D map of a human HAT by negative-stain transmission electron microscopy. Here we report the important stabilization of purified human 4F2hc-LAT2 using a combination of two detergents, i.e., n-dodecyl-beta-D-maltopyranoside and lauryl maltose neopentyl glycol, and cholesteryl hemisuccinate. The superior quality and stability of purified 4F2hc-LAT2 allowed the measurement of substrate binding by scintillation proximity assay. In addition, an improved 3D map of this HAT could be obtained. The detergent-induced stabilization of the purified human 4F2hc-LAT2 complex presented here paves the way towards its crystallization and structure determination at high-resolution, and thus the elucidation of the working mechanism of this important protein complex at the molecular level.	[Meury, Marcel; Costa, Meritxell; Harder, Daniel; Stauffer, Mirko; Jeckelmann, Jean-Marc; Ilgue, Hueseyin; Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Meury, Marcel; Costa, Meritxell; Harder, Daniel; Stauffer, Mirko; Jeckelmann, Jean-Marc; Ilgue, Hueseyin; Fotiadis, Dimitrios] Univ Bern, Swiss Natl Ctr Competence Res NCCR, Bern, Switzerland; [Bruehlmann, Bela; Kovar, Karin] Zurich Univ Appl Sci ZHAW, Sch Life Sci, Inst Biotechnol, Wadenswil, Switzerland; [Bruehlmann, Bela; Kovar, Karin] Zurich Univ Appl Sci ZHAW, Facil Management, Wadenswil, Switzerland; [Rosell, Albert; Palacin, Manuel] IRB Barcelona, Barcelona, Spain; [Rosell, Albert; Palacin, Manuel] Ctr Invest n Biomed Red Enfermedades Rares, Barcelona, Spain; [Palacin, Manuel] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain	University of Bern; University of Bern; Zurich University of Applied Sciences; Zurich University of Applied Sciences; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona	Palacin, M (corresponding author), IRB Barcelona, Barcelona, Spain.	manuel.palacin@irbbarcelona.org; dimitrios.fotiadis@ibmm.unibe.ch	Palacín, Manuel/G-9786-2015; Ilgu, Huseyin/S-2750-2019; Kovar, Karin/M-9093-2018	Harder, Daniel/0000-0003-4226-9748; Palacin, Manuel/0000-0002-8670-293X; Jeckelmann, Jean-Marc/0000-0001-9973-2700; Stauffer, Mirko/0000-0003-1608-1047	University of Bern; Swiss National Science Foundation [31003A_144168]; Bern University Research Foundation; Novartis Foundation; Marie Curie Actions International Fellowship Program (IFP); NCCR TransCure; Spanish Ministry of Science and Innovation [SAF2012-40080-C02-01]; Fundacion Ramon Areces and the Generalitat de Catalunya [SGR2009-1355]	University of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bern University Research Foundation; Novartis Foundation(Novartis); Marie Curie Actions International Fellowship Program (IFP); NCCR TransCure; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces and the Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the University of Bern, the Swiss National Science Foundation (Grant 31003A_144168), the Bern University Research Foundation, the Novartis Foundation, and the Marie Curie Actions International Fellowship Program (IFP) and the NCCR TransCure (to D. F.), and the Spanish Ministry of Science and Innovation (Grant SAF2012-40080-C02-01), the Fundacion Ramon Areces and the Generalitat de Catalunya (SGR2009-1355) (to M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; BUSCH AE, 1994, J BIOL CHEM, V269, P25581; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Costa M, 2013, PROTEIN EXPRES PURIF, V87, P35, DOI 10.1016/j.pep.2012.10.003; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; Harder D, 2012, NAT PROTOC, V7, P1569, DOI 10.1038/nprot.2012.090; Hyka P, 2010, APPL ENVIRON MICROB, V76, P4486, DOI 10.1128/AEM.02475-09; Ilgu H, 2014, BIOPHYS J, V106, P1660, DOI 10.1016/j.bpj.2014.02.024; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; O'Malley MA, 2011, BIOPHYS J, V100, pL11, DOI 10.1016/j.bpj.2010.12.3698; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Rosell A, 2014, P NATL ACAD SCI USA, V111, P2966, DOI 10.1073/pnas.1323779111; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595	35	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109882	10.1371/journal.pone.0109882	http://dx.doi.org/10.1371/journal.pone.0109882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299125	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200083
J	Platonova, N; Miquel, G; Chiu, LY; Taouji, S; Moroni, E; Colombo, G; Chevet, E; Sue, SC; Bikfalvi, A				Platonova, Natalia; Miquel, Geraldine; Chiu, Liang-Yuan; Taouji, Said; Moroni, Elisabetta; Colombo, Giorgio; Chevet, Eric; Sue, Shih-Che; Bikfalvi, Andreas			Dimerization Capacities of FGF2 Purified with or without Heparin-Affinity Chromatography	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SELF-ASSOCIATION; STRUCTURAL BASIS; RECEPTOR; BINDING; MITOGENESIS; RESOLUTION; ROLES	Fibroblast growth factor-2 (FGF2) is a pleiotropic growth factor exhibiting a variety of biological activities. In this article, we studied the capacity of FGF2 purified with or without heparin affinity chromatography to self-associate. Analyzing the NMR HSQC spectra for different FGF2 concentrations, heparin-affinity purified FGF2 showed perturbations that indicate dimerization and are a higher-order oligomerization state. HSQC perturbation observed with different FGF2 concentrations revealed a heparin-binding site and two dimer interfaces. Thus, with increasing protein concentrations, FGF2 monomers make contacts with each other and form dimers or higher order oligomers. On the contrary, FGF2 purified with ion-exchange chromatography did not show similar perturbation indicating that self-association of FGF2 is eliminated if purification is done without heparin-affinity chromatography. The HSQC spectra of heparin-affinity purified FGF2 can be reproduced to some extent by adding heparin tetra-saccharide to ion exchange chromatography purified FGF2. Heparin-affinity purified FGF2 bound to acceptor and donor beads in a tagged form using His-tagged or GST-tagged proteins, also dimerized in the AlphaScreen (TM) assay. This assay was further validated using different experimental conditions and competitors. The assay constitutes an interesting tool to study dimerization of other FGF forms as well.	[Platonova, Natalia; Miquel, Geraldine; Bikfalvi, Andreas] INSERM, U1029, Pessac, France; [Platonova, Natalia; Miquel, Geraldine; Bikfalvi, Andreas] Univ Bordeaux 1, Pessac, France; [Taouji, Said; Chevet, Eric] INSERM, U1053, Team Avenir, Bordeaux, France; [Chiu, Liang-Yuan; Sue, Shih-Che] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Moroni, Elisabetta; Colombo, Giorgio] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; National Tsing Hua University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Bikfalvi, A (corresponding author), INSERM, U1029, Allee Geoffroy St Hilaire, Pessac, France.	andreas.bikfalvi@u-bordeaux.fr	Colombo, Giorgio/A-2730-2012; Moroni, Elisabetta/ABH-7293-2020; chevet, eric/E-4992-2016	Colombo, Giorgio/0000-0002-1318-668X; Moroni, Elisabetta/0000-0002-7705-7457; chevet, eric/0000-0001-5855-4522; TAOUJI, Said/0000-0001-6736-9716	Institut National de la Recherche Scientifique (INSERM) Ligue National Contre le Cancer	Institut National de la Recherche Scientifique (INSERM) Ligue National Contre le Cancer	This work was supported by Institut National de la Recherche Scientifique (INSERM) Ligue National Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche Michele, 1995, Progress in Growth Factor Research, V6, P35, DOI 10.1016/0955-2235(95)00041-0; [Anonymous], 2004, PRACT GUID WORK ALPH; Arkin MR, 2012, ASSAY GUIDANCE MANUA; Batra R, 2001, NAT STRUCT BIOL, V8, P810, DOI 10.1038/nsb0901-810; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Chiu LY, 2014, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j, DOI 10.1016/J]; Davis JC, 1999, BIOCHEM J, V341, P613, DOI 10.1042/0264-6021:3410613; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Hagl CI, 2013, HISTOCHEM CELL BIOL, V139, P47, DOI 10.1007/s00418-012-1023-3; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Herr AB, 1997, J BIOL CHEM, V272, P16382, DOI 10.1074/jbc.272.26.16382; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; Kwan CP, 2001, J BIOL CHEM, V276, P23421, DOI 10.1074/jbc.M010786200; Lee SC, 2005, J BIOL CHEM, V280, P9567, DOI 10.1074/jbc.M412398200; Lozano RM, 2001, J BIOL CHEM, V276, P35723, DOI 10.1074/jbc.M101565200; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Platonova N, 2013, BLOOD, V121, P1229, DOI 10.1182/blood-2012-08-450502; Robinson ML, 2013, INVEST OPHTH VIS SCI, V1, P54; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Sabbieti MG, 2013, ENDOCRINOLOGY, V154, P2723, DOI 10.1210/en.2013-1025; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Van den Berghe L, 1998, BIOCHEM BIOPH RES CO, V252, P420, DOI 10.1006/bbrc.1998.9668	30	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110055	10.1371/journal.pone.0110055	http://dx.doi.org/10.1371/journal.pone.0110055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299071	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200099
J	Adriaens, A; Peremans, K; Waelbers, T; Vandermeulen, E; Croubels, S; Duchateau, L; Dobbeleir, A; Audenaerts, K; Eersels, J; Vermeire, S; De Spiegeleer, B; Polis, I				Adriaens, Antita; Peremans, Kathelijne; Waelbers, Tim; Vandermeulen, Eva; Croubels, Siska; Duchateau, Luc; Dobbeleir, Andre; Audenaerts, Kurt; Eersels, Jos; Vermeire, Simon; De Spiegeleer, Bart; Polis, Ingeborgh			The Effect of Morphine on Regional Cerebral Blood Flow Measured by Tc-99m-ECD SPECT in Dogs	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CYSTEINATE DIMER SPECT; MU-OPIOID RECEPTOR; CONSCIOUS DOGS; NALOXONE; FENTANYL; RAT; REMIFENTANIL; PHARMACOLOGY; METABOLISM	To gain insights into the working mechanism of morphine, regional cerebral blood flow (rCBF) patterns after morphine administration were assessed in dogs. In a randomized cross-over experimental study, rCBF was estimated with Tc-99m-Ethylcysteinate Dimer single photon emission computed tomography in 8 dogs at baseline, at 30 minutes and at 120 minutes after a single bolus of morphine. Perfusion indices (PI) in the frontal, parietal, temporal and occipital cortex and in the subcortical and cerebellar region were calculated. PI was significantly decreased 30 min after morphine compared to baseline in the right frontal cortex. The left parietal cortex and subcortical region showed a significantly increased PI 30 min after morphine compared to baseline. No significant differences were noted for the other regions or at other time points. In conclusion, a single bolus of morphine generated a changing rCBF pattern at different time points.	[Adriaens, Antita; Waelbers, Tim; Polis, Ingeborgh] Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Merelbeke, Belgium; [Peremans, Kathelijne; Vandermeulen, Eva; Dobbeleir, Andre; Vermeire, Simon] Univ Ghent, Fac Vet Med, Dept Med Imaging Domest Anim, Merelbeke, Belgium; [Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Biochem & Toxicol, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Physiol & Biometry, Merelbeke, Belgium; [Audenaerts, Kurt] Univ Ghent, Fac Med & Hlth Sci, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; [Eersels, Jos] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University; Vrije Universiteit Amsterdam; Ghent University	Adriaens, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Merelbeke, Belgium.	Antita.Adriaens@UGent.be	Adriaens, Mieke/F-2520-2013; De Spiegeleer, Bart/A-2001-2008	Adriaens, Mieke/0000-0003-4034-1881; De Spiegeleer, Bart/0000-0001-6794-3108; Eersels, Jos Leon/0000-0001-7521-583X; Croubels, Siska/0000-0001-6357-3517; Vandermeulen, Eva/0000-0001-9215-2869	Ghent University Special Research Fund scholarship (BOF) [01J06109]	Ghent University Special Research Fund scholarship (BOF)	This study was supported by Ghent University Special Research Fund scholarship (BOF no 01J06109, www.ugent.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LJ, 1997, ANESTH ANALG, V84, P120, DOI 10.1097/00000539-199701000-00023; Adriaens AM, 2012, J NUCL MED, V53, P1969, DOI 10.2967/jnumed.112.103796; Armitage-Chan EA, 2007, J VET EMERG CRIT CAR, V17, P5, DOI 10.1111/j.1476-4431.2006.00194.x; ARMSTEAD WM, 1990, J PHARMACOL EXP THER, V255, P1083; Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; BUCHWEITZ E, 1984, BRAIN RES, V291, P301, DOI 10.1016/0006-8993(84)91262-9; DEVINE JO, 1995, BRAIN RES, V675, P257, DOI 10.1016/0006-8993(95)00081-Z; Firestone LL, 1996, ANESTH ANALG, V82, P1247, DOI 10.1097/00000539-199606000-00025; FULLER SA, 1991, PHARMACOL BIOCHEM BE, V40, P339, DOI 10.1016/0091-3057(91)90564-I; Gadeyne C, 2011, J VET PHARMACOL THER, V34, P417, DOI 10.1111/j.1365-2885.2010.01264.x; Gerrits RJ, 1998, BRAIN RES, V783, P151, DOI 10.1016/S0006-8993(97)01320-6; Guedes AGP, 2008, J VET PHARMACOL THER, V31, P334, DOI 10.1111/j.1365-2885.2008.00966.x; Guedes AGP, 2007, J VET PHARMACOL THER, V30, P516, DOI 10.1111/j.1365-2885.2007.00911.x; HOFFMAN WE, 1993, ANESTHESIOLOGY, V79, P107, DOI 10.1097/00000542-199307000-00016; HUG CC, 1981, ANESTHESIOLOGY, V54, P38, DOI 10.1097/00000542-198101000-00008; Khalili-Mahani N, 2011, J CEREBR BLOOD F MET, V31, P1321, DOI 10.1038/jcbfm.2010.234; KuKanich B, 2005, AM J VET RES, V66, P1616, DOI 10.2460/ajvr.2005.66.1616; Lamont LA, 2007, LUMB JONES VET ANEST, P241; Maiante AA, 2009, J VET PHARMACOL THER, V32, P317, DOI 10.1111/j.1365-2885.2008.01042.x; MANSOUR A, 1995, J CHEM NEUROANAT, V8, P283, DOI 10.1016/0891-0618(95)00055-C; MARTIN WR, 1983, PHARMACOL REV, V35, P283; MATSUMIYA N, 1983, ANESTHESIOLOGY, V59, P175; Meng ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007742; MILDE LN, 1990, ANESTH ANALG, V70, P138; MILDE LN, 1989, BRIT J ANAESTH, V63, P710, DOI 10.1093/bja/63.6.710; Nikolaishvili L S, 2004, Neurosci Behav Physiol, V34, P467, DOI 10.1023/B:NEAB.0000022631.46176.6b; Ohara PT, 2005, CELL MOL LIFE SCI, V62, P44, DOI 10.1007/s00018-004-4283-9; Peremans K, 2003, EUR J NUCL MED MOL I, V30, P1538, DOI 10.1007/s00259-003-1250-x; Peremans K, 2001, VET RADIOL ULTRASOUN, V42, P562, DOI 10.1111/j.1740-8261.2001.tb00987.x; PEROUTKA SJ, 1980, SCIENCE, V208, P610, DOI 10.1126/science.6102801; ROSEN CL, 1989, AM J PHYSIOL, V256, pH1651, DOI 10.1152/ajpheart.1989.256.6.H1651; TAKESHITA H, 1972, ANESTHESIOLOGY, V37, P605, DOI 10.1097/00000542-197212000-00007; TRUSK TC, 1987, BRAIN RES, V406, P238, DOI 10.1016/0006-8993(87)90788-8; Waelbers T, 2011, RES VET SCI, V91, P138, DOI 10.1016/j.rvsc.2010.08.003; Waelbers T, 2012, J VET BEHAV, V7, P261, DOI 10.1016/j.jveb.2012.05.001; Wagner KJ, 2001, ANESTHESIOLOGY, V94, P732, DOI 10.1097/00000542-200105000-00008; Wagner KJ, 2007, ANESTHESIOLOGY, V106, P548, DOI 10.1097/00000542-200703000-00020; WAHL M, 1985, J CEREBR BLOOD F MET, V5, P451, DOI 10.1038/jcbfm.1985.61; WERNER C, 1991, ANESTH ANALG, V72, P177, DOI 10.1213/00000539-199102000-00006; Whistler JL, 2012, DRUG ALCOHOL DEPEN, V121, P189, DOI 10.1016/j.drugalcdep.2011.10.031; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Yaksh TL, 1997, ACTA ANAESTH SCAND, V41, P94, DOI 10.1111/j.1399-6576.1997.tb04623.x; Zelaya FO, 2012, MAGN RESON MATER PHY, V25, P163, DOI 10.1007/s10334-011-0293-4	43	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109680	10.1371/journal.pone.0109680	http://dx.doi.org/10.1371/journal.pone.0109680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295733	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000091
J	Ghiwot, Y; Degarege, A; Erko, B				Ghiwot, Yirgalem; Degarege, Abraham; Erko, Berhanu			Prevalence of Intestinal Parasitic Infections among Children under Five Years of Age with Emphasis on Schistosoma mansoni in Wonji Shoa Sugar Estate, Ethiopia	PLOS ONE			English	Article							HELMINTH INFECTIONS; DISEASE; BURDEN; NEED	Intestinal parasite infections are major public health problems of children in developing countries causing undernutrition, anemia, intestinal obstruction and mental and physical growth retardation. This study was conducted to assess the prevalence of intestinal helminthic infections among children under five years of age with emphasis on Schistosoma mansoni in Wonji Shoa Sugar Estate, Ethiopia. A cross-sectional parasitological survey was conducted in under-five children living in Wonji Shoa Sugar Estate Ethiopia, April, 2013. Stool samples were collected and examined for intestinal parasites using single Kato-Katz and single Sodium acetate-acetic acid-formalin (SAF) solution concentration methods. Out of 374 children examined using single Kato-Katz and single SAF-concentration methods, 24.3% were infected with at least one intestinal parasite species. About 10.4%, 8.8%, 4.6%, 2.9%, 1.6% and 0.8% of the children were infected with Hymenolepis nana, Schistosoma mansoni, Ascaris lumbricoides, Trichuris trichiura, Enterobius vermicularis and hookworm, respectively. Prevalence of double, triple and quadruple intestinal helminthic infection was 6.4%, 0.54% and 1.1%, respectively. A significant increase in prevalence of S. mansoni (8.3% versus 3.2%) and T. trichiura (2.7% versus 0.5%) infection was observed when determined via the single Kato-Katz method compared to the prevalence of the parasites determined via the single SAF-concentration method. On the other hand, the single SAF-concentration method (9.1%) revealed a significantly higher prevalence of H. nana infection than the single Kato-Katz (1.6%) does. In conclusion, intestinal helminths infections particularly S. mansoni and H. nana were prevalent in under-five children of Wonji Shoa Sugar Estate. Including praziquantel treatment in the deworming program as per the World Health Organization guidelines would be vital to reduce the burden of these diseases in areas where S. mansoni and H. nana infections are prevalent among under-fives. Kato-Katz can be used in estimating the prevalence of S. mansoni and other helminth infections.	[Ghiwot, Yirgalem; Degarege, Abraham; Erko, Berhanu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia	Addis Ababa University	Degarege, A (corresponding author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	abrahamdegarege@yahoo.com		Degarege, Abraham/0000-0002-1537-6639	Aklilu Lemma Institute of Pathobiology, Addis Ababa University	Aklilu Lemma Institute of Pathobiology, Addis Ababa University	This work was supported by Aklilu Lemma Institute of Pathobiology, Addis Ababa University (www.aau.edu.et/aaubeta/alipb/). BE, AD and YG get the funding from the institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I., 1999, Ethiopian Journal of Health Development, V13, P157; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P141; Asfaw S. T., 2000, Ethiopian Journal of Health Development, V14, P67; Belyhun Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-21; Birrie H, 1998, ETHIOP J HEALTH DEV, V12, P63; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; Girum Tadesse, 2005, Ethiopian Journal of Health Development, V19, P140; Hodges MH, 2012, ACTA TROP, V124, P120, DOI 10.1016/j.actatropica.2012.07.005; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Leggese M, 2004, ETHIOP J HEALTH DEV, V18, P117; Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582; Nyantekyi LA, 2010, ETHIOP J HEALTH DEV, V24, P185; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Utzinger J, 2010, CLIN MICROBIOL INFEC, V16, P267, DOI 10.1111/j.1469-0691.2009.02782.x; WHO, 2010, WHO TECH REP SER, V949, P1; who, SCHIST FACT SHEET; World Health Organization, 1991, BAS LAB METH MED PAR, P25; World Health Organization (WHO), 2014, SCHIST FACT SHEET	20	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109793	10.1371/journal.pone.0109793	http://dx.doi.org/10.1371/journal.pone.0109793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296337	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000095
J	He, XC; Korytar, T; Zhu, YQ; Pikula, J; Bandouchova, H; Zukal, J; Kollner, B				He, Xiaocui; Korytar, Tomas; Zhu, Yaqing; Pikula, Jiri; Bandouchova, Hana; Zukal, Jan; Koellner, Bernd			Establishment of Myotis myotis Cell Lines - Model for Investigation of Host-Pathogen Interaction in a Natural Host for Emerging Viruses	PLOS ONE			English	Article							BAT LYSSAVIRUS; HUMAN RABIES; FRUIT BATS; INFECTION; INTERFERON; EXPRESSION; RESERVOIRS; SURVEILLANCE; INDUCTION; MICROGLIA	Bats are found to be the natural reservoirs for many emerging viruses. In most cases, severe clinical signs caused by such virus infections are normally not seen in bats. This indicates differences in the virus-host interactions and underlines the necessity to develop natural host related models to study these phenomena. Due to the strict protection of European bat species, immortalized cell lines are the only alternative to investigate the innate anti-virus immune mechanisms. Here, we report about the establishment and functional characterization of Myotis myotis derived cell lines from different tissues: brain (MmBr), tonsil (MmTo), peritoneal cavity (MmPca), nasal epithelium (MmNep) and nervus olfactorius (MmNol) after immortalization by SV 40 large T antigen. The usefulness of these cell lines to study antiviral responses has been confirmed by analysis of their susceptibility to lyssavirus infection and the mRNA patterns of immune-relevant genes after poly I: C stimulation. Performed experiments indicated varying susceptibility to lyssavirus infection with MmBr being considerably less susceptible than the other cell lines. Further investigation demonstrated a strong activation of interferon mediated antiviral response in MmBr contributing to its resistance. The pattern recognition receptors: RIG-I and MDA5 were highly upregulated during rabies virus infection in MmBr, suggesting their involvement in promotion of antiviral responses. The presence of CD14 and CD68 in MmBr suggested MmBr cells are microglia-like cells which play a key role in host defense against infections in the central nervous system (CNS). Thus the expression pattern of MmBr combined with the observed limitation of lyssavirus replication underpin a protective mechanism of the CNS controlling the lyssavirus infection. Overall, the established cell lines are important tools to analyze antiviral innate immunity in M. myotis against neurotropic virus infections and present a valuable tool for a broad spectrum of future investigations in cellular biology of M. myotis.	[He, Xiaocui; Korytar, Tomas; Zhu, Yaqing; Koellner, Bernd] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany; [Pikula, Jiri; Bandouchova, Hana] Univ Vet & Pharmaceut Sci Brno, Fac Vet Hyg & Ecol, Dept Ecol & Dis Game Fish & Bees, Brno, Czech Republic; [Zukal, Jan] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Zukal, Jan] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic	Friedrich Loeffler Institute; University of Veterinary Sciences Brno; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Masaryk University Brno	Kollner, B (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany.	bernd.koellner@fli.bund.de	Korytář, Tomáš/AAD-7130-2019; Korytář, Tomáš/AAY-7683-2020; Zukal, Jan/G-1180-2014; Pikula, Jiri/V-8620-2018; Bandouchova, Hana/AAI-1213-2020	Korytář, Tomáš/0000-0002-6913-0415; Zukal, Jan/0000-0003-4967-6880; Pikula, Jiri/0000-0001-8747-9365; Bandouchova, Hana/0000-0003-0373-7940	Bundesministerium fur Forschung und Technologie German Ministry for Research and Technology [01KI1016A]	Bundesministerium fur Forschung und Technologie German Ministry for Research and Technology	Bundesministerium fur Forschung und Technologie German Ministry for Research and Technology Grant 01KI1016A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceballos NA, 2013, EMERG INFECT DIS, V19, P793, DOI 10.3201/eid1905.121071; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Carty M, 2013, TRENDS IMMUNOL; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Eckerle I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084679; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Harris SL, 2006, VET REC, V159, P439, DOI 10.1136/vr.159.14.439; He X, 2014, J VIROL, V88, P5444, DOI 10.1128/JVI.03403-13; Heinsohn S, 2005, HAEMATOLOGICA, V90, P94; HOLNESS CL, 1993, BLOOD, V81, P1607; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Johnson N, 2010, VET MICROBIOL, V142, P151, DOI 10.1016/j.vetmic.2010.02.001; Johnson N, 2008, J GEN VIROL, V89, P2662, DOI 10.1099/vir.0.2008/003889-0; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUMIO J, 1986, LANCET, V1, P378; Mackenzie JS, 2004, ARCH VIROL, P97; McColl KA, 2002, AUST VET J, V80, P636, DOI 10.1111/j.1751-0813.2002.tb10973.x; McElhinney LM, 2013, ZOONOSES PUBLIC HLTH, V60, P35, DOI 10.1111/zph.12003; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Mourya DT, 2013, INDIAN J MED RES, V138, P224; Muller MA, 2007, EMERG INFECT DIS, V13, P1367, DOI 10.3201/eid1309.070342; Nakamichi K, 2005, J VIROL, V79, P11801, DOI 10.1128/JVI.79.18.11801-11812.2005; Nathwani D, 2003, CLIN INFECT DIS, V37, P598, DOI 10.1086/376641; Ray NB, 1997, ARCH VIROL, V142, P1011, DOI 10.1007/s007050050136; Rieder M, 2011, ADV VIRUS RES, V79, P91, DOI 10.1016/B978-0-12-387040-7.00006-8; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Schatz J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002835; Shi ZL, 2008, VIRUS RES, V133, P74, DOI 10.1016/j.virusres.2007.03.012; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Stantic-Pavlinic M, 2005, Euro Surveill, V10, P217; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Virtue ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022488; Wibbelt G, 2010, BIOL LETTERS, V6, P438, DOI 10.1098/rsbl.2010.0267; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Wynne JW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003651; Zhao PS, 2013, INFECT GENET EVOL, V20, P257, DOI 10.1016/j.meegid.2013.09.016; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115; Zukal J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097224	50	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109795	10.1371/journal.pone.0109795	http://dx.doi.org/10.1371/journal.pone.0109795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295526	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000096
J	Kisoka, WJ; Simonsen, PE; Malecela, MN; Tersbol, BP; Mushi, DL; Meyrowitsch, DW				Kisoka, William J.; Simonsen, Paul E.; Malecela, Mwelecele N.; Tersbol, Britt P.; Mushi, Declare L.; Meyrowitsch, Dan W.			Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania	PLOS ONE			English	Article							BANCROFTIAN FILARIASIS; ENDEMIC COMMUNITIES; PROGRAM; ELIMINATION; INFECTION; DISEASE; ORISSA; TRANSMISSION; PREVALENCE; PATTERNS	Background: In most countries of Sub-Saharan Africa, control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole. Treatment coverages are however often suboptimal for programmes to reach the goal of transmission interruption within reasonable time. The present study aimed to identify predictors and barriers to individual drug uptake during MDA implementation by the National LF Elimination Programme in Tanzania. Methods: A questionnaire based cross sectional household survey was carried out in two rural and two urban districts in Lindi and Morogoro regions shortly after the 2011 MDA. 3279 adults (>= 15 years) were interviewed about personal characteristics, socio-economic status, MDA drug uptake among themselves and their children, reasons for taking/not taking drugs, and participation in previous MDA activities for LF control. Findings: The overall drug uptake rate was 55.1% (range of 44.5-75.6% between districts). There was no overall major difference between children (54.8%) and adults (55.2%) or between females (54.9%) and males (55.8%), but the role of these and other predictors varied to some extent between study sites. Major overall predictors of drug uptake among the interviewed adults were increasing age and history of previous drug uptake. Being absent from home during drug distribution was the main reason for not taking the drugs (50.2%) followed by clinical contraindications to treatment (10.8%), missing household visits of drug distributors (10.6%), and households not being informed about the distribution (9.0%). Conclusion: Drug uptake relied more on easily modifiable provider-related factors than on individual perceptions and practices in the target population. Limited investments in appropriate timing, dissemination of accurate timing information to recipients and motivation of drug distributors to visit all households (repeatedly when residents are absent) are likely to have considerable potential for increasing drug uptake, in support of successful LF transmission elimination.	[Kisoka, William J.; Malecela, Mwelecele N.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Simonsen, Paul E.] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark; [Tersbol, Britt P.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Kisoka, William J.; Mushi, Declare L.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Meyrowitsch, Dan W.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	National Institute of Medical Research; University of Copenhagen; University of Copenhagen; University of Copenhagen	Meyrowitsch, DW (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.	dame@sund.ku.dk	Mushi, Declare/H-2924-2019	Meyrowitsch, Dan/0000-0003-1108-8987; , Britt Pinkowski Tersbol/0000-0001-8260-1317	Research Council, Denmark (FFU) [09-096LIFE]; Direct For Education and Human Resources [0941984] Funding Source: National Science Foundation; Directorate For Engineering [1343533] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1337525] Funding Source: National Science Foundation	Research Council, Denmark (FFU); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study received financial support from Danida Research Council, Denmark (FFU grant #09-096LIFE). The funder had no role in development of study design, data collection and analysis, interpretation of results, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2001, ACTA TROP, V80, P215, DOI 10.1016/S0001-706X(01)00159-0; Allen T, 2011, THIRD WORLD Q, V32, P91, DOI 10.1080/01436597.2011.543816; Amarillo MLE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-14; [Anonymous], 2011, MON EP ASS MASS DRUG; Anto F, 2014, J BACTERIOL PARASITO, V5, P180, DOI [10.4172/2155-9597.1000180, DOI 10.4172/2155-9597.1000180]; Babu B, 2004, TROP MED INT HEALTH, V9, P702, DOI 10.1111/j.1365-3156.2004.01247.x; Babu BV, 2008, T ROY SOC TROP MED H, V102, P1207, DOI 10.1016/j.trstmh.2008.05.023; Cantey PT, 2010, TROP MED INT HEALTH, V15, P224, DOI 10.1111/j.1365-3156.2009.02443.x; El-Setouhy M, 2007, AM J TROP MED HYG, V77, P1069, DOI 10.4269/ajtmh.2007.77.1069; Gunawardena S, 2007, T ROY SOC TROP MED H, V101, P445, DOI 10.1016/j.trstmh.2006.09.002; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; King JD, 2011, ACTA TROP, V120, pS48, DOI 10.1016/j.actatropica.2010.08.021; Krentel A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002447; Malecela MN., 2009, J LYMPHOEDEMA, V4, P10; Mathieu E, 2006, TROP MED INT HEALTH, V11, P862, DOI 10.1111/j.1365-3156.2006.01626.x; MCMAHON JE, 1981, ANN TROP MED PARASIT, V75, P415, DOI 10.1080/00034983.1981.11687461; Meyrowitsch DW, 1995, ANN TROP MED PARASIT, V89, P653, DOI 10.1080/00034983.1995.11812999; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Minjas J. N., 1991, HLTH DIS TANZANIA, P159; NBS, 2013, POP HOUS CENS 2012, VI; Njomo DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048395; Nujum ZT, 2011, INT HEALTH, V3, P22, DOI 10.1016/j.inhe.2010.12.001; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Parker M, 2013, J BIOSOC SCI, V45, P517, DOI 10.1017/S0021932012000466; Rwegoshora RT, 2005, ANN TROP MED PARASIT, V99, P253, DOI 10.1179/136485905X29675; Simonsen PE, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-335; Simonsen PE, 2013, PARASITOL RES, V112, P35, DOI 10.1007/s00436-012-3226-x; Simonsen PE, 1995, ACTA TROP, V60, P179, DOI 10.1016/0001-706X(95)00126-Y; Simonsen PE, 2002, AM J TROP MED HYG, V66, P550, DOI 10.4269/ajtmh.2002.66.550; Simonsen PE, 2014, MANSONS TROPICAL DIS, P737, DOI DOI 10.1016/B978-0-7020-5101-2.00055-8; WHO, 2021, LYMPHATIC FILARIASIS, Vsecond; WHO, 2006, PREV CHEM HUM HELM; WHO, 2007, GLOB PROGR EL LYMPH; World Health Organization, 2006, QUAL CAR PROC MAK ST	34	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109316	10.1371/journal.pone.0109316	http://dx.doi.org/10.1371/journal.pone.0109316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296034	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000058
J	Yang, DY; Guo, K; Wang, Y; Guo, YY; Yang, XR; Jing, XX; Guo, HK; Tao, Y; Zhu, D; Jonass, JB				Yang, Da Yong; Guo, Kai; Wang, Yan; Guo, Yuan Yuan; Yang, Xian Rong; Jing, Xin Xia; Guo, Hai Ke; Tao, Yong; Zhu, Dan; Jonass, Jost B.			Intraocular Pressure and Associations in Children. The Gobi Desert Children Eye Study	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; SYSTEMIC BLOOD-PRESSURE; INTRACRANIAL-PRESSURE; TONO-PEN; TONOMETER; GLAUCOMA; DETERMINANTS; POPULATION; CURVATURE; INCREASES	Purpose: To assess the intraocular pressure (IOP) and its association in children in a population living in an oasis in the Gobi Desert. Methods: The cross-sectional school-based study included all schools in the Ejina region. The children underwent an ophthalmic examination, non-contact tonometry and measurement of blood pressure and body height and weight. Results: Out of eligible 1911 children, 1565 (81.9%) children with a mean age of 11.9 +/- 3.5 years (range: 6-21 years) participated. Mean spherical refractive error was -1.58 +/- 2.00 diopters. In multivariate analysis, higher IOP (right eye) was associated with younger age (P<0.001; standardized coefficient beta: -0.13; regression coefficient B: -0.13; 95% Confidence interval (CI):-0.18, -0.07), higher diastolic blood pressure (P<0.001;beta:0.13;B:0.05;95%CI:0.03,0.07), higher corneal refractive power (P<0.001;beta:0.11;B:0.23;95%CI:0.12,0.34), more myopic refractive error (P=0.035;beta: -0.06;B: -0.10;95%CI: -0.19, -0.001), and Han Chinese ethnicity of the father (P=0.03;beta:0.06;B:0.42;95%CI:0.04,0.89). If age and diastolic blood pressure were dropped, higher IOP was associated with higher estimated cerebrospinal fluid pressure (CSFP) (P<0.001;beta:0.09; B:0.13;95%CI:0.06,0.21) after adjusting for higher corneal refractive power (P<0.001) and Han Chinese ethnicity of the father (P = 0.04). Correspondingly, higher IOP of the left eye was associated with younger age (P<0.001;beta: -0.15;B: -0.16;95%CI: -0.21, -0.10), female gender (P<0.001;beta:0.09;B:0.65;95%CI:0.30,1.01), higher corneal refractive power (P<0.001;beta:0.08;B:0.19;95%CI:0.06,0.32), more myopic refractive error (P = 0.03;beta: -0.06;B: -0.12;95%CI: -0.22, -0.01), and higher estimated CSFP (P<0.001;beta:0.11;B:0.17;95%CI:0.09,0.24). Conclusions: In school children, higher IOP was associated with steeper corneal curvature and with younger age and higher blood pressure, or alternatively, with higher estimated CSFP. Corneal curvature radius should be included in the correction of IOP measurements. The potential association between IOP and CSFP as also assumed in adults may warrant further research.	[Yang, Da Yong] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Yang, Da Yong; Guo, Hai Ke] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Guo, Kai; Wang, Yan; Guo, Yuan Yuan; Yang, Xian Rong; Jing, Xin Xia; Zhu, Dan] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Tao, Yong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Tao, Yong] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Jonass, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Inner Mongolia Medical University; Peking University; Ruprecht Karls University Heidelberg	Guo, HK (corresponding author), Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China.	guohaike@medmail.com.cn; drtaoyong@163.com; zhudan1968@163.com		Tao, Yong/0000-0003-1443-2667	Program for New Century Excellent Talents in University (Beijing, China) [NCET-12-0010]; FOK YING TONG education foundation (Hong Kong, China)	Program for New Century Excellent Talents in University (Beijing, China)(Program for New Century Excellent Talents in University (NCET)); FOK YING TONG education foundation (Hong Kong, China)	This study was supported by Program for New Century Excellent Talents in University (No: NCET-12-0010) (Beijing, China) and FOK YING TONG education foundation (Hong Kong, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broman AT, 2007, J GLAUCOMA, V16, P581, DOI 10.1097/IJG.0b013e3180640f40; DIELEMANS I, 1995, OPHTHALMOLOGY, V102, P54; DUCKMAN RH, 1992, OPTOMETRY VISION SCI, V69, P705, DOI 10.1097/00006324-199209000-00007; Edwards MH, 1996, OPHTHAL PHYSL OPT, V16, P243, DOI 10.1016/0275-5408(95)00064-X; EDWARDS MH, 1993, OPTOMETRY VISION SCI, V70, P15, DOI 10.1097/00006324-199301000-00004; EDWARDS MH, 1993, OPTOMETRY VISION SCI, V70, P198, DOI 10.1097/00006324-199303000-00004; Foster PJ, 2003, INVEST OPHTH VIS SCI, V44, P3885, DOI 10.1167/iovs.03-0012; Goss DA, 1999, OPTOMETRY VISION SCI, V76, P286, DOI 10.1097/00006324-199905000-00015; JAAFAR MS, 1993, J PEDIATR OPHTHALMOL, V30, P284; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Jonas JB, 2011, J GLAUCOMA, V20, P405, DOI 10.1097/IJG.0b013e3181f7af9b; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; Klein BEK, 2005, BRIT J OPHTHALMOL, V89, P284, DOI 10.1136/bjo.2004.048710; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Mark HH, 2003, EYE, V17, P617, DOI 10.1038/sj.eye.6700417; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; PENSIERO S, 1992, J PEDIATR OPHTHALMOL, V29, P79, DOI 10.3928/0191-3913-19920301-05; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Sahin A, 2008, J GLAUCOMA, V17, P57, DOI 10.1097/IJG.0b013e31806ab33e; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; SHIOSE Y, 1986, AM J OPHTHALMOL, V101, P714, DOI 10.1016/0002-9394(86)90776-2; Sihota R, 2006, J PEDIAT OPHTH STRAB, V43, P14, DOI 10.3928/01913913-20060101-01; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; WANG Y, 2013, PLOS ONE, V2013; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013; Yildirim N, 2007, J PEDIAT OPHTH STRAB, V44, P216, DOI 10.3928/01913913-20070701-02; Youn D H, 1990, Korean J Ophthalmol, V4, P26; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	34	13	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109355	10.1371/journal.pone.0109355	http://dx.doi.org/10.1371/journal.pone.0109355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295855	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000064
J	Gustin, SM; McKay, JG; Petersen, ET; Peck, CC; Murray, GM; Henderson, LA				Gustin, Sylvia M.; McKay, Jamie G.; Petersen, Esben T.; Peck, Chris C.; Murray, Greg M.; Henderson, Luke A.			Subtle Alterations in Brain Anatomy May Change an Individual's Personality in Chronic Pain	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; DECISION-MAKING; DISORDERS; PLASTICITY; REORGANIZATION; FIBROMYALGIA; MYELINATION; TEMPERAMENT; PROFILES; PATTERNS	It is well established that gross prefrontal cortex damage can affect an individual's personality. It is also possible that subtle prefrontal cortex changes associated with conditions such as chronic pain, and not detectable until recent advances in human brain imaging, may also result in subtle changes in an individual's personality. In an animal model of chronic neuropathic pain, subtle prefrontal cortex changes including altered basal dendritic length, resulted in altered decision making ability. Using multiple magnetic resonance imaging techniques, we found in humans, although gray matter volume and on-going activity were unaltered, chronic neuropathic pain was associated with reduced free and bound proton movement, indicators of subtle anatomical changes, in the medial prefrontal cortex, anterior cingulate cortex and mediodorsal thalamus. Furthermore, proton spectroscopy revealed an increase in neural integrity in the medial prefrontal cortex in neuropathic pain patients, the degree of which was significantly correlated to the personality temperament of novelty seeking. These data reveal that even subtle changes in prefrontal cortex anatomy may result in a significant change in an individual's personality.	[Gustin, Sylvia M.] Neurosci Res Australia, Randwick, NSW, Australia; [McKay, Jamie G.; Henderson, Luke A.] Univ Sydney, Dept Anat & Histol, Sydney, NSW 2006, Australia; [Petersen, Esben T.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Petersen, Esben T.] Univ Med Ctr Utrecht, Dept Radiotherapy, Utrecht, Netherlands; [Peck, Chris C.; Murray, Greg M.] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia	Neuroscience Research Australia; University of Sydney; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Sydney	Gustin, SM (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	sylvia.gustin@gmail.com	Petersen, Esben Thade/Q-8266-2019; Gustin, Sylvia M/H-9648-2018	Petersen, Esben Thade/0000-0001-7529-3432; Gustin, Sylvia M/0000-0002-9613-9845; Henderson, Luke/0000-0002-1026-0151; Peck, Christopher Charles/0000-0003-0092-6770	National Health and Medical Research Council of Australia; Australian Dental Research Foundation, Inc.; Early Career Researchers/New Staff grant scheme of the University of Sydney	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Dental Research Foundation, Inc.; Early Career Researchers/New Staff grant scheme of the University of Sydney	This research was supported by the National Health and Medical Research Council of Australia, the Australian Dental Research Foundation, Inc. and the Early Career Researchers/New Staff grant scheme of the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Barker PB, 2001, ANN NEUROL, V49, P423, DOI 10.1002/ana.90; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Burgmer M, 2009, PSYCHOSOM MED, V71, P566, DOI 10.1097/PSY.0b013e3181a32da0; Clarke CE, 2001, EUR J NEUROL, V8, P573, DOI 10.1046/j.1468-1331.2001.00308.x; Cloninger CR, 2012, J AFFECT DISORDERS, V136, P758, DOI 10.1016/j.jad.2011.09.046; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Cloninger RC., 1994, TEMPERAMENT CHARACTE; Conrad R, 2007, PAIN, V133, P197, DOI 10.1016/j.pain.2007.07.024; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Danielsen E.R., 1999, MAGNETIC RESONANCE S, V1st; Dellu F, 1996, NEUROPSYCHOBIOLOGY, V34, P136, DOI 10.1159/000119305; DIETRICH RB, 1988, AM J ROENTGENOL, V150, P889, DOI 10.2214/ajr.150.4.889; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Gustin SM, 2013, J PAIN, V14, P1642, DOI 10.1016/j.jpain.2013.08.005; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Gwilym SE, 2010, ARTHRITIS RHEUM-US, V62, P2930, DOI 10.1002/art.27585; Henderson LA, 2013, J NEUROSCI, V33, P7574, DOI 10.1523/JNEUROSCI.0174-13.2013; Iversen SD, 1977, DRUGS NEUROTRANSMITT, P333; Jung RE, 2000, CLIN NEUROPSYCHOL, V14, P535, DOI 10.1076/clin.14.4.535.7198; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Malmgren-Olsson EB, 2006, CLIN J PAIN, V22, P625, DOI 10.1097/01.ajp.0000210907.65170.a3; MATHURDEVRE R, 1984, BRIT J RADIOL, V57, P955, DOI 10.1259/0007-1285-57-683-955; MENZA MA, 1993, NEUROLOGY, V43, P505, DOI 10.1212/WNL.43.3_Part_1.505; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Musen G, 2006, DIABETES, V55, P326, DOI 10.2337/diabetes.55.02.06.db05-0520; Nurmikko TJ, 2001, BRIT J ANAESTH, V87, P117, DOI 10.1093/bja/87.1.117; ONO J, 1993, BRAIN DEV-JPN, V15, P433, DOI 10.1016/0387-7604(93)90083-K; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Stellar J. R., 1985, NEUROBIOLOGY MOTIVAT; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; Verdejo-Garcia A, 2009, ARCH CLIN NEUROPSYCH, V24, P113, DOI 10.1093/arclin/acp014; Vogt BA, 1993, NEUROBIOLOGY CINGULA; Wang HD, 2008, NEUROPSYCHOPHARMACOL, V33, P1276, DOI 10.1038/sj.npp.1301521; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006; Youssef AM, 2014, PAIN, V155, P467, DOI 10.1016/j.pain.2013.11.008; Zermatten A, 2005, J NERV MENT DIS, V193, P647, DOI 10.1097/01.nmd.0000180777.41295.65	48	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109664	10.1371/journal.pone.0109664	http://dx.doi.org/10.1371/journal.pone.0109664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ4VK	25291361	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000075
J	Ahmed, S; Stepp, JR; Orians, C; Griffin, T; Matyas, C; Robbat, A; Cash, S; Xue, DY; Long, CL; Unachukwu, U; Buckley, S; Small, D; Kennelly, E				Ahmed, Selena; Stepp, John Richard; Orians, Colin; Griffin, Timothy; Matyas, Corene; Robbat, Albert; Cash, Sean; Xue, Dayuan; Long, Chunlin; Unachukwu, Uchenna; Buckley, Sarabeth; Small, David; Kennelly, Edward			Effects of Extreme Climate Events on Tea (Camellia sinensis) Functional Quality Validate Indigenous Farmer Knowledge and Sensory Preferences in Tropical China	PLOS ONE			English	Article							SEASONAL-VARIATIONS; GREEN; PERCEPTIONS; RESPONSES; ENERGY	Climate change is impacting agro-ecosystems, crops, and farmer livelihoods in communities worldwide. While it is well understood that more frequent and intense climate events in many areas are resulting in a decline in crop yields, the impact on crop quality is less acknowledged, yet it is critical for food systems that benefit both farmers and consumers through high-quality products. This study examines tea (Camellia sinensis; Theaceae), the world's most widely consumed beverage after water, as a study system to measure effects of seasonal precipitation variability on crop functional quality and associated farmer knowledge, preferences, and livelihoods. Sampling was conducted in a major tea producing area of China during an extreme drought through the onset of the East Asian Monsoon in order to capture effects of extreme climate events that are likely to become more frequent with climate change. Compared to the spring drought, tea growth during the monsoon period was up to 50% higher. Concurrently, concentrations of catechin and methylxanthine secondary metabolites, major compounds that determine tea functional quality, were up to 50% lower during the monsoon while total phenolic concentrations and antioxidant activity increased. The inverse relationship between tea growth and concentrations of individual secondary metabolites suggests a dilution effect of precipitation on tea quality. The decrease in concentrations of tea secondary metabolites was accompanied by reduced farmer preference on the basis of sensory characteristics as well as a decline of up to 50% in household income from tea sales. Farmer surveys indicate a high degree of agreement regarding climate patterns and the effects of precipitation on tea yields and quality. Extrapolating findings from this seasonal study to long-term climate scenario projections suggests that farmers and consumers face variable implications with forecasted precipitation scenarios and calls for research on management practices to facilitate climate adaptation for sustainable crop production.	[Ahmed, Selena] Montana State Univ, Dept Hlth & Human Dev, Sustainable Food & Bioenergy Syst Program, Bozeman, MT 59717 USA; [Ahmed, Selena; Orians, Colin; Buckley, Sarabeth] Tufts Univ, Dept Biol, Medford, MA USA; [Ahmed, Selena; Stepp, John Richard; Xue, Dayuan; Long, Chunlin; Kennelly, Edward] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China; [Stepp, John Richard] Univ Gainesville, Dept Anthropol, Gainesville, FL USA; [Griffin, Timothy; Cash, Sean] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Matyas, Corene] Univ Gainesville, Dept Geog, Gainesville, FL USA; [Robbat, Albert] Tufts Univ, Dept Chem, Medford, MA USA; [Unachukwu, Uchenna; Kennelly, Edward] CUNY, Grad Ctr, Dept Biochem, New York, NY USA; [Small, David] Tufts Univ, Sch Engn, Medford, MA 02155 USA	Montana State University System; Montana State University Bozeman; Tufts University; Minzu University of China; Tufts University; Tufts University; City University of New York (CUNY) System; Tufts University	Ahmed, S (corresponding author), Montana State Univ, Dept Hlth & Human Dev, Sustainable Food & Bioenergy Syst Program, Bozeman, MT 59717 USA.	selena.ahmed@montana.edu	Matyas, Corene/A-6435-2008	Matyas, Corene/0000-0002-9773-2501; unachukwu, uchenna/0000-0001-8248-5723; Long, Chunlin/0000-0002-6573-6049; Ahmed, Selena/0000-0001-5779-0697; Orians, Colin/0000-0003-3773-0894; Kennelly, Edward/0000-0002-1682-2696; Stepp, John Richard/0000-0001-9594-9187; Cash, Sean/0000-0002-7561-3392	TEACRS Program (NIGMS) at Tufts University [IRACDA-K12GM074869]; Program 111 in Ethnobiology of the Chinese Ministry in Education/Minzu University of China; Tufts Institute of the Environment; Tropical Conservation and Development Program at the University of Florida; Tufts University Provost Office; NSF REU Program at Tufts University (NSF) [DBI 1005082]; NSF Coupled Natural Human Systems (NSF) [BCS-1313775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM074869] Funding Source: NIH RePORTER	TEACRS Program (NIGMS) at Tufts University; Program 111 in Ethnobiology of the Chinese Ministry in Education/Minzu University of China; Tufts Institute of the Environment; Tropical Conservation and Development Program at the University of Florida; Tufts University Provost Office; NSF REU Program at Tufts University (NSF); NSF Coupled Natural Human Systems (NSF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the TEACRS Program (NIGMS IRACDA-K12GM074869) at Tufts University, Program 111 in Ethnobiology of the Chinese Ministry in Education/Minzu University of China, the Tufts Institute of the Environment, the Tropical Conservation and Development Program at the University of Florida, Tufts University Provost Office (Tufts Collaborates!), NSF REU Program at Tufts University (NSF DBI 1005082), and the NSF Coupled Natural Human Systems (NSF grant #BCS-1313775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, CONSERV LETT, V5, P28; Ahmed S, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plt054; Ahmed S, 2010, ECOL SOC, V15; Ahmed S, 2010, J ETHNOPHARMACOL, V132, P176, DOI 10.1016/j.jep.2010.08.016; Bhagat R. M., 2010, Journal of Environmental Research and Development, V4, P1017; Bolling BW, 2009, CURR OPIN CLIN NUTR, V12, P42, DOI 10.1097/MCO.0b013e32831b9c48; Borgatti SP, 2011, UCINET 6 362; BRIGGS MA, 1990, OECOLOGIA, V83, P32, DOI 10.1007/BF00324630; Chen ZM, 2002, MED AROMATIC PLANTS; Choudhury M. N. D., 1986, Two and a Bud, V33, P33; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Decision and Policy Analyses Group, 2011, FUT CLIM SCEN KEN TE; [窦军霞 DOU JunXia], 2007, [生态学报, Acta Ecologica Sinica], V27, P3099, DOI 10.1016/S1872-2032(07)60064-X; Ellen Roy., 2000, INDIGENOUS ENV KNOWL, P1; Gulati A, 2003, J AGR FOOD CHEM, V51, P4764, DOI 10.1021/jf026227q; Gulati A, 1996, J SCI FOOD AGR, V71, P231, DOI [10.1002/(SICI)1097-0010(199606)71:2&lt;231::AID-JSFA573&gt;3.0.CO;2-Y, 10.1002/(SICI)1097-0010(199606)71:2<231::AID-JSFA573>3.3.CO;2-P]; Han W., 2012, CLIMATE CHANGE ITS I; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; Herath N. L., 1991, Sri Lanka Journal of Tea Science, V60, P36; Honow R, 2010, UROL RES, V38, P377, DOI 10.1007/s00240-009-0245-x; Hunn E., 1993, TRADITIONAL ECOLOGIC, P13; Jeyaramraja P, 2003, J SCI FOOD AGR, V83, P1187, DOI 10.1002/jsfa.1440; Johns Timothy, 2004, Food and Nutrition Bulletin, V25, P143; Kottur G., 2010, J BIOSCIENCE RES, V1, P74; Kozlowski T.T., 1991, PHYSL ECOLOGY WOODY, DOI 10.1016/B978-0-12-424160-2.50005-7; Kumar N, 1992, J PLANTN CROPS, V20, P323; Lin BB, 2007, AGR FOREST METEOROL, V144, P85, DOI 10.1016/j.agrformet.2006.12.009; Lin LZ, 2008, J AGR FOOD CHEM, V56, P8130, DOI 10.1021/jf800986s; Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Maddison D., 2006, PERCEPTION ADAPTATIO, V4308; Maplecroft website, 2011, COUNTR RISK BRIEF; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Muthumani T., 2013, Journal of Natural Product and Plant Resources, V3, P30; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Nautiyal S, 2013, KNOWLEDGE SYSTEMS SO; Nelson G.C., 2009, CLIMATE CHANGE IMPAC, DOI [DOI 10.2499/0896295354, 10.2499/0896295354]; OWUOR PO, 1986, FOOD CHEM, V20, P225, DOI 10.1016/0308-8146(86)90175-5; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Rocha J. M., 2005, FIELD METHOD, V17, P356, DOI [DOI 10.1177/1525822X05275380, 10.1177/1525822X05275380]; ROMNEY AK, 1986, AM ANTHROPOL, V88, P313, DOI 10.1525/aa.1986.88.2.02a00020; Rounsevell MDA, 2005, AGR ECOSYST ENVIRON, V107, P117, DOI 10.1016/j.agee.2004.12.002; Saikia P, 2002, J AGR FOOD CHEM, V50, P7691, DOI 10.1021/jf0257345; Schepp K, 2009, STRATEGY ADAPT CLIMA; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Tobin MF, 1999, BIOTROPICA, V31, P570, DOI 10.1111/j.1744-7429.1999.tb00404.x; Unachukwu UJ, 2010, J FOOD SCI, V75, pC541, DOI 10.1111/j.1750-3841.2010.01705.x; Verchot L. V., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P901, DOI 10.1007/s11027-007-9105-6; WELLER SC, 1988, SYSTEMATIC DATA COLL; Wickremasinghe RL, 1966, TEA Q, V37, P232; Wijeratne MA, 1996, WATER AIR SOIL POLL, V92, P87; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2	57	87	89	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109126	10.1371/journal.pone.0109126	http://dx.doi.org/10.1371/journal.pone.0109126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286362	gold, Green Published			2022-12-27	WOS:000345743700046
J	Schmithals, A; Kuhn, N				Schmithals, Anja; Kuehn, Norbert			To Burn or Not to Burn? Effect of Management Strategy on North American Prairie Vegetation for Public Urban Areas in Germany	PLOS ONE			English	Article							TALLGRASS PRAIRIE; LONG-TERM; FIRE SEASON; DISTURBANCE; DIVERSITY; ESTABLISHMENT; DETERMINANTS; FREQUENCY; RESPONSES; PATTERNS	North American prairie vegetation has been a role model for designing highly attractive plantings for German urban green spaces for the past decade. In combination with gravel mulch top layers on planting sites and non-selective maintenance techniques like mowing or burning, prairie plantings are considered to be cost-effective and low-maintenance. This study was undertaken to assess the impact of different maintenance strategies and especially the necessity of fire management on the development success of ornamental prairie plantings in central Europe. A four factorial split-plot-block design was set up for investigation of different mixtures of prairie species under varying management conditions (mow-only, mowing plus selective weeding, mowing plus weeding and burning) on two differing soil types (in-situ topsoil and in-situ topsoil with a graywacke gravel mulch top layer) over three years. Significant effects of maintenance strategy on mortality rates and vitality were documented for a number of target species, which responded species specifically, either being slightly affected by the burning or thriving on it. Those effects were mostly restricted to topsoil sites. A strong impact on weed species presence and abundance and resulting maintenance times was found on both soil types. On topsoil sites, mow-only treatment resulted in a short-term loss of the original planting due to extensive weed growth. Corresponding gravel mulch sites were generally less colonised and visually dominated by weeds. Differences between weeded and weeded plus burned sites were minor. Unexpectedly, weed species populations were mostly unaffected by the additional burning treatment, while maintenance times and costs increased. No overall benefit of fire management for the establishment of prairie plantings was documented. The most effective management combination proved to be mowing plus regular selective weeding measures on gravel mulched planting sites.	[Schmithals, Anja; Kuehn, Norbert] Berlin Inst Technol, Dept Landscape Architecture & Environm Planning, Chair Vegetat Technol & Planting Design, Berlin, Germany	Technical University of Berlin	Schmithals, A (corresponding author), Berlin Inst Technol, Dept Landscape Architecture & Environm Planning, Chair Vegetat Technol & Planting Design, Berlin, Germany.	anja.schmithals@tu-berlin.de			Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Becker C, 1995, STADT GRUN, V7, P461; BIONDINI ME, 1989, VEGETATIO, V85, P21, DOI 10.1007/BF00042252; BOWLES M, 2002, AM MIDL NAT, V149, P35; Briggs JM, 2001, PLANT ECOL, V152, P93, DOI 10.1023/A:1011400101014; Cascorbi U, 2007, STADT GRUN, V5, P49; Collins S. L., 1998, GRASSLAND DYNAMICS L, P140; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; COLLINS SL, 1987, ECOLOGY, V68, P1243, DOI 10.2307/1939208; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; COLLINS SL, 1992, ECOLOGY, V73, P2001, DOI 10.2307/1941450; COLLINS SL, 1985, VEGETATIO, V64, P87; Copeland TE, 2002, RESTOR ECOL, V10, P315, DOI 10.1046/j.1526-100X.2002.02023.x; Daubenmire R., 1968, Advances in Ecological Research, V5, P209, DOI 10.1016/S0065-2504(08)60226-3; de la Fleur M, 2001, GARTENPRAXIS, V10, P29; Elsner AK, 2007, GARTEN LANDSCHAFT, V5, P16; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Foster BL, 1999, J ECOL, V87, P476, DOI 10.1046/j.1365-2745.1999.00366.x; GIBSON DJ, 1993, J APPL ECOL, V30, P247, DOI 10.2307/2404626; GLENNLEWIN DC, 1990, FIRE N AM TALLGRASS, P28; Grime J. P., 2001, PLANT STRATEGIES VEG; Guldner I, 2005, STADT GRUN, V7, P29; Hansen R., 1981, STAUDEN IHRE LEBENSB; Hanzen T, 2013, STADT GRUN, V3, P19; Hertlein-Rieder V, 2006, GARTEN LANDSCHAFT, V1, P10; Hitchmough J, 2006, LANDSCAPE URBAN PLAN, V78, P386, DOI 10.1016/j.landurbplan.2005.11.005; HOWE HF, 1994, ECOL APPL, V4, P121, DOI 10.2307/1942122; HULBERT LC, 1988, ECOLOGY, V69, P46, DOI 10.2307/1943159; Jakob F, 2002, GARTENPRAXIS, V6, P47; Kietsch U, 2005, GARTENPRAXIS, V8, P18; KNAPP AK, 1986, BIOSCIENCE, V36, P662, DOI 10.2307/1310387; KNAPP AK, 1984, AM J BOT, V71, P220, DOI 10.2307/2443749; Kohlein F, 2002, DEGA, V11, P16; KUCERA C. L., 1964, AMER MIDLAND NATUR, V72, P142, DOI 10.2307/2423217; Kucera CL, 1970, P S PRAIR PRAIR REST, P12; Kuhn N, 2013, GARTEN LANDSCHAFT, V4, P18; Leach MK, 1996, SCIENCE, V273, P1555, DOI 10.1126/science.273.5281.1555; Loydi A, 2013, J ECOL, V101, P454, DOI 10.1111/1365-2745.12033; Luz H, 2005, GARTENPRAXIS, V5, P51; Mayer F, 2000, THESIS TU MUNCHEN; Oehmichen F, 2000, GARTENPRAXIS, V4, P39; Ohlenbusch PD, 1997, MF2291 KANS STAT U A; OJIMA DS, 1994, BIOGEOCHEMISTRY, V24, P67, DOI 10.1007/BF02390180; Rebele F, 2001, FLORA, V196, P325, DOI 10.1016/S0367-2530(17)30069-5; Reif J, 2013, STADT GRUN, V1, P59; Rogers WE, 2001, PLANT ECOL, V155, P99, DOI 10.1023/A:1013264308786; Rothmund S, 2000, GARTENPRAXIS, V12, P31; Schacht WH, 1998, J RANGE MANAGE, V51, P442, DOI 10.2307/4003331; Schmidt C, 2004, GARTENPRAXIS, V5, P32; Schmidt C, 2005, STAT GRUN, V3, P30; Schmidt C, 2003, GRUNFORUMLA, V12, P29; Schmidt C, 2004, GARTENPRAXIS, V7, P17; Schmidt C, 2007, GARTENPRAXIS, V1, P32; Schmidt C, 2004, DEGA, V11, P12; Schmidt C, 2003, GRUNFORUMLA, V3, P18; Schmidt C, 2005, GRUNFORUMLA, V2, P24; Schmidt H, 2005, STADT GRUN, P18; Steinauer EM., 1996, PRAIRIE CONSERVATION, P39; Thomas E, 2006, FELDVERSUCHSWESEN; Tix BA, 2003, 200320 MNRC U MINN D; Tix D, 2006, RESTOR ECOL, V14, P561, DOI 10.1111/j.1526-100X.2006.00167.x; Towne EG, 1995, P 14 ANN N AM PRAIR, P75; TOWNE G, 1984, J RANGE MANAGE, V37, P392, DOI 10.2307/3899622; Vogl RJ., 1974, FIRE ECOSYSTEMS, P139, DOI DOI 10.1016/B978-0-12-424255-5.50010-9	64	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108588	10.1371/journal.pone.0108588	http://dx.doi.org/10.1371/journal.pone.0108588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286061	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700023
J	Tran, V; Weier, D; Radchuk, R; Thiel, J; Radchuk, V				Van Tran; Weier, Diana; Radchuk, Ruslana; Thiel, Johannes; Radchuk, Volodymyr			Caspase-Like Activities Accompany Programmed Cell Death Events in Developing Barley Grains	PLOS ONE			English	Article							SEED DEVELOPMENT; ENDOSPERM DEVELOPMENT; NUCELLAR PROJECTION; STARCH ACCUMULATION; CEREAL ENDOSPERM; PLANT CASPASES; PROTEASES; EMBRYO; ENDOREDUPLICATION; EMBRYOGENESIS	Programmed cell death is essential part of development and cell homeostasis of any multicellular organism. We have analyzed programmed cell death in developing barley caryopsis at histological, biochemical and molecular level. Caspase-1, -3, -4, -6 and -8-like activities increased with aging of pericarp coinciding with abundance of TUNEL positive nuclei and expression of HvVPE4 and HvPhS2 genes in the tissue. TUNEL-positive nuclei were also detected in nucellus and nucellar projection as well as in embryo surrounding region during early caryopsis development. Quantitative RT-PCR analysis of micro-dissected grain tissues revealed the expression of HvVPE2a, HvVPE2b, HvVPE2d, HvPhS2 and HvPhS3 genes exclusively in the nucellus/nucellar projection. The first increase in cascade of caspase-1, -3, -4, -6 and -8-like activities in the endosperm fraction may be related to programmed cell death in the nucellus and nucellar projection. The second increase of all above caspase-like activities including of caspase-9-like was detected in the maturating endosperm and coincided with expression of HvVPE1 and HvPhS1 genes as well as with degeneration of nuclei in starchy endosperm and transfer cells. The distribution of the TUNEL-positive nuclei, tissues-specific expression of genes encoding proteases with potential caspase activities and cascades of caspase-like activities suggest that each seed tissue follows individual pattern of development and disintegration, which however harmonizes with growth of the other tissues in order to achieve proper caryopsis development.	[Van Tran; Weier, Diana; Radchuk, Ruslana; Thiel, Johannes; Radchuk, Volodymyr] Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Radchuk, V (corresponding author), Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.	radchukv@ipk-gatersleben.de		Radchuk, Ruslana/0000-0001-8994-040X; Radchuk, Volodymyr/0000-0002-0472-6605	Deutsche Forschungsgemeinschaft (DFG) [WE1608/2-1, RA2061/3-1]; Vietnam Ministry of Education and Training for Van Tran	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Vietnam Ministry of Education and Training for Van Tran	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG grants WE1608/2-1 for Volodymyr Radchuk and RA2061/3-1 for Ruslana Radchuk) and a grant of Vietnam Ministry of Education and Training for Van Tran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Boren M, 2006, J EXP BOT, V57, P3747, DOI 10.1093/jxb/erl136; Borisjuk L, 2014, FRONT PLANT SC UNPUB; Cai YM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00041; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Della Mea A, 2007, AMINO ACIDS, V33, P395; Dominguez F, 2001, PLANTA, V213, P352, DOI 10.1007/s004250000517; Dominguez F, 2012, J EXP BOT, V63, P5475, DOI 10.1093/jxb/ers199; ENGELL K, 1989, NORD J BOT, V9, P265, DOI 10.1111/j.1756-1051.1989.tb01002.x; Gubatz S, 2007, PLANT J, V52, P779, DOI 10.1111/j.1365-313X.2007.03260.x; Gunawardena AHLAN, 2008, J EXP BOT, V59, P445, DOI 10.1093/jxb/erm189; Han JJ, 2012, PLANT J, V72, P129, DOI 10.1111/j.1365-313X.2012.05070.x; Hands P, 2012, J EXP BOT, V63, P6253, DOI 10.1093/jxb/ers281; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; Heckel T, 1999, PLANTA, V210, P1, DOI 10.1007/s004250050647; Ho PK, 2005, FEBS J, V272, P5436, DOI 10.1111/j.1742-4658.2005.04966.x; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Julian I, 2013, J EXP BOT, V64, P2929, DOI 10.1093/jxb/ert132; KIESSELBACH TA, 1952, AM J BOT, V39, P561, DOI 10.2307/2438703; Kobayashi H, 2013, PLANTA, V237, P1393, DOI 10.1007/s00425-013-1854-8; Kraus D., 2014, DANIELS XL TOOLBOX A; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Linnestad C, 1998, PLANT PHYSIOL, V118, P1169, DOI 10.1104/pp.118.4.1169; Lombardi L, 2007, J EXP BOT, V58, P2949, DOI 10.1093/jxb/erm137; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P4; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Nakaune S, 2005, PLANT CELL, V17, P876, DOI 10.1105/tpc.104.026872; Nguyen H. N., 2007, V8, P21, DOI 10.1007/7089_2007_107; Offler CE, 2003, ANNU REV PLANT BIOL, V54, P431, DOI 10.1146/annurev.arplant.54.031902.134812; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Radchuk V, 2006, PLANT CELL, V18, P1652, DOI 10.1105/tpc.106.041335; Radchuk V, 2011, J EXP BOT, V62, P1217, DOI 10.1093/jxb/erq348; Radchuk VV, 2009, PLANT PHYSIOL, V150, P190, DOI 10.1104/pp.108.133520; Rodriguez-Serrano M, 2012, J EXP BOT, V63, P2007, DOI 10.1093/jxb/err400; Rolletschek H, 2004, J EXP BOT, V55, P1351, DOI 10.1093/jxb/erh130; Sabelli PA, 2012, J CEREAL SCI, V56, P9, DOI 10.1016/j.jcs.2011.09.006; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; SMART MG, 1983, PROTOPLASMA, V114, P1, DOI 10.1007/BF01279863; Smertenko A, 2014, J EXP BOT, V65, P1343, DOI 10.1093/jxb/eru005; Solis MT, 2014, PLANT CELL PHYSIOL, V55, P16, DOI 10.1093/pcp/pct152; Thiel J, 2008, PLANT PHYSIOL, V148, P1436, DOI 10.1104/pp.108.127001; Thiel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041867; Vartapetian AB, 2011, CELL DEATH DIFFER, V18, P1289, DOI 10.1038/cdd.2011.49; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Visser EJW, 2006, NEW PHYTOL, V171, P305, DOI 10.1111/j.1469-8137.2006.01764.x; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Woltering EJ, 2002, PLANT PHYSIOL, V130, P1764, DOI 10.1104/pp.006338; Xiong F, 2013, PLANT CELL REP, V32, P1309, DOI 10.1007/s00299-013-1445-y; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Young TE, 2000, PLANT MOL BIOL, V44, P283, DOI 10.1023/A:1026588408152	57	28	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109426	10.1371/journal.pone.0109426	http://dx.doi.org/10.1371/journal.pone.0109426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286287	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700064
J	Yepes, E; Varela-M, RE; Lopez-Aban, J; Dakir, ELH; Mollinedo, F; Muro, A				Yepes, Edward; Varela-M, Ruben E.; Lopez-Aban, Julio; Dakir, E. L. Habib; Mollinedo, Faustino; Muro, Antonio			In Vitro and In Vivo Anti-Schistosomal Activity of the Alkylphospholipid Analog Edelfosine	PLOS ONE			English	Article							ANTISCHISTOSOMAL ACTION; ET-18-OCH3 EDELFOSINE; MANSONI; PRAZIQUANTEL; MILTEFOSINE; APOPTOSIS; HAEMATOBIUM; MECHANISMS; RAFTS; RECRUITMENT	Background: Schistosomiasis is a parasitic disease caused by trematodes of the genus Schistosoma. Five species of Schistosoma are known to infect humans, out of which S. haematobium is the most prevalent, causing the chronic parasitic disease schistosomiasis that still represents a major problem of public health in many regions of the world and especially in tropical areas, leading to serious manifestations and mortality in developing countries. Since the 1970s, praziquantel (PZQ) is the drug of choice for the treatment of schistosomiasis, but concerns about relying on a single drug to treat millions of people, and the potential appearance of drug resistance, make identification of alternative schistosomiasis chemotherapies a high priority. Alkylphospholipid analogs (APLs), together with their prototypic molecule edelfosine (EDLF), are a family of synthetic antineoplastic compounds that show additional pharmacological actions, including antiparasitic activities against several protozoan parasites. Methodology/Principal Findings: We found APLs ranked edelfosine > perifosine > erucylphosphocholine > miltefosine for their in vitro schistosomicidal activity against adult S. mansoni worms. Edelfosine accumulated mainly in the worm tegument, and led to tegumental alterations, membrane permeabilization, motility impairment, blockade of male-female pairing as well as induction of apoptosis-like processes in cells in the close vicinity to the tegument. Edelfosine oral treatment also showed in vivo schistosomicidal activity and decreased significantly the egg burden in the liver, a key event in schistosomiasis. Conclusions/Significance: Our data show that edelfosine is the most potent APL in killing S. mansoni adult worms in vitro. Edelfosine schistosomicidal activity seems to depend on its action on the tegumental structure, leading to tegumental damage, membrane permeabilization and apoptosis-like cell death. Oral administration of edelfosine diminished worm and egg burdens in S. mansoni-infected CD1 mice. Here we report that edelfosine showed promising antischistosomal properties in vitro and in vivo.	[Yepes, Edward; Lopez-Aban, Julio; Muro, Antonio] Univ Salamanca, Fac Farm, CIETUS, IBSAL, E-37008 Salamanca, Spain; [Yepes, Edward; Varela-M, Ruben E.; Dakir, E. L. Habib; Mollinedo, Faustino] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Muro, A (corresponding author), Univ Salamanca, Fac Farm, CIETUS, IBSAL, E-37008 Salamanca, Spain.	ama@usal.es	Varela, Ruben/CAF-2174-2022; López-Abán, Julio/B-3557-2015; DAKIR, EL HABIB/O-1383-2015	Varela, Ruben/0000-0002-1635-0166; López-Abán, Julio/0000-0001-8509-0727; DAKIR, EL HABIB/0000-0002-8482-3412; Muro, Antonio/0000-0003-0244-4740; Yepes, Edward/0000-0003-0361-9370	Spanish Ministerio de Ciencia e Innovacion (Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional of the European Union) [SAF2011-30518, RD12/0036/0065]; European Community [HEALTH-F2-2011-256986]; Junta de Castilla y Leon [CSI052A11-2, SA342U13]; Sociedad Espanola de Medicina Tropical y Salud Internacional (RFEF-SEMTSI); Universidad de Salamanca [USAL17008]	Spanish Ministerio de Ciencia e Innovacion (Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional of the European Union); European Community(European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); Sociedad Espanola de Medicina Tropical y Salud Internacional (RFEF-SEMTSI); Universidad de Salamanca	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (SAF2011-30518, and RD12/0036/0065 from Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, cofunded by the Fondo Europeo de Desarrollo Regional of the European Union), European Community's Seventh Framework Programme FP7-2007-2013 (grant HEALTH-F2-2011-256986, PANACREAS), Junta de Castilla y Leon (CSI052A11-2and SA342U13), Sociedad Espanola de Medicina Tropical y Salud Internacional (RFEF-SEMTSI 2013) and the Universidad de Salamanca (USAL17008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzi A, 2011, ADV PARASIT, V77, P1, DOI 10.1016/B978-0-12-391429-3.00005-8; Bertao HG, 2012, PARASITOL RES, V110, P2465, DOI 10.1007/s00436-011-2786-5; CHEEVER A W, 1970, Bulletin of the World Health Organization, V43, P601; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Cota GF, 2012, CASE REP MED, V2012, DOI 10.1155/2012/240512; Danker K, 2010, BRIT J PHARMACOL, V160, P36, DOI 10.1111/j.1476-5381.2009.00626.x; Danso-Appiah A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000528.pub2; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Eissa MM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-73; Eissa MM, 2011, INT J PARASITOL, V41, P235, DOI 10.1016/j.ijpara.2010.09.010; de Mendoza AEH, 2009, CLIN CANCER RES, V15, P858, DOI 10.1158/1078-0432.CCR-08-1654; Faghiri Z, 2009, FASEB J, V23, P2780, DOI 10.1096/fj.09-130757; Fallon PG, 1996, PARASITOLOGY, V112, P47, DOI 10.1017/S0031182000065069; Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005; Fenwick A, 2006, CURR OPIN INFECT DIS, V19, P577, DOI 10.1097/01.qco.0000247591.13671.6a; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2012, ONCOGENE, V31, P2627, DOI 10.1038/onc.2011.446; Gajate C, 2002, CURR DRUG METAB, V3, P491, DOI 10.2174/1389200023337225; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Galanti SE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001509; GONNERT R, 1977, Z PARASITENKD, V52, P129, DOI 10.1007/BF00389899; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Hassan MF, 2006, AM J PATHOL, V169, P943, DOI 10.2353/ajpath.2006.051319; Jones MK, 2004, BIOESSAYS, V26, P752, DOI 10.1002/bies.20058; Jurberg AD, 2009, DEV GENES EVOL, V219, P219, DOI 10.1007/s00427-009-0285-9; Keiser J, 2011, J ANTIMICROB CHEMOTH, V66, P1791, DOI 10.1093/jac/dkr178; King CH, 2000, EMERG INFECT DIS, V6, P585, DOI 10.3201/eid0606.000606; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; La Flamme AC, 2002, PARASITE IMMUNOL, V24, P339, DOI 10.1046/j.1365-3024.2002.00473.x; Lewis F, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1901s28; Liu R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-201; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Manneck T, 2010, PARASITOLOGY, V137, P85, DOI 10.1017/S0031182009990965; Marr JJ, 2003, MOL MED PARASITOLOGY, Vxii; MCLAREN DJ, 1977, NATURE, V269, P147, DOI 10.1038/269147a0; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; Mollinedo F, 2010, ONCOGENE, V29, P3748, DOI 10.1038/onc.2010.131; Mollinedo F, 2007, EXPERT OPIN THER PAT, V17, P385, DOI 10.1517/13543776.17.4.385; Mollinedo F, 2010, CLIN CANCER RES, V16, P2046, DOI 10.1158/1078-0432.CCR-09-2456; Mollinedo F, 2009, J PHARMACOL EXP THER, V329, P439, DOI 10.1124/jpet.108.148254; Muro A, 2012, MOL DETECTION HUMAN, P441; NARE B, 1991, BIOCHEM PHARMACOL, V42, P1287, DOI 10.1016/0006-2952(91)90267-9; Neves JKAL, 2011, EXP PARASITOL, V128, P82, DOI 10.1016/j.exppara.2011.01.021; Norton AJ, 2010, AM J TROP MED HYG, V83, P951, DOI 10.4269/ajtmh.2010.10-0283; O'Neal SE, 2007, J INFECT DIS, V195, P142, DOI 10.1086/509808; Peak E, 2011, AN ACAD BRAS CIENC, V83, P649, DOI 10.1590/S0001-37652011000200024; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Pereira ASA, 2011, PARASITOL RES, V109, P1395, DOI 10.1007/s00436-011-2386-4; del Villar LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045867; Pica-Mattoccia L, 2012, PARASITIC HELMINTHS, P309; Rokni MB, 2012, SCHISTOSOMIASIS, P310; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; RUPPEL A, 1986, EXP PARASITOL, V62, P223, DOI 10.1016/0014-4894(86)90027-5; SHAW MK, 1983, Z PARASITENKD, V69, P643, DOI 10.1007/BF00926674; Skelly PJ, 2005, WORLD CL PARASITES, V10, P81; Soliman MFM, 2005, ACTA TROP, V93, P1, DOI 10.1016/j.actatropica.2004.08.006; Sundar S, 2006, T ROY SOC TROP MED H, V100, pS26, DOI 10.1016/j.trstmh.2006.02.011; Utzinger J, 2001, ACTA TROP, V80, P9, DOI 10.1016/S0001-706X(01)00138-3; van Blitterswijk WJ, 2013, BBA-MOL CELL BIOL L, V1831, P663, DOI 10.1016/j.bbalip.2012.10.008; Van Hellemond JJ, 2006, INT J PARASITOL, V36, P691, DOI 10.1016/j.ijpara.2006.01.007; Varela RE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001612; Wilson RA, 2012, PROTOPLASMA, V249, P503, DOI 10.1007/s00709-011-0326-x; World Health Organization, SCHISTOSOMIASIS; Xiao SH, 2000, ACTA TROP, V75, P341, DOI 10.1016/S0001-706X(00)00067-X; Xiao SH, 2007, ANTIMICROB AGENTS CH, V51, P1440, DOI 10.1128/AAC.01537-06; Xiao SH, 2010, PARASITOL RES, V106, P1179, DOI 10.1007/s00436-010-1782-5; Zhang CW, 2009, PARASITOL RES, V104, P1407, DOI 10.1007/s00436-009-1341-0	73	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109431	10.1371/journal.pone.0109431	http://dx.doi.org/10.1371/journal.pone.0109431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302497	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400056
J	Faivre, JP; Maureille, B; Bayle, P; Crevecoeur, I; Duvals, M; Grun, R; Bemilli, C; Bonilauri, S; Coutard, S; Bessoul, M; Limondin-Lozouetn, N; Cottard, A; Deshayes, T; Douillard, A; Henaff, X; Pautret-Homerville, C; Kinsley, L; Trinkaus, E				Faivre, Jean-Philippe; Maureille, Bruno; Bayle, Priscilla; Crevecoeur, Isabelle; Duvals, Mathieu; Gruen, Rainer; Bemilli, Celine; Bonilauri, Stephanie; Coutard, Sylvie; Bessoul, Maryelle; Limondin-Lozouetn, Nicole; Cottard, Antoine; Deshayes, Thierry; Douillard, Aurelie; Henaff, Xavier; Pautret-Homerville, Caroline; Kinsley, Les; Trinkaus, Erik			Middle Pleistocene Human Remains from Tourville-la-Riviere (Normandy, France) and Their Archaeological Context	PLOS ONE			English	Article							HUMAN CRANIUM; LOS HUESOS; PHYLOGENETIC POSITION; HOMINID; ATAPUERCA; EUROPE; SIMA; HOMO; NEANDERTHALS; ROBUSTICITY	Despite numerous sites of great antiquity having been excavated since the end of the 19th century, Middle Pleistocene human fossils are still extremely rare in northwestern Europe. Apart from the two partial crania from Biache-Saint-Vaast in northern France, all known human fossils from this period have been found from ten sites in either Germany or England. Here we report the discovery of three long bones from the same left upper limb discovered at the open-air site of Tourvillela-Riviere in the Seine Valley of northern France. New U-series and combined US-ESR dating on animal teeth produced an age range for the site of 183 to 236 ka. In combination with paleoecological indicators, they indicate an age toward the end of MIS 7. The human remains from Tourville-la-Rivie` re are attributable to the Neandertal lineage based on morphological and metric analyses. An abnormal crest on the left humerus represents a deltoid muscle enthesis. Micro- and or macro-traumas connected to repetitive movements similar to those documented for professional throwing athletes could be origin of abnormality.	[Faivre, Jean-Philippe; Maureille, Bruno; Crevecoeur, Isabelle] Univ Bordeaux, CNRS, PACEA, Culture Environm & Anthropol UMR 5199,Unite Mixte, Talence, France; Univ Bordeaux, PACEA, Culture Environm & Anthropol UMR 5199, Unite Mixte Rech 5199, Talence, France; [Duvals, Mathieu] CENIEH, Burgos, Spain; [Gruen, Rainer] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Bemilli, Celine] INRAP, Ctr Archeolog Grand Quevilly, Grand Quevilly, France; [Bemilli, Celine] Museum Natl Hist Nat, Unite Mixte Rech Archeozool Archeobotan 7209, F-75231 Paris, France; [Bonilauri, Stephanie] ARSCAN, UMR 7071, ANTET, Nanterre, France; [Coutard, Sylvie] INRAP, Ctr Archeol Amiens, Amiens, France; [Coutard, Sylvie] Lab Geogr Phys Environm Quaternaires & Actuels, UMR 8591, Meudon, France; [Bessoul, Maryelle] Univ Bordeaux, PACEA, Prehist Actuel Culture Environm & Anthropol UMR 5, Unite Mixte Rech 5199, Talence, France; [Limondin-Lozouetn, Nicole] CNRS, Lab Geogr Phys Environm Quaternaires & Actuels, Unite Mixte Rech 8591, Meudon, France; [Deshayes, Thierry; Douillard, Aurelie] INRAP, Ctr Archeol Grand Quevilly, Grand Quevilly, France; [Henaff, Xavier; Pautret-Homerville, Caroline] INRAP, Grand Ouest Ctr Archeol Carquefou, Carquefou, France; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Trinkaus, Erik] Washington Univ, Dept Anthropol, St Louis, DC USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Australian National University; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Australian National University	Faivre, JP (corresponding author), Univ Bordeaux, CNRS, PACEA, Culture Environm & Anthropol UMR 5199,Unite Mixte, Talence, France.	jp.faivre@pacea.u-bordeaux1.fr	Duval, Mathieu/U-9446-2018; Grun, Rainer/A-1437-2012	Duval, Mathieu/0000-0003-3181-7753; Grun, Rainer/0000-0003-1366-3674; Maureille, Bruno/0000-0002-7616-0073	Inrap; Universite de Bordeaux [UMR5199 PACEA]; CNRS; MCC; Centre national de la recherche scientifique (CNRS)	Inrap; Universite de Bordeaux; CNRS(Centre National de la Recherche Scientifique (CNRS)); MCC; Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study was funded by Inrap (http://www.inrap.fr), the UMR5199 PACEA - Universite de Bordeaux, CNRS, MCC (http://www.pacea.u-bordeaux1.fr/), the Centre national de la recherche scientifique (CNRS; http://www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alduc D, 1979, B INFORM GEOLOGUES B, V16, P27; Ameloot-Van Der Heijden N, 1994, DOSS DOC ARCHEOL, V18, P63; Antoine P, 1998, QUATERNAIRE, V9, P227; Arsuaga JL, 1997, J HUM EVOL, V33, P105, DOI 10.1006/jhev.1997.0169; Arsuaga JL, 1992, HUMAN EVOLUTION EURO, P283; August Patrick, 2003, Quaternaire, V14, P5; Bak K, 2000, KNEE SURG SPORT TR A, V8, P113, DOI 10.1007/s001670050197; Balescu S, 1997, BOREAS, V26, P61; Balzeau A, 2010, J HUM EVOL, V58, P1, DOI 10.1016/j.jhevol.2009.05.016; Behrensmeyer A.K., 1990, P232; Boeda E, 1990, MEMOIRES MUSEE PREHI, V3, P63; Boeda Eric, 1988, MUTATION, V8, P41; Bonilauri S, 2012, P EUR SOC STUD HUM E, V2, P43; Cahen D, 1984, PEUPLES CHASSEURS BE, P133; CARBONELL E, 1995, SCIENCE, V269, P826, DOI 10.1126/science.7638598; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carpentier G, 1982, B CTRE GEOMORPHO CAE, V26, P31; Carpentier G, 1984, B CTR GEOMORPHOLOGIE, V29, P49; Carretero JM, 1997, J HUM EVOL, V33, P357, DOI 10.1006/jhev.1997.0128; Chung CB, 1999, AM J ROENTGENOL, V173, P351, DOI 10.2214/ajr.173.2.10430134; CLIQUET D, 1991, CR ACAD SCI II, V313, P823; Commandre F, 1977, PATHOLOGIE ABARTICUL; CONARD NJ, 1990, J ANTHROPOL RES, V46, P243, DOI 10.1086/jar.46.3.3630426; Condemi S, 1992, HOMMES FOSSILES SACC; Cordy Jean-Marie, 2003, Quaternaire, V14, P15; Cowgill LW, 2012, INT J OSTEOARCHAEOL, DOI [10.1002/(ISSN)1099-1212, DOI 10.1002/(ISSN)1099-1212]; Czarnetzki Alfred, 1999, Human Evolution, V14, P175, DOI 10.1007/BF02440155; de Lumley H, 2004, ANTHROPOLOGIE, V108, P159, DOI 10.1016/j.anthro.2004.05.001; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; deCastro JMB, 1997, SCIENCE, V276, P1392; Delagnes A, 1996, DAF, V56; Dennell R, 1996, ANTIQUITY, V70, P535, DOI 10.1017/S0003598X00083691; Depaepe P, 2007, MEM SOC PREHIST FR, V41; Descombes JC, 1983, B ASS FRANCAISE ETUD, V20, P161; Descombes JC, 1987, B CTRE GEOMORPHO, V27, P19; Duday H, 2011, ARCHEOLOGY DEAD LECT; Duday H, 1991, SQUELETTE MOUSTERIEN, V2, p[179, 179]; Faivre JP, 2012, P EUR SOC STUD HUM E, V2, P77; Fennell KJ, 1997, J ARCHAEOL SCI, V24, P985, DOI 10.1006/jasc.1996.0176; Fleisig GS, 1996, SPORTS MED, V21, P421, DOI 10.2165/00007256-199621060-00004; Fosse G, 1982, B ASS FRANCAISE ETUD, V19, P83; Gaquerel C, 1984, B CTRE GEOMORPHO CAE, V29, P85; Gouedo JM, 1994, DAF, V47, P84; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; Gran R., 2000, ANCIENT TL, V18, P1; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Guilbaud M, 1995, B SOC PREHISTORIQUE, V3, P289; Guipert G, 2011, CR PALEVOL, V10, P21, DOI 10.1016/j.crpv.2010.10.006; Haidle MN, 2010, QUATERN INT, V223, P143, DOI 10.1016/j.quaint.2010.02.009; Hambucken A, 1993, COMP AVEC HOMME MODE; Hambucken Anne, 1998, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V10, P213, DOI 10.3406/bmsap.1998.2516; HAWKEY DE, 1995, INT J OSTEOARCHAEOL, V5, P324, DOI 10.1002/oa.1390050403; Hirsch EF, 1939, ARCH SURG-CHICAGO, V39, P824, DOI 10.1001/archsurg.1939.01200170135012; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Hubling JJ, 1991, THESIS U BORDEAUX I; Hutton Estabrook V, 2013, BIOARCHAEOL IN PRESS; Jurmain R, 2010, DOCUMENT PUBLSIHED O, P2; Lautridou JP, 1982, B CTRE GEOMORPHO CAE, V26; Lautridou JP, 1977, B SOC GEOL NORMANDIE, V4, P119; Lautridou JP, 2003, QUATERNAIRE, V14, P25; Lebel S, 2002, J HUM EVOL, V43, P659, DOI 10.1006/jhev.2002.0598; Locht JL, 1994, DOSS DOC ARCHEOL, V18, P103; Ludewig PM, 2011, JOINT STRUCTURE FUNC, P230; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Maki JM, 2013, THESIS WASHINGTON U; Mann A, 2008, NEW INSIGHTS KRAPINA, P261; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; McCown TD, 1939, STONE AGE MOUTN CARM; Mednikova MB, 2010, ARCHAEOL ETHNOL ANTH, V38, P102, DOI 10.1016/j.aeae.2010.05.013; Meyer V, 2013, THESIS U BORDEAUX I, P1; Monge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064539; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Oms O, 2000, P NATL ACAD SCI USA, V97, P10666, DOI 10.1073/pnas.180319797; Otte M, 1990, HELINIUM, V24, P3; Patte E, 1957, ENFANT NEANDERTHELAI; Puissegur JJ, 1983, B CTRE GEOMORPHO CAE, V26, P151; Revillion S, 1995, B SOC PREHISTORIQUE, V92, P425, DOI [10.3406/bspf.1995.10058, DOI 10.3406/BSPF.1995.10058]; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499; ROEBROEKS W, 1994, ANTIQUITY, V68, P489, DOI 10.1017/S0003598X00047001; ROEBROEKS W, 1992, CURR ANTHROPOL, V33, P551, DOI 10.1086/204113; Rougier H, 2003, ETUDE DESCRIPTIVE CO; Rousseau DD, 1986, B CTR GEOMORPH CAEN, V31, P5; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Schick KD, 1986, BAR INT SERIES; Shang H, 2008, AM J PHYS ANTHROPOL, V135, P431, DOI 10.1002/ajpa.20763; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Spoor F, 1998, AM J PHYS ANTHROPOL, V107, P41, DOI 10.1002/(SICI)1096-8644(199809)107:1<41::AID-AJPA4>3.0.CO;2-G; Stremme HE, 1985, B ASS FRANCAISE ETUD, V2-3, P159; Stringer CB, 1998, J HUM EVOL, V34, P509, DOI 10.1006/jhev.1998.0215; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Thieme H, 2007, THESIS; Trinkaus, 2014, SHANIDAR NEANDERTALS; Trinkaus E, 1999, J ARCHAEOL SCI, V26, P753, DOI 10.1006/jasc.1998.0345; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; TRINKAUS E, 1988, AM J PHYS ANTHROPOL, V75, P15, DOI 10.1002/ajpa.1330750103; Trinkaus E, 1999, J ARCHAEOL SCI, V26, P173, DOI 10.1006/jasc.1998.0314; Trinkaus E, 2014, PEOPLE SUNGHIR BURAI; Trinkaus E, 2008, AM J PHYS ANTHROPOL, V137, P106, DOI 10.1002/ajpa.20833; Tuffreau A, 1994, B SOC PREHISTORIQUE, V91, P23; Tuffreau A, 1988, MEM SOC PREHIST FR, V21; Turq A, 2013, J HUM EVOL, V65, P641, DOI 10.1016/j.jhevol.2013.07.014; Vallin L, 1991, CAHIERS QUATERNAIRE, V16, P241; VANDERMEERSCH B, 1995, J HUM EVOL, V28, P439, DOI 10.1006/jhev.1995.1034; Vandermeersch B, 1982, HOMO ERECTUS PLACE H, P894; Villa P, 2010, J ANTHROPOL RES, V66, P5, DOI 10.3998/jar.0521004.0066.102; Villotte S, 2013, INT J OSTEOARCHAEOL, V23, P135, DOI 10.1002/oa.2289; Villotte S, 2009, BAR INT SERIES; Volpato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043949; Voorhies MR, 1969, U WYOMING CONTRIBUTI, V1, P1, DOI DOI 10.2113/GSROCKY.8.SPECIAL_PAPER_1.1; Weiner J, 1964, SWANSCOMBE SKULL, P175; Wu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059587; Wu XJ, 2011, P NATL ACAD SCI USA, V108, P19558, DOI 10.1073/pnas.1117113108	114	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e104111	10.1371/journal.pone.0104111	http://dx.doi.org/10.1371/journal.pone.0104111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AT8TE	25295956	Green Published, gold			2022-12-27	WOS:000345204000002
J	Saluveer, O; Larsson, P; Ridderstrale, W; Hrafnkelsdottir, TJ; Jern, S; Bergh, N				Saluveer, Ott; Larsson, Pia; Ridderstrale, Wilhelm; Hrafnkelsdottir, Thordis J.; Jern, Sverker; Bergh, Niklas			Profibrinolytic Effect of the Epigenetic Modifier Valproic Acid in Man	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; RECURRENT MYOCARDIAL-INFARCTION; IN-VIVO; ENDOTHELIAL-CELLS; IMPAIRED CAPACITY; PAI-1 COMPLEX; ACUTE RELEASE; RISK-FACTOR; T-PA; HYPERTENSION	Aims: The aim of the study was to test if pharmacological intervention by valproic acid (VPA) treatment can modulate the fibrinolytic system in man, by means of increased acute release capacity of tissue plasminogen activator (t-PA) as well as an altered t-PA/Plasminogen activator inhibitor -1 (PAI-1) balance. Recent data from in vitro research demonstrate that the fibrinolytic system is epigenetically regulated mainly by histone deacetylase (HDAC) inhibitors. HDAC inhibitors, including VPA markedly upregulate t-PA gene expression in vitro. Methods and Results: The trial had a cross-over design where healthy men (n = 10), were treated with VPA (Ergenyl Retard) 500 mg depot tablets twice daily for 2 weeks. Capacity for stimulated t-PA release was assessed in the perfused-forearm model using intra-brachial Substance P infusion and venous occlusion plethysmography. Each subject was investigated twice, untreated and after VPA treatment, with 5 weeks wash-out in-between. VPA treatment resulted in considerably decreased levels of circulating PAI-1 antigen from 22.2 (4.6) to 10.8 (2.1) ng/ml (p<0.05). It slightly decreased the levels of circulating venous t-PA antigen (p<0.05), and the t-PA: PAI-1 antigen ratio increased (p<0.01). Substance P infusion resulted in an increase in forearm blood flow (FBF) on both occasions (p<0.0001 for both). The acute t-PA release in response to Substance P was not affected by VPA (p = ns). Conclusion: Valproic acid treatment lowers plasma PAI-1 antigen levels and changes the fibrinolytic balance measured as tPA/PAI-1 ratio in a profibrinolytic direction. This may in part explain the reduction in incidence of myocardial infarctions by VPA treatment observed in recent pharmacoepidemiological studies.	[Saluveer, Ott; Larsson, Pia; Ridderstrale, Wilhelm; Hrafnkelsdottir, Thordis J.; Jern, Sverker; Bergh, Niklas] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Hrafnkelsdottir, Thordis J.] Landspitali Univ Hosp, Dept Cardiol, Reykjavik, Iceland; [Hrafnkelsdottir, Thordis J.] Univ Iceland, Reykjavik, Iceland	University of Gothenburg; Landspitali National University Hospital; University of Iceland	Saluveer, O (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden.	ott.saluveer@gu.se		Bergh, Niklas/0000-0002-7440-2366; Hrafnkelsdottir, THordis Jona/0000-0002-4398-2898; Larsson, Pia/0000-0001-9115-4213	Swedish Heart-Lung Foundation; Swedish Research Council; Emelle Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Emelle Foundation	The study was supported by research grants from The Swedish Heart-Lung Foundation, the Swedish Research Council, and the Emelle Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2004, ARCH MAL COEUR VAISS, V97, P673; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Brogren H, 2008, THROMB RES, V122, P271, DOI 10.1016/j.thromres.2008.04.008; Brogren H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026762; CARMELIET P, 1995, THROMB HAEMOSTASIS, V74, P429; CHANDLER WL, 1990, BLOOD, V76, P930; Chandler WL, 1997, CIRCULATION, V96, P761; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; EMEIS JJ, 1992, ANN NY ACAD SCI, V667, P249, DOI 10.1111/j.1749-6632.1992.tb51622.x; Fogari R, 2006, AM J HYPERTENS, V19, P1293, DOI 10.1016/j.amjhyper.2006.04.013; HAMSTEN A, 1987, LANCET, V2, P3; Hrafnkelsdottir T, 2004, J THROMB HAEMOST, V2, P1960, DOI 10.1111/j.1538-7836.2004.00948.x; Hrafnkelsdottir T, 1998, LANCET, V352, P1597, DOI 10.1016/S0140-6736(05)61044-6; Hrafnkelsdottir T, 2001, THROMB HAEMOSTASIS, V85, P875; Hrafnkelsdottir T, 2004, HYPERTENSION, V44, P300, DOI 10.1161/01.HYP.0000137380.91476.fb; Koenig S, 2008, BLOOD COAGUL FIBRIN, V19, P375, DOI 10.1097/MBC.0b013e3282f3f9ec; Larsson P, 2013, J THROMB THROMBOLYS, V35, P185, DOI 10.1007/s11239-012-0831-6; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Newby DE, 2001, CIRCULATION, V103, P1936; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P964, DOI 10.1002/pds.2186; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Osterlund B, 2008, ACTA ANAESTH SCAND, V52, P1375, DOI 10.1111/j.1399-6576.2008.01741.x; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Ridderstrale W, 2006, HYPERTENSION, V47, P686, DOI 10.1161/01.HYP.0000210540.35296.62; Ridderstrale W, 2011, J THROMB THROMBOLYS, V32, P399, DOI 10.1007/s11239-011-0595-4; Ridker, 1994, J Thromb Thrombolysis, V1, P35, DOI 10.1007/BF01061993; Robinson SD, 2007, ARTERIOSCL THROM VAS, V27, P1651, DOI 10.1161/ATVBAHA.107.143248; SALOMAA V, 1995, CIRCULATION, V91, P284, DOI 10.1161/01.CIR.91.2.284; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tjarnlund-Wolf A, 2012, STROKE, V43, P2833, DOI 10.1161/STROKEAHA.111.622217; Wall U, 1997, J HYPERTENS, V15, P1641, DOI 10.1097/00004872-199715120-00066; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019	34	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107582	10.1371/journal.pone.0107582	http://dx.doi.org/10.1371/journal.pone.0107582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295869	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204000008
J	Viruel, J; Catalan, P; Segarra-Moragues, JG				Viruel, Juan; Catalan, Pilar; Segarra-Moragues, Jose Gabriel			Latitudinal Environmental Niches and Riverine Barriers Shaped the Phylogeography of the Central Chilean Endemic Dioscorea humilis (Dioscoreaceae)	PLOS ONE			English	Article							LIOLAEMUS-MONTICOLA; GENETIC DIVERSITY; NORTHERN CHILE; MICROSATELLITE; SOFTWARE; DISPERSAL; EPIPETRUM; PATTERNS; MAXIMUM; REFUGIA	The effects of Pleistocene glaciations and geographical barriers on the phylogeographic patterns of lowland plant species in Mediterranean-climate areas of Central Chile are poorly understood. We used Dioscorea humilis (Dioscoreaceae), a dioecious geophyte extending 530 km from the Valparaiso to the Bio-Bio Regions, as a case study to disentangle the spatio-temporal evolution of populations in conjunction with latitudinal environmental changes since the Last Inter-Glacial (LIG) to the present. We used nuclear microsatellite loci, chloroplast (cpDNA) sequences and environmental niche modelling (ENM) to construct current and past scenarios from bioclimatic and geographical variables and to infer the evolutionary history of the taxa. We found strong genetic differentiation at nuclear microsatellite loci between the two subspecies of D. humilis, probably predating the LIG. Bayesian analyses of population structure revealed strong genetic differentiation of the widespread D. humilis subsp. humilis into northern and southern population groups, separated by the Maipo river. ENM revealed that the ecological niche differentiation of both groups have been maintained up to present times although their respective geographical distributions apparently fluctuated in concert with the climatic oscillations of the Last Glacial Maximum (LGM) and the Holocene. Genetic data revealed signatures of eastern and western postglacial expansion of the northern populations from the central Chilean depression, whereas the southern ones experienced a rapid southward expansion after the LGM. This study describes the complex evolutionary histories of lowland Mediterranean Chilean plants mediated by the summed effects of spatial isolation caused by riverine geographical barriers and the climatic changes of the Quaternary.	[Viruel, Juan; Catalan, Pilar] Univ Zaragoza, Escuela Politecn Super Huesca, Dept Agr & Econ Agr, Huesca, Spain; [Catalan, Pilar] Tomsk State Univ, Inst Biol, Dept Bot, Tomsk 634050, Russia; [Segarra-Moragues, Jose Gabriel] CSIC, Ctr Invest Desertificac CIDE, Dept Ecol, Valencia, Spain	University of Zaragoza; Tomsk State University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Segarra-Moragues, JG (corresponding author), CSIC, Ctr Invest Desertificac CIDE, Dept Ecol, Valencia, Spain.	jogasemo@gmail.com	Viruel, Juan/H-4227-2015; Segarra-Moragues, José Gabriel/I-7352-2012; Catalan, Pilar/N-7641-2014; Catalan, Pilar/AAL-8833-2020	Viruel, Juan/0000-0001-5658-8411; Segarra-Moragues, José Gabriel/0000-0003-0061-8647; Catalan Rodriguez, Maria Pilar/0000-0001-7793-5259	Fundacion BBVA BIOCON [05-093/06]; Fundacion BBVA Ph.D. grant; Spanish Aragon Government "Araid"; Spanish Ministry of Science and Innovation "Ramon y Cajal"; Bioflora; Spanish Aragon Government; European Social Fund	Fundacion BBVA BIOCON(BBVA Foundation); Fundacion BBVA Ph.D. grant(BBVA Foundation); Spanish Aragon Government "Araid"; Spanish Ministry of Science and Innovation "Ramon y Cajal"(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Bioflora; Spanish Aragon Government(Gobierno de Aragon); European Social Fund(European Social Fund (ESF))	Financial support for this study was provided by a Fundacion BBVA BIOCON 05-093/06 project grant to PC and JGSM. JV was supported by a Fundacion BBVA Ph.D. grant. JGSM was supported by two consecutive Spanish Aragon Government "Araid" and Spanish Ministry of Science and Innovation "Ramon y Cajal" postdoctoral contracts. PC was partially funded by a Bioflora (http://bifi.es/bioflora/) research team grant co-funded by the Spanish Aragon Government and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo J, 1998, PLANT ECOL, V136, P9, DOI 10.1023/A:1009714201917; Belkhir K, 2004, 5000 CNRS UMR LAB GE; Bonilla CA, 2011, J HYDROL, V410, P126, DOI 10.1016/j.jhydrol.2011.09.022; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Bull-Herenu K, 2005, J BIOGEOGR, V32, P1129, DOI 10.1111/j.1365-2699.2004.01209.x; Canestrelli D, 2008, J BIOGEOGR, V35, P1923, DOI 10.1111/j.1365-2699.2008.01946.x; Castillo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-266; Caviedes CN, 1975, J GLACIOL, V14, P155; CLAPPERTON CM, 1994, REV CHIL HIST NAT, V67, P369; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Dillon MO, 2009, J SYST EVOL, V47, P457, DOI 10.1111/j.1759-6831.2009.00040.x; Donato M, 2006, J ARID ENVIRON, V66, P421, DOI 10.1016/j.jaridenv.2006.01.006; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Goudet J, 2001, FSTAT V 2 9 3 2 PROG; GRAF K, 1994, REV CHIL HIST NAT, V67, P405; Grill A, 2009, MOL ECOL, V18, P2687, DOI 10.1111/j.1365-294X.2009.04215.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HASUMI H, 2004, 1 K1 U TOK CTR CLIM; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jabaily RS, 2010, AM J BOT, V97, P337, DOI 10.3732/ajb.0900107; Lamborot M, 1997, J ZOOL SYST EVOL RES, V35, P105; Lamy F, 1999, QUATERNARY RES, V51, P83, DOI 10.1006/qres.1998.2010; Langella O, 2000, POPULATIONS LOGICIEL; Li YC, 2000, MOL BIOL EVOL, V17, P851, DOI 10.1093/oxfordjournals.molbev.a026365; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Orme A.R., 2007, PHYS GEOGRAPHY S AM, P184; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pease KM, 2009, MOL ECOL, V18, P1848, DOI 10.1111/j.1365-294X.2009.04112.x; Pezoa L, 2003, THESIS U AUSTRAL CHI; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pritchard JK, 2002, DOCUMENTATION STRUCT; Rohlf FJ, 2002, NTSYSPC NUMERICAL TA; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sallaberry-Pincheira N, 2011, DIVERS DISTRIB, V17, P152, DOI 10.1111/j.1472-4642.2010.00729.x; SANTANAAGUILAR M, 1973, B ASS GEOGRAPHY FRAN, V406, P473; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Segarra-Moragues JG, 2005, MOL ECOL, V14, P969, DOI 10.1111/j.1365-294X.2005.02482.x; Segarra-Moragues JG, 2007, J BIOGEOGR, V34, P1893, DOI 10.1111/j.1365-2699.2007.01740.x; SLATKIN M, 1995, GENETICS, V139, P457; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1983, GENETICS, V105, P437; Van Heusen C., 1967, GEOGRAPHISCHE HEFTE, V4, P1; Vasquez M, 2007, HERPETOL J, V17, P149; Veit H, 1996, PALAEOGEOGR PALAEOCL, V123, P107, DOI 10.1016/0031-0182(95)00118-2; VILLAGRAN C, 1991, REV CHIL HIST NAT, V64, P447; Villagran C, 2001, REV CHIL HIST NAT, V74, P783; Viruel J, 2008, NEW ZEAL J BOT, V46, P327, DOI 10.1080/00288250809509771; Viruel J, 2012, J BIOGEOGR, V39, P1073, DOI 10.1111/j.1365-2699.2011.02658.x; Viruel J, 2010, AM J BOT, V97, pE121, DOI 10.3732/ajb.1000304; Viruel J, 2010, SYST BOT, V35, P40, DOI 10.1600/036364410790862579; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zhang ZY, 2007, BIOCHEM SYST ECOL, V35, P506, DOI 10.1016/j.bse.2007.01.014	62	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e110029	10.1371/journal.pone.0110029	http://dx.doi.org/10.1371/journal.pone.0110029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295517	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000110
J	Garcia-R, JC; Gibb, GC; Trewick, SA				Garcia-R, Juan C.; Gibb, Gillian C.; Trewick, Steve A.			Eocene Diversification of Crown Group Rails (Aves: Gruiformes: Rallidae)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; FOSSIL RECORD; MODERN BIRDS; EVOLUTIONARY HISTORY; EARLY OLIGOCENE; PHYLOGENY; DNA; TERTIARY; SEQUENCES; BIOGEOGRAPHY	Central to our understanding of the timing of bird evolution is debate about an apparent conflict between fossil and molecular data. A deep age for higher level taxa within Neoaves is evident from molecular analyses but much remains to be learned about the age of diversification in modern bird families and their evolutionary ecology. In order to better understand the timing and pattern of diversification within the family Rallidae we used a relaxed molecular clock, fossil calibrations, and complete mitochondrial genomes from a range of rallid species analysed in a Bayesian framework. The estimated time of origin of Rallidae is Eocene, about 40.5 Mya, with evidence of intrafamiliar diversification from the Late Eocene to the Miocene. This timing is older than previously suggested for crown group Rallidae, but fossil calibrations, extent of taxon sampling and substantial sequence data give it credence. We note that fossils of Eocene age tentatively assigned to Rallidae are consistent with our findings. Compared to available studies of other bird lineages, the rail clade is old and supports an inference of deep ancestry of ground-dwelling habits among Neoaves.	[Garcia-R, Juan C.; Gibb, Gillian C.; Trewick, Steve A.] Massey Univ, Inst Agr & Environm, Phoenix Lab, Ecol Grp, Palmerston North, New Zealand	Massey University	Garcia-R, JC (corresponding author), Massey Univ, Inst Agr & Environm, Phoenix Lab, Ecol Grp, Palmerston North, New Zealand.	j.c.garciaramirez@massey.ac.nz	Garcia-R, Juan C./X-3399-2019; Gibb, Gillian/AAF-9175-2020	Garcia-R, Juan C./0000-0002-6665-9671; Gibb, Gillian/0000-0002-4283-9790; Trewick, Steven/0000-0002-4680-8457	Royal Society of New Zealand; Institute of Agriculture and Environment at Massey University	Royal Society of New Zealand(Royal Society of New Zealand); Institute of Agriculture and Environment at Massey University	This work was assisted by the Hutton Fund (JCGR) of the Royal Society of New Zealand and the Institute of Agriculture and Environment at Massey University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin FL, 2012, PALAEONTOL Z, V86, P85, DOI 10.1007/s12542-011-0112-2; Agnolin FL, 2006, AMEGHINIANA, V43, P245; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Baker AJ, 2014, MOL BIOL EVOL; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton Michael J., 2009, P35; Brocklehurst N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039056; Brown J.W., 2011, LIVING DINOSAURS EVO, P306; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Brown JW, 2007, BIOL LETTERS, V3, P257, DOI 10.1098/rsbl.2006.0611; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clements J.F., 2012, CLEMENTS CHECKLIST B; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; De Pietri VL, 2014, J ZOOL SYS EVOL RES; Drummond A.J., 2012, GENEIOUS V6 05; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dyke GJ, 2008, CLADISTICS, V24, P77, DOI 10.1111/j.1096-0031.2007.00188.x; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; Elzanowski A, 2011, AUK, V128, P138, DOI 10.1525/auk.2011.10113; Eo SH, 2010, P R SOC B; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2007, MOL PHYLOGENET EVOL, V43, P515, DOI 10.1016/j.ympev.2007.02.015; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Fordyce R.E., 1990, P419; FORDYCE RE, 1986, GEOLOGICAL SOC NZ NE, V74, P56; Fountaine TMR, 2005, P ROY SOC B-BIOL SCI, V272, P289, DOI 10.1098/rspb.2004.2923; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haddrath O, 2001, P ROY SOC B-BIOL SCI, V268, P939, DOI 10.1098/rspb.2001.1587; Haddrath O, 2012, P R SOC B; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holland BR, 2003, SYST BIOL, V52, P229, DOI 10.1080/10635150390192771; Hou Lianhai, 1990, Vertebrata Palasiatica, V28, P34; HOUDE P, 1986, NATURE, V324, P563, DOI 10.1038/324563a0; HOUDE P, 1981, SCIENCE, V214, P1236, DOI 10.1126/science.214.4526.1236; Houde Peter, 2009, P440; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; JOHNSON NK, 1989, CONDOR, V91, P379, DOI 10.2307/1368317; Jonsson KA, 2010, J BIOGEOGR, V37, P245, DOI 10.1111/j.1365-2699.2009.02220.x; Kan X-Z, CHARACTERIZATI UNPUB; Kirchman JJ, 2012, AUK, V129, P56, DOI 10.1525/auk.2011.11096; Kirchman JJ, 2009, BIOL J LINN SOC, V96, P601, DOI 10.1111/j.1095-8312.2008.01160.x; Krajewski C, 2010, AUK, V127, P440, DOI 10.1525/auk.2009.09045; Ksepka DT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0677; Lanfear R, 2007, P NATL ACAD SCI USA, V104, P15388, DOI 10.1073/pnas.0703359104; Lepage D, 2013, AVIBASE WORLD BIRD D; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Lindow BEK, 2006, BIOL REV, V81, P483, DOI 10.1017/S146479310600707X; Livezey BC, 2003, EVOLUTION FLIGHTLESS; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G, 2006, ARDEA, V94, P23; Mayr G, 2014, J ROY SOC NEW ZEAL, V44, P48, DOI 10.1080/03036758.2013.863788; Mayr G, 2001, GEOBIOS-LYON, V34, P547, DOI 10.1016/S0016-6995(01)80069-3; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2006, CONDOR, V108, P717, DOI 10.1650/0010-5422(2006)108[717:ASSPBF]2.0.CO;2; Mayr G, 2014, PALAEONTOLOGY, V57, P231, DOI 10.1111/pala.12103; Mayr G, 2013, SYST BIODIVERS, V11, P7, DOI 10.1080/14772000.2013.765521; Mayr G, 2011, J ZOOL SYST EVOL RES, V49, P58, DOI 10.1111/j.1439-0469.2010.00586.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1977, RAILS WORLD MONOGRAP, P339; OLSON SL, 1973, WILSON BULL, V85, P381; Olson SL, 2003, P BIOL SOC WASH, V116, P732; Olson SL, 1989, P 19 INT ORN C, P2023; Ozaki K, 2010, GENES GENET SYST, V85, P55, DOI 10.1266/ggs.85.55; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Paton TA, 2003, MOL PHYLOGENET EVOL, V29, P268, DOI 10.1016/S1055-7903(03)00098-8; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pratt RC, 2009, MOL BIOL EVOL, V26, P313, DOI 10.1093/molbev/msn248; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruan LZ, 2012, BIOCHEM GENET, V50, P959, DOI 10.1007/s10528-012-9535-z; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Slikas B, 2002, J AVIAN BIOL, V33, P5, DOI 10.1034/j.1600-048X.2002.330103.x; Smith VS, 2011, BIOL LETTERS, V7, P782, DOI 10.1098/rsbl.2011.0105; Springer MS, 1996, J MOL EVOL, V43, P357; Stidham TA, 1998, NATURE, V396, P29, DOI 10.1038/23841; Tennyson AJD, 2010, REC AUST MUS, V62, P105, DOI 10.3853/j.0067-1975.62.2010.1546; Trewick SA, 1997, PHILOS T R SOC B, V352, P429, DOI 10.1098/rstb.1997.0031; Trewick SA, 2010, IBIS, V152, P226, DOI 10.1111/j.1474-919X.2010.01018.x; Van Perlo, 1998, RAILS GUIDE RAILS CR; Wang ML, 2012, INT CONF SPEECH DATA, P1, DOI 10.1109/ICSDA.2012.6422457; Wetmore A., 1931, Condor Berkeley, V33, P107, DOI 10.2307/1363575; White NE, 2011, MOL PHYLOGENET EVOL, V59, P615, DOI 10.1016/j.ympev.2011.03.011; Worthy TH, 2007, J SYST PALAEONTOL, V5, P1, DOI 10.1017/S1477201906001957; Yang R, 2010, MOL BIOL REP, V37, P3057, DOI 10.1007/s11033-009-9878-7; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	113	22	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109635	10.1371/journal.pone.0109635	http://dx.doi.org/10.1371/journal.pone.0109635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291147	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000074
J	McCullough, RM; Almasri, EA; Guan, XJ; Geis, JA; Hicks, SC; Mazloom, AR; Deciu, C; Oeth, P; Bombard, AT; Paxton, B; Dharajiya, N; Saldivar, JS				McCullough, Ron M.; Almasri, Eyad A.; Guan, Xiaojun; Geis, Jennifer A.; Hicks, Susan C.; Mazloom, Amin R.; Deciu, Cosmin; Oeth, Paul; Bombard, Allan T.; Paxton, Bill; Dharajiya, Nilesh; Saldivar, Juan-Sebastian			Non-Invasive Prenatal Chromosomal Aneuploidy Testing - Clinical Experience: 100,000 Clinical Samples	PLOS ONE			English	Article							CONFINED PLACENTAL MOSAICISM; FETAL ANEUPLOIDY; DNA; DIAGNOSIS; AMNIOCENTESIS	Objective: As the first laboratory to offer massively parallel sequencing-based noninvasive prenatal testing (NIPT) for fetal aneuploidies, Sequenom Laboratories has been able to collect the largest clinical population experience data to date, including >100,000 clinical samples from all 50 U.S. states and 13 other countries. The objective of this study is to give a robust clinical picture of the current laboratory performance of the MaterniT21 PLUS LDT. Study Design: The study includes plasma samples collected from patients with high-risk pregnancies in our CLIA-licensed, CAP-accredited laboratory between August 2012 to June 2013. Samples were assessed for trisomies 13, 18, 21 and for the presence of chromosome Y-specific DNA. Sample data and ad hoc outcome information provided by the clinician was compiled and reviewed to determine the characteristics of this patient population, as well as estimate the assay performance in a clinical setting. Results: NIPT patients most commonly undergo testing at an average of 15 weeks, 3 days gestation; and average 35.1 years of age. The average turnaround time is 4.54 business days and an overall 1.3% not reportable rate. The positivity rate for Trisomy 21 was 1.51%, followed by 0.45% and 0.21% rate for Trisomies 18 and 13, respectively. NIPT positivity rates are similar to previous large clinical studies of aneuploidy in women of maternal age >= 35 undergoing amniocentesis. In this population 3519 patients had multifetal gestations (3.5%) with 2.61% yielding a positive NIPT result. Conclusion: NIPT has been commercially offered for just over 2 years and the clinical use by patients and clinicians has increased significantly. The risks associated with invasive testing have been substantially reduced by providing another assessment of aneuploidy status in high-risk patients. The accuracy and NIPT assay positivity rate are as predicted by clinical validations and the test demonstrates improvement in the current standard of care.	[McCullough, Ron M.; Almasri, Eyad A.; Guan, Xiaojun; Geis, Jennifer A.; Hicks, Susan C.; Mazloom, Amin R.; Deciu, Cosmin; Oeth, Paul; Bombard, Allan T.; Paxton, Bill; Dharajiya, Nilesh; Saldivar, Juan-Sebastian] Sequenom Labs, San Diego, CA 92121 USA	Sequenom	McCullough, RM (corresponding author), Sequenom Labs, San Diego, CA 92121 USA.	rmccullough@sequenom.com						Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Devers P, 2012, NONINVASIVE PRENATAL; FERGUSONSMITH MA, 1984, PRENATAL DIAG, V4, P5, DOI 10.1002/pd.1970040704; Forabosco A, 2009, EUR J HUM GENET, V17, P897, DOI 10.1038/ejhg.2008.265; Futch T, 2013, PRENATAL DIAG, V33, P569, DOI 10.1002/pd.4123; Jensen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057381; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Lestou VS, 1998, ARCH DIS CHILD-FETAL, V79, pF223, DOI 10.1136/fn.79.3.F223; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Norwitz Errol R, 2013, Rev Obstet Gynecol, V6, P48; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Tabor A, 2009, ULTRASOUND OBST GYN, V34, P19, DOI 10.1002/uog.6377; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Wilkins-Haug L, 2006, PRENATAL DIAG, V26, P428, DOI 10.1002/pd.1430; ZIMMERMAN B, 2012, PRENATAL DIAGNOSIS, V32, P1	24	89	102	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109173	10.1371/journal.pone.0109173	http://dx.doi.org/10.1371/journal.pone.0109173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289665	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000044
J	Su, BB; Xu, BX; Wan, J				Su, Binbin; Xu, Baixuan; Wan, Jun			Correlation between Long-Term Aspirin Use and F-Fluorodeoxyglucose Uptake in Colorectal Cancer Measured by PET/CT	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUES; LOW-DOSE ASPIRIN; FDG-PET; TUMOR VASCULATURE; EARLY PREDICTION; BREAST-CANCER; F-18-FDG PET; CHEMOTHERAPY; ESOPHAGEAL	Purpose: The aim of this study was to evaluate the relationship between long-term aspirin use with pretreatment 18 Fluorodeoxyglucose (FDG) uptake of primary lesions of Colorectal cancer (CRC) and evaluate their clinical significance. Materials and Methods: We enrolled 84 patients with CRC who underwent 18F-FDG PET/CT scanning before surgery between 1st July 2008 and 1st March 2013 and followed up until 1st March 2014. Maximum standardized uptake value (SUVmax) of the primary tumor was measured by 18F-FDG PET/CT. The history of aspirin taken and other clinicopathogical factors were also obtained and their relationships were examined by Mann-Whitney or chi 2 tests. Progression-free survival (PFS) was determined by standard Kaplan-Meier survival analysis. Cox proportional hazards regression was performed to determine whether history of aspirin taken, pretreatment SUVmax, age, gender, TNM stage, tumor sizes and differentiation influenced outcomes. Results: CRC Patients with long-term history of aspirin use had lower SUVmax of primary lesions than control group (9.74 +/- 2.62 vs. 13.91 +/- 6.18) and showed a trend towards improved PFS after curative surgery. However, pretreatment of SUVmax showed no prognostic value in patients with CRC. Conclusions: Long-term aspirin use is associated with lower pretreatment SUVmax of CRC and is a promising prognostic factor for predicting PFS in patients with CRC.	[Su, Binbin; Wan, Jun] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Xu, Baixuan] Chinese Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Xu, BX (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing, Peoples R China.	xubxpla@126.com; wanjunpla@126.com			Beijing Municipal Natural Science Foundation of China [14G30118]	Beijing Municipal Natural Science Foundation of China	This work was supported by a grant from Beijing Municipal Natural Science Foundation of China (No. 14G30118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti R, 2014, BREAST, V23, P334, DOI 10.1016/j.breast.2014.01.001; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Bystrom P, 2009, ANN ONCOL, V20, P1057, DOI 10.1093/annonc/mdn744; Cardwell CR, 2014, GASTROENTEROLOGY, V146, P700, DOI 10.1053/j.gastro.2013.11.005; Cerfolio RJ, 2006, ANN THORAC SURG, V82, P391, DOI 10.1016/j.athoracsur.2006.03.045; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Chen SW, 2014, CLIN NUCL MED, V39, P685, DOI 10.1097/RLU.0000000000000481; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; CREAGAN ET, 1991, J CLIN ONCOL, V9, P2104, DOI 10.1200/JCO.1991.9.12.2104; Crippa F, 1998, EUR J NUCL MED, V25, P1429, DOI 10.1007/s002590050319; de Geus-Oei LF, 2008, ANN ONCOL, V19, P348, DOI 10.1093/annonc/mdm470; Dierckx RA, 2008, EUR J NUCL MED MOL I, V35, P1544, DOI 10.1007/s00259-008-0758-5; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Evangelista V, 2006, CIRC RES, V98, P593, DOI 10.1161/01.RES.0000214553.37930.3e; Findlay M, 1996, J CLIN ONCOL, V14, P700, DOI 10.1200/JCO.1996.14.3.700; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Furuta M, 1997, EUR J NUCL MED, V24, P435, DOI 10.1007/BF00881817; Gayed I, 2004, J NUCL MED, V45, P17; HABERKORN U, 1991, J NUCL MED, V32, P1548; Hong D, 2005, CANCER-AM CANCER SOC, V104, P1620, DOI 10.1002/cncr.21356; ICHIYA Y, 1991, J NUCL MED, V32, P1655; Ikenaga N, 2007, AM SURGEON, V73, P1151; Il Na I, 2008, CLIN CANCER RES, V14, P2036, DOI 10.1158/1078-0432.CCR-07-4074; Izuishi K, 2010, J GASTROINTEST SURG, V14, P1151, DOI 10.1007/s11605-010-1207-x; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonsson F, 2013, BRIT J CANCER, V109, P1921, DOI 10.1038/bjc.2013.411; Kato H, 2009, CANCER-AM CANCER SOC, V115, P3196, DOI 10.1002/cncr.24399; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Kumar A, 2012, MOL CELL BIOCHEM, V371, P43, DOI 10.1007/s11010-012-1421-9; Kumar A, 2012, BIOSCIENCE REP, V32, P91, DOI 10.1042/BSR20110027; LEBEAU B, 1993, CANCER, V71, P1741, DOI 10.1002/1097-0142(19930301)71:5<1741::AID-CNCR2820710507>3.0.CO;2-Q; Lee JE, 2012, WORLD J GASTROENTERO, V18, P5072, DOI 10.3748/wjg.v18.i36.5072; McCowan C, 2013, EUR J CANCER, V49, P1049, DOI 10.1016/j.ejca.2012.10.024; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Radziwon-Balicka A, 2012, CAN J PHYSIOL PHARM, V90, P679, DOI [10.1139/Y2012-036, 10.1139/y2012-036]; Riedl CC, 2007, J NUCL MED, V48, P771, DOI 10.2967/jnumed.106.037291; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; RUMBLE RH, 1980, BRIT J CLIN PHARMACO, V9, P41, DOI 10.1111/j.1365-2125.1980.tb04794.x; Symeonidis D, 2012, WORLD J GASTRO ENDOS, V4, P409, DOI 10.4253/wjge.v4.i9.409; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Walker AJ, 2012, BRIT J CANCER, V107, P1602, DOI 10.1038/bjc.2012.427	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109459	10.1371/journal.pone.0109459	http://dx.doi.org/10.1371/journal.pone.0109459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290692	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000062
J	Zhang, XL; Wang, Q; Gilliam, FS; Wang, YL; Cha, FN; Li, CH				Zhang, Xuelin; Wang, Qun; Gilliam, Frank S.; Wang, Yilun; Cha, Feina; Li, Chaohai			Spatial Variation in Carbon and Nitrogen in Cultivated Soils in Henan Province, China: Potential Effect on Crop Yield	PLOS ONE			English	Article							ORGANIC-MATTER CONTENT; WATER-RETENTION; STORAGE; PRODUCTIVITY; EROSION; BALANCE; TOPSOIL; REGION; STOCKS	Improved management of soil carbon (C) and nitrogen (N) storage in agro-ecosystems represents an important strategy for ensuring food security and sustainable agricultural development in China. Accurate estimates of the distribution of soil C and N stores and their relationship to crop yield are crucial to developing appropriate cropland management policies. The current study examined the spatial variation of soil organic C (SOC), total soil N (TSN), and associated variables in the surface layer (0-40 cm) of soils from intensive agricultural systems in 19 counties within Henan Province, China, and compared these patterns with crop yield. Mean soil C and N concentrations were 14.9 g kg(-1) and 1.37 g kg(-1), respectively, whereas soil C and N stores were 4.1 kg m(-2) and 0.4 kg m(-2), respectively. Total crop production of each county was significantly, positively related to SOC, TSN, soil C and N store, and soil C and N stock. Soil C and N were positively correlated with soil bulk density but negatively correlated with soil porosity. These results indicate that variations in soil C could regulate crop yield in intensive agricultural systems, and that spatial patterns of C and N levels in soils may be regulated by both climatic factors and agro-ecosystem management. When developing suitable management programs, the importance of soil C and N stores and their effects on crop yield should be considered.	[Zhang, Xuelin; Wang, Qun; Wang, Yilun; Li, Chaohai] Incubation Base Natl Key Lab Physiol Ecol & Genet, Zhengzhou, Peoples R China; [Zhang, Xuelin; Wang, Qun; Wang, Yilun; Li, Chaohai] Henan Agr Univ, Agron Coll, Zhengzhou, Peoples R China; [Gilliam, Frank S.] Marshall Univ, Dept Biol Sci, Huntington, WV USA; [Cha, Feina] Meteorol Bur Zhengzhou, Zhengzhou, Peoples R China	Henan Agricultural University; Marshall University	Zhang, XL (corresponding author), Incubation Base Natl Key Lab Physiol Ecol & Genet, Zhengzhou, Peoples R China.	xuelinzhang1998@163.com	Gilliam, Frank S./M-9767-2019	Gilliam, Frank S./0000-0002-5525-0766	Henan Science and Technology Department of China under the Key Research Project [30200051]	Henan Science and Technology Department of China under the Key Research Project	This study was supported by grants from Henan Science and Technology Department of China under the Key Research Project (30200051). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batjes NH, 2002, SOIL USE MANAGE, V18, P324, DOI 10.1079/SUM2002138; BAUER A, 1994, SOIL SCI SOC AM J, V58, P185, DOI 10.2136/sssaj1994.03615995005800010027x; Dersch G, 2001, NUTR CYCL AGROECOSYS, V60, P49, DOI 10.1023/A:1012607112247; Diaz-Zorita M, 2000, SOIL TILL RES, V54, P121, DOI 10.1016/S0167-1987(00)00089-1; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Duxbury J. M., 2000, Journal of Crop Production, V3, P27, DOI 10.1300/J144v03n02_02; EMERSON WW, 1995, AUST J SOIL RES, V33, P241, DOI 10.1071/SR9950241; Feller C, 1997, GEODERMA, V79, P69, DOI 10.1016/S0016-7061(97)00039-6; Feng S, 2011, J AGR SCI-CAMBRIDGE, V149, P557, DOI 10.1017/S0021859611000323; Gilliam FS, 2004, ENVIRON MANAGE, V33, pS108, DOI 10.1007/s00267-003-9121-6; Gilliam FS, 2003, J VEG SCI, V14, P297, DOI 10.1658/1100-9233(2003)014[0297:MMSOTO]2.0.CO;2; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hairiah K, 2000, NETH J AGR SCI, V48, P3, DOI 10.1016/S1573-5214(00)80001-9; Harper RJ, 1995, ASSESSMENT METHODS S, P577; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Larney FJ, 2000, CAN J SOIL SCI, V80, P515, DOI 10.4141/S99-100; Liao QL, 2009, GLOBAL CHANGE BIOL, V15, P861, DOI 10.1111/j.1365-2486.2008.01792.x; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu ZP, 2011, AGR ECOSYST ENVIRON, V142, P184, DOI 10.1016/j.agee.2011.05.002; Maia SMF, 2010, SOIL TILL RES, V106, P177, DOI 10.1016/j.still.2009.12.005; [潘根兴 Pan Genxing], 2005, [地球科学进展, Advance in Earth Sciences], V20, P384; Pan GX, 2005, J ENVIRON SCI, V17, P1; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; POST WM, 1985, NATURE, V317, P613, DOI 10.1038/317613a0; Powlson DS, 2001, NUTR CYCL AGROECOSYS, V61, P41, DOI 10.1023/A:1013338028454; SCHERTZ DL, 1989, J SOIL WATER CONSERV, V44, P604; Smith WN, 2000, GLOBAL CHANGE BIOL, V6, P557, DOI 10.1046/j.1365-2486.2000.00340.x; Wang ZM, 2010, PEDOSPHERE, V20, P80, DOI 10.1016/S1002-0160(09)60285-X; Wu HB, 2009, AGR ECOSYST ENVIRON, V129, P413, DOI 10.1016/j.agee.2008.10.020; Zhang HB, 2007, GEODERMA, V139, P412, DOI 10.1016/j.geoderma.2007.03.003; Zhang XL, 2012, FIELD CROP RES, V130, P28, DOI 10.1016/j.fcr.2012.02.008	34	0	0	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109188	10.1371/journal.pone.0109188	http://dx.doi.org/10.1371/journal.pone.0109188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289703	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000046
J	Rosa, RG; Goldani, LZ				Rosa, Regis G.; Goldani, Luciano Z.			Factors Associated with Hospital Length of Stay among Cancer Patients with Febrile Neutropenia	PLOS ONE			English	Article							COLONY-STIMULATING FACTORS; CHEMOTHERAPY; MANAGEMENT; COMPLICATIONS; METAANALYSIS; BACTEREMIA; MORTALITY; CHILDREN; COST	Purpose: This study sought to evaluate factors associated with hospital length of stay in cancer patients with febrile neutropenia. Methods: A prospective cohort study was performed at a single tertiary referral hospital in southern Brazil from October 2009 to August 2011. All adult cancer patients with febrile neutropenia admitted to the hematology ward were evaluated. Stepwise random-effects negative binomial regression was performed to identify risk factors for prolonged length of hospital stay. Results: In total, 307 cases of febrile neutropenia were evaluated. The overall median length of hospital stay was 16 days (interquartile range 18 days). According to multiple negative binomial regression analysis, hematologic neoplasms (P = 0.003), high-dose chemotherapy regimens (P<0.001), duration of neutropenia (P<0.001), and bloodstream infection involving Gram-negative multi-drug-resistant bacteria (P = 0.003) were positively associated with prolonged hospital length of stay in patients with febrile neutropenia. The condition index showed no evidence of multi-collinearity effect among the independent variables. Conclusions: Hematologic neoplasms, high-dose chemotherapy regimens, prolonged periods of neutropenia, and bloodstream infection with Gram-negative multi-drug-resistant bacteria are predictors of prolonged length hospital of stay among adult cancer patients with febrile neutropenia.	[Rosa, Regis G.; Goldani, Luciano Z.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Infect Dis Unit, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Goldani, LZ (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Infect Dis Unit, Porto Alegre, RS, Brazil.	lgoldani@ufrgs.br	Goldani, Luciano Zubaran/U-4617-2019; Rosa, Regis/M-2291-2015; Rosa, Regis/V-2859-2017; Rosa, Regis Goulart/P-6422-2019	Rosa, Regis/0000-0001-7881-9866; Rosa, Regis/0000-0001-7881-9866; 	FIPE/HCPA (Incentive Fund for Research and Events of Hospital de Clinicas de Porto Alegre)	FIPE/HCPA (Incentive Fund for Research and Events of Hospital de Clinicas de Porto Alegre)	This study received financial support from FIPE/HCPA (Incentive Fund for Research and Events of Hospital de Clinicas de Porto Alegre). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu SK, 2005, J CLIN ONCOL, V23, P7958, DOI 10.1200/JCO.2005.01.6378; Bow EJ, 2013, CRIT CARE CLIN, V29, P411, DOI 10.1016/j.ccc.2013.03.002; Callaghan K, 2008, PRACTICAL ASSESSMENT, V13; Cameron D, 2009, BRIT J CANCER, V101, pS18, DOI 10.1038/sj.bjc.6605272; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; de Naurois J, 2010, ANN ONCOL, V21, pv252, DOI 10.1093/annonc/mdq196; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dulisse Brian, 2013, J Med Econ, V16, P720, DOI 10.3111/13696998.2013.782034; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Haeusler GM, 2013, PEDIATR INFECT DIS J, V32, P723, DOI 10.1097/INF.0b013e31828aebc8; Kim S, 2012, ARCH PHARM RES, V35, P2013, DOI 10.1007/s12272-012-1119-2; Kirkwood BR, 2003, ESSENTIALS MED STAT, P355; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Klastersky J, 2004, CLIN INFECT DIS, V39, pS32, DOI 10.1086/383050; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; Lee YM, 2013, INT J NURS PRACT, V19, P557, DOI 10.1111/ijn.12099; Montassier E, 2013, EUR J CLIN MICROBIOL, V32, P841, DOI 10.1007/s10096-013-1819-7; Renner P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007913.pub2; Sasse EC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004139.pub2; Schilling MB, 2011, EXP THER MED, V2, P859, DOI 10.3892/etm.2011.312; Sutter DE, 2011, INFECT CONT HOSP EP, V32, P854, DOI 10.1086/661284; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Weycker D, 2008, ANN ONCOL, V19, P454, DOI 10.1093/annonc/mdm525; Weycker D, 2014, J ONCOL PHARM PRACT, V20, P190, DOI 10.1177/1078155213492450; Zhou YP, 2014, SUPPORT CARE CANCER, V22, P1447, DOI 10.1007/s00520-013-2055-5	25	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108969	10.1371/journal.pone.0108969	http://dx.doi.org/10.1371/journal.pone.0108969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285790	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700041
J	Yang, CJ; Lee, NY; Chen, TC; Lin, YH; Liang, SH; Lu, PL; Huang, WC; Tang, HJ; Lee, CH; Lin, HH; Chen, YH; Ko, WC; Hung, CC				Yang, Chia-Jui; Lee, Nan-Yao; Chen, Tun-Chieh; Lin, Yu-Hui; Liang, Shiou-Haur; Lu, Po-Liang; Huang, Wen-Chi; Tang, Hung-Jen; Lee, Chen-Hsiang; Lin, Hsi-Hsun; Chen, Yen-Hsu; Ko, Wen-Chien; Hung, Chien-Ching			One Dose versus Three Weekly Doses of Benzathine Penicillin G for Patients Co-Infected with HIV and Early Syphilis: A Multicenter, Prospective Observational Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GUIDELINES; MANAGEMENT; FAILURE	Background: One dose of benzathine penicillin G (BPG) has been recommended for HIV-infected patients with early syphilis (primary, secondary, and early latent syphilis) in the sexually transmitted diseases treatment guidelines, but clinical data to support such a recommendation are limited. Methods: We prospectively observed the serological response to 1 or 3 weekly doses of BPG in HIV-infected adults who sought treatment of early syphilis at 8 hospitals around Taiwan. Rapid plasma reagin (RPR) titers were followed every 3-6 months after treatment. The serological response was defined as a 4-fold or greater decline in RPR titers at 12 months of treatment. The missing values were treated by following the last-observed-carried-forward principle. We hypothesized that 1 dose was non-inferior to 3 weekly doses of BPG with the non-inferiority margin for the difference of serological response set to 10%. Results: Between 2007 and 2012, 573 patients completed at least 12 months of follow-up: 295 (51.5%) receiving 1 dose of BPG (1-dose group) and 278 (48.5%) 3 doses (3-dose group). Overall, 198 patients (67.1%; 95% confidence interval [CI], 61.4-72.5%) in the 1-dose group achieved serological response at 12 months, as did 208 patients (74.8%; 95% CI, 69.3-79.8%) in the 3-dose group (one-sided 95% CI of the difference, 15.1%). In the multivariate analysis, secondary syphilis (adjusted odds ratio [AOR], 1.90; 95% CI 1.17-3.09), RPR titer >= 32 (AOR, 1.93; 95% CI, 1.38-2.69), and 3 doses of BPG (AOR, 1.68; 95% CI, 1.20-2.36) were independently associated with a serological response. The time to the first episode of treatment failure was 1184 (standard deviation [SD], 70.5) and 1436 (SD, 80.0) days for 1- and 3-dose group, respectively. Conclusions: Single-dose BPG resulted in a higher serological failure rate and shorter time to treatment failure than 3 weekly doses of BPG in the treatment of early syphilis in HIV-infected patients.	[Yang, Chia-Jui] Far East Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Lee, Nan-Yao; Ko, Wen-Chien] Natl Cheng Kung Univ Coll Med & Hosp, Dept Internal Med, Tainan, Taiwan; [Chen, Tun-Chieh; Lu, Po-Liang; Chen, Yen-Hsu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp & Coll Med, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Tun-Chieh] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Yu-Hui] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Liang, Shiou-Haur; Lin, Hsi-Hsun] I Shou Univ, E Da Hospital, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Wen-Chi; Lee, Chen-Hsiang] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	Far Eastern Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Taichung Veterans General Hospital; E-Da Hospital; I Shou University; Chang Gung Memorial Hospital; Chang Gung University; Chi Mei Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Ko, WC (corresponding author), Natl Cheng Kung Univ Coll Med & Hosp, Dept Internal Med, Tainan, Taiwan.	winston3415@gmail.com; hcc0401@ntu.edu.tw	Ko, Wen-Chien/ABG-4316-2020; Lu, Po-Liang/D-4499-2009; Chen, Tun-Chieh/J-2877-2013	Ko, Wen-Chien/0000-0001-7497-149X; Lu, Po-Liang/0000-0002-7423-6783; Chen, Tun-Chieh/0000-0002-9258-0692; Hung, Chien-Ching/0000-0001-7345-0836; Chen, Yen-hsu/0000-0002-8667-4844	Centers for Disease Control, Taiwan [DOH102-DC-1401]	Centers for Disease Control, Taiwan	This study was supported by grants from the Centers for Disease Control, Taiwan (grant number DOH102-DC-1401 to CCH). The funding source had no role in study design and conduct; data collection, analysis, or interpretation; or in the writing of the manuscript or the decision to submit it for publication.	Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Centers for Disease Control and Prevention, 2012, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P649; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; CUDDY PG, 1982, DRUG INTEL CLIN PHAR, V16, P205, DOI 10.1177/106002808201600303; CURRIE BJ, 1994, ANTIMICROB AGENTS CH, V38, P1203, DOI 10.1128/AAC.38.5.1203; DoRHaR, WHO GLOB INC PREV SE; Dowell D, 2009, CLIN INFECT DIS, V49, P1526, DOI 10.1086/644737; Farhi D, 2009, MEDICINE, V88, P331, DOI 10.1097/MD.0b013e3181c2af86; Fenton KA, 2004, SEX TRANSM INFECT, V80, P255, DOI 10.1136/sti.2004.009415; French P, 2009, INT J STD AIDS, V20, P300, DOI 10.1258/ijsa.2008.008510; Ghanem KG, 2007, SEX TRANSM INFECT, V83, P97, DOI 10.1136/sti.2006.021402; Ghanem KG, 2008, CLIN INFECT DIS, V47, P258, DOI 10.1086/589295; Gonzalez-Lopez JJ, 2009, CLIN INFECT DIS, V49, P1505, DOI 10.1086/644618; Jinno S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-605; Kingston M, 2008, INT J STD AIDS, V19, P729, DOI 10.1258/ijsa.2008.008279; LUKEHART SA, 1991, ANN INTERN MED, V114, P1057, DOI 10.7326/0003-4819-114-12-1057; Manavi K, 2007, INT J STD AIDS, V18, P814, DOI 10.1258/095646207782717018; Rolfs RT, 1997, NEW ENGL J MED, V337, P307, DOI 10.1056/NEJM199707313370504; Savage EJ, 2012, EUROSURVEILLANCE B E, V17; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Velicko I, 2012, EUROSURVEILLANCE B E, V17; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	23	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109667	10.1371/journal.pone.0109667	http://dx.doi.org/10.1371/journal.pone.0109667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286091	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700082
J	Cristina, RT; Hanganu, F; Dumitrescu, E; Muselin, F; Butnariu, M; Constantin, A; Chiurciu, V				Cristina, Romeo Teodor; Hanganu, Flavia; Dumitrescu, Eugenia; Muselin, Florin; Butnariu, Monica; Constantin, Adriana; Chiurciu, Viorica			The Impact of Exogenic Testosterone and Nortestosterone-Decanoate Toxicological Evaluation Using a Rat Model	PLOS ONE			English	Article							NANDROLONE DECANOATE; HERSHBERGER ASSAY; SPERM QUALITY; METABOLISM; TOXICITY; ANDROGEN; HORMONES; CATTLE	The impact of exogenic testosterone (T): 1.5 and 3.0 mg/kg.bw) and 19-nortestosterone 17-decanoate (ND): 1.5 and 7.5 mg/kg.bw) in castrated male rats was evaluated based on: (a) weight increase of the androgen target tissues, respecting the Hershberger methodology; (b) the 17 alpha and beta-testosterone, 17 alpha and beta-estradiol and 17 alpha and beta-nortestosterone levels using the GC-MS/MS technique; and (c) observation of the serum free thyroxine levels (T-4). Results revealed that T and ND significantly increased the weight of androgen target tissues as follows: ND was more influential on seminal vesicles, levator ani-bulbocavernosus muscle (LABC) and Cowper's glands and T (at a dose of 3.0 mg/kg.bw) influenced the weight of the ventral prostate and glans penis. Serum samples analyzed for steroid hormone levels showed the presence of 17 beta-testosterone, 17 beta-estradiol and 17 beta-nor-testosterone, in castrated male rats injected with testosterone and nortestosterone, but no significant differences were found between thyroid responses and thyroid hormone levels. The results of this research proved the disrupting activity of T and ND when administered in high doses and the useful application of the Hershberger bioassay in the case of ND.	[Cristina, Romeo Teodor; Hanganu, Flavia; Dumitrescu, Eugenia] Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Pharmacol, Timisoara, Timis, Romania; [Cristina, Romeo Teodor; Hanganu, Flavia; Dumitrescu, Eugenia] Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Pharm, Timisoara, Timis, Romania; [Muselin, Florin] Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Toxicol, Timisoara, Timis, Romania; [Butnariu, Monica] Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Biochem, Timisoara, Timis, Romania; [Constantin, Adriana] Natl Reference Lab A3 Steroids, Constanta, Romania; [Chiurciu, Viorica] Romvac Co, Drugs Prod Dept, Voluntari, Ilfov, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine	Cristina, RT (corresponding author), Banats Univ Agr Sci & Vet Med King Michael Romani, Dept Pharmacol, Timisoara, Timis, Romania.	rtcristina@yahoo.com	Muselin, Florin/H-9761-2014; CRISTINA, Romeo Teodor/G-2067-2011; Dumitrescu, Eugenia/AAY-4279-2021; BUTNARIU, Monica/E-7217-2010; Muselin, Florin/HHC-1662-2022	CRISTINA, Romeo Teodor/0000-0002-5420-1516; BUTNARIU, Monica/0000-0002-2032-5000; Muselin, Florin/0000-0003-2907-4233	Pilot Programme [POSDRU/6/1.5/S/21, 6540]	Pilot Programme	The study was possible due to grant POSDRU/6/1.5/S/21, Project ID 6540, "Pilot Programme for the Support of Scholarship PhD Students Research.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann P, 1986, ENV HLTH PERSPECT, V70, P149; [Anonymous], 1986, EUR CONV PROT VERT A; [Anonymous], 2010, FREE T4 ARCHITECT SY; [Anonymous], 2011, RA 1235 OSSMPC 9 DEC; BELKIEN L, 1985, J STEROID BIOCHEM, V22, P623, DOI 10.1016/0022-4731(85)90215-8; BIJLSMA JWJ, 1982, ACTA ENDOCRINOL-COP, V101, P108, DOI 10.1530/acta.0.1010108; Courant F, 2009, ANALYST, V134, P1637, DOI 10.1039/b901813a; EDSTAC, 2011, END DISR SCREEN TEST; Freyberger Alexius, 2005, Arhiv za Higijenu Rada i Toksikologiju, V56, P131; GATTI GC, 1993, ANAL CHIM ACTA, V275, P105, DOI 10.1016/0003-2670(93)80281-O; GEUSENS P, 1995, CLIN RHEUMATOL, V14, P32, DOI 10.1007/BF02210686; Gray Jr L.E., 2005, CURRENT PROTOCOLS TO, P16; Hale DH, 1972, S AFR J ANIM SCI, V3, P39; Karbalay-Doust S, 2007, ASIAN J ANDROL, V9, P235, DOI 10.1111/j.1745-7262.2007.00203.x; Kennel PF, 2004, REPROD TOXICOL, V18, P63, DOI 10.1016/j.reprotox.2003.10.012; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Kumar V, 2008, TOXICOL APPL PHARM, V226, P60, DOI 10.1016/j.taap.2007.08.023; Le Bizec B, 1999, J CHROMATOGR B, V723, P157, DOI 10.1016/S0378-4347(98)00541-6; Lee DM, 2010, ASIAN AUSTRAL J ANIM, V23, P1566, DOI 10.5713/ajas.2010.10278; Lephart ED, 1996, BRAIN RES REV, V22, P1; Mate? N, 2001, CHIRURG OPERATOARE V, P483; Mulligan K, 2005, ARCH INTERN MED, V165, P578, DOI 10.1001/archinte.165.5.578; OECD, 2013, ORG EC COOP DEV 2011; Oh JA, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-22; Owens W, 2006, ENVIRON HEALTH PERSP, V114, P1259, DOI 10.1289/ehp.8751; Peirce S, 2006, SVH AEC SOP 26 EUTHA; Pritchard JD, 2007, HPACHAPD002; Purkayastha S., 2012, WORLD J LIFE SCI MED, V2, P123; Scarth J, 2009, FOOD ADDIT CONTAM A, V26, P640, DOI 10.1080/02652030802627160; Scarth JP, 2011, FOOD ADDIT CONTAM A, V28, P44, DOI 10.1080/19440049.2010.539628; Schanzer W, 1996, CLIN CHEM, V42, P1001; SCHMIDELY P, 1993, REPROD NUTR DEV, V33, P297, DOI 10.1051/rnd:19930401; Shahidi NT, 2001, CLIN THER, V23, P1355, DOI 10.1016/S0149-2918(01)80114-4; Takahashi M, 2004, ENDOCR J, V51, P425, DOI 10.1507/endocrj.51.425; THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665; Torres-Calleja J, 2001, LIFE SCI, V68, P1769, DOI 10.1016/S0024-3205(01)00972-9; Umano T, 2009, ARCH TOXICOL, V83, P459, DOI 10.1007/s00204-008-0357-z; Yamada T, 2004, TOXICOL SCI, V79, P64, DOI 10.1093/toxsci/kfh093; Yamasaki K, 2002, ARCH TOXICOL, V75, P703, DOI 10.1007/s00204-001-0296-4	39	11	11	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109219	10.1371/journal.pone.0109219	http://dx.doi.org/10.1371/journal.pone.0109219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302584	gold, Green Submitted, Green Published			2022-12-27	WOS:000343730400046
J	Garaizar, P; Vadillo, MA; Lopez-de-Ipina, D				Garaizar, Pablo; Vadillo, Miguel A.; Lopez-de-Ipina, Diego			Presentation Accuracy of the Web Revisited: Animation Methods in the HTML5 Era	PLOS ONE			English	Article							REACTION-TIME MEASUREMENT; ADOBE FLASH	Using the Web to run behavioLiral and social experiments quickly and efficiently has become increasingly popular in recent years, but there is some controversy about the suitability of using the Web for these objectives. Several studies have analysed the accuracy and precision of different web technologies in order to determine their limitations. This paper updates the extant evidence about Presentation accuracy and Precision of the Web and extends the study of the accuracy and precision in the presentation of multimedia stimuli to HTML5-based solutions, which were previously untested. The accuracy and precision in the presentation of visual content in classic web technologies is acceptable for use in online experiments, although some results suggest that these technologies should be used with caution in certain circumstances. Declarative animations based on CSS are the best alternative when animation intervals are above 50 milliseconds. The performance of procedural web technologies based on the HTML5 standard is similar to that of previous web technologies. These technologies are being progressively adopted by the scientific commLlnity and have promising fLitures, which makes heir use advisable to utilizing more obsolete technologies.	[Garaizar, Pablo; Lopez-de-Ipina, Diego] Univ Deusto, DeustoTech, Deusto Inst Technol, Bilbao, Spain; [Vadillo, Miguel A.] UCL, Dept Expt Psychol, London, England	University of Deusto; University of London; University College London	Garaizar, P (corresponding author), Univ Deusto, DeustoTech, Deusto Inst Technol, Bilbao, Spain.	garaizar@deusto.es	López-de-Ipiña, Diego/A-9651-2012; Vadillo, Miguel A./A-8702-2011; Garaizar, Pablo/A-9031-2011; Garaizar, Pablo/U-6469-2019	López-de-Ipiña, Diego/0000-0001-8055-6823; Vadillo, Miguel A./0000-0001-8421-816X; Garaizar, Pablo/0000-0001-8160-9130; Garaizar, Pablo/0000-0001-8160-9130	Direccion General de Investigacion of the Spanish Government [PSI2011-26965]; Basque Government [IT363-10]	Direccion General de Investigacion of the Spanish Government; Basque Government(Basque Government)	This work is funded by Grant PSI2011-26965 from Direccion General de Investigacion of the Spanish Government (http://www.idi.mineco.gob.es/ portal/site/MICINN/) and Grant IT363-10 from the Basque Government (http://www.hezkuntza.ejgv.euskadi.net/r43-2518/es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2010, HTML5 VERSUS FLASH A; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Chappell D, 1996, UNDERSTANDING ACTIVE; CompuServe, 1990, GRAPH INT FORM PROGR; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Eichstaedt J, 2001, BEHAV RES METH INS C, V33, P179, DOI 10.3758/BF03195364; Garaizar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085108; Goodin Dan, 2013, ARS TECHNICA; Hassin RR, 2007, P NATL ACAD SCI USA, V104, P19757, DOI 10.1073/pnas.0704679104; Jackson D, 2013, CSS ANIMATI IN PRESS; Jobs S., 2010, THOUGHTS FLASH; Keller F, 2009, BEHAV RES METHODS, V41, P1, DOI 10.3758/BRM.41.1.12; McGraw KO, 2000, PSYCHOL SCI, V11, P502, DOI 10.1111/1467-9280.00296; Neath I, 2011, BEHAV RES METHODS, V43, P353, DOI 10.3758/s13428-011-0069-9; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Oeschger I, 2002, API REFERENCE NETSCA; Plant RR, 2013, COGN AFFECT BEHAV NE, V13, P598, DOI 10.3758/s13415-013-0166-6; Plant RR, 2004, BEHAV RES METH INS C, V36, P291, DOI 10.3758/BF03195575; Reimers S, 2015, BEHAV RES METHODS, V47, P309, DOI 10.3758/s13428-014-0471-1; Reimers S, 2008, BEHAV RES METHODS, V40, P1170, DOI 10.3758/BRM.40.4.1170; Reimers S, 2007, BEHAV RES METHODS, V39, P365, DOI 10.3758/BF03193004; Resig J, 2008, ACCURACY JAVASCRIPT; Schmidt WC, 2001, BEHAV RES METH INS C, V33, P187, DOI 10.3758/BF03195365; Schubert TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067769; Stewart N, 2006, BEHAV RES METHODS, V38, P142, DOI 10.3758/BF03192759; Voss A, 2013, J EXP PSYCHOL GEN, V142, P536, DOI 10.1037/a0029459; W3Techs, 2014, US JAV WEBS; Winokur D., 2011, FLASH FOCUS PC BROWS; Yee B, 2009, P IEEE S SECUR PRIV, P79, DOI 10.1109/SP.2009.25	30	15	15	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109812	10.1371/journal.pone.0109812	http://dx.doi.org/10.1371/journal.pone.0109812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302791	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400081
J	Blank, PJ; Sample, DW; Williams, CL; Turner, MG				Blank, Peter J.; Sample, David W.; Williams, Carol L.; Turner, Monica G.			Bird Communities and Biomass Yields in Potential Bioenergy Grasslands	PLOS ONE			English	Article							HARVESTING SWITCHGRASS; SPECIES COMPOSITION; LANDSCAPE FACTORS; AREA SENSITIVITY; BIOFUELS; HABITAT; ENERGY; MANAGEMENT; FIELDS; INTENSIFICATION	Demand for bioenergy is increasing, but the ecological consequences of bioenergy crop production on working lands remain unresolved. Corn is currently a dominant bioenergy crop, but perennial grasslands could produce renewable bioenergy resources and enhance biodiversity. Grassland bird populations have declined in recent decades and may particularly benefit from perennial grasslands grown for bioenergy. We asked how breeding bird community assemblages, vegetation characteristics, and biomass yields varied among three types of potential bioenergy grassland fields (grass monocultures, grass-dominated fields, and forb-dominated fields), and assessed tradeoffs between grassland biomass production and bird habitat. We also compared the bird communities in grassland fields to nearby cornfields. Cornfields had few birds compared to perennial grassland fields. Ten bird Species of Greatest Conservation Need (SGCN) were observed in perennial grassland fields. Bird species richness and total bird density increased with forb cover and were greater in forbdominated fields than grass monocultures. SGCN density declined with increasing vertical vegetation density, indicating that tall, dense grassland fields managed for maximum biomass yield would be of lesser value to imperiled grassland bird species. The proportion of grassland habitat within 1 km of study sites was positively associated with bird species richness and the density of total birds and SGCNs, suggesting that grassland bioenergy fields may be more beneficial for grassland birds if they are established near other grassland parcels. Predicted total bird density peaked below maximum biomass yields and predicted SGCN density was negatively related to biomass yields. Our results indicate that perennial grassland fields could produce bioenergy feedstocks while providing bird habitat. Bioenergy grasslands promote agricultural multifunctionality and conservation of biodiversity in working landscapes.	[Blank, Peter J.; Turner, Monica G.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Sample, David W.] Wisconsin Dept Nat Resources, Madison, WI USA; [Williams, Carol L.] Univ Wisconsin, Wisconsin Energy Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Blank, PJ (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	blankpj@gmail.com	Turner, Monica G/B-2099-2010	Turner, Monica G/0000-0003-1903-2822	Wisconsin Department of Natural Resources Federal Wildlife Restoration [W-160-P]	Wisconsin Department of Natural Resources Federal Wildlife Restoration	Funding for this project came from the Wisconsin Department of Natural Resources Federal Wildlife Restoration Grant W-160-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; Anderson-Teixeira KJ, 2012, ECOL APPL, V22, P2035, DOI 10.1890/12-0711.1; Askins Robert A., 2007, Ornithological Monographs, V64, pi; Bates D, 2012, LME4 LINEAR MIXED EF; Behrman KD, 2013, ECOL APPL, V23, P73, DOI 10.1890/12-0436.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Dauber J, 2010, GCB BIOENERGY, V2, P289, DOI 10.1111/j.1757-1707.2010.01058.x; Davis SK, 2013, J WILDLIFE MANAGE, V77, P908, DOI 10.1002/jwmg.537; Diefenbach DR, 2003, AUK, V120, P1168, DOI 10.1642/0004-8038(2003)120[1168:VIGBCR]2.0.CO;2; ESRI, 2011, ARCGIS DESKT REL 10; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fletcher RJ, 2002, J WILDLIFE MANAGE, V66, P1011, DOI 10.2307/3802933; Fletcher RJ, 2011, FRONT ECOL ENVIRON, V9, P161, DOI 10.1890/090091; Garlock RJ, 2012, BIOMASS BIOENERG, V37, P49, DOI 10.1016/j.biombioe.2011.12.036; Gill DE, 2006, WILDLIFE SOC B, V34, P944, DOI 10.2193/0091-7648(2006)34[944:PABBRO]2.0.CO;2; Griffith AP, 2011, AGRON J, V103, P617, DOI 10.2134/agronj2010.0336; Groom MJ, 2008, CONSERV BIOL, V22, P602, DOI 10.1111/j.1523-1739.2007.00879.x; Helzer CJ, 1999, ECOL APPL, V9, P1448; Hull S., 2011, WISCONSIN SUSTAINABL; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Jordan N, 2010, BIOSCIENCE, V60, P60, DOI 10.1525/bio.2010.60.1.10; Karanth KK, 2014, ECOGRAPHY, V37, P626, DOI 10.1111/j.1600-0587.2013.00367.x; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; McCoy TD, 2001, WILDLIFE SOC B, V29, P979; McIntyre NE, 2003, AM MIDL NAT, V150, P291, DOI 10.1674/0003-0031(2003)150[0291:ACOCRP]2.0.CO;2; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Miesel JR, 2012, BIOMASS BIOENERG, V36, P121, DOI 10.1016/j.biombioe.2011.10.018; Mulkey VR, 2008, BIORESOURCE TECHNOL, V99, P609, DOI 10.1016/j.biortech.2006.12.035; Murray LD, 2003, J WILDLIFE MANAGE, V67, P611, DOI 10.2307/3802718; Murray LD, 2003, BIOMASS BIOENERG, V25, P167, DOI 10.1016/S0961-9534(02)00187-3; NOAA, 2013, 2012 WISC YEARL WEAT; NOAA, 2013, MILW SULL UN LOC CLI; Paine LK, 1996, BIOMASS BIOENERG, V10, P231, DOI 10.1016/0961-9534(95)00072-0; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Pinheiro J., 2019, NLME LINEAR NONLINEA; Porter P. A., 2008, GROWING WISCONSIN EN; R Core Development Team, 2013, R LANG ENV STAT COMP; Reese GC, 2013, METHODS ECOL EVOL, V4, P891, DOI 10.1111/2041-210X.12070; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; Ribic CA, 2009, AUK, V126, P233, DOI 10.1525/auk.2009.1409; Ribic CA, 2009, AM MIDL NAT, V161, P110, DOI 10.1674/0003-0031-161.1.110; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Robertson BA, 2013, BIOENERG RES, V6, P311, DOI 10.1007/s12155-012-9258-3; Robertson BA, 2012, CONDOR, V114, P679, DOI 10.1525/cond.2012.110136; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Robertson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016941; Roth AM, 2005, BIOMASS BIOENERG, V28, P490, DOI 10.1016/j.biombioe.2004.11.001; Runge TM, 2013, BIOFUELS-UK, V4, P493, DOI [10.4155/bfs.13.39, 10.4155/BFS.13.39]; Sagar AD, 2007, ANNU REV ENV RESOUR, V32, P131, DOI 10.1146/annurev.energy.32.062706.132042; SAMPLE D, 1989, THESIS U WISCONSIN M; SAMPLE DW, 1997, PUBLSS92597 WISC DEP; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; United States Department of Agriculture (USDA), 2013, WEB SOIL SURV; US EPA, 2011, BIOF ENV 1 TRIENN RE; USDA, 2011, NAT AGR STAT SERV CR; USDA, 1978, SOIL SURV DAN COUNT; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Wang D, 2010, GCB BIOENERGY, V2, P16, DOI 10.1111/j.1757-1707.2010.01035.x; Webster CR, 2010, BIOFUELS-UK, V1, P451, DOI 10.4155/BFS.10.18; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Williams CL, 2013, J SOIL WATER CONSERV, V68, p141A, DOI 10.2489/jswc.68.6.141A; Winter M, 1999, CONSERV BIOL, V13, P1424, DOI 10.1046/j.1523-1739.1999.98430.x; Wisconsin Department of Natural Resources, 2005, WISC STRAT WILDL SPE; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Zuur Alain F., 2009, P1	72	17	17	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109989	10.1371/journal.pone.0109989	http://dx.doi.org/10.1371/journal.pone.0109989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299593	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200095
J	Hong, JT; Wang, XD; Wu, JB				Hong, Jiangtao; Wang, Xiaodan; Wu, Jianbo			Stoichiometry of Root and Leaf Nitrogen and Phosphorus in a Dry Alpine Steppe on the Northern Tibetan Plateau	PLOS ONE			English	Article							SIMULATED CLIMATE-CHANGE; NUTRIENT CONCENTRATION; GLOBAL PATTERNS; SCALE PATTERNS; ARCTIC SOILS; MINERALIZATION; TEMPERATURE; CARBON; GRASSLAND; WORLDWIDE	Leaf nitrogen (N) and phosphorus (P) have been used widely in the ecological stoichiometry to understand nutrient limitation in plant. However, few studies have focused on the relationship between root nutrients and environmental factors. The main objective of this study was to clarify the pattern of root and leaf N and P concentrations and the relationships between plant nitrogen (N) and phosphorus (P) concentrations with climatic factors under low temperature conditions in the northern Tibetan Plateau of China. We conducted a systematic census of N and P concentrations, and the N:P ratio in leaf and root for 139 plant samples, from 14 species and 7 families in a dry Stipa purpurea alpine steppe on the northern Tibetan Plateau of China. The results showed that the mean root N and P concentrations and the N: P ratios across all species were 13.05 mg g(-1), 0.60 mg g(-1) and 23.40, respectively. The mean leaf N and P concentrations and the N:P ratio were 23.20 mg g(-1), 1.38 mg g(-1), and 17.87, respectively. Compared to global plant nutrients concentrations, plants distributing in high altitude area have higher N concentrations and N:P, but lower P concentrations, which could be used to explain normally-observed low growth rate of plant in the cold region. Plant N concentrations were unrelated to the mean annual temperature (MAT). The root and leaf P concentrations were negatively correlated with the MAT, but the N:P ratios were positively correlated with the MAT. It is highly possible this region is not N limited, it is P limited, thus the temperature-biogeochemical hypothesis (TBH) can not be used to explain the relationship between plant N concentrations and MAT in alpine steppe. The results were valuable to understand the bio-geographic patterns of root and leaf nutrients traits and modeling ecosystem nutrient cycling in cold and dry environments.	[Hong, Jiangtao; Wang, Xiaodan; Wu, Jianbo] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Hong, Jiangtao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XD (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China.	wxd@imde.ac.cn			Western Action Plan Project of the Chinese Academy of Sciences [KZCX2-XB3-08]; Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences [XDB03030505]	Western Action Plan Project of the Chinese Academy of Sciences; Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences	This study was supported by the Western Action Plan Project of the Chinese Academy of Sciences (Grant No. KZCX2-XB3-08), the Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences (Grant No. XDB03030505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; [Anonymous], 1982, CHEM MICROBIOLOGY PR; [白虎志 Bai Huzhi], 2005, [高原气象, Plateau Meteorology], V24, P311; Belnap J, 2001, SOIL BIOLOGY, P371; Buschiazzo DE, 2007, J ARID ENVIRON, V69, P29, DOI 10.1016/j.jaridenv.2006.08.013; CLEIN JS, 1995, SOIL BIOL BIOCHEM, V27, P1231, DOI 10.1016/0038-0717(95)00044-F; Day TA, 2008, GLOBAL CHANGE BIOL, V14, P1827, DOI 10.1111/j.1365-2486.2008.01623.x; Gonzalez E, 2010, PERSPECT PLANT ECOL, V12, P257, DOI 10.1016/j.ppees.2010.07.001; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hartley AE, 1999, OIKOS, V86, P331, DOI 10.2307/3546450; He JS, 2008, OECOLOGIA, V155, P301, DOI 10.1007/s00442-007-0912-y; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; Hobbie SE, 1996, BIOGEOCHEMISTRY, V35, P327, DOI 10.1007/BF02179958; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Horst M, 1995, ACTA PHYSIOL PLANT, V17, P393; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; JONASSON S, 1993, OECOLOGIA, V95, P179, DOI 10.1007/BF00323488; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Korner C, 1999, ALPINE PLANT LIFE FU, P1; Larsen KS, 2011, GLOBAL CHANGE BIOL, V17, P1884, DOI 10.1111/j.1365-2486.2010.02351.x; Li FR, 2009, PLANT SOIL, V317, P79, DOI 10.1007/s11104-008-9789-8; Lu CF, 1998, CHINESE B BOT, V15, P17; Marschner H, 1997, BOT ACTA, V110, P265, DOI 10.1111/j.1438-8677.1997.tb00639.x; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; National soil survey office of China, 1998, SOILS CHIN, P483; Neff JC, 2000, BIOGEOCHEMISTRY, V51, P283, DOI 10.1023/A:1006414517212; Neff JC, 2005, ECOL APPL, V15, P87, DOI 10.1890/04-0268; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sardans J, 2011, FOREST ECOL MANAG, V262, P2024, DOI 10.1016/j.foreco.2011.08.019; Sardans J, 2008, GLOBAL CHANGE BIOL, V14, P2304, DOI 10.1111/j.1365-2486.2008.01656.x; Schmidt IK, 1999, APPL SOIL ECOL, V11, P147, DOI 10.1016/S0929-1393(98)00147-4; Schmidt IK, 2002, PLANT SOIL, V242, P93, DOI 10.1023/A:1019642007929; Shaw MR, 2001, GLOBAL CHANGE BIOL, V7, P193, DOI 10.1046/j.1365-2486.2001.00390.x; Shi WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044628; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, P46; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Tibet Land Administrative Bureau, 1994, TIB SOIL RES, P151; Wei J., 2000, ACTA PHYTOECOL SIN, V24, P304; Weintraub MN, 2011, SOIL BIOL, V26, P295, DOI 10.1007/978-3-642-15271-9_12; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yuan Z, 2011, NATURE COMMUN, V2, P1; Yuan ZY, 2009, GLOBAL ECOL BIOGEOGR, V18, P11, DOI 10.1111/j.1466-8238.2008.00425.x; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Zhou Peng, 2010, Chinese Journal of Plant Ecology, V34, P7, DOI 10.3773/j.issn.1005-264x.2010.01.003	53	28	41	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109052	10.1371/journal.pone.0109052	http://dx.doi.org/10.1371/journal.pone.0109052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299642	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200032
J	Kim, ES; Mo, EY; Moon, SD; Han, JH				Kim, Eun Sook; Mo, Eun Young; Moon, Sung Dae; Han, Je Ho			Inverse Association between Serum Bilirubin Levels and Arterial Stiffness in Korean Women with Type 2 Diabetes	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; GLYCEMIC CONTROL; MEN; RISK; EVENTS; HYPERTENSION; HEALTH	Background: Considerable evidence suggests that bilirubin is a potent physiologic antioxidant that may provide important protection against cardiovascular disease (CVD) and inflammation. We investigated the relationship between serum total bilirubin (TB) levels and arterial stiffness, measured by the brachial-ankle pulse wave velocity (baPWV), in patients with type 2 diabetes. Methods: We conducted a cross-sectional analysis of 1,711 subjects with type 2 diabetes (807 men and 904 women; mean age, 57.1 years). The subjects were stratified based on gender-specific tertiles of TB values, and a high baPWV was defined as greater than 1,745 cm/s (>75th percentile). Results: The serum TB concentration was negatively correlated with the duration of diabetes, HbA1c, the 10-year Framingham risk score, and baPWV and was positively correlated with high-density lipoprotein cholesterol and the eGFR in both genders. Inverse association between TB categories and unadjusted prevalence of high PWV was only observed in women. After adjusting for confounding factors, the TB levels were inversely associated with a greater risk of a high baPWV, both as a continuous variable [a 1-SD difference; odds ratio (OR), 0.70; 95% confidence interval (CI), 0.54-0.90; P = 0.005] and when categorized in tertiles (the highest vs. the lowest tertile; OR, 0.49; 95% CI, 0.28-0.85; P = 0.011) in women but not in men. The relationship remained significant even after adjusting for retinopathy and nephropathy. Conclusions: Low TB levels were significantly associated with arterial stiffness in Korean women with type 2 diabetes. Our data suggested that bilirubin may protect against macrovascular disease in diabetic women.	[Kim, Eun Sook; Mo, Eun Young; Moon, Sung Dae; Han, Je Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Kim, Eun Sook; Mo, Eun Young; Moon, Sung Dae; Han, Je Ho] Catholic Univ Korea Incheon, St Marys Hosp, Inchon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University Korea Hospital	Moon, SD (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	sungdaem@gmail.com			AJU Pharmaceutical Co. Ltd.	AJU Pharmaceutical Co. Ltd.	This study was supported by AJU Pharmaceutical Co. Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chan KH, 2013, DIABETOLOGIA, V56, P724, DOI 10.1007/s00125-012-2818-4; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Chung JO, 2013, DIABETIC MED; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Dullaart RPF, 2012, CLIN CHIM ACTA, V414, P161, DOI 10.1016/j.cca.2012.08.029; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Endler G, 2003, CLIN CHEM, V49, P1201, DOI 10.1373/49.7.1201; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Hunt SC, 2001, ATHEROSCLEROSIS, V154, P747, DOI 10.1016/S0021-9150(00)00420-2; Hwang HJ, 2011, CLIN CHEM LAB MED, V49, P1823, DOI 10.1515/CCLM.2011.662; IDF, 2019, IDF DIABETES ATLAS; Inoguchi T, 2007, JAMA-J AM MED ASSOC, V298, P1398, DOI 10.1001/jama.298.12.1398-b; Jung CH, 2014, METABOLISM, V63, P87, DOI 10.1016/j.metabol.2013.09.011; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; KWAK JY, 1991, BIOCHIM BIOPHYS ACTA, V1076, P369, DOI 10.1016/0167-4838(91)90478-I; Laurent S, 2007, HYPERTENSION, V49, P1202, DOI 10.1161/HYPERTENSIONAHA.106.076166; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li Y, 2013, NUTR METAB CARDIOVAS, V23, P375, DOI 10.1016/j.numecd.2011.09.004; Lundvig DMS, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00081; Oda E, 2012, HEART VESSELS, V27, P29, DOI 10.1007/s00380-011-0123-7; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Riphagen IJ, 2014, DIABETES, V63, P2845, DOI 10.2337/db13-1652; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Stehouwer CDA, 2008, DIABETOLOGIA, V51, P527, DOI 10.1007/s00125-007-0918-3; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Yasuda M, 2011, OPHTHALMOLOGY, V118, P1423, DOI 10.1016/j.ophtha.2010.12.009; Yeh SY, 2009, VASC MED, V14, P129, DOI 10.1177/1358863X08098273; Zhang ZY, 2013, HEART VESSELS, V28, P453, DOI 10.1007/s00380-012-0261-6	36	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109251	10.1371/journal.pone.0109251	http://dx.doi.org/10.1371/journal.pone.0109251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299316	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200045
J	Laporta, J; Keil, KP; Vezina, CM; Hernandez, LL				Laporta, Jimena; Keil, Kimberly P.; Vezina, Chad M.; Hernandez, Laura L.			Peripheral Serotonin Regulates Maternal Calcium Trafficking in Mammary Epithelial Cells during Lactation in Mice	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; SENSING RECEPTOR; SUBCLINICAL HYPOCALCEMIA; PLASMA-MEMBRANE; GLAND; TRANSPORT; BONE; METABOLISM; ACTIVATION; LOCALIZATION	Lactation is characterized by massive transcellular flux of calcium, from the basolateral side of the mammary alveolar epithelium (blood) into the ductal lumen (milk). Regulation of calcium transport during lactation is critical for maternal and neonatal health. The monoamine serotonin (5-HT) is synthesized by the mammary gland and functions as a homeostatic regulation of lactation. Genetic ablation of tryptophan hydroxylase 1 (Tph1), which encodes the rate-limiting enzyme in non neuronal serotonin synthesis, causes a deficiency in circulating serotonin. As a consequence maternal calcium concentrations decrease, mammary epithelial cell morphology is altered, and cell proliferation is decreased during lactation. Here we demonstrate that serotonin deficiency decreases the expression and disrupts the normal localization of calcium transporters located in the apical (PMCA2) and basolateral (CaSR, ORAI-1) membranes of the lactating mammary gland. In addition, serotonin deficiency decreases the mRNA expression of calcium transporters located in intracellular compartments (SERCA2, SPCA1 and 2). Mammary expression of serotonin receptor isoform 2b and its downstream pathways (PLC beta 3, PKC and MAP-ERK1/2) are also decreased by serotonin deficiency, which might explain the numerous phenotypic alterations described above. In most cases, addition of exogenous 5-hydroxy-L-tryptophan to the Tph1 deficient mice rescued the phenotype. Our data supports the hypothesis that serotonin is necessary for proper mammary gland structure and function, to regulate blood and mammary epithelial cell transport of calcium during lactation. These findings can be applicable to the treatment of lactation-induced hypocalcemia in dairy cows and can have profound implications in humans, given the wide-spread use of selective serotonin reuptake inhibitors as antidepressants during pregnancy and lactation.	[Laporta, Jimena; Hernandez, Laura L.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Keil, Kimberly P.; Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, LL (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu	Vezina, Chad/GRO-2299-2022; Laporta, Jimena/AAX-3093-2021	Hernandez, Laura/0000-0001-7591-5203; Keil Stietz, Kimberly/0000-0002-7006-9420; Vezina, Chad/0000-0001-7058-5399	University of Wisconsin-Madison startup funds	University of Wisconsin-Madison startup funds	This work was supported by University of Wisconsin-Madison startup funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; [Anonymous], 2013, ONE; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Collier RJ, 2012, DOMEST ANIM ENDOCRIN, V43, P161, DOI 10.1016/j.domaniend.2012.03.006; Cross BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067348; Davidson AP, 2012, TOP COMPANION ANIM M, V27, P165, DOI 10.1053/j.tcam.2012.09.002; Ducy P, 2011, CURR OPIN PHARMACOL, V11, P34, DOI 10.1016/j.coph.2011.01.007; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Goff JP, 2008, VET J, V176, P50, DOI 10.1016/j.tvjl.2007.12.020; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hernandez LL, 2008, J DAIRY SCI, V91, P1834, DOI 10.3168/jds.2007-0766; Hernandez LL, 2011, J ENDOCRINOL, V209, P45, DOI 10.1530/JOE-10-0452; Hernandez LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032598; Hernandez LL, 2012, AM J PHYSIOL-ENDOC M, V302, pE1009, DOI 10.1152/ajpendo.00666.2011; Hernandez LL, 2009, J ENDOCRINOL, V203, P123, DOI 10.1677/JOE-09-0187; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Laporta J, 2013, J DAIRY SCI, V96, P5146, DOI 10.3168/jds.2013-6718; Laporta J, 2013, DOMEST ANIM ENDOCRIN, V44, P176, DOI 10.1016/j.domaniend.2013.01.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamillapalli R, 2013, ENDOCRINOLOGY, V154, P3031, DOI 10.1210/en.2012-2195; Martinez N, 2012, J DAIRY SCI, V95, P7158, DOI 10.3168/jds.2012-5812; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Neville MC, 2005, J MAMMARY GLAND BIOL, V10, P119, DOI 10.1007/s10911-005-5395-z; Niebert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021395; OETZEL GR, 1988, VET CLIN N AM-FOOD A, V4, P351, DOI 10.1016/S0749-0720(15)31053-7; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Reinhardt TA, 1999, AM J PHYSIOL-CELL PH, V276, pC796, DOI 10.1152/ajpcell.1999.276.4.C796; Reinhardt TA, 2011, VET J, V188, P122, DOI 10.1016/j.tvjl.2010.03.025; Ross DGF, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-57; Rozen S, 2000, Methods Mol Biol, V132, P365; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; VanHouten J, 2004, J CLIN INVEST, V113, P598, DOI 10.1172/JCI200418776; VanHouten JN, 2005, J MAMMARY GLAND BIOL, V10, P129, DOI 10.1007/s10911-005-5396-y; VanHouten JN, 2007, J MAMMARY GLAND BIOL, V12, P223, DOI 10.1007/s10911-007-9057-1; VanHouten JN, 2013, BEST PRACT RES CL EN, V27, P403, DOI 10.1016/j.beem.2013.02.011; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wysolmerski JJ, 2010, ANN NY ACAD SCI, V1192, P161, DOI 10.1111/j.1749-6632.2009.05249.x	43	47	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110190	10.1371/journal.pone.0110190	http://dx.doi.org/10.1371/journal.pone.0110190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299122	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200107
J	Segers, FM; Verdam, FJ; de Jonge, C; Boonen, B; Driessen, A; Shiri-Sverdlov, R; Bouvy, ND; Greve, JWM; Buurman, WA; Rensen, SS				Segers, Filip M.; Verdam, Froukje J.; de Jonge, Charlotte; Boonen, Bas; Driessen, Ann; Shiri-Sverdlov, Ronit; Bouvy, Nicole D.; Greve, Jan Willem M.; Buurman, Wim A.; Rensen, Sander S.			Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; VASCULAR ENDOTHELIAL-CELLS; DECAY-ACCELERATING FACTOR; MEMBRANE-ATTACK COMPLEX; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; PROPERDIN; PROTECTS; SYSTEM; IMMUNE	The innate immune system plays a major role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Recently we reported complement activation in human NASH. However, it remained unclear whether the alternative pathway of complement, which amplifies C3 activation and which is frequently associated with pathological complement activation leading to disease, was involved. Here, alternative pathway components were investigated in liver biopsies of obese subjects with healthy livers (n = 10) or with NASH (n = 12) using quantitative PCR, Western blotting, and immunofluorescence staining. Properdin accumulated in areas where neutrophils surrounded steatotic hepatocytes, and colocalized with the C3 activation product C3c. C3 activation status as expressed by the C3c/native C3 ratio was 2.6-fold higher (p<0.01) in subjects with NASH despite reduced native C3 concentrations (0.94 +/- 0.12 vs. 0.57 +/- 0.09; p<0.01). Hepatic properdin levels positively correlated with levels of C3c (r(s) = 0.69; p<0.05) and C3c/C3 activation ratio (rs = 0.59; p<0.05). C3c, C3 activation status (C3c/C3 ratio) and properdin levels increased with higher lobular inflammation scores as determined according to the Kleiner classification (C3c: p<0.01, C3c/C3 ratio: p<0.05, properdin: p<0.05). Hepatic mRNA expression of factor B and factor D did not differ between subjects with healthy livers and subjects with NASH (factor B: 1.00 +/- 0.19 vs. 0.71 +/- 0.07, p = 0.26; factor D: 1.00 +/- 0.21 vs. 0.66 +/- 0.14, p = 0.29;). Hepatic mRNA and protein levels of Decay Accelerating Factor tended to be increased in subjects with NASH (mRNA: 1.00 +/- 0.14 vs. 2.37 +/- 0.72; p = 0.22; protein: 0.51 +/- 0.11 vs. 1.97 +/- 0.67; p = 0.28). In contrast, factor H mRNA was downregulated in patients with NASH (1.00 +/- 0.09 vs. 0.71 +/- 0.06; p<0.05) and a similar trend was observed with hepatic protein levels (1.12 +/- 0.16 vs. 0.78 +/- 0.07; p = 0.08). Collectively, these data suggest a role for alternative pathway activation in driving hepatic inflammation in NASH. Therefore, alternative pathway factors may be considered attractive targets for treating NASH by inhibiting complement activation.	[Segers, Filip M.; Verdam, Froukje J.; de Jonge, Charlotte; Boonen, Bas; Bouvy, Nicole D.; Buurman, Wim A.; Rensen, Sander S.] Maastricht Univ, Med Ctr, Dept Gen Surg, Maastricht, Netherlands; [de Jonge, Charlotte; Greve, Jan Willem M.] Atrium Med Ctr Parkstad, Dept Surg, Heerlen, Netherlands; [Driessen, Ann] Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands; [Shiri-Sverdlov, Ronit] Maastricht Univ, Med Ctr, Dept Genet & Cell Biol, Maastricht, Netherlands	Maastricht University; Atrium Medical Center; Maastricht University; Maastricht University	Rensen, SS (corresponding author), Maastricht Univ, Med Ctr, Dept Gen Surg, Maastricht, Netherlands.	s.rensen@maastrichtuniversity.nl	Rensen, Sander/J-3224-2019; Driessen, Ann/D-3768-2017; Bouvy, Nicole/AAD-2844-2021; Shiri-Sverdlov, Ronit/X-2642-2019; Shiri-Sverdlov, Ronit/E-5571-2017	Rensen, Sander/0000-0001-5054-8400; Driessen, Ann/0000-0003-4148-610X; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Verdam, Froukje/0000-0002-3986-5250	Senter Novem IOP Genomics grant [IGE05012A]; Transnational University Limburg grant; Dutch Digestive Foundation [WO 09-46]	Senter Novem IOP Genomics grant; Transnational University Limburg grant; Dutch Digestive Foundation	This work was financially supported by a Senter Novem IOP Genomics grant (http://www.rvo.nl/subsidies-regelingen/iop-genomics) to W.A.B. and J.W.G. (IGE05012A), and a Transnational University Limburg grant and project grant WO 09-46 from the Dutch Digestive Foundation (http://www.mlds.nl) to S.S.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SR, 2003, IMMUNOLOGY, V110, P258, DOI 10.1046/j.1365-2567.2003.01733.x; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Emlen W, 2010, SEMIN THROMB HEMOST, V36, P660, DOI 10.1055/s-0030-1262888; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Gauvreau D, 2012, MOL IMMUNOL, V51, P73, DOI 10.1016/j.molimm.2012.02.110; Ikura Y, 2006, HEPATOLOGY, V43, P506, DOI 10.1002/hep.21070; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kemper C, 2008, MOL IMMUNOL, V45, P4048, DOI 10.1016/j.molimm.2008.06.034; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Moreno-Navarrete JM, 2010, DIABETES, V59, P200, DOI 10.2337/db09-0700; Maslowska M, 2005, VITAM HORM, V70, P309, DOI 10.1016/S0083-6729(05)70010-8; Mason JC, 1999, BLOOD, V94, P1673, DOI 10.1182/blood.V94.5.1673.417a05_1673_1682; Naughton MA, 1996, J IMMUNOL, V156, P3051; NOLAN KF, 1993, METHOD ENZYMOL, V223, P35; Pan XM, 2010, HEPATOLOGY, V51, P2061, DOI 10.1002/hep.23581; PHAM BN, 1995, GASTROENTEROLOGY, V108, P495, DOI 10.1016/0016-5085(95)90079-9; Rensen SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052411; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Schwaeble WJ, 1999, IMMUNOL TODAY, V20, P17, DOI 10.1016/S0167-5699(98)01376-0; Somani R, 2012, DIABETES CARE, V35, P894, DOI 10.2337/dc11-1483; Spiller OB, 2000, CLIN EXP IMMUNOL, V121, P234, DOI 10.1046/j.1365-2249.2000.01305.x; Sreekumar R, 2003, HEPATOLOGY, V38, P244, DOI 10.1053/jhep.2003.50290; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Wirthmueller U, 1997, J IMMUNOL, V158, P4444; Wlazlo N, 2012, METABOLISM, V61, P1787, DOI 10.1016/j.metabol.2012.05.015; Yesilova Z, 2005, AM J GASTROENTEROL, V100, P842, DOI 10.1111/j.1572-0241.2005.40838.x	38	21	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110053	10.1371/journal.pone.0110053	http://dx.doi.org/10.1371/journal.pone.0110053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299043	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200098
J	Wang, T; Wang, SW; Zhang, Y; Wu, XF; Peng, Y; Cao, Z; Ge, BY; Wang, X; Wu, Q; Lin, JT; Zhang, WQ; Li, S; Zhao, J				Wang, Tao; Wang, Shi-Wei; Zhang, Yue; Wu, Xue-Fei; Peng, Yan; Cao, Zhen; Ge, Bi-Ying; Wang, Xi; Wu, Qiong; Lin, Jin-Tao; Zhang, Wan-Qin; Li, Shao; Zhao, Jie			Scorpion Venom Heat-Resistant Peptide (SVHRP) Enhances Neurogenesis and Neurite Outgrowth of Immature Neurons in Adult Mice by Up-Regulating Brain-Derived Neurotrophic Factor (BDNF)	PLOS ONE			English	Article							NEURAL STEM-CELLS; BUTHUS-MARTENSII KARSCH; HIPPOCAMPAL-NEURONS; SUBVENTRICULAR ZONE; ADHESION MOLECULE; OLFACTORY-BULB; IN-VITRO; PROLIFERATION; DIFFERENTIATION; EXPRESSION	Scorpion venom heat-resistant peptide (SVHRP) is a component purified from Buthus martensii Karsch scorpion venom. Although scorpions and their venom have been used in Traditional Chinese Medicine (TCM) to treat chronic neurological disorders, the underlying mechanisms of these treatments remain unknown. We applied SVHRP in vitro and in vivo to understand its effects on the neurogenesis and maturation of adult immature neurons and explore associated molecular mechanisms. SVHRP administration increased the number of 5-bromo-2'-dexoxyuridine (BrdU)-positive cells, BrdU- positive/neuron-specific nuclear protein (NeuN)-positive neurons, and polysialylated-neural cell adhesion molecule (PSA-NCAM)-positive immature neurons in the subventricular zone (SVZ) and subgranular zone (SGZ) of hippocampus. Furthermore immature neurons incubated with SVHRP-pretreated astrocyte-conditioned medium exhibited significantly increased neurite length compared with those incubated with normal astrocyte-conditioned medium. This neurotrophic effect was further confirmed in vivo by detecting an increased average single area and whole area of immature neurons in the SGZ, SVZ and olfactory bulb (OB) in the adult mouse brain. In contrast to normal astrocyte-conditioned medium, higher concentrations of brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF) or glial cell line-derived neurotrophic factor (GDNF) was detected in the conditioned medium of SVHRP-pretreated astrocytes, and blocking BDNF using anti-BDNF antibodies eliminated these SVHRP-dependent neurotrophic effects. In SVHRP treated mouse brain, more glial fibrillary acidic protein (GFAP)-positive cells were detected. Furthermore, immunohistochemistry revealed increased numbers of GFAP/BDNF double-positive cells, which agrees with the observed changes in the culture system. This paper describes novel effects of scorpion venom-originated peptide on the stem cells and suggests the potential therapeutic values of SVHRP.	[Wang, Tao; Wang, Shi-Wei; Wu, Xue-Fei; Peng, Yan; Cao, Zhen; Wang, Xi; Wu, Qiong; Zhang, Wan-Qin; Li, Shao; Zhao, Jie] Dalian Med Univ, Dept Physiol, Dalian, Peoples R China; [Wang, Tao; Zhang, Yue; Ge, Bi-Ying; Zhao, Jie] Liaoning Engn Technol Ctr Target based Nat Prod P, Dalian, Peoples R China; [Wang, Shi-Wei] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Lin, Jin-Tao] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China	Dalian Medical University; University of Tasmania; Dalian Medical University	Li, S (corresponding author), Dalian Med Univ, Dept Physiol, Dalian, Peoples R China.	lishao89@hotmail.com; dlzhaoj@163.com			National Natural Science Foundation of China [81371223, 81371437]; Research Fund for the Doctoral Program of Higher Education of China [20122105110010]; Liaoning Province Science and Technology Plan Projects [2011226006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Liaoning Province Science and Technology Plan Projects	The work was supported by the National Natural Science Foundation of China (NO 81371223 and 81371437, http://www.nsfc.gov.cn), the Research Fund for the Doctoral Program of Higher Education of China (20122105110010, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) and Liaoning Province Science and Technology Plan Projects (2011226006, http://www.lninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Brannen CL, 2000, NEUROREPORT, V11, P1123, DOI 10.1097/00001756-200004070-00042; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Cologna CT, 2011, TOXICON, V58, P54, DOI 10.1016/j.toxicon.2011.05.001; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Lepore AC, 2006, NEUROSCIENCE, V142, P285, DOI 10.1016/j.neuroscience.2005.12.068; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Liu B, 2000, NEUROSCIENCE, V97, P749, DOI 10.1016/S0306-4522(00)00057-9; Liu YF, 2003, PROTEIN EXPRES PURIF, V27, P253, DOI 10.1016/S1046-5928(02)00609-5; Lu HX, 2008, BRAIN RES BULL, V77, P158, DOI 10.1016/j.brainresbull.2008.02.037; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Mang Xiao-Yun, 2007, Shengli Xuebao, V59, P278; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morrens J, 2012, GLIA, V60, P159, DOI 10.1002/glia.21247; Nacher J, 2013, NEUROCHEM RES, V38, P1122, DOI 10.1007/s11064-013-0977-4; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Qiu YF, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-28; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Wang CG, 2001, EUR J BIOCHEM, V268, P2480, DOI 10.1046/j.1432-1327.2001.02132.x; Wang CM, 2011, NEUROSCI LETT, V488, P70, DOI 10.1016/j.neulet.2010.10.079; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Wang Y, 2011, BIOMED CHROMATOGR, V25, P801, DOI 10.1002/bmc.1519; Wang Yue, 2007, Shengli Xuebao, V59, P87; Yu SB, 2009, NEURAL REGEN RES, V4, P1030, DOI 10.3969/j.issn.1673-5374.2009.12.011; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zhang WQ, 2004, METHOD PREPARING EFF; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136; Zhu YH, 2009, STEM CELLS, V27, P1433, DOI 10.1002/stem.65; Zhu ZH, 2006, BRAIN RES, V1114, P1, DOI 10.1016/j.brainres.2006.07.070	39	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109977	10.1371/journal.pone.0109977	http://dx.doi.org/10.1371/journal.pone.0109977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299676	Green Submitted, gold, Green Published			2022-12-27	WOS:000343941200089
J	Xia, X; Wu, WD; Zhang, KD; Cen, G; Jiang, T; Cao, J; Huang, KJ; Huang, C; Qiu, ZJ				Xia, Xiang; Wu, Weidong; Zhang, Kundong; Cen, Gang; Jiang, Tao; Cao, Jun; Huang, Kejian; Huang, Chen; Qiu, Zhengjun			Prognostic Significance of Complications after Laparoscopic Colectomy for Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; ANASTOMOTIC LEAKAGE; GASTRIC-CANCER; GASTROESOPHAGEAL JUNCTION; INFLAMMATORY ONCOTAXIS; SURGICAL COMPLICATIONS; CURATIVE RESECTION; BREAST-CANCER; TUMOR-CELLS; SURVIVAL	Aims: This study sought to evaluate the prognostic significance of postoperative complications for colon cancer patients undergoing laparoscopic surgery. Methods: From May 2006 to May 2009, a total 224 patients who underwent laparoscopic curative resection (R0) for colon cancer were included in our retrospective study. Postoperative complications were evaluated according to a standardized grading system. The main outcome measurements of our study were overall survival (OS) and relapse-free survival ( RFS), which were then compared between the no complication and complication groups. Univariate and multivariate analysis were used to assess the correlation between complications and prognosis. Results: Fifty-nine postoperative complications occurred in 43 patients. The overall morbidity rate was 26.3%. The 5-year OS in the complication group was 41.4% compared with 78.5% in the no complication group (P, 0.001). The cumulative incidence of relapse was also more aggressive in patients with complications (5-year RFS: complication group 40.9% vs. no complication group 82.1%, P, 0.001). Multivariate analysis identified complications as a significant factor increasing the risk for both OS (RR 2.737; 95% Cl 1.512-4.952; P = 0.001) and RFS (RR 4.247; 95% Cl 2.291-7.876; P, 0.001). Conclusion: Postoperative complications could pose a significant adverse impact not only on OS but also on RFS in patients with colon cancer even when laparoscopic R0 resection is available.	[Xia, Xiang; Wu, Weidong; Zhang, Kundong; Cen, Gang; Jiang, Tao; Cao, Jun; Huang, Kejian; Huang, Chen; Qiu, Zhengjun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Gen Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Huang, KJ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Gen Surg, Shanghai 200030, Peoples R China.	huangkjdoctor@sina.com; qiuzjdoctor@sina.com			National Natural Science Foundation of China [81372640]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81372640). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, N ENGL J MED, V350, P2050; CLAVIEN PA, 1992, SURGERY, V111, P518; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; DERHAGOPIAN RP, 1978, JAMA-J AM MED ASSOC, V240, P374, DOI 10.1001/jama.240.4.374; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Huang C, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-127; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kubota T, 2014, ANN SURG ONCOL, V21, P891, DOI 10.1245/s10434-013-3384-9; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marshall JR, 2009, CURR OPIN CLIN NUTR, V12, P539, DOI 10.1097/MCO.0b013e32832d6c5f; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Mimori K, 2008, CLIN CANCER RES, V14, P2609, DOI 10.1158/1078-0432.CCR-07-4354; Murthy BL, 2007, BRIT J CANCER, V97, P1211, DOI 10.1038/sj.bjc.6604004; Paholyuk TD, 2004, EXP ONCOL, V26, P161; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Ptok H, 2007, BRIT J SURG, V94, P1548, DOI 10.1002/bjs.5707; Rizk NP, 2004, J AM COLL SURGEONS, V198, P42, DOI 10.1016/j.jamcollsurg.2003.08.007; SHINE T, 1981, CANCER-AM CANCER SOC, V47, P1325, DOI 10.1002/1097-0142(19810315)47:6<1325::AID-CNCR2820470615>3.0.CO;2-B; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Sun J, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-85; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yoo HM, 2011, J SURG ONCOL, V104, P734, DOI 10.1002/jso.22045	26	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108348	10.1371/journal.pone.0108348	http://dx.doi.org/10.1371/journal.pone.0108348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299478	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200014
J	Zhang, ZH; Huang, Y; Xie, H; Pan, JX; Liu, FF; Li, XZ; Chen, WS; Hu, JY; Liu, ZG				Zhang, Zhenhao; Huang, Yue; Xie, Hui; Pan, Juxin; Liu, Fanfei; Li, Xuezhi; Chen, Wensheng; Hu, Jiaoyue; Liu, Zuguo			Benzalkonium Chloride Suppresses Rabbit Corneal Endothelium Intercellular Gap Junction Communication	PLOS ONE			English	Article							CONNEXIN43 PHOSPHORYLATION; DOWN-REGULATION; CELLS; PROTEIN; ZO-1; OCCLUDENS-1; INHIBITION; TRANSITION; EXPRESSION; EPITHELIUM	Purpose: Gap junction intercellular communication (GJIC) plays a critical role in the maintenance of corneal endothelium homeostasis. We determined if benzalkonium chloride (BAK) alters GJIC activity in the rabbit corneal endothelium since it is commonly used as a drug preservative in ocular eyedrop preparations even though it can have cytotoxic effects. Methods: Thirty-six adult New Zealand albino rabbits were randomly divided into three groups. BAK at 0.01%, 0.05%, and 0.1% was applied twice daily to one eye of each of the rabbits in one of the three groups for seven days. The contralateral untreated eyes were used as controls. Corneal endothelial morphological features were observed by in vivo confocal microscopy (IVCM). Immunofluorescent staining resolved changes in gap junction integrity and localization. Western blot analysis and RT-PCR evaluated changes in levels of connexin43 (Cx43) and tight junction zonula occludens-1 (ZO-1) gene and protein expression, respectively. Cx43 and ZO-1 physical interaction was detected by immunoprecipitation (IP). Primary rabbit corneal endothelial cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) containing BAK for 24 hours. The scrape-loading dye transfer technique (SLDT) was used to assess GJIC activity. Results: Topical administration of BAK (0.05%, 0.1%) dose dependently disrupted corneal endothelial cell morphology, altered Cx43 and ZO-1 distribution and reduced Cx43 expression. BAK also markedly induced increases in Cx43 phosphorylation status concomitant with decreases in the Cx43-ZO-1 protein-protein interaction. These changes were associated with marked declines in GJIC activity. Conclusions: The dose dependent declines in rabbit corneal endothelial GJIC activity induced by BAK are associated with less Cx43-ZO-1 interaction possibly arising from increases in Cx43 phosphorylation and declines in its protein expression. These novel changes provide additional evidence that BAK containing eyedrop preparations should be used with caution to avoid declines in corneal transparency resulting from losses in GJIC activity and endothelial function.	[Zhang, Zhenhao; Xie, Hui; Pan, Juxin; Liu, Fanfei; Li, Xuezhi; Chen, Wensheng; Hu, Jiaoyue; Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; [Zhang, Zhenhao; Xie, Hui; Pan, Juxin; Liu, Fanfei; Li, Xuezhi; Chen, Wensheng; Hu, Jiaoyue; Liu, Zuguo] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Zhang, Zhenhao; Xie, Hui; Pan, Juxin; Liu, Fanfei; Li, Xuezhi; Chen, Wensheng; Hu, Jiaoyue; Liu, Zuguo] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Vis Sci, Xiamen, Fujian, Peoples R China; [Huang, Yue] Xiamen Univ, Coll Med, Inst Stem Cell & Regenerat Med, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Xiamen University	Hu, JY (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	mydear_22000@163.com; zuguoliu@xmu.edu.cn	Huang, Yue/ABD-7847-2021		National Natural Science Foundation of China, Beijing, China [81100638, 81270978]; Key Program of National Natural Science of China, Beijing, China [81330022]; Cross-Straits Science Foundation, Beijing, China [U1205025]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Key Program of National Natural Science of China, Beijing, China; Cross-Straits Science Foundation, Beijing, China	This work was supported by National Natural Science Foundation of China, Beijing, China (81100638, 81270978); Key Program of National Natural Science of China, Beijing, China (81330022) and Cross-Straits Science Foundation, Beijing, China (U1205025). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Alves LA, 1996, BLOOD, V88, P328; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bourne WM, 2010, EYE CONTACT LENS, V36, P310, DOI 10.1097/ICL.0b013e3181ee1450; BOURNE WM, 1976, AM J OPHTHALMOL, V81, P482, DOI 10.1016/0002-9394(76)90305-6; Bourne WM, 2004, EXP EYE RES, V78, P561, DOI 10.1016/j.exer.2003.08.002; Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; BOURNE WM, 1976, AM J OPHTHALMOL, V82, P44, DOI 10.1016/0002-9394(76)90662-0; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Chen WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026103; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Gomes P, 2006, EXP EYE RES, V83, P1225, DOI 10.1016/j.exer.2006.06.012; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gros DB, 1996, BIOESSAYS, V18, P719, DOI 10.1002/bies.950180907; Grupcheva CN, 2012, INVEST OPHTH VIS SCI, V53, P1130, DOI 10.1167/iovs.11-8711; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 1998, INVEST OPHTH VIS SCI, V39, P2572; Kimura K, 2010, INVEST OPHTH VIS SCI, V51, P1943, DOI 10.1167/iovs.09-3573; LAING RA, 1976, AM J OPHTHALMOL, V82, P459, DOI 10.1016/0002-9394(76)90495-5; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; Miura T, 2004, AM J PHYSIOL-HEART C, V286, pH214, DOI 10.1152/ajpheart.00441.2003; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Oyamada M, 2005, BBA-BIOMEMBRANES, V1719, P6, DOI 10.1016/j.bbamem.2005.11.002; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Richard G, 2005, CLIN DERMATOL, V23, P23, DOI 10.1016/j.clindermatol.2004.09.010; Rivedal E, 2001, CARCINOGENESIS, V22, P1543, DOI 10.1093/carcin/22.9.1543; Roh DS, 2011, INVEST OPHTH VIS SCI, V52, P5174, DOI 10.1167/iovs.11-7272; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sumide T, 2003, J BIOMED MATER RES B, V64B, P57, DOI 10.1002/jbm.b.10510; Tien T, 2013, INVEST OPHTH VIS SCI, V54, P6518, DOI 10.1167/iovs.13-11763; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; Williams KK, 2004, CURR EYE RES, V28, P109, DOI 10.1076/ceyr.28.2.109.26234; Williams KK, 2002, CURR EYE RES, V25, P29	44	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109708	10.1371/journal.pone.0109708	http://dx.doi.org/10.1371/journal.pone.0109708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299343	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200069
J	Diene, O; Sakagami, N; Narisawa, K				Diene, Ousmane; Sakagami, Nobuo; Narisawa, Kazuhiko			The Role of Dark Septate Endophytic Fungal Isolates in the Accumulation of Cesium by Chinese Cabbage and Tomato Plants under Contaminated Environments	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; HETEROCONIUM-CHAETOSPIRA; CS-137; FUKUSHIMA; SOIL; PHYTOREMEDIATION; DEPOSITION; FOREST	Following the 2011 Fukushima Daiichi Nuclear Power Plant accident, the preservation of the food chain from radionuclides contamination has become of crucial importance. The potential of Dark septate endophytic fungi in the management of Cs accumulation in plants under contaminated environments was investigated using Chinese cabbage and tomato plants. Four endophytic fungal isolates of different species, i.e. Pseudosigmoidea ibarakiensis I.4-2-1, Veronaeopsis simplex Y34, Helminthosporium velutinum 41-1, and as yet unidentified taxon 312-6 were tested In Vitro in two levels of Cs (5ppm and 10ppm). On the plant growth, the inoculation of the selected DSEs to both Chinese cabbage and tomato resulted in an increased biomass of up to 82% and 122%, respectively compared to control (non-inoculated) plants. With regards to the Cs accumulation, it varied with the host plant considered. In Chinese cabbage, DSEs inoculation caused higher Cs accumulation in above ground plant parts, whereas in tomato, Cs accumulation decreased significantly with three of the isolates tested, i.e., V. simplex Y34, P. ibarakiensis I.4-2-1, and the as yet unidentified taxon 312-6 suggesting low-risk transfer on the above ground plants parts as a result of high and negative plant reactions rather than high and positive reactions as it is the case with Chinese cabbage. These results suggested that DSEs can be recommended for use with Chinese cabbage to enhance phytoremediation of Cs in surrounding contaminated areas. With tomato, DSEs can be recommended for decreasing the accumulation of Cs in plants under contaminated environments.	[Diene, Ousmane] Minist Agr & Equipement Rural, Direct Protect Vegetaux, Dakar, Senegal; [Sakagami, Nobuo; Narisawa, Kazuhiko] Ibaraki Univ, Coll Agr, Ami, Ibaraki 30003, Japan	Ibaraki University	Diene, O (corresponding author), Minist Agr & Equipement Rural, Direct Protect Vegetaux, Dakar, Senegal.	odiene16@yahoo.com			Japan Society for the Promotion of Science [23380190]; Grants-in-Aid for Scientific Research [25660273] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 23380190) from the Japan Society for the Promotion of Science (to K. N.). http://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2004, TOX PROF CES; Baeza A, 2005, J ENVIRON RADIOACTIV, V81, P89, DOI 10.1016/j.jenvrad.2004.12.006; Chen LA, 2010, APPL SOIL ECOL, V46, P383, DOI 10.1016/j.apsoil.2010.10.003; CLINT GM, 1991, MYCOL RES, V95, P1047, DOI 10.1016/S0953-7562(09)80544-3; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Diene O, 2013, MICROBES ENVIRON, V28, P381, DOI 10.1264/jsme2.ME13002; Diene O, 2010, MICROBES ENVIRON, V25, P216, DOI 10.1264/jsme2.ME09165; DIGHTON J, 1991, MYCOL RES, V95, P1052, DOI 10.1016/S0953-7562(09)80545-5; Dubchak S, 2010, SPAN J AGRIC RES, V8, pS103; Entry JA, 1999, ENVIRON POLLUT, V104, P449, DOI 10.1016/S0269-7491(98)00163-8; Environment Protection Agency (EPA), 2002, FACTS CES 137; Gasoni L, 1997, MYCOL RES, V101, P867, DOI 10.1017/S0953756296003462; Glick BR, 2003, BIOTECHNOL ADV, V21, P383, DOI 10.1016/S0734-9750(03)00055-7; Hampton CR, 2004, PLANT PHYSIOL, V136, P3824, DOI 10.1104/pp.104.046672; Hashimoto S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00416; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 2001, MYCORRHIZA, V11, P207, DOI 10.1007/s005720100112; Khastini RO, 2012, J MICROBIOL, V50, P618, DOI 10.1007/s12275-012-2105-6; KORDAN HA, 1987, NEW PHYTOL, V107, P395, DOI 10.1111/j.1469-8137.1987.tb00191.x; Leyval C, 2002, MYCORRHIZAL TECHNOLOGY IN AGRICULTURE: FROM GENES TO BIOPRODUCTS, P175; Lotter DW, 2003, J SUSTAIN AGR, V21, P59, DOI 10.1300/J064v21n04_06; Mandyam K, 2005, STUD MYCOL, P173; Mizuno T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01742; Murakami M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03599; Nadeem SM, 2014, BIOTECHNOL ADV, V32, P429, DOI 10.1016/j.biotechadv.2013.12.005; Narisawa Kazuhiko, 2007, Mycoscience, V48, P274, DOI 10.1007/s10267-007-0364-6; Nimis P. L., 1996, STUD GEOBOT, V15, P3; ROBISON W L, 1992, Health Physics, V62, P496, DOI 10.1097/00004032-199206000-00002; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Rosen K, 2005, SCI TOTAL ENVIRON, V338, P283, DOI 10.1016/j.scitotenv.2004.07.015; Sieber T. N., 2002, Plant roots: the hidden half, P887; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Strandberg M, 1998, J ENVIRON RADIOACTIV, V40, P175, DOI 10.1016/S0265-931X(97)00074-X; Tak HI, 2013, REV ENVIRON CONTAM T, V223, P33, DOI 10.1007/978-1-4614-5577-6_2; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; Vinichuk M, 2013, J ENVIRON RADIOACTIV, V115, P151, DOI 10.1016/j.jenvrad.2012.08.004; Wu HB, 2009, J HAZARD MATER, V170, P861, DOI 10.1016/j.jhazmat.2009.05.069; Xiao W, 2012, ENVIRON SCI POLLUT R, V20, P380; Xiao X, 2010, BIORESOURCE TECHNOL, V101, P1668, DOI 10.1016/j.biortech.2009.09.083; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Zhuang XL, 2007, ENVIRON INT, V33, P406, DOI 10.1016/j.envint.2006.12.005	42	16	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109233	10.1371/journal.pone.0109233	http://dx.doi.org/10.1371/journal.pone.0109233			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296037	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000051
J	Suga, USG; Terada, RSS; Ubaldini, ALM; Fujimaki, M; Pascotto, RC; Batilana, AP; Pietrobon, R; Vissoci, JRN; Rodrigues, CG				Suga, Uhana Seifert Guimaraes; Terada, Raquel Sano Suga; Ubaldini, Adriana Lemos Mori; Fujimaki, Mitsue; Pascotto, Renata Correa; Batilana, Adelia Portero; Pietrobon, Ricardo; Vissoci, Joao Ricardo N.; Rodrigues, Clarissa G.			Factors That Drive Dentists towards or Away from Dental Caries Preventive Measures: Systematic Review and Metasummary	PLOS ONE			English	Article							ORAL-HEALTH; SERVICE PROVISION; CHILDREN; PERCEPTIONS; ATTITUDES; BARRIERS; BURDEN; TRENDS; AGENTS; CARE	Background: Dental caries is a serious public health concern. The high cost of dental treatment can be avoided by effective preventive measures, which are dependent on dentists' adherence. This study aimed to evaluate the factors that drive dentists towards or away from dental caries preventive measures. Methods and Findings: This systematic review was registered in PROSPERO (CRD42012002235). Several databases as well as the reference lists and citations of the included publications were searched according to PRISMA guidelines, yielding 18,276 titles and abstracts, which were assessed to determine study eligibility. Seven qualitative studies and 41 surveys (36,501 participants) remained after data extraction and interpretation. A total of 43 findings were abstracted from the reports and were grouped together into 6 categories that were judged to be topically similar: education and training, personal beliefs, work conditions, remuneration, gender, place of residence and patients. The main findings for adherence based on their calculated frequency effect sizes (ES) were teamwork (21%) and post-graduation (12%), while for non-adherence were biologicism (27%), and remuneration for preventive procedures (25%). Intensity ES were also calculated and demonstrated low prevalence of the findings. Quality assessment of the studies demonstrated that the methodological quality, particularly of surveys, varied widely among studies. Conclusions: Despite the questionable quality of the included reports, the evidence that emerged seems to indicate that further education and training coupled with a fairer pay scheme would be a reasonable approach to change the balance in favor of the provision of dental caries preventive measures by dentists. The results of this review could be of value in the planning and decision making processes aimed at encouraging changes in professional dental practice that could result in the improvement of the oral health care provided to the population in general.	[Suga, Uhana Seifert Guimaraes; Terada, Raquel Sano Suga; Ubaldini, Adriana Lemos Mori; Fujimaki, Mitsue; Pascotto, Renata Correa] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil; [Batilana, Adelia Portero; Pietrobon, Ricardo; Vissoci, Joao Ricardo N.; Rodrigues, Clarissa G.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Vissoci, Joao Ricardo N.] Fac Inga, Dept Med, Maringa, Parana, Brazil; [Rodrigues, Clarissa G.] Fundacao Univ Cardiol IC FUC, Inst Cardiol Rio Grande Sul, Porto Alegre, RS, Brazil	Universidade Estadual de Maringa; Duke University; Centro Universitario Inga (UNINGA); Fundacao Universitaria de Cardiologia	Terada, RSS (corresponding author), Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.	rssterada@uem.br	Terada, Raquel Sano Suga/E-7166-2017; Pascotto, Renata/C-3202-2014	Terada, Raquel Sano Suga/0000-0003-1344-9870; Fujimaki, Mitsue/0000-0002-7824-3868; Pascotto, Renata/0000-0002-8396-6016				Abdul Razak I, 1994, J Clin Pediatr Dent, V18, P313; American Dental Association Health Foundation, 1984, J AM DENT ASSOC, V108, P811; Ananaba Nejay, 2010, J Mich Dent Assoc, V92, P38; Anderson R., 2002, INT J HLTH PROMOT ED, V40, P9, DOI [DOI 10.1080/14635240.2002.10806190, 10.1080/14635240.2002.10806190]; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Brennan D, 1998, AUST DENT J, V43, P331, DOI 10.1111/j.1834-7819.1998.tb00184.x; Brennan D S, 2003, Community Dent Health, V20, P5; Brennan D, 2007, AUST J RURAL HEALTH, V15, P189, DOI 10.1111/j.1440-1584.2007.00883.x; Brennan DS, 1996, COMMUNITY DENT ORAL, V24, P145, DOI 10.1111/j.1600-0528.1996.tb00832.x; Brennan DS, 2001, AUST DENT J, V46, P186, DOI 10.1111/j.1834-7819.2001.tb00280.x; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009853.pub2; Calnan M, 2000, SOCIOL HEALTH ILL, V22, P742, DOI 10.1111/1467-9566.00229; Cashmore AW, 2011, HEALTH PROMOT J AUST, V22, P17, DOI 10.1071/HE11017; CHEN M, 1990, COMMUNITY DENT ORAL, V18, P239, DOI 10.1111/j.1600-0528.1990.tb00067.x; Chestnutt Ivor G, 2007, Prim Dent Care, V14, P13, DOI 10.1308/135576107779398228; CRAFT M, 1976, BRIT DENT J, V141, P371, DOI 10.1038/sj.bdj.4803850; Badan DED, 2010, CIENC SAUDE COLETIVA, V15, P1811, DOI 10.1590/S1413-81232010000700093; Fiset L, 1997, J AM DENT ASSOC, V128, P337, DOI 10.14219/jada.archive.1997.0197; Freeman Ruth, 2005, Prim Dent Care, V12, P42, DOI 10.1308/1355761053695185; Ghasemi Hadi, 2007, Eur J Dent, V1, P222; Ghasemi H, 2009, ORAL HLTH PREV DENT, V7, P339; Ghasemi H, 2008, ORAL HLTH PREV DENT, V6, P53; Gonzalez Serrano A, 1990, Rev Eur Odontoestomatol, V2, P107; GREMBOWSKI D, 1990, J PUBLIC HEALTH DENT, V50, P244, DOI 10.1111/j.1752-7325.1990.tb02130.x; Gussy MG, 2006, BRIT DENT J, V201, P165, DOI 10.1038/sj.bdj.4813849; Holloway P J, 1994, Int Dent J, V44, P317; Humphreys RE, 2010, BRIT DENT J, V209, P601, DOI 10.1038/sj.bdj.2010.1133; Kallestal C, 1999, COMMUNITY DENT ORAL, V27, P144, DOI 10.1111/j.1600-0528.1999.tb02004.x; Kay EJ, 2003, BRIT DENT J, V194, P621, DOI 10.1038/sj.bdj.4810259; Malcheff S, 2009, PEDIATR DENT, V31, P202; Milgrom P, 1988, J Am Coll Dent, V55, P48; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moon HS, 1998, J PUBLIC HEALTH DENT, V58, P51, DOI 10.1111/j.1752-7325.1998.tb02990.x; Murtomaa H, 1988, Community Dent Health, V5, P369; Nadanovsky P, 1995, COMMUNITY DENT ORAL, V23, P331, DOI 10.1111/j.1600-0528.1995.tb00258.x; Nettleton S, 1989, Community Dent Health, V6, P47; Nuca CI, 2011, OHDM, V10, P131; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Pine Cynthia M, 2004, Community Dent Health, V21, P112; Pourat N, 2011, J AM DENT ASSOC, V142, P1050, DOI 10.14219/jada.archive.2011.0327; Riley JL, 2010, ORAL HLTH PREV DENT, V8, P351; Riley JL, 2011, J AM DENT ASSOC, V142, P429, DOI 10.14219/jada.archive.2011.0199; Riley JL, 2010, COMMUNITY DENT ORAL, V38, P360, DOI 10.1111/j.1600-0528.2010.00547.x; ROCK WP, 1976, BRIT DENT J, V140, P61, DOI 10.1038/sj.bdj.4803703; Sandelowski M, 2007, RES NURS HEALTH, V30, P99, DOI 10.1002/nur.20176; Sbaraini A, 2012, BR DENT J, V212, P1; Sesma N, 2006, REV ODONTOLGIA U CID, V18, P257; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Silva RP, 2006, BRAZ J ORAL SCI, V5, P1022; Threlfall AG, 2007, BR DENT J, V202, P1; Tomlinson P, 2006, BRIT DENT J, V200, P393, DOI 10.1038/sj.bdj.4813425; Tryon A F, 1974, J Am Soc Prev Dent, V4, P20; Tseveenjav Battsetseg, 2005, Oral Health Prev Dent, V3, P183; Tseveenjav Battsetseg, 2004, Oral Health Prev Dent, V2, P203; World Health Organization, 2014, WHAT IS BURD OR DIS; Yee R, 2002, INT DENT J, V52, P1	58	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107831	10.1371/journal.pone.0107831	http://dx.doi.org/10.1371/journal.pone.0107831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296335	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000011
J	Baicharoen, S; Miyabe-Nishiwaki, T; Arsaithamkul, V; Hirai, Y; Duangsa-ard, K; Siriaroonrat, B; Domae, H; Srikulnath, K; Koga, A; Hirai, H				Baicharoen, Sudarath; Miyabe-Nishiwaki, Takako; Arsaithamkul, Visit; Hirai, Yuriko; Duangsa-ard, Kwanruen; Siriaroonrat, Boripat; Domae, Hiroshi; Srikulnath, Kornsorn; Koga, Akihiko; Hirai, Hirohisa			Locational Diversity of Alpha Satellite DNA and Intergeneric Hybridization Aspects in the Nomascus and Hylobates Genera of Small Apes	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOME REARRANGEMENTS; EVOLUTIONARY HISTORY; TELOMERE REGION; AGILE GIBBONS; PHYLOGENY; HETEROCHROMATIN; PRIMATES; UNIQUE	Recently, we discovered that alpha satellite DNA has unique and genus-specific localizations on the chromosomes of small apes. This study describes the details of alpha satellite localization in the genera Nomascus and Hylobates and explores their usefulness in distinguishing parental genome sets in hybrids between these genera. Fluorescence in situ hybridization was used to establish diagnostic criteria of alpha satellite DNA markers in discriminating small ape genomes. In particular we established the genus specificity of alpha satellite distribution in three species of light-cheeked gibbons (Nomascus leucogenys, N. siki, and N. gabriellae) in comparison to that of Hylobates lar. Then we determined the localization of alpha satellite DNA in a hybrid individual which resulted from a cross between these two genera. In Nomascus the alpha satellite DNA blocks were located at the centromere, telomere, and four interstitial regions. In Hylobates detectable amounts of alpha satellite DNA were seen only at centromeric regions. The differences in alpha satellite DNA locations between Nomascus and Hylobates allowed us to easily distinguish the parental chromosomal sets in the genome of intergeneric hybrid individuals found in Thai and Japanese zoos. Our study illustrates how molecular cytogenetic markers can serve as diagnostic tools to identify the origin of individuals. These molecular tools can aid zoos, captive breeding programs and conservation efforts in managing small apes species. Discovering more information on alpha satellite distribution is also an opportunity to examine phylogenetic and evolutionary questions that are still controversial in small apes.	[Baicharoen, Sudarath] Kasetsart Univ, Fac Sci, Biosci Program, Bangkok, Thailand; [Baicharoen, Sudarath; Srikulnath, Kornsorn] Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, Bangkok, Thailand; [Baicharoen, Sudarath; Arsaithamkul, Visit; Siriaroonrat, Boripat] Zool Pk Org, Conservat Res & Educ Div, Bangkok, Thailand; [Miyabe-Nishiwaki, Takako; Hirai, Yuriko; Koga, Akihiko; Hirai, Hirohisa] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Duangsa-ard, Kwanruen] Chiang Mai Zoo, Chiang Mai, Thailand; [Domae, Hiroshi] Ishikawa Zoo, Noumi, Ishikawa, Japan; [Srikulnath, Kornsorn] Kasetsart Univ, Fac Sci, Dept Genet, Bangkok, Thailand	Kasetsart University; Kasetsart University; Kyoto University; Kasetsart University	Hirai, H (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	hirohisa.hirai.7w@kyoto-u.ac.jp	Srikulnath, Kornsorn/GLU-1326-2022	Srikulnath, Kornsorn/0000-0002-5985-7258	Japan Society for the Promotion of Science [20405016, 22247037, 24255009, 23657165]; Japan Student Service Organization; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, Kasetsart University, Thailand (CASTNAR, NRU-KU, Thailand)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Student Service Organization; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, Kasetsart University, Thailand (CASTNAR, NRU-KU, Thailand)	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (20405016, 22247037, 24255009 to HH; 23657165 to AK) and a Short-Term Stay/Short-Term Visit Program Fellowship to SB from the Japan Student Service Organization. This work was also supported by Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, Kasetsart University, Thailand (CASTNAR, NRU-KU, Thailand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Baicharoen S, 2012, GENOME, V55, P809, DOI 10.1139/gen-2012-0123; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; BROCKELMAN WY, 1984, NATURE, V312, P634, DOI 10.1038/312634a0; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Capozzi O, 2012, GENOME RES, V22, P2520, DOI 10.1101/gr.138651.112; Carbone L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000538; Carbone L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004999; Cellamare A, 2009, MOL BIOL EVOL, V26, P1889, DOI 10.1093/molbev/msp101; Chan YC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-82; Chiarelli B., 1972, P90; COUTURIER J, 1991, FOLIA PRIMATOL, V56, P95, DOI 10.1159/000156533; Detwiler KM, 2005, INT J PRIMATOL, V26, P661, DOI 10.1007/s10764-005-4372-0; Disotell TR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-240; Groves C.P., 2001, PRIMATE TAXONOMY; Hirai H, 2005, CHROMOSOME RES, V13, P123, DOI 10.1007/s10577-005-7475-8; Hirai H, 2003, CHROMOSOME RES, V11, P37, DOI 10.1023/A:1022006015379; Hirai H, 2007, HUM GENET, V122, P477, DOI 10.1007/s00439-007-0425-0; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Jolly CJ, 1997, INT J PRIMATOL, V18, P597, DOI 10.1023/A:1026367307470; KOEHLER U, 1995, GENOMICS, V30, P287, DOI 10.1006/geno.1995.9875; Koga A, 2012, HEREDITY, V109, P180, DOI 10.1038/hdy.2012.28; Koga A, 2014, DNA RES, V21, P407, DOI 10.1093/dnares/dsu005; MAIO JJ, 1971, J MOL BIOL, V56, P579, DOI 10.1016/0022-2836(71)90403-7; Marshall J., 1986, P137; Misceo D, 2008, GENOME RES, V18, P1530, DOI 10.1101/gr.078295.108; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; Mootnick Alan R., 2006, Primate Conservation, V21, P103, DOI 10.1896/0898-6207.21.1.103; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; MYERS RH, 1979, SCIENCE, V205, P308, DOI 10.1126/science.451603; PROUTY LA, 1983, CYTOGENET CELL GENET, V35, P141, DOI 10.1159/000131856; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; STANYON R, 1987, FOLIA PRIMATOL, V48, P56, DOI 10.1159/000156285; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Tosi AJ, 2003, EVOLUTION, V57, P1419; VANTUINEN P, 1983, AM J PHYS ANTHROPOL, V61, P453, DOI 10.1002/ajpa.1330610408; Wienberg J, 2005, CYTOGENET GENOME RES, V108, P139, DOI 10.1159/000080811; Wijayanto H, 2005, CHROMOSOME RES, V13, P717, DOI 10.1007/s10577-005-1007-4; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0	40	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109151	10.1371/journal.pone.0109151	http://dx.doi.org/10.1371/journal.pone.0109151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290445	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000039
J	Cai, X; Dai, ZP; Reeves, RS; Caballero-Benitez, A; Duran, KL; Delrow, JJ; Porter, PL; Spies, T; Groh, V				Cai, Xin; Dai, Zhenpeng; Reeves, Rebecca S.; Caballero-Benitez, Andrea; Duran, Kate L.; Delrow, Jeffrey J.; Porter, Peggy L.; Spies, Thomas; Groh, Veronika			Autonomous Stimulation of Cancer Cell Plasticity by the Human NKG2D Lymphocyte Receptor Coexpressed with Its Ligands on Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; POOR-PROGNOSIS; OVARIAN-CANCER; TUMOR-CELLS; PROMOTES; EMT; IDENTIFICATION; METASTASIS; ACTIVATION	The stimulatory NKG2D receptor on lymphocytes promotes tumor immune surveillance by targeting ligands selectively induced on cancer cells. Progressing tumors counteract by employing tactics to disable lymphocyte NKG2D. This negative dynamic is escalated as some human cancer cells co-opt expression of NKG2D, thereby complementing the presence of its ligands for autonomous stimulation of oncogenic signaling. Clinical association data imply relationships between cancer cell NKG2D and metastatic disease. Here we show that NKG2D promotes cancer cell plasticity by induction of phenotypic, molecular, and functional signatures diagnostic of the epithelial-mesenchymal transition, and of stem-like traits via induction of Sox9, a key transcriptional regulator of breast stem cell maintenance. These findings obtained with model breast tumor lines and xenotransplants were recapitulated by ex vivo cancer cells from primary invasive breast carcinomas. Thus, NKG2D may have the capacity to drive high malignancy traits underlying metastatic disease.	[Cai, Xin; Dai, Zhenpeng; Reeves, Rebecca S.; Caballero-Benitez, Andrea; Duran, Kate L.; Delrow, Jeffrey J.; Spies, Thomas; Groh, Veronika] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Porter, Peggy L.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Spies, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	tspies@fhcrc.org			National Institutes of Health [P50 CA083636, R01 CA174470]; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA174470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant P50 CA083636 and National Institutes of Health grant R01 CA174470. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2010, J CELL SCI, V123, P2357, DOI 10.1242/jcs.054296; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Benitez AC, 2011, P NATL ACAD SCI USA, V108, P4081, DOI 10.1073/pnas.1018603108; Cedile O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013466; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duan XH, 2011, MED ONCOL, V28, P466, DOI 10.1007/s12032-010-9480-9; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; El-Gazzar A, 2014, ONCOGENE, V33, P4932, DOI 10.1038/onc.2013.435; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krieg S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00388; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lehner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031210; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McGilvray RW, 2010, INT J CANCER, V127, P1412, DOI 10.1002/ijc.25156; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Oktem G, 2012, INT J GYNECOL CANCER, V22, P23, DOI 10.1097/IGC.0b013e31823228b2; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popa N, 2011, GLIA, V59, P35, DOI 10.1002/glia.21074; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song DG, 2013, HUM GENE THER, V24, P295, DOI 10.1089/hum.2012.143; Spear Paul, 2013, Cancer Immun, V13, P8; Sun L, 2013, STEM CELLS, V31, P1454, DOI 10.1002/stem.1394; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Upshaw JL, 2006, SEMIN IMMUNOL, V18, P167, DOI 10.1016/j.smim.2006.03.001; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	44	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108942	10.1371/journal.pone.0108942	http://dx.doi.org/10.1371/journal.pone.0108942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291178	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000030
J	Gong, Z; Jain, AD; Tran, D; Yi, DH; Wu, F; Zorn, A; Ratilal, P; Makris, NC				Gong, Zheng; Jain, Ankita D.; Duong Tran; Yi, Dong Hoon; Wu, Fan; Zorn, Alexander; Ratilal, Purnima; Makris, Nicholas C.			Ecosystem Scale Acoustic Sensing Reveals Humpback Whale Behavior Synchronous with Herring Spawning Processes and Re-Evaluation Finds No Effect of Sonar on Humpback Song Occurrence in the Gulf of Maine in Fall 2006	PLOS ONE			English	Article							AMBIENT-SEA-NOISE; MEGAPTERA-NOVAEANGLIAE; CLUPEA-HARENGUS; TRANSMISSION SCINTILLATION; EUBALAENA-GLACIALIS; SOUND-PROPAGATION; RADIATED NOISE; SOUTHERN GULF; OCEAN; SCATTERING	We show that humpback-whale vocalization behavior is synchronous with peak annual Atlantic herring spawning processes in the Gulf of Maine. With a passive, wide-aperture, densely-sampled, coherent hydrophone array towed north of Georges Bank in a Fall 2006 Ocean Acoustic Waveguide Remote Sensing (OAWRS) experiment, vocalizing whales could be instantaneously detected and localized over most of the Gulf of Maine ecosystem in a roughly 400-km diameter area by introducing array gain, of 18 dB, orders of magnitude higher than previously available in acoustic whale sensing. With humpback-whale vocalizations consistently recorded at roughly 2000/day, we show that vocalizing humpbacks (i) were overwhelmingly distributed along the northern flank of Georges Bank, coinciding with the peak spawning time and location of Atlantic herring, and (ii) their overall vocalization behavior was strongly diurnal, synchronous with the formation of large nocturnal herring shoals, with a call rate roughly ten-times higher at night than during the day. Humpback-whale vocalizations were comprised of (1) highly diurnal non-song calls, suited to hunting and feeding behavior, and (2) songs, which had constant occurrence rate over a diurnal cycle, invariant to diurnal herring shoaling. Before and during OAWRS survey transmissions: (a) no vocalizing whales were found at Stellwagen Bank, which had negligible herring populations, and (b) a constant humpback-whale song occurrence rate indicates the transmissions had no effect on humpback song. These measurements contradict the conclusions of Risch et al. Our analysis indicates that (a) the song occurrence variation reported in Risch et al. is consistent with natural causes other than sonar, (b) the reducing change in song reported in Risch et al. occurred days before the sonar survey began, and (c) the Risch et al. method lacks the statistical significance to draw the conclusions of Risch et al. because it has a 98-100% false-positive rate and lacks any true-positive confirmation.	[Gong, Zheng; Duong Tran; Wu, Fan; Zorn, Alexander; Ratilal, Purnima] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Jain, Ankita D.; Yi, Dong Hoon; Makris, Nicholas C.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Northeastern University; Massachusetts Institute of Technology (MIT)	Makris, NC (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	makris@mit.edu	Gong, Zheng/K-5808-2012		National Oceanographic Partnership Program; Census of Marine Life; Office of Naval Research; Alfred P. Sloan Foundation; National Science Foundation; Presidential Early Career Award for Scientists and Engineers; Northeastern University; Massachusetts Institute of Technology	National Oceanographic Partnership Program; Census of Marine Life; Office of Naval Research(Office of Naval Research); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Presidential Early Career Award for Scientists and Engineers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern University; Massachusetts Institute of Technology	This research was supported by the National Oceanographic Partnership Program, the Census of Marine Life, the Office of Naval Research, the Alfred P. Sloan Foundation, the National Science Foundation, the Presidential Early Career Award for Scientists and Engineers, Northeastern University, and Massachusetts Institute of Technology. The authors thank David Reed for providing technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B, 2011, COMMENTS DRAKES BAY; Allen JK, 2012, J ACOUST SOC AM, V132, pEL229, DOI 10.1121/1.4739251; Altman DG., 1999, PRACTICAL STAT MED R; Andrews M, 2011, J ACOUST SOC AM, V130, P1253, DOI 10.1121/1.3614542; Andrews M, 2009, J ACOUST SOC AM, V125, P111, DOI 10.1121/1.3037228; [Anonymous], TECHNICAL REPORT; [Anonymous], ARG DAT; [Anonymous], FURUNO MAR GPS NAV M; [Anonymous], INTR NEFSC FISH AC S; Archer D, 2007, GLOBAL WARMING UNDER, P48; Arveson PT, 2000, J ACOUST SOC AM, V107, P118, DOI 10.1121/1.428344; Ashforth A, 2001, AIDS WITCHCRAFT PROB; Au W.W, 1993, SONAR DOLPHINS, DOI DOI 10.1007/978-1-4612-4356-4; Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; Au WWL, 2001, TECHNICAL REPORT; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Battista T, 2006, 42 NCCOS, V45, P1; Baumgartner MF, 2011, J ACOUST SOC AM, V129, P2889, DOI 10.1121/1.3562166; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Becker KM, 2003, OCEANS 2003 MTS/IEEE: CELEBRATING THE PAST...TEAMING TOWARD THE FUTURE, P2607, DOI 10.1109/OCEANS.2003.178321; Behringer W, 1999, CLIMATIC CHANGE, V43, P335, DOI 10.1023/A:1005554519604; Berger E., 2003, NOISE MANUAL; Born M., 2013, PRINCIPLES OPTICS EL; Brekhovskikh L.M., 2003, FUNDAMENTALS OCEAN A, V3; Bretz F., 2010, MULTIPLE COMP USING; Burdic WS, 1984, UNDERWATER ACOUSTIC, V2, P322; BURGESS AS, 1983, J ACOUST SOC AM, V73, P201, DOI 10.1121/1.388840; Cato D., 2006, P ACOUSTICS, V2006, P453; Cato D, 1992, ACOUST AUST, V20, P76; CATO D H, 1991, Memoirs of the Queensland Museum, V30, P277; CATO DH, 1976, J ACOUST SOC AM, V60, P320, DOI 10.1121/1.381109; Cato DH, 1998, J ACOUST SOC AM, V104, P1667, DOI 10.1121/1.424379; Cato DH, 1997, APPL ACOUST, V51, P317, DOI 10.1016/S0003-682X(97)00001-7; Cato DH., 2001, MEM QUEENSL MUS, V47, P481; Cerchio Salvatore, 2001, Bioacoustics, V11, P277; Chia CS, 2000, J ACOUST SOC AM, V108, P2053, DOI 10.1121/1.1308047; Chow S.-C., 1998, DESIGN ANAL CLIN TRI; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Clay CS, 1977, ACOUSTICAL OCEANOGRA, P494; COLLINS MD, 1993, J ACOUST SOC AM, V93, P1736, DOI 10.1121/1.406739; Council NEFM, 2011, TECHNICAL REPORT, V1; Council NR, 1997, TECHNICAL REPORT; Crocker M.J., 1998, HDB ACOUSTICS; CROUCH WW, 1972, J ACOUST SOC AM, V51, P1066, DOI 10.1121/1.1912926; Darling JD, 2006, BEHAVIOUR, V143, P1051, DOI 10.1163/156853906778607381; Dunlop RA, 2008, MAR MAMMAL SCI, V24, P613, DOI 10.1111/j.1748-7692.2008.00208.x; Dunlop RA, 2007, J ACOUST SOC AM, V122, P2893, DOI 10.1121/1.2783115; Tran D, 2012, J ACOUST SOC AM, V132, P3659, DOI 10.1121/1.4763547; DYER I, 1970, J ACOUST SOC AM, V48, P337, DOI 10.1121/1.1912133; Edds-Walton Peggy L., 1997, Bioacoustics, V8, P47; Edds-Walton Peggy L., 2000, Bioacoustics, V11, P31; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Etter PC, 2013, UNDERWATER ACOUSTIC MODELING AND SIMULATION, 4TH EDITION, P1, DOI 10.1201/b13906; Gerry E, STUDDS STELLWAGEN BA; Glockner DA., 1983, COMMUNICATION BEHAV, P447; Goldman R, 1985, STAT INTRO, P240; Gong Z, 2012, THESIS NE U DEP ELEC; Gong Z, 2013, J ACOUST SOC AM, V134, P3705, DOI 10.1121/1.4821989; Gong Z, 2010, J ACOUST SOC AM, V127, P104, DOI 10.1121/1.3268595; Greene CR, 1995, MARINE MAMMALS NOISE, P437; Greening MV, 2002, J ACOUST SOC AM, V112, P2872, DOI 10.1121/1.1514931; Hare J, TECHNICAL REPORT; Hatch L, 2008, ENVIRON MANAGE, V42, P735, DOI 10.1007/s00267-008-9169-4; HINICH MJ, 1975, J ACOUST SOC AM, V58, P1023, DOI 10.1121/1.380761; Jagannathan S, 2012, J ACOUST SOC AM, V132, P680, DOI 10.1121/1.4726073; Jagannathan S, 2009, MAR ECOL PROG SER, V395, P137, DOI 10.3354/meps08266; Jech JM, 2006, CAN J FISH AQUAT SCI, V63, P2225, DOI 10.1139/F06-126; Jech JM, 2012, AQUAT LIVING RESOUR, V25, P1, DOI 10.1051/alr/2012003; Jensen FB, 2011, MOD ACOUST SIGN PROC, P1, DOI 10.1007/978-1-4419-8678-8; Johnson M, 2008, P ROY SOC B-BIOL SCI, V275, P133, DOI 10.1098/rspb.2007.1190; Kay S., 1998, FUNDAMENTALS STAT SI, V7; KEWLEY DJ, 1990, J ACOUST SOC AM, V88, P1894, DOI 10.1121/1.400212; King J, 2011, MASSACHUSEETS FISHER; Kipple B, 2004, P GLACIER BAY SCI S, P172; Knowlton A., 1991, J ACOUST SOC AM, V89, P1968, DOI [10.1121/1.2029710, DOI 10.1121/1.2029710]; Lai Y, 2004, THESIS MIT; Laurinolli MH, 2003, MAR MAMMAL SCI, V19, P708, DOI 10.1111/j.1748-7692.2003.tb01126.x; Lee S, 2006, J ACOUST SOC AM, V119, P336, DOI 10.1121/1.2139074; Lesage V, 1999, MAR MAMMAL SCI, V15, P65, DOI 10.1111/j.1748-7692.1999.tb00782.x; Levenson C, 1972, 77007706 NAVOCEANO; Li QH, 2012, DIGITAL SONAR DESIGN IN UNDERWATER ACOUSTICS: PRINCIPLES AND APPLICATIONS, P1, DOI 10.1007/978-3-642-18290-7; Lurton X., 2002, INTRO UNDERWATER ACO; Mackinson S, 1999, ICES J MAR SCI, V56, P613, DOI 10.1006/jmsc.1999.0513; Madsen PT, 2002, BEHAV ECOL SOCIOBIOL, V53, P31, DOI 10.1007/s00265-002-0548-1; Makris NC, 1999, J ACOUST SOC AM, V106, P2491, DOI 10.1121/1.428138; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; MAKRIS NC, 1993, J ACOUST SOC AM, V94, P983, DOI 10.1121/1.408200; MAKRIS NC, 1995, J ACOUST SOC AM, V97, P3547, DOI 10.1121/1.412440; Makris NC, 1996, J ACOUST SOC AM, V100, P769, DOI 10.1121/1.416239; MAKRIS NC, 1994, J ACOUST SOC AM, V95, P1865, DOI 10.1121/1.408702; Makris NC, 2003, GEOCLUTTER ACOUSTICS; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Matthews J. N., 2001, Journal of Cetacean Research and Management, V3, P271; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; McCarthy E, 2004, INT REGULATION UNDER; McCarthy E, 2004, INT REGULATION UNDER; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; Medwin H, 2005, SOUNDS SEA OCEAN ACO; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2000, MAR MAMMAL SCI, V16, P739, DOI 10.1111/j.1748-7692.2000.tb00969.x; Miguel E, 2005, REV ECON STUD, V72, P1153, DOI 10.1111/0034-6527.00365; Milinski Manfred, 1993, Fish and Fisheries Series, V7, P285; Moore D, 2010, INTRO PRACTICE STAT; Mukhopadhyay N, 2013, APPL SEQUENTIAL METH, P11; Nero RW, 2004, ICES J MAR SCI, V61, P323, DOI 10.1016/j.icesjms.2003.09.006; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; Noad M. J., 2001, MEM QUEENSLAND MUS, V47, P507; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Noad MJ., 2004, AUSTR AC SOC ANN C N; Northeast Fisheries Science Center, 2012, 54 NE REG STOCK ASS, P12; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Ocean Studies Board National Research Council, 2000, MAR MAMM LOW FREQ SO; Ocean Studies Board National Research Council, 2000, MAR MAMM LOW FREQ SO; Ocean Studies Board The Division on Earth and Life Studies The National Academies, 2012, SCI REV DRAFT ENV IM; Oster E, 2004, J ECON PERSPECT, V18, P215, DOI 10.1257/089533004773563502; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Pack AA, 2001, TECHNICAL REPORT; Parks S. E., 2011, Endangered Species Research, V15, P63, DOI 10.3354/esr00368; Parks SE, 2005, MAR MAMMAL SCI, V21, P458, DOI 10.1111/j.1748-7692.2005.tb01244.x; Pater LL, 2009, J WILDLIFE MANAGE, V73, P788, DOI 10.2193/2006-235; Pavlac BA, 2009, WITCH HUNTS W WORLD, P1; PAYNE PM, 1990, FISH B-NOAA, V88, P687; Pierce A. D., 1989, ACOUSTICS INTRO ITS; PIGGOTT CL, 1964, J ACOUST SOC AM, V36, P2152, DOI 10.1121/1.1919337; Pol M, 2002, DEV LOW IMPACT SEA S; R Development Core Team, R LANG ENV STAT COMP; Rankin S, 2007, BIOACOUSTICS, V16, P137, DOI 10.1080/09524622.2007.9753572; Ratilal P, 2005, J ACOUST SOC AM, V117, P1977, DOI 10.1121/1.1799252; Rayleigh L., 1879, LONDON EDINBURGH DUB, V8, P261, DOI [10.1080/14786447908639684, DOI 10.1080/14786447908639684]; Rebull OG, 2006, J ACOUST SOC AM, V120, P2077, DOI 10.1121/1.2336751; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Rose G. A., 2007, COD ECOLOGICAL HIST; Rossing T., 2007, SPRINGER HDB ACOUSTI; Simmen J, 1997, J ACOUST SOC AM, V102, P239, DOI 10.1121/1.419820; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stimpert AK, 2007, BIOL LETTERS, V3, P467, DOI 10.1098/rsbl.2007.0281; Stimpert AK, 2011, J ACOUST SOC AM, V129, P476, DOI 10.1121/1.3504708; Swartz SL, 2002, ACOUSTIC VISUAL SURV; Thode A, 2004, J ACOUST SOC AM, V116, P245, DOI 10.1121/1.1758972; Thode A, 2010, J ACOUST SOC AM, V128, P2681, DOI 10.1121/1.3495945; Thode AM, 2006, IEEE J OCEANIC ENG, V31, P696, DOI 10.1109/JOE.2006.880431; THOMPSON PO, 1986, J ACOUST SOC AM, V80, P735, DOI 10.1121/1.393947; Thompson TJ, 1979, MYSTICETE SOUNDS; Tolstoy I, 1966, OCEAN ACOUSTICS THEO; Tukey J, 1991, STAT SCI, V6, P100, DOI DOI 10.1214/SS/1177011945; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Tyack PL, 2000, SPR HDB AUD, V12, P156; Urick RJ, 1983, PRINCIPLES UNDERWATE, P29; Urick RJ, 1983, PRINCIPLES UNDERWATE, P343; Van Trees H.L., 2001, DETECTION ESTIMATION, P19; Vanderlaan ASM, 2003, IEEE J OCEANIC ENG, V28, P164, DOI 10.1109/JOE.2003.813943; Vasconcelos RO, 2007, J EXP BIOL, V210, P2104, DOI 10.1242/jeb.004317; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; Watkins WA, 2004, DEEP-SEA RES PT I, V51, P1889, DOI 10.1016/j.dsr.2004.08.006; Watkins William A., 2000, Oceanography, V13, P62; Weinrich M, 1997, FISH B-NOAA, V95, P826; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Wilson JD, 2006, J ACOUST SOC AM, V119, P168, DOI 10.1121/1.2130961; Wilson JD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033200; Winn H.E., 1970, Proceedings a Conf biol Sonar diving Mamm, V7, P39; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631; Zar J., 1984, BIOSTAT ANAL, V1, P185; Zingarelli R.A., RAM NAVY STANDARD PA	165	17	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e104733	10.1371/journal.pone.0104733	http://dx.doi.org/10.1371/journal.pone.0104733			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289938	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000002
J	Markun, S; Brandle, E; Dishy, A; Rosemann, T; Frei, A				Markun, Stefan; Braendle, Elisabeth; Dishy, Avraham; Rosemann, Thomas; Frei, Anja			The Concordance of Care for Age Related Macular Degeneration with the Chronic Care Model: A Multi-Centered Cross-Sectional Study	PLOS ONE			English	Article							CHRONIC ILLNESS CARE; RANDOMIZED CONTROLLED-TRIAL; PATIENT ASSESSMENT; CASE-MANAGEMENT; HEALTH-CARE; DEPRESSION; QUESTIONNAIRE; PHQ-9; INSTRUMENT; VALIDITY	Aims: The aim of the study was to assess the concordance of care for age related macular degeneration with the evidence-based framework for care for chronic medical conditions known as the chronic care model. Furthermore we aimed to identify factors associated with the concordance of care with the chronic care model. Methods: Multi-centered cross-sectional study. 169 patients beginning medical treatment for age related macular degeneration were recruited and analyzed. Patients completed the Patient Assessment of Chronic Illness Care (PACIC) questionnaire, reflecting accordance to the chronic care model from a patient's perspective, the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25) and Patient Health Questionnaire (PHQ-9). Visual acuity and chronic medical conditions were assessed. Nonparametric tests and correlation analyses were performed, also multivariable regression analysis. Results: The median PACIC summary score was 2.4 (interquartile range 1.75 to 3.25), the lowest PACIC subscale score was "follow-up/coordination" with a median of 1.8 (interquartile range 1.00 to 2.60). In multivariable regression analysis the presence of diabetes type 2 was strongly associated with low PACIC scores (coefficient = -0.85, p = 0.007). Conclusion: Generally, care for patients with age related macular degeneration by ophthalmologists is in moderate concordance with the chronic care model. Concerning follow-up and coordination of health service, large improvements are possible. Future research should answer the question how healthcare delivery can be improved effecting relevant benefits to patients with AMD.	[Markun, Stefan; Braendle, Elisabeth; Rosemann, Thomas; Frei, Anja] Univ Zurich, Univ Zurich Hosp, Inst Gen Practice & Hlth Serv Res, Zurich, Switzerland; [Dishy, Avraham] Cantonal Hosp Aarau, Dept Ophthalmol, Aarau, Switzerland; [Frei, Anja] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of Zurich; University Zurich Hospital; Kantonsspital Aarau AG (KSA); University of Zurich	Markun, S (corresponding author), Univ Zurich, Univ Zurich Hosp, Inst Gen Practice & Hlth Serv Res, Zurich, Switzerland.	stefan.markun@usz.ch		Markun, Stefan/0000-0003-3317-0957	non-commercial foundation "Zukunft Hausarzt, Zurcher Stiftung zur Forderung der Hausarztmedizin", Zurich	non-commercial foundation "Zukunft Hausarzt, Zurcher Stiftung zur Forderung der Hausarztmedizin", Zurich	This trial was supported by the non-commercial foundation "Zukunft Hausarzt, Zurcher Stiftung zur Forderung der Hausarztmedizin", Zurich (www.zukunfthausarzt.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand CS, 2012, EYE, V26, pS1, DOI 10.1038/eye.2012.32; Brody BL, 2001, OPHTHALMOLOGY, V108, P1893, DOI 10.1016/S0161-6420(01)00754-0; Chakravarthy U, 2013, EYE, V27, P1429, DOI 10.1038/eye.2013.233; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Frei A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-70; Frei A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-221; Gensichen J, 2009, ANN INTERN MED, V151, P369, DOI 10.7326/0003-4819-151-6-200909150-00001; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Gugiu C, 2010, J EVAL CLIN PRACT, V16, P509, DOI 10.1111/j.1365-2753.2009.01151.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamoureux EL, 2009, OPTOMETRY VISION SCI, V86, P139, DOI 10.1097/OPX.0b013e318194eb47; Lochner KA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120137; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Mangione C., 2000, NATL EYE I 25 ITEM V; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Randell RL, 2013, INFLAMM BOWEL DIS, V19, P1428, DOI 10.1097/MIB.0b013e3182813434; Rasmussen A, 2013, OPHTHALMOLOGY, V120, P2630, DOI 10.1016/j.ophtha.2013.05.018; Revicki DA, 2010, INVEST OPHTH VIS SCI, V51, P712, DOI 10.1167/iovs.09-3766; Rosemann T, 2007, ARTHRIT RHEUM-ARTHR, V57, P1390, DOI 10.1002/art.23080; Rosemann T, 2007, J EVAL CLIN PRACT, V13, P806, DOI 10.1111/j.1365-2753.2007.00786.x; Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5; Stellefson M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120180; Thorpe KE, 2010, HEALTH AFFAIR, V29, P718, DOI 10.1377/hlthaff.2009.0474; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Vedula SS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub2; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	27	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108536	10.1371/journal.pone.0108536	http://dx.doi.org/10.1371/journal.pone.0108536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290915	gold, Green Published, Green Accepted			2022-12-27	WOS:000342798000019
J	Peng, F; You, QG; Xu, MH; Guo, J; Wang, T; Xue, X				Peng, Fei; You, Quangang; Xu, Manhou; Guo, Jian; Wang, Tao; Xue, Xian			Effects of Warming and Clipping on Ecosystem Carbon Fluxes across Two Hydrologically Contrasting Years in an Alpine Meadow of the Qinghai-Tibet Plateau	PLOS ONE			English	Article							SOIL RESPIRATION; CLIMATIC-CHANGE; CO2 FLUXES; TEMPERATURE; NITROGEN; RESPONSES; EXCHANGE; GRASSLANDS; GROWTH; METAANALYSIS	Responses of ecosystem carbon (C) fluxes to human disturbance and climatic warming will affect terrestrial ecosystem C storage and feedback to climate change. We conducted a manipulative experiment to investigate the effects of warming and clipping on soil respiration (Rs), ecosystem respiration (ER), net ecosystem exchange (NEE) and gross ecosystem production (GEP) in an alpine meadow in a permafrost region during two hydrologically contrasting years (2012, with 29.9% higher precipitation than the long-term mean, and 2013, with 18.9% lower precipitation than the long-tem mean). Our results showed that GEP was higher than ER, leading to a net C sink (measured by NEE) over the two growing seasons. Warming significantly stimulated ecosystem C fluxes in 2012 but did not significantly affect these fluxes in 2013. On average, the warming-induced increase in GEP (1.49 mu mol m(-2)s(-1)) was higher than in ER (0.80 mu mol m(-2)s(-1)), resulting in an increase in NEE (0.70 mu mol m(-2)s(-1)). Clipping and its interaction with warming had no significant effects on C fluxes, whereas clipping significantly reduced aboveground biomass (AGB) by 51.5 g m(-2) in 2013. These results suggest the response of C fluxes to warming and clipping depends on hydrological variations. In the wet year, the warming treatment caused a reduction in water, but increases in soil temperature and AGB contributed to the positive response of ecosystem C fluxes to warming. In the dry year, the reduction in soil moisture, caused by warming, and the reduction in AGB, caused by clipping, were compensated by higher soil temperatures in warmed plots. Our findings highlight the importance of changes in soil moisture in mediating the responses of ecosystem C fluxes to climate warming in an alpine meadow ecosystem.	[Peng, Fei; You, Quangang; Xu, Manhou; Guo, Jian; Wang, Tao; Xue, Xian] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Peng, F (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Desert & Desertificat, Lanzhou, Peoples R China.	pengguy02@yahoo.com; xianxue@lzb.ac.cn	manhou, xu/AAA-3630-2019; Peng, Fei/AAO-8461-2020; You, Quan Gang/L-8934-2019	Peng, Fei/0000-0002-5816-4898; manhou, xu/0000-0001-7558-6227	Foundation for Excellent Youth Scholars of CAREERI, CAS [351191001]; National Natural Science Foundation of China [41301210, 41201195, 41301211]; Chinese Academy of Sciences (Hundred Talents Program)	Foundation for Excellent Youth Scholars of CAREERI, CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (Hundred Talents Program)(Chinese Academy of Sciences)	Financial support came from the Foundation for Excellent Youth Scholars of CAREERI, CAS (351191001), National Natural Science Foundation of China (41301210, 41201195 and 41301211), and Chinese Academy of Sciences (Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Barr AG, 2002, CAN J FOREST RES, V32, P813, DOI [10.1139/x01-131, 10.1139/X01-131]; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; De Boeck HJ, 2007, ENVIRON EXP BOT, V60, P95, DOI 10.1016/j.envexpbot.2006.07.001; Derner JD, 2006, PLANT SOIL, V280, P77, DOI 10.1007/s11104-005-2554-3; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gilgen AK, 2009, BIOGEOSCIENCES, V6, P2525, DOI 10.5194/bg-6-2525-2009; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; Kato T, 2004, AGR FOREST METEOROL, V124, P121, DOI 10.1016/j.agrformet.2003.12.008; Kato T, 2006, GLOBAL CHANGE BIOL, V12, P1285, DOI 10.1111/j.1365-2486.2006.01153.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; [李娜 Li Na], 2011, [生态学报, Acta Ecologica Sinica], V31, P895; Li Na, 2011, Soil Biology & Biochemistry, V43, P942, DOI 10.1016/j.soilbio.2011.01.009; Li XJ, 2011, ENVIRON EARTH SCI, V64, P1911, DOI 10.1007/s12665-011-1004-1; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Lu M, 2013, ECOLOGY; [陆子建 Lu Zijian], 2006, [冰川冻土, Journal of Glaciology and Geocryology], V28, P642; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2010, ECOLOGY, V91, P3261, DOI 10.1890/09-1634.1; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Niu SL, 2013, ECOSYSTEMS; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; Pang QQ, 2009, COLD REG SCI TECHNOL, V57, P23, DOI 10.1016/j.coldregions.2009.01.005; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; Rogiers N, 2005, THEOR APPL CLIMATOL, V80, P187, DOI 10.1007/s00704-004-0099-7; Ross DJ, 1999, SOIL BIOL BIOCHEM, V31, P803, DOI 10.1016/S0038-0717(98)00180-1; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Sebastia MT, 2007, J APPL ECOL, V44, P158, DOI 10.1111/j.1365-2664.2006.01232.x; Soloman S., 2007, CONTR WORK GROUP 1 4, P749; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Wang GX, 2007, CATENA, V70, P506, DOI 10.1016/j.catena.2007.01.001; Williams M, 2001, TREE PHYSIOL, V21, P287, DOI 10.1093/treephys/21.5.287; Wu QB, 2004, COLD REG SCI TECHNOL, V38, P85, DOI 10.1016/S0165-232X(03)00064-8; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Xu MH, 2014, ENV EXP BOT IN PRESS; Yang G.H., 2000, RESOURCES SCI, V22, P72; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zhang PC, 2009, SOIL BIOL BIOCHEM, V41, P663, DOI 10.1016/j.soilbio.2008.12.026; Zhao W, 2008, PLANT ECOL, V196, P85, DOI 10.1007/s11258-007-9336-3; Zheng D., 2000, MOUNTAIN GEOECOLOGY; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	56	44	57	16	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109319	10.1371/journal.pone.0109319	http://dx.doi.org/10.1371/journal.pone.0109319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291187	gold, Green Published, Green Submitted			2022-12-27	WOS:000342798000053
J	Reischauer, C; Froehlich, JM; Pless, M; Binkert, CA; Koh, DM; Gutzeit, A				Reischauer, Carolin; Froehlich, Johannes Malte; Pless, Miklos; Binkert, Christoph Andreas; Koh, Dow-Mu; Gutzeit, Andreas			Early Treatment Response in Non-Small Cell Lung Cancer Patients Using Diffusion-Weighted Imaging and Functional Diffusion Maps - A Feasibility Study	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; BIOMARKER; CHEMOTHERAPY; PREDICTION; CARCINOMA; THERAPY; CHEMORADIATION; METASTASES; SURVIVAL	Objective: The aim of this study was to prospectively evaluate the feasibility of monitoring treatment response to chemotherapy in patients with non-small cell lung carcinoma using functional diffusion maps (fDMs). Materials and Methods: This study was approved by the Cantonal Research Ethics Committee and informed written consent was obtained from all patients. Nine patients (mean age = 66 years; range = 53-76 years, 5 females, 4 males) with overall 13 lesions were included. Imaging was performed within two weeks before initiation of chemotherapy and at one, two, and six weeks after initiation of chemotherapy. Imaging included a respiratory-triggered diffusion-weighted sequence including three b-factors (100, 600, and 800 s/mm(2)). Treatment response was defined by change in tumor diameter on computed tomography (CT) after two cycles of chemotherapy. Changes in the apparent diffusion coefficient (ADC) on a perlesion basis and the percentages of voxel with significantly increased or decreased ADCs on fDMs were analyzed using repeated measures analysis of variance (ANOVA). Changes in tumor size were used as covariate to examine the ability of ADCs and fDM parameters to predict treatment response. Results: Repeated measures ANOVA revealed that the percentage of voxels with increased ADCs on fDMs (p = 0.002) as well as the mean ADC increase (p = 0.011) were significantly higher in good responders with a large reduction in tumor size on CT. Conclusion: Our results indicate that the percentage of voxels with significantly increased ADCs on fDMs seems to be a promising biomarker for early prediction of treatment response in patients with non-small cell lung carcinoma. Contrary to averaged values, this approach allows the spatial heterogeneity of treatment response to be resolved.	[Reischauer, Carolin; Froehlich, Johannes Malte; Gutzeit, Andreas] Hirslanden Hosp St Anna, Inst Radiol & Nucl Med, Clin Res Unit, Luzern, Switzerland; [Reischauer, Carolin] Cantonal Hosp Winterthur, Dept Radiol, Winterthur, Switzerland; [Reischauer, Carolin; Binkert, Christoph Andreas; Gutzeit, Andreas] Paracelsus Med Univ Salzburg, Dept Radiol, Salzburg, Austria; [Pless, Miklos] Cantonal Hosp Winterthur, Dept Oncol, Winterthur, Switzerland; [Koh, Dow-Mu] Royal Marsden NHS Fdn Trust, Acad Dept Radiol, Sutton, Surrey, England; [Koh, Dow-Mu] Inst Canc Res, CR UK, Sutton, Surrey, England; [Koh, Dow-Mu] Inst Canc Res, EPSRC Canc Imaging Ctr, Sutton, Surrey, England	Paracelsus Private Medical University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK	Reischauer, C (corresponding author), Hirslanden Hosp St Anna, Inst Radiol & Nucl Med, Clin Res Unit, Luzern, Switzerland.	carolin.reischauer@hirslanden.ch	Pless, Miklos/ABC-4054-2021	Koh, Dow-Mu/0000-0001-7654-8011; Reischauer, Carolin/0000-0002-6624-6615				[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; DeVries AF, 2003, INT J RADIAT ONCOL, V56, P958, DOI 10.1016/S0360-3016(03)00208-6; Dudeck O, 2008, J MAGN RESON IMAGING, V27, P1109, DOI 10.1002/jmri.21358; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellingson BM, 2011, NEURO-ONCOLOGY, V13, P1151, DOI 10.1093/neuonc/nor079; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Harry VN, 2008, GYNECOL ONCOL, V111, P213, DOI 10.1016/j.ygyno.2008.07.048; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; King AD, 2013, RADIOLOGY, V266, P531, DOI 10.1148/radiol.12120167; Lee KC, 2007, NEOPLASIA, V9, P1003, DOI 10.1593/neo.07954; Lee KC, 2007, CLIN CANCER RES, V13, P443, DOI 10.1158/1078-0432.CCR-06-1888; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Pirker R, 2014, CURR OPIN ONCOL, V26, P145, DOI 10.1097/CCO.0000000000000056; Reischauer C, 2012, J MAGN RESON IMAGING, V36, P1002, DOI 10.1002/jmri.23690; Reischauer C, 2010, RADIOLOGY, V257, P523, DOI 10.1148/radiol.10092469; Stella GM, 2013, LANCET RESP MED, V1, P251, DOI 10.1016/S2213-2600(13)70009-2; Woodhams R, 2010, RADIOLOGY, V254, P357, DOI 10.1148/radiol.2542090405; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503; Yankeelov TE, 2007, MAGN RESON IMAGING, V25, P1, DOI 10.1016/j.mri.2006.09.006	24	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108052	10.1371/journal.pone.0108052	http://dx.doi.org/10.1371/journal.pone.0108052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289671	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000012
J	Risch, D; Corkeron, PJ; Ellison, WT; Van Parijs, SM				Risch, Denise; Corkeron, Peter J.; Ellison, William T.; Van Parijs, Sofie M.			Formal Comment to Gong et al.: Ecosystem Scale Acoustic Sensing Reveals Humpback Whale Behavior Synchronous with Herring Spawning Processes and Re-Evaluation Finds No Effect of Sonar on Humpback Song Occurrence in the Gulf of Maine in Fall 2006	PLOS ONE			English	Editorial Material							AVOIDANCE		[Risch, Denise] Integrated Stat, Woods Hole, MA USA; [Corkeron, Peter J.; Van Parijs, Sofie M.] Northeast Fisheries Sci Ctr, Woods Hole, MA USA; [Ellison, William T.] Marine Acoust Inc, Middletown, RI USA		Risch, D (corresponding author), Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	denise.risch@sams.ac.uk	Risch, Denise/W-1070-2019; Corkeron, Peter/I-1170-2019	Risch, Denise/0000-0002-3719-7420; Corkeron, Peter/0000-0003-1553-1253				Antunes R, 2014, MAR POLLUT BULL, V83, P165, DOI 10.1016/j.marpolbul.2014.03.056; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P123, DOI 10.3354/meps264123; Cerchio Salvatore, 2001, Bioacoustics, V11, P277; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Cole TVN, 2013, ENDANGER SPECIES RES, V21, P55, DOI 10.3354/esr00507; DeRuiter SL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0223; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Dunlop RA, 2007, J ACOUST SOC AM, V122, P2893, DOI 10.1121/1.2783115; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Goldbogen JA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0657; Gong Z, 2014, PLOS ONE; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Miller PJO, 2014, J ACOUST SOC AM, V135, P975, DOI 10.1121/1.4861346; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Rankin S, 2007, PAC SCI, V61, P395, DOI 10.2984/1534-6188(2007)61[395:AVSAAD]2.0.CO;2; Risch D, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0175; Risch D, 2013, MAR ECOL PROG SER, V489, P279, DOI 10.3354/meps10426; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Rynne E, 2008, NOPPN0001405WX20851; Sirovic A, 2014, MAR MAMMAL SCI, V30, P399, DOI 10.1111/mms.12036; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Stanistreet JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061263; Stimpert AK, 2007, BIOL LETTERS, V3, P467, DOI 10.1098/rsbl.2007.0281; Stimpert AK, 2011, J ACOUST SOC AM, V129, P476, DOI 10.1121/1.3504708; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390	29	0	0	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109225	10.1371/journal.pone.0109225	http://dx.doi.org/10.1371/journal.pone.0109225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290344	Green Published, gold			2022-12-27	WOS:000342798000049
J	Abu, N; Akhtar, MN; Yeap, SK; Lim, KL; Ho, WY; Zulfadli, AJ; Omar, AR; Sulaiman, MR; Abdullah, MP; Alitheen, NB				Abu, Nadiah; Akhtar, M. Nadeem; Yeap, Swee Keong; Lim, Kian Lam; Ho, Wan Yong; Zulfadli, Aimi Jamil; Omar, Abdul Rahman; Sulaiman, Mohd Roslan; Abdullah, Mohd Puad; Alitheen, Noorjahan Banu			Flavokawain A Induces Apoptosis in MCF-7 and MDA-MB231 and Inhibits the Metastatic Process In Vitro	PLOS ONE			English	Article								Introduction: The kava-kava plant (Piper methsyticum) is traditionally known as the pacific elixir by the pacific islanders for its role in a wide range of biological activities. The extract of the roots of this plant contains a variety of interesting molecules including Flavokawain A and this molecule is known to have anti-cancer properties. Breast cancer is still one of the leading diagnosed cancers in women today. The metastatic process is also very pertinent in the progression of tumorigenesis. Methods: MCF-7 and MDA-MB231 cells were treated with several concentrations of FKA. The apoptotic analysis was done through the MTT assay, BrdU assay, Annexin V analysis, cell cycle analysis, JC-1 mitochondrial dye, AO/PI dual staining, caspase 8/9 fluorometric assay, quantitative real time PCR and western blot. For the metastatic assays, the in vitro scratch assay, trans-well migration/invasion assay, HUVEC tube formation assay, ex vivo rat aortic ring assay, quantitative real time PCR and western blot were employed. Results: We have investigated the effects of FKA on the apoptotic and metastatic process in two breast cancer cell lines. FKA induces apoptosis in both MCF-7 and MDA-MB231 in a dose dependent manner through the intrinsic mitochondrial pathway. Additionally, FKA selectively induces a G2/M arrest in the cell cycle machinery of MDA-MB231 and G1 arrest in MCF-7. This suggests that FKA's anti-cancer activity is dependent on the p53 status. Moreover, FKA also halted the migration and invasion process in MDA-MB231. The similar effects can be seen in the inhibition of the angiogenesis process as well. Conclusions: FKA managed to induce apoptosis and inhibit the metastatic process in two breast cancer cell lines, in vitro. Overall, FKA may serve as a promising candidate in the search of a new anti-cancer drug especially in halting the metastatic process but further in vivo evidence is needed.	[Abu, Nadiah] Univ Malaya, Bright Sparks Unit, Kuala Lumpur, Malaysia; [Abu, Nadiah; Zulfadli, Aimi Jamil; Abdullah, Mohd Puad; Alitheen, Noorjahan Banu] Univ Putra Malaysia, Fac Biotechnol & Bimol Sci, Serdang 43400, Selangor Darul, Malaysia; [Akhtar, M. Nadeem] Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan, Pahang, Malaysia; [Yeap, Swee Keong; Omar, Abdul Rahman] Univ Putra Malaysia, Inst Biosci, Serdang 43400, Selangor Darul, Malaysia; [Lim, Kian Lam] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Cheras, Selangor, Malaysia; [Ho, Wan Yong] Univ Nottingham Malaysia Campus, Sch Biomed Sci, Semenyih, Selangor, Malaysia; [Sulaiman, Mohd Roslan] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang 43400, Selangor Darul, Malaysia	Universiti Malaya; Universiti Putra Malaysia; Universiti Malaysia Pahang; Universiti Putra Malaysia; University of Nottingham Malaysia; Universiti Putra Malaysia	Alitheen, NB (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Bimol Sci, Serdang 43400, Selangor Darul, Malaysia.	noorjahan@upm.edu.my	Yeap, Swee Keong/H-9285-2013; Abu, Nadiah/N-8531-2016; Alitheen, Noorjahan/AAL-3713-2020; Ho, Wan Yong/I-1050-2016	Yeap, Swee Keong/0000-0002-4736-0674; Ho, Wan Yong/0000-0001-5768-0738; ABU, NADIAH/0000-0002-1488-2951	Fundamental Research Grant Scheme from the Ministry of Education, Government of Malaysia [FRGS/1/2012/SG05/UPM/02/5]	Fundamental Research Grant Scheme from the Ministry of Education, Government of Malaysia	This study was supported by Fundamental Research Grant Scheme (FRGS/1/2012/SG05/UPM/02/5) from the Ministry of Education, Government of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu N, 2013, CANCER CELL INT, V12, P7; Airley R, 2001, CLIN CANCER RES, V7, P6; Batovska DI, 2010, CURRENT CLIN PHARM, V5, P29; Bauma M, 2005, EUR J CANCER, V41, P7; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Cegolon L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-4; Chen H, 2005, METHOD MOL BIOL, V294, P7; Cossarizza A, 1993, BIOCH BIOPHYSICAL RE, V197, P5; Dharmaratne HRW, 2002, PHYTOCHEMISTRY, V59, P429; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Fidler I, 2000, CANCER J, V6, P7; Fu Z, 2008, NATURE CELL BIOL, V10, P6; Ganz PA, 2011, J CLIN ONCOL, V29, P8; Gartel AL, 2003, ONCOL RES, V13, P405; Haughland R, 2002, HDB FLUORESCENT PROB, V9; Janicke RU, 2009, BREAST CANC RES TREA, V117, P3; Jiang X, 2004, ANNU REV BIOCHEM, V73, P19; Kruidering M, 2000, LIFE, V50, P5; Krzeslak A, 2012, PATHOLOGY ONCOLOGY R, V18, P7; Lebot V, 1997, KAVA PACIFIC ELIXIR; Liang C, 2007, NATURE PROTOCOLS, V2, P4; Liu X, 2003, PNAS, V100, P5; Mosmann T, 1983, J IMMUNOL METHODS, V65, P8; Newman DJ, 2012, J NAT PRODUCTS, V75, P24; Parrish AB, 2013, COLD SPRING HARBOR P, V5; Ponce ML, 2009, METHOD MOL BIOL, V467, P5; Robey I, 2008, NEOPLASIA, V10, P11; Rocha AB, 2001, CURR OPIN PHARMACOL, V1, P5; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smiley ST, 1990, PNAS, V88, P4; Steiner G, 2000, HAWAII MED J, V59, P2; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tang Y, 2008, CANC PREVENTION RES, V1; Wang-Johanning F, 2012, JNCI-J NATL CANCER I, V104, P21; Zijl Fv, 2011, MUTAT RES-REV MUTAT, V728, P11	36	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e105244	10.1371/journal.pone.0105244	http://dx.doi.org/10.1371/journal.pone.0105244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286005	gold, Green Published, Green Submitted			2022-12-27	WOS:000345743700003
J	Anjukandi, P; Dopieralski, P; Ribas-Arino, J; Marx, D				Anjukandi, Padmesh; Dopieralski, Przemyslaw; Ribas-Arino, Jordi; Marx, Dominik			The Effect of Tensile Stress on the Conformational Free Energy Landscape of Disulfide Bonds	PLOS ONE			English	Article							MOLECULE FORCE SPECTROSCOPY; PROTEIN; MECHANOCHEMISTRY; SWITCHES; ISOMERIZATION; REDUCTION; STABILITY; DYNAMICS; CLEAVAGE; KINETICS	Disulfide bridges are no longer considered to merely stabilize protein structure, but are increasingly recognized to play a functional role in many regulatory biomolecular processes. Recent studies have uncovered that the redox activity of native disulfides depends on their C-C-S-S dihedrals, chi(2) and chi(2)'. Moreover, the interplay of chemical reactivity and mechanical stress of disulfide switches has been recently elucidated using force-clamp spectroscopy and computer simulation. The chi(2) and chi(2)' angles have been found to change from conformations that are open to nucleophilic attack to sterically hindered, so-called closed states upon exerting tensile stress. In view of the growing evidence of the importance of C-C-S-S dihedrals in tuning the reactivity of disulfides, here we present a systematic study of the conformational diversity of disulfides as a function of tensile stress. With the help of force-clamp metadynamics simulations, we show that tensile stress brings about a large stabilization of the closed conformers, thereby giving rise to drastic changes in the conformational free energy landscape of disulfides. Statistical analysis shows that native TDi, DO and interchain Ig protein disulfides prefer open conformations, whereas the intrachain disulfide bridges in Ig proteins favor closed conformations. Correlating mechanical stress with the distance between the two alpha-carbons of the disulfide moiety reveals that the strain of intrachain Ig protein disulfides corresponds to a mechanical activation of about 100 pN. Such mechanical activation leads to a severalfold increase of the rate of the elementary redox S(N)2 reaction step. All these findings constitute a step forward towards achieving a full understanding of functional disulfides.	[Anjukandi, Padmesh; Dopieralski, Przemyslaw; Ribas-Arino, Jordi; Marx, Dominik] Ruhr Univ Bochum, Lehrstuhl Theoret Chem, Bochum, Germany; [Dopieralski, Przemyslaw] Univ Wroclaw, Fac Chem, PL-50138 Wroclaw, Poland	Ruhr University Bochum; University of Wroclaw	Anjukandi, P (corresponding author), Ruhr Univ Bochum, Lehrstuhl Theoret Chem, Bochum, Germany.	padmesh.anjukandi@theochem.rub.de	Ribas, Jordi/G-8076-2011	Ribas, Jordi/0000-0003-4088-6187; Dopieralski, Przemyslaw/0000-0002-4309-6597	Deutsche Forschungsgemeinsschaft [MA 1547/9]; Alexander von Humboldt Stiftung; Spanish Government	Deutsche Forschungsgemeinsschaft(German Research Foundation (DFG)); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Spanish Government(Spanish GovernmentEuropean Commission)	The authors are grateful to Deutsche Forschungsgemeinsschaft (Reinhart Koselleck Grant MA 1547/9 to D.M.), Alexander von Humboldt Stiftung (Humboldt Fellowships to J.R.A), and the Spanish Government ("Ramon y Cajal" contract to J.R.A.) for partial financial support. The authors gratefully acknowledge the Gauss Centre for Supercomputing (GCS) for providing computing time for a GCS Large Scale Project on the IBM Blue Gene/Q system JUQUEEN at Julich Supercomputing Centre (JSC) as well as computational support by BOVILAB@RUB and Rechnerverbund-NRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P6479, DOI 10.1021/ja800180u; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; [Anonymous], 2009, NAT REV MOL CELL BIO, P10; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Baldus IB, 2012, BIOPHYS J, V102, P622, DOI 10.1016/j.bpj.2011.12.039; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Caruso MM, 2009, CHEM REV, V109, P5755, DOI 10.1021/cr9001353; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; Dopieralski P, 2013, NAT CHEM, V5, P685, DOI [10.1038/NCHEM.1676, 10.1038/nchem.1676]; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Galera-Prat A, 2010, CURR OPIN STRUC BIOL, V20, P63, DOI 10.1016/j.sbi.2010.01.003; Garcia-Manyes S, 2009, NAT CHEM, V1, P236, DOI [10.1038/NCHEM.207, 10.1038/nchem.207]; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Haworth NL, 2007, MOL SIMULAT, V33, P475, DOI 10.1080/08927020701361876; Haworth NL, 2013, RSC ADV, V3, P24680, DOI 10.1039/c3ra42486c; Haworth NL, 2010, AUST J CHEM, V63, P379, DOI 10.1071/CH09456; Hofbauer F, 2012, CHEM-EUR J, V18, P16332, DOI 10.1002/chem.201202065; Hofbauer F, 2010, CHEM-EUR J, V16, P5097, DOI 10.1002/chem.200902831; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Huang Z, 2011, CHEM SOC REV, V40, P2359, DOI 10.1039/c0cs00148a; Iozzi MF, 2011, J PHYS CHEM A, V115, P2308, DOI 10.1021/jp109428g; Ishikawa H, 2007, P NATL ACAD SCI USA, V104, P19309, DOI 10.1073/pnas.0709760104; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Keten S, 2012, J MECH BEHAV BIOMED, V5, P32, DOI 10.1016/j.jmbbm.2011.08.017; KIKUCHI H, 1986, BIOCHEMISTRY-US, V25, P2009, DOI 10.1021/bi00356a026; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kucharski TJ, 2009, ANGEW CHEM INT EDIT, V48, P7040, DOI 10.1002/anie.200901511; Li WJ, 2010, J AM CHEM SOC, V132, P16790, DOI 10.1021/ja104763q; Liang J, 2009, ACS NANO, V3, P1628, DOI 10.1021/nn900294n; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; Marx D., 2009, AB INITIO MOL DYNAMI; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Raina S, 1997, ANNU REV MICROBIOL, V51, P179, DOI 10.1146/annurev.micro.51.1.179; Ribas-Arino J, 2012, CHEM REV, V112, P5412, DOI 10.1021/cr200399q; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Richardson JS., 1989, PREDICT PROTEIN STRU; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Tian YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3538; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Wong JWH, 2011, PROTEIN REV, V14, P151, DOI 10.1007/978-1-4419-7273-6_8; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200	59	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108812	10.1371/journal.pone.0108812	http://dx.doi.org/10.1371/journal.pone.0108812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286308	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700035
J	Billeke, P; Zamorano, F; Chavez, M; Cosmelli, D; Aboitiz, F				Billeke, Pablo; Zamorano, Francisco; Chavez, Mario; Cosmelli, Diego; Aboitiz, Francisco			Functional Cortical Network in Alpha Band Correlates with Social Bargaining	PLOS ONE			English	Article							PHASE SYNCHRONY; NEURAL BASIS; MU RHYTHM; EEG-DATA; BRAIN; CONNECTIVITY; OSCILLATIONS; ARCHITECTURE; ATTENTION; NEUROSCIENCE	Solving demanding tasks requires fast and flexible coordination among different brain areas. Everyday examples of this are the social dilemmas in which goals tend to clash, requiring one to weigh alternative courses of action in limited time. In spite of this fact, there are few studies that directly address the dynamics of flexible brain network integration during social interaction. To study the preceding, we carried out EEG recordings while subjects played a repeated version of the Ultimatum Game in both human (social) and computer (non-social) conditions. We found phase synchrony (inter-site-phase-clustering) modulation in alpha band that was specific to the human condition and independent of power modulation. The strength and patterns of the inter-site-phase-clustering of the cortical networks were also modulated, and these modulations were mainly in frontal and parietal regions. Moreover, changes in the individuals' alpha network structure correlated with the risk of the offers made only in social conditions. This correlation was independent of changes in power and inter-site-phase-clustering strength. Our results indicate that, when subjects believe they are participating in a social interaction, a specific modulation of functional cortical networks in alpha band takes place, suggesting that phase synchrony of alpha oscillations could serve as a mechanism by which different brain areas flexibly interact in order to adapt ongoing behavior in socially demanding contexts.	[Billeke, Pablo; Zamorano, Francisco] Univ Desarrollo, Fac Gobierno, CICS, Div Neurociencia Conducta, Santiago, Chile; [Billeke, Pablo; Zamorano, Francisco; Cosmelli, Diego; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencias, Santiago, Chile; [Billeke, Pablo; Zamorano, Francisco; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Escuela Med, Dept Psiquiatria, Santiago, Chile; [Cosmelli, Diego] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile; [Chavez, Mario] Hop La Pitie Salpetriere, CNRS, UMR 7225, Paris, France	Universidad del Desarrollo; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Billeke, P (corresponding author), Univ Desarrollo, Fac Gobierno, CICS, Div Neurociencia Conducta, Santiago, Chile.	pbilleke@udd.cl	Zamorano, Francisco/J-4869-2015; Billeke, Pablo/D-5311-2011; Chavez, Mario/D-8495-2011	Zamorano, Francisco/0000-0002-3516-3630; Billeke, Pablo/0000-0003-4261-0678; Chavez, Mario/0000-0003-0390-4833	CONICYT [791220014]; Millennium Center for the Neuroscience of Memory, Chile [NC10-001-F]; EU-LASAGNE Project [318132]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Millennium Center for the Neuroscience of Memory, Chile; EU-LASAGNE Project	This work was supported by CONICYT [Grant number 791220014 to PB], Project "Anillo en Complejidad Social'' [SOC-1101 to PB, DC and FZ] and by the Millennium Center for the Neuroscience of Memory, Chile [NC10-001-F], which is developed with funds from the Innovation for Competitivity from the Ministry for Economics, Fomentation and Tourism, Chile. MC is partially supported by the EU-LASAGNE Project [ Contract no. 318132 (STREP)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; ARROYO S, 1993, ELECTROEN CLIN NEURO, V87, P76, DOI 10.1016/0013-4694(93)90114-B; Avrahami J, 2013, J SOCIO-ECON, V47, P47, DOI 10.1016/j.socec.2013.08.009; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; BATSON CD, 1990, AM PSYCHOL, V45, P336, DOI 10.1037/0003-066X.45.3.336; Betti V, 2009, J NEUROSCI, V29, P12384, DOI 10.1523/JNEUROSCI.2759-09.2009; Billeke P, 2014, SOC COGN AFFECT NEUR, V9, P2041, DOI 10.1093/scan/nsu012; Billeke P, 2013, TRANSL NEUROSCI, V4, P437, DOI 10.2478/s13380-013-0147-9; Billeke P, 2013, CEREB CORTEX, V23, P2872, DOI 10.1093/cercor/bhs269; Billeke Pablo, 2013, Front Psychiatry, V4, P4, DOI 10.3389/fpsyt.2013.00004; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Clerc M, 2010, IFMBE PROC, V28, P109; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cosmelli D, 2011, PSYCHOPHYSIOLOGY, V48, P312, DOI 10.1111/j.1469-8986.2010.01066.x; Couture SM, 2011, SCHIZOPHR RES, V125, P152, DOI 10.1016/j.schres.2010.09.020; Cusi AM, 2012, J PSYCHIATR NEUROSCI, V37, P154, DOI 10.1503/jpn.100179; Declerck CH, 2013, BRAIN COGNITION, V81, P95, DOI 10.1016/j.bandc.2012.09.009; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Fisher N., 1995, STAT ANAL CIRCULAR D; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Gramfort A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/923703; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hanslmayr S, 2005, NEUROSCI LETT, V375, P64, DOI 10.1016/j.neulet.2004.10.092; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Humphrey N, 1976, GROWING POINTS ETHOL; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Koster-Hale J, 2013, NEURON, V79, P836, DOI 10.1016/j.neuron.2013.08.020; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mazaheri A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00177; Naeem M, 2012, CLIN NEUROPHYSIOL, V123, P1789, DOI 10.1016/j.clinph.2012.02.065; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; Perry A, 2011, NEUROIMAGE, V58, P895, DOI 10.1016/j.neuroimage.2011.06.060; Phillips JM, 2014, CEREB CORTEX, V24, P1996, DOI 10.1093/cercor/bht050; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Popov T, 2013, J NEUROSCI, V33, P6018, DOI 10.1523/JNEUROSCI.2763-12.2013; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Sadaghiani S, 2012, J NEUROSCI, V32, P14305, DOI 10.1523/JNEUROSCI.1358-12.2012; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Slembeck T, 1999, DISCUSS PAP DEP EC U, V9904, P29; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Valencia M, 2009, CHAOS, V19, DOI 10.1063/1.3129783; Vanderwert RE, 2013, NEUROSCI LETT, V540, P15, DOI 10.1016/j.neulet.2012.10.006; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; VARELA FJ, 1981, NEUROPSYCHOLOGIA, V19, P675; Zamorano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087232	63	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109829	10.1371/journal.pone.0109829	http://dx.doi.org/10.1371/journal.pone.0109829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286240	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700094
J	Garcia, CC; Riedt, T; Li, J; Dotten, M; Brossart, P; Janzen, V				Garcia, Carmen Carrillo; Riedt, Tamara; Li, Jin; Dotten, Manuela; Brossart, Peter; Janzen, Viktor			Simultaneous Deletion of p21(Cip1/Waf1) and Caspase-3 Accelerates Proliferation and Partially Rescues the Differentiation Defects of Caspase-3 Deficient Hematopoietic Stem Cells	PLOS ONE			English	Article							3/P21 COMPLEX-FORMATION; IN-VIVO; SELF-RENEWAL; GENE FAMILY; C-MYC; CYCLE; QUIESCENCE; APOPTOSIS; P27(KIP1); DEATH	Specialized blood cells are generated through the entire life of an organism by differentiation of a small number of hematopoietic stem cells (HSC). There are strictly regulated mechanisms assuring a constant and controlled production of mature blood cells. Although such mechanisms are not completely understood, some factors regulating cell cycle and differentiation have been identified. We have previously shown that Caspase-3 is an important regulator of HSC homeostasis and cytokine responsiveness. p21(cip1/waf1) is a known cell cycle regulator, however its role in stem cell homeostasis seems to be limited. Several reports indicate interactions between p21(cip1/waf1) and Caspase-3 in a cell type dependent manner. Here we studied the impact of simultaneous depletion of both factors on HSC homeostasis. Depletion of both Caspase-3 and p21(cip1/waf1) resulted in an even more pronounced increase in the frequency of hematopoietic stem and progenitor cells. In addition, simultaneous deletion of both genes revealed a further increase of cell proliferation compared to single knock-outs and WT control mice, while apoptosis or self-renewal ability were not affected in any of the genotypes. Upon transplantation, p21(cip1/waf1-/-) bone marrow did not reveal significant alterations in engraftment of lethally irradiated mice, while Caspase-3 deficient HSPC displayed a significant reduction of blood cell production. However, when both p21(cip1/waf1) and Caspase-3 were eliminated this differentiation defect caused by Caspase-3 deficiency was abrogated.	[Garcia, Carmen Carrillo; Riedt, Tamara; Li, Jin; Dotten, Manuela; Brossart, Peter; Janzen, Viktor] Univ Bonn, Dept Internal Med 3, Div Hematol Oncol, Bonn, Germany	University of Bonn	Janzen, V (corresponding author), Univ Bonn, Dept Internal Med 3, Div Hematol Oncol, Bonn, Germany.	viktor.janzen@ukb.uni-bonn.de		Carrillo Garcia, Carmen/0000-0003-1692-7460	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [JA/1967/1-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) to VJ, grant number JA/1967/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradford GB, 1997, EXP HEMATOL, V25, P445; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheng T, 2001, BLOOD, V98, P3643, DOI 10.1182/blood.V98.13.3643; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Janicke RU, 2007, CELL CYCLE, V6, P407; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; Matsumoto A, 2013, BBA-GEN SUBJECTS, V1830, P2335, DOI 10.1016/j.bbagen.2012.07.004; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Stier S, 2003, BLOOD, V102, P1260, DOI 10.1182/blood-2002-10-3053; Suzuki A, 2000, CELL DEATH DIFFER, V7, P721, DOI 10.1038/sj.cdd.4400706; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; Suzuki A, 2000, ONCOGENE, V19, P1346, DOI 10.1038/sj.onc.1203429; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Tesio M, 2011, CELL STEM CELL, V9, P187, DOI 10.1016/j.stem.2011.08.005; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Xu SQ, 2000, BIOCHEM BIOPH RES CO, V269, P179, DOI 10.1006/bbrc.2000.2247; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109266	10.1371/journal.pone.0109266	http://dx.doi.org/10.1371/journal.pone.0109266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286245	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700055
J	Leal, G; Afonso, PM; Duarte, CB				Leal, Graciano; Afonso, Pedro M.; Duarte, Carlos B.			Neuronal Activity Induces Synaptic Delivery of hnRNP A2/B1 by a BDNF-Dependent Mechanism in Cultured Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CYTOSKELETON-ASSOCIATED PROTEIN; MYELIN BASIC-PROTEIN; MESSENGER-RNA; KINASE-II; TRANSPORT; STAUFEN; ARC; TRANSLATION; ACTIVATION	Dendritic protein synthesis plays a critical role in several forms of synaptic plasticity, including BDNF (brain-derived neurotrophic factor)-mediated long-term synaptic potentiation (LTP). Dendritic transcripts are typically transported in a repressed state as components of large ribonucleoprotein complexes, and then translated upon stimulation at, or in the vicinity, of activated synapses. Heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1) is a trans-acting factor involved in dendritic mRNA trafficking, but how the distribution of the protein in dendrites is regulated has not been characterized. Here we found that a fraction of hnRNP A2/B1 is present at the synapse under resting conditions in cultured hippocampal neurons. Accordingly, this ribonucleoprotein was detected in free mRNP, monosomal, and polyribosomal fractions obtained from synaptoneurosomes. Neuronal activity and BDNF treatment increased hnRNP A2/B1 protein levels in the cell body and dendritic compartments, and induced the delivery of this protein to synaptic sites. The activity-dependent accumulation of hnRNP A2/B1 at the synapse required, at least in part, the activation of TrkB receptors, presumably by BDNF. This neurotrophin also upregulated the hnRNP A2/B1 mRNA in the soma but was without effect on the abundance of neuritic hnRNP A2/B1 transcripts. These results show that the distribution of hnRNP A2/B1 is regulated by BDNF and by neuronal activity, an effect that may have a role in BDNF-induced synaptic plasticity events.	[Leal, Graciano; Afonso, Pedro M.; Duarte, Carlos B.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Leal, Graciano; Duarte, Carlos B.] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Afonso, Pedro M.] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Duarte, CB (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	cbduarte@ci.uc.pt	Duarte, Carlos B/K-6358-2013	Duarte, Carlos B/0000-0002-1474-0208; Leal, Graciano/0000-0001-6333-6095	Fundacao para a Ciencia e a Tecnologia (FCT); COMPETE (Programa Operacional Factores de Competitividade); QREN; FEDER (Fundo Europeu de Desenvolvimento Regional) [PTDC/SAU-NEU/104297/2008, PEst-C/SAU/LA0001/2013-2014]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE (Programa Operacional Factores de Competitividade); QREN; FEDER (Fundo Europeu de Desenvolvimento Regional)(European Commission)	This work was funded by Fundacao para a Ciencia e a Tecnologia (FCT), COMPETE (Programa Operacional Factores de Competitividade), QREN and FEDER (Fundo Europeu de Desenvolvimento Regional) (PTDC/SAU-NEU/104297/2008 and PEst-C/SAU/LA0001/2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Caldeira MV, 2013, BBA-MOL BASIS DIS, V1832, P263, DOI 10.1016/j.bbadis.2012.10.009; Catarino T, 2013, J CELL SCI, V126, P149, DOI 10.1242/jcs.110742; Chen GQ, 1999, J NEUROSCI, V19, P7983; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Gomes JR, 2012, J NEUROSCI, V32, P4610, DOI 10.1523/JNEUROSCI.0374-12.2012; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Havik B, 2003, EUR J NEUROSCI, V17, P2679, DOI 10.1046/j.1460-9568.2003.02712.x; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Lebeau G, 2008, MOL CELL BIOL, V28, P2896, DOI 10.1128/MCB.01844-07; Lessmann V, 2009, NEUROSCI RES, V65, P11, DOI 10.1016/j.neures.2009.06.004; Luo M, 2002, BIOCHEM J, V365, P817, DOI 10.1042/BJ20020263; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Martin KJ, 2011, NEUROPHARMACOLOGY, V61, P148, DOI 10.1016/j.neuropharm.2011.03.021; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Muller C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00169; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Muslimov IA, 2006, J CELL BIOL, V175, P427, DOI 10.1083/jcb.200607008; Muslimov IA, 2011, J CELL BIOL, V194, P441, DOI 10.1083/jcb.201010027; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Raju CS, 2011, MOL BIOL CELL, V22, P1864, DOI 10.1091/mbc.E10-11-0904; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Righi M, 2000, J NEUROSCI, V20, P3165, DOI 10.1523/JNEUROSCI.20-09-03165.2000; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; Santos SD, 2012, J BIOL CHEM, V287, P6868, DOI 10.1074/jbc.M111.322909; Shan JG, 2003, J NEUROSCI, V23, P8859; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tatavarty V, 2012, MOL BIOL CELL, V23, P918, DOI 10.1091/mbc.E11-07-0622; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024	61	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108175	10.1371/journal.pone.0108175	http://dx.doi.org/10.1371/journal.pone.0108175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286195	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700014
J	Zhang, JX; Wu, JH; Peng, XL; Song, J; Wang, J; Dong, WG				Zhang, Jixiang; Wu, Jianhong; Peng, Xiulan; Song, Jia; Wang, Jun; Dong, Weiguo			Associations between STAT3 rs744166 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; GENETICS; LOCI; VARIANTS; CELLS; POPULATION; PREVALENCE; ACTIVATION; MULTIPLE	Background: Many studies have investigated the associations between the signal transducer and activator of transcription 3 (STAT3) in the susceptibility to ulcerative colitis (UC) and Crohn's disease (CD). However, the results remain inconsistent. This meta-analysis determined the risk of STAT3 rs744166 polymorphism-conferred UC and CD susceptibility. Materials and Methods: Electronic databases, including PubMed, EMBASE and the Cochrane Library, were searched for all eligible studies that evaluated the association between STAT3 rs744166 polymorphisms with UC and CD risk up to August 21, 2014. The pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using fixed-or randomeffects models. Results: Twelve studies containing 10298 patients with CD, 4244 patients with UC and 11191 controls were included in this meta-analysis. The results indicated that the STAT3 rs744166 polymorphism was associated with CD and UC susceptibility (CD: GA+ AA vs. GG, OR = 1.20, 95% CI, 1.11-1.30, I-2 = 0%, P-unadjusted<0.00001, P-Bonferroni<0.00005, P-FDR<0.00001; UC: GA+AA vs. GG, OR = 1.21, 95% CI, 1.08-1.36, I-2 = 1%, P-unadjusted = 0.001, P-Bonferroni = 0.005, P-FDR = 0.00125). In subgroup analyses by ethnicity, the significant association was found only among Caucasians. However, when grouped by age of onset, positive associations were found both among adults and children. In addition, when stratified by study design and genotyping methods, the risk of CD was significantly associated with the STAT3 rs744166 polymorphism in hospital-based and population-based groups and in SNP Array and SNPlex groups. For UC, significant associations were also found in population-based, PCR-RFLP and SNPlex groups. Moreover, these findings were sufficiently robust to withstand the Bonferroni correction and false discovery rate (FDR). Conclusion: This meta-analysis indicates that carriers of the STAT3 rs744166 'A' allele have a significantly greater risk of CD and UC, especially among Caucasians.	[Zhang, Jixiang; Song, Jia; Wang, Jun; Dong, Weiguo] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China; [Wu, Jianhong] Wuhan Med Treatment Ctr, Wuhan, Hubei Province, Peoples R China; [Peng, Xiulan] Fifth Hosp Wuhan, Dept Oncol, Wuhan, Hubei Province, Peoples R China	Wuhan University	Dong, WG (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China.	dwg@whu.edu.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507				Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Amre DK, 2010, ALIMENT PHARM THER, V31, P1186, DOI 10.1111/j.1365-2036.2010.04294.x; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Cenit MC, 2010, GENES IMMUN, V11, P264, DOI 10.1038/gene.2010.10; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P108, DOI 10.1016/j.mrfmmm.2010.01.017; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Glas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054338; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hammer HF, 2011, DIGEST DIS, V29, P550, DOI 10.1159/000332981; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426; Henckaerts L, 2009, CLIN GASTROENTEROL H, V7, P972, DOI 10.1016/j.cgh.2009.05.001; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Jung C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052223; Latella G, 2012, WORLD J GASTROENTERO, V18, P3790, DOI 10.3748/wjg.v18.i29.3790; Laukens D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013795; Lee JC, 2011, BRIEF FUNCT GENOMICS, V10, P71, DOI 10.1093/bfgp/elr009; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Leone V, 2013, J GASTROENTEROL, V48, P315, DOI 10.1007/s00535-013-0777-2; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Peter I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-63; Polgar N, 2012, INT J IMMUNOGENET, V39, P247, DOI 10.1111/j.1744-313X.2012.01084.x; Stone CD, 2012, DIGEST DIS SCI, V57, P3042, DOI 10.1007/s10620-012-2417-8; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Thompson AI, 2011, INFLAMM BOWEL DIS, V17, P831, DOI 10.1002/ibd.21375; Tsianos EV, 2012, WORLD J GASTROENTERO, V18, P105, DOI 10.3748/wjg.v18.i2.105; Umeno J, 2011, INFLAMM BOWEL DIS, V17, P2407, DOI 10.1002/ibd.21651; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; Willson TA, 2012, J PEDIATR GASTR NUTR, V55, P32, DOI 10.1097/MPG.0b013e318246be78; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	38	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109625	10.1371/journal.pone.0109625	http://dx.doi.org/10.1371/journal.pone.0109625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286337	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700075
J	Poolsup, N; Suksomboon, N; Amin, M				Poolsup, Nalinee; Suksomboon, Naeti; Amin, Muhammad			Efficacy and Safety of Oral Antidiabetic Drugs in Comparison to Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; METFORMIN; WOMEN; GLYBURIDE; MANAGEMENT; LIFE; GLIBENCLAMIDE; OVERWEIGHT; OUTCOMES; INFANTS	Objective: To assess the efficacy and safety of oral antidiabetic drugs (OADs) in gestational diabetes mellitus (GDM) in comparison to insulin. Methods: A meta-analysis of randomized controlled trials was conducted. The efficacy and safety of OADs in comparison to insulin in GDM patients were explored. Studies were identified by conducting a literature search using the electronic databases of Med line, CENTRAL CINAHL, LILACS, Scopus and Web of Science in addition to conducting hand search of relevant journals from inception until October 2013. Results:Thirteen studies involving 2,151 patients met the inclusion criteria. These studies were randomized controlled trials of metformin and glyburide in comparison to insulin therapy. Our results indicated a significant increase in the risk for preterm births (RR, 1.51; 95% Cl, 1.04-2.19, p =0.03) with metformin compared to insulin. However, a significant decrease in the risk for gestational hypertension (RR, 0.54; 95% Cl, 0.31-0.91, p=0.02) was found. Postprandial glucose levels also decreased significantly in patients receiving metformin (MD, 2.47 mg/cIL; 95% Cl, 4.00, 0.94, p = 0.002). There was no significant difference between the two groups for the remaining outcomes. There were significant increases in the risks of macrosomia (RR, 2.34; 95% Cl, 1.18-4.63, p 0.03) and neonatal hypoglycemia (RR, 2.06; 95% Cl, 1.27-3.34, p 0.005) in the glyburide group compared to insulin whereas results for the other analyzed outcomes remained non-significant. Conclusion: The available evidence suggests favorable effects of metformin in treating GDM patients. Metformin seems to be an efficacious alternative to insulin and a better choice than glyburide especially those with mild form of disease.	[Poolsup, Nalinee] Silpakorn Univ, Fac Pharm, Dept Pharm, Nakhon Pathom, Thailand; [Suksomboon, Naeti; Amin, Muhammad] Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok 10700, Thailand	Silpakorn University; Mahidol University	Suksomboon, N (corresponding author), Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok 10700, Thailand.	naeti.suk@mahidol.ac.th						Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anjalakshi C, 2007, DIABETES RES CLIN PR, V76, P474, DOI 10.1016/j.diabres.2006.09.031; [Anonymous], [No title captured], DOI DOI 10.1097/01.AOG.0000433006.09219.F1; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bertini AM, 2005, J PERINAT MED, V33, P519, DOI 10.1515/JPM.2005.092; Charles B, 2006, THER DRUG MONIT, V28, P67, DOI 10.1097/01.ftd.0000184161.52573.0e; Dhulkotia JS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.044; DOUGLAS CP, 1967, DIABETES, V16, P60, DOI 10.2337/diab.16.1.60; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELLIOTT BD, 1994, AM J OBSTET GYNECOL, V171, P653, DOI 10.1016/0002-9378(94)90078-7; Forman MR, 2005, CANCER INVEST, V23, P609, DOI 10.1080/07357900500283093; Gilbert C, 2006, FERTIL STERIL, V86, P658, DOI 10.1016/j.fertnstert.2006.02.098; Glueck CJ, 2004, HUM REPROD, V19, P1323, DOI 10.1093/humrep/deh263; Glueck CJ, 2002, HUM REPROD, V17, P2858, DOI 10.1093/humrep/17.11.2858; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Hebert MF, 2009, CLIN PHARMACOL THER, V85, P607, DOI 10.1038/clpt.2009.5; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Ijas H, 2011, BJOG-INT J OBSTET GY, V118, P880, DOI 10.1111/j.1471-0528.2010.02763.x; JOVANOVICPETERSON L, 1992, AM J OBSTET GYNECOL, V167, P1325, DOI 10.1016/S0002-9378(11)91710-4; Ju Hong, 2008, BMC Pregnancy Childbirth, V8, P31, DOI 10.1186/1471-2393-8-31; KEMBALL ML, 1970, ARCH DIS CHILD, V45, P696, DOI 10.1136/adc.45.243.696; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Lain KY, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.038; Langer O, 2005, AM J OBSTET GYNECOL, V192, P1768, DOI 10.1016/j.ajog.2004.12.049; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore LE, 2007, J REPROD MED, V52, P1011; National Institute for Health and Clinical Excellence, 2008, DIAB PREGN MAN DIAB; Nicholson W, 2009, OBSTET GYNECOL, V113, P193, DOI 10.1097/AOG.0b013e318190a459; Niromanesh S, 2012, DIABETES RES CLIN PR, V98, P422, DOI 10.1016/j.diabres.2012.09.031; Ogunyemi Dotun, 2007, Endocr Pract, V13, P427; Ornoy Asher, 2005, Pediatr Endocrinol Rev, V3, P104; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Rowan JA, 2008, NEW ENGL J MED, V359, P106; Sadeh-Mestechkin D, 2008, ARCH GYNECOL OBSTET, V278, P225, DOI 10.1007/s00404-008-0566-y; Silva JC, 2007, ARQ BRAS ENDOCRINOL, V51, P541, DOI 10.1590/S0004-27302007000400007; Slining M, 2010, J PEDIATR-US, V157, P20, DOI 10.1016/j.jpeds.2009.12.054; Spaulonci CP, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.022; Tempe A, 2013, J OBSTET GYNAECOL RE, V39, P1147, DOI 10.1111/jog.12042; Tertti K, 2013, DIABETES OBES METAB, V15, P246, DOI 10.1111/dom.12017; Vanky E, 2012, ACTA OBSTET GYN SCAN, V91, P1460, DOI 10.1111/aogs.12015; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Zeng YC, 2014, ADV MED SCI-POLAND, V59, P95, DOI 10.1016/j.advms.2014.03.001	48	57	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109985	10.1371/journal.pone.0109985	http://dx.doi.org/10.1371/journal.pone.0109985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302493	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400100
J	Zhao, Q; Li, T; Qi, JN; Liu, J; Qin, CY				Zhao, Qi; Li, Tao; Qi, Jianni; Liu, Juan; Qin, Chengyong			The miR-545/374a Cluster Encoded in the Ftx IncRNA is Overexpressed in HBV-Related Hepatocellular Carcinoma and Promotes Tumorigenesis and Tumor Progression	PLOS ONE			English	Article							LONG NONCODING RNAS; HEPATITIS-B; EXPRESSION	Hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC). Previous studies have shown several long noncoding RNAs (lncRNAs) play various roles in HCC progression, but no research has focused on the expression pattern of microRNA clusters encoded in IncRNAs. The Ftx gene encodes a IncRNA which harbors 2 clusters of microRNAs in its introns, the miR-374b/421 cluster and the miR-545/374a cluster. To date, no research has focused on the role of the miR-545/374a and miR-374b/421 clusters in HBV-related HCC. In this study, 66 pairs of HBV-related HCC tissue and matched non-cancerous liver tissue specimens were analyzed for the expression of the Ftx microRNA clusters. Our results showed that the miR-545/374a cluster was upregulated in HBV-HCC tissue and significantly correlated with prognosis-related clinical features, including histological grade, metastasis and tumor capsule. Transfection studies with microRNA mimics and inhibitors revealed that miR-545/374a expression promoted in vitro cell proliferation, cell migration and invasion. The wild-type HBV-genome-containing plasmid or full-length HBx protein encoding plasmid was transfected into the Bel-7402 cell line and observed for their influence on miR-545/374a expression. We found that transfection of the HBV genome or HBx alone resulted in an increase in miR-545/374a expression. Next, by monitoring the expression of sera miR-545/374a before and after surgical tumor excision, we found serum miR-545/374a was tumor-derived and exhibited a sharp decrease 25 days after tumor excision. We also examined the gender-based difference in miR-545/374a expression among HCC patients and utilized microRNA target prediction software to find the targets of miR-545/374a. One of these targets, namely estrogen-related receptor gamma (ESRRG) was inversely correlated with miR-545 expression. In conclusion, the overexpression of miR-545/374a cluster located in the Ftx IncRNA is partially responsible for a poor prognosis, and monitoring sera levels of miR-545/374a may be a useful diagnostic marker for HCC.	[Zhao, Qi; Liu, Juan; Qin, Chengyong] Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan, Peoples R China; [Li, Tao] Shandong Univ, Prov Hosp, Dept Infect Dis, Jinan, Peoples R China; [Qi, Jianni] Shandong Univ, Shandong Prov Hosp, Cent Lab, Jinan, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Qin, CY (corresponding author), Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan, Peoples R China.	chengyongqin016@gmail.com			Shandong Science and Technology Committee of China [2013GG3202192]; Postdoctoral Science Foundation of China [2013M541926]; Postdoctoral Innovation Project Special Foundation of Shandong Province [201302031]	Shandong Science and Technology Committee of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Innovation Project Special Foundation of Shandong Province	This work was supported by grants from the Shandong Science and Technology Committee of China (2013GG3202192), the Postdoctoral Science Foundation of China (2013M541926), and the Postdoctoral Innovation Project Special Foundation of Shandong Province (201302031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; Huang JL, 2013, CARCINOGENESIS; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li C.L., 2014, INT J CANC; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062844; Romito A, 2011, BIOCHIMIE, V93, P1935, DOI 10.1016/j.biochi.2011.07.009; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Xu D, 2013, HEPATOLOGY, V58, P739, DOI 10.1002/hep.26361; Xu XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-276; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Zhao Q, 2013, J VIRAL HEPATITIS, V20, P430, DOI 10.1111/jvh.12048	16	71	71	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109782	10.1371/journal.pone.0109782	http://dx.doi.org/10.1371/journal.pone.0109782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299640	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200072
J	Chudnovskiy, R; Thompson, A; Tharp, K; Hellerstein, M; Napoli, JL; Stahl, A				Chudnovskiy, Rostislav; Thompson, Airlia; Tharp, Kevin; Hellerstein, Marc; Napoli, Joseph L.; Stahl, Andreas			Consumption of Clarified Grapefruit Juice Ameliorates High-Fat Diet Induced Insulin Resistance and Weight Gain in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; METABOLISM; RECEPTORS; OBESITY; DRUGS; FRUIT	To determine the metabolic effects of grapefruit juice consumption we established a model in which C57Bl/6 mice drank 25-50% sweetened GFJ, clarified of larger insoluble particles by centrifugation (cGFJ), ad libitum as their sole source of liquid or isocaloric and sweetened water. cGFJ and control groups consumed similar amounts of liquids and calories. Mice fed a high-fat diet and cGFJ experienced a 18.4% decrease in weight, a 13-17% decrease in fasting blood glucose, a three-fold decrease in fasting serum insulin, and a 38% decrease in liver triacylglycerol values, compared to controls. Mice fed a low-fat diet that drank cGFJ experienced a two-fold decrease in fasting insulin, but not the other outcomes observed with the high-fat diet. cGFJ consumption decreased blood glucose to a similar extent as the commonly used anti-diabetic drug metformin. Introduction of cGFJ after onset of diet-induced obesity also reduced weight and blood glucose. A bioactive compound in cGFJ, naringin, reduced blood glucose and improved insulin tolerance, but did not ameliorate weight gain. These data from a well-controlled animal study indicate that GFJ contains more than one health-promoting neutraceutical, and warrant further studies of GFJ effects in the context of obesity and/or the western diet.	[Chudnovskiy, Rostislav; Thompson, Airlia; Tharp, Kevin; Hellerstein, Marc; Napoli, Joseph L.; Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Grad Program Metab Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Grad Program Metab Biol, Berkeley, CA 94720 USA.	jna@berkeley.edu; astahl@berkeley.edu		tharp, kevin/0000-0002-3543-3266	California Grapefruit Growers Cooperative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK036870, T32DK061918] Funding Source: NIH RePORTER	California Grapefruit Growers Cooperative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The California Grapefruit Growers Cooperative provided financial support for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have financial or non-financial competing interests to disclose.	Agosti S, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2010.08.031; Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bailey DG, 2013, CAN MED ASSOC J, V185, P309, DOI 10.1503/cmaj.120951; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Diaconu CH, REV MED CHIR SOC MED, V115, P245; Eloranta JJ, 2005, METHOD ENZYMOL, V400, P511, DOI 10.1016/S0076-6879(05)00028-5; Fallingborg J, 1999, DAN MED BULL, V46, P183; Fujioka K, 2006, J MED FOOD, V9, P49, DOI 10.1089/jmf.2006.9.49; Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22; Grande LA, 2009, LANCET, V373, P1222, DOI 10.1016/S0140-6736(09)60289-0; Hanley MJ, 2011, EXPERT OPIN DRUG MET, V7, P267, DOI 10.1517/17425255.2011.553189; Holman RR, 2013, NAT REV ENDOCRINOL, V9, P67, DOI 10.1038/nrendo.2012.243; Hwang YP, 2010, MOL NUTR FOOD RES, V54, P977, DOI 10.1002/mnfr.200900283; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kannappan S, 2010, EUR J NUTR, V49, P101, DOI 10.1007/s00394-009-0054-6; Khalifeh-Soltani A, 2014, NAT MED, V20, P175, DOI 10.1038/nm.3450; Mazokopakis EE, 2008, INTERN MED J, V38, P364, DOI 10.1111/j.1445-5994.2007.01550.x; Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404; Pearen MA, 2012, PHYSIOLOGY, V27, P156, DOI 10.1152/physiol.00007.2012; Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026; Risinger FO, 2002, PSYCHOPHARMACOLOGY, V160, P225, DOI 10.1007/s00213-001-0973-2; Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Shirasaka Y, 2013, J PHARM SCI-US, V102, P280, DOI [10.1002/jps.23653, 10.1002/jps.23357]; Silver HJ, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-8; STAROSCIK JA, 1980, J AM DIET ASSOC, V77, P567; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Varady KA, 2010, J NUTR BIOCHEM, V21, P188, DOI 10.1016/j.jnutbio.2008.11.001; Vidal J, 2011, NEUROIMMUNOMODULAT, V18, P191, DOI 10.1159/000323772	34	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108408	10.1371/journal.pone.0108408	http://dx.doi.org/10.1371/journal.pone.0108408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296035	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000016
J	Schneider, SE; Thomas, JH				Schneider, Sean E.; Thomas, James H.			Accidental Genetic Engineers: Horizontal Sequence Transfer from Parasitoid Wasps to Their Lepidopteran Hosts	PLOS ONE			English	Article							SONORENSIS VIRUS-DNA; POLYDNAVIRUS DNA; GENOME; INTEGRATION; EXPRESSION; ORGANIZATION; TRANSPOSONS; BRACONIDAE; ALIGNMENT; ORIGIN	We show here that 105 regions in two Lepidoptera genomes appear to derive from horizontally transferred wasp DNA. We experimentally verified the presence of two of these sequences in a diverse set of silkworm (Bombyx mori) genomes. We hypothesize that these horizontal transfers are made possible by the unusual strategy many parasitoid wasps employ of injecting hosts with endosymbiotic polydnaviruses to minimize the host's defense response. Because these virus-like particles deliver wasp DNA to the cells of the host, there has been much interest in whether genetic information can be permanently transferred from the wasp to the host. Two transferred sequences code for a BEN domain, known to be associated with polydnaviruses and transcriptional regulation. These findings represent the first documented cases of horizontal transfer of genes between two organisms by a polydnavirus. This presents an interesting evolutionary paradigm in which host species can acquire new sequences from parasitoid wasps that attack them. Hymenoptera and Lepidoptera diverged similar to 300 MYA, making this type of event a source of novel sequences for recipient species. Unlike many other cases of horizontal transfer between two eukaryote species, these sequence transfers can be explained without the need to invoke the sequences hitchhiking on a third organism (e.g. retrovirus) capable of independent reproduction. The cellular machinery necessary for the transfer is contained entirely in the wasp genome. The work presented here is the first such discovery of what is likely to be a broader phenomenon among species affected by these wasps.	[Schneider, Sean E.; Thomas, James H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schneider, SE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	seaneric@uw.edu						ALBRECHT U, 1994, J GEN VIROL, V75, P3353, DOI 10.1099/0022-1317-75-12-3353; Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007; Austin AD, 1998, AUST J BOT, V46, P559; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Beck MH, 2011, J VIROL, V85, P11685, DOI 10.1128/JVI.05726-11; Belle E, 2002, J VIROL, V76, P5793, DOI 10.1128/JVI.76.11.5793-5796.2002; Bertsch C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-21; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bezier A, 2008, ARCH INSECT BIOCHEM, V67, P172, DOI 10.1002/arch.20219; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Burke GR, 2012, J VIROL, V86, P3293, DOI 10.1128/JVI.06434-11; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Choi JY, 2009, ARCH VIROL, V154, P1313, DOI 10.1007/s00705-009-0441-6; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; Doucet D, 2007, J GEN VIROL, V88, P105, DOI 10.1099/vir.0.82314-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espagne E, 2005, J VIROL, V79, P9765, DOI 10.1128/JVI.79.15.9765-9776.2005; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Flegel TW, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-32; FLEMING JAGW, 1986, J VIROL, V57, P552, DOI 10.1128/JVI.57.2.552-562.1986; FLEMING JAGW, 1991, P NATL ACAD SCI USA, V88, P9770, DOI 10.1073/pnas.88.21.9770; Friedman R, 2006, INFECT GENET EVOL, V6, P315, DOI 10.1016/j.meegid.2005.10.001; Gilbert C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4348; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gundersen-Rindal D, 2000, VIRUS RES, V66, P27, DOI 10.1016/S0168-1702(99)00125-2; Gundersen-Rindal DE, 2003, J INSECT PHYSIOL, V49, P453, DOI 10.1016/S0022-1910(03)00062-3; Hepat R, 2011, BIOCHEM BIOPH RES CO, V415, P279, DOI 10.1016/j.bbrc.2011.10.040; INFANTE F, 1995, ANN ENTOMOL SOC AM, V88, P406, DOI 10.1093/aesa/88.4.406; Johnson BR, 2013, CURR BIOL, V23, P2058, DOI 10.1016/j.cub.2013.08.050; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Koonin EV, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-2; Kuraku S, 2012, GENOME BIOL EVOL, V4, P929, DOI 10.1093/gbe/evs069; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; Labropoulou V, 2008, CELL MICROBIOL, V10, P2118, DOI 10.1111/j.1462-5822.2008.01195.x; Le NT, 2003, J INSECT PHYSIOL, V49, P533, DOI 10.1016/S0022-1910(03)00052-0; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Peters RS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-52; Pruijssers AJ, 2009, J EXP BIOL, V212, P2998, DOI 10.1242/jeb.030635; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; Serbielle C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-38; Simon S, 2012, GENOME BIOL EVOL, V4, P1295, DOI 10.1093/gbe/evs104; STOLTZ DB, 1976, CAN J MICROBIOL, V22, P1013, DOI 10.1139/m76-148; STOLTZ DB, 1984, INTERVIROLOGY, V21, P1, DOI 10.1159/000149497; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; THEILMANN DA, 1986, J GEN VIROL, V67, P1961, DOI 10.1099/0022-1317-67-9-1961; Theze J, 2011, P NATL ACAD SCI USA, V108, P15931, DOI 10.1073/pnas.1105580108; Thomas J, 2010, GENOME BIOL EVOL, V2, P656, DOI 10.1093/gbe/evq050; Volkoff AN, 2001, J GEN VIROL, V82, P963, DOI 10.1099/0022-1317-82-4-963; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Walsh AM, 2013, P NATL ACAD SCI USA, V110, P1012, DOI 10.1073/pnas.1205856110; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Whitfield JB, 1997, NATURWISSENSCHAFTEN, V84, P502, DOI 10.1007/s001140050434; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	57	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109446	10.1371/journal.pone.0109446	http://dx.doi.org/10.1371/journal.pone.0109446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296163	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000073
J	Averill, MM; Kim, EJ; Goodspeed, L; Wang, SR; Subramanian, S; Den Hartigh, LJ; Tang, CR; Ding, YL; Reardon, CA; Getz, GS; Chait, A				Averill, Michelle M.; Kim, Eung Ju; Goodspeed, Leela; Wang, Shari; Subramanian, Savitha; Den Hartigh, Laura J.; Tang, Chongren; Ding, Yilei; Reardon, Catherine A.; Getz, Godfrey S.; Chait, Alan			The Apolipoprotein-AI Mimetic Peptide L4F at a Modest Dose Does Not Attenuate Weight Gain, Inflammation, or Atherosclerosis in LDLR-Null Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; BODY-COMPOSITION ANALYSIS; RECEPTOR-DEFICIENT MICE; INSULIN SENSITIVITY; SMALL-INTESTINE; AMINO-ACIDS; OBESE MICE; CHOLESTEROL; FRAMINGHAM; DISEASE	Objective: High density lipoprotein (HDL) cholesterol levels are inversely related to cardiovascular disease risk and associated with a reduced risk of type 2 diabetes. Apolipoprotein A-I (apoA-I; major HDL protein) mimetics have been reported to reduce atherosclerosis and decrease adiposity. This study investigated the effect of L4F mimetic peptide and apoA-I overexpression on weight gain, insulin resistance, and atherosclerosis in an LDL receptor deficient (Ldlr(-/-)) model fed a high fat high sucrose with cholesterol (HFHSC) diet. Methods: Studies in differentiated 3T3-L1 adipocytes tested whether L4F could inhibit palmitate-induced adipocyte inflammation. In vivo studies used male Ldlr(-/-) mice fed a HFHSC diet for 12 weeks and were injected daily with L4F (100 mu g/mouse) subcutaneously during the last 8 weeks. Wild-type and apoA-I overexpressing Ldlr(-/-) mice were fed HFHSC diet for 16 weeks. Results: Neither L4F administration nor apoA-I overexpression affected weight gain, total plasma cholesterol or triglycerides in our studies. While pre-treatment of 3T3-L1 adipocytes with either L4F or HDL abolished palmitate-induced cytokine expression in vitro, L4F treatment did not affect circulating or adipose tissue inflammatory markers in vivo. Neither L4F administration nor apoA-I overexpression affected glucose tolerance. ApoA-I overexpression significantly reduced atherosclerotic lesion size, yet L4F treatment did not affect atherosclerosis. Conclusion: Our results suggest that neither L4F (100 mu g/day/mouse) nor apoA-I overexpression affects adiposity or insulin resistance in this model. We also were unable to confirm a reduction in atherosclerosis with L4F in our particular model. Further studies on the effect of apoA-I mimetics on atherosclerosis and insulin resistance in a variety of dietary contexts are warranted.	[Averill, Michelle M.] Univ Washington, Dept Environm & Occupat Hlth, Seattle, WA 98195 USA; [Kim, Eung Ju; Goodspeed, Leela; Wang, Shari; Subramanian, Savitha; Den Hartigh, Laura J.; Tang, Chongren; Ding, Yilei; Chait, Alan] Univ Washington, Dept Med, Seattle, WA 98122 USA; [Reardon, Catherine A.; Getz, Godfrey S.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago	Chait, A (corresponding author), Univ Washington, Dept Med, Seattle, WA 98122 USA.	achait@u.washington.edu		Subramanian, Savitha/0000-0002-4866-2009	National Institutes of Health [RO1 HL094352, P01 HL092969, P30 DK-035816, R01 HL 106145]; National Center for Complementary & Integrative Health [K01AT007177] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007028, R01HL094352, P01HL092969, R01HL106145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (www.nih.gov) grants RO1 HL094352 (AC), P01 HL092969 (AC),P30 DK-035816 (AC), and R01 HL 106145 (CR, GG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Getz GS, 2011, J INFLAMM RES, V4, P83, DOI 10.2147/JIR.S12983; Getz GS, 2010, CURR ATHEROSCLER REP, V12, P96, DOI 10.1007/s11883-010-0097-4; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Marino JS, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.4; Montes VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067709; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab M, 2013, J LIPID RES, V54, P3403, DOI 10.1194/jlr.M042051; Navab M, 2012, J LIPID RES, V53, P437, DOI 10.1194/jlr.M023523; Navab M, 2011, J LIPID RES, V52, P1200, DOI 10.1194/jlr.M013144; Navab M, 2009, DIABETES, V58, P2711, DOI 10.2337/db09-0538; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Peterson SJ, 2008, J LIPID RES, V49, P1658, DOI 10.1194/jlr.M800046-JLR200; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Schreyer SA, 2003, ATHEROSCLEROSIS, V171, P49, DOI 10.1016/j.atherosclerosis.2003.07.010; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Umemoto T, 2013, CIRC RES, V112, P1345, DOI 10.1161/CIRCRESAHA.111.300581; Valenta DT, 2006, ATHEROSCLEROSIS, V189, P255, DOI 10.1016/j.atherosclerosis.2005.12.019; Van Lenten BJ, 2007, J LIPID RES, V48, P2344, DOI 10.1194/jlr.M700138-JLR200; WILSON PWF, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90532-2; Wool GD, 2008, J LIPID RES, V49, P1268, DOI 10.1194/jlr.M700552-JLR200; Wool GD, 2011, FASEB J, V25, P290, DOI 10.1096/fj.10-165670	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109252	10.1371/journal.pone.0109252	http://dx.doi.org/10.1371/journal.pone.0109252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286043	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700053
J	Menant, JC; Sturnieks, DL; Brodie, MAD; Smith, ST; Lord, SR				Menant, Jasmine C.; Sturnieks, Daina L.; Brodie, Matthew A. D.; Smith, Stuart T.; Lord, Stephen R.			Visuospatial Tasks Affect Locomotor Control More than Nonspatial Tasks in Older People	PLOS ONE			English	Article							COGNITIVE FUNCTION; GAIT VARIABILITY; WORKING-MEMORY; POSTURAL STABILITY; FALL RISK; PRIORITIZATION; INTERFERENCE; ATTENTION; PATTERNS; HEALTHY	Background: Previous research has shown that visuospatial processing requiring working memory is particularly important for balance control during standing and stepping, and that limited spatial encoding contributes to increased interference in postural control dual tasks. However, visuospatial involvement during locomotion has not been directly determined. This study examined the effects of a visuospatial cognitive task versus a nonspatial cognitive task on gait speed, smoothness and variability in older people, while controlling for task difficulty. Methods: Thirty-six people aged >= 75 years performed three walking trials along a 20 m walkway under the following conditions: (i) an easy nonspatial task; (ii) a difficult nonspatial task; (iii) an easy visuospatial task; and (iv) a difficult visuospatial task. Gait parameters were computed from a tri-axial accelerometer attached to the sacrum. The cognitive task response times and percentage of correct answers during walking and seated trials were also computed. Results: No significant differences in either cognitive task type error rates or response times were evident in the seated conditions, indicating equivalent task difficulty. In the walking trials, participants responded faster to the visuospatial tasks than the nonspatial tasks but at the cost of making significantly more cognitive task errors. Participants also walked slower, took shorter steps, had greater step time variability and less smooth pelvis accelerations when concurrently performing the visuospatial tasks compared with the nonspatial tasks and when performing the difficult compared with the easy cognitive tasks. Conclusions: Compared with nonspatial cognitive tasks, visuospatial cognitive tasks led to a slower, more variable and less smooth gait pattern. These findings suggest that visuospatial processing might share common networks with locomotor control, further supporting the hypothesis that gait changes during dual task paradigms are not simply due to limited attentional resources but to competition for common networks for spatial information encoding.	[Menant, Jasmine C.; Sturnieks, Daina L.; Brodie, Matthew A. D.; Smith, Stuart T.; Lord, Stephen R.] Neurosci Res Australia, Falls & Balance Res Grp, Sydney, NSW, Australia; [Menant, Jasmine C.; Sturnieks, Daina L.; Lord, Stephen R.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Smith, Stuart T.] Univ Tasmania, Fac Hlth Sci, Launceston, Tas 7250, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Tasmania	Menant, JC (corresponding author), Neurosci Res Australia, Falls & Balance Res Grp, Sydney, NSW, Australia.	j.menant@neura.edu.au	Brodie, Matthew Andrew/HDN-0096-2022; Smith, Stuart T/B-8144-2011; Brodie, Matthew A D/ABG-1640-2020; Sturnieks, Daina L/D-5379-2011; Lord, Stephen R/C-9612-2011; Menant, Jasmine C/A-7457-2015	Brodie, Matthew Andrew/0000-0002-5711-3458; Smith, Stuart T/0000-0002-4735-6026; Brodie, Matthew A D/0000-0002-5711-3458; Menant, Jasmine C/0000-0001-8686-0500; Lord, Stephen R/0000-0002-7111-8802; Sturnieks, Daina/0000-0002-4602-7685	National Health and Medical Research Council of Australia [350833, 568975, 568940]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia, Program Grant 350833, Partnership Grant 568975 and Capacity Building Grant 568940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alichniewicz KK, 2012, NEUROBIOL AGING, V33, P2782, DOI 10.1016/j.neurobiolaging.2012.02.010; Amboni M, 2012, MOVEMENT DISORD, V27, P1536, DOI 10.1002/mds.25165; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barra J, 2006, EXP BRAIN RES, V174, P734, DOI 10.1007/s00221-006-0519-2; Beauchet O, 2007, AGE AGEING, V36, P418, DOI 10.1093/ageing/afm011; Beauchet O, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-12; Brown LA, 2002, J GERONTOL A-BIOL, V57, pM785, DOI 10.1093/gerona/57.12.M785; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Chong RKY, 2010, NEUROPSYCHOLOGIA, V48, P2709, DOI 10.1016/j.neuropsychologia.2010.05.018; Dietz V, 2003, CLIN NEUROPHYSIOL, V114, P1379, DOI 10.1016/S1388-2457(03)00120-2; Doumas M, 2008, EXP BRAIN RES, V187, P275, DOI 10.1007/s00221-008-1302-3; Faulkner KA, 2007, J AM GERIATR SOC, V55, P570, DOI 10.1111/j.1532-5415.2007.01147.x; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Heo S, 2010, BRAIN RES, V1315, P119, DOI 10.1016/j.brainres.2009.12.020; Hill K, 1999, AUST NZ J PUBL HEAL, V23, P41, DOI 10.1111/j.1467-842X.1999.tb01203.x; Huang CY, 2013, HUM BRAIN MAPP, V34, P635, DOI 10.1002/hbm.21460; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Martin KL, 2013, J GERONTOL A-BIOL, V68, P1091, DOI 10.1093/gerona/glt010; Martin KL, 2013, J GERONTOL A-BIOL, V68, P726, DOI 10.1093/gerona/gls224; Maylor EA, 2001, BRIT J PSYCHOL, V92, P319, DOI 10.1348/000712601162211; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nadkarni Neelesh K, 2010, Motor Control, V14, P195; Nantel J, 2012, NEUROSCIENCE, V221, P151, DOI 10.1016/j.neuroscience.2012.07.007; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schott JM, 2006, CURR OPIN NEUROL, V19, P552, DOI 10.1097/01.wco.0000247611.44106.76; Sheridan PL, 2007, DEMENT GERIATR COGN, V24, P125, DOI 10.1159/000105126; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Sturnieks DL, 2008, J GERONTOL A-BIOL, V63, P1063, DOI 10.1093/gerona/63.10.1063; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Woollacott M, 2008, BRAIN RES, V1208, P95, DOI 10.1016/j.brainres.2008.03.005; Yardley L, 1999, NEUROREPORT, V10, P215, DOI 10.1097/00001756-199902050-00003; Yardley L, 2001, J NEUROL NEUROSUR PS, V71, P48, DOI 10.1136/jnnp.71.1.48; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zago L, 2002, NEUROSCI LETT, V331, P45, DOI 10.1016/S0304-3940(02)00833-9; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	47	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109802	10.1371/journal.pone.0109802	http://dx.doi.org/10.1371/journal.pone.0109802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XC	25285913	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700091
J	Wehner, S; Mannala, GK; Qing, XX; Madhugiri, R; Chakraborty, T; Mraheil, MA; Hain, T; Marz, M				Wehner, Stefanie; Mannala, Gopala K.; Qing, Xiaoxing; Madhugiri, Ramakanth; Chakraborty, Trinad; Mraheil, Mobarak A.; Hain, Torsten; Marz, Manja			Detection of Very Long Antisense Transcripts by Whole Transcriptome RNA-Seq Analysis of Listeria monocytogenes by Semiconductor Sequencing Technology	PLOS ONE			English	Article							COMPARATIVE GENOMICS; MESSENGER-RNA; GENES; EXPRESSION; ADAPTATION; PREDICTION; GROWTH; NOV.; RFAM	The Gram-positive bacterium Listeria monocytogenes is the causative agent of listeriosis, a severe food-borne infection characterised by abortion, septicaemia, or meningoencephalitis. L. monocytogenes causes outbreaks of febrile gastroenteritis and accounts for community-acquired bacterial meningitis in humans. Listeriosis has one of the highest mortality rates (up to 30%) of all food-borne infections. This human pathogenic bacterium is an important model organism for biomedical research to investigate cell-mediated immunity. L. monocytogenes is also one of the best characterised bacterial systems for the molecular analysis of intracellular parasitism. Recently several transcriptomic studies have also made the ubiquitous distributed bacterium as a model to understand mechanisms of gene regulation from the environment to the infected host on the level of mRNA and non-coding RNAs (ncRNAs). We have used semiconductor sequencing technology for RNA-seq to investigate the repertoire of listerial ncRNAs under extra-and intracellular growth conditions. Furthermore, we applied a new bioinformatic analysis pipeline for detection, comparative genomics and structural conservation to identify ncRNAs. With this work, in total, 741 ncRNA locations of potential ncRNA candidates are now known for L. monocytogenes, of which 611 ncRNA candidates were identified by RNA-seq. 441 transcribed ncRNAs have never been described before. Among these, we identified novel long non-coding antisense RNAs with a length of up to 5,400 nt e.g. opposite to genes coding for internalins, methylases or a high-affinity potassium uptake system, namely the kdpABC operon, which were confirmed by qRT-PCR analysis. RNA-seq, comparative genomics and structural conservation of L. monocytogenes ncRNAs illustrate that this human pathogen uses a large number and repertoire of ncRNA including novel long antisense RNAs, which could be important for intracellular survival within the infected eukaryotic host.	[Wehner, Stefanie; Marz, Manja] Univ Jena, Fac Math & Comp Sci, Jena, Germany; [Mannala, Gopala K.; Qing, Xiaoxing; Chakraborty, Trinad; Mraheil, Mobarak A.; Hain, Torsten] Univ Giessen, Inst Med Microbiol, D-35390 Giessen, Germany; [Chakraborty, Trinad; Hain, Torsten] German Ctr Infect Res DZIF, Giessen, Germany; [Madhugiri, Ramakanth] Univ Giessen, Inst Med Virol, D-35390 Giessen, Germany	Friedrich Schiller University of Jena; Justus Liebig University Giessen; German Center for Infection Research; Justus Liebig University Giessen	Hain, T (corresponding author), Univ Giessen, Inst Med Microbiol, D-35390 Giessen, Germany.	Torsten.Hain@mikrobio.med.uni-giessen.de; manja@uni-jena.de	Mannala, Gopala Krishna/ABF-2325-2020	Wehner, Stefanie/0000-0002-3632-2584; Madhugiri, Ramakanth/0000-0002-9306-4155; Marz, Manja/0000-0003-4783-8823	German Federal Ministry of Education and Research through ERA-NET program; German Centre for Infection Research, Justus-Liebig University Giessen; Carl-Zeiss-Stiftung; DFG [MA5082/1-1]	German Federal Ministry of Education and Research through ERA-NET program; German Centre for Infection Research, Justus-Liebig University Giessen; Carl-Zeiss-Stiftung; DFG(German Research Foundation (DFG))	This project was funded by the German Federal Ministry of Education and Research through ERA-NET program grants sncRNAomics to T. H. and the German Centre for Infection Research, Justus-Liebig University Giessen to T. H. and T. C. This work was funded in part by the Carl-Zeiss-Stiftung, and DFG MA5082/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Bertsch D, 2013, INT J SYST EVOL MICR, V63, P526, DOI 10.1099/ijs.0.036947-0; Brondsted L, 2003, FEMS MICROBIOL LETT, V219, P233, DOI 10.1016/S0378-1097(03)00052-1; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; de las Heras A, 2011, CURR OPIN MICROBIOL, V14, P118, DOI 10.1016/j.mib.2011.01.005; den Bakker HC, 2013, INT J SYST EVOL MICR, V63, P3257, DOI 10.1099/ijs.0.048587-0; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Glaser P, 2001, SCIENCE, V294, P849; Gouin E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/pnas.1007765107; Graves LM, 2010, INT J SYST EVOL MICR, V60, P1280, DOI 10.1099/ijs.0.014118-0; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hain T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/j.ijmm.2007.03.016; Hain T, 2006, J BACTERIOL, V188, P7405, DOI 10.1128/JB.00758-06; Hain T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-144; Halter EL, 2013, INT J SYST EVOL MICR, V63, P641, DOI 10.1099/ijs.0.036830-0; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lechner M, 2013, BACPROT PRO IN PRESS; Leclercq A, 2010, INT J SYST EVOL MICR, V60, P2210, DOI 10.1099/ijs.0.017376-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mellin JR, 2013, P NATL ACAD SCI USA, V110, P13132, DOI 10.1073/pnas.1304795110; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pizarro-Cerda J, 2012, COLD SPRING HARBPERS, V2; POLAREK JW, 1992, J BACTERIOL, V174, P2145, DOI 10.1128/JB.174.7.2145-2151.1992; Raghavan R, 2012, MBIO, V3, DOI 10.1128/mBio.00156-12; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; Stazic D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/nar/gkr037; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Tasara T, 2007, FEMS MICROBIOL LETT, V269, P265, DOI 10.1111/j.1574-6968.2007.00633.x; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wieseke Nicolas, 2013, Bioinformatics Research and Applications. 9th International Symposium, ISBRA 2013. Proceedings, P249, DOI 10.1007/978-3-642-38036-5_25; Williams T, 2005, INFECT IMMUN, V73, P3152, DOI 10.1128/IAI.73.5.3152-3159.2005; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11	50	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108639	10.1371/journal.pone.0108639	http://dx.doi.org/10.1371/journal.pone.0108639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286309	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700025
J	Chen, WL; Wang, CC; Wu, LW; Kao, TW; Chan, JYH; Chen, YJ; Yang, YH; Chang, YW; Peng, TC				Chen, Wei-Liang; Wang, Chung-Ching; Wu, Li-Wei; Kao, Tung-Wei; Chan, James Yi-Hsin; Chen, Ying-Jen; Yang, Ya-Hui; Chang, Yaw-Wen; Peng, Tao-Chun			Relationship between Lung Function and Metabolic Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PULMONARY-FUNCTION; ABDOMINAL OBESITY; NUTRITION EXAMINATION; GENERAL-POPULATION; INSULIN-RESISTANCE; NATIONAL-HEALTH; NORMAL-WEIGHT; ASSOCIATION; CHOLESTEROL	Although the link between impaired lung function and cardiovascular events and type 2 diabetes mellitus has been recognized, the association between impaired lung function and metabolic syndrome has not been comprehensively assessed in the United States (U.S.) population. The aim of our study was to explore the association between impaired lung function and metabolic syndrome in a nationally representative sample of men and women. This cross-sectional population-based study included 8602 participants aged 20-65 years in the Third National Health and Nutrition Examination Survey (NHANES III). We examined the relationship between the different features of metabolic syndrome and lung function, including forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1). After adjusting for potential confounders such as age, body mass index, inflammatory factors, medical condition, and smoking status, participants with more components of metabolic syndrome had lower predicted values of FVC and FEV1 (p for trend <0.001 for both). Impaired pulmonary function was also associated with individual components of metabolic syndrome, such as abdominal obesity, high blood pressure, high triglycerides, and low high density lipoprotein (HDL) cholesterol (p<0.05 for all parameters). These results from a nationally representative sample of US adults suggest that a greater number of features of metabolic syndrome is strongly associated with poorer FVC and FEV1. In clinical practice, more comprehensive management strategies to address subjects with metabolic syndrome and impaired lung function need to be developed and investigated.	[Chen, Wei-Liang; Wang, Chung-Ching; Wu, Li-Wei; Kao, Tung-Wei; Chan, James Yi-Hsin; Chang, Yaw-Wen; Peng, Tao-Chun] Tri Serv Gen Hosp & Sch Med, Natl Def Med Ctr, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Chen, Wei-Liang; Wu, Li-Wei; Kao, Tung-Wei; Chang, Yaw-Wen] Tri Serv Gen Hosp & Sch Med, Natl Def Med Ctr, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Chen, Wei-Liang; Chan, James Yi-Hsin; Chen, Ying-Jen] Grad Inst Med Sci, Natl Def Med Ctr, Taipei, Taiwan; [Yang, Ya-Hui] Fooyin Univ, Dept Occupat Safety & Hyg, Kaohsiung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Fooyin University	Peng, TC (corresponding author), Tri Serv Gen Hosp & Sch Med, Natl Def Med Ctr, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.	koigojaff@gmail.com	Chang, Yaw-Wen/AAF-2630-2020; Peng, Tao‑Chun/AAY-7035-2020	Chang, Yaw-Wen/0000-0002-8436-0518; Yang, Ya-Hui/0000-0002-1785-5123				[Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Chen Y, 2007, AM J CLIN NUTR, V85, P35, DOI 10.1093/ajcn/85.1.35; Choi JH, 2011, ENDOCR J, V58, P459, DOI 10.1507/endocrj.K11E-011; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; ERVIN RB, 2009, NATL HLTH STAT REPOR, V13, P1; Faber DR, 2010, ATHEROSCLEROSIS, V212, P274, DOI 10.1016/j.atherosclerosis.2010.04.029; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Klisic AN, 2014, LABMEDICINE, V45, P12, DOI 10.1309/LMI6I2RN7AMPEUUL; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Lee HM, 2009, CHEST, V136, P171, DOI 10.1378/chest.08-1901; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; NELSON SB, 1990, CHEST, V97, P288, DOI 10.1378/chest.97.2.288; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Rein P, 2010, DIABETES CARE, V33, P1853, DOI 10.2337/dc09-2376; Rogliani P, 2010, RESP MED, V104, P47, DOI 10.1016/j.rmed.2009.08.009; SAAD MF, 1991, NEW ENGL J MED, V324, P733, DOI 10.1056/NEJM199103143241105; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Thijs W, 2014, RESP MED, V108, P351, DOI 10.1016/j.rmed.2013.10.003; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Yamamoto Y, 2014, JPN CLIN MED, V5, P1, DOI 10.4137/JCM.S13564; Yang T, 2013, ENDOCRINE, V43, P351, DOI 10.1007/s12020-012-9743-7; Yoshimura C, 2012, INTERNAL MED, V51, P2291, DOI 10.2169/internalmedicine.51.7427; Yu D, 2014, DIABETIC MED, V31, P595, DOI 10.1111/dme.12346	36	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108989	10.1371/journal.pone.0108989	http://dx.doi.org/10.1371/journal.pone.0108989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299452	Green Submitted, gold, Green Published			2022-12-27	WOS:000343941200030
J	Fan, ZQ; Li, W; Lee, SR; Meng, QG; Shi, B; Bunch, TD; White, KL; Kong, IK; Wang, ZD				Fan, Zhiqiang; Li, Wei; Lee, Sang R.; Meng, Qinggang; Shi, Bi; Bunch, Thomas D.; White, Kenneth L.; Kong, Il-Keun; Wang, Zhongde			Efficient Gene Targeting in Golden Syrian Hamsters by the CRISPR/Cas9 System	PLOS ONE			English	Article							ONE-STEP GENERATION; GENOME MODIFICATION; CRISPR-CAS9 SYSTEM; CAS SYSTEM; MODEL; EMBRYOS; MICE; KNOCKOUT; ENDONUCLEASES; SPECIFICITY	The golden Syrian hamster is the model of choice or the only rodent model for studying many human diseases. However, the lack of gene targeting tools in hamsters severely limits their use in biomedical research. Here, we report the first successful application of the CRISPR/Cas9 system to efficiently conduct gene targeting in hamsters. We designed five synthetic single-guide RNAs (sgRNAs)-three for targeting the coding sequences for different functional domains of the hamster STAT2 protein, one for KCNQ1, and one for PPP1R12C-and demonstrated that the CRISPR/Cas9 system is highly efficient in introducing site-specific mutations in hamster somatic cells. We then developed unique pronuclear (PN) and cytoplasmic injection protocols in hamsters and produced STAT2 knockout (KO) hamsters by injecting the sgRNA/Cas9, either in the form of plasmid or mRNA, targeting exon 4 of hamster STAT2. Among the produced hamsters, 14.3% and 88.9% harbored germline-transmitted STAT2 mutations from plasmid and mRNA injection, respectively. Notably, 10.4% of the animals produced from mRNA injection were biallelically targeted. This is the first success in conducting site-specific gene targeting in hamsters and can serve as the foundation for developing other genetically engineered hamster models for human disease.	[Fan, Zhiqiang; Li, Wei; Lee, Sang R.; Meng, Qinggang; Shi, Bi; Bunch, Thomas D.; White, Kenneth L.; Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Kong, Il-Keun] Gyeongsang Natl Univ, Dept Anim Sci, Div Appl Life Sci, Jinju, Gyeongnam Provi, South Korea; [Kong, Il-Keun] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, Gyeongnam Provi, South Korea; [Wang, Zhongde] Auratus Bio LLC, Canton, SD USA	Utah System of Higher Education; Utah State University; Gyeongsang National University; Gyeongsang National University	Wang, ZD (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	zonda.wang@usu.edu		Wang, Zhongde/0000-0003-2441-4729	Utah Science Technology and Research (USTAR) initiative; Rural Development Administration (RDA) [PJ009587022013]; BK21 plus program, Republic of Korea	Utah Science Technology and Research (USTAR) initiative; Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); BK21 plus program, Republic of Korea	This work was supported by the Utah Science Technology and Research (USTAR) initiative (to ZW); and the Next-Generation Bio-Green 21 Program (No. PJ009587022013) by the Rural Development Administration (RDA) and BK21 plus program, Republic of Korea (to IKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT DK, 1992, BIOL REPROD, V47, P297, DOI 10.1095/biolreprod47.2.297; Best EL, 2012, GUT MICROBES, V3, P145, DOI 10.4161/gmic.19526; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Guillaume V, 2009, VIROLOGY, V387, P459, DOI 10.1016/j.virol.2009.03.001; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Jove M, 2013, CARDIOVASC RES, V97, P642, DOI 10.1093/cvr/cvs368; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; McKiernan SH, 2000, HUM REPROD, V15, P157, DOI 10.1093/humrep/15.1.157; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Paciello O, 2010, MUSCLE NERVE, V41, P355, DOI 10.1002/mus.21502; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Safronetz D, 2012, ANTIVIR RES, V95, P282, DOI 10.1016/j.antiviral.2012.06.002; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Squirrell JM, 2001, BIOL REPROD, V64, P1845, DOI 10.1095/biolreprod64.6.1845; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Takahashi Mami, 2011, Cancers (Basel), V3, P582, DOI 10.3390/cancers3010582; Takenaka M, 2007, P NATL ACAD SCI USA, V104, P14289, DOI 10.1073/pnas.0706687104; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tzur YB, 2013, GENETICS, V195, P1181, DOI 10.1534/genetics.113.156075; Valraktaris E, 2008, ORAL ONCOL, V44, P315, DOI 10.1016/j.oraloncology.2007.08.015; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wold WSM, 2012, ADV CANCER RES, V115, P69, DOI 10.1016/B978-0-12-398342-8.00003-3; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825	38	50	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109755	10.1371/journal.pone.0109755	http://dx.doi.org/10.1371/journal.pone.0109755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299451	gold, Green Published			2022-12-27	WOS:000343941200070
J	Kang, D; Yun, JS; Ko, SH; Lim, TS; Ahn, YB; Park, YM; Ko, SH				Kang, Donghoon; Yun, Jae-Seung; Ko, Sun-Hye; Lim, Tae-Seok; Ahn, Yu-Bae; Park, Yong-Moon; Ko, Seung-Hyun			Higher Prevalence of Metformin-Induced Vitamin B-12 Deficiency in Sulfonylurea Combination Compared with Insulin Combination in Patients with Type 2 Diabetes: A Cross-Sectional Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; SERUM CONCENTRATIONS; NATIONAL-HEALTH; ASSOCIATION; DIAGNOSIS; ANEMIA; POLYNEUROPATHY; MALABSORPTION; HOMOCYSTEINE; MANAGEMENT	Long-term and high-dose treatment with metformin is known to be associated with vitamin B-12 deficiency in patients with type 2 diabetes. We investigated whether the prevalence of B-12 deficiency was different in patients treated with different combination of hypoglycemic agents with metformin during the same time period. A total of 394 patients with type 2 diabetes treated with metformin and sulfonylurea (S+M group, n = 299) or metformin and insulin (I+M group, n = 95) were consecutively recruited. The vitamin B-12 and folate levels were quantified using the chemiluminescent enzyme immunoassay. Vitamin B-12 deficiency was defined as vitamin B-12 <= 300 pg/mL without folate deficiency (folate>4 ng/mL). The mean age of and duration of diabetes in the subjects were 59.4 +/- 10.5 years and 12.2 +/- 6.7 years, respectively. The mean vitamin B-12 level of the total population was 638.0 +/- 279.6 pg/mL. The mean serum B12 levels were significantly lower in the S+M group compared with the I+M group (600.0 +/- 266.5 vs. 757.7 +/- 287.6 pg/mL, P<0.001). The prevalence of vitamin B-12 deficiency in the metformin-treated patients was significantly higher in the S+M group compared with the I+M group (17.4% vs. 4.2%, P = 0.001). After adjustment for various factors, such as age, sex, diabetic duration, duration or daily dose of metformin, diabetic complications, and presence of anemia, sulfonylurea use was a significant independent risk factor for B-12 deficiency (OR = 4.74, 95% CI 1.41-15.99, P = 0.012). In conclusion, our study demonstrated that patients with type 2 diabetes who were treated with metformin combined with sulfonylurea require clinical attention for vitamin B-12 deficiency and regular monitoring of their vitamin B-12 levels.	[Kang, Donghoon; Yun, Jae-Seung; Ko, Sun-Hye; Lim, Tae-Seok; Ahn, Yu-Bae; Ko, Seung-Hyun] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ko, SH (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea.	kosh@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Kang, Donghoon/0000-0002-7278-2174; Ko, Sun Hye/0000-0003-3387-3986				ADAMS JF, 1983, DIABETOLOGIA, V24, P16, DOI 10.1007/BF00275941; Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Andres E, 2002, ARCH INTERN MED, V162, P2251, DOI 10.1001/archinte.162.19.2251-a; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; Bell DSH, 2010, SOUTH MED J, V103, P265, DOI 10.1097/SMJ.0b013e3181ce0e4d; Bouchoucha M, 2011, DIABETES METAB, V37, P90, DOI 10.1016/j.diabet.2010.11.002; CARMEL R, 1988, ARCH INTERN MED, V148, P1712, DOI 10.1001/archinte.148.8.1712; Chan CWJ, 2007, INT J LAB HEMATOL, V29, P163, DOI 10.1111/j.1751-553X.2007.00911.x; de Jager J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2181; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Filioussi Kalitsa, 2003, Aust Fam Physician, V32, P383; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Hermann LS, 2004, BRIT J DIABETES VASC, V4, P401; Hin H, 2006, AGE AGEING, V35, P416, DOI 10.1093/ageing/afl033; Kibirige D, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-17; Ko SH, 2014, DIABETES METAB J, V38, P51, DOI 10.4093/dmj.2014.38.1.51; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Ko SH, 2014, J KOREAN MED SCI, V29, P965, DOI 10.3346/jkms.2014.29.7.965; Leishear K, 2012, J AM GERIATR SOC, V60, P1057, DOI 10.1111/j.1532-5415.2012.03998.x; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; Liu KW, 2006, AGE AGEING, V35, P200, DOI 10.1093/ageing/afj042; Long AN, 2012, DIABETES CARE, V35, pE84, DOI 10.2337/dc12-0980; Mazokopakis EE, 2012, DIABETES RES CLIN PR, V97, P359, DOI 10.1016/j.diabres.2012.06.001; Meijer JWG, 2002, DIABETIC MED, V19, P962, DOI 10.1046/j.1464-5491.2002.00819.x; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Naha K, 2012, BMJ CASE REP, V2012; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Pflipsen MC, 2009, J AM BOARD FAM MED, V22, P528, DOI 10.3122/jabfm.2009.05.090044; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Sahin M, 2007, J DIABETES COMPLICAT, V21, P118, DOI 10.1016/j.jdiacomp.2005.10.005; Schernthaner G, 2004, EUR J CLIN INVEST, V34, P535, DOI 10.1111/j.1365-2362.2004.01381.x; STABLER SP, 1990, BLOOD, V76, P871; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975; TOMKIN GH, 1971, BMJ-BRIT MED J, V2, P685, DOI 10.1136/bmj.2.5763.685; Turner LW, 2014, DIABETES CARE, V37, P985, DOI 10.2337/dc13-2097; Wickramasinghe SN, 2006, BLOOD REV, V20, P299, DOI 10.1016/j.blre.2006.02.002; Wile DJ, 2010, DIABETES CARE, V33, P156, DOI 10.2337/dc09-0606; World Health Organization, 2001, INT CLASS FUNCT DIS, P1; Wulffele MG, 2003, J INTERN MED, V254, P455, DOI 10.1046/j.1365-2796.2003.01213.x	40	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109878	10.1371/journal.pone.0109878	http://dx.doi.org/10.1371/journal.pone.0109878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299054	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200082
J	Keefover-Ring, K; Ahnlund, M; Abreu, IN; Jansson, S; Moritz, T; Albrectsen, BR				Keefover-Ring, Ken; Ahnlund, Maria; Abreu, Ilka Nacif; Jansson, Stefan; Moritz, Thomas; Albrectsen, Benedicte Riber			No Evidence of Geographical Structure of Salicinoid Chemotypes within Populus Tremula	PLOS ONE			English	Article							ADAPTIVE POPULATION DIFFERENTIATION; PHENOLIC GLYCOSIDES; SECONDARY METABOLITES; CHEMICAL DEFENSE; WILLOW SALIX; TIGER SWALLOWTAIL; HERBIVORE DEFENSE; CONDENSED TANNINS; S-ERIOCEPHALA; QUAKING ASPEN	Salicinoids are well-known defense compounds in salicaceous trees and careful screening at the population level is warranted to fully understand their diversity and function. European aspen, Populus tremula, is a foundation species in Eurasia and highly polymorphic in Sweden. We exhaustively surveyed 102 replicated genotypes from the Swedish Aspen collection (SwAsp) for foliar salicinoids using UHPLC-ESI-TOF/MS and identified nine novel compounds, bringing the total to 19 for this species. Salicinoid structure followed a modular architecture of a salicin skeleton with added side groups, alone or in combination. Two main moieties, 2'-cinnamoyl and 2'-acetyl, grouped the SwAsp population into four distinct chemotypes, and the relative allocation of salicinoids was remarkably constant between different environments, implying a highly channeled biosynthesis of these compounds. Slightly more than half of the SwAsp genotypes belonged to the cinnamoyl chemotype. A fraction synthesized the acetyl moiety alone (similar to 7%) or in combination with cinnamoyl (similar to 2%), and close to forty percent lacked either of the two characteristic moieties, and thus resemble P. tremuloides in their salicinoid profile. The two most abundant chemotypes were evenly distributed throughout Sweden, unlike geographical patterns reported for SwAsp phenology traits, plant defense genes, and herbivore community associations. Here we present the salicinoid characterization of the SwAsp collection as a resource for future studies of aspen chemical ecology, salicinoid biosynthesis, and genetics.	[Keefover-Ring, Ken; Abreu, Ilka Nacif; Jansson, Stefan; Albrectsen, Benedicte Riber] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Keefover-Ring, Ken] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Ahnlund, Maria; Abreu, Ilka Nacif; Moritz, Thomas] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Albrectsen, Benedicte Riber] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark	Umea University; University of Wisconsin System; University of Wisconsin Madison; Swedish University of Agricultural Sciences; Umea University; University of Copenhagen	Albrectsen, BR (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	benedicte.albrectsen@umu.se	Jansson, Stefan/A-1119-2009	Jansson, Stefan/0000-0002-7906-6891; Albrectsen, Benedicte Riber/0000-0002-9337-4540; Moritz, Thomas/0000-0002-4258-3190; Abreu, Ilka N/0000-0003-4728-0161	Carl Trygger Foundation for Scientific Research; Swedish Foundation for Strategic Research; Swedish Research Foundation	Carl Trygger Foundation for Scientific Research; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Foundation	The authors thank the Carl Trygger Foundation for Scientific Research, the Swedish Foundation for Strategic Research, and the Swedish Research Foundation for funding. The staff of the Swedish Metabolomics Center (www.swedishmetabolomicscentre.se) was instrumental in the completion of chemical analyses for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; Albrectsen BR, 2007, ECOL ENTOMOL, V32, P211; Albrectsen BR, 2010, ECOGRAPHY, V33, P483, DOI 10.1111/j.1600-0587.2009.05982.x; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; AUDETTE RCS, 1966, J CHROMATOGR, V25, P367, DOI 10.1016/S0021-9673(01)98254-8; Babst BA, 2010, J CHEM ECOL, V36, P286, DOI 10.1007/s10886-010-9757-7; Bailey JK, 2007, BIOL INVASIONS, V9, P715, DOI 10.1007/s10530-006-9071-z; Bernhardsson C, 2012, MOL ECOL, V21, P2197, DOI 10.1111/j.1365-294X.2012.05524.x; BINNS WW, 1968, PHYTOCHEMISTRY, V7, P1577, DOI 10.1016/S0031-9422(00)88609-4; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Caseys C, 2012, PLANT ECOL DIVERS, V5, P457, DOI 10.1080/17550874.2012.748850; Chen F, 2009, CRIT REV PLANT SCI, V28, P375, DOI 10.1080/07352680903241279; Constabel CP, 2010, PLANT GENET GENOMICS, V8, P279, DOI 10.1007/978-1-4419-1541-2_13; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Fritz RS, 2001, OECOLOGIA, V129, P87, DOI 10.1007/s004420100703; Haikio E, 2009, J CHEM ECOL, V35, P664, DOI 10.1007/s10886-009-9644-2; Hall D, 2007, EVOLUTION, V61, P2849, DOI 10.1111/j.1558-5646.2007.00230.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hjalten J, 2007, OIKOS, V116, P751, DOI [10.1111/j.2007.0030-1299.15365.x, 10.1111/j.0030-1299.2007.15365.x]; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Keefover-Ring K, 2014, PHYTOCHEM LETT, V7, P212, DOI 10.1016/j.phytol.2013.11.012; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; LINDROTH RL, 1988, ECOLOGY, V69, P814, DOI 10.2307/1941031; Lindroth RL, 1999, J CHEM ECOL, V25, P1331, DOI 10.1023/A:1020926809508; LINDROTH RL, 1986, OECOLOGIA, V70, P13, DOI 10.1007/BF00377106; LINDROTH RL, 1987, BIOCHEM SYST ECOL, V15, P681, DOI 10.1016/0305-1978(87)90046-9; LINDROTH RL, 1987, BIOCHEM SYST ECOL, V15, P677, DOI 10.1016/0305-1978(87)90045-7; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Morse AM, 2007, PHYTOCHEMISTRY, V68, P2043, DOI 10.1016/j.phytochem.2007.05.014; Orians CM, 2000, BIOCHEM SYST ECOL, V28, P619, DOI 10.1016/S0305-1978(99)00101-5; Orians CM, 1997, ENTOMOL EXP APPL, V83, P285, DOI 10.1046/j.1570-7458.1997.00183.x; ORIANS CM, 1995, J CHEM ECOL, V21, P1245, DOI 10.1007/BF02027559; PALO RT, 1984, J CHEM ECOL, V10, P499, DOI 10.1007/BF00988096; Paunonen R, 2009, IND CROP PROD, V29, P261, DOI 10.1016/j.indcrop.2008.05.009; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RANK NE, 1994, OECOLOGIA, V97, P342, DOI 10.1007/BF00317324; Rehill B, 2005, BIOCHEM SYST ECOL, V33, P125, DOI 10.1016/j.bse.2004.06.004; REICHARDT PB, 1990, J CHEM ECOL, V16, P1941, DOI 10.1007/BF01020507; REICHARDT PB, 1992, J NAT PROD, V55, P970, DOI 10.1021/np50085a022; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Robinson KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037679; Ruuhola T, 2003, J CHEM ECOL, V29, P1083, DOI 10.1023/A:1023821304656; Ruuhola T, 2003, J CHEM ECOL, V29, P1565, DOI 10.1023/A:1024266612585; *SAS I, 2003, SAS VERS 9 1; Shelton AL, 2004, EVOL ECOL RES, V6, P709; Shelton AL, 2000, EVOL ECOL RES, V2, P231; Sterky F, 1998, P NATL ACAD SCI USA, V95, P13330, DOI 10.1073/pnas.95.22.13330; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Tegelberg R, 2001, PHYSIOL PLANTARUM, V113, P541, DOI 10.1034/j.1399-3054.2001.1130413.x; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Umetrics, 2012, SIMCA P V 12 0; Wooley S. C., 2008, RANGELANDS, V30, P17	55	29	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e107189	10.1371/journal.pone.0107189	http://dx.doi.org/10.1371/journal.pone.0107189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299342	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200005
J	Olsen, E; Fluharty, D; Hoel, AH; Hostens, K; Maes, F; Pecceu, E				Olsen, Erik; Fluharty, David; Hoel, Alf Hakon; Hostens, Kristian; Maes, Frank; Pecceu, Ellen			Integration at the Round Table: Marine Spatial Planning in Multi-Stakeholder Settings	PLOS ONE			English	Article							MANAGEMENT; POLICY; OCEAN; RESOURCES; SEA	Marine spatial planning (MSP) is often considered as a pragmatic approach to implement an ecosystem based management in order to manage marine space in a sustainable way. This requires the involvement of multiple actors and stakeholders at various governmental and societal levels. Several factors affect how well the integrated management of marine waters will be achieved, such as different governance settings (division of power between central and local governments), economic activities (and related priorities), external drivers, spatial scales, incentives and objectives, varying approaches to legislation and political will. We compared MSP in Belgium, Norway and the US to illustrate how the integration of stakeholders and governmental levels differs among these countries along the factors mentioned above. Horizontal integration (between sectors) is successful in all three countries, achieved through the use of neutral 'round-table' meeting places for all actors. Vertical integration between government levels varies, with Belgium and Norway having achieved full integration while the US lacks integration of the legislature due to sharp disagreements among stakeholders and unsuccessful partisan leadership. Success factors include political will and leadership, process transparency and stakeholder participation, and should be considered in all MSP development processes.	[Olsen, Erik] Inst Marine Res, N-5024 Bergen, Norway; [Fluharty, David] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Hoel, Alf Hakon] Inst Marine Res, Tromso, Norway; [Hostens, Kristian; Pecceu, Ellen] ILVO Inst Agr & Fisheries Res, Oostende, Belgium; [Maes, Frank] Univ Ghent, Maritime Inst, B-9000 Ghent, Belgium	Institute of Marine Research - Norway; University of Washington; University of Washington Seattle; Institute of Marine Research - Norway; Institute For Agricultural & Fisheries Research; Ghent University	Olsen, E (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	eriko@imr.no		Olsen, Erik/0000-0002-7552-2335	EU FP-7 research project "Monitoring and evaluation of spatially managed areas (MESMA)''; Institute of Marine Research; University of Washington; Ghent University; Institute for Agricultural and Fisheries Research (ILVO)	EU FP-7 research project "Monitoring and evaluation of spatially managed areas (MESMA)''; Institute of Marine Research; University of Washington(University of Washington); Ghent University(Ghent University); Institute for Agricultural and Fisheries Research (ILVO)	The project was jointly funded by the EU FP-7 research project "Monitoring and evaluation of spatially managed areas (MESMA)'' www.mesma.org, and by internal funding from the authors institutions: the Institute of Marine Research, University of Washington, Ghent University and the Institute for Agricultural and Fisheries Research (ILVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, HELHETLIG FORVALTNIN; [Anonymous], 2013, IMPLEMENTATION; [Anonymous], 2009, IOC MARINE SPATIAL P; [Anonymous], 2001, SEM ERKLAERINGEN SEM; Barange M, 2003, FRONT ECOL ENVIRON, V1, P190, DOI 10.2307/3868063; Bogaert D, 2008, WHOI RULES COAST, P59; Browman HI, 2004, MAR ECOL PROG SER, V274, P269, DOI 10.3354/meps274269; Collie JS, 2013, ESTUAR COAST SHELF S, V117, P1, DOI 10.1016/j.ecss.2012.11.010; Day V, 2008, MAR POLICY, V32, P535, DOI 10.1016/j.marpol.2007.10.009; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Environmental Law Institute, 2009, MAR SPAT PLANN US WA; Glazier E, 2011, ECOSYSTEM-BASED FISHERIES MANAGEMENT IN THE WESTERN PACIFIC, P1, DOI 10.1002/9780470959480; Hoel AH, 2012, AMBIO, V41, P85, DOI 10.1007/s13280-011-0229-2; Katsanevakis S, 2011, OCEAN COAST MANAGE, V54, P807, DOI 10.1016/j.ocecoaman.2011.09.002; Kenchington R, 2011, J COAST CONSERV, V15, P271, DOI 10.1007/s11852-011-0147-2; Link JS, 2014, ICES J MAR SCI, V71, P1170, DOI 10.1093/icesjms/fsu026; Lubchenco J, 2010, SCIENCE, V328, P1485, DOI 10.1126/science.1190041; Maes F., 2013, COMPENDIUM COAST SEA, P261; Misund OA, 2013, ICES J MAR SCI, V70, P722, DOI 10.1093/icesjms/fst086; National Ocean Council, 2013, MAR PLANN HDB; Ogden JC, 2010, REV BIOL TROP, V58, P71; Olsen E, 2007, ICES J MAR SCI, V64, P599, DOI 10.1093/icesjms/fsm005; Ottersen G, 2011, MAR POLICY, V35, P389, DOI 10.1016/j.marpol.2010.10.017; Pecceu E, 2013, EVOLUTION MARINE PRO; Portman ME, 2011, ICES J MAR SCI, V68, P2191, DOI 10.1093/icesjms/fsr157; Qiu WF, 2013, MAR POLICY, V39, P182, DOI 10.1016/j.marpol.2012.10.010; Sievanen L, 2011, CONSERV LETT, V4, P298, DOI 10.1111/j.1755-263X.2011.00178.x; United Nations, 2002, REP WORLD SUMM SUST	28	71	71	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109964	10.1371/journal.pone.0109964	http://dx.doi.org/10.1371/journal.pone.0109964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299595	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200087
J	Zabrady, M; Hrdinova, V; Muller, B; Conrad, U; Hejatko, J; Janda, L				Zabrady, Matej; Hrdinova, Vendula; Mueller, Bruno; Conrad, Udo; Hejatko, Jan; Janda, Lubomir			Targeted In Vivo Inhibition of Specific Protein-Protein Interactions Using Recombinant Antibodies	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; SINGLE-CHAIN ANTIBODIES; KINASE CKI1; IMMUNOMODULATION; EXPRESSION; CYTOKININ; SELECTION; DOMAIN; TRANSFORMATION; INTRABODIES	With the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated "silencing" represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for selecting recombinant antibodies with a specific purpose in mind, which is to inhibit intrinsic protein-protein interactions in the cytosol of plant cells. Experimental procedures were designed for conveniently evaluating desired properties of recombinant antibodies in consecutive steps. Our selection method was successfully used to develop a recombinant antibody inhibiting the interaction of ARABIDOPSIS HISTIDINE PHOSPHO-TRANSFER PROTEIN 3 with such of its upstream interaction partners as the receiver domain of CYTOKININ INDEPENDENT HISTIDINE KINASE 1. The specific down-regulation of the cytokinin signaling pathway in vivo demonstrates the validity of our approach. This selection method can serve as a prototype for developing unique recombinant antibodies able to interfere with virtually any biomolecule in the living cell.	[Zabrady, Matej; Hrdinova, Vendula; Hejatko, Jan; Janda, Lubomir] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Mueller, Bruno] Univ Zurich, Inst Plant Biol, Zurich, Switzerland; [Mueller, Bruno] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Mol Genet, Gatersleben, Germany	Masaryk University Brno; University of Zurich; University of Zurich; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Janda, L (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	ljanda@sci.muni.cz	Hejatko, Jan/H-4296-2014; Janda, Lubomir/D-8048-2012; Mueller, Bruno/E-9888-2017; Hejatko, Jan/AAN-1182-2021; Zábrady, Matej/E-3042-2012	Hejatko, Jan/0000-0002-2622-6046; Mueller, Bruno/0000-0003-2664-7219; Zábrady, Matej/0000-0002-1356-3270	Czech Science Foundation [521/09/1699, P305/11/0756, 13-25280S]; 7th Framework Programme of the EC (BioNMR) [261863]; European Social Fund [CZ.1.07/2.3.00/20.0189]; European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Swiss National Science Foundation [31003A_125118]	Czech Science Foundation(Grant Agency of the Czech Republic); 7th Framework Programme of the EC (BioNMR); European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by grants from the Czech Science Foundation (Grants 521/09/1699; P305/11/0756 and 13-25280S), from the 7th Framework Programme of the EC (BioNMR, no 261863) and from European Social Fund (CZ.1.07/2.3.00/20.0189). This work was also supported by the project "CEITEC - Central European Institute of Technology" (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund and by a grant from the Swiss National Science Foundation (31003A_125118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist KC, 2004, PLANT BIOTECHNOL J, V2, P189, DOI 10.1111/j.1467-7652.2004.00060.x; Alvarez RD, 2000, CLIN CANCER RES, V6, P3081; BIOCCA S, 1990, EMBO J, V9, P101, DOI 10.1002/j.1460-2075.1990.tb08085.x; Boonrod KJ, 2004, NAT BIOTECHNOL, V22, P856, DOI 10.1038/nbt983; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; da Silva FA, 2004, J MOL BIOL, V340, P525, DOI 10.1016/j.jmb.2004.04.062; David KM, 2007, PLANT J, V50, P197, DOI 10.1111/j.1365-313X.2007.03038.x; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Deng Y, 2010, PLANT CELL, V22, P1232, DOI 10.1105/tpc.108.065128; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gahrtz Manfred, 2009, V483, P289, DOI 10.1007/978-1-59745-407-0_17; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gronwall C, 2009, J BIOTECHNOL, V140, P254, DOI 10.1016/j.jbiotec.2009.01.014; Harwood C.R., 1990, MOL BIOL METHODS BAC; Horak J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-77; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; James P, 1996, GENETICS, V144, P1425; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; Kontermann R, 2010, ANTIBODY ENG, V2; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Malembic-Maher S, 2005, PLANT SCI, V168, P349, DOI 10.1016/j.plantsci.2004.08.008; MARASCO WA, 1993, P NATL ACAD SCI USA, V90, P7889, DOI 10.1073/pnas.90.16.7889; Miroshnichenko S, 2005, PLANT J, V41, P269, DOI 10.1111/j.1365-313X.2004.02290.x; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Muyldermans S, 2001, J Biotechnol, V74, P277; OWEN M, 1992, BIO-TECHNOL, V10, P790, DOI 10.1038/nbt0792-790; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Pekarova B, 2011, PLANT J, V67, P827, DOI 10.1111/j.1365-313X.2011.04637.x; Portner-Taliana A, 2000, J IMMUNOL METHODS, V238, P161, DOI 10.1016/S0022-1759(00)00145-9; Radchuk R, 2010, PLANT J, V64, P715, DOI 10.1111/j.1365-313X.2010.04376.x; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Santos MO, 2004, MOL BREEDING, V13, P333, DOI 10.1023/B:MOLB.0000034088.64105.13; Schouten A, 2002, J BIOL CHEM, V277, P19339, DOI 10.1074/jbc.M201245200; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; ten Hoopen P, 2007, J EXP BOT, V58, P2525, DOI 10.1093/jxb/erm122; Tromas A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3496; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Urakami E, 2008, PLANTA, V228, P863, DOI 10.1007/s00425-008-0788-z; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Visintin M, 2002, J MOL BIOL, V317, P73, DOI 10.1006/jmbi.2002.5392; Yajima W, 2010, NEW BIOTECHNOL, V27, P816, DOI 10.1016/j.nbt.2010.09.010; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	46	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109875	10.1371/journal.pone.0109875	http://dx.doi.org/10.1371/journal.pone.0109875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299686	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000343941200081
J	Eriksson, PO; Aaltonen, E; Petoral, R; Lauritzson, P; Miyazaki, H; Pietras, K; Mansson, S; Hansson, L; Leander, P; Axelsson, O				Eriksson, Per-Olof; Aaltonen, Emil; Petoral, Rodrigo, Jr.; Lauritzson, Petter; Miyazaki, Hideki; Pietras, Kristian; Mansson, Sven; Hansson, Lennart; Leander, Peter; Axelsson, Oskar			Novel Nano-Sized MR Contrast Agent Mediates Strong Tumor Contrast Enhancement in an Oncogene-Driven Breast Cancer Model	PLOS ONE			English	Article							PERMEABILITY; MNDPDP	The current study was carried out to test the potential of a new nanomaterial (Spago Pix) as a macromolecular magnetic MR contrast agent for tumor detection and to verify the presence of nanomaterial in tumor tissue. Spago Pix, synthesized by Spago Nanomedical AB, is a nanomaterial with a globular shape, an average hydrodynamic diameter of 5 nm, and a relaxivity (r(1)) of approximately 30 (mM Mn)(-1) s(-1) (60 MHz). The material consists of an organophosphosilane hydrogel with strongly chelated manganese (II) ions and a covalently attached PEG surface layer. In vivo MRI of the MMTV-PyMT breast cancer model was performed on a 3 T clinical scanner. Tissues were thereafter analyzed for manganese and silicon content using inductively coupled plasma-atomic emission spectroscopy (ICP-AES). The presence of nanomaterial in tumor and muscle tissue was assessed using an anti-PEG monoclonal antibody. MR imaging of tumor-bearing mice (n = 7) showed a contrast enhancement factor of 1.8 (tumor versus muscle) at 30 minutes post-administration. Contrast was retained and further increased 2-4 hours after administration. ICP-AES and immunohistochemistry confirmed selective accumulation of nanomaterial in tumor tissue. A blood pharmacokinetics analysis showed that the concentration of Spago Pix gradually decreased over the first hour, which was in good agreement with the time frame in which the accumulation in tumor occurred. In summary, we demonstrate that Spago Pix selectively enhances MR tumor contrast in a clinically relevant animal model. Based on the generally higher vascular leakiness in malignant compared to benign tissue lesions, Spago Pix has the potential to significantly improve cancer diagnosis and characterization by MRI.	[Eriksson, Per-Olof; Aaltonen, Emil; Petoral, Rodrigo, Jr.; Lauritzson, Petter; Hansson, Lennart; Axelsson, Oskar] Spago Nanomed, Lund, Sweden; [Miyazaki, Hideki; Pietras, Kristian] Lund Univ, Dept Lab Med Lund, Div Translat Canc Res, Lund, Sweden; [Mansson, Sven] Lund Univ, Skane Univ Hosp, Dept Med Radiat Phys, Malmo, Sweden; [Leander, Peter] Lund Univ, Skane Univ Hosp, Dept Radiol, Malmo, Sweden; [Pietras, Kristian] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Karolinska Institutet	Aaltonen, E (corresponding author), Spago Nanomed, Lund, Sweden.	emil.aaltonen@spagoimaging.se	Pietras, Kristian/ABG-2097-2021; Pietras, Kristian/ABE-8727-2020; Månsson, Sven/AFU-0486-2022; Månsson, Sven/F-7277-2011	Pietras, Kristian/0000-0001-6738-4705; Månsson, Sven/0000-0002-5706-5142; Månsson, Sven/0000-0002-5706-5142	Vinnova [2011-03146]; Spago Nanomedical AB	Vinnova(Vinnova); Spago Nanomedical AB	The study was funded by a grant to Spago Imaging AB and OA from Vinnova (2011-03146; http://www.vinnova.se/en/). Per-Olof Eriksson, Emil Aaltonen, Rodrigo Petoral Jr., Petter Lauritzson, Lennart Hansson, and Oskar Axelsson are employees at Spago Nanomedical AB. Sven Mansson was financially compensated by Spago Nanomedical AB for operating the MRI instrument, but not for his expertise as an independent scientist in evaluation of the results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson O, 2013, NOVEL MANGANESE COMP; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Beauregard DA, 2001, CANCER RES, V61, P6811; Bumb A, 2010, ACTA RADIOL, V51, P751, DOI 10.3109/02841851.2010.491091; Chabanova E, 2011, OPEN DRUG SAFETY J, V2, P29; Chen JH, 2011, RADIOLOGY, V261, P735, DOI 10.1148/radiol.11110814; Daldrup H, 1998, AM J ROENTGENOL, V171, P941, DOI 10.2214/ajr.171.4.9762973; Daldrup-Link HE, 2000, ACAD RADIOL, V7, P934, DOI 10.1016/S1076-6332(00)80175-0; Daldrup-Link HE, 2003, RADIOLOGY, V229, P885, DOI 10.1148/radiol.2293021045; ELIZONDO G, 1991, RADIOLOGY, V178, P73, DOI 10.1148/radiology.178.1.1898538; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Federle MP, 2000, J MAGN RESON IMAGING, V12, P186, DOI 10.1002/1522-2586(200007)12:1<186::AID-JMRI21>3.0.CO;2-2; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Heijnen LA, 2014, EUR RADIOL, V24, P371, DOI 10.1007/s00330-013-3016-6; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Kueny-Stotz M, 2012, EUR J INORG CHEM, P1987, DOI 10.1002/ejic.201101163; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Padhani AR, 2002, J MAGN RESON IMAGING, V16, P407, DOI 10.1002/jmri.10176; Pan DPJ, 2011, TETRAHEDRON, V67, P8431, DOI 10.1016/j.tet.2011.07.076; Rippe B, 2004, PERITON DIALYSIS INT, V24, P10; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Turetschek K, 2003, EUR J NUCL MED MOL I, V30, P448, DOI 10.1007/s00259-002-1000-5; Turetschek K, 2001, J MAGN RESON IMAGING, V14, P237, DOI 10.1002/jmri.1179	26	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e107762	10.1371/journal.pone.0107762	http://dx.doi.org/10.1371/journal.pone.0107762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296030	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000009
J	Bahrami, AJ; Gunaje, JJ; Hayes, BJ; Riehle, KJ; Kenerson, HL; Yeung, RS; Stempien-Otero, AS; Campbell, JS; Mahoney, WM				Bahrami, Arya J.; Gunaje, Jagadambika J.; Hayes, Brian J.; Riehle, Kimberly J.; Kenerson, Heidi L.; Yeung, Raymond S.; Stempien-Otero, April S.; Campbell, Jean S.; Mahoney, William M., Jr.			Regulator of G-Protein Signaling-5 Is a Marker of Hepatic Stellate Cells and Expression Mediates Response to Liver Injury	PLOS ONE			English	Article							COLLAGEN GENE-EXPRESSION; BLOOD-PRESSURE; CARBON-TETRACHLORIDE; CIRRHOTIC LIVER; PORTAL PRESSURE; ANIMAL-MODELS; ENDOTHELIN; RGS5; RAT; PROLIFERATION	Liver fibrosis is mediated by hepatic stellate cells (HSCs), which respond to a variety of cytokine and growth factors to moderate the response to injury and create extracellular matrix at the site of injury. G-protein coupled receptor (GPCR)mediated signaling, via endothelin-1 (ET-1) and angiotensin II (AngII), increases HSC contraction, migration and fibrogenesis. Regulator of G-protein signaling-5 (RGS5), an inhibitor of vasoactive GPCR agonists, functions to control GPCR-mediated contraction and hypertrophy in pericytes and smooth muscle cells (SMCs). Therefore we hypothesized that RGS5 controls GPCR signaling in activated HSCs in the context of liver injury. In this study, we localize RGS5 to the HSCs and demonstrate that Rgs5 expression is regulated during carbon tetrachloride (CCl4)-induced acute and chronic liver injury in Rgs5(LacZ/LacZ) reporter mice. Furthermore, CCl4 treated RGS5-null mice develop increased hepatocyte damage and fibrosis in response to CCl4 and have increased expression of markers of HSC activation. Knockdown of Rgs5 enhances ET-1-mediated signaling in HSCs in vitro. Taken together, we demonstrate that RGS5 is a critical regulator of GPCR signaling in HSCs and regulates HSC activation and fibrogenesis in liver injury.	[Bahrami, Arya J.; Gunaje, Jagadambika J.; Hayes, Brian J.; Kenerson, Heidi L.; Yeung, Raymond S.; Stempien-Otero, April S.; Campbell, Jean S.; Mahoney, William M., Jr.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Riehle, Kimberly J.; Kenerson, Heidi L.; Yeung, Raymond S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Stempien-Otero, April S.] Univ Washington, Dept Cardiol, Seattle, WA 98195 USA; [Stempien-Otero, April S.; Mahoney, William M., Jr.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Stempien-Otero, April S.; Mahoney, William M., Jr.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mahoney, WM (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	wmahoney@uw.edu	Mahoney, William/GQB-0802-2022	Hayes, Brian J/0000-0002-0930-0160; Campbell, Jean/0000-0002-9187-2204	Heart, Blood and Lung Institute of the National Institutes of Health (NIH) [HL087513, HL094374]; University of Washington, Department of Pathology start-up funds; NIH [T32HL007312]; University of Washington-Howard Hughes Medical Institute program in Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312, R00HL087513, K99HL087513, P01HL094374] Funding Source: NIH RePORTER	Heart, Blood and Lung Institute of the National Institutes of Health (NIH); University of Washington, Department of Pathology start-up funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington-Howard Hughes Medical Institute program in Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the Heart, Blood and Lung Institute of the National Institutes of Health (NIH), under award HL087513 and HL094374 and University of Washington, Department of Pathology start-up funds (WMM). In addition, AJB and BJH were supported by NIH T32HL007312 and the University of Washington-Howard Hughes Medical Institute program in Molecular Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Anger T, 2007, J BIOCHEM MOL BIOL, V40, P899; Ankoma-Sey V, 2000, HEPATOLOGY, V31, P141, DOI 10.1002/hep.510310122; Anselmi K, 2002, J GASTROEN HEPATOL, V17, P589, DOI 10.1046/j.1440-1746.2002.02705.x; Bahde R, 2011, LIVER INT, V31, P642, DOI 10.1111/j.1478-3231.2011.02493.x; Baratta JL, 2009, HISTOCHEM CELL BIOL, V131, P713, DOI 10.1007/s00418-009-0577-1; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; BERGASA NV, 1992, LIVER, V12, P168; Bilger A, 2004, GENETICS, V167, P859, DOI 10.1534/genetics.103.024521; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Boss CN, 2007, CLIN CANCER RES, V13, P3347, DOI 10.1158/1078-0432.CCR-06-2156; Boyd R, 2011, AM J PHYSIOL-HEART C, V301, pH2271, DOI 10.1152/ajpheart.00869.2010; Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989; Breitkopf K, 2005, CYTOKINE, V31, P349, DOI 10.1016/j.cyto.2005.06.005; Cavasin MA, 2010, CAN J PHYSIOL PHARM, V88, P636, DOI 10.1139/Y10-038; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chen X, 2004, MODERN PATHOL, V17, P1198, DOI 10.1038/modpathol.3800167; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Cho JJ, 2000, GASTROENTEROLOGY, V118, P1169, DOI 10.1016/S0016-5085(00)70370-2; Deng W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030256; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Faouzi S, 1999, LAB INVEST, V79, P485; Faruque MU, 2011, J HYPERTENS, V29, P1906, DOI 10.1097/HJH.0b013e32834b000d; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gandhi CR, 2000, EUR J PHARMACOL, V406, P311, DOI 10.1016/S0014-2999(00)00683-X; Gunaje JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC478, DOI 10.1152/ajpcell.00348.2010; Han SS, 2014, ONCOL REP, V31, P641, DOI 10.3892/or.2013.2872; Hellerbrand C, 2013, PFLUG ARCH EUR J PHY, V465, P775, DOI 10.1007/s00424-012-1209-5; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Heron Melonie, 2011, Natl Vital Stat Rep, V59, P1; Holobotovskyy V, 2013, CIRC RES, V112, P781, DOI 10.1161/CIRCRESAHA.111.300142; HSU CT, 1992, J AUTONOM NERV SYST, V37, P163, DOI 10.1016/0165-1838(92)90038-I; Hu MH, 2013, J SURG ONCOL, V108, P192, DOI 10.1002/jso.23367; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hurst JH, 2009, CELL MOL BIOL LETT, V14, P153, DOI 10.2478/s11658-008-0040-7; Iankova I, 2008, ENDOCRINOLOGY, V149, P5706, DOI 10.1210/en.2008-0717; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; Khimji A, 2011, PHARMACOL RES, V63, P512, DOI 10.1016/j.phrs.2011.03.005; Kitamura K, 2007, J GASTROEN HEPATOL, V22, P2022, DOI 10.1111/j.1440-1746.2006.04735.x; Koda Masahiko, 2006, Comp Hepatol, V5, P5, DOI 10.1186/1476-5926-5-5; Lavelle A, 2009, EUR RESPIR J, V34, P770, DOI 10.1183/09031936.00058409; Lepreux S, 2004, J HEPATOL, V40, P774, DOI 10.1016/j.jhep.2004.01.008; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Li J, 2004, J VASC SURG, V40, P519, DOI 10.1016/j.jvs.2004.06.021; Li MK, 2004, SEMIN LIVER DIS, V24, P21; Li TS, 2012, OTHER TITL APPL MATH, V126, P1; Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012; Mallat A, 1998, J BIOL CHEM, V273, P27300, DOI 10.1074/jbc.273.42.27300; Maschmeyer P, 2011, JOVE-J VIS EXP, DOI 10.3791/2710; May D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021478; Mitchell TS, 2008, ANGIOGENESIS, V11, P141, DOI 10.1007/s10456-007-9085-x; Ning HX, 2011, BIOCHEM BIOPH RES CO, V413, P353, DOI 10.1016/j.bbrc.2011.08.104; Nisancioglu MH, 2008, MOL CELL BIOL, V28, P2324, DOI 10.1128/MCB.01252-07; Oben JA, 2003, BIOCHEM BIOPH RES CO, V308, P284, DOI 10.1016/S0006-291X(03)01360-3; Oben JA, 2003, BIOCHEM BIOPH RES CO, V302, P685, DOI 10.1016/S0006-291X(03)00232-8; Oben JA, 2003, BIOCHEM BIOPH RES CO, V300, P172, DOI 10.1016/S0006-291X(02)02773-0; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Pinzani M, 1996, GASTROENTEROLOGY, V110, P534, DOI 10.1053/gast.1996.v110.pm8566602; Puche JE, 2013, HEPATOLOGY, V57, P340, DOI 10.1002/hep.26053; Reichenbach V, 2012, J HEPATOL, V57, P967, DOI 10.1016/j.jhep.2012.07.012; Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222; Rockey DC, 1996, J CLIN INVEST, V98, P1381, DOI 10.1172/JCI118925; Rockey DC, 1996, HEPATOLOGY, V24, P233; Sato M, 2003, CELL STRUCT FUNCT, V28, P105; SEGER R, 1994, J BIOL CHEM, V269, P25699; Shafiei MS, 2012, LAB INVEST, V92, P305, DOI 10.1038/labinvest.2011.155; Sokolov E, 2011, CELL SIGNAL, V23, P1603, DOI 10.1016/j.cellsig.2011.05.012; Starkel P, 2011, BEST PRACT RES CL GA, V25, P319, DOI 10.1016/j.bpg.2011.02.004; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Vinay K, 2005, ROBBINS COTRAN PATHO, P166; Wang X, 2008, J MOL CELL CARDIOL, V44, P539, DOI 10.1016/j.yjmcc.2007.11.019; Watanabe N, 2007, J GASTROENTEROL, V42, P775, DOI 10.1007/s00535-007-2093-1; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhou J, 2001, LIFE SCI, V68, P1457, DOI 10.1016/S0024-3205(01)00939-0; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	86	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108505	10.1371/journal.pone.0108505	http://dx.doi.org/10.1371/journal.pone.0108505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290689	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000018
J	Liu, YQ; He, Y; Li, TJ; Xie, L; Wang, J; Qin, X; Li, S				Liu, Yanqiong; He, Yu; Li, Taijie; Xie, Li; Wang, Jian; Qin, Xue; Li, Shan			Risk of Primary Liver Cancer Associated with Gallstones and Cholecystectomy: A Meta-Analysis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; CHOLANGIOCARCINOMA; HETEROGENEITY; POPULATION; METABOLISM; DISEASE; BIAS	Background: Recent epidemiological evidence points to an association between gallstones or cholecystectomy and the incidence risk of liver cancer, but the results are inconsistent. We present a meta-analysis of observational studies to explore this association. Methods: We identified studies by a literature search of PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and relevant conference proceedings up to March 2014. A random-effects model was used to generate pooled multivariable adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Between-study heterogeneity was assessed using Cochran's Q statistic and the I-2. Results: Fifteen studies (five case-control and 10 cohort studies) were included in this analysis. There were 4,487,662 subjects in total, 17,945 diagnoses of liver cancer, 328,420 exposed to gallstones, and 884,507 exposed to cholecystectomy. Pooled results indicated a significant increased risk of liver cancer in patients with a history of gallstones (OR = 2.54; 95% CI, 1.71-3.79; n = 11 studies), as well as cholecystectomy (OR = 1.62; 95% CI, 1.29-2.02; n = 12 studies), but there was considerable heterogeneity among these studies. The effects estimates did not vary markedly when stratified by gender, study design, study region, and study quality. The multivariate meta-regression analysis suggested that study region and study quality appeared to explain the heterogeneity observed in the cholecystectomy analysis. Conclusions: Our results suggest that individuals with a history of gallstones and cholecystectomy may have an increased risk of liver cancer.	[Liu, Yanqiong; He, Yu; Li, Taijie; Xie, Li; Wang, Jian; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University	Li, S (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China.	lis8858@126.com						Ahmed I, 2009, SURGERY, V27, P30, DOI DOI 10.1016/J.MPSUR.2008.12.005; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; BERR F, 1992, J CLIN INVEST, V90, P859, DOI 10.1172/JCI115961; Chang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069981; Chen Y, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/419375; Chiong C, 2012, WORLD J SURG, V36, P2202, DOI 10.1007/s00268-012-1646-5; Chiong C, 2012, SCAND J GASTROENTERO, V47, P553, DOI 10.3109/00365521.2012.660538; Chow WH, 1999, BRIT J CANCER, V79, P640, DOI 10.1038/sj.bjc.6690101; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; CHUNG SCS, 1990, BRIT J SURG, V77, P534, DOI 10.1002/bjs.1800770521; Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EKBOM A, 1993, LANCET, V342, P1262, DOI 10.1016/0140-6736(93)92359-2; Ferlay J., 2013, GLOBOCAN 2012 V1 0; Ge ZM, 2012, SAUDI MED J, V33, P1073; GIOVANNUCCI E, 1993, GASTROENTEROLOGY, V105, P130, DOI 10.1016/0016-5085(93)90018-8; Goldacre MJ, 2005, BRIT J CANCER, V92, P1307, DOI 10.1038/sj.bjc.6602392; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Ha NB, 2012, CANCER CAUSE CONTROL, V23, P455, DOI 10.1007/s10552-012-9895-z; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jaunoo SS, 2010, INT J SURG, V8, P15, DOI 10.1016/j.ijsu.2009.10.008; Johansen C, 1996, GUT, V39, P439, DOI 10.1136/gut.39.3.439; Kao WY, 2013, J GASTROINTEST SURG, V17, P345, DOI 10.1007/s11605-012-2090-4; Lagergren J, 2011, BRIT J CANCER, V105, P154, DOI 10.1038/bjc.2011.181; Lin GL, 2012, CANCER CAUSE CONTROL, V23, P59, DOI 10.1007/s10552-011-9856-y; MALAGELADA JR, 1973, AM J DIG DIS, V18, P455, DOI 10.1007/BF01076595; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nogueira L, 2014, AM J EPIDEMIOL, V179, P731, DOI 10.1093/aje/kwt322; Nogueira L, 2013, CANCER RES, V73, DOI 10.1158/1538-7445.AM2013-4804; Nordenstedt H, 2012, BRIT J CANCER, V106, P1011, DOI 10.1038/bjc.2011.607; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; POMARE EW, 1973, GUT, V14, P885, DOI 10.1136/gut.14.11.885; POMARE EW, 1973, GUT, V14, P753, DOI 10.1136/gut.14.10.753; Reid FDA, 1996, SCAND J GASTROENTERO, V31, P160, DOI 10.3109/00365529609031981; Tavani A, 2012, ANN ONCOL, V23, P2173, DOI 10.1093/annonc/mdr581; Vogtmann E, 2014, J EPIDEMIOL COMMUNIT; Wells GA, 2014, NEWCASTLEOTTAWA SCAL; Welzel TM, 2007, INT J CANCER, V120, P638, DOI 10.1002/ijc.22283; Welzel TM, 2007, CLIN GASTROENTEROL H, V5, P1221, DOI 10.1016/j.cgh.2007.05.020; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhao CJ, 2012, EUR J GASTROEN HEPAT, V24, P375, DOI 10.1097/MEG.0b013e328350f86b	47	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109733	10.1371/journal.pone.0109733	http://dx.doi.org/10.1371/journal.pone.0109733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290940	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000084
J	McHarg, S; Hopkins, G; Lim, L; Garrod, D				McHarg, Selina; Hopkins, Gemma; Lim, Lusiana; Garrod, David			Down-Regulation of Desmosomes in Cultured Cells: The Roles of PKC, Microtubules and Lysosomal/Proteasomal Degradation	PLOS ONE			English	Article							PROTEIN-KINASE-C; MDCK EPITHELIAL-CELLS; PEMPHIGUS-VULGARIS; MONOCLONAL-ANTIBODY; ENDOCYTIC VESICLES; E-CADHERIN; ORGANIZATION; DESMOPLAKIN; CENTROSOME; PROTEASOME	Desmosomes are intercellular adhesive junctions of major importance for tissue integrity. To allow cell motility and migration they are down-regulated in epidermal wound healing. Electron microscopy indicates that whole desmosomes are internalised by cells in tissues, but the mechanism of down-regulation is unclear. In this paper we provide an overview of the internalisation of half-desmosomes by cultured cells induced by calcium chelation. Our results show that: (i) half desmosome internalisation is dependent on conventional PKC isoforms; (ii) microtubules transport internalised half desmosomes to the region of the centrosome by a kinesin-dependent mechanism; (iii) desmosomal proteins remain colocalised after internalisation and are not recycled to the cell surface; (iv) internalised desmosomes are degraded by the combined action of lysosomes and proteasomes. We also confirm that half desmosome internalisation is dependent upon the actin cytoskeleton. These results suggest that half desmosomes are not disassembled and recycled during or after internalisation but instead are transported to the centrosomal region where they are degraded. These findings may have significance for the down-regulation of desmosomes in wounds.	[McHarg, Selina; Hopkins, Gemma; Lim, Lusiana; Garrod, David] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Garrod, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	d.garrod@manchester.ac.uk			Wellcome Trust [08618/Z/08/Z]; Medical Research Council [G0800004]; MRC Research Studentship; Medical Research Council [G9630879] Funding Source: researchfish; MRC [G9630879, G0800004] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Research Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust grant 08618/Z/08/Z, Medical Research Council Grant G0800004 and a MRC Research Studentship to GH. (http://www.wellcome.ac.uk/; http://www.mrc.ac.uk/index.htm) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; ALLEN TD, 1975, J ULTRA MOL STRUCT R, V51, P94, DOI 10.1016/S0022-5320(75)80011-6; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; BROWN CR, 1994, J CELL PHYSIOL, V160, P47, DOI 10.1002/jcp.1041600107; BURDETT IDJ, 1993, J CELL SCI, V106, P1115; Cheeseman KL, 2006, MOL BIOL CELL, V17, P799, DOI 10.1091/mbc.E04-12-1100; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; DEMLEHNER MP, 1995, J CELL BIOL, V131, P745, DOI 10.1083/jcb.131.3.745; Didier C, 2008, MOL BIOL CELL, V19, P1220, DOI 10.1091/mbc.E06-12-1140; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Ehrhardt AG, 2005, J CELL PHYSIOL, V204, P808, DOI 10.1002/jcp.20335; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Gillingham AK, 2000, EMBO REP, V1, P524; GOLTZ JS, 1992, P NATL ACAD SCI USA, V89, P7026, DOI 10.1073/pnas.89.15.7026; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOLM PK, 1993, EUR J CELL BIOL, V62, P362; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; KARTENBECK J, 1982, EMBO J, V1, P725, DOI 10.1002/j.1460-2075.1982.tb01237.x; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Kimura TE, 2012, DEV BIOL, V369, P286, DOI 10.1016/j.ydbio.2012.06.025; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; MATTEY DL, 1986, J CELL SCI, V85, P113; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; OVERTON J, 1962, DEV BIOL, V4, P532, DOI 10.1016/0012-1606(62)90056-8; PARRISH EP, 1990, J CELL SCI, V96, P239; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; PASDAR M, 1991, J CELL BIOL, V113, P645, DOI 10.1083/jcb.113.3.645; PASDAR M, 1992, CELL MOTIL CYTOSKEL, V23, P201, DOI 10.1002/cm.970230304; SCHWARTZ AL, 1992, P NATL ACAD SCI USA, V89, P5542, DOI 10.1073/pnas.89.12.5542; STANLEY JR, 1984, J CLIN INVEST, V74, P313, DOI 10.1172/JCI111426; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Sumigray KD, 2011, J CELL BIOL, V194, P631, DOI 10.1083/jcb.201104009; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Thomason HA, 2012, J PATHOL, V227, P346, DOI 10.1002/path.4016; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; VILELA MJ, 1995, J CELL SCI, V108, P1743; VILELA MJ, 1987, J PATHOL, V153, P365, DOI 10.1002/path.1711530410; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WACKER IU, 1992, J CELL BIOL, V117, P813, DOI 10.1083/jcb.117.4.813; Wallis S, 2000, MOL BIOL CELL, V11, P1077, DOI 10.1091/mbc.11.3.1077; Wan H, 2007, EXP CELL RES, V313, P2336, DOI 10.1016/j.yexcr.2007.01.010; WATT FM, 1984, J CELL BIOL, V99, P2211, DOI 10.1083/jcb.99.6.2211; Wigley WC, 1999, J CELL BIOL, V145, P481; Windoffer R, 2002, J CELL SCI, V115, P1717; Yamada H, 2007, MOL BIOL CELL, V18, P4669, DOI 10.1091/mbc.E07-04-0296; Yang Y, 2011, INT J BIOCHEM CELL B, V43, P1147, DOI 10.1016/j.biocel.2011.04.007; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6	72	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108570	10.1371/journal.pone.0108570	http://dx.doi.org/10.1371/journal.pone.0108570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291180	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000020
J	Sharma, R; Rawat, V; Suresh, CG				Sharma, Ranu; Rawat, Vimal; Suresh, C. G.			Genome-Wide Identification and Tissue-Specific Expression Analysis of UDP-Glycosyltransferases Genes Confirm Their Abundance in Cicer arietinum (Chickpea) Genome	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; BIOCHEMICAL-CHARACTERIZATION; ANTHOCYANIN BIOSYNTHESIS; HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; SEQUENCE; PROTEIN; HOMOLOGY; FAMILY; ACID	UDP-glycosyltransferases (EC 2.4.1.x; UGTs) are enzymes coded by an important gene family of higher plants. They are involved in the modification of secondary metabolites, phytohormones, and xenobiotics by transfer of sugar moieties from an activated nucleotide molecule to a wide range of acceptors. This modification regulates various functions like detoxification of xenobiotics, hormone homeostasis, and biosynthesis of secondary metabolites. Here, we describe the identification of 96 UGT genes in Cicer arietinum (CaUGT) and report their tissue-specific differential expression based on publically available RNA-seq and expressed sequence tag data. This analysis has established medium to high expression of 84 CaUGTs and low expression of 12 CaUGTs. We identified several closely related orthologs of CaUGTs in other genomes and compared their exon-intron arrangement. An attempt was made to assign functional specificity to chickpea UGTs by comparing substrate binding sites with experimentally determined specificity. These findings will assist in precise selection of candidate genes for various applications and understanding functional genomics of chickpea.	[Sharma, Ranu; Suresh, C. G.] CSIR, Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India; [Rawat, Vimal] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Max Planck Society	Suresh, CG (corresponding author), CSIR, Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India.	cg.suresh@ncl.res.in		rawat, vimal/0000-0002-6566-9253	Council of Scientific and Industrial Research (CSIR), India; CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC); International Max Planck Research School (IMPRS) fellowship	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC); International Max Planck Research School (IMPRS) fellowship	Council of Scientific and Industrial Research (CSIR), India, CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC), and International Max Planck Research School (IMPRS) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cao PJ, 2008, MOL PLANT, V1, P858, DOI 10.1093/mp/ssn052; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ford CM, 1998, J BIOL CHEM, V273, P9224, DOI 10.1074/jbc.273.15.9224; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; FURTEK D, 1988, PLANT MOL BIOL, V11, P473, DOI 10.1007/BF00039028; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Griesser M, 2008, J EXP BOT, V59, P2611, DOI 10.1093/jxb/ern117; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; HUGHES J, 1994, DNA SEQUENCE, V5, P41, DOI 10.3109/10425179409039703; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kahlon T. S., 2012, Food and Nutrition Sciences, V3, P401; KROON J, 1994, PLANT J, V5, P69, DOI 10.1046/j.1365-313X.1994.5010069.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Louveau T, 2011, FEBS J, V278, P390, DOI 10.1111/j.1742-4658.2010.07962.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Miller KD, 1999, J BIOL CHEM, V274, P34011, DOI 10.1074/jbc.274.48.34011; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Morita Y, 2005, PLANT J, V42, P353, DOI 10.1111/j.1365-313X.2005.02383.x; Nakatsuka T, 2008, J EXP BOT, V59, P1241, DOI 10.1093/jxb/ern031; Noguchi A, 2007, J BIOL CHEM, V282, P23581, DOI 10.1074/jbc.M702651200; Ogata J, 2005, NATURE, V435, P757, DOI 10.1038/nature435757a; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schro dinger Suite, 2012, SCHROD SUIT 2011 PRO; Schrodinger Suite, 2012, SCHROD SUIT IMP VERS; Schrodinger Suite, 2012, SCHROD SUIT PRIM VER; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092636; Sharma S, 2011, INT FOOD RES J, V20, P805; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Taguchi G, 2001, EUR J BIOCHEM, V268, P4086, DOI 10.1046/j.1432-1327.2001.02325.x; Tanaka Y, 1996, PLANT CELL PHYSIOL, V37, P711, DOI 10.1093/oxfordjournals.pcp.a029004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WISE RP, 1990, PLANT MOL BIOL, V14, P277, DOI 10.1007/BF00018568; Woo HH, 2007, GENOMICS, V90, P143, DOI 10.1016/j.ygeno.2007.03.014; Xu ZJ, 2002, PLANT PHYSIOL, V129, P1285, DOI 10.1104/pp.001784; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x	58	25	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109715	10.1371/journal.pone.0109715	http://dx.doi.org/10.1371/journal.pone.0109715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290312	Green Published, gold			2022-12-27	WOS:000342798000081
J	Siva, S; MacManus, M; Kron, T; Best, N; Smith, J; Lobachevsky, P; Ball, D; Martin, O				Siva, Shankar; MacManus, Michael; Kron, Tomas; Best, Nickala; Smith, Jai; Lobachevsky, Pavel; Ball, David; Martin, Olga			A Pattern of Early Radiation-Induced Inflammatory Cytokine Expression Is Associated with Lung Toxicity in Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							VOLUME HISTOGRAM ANALYSIS; NORMAL TISSUE; RADIOTHERAPY; PNEUMONITIS; PREDICTOR; RISK; MECHANISMS; PARAMETERS; INDUCTION; RESPONSES	Purpose: Lung inflammation leading to pulmonary toxicity after radiotherapy (RT) can occur in patients with non-small cell lung cancer (NSCLC). We investigated the kinetics of RT induced plasma inflammatory cytokines in these patients in order to identify clinical predictors of toxicity. Experimental Design: In 12 NSCLC patients, RT to 60 Gy (30 fractions over 6 weeks) was delivered; 6 received concurrent chemoradiation (chemoRT) and 6 received RT alone. Blood samples were taken before therapy, at 1 and 24 hours after delivery of the 1st fraction, 4 weeks into RT, and 12 weeks after completion of treatment, for analysis of a panel of 22 plasma cytokines. The severity of respiratory toxicities were recorded using common terminology criteria for adverse events (CTCAE) v4.0. Results: Twelve cytokines were detected in response to RT, of which ten demonstrated significant temporal changes in plasma concentration. For Eotaxin, IL-33, IL-6, MDC, MIP-1 alpha and VEGF, plasma concentrations were dependent upon treatment group (chemoRT vs RT alone, all p-values < 0.05), whilst concentrations of MCP-1, IP-10, MCP-3, MIP-1 beta, TIMP-1 and TNF-alpha were not. Mean lung radiation dose correlated with a reduction at 1 hour in plasma levels of IP-10 (r(2) = 0.858, p < 0.01), MCP-1 (r(2) = 0.653, p < 0.01), MCP-3 (r(2) = 0.721, p < 0.01), and IL-6 (r(2) = 0.531, p = 0.02). Patients who sustained pulmonary toxicity demonstrated significantly different levels of IP-10 and MCP-1 at 1 hour, and Eotaxin, IL-6 and TIMP-1 concentration at 24 hours (all p-values,0.05) when compared to patients without respiratory toxicity. Conclusions: Inflammatory cytokines were induced in NSCLC patients during and after RT. Early changes in levels of IP-10, MCP-1, Eotaxin, IL-6 and TIMP-1 were associated with higher grade toxicity. Measurement of cytokine concentrations during RT could help predict lung toxicity and lead to new therapeutic strategies.	[Siva, Shankar; MacManus, Michael; Ball, David; Martin, Olga] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, Melbourne, Vic, Australia; [MacManus, Michael; Kron, Tomas; Lobachevsky, Pavel; Ball, David; Martin, Olga] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Kron, Tomas] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Best, Nickala; Smith, Jai; Lobachevsky, Pavel; Martin, Olga] Peter MacCallum Canc Ctr, Mol Radiat Biol Lab, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Siva, S (corresponding author), Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, Melbourne, Vic, Australia.	Shankar.Siva@petermac.org	Lobachevsky, Pavel/AAG-9157-2021; Kron, Tomas/A-7217-2010	Kron, Tomas/0000-0002-5189-4046; MacManus, Michael/0000-0002-0900-5815; Smith, Jai/0000-0003-4997-6189	National Health and Medical Research Council [APP1038399]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Dr Shankar Siva has received National Health and Medical Research Council scholarship funding for this research, APP1038399. http://www.nhmrc.gov.au/grants/apply-funding/postgraduate-scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anscher MS, 1998, INT J RADIAT ONCOL, V41, P1029, DOI 10.1016/S0360-3016(98)00154-0; Anscher MS, 1997, INT J RADIAT ONCOL, V37, P253, DOI 10.1016/S0360-3016(96)00529-9; ANSCHER MS, 1994, INT J RADIAT ONCOL, V30, P671, DOI 10.1016/0360-3016(92)90954-G; Ao XP, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-6; Arpin D, 2005, J CLIN ONCOL, V23, P8748, DOI 10.1200/JCO.2005.01.7145; Australian Cancer Network Colorectal Cancer Guidelines Revision Committee, 2004, CLIN PRACT GUID PREV; Brush J, 2007, SEMIN RADIAT ONCOL, V17, P121, DOI 10.1016/j.semradonc.2006.11.008; Cappuccini F, 2011, RADIOTHER ONCOL, V101, P86, DOI 10.1016/j.radonc.2011.05.064; Chen YY, 2001, INT J RADIAT ONCOL, V49, P641, DOI 10.1016/S0360-3016(00)01445-0; Chen YY, 2002, SEMIN RADIAT ONCOL, V12, P26, DOI 10.1053/srao.2002.31360; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Crohns M, 2010, CYTOKINE, V50, P30, DOI 10.1016/j.cyto.2009.11.017; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Desai S, 2013, CYTOKINE, V61, P54, DOI 10.1016/j.cyto.2012.08.022; Ding NH, 2013, CURR DRUG TARGETS, V14, P1347; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Fay M, 2005, INT J RADIAT ONCOL, V61, P1355, DOI 10.1016/j.ijrobp.2004.08.025; Feng M, 2009, INT J RADIAT ONCOL, V73, P1228, DOI 10.1016/j.ijrobp.2008.10.054; Fu XL, 2001, INT J RADIAT ONCOL, V50, P899, DOI 10.1016/S0360-3016(01)01524-3; Gallet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029399; Graham MV, 1999, INT J RADIAT ONCOL, V45, P323, DOI 10.1016/S0360-3016(99)00183-2; Guo RF, 2001, J IMMUNOL, V166, P5208, DOI 10.4049/jimmunol.166.8.5208; Johnston CJ, 1998, EXP LUNG RES, V24, P321, DOI 10.3109/01902149809041538; Johnston CJ, 2009, RAD INDUCED PULMONAR; Lilly CM, 1997, J CLIN INVEST, V99, P1767, DOI 10.1172/JCI119341; Malik IA, 2010, AM J PATHOL, V176, P1801, DOI 10.2353/ajpath.2010.090505; Mauguen A, 2012, J CLIN ONCOL, V30, P2788, DOI 10.1200/JCO.2012.41.6677; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Mehta V, 2005, INT J RADIAT ONCOL, V63, P5, DOI 10.1016/j.ijrobp.2005.03.047; Naito Yuji, 2005, Molecular Aspects of Medicine, V26, P379; Neta R, 1997, ENVIRON HEALTH PERSP, V105, P1463, DOI 10.2307/3433652; Palma DA, 2013, INT J RADIAT ONCOL, V85, P444, DOI 10.1016/j.ijrobp.2012.04.043; Provatopoulou X, 2008, ANTICANCER RES, V28, P2421; Rodemann HP, 2007, SEMIN RADIAT ONCOL, V17, P81, DOI 10.1016/j.semradonc.2006.11.005; Rossi DL, 1997, J IMMUNOL, V158, P1033; Rube CE, 2004, STRAHLENTHER ONKOL, V180, P541, DOI 10.1007/s00066-004-1279-1; Rube CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002898; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; TALAS M, 1972, ARCH GES VIRUSFORSCH, V38, P143, DOI 10.1007/BF01249664; Thomson AW, 2003, CYTOKINE HDB; Vujaskovic Z, 2000, SEMIN RADIAT ONCOL, V10, P296, DOI 10.1053/srao.2000.9424; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Zhang M, 2012, CYTOKINE, V58, P169, DOI 10.1016/j.cyto.2011.12.023; Zhao LJ, 2009, INT J RADIAT ONCOL, V74, P1385, DOI 10.1016/j.ijrobp.2008.10.065	46	73	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109560	10.1371/journal.pone.0109560	http://dx.doi.org/10.1371/journal.pone.0109560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289758	Green Published, gold			2022-12-27	WOS:000342798000068
J	Alonso, A; Jensen, PN; Lopez, FL; Chen, LY; Psaty, BM; Folsom, AR; Heckbert, SR				Alonso, Alvaro; Jensen, Paul N.; Lopez, Faye L.; Chen, Lin Y.; Psaty, Bruce M.; Folsom, Aaron R.; Heckbert, Susan R.			Association of Sick Sinus Syndrome with Incident Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities Study and Cardiovascular Health Study	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; ATRIAL-FIBRILLATION; NODE DISEASE; FOLLOW-UP; SURVIVAL; STROKE; ADULTS; DEATH	Background: Sick sinus syndrome (SSS) is a common indication for pacemaker implantation. Limited information exists on the association of sick sinus syndrome (SSS) with mortality and cardiovascular disease (CVD) in the general population. Methods: We studied 19,893 men and women age 45 and older in the Atherosclerosis Risk in Communities (ARIC) study and the Cardiovascular Health Study (CHS), two community-based cohorts, who were without a pacemaker or atrial fibrillation (AF) at baseline. Incident SSS cases were validated by review of medical charts. Incident CVD and mortality were ascertained using standardized protocols. Multivariable Cox models were used to estimate the association of incident SSS with selected outcomes. Results: During a mean follow-up of 17 years, 213 incident SSS events were identified and validated (incidence, 0.6 events per 1,000 person-years). After adjustment for confounders, SSS incidence was associated with increased mortality (hazard ratio [HR] 1.39, 95% confidence interval [CI] 1.14-1.70), coronary heart disease (HR 1.72, 95% CI 1.11-2.66), heart failure (HR 2.87, 95% CI 2.17-3.80), stroke (HR 1.56, 95% CI 0.99-2.46), AF (HR 5.75, 95% CI 4.43-7.46), and pacemaker implantation (HR 53.7, 95% CI 42.9-67.2). After additional adjustment for other incident CVD during follow-up, SSS was no longer associated with increased mortality, coronary heart disease, or stroke, but remained associated with higher risk of heart failure (HR 2.00, 95% CI 1.51-2.66), AF (HR 4.25, 95% CI 3.28-5.51), and pacemaker implantation (HR 25.2, 95% CI 19.8-32.1). Conclusion: Individuals who develop SSS are at increased risk of death and CVD. The mechanisms underlying these associations warrant further investigation.	[Alonso, Alvaro; Lopez, Faye L.; Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Jensen, Paul N.; Heckbert, Susan R.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Cardiovasc Div, Minneapolis, MN 55455 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Alonso, A (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.	alonso@umn.edu	Alonso, Alvaro/A-4917-2010; Norby, Faye/S-3729-2017	Alonso, Alvaro/0000-0002-2225-8323; Chen, Lin/0000-0002-0700-814X; Norby, Faye/0000-0002-1975-0405	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, HL080295, R21 HL109611]; National Institute on Aging (NIA) [AG023629]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085082, N01HC085079, N01HC085081, N01HC085080, N01HC085086, N01HC085083, N01HC055222] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, U01HL080295, R21HL109611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629, R56AG023629] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). This Cardiovascular Health Study research was supported by contracts HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, and grant HL080295 from the NHLBI, with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by AG023629 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org. This study was additionally funded by grant R21 HL109611 from the NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan V, 2003, AM FAM PHYSICIAN, V67, P1725; Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Andersen HR, 1997, LANCET, V350, P1210, DOI 10.1016/S0140-6736(97)03425-9; Bernstein AD, 1996, AM J CARDIOL, V78, P187, DOI 10.1016/S0002-9149(96)90394-X; Connolly SJ, 2000, NEW ENGL J MED, V342, P1385, DOI 10.1056/NEJM200005113421902; D'Ascenzi Flavio, 2010, Clin Cardiol, V33, pE35, DOI 10.1002/clc.20638; Duhme N, 2013, EUR HEART J, V34, P2768, DOI 10.1093/eurheartj/ehs391; Fedorov VV, 2010, CIRCULATION, V122, P782, DOI 10.1161/CIRCULATIONAHA.109.935288; FERRER MI, 1973, CIRCULATION, V47, P635, DOI 10.1161/01.CIR.47.3.635; FERRER MI, 1968, J AMER MED ASSOC, V206, P645, DOI 10.1001/jama.206.3.645; Flaker G, 2003, AM HEART J, V146, P887, DOI 10.1016/S0002-8703(03)00429-0; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jensen PN, 2014, J AM COLL CARDIOL, V64, P531, DOI 10.1016/j.jacc.2014.03.056; Lamas GA, 2002, NEW ENGL J MED, V346, P1854, DOI 10.1056/NEJMoa013040; Lau CP, 2013, CIRCULATION, V128, P687, DOI 10.1161/CIRCULATIONAHA.113.001644; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Nielsen JC, 2011, EUR HEART J, V32, P686, DOI 10.1093/eurheartj/ehr022; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Psaty BM, 1997, CIRCULATION, V96, P2455; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Sanders P, 2004, CIRCULATION, V110, P897, DOI 10.1161/01.CIR.0000139336.69955.AB; Sanders P, 2004, CIRCULATION, V109, P1514, DOI 10.1161/01.CIR.0000121734.47409.AA; Schellenbaum GD, 2006, ANN EPIDEMIOL, V16, P115, DOI 10.1016/j.annepidem.2005.02.012; SHAW DB, 1980, BMJ-BRIT MED J, V280, P139, DOI 10.1136/bmj.280.6208.139; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Sweeney MO, 2007, NEW ENGL J MED, V357, P1000, DOI 10.1056/NEJMoa071880; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; TUNG RT, 1994, AM J CARDIOL, V74, P1016, DOI 10.1016/0002-9149(94)90851-6; Weijs B, 2012, HEART RHYTHM, V9, P1923, DOI 10.1016/j.hrthm.2012.08.013; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	34	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109662	10.1371/journal.pone.0109662	http://dx.doi.org/10.1371/journal.pone.0109662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285853	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700080
J	Bhowmick, R; Pore, D; Chakrabarti, MK				Bhowmick, Rajsekhar; Pore, Debasis; Chakrabarti, Manoj K.			Outer Membrane Protein A (OmpA) of Shigella flexneri 2a Induces TLR2-Mediated Activation of B Cells: Involvement of Protein Tyrosine Kinase, ERK and NF-kappa B	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; INNATE IMMUNITY; INDUCTION; PATHWAYS; COSTIMULATION; RECOGNITION; LYMPHOCYTES; ENGAGEMENT; EXPRESSION; PROTECTION	B cells are critically important in combating bacterial infections and their differentiation into plasma cells and memory cells aids bacterial clearance and long-lasting immunity conferred by essentially all vaccines. Outer membrane protein A (OmpA) of Shigella flexneri 2a has been demonstrated to induce the production of IgG and IgA in vivo following immunization of mice through intranasal route, but the direct involvement of B cells in OmpA-mediated immune regulation was not determined. Consequently, we investigated whether OmpA can modulate B cell functions and identified the molecular events involved in OmpA-induced B cell immune response in vitro. We show that OmpA of S. flexneri 2a activates B cells to produce protective cytokines, IL-6 and IL-10 as well as facilitates their differentiation into antibody secreting cells (ASCs). The immunostimulatory properties of OmpA are attributed to the increased surface expression of MHCII and CD86 on B cells. We also report here that B cell activation by OmpA is mediated strictly through recognition by TLR2, resulting in initiation of cascades of signal transduction events, involving increased phosphorylation of protein tyrosine kinases (PTKs), ERK and I kappa B alpha, leading to nuclear translocation of NF-kappa B. Importantly, a TLR2 antibody diminishes OmpA-induced upregulation of MHCII and CD86 on B cell surface as well as significantly inhibits B cell differentiation and cytokine secretion. Furthermore, we illustrate that B cell differentiation into ASCs and induction of cytokine secretion by OmpA are dependent on PTKs activity. Moreover, we identify that OmpA-induced B cell differentiation is entirely dependent on ERK pathway, whereas both NF-kappa B and ERK are essential for cytokine secretion by B cells. Overall, our data demonstrate that OmpA of S. flexneri 2a amplifies TLR signaling in B cells and triggers B cell immune response, which is critical for the development of an effective adaptive immunity to an optimal vaccine antigen.	[Bhowmick, Rajsekhar; Pore, Debasis; Chakrabarti, Manoj K.] Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chakrabarti, MK (corresponding author), Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, W Bengal, India.	mkc_niced@yahoo.co.in			Indian Council of Medical Research; Council of Scientific and Industrial Research, New Delhi, India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by Indian Council of Medical Research and Council of Scientific and Industrial Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi S, 2003, J ANTIMICROB CHEMOTH, V51, P427, DOI 10.1093/jac/dkg080; Barbeau B, 1997, J BIOL CHEM, V272, P12968, DOI 10.1074/jbc.272.20.12968; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bebbington C, 2008, CURR OPIN BIOTECH, V19, P613, DOI 10.1016/j.copbio.2008.10.002; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Casadevall A, 2006, ADV IMMUNOL, V91, P1, DOI 10.1016/S0065-2776(06)91001-3; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chang A, 2011, HUM VACCINES, V7, P102, DOI 10.4161/hv.7.1.13351; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CONSTANT S, 1995, J IMMUNOL, V155, P3734; DALRYMPLE SA, 1995, INFECT IMMUN, V63, P2262, DOI 10.1128/IAI.63.6.2262-2268.1995; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; GENG Y, 1993, J IMMUNOL, V151, P6692; Gerondakis S, 2007, IMMUNOL CELL BIOL, V85, P471, DOI 10.1038/sj.icb.7100097; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kurosaki T, 2009, IMMUNOL REV, V228, P132, DOI 10.1111/j.1600-065X.2008.00748.x; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; MacLeod H, 2008, CLIN VACCINE IMMUNOL, V15, P630, DOI 10.1128/CVI.00435-07; Marshall-Clarke S, 2003, IMMUNOLOGY, V109, P102, DOI 10.1046/j.1365-2567.2003.01638.x; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mes THM, 2007, J MOL EVOL, V64, P411, DOI 10.1007/s00239-006-0021-2; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; MURAGUCHI A, 1988, J EXP MED, V167, P332, DOI 10.1084/jem.167.2.332; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Pore D, 2013, VACCINE, V31, P3644, DOI 10.1016/j.vaccine.2013.05.100; Pore D, 2012, J BIOL CHEM, V287, P12589, DOI 10.1074/jbc.M111.335554; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Pore D, 2010, MOL IMMUNOL, V47, P1739, DOI 10.1016/j.molimm.2010.03.001; Pore D, 2009, VACCINE, V27, P5855, DOI 10.1016/j.vaccine.2009.07.054; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Torres AG, 2006, INFECT IMMUN, V74, P2676, DOI 10.1128/IAI.74.5.2676-2685.2006; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yasuda T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001592	55	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109107	10.1371/journal.pone.0109107	http://dx.doi.org/10.1371/journal.pone.0109107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286253	Green Submitted, gold, Green Published			2022-12-27	WOS:000345743700045
J	Cheng, HH; Ding, Y; Yu, RJ; Chen, JS; Wu, CY				Cheng, Huanhuan; Ding, Yong; Yu, Rongjie; Chen, Jiansu; Wu, Chunyun			Neuroprotection of a Novel Cyclopeptide C*HSDGIC* from the Cyclization of PACAP (1-5) in Cellular and Rodent Models of Retinal Ganglion Cell Apoptosis	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; INDUCED DIABETIC-RATS; RGC-5 CELLS; NEUROPEPTIDE PACAP; SIGNALING PATHWAYS; LINE RGC-5; DEATH; MITOCHONDRIA; RECEPTORS; EXPRESSION	Purpose: To investigate the protective effects of a novel cyclopeptide C*HSDGIC* (CHC) from the cyclization of Pituitary adenylate cyclase-activating polypeptide (PACAP) (1-5) in cellular and rodent models of retinal ganglion cell apoptosis. Methodology/Principal Findings: Double-labeling immunohistochemistry was used to detect the expression of Thy-1 and PACAP receptor type 1 in a retinal ganglion cell line RGC-5. The apoptosis of RGC-5 cells was induced by 0.02 J/cm(2) Ultraviolet B irradiation. MTT assay, flow cytometry, fluorescence microscopy were used to investigate the viability, the level of reactive oxygen species (ROS) and apoptosis of RGC-5 cells respectively. CHC attenuated apoptotic cell death induced by Ultraviolet B irradiation and inhibited the excessive generation of ROS. Moreover, CHC treatment resulted in decreased expression of Bax and concomitant increase of Bcl-2, as was revealed by western-blot analysis. The in vivo apoptosis of retinal ganglion cells was induced by injecting 50 mM N-methyl-D-aspartate (NMDA) (100 nmol in a 2 mu L saline solution) intravitreally, and different dosages of CHC were administered. At day 7, rats in CHC+ NMDA-treated groups showed obvious aversion to light when compared to NMDA rats. Electroretinogram recordings revealed a marked decrease in the amplitudes of a-wave, b-wave, and photopic negative response due to NMDA damage. In retina receiving intravitreal NMDA and CHC co-treatment, these values were significantly increased. CHC treatment also resulted in less NMDA-induced cell loss and a decrease in the proportion of dUTP end-labeling-positive cells in ganglion cell line. Conclusions: C*HSDGIC*, a novel cyclopeptide from PACAP (1-5) attenuates apoptosis in RGC-5 cells and inhibits NMDA-induced retinal neuronal death. The beneficial effects may occur via the mitochondria pathway. PACAP derivatives like CHC may serve as a promising candidate for neuroprotection in glaucoma.	[Cheng, Huanhuan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Ding, Yong] Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjie] Jinan Univ, Bioengn Inst, Guangzhou, Guangdong, Peoples R China; [Chen, Jiansu] Jinan Univ, Coll Med, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Wu, Chunyun] Jinan Univ, Coll Med, Dept Parasitol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University; Jinan University; Jinan University; Jinan University	Ding, Y (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China.	dingyongjnu@163.com			National Natural Science Foundation of China [31100545]; Science and Technology Bureau of Guangdong Province [2012B010300015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Guangdong Province	This study was supported by National Natural Science Foundation of China (No. 31100545) (http://www.nsfc.gov.cn/nsfc/cen/daima/index.html) and the Science and Technology Bureau of Guangdong Province (2012B010300015) (http://pro.gdstc.gov.cn/stms/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, MOL VIS, V13, P1311; Agarwal N, 2013, INVEST OPHTH VIS SCI, V54, P7884, DOI 10.1167/iovs.13-13292; Atlasz T, 2010, ANN NY ACAD SCI, V1200, P128, DOI 10.1111/j.1749-6632.2010.05512.x; Atlasz T, 2011, J MOL NEUROSCI, V43, P51, DOI 10.1007/s12031-010-9392-3; Atlasz T, 2009, ANN NY ACAD SCI, V1163, P348, DOI 10.1111/j.1749-6632.2008.03650.x; Balaiya S, 2010, CLIN OPHTHALMOL, V4, P33; Bourgault S, 2009, J MED CHEM, V52, P3308, DOI 10.1021/jm900291j; Carini M, 2000, FARMACO, V55, P526, DOI 10.1016/S0014-827X(00)00037-9; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Charles I, 2005, INVEST OPHTH VIS SCI, V46, P1330, DOI 10.1167/iovs.04-0363; Chen HL, 2008, DOC OPHTHALMOL, V117, P129, DOI 10.1007/s10633-008-9114-0; Corcho FJ, 2009, BIOPOLYMERS, V91, P391, DOI 10.1002/bip.21147; David C, 2005, J MOL NEUROSCI, V27, P91, DOI 10.1385/JMN:27:01:91; Delcourt N, 2007, EMBO J, V26, P1542, DOI 10.1038/sj.emboj.7601608; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Ding Y, 2012, PEPTIDES, V36, P280, DOI 10.1016/j.peptides.2012.06.003; Endo K, 2011, J MOL NEUROSCI, V43, P22, DOI 10.1007/s12031-010-9434-x; Giunta S, 2012, PEPTIDES, V37, P32, DOI 10.1016/j.peptides.2012.06.004; Green BD, 2006, PEPTIDES, V27, P1349, DOI 10.1016/j.peptides.2005.11.010; Hironaka K, 2011, EUR J PHARM BIOPHARM, V79, P119, DOI 10.1016/j.ejpb.2011.01.019; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Jung SH, 2010, NEUROCHEM INT, V57, P713, DOI 10.1016/j.neuint.2010.08.005; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kang KD, 2010, NEUROCHEM RES, V35, P1828, DOI 10.1007/s11064-010-0249-5; Kido N, 2000, BRAIN RES, V884, P59, DOI 10.1016/S0006-8993(00)02887-0; Li J, 2011, BIOCHEM BIOPH RES CO, V410, P40, DOI 10.1016/j.bbrc.2011.05.101; Li M, 2007, PEPTIDES, V28, P1891, DOI 10.1016/j.peptides.2007.05.002; Nieto PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026417; Nucci C, 2013, CURR OPIN PHARMACOL, V13, P1, DOI 10.1016/j.coph.2012.10.009; Onoue S, 2002, PEPTIDES, V23, P1471, DOI 10.1016/S0196-9781(02)00085-2; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Osborne NN, 2008, PROG BRAIN RES, V173, P339, DOI 10.1016/S0079-6123(08)01124-2; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pinazo-Duran MD, 2013, CURR OPIN PHARMACOL, V13, P98, DOI 10.1016/j.coph.2012.10.007; Racz B, 2006, REGUL PEPTIDES, V137, P20, DOI 10.1016/j.regpep.2006.02.009; Seki T, 2000, ANN NY ACAD SCI, V921, P366; Seki T, 2011, J MOL NEUROSCI, V43, P30, DOI 10.1007/s12031-010-9410-5; Shimazaki H, 2011, INVEST OPHTH VIS SCI, V52, P7289, DOI 10.1167/iovs.11-7983; Szabadfi K, 2014, NEUROCHEM INT, V64, P84, DOI 10.1016/j.neuint.2013.11.005; Szabadfi K, 2012, CELL TISSUE RES, V348, P37, DOI 10.1007/s00441-012-1349-0; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Ueda Y, 2007, BRAIN RES, V1178, P20, DOI 10.1016/j.brainres.2007.08.022; Varga B, 2011, J MOL NEUROSCI, V43, P44, DOI 10.1007/s12031-010-9406-1; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Wada Y, 2013, J MOL NEUROSCI, V51, P493, DOI 10.1007/s12031-013-0017-5; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Yamauchi M, 2011, EUR J PHARMACOL, V650, P110, DOI 10.1016/j.ejphar.2010.09.081; Yu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051811; Yu RJ, 2010, PEPTIDES, V31, P1062, DOI 10.1016/j.peptides.2010.03.008; Zhu B, 2008, EXP EYE RES, V86, P375, DOI 10.1016/j.exer.2007.11.010	51	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108090	10.1371/journal.pone.0108090	http://dx.doi.org/10.1371/journal.pone.0108090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286089	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700013
J	Morris, MD; Evans, J; Montgomery, M; Yu, M; Briceno, A; Page, K; Hahn, JA				Morris, Meghan D.; Evans, Jennifer; Montgomery, Martha; Yu, Michelle; Briceno, Alya; Page, Kimberly; Hahn, Judith A.			Intimate Injection Partnerships Are at Elevated Risk of High-Risk Injecting: A Multi-Level Longitudinal Study of HCV-Serodiscordant Injection Partnerships in San Francisco, CA	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; 5 US CITIES; DRUG-USERS; HEPATITIS-C; GENDER-DIFFERENCES; HETEROSEXUAL COUPLES; SEXUAL RELATIONSHIPS; PREVENTION PROGRAM; HIV-INFECTION; CONDOM USE	Background: It is increasingly recognized that the risk for HIV and hepatitis C (HCV) transmission among people who inject drugs (PWID), such as syringe sharing, occurs in the context of relationships between (at least) two people. Evidence suggests that the risk associated with injection behavior varies with injection partner types. Methods: We utilized longitudinal dyad-level data from a study of young PWID from San Francisco (2006 to 2013) to investigate the relationship-level factors influencing high-risk injecting within HCV-serodiscordant injection partners (i.e., individuals who injected together >= 5 times in the prior month). Utilizing data from 70 HCV-serodiscordant injection partnerships, we used generalized linear models to examine relationship-level predictors (i.e., partnership composition, partnership closeness, and partnership dynamics) of: (1) receptive syringe sharing (RSS); and (2) receptive cooker use (RCU), as reported by the HCV-negative injection partner. Results: As reported by the "at-risk'' HCV-negative injection partner, receptive syringe sharing (RSS) and receptive cooker use (RCU) were 19% and 33% at enrollment, and 11% and 12% over all visits (total follow-up time 55 person-years) resulting in 13 new HCV-infections (incidence rate: 23.8/100 person-years). Person-level factors, injection partnership composition, and partnership dynamics were not significantly associated with either RSS or RCU. Instead, intimate injection partnerships (those who lived together and were also in a sexual relationship) were independently associated with a 5-times greater risk of both RSS and a 7-times greater risk of RCU when compared to injecting only partnerships. Conclusion: Our findings suggest a positive, and amplified effect of relationship factors on injecting drug risk behaviors among young PWID injection partnerships. The majority of interventions to reduce injection drug use related harms focus on individual-based education to increase drug use knowledge. Our findings support the need to expand harm reduction strategies to relationship-based messaging and interventions.	[Morris, Meghan D.; Evans, Jennifer; Yu, Michelle; Briceno, Alya] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Montgomery, Martha] Univ Calif San Francisco, Joint Med Program, San Francisco, CA 94143 USA; [Montgomery, Martha] Univ Calif San Francisco, Program Med Educ Urban Underserved, San Francisco, CA 94143 USA; [Montgomery, Martha] Univ Calif Berkeley, San Francisco, CA USA; [Page, Kimberly] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Hahn, Judith A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of New Mexico; University of New Mexico's Health Sciences Center; University of California System; University of California San Francisco	Morris, MD (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	Meghan.Morris@ucsf.edu	Hahn, Judith/J-5813-2014	Hahn, Judith/0000-0002-2697-8264; Page, Kimberly/0000-0002-7120-1673	National Institute on Drug Abuse Award [R01DA16017, R01DA031056, K01DA023365]; University of California San Francisco CTSI (NIH) [UL1-RR02431]; University of California San Francisco Liver Center (NIH) [P30-DK026743]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA022586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA037802, K01DA023365, R01DA031056, R01DA016017] Funding Source: NIH RePORTER	National Institute on Drug Abuse Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of California San Francisco CTSI (NIH); University of California San Francisco Liver Center (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The UFO Study is supported by the National Institute on Drug Abuse Award number R01DA16017. MDM is supported by a National Institute on Drug Abuse Award number R01DA031056. JAH is supported by a National Institute on Drug Abuse Award number K01DA023365. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institute of Health. The authors also acknowledge support from the University of California San Francisco CTSI (NIH UL1-RR02431) and the University of California San Francisco Liver Center (NIH P30-DK026743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; [Anonymous], 2012, MMWR MORBIDITY MORTA, V61, P133; [Anonymous], 2002, AIDS BEHAV; BARNARD MA, 1993, ADDICTION, V88, P805, DOI 10.1111/j.1360-0443.1993.tb02094.x; Bennett GA, 2000, AIDS CARE, V12, P77, DOI 10.1080/09540120047495; Bing S, 2004, FORTUNE, V150, P140; Bourgois P, 2004, HUM ORGAN, V63, P253, DOI 10.17730/humo.63.3.h1phxbhrb7m4mlv0; Bryant J, 2010, DRUG ALCOHOL REV, V29, P364, DOI 10.1111/j.1465-3362.2009.00154.x; Burt RD, 2009, DRUG ALCOHOL DEPEN, V105, P215, DOI 10.1016/j.drugalcdep.2009.07.005; Cavacuiti CA, 2004, SUBST USE MISUSE, V39, P645, DOI 10.1081/JA-120030064; Costenbader EC, 2006, ADDICTION, V101, P1003, DOI 10.1111/j.1360-0443.2006.01431.x; Cox J, 2009, SUBST USE MISUSE, V44, P548, DOI 10.1080/10826080802544349; Davey-Rothwell MA, 2007, J URBAN HEALTH, V84, P691, DOI 10.1007/s11524-007-9215-1; De P, 2009, SCAND J INFECT DIS, V41, P206, DOI 10.1080/00365540902721376; Desgrees-du-Lou A, 2008, REPROD HEALTH MATTER, V16, P151, DOI 10.1016/S0968-8080(08)32407-0; El-Bassel N, 2003, AM J PUBLIC HEALTH, V93, P963, DOI 10.2105/AJPH.93.6.963; Evans JL, 2014, DRUG ALCOHOL DEPEN, V142, P239, DOI 10.1016/j.drugalcdep.2014.06.028; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Frajzyngier V, 2007, DRUG ALCOHOL DEPEN, V89, P145, DOI 10.1016/j.drugalcdep.2006.12.021; Gyarmathy VA, 2006, DRUG ALCOHOL DEPEN, V82, pS65, DOI 10.1016/S0376-8716(06)80011-6; Gyarmathy VA, 2010, AIDS BEHAV, V14, P141, DOI 10.1007/s10461-008-9518-6; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Hahn JA, 2010, ADDICTION, V105, P1254, DOI 10.1111/j.1360-0443.2010.02949.x; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd, DOI [10.1201/b13880, DOI 10.1201/B13880]; Harvey SM, 2002, WOMEN HEALTH, V36, P69, DOI 10.1300/J013v36n04_06; Horyniak D, 2013, DRUG ALCOHOL DEPEN, V132, P541, DOI 10.1016/j.drugalcdep.2013.03.021; KIYOSAWA K, 1991, ANN INTERN MED, V115, P367, DOI 10.7326/0003-4819-115-5-367; Lakon CM, 2006, SOC SCI MED, V63, P2489, DOI 10.1016/j.socscimed.2006.06.015; Lazuardi E, 2012, CULT HEALTH SEX, V14, P491, DOI 10.1080/13691058.2012.671960; LOXLEY W, 1995, AIDS CARE, V7, P337, DOI 10.1080/09540129550126551; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McMahon James M, 2003, BMC Med Res Methodol, V3, P24, DOI 10.1186/1471-2288-3-24; Miller Cari L, 2007, Harm Reduct J, V4, P1, DOI 10.1186/1477-7517-4-1; MITSUI T, 1992, HEPATOLOGY, V16, P1109, DOI 10.1002/hep.1840160502; Musaba E, 1998, SEX TRANSM DIS, V25, P260, DOI 10.1097/00007435-199805000-00008; NEAIGUS A, 1994, SOC SCI MED, V38, P67, DOI 10.1016/0277-9536(94)90301-8; Neaigus A, 1995, NIDA Res Monogr, V151, P20; PADIAN NS, 1993, J ACQ IMMUN DEF SYND, V6, P1043; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Porco TC, 2001, AM J PUBLIC HEALTH, V91, P636, DOI 10.2105/AJPH.91.4.636; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Rhodes T, 1998, SOC SCI MED, V46, P157, DOI 10.1016/S0277-9536(97)00156-1; Rhodes T, 2008, ADDICTION, V103, P1593, DOI 10.1111/j.1360-0443.2008.02306.x; Riehman KS, 2004, J URBAN HEALTH, V81, P249, DOI 10.1093/jurban/jth111; Roy E, 2007, INT J STD AIDS, V18, P23, DOI 10.1258/095646207779949880; Roy E, 2007, INT J DRUG POLICY, V18, P397, DOI 10.1016/j.drugpo.2007.02.005; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Shaw SY, 2007, ADDICTION, V102, P1626, DOI 10.1111/j.1360-0443.2007.01940.x; Simmons J., 2006, SUBSTANCE ABUSE TREA, V1, P1; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Stephenson R, 2011, AIDS BEHAV, V15, pS80, DOI 10.1007/s10461-011-9893-2; Thiede H, 2007, DRUG ALCOHOL DEPEN, V91, pS39, DOI 10.1016/j.drugalcdep.2007.03.001; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Tsui JI, 2009, DRUG ALCOHOL DEPEN, V105, P160, DOI 10.1016/j.drugalcdep.2009.05.022; Weeks MR, 2009, SUBST USE MISUSE, V44, P253, DOI 10.1080/10826080802347677; Wu Elwin, 2010, Open AIDS J, V4, P123, DOI 10.2174/1874613601004030123	58	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109282	10.1371/journal.pone.0109282	http://dx.doi.org/10.1371/journal.pone.0109282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6XC	25286346	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700056
J	Burgess, S; Freitag, DF; Khan, H; Gorman, DN; Thompson, SG				Burgess, Stephen; Freitag, Daniel F.; Khan, Hassan; Gorman, Donal N.; Thompson, Simon G.			Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENETIC-VARIANTS; RISK-FACTORS; TRIGLYCERIDES	Background: Previous Mendelian randomization studies have suggested that, while low-density lipoprotein cholesterol (LDL-c) and triglycerides are causally implicated in coronary artery disease (CAD) risk, high-density lipoprotein cholesterol (HDL-c) may not be, with causal effect estimates compatible with the null. Principal Findings: The causal effects of these three lipid fractions can be better identified using the extended methods of 'multivariable Mendelian randomization'. We employ this approach using published data on 185 lipid-related genetic variants and their associations with lipid fractions in 188,578 participants, and with CAD risk in 22,233 cases and 64,762 controls. Our results suggest that HDL-c may be causally protective of CAD risk, independently of the effects of LDL-c and triglycerides. Estimated causal odds ratios per standard deviation increase, based on 162 variants not having pleiotropic associations with either blood pressure or body mass index, are 1.57 (95% credible interval 1.45 to 1.70) for LDL-c, 0.91 (0.83 to 0.99, p-value = 0.028) for HDL-c, and 1.29 (1.16 to 1.43) for triglycerides. Significance: Some interventions on HDL-c concentrations may influence risk of CAD, but to a lesser extent than interventions on LDL-c. A causal interpretation of these estimates relies on the assumption that the genetic variants do not have pleiotropic associations with risk factors on other pathways to CAD. If they do, a weaker conclusion is that genetic predictors of LDL-c, HDL-c and triglycerides each have independent associations with CAD risk.	[Burgess, Stephen; Freitag, Daniel F.; Khan, Hassan; Gorman, Donal N.; Thompson, Simon G.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England	University of Cambridge	Burgess, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England.	sb452@medschl.cam.ac.uk	Khan, Hassan/D-6267-2013	Khan, Hassan/0000-0003-1468-8654; Burgess, Stephen/0000-0001-5365-8760	Wellcome Trust [100114]; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors received no specific funding for this work. Stephen Burgess is supported by a fellowship from the Wellcome Trust (100114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGRIST JD, 2006, J EXPT CRIMINOLOGY, V0002; [Anonymous], 2014, R LANG ENV STAT COMP; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Burgess S, 2014, AM J EPIDEMIOL UNPUB; Burgess S, 2014, INT J EPIDEMIOL, V43, P922, DOI 10.1093/ije/dyu005; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; Hindorff L, 2013, TECHNICAL REPORT; Holmes MV, 2014, EUROPEAN HEART J; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Sarwar N, 2009, CURR OPIN LIPIDOL, V20, P275, DOI 10.1097/MOL.0b013e32832dd4dc; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2011, EPIDEMIOLOGY, V22, P460, DOI 10.1097/EDE.0b013e31821d0426; Taylor F, 2011, COCHRANE DATABASE SY, V1; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	25	59	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108891	10.1371/journal.pone.0108891	http://dx.doi.org/10.1371/journal.pone.0108891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302496	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400034
J	da Costa, MGS; Santos, MD; Sarti, FM; Senna, KMSE; Tura, BR; Goulart, MC				Santos da Costa, Marcia Gisele; Santos, Marisa da Silva; Sarti, Flavia Mori; Simoes e Senna, Katia Marie; Tura, Bernardo Rangel; Goulart, Marcelo Correia			Cost-Effectiveness of Procedures for Treatment of Ostium Secundum Atrial Septal Defects Occlusion Comparing Conventional Surgery and Septal Percutaneous Implant	PLOS ONE			English	Article							TRANSCATHETER CLOSURE; OCCLUDER DEVICE; CHILDREN	Objectives: The study performs a cost-effectiveness analysis of procedures for atrial septal defects occlusion, comparing conventional surgery to septal percutaneous implant. Methods: A model of analytical decision was structured with symmetric branches to estimate cost-effectiveness ratio between the procedures. The decision tree model was based on evidences gathered through meta-analysis of literature, and validated by a panel of specialists. The lower number of surgical procedures performed for atrial septal defects occlusion at each branch was considered as the effectiveness outcome. Direct medical costs and probabilities for each event were inserted in the model using data available from Brazilian public sector database system and information extracted from the literature review, using micro-costing technique. Sensitivity analysis included price variations of percutaneous implant. Results: The results obtained from the decision model demonstrated that the percutaneous implant was more cost effective in cost-effectiveness analysis at a cost of US$8,936.34 with a reduction in the probability of surgery occurrence in 93% of the cases. Probability of atrial septal communication occlusion and cost of the implant are the determinant factors of cost-effectiveness ratio. Conclusions: The proposal of a decision model seeks to fill a void in the academic literature. The decision model proposed includes the outcomes that present major impact in relation to the overall costs of the procedure. The atrial septal defects occlusion using percutaneous implant reduces the physical and psychological distress to the patients in relation to the conventional surgery, which represent intangible costs in the context of economic evaluation.	[Santos da Costa, Marcia Gisele; Santos, Marisa da Silva; Simoes e Senna, Katia Marie; Tura, Bernardo Rangel; Goulart, Marcelo Correia] Natl Inst Cardiol, Ctr Technol Assessment Hlth, Rio De Janeiro, Brazil; [Sarti, Flavia Mori] Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	da Costa, MGS (corresponding author), Natl Inst Cardiol, Ctr Technol Assessment Hlth, Rio De Janeiro, Brazil.	mgisele@gmail.com	Sarti, Flavia Mori/D-4767-2009; da Silva Santos, Marisa/ABA-3418-2020	Sarti, Flavia Mori/0000-0003-2834-2005; da Silva Santos, Marisa/0000-0002-2174-6800				Bettencourt Nuno, 2003, Rev Port Cardiol, V22, P1203; Bialkowski J, 2004, TEX HEART I J, V31, P220; Bove T, 2005, ACTA CHIR BELG, V105, P497, DOI 10.1080/00015458.2005.11679767; Braga Sérgio Luiz Navarro, 2004, Arq. Bras. Cardiol., V83, P7, DOI 10.1590/S0066-782X2004001900003; Brown S C, 2004, Cardiovasc J S Afr, V15, P28; Chessa M, 2002, J AM COLL CARDIOL, V39, P1061, DOI 10.1016/S0735-1097(02)01711-4; Dialetto G., 2006, J AM SOC ECHOCARDIOG, V19, DOI 10.1016/j.echo.2006.01.027; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4; Durongpisitkul K, 2002, PEDIATR CARDIOL, V23, P36, DOI 10.1007/s00246-001-0010-6; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Harper RW, 2002, CATHETER CARDIO INTE, V57, P508, DOI 10.1002/ccd.10353; Hessling G, 2003, PEDIATR CARDIOL, V24, P259, DOI 10.1007/s00246-002-0247-8; Hughes ML, 2002, HEART, V88, P67, DOI 10.1136/heart.88.1.67; Jones TK, 2007, J AM COLL CARDIOL, V49, P2215, DOI 10.1016/j.jacc.2006.11.053; Kamouh A, 2011, ANN THORAC SURG, V91, P1608, DOI 10.1016/j.athoracsur.2010.10.076; Kannan BRJ, 2003, CATHETER CARDIO INTE, V59, P522, DOI 10.1002/ccd.10575; Kim JJ, 2002, MED SCI MONITOR, V8, pCR787; Kong XQ, 2002, CHINESE MED J-PEKING, V115, P126; Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066; National Institute for Health and Clinical Excellence (NICE), 2004, END CLOS ATR SEPT DE; Pedra Carlos A. C., 2003, Arq. Bras. Cardiol., V80, P650, DOI 10.1590/S0066-782X2003000600010; Rossi Filho Raul Ivo, 2010, Rev. Bras. Cardiol. Invasiva, V18, P212, DOI 10.1590/S2179-83972010000200017; Sauer HH, 2006, ANN THORAC SURG, V81, P2312, DOI 10.1016/j.athoracsur.2005.08.008; Thomson JDR, 2002, HEART, V87, P466, DOI 10.1136/heart.87.5.466; Vida VL, 2006, J AM COLL CARDIOL, V47, P326, DOI 10.1016/j.jacc.2005.06.086; Wei XF, 2011, J THORAC CARDIOV SUR, V142, P113, DOI 10.1016/j.jtcvs.2010.10.034; World Health Organization, 2005, THRESH VAL INT COST	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108966	10.1371/journal.pone.0108966	http://dx.doi.org/10.1371/journal.pone.0108966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302806	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400037
J	Yamazaki, T; Mori, M; Arai, S; Tateishi, R; Abe, M; Ban, M; Nishijima, A; Maeda, M; Asano, T; Kai, T; Izumino, K; Takahashi, J; Aoyama, K; Harada, S; Takebayashi, T; Gunji, T; Ohnishi, S; Seto, S; Yoshida, Y; Hiasa, Y; Koike, K; Yamamura, K; Inoue, K; Miyazaki, T				Yamazaki, Tomoko; Mori, Mayumi; Arai, Satoko; Tateishi, Ryosuke; Abe, Masanori; Ban, Mihoko; Nishijima, Akemi; Maeda, Maki; Asano, Takeharu; Kai, Toshihiro; Izumino, Kiyohiro; Takahashi, Jun; Aoyama, Kayo; Harada, Sei; Takebayashi, Toru; Gunji, Toshiaki; Ohnishi, Shin; Seto, Shinji; Yoshida, Yukio; Hiasa, Yoichi; Koike, Kazuhiko; Yamamura, Ken-ichi; Inoue, Ken-ichiro; Miyazaki, Toru			Circulating AIM as an Indicator of Liver Damage and Hepatocellular Carcinoma in Humans	PLOS ONE			English	Article							X-RECEPTOR-ALPHA; FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS; APOPTOSIS INHIBITOR; METABOLIC SYNDROME; GENE-EXPRESSION; NATURAL-HISTORY; HORMONE-THERAPY; MACROPHAGE AIM; ESTROGEN	Background: Hepatocellular carcinoma (HCC), the fifth most common cancer type and the third highest cause of cancer death worldwide, develops in different types of liver injuries, and is mostly associated with cirrhosis. However, non-alcoholic fatty liver disease often causes HCC with less fibrosis, and the number of patients with this disease is rapidly increasing. The high mortality rate and the pathological complexity of liver diseases and HCC require blood biomarkers that accurately reflect the state of liver damage and presence of HCC. Methods and Findings: Here we demonstrate that a circulating protein, apoptosis inhibitor of macrophage (AIM) may meet this requirement. A large-scale analysis of healthy individuals across a wide age range revealed a mean blood AIM of 4.99 +/- 1.8 mu g/ml in men and 6.06 +/- 2.1 mu g/ml in women. AIM levels were significantly augmented in the younger generation (20s-40s), particularly in women. Interestingly, AIM levels were markedly higher in patients with advanced liver damage, regardless of disease type, and correlated significantly with multiple parameters representing liver function. In mice, AIM levels increased in response to carbon tetrachloride, confirming that the high AIM observed in humans is the result of liver damage. In addition, carbon tetrachloride caused comparable states of liver damage in AIM-deficient and wild-type mice, indicating no influence of AIM levels on liver injury progression. Intriguingly, certain combinations of AIM indexes normalized to liver marker score significantly distinguished HCC patients from non-HCC patients and thus could be applicable for HCC diagnosis. Conclusion: AIM potently reveals both liver damage and HCC. Thus, our results may provide the basis for novel diagnostic strategies for this widespread and fatal disease.	[Yamazaki, Tomoko; Mori, Mayumi; Arai, Satoko; Nishijima, Akemi; Kai, Toshihiro; Aoyama, Kayo; Miyazaki, Toru] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan; [Tateishi, Ryosuke; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan; [Ban, Mihoko; Maeda, Maki; Izumino, Kiyohiro; Takahashi, Jun; Seto, Shinji; Inoue, Ken-ichiro] Inoue Hosp, Shunkaikai, Nagasaki, Japan; [Asano, Takeharu; Yoshida, Yukio] Jichi Med Univ, Saitama Med Ctr, Dept Gastroenterol, Omiya, Saitama, Japan; [Harada, Sei; Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Gunji, Toshiaki] NTT Med Ctr, Ctr Prevent Med, Tokyo, Japan; [Ohnishi, Shin] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Yamamura, Ken-ichi] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto, Japan; [Miyazaki, Toru] Max Planck Univ Tokyo, Ctr Integrat Inflammol, Tokyo, Japan; [Miyazaki, Toru] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	University of Tokyo; University of Tokyo; Ehime University; Jichi Medical University; Keio University; Kanto Medical Center NTT EC; National Center for Global Health & Medicine - Japan; Kumamoto University; Japan Science & Technology Agency (JST)	Miyazaki, T (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan.	tm@m.u-tokyo.ac.jp	Hiasa, Yoichi/ABD-2759-2021; Takebayashi, Toru/AAB-9356-2019; Takebayashi, Toru/K-7526-2013; Harada, Sei/ABA-5975-2020; Tateishi, Ryosuke/G-7758-2014	Hiasa, Yoichi/0000-0003-4117-339X; Takebayashi, Toru/0000-0002-8268-8026; Takebayashi, Toru/0000-0002-8268-8026; Harada, Sei/0000-0003-2666-4932; Tateishi, Ryosuke/0000-0003-3021-2517; Mori, Mayumi/0000-0001-6190-9785; Arai, Satoko/0000-0002-6145-8686; Miyazaki, Toru/0000-0003-3842-4362	Japan Society for the Promotion of Science; CREST (JST); ONSENDO Co., Ltd.; Tokyo Biochemical Research Foundation; Takeda Science Foundation; Ono Medical Research Foundation; Grants-in-Aid for Scientific Research [221S0001, 25253056] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ONSENDO Co., Ltd.; Tokyo Biochemical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Medical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (A) (Japan Society for the Promotion of Science), CREST (JST), research grants by ONSENDO Co., Ltd. (to TM), Grants-in-Aid for Scientific Research (B) (Japan Society for the Promotion of Science) (to SA), research grants by The Tokyo Biochemical Research Foundation, Takeda Science Foundation and Ono Medical Research Foundation (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Arai S, 2014, SEMIN IMMUNOPATHOL, V36, P3, DOI 10.1007/s00281-013-0405-5; Arai S, 2013, CELL REP, V3, P1187, DOI 10.1016/j.celrep.2013.03.006; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; BAZIN H, 1969, IMMUNOLOGY, V17, P345; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Chagas AL, 2009, BRAZ J MED BIOL RES, V42, P958, DOI 10.1590/S0100-879X2009005000019; Day C P, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS377, DOI 10.1046/j.1440-1746.17.s3.31.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Gray J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-271; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Hage FG, 2013, CURR OPIN CARDIOL, V28, P411, DOI 10.1097/HCO.0b013e32836205e7; Hamada M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4147; Han SI, 2014, HEPATOLOGY, V59, P1791, DOI 10.1002/hep.26951; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hydroglou P, 2007, GASTROENTEROL CLIN N, V36, P867, DOI 10.1016/j.gtc.2007.08.010; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Iwamura Y, 2012, BIOCHEM BIOPH RES CO, V422, P476, DOI 10.1016/j.bbrc.2012.05.018; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097037; Kawada N, 2009, J GASTROENTEROL, V44, P1190, DOI 10.1007/s00535-009-0112-0; Kim WK, 2008, EXP MOL MED, V40, P677, DOI 10.3858/emm.2008.40.6.677; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Li XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008412; Lundholm L, 2004, J MOL ENDOCRINOL, V32, P879, DOI 10.1677/jme.0.0320879; Mera K, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-27; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Miyazaki T, 2011, CIRC J, V75, P2522, DOI 10.1253/circj.CJ-11-0891; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Takuma Y, 2010, WORLD J GASTROENTERO, V16, P1436, DOI 10.3748/wjg.v16.i12.1436; Tiano JP, 2012, ENDOCRINOLOGY, V153, P2997, DOI 10.1210/en.2011-1980; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; Torres DM, 2012, SEMIN LIVER DIS, V32, P30, DOI 10.1055/s-0032-1306424; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Wang H, 2014, INT J MOL MED, V33, P550, DOI 10.3892/ijmm.2014.1619; Xu YX, 2012, CELL IMMUNOL, V278, P125, DOI 10.1016/j.cellimm.2012.07.007	48	29	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109123	10.1371/journal.pone.0109123	http://dx.doi.org/10.1371/journal.pone.0109123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302503	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400045
J	Alhassan, A; Makepeace, BL; LaCourse, EJ; Osei-Atweneboana, MY; Carlow, CKS				Alhassan, Andy; Makepeace, Benjamin L.; LaCourse, Elwyn James; Osei-Atweneboana, Mike Y.; Carlow, Clotilde K. S.			A Simple Isothermal DNA Amplification Method to Screen Black Flies for Onchocerca volvulus Infection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GLUTATHIONE-S-TRANSFERASE; PROTEIN DATABASE SEARCHES; IVERMECTIN TREATMENT; SENSITIVE DETECTION; ENDEMIC FOCI; DIAGNOSIS; TRANSMISSION; PCR; PREVALENCE	Onchocerciasis is a debilitating neglected tropical disease caused by infection with the filarial parasite Onchocerca volvulus. Adult worms live in subcutaneous tissues and produce large numbers of microfilariae that migrate to the skin and eyes. The disease is spread by black flies of the genus Simulium following ingestion of microfilariae that develop into infective stage larvae in the insect. Currently, transmission is monitored by capture and dissection of black flies and microscopic examination of parasites, or using the polymerase chain reaction to determine the presence of parasite DNA in pools of black flies. In this study we identified a new DNA biomarker, encoding O. volvulus glutathione S-transferase 1a (OvGST1a), to detect O. volvulus infection in vector black flies. We developed an OvGST1a-based loop-mediated isothermal amplification (LAMP) assay where amplification of specific target DNA is detectable using turbidity or by a hydroxy naphthol blue color change. The results indicated that the assay is sensitive and rapid, capable of detecting DNA equivalent to less than one microfilaria within 60 minutes. The test is highly specific for the human parasite, as no cross-reaction was detected using DNA from the closely related and sympatric cattle parasite Onchocerca ochengi. The test has the potential to be developed further as a field tool for use in the surveillance of transmission before and after implementation of mass drug administration programs for onchocerciasis.	[Alhassan, Andy; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Genome Biol, Ipswich, MA 01938 USA; [Makepeace, Benjamin L.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [LaCourse, Elwyn James] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Osei-Atweneboana, Mike Y.] Water Res Inst, Council Sci & Ind Res, Accra, Ghana	New England Biolabs; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Carlow, CKS (corresponding author), New England Biolabs Inc, Div Genome Biol, Ipswich, MA 01938 USA.	carlow@neb.com		LaCourse, James/0000-0001-9261-7136	New England Biolabs	New England Biolabs	CKSC and AA received funding from New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Programme for Onchocerciasis Control APOC, 2009, INF CONS EL ONCH TRA; Alhassan A, 2007, VET PARASITOL, V143, P155, DOI 10.1016/j.vetpar.2006.08.014; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Boatin BA, 1998, ANN TROP MED PARASIT, V92, pS41, DOI 10.1080/00034983.1998.11813364; Boatin BA, 2002, PARASITOLOGY, V125, P545, DOI 10.1017/S0031182002002494; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Bradley JE, 1996, ADV PARASIT, V37, P57, DOI 10.1016/S0065-308X(08)60219-5; Chandrashekar R, 1996, TROP MED INT HEALTH, V1, P575; Coffeng LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002759; Crump A, 2012, TRENDS PARASITOL, V28, P280, DOI 10.1016/j.pt.2012.04.005; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Enomoto Y, 2005, J CLIN MICROBIOL, V43, P951, DOI 10.1128/JCM.43.2.951-955.2005; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Fink DL, 2011, J CLIN MICROBIOL, V49, P42, DOI 10.1128/JCM.01697-10; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Gopal H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001712; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Guevara AG, 2003, AM J TROP MED HYG, V68, P222, DOI 10.4269/ajtmh.2003.68.222; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Iseki H, 2007, J MICROBIOL METH, V71, P281, DOI 10.1016/j.mimet.2007.09.019; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; KATHOLI CR, 1995, J INFECT DIS, V172, P1414, DOI 10.1093/infdis/172.5.1414; Krause S, 2001, MOL BIOCHEM PARASIT, V117, P145, DOI 10.1016/S0166-6851(01)00342-5; Krueger A, 2007, ACTA TROP, V101, P1, DOI 10.1016/j.actatropica.2006.11.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Liebau E, 2000, MOL BIOCHEM PARASIT, V109, P101, DOI 10.1016/S0166-6851(00)00232-2; Lindblade KA, 2007, AM J TROP MED HYG, V77, P334, DOI 10.4269/ajtmh.2007.77.334; LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/ajtmh.1994.51.314; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MEREDITH SEO, 1991, EXP PARASITOL, V73, P335, DOI 10.1016/0014-4894(91)90105-6; Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629; Mitashi P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002504; Morales-Hojas R, 2006, J HELMINTHOL, V80, P281, DOI 10.1079/JOH2005331; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nagamine K, 2001, CLIN CHEM, V47, P1742; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Osei-Atweneboana MY, 2012, INT J PARASITOL-DRUG, V2, P20, DOI 10.1016/j.ijpddr.2012.01.005; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perbandt M, 2005, J BIOL CHEM, V280, P12630, DOI 10.1074/jbc.M413551200; Perbandt M, 2008, J MOL BIOL, V377, P501, DOI 10.1016/j.jmb.2008.01.029; Pischke S, 2002, TROP MED INT HEALTH, V7, P526, DOI 10.1046/j.1365-3156.2002.00890.x; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; Poon LLM, 2006, CLIN CHEM, V52, P303; Rodriguez-Perez MA, 2003, T ROY SOC TROP MED H, V97, P539, DOI 10.1016/S0035-9203(03)80018-4; Rodriguez-Perez MA, 2004, AM J TROP MED HYG, V70, P38, DOI 10.4269/ajtmh.2004.70.38; Rodriguez-Perez MA, 2006, AM J TROP MED HYG, V74, P1026, DOI 10.4269/ajtmh.2006.74.1026; Rodriguez-Perez MA, 2013, PARASITOL RES, V112, P3925, DOI 10.1007/s00436-013-3583-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sommer A, 2001, INFECT IMMUN, V69, P7718, DOI 10.1128/IAI.69.12.7718-7728.2001; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOE L, 1994, AM J TROP MED HYG, V51, P676, DOI 10.4269/ajtmh.1994.51.676; Toe L, 1998, J INFECT DIS, V178, P282, DOI 10.1086/517454; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; TREES AJ, 1992, PARASITOLOGY, V104, P247, DOI 10.1017/S0031182000061680; TREES AJ, 1992, PARASITOL TODAY, V8, P337, DOI 10.1016/0169-4758(92)90068-D; Unnasch T R, 1996, Methods Mol Biol, V50, P293; WAHL G, 1994, VET PARASITOL, V52, P297, DOI 10.1016/0304-4017(94)90121-X; Wahl G, 1998, PARASITOLOGY, V116, P327, DOI 10.1017/S0031182097002333; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629; World Health Organization, 2001, CERT EL HUM ONCH CRI; World Health Organization (WHO), 2010, REP WORK OV GLOB IMP; Yameogo L, 1999, AM J TROP MED HYG, V60, P124, DOI 10.4269/ajtmh.1999.60.124; Yang BY, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-38; ZIMMERMAN PA, 1994, MOL BIOL EVOL, V11, P384; ZIMMERMAN PA, 1993, MOL BIOCHEM PARASIT, V58, P259, DOI 10.1016/0166-6851(93)90047-2	71	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108927	10.1371/journal.pone.0108927	http://dx.doi.org/10.1371/journal.pone.0108927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299656	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000343941200024
J	Chaudhari, V; Raghavan, V; Rao, BJ				Chaudhari, Vishalsingh; Raghavan, Vandana; Rao, Basuthkar J.			Preparation of Efficient Excision Repair Competent Cell-Free Extracts from C. reinhardtii Cells	PLOS ONE			English	Article							UV-SENSITIVE MUTANTS; INDUCED DNA-DAMAGE; DARK REPAIR; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS; HOMOLOG; GENE; NUCLEOTIDE; INHIBITION; RADIATION	Chlamydomonas reinhardtii is a prospective model system for understanding molecular mechanisms associated with DNA repair in plants and algae. To explore this possibility, we have developed an in vitro repair system from C. reinhardtii cell-free extracts that can efficiently repair UVC damage (Thymine-dimers) in the DNA. We observed that excision repair (ER) synthesis based nucleotide incorporation, specifically in UVC damaged supercoiled (SC) DNA, was followed by ligation of nicks. Photoreactivation efficiently competed out the ER in the presence of light. In addition, repair efficiency in cell-free extracts from ER deficient strains was several fold lower than that of wild-type cell extract. Interestingly, the inhibitor profile of repair DNA polymerase involved in C. reinhardtii in vitro ER system was akin to animal rather than plant DNA polymerase. The methodology to prepare repair competent cell-free extracts described in the current study can aid further molecular characterization of ER pathway in C. reinhardtii.	[Chaudhari, Vishalsingh; Raghavan, Vandana; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Rao, BJ (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	bjrao@tifr.res.in	Chaudhari, Vishalsingh/AAA-3269-2019	Chaudhari, Vishalsingh/0000-0002-6421-8602	Tata Institute of Fundamental Research (Department of Atomic Energy); Sir JC Bose Fellowship grant (Department of Science and Technology)	Tata Institute of Fundamental Research (Department of Atomic Energy); Sir JC Bose Fellowship grant (Department of Science and Technology)	Funding support was from the Tata Institute of Fundamental Research (Department of Atomic Energy) and Sir JC Bose Fellowship grant (Department of Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; BRITT AB, 1993, SCIENCE, V261, P1571, DOI 10.1126/science.8372351; Cenkci B, 2003, J BIOL CHEM, V278, P22574, DOI 10.1074/jbc.M303249200; Cordoba-Canero Dolores, 2012, Methods Mol Biol, V920, P263, DOI 10.1007/978-1-61779-998-3_18; Cordoba-Canero D, 2011, PLANT J, V68, P693, DOI 10.1111/j.1365-313X.2011.04720.x; Cordoba-Canero D, 2010, J BIOL CHEM, V285, P7475, DOI 10.1074/jbc.M109.067173; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; DAVIES DR, 1967, MUTAT RES, V4, P765, DOI 10.1016/0027-5107(67)90085-1; Fidantsef AL, 2000, PLANT PHYSIOL, V124, P579, DOI 10.1104/pp.124.2.579; Gallego F, 2000, PLANT J, V21, P507, DOI 10.1046/j.1365-313x.2000.00694.x; Goldschmidt M, 2006, EMBO PRACTICAL COURS; Gutman BL, 2009, J BIOL CHEM, V284, P17006, DOI 10.1074/jbc.M109.008342; HARLOW GR, 1994, PLANT CELL, V6, P227, DOI 10.1105/tpc.6.2.227; Martinez-Macias MI, 2013, J BIOL CHEM, V288, P5496, DOI 10.1074/jbc.M112.427617; Martinez-Macias MI, 2012, MOL CELL, V45, P357, DOI 10.1016/j.molcel.2011.11.034; JENKINS ME, 1995, GENETICS, V140, P725; Li A, 2002, PLANT CELL, V14, P263, DOI 10.1105/tpc.010258; LITVAK S, 1985, PLANT MOL BIOL, V4, P311, DOI 10.1007/BF02418250; Liu ZR, 2000, PLANT J, V21, P519, DOI 10.1046/j.1365-313x.2000.00707.x; Liu ZR, 2003, PLANT PHYSIOL, V132, P1405, DOI 10.1104/pp.103.021808; Liu ZR, 2001, PLANT J, V26, P329, DOI 10.1046/j.1365-313X.2001.01031.x; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V50, P639, DOI 10.1111/j.1751-1097.1989.tb04320.x; Nikaido SS, 2000, PHOTOCHEM PHOTOBIOL, V71, P758, DOI 10.1562/0031-8655(2000)071<0758:DACVIS>2.0.CO;2; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; PATRICK MH, 1977, PHOTOCHEM PHOTOBIOL, V25, P357, DOI 10.1111/j.1751-1097.1977.tb07355.x; Plecenikova A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105482; PODSTAVKOVA S, 1992, MUTAT RES, V293, P65, DOI 10.1016/0921-8777(92)90009-R; RASMUSSEN RE, 1964, NATURE, V203, P1360, DOI 10.1038/2031360a0; Roy S, 2011, PLANT CELL PHYSIOL, V52, P448, DOI 10.1093/pcp/pcr002; Sancar GB, 2000, MUTAT RES-FUND MOL M, V451, P25, DOI 10.1016/S0027-5107(00)00038-5; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; SMALL GD, 1987, MUTAT RES, V181, P31, DOI 10.1016/0027-5107(87)90284-3; SMALL GD, 1977, NUCLEIC ACIDS RES, V4, P2893, DOI 10.1093/nar/4.8.2893; Vlcek D, 1997, MUTAT RES-DNA REPAIR, V385, P243, DOI 10.1016/S0921-8777(97)00052-9; VLCEK D, 1987, MUTAT RES, V183, P169, DOI 10.1016/0167-8817(87)90059-9; Vlcek D, 2008, CURR GENET, V53, P1, DOI 10.1007/s00294-007-0163-9; Vonarx EJ, 1998, MUTAT RES-FUND MOL M, V400, P187, DOI 10.1016/S0027-5107(98)00043-8; Winters TA, 1999, NUCLEIC ACIDS RES, V27, P2423, DOI 10.1093/nar/27.11.2423; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Wood Richard D., 1995, Methods (Orlando), V7, P163, DOI 10.1006/meth.1995.1022; You ZY, 1998, MOL CELL BIOL, V18, P2668, DOI 10.1128/MCB.18.5.2668	42	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109160	10.1371/journal.pone.0109160	http://dx.doi.org/10.1371/journal.pone.0109160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299516	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200039
J	Kinjo, ER; Higa, GSV; Morya, E; Valle, AC; Kihara, AH; Britto, LRG				Kinjo, Erika R.; Higa, Guilherme S. V.; Morya, Edgard; Valle, Angela C.; Kihara, Alexandre H.; Britto, Luiz R. G.			Reciprocal Regulation of Epileptiform Neuronal Oscillations and Electrical Synapses in the Rat Hippocampus	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; PILOCARPINE MODEL; FREQUENCY OSCILLATIONS; INHIBITORY NETWORKS; GABA(A) RECEPTORS; CELL-DEATH; IN-VITRO; EXPRESSION; BRAIN; CARBENOXOLONE	Gap junction (GJ) channels have been recognized as an important mechanism for synchronizing neuronal networks. Herein, we investigated the participation of GJ channels in the pilocarpine-induced status epilepticus (SE) by analyzing electrophysiological activity following the blockade of connexins (Cx)-mediated communication. In addition, we examined the regulation of gene expression, protein levels, phosphorylation profile and distribution of neuronal Cx36, Cx45 and glial Cx43 in the rat hippocampus during the acute and latent periods. Electrophysiological recordings revealed that the GJ blockade anticipates the occurrence of low voltage oscillations and promotes a marked reduction of power in all analyzed frequencies. Cx36 gene expression and protein levels remained stable in acute and latent periods, whereas upregulation of Cx45 gene expression and protein redistribution were detected in the latent period. We also observed upregulation of Cx43 mRNA levels followed by changes in the phosphorylation profile and protein accumulation. Taken together, our results indisputably revealed that GJ communication participates in the epileptiform activity induced by pilocarpine. Moreover, considering that specific Cxs undergo alterations through acute and latent periods, this study indicates that the control of GJ communication may represent a focus in reliable anti-epileptogenic strategies.	[Kinjo, Erika R.; Higa, Guilherme S. V.; Kihara, Alexandre H.; Britto, Luiz R. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol, BR-05508 Sao Paulo, Brazil; [Kinjo, Erika R.; Higa, Guilherme S. V.; Kihara, Alexandre H.] Univ Fed ABC, Ctr Matemat Computacao Cognicao, Sao Paulo, Brazil; [Morya, Edgard] Inst Int Neurociencia Natal Edmond & Lily Safra, Natal, RN, Brazil; [Valle, Angela C.] Univ Sao Paulo, Fac Med, Dept Patol, Lab Neurociencias LIM 01, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Kinjo, ER (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol, BR-05508 Sao Paulo, Brazil.	erikareime@gmail.com; alexandrekihara@gmail.com	Kihara, Alexandre H/C-2458-2012; Morya, Edgard/K-4153-2012; Higa, Guilherme S. V./G-4282-2016; Valle, Angela/L-4400-2017; KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Kinjo, Erika R/C-9381-2014; MORYA, EDGARD/R-1251-2019	Kihara, Alexandre H/0000-0002-4027-7261; Morya, Edgard/0000-0003-0954-5317; Higa, Guilherme S. V./0000-0001-7006-9263; KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; MORYA, EDGARD/0000-0003-0954-5317; Kinjo, Erika/0000-0003-2788-0880	FAPESP; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the following funders: FAPESP and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2001, ACTA NEUROPATHOL, V101, P449; Avoli M, 1996, EPILEPSIA, V37, P1035, DOI 10.1111/j.1528-1157.1996.tb01022.x; Beaumont M, 2011, J PHYSIOL-LONDON, V589, P1663, DOI 10.1113/jphysiol.2010.201491; Beheshti S, 2010, PROG NEURO-PSYCHOPH, V34, P510, DOI 10.1016/j.pnpbp.2010.02.006; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Butovas S, 2006, J NEUROPHYSIOL, V96, P1227, DOI 10.1152/jn.01170.2005; Buzsaki G, 1997, CAN J PHYSIOL PHARM, V75, P508, DOI 10.1139/cjpp-75-5-508; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; CAVALHEIRO EA, 1995, ITAL J NEUROL SCI, V16, P33, DOI 10.1007/BF02229072; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062952; Collignon F, 2006, J NEUROSURG, V105, P77, DOI 10.3171/jns.2006.105.1.77; Condorelli DF, 2003, EUR J NEUROSCI, V18, P1807, DOI 10.1046/j.1460-9568.2003.02910.x; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; COYLE P, 1978, EXP NEUROL, V58, P549, DOI 10.1016/0014-4886(78)90108-5; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Cusato K, 2003, J NEUROSCI, V23, P6413; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Dere E, 2012, NEUROSCI BIOBEHAV R, V36, P206, DOI 10.1016/j.neubiorev.2011.05.015; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Fujikawa DG, 1996, BRAIN RES, V725, P11, DOI 10.1016/0006-8993(96)00203-X; Gajda Z, 2005, EPILEPSIA, V46, P1581, DOI 10.1111/j.1528-1167.2005.00254.x; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; GAMBARDELLA A, 1995, EPILEPSIA, V36, P122, DOI 10.1111/j.1528-1157.1995.tb00970.x; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Gigout S, 2006, NEUROBIOL DIS, V22, P496, DOI 10.1016/j.nbd.2005.12.011; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; HOSSAIN MZ, 1994, J NEUROCHEM, V62, P2394; Jacobson GM, 2010, BRAIN RES, V1360, P198, DOI 10.1016/j.brainres.2010.09.006; JELLINCK PH, 1993, J STEROID BIOCHEM, V46, P209, DOI 10.1016/0960-0760(93)90296-9; Kihara AH, 2008, DEV NEUROBIOL, V68, P1287, DOI 10.1002/dneu.20652; Kihara AH, 2005, J NEUROSCI METH, V148, P103, DOI 10.1016/j.jneumeth.2005.04.019; Kihara AH, 2010, INT J DEV NEUROSCI, V28, P39, DOI 10.1016/j.ijdevneu.2009.09.006; Kinjo ER, 2013, EXP NEUROL, V248, P546, DOI 10.1016/j.expneurol.2013.07.022; Kirkpatrick MP, 2011, EPILEPSY BEHAV, V20, P392, DOI 10.1016/j.yebeh.2010.11.020; Kohling R, 2001, NEUROSCIENCE, V105, P579, DOI 10.1016/S0306-4522(01)00222-6; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Lehmkuhle MJ, 2009, J NEUROPHYSIOL, V101, P1660, DOI 10.1152/jn.91062.2008; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Maier N, 2002, J PHYSIOL-LONDON, V541, P521, DOI 10.1113/jphysiol.2002.017624; Maxeiner S, 2003, NEUROSCIENCE, V119, P689, DOI 10.1016/S0306-4522(03)00077-0; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Medvedev A, 2000, BRAIN RES BULL, V52, P89, DOI 10.1016/S0361-9230(00)00239-2; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Pais I, 2003, J NEUROPHYSIOL, V89, P2046, DOI 10.1152/jn.00549.2002; Parviainen I, 2002, NEUROLOGY, V59, P1249, DOI 10.1212/01.WNL.0000032253.88378.D7; Paschon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045449; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Perkins KL, 2002, J NEUROPHYSIOL, V87, P1404, DOI 10.1152/jn.00430.2001; Pestana RRF, 2010, NEUROSCI LETT, V484, P187, DOI 10.1016/j.neulet.2010.08.049; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Postma F, 2011, P NATL ACAD SCI USA, V108, P13770, DOI 10.1073/pnas.1100166108; RAMSAY RE, 1993, EPILEPSIA, V34, pS71, DOI 10.1111/j.1528-1157.1993.tb05908.x; RASHKIN MC, 1987, NEUROLOGY, V37, P500, DOI 10.1212/WNL.37.3.500; Roopun AK, 2010, P NATL ACAD SCI USA, V107, P338, DOI 10.1073/pnas.0912652107; Ross FM, 2000, NEUROSCIENCE, V100, P789, DOI 10.1016/S0306-4522(00)00346-8; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Sohl G, 2000, MOL BRAIN RES, V83, P44, DOI 10.1016/S0169-328X(00)00195-9; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; STERIADE M, 1994, ELECTROEN CLIN NEURO, V90, P1, DOI 10.1016/0013-4694(94)90108-2; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Striedinger K, 2005, EUR J NEUROSCI, V22, P605, DOI 10.1111/j.1460-9568.2005.04228.x; SWANK RL, 1949, J NEUROPHYSIOL, V12, P137, DOI 10.1152/jn.1949.12.2.137; Szente M, 2002, NEUROSCIENCE, V115, P1067, DOI 10.1016/S0306-4522(02)00533-X; Taira T, 1997, J NEUROPHYSIOL, V77, P2213, DOI 10.1152/jn.1997.77.4.2213; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; TIMOIARIA C, 1970, PHYSIOL BEHAV, V5, P1057, DOI 10.1016/0031-9384(70)90162-9; Traub RD, 2001, EPILEPSIA, V42, P153, DOI 10.1046/j.1528-1157.2001.26900.x; Traub RD, 2001, J NEUROPHYSIOL, V85, P1246, DOI 10.1152/jn.2001.85.3.1246; TREIMAN DM, 1990, EPILEPSY RES, V5, P49, DOI 10.1016/0920-1211(90)90065-4; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uusisaaria M, 2002, NEUROPHARMACOLOGY, V43, P563, DOI 10.1016/S0028-3908(02)00156-9; VANNESS PC, 1990, EPILEPSIA, V31, P61; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Volgyi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069426; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Weickert S, 2005, MOL BRAIN RES, V133, P102, DOI 10.1016/j.molbrainres.2004.09.026; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; Xu L, 2009, NEUROBIOL DIS, V34, P291, DOI 10.1016/j.nbd.2009.01.010; Zhang XL, 2004, J PHYSIOL-LONDON, V558, P825, DOI 10.1113/jphysiol.2004.065649; Zhang Y, 1998, J NEUROSCI, V18, P9256; Zsiros V, 2007, J PHYSIOL-LONDON, V578, P527, DOI 10.1113/jphysiol.2006.123463	96	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109149	10.1371/journal.pone.0109149	http://dx.doi.org/10.1371/journal.pone.0109149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299405	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200038
J	Lovas, TO; Bruusgaard, JC; Oynebraten, I; Gundersen, K; Bogen, B				Lovas, Tom-Ole; Bruusgaard, Jo C.; Oynebraten, Inger; Gundersen, Kristian; Bogen, Bjarne			DNA Vaccines: MHC II-Targeted Vaccine Protein Produced by Transfected Muscle Fibres Induces a Local Inflammatory Cell Infiltrate in Mice	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; IN-VIVO; RECOMBINANT ANTIBODIES; FLUORESCENT PROTEINS; GENE DELIVERY; B-CELLS; ELECTROPORATION; IMMUNOGENICITY; EPITOPES; IMMUNOGLOBULIN	Vaccination with naked DNA holds great promise but immunogenicity needs to be improved. DNA constructs encoding bivalent proteins that bind antigen-presenting cells (APC) for delivery of antigen have been shown to enhance T and B cell responses and protection in tumour challenge experiments. However, the mechanism for the increased potency remains to be determined. Here we have constructed DNA vaccines that express the fluorescent protein mCherry, a strategy which allowed tracking of vaccine proteins. Transfected muscle fibres in mice were visualized, and their relationship to infiltrating mononuclear cells could be determined. Interestingly, muscle fibers that produced MHC class II-specific dimeric vaccine proteins with mCherry were for weeks surrounded by a localized intense cellular infiltrate composed of CD45(+), MHC class II+ and CD11b(+) cells. Increasing numbers of eosinophils were observed among the infiltrating cells from day 7 after immunization. The local infiltrate surrounding mCherry(+) muscle fibers was dependent on the MHC II-specificity of the vaccine proteins since the control, a non-targeted vaccine protein, failed to induce similar infiltrates. Chemokines measured on day 3 in immunized muscle indicate both a DNA effect and an electroporation effect. No influence of targeting was observed. These results contribute to our understanding for why targeted DNA vaccines have an improved immunogenicity.	[Lovas, Tom-Ole; Oynebraten, Inger; Bogen, Bjarne] Univ Oslo, Dept Immunol, Oslo, Norway; [Lovas, Tom-Ole; Oynebraten, Inger; Bogen, Bjarne] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Lovas, Tom-Ole; Oynebraten, Inger; Bogen, Bjarne] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Bruusgaard, Jo C.; Gundersen, Kristian] Univ Oslo, Dept Biosci, Oslo, Norway; [Bruusgaard, Jo C.] Kristiania Univ Coll, Norwegian Sch Hlth Sci, Oslo, Norway; [Bogen, Bjarne] Univ Oslo, KG Jebsen Ctr Res Influenza Vaccines, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Kristiania University College; University of Oslo	Lovas, TO (corresponding author), Univ Oslo, Dept Immunol, Oslo, Norway.	tomolel@gmail.com; bjarne.bogen@medisin.uio.no	Øynebråten, Inger/W-3369-2019	Øynebråten, Inger/0000-0001-8914-5676; Bruusgaard, Jo Christiansen/0000-0001-8163-5849	University of Oslo; Medical Student Research Program	University of Oslo; Medical Student Research Program	This study was supported by the University of Oslo, The Medical Student Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; BAIER G, 1995, J VIROL, V69, P2357, DOI 10.1128/JVI.69.4.2357-2365.1995; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005; Bruusgaard JC, 2005, ACTA PHYSIOL SCAND, V185, P141, DOI 10.1111/j.1365-201X.2005.01462.x; Bruusgaard JC, 2003, J PHYSIOL-LONDON, V551, P467, DOI 10.1113/jphysiol.2003.045328; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; CASTEN LA, 1988, J IMMUNOL, V140, P404; Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850; Figarella-Branger D, 2003, MUSCLE NERVE, V28, P659, DOI 10.1002/mus.10462; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Fredriksen AB, 2006, MOL THER, V13, P776, DOI 10.1016/j.ymthe.2005.10.019; Fredriksen AB, 2007, BLOOD, V110, P1797, DOI 10.1182/blood-2006-06-032938; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Grodeland G, 2013, J IMMUNOL, V191, P3221, DOI 10.4049/jimmunol.1300504; Gronevik E, 2005, J GENE MED, V7, P218, DOI 10.1002/jgm.650; Gronevik E, 2003, J GENE MED, V5, P909, DOI 10.1002/jgm.416; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; KAWAMURA H, 1986, J IMMUNOL, V136, P58; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Liu JY, 2008, J VIROL, V82, P5643, DOI 10.1128/JVI.02564-07; Lunde E, 1999, NAT BIOTECHNOL, V17, P670, DOI 10.1038/10883; Lunde E, 1997, MOL IMMUNOL, V34, P1167, DOI 10.1016/S0161-5890(97)00143-0; Lunde E, 2002, J IMMUNOL, V168, P2154, DOI 10.4049/jimmunol.168.5.2154; Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; NEUBERGER MS, 1981, P NATL ACAD SCI-BIOL, V78, P1138, DOI 10.1073/pnas.78.2.1138; Oynebraten I, 2012, SCAND J IMMUNOL, V75, P379, DOI 10.1111/j.1365-3083.2011.02639.x; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Peng BW, 2007, VACCINE, V25, P2064, DOI 10.1016/j.vaccine.2006.11.042; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Rasmussen IB, 2001, P NATL ACAD SCI USA, V98, P10296, DOI 10.1073/pnas.181336898; Rasmussen IB, 2012, PROTEIN ENG DES SEL, V25, P89, DOI 10.1093/protein/gzr063; Ratanamart J, 2010, J GENE MED, V12, P377, DOI 10.1002/jgm.1448; Schjetne KW, 2007, J IMMUNOL, V178, P4169, DOI 10.4049/jimmunol.178.7.4169; Schjetne KW, 2005, EUR J IMMUNOL, V35, P3142, DOI 10.1002/eji.200425947; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SNIDER DP, 1987, J IMMUNOL, V139, P1609; Stan AC, 2001, EUR J IMMUNOL, V31, P301, DOI 10.1002/1521-4141(200101)31:1<301::AID-IMMU301>3.0.CO;2-K; Tjelle TE, 2004, MOL THER, V9, P328, DOI 10.1016/j.ymthe.2003.12.007; Tunheim G, 2008, INT IMMUNOL, V20, P295, DOI 10.1093/intimm/dxm141; Tunheim G, 2007, VACCINE, V25, P4723, DOI 10.1016/j.vaccine.2007.04.004; Villarreal DO, 2013, EXPERT REV VACCINES, V12, P537, DOI [10.1586/erv.13.33, 10.1586/ERV.13.33]	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108069	10.1371/journal.pone.0108069	http://dx.doi.org/10.1371/journal.pone.0108069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299691	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200009
J	Pandey, S; Johnson, D; Kaplan, R; Klobusicky, J; Menon, G; Gracias, DH				Pandey, Shivendra; Johnson, Daniel; Kaplan, Ryan; Klobusicky, Joseph; Menon, Govind; Gracias, David H.			Self-Assembly of Mesoscale Isomers: The Role of Pathways and Degrees of Freedom	PLOS ONE			English	Article							FOLDING POLYHEDRA; CLUSTER; ARCHITECTURE; CHEMISTRY; SILICON; DESIGN; DNA	The spontaneous self-organization of conformational isomers from identical precursors is of fundamental importance in chemistry. Since the precursors are identical, it is the multi-unit interactions, characteristics of the intermediates, and assembly pathways that determine the final conformation. Here, we use geometric path sampling and a mesoscale experimental model to investigate the self-assembly of a model polyhedral system, an octahedron, that forms two isomers. We compute the set of all possible assembly pathways and analyze the degrees of freedom or rigidity of intermediates. Consequently, by manipulating the degrees of freedom of a precursor, we were able to experimentally enrich the formation of one isomer over the other. Our results suggest a new approach to direct pathways in both natural and synthetic self-assembly using simple geometric criteria. We also compare the process of folding and unfolding in this model with a geometric model for cyclohexane, a well-known molecule with chair and boat conformations.	[Pandey, Shivendra; Gracias, David H.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Johnson, Daniel; Kaplan, Ryan; Klobusicky, Joseph; Menon, Govind] Brown Univ, Div Appl Math, Providence, RI 02912 USA	Johns Hopkins University; Brown University	Menon, G (corresponding author), Brown Univ, Div Appl Math, Providence, RI 02912 USA.	menon@dam.brown.edu; dgracias@jhu.edu	Gracias, David/A-1942-2010	Gracias, David/0000-0003-2735-4725	National Science Foundation [EFRI 10-22730, EFRI 10-22638, CMMI 1200241]; Direct For Mathematical & Physical Scien [0748482] Funding Source: National Science Foundation; Div Of Civil, Mechanical, & Manufact Inn [1200241] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding for this work came from National Science Foundation EFRI 10-22730 (http://nsf.gov) to DG and SP. Additional support came from National Science Foundation EFRI 10-22638 (http://nsf.gov) to RK, DJ, JK, and GM. Support for this work came from the National Science Foundation CMMI 1200241 (http://nsf.gov) to DG and SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Boldyrev AI, 1997, J AM CHEM SOC, V119, P4618, DOI 10.1021/ja964063m; Bowden NB, 2001, ACCOUNTS CHEM RES, V34, P231, DOI 10.1021/ar0000760; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Bruice P. Y, 2004, ORGANIC CHEM; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; Connelly R, 1977, PUBL MATH-PARIS, V47, P333, DOI DOI 10.1007/BF02684342; COOK KH, 1979, P NATL ACAD SCI USA, V76, P6157, DOI 10.1073/pnas.76.12.6157; Demaine ED, 2007, GEOMETRIC FOLDING ALGORITHMS: LINKAGES, ORIGAMI, POLYHEDRA, P299, DOI 10.1017/CBO9780511735172.023; EATON PE, 1964, J AM CHEM SOC, V86, P3157, DOI 10.1021/ja01069a041; Gracias DH, 2001, ALGORITHMIC AND COMPUTATIONAL ROBOTICS: NEW DIRECTIONS, P1; Gross R, 2008, P IEEE, V96, P1490, DOI 10.1109/JPROC.2008.927352; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Herman P, 1981, CHEM CATALYTIC HYDRO, P25; Jensen HJ, 2003, SELF ORG CRITICALITY; Jones W, 2008, SUPRAMOLECULAR ORG M; Kaur P, 1996, CHEM COMMUN, P273, DOI 10.1039/cc9960000273; KROTO HW, 1991, CHEM REV, V91, P1213, DOI 10.1021/cr00006a005; Leininger S, 2000, P NATL ACAD SCI USA, V97, P1380, DOI 10.1073/pnas.030264697; Leong TG, 2007, LANGMUIR, V23, P8747, DOI 10.1021/la700913m; Liu YZ, 2011, SCIENCE, V333, P436, DOI 10.1126/science.1204369; MAIER G, 1988, ANGEW CHEM INT EDIT, V27, P309, DOI 10.1002/anie.198803093; Pandey S, 2011, P NATL ACAD SCI USA, V108, P19885, DOI 10.1073/pnas.1110857108; PAQUETTE LA, 1983, J AM CHEM SOC, V105, P5446, DOI 10.1021/ja00354a043; Park SH, 1999, LANGMUIR, V15, P266, DOI 10.1021/la980658e; Popa Dan O., 2004, J MANUF PROCESS, V6, P52, DOI DOI 10.1016/S1526-6125(04)70059-6; Russel CA, 1975, ACS SYM SER, V12, P159; Sachse H., 1890, BER DTSCH CHEM GES, V23, P1363; Shea SL, 2003, PURE APPL CHEM, V75, P1239, DOI 10.1351/pac200375091239; SLEE T, 1989, INORG CHEM, V28, P2256, DOI 10.1021/ic00311a004; Somorjai G.A., 2010, INTRO SURFACE CHEM C; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; Suzuki K, 2009, CHEM COMMUN, P1638, DOI 10.1039/b822311d; Van der Spek TM, 2006, ANN SCI, V63, P157, DOI 10.1080/00033790500480816; Weck M, 2000, J AM CHEM SOC, V122, P3546, DOI 10.1021/ja994099p; Wei J, 1999, IND ENG CHEM RES, V38, P5019, DOI 10.1021/ie990588m; WEIDENBRUCH M, 1993, ANGEW CHEM INT EDIT, V32, P545, DOI 10.1002/anie.199305451; WILLIAMS RC, 1958, BIOCHIM BIOPHYS ACTA, V28, P464, DOI 10.1016/0006-3002(58)90507-9; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zheng YR, 2011, J AM CHEM SOC, V133, P17045, DOI 10.1021/ja207217t	40	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108960	10.1371/journal.pone.0108960	http://dx.doi.org/10.1371/journal.pone.0108960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299051	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200026
J	Planque, B; Lindstrom, U; Subbey, S				Planque, Benjamin; Lindstrom, Ulf; Subbey, Sam			Non-Deterministic Modelling of Food-Web Dynamics	PLOS ONE			English	Article							ECOSYSTEM; COMPLEXITY; UNCERTAINTY; VALIDATION; PROTOCOL; ECOPATH; LESSONS; SYSTEMS; DIET; END	A novel approach to model food-web dynamics, based on a combination of chance (randomness) and necessity (system constraints), was presented by Mullon et al. in 2009. Based on simulations for the Benguela ecosystem, they concluded that observed patterns of ecosystem variability may simply result from basic structural constraints within which the ecosystem functions. To date, and despite the importance of these conclusions, this work has received little attention. The objective of the present paper is to replicate this original model and evaluate the conclusions that were derived from its simulations. For this purpose, we revisit the equations and input parameters that form the structure of the original model and implement a comparable simulation model. We restate the model principles and provide a detailed account of the model structure, equations, and parameters. Our model can reproduce several ecosystem dynamic patterns: pseudo-cycles, variation and volatility, diet, stock-recruitment relationships, and correlations between species biomass series. The original conclusions are supported to a large extent by the current replication of the model. Model parameterisation and computational aspects remain difficult and these need to be investigated further. Hopefully, the present contribution will make this approach available to a larger research community and will promote the use of non-deterministic-network-dynamics models as 'null models of food-webs' as originally advocated.	[Planque, Benjamin; Lindstrom, Ulf] Inst Marine Res, Tromso, Norway; [Subbey, Sam] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway	Planque, B (corresponding author), Inst Marine Res, Tromso, Norway.	benjamin.planque@imr.no	Lindstrom, Ulf/AAU-1327-2020; Planque, Benjamin/D-2729-2013	Planque, Benjamin/0000-0002-0557-7410; Chiaradia, Andre/0000-0002-6178-4211	Norwegian Research Council [200796/E10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council project 200796/E10 BarEcoRe: Barents Sea Ecosystem Resilience under global environmental change. The Norwegian Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Allen JI, 2007, J MARINE SYST, V64, P3, DOI 10.1016/j.jmarsys.2006.02.010; Aubin JP, 2011, VIABILITY THEORY: NEW DIRECTIONS, SECOND EDITION, P1, DOI 10.1007/978-3-642-16684-6; Bakun A., 1996, OCEAN PROCESSES MARI; Begley J, 2004, 2004FF ICES CM; Black AJ, 2012, TRENDS ECOL EVOL, V27, P337, DOI 10.1016/j.tree.2012.01.014; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Coulson T, 2004, TRENDS ECOL EVOL, V19, P359, DOI 10.1016/j.tree.2004.05.008; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; Cury PM, 2005, ICES J MAR SCI, V62, P577, DOI 10.1016/j.icesjms.2004.10.007; De Martino D, 2013, ARXIV13125228; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; DYER ME, 1988, SIAM J COMPUT, V17, P967, DOI 10.1137/0217060; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gilioli G, 2012, MATH BIOSCI ENG, V9, P75, DOI 10.3934/mbe.2012.9.75; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hartig F, 2011, ECOL LETT, V14, P816, DOI 10.1111/j.1461-0248.2011.01640.x; HILBORN R, 1992; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Hutchings L, 1998, S AFR J MARINE SCI, V19, P211; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Kavanagh P, 2004, ECOL MODEL, V172, P141, DOI 10.1016/j.ecolmodel.2003.09.004; Kearney KA, 2012, ECOL MODEL, V237, P43, DOI 10.1016/j.ecolmodel.2012.04.006; Koen-Alonso Mariano, 2007, P1; Lehuta S, 2013, FISH RES, V143, P57, DOI 10.1016/j.fishres.2013.01.008; Levin SA, 2005, BIOSCIENCE, V55, P1075, DOI 10.1641/0006-3568(2005)055[1075:SATEOC]2.0.CO;2; Lovasz L, 1999, MATH PROGRAM, V86, P443, DOI 10.1007/s101070050099; Monod J, 1970, HASARD NE CESSITE ES; Morris DJ, 2014, ECOL MODEL, V273, P251, DOI 10.1016/j.ecolmodel.2013.11.019; Mullon C., 2014, NETWORK EC MARINE EC; Mullon C, 2009, FISH FISH, V10, P115, DOI 10.1111/j.1467-2979.2008.00296.x; Niiranen S, 2012, AMBIO, V41, P613, DOI 10.1007/s13280-012-0324-z; Pinnegar JK, 2003, J FISH BIOL, V63, P197, DOI 10.1111/j.1095-8649.2003.00204.x; Plaganyi EE., 2007, FAO FISHERIES TECHNI; Plounevez S, 1999, ESTUAR COAST SHELF S, V49, P177, DOI 10.1006/ecss.1999.0497; Polovina J.J., 1984, FISHBYTE, V2, P5; Prigogine I., 1996, FIN CERTITUDES; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Sydeman WJ, 2001, PROG OCEANOGR, V49, P309, DOI 10.1016/S0079-6611(01)00028-3; Ulanowicz RE, 2014, ECOL LETT, V17, P127, DOI 10.1111/ele.12216; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	49	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108243	10.1371/journal.pone.0108243	http://dx.doi.org/10.1371/journal.pone.0108243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299245	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200012
J	Schmidt, J; Jentsch, H; Stingu, CS; Sack, U				Schmidt, Jana; Jentsch, Holger; Stingu, Catalina-Suzana; Sack, Ulrich			General Immune Status and Oral Microbiology in Patients with Different Forms of Periodontitis and Healthy Control Subjects	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE; AGGRESSIVE PERIODONTITIS; CYTOKINE; DISEASE; CELLS; INNATE; EXPRESSION; MONOCYTES; RESPONSES; FEATURES	Objective: Immunological processes in the etiopathogenesis of periodontitis, especially the aggressive form, are not well understood. This study examined clinical as well as systemic immunological and local microbiological features in healthy controls and patients with different forms of periodontitis. Materials and Methods: 14 healthy subjects, 15 patients diagnosed with aggressive periodontitis, and 11 patients with chronic periodontitis were recruited. Periodontal examination was performed and peripheral blood was collected from each patient. Lymphocyte populations as well as the release of cytokines by T-helper cells were determined by flow cytometry and enzyme linked immunosorbent spot assay. Subgingival plaque samples were taken from each individual and immediately cultivated for microbiological examination. Results: When stimulating peripheral blood mononuclear cells (PBMCs) with lipopolysaccharide, a higher IL-1 beta release was found in patients with moderate chronic periodontitis compared to the other groups (p<0.01). Numbers of B-cells, naive and transitional B-cells, memory B-cells, and switched memory B-cells were within the reference range for all groups, but patients with chronic periodontitis showed the highest percentage of memory B-cells without class switch (p = 0.01). The subgingival plaque differed quantitatively as well as qualitatively with a higher number of Gram-negative anaerobic species in periodontitis patients. Prevotella denticola was found more often in patients with aggressive periodontitis (p<0.001) but did not show an association to any of the systemic immunological findings. Porphyromonas gingivalis, which was only found in patients with moderate chronic periodontitis, seems to be associated with an activation of the systemic immune response. Conclusion: Differences between aggressive periodontitis and moderate chronic periodontitis are evident, which raises the question of an inadequate balance between systemic immune response and bacterial infection in aggressive periodontitis.	[Sack, Ulrich] Univ Leipzig, Inst Clin Immunol, D-04109 Leipzig, Germany; [Sack, Ulrich] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Schmidt, Jana; Jentsch, Holger] Univ Leipzig, Dept Cariol Endodontol & Periodontol, D-04109 Leipzig, Germany; [Stingu, Catalina-Suzana] Univ Leipzig, Inst Med Microbiol & Epidemiol Infect Dis, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Schmidt, J (corresponding author), Univ Leipzig, Dept Cariol Endodontol & Periodontol, D-04109 Leipzig, Germany.	jana.schmidt@medizin.uni-leipzig.de	Sack, Ulrich/J-6301-2015	Sack, Ulrich/0000-0002-7813-0492	German Federal Ministry of Education and Research (BMBF) [1315883]; Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF 1315883). The study was supported by the Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany (http://www.trm.uni-leipzig.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2010, PERIODONTOL 2000, V53, P12, DOI 10.1111/j.1600-0757.2010.00353.x; Becerik S, 2012, J PERIODONTOL, V83, P1304, DOI 10.1902/jop.2012.110616; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Bostanci N, 2007, ORAL MICROBIOL IMMUN, V22, P52; Brown LJ, 2002, PERIODONTOL 2000, V29, P223, DOI 10.1034/j.1600-0757.2002.290111.x; Chi AC, 2010, AM FAM PHYSICIAN, V82, P1381; Darveau RP, 2009, DNA CELL BIOL, V28, P389, DOI 10.1089/dna.2009.0864; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dias IHK, 2011, J CLIN PERIODONTOL, V38, P1, DOI 10.1111/j.1600-051X.2010.01628.x; Ebersole JL, 2013, PERIODONTOL 2000, V62, P163, DOI 10.1111/prd.12005; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Gaffen SL, 2008, J DENT RES, V87, P817, DOI 10.1177/154405910808700908; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Goncalves TO, 2010, ARCH ORAL BIOL, V55, P975, DOI 10.1016/j.archoralbio.2010.08.002; Gonzales JR, 2007, J CLIN PERIODONTOL, V34, P473, DOI 10.1111/j.1600-051X.2007.01086.x; Guentsch A, 2009, J PERIODONTAL RES, V44, P368, DOI 10.1111/j.1600-0765.2008.01113.x; Imai Kenichi, 2011, J Oral Sci, V53, P1; Kobayashi R, 2011, J DENT RES, V90, P653, DOI 10.1177/0022034510397838; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lafaurie GI, 2007, J PERIODONTOL, V78, P629, DOI 10.1902/jop.2007.060187; Lange D E, 1977, Dtsch Zahnarztl Z, V32, P44; Li XY, 2012, J CELL BIOCHEM, V113, P2822, DOI 10.1002/jcb.24157; Lindhe J, 1999, ANN PERIODONTOL, V4, P38, DOI DOI 10.1902/ANNALS.1999.4.1.38; MARAZITA ML, 1994, J PERIODONTOL, V65, P623, DOI 10.1902/jop.1994.65.6.623; MODLIN RL, 1993, CURR OPIN IMMUNOL, V5, P511, DOI 10.1016/0952-7915(93)90031-M; Mombelli A, 2002, J CLIN PERIODONTOL, V29, P10, DOI 10.1034/j.1600-051X.29.s3.1.x; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Nagasawa T, 2004, J PERIODONTAL RES, V39, P72, DOI 10.1111/j.1600-0765.2004.00713.x; Nakajima T, 2005, J DENT RES, V84, P639, DOI 10.1177/154405910508400711; Ogawa T, 2007, FRONT BIOSCI-LANDMRK, V12, P3795, DOI 10.2741/2353; Ohlrich EJ, 2009, AUST DENT J, V54, pS2, DOI 10.1111/j.1834-7819.2009.01139.x; Papaioannou W, 2009, ORAL MICROBIOL IMMUN, V24, P183, DOI 10.1111/j.1399-302X.2008.00493.x; Pitt T, 2011, ALLERGY ASTHMA CL IM, V7, DOI [10.1186/1710-1492-7-S1-S1, 10.1186/1710-1492-7-S1-S10]; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Rescala B, 2010, J PERIODONTOL, V81, P1308, DOI 10.1902/jop.2010.090643; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Salvi GE, 2008, J CLIN PERIODONTOL, V35, P398, DOI 10.1111/j.1600-051X.2008.01282.x; Scheres N, 2010, J PERIODONTAL RES, V45, P262, DOI 10.1111/j.1600-0765.2009.01229.x; Shiau HJ, 2010, J PERIODONTOL, V81, P1379, DOI 10.1902/jop.2010.100044; Slots J, 2003, INT DENT J, V53, P200, DOI 10.1111/j.1875-595X.2003.tb00771.x; Smedman C, 2009, J IMMUNOL METHODS, V346, P1, DOI 10.1016/j.jim.2009.04.001; Smith M, 2010, PERIODONTOL 2000, V53, P45, DOI 10.1111/j.1600-0757.2010.00354.x; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stingu CS, 2012, QUINTESSENCE INT, V43, pE23; Sugita N, 2012, J PERIODONTAL RES, V47, P105, DOI 10.1111/j.1600-0765.2011.01411.x; Taylor JJ, 2010, PERIODONTOL 2000, V54, P160, DOI 10.1111/j.1600-0757.2009.00344.x; Timmerman M F, 2006, Int J Dent Hyg, V4, P2; Turvey SE, 2010, J ALLERGY CLIN IMMUN, V125, pS24, DOI 10.1016/j.jaci.2009.07.016; van der Weijden F, 2011, PERIODONTOL 2000, V55, P104, DOI 10.1111/j.1600-0757.2009.00337.x; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yun PLW, 2002, INFECT IMMUN, V70, P5695, DOI 10.1128/IAI.70.10.5695-5705.2002; Zaric S, 2010, INFECT IMMUN, V78, P4151, DOI 10.1128/IAI.00600-10	57	22	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109187	10.1371/journal.pone.0109187	http://dx.doi.org/10.1371/journal.pone.0109187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299619	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200040
J	Velroyen, A; Bech, M; Zanette, I; Schwarz, J; Rack, A; Tympner, C; Herrler, T; Staab-Weijnitz, C; Braunagel, M; Reiser, M; Bamberg, F; Pfeiffer, F; Notohamiprodjo, M				Velroyen, Astrid; Bech, Martin; Zanette, Irene; Schwarz, Jolanda; Rack, Alexander; Tympner, Christiane; Herrler, Tanja; Staab-Weijnitz, Claudia; Braunagel, Margarita; Reiser, Maximilian; Bamberg, Fabian; Pfeiffer, Franz; Notohamiprodjo, Mike			X-Ray Phase-Contrast Tomography of Renal Ischemia-Reperfusion Damage	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; COMPUTED-TOMOGRAPHY; DARK-FIELD; GRATING INTERFEROMETER; DISEASE; CT; MICROTOMOGRAPHY; ERYTHROCYTE; PERFUSION; FAILURE	Purpose: The aim of the study was to investigate microstructural changes occurring in unilateral renal ischemia-reperfusion injury in a murine animal model using synchrotron radiation. Material and Methods: The effects of renal ischemia-reperfusion were investigated in a murine animal model of unilateral ischemia. Kidney samples were harvested on day 18. Grating-Based Phase-Contrast Imaging (GB-PCI) of the paraffin-embedded kidney samples was performed at a Synchrotron Radiation Facility (beam energy of 19 keV). To obtain phase information, a two-grating Talbot interferometer was used applying the phase stepping technique. The imaging system provided an effective pixel size of 7.5 mu m. The resulting attenuation and differential phase projections were tomographically reconstructed using filtered back-projection. Semi-automated segmentation and volumetry and correlation to histopathology were performed. Results: GB-PCI provided good discrimination of the cortex, outer and inner medulla in non-ischemic control kidneys. Post-ischemic kidneys showed a reduced compartmental differentiation, particularly of the outer stripe of the outer medulla, which could not be differentiated from the inner stripe. Compared to the contralateral kidney, after ischemia a volume loss was detected, while the inner medulla mainly retained its volume (ratio 0.94). Post-ischemic kidneys exhibited severe tissue damage as evidenced by tubular atrophy and dilatation, moderate inflammatory infiltration, loss of brush borders and tubular protein cylinders. Conclusion: In conclusion GB-PCI with synchrotron radiation allows for non-destructive microstructural assessment of parenchymal kidney disease and vessel architecture. If translation to lab-based approaches generates sufficient density resolution, and with a time-optimized image analysis protocol, GB-PCI may ultimately serve as a non-invasive, non-enhanced alternative for imaging of pathological changes of the kidney.	[Velroyen, Astrid; Bech, Martin; Zanette, Irene; Schwarz, Jolanda; Pfeiffer, Franz] Dept Phys E17, Chair Biomed Phys, Munich, Bavaria, Germany; [Bech, Martin] Lund Univ, Lund, Sweden; [Rack, Alexander] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Tympner, Christiane] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Herrler, Tanja] Univ Munich, Hosp Munich, Dept Gen Trauma Hand & Plast Surg, Munich, Germany; [Staab-Weijnitz, Claudia; Braunagel, Margarita; Reiser, Maximilian; Bamberg, Fabian; Notohamiprodjo, Mike] Univ Hosp Munich, Inst Clin Radiol, Munich, Germany; [Staab-Weijnitz, Claudia] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Munich, Germany; [Staab-Weijnitz, Claudia] Helmholtz Zentrum Munich, Munich, Germany; [Bamberg, Fabian; Notohamiprodjo, Mike] Univ Hosp Tuebingen, Dept Radiol, Tubingen, Germany	Lund University; European Synchrotron Radiation Facility (ESRF); University of Munich; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Notohamiprodjo, M (corresponding author), Univ Hosp Munich, Inst Clin Radiol, Munich, Germany.	mike.notohamiprodjo@uni-tuebingen.de	Staab-Weijnitz, Claudia A./P-1148-2016; Alexander, Rack/C-9397-2012; Bech, Martin/K-4331-2012	Staab-Weijnitz, Claudia A./0000-0002-1211-7834; Alexander, Rack/0000-0001-9486-3621; Bech, Martin/0000-0001-9109-7175; Zanette, Irene/0000-0001-6096-6059	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP) [DFG EXC-158]; DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC, FP7) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC, FP7)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP, Grant no. DFG EXC-158), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT, www.kit.edu). A. Velroyen acknowledges the TUM Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYATI A, 1990, ACTA PHYSIOL SCAND, V138, P13, DOI 10.1111/j.1748-1716.1990.tb08808.x; Bech M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03209; Bech M, 2010, PHYS MED BIOL, V55, P5529, DOI 10.1088/0031-9155/55/18/017; Bennett EE, 2010, MED PHYS, V37, P6047, DOI 10.1118/1.3501311; Braunagel M, 2013, WORLD J UROL; Chen GH, 2010, OPT EXPRESS, V18, P12960, DOI 10.1364/OE.18.012960; Chen XJ, 2012, ACAD RADIOL, V19, P562, DOI 10.1016/j.acra.2012.01.005; De Greef KE, 2003, KIDNEY INT, V63, P1697, DOI 10.1046/j.1523-1755.2003.00909.x; Diemoz PC, 2011, OPT EXPRESS, V19, P1691, DOI 10.1364/OE.19.001691; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Gang L, 2005, NUCL INSTRUM METH A, V548, P200, DOI 10.1016/j.nima.2005.03.090; Hahn D, 2013, BONE ARTIFACT REDUCT, P416; Hauser N, 2013, INVEST RADIOL; HELLBERG POA, 1990, KIDNEY INT, V37, P1240, DOI 10.1038/ki.1990.107; Herrler T, 2013, CELL TRANSPLANT, V22, P2091, DOI 10.3727/096368912X658700; Herrler T, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-2; Hetterich H, 2013, Z MED PHYS, V23, P194, DOI 10.1016/j.zemedi.2012.12.001; Hoste EAJ, 2007, CONTRIB NEPHROL, V156, P32; Hueper K, 2013, RADIOLOGY; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; Hueper K, 2011, EUR RADIOL, V21, P2427, DOI 10.1007/s00330-011-2189-0; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kang SK, 2013, INVEST RADIOL, V48, P687, DOI 10.1097/RLI.0b013e3182909e7b; KARLBERG L, 1982, SCAND J UROL NEPHROL, V16, P173, DOI 10.3109/00365598209179749; Lanzman RS, 2013, RADIOLOGY, V266, P218, DOI 10.1148/radiol.12112522; MASON J, 1984, KIDNEY INT, V26, P283, DOI 10.1038/ki.1984.171; MASON J, 1987, KIDNEY INT, V31, P65, DOI 10.1038/ki.1987.10; Meinel FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059526; Momose A, 2003, OPT EXPRESS, V11, P2303, DOI 10.1364/OE.11.002303; Momose A, 2009, OPT EXPRESS, V17, P12540, DOI 10.1364/OE.17.012540; Nesch I, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3213621; Noel PB, 2013, Z MED PHYS, V23, P204, DOI 10.1016/j.zemedi.2013.02.006; Nordsletten DA, 2006, AM J PHYSIOL-HEART C, V291, pH296, DOI 10.1152/ajpheart.00814.2005; Notohamiprodjo M, 2011, J MAGN RESON IMAGING, V34, P595, DOI 10.1002/jmri.22640; Notohamiprodjo M, 2010, EUR J RADIOL, V76, P337, DOI 10.1016/j.ejrad.2010.05.033; Notohamiprodjo M, 2010, INVEST RADIOL, V45, P245, DOI 10.1097/RLI.0b013e3181d83abc; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pollard R, 2006, COMPARATIVE MED, V56, P215; Reinhard B., 1850, CHARITE ANN, V1, P185; Rossi C, 2013, INVEST RADIOL, V48, P671, DOI 10.1097/RLI.0b013e31828b9830; Saam T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073513; Schleede S, 2012, P NATL ACAD SCI USA, V109, P17880, DOI 10.1073/pnas.1206684109; Schulz G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00826; Shirai R, 2014, J SYNCHROTRON RADIAT, V21, P795, DOI 10.1107/S1600577514010558; Sidebotham David, 2012, J Extra Corpor Technol, V44, P235; Singh P, 2013, CLIN EXP PHARMACOL P, V40, P138, DOI 10.1111/1440-1681.12036; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Tanaka J, 2013, Z MED PHYS, V23, P222, DOI 10.1016/j.zemedi.2012.11.004; Velroyen A, 2013, PHYS MED BIOL, V58, pN37, DOI 10.1088/0031-9155/58/4/N37; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wallace D, 2008, KIDNEY INT, V73, P778, DOI 10.1038/sj.ki.5002771; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Weitkamp T, 2010, P SPIE, V7804; Wu J, 2009, KIDNEY INT, V75, P945, DOI 10.1038/ki.2009.42; Xie L, 2014, MAGN RESON MED; Yalavarthy Rajesh, 2007, Hemodial Int, V11 Suppl 3, pS7, DOI 10.1111/j.1542-4758.2007.00223.x; Yaroshenko A, 2013, RADIOLOGY, V269, P426, DOI 10.1148/radiol.13122413; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109; Zimmer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053849	62	21	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109562	10.1371/journal.pone.0109562	http://dx.doi.org/10.1371/journal.pone.0109562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299243	Green Submitted, Green Published, gold			2022-12-27	WOS:000343941200060
J	Weinstock, M; Grimm, I; Dreier, J; Knabbe, C; Vollmer, T				Weinstock, Melanie; Grimm, Imke; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja			Genetic Variants in Genes of the Inflammatory Response in Association with Infective Endocarditis	PLOS ONE			English	Article							TNF-ALPHA; PROMOTER POLYMORPHISM; SEPTIC SHOCK; HEART-VALVES; IL-1-BETA; MORTALITY; SEPSIS; SUSCEPTIBILITY; EXPRESSION; SECRETION	Aims: Inflammation in infective endocarditis (IE) is a complex network including interactions of inflammatory cytokines and other components of host response. Certainly, any variation in this network could influence susceptibility or disease progression of IE. In this study, 14 single nucleotide variants (SNVs) in genes coding for interleukin-1 beta, interleukin-6, interleukin-10, toll-like receptor-4, tumor necrosis factor-alpha, selectin E and intercellular adhesion molecule-1 were analyzed for an association with susceptibility to IE and correlated with disease-related laboratory parameters. Furthermore, the occurrence of SNVs was examined to elucidate pathogen-dependent associations. Methods and Results: The distribution of SNVs was determined in IE-patients and healthy blood donors by RFLP analysis. White blood cells (WBC) were counted using flow cytometry, concentration of C-reactive protein and procalcitonin was measured immunologically. Interleukin-6 c. 471+870G>A genotypes differed significantly between IE patients and controls. The frequency of the heterozygote genotype GA was considerably higher in the patient group (68.9% vs. 43.8%, P-c<0.0003). Interleukin-6 c.-237 minor allele frequency was increased in patients, although not statistically significant. Additionally, we detected a potential relation between interleukin-1 beta c.315C>T and IE. Pathogen-dependent analysis showed no significantly associated subgroup in relation to IE susceptibility, but gave hints towards alterations regarding Enterococcus-caused IE cases. Patients with genotype selectin-E c.-19 GT tend to have higher preoperative WBC counts than patients with genotype GG. We further showed an association between two interleukin-1 beta SNVs and laboratory biomarkers. Conclusion: This study shows genetic predispositions for the establishment of IE. Furthermore, correlation of SNVs with disease-related biomarkers suggests a role of genetic variants regarding the inflammatory response in IE.	[Weinstock, Melanie; Grimm, Imke; Dreier, Jens; Knabbe, Cornelius; Vollmer, Tanja] Ruhr Univ Bochum, Univ Klinikum, Herz & Diabet Zentrum Nordrhein Westfalen, Inst Lab & Transfus Med, Bad Oeynhausen, Germany	Ruhr University Bochum	Vollmer, T (corresponding author), Ruhr Univ Bochum, Univ Klinikum, Herz & Diabet Zentrum Nordrhein Westfalen, Inst Lab & Transfus Med, Bad Oeynhausen, Germany.	tvollmer@hdz-nrw.de	Vollmer, Tanja/F-1149-2013; Dreier, Jens/F-1134-2013	Vollmer, Tanja/0000-0001-7032-5423; Dreier, Jens/0000-0002-1337-7750	Ruhr-Universitat Bochum Medizinische Fakultat (FoRUM)	Ruhr-Universitat Bochum Medizinische Fakultat (FoRUM)	This work was supported by Ruhr-Universitat Bochum Medizinische Fakultat (FoRUM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber RC, 2006, CLIN MED RES, V4, P250, DOI 10.3121/cmr.4.4.250; Bashore TM, 2006, CURR PROB CARDIOLOGY, V31, P274, DOI 10.1016/j.cpcardiol.2005.12.001; Bustamante J, 2011, REV ESP CARDIOL, V64, P1056, DOI [10.1016/j.recesp.2011.02.024, 10.1016/j.rec.2011.02.027]; Cornelissen CG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-272; Daga S, 2011, MICROBES INFECT, V13, P216, DOI 10.1016/j.micinf.2010.10.016; Dahmer Mary K, 2005, Pediatr Crit Care Med, V6, pS61, DOI 10.1097/01.PCC.0000161970.44470.C7; Dankert J, 2006, INFECT IMMUN, V74, P947, DOI 10.1128/IAI.74.2.947-952.2006; Eklund C, 2003, EUR CYTOKINE NETW, V14, P168; Enquobahrie DA, 2009, ATHEROSCLEROSIS, V202, P513, DOI 10.1016/j.atherosclerosis.2008.05.018; Fedeli U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-48; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hoen B, 2013, NEW ENGL J MED, V369, P785, DOI 10.1056/NEJMc1307282; Humphries SE, 2001, EUR HEART J, V22, P2243, DOI 10.1053/euhj.2001.2678; Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108; Jilma B, 2005, BLOOD, V105, P2380, DOI 10.1182/blood-2004-09-3752; Khankhanian P, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-126; Kimura R, 2004, GENES IMMUN, V5, P572, DOI 10.1038/sj.gene.6364128; Kumpf O, 2008, INT J ANTIMICROB AG, V32, pS44, DOI 10.1016/j.ijantimicag.2008.08.002; Mekinian A, 2011, EUR CYTOKINE NETW, V22, P88, DOI 10.1684/ecn.2011.0285; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Muller AM, 2000, J PATHOL, V191, P54, DOI 10.1002/(SICI)1096-9896(200005)191:1<54::AID-PATH568>3.0.CO;2-Y; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Sabelnikovs O N-ZL, 2012, J SCI RES REPORTS; Shun CT, 2005, INFECT IMMUN, V73, P3261, DOI 10.1128/IAI.73.6.3261-3270.2005; Sutherland AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7702; Tischendorf JJW, 2007, INT J IMMUNOGENET, V34, P413, DOI 10.1111/j.1744-313X.2007.00712.x; Vollmer T, 2010, EUR HEART J, V31, P1105, DOI 10.1093/eurheartj/ehp600; Vollmer T, 2009, CLIN BIOCHEM, V42, P1413, DOI 10.1016/j.clinbiochem.2009.06.010; Wallace SM, 2002, HEART, V88, P53, DOI 10.1136/heart.88.1.53; Yoshida M, 2003, ARTERIOSCL THROM VAS, V23, P783, DOI 10.1161/01.ATV.0000067427.40133.59	31	15	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110151	10.1371/journal.pone.0110151	http://dx.doi.org/10.1371/journal.pone.0110151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299518	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200103
J	Chazal, M; Nzounza, P; Pique, C; Ramirez, BC				Chazal, Maxime; Nzounza, Patrycja; Pique, Claudine; Ramirez, Bertha Cecilia			Loss of Infectivity of HIV-1 Particles Produced by Mobile Lymphocytes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; SPREAD	HIV-1 spreads by cell-free particles and through direct cell contacts. To discriminate between these two modes of dissemination, an assay in which the cells are cultured under shaking conditions impairing cell-to-cell transmission has been described. We addressed the impact of shaking on HIV-1 particle infectivity. Kinetics of HIV-1 infection in static or shaking conditions confirmed that HIV-1 replication is reduced in mobile lymphocyte T cells. Strikingly, the infectivity of viruses produced by mobile lymphocytes was dramatically reduced. In parallel, the amount of envelope protein present on these particles showed a continuous decrease over time. We conclude that inefficient HIV-1 replication in mobile lymphocytes in this experimental system is not only due to avoidance of viral cell-to-cell transfer but also to the loss of infectivity of the viral particles due to the alteration of the composition and functionality of the particles produced by these lymphocytes. It is important to take these observations into account when studying viral transmission under shaking conditions.	[Chazal, Maxime; Nzounza, Patrycja; Pique, Claudine; Ramirez, Bertha Cecilia] INSERM, Inst Cochin, U1016, Paris, France; [Chazal, Maxime; Nzounza, Patrycja; Pique, Claudine; Ramirez, Bertha Cecilia] CNRS, UMR8104, Paris, France; [Chazal, Maxime; Nzounza, Patrycja; Pique, Claudine; Ramirez, Bertha Cecilia] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Ramirez, BC (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.	cecilia.ramirez@inserm.fr	Pique, Claudine/O-6088-2017; RAMIREZ, Cecilia/O-6100-2017	Pique, Claudine/0000-0001-8690-2440; RAMIREZ, Cecilia/0000-0002-6670-9827; CHAZAL, Maxime/0000-0002-3144-5032	SIDACTION; Agence National de Recherche contre le SIDA (ANRS)	SIDACTION; Agence National de Recherche contre le SIDA (ANRS)	This study was supported by grants from SIDACTION and the Agence National de Recherche contre le SIDA (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Hammonds J, 2003, VIROLOGY, V314, P636, DOI 10.1016/S0042-6822(03)00467-7; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Keler T, 1996, J ACQ IMMUN DEF SYND, V13, P117, DOI 10.1097/00042560-199610010-00002; Komarova NL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1049; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Nzounza P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030130; Puigdomenech I, 2013, J VIROL, V87, P2846, DOI 10.1128/JVI.02514-12; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	12	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109601	10.1371/journal.pone.0109601	http://dx.doi.org/10.1371/journal.pone.0109601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295863	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000085
J	Kilby, MC; Slobounov, SM; Newell, KM				Kilby, Melissa C.; Slobounov, Semyon M.; Newell, Karl M.			Postural Instability Detection: Aging and the Complexity of Spatial-Temporal Distributional Patterns for Virtually Contacting the Stability Boundary in Human Stance	PLOS ONE			English	Article							TIME-TO-CONTACT; DYNAMICAL STRUCTURE; RISK; DIRECTION; FALLS; SWAY; ASYMMETRY; BALANCE; LIMITS; MODEL	Falls among the older population can severely restrict their functional mobility and even cause death. Therefore, it is crucial to understand the mechanisms and conditions that cause falls, for which it is important to develop a predictive model of falls. One critical quantity for postural instability detection and prediction is the instantaneous stability of quiet upright stance based on motion data. However, well-established measures in the field of motor control that quantify overall postural stability using center-of-pressure (COP) or center-of-mass (COM) fluctuations are inadequate predictors of instantaneous stability. For this reason, 2D COP/COM virtual-time-to-contact (VTC) is investigated to detect the postural stability deficits of healthy older people compared to young adults. VTC predicts the temporal safety margin to the functional stability boundary (= limits of the region of feasible COP or COM displacement) and, therefore, provides an index of the risk of losing postural stability. The spatial directions with increased instability were also determined using quantities of VTC that have not previously been considered. Further, Lempel-Ziv-Complexity (LZC), a measure suitable for on-line monitoring of stability/instability, was applied to explore the temporal structure or complexity of VTC and the predictability of future postural instability based on previous behavior. These features were examined as a function of age, vision and different load weighting on the legs. The primary findings showed that for old adults the stability boundary was contracted and VTC reduced. Furthermore, the complexity decreased with aging and the direction with highest postural instability also changed in aging compared to the young adults. The findings reveal the sensitivity of the time dependent properties of 2D VTC to the detection of postural instability in aging, availability of visual information and postural stance and potential applicability as a predictive model of postural instability during upright stance.	[Kilby, Melissa C.; Slobounov, Semyon M.; Newell, Karl M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Slobounov, Semyon M.; Newell, Karl M.] Penn State Univ, Ctr Sport Concuss Res & Serv, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kilby, MC (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.	mck18@psu.edu						Allum JHJ, 2002, J PHYSIOL-LONDON, V542, P643, DOI 10.1113/jphysiol.2001.015644; Blaszczyk JW, 2000, J BIOMECH, V33, P1243, DOI 10.1016/S0021-9290(00)00097-X; Close JCT, 2005, BEST PRACT RES CL RH, V19, P913, DOI 10.1016/j.berh.2005.06.002; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; CUMMING RG, 1994, J AM GERIATR SOC, V42, P774, DOI 10.1111/j.1532-5415.1994.tb06540.x; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Dubowsky S., 2000, P IEEE INT C ROB AUT, V1, P570, DOI DOI 10.1109/R0B0T.2000.844114; Forth KE, 2007, GAIT POSTURE, V25, P56, DOI 10.1016/j.gaitpost.2005.12.008; Gu MJ, 1996, J BIOMECH, V29, P319, DOI 10.1016/0021-9290(95)00052-6; Haddad JM, 2008, EXP BRAIN RES, V190, P431, DOI 10.1007/s00221-008-1483-9; Haibach PS, 2007, EXP BRAIN RES, V177, P471, DOI 10.1007/s00221-006-0703-4; Hasson CJ, 2009, EXP BRAIN RES, V196, P413, DOI 10.1007/s00221-009-1865-7; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; KASPAR F, 1987, PHYS REV A, V36, P842, DOI 10.1103/PhysRevA.36.842; Kazennikov O. V., 2013, Human Physiology, V39, P392, DOI 10.1134/S0362119713030109; King AC, 2012, EXP BRAIN RES, V220, P239, DOI 10.1007/s00221-012-3133-5; KING MB, 1994, J GERONTOL, V49, pM258, DOI 10.1093/geronj/49.6.M258; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Manckoundia P, 2008, CLIN INTERV AGING, V3, P667; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Maurer MS, 2005, J GERONTOL A-BIOL, V60, P1157, DOI 10.1093/gerona/60.9.1157; NEWELL KM, 1993, GAIT POSTURE, V1, P225, DOI 10.1016/0966-6362(93)90050-B; Newell KM, 1998, APPLICATIONS OF NONLINEAR DYNAMICS TO DEVELOPMENTAL PROCESS MODELING, P63; Newell KM, 1997, EXP BRAIN RES, V113, P158, DOI 10.1007/BF02454152; Park JW, 2014, J PHYS THER SCI, V26, P381, DOI 10.1589/jpts.26.381; Patton JL, 1999, GAIT POSTURE, V9, P38, DOI 10.1016/S0966-6362(98)00037-X; Prado JM, 2011, GAIT POSTURE, V33, P93, DOI 10.1016/j.gaitpost.2010.10.003; RICCIO GE, 1993, VARIABILITY AND MOTOR CONTROL, P317; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Rothwell JC, 1993, CONTROL HUMAN VOLUNT; SHELDON JH, 1963, GERONTOLOGY, V5, P129; Slobounov S, 2008, NEUROSCI LETT, V442, P309, DOI 10.1016/j.neulet.2008.07.021; Slobounov SM, 1997, J MOTOR BEHAV, V29, P263, DOI 10.1080/00222899709600841; Slobounov SM, 1998, J GERONTOL A-BIOL, V53, pB71, DOI 10.1093/gerona/53A.1.B71; Stalenhoef PA, 2002, J CLIN EPIDEMIOL, V55, P1088, DOI 10.1016/S0895-4356(02)00502-4; Tolkiehn M, 2011, IEEE ENG MED BIO, P369, DOI 10.1109/IEMBS.2011.6090120; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	49	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108905	10.1371/journal.pone.0108905	http://dx.doi.org/10.1371/journal.pone.0108905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295589	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204000027
J	Patel, AV; Hildebrand, JS; Gapstur, SM				Patel, Alpa V.; Hildebrand, Janet S.; Gapstur, Susan M.			Body Mass Index and All-Cause Mortality in a Large Prospective Cohort of White and Black US Adults	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; FOLLOW-UP; ABDOMINAL ADIPOSITY; NATIONAL-HEALTH; WEIGHT CHANGE; OBESITY; WOMEN; OVERWEIGHT; RISK; ASSOCIATION	Remaining controversies on the association between body mass index (BMI) and mortality include the effects of smoking and prevalent disease on the association, whether overweight is associated with higher mortality rates, differences in associations by race and the optimal age at which BMI predicts mortality. To assess the relative risk (RR) of mortality by BMI in Whites and Blacks among subgroups defined by smoking, prevalent disease, and age, 891,572 White and 38,119 Black men and women provided height, weight and other information when enrolled in the Cancer Prevention Study II in 1982. Over 28 years of follow-up, there were 434,400 deaths in Whites and 18,702 deaths in Blacks. Cox proportional-hazards regression was used to estimate multivariable-adjusted relative risks (RR) and 95% confidence intervals (CI). Smoking and prevalent disease status significantly modified the BMI-mortality relationship in Whites and Blacks; higher BMI was most strongly associated with higher risk of mortality among never smokers without prevalent disease. All levels of overweight and obesity were associated with a statistically significantly higher risk of mortality compared to the reference category (BMI 22.5-24.9 kg/m(2)), except among Black women where risk was elevated but not statistically significant in the lower end of overweight. Although absolute mortality rates were higher in Blacks than Whites within each BMI category, relative risks (RRs) were similar between race groups for both men and women (p-heterogeneity by race =0.20 for men and 0.23 for women). BMI was most strongly associated with mortality when reported before age 70 years. Results from this study demonstrate for the first time that the BMI-mortality relationship differs for men and women who smoke or have prevalent disease compared to healthy never-smokers. These findings further support recommendations for maintaining a BMI between 20-25 kg/m(2) for optimal health and longevity.	[Patel, Alpa V.; Hildebrand, Janet S.; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA	American Cancer Society	Patel, AV (corresponding author), Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA.	apatel@cancer.org						Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; CORNONIHUNTLEY JC, 1991, J CLIN EPIDEMIOL, V44, P743, DOI 10.1016/0895-4356(91)90126-T; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; FREEDMAN DS, 1995, AM J EPIDEMIOL, V142, P53, DOI 10.1093/oxfordjournals.aje.a117545; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; Gelber RP, 2007, INT J OBESITY, V31, P1240, DOI 10.1038/sj.ijo.0803564; Hjartaker A, 2005, EUR J EPIDEMIOL, V20, P747, DOI 10.1007/s10654-005-2145-x; Jain MG, 2005, INT J OBESITY, V29, P792, DOI 10.1038/sj.ijo.0802952; Janssen I, 2007, OBESITY, V15, P1827, DOI 10.1038/oby.2007.217; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; JOHNSON JL, 1986, AM J EPIDEMIOL, V123, P209, DOI 10.1093/oxfordjournals.aje.a114230; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kivimaki M, 2008, OBESITY, V16, P1926, DOI 10.1038/oby.2008.322; Koster A, 2008, AM J CLIN NUTR, V88, P1206, DOI 10.3945/ajcn.2008.26298; Kuriyama S, 2006, J EPIDEMIOL, V16, P139, DOI 10.2188/jea.16.139; Lahmann PH, 2002, OBES RES, V10, P361, DOI 10.1038/oby.2002.50; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Pan L., 2009, Morbidity and Mortality Weekly Report, V58, P740; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Singh PN, 1998, EPIDEMIOLOGY, V9, P246, DOI 10.1097/00001648-199805000-00007; Song YM, 2007, ANN EPIDEMIOL, V17, P556, DOI 10.1016/j.annepidem.2007.01.028; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; STEVENS J, 1992, ARCH INTERN MED, V152, P1257, DOI 10.1001/archinte.152.6.1257; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; Stevens June, 1998, New England Journal of Medicine, V338, P1, DOI 10.1056/NEJM199801013380101; Weitoft GR, 2008, SCAND J PUBLIC HEALT, V36, P169, DOI 10.1177/1403494807085080; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WIENPAHL J, 1990, J CLIN EPIDEMIOL, V43, P949, DOI 10.1016/0895-4356(90)90078-4; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; 1986, B WHO, V64, P929	52	48	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109153	10.1371/journal.pone.0109153	http://dx.doi.org/10.1371/journal.pone.0109153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295620	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000041
J	Zhang, CW; Tatham, AJ; Medeiros, FA; Zangwill, LM; Yang, ZY; Weinreb, RN				Zhang, Chunwei; Tatham, Andrew J.; Medeiros, Felipe A.; Zangwill, Linda M.; Yang, Zhiyong; Weinreb, Robert N.			Assessment of Choroidal Thickness in Healthy and Glaucomatous Eyes Using Swept Source Optical Coherence Tomography	PLOS ONE			English	Article							FIBER LAYER THICKNESS; VISUAL-FIELD; OPEN-ANGLE; INTRAOCULAR-PRESSURE; AXIAL LENGTH; POSTERIOR SEGMENT; AFRICAN DESCENT; BLOOD-FLOW; NERVE HEAD; CLOSURE	Purpose: To evaluate choroidal thickness (CT) in healthy and glaucomatous eyes using Swept Source Optical Coherence Tomography (SS-OCT). Methods: A cross-sectional observational study of 216 eyes of 140 subjects with glaucoma and 106 eyes of 67 healthy subjects enrolled in the Diagnostic Innovations in Glaucoma Study. CT was assessed from wide-field (12x9 mm) SS-OCT scans. The association between CT and potential confounding variables including age, gender, axial length, intraocular pressure, central corneal thickness and ocular perfusion pressure was examined using univariable and multivariable regression analyses. Results: Overall CT was thinner in glaucomatous eyes with a mean (6 standard deviation) of 157.7 +/- 48.5 mm in glaucoma compared to 179.9 +/- 36.1 mm in healthy eyes (P<0.001). The choroid was thinner in both the peripapillary and macular regions in glaucoma compared to controls. Mean peripapillary CT was 154.1 +/- 44.1 mm and 134.0 +/- 56.9 mm (P<0.001) and macular CT 199.3 +/- 46.1 mm and 176.2 +/- 57.5 mm (P<0.001) for healthy and glaucomatous eyes respectively. However, older age (P<0.001) and longer axial length (P<0.001) were also associated with thinner choroid and when differences in age and axial length between glaucomatous and healthy subjects were accounted for, glaucoma was not significantly associated with CT. There was also no association between glaucoma severity and CT. Conclusions: Glaucoma was not associated with CT measured using SS-OCT; however, older age and longer axial length were associated with thinner choroid so should be considered when interpreting CT measurements.	[Zhang, Chunwei; Tatham, Andrew J.; Medeiros, Felipe A.; Zangwill, Linda M.; Yang, Zhiyong; Weinreb, Robert N.] Univ Calif San Diego, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA; [Zhang, Chunwei; Tatham, Andrew J.; Medeiros, Felipe A.; Zangwill, Linda M.; Yang, Zhiyong; Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA; [Zhang, Chunwei] Harbin Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Harbin, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; Harbin Medical University	Weinreb, RN (corresponding author), Univ Calif San Diego, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA.	rweinreb@ucsd.edu		Tatham, Andrew/0000-0003-0372-3100	National Institutes of Health/National Eye Institute [EY021818, EY11008, EY14267, EY019869, P30EY022589]; Research to Prevent Blindness; Alcon Laboratories; Allergan; Pfizer; Santen; NATIONAL EYE INSTITUTE [R01EY019869, R01EY011008, U10EY014267, R01EY021818, P30EY022589] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Alcon Laboratories(Novartis); Allergan(AbbVieAllergan); Pfizer(Pfizer); Santen; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study was supported in part by National Institutes of Health/National Eye Institute grants EY021818 (to FAM), EY11008 (to LMZ), EY14267 (to LMZ), Cover Letter EY019869 (to LMZ), core grant P30EY022589 (http://www.nei.nih.gov/index.asp) and an unrestricted grant from Research to Prevent Blindness (http://www.rpbusa.org/rpb/). The study was funded in part by participant retention incentive grants in the form of glaucoma medication at no cost from Alcon Laboratories, Allergan, Pfizer, and Santen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasil T, 2013, J GLAUCOMA, V22, P532, DOI 10.1097/IJG.0b013e318255bb4a; Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P7813, DOI 10.1167/iovs.12-10483; Banitt M, 2013, CURR OPIN OPHTHALMOL, V24, P125, DOI 10.1097/ICU.0b013e32835d9245; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; CRISTINI G, 1991, OPHTHALMOLOGICA, V202, P81, DOI 10.1159/000310179; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; Esmaeelpour M, 2010, INVEST OPHTH VIS SCI, V51, P5260, DOI 10.1167/iovs.10-5196; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Fenolland JR, 2011, J FR OPHTALMOL, V34, P313, DOI 10.1016/j.jfo.2011.02.004; FRANCOIS J, 1964, ARCH OPHTHALMOL-CHIC, V71, P219; Fujiwara A, 2012, JPN J OPHTHALMOL, V56, P230, DOI 10.1007/s10384-012-0128-5; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Galassi F, 2003, ARCH OPHTHALMOL-CHIC, V121, P1711, DOI 10.1001/archopht.121.12.1711; Goldberg I, 2003, SURV OPHTHALMOL, V48, pS3, DOI 10.1016/S0039-6257(03)00006-7; Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P2329; Hata M, 2012, JPN J OPHTHALMOL, V56, P564, DOI 10.1007/s10384-012-0173-0; Hayamizu Fukuko, 2013, Nippon Ganka Gakkai Zasshi, V117, P609; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Hirooka K, 2012, CLIN EXP OPHTHALMOL, V40, P576, DOI 10.1111/j.1442-9071.2012.02762.x; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; KIEL JW, 1995, INVEST OPHTH VIS SCI, V36, P579; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; KUBOTA T, 1993, BRIT J OPHTHALMOL, V77, P430, DOI 10.1136/bjo.77.7.430; Lee J, 2013, J GLAUCOMA IN PRESS; Li L, 2013, AM J OPHTHALMOL, V156, P1277, DOI 10.1016/j.ajo.2013.07.011; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Mansouri K, 2014, AM J OPHTHALMOL, V13, P1; Mansouri K, 2013, OPHTHALMOLOGY, V120, P2508, DOI 10.1016/j.ophtha.2013.07.040; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Matsuo Y, 2013, INVEST OPHTH VIS SCI, V54, P7630, DOI 10.1167/iovs.13-13135; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; McCourt Emily A, 2010, Ophthalmic Surg Lasers Imaging, V41 Suppl, pS28, DOI 10.3928/15428877-20101031-14; Medeiros FA, 2005, AM J OPHTHALMOL, V139, P1010, DOI 10.1016/j.ajo.2005.01.003; Mwanza JC, 2012, INVEST OPHTH VIS SCI, V53, P6695, DOI 10.1167/iovs.12-10388; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Nicolela MT, 1996, AM J OPHTHALMOL, V122, P775, DOI 10.1016/S0002-9394(14)70373-3; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Pellegrini M, 2014, OPHTHALMOLOGY, V121, P257, DOI 10.1016/j.ophtha.2013.08.030; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; Rhew JY, 2014, J GLAUCOMA, V23, P46, DOI 10.1097/IJG.0b013e31825af772; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Shetgar AC, 2013, J CLIN DIAGN RES, V7, P1063, DOI 10.7860/JCDR/2013/4292.3022; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spraul CW, 2002, VISION RES, V42, P923, DOI 10.1016/S0042-6989(02)00022-6; Usui S, 2013, CLIN OPHTHALMOL, V7, P1155, DOI 10.2147/OPTH.S44884; Wang W, 2013, INVEST OPHTH VIS SCI, V54, P3538, DOI 10.1167/iovs.13-11728; Weinreb RN, 2009, OCULAR BLOOD FLOW GL, P155; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Yasuno Y, 2007, OPT EXPRESS, V15, P6121, DOI 10.1364/OE.15.006121; Yin ZQ, 1997, J GLAUCOMA, V6, P23	55	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109683	10.1371/journal.pone.0109683	http://dx.doi.org/10.1371/journal.pone.0109683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295876	Green Published, gold			2022-12-27	WOS:000345204000092
J	Erdoes, G; Huber, C; Basciani, R; Stortecky, S; Windecker, S; Wenaweser, P; Carrel, T; Eberle, B				Erdoes, Gabor; Huber, Christoph; Basciani, Reto; Stortecky, Stefan; Windecker, Stephan; Wenaweser, Peter; Carrel, Thierry; Eberle, Balthasar			The Self-Expanding Symetis Acurate Does Not Increase Cerebral Microembolic Load When Compared to the Balloon-Expandable Edwards Sapien Prosthesis: A Transcranial Doppler Study in Patients Undergoing Transapical Aortic Valve Implantation	PLOS ONE			English	Article							TRANSCATHETER; REPLACEMENT; RISK; EMBOLISM; OUTCOMES; STENOSIS; SILENT	Objectives: The aim of this study was to quantify potential differences in count, frequency and pattern of high-intensity transient signals (HITS) during transapical transcatheter aortic valve implantation (TA-TAVI), by comparing the Symetis Acurate TA (SA) with the balloon-expandable Edwards Sapien XT (ES) system. Background: Recently, the Symetis Acurate TA revalving system has been introduced for TA-TAVI. The Symetis Acurate TA aortic bioprosthesis is self-expanding and is deployed by a specific two-step implantation technique. Whether this novel method increases the load of intraprocedural emboli, detected by transcranial Doppler ultrasound (TCD) as HITS, or not is not clear. Methods: Twenty-two patients (n = 11 in each study arm, median logistic EuroScore 20%, median STS score 7%) displayed continuous TCD signals of good quality throughout the entire TA-TAVI procedure and were included in the final analysis. Data are presented as median with interquartile ranges. Results: No significant differences were detected in total procedural or interval-related HITS load (SA: 303 [200; 594], ES: 499 [285; 941]; p = 0.16). With both devices, HITS peaked during prosthesis deployment (PD), whereas significantly fewer HITS occurred during instrumentation (SA: p = 0.002; ES: <0.001) or post-implantation PI (SA: p = 0.007; ES: <0.001). PD-associated HITS amounted to almost half of the total HITS load. One patient suffered new disabling stroke at 30 days. Thirtyday mortality amounted to 13.6% (3 of 22 patients). Conclusions: Simplified transapical delivery using the self-expanding SA device does not increase HITS, despite of a two-step deployment technique with more interactions with the native aortic valve, when compared to the balloon-expandable ES valve. The similarity in HITS count, frequency and pattern with the two systems suggests a common mechanism for the release of cerebral microemboli.	[Erdoes, Gabor; Basciani, Reto; Eberle, Balthasar] Univ Hosp Bern, Dept Anesthesiol & Pain Therapy, Inselspital, CH-3010 Bern, Switzerland; [Huber, Christoph; Carrel, Thierry] Univ Hosp Bern, Inselspital, Dept Cardiovasc Surg, CH-3010 Bern, Switzerland; [Stortecky, Stefan; Windecker, Stephan; Wenaweser, Peter] Univ Hosp Bern, Inselspital, Dept Cardiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Erdoes, G (corresponding author), Univ Hosp Bern, Dept Anesthesiol & Pain Therapy, Inselspital, CH-3010 Bern, Switzerland.	gabor.erdoes@insel.ch	Carrel, Thierry/AAI-5910-2021; Erdoes, Gabor/J-5742-2014; Stortecky, Stefan/AAS-9140-2021; Wenaweser, Peter/AAN-7009-2021	Erdoes, Gabor/0000-0002-6742-1016; Stortecky, Stefan/0000-0002-5076-0177; Huber, Christoph/0000-0001-9048-849X	Department of Anaesthesiology and Pain Therapy, University Hospital Bern	Department of Anaesthesiology and Pain Therapy, University Hospital Bern	Department of Anaesthesiology and Pain Therapy, University Hospital Bern, provided support for the maintenance of the emboli detection machine (Transcranial Doppler Sonography). This funder did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2010, JACC-CARDIOVASC INTE, V3, P1126, DOI 10.1016/j.jcin.2010.09.008; Buellesfeld L, 2010, EUR HEART J, V31, P984, DOI 10.1093/eurheartj/ehp570; Drews T, 2011, THORAC CARDIOV SURG, V59, P237, DOI 10.1055/s-0030-1250495; Eggebrecht H, 2012, EUROINTERVENTION, V8, P129, DOI 10.4244/EIJV8I1A20; Erdoes G, 2012, EUR J CARDIO-THORAC, V41, P778, DOI 10.1093/ejcts/ezr068; Ghanem A, 2010, J AM COLL CARDIOL, V55, P1427, DOI 10.1016/j.jacc.2009.12.026; Huber CH, 2005, J AM COLL CARDIOL, V46, P366, DOI 10.1016/j.jacc.2005.04.028; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kahlert P, 2012, CIRCULATION, V126, P1245, DOI 10.1161/CIRCULATIONAHA.112.092544; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; Kempfert J, 2013, EUR J CARDIO-THORAC, V43, P52, DOI 10.1093/ejcts/ezs139; Kempfert J, 2011, EUR J CARDIO-THORAC, V40, P1114, DOI 10.1016/j.ejcts.2011.01.078; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Omran H, 2003, LANCET, V361, P1241, DOI 10.1016/S0140-6736(03)12978-9; Reinsfelt B, 2012, ACTA ANAESTH SCAND, V56, P240, DOI 10.1111/j.1399-6576.2011.02563.x; Rodes-Cabau J, 2011, J AM COLL CARDIOL, V57, P18, DOI 10.1016/j.jacc.2010.07.036; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stortecky S, 2012, EUROINTERVENTION, V8, pQ60, DOI 10.4244/EIJV8SQA11; Walther T, 2009, ANN THORAC SURG, V87, P276, DOI 10.1016/j.athoracsur.2008.08.017	20	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108191	10.1371/journal.pone.0108191	http://dx.doi.org/10.1371/journal.pone.0108191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289688	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000013
J	Kellogg, CA; Piceno, YM; Tom, LM; DeSantis, TZ; Gray, MA; Andersen, GL				Kellogg, Christina A.; Piceno, Yvette M.; Tom, Lauren M.; DeSantis, Todd Z.; Gray, Michael A.; Andersen, Gary L.			Comparing Bacterial Community Composition of Healthy and Dark Spot-Affected Siderastrea siderea in Florida and the Caribbean	PLOS ONE			English	Article							BLACK BAND DISEASE; CORAL MICROBIAL ECOLOGY; REEF-BUILDING CORALS; WEST-INDIES; SHIFTS; PATTERNS; DOMINICA; DECLINE; SPREAD	Coral disease is one of the major causes of reef degradation. Dark Spot Syndrome (DSS) was described in the early 1990's as brown or purple amorphous areas of tissue on a coral and has since become one of the most prevalent diseases reported on Caribbean reefs. It has been identified in a number of coral species, but there is debate as to whether it is in fact the same disease in different corals. Further, it is questioned whether these macroscopic signs are in fact diagnostic of an infectious disease at all. The most commonly affected species in the Caribbean is the massive starlet coral Siderastrea siderea. We sampled this species in two locations, Dry Tortugas National Park and Virgin Islands National Park. Tissue biopsies were collected from both healthy colonies and those with dark spot lesions. Microbial-community DNA was extracted from coral samples (mucus, tissue, and skeleton), amplified using bacterial-specific primers, and applied to PhyloChip G3 microarrays to examine the bacterial diversity associated with this coral. Samples were also screened for the presence of a fungal ribotype that has recently been implicated as a causative agent of DSS in another coral species, but the amplifications were unsuccessful. S. siderea samples did not cluster consistently based on health state (i.e., normal versus dark spot). Various bacteria, including Cyanobacteria and Vibrios, were observed to have increased relative abundance in the discolored tissue, but the patterns were not consistent across all DSS samples. Overall, our findings do not support the hypothesis that DSS in S. siderea is linked to a bacterial pathogen or pathogens. This dataset provides the most comprehensive overview to date of the bacterial community associated with the scleractinian coral S. siderea.	[Kellogg, Christina A.; Gray, Michael A.] US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL 33701 USA; [Piceno, Yvette M.; Tom, Lauren M.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [DeSantis, Todd Z.] Second Genome Inc, San Bruno, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kellogg, CA (corresponding author), US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL 33701 USA.	ckellogg@usgs.gov	Tom, Lauren/E-9739-2015; Andersen, Gary/G-2792-2015; Piceno, Yvette/I-6738-2016	Andersen, Gary/0000-0002-1618-9827; Piceno, Yvette/0000-0002-7915-4699	Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program; United States Department of Energy [DE-AC02-05CH11231]	Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program; United States Department of Energy(United States Department of Energy (DOE))	This project was supported by the Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program (http://marine.usgs.gov). A portion of this work was performed under the auspices of the United States Department of Energy under contract DE-AC02-05CH11231 to Lawrence Berkeley National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Borger JL, 2005, B MAR SCI, V77, P137; Borger JL, 2005, CORAL REEFS, V24, P139, DOI 10.1007/s00338-004-0434-6; Borger JL, 2003, REV BIOL TROP, V51, P25; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Closek CJ, 2014, ISME J IN PRESS; Correa AMS, 2009, CORAL REEFS, V28, P437, DOI 10.1007/s00338-008-0464-6; Croquer A, 2009, DIS AQUAT ORGAN, V87, P33, DOI 10.3354/dao02164; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Galloway SB, 2007, 56 NOAA NOS NCCO; Gantar M, 2009, MICROB ECOL, V58, P856, DOI 10.1007/s00248-009-9540-x; GARZONFERREIRA J, 1998, REEF ENCOUNTER, V24, P10; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; Gil-Agudelo DL, 2004, CORAL HEALTH AND DISEASE, P337; Gil-Agudelo DL, 2001, B MAR SCI, V69, P619; Gochfeld DJ, 2006, DIS AQUAT ORGAN, V69, P53, DOI 10.3354/dao069053; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Gray MA, 2011, FEMS MICROBIOL ECOL, V76, P109, DOI 10.1111/j.1574-6941.2010.01033.x; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hsiang T., 2007, Acta Silvatica & Lignaria Hungarica, VSpecial, P71; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kellogg CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079801; Kellogg CA, 2012, J MICROBIOL METH, V88, P103, DOI 10.1016/j.mimet.2011.10.019; Kramarsky-Winter E, 2013, MICROB ECOL, P1; Lins-de-Barros MM, 2010, MICROB ECOL, V59, P523, DOI 10.1007/s00248-009-9612-y; Lins-de-Barros MM, 2013, MICROB ECOL, V65, P205, DOI 10.1007/s00248-012-0095-x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pollock FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002183; Porter JW, 2011, J EXP MAR BIOL ECOL, V408, P79, DOI 10.1016/j.jembe.2011.07.027; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Rasoulouniriana D, 2009, DIS AQUAT ORGAN, V87, P91, DOI 10.3354/dao02089; Renegar D.A., 2008, P 11 INT COR REEF S, P185; Richardson L.L., 2002, P1225; Rogers CS, 2010, DIS AQUAT ORGAN, V91, P167, DOI 10.3354/dao02261; Rogers C, 2009, P R SOC B, V276, P197, DOI 10.1098/rspb.2008.0606; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Solano Oscar David, 1993, Anales del Instituto de Investigaciones Marinas de Punta de Betin, V22, P97; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Veron J.E.N., 2000, CORALS WORLD, V1-3; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27; Work T.M., 2014, ECOHEALTH, P1; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011	58	17	17	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108767	10.1371/journal.pone.0108767	http://dx.doi.org/10.1371/journal.pone.0108767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289937	Green Published, Green Submitted, gold			2022-12-27	WOS:000342798000024
J	Clemencon, B; Luscher, BP; Fine, M; Baumann, MU; Surbek, DV; Bonny, O; Hediger, MA				Clemencon, Benjamin; Luescher, Benjamin P.; Fine, Michael; Baumann, Marc U.; Surbek, Daniel V.; Bonny, Olivier; Hediger, Matthias A.			Expression, Purification, and Structural Insights for the Human Uric Acid Transporter, GLUT9, Using the Xenopus laevis Oocytes System	PLOS ONE			English	Article							GLUCOSE TRANSPORTERS; ELECTRON-MICROSCOPY; SLC2A9	The urate transporter, GLUT9, is responsible for the basolateral transport of urate in the proximal tubule of human kidneys and in the placenta, playing a central role in uric acid homeostasis. GLUT9 shares the least homology with other members of the glucose transporter family, especially with the glucose transporting members GLUT1-4 and is the only member of the GLUT family to transport urate. The recently published high-resolution structure of XylE, a bacterial D-xylose transporting homologue, yields new insights into the structural foundation of this GLUT family of proteins. While this represents a huge milestone, it is unclear if human GLUT9 can benefit from this advancement through subsequent structural based targeting and mutagenesis. Little progress has been made toward understanding the mechanism of GLUT9 since its discovery in 2000. Before work can begin on resolving the mechanisms of urate transport we must determine methods to express, purify and analyze hGLUT9 using a model system adept in expressing human membrane proteins. Here, we describe the surface expression, purification and isolation of monomeric protein, and functional analysis of recombinant hGLUT9 using the Xenopus laevis oocyte system. In addition, we generated a new homology-based high-resolution model of hGLUT9 from the XylE crystal structure and utilized our purified protein to generate a low-resolution single particle reconstruction. Interestingly, we demonstrate that the functional protein extracted from the Xenopus system fits well with the homology-based model allowing us to generate the predicted urate-binding pocket and pave a path for subsequent mutagenesis and structure-function studies.	[Clemencon, Benjamin; Fine, Michael; Hediger, Matthias A.] Univ Bern, IBMM, Bern, Switzerland; [Clemencon, Benjamin; Fine, Michael; Hediger, Matthias A.] Univ Bern, NCCR TransCure, Bern, Switzerland; [Luescher, Benjamin P.; Baumann, Marc U.; Surbek, Daniel V.] Univ Hosp Bern, Dept Obstet & Gynecol, CH-3010 Bern, Switzerland; [Luescher, Benjamin P.; Baumann, Marc U.; Surbek, Daniel V.] Univ Bern, Dept Clin Res, Bern, Switzerland; [Bonny, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne	Clemencon, B (corresponding author), Univ Bern, IBMM, Bern, Switzerland.	benjamin.clemencon@ibmm.unibe.ch; matthias.hediger@ibmm.unibe.ch		Hediger, Matthias/0000-0003-1946-027X; Surbek, Daniel/0000-0001-7705-1584; Fine, Michael/0000-0002-8436-3073; bonny, olivier/0000-0003-4123-4279	Swiss National Science Foundation (SNSF) through the National Centre of Competence in Research (NCCR) TransCure; The TransCure International Fellowship Program (IFP TransCure) - FP7 European Marie Curie Actions	Swiss National Science Foundation (SNSF) through the National Centre of Competence in Research (NCCR) TransCure(Swiss National Science Foundation (SNSF)); The TransCure International Fellowship Program (IFP TransCure) - FP7 European Marie Curie Actions	This study was supported by the Swiss National Science Foundation (SNSF) through the National Centre of Competence in Research (NCCR) TransCure and The TransCure International Fellowship Program (IFP TransCure), funded in part by an FP7 European Marie Curie Actions grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bergeron MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021901; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Clemencon B, 2014, PROTEIN EXPRES PURIF, V95, P169, DOI 10.1016/j.pep.2013.11.017; Doblado M, 2009, AM J PHYSIOL-ENDOC M, V297, pE831, DOI 10.1152/ajpendo.00296.2009; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Grisshammer R, 2009, METHOD ENZYMOL, V463, P631, DOI 10.1016/S0076-6879(09)63036-6; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; Mobasheri A, 2005, CELL BIOL INT, V29, P249, DOI 10.1016/j.cellbi.2004.11.024; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106	22	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108852	10.1371/journal.pone.0108852	http://dx.doi.org/10.1371/journal.pone.0108852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286413	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700037
J	Hyatt, LD; Wasserman, GA; Rah, YJ; Matsuura, KY; Coleman, FT; Hilliard, KL; Pepper-Cunningham, ZA; Ieong, M; Stumpo, DJ; Blackshear, PJ; Quinton, LJ; Mizgerd, JP; Jones, MR				Hyatt, Lynnae D.; Wasserman, Gregory A.; Rah, Yoon J.; Matsuura, Kori Y.; Coleman, Fadie T.; Hilliard, Kristie L.; Pepper-Cunningham, Zachary Ash; Ieong, Michael; Stumpo, Deborah J.; Blackshear, Perry J.; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.			Myeloid ZFP36L1 Does Not Regulate Inflammation or Host Defense in Mouse Models of Acute Bacterial Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; AU-RICH ELEMENT; MESSENGER-RNA TURNOVER; ZINC-FINGER PROTEINS; TRISTETRAPROLIN-DEFICIENCY SYNDROME; VENTILATOR-ASSOCIATED PNEUMONIA; ACUTE-PHASE RESPONSE; KAPPA-B RELA; PNEUMOCOCCAL PNEUMONIA; NEUTROPHIL RECRUITMENT	Zinc finger protein 36, C3H type-like 1 (ZFP36L1) is one of several Zinc Finger Protein 36 (Zfp36) family members, which bind AU rich elements within 39 untranslated regions (UTRs) to negatively regulate the post-transcriptional expression of targeted mRNAs. The prototypical member of the family, Tristetraprolin (TTP or ZFP36), has been well-studied in the context of inflammation and plays an important role in repressing pro-inflammatory transcripts such as TNF-alpha. Much less is known about the other family members, and none have been studied in the context of infection. Using macrophage cell lines and primary alveolar macrophages we demonstrated that, like ZFP36, ZFP36L1 is prominently induced by infection. To test our hypothesis that macrophage production of ZFP36L1 is necessary for regulation of the inflammatory response of the lung during pneumonia, we generated mice with a myeloid-specific deficiency of ZFP36L1. Surprisingly, we found that myeloid deficiency of ZFP36L1 did not result in alteration of lung cytokine production after infection, altered clearance of bacteria, or increased inflammatory lung injury. Although alveolar macrophages are critical components of the innate defense against respiratory pathogens, we concluded that myeloid ZFP36L1 is not essential for appropriate responses to bacteria in the lungs. Based on studies conducted with myeloid-deficient ZFP36 mice, our data indicate that, of the Zfp36 family, ZFP36 is the predominant negative regulator of cytokine expression in macrophages. In conclusion, these results imply that myeloid ZFP36 may fully compensate for loss of ZFP36L1 or that Zfp36l1-dependent mRNA expression does not play an integral role in the host defense against bacterial pneumonia.	[Hyatt, Lynnae D.; Wasserman, Gregory A.; Rah, Yoon J.; Matsuura, Kori Y.; Coleman, Fadie T.; Hilliard, Kristie L.; Pepper-Cunningham, Zachary Ash; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Hyatt, Lynnae D.; Ieong, Michael; Quinton, Lee J.; Mizgerd, Joseph P.; Jones, Matthew R.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wasserman, Gregory A.; Coleman, Fadie T.; Hilliard, Kristie L.; Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Stumpo, Deborah J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Quinton, Lee J.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Mizgerd, Joseph P.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University; Boston University; Boston University	Jones, MR (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	mattj@bu.edu	Blackshear, Perry J./C-6206-2019; Mizgerd, Joseph/GRY-6369-2022	Blackshear, Perry J./0000-0002-9561-8529; Wasserman, Gregory/0000-0002-0136-272X; Jones, Matthew/0000-0003-4647-2962; Quinton, Lee/0000-0003-1938-2507; Mizgerd, Joseph/0000-0002-4042-3169	NIH [R00-HL092956, R01-HL111449, T32-HL007035, R01-HL068153, R01-HL079392, R01-HL104053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068153, R01HL111449, R01HL104053, R01HL079392, T32HL007035, R00HL092956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by NIH grants, R00-HL092956 (LJQ), R01-HL111449 (LJQ), T32-HL007035 (for LDH), R01-HL068153 (JPM), R01-HL079392 (JPM), and R01-HL104053 (MRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed QAA, 2001, CLIN CHEST MED, V22, P71, DOI 10.1016/S0272-5231(05)70026-5; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Asakawa D, 2013, J MASS SPECTROM, V48, P352, DOI 10.1002/jms.3182; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bauer TT, 2006, CLIN INFECT DIS, V43, P748, DOI 10.1086/506430; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Cao HP, 2008, OBESITY, V16, P1208, DOI 10.1038/oby.2008.65; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Delclaux C, 2003, EUR RESPIR J, V22, p10S, DOI 10.1183/09031936.03.00420203; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Echterbille J, 2013, ANAL CHEM; El Solh AA, 2007, CRIT CARE MED, V35, P490, DOI 10.1097/01.CCM.0000253308.93761.09; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Grommes J, 2010, MOL MED; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Ieong MH, 2000, AM J RESP CRIT CARE, V162, P966, DOI 10.1164/ajrccm.162.3.9912054; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Jones MR, 2006, J INFECT DIS, V193, P360, DOI 10.1086/499312; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Mizgerd JP, 2008, AM J PHYSIOL-LUNG C, V294, pL387, DOI 10.1152/ajplung.00330.2007; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Mizgerd JP, 2002, AM J RESP CELL MOL, V27, P575, DOI 10.1165/rcmb.2002-0015OC; Nasir A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052187; Pittet LA, 2011, AM J RESP CELL MOL, V45, P573, DOI 10.1165/rcmb.2010-0210OC; PROBERT L, 1993, J IMMUNOL, V151, P1894; Qiu LQ, 2012, J IMMUNOL, V188, P5150, DOI 10.4049/jimmunol.1103700; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Quinton LJ, 2012, AM J RESP CRIT CARE, V186, P943, DOI 10.1164/rccm.201209-1702ED; Quinton LJ, 2012, J CLIN INVEST, V122, P1758, DOI 10.1172/JCI59408; Quinton LJ, 2009, INFECT IMMUN, V77, P2417, DOI 10.1128/IAI.01300-08; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Shimabukuro DW, 2003, CRIT CARE MED, V31, pS524, DOI 10.1097/01.CCM.0000081437.06466.B3; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Tan FE, 2014, P NATL ACAD SCI USA, V111, pE1740, DOI 10.1073/pnas.1320873111; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC; Yamamoto K, 2013, AM J RESP CELL MOL B; Yamamoto K, 2014, AM J RESP CELL MOL, V50, P253, DOI 10.1165/rcmb.2013-0114OC; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	67	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109072	10.1371/journal.pone.0109072	http://dx.doi.org/10.1371/journal.pone.0109072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299049	Green Submitted, gold, Green Published			2022-12-27	WOS:000343941200034
J	Stone, LS; German, JP; Kitto, KF; Fairbanks, CA; Wilcox, GL				Stone, Laura S.; German, Jonathan P.; Kitto, Kelly F.; Fairbanks, Carolyn A.; Wilcox, George L.			Morphine and Clonidine Combination Therapy Improves Therapeutic Window in Mice: Synergy in Antinociceptive but Not in Sedative or Cardiovascular Effects	PLOS ONE			English	Article							INTRATHECAL MORPHINE; EPIDURAL CLONIDINE; CHRONIC PAIN; ANALGESIA; FENTANYL; POTENTIATION; RECEPTOR; AGONIST; MANAGEMENT; CELECOXIB	Opioids are used to manage all types of pain including acute, cancer, chronic neuropathic and inflammatory pain. Unfortunately, opioid-related adverse effects such as respiratory depression, tolerance, physical dependence and addiction have led to an underutilization of these compounds for adequate pain relief. One strategy to improve the therapeutic utility of opioids is to co-administer them with other analgesic agents such as agonists acting at alpha(2)-adrenergic receptors (alpha(2)ARs). Analgesics acting at alpha(2)ARs and opioid receptors (ORs) frequently synergize when co-administered in vivo. Multimodal analgesic techniques offer advantages over single drug treatments as synergistic combination therapies produce analgesia at lower doses, thus reducing undesired side effects. This inference presumes, however, that the synergistic interaction is limited to the analgesic effects. In order to test this hypothesis, we examined the effects of alpha(2)AR/OR combination therapy in acute antinociception and in the often-undesired side effects of sedation and cardiovascular depression in awake unrestrained mice. Morphine, clonidine or their combination was administered by spinal or systemic injection in awake mice. Antinociception was determined using the warm water tail flick assay (52.5 degrees C). Sedation/motor impairment was evaluated using the accelerating rotarod assay and cardiovascular function was monitored by pulse oximetry. Data were converted to percent maximum possible effect and isobolographic analysis was performed to determine if an interaction was subadditive, additive or synergistic. Synergistic interactions between morphine and clonidine were observed in the antinociceptive but not in the sedative/motor or cardiovascular effects. As a result, the therapeutic window was improved, similar to 200-fold and antinociception was achieved at non-sedating doses with little to no cardiovascular depression. In addition, combination therapy resulted in greater maximum analgesic efficacy over either drug alone. These data support the utility of combination adrenergic/opioid therapy in pain management for antinociceptive efficacy with reduced side-effect liability.	[Stone, Laura S.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada; [Stone, Laura S.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Dept Anesthesiol, Montreal, PQ, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Fairbanks, Carolyn A.] Univ Minnesota, Coll Pharm, Dept Pharmaceut, Minneapolis, MN 55455 USA; [German, Jonathan P.; Kitto, Kelly F.; Fairbanks, Carolyn A.; Wilcox, George L.] Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; [Fairbanks, Carolyn A.; Wilcox, George L.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Wilcox, George L.] Univ Minnesota, Sch Med, Dept Dermatol, Minneapolis, MN 55455 USA	McGill University; McGill University; McGill University; McGill University; McGill University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stone, LS (corresponding author), McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada.	laura.s.stone@mcgill.ca		Wilcox, George/0000-0002-6411-0423; Fairbanks, Carolyn/0000-0003-4252-8586	National Institute of Health; National Institute of Drug Abuse [R21-DA-017075, R01-DA-04274, R01-DA-15438, K01-DA-00509]; Canadian Institutes for Health Research [MOP-86691]; Fonds de la Recherche en Sante Quebec; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA000509, R01DA015438, R21DA017075, R01DA004274] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Health (www.nih.gov), National Institute of Drug Abuse grants to LSS [R21-DA-017075], GLW [R01-DA-04274, R01-DA-15438] and CAF [K01-DA-00509], Canadian Institutes for Health Research (www.cihr-irsc.gc.ca) Operating Grant [MOP-86691] to LSS and a Fonds de la Recherche en Sante Quebec (www.frsq.gouv.qc.ca) Salary Award to LSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Pain Society, 2006, PAIN CONTR PRIM CAR; BOUAZIZ H, 1995, REGION ANESTH, V20, P121; Chabot-Dore AJ, 2013, J PHARMACOL EXP THER, V347, P773, DOI 10.1124/jpet.113.206581; Chaparro LE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008943.pub2; COOMBS DW, 1986, J NEUROSURG, V64, P890, DOI 10.3171/jns.1986.64.6.0890; COUSINS MJ, 1984, ANESTHESIOLOGY, V61, P276; DRASNER K, 1988, PAIN, V32, P309, DOI 10.1016/0304-3959(88)90042-5; EISENACH JC, 1995, PAIN, V61, P391, DOI 10.1016/0304-3959(94)00209-W; EISENACH JC, 1989, ANESTHESIOLOGY, V71, P647, DOI 10.1097/00000542-198911000-00004; EISENACH JC, 1994, ANESTH ANALG, V79, P285; EISENACH JC, 1989, ANESTHESIOLOGY, V71, P640, DOI 10.1097/00000542-198911000-00003; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; Fairbanks CA, 2000, ANESTHESIOLOGY, V93, P765, DOI 10.1097/00000542-200009000-00026; Gilron I, 2013, LANCET NEUROL, V12, P1084, DOI 10.1016/S1474-4422(13)70193-5; Giovannoni MP, 2009, MED RES REV, V29, P339, DOI 10.1002/med.20134; Hassenbusch SJ, 2002, PAIN MED, V3, P85, DOI 10.1046/j.1526-4637.2002.02014.x; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; JANSSEN PAJ, 1963, ARZNEIMITTEL-FORSCH, V13, P502; Kedlaya Divakara, 2002, Best Pract Res Clin Anaesthesiol, V16, P651, DOI 10.1053/bean.2002.0253; LOOMIS CW, 1985, CAN J PHYSIOL PHARM, V63, P656, DOI 10.1139/y85-109; LOOMIS CW, 1988, NEUROPHARMACOLOGY, V27, P191, DOI 10.1016/0028-3908(88)90170-0; MEERT TF, 1994, ANESTHESIOLOGY, V81, P677, DOI 10.1097/00000542-199409000-00022; MENDEZ R, 1990, ANESTHESIOLOGY, V73, P848, DOI 10.1097/00000542-199011000-00009; Meske DS, 2013, NEUROSCIENCE LETT; MONASKY MS, 1990, J PHARMACOL EXP THER, V254, P383; MURGA G, 1994, ANAESTHESIA, V49, P999, DOI 10.1111/j.1365-2044.1994.tb04323.x; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Ossipov MH, 1997, ANESTHESIOLOGY, V86, P196, DOI 10.1097/00000542-199701000-00024; OSSIPOV MH, 1990, ANESTHESIOLOGY, V73, P1227, DOI 10.1097/00000542-199012000-00022; OSSIPOV MH, 1990, J PHARMACOL EXP THER, V255, P1107; OSSIPOV MH, 1990, LIFE SCI, V47, pPL71, DOI 10.1016/0024-3205(90)90530-5; PAALZOW L, 1974, J PHARM PHARMACOL, V26, P361, DOI 10.1111/j.2042-7158.1974.tb09291.x; Paech MJ, 2002, ANESTH ANALG, V95, P1396, DOI 10.1097/00000539-200211000-00054; Paech MJ, 2004, ANESTH ANALG, V98, P1460, DOI 10.1213/01.ANE.0000111208.08867.3C; PLUMMER JL, 1992, PAIN, V49, P145, DOI 10.1016/0304-3959(92)90201-L; Puig MM, 1996, ANESTHESIOLOGY, V85, P1403, DOI 10.1097/00000542-199612000-00022; RAFFA RB, 1993, J PHARMACOL EXP THER, V267, P331; RANDICH A, 1992, J NEUROPHYSIOL, V68, P1027, DOI 10.1152/jn.1992.68.4.1027; RAUCK RL, 1993, ANESTHESIOLOGY, V79, P1163, DOI 10.1097/00000542-199312000-00005; REDDY SVR, 1980, J PHARMACOL EXP THER, V213, P525; REDDY SVR, 1980, BRAIN RES, V189, P391; Reuben SS, 2007, J BONE JOINT SURG AM, V89A, P1343, DOI 10.2106/JBJS.F.00906; Reuben SS, 2006, ANESTH ANALG, V103, P1271, DOI 10.1213/01.ane.0000237279.08847.2d; Roerig SC, 1995, LIFE SCI, V56, pPL115; Siddall PJ, 2000, ANESTH ANALG, V91, P1493, DOI 10.1097/00000539-200012000-00037; SIDDALL PJ, 1994, PAIN, V59, P147, DOI 10.1016/0304-3959(94)90059-0; SOLOMON RE, 1989, J PHARMACOL EXP THER, V251, P27; SOLOMON RE, 1994, ANESTH ANALG, V78, P1164; SOLOMON RE, 1988, J PHARMACOL EXP THER, V245, P444; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Tajerian M, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/150842; Tallarida RJ, 2002, PAIN, V98, P163, DOI 10.1016/S0304-3959(02)00041-6; TALLARIDA RJ, 1992, PAIN, V49, P93, DOI 10.1016/0304-3959(92)90193-F; Tallarida RJ, 1987, MANUAL PHARMACOLOGIC, P26; Uhle EI, 2000, STEREOT FUNCT NEUROS, V75, P167, DOI 10.1159/000048402; Walker SM, 2002, ANESTH ANALG, V95, P674, DOI 10.1213/01.ANE.0000023209.14008.5B; WILCOX GL, 1987, BRAIN RES, V405, P84, DOI 10.1016/0006-8993(87)90992-9; YAKSH TL, 1981, ANESTHESIOLOGY, V54, P451, DOI 10.1097/00000542-198106000-00004; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	60	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109903	10.1371/journal.pone.0109903	http://dx.doi.org/10.1371/journal.pone.0109903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299457	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200086
J	Vickers, TA; Crooke, ST				Vickers, Timothy A.; Crooke, Stanley T.			Antisense Oligonucleotides Capable of Promoting Specific Target mRNA Reduction via Competing RNase H1-Dependent and Independent Mechanisms	PLOS ONE			English	Article							GENE-EXPRESSION; RIBONUCLEASE-H; INHIBITION; INITIATION; COMPLEX; BINDING; PROTEIN	Antisense oligonucleotides (ASOs) are most commonly designed to reduce targeted RNA via RNase H1-dependent degradation. In this paper we demonstrate that cellular proteins can compete for sites targeted by RNase H1-dependent ASOs. We further show that some ASOs designed to mediate RNase H1 cleavage can, in certain instances, promote target reduction both by RNase H1-mediated cleavage and by steric inhibition of binding of splicing factors at a site required for efficient processing of the pre-mRNA. In the latter case, RNase H cleavage was prevented by binding of a second protein, HSPA8, to the ASO/pre-mRNA heteroduplex. In addition, using a precisely controlled minigene system, we directly demonstrated that activity of ASOs targeting sites in introns is strongly influenced by splicing efficiency.	[Vickers, Timothy A.; Crooke, Stanley T.] ISIS Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA USA	Isis Pharmaceuticals Inc	Vickers, TA (corresponding author), ISIS Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA USA.	tvickers@isisph.com			ISIS Pharmaceuticals, Inc.	ISIS Pharmaceuticals, Inc.	This work was supported by ISIS Pharmaceuticals, Inc. The funder provided support in the form of salaries for authors TAV and STC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; BAKER BF, 1992, J BIOL CHEM, V267, P11495; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chou MY, 1999, MOL CELL BIOL, V19, P69; Cook P.D., 1993, ANTISENSE RES APPL, P149; Crooke S.T., 2007, ANTISENSE DRUG TECHN, P3, DOI 10.1201/9780849387951; Crooke ST, 1999, BIOCHIM BIOPHYS ACTA, V1489, P30; Crouch RJ, 1985, NUCLEASES, P211; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Hashimoto JG, 2004, BIOTECHNIQUES, V36, P54, DOI 10.2144/04361BM06; HODGE D, 1995, MOL PHARMACOL, V48, P905; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; KOGOMA T, 1985, MOL GEN GENET, V200, P103, DOI 10.1007/BF00383320; Liang XH, 2014, NUCLEIC ACIDS RES, V42, P7819, DOI 10.1093/nar/gku484; Lima WF, 2007, MOL PHARMACOL, V71, P83, DOI 10.1124/mol.106.025015; Lima WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101752; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Monia BP, 1996, J BIOL CHEM, V271, P14533, DOI 10.1074/jbc.271.24.14533; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Pastor T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023349; Rigo F, 2012, NAT CHEM BIOL, V8, P555, DOI [10.1038/nchembio.939, 10.1038/NCHEMBIO.939]; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Sproat BS, 1993, ANTISENSE RES APPLIC, P351; Talukdar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027869; Tang XY, 2011, MOL CELL BIOCHEM, V357, P55, DOI 10.1007/s11010-011-0875-5; VICKERS T, 1991, NUCLEIC ACIDS RES, V19, P3359, DOI 10.1093/nar/19.12.3359; Vickers TA, 2001, NUCLEIC ACIDS RES, V29, P1293, DOI 10.1093/nar/29.6.1293; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Vickers TA, 2006, J IMMUNOL, V176, P3652, DOI 10.4049/jimmunol.176.6.3652; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200; Wu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071006	38	42	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e108625	10.1371/journal.pone.0108625	http://dx.doi.org/10.1371/journal.pone.0108625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299183	gold, Green Published, Green Submitted			2022-12-27	WOS:000343941200019
J	Ballestriero, F; Daim, M; Penesyan, A; Nappi, J; Schleheck, D; Bazzicalupo, P; Di Schiavi, E; Egan, S				Ballestriero, Francesco; Daim, Malak; Penesyan, Anahit; Nappi, Jadranka; Schleheck, David; Bazzicalupo, Paolo; Di Schiavi, Elia; Egan, Suhelen			Antinematode Activity of Violacein and the Role of the Insulin/IGF-1 Pathway in Controlling Violacein Sensitivity in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-SPAN; GENES; RESISTANCE; BACTERIA; PREDATION; DEFENSES; IMMUNITY; MUTANTS; ENZYMES; DAF-16	The purple pigment violacein is well known for its numerous biological activities including antibacterial, antiviral, antiprotozoan, and antitumor effects. In the current study we identify violacein as the antinematode agent produced by the marine bacterium Microbulbifer sp. D250, thereby extending the target range of this small molecule. Heterologous expression of the violacein biosynthetic pathway in E. coli and experiments using pure violacein demonstrated that this secondary metabolite facilitates bacterial accumulation in the nematode intestine, which is accompanied by tissue damage and apoptosis. Nematodes such as Caenorhabditis elegans utilise a well-defined innate immune system to defend against pathogens. Using C. elegans as a model we demonstrate the DAF-2/DAF-16 insulin/IGF-1 signalling (IIS) component of the innate immune pathway modulates sensitivity to violacein-mediated killing. Further analysis shows that resistance to violacein can occur due to a loss of DAF-2 function and/or an increased function of DAF-16 controlled genes involved in antimicrobial production (spp-1) and detoxification (sod-3). These data suggest that violacein is a novel candidate antinematode agent and that the IIS pathway is also involved in the defence against metabolites from non-pathogenic bacteria.	[Ballestriero, Francesco; Daim, Malak; Nappi, Jadranka; Egan, Suhelen] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Ballestriero, Francesco; Daim, Malak; Nappi, Jadranka; Egan, Suhelen] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Penesyan, Anahit] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Schleheck, David] Univ Konstanz, Dept Biol, Constance, Germany; [Bazzicalupo, Paolo; Di Schiavi, Elia] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy	University of New South Wales Sydney; University of New South Wales Sydney; Macquarie University; University of Konstanz; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Egan, S (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	s.egan@unsw.edu.au	Di Schiavi, Elia/B-8046-2015; Penesyan, Anahit/Y-6884-2019; Penesyan, Anahit/A-9442-2012	Di Schiavi, Elia/0000-0002-8179-6666; Penesyan, Anahit/0000-0002-2502-0740; Penesyan, Anahit/0000-0002-2502-0740; Egan, Suhelen/0000-0003-3286-4279				Ahmetagic A, 2011, PLASMID, V66, P152, DOI 10.1016/j.plasmid.2011.07.006; Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda S, 2011, MICROB ECOL, V62, P446, DOI 10.1007/s00248-011-9840-9; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; Back P, 2010, EXP GERONTOL, V45, P603, DOI 10.1016/j.exger.2010.01.014; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Ballestriero F, 2010, APPL ENVIRON MICROB, V76, P5710, DOI 10.1128/AEM.00695-10; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; BRENNER S, 1974, GENETICS, V77, P71; Bromberg N, 2010, CHEM-BIOL INTERACT, V186, P43, DOI 10.1016/j.cbi.2010.04.016; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; de Carvalho DD, 2006, TOXICOL IN VITRO, V20, P1514, DOI 10.1016/j.tiv.2006.06.007; Durai S, 2011, J MICROBIOL BIOTECHN, V21, P1026, DOI 10.4014/jmb.1102.02006; Duran M, 2012, MED CHEM RES, V21, P1524, DOI 10.1007/s00044-011-9654-9; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2000, GENETICS, V154, P1597; Hakvag S, 2009, MAR DRUGS, V7, P576, DOI 10.3390/md7040576; Harrington D, 2005, LINEAR RANK TESTS SU; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Jiang PX, 2012, APPL MICROBIOL BIOT, V94, P1521, DOI 10.1007/s00253-012-3960-0; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Kawli T, 2010, DIS MODEL MECH, V3, P721, DOI 10.1242/dmm.003871; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kho MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029122; Kleino A, 2012, CELL HOST MICROBE, V11, P320, DOI 10.1016/j.chom.2012.04.002; Konzen M, 2006, BIOORGAN MED CHEM, V14, P8307, DOI 10.1016/j.bmc.2006.09.013; Lu Y, 2009, BIOCHEM ENG J, V43, P135, DOI 10.1016/j.bej.2008.09.009; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MARDEN P, 1985, ARCH MICROBIOL, V142, P326, DOI 10.1007/BF00491898; Marsh EK, 2012, APPL ENVIRON MICROB, V78, P2075, DOI 10.1128/AEM.07486-11; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pantanella F, 2007, J APPL MICROBIOL, V102, P992, DOI 10.1111/j.1365-2672.2006.03155.x; Penesyan A, 2013, MAR DRUGS, V11, P40, DOI 10.3390/md11010040; Penesyan A, 2009, FEMS MICROBIOL ECOL, V69, P113, DOI 10.1111/j.1574-6941.2009.00688.x; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Prichard RK, 2008, NATURE, V452, P157, DOI 10.1038/452157a; Roeder T, 2010, DEV COMP IMMUNOL, V34, P203, DOI 10.1016/j.dci.2009.09.010; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Stiernagle Theresa, 2006, WormBook, P1; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Tan MW, 2011, CELL MICROBIOL, V13, P497, DOI 10.1111/j.1462-5822.2011.01570.x; Taylor CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003149; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Yang LH, 2007, LETT APPL MICROBIOL, V44, P625, DOI 10.1111/j.1472-765X.2007.02125.x; Zhang X, 2011, APPL MICROBIOL BIOT, V90, P1963, DOI 10.1007/s00253-011-3203-9; Zhang XD, 2009, CELL HOST MICROBE, V5, P425, DOI 10.1016/j.chom.2009.05.003	61	25	26	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109201	10.1371/journal.pone.0109201	http://dx.doi.org/10.1371/journal.pone.0109201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295516	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000047
J	Lopez-Arbarello, A; Stockar, R; Burgin, T				Lopez-Arbarello, Adriana; Stockar, Rudolf; Buergin, Toni			Phylogenetic Relationships of the Triassic Archaeosemionotus Deecke (Halecomorphi, Ionoscopiformes) from the 'Perledo Fauna'	PLOS ONE			English	Article							MERIDE CANTON TICINO; SOUTHERN SWITZERLAND; FISH HALECOMORPHI; MIDDLE; ACTINOPTERYGII; EVOLUTION; SKELETON; GENUS	The lagerstatten in the Monte San Giorgio have provided excellent fossils representing one of the most important windows to the marine life during the Triassic. Among these fossils, fishes are abundant and extraordinarily well preserved. Most of these fishes represent extinct lineages and were difficult to understand and classify during the early years after discovery. These difficulties usually led to a mixture of species under the same taxonomic name. This is the case of fishes referred to the genus Archaeosemionotus. The name bearing type of A. connectens, the type species of this genus, represents a basal halecomorph, but most other fishes referred to this genus represent basal ginglymodians. Therefore, we conducted this study to clarify the taxonomic status and phylogenetic relationships of A. connectens, which is a member of the family Furidae (Halecomorphi, Ionoscopiformes) representing the second cladistically supported evidence of ionoscopiforms in the Triassic and it is thus one of the two oldest reliable records of this group. Ionoscopiforms have a long stratigraphic range, though their fossil record is rather patchy. In our analysis, the sister taxon of Archaeosemionotus is Robustichthys from the Anisian of China, and they together form a clade with Furo, which is known from several localities ranging from the Early to the Late Jurassic. Other ionoscopiforms are so far known from the Kimmeridgian to the Albian and it is thus evident that recent efforts have concentrated on the later history of the group (Late Jurassic to Cretaceous). The phylogenetic relationships obtained for the Ionoscopiformes do not show a clear palaeobiogeographic pattern, but give important new insights into the origin, divergence date and early history of this clade.	[Lopez-Arbarello, Adriana] Univ Munich, SNSB Bavarian State Collect Palaeontol & Geol, Munich, Germany; [Lopez-Arbarello, Adriana] Univ Munich, GeoBioctr, Munich, Germany; [Stockar, Rudolf] Museo Cantonale Storia Nat, Lugano, Switzerland; [Buergin, Toni] Naturmuseum, Gallen, Switzerland	University of Munich; University of Munich	Lopez-Arbarello, A (corresponding author), Univ Munich, SNSB Bavarian State Collect Palaeontol & Geol, Munich, Germany.	a.Lopez-Arbarello@lrz.uni-muenchen.de	Lopez-Arbarello, Adriana/N-1834-2018	Lopez-Arbarello, Adriana/0000-0002-2924-3319	German Research Foundation [LO1405/3]; Dipartimento del territorio del Cantone Ticino; Swiss Federal Office for the Environment	German Research Foundation(German Research Foundation (DFG)); Dipartimento del territorio del Cantone Ticino; Swiss Federal Office for the Environment	This research has been financed through project LO1405/3 from the German Research Foundation (http://www.dfg.de/) and by the Dipartimento del territorio del Cantone Ticino and the Swiss Federal Office for the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassiz L., 1834, NEUES JB MINERALOGIE, V1834; Alvarado-Ortega J, 2008, J PALEONTOL, V82, P163, DOI 10.1666/04-152.1; Applegate SP, 1988, REV I GEOL UNAM, V7, P200; Balsamo-Crivelli G, 1839, POLITECNICO MILANO, V1, P421; Bartram A. W. H., 1977, Bulletin Br. Mus. nat. Hist. (Geol.), V29, P137; BARTRAM AWH, 1975, ZOOL J LINN SOC-LOND, V56, P183, DOI 10.1111/j.1096-3642.1975.tb00263.x; Bassani F., 1886, ATTI SOCIETA ITALIAN, V29, P15; Bellotti C, 1857, STUDII GEOLOGICI PAL, P491; BELTAN L L, 1972, Memorias de la Real Academia de Ciencias y Artes de Barcelona, V41, P281; Brack P, 2005, EPISODES, V28, P233, DOI 10.18814/epiiugs/2005/v28i4/001; BURGIN T, 1991, ECLOGAE GEOL HELV, V84, P921; Burgin T, 1995, ECLOGAE GEOL HELV, V88, P803; Burgin Toni, 1999, P481; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Cope E.D., 1887, AM NAT, V21, P1014, DOI DOI 10.1086/274597; De Alessandri G., 1910, MEM SOC ITAL SCI NAT, V7, P1; Deecke W., 1889, PALAEONTOGRAPHICA, V35, P13; Furrer H, 1995, ECLOGAE GEOL HELV, V88, P827; Furrer H, 2001, INT M MES FISH 3 SYS, P1; Furrer H, 2009, SO KAM FISH BERG EIN; Furrer Heinz, 2003, Neujahrsblatt der Naturforschenden Gesellschaft in Zuerich, V206, P1; Gaetani M, 1992, RIV ITAL PALEONTOL S, V97, P329; Gardiner Brian G., 1996, P117, DOI 10.1016/B978-012670950-6/50007-2; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; HUTCHINSON P, 1973, B BRIT MUS NAT HIST, V22, P235; Huxley T.H., 1861, MEMOIRS GEOLOGICAL S, V10, P1; Jordan DS, 1923, STANFORD U PUBL U BS, V3, P77, DOI [10.5962/bhl.title.161386, DOI 10.5962/BHL.TITLE.161386]; Kramberger-Gorjanovic K., 1905, Beitraege zur Palaeontologie Oesterreich-Ungarns, Vxviii, P193; Lambers Paul H., 1995, Geobios Memoire Special (Villeurbanne), V19, P201; Lambers Paul H., 1998, Oryctos, V1, P23; Lane JA, 2012, J VERTEBR PALEONTOL, V32, P799, DOI 10.1080/02724634.2012.680325; Lombardo C, 2001, RIV ITAL PALEONTOL S, V107, P345, DOI 10.13130/2039-4942/5439; Lopez-Arbarello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039370; Machado GP, 2013, J VERTEBR PALEONTOL, V33, P482, DOI 10.1080/02724634.2013.729962; Maddison WP, 2011, MESQUITE MODULAR SYS; Muller J., 1846, PHYSIKALISCH MATHEMA, V1846, P117; O'Leary MA, 2012, MORPH BANK 3 0 WEB A; PATTERSON COLIN, 1968, BULL BRIT MUS [NATUR HIS] GEOL, V16, P203; Pinna G., 1991, Natura (Milan), V82, P1; Regan CT, 1923, P ZOOL SOC LOND, V1923, P445; SCHAEFFER BOBB, 1960, AMER MUS NOVITATES, V2011, P1; Schultze Hans-Peter, 1996, P83; SCHULTZE HP, 1989, ZOOL J LINN SOC-LOND, V97, P189, DOI 10.1111/j.1096-3642.1989.tb00547.x; Sieber R, 1950, CARINTHIA, V2, P91; Stockar R, 2012, SWISS J GEOSCI, V105, P85, DOI 10.1007/s00015-012-0093-5; Stockar R, 2010, SWISS J GEOSCI, V103, P101, DOI 10.1007/s00015-010-0008-2; Stutzer PH, 1972, THESIS LUDIWIG MAXIM; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tintori A, 1998, RIV ITAL PALEONTOL S, V104, P417, DOI 10.13130/2039-4942/5342; Tintori A, 2007, RIV ITAL PALEONTOL S, V113, P369, DOI 10.13130/2039-4942/5881; Tintori Andrea, 1999, P495; Wenz S., 1967, Cent Nat Rech Sci Paris, P1; Wenz S, 1986, B MUSEUM NATL HIST C, P77; Woodward A.S., 1895, MEMOIRS GEOLOGICAL S, V9, P1; Xu GH, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0204	55	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e108665	10.1371/journal.pone.0108665	http://dx.doi.org/10.1371/journal.pone.0108665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296174	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000017
J	Lu, Q; Wang, JY; Wang, LM; Jiang, XC; Chu, YW				Lu, Qing; Wang, Ji-Yang; Wang, Luman; Jiang, Xuechao; Chu, Yiwei			Self DNA from Lymphocytes That Have Undergone Activation-Induced Cell Death Enhances Murine B Cell Proliferation and Antibody Production	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; SHORT-LIVED PLASMABLASTS; MARGINAL-ZONE; GERMINAL CENTER; INCREASED FREQUENCY; AUTOIMMUNE-DISEASE; IMMUNE-COMPLEXES; DYING CELLS; NZB/W MICE	Systemic lupus erythematosus (SLE) is characterized by prominent autoinflammatory tissue damage associated with impaired removal of dying cells and DNA. Self DNA-containing immune complexes are able to activate both innate and adaptive immune responses and play an important role in the maintenance and exacerbation of autoimmunity in SLE. In this study, we used DNA from lymphocytes that have undergone activation-induced cell death (ALD-DNA) and analyzed its role on the activation and differentiation of B cells from normal BALB/c mice as well as lupus-prone MRL+/+ and MRL/lpr mice. We found that ALD-DNA directly increased the expression of costimulatory molecules and the survival of naive B cells in vitro. Although ALD-DNA alone had little effect on the proliferation of naive B cells, it enhanced LPS-activated B cell proliferation in vitro and in vivo. In addition, ALD-DNA increased plasma cell numbers and IgG production in LPS-stimulated cultures of naive B cells, in part via enhancing IL-6 production. Importantly, B cells from lupus mice were hyperresponsive to ALD-DNA and/or LPS relative to normal control B cells in terminal plasma cell differentiation, as evidenced by increases in CD138(+) cell numbers, IgM production, and mRNA levels of B lymphocyte-induced maturation protein-1 (Blimp-1) and the X-box binding protein 1 (XBP1). Furthermore, ALD-DNA enhanced CD40-activated naive B cell proliferation. Collectively, these data indicate that self DNA can serve as a DAMP (damage-associated molecular pattern) that cooperates with signals from both innate and adaptive immunity to promote polyclonal B cell activation, a common characteristic of autoimmune diseases.	[Lu, Qing; Wang, Ji-Yang; Wang, Luman; Jiang, Xuechao; Chu, Yiwei] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China; [Wang, Ji-Yang; Chu, Yiwei] Fudan Univ, Biotherapy Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chu, YW (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Immunol, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China.	yiwei_chu@126.com			Chinese Natural Sciences Foundation [30872337, 81273215, 81330080]; Grants-in-Aid for Scientific Research [25460604] Funding Source: KAKEN	Chinese Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by grants from the Chinese Natural Sciences Foundation (Grant 30872337 [QL], 81273215 [YC] and 81330080 [OL]) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Brummel R, 2005, J IMMUNOL, V174, P2429, DOI 10.4049/jimmunol.174.4.2429; Cai YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062465; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Dall'Era MC, 2005, ANN RHEUM DIS, V64, P1692, DOI 10.1136/ard.2004.033753; Dil N, 2009, MOL IMMUNOL, V46, P1970, DOI 10.1016/j.molimm.2009.03.010; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x; Eisner MD, 1996, SEMIN ARTHRITIS RHEU, V26, P477, DOI 10.1016/S0049-0172(96)80028-X; EMLEN W, 1994, J IMMUNOL, V152, P3685; Finke D, 2007, EUR J IMMUNOL, V37, P1702, DOI 10.1002/eji.200636719; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Gergely P, 2002, ARTHRITIS RHEUM-US, V46, P175, DOI 10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Gunn KE, 2006, J IMMUNOL, V177, P3791, DOI 10.4049/jimmunol.177.6.3791; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; Jacob N, 2010, AUTOIMMUNITY, V43, P84, DOI 10.3109/08916930903374600; Jiang N, 2005, J LEUKOCYTE BIOL, V77, P296, DOI 10.1189/jlb.0704411; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; KAWANO Y, 1995, IMMUNOLOGY, V84, P278; KLINMAN DM, 1990, J CLIN INVEST, V86, P1249, DOI 10.1172/JCI114831; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marcelletti JF, 1996, J IMMUNOL, V157, P3323; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Ouchida R, 2012, P NATL ACAD SCI USA, V109, pE2699, DOI 10.1073/pnas.1210706109; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Pisetsky DS, 2013, EUR J IMMUNOL, V43, P3163, DOI 10.1002/eji.201344175; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Qian Y, 2006, BLOOD, V108, P974, DOI 10.1182/blood-2005-12-006858; SANO H, 1982, J IMMUNOL, V128, P1341; SANO H, 1989, SCAND J IMMUNOL, V30, P51, DOI 10.1111/j.1365-3083.1989.tb01188.x; Santiago-Raber ML, 2004, AUTOIMMUN REV, V3, P33, DOI 10.1016/S1568-9972(03)00062-4; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schroeder K, 2013, AUTOIMMUNITY, V46, P121, DOI 10.3109/08916934.2012.748751; Su KY, 2009, SCAND J IMMUNOL, V70, P175, DOI 10.1111/j.1365-3083.2009.02300.x; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tuvim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030596; Vinuesa CG, 2013, NAT IMMUNOL, V14, P119, DOI 10.1038/ni.2511; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315	62	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109095	10.1371/journal.pone.0109095	http://dx.doi.org/10.1371/journal.pone.0109095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296026	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000037
J	Sterflinger, K; Lopandic, K; Pandey, RV; Blasi, B; Kriegner, A				Sterflinger, Katja; Lopandic, Ksenija; Pandey, Ram Vinay; Blasi, Barbara; Kriegner, Albert			Nothing Special in the Specialist? Draft Genome Sequence of Cryomyces antarcticus, the Most Extremophilic Fungus from Antarctica	PLOS ONE			English	Article							ROCK-INHABITING FUNGI; EXOPHIALA; EVOLUTION	The draft genome of the Antarctic endemic fungus Cryomyces antarcticus is presented. This rock inhabiting, microcolonial fungus is extremely stress tolerant and it is a model organism for exobiology and studies on stress resistance in Eukaryots. Since this fungus is a specialist in the most extreme environment of the Earth, the analysis of its genome is of important value for the understanding of fungal genome evolution and stress adaptation. A comparison with Neurospora crassa as well as with other microcolonial fungi shows that the fungus has a genome size of 24 Mbp, which is the average in the fungal kingdom. Although sexual reproduction was never observed in this fungus, 34 mating genes are present with protein homologs in the classes Eurotiomycetes, Sordariomycetes and Dothideomycetes. The first analysis of the draft genome did not reveal any significant deviations of this genome from comparative species and mesophilic hyphomycetes.	[Sterflinger, Katja; Lopandic, Ksenija; Blasi, Barbara] Univ Nat Resources & Life Sci, VIBT Extremophile Ctr, Vienna, Austria; [Pandey, Ram Vinay; Kriegner, Albert] Austrian Inst Technol, Vienna, Austria; [Pandey, Ram Vinay] Univ Vet Med, Inst Populat Genet, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Austrian Institute of Technology (AIT); University of Veterinary Medicine Vienna	Sterflinger, K (corresponding author), Univ Nat Resources & Life Sci, VIBT Extremophile Ctr, Vienna, Austria.	Katja.Sterflinger@boku.ac.at	Pandey, Ram Vinay/AAL-1701-2021; Pandey, Ram Vinay/AAA-3544-2022	Blasi, Barbara/0000-0002-3776-6363; Sterflinger, Katja/0000-0002-0296-6728; Lopandic, Ksenija/0000-0003-2674-2849; Pandey, Ram Vinay/0000-0002-2533-8687	city of Vienna (ZID); Austrian Ministry of Science, Research and Economy	city of Vienna (ZID); Austrian Ministry of Science, Research and Economy	The equipment and consumables were funded by a non-profit organisation including the city of Vienna (ZID) and by the Austrian Ministry of Science, Research and Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; De Hoog GS, 2006, ANTON LEEUW INT J G, V90, P257, DOI 10.1007/s10482-006-9080-z; Dhillon B, 2011, METHODS MOL BIOL, V722, P33, DOI 10.1007/978-1-61779-040-9_3; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Gostincar C, 2010, FEMS MICROBIOL ECOL, V71, P2, DOI 10.1111/j.1574-6941.2009.00794.x; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Heitman J, 2013, MYCOLOGIA, V105, P1, DOI 10.3852/12-253; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Lenassi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071328; Marzban G, 2013, NAT SCI, V5, P640, DOI DOI 10.4236/NS.2013.55079; Matos T, 2002, MYCOSES, V45, P373, DOI 10.1046/j.1439-0507.2002.00779.x; Matos T, 2003, ANTON LEEUW INT J G, V83, P293, DOI 10.1023/A:1023373329502; Onofri S, 2004, PLANET SPACE SCI, V52, P229, DOI 10.1016/j.pss.2003.08.019; Onofri S, 2008, STUD MYCOL, P99, DOI 10.3114/sim.2008.61.10; Onofri S, 2012, ASTROBIOLOGY, V12, P508, DOI 10.1089/ast.2011.0736; Schoustra SE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030068; Selbmann L, 2005, STUD MYCOL, P1; Selbmann L, 2008, STUD MYCOL, P1, DOI 10.3114/sim.2008.61.01; Selbmann L, 2011, FUNGAL BIOL-UK, V115, P937, DOI 10.1016/j.funbio.2011.02.016; Shear CL, 1927, J AGRIC RES, V34, P1019; Sterflinger K, 1997, ANTON LEEUW INT J G, V72, P349, DOI 10.1023/A:1000570429688; Sterflinger K, 2001, ANTON LEEUW INT J G, V80, P275, DOI 10.1023/A:1013060308809; Sterflinger K, 1998, ANTON LEEUW INT J G, V74, P271, DOI 10.1023/A:1001753131034; Sterflinger K, 2012, FUNGAL ECOL, V5, P453, DOI 10.1016/j.funeco.2011.12.007; STORCK R, 1966, J BACTERIOL, V91, P227, DOI 10.1128/JB.91.1.227-230.1966; Tesei D, 2012, FUNGAL BIOL-UK, V116, P932, DOI 10.1016/j.funbio.2012.06.004; Zakharova K, 2014, NAT SCI, V5, P640; Zakharova K, 2013, MYCOPATHOLOGIA, V175, P537, DOI 10.1007/s11046-012-9592-1; Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06	30	14	15	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109908	10.1371/journal.pone.0109908	http://dx.doi.org/10.1371/journal.pone.0109908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296285	Green Published, gold			2022-12-27	WOS:000345204000102
J	Goswami, A; Chakraborty, U; Mahapatra, T; Mahapatra, S; Mukherjee, T; Das, S; Das, A; Dey, SK; Ray, S; Bhattacharya, B; Pal, NK				Goswami, Avranil; Chakraborty, Urmita; Mahapatra, Tanmay; Mahapatra, Sanchita; Mukherjee, Tapajyoti; Das, Shibali; Das, Aritra; Dey, Subir Kumar; Ray, Sudhin; Bhattacharya, Basudev; Pal, Nishith Kumar			Correlates of Treatment Outcomes and Drug Resistance among Pulmonary Tuberculosis Patients Attending Tertiary Care Hospitals of Kolkata, India	PLOS ONE			English	Article							CHAIN-REACTION PCR; RISK-FACTORS; PREVALENCE; DEFAULT; IDENTIFICATION; RETREATMENT; FAILURE; RELAPSE; SPUTUM	Background: Worldwide highest number of new pulmonary tuberculosis (PTB) cases, was reported from India in 2012. Adverse treatment outcomes and emergence of drug resistance further complicated the prevailing scenario owing to increased duration, cost and toxicity associated with the treatment of drug-resistant cases. Hence to reinforce India's fight against TB, identification of the correlates of adverse treatment outcomes and drug resistance, seemed critical. Methods: To estimate the associations between diagnostic findings, patient types (based on treatment outcomes), drug resistance and socio-demographic characteristics of PTB patients, a cross-sectional study was conducted in two tertiary-care hospitals in Kolkata between April 2010 and March 2013. Altogether, 350 consenting Mycobacterium tuberculosis sputum-culture positive PTB patients were interviewed about their socio-demographic background, evaluated regarding their X-ray findings (minimal/moderately advanced/far advanced/cavities), sputum-smear positivity, and treatment history/outcomes (new/defaulter/relapse/treatment-failure cases). Multiple-allele-specific polymerase chain reaction (MAS-PCR) was conducted to diagnose drug resistance. Results: Among all participants, 31.43% were newly diagnosed, while 44%, 15.43% and 9.14% patients fell into the categories of relapsed, defaulters and treatment-failures, respectively. 12.29% were multi-drug-resistant (MDR: resistant to at least isoniazid and rifampicin), 57.71% had non-MDR two-drug resistance and 12% had single-drug resistance. Subjects with higher BMI had lower odds of being a relapse/defaulter/treatment failure case while females were more likely to be defaulters and older age-groups had more relapse. Elderly, females, unmarried, those with low BMI and higher grade of sputum-smear positivity were more likely to have advanced X-ray features. Higher grade of sputum-smear positivity and advanced chest X-ray findings were associated with relapse/treatment-failures. Elderly, unmarried, relapse/defaulter/treatment-failure cases had higher odds and those with higher BMI and moderately/far advanced X-ray findings had lower odds of having MDR/non-MDR two-drug resistant PTB. Conclusion: Targeted intervention and appropriate counseling are needed urgently to prevent adverse treatment outcomes and development of drug resistance among PTB patients in Kolkata.	[Goswami, Avranil; Chakraborty, Urmita; Bhattacharya, Basudev; Pal, Nishith Kumar] Postgrad Inst Med Educ & Res, Kolkata, India; [Mahapatra, Tanmay; Mahapatra, Sanchita; Das, Aritra] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA USA; [Mukherjee, Tapajyoti] Burdwan Med Coll & Hosp, Burdwan, W Bengal, India; [Das, Shibali] Bose Inst, Kolkata, India; [Dey, Subir Kumar] Calcutta Natl Med Coll, Kolkata, India; [Ray, Sudhin] SSKM Hosp, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; University of California System; University of California Los Angeles; Department of Science & Technology (India); Bose Institute; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Pal, NK (corresponding author), Postgrad Inst Med Educ & Res, Kolkata, India.	nishithkpal53@gmail.com	Das, Shibali/AAA-2683-2021; Das, Aritra/C-9076-2014	Das, Shibali/0000-0003-1263-8178; Das, Aritra/0000-0002-7033-1441	Institute of Postgraduate Medical Education and Research, Kolkata, India	Institute of Postgraduate Medical Education and Research, Kolkata, India	This study was supported by The Institute of Postgraduate Medical Education and Research, Kolkata, India by allowing the authors to use the existing infrastructure of the institute (http://www.ipgmer.gov.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SP, 2005, TUBERCULOSIS CONTROL; Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545; Bhattacharya B, 2003, TROP MED INT HEALTH, V8, P150, DOI 10.1046/j.1365-3156.2003.01007.x; Chakraborty U, 2013, INT J TUBERC LUNG D, V17, P505, DOI 10.5588/ijtld.12.0196; Chowdhury IH, 2012, J CLIN MICROBIOL, V50, P2082, DOI 10.1128/JCM.06093-11; Della-Latta P, 2007, CLIN MICROBIOLOGY PR, P701; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Hosek J, 2006, VET MED-CZECH, V51, P180, DOI 10.17221/5538-VETMED; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Kent PT, 1985, GUIDE LEVEL 3 LAB; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009; Leitch AG, 2002, CROFTON DOUGLASS RES, P507; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Maurya AK, 2013, INDIAN J MED MICROBI, V31, P40, DOI 10.4103/0255-0857.108720; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Patel D, 2000, OCCUP MED-OXFORD, V50, P395, DOI 10.1093/occmed/50.6.395; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Sharma SK, 2011, INDIAN J MED RES, V133, P312; Sharma SK, 2011, INDIAN J MED RES, V133, P308; SNIDER DE, 1985, AM REV RESPIR DIS, V132, P125; Weyer K, 2007, SAMJ S AFR MED J, V97, P1120; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization (WHO), 2013, WORLD TB DAY 2013; Yang ZH, 2005, DIAGN MICR INFEC DIS, V53, P201, DOI 10.1016/j.diagmicrobio.2005.06.007; Young J, 2004, HLTH DEV WORLD HLTH; Zaveri HG, 2010, INDIAN J PHARMACOL, V42, P95, DOI 10.4103/0253-7613.64499	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109563	10.1371/journal.pone.0109563	http://dx.doi.org/10.1371/journal.pone.0109563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289974	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000069
J	Lewandowska, L; Matuszkiewicz-Rowinska, J; Jayakumar, C; Oldakowska-Jedynak, U; Looney, S; Galas, M; Dutkiewicz, M; Krawczyk, M; Ramesh, G				Lewandowska, Lidia; Matuszkiewicz-Rowinska, Joanna; Jayakumar, Calpurnia; Oldakowska-Jedynak, Urszula; Looney, Stephen; Galas, Michalina; Dutkiewicz, Malgorzata; Krawczyk, Marek; Ramesh, Ganesan			Netrin-1 and Semaphorin 3A Predict the Development of Acute Kidney Injury in Liver Transplant Patients	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; ISCHEMIA-REPERFUSION INJURY; CYCLE ARREST BIOMARKERS; RISK-FACTORS; DEFINITION; VALIDATION; DIALYSIS; PROTECTS; RIFLE	Acute kidney injury (AKI) is a serious complication after liver transplantation. Currently there are no validated biomarkers available for early diagnosis of AKI. The current study was carried out to determine the usefulness of the recently identified biomarkers netrin-1 and semaphorin 3A in predicting AKI in liver transplant patients. A total of 63 patients' samples were collected and analyzed. AKI was detected at 48 hours after liver transplantation using serum creatinine as a marker. In contrast, urine netrin-1 (897.8 +/- 112.4 pg/mg creatinine), semaphorin 3A (847.9 +/- 93.3 pg/mg creatinine) and NGAL (2172.2 +/- 378.1 ng/mg creatinine) levels were increased significantly and peaked at 2 hours after liver transplantation but were no longer significantly elevated at 6 hours after transplantation. The predictive power of netrin-1, as demonstrated by the area under the receiver-operating characteristic curve for diagnosis of AKI at 2, 6, and 24 hours after liver transplantation was 0.66, 0.57 and 0.59, respectively. The area under the curve for diagnosis of AKI was 0.63 and 0.65 for semaphorin 3A and NGAL at 2 hr respectively. Combined analysis of two or more biomarkers for simultaneous occurrence in urine did not improve the AUC for the prediction of AKI whereas the AUC was improved significantly (0.732) only when at least 1 of the 3 biomarkers in urine was positive for predicting AKI. Adjusting for BMI, all three biomarkers at 2 hours remained independent predictors of AKI with an odds ratio of 1.003 (95% confidence interval: 1.000 to 1.006; P = 0.0364). These studies demonstrate that semaphorin 3A and netrin-1 can be useful early diagnostic biomarkers of AKI after liver transplantation.	[Jayakumar, Calpurnia; Ramesh, Ganesan] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30901 USA; [Lewandowska, Lidia; Matuszkiewicz-Rowinska, Joanna] Med Univ Warsaw, Dept Nephrol Dialysis & Internal Dis, Warsaw, Poland; [Oldakowska-Jedynak, Urszula; Galas, Michalina; Krawczyk, Marek] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Warsaw, Poland; [Looney, Stephen] Georgia Regents Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Dutkiewicz, Malgorzata] Med Univ Warsaw, Dept Gen & Nutr Biochem, Warsaw, Poland	University System of Georgia; Augusta University; Medical University of Warsaw; Medical University of Warsaw; University System of Georgia; Augusta University; Medical University of Warsaw	Ramesh, G (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30901 USA.	gramesh@gru.edu	Dutkiewicz, Malgorzata/T-9898-2018	Dutkiewicz, Malgorzata/0000-0002-5701-7490	NIH-NIDDK [1R01DK083379 - 01A3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083379] Funding Source: NIH RePORTER	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an R01 grant (1R01DK083379 - 01A3) to Ganesan Ramesh from NIH-NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Bilbao I, 1998, CLIN TRANSPLANT, V12, P123; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; CAREGARO L, 1994, ARCH INTERN MED, V154, P201, DOI 10.1001/archinte.154.2.201; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jayakumar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058446; Jayakumar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026776; Jeong TD, 2012, CLIN TRANSPLANT, V26, P775, DOI 10.1111/j.1399-0012.2012.01610.x; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Li Y, 2012, BIOMARKERS, V17, P336, DOI 10.3109/1354750X.2012.672458; Lima EQ, 2003, RENAL FAILURE, V25, P553, DOI 10.1081/JDI-120022546; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Niemann CU, 2009, LIVER TRANSPLANT, V15, P1852, DOI 10.1002/lt.21938; Portal AJ, 2010, LIVER TRANSPLANT, V16, P1257, DOI 10.1002/lt.22158; Ramesh G, 2010, TRANSPL P, V42, P1519, DOI 10.1016/j.transproceed.2009.11.040; Ramesh G, 2010, CLIN J AM SOC NEPHRO, V5, P395, DOI 10.2215/CJN.05140709; Reeves WB, 2008, AM J PHYSIOL-RENAL, V294, pF731, DOI 10.1152/ajprenal.00507.2007; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; RIMOLA A, 1987, GASTROENTEROLOGY, V93, P148, DOI 10.1016/0016-5085(87)90327-1; Sirota JC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-17; Tapia R, 2008, KIDNEY INT, V73, P733, DOI 10.1038/sj.ki.5002726; Utsumi M, 2013, TRANSPL INT, V26, P842, DOI 10.1111/tri.12138; Wagener G, 2011, NEPHROL DIAL TRANSPL, V26, P1717, DOI 10.1093/ndt/gfq770; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224	30	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107898	10.1371/journal.pone.0107898	http://dx.doi.org/10.1371/journal.pone.0107898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289643	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000010
J	Phillips, A; Cambiano, V; Nakagawa, F; Magubu, T; Miners, A; Ford, D; Pillay, D; De Luca, A; Lundgren, J; Revill, P				Phillips, Andrew; Cambiano, Valentina; Nakagawa, Fumiyo; Magubu, Travor; Miners, Alec; Ford, Debbie; Pillay, Deenan; De Luca, Andrea; Lundgren, Jens; Revill, Paul			Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings	PLOS ONE			English	Article							CD4 CELL COUNT; STRATALL ANRS 12110/ESTHER; RESOURCE-LIMITED SETTINGS; VIRAL LOAD; INFECTED PATIENTS; POTENTIAL IMPACT; OUTCOMES; AFRICA; ADULTS; TRANSMISSION	Background: To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identified. Methods: An individual level simulation model of HIV transmission, progression and the effect of ART which accounts for adherence and resistance development was used to compare outcomes of various potential monitoring strategies in a typical low income setting in sub-Saharan Africa. Underlying monitoring strategies considered were based on clinical disease, CD4 count or viral load. Within each we considered a strategy in which no further measures are performed, one with a viral load measure to confirm failure, and one with both a viral load measure and a resistance test. Predicted outcomes were assessed over 2015-2025 in terms of viral suppression, first line failure, switching to second line regimen, death, HIV incidence, disability-adjusted-life-years averted and costs. Potential future low costs of resistance tests ($30) were used. Results: The most effective strategy, in terms of DALYs averted, was one using viral load monitoring without confirmation. The incremental cost-effectiveness ratio for this strategy was $2113 (the same as that for viral load monitoring with confirmation). ART monitoring strategies which involved resistance testing did not emerge as being more effective or cost effective than strategies not using it. The slightly reduced ART costs resulting from use of resistance testing, due to less use of second line regimens, was of similar magnitude to the costs of resistance tests. Conclusion: Use of resistance testing at the time of first line failure as part of the decision whether to switch to second line therapy was not cost-effective, even though the test was assumed to be very inexpensive.	[Phillips, Andrew; Cambiano, Valentina; Nakagawa, Fumiyo] UCL, Res Dept Infect & Populat Hlth, London, England; [Magubu, Travor] Univ Zimbabwe, Clin Res Ctr, Harare, Zimbabwe; [Miners, Alec] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Ford, Debbie] UCL, MRC Clin Trials Unit, London, England; [Pillay, Deenan] Africa Ctr, Kwa Zulu, South Africa; [De Luca, Andrea] Siena Univ Hosp, Univ Div Infect Dis, Siena, Italy; [Lundgren, Jens] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Revill, Paul] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of London; University College London; University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine; Medical Research Council Clinical Trials Unit; University of London; University College London; University of Siena; University Hospital of Siena; Rigshospitalet; University of Copenhagen; University of York - UK	Phillips, A (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	andrew.phillips@ucl.ac.uk	De Luca, Andrea/G-8810-2011; Phillips, Andrew N/B-4427-2008; Lundgren, Jens/AAE-6876-2019	De Luca, Andrea/0000-0002-9561-9193; Phillips, Andrew N/0000-0003-2384-4807; Revill, Paul/0000-0001-8632-0600; Nakagawa, Fumiyo/0000-0002-6646-8744; Lundgren, Jens/0000-0001-8901-7850; Pillay, Dorsamy/0000-0003-3640-2573	Bill & Melinda Gates Foundation; MRC [MC_U122886353, MC_UU_12023/17] Funding Source: UKRI; Medical Research Council [MC_UU_12023/17, MC_U122886353] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is funded by the Bill & Melinda Gates Foundation. Bill and Melinda Gates foundation officers were involved in the design of the study, the decision regarding assumptions and scenarios evaluated, but had no role in the conduct of the analyses or interpretation of results or the decision to submit the manuscript for publication. The corresponding author had final responsibility for the decision to submit for publication.	AIDSInfo, 2013, GUID US ANT AG HIV 1; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Boyer S, 2013, LANCET INFECT DIS, V13, P577, DOI 10.1016/S1473-3099(13)70073-2; Braithwaite RS, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-38; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Chung M, 2014, COMMUNICATION; Claxton K, 2010, 54 U YORK CTR HLTH E, P54; Cozzi-Lepri A, 2010, CLIN INFECT DIS, V50, P1275, DOI 10.1086/651684; Estill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057611; Estill J, 2012, AIDS, V26, P1403, DOI 10.1097/QAD.0b013e3283536988; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Hamers RL, 2012, AIDS, V26, P1663, DOI 10.1097/QAD.0b013e3283560678; [ICF International Zimbabwe National Statistics Agency (ZIMSTAT)], 2012, ZIMB DEM HLTH SURV 2; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnston V, 2014, J INFECT DIS, V209, P711, DOI 10.1093/infdis/jit411; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Jourdain G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001494; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Keebler D, 2014, LANCET GLOB HEALTH, V2, pE35, DOI 10.1016/S2214-109X(13)70048-2; Kimmel AD, 2010, JAIDS-J ACQ IMM DEF, V54, P258, DOI 10.1097/QAI.0b013e3181d0db97; Klimkait T, 2013, PLOS ONE, V8; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Levison JH, 2013, CLIN INFECT DIS, V56, P587, DOI 10.1093/cid/cis887; Mabugu T, 2013, COMMUNICATION; Medecins Sans Frontieres, 2013, UNT WEB ANT PRIC RED; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Rosen S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-24; Sabin CA, 2008, AIDS, V22, P1943, DOI 10.1097/QAD.0b013e32830e4cf3; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Walensky RP, 2007, AIDS, V21, P973, DOI 10.1097/QAD.0b013e328011ec53; WHO, 2012, WHO HIV DRUG RES REP; WHO, 2013, GLOB UPD HIV TREATM; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]	38	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109148	10.1371/journal.pone.0109148	http://dx.doi.org/10.1371/journal.pone.0109148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290340	Green Published, gold			2022-12-27	WOS:000342798000038
J	Armour, KL; Smith, CS; Ip, NCY; Ellison, CJ; Kirton, CM; Wilkes, AM; Williamson, LM; Clark, MR				Armour, Kathryn L.; Smith, Cheryl S.; Ip, Natasha C. Y.; Ellison, Cara J.; Kirton, Christopher M.; Wilkes, Anthony M.; Williamson, Lorna M.; Clark, Michael R.			Clearance of Human IgG1-Sensitised Red Blood Cells In Vivo in Humans Relates to the In Vitro Properties of Antibodies from Alternative Cell Lines	PLOS ONE			English	Article							FC-GAMMA-RIIIA; ANTI-D ANTIBODIES; LOW-FUCOSE IGG1; MONOCLONAL-ANTIBODY; CLINICAL-TRIALS; BINDING; CYTOTOXICITY; AFFINITY; RECOMBINANT; PHARMACOKINETICS	We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma cell line, YB2/0. When human, autologous RhD-positive red blood cells (RBC) were sensitised with this IgG1 antibody and re-injected, they were cleared much more rapidly from the circulation than had been seen earlier with the original human-mouse heterohybridoma-produced Fog-1. Since the IgG have the same amino acid sequence, this disparity is likely to be due to alternative glycosylation that results from the rat and mouse cell lines. By comparing the in vitro properties of YB2/0-produced Fog-1 IgG1 and the same antibody produced in the mouse myeloma cell line NS0, we now have a unique opportunity to pinpoint the cause of the difference in ability to clear RBC in vivo. Using transfected cell lines that express single human Fc gamma R, we showed that IgG1 made in YB2/0 and NS0 cell lines bound equally well to receptors of the Fc gamma RI and Fc gamma RII classes but that the YB2/0 antibody was superior in Fc gamma RIII binding. When measuring complexed IgG binding, the difference was 45-fold for Fc gamma RIIIa 158F, 20-fold for Fc gamma RIIIa 158V and approximately 40-fold for Fc gamma RIIIb. The dissimilarity was greater at 100-fold in monomeric IgG binding assays with Fc gamma RIIIa. When used to sensitise RBC, the YB2/0 IgG1 generated 100-fold greater human NK cell antibody-dependent cell-mediated cytotoxicity and had a 10(3)-fold advantage over the NS0 antibody in activating NK cells, as detected by CD54 levels. In assays of monocyte activation and macrophage adherence/phagocytosis, where Fc gamma RI plays major roles, RBC sensitised with the two antibodies produced much more similar results. Thus, the alternative glycosylation profiles of the Fog-1 antibodies affect only Fc gamma RIII binding and Fc gamma RIII-mediated functions. Relating this to the in vivo studies confirms the importance of Fc gamma RIII in RBC clearance.	[Armour, Kathryn L.; Smith, Cheryl S.; Ip, Natasha C. Y.; Ellison, Cara J.; Kirton, Christopher M.; Clark, Michael R.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Wilkes, Anthony M.] Bristol Inst Transfus Sci, Bristol, Avon, England; [Williamson, Lorna M.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Williamson, Lorna M.] Univ Cambridge, Dept Haematol, Cambridge CB2 1QP, England	University of Cambridge; NHS Blood & Transplant (NHSBT); University of Cambridge	Armour, KL (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	kla22@cam.ac.uk	Clark, Michael R/D-2479-2011	Clark, Michael R/0000-0002-5539-4997; Ellison, Cara/0000-0003-3483-6896	Department of Pathology, University of Cambridge	Department of Pathology, University of Cambridge(University of Cambridge)	The work was supported by funding from the Department of Pathology, University of Cambridge through income that was derived from commercial exploitation of patented antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour KL, 2014, EUR J IMMUNOL, V44, P905, DOI 10.1002/eji.201343825; Armour KL, 2010, J IMMUNOL METHODS, V354, P20, DOI 10.1016/j.jim.2010.01.011; Armour KL, 2006, BLOOD, V107, P2619, DOI 10.1182/blood-2005-03-0989; Armour KL, 2003, MOL IMMUNOL, V40, P585, DOI 10.1016/j.molimm.2003.08.004; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Armour KL, 2000, HEMATOL J S1, V1, P27; Beliard R, 2006, TRANSFUS CLIN BIOL, V13, P58, DOI 10.1016/j.tracli.2006.03.013; Beliard R, 2008, BRIT J HAEMATOL, V141, P109, DOI 10.1111/j.1365-2141.2008.06985.x; Bowles JA, 2006, BLOOD, V108, P2648, DOI 10.1182/blood-2006-04-020057; Brinc Davor, 2009, Hematology Am Soc Hematol Educ Program, P185, DOI 10.1182/asheducation-2009.1.185; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P1237, DOI 10.1016/j.jaci.2010.04.005; Bux J, 1999, BLOOD, V93, P357, DOI 10.1182/blood.V93.1.357.401k39_357_362; BYE JM, 1992, J CLIN INVEST, V90, P2481, DOI 10.1172/JCI116140; Chapman GE, 2007, CLIN EXP IMMUNOL, V150, P30, DOI 10.1111/j.1365-2249.2007.03458.x; CLARK MR, 1981, SOMAT CELL GENET, V7, P657, DOI 10.1007/BF01538755; CLARKSON SB, 1986, NEW ENGL J MED, V314, P1236, DOI 10.1056/NEJM198605083141907; CLARKSON SB, 1986, J EXP MED, V164, P474, DOI 10.1084/jem.164.2.474; Ernst LK, 2002, J MOL MED, V80, P248, DOI 10.1007/s00109-001-0294-2; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; JEFFERIS R, 1990, BIOCHEM J, V268, P529, DOI 10.1042/bj2680529; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kumpel BM, 2008, CLIN EXP IMMUNOL, V154, P1, DOI 10.1111/j.1365-2249.2008.03735.x; Kumpel BM, 2007, VOX SANG, V93, P99, DOI 10.1111/j.1423-0410.2007.00945.x; Lifely MR, 1995, GLYCOBIOLOGY, V5, P813, DOI 10.1093/glycob/5.8.813; MELAMED MD, 1987, J IMMUNOL METHODS, V104, P245, DOI 10.1016/0022-1759(87)90511-4; MOLLISON PL, 1965, BRIT J HAEMATOL, V11, P461, DOI 10.1111/j.1365-2141.1965.tb06609.x; Niwa R, 2005, J IMMUNOL METHODS, V306, P151, DOI 10.1016/j.jim.2005.08.009; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; Niwa R, 2004, CLIN CANCER RES, V10, P6248, DOI 10.1158/1078-0432.CCR-04-0850; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Quagliaroli D, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1371, DOI 10.1134/S0006297913120080; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Su K, 2002, GENES IMMUN, V3, pS51, DOI 10.1038/sj.gene.6363879; THOMSON A, 1990, LANCET, V336, P1147, DOI 10.1016/0140-6736(90)92767-C; Tobinai K, 2012, CURR HEMATOL MALIG R, V7, P235, DOI 10.1007/s11899-012-0124-3; van Sorge NM, 2003, TISSUE ANTIGENS, V61, P189, DOI 10.1034/j.1399-0039.2003.00037.x; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yamane-Ohnuki N, 2009, MABS-AUSTIN, V1, P230, DOI 10.4161/mabs.1.3.8328; Yver A, 2012, VOX SANG, V103, P213, DOI 10.1111/j.1423-0410.2012.01603.x	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109463	10.1371/journal.pone.0109463	http://dx.doi.org/10.1371/journal.pone.0109463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302805	Green Published, gold			2022-12-27	WOS:000343730400059
J	Ferenczi, S; Cserhati, M; Krifaton, C; Szoboszlay, S; Kukolya, J; Szoke, Z; Koszegi, B; Albert, M; Barna, T; Mezes, M; Kovacs, KJ; Kriszt, B				Ferenczi, Szilamer; Cserhati, Matyas; Krifaton, Csilla; Szoboszlay, Sandor; Kukolya, Jozsef; Szoke, Zsuzsanna; Koszegi, Balazs; Albert, Mihaly; Barna, Terez; Mezes, Miklos; Kovacs, Krisztina J.; Kriszt, Balazs			A New Ochratoxin A Biodegradation Strategy Using Cupriavidus basilensis Or16 Strain	PLOS ONE			English	Article							BALKAN ENDEMIC NEPHROPATHY; RENAL-CELL CARCINOMA; IN-VITRO; TRICHOSPORON-MYCOTOXINIVORANS; BIOLOGICAL DETOXIFICATION; BROILER CHICKS; FUNGAL TOXINS; HUMAN BLOOD; EXPRESSION; FOOD	Ochratoxin-A (OTA) is a mycotoxin with possibly carcinogenic and nephrotoxic effects in humans and animals. OTA is often found as a contaminant in agricultural commodities. The aim of the present work was to evaluate OTA-degrading and detoxifying potential of Cupriavidus basilensis OR16 strain. In vivo administration of OTA in CD1 male mice (1 or 10 mg/kg body weight for 72 hours or 0.5 mg/kg body weight for 21 days) resulted in significant elevation of OTA levels in the blood, histopathological alterations- and transcriptional changes in OTA-dependent genes (annexinA2, clusterin, sulphotransferase and gadd45 and gadd153) in the renal cortex. These OTA-induced changes were not seen in animals that have been treated with culture supernatants in which OTA was incubated with Cupriavidus basilensis OR16 strain for 5 days. HPLC and ELISA methods identified ochratoxin a as the major metabolite of OTA in Cupriavidus basilensis OR16 cultures, which is not toxic in vivo. This study has demonstrated that Cupriavidus basilensis OR16 efficiently degrade OTA without producing toxic adventitious metabolites.	[Ferenczi, Szilamer; Kovacs, Krisztina J.] Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary; [Cserhati, Matyas; Krifaton, Csilla; Szoboszlay, Sandor; Kriszt, Balazs] Szent Istvan Univ, Dept Environm Protect & Safety, Godollo, Hungary; [Kukolya, Jozsef] Cent Environm & Food Sci Res Inst, Dept Microbiol, Budapest, Hungary; [Szoke, Zsuzsanna; Koszegi, Balazs] Soft Flow Hungary R&D Ltd, Pecs, Hungary; [Albert, Mihaly] CEVA Phylaxia Ltd, Budapest, Hungary; [Barna, Terez] Univ Debrecen, Dept Genet & Appl Microbiol, H-4012 Debrecen, Hungary; [Mezes, Miklos] Szent Istvan Univ, Dept Nutr, Godollo, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hungarian University of Agriculture & Life Sciences; Ceva Sante Animale; University of Debrecen; Hungarian University of Agriculture & Life Sciences	Ferenczi, S (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary.	ferenczi@koki.hu	barna, terez/R-1357-2018	Szoke, Zsuzsanna/0000-0001-9302-1115; Kriszt, Balazs/0000-0002-9236-2820; Szoboszlay, Sandor/0000-0002-0479-6726; Koszegi, Balazs/0000-0001-6743-0441	TAMOP [4.2.1.B-11/2/KMR-2011-0003, 4.2.1/B-09/1/KONV-2010-0007]; KTIA [AIK_12-1-2013-0017]; Research Centre of Excellence [17586-4/2013/TUDPOL, 8526-5/2014/TUDPOL]; Hungarian Research Fund OTKA [109622];  [109744]	TAMOP; KTIA; Research Centre of Excellence; Hungarian Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); 	This study was supported by the TAMOP-4.2.1.B-11/2/KMR-2011-0003, KTIA-AIK_12-1-2013-0017, Research Centre of Excellence-17586-4/2013/TUDPOL, TAMOP 4.2.1/B-09/1/KONV-2010-0007 and the work was supported by grants from Hungarian Research Fund OTKA 109622 to K.J.K.; 109744 to Sz.F., and Research Centre of Excellence - 8526-5/2014/TUDPOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrunhosa L, 2010, TOXINS, V2, P1078, DOI 10.3390/toxins2051078; Al-Anati L, 2006, J VET PHARMACOL THER, V29, P79, DOI 10.1111/j.1365-2885.2006.00718.x; Aoudia N, 2008, FOOD CHEM TOXICOL, V46, P871, DOI 10.1016/j.fct.2007.10.029; Arbillaga L, 2008, TOXICOL APPL PHARM, V230, P197, DOI 10.1016/j.taap.2008.02.018; Beard SE, 1996, MUTAT RES-GENET TOX, V371, P1, DOI 10.1016/S0165-1218(96)90089-0; Bruinink A., 1998, Natural Toxins, V6, P173, DOI 10.1002/(SICI)1522-7189(199809/10)6:5<173::AID-NT10>3.0.CO;2-4; Castegnaro M, 2005, TOXICOL LETT, V156, P315, DOI 10.1016/j.toxlet.2004.07.016; Clark HA, 2006, J TOXICOL ENV HEAL B, V9, P265, DOI 10.1080/15287390500195570; CREPPY EE, 1983, INFECT IMMUN, V39, P1015, DOI 10.1128/IAI.39.3.1015-1018.1983; Cserhati M, 2012, J BACTERIOL, V194, P2109, DOI 10.1128/JB.06752-11; Cui XQ, 2009, AM J NEPHROL, V30, P413, DOI 10.1159/000235993; DIRHEIMER G, 1991, IARC SCI PUBL, V115, P171; Duarte SC, 2012, VET J, V192, P286, DOI 10.1016/j.tvjl.2011.11.002; ELLING F, 1977, LANCET, V1, P1213; HALD B, 1991, IARC SCI PUBL, V115, P159; Hassan ZU, 2012, J IMMUNOTOXICOL, V9, P56, DOI 10.3109/1547691X.2011.627393; HELLER K, 1978, CAN J MICROBIOL, V24, P466, DOI 10.1139/m78-076; Hickey PW, 2009, J CLIN MICROBIOL, V47, P3091, DOI 10.1128/JCM.00460-09; Karlovsky P, 1999, NAT TOXINS, V7, P1, DOI 10.1002/(SICI)1522-7189(199902)7:1<1::AID-NT37>3.0.CO;2-9; KROGH P, 1973, ACTA PATH MICRO IM B, VB 81, P689; KROGH P, 1977, ACTA PATH MICRO IM B, V85, P238; KROGH P, 1977, NORD VET MED, V29, P402; KUMBLE KD, 1992, CANCER RES, V52, P163; Li S, 1997, TOXICOL APPL PHARM, V145, P82, DOI 10.1006/taap.1997.8155; Luhe A, 2003, TOXICOL SCI, V73, P315, DOI 10.1093/toxsci/kfg073; Mantle PG, 2008, FOOD CHEM TOXICOL, V46, P1808, DOI 10.1016/j.fct.2008.01.020; Miyake H, 2002, J UROLOGY, V167, P703, DOI 10.1016/S0022-5347(01)69130-4; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; Obrecht-Pflumio S, 2000, CHEM-BIOL INTERACT, V127, P29, DOI 10.1016/S0009-2797(00)00169-1; Petchkongkaew A, 2008, J APPL MICROBIOL, V104, P1495, DOI 10.1111/j.1365-2672.2007.03700.x; Piotrowska Malgorzata, 2005, Polish Journal of Microbiology, V54, P279; PITOUT MJ, 1969, BIOCHEM PHARMACOL, V18, P485, DOI 10.1016/0006-2952(69)90224-X; Politis I, 2005, BRIT POULTRY SCI, V46, P58, DOI 10.1080/00071660400023904; Rached E, 2008, TOXICOL SCI, V103, P371, DOI 10.1093/toxsci/kfn040; Raters M, 2005, Mycotoxin Res, V21, P182, DOI 10.1007/BF02959259; Rodrigues I, 2012, TOXINS, V4, P663, DOI 10.3390/toxins4090663; Rodriguez H, 2011, J AGR FOOD CHEM, V59, P10755, DOI 10.1021/jf203061p; RungeMorris MA, 1997, FASEB J, V11, P109, DOI 10.1096/fasebj.11.2.9039952; Schatzmayr G, 2003, Mycotoxin Res, V19, P124, DOI 10.1007/BF02942950; SINGH GSP, 1990, J COMP PATHOL, V103, P399, DOI 10.1016/S0021-9975(08)80028-X; Skouteris GG, 1996, J BIOL CHEM, V271, P27266, DOI 10.1074/jbc.271.44.27266; Stander MA, 2000, J AGR FOOD CHEM, V48, P5736, DOI 10.1021/jf000413j; Stoev SD, 1998, VET HUM TOXICOL, V40, P352; Stoev SD, 2001, VET RES COMMUN, V25, P205, DOI 10.1023/A:1006433709685; Tanaka T, 2000, AM J PATHOL, V156, P2149, DOI 10.1016/S0002-9440(10)65085-7; VANDERME.KJ, 1965, NATURE, V205, P1112, DOI 10.1038/2051112a0; Vega FE, 2006, MYCOLOGIA, V98, P31, DOI 10.3852/mycologia.98.1.31; Walker R, 2002, ADV EXP MED BIOL, V504, P249; Xiao H, 1996, TOXICOL APPL PHARM, V137, P182, DOI 10.1006/taap.1996.0071; Zeljezic D, 2006, BRAZ J MED BIOL RES, V39, P1563, DOI 10.1590/S0100-879X2006005000029; ZIMMERLI B, 1995, J CHROMATOGR B, V666, P85, DOI 10.1016/0378-4347(94)00569-Q	51	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109817	10.1371/journal.pone.0109817	http://dx.doi.org/10.1371/journal.pone.0109817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302950	Green Submitted, gold, Green Published			2022-12-27	WOS:000343730400082
J	Vafaee, Y; Staniek, A; Mancheno-Solano, M; Warzecha, H				Vafaee, Yavar; Staniek, Agata; Mancheno-Solano, Maria; Warzecha, Heribert			A Modular Cloning Toolbox for the Generation of Chloroplast Transformation Vectors	PLOS ONE			English	Article							TOBACCO CHLOROPLASTS; PLASTID GENOME; HIGHER-PLANTS; SYNTHETIC BIOLOGY; TOMATO PLASTIDS; MESSENGER-RNAS; ONE-POT; EXPRESSION; PROTEIN; IDENTIFICATION	Plastid transformation is a powerful tool for basic research but also for the generation of stable genetically engineered plants producing recombinant proteins at high levels or for metabolic engineering purposes. However, due to the genetic makeup of plastids and the distinct features of the transformation process, vector design, and the use of specific genetic elements, a large set of basic transformation vectors is required, making cloning a tedious and time-consuming effort. Here we describe the adoption of standardized modular cloning (GoldenBraid) to the design and assembly of the full spectrum of plastid transformation vectors. The modular design of genetic elements allows straightforward and time-efficient build-up of transcriptional units as well as construction of vectors targeting any homologous recombination site of choice. In a three-level assembly process, we established a vector fostering gene expression and formation of griffithsin, a potential viral entry inhibitor and HIV prophylactic, in the plastids of tobacco. Successful transformation as transcript and protein production could be shown. In concert with the aforesaid endeavour, a set of modules facilitating plastid transformation was generated thus augmenting the GoldenBraid toolbox. In short he work presented in this study enables efficient application of synthetic biology methods to plastid transformation in plants.	[Vafaee, Yavar; Staniek, Agata; Mancheno-Solano, Maria; Warzecha, Heribert] Tech Univ Darmstadt, Darmstadt, Germany	Technical University of Darmstadt	Warzecha, H (corresponding author), Tech Univ Darmstadt, Darmstadt, Germany.	warzecha@bio.tu-darmstadt.de	Vafaee, Yavar/AGD-6085-2022; Vafaee, Yavar/D-3574-2017	Vafaee, Yavar/0000-0003-2348-9390; Vafaee, Yavar/0000-0003-2348-9390	German Academic Exchange Service	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	W and MM-S were funded by the German Academic Exchange Service, https://www.daad.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel W, 2010, PLANT J, V63, P636, DOI 10.1111/j.1365-313X.2010.04268.x; Bock R, 2010, TRENDS BIOTECHNOL, V28, P246, DOI 10.1016/j.tibtech.2010.01.006; Borchers AMI, 2012, PLANT BIOTECHNOL J, V10, P422, DOI 10.1111/j.1467-7652.2011.00675.x; De Marchis F, 2009, TRANSGENIC RES, V18, P17, DOI 10.1007/s11248-008-9193-4; Elghabi Z, 2011, PLANT BIOTECHNOL J, V9, P599, DOI 10.1111/j.1467-7652.2011.00598.x; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Gardner TS, 2013, CURR OPIN CHEM BIOL, V17, P871, DOI 10.1016/j.cbpa.2013.09.013; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Glenz K, 2006, NAT BIOTECHNOL, V24, P76, DOI 10.1038/nbt1170; Gottschamel J, 2013, TRANSGENIC RES, V22, P1273, DOI 10.1007/s11248-013-9726-3; Gray BN, 2009, TRANSGENIC RES, V18, P559, DOI 10.1007/s11248-009-9246-3; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hennig A, 2007, FEBS J, V274, P5749, DOI 10.1111/j.1742-4658.2007.06095.x; Herz S, 2005, TRANSGENIC RES, V14, P969, DOI 10.1007/s11248-005-2542-7; Knight T., 2003, STRUCTURE, V1, P11, DOI 10.21236/ADA457791; Kuroda H, 2001, NUCLEIC ACIDS RES, V29, P970, DOI 10.1093/nar/29.4.970; Lassen LM, 2014, ACS SYNTH BIOL, V3, P1, DOI 10.1021/sb400136f; Lu YH, 2013, P NATL ACAD SCI USA, V110, pE623, DOI 10.1073/pnas.1216898110; Lutz KA, 2007, PLANT PHYSIOL, V145, P1201, DOI 10.1104/pp.107.106963; Monde RA, 2000, PLANT MOL BIOL, V44, P529, DOI 10.1023/A:1026540310934; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Oey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086841; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Patron NJ, 2014, CURR OPIN PLANT BIOL, V19, P14, DOI 10.1016/j.pbi.2014.02.004; Sinagawa-Garcia SR, 2009, PLANT MOL BIOL, V70, P487, DOI 10.1007/s11103-009-9486-x; Rebatchouk D, 1996, P NATL ACAD SCI USA, V93, P10891, DOI 10.1073/pnas.93.20.10891; Renault H, 2014, CURR OPIN PLANT BIOL, V19, P27, DOI 10.1016/j.pbi.2014.03.004; Ruf S, 2001, NAT BIOTECHNOL, V19, P870, DOI 10.1038/nbt0901-870; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618, DOI 10.1104/pp.113.217661; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Smolke CD, 2009, NAT BIOTECHNOL, V27, P1099, DOI 10.1038/nbt1209-1099; Surowiecki J, 2002, TURN CENTURY WIRED 1; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zhou F, 2007, PLANT J, V52, P961, DOI 10.1111/j.1365-313X.2007.03261.x	40	26	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110222	10.1371/journal.pone.0110222	http://dx.doi.org/10.1371/journal.pone.0110222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302695	Green Published, gold			2022-12-27	WOS:000343730400124
J	Favaretto, F; Milan, G; Collin, GB; Marshall, JD; Stasi, F; Maffei, P; Vettor, R; Naggert, JK				Favaretto, Francesca; Milan, Gabriella; Collin, Gayle B.; Marshall, Jan D.; Stasi, Fabio; Maffei, Pietro; Vettor, Roberto; Naggert, Juergen K.			GLUT4 Defects in Adipose Tissue Are Early Signs of Metabolic Alterations in Alms1(GT/GT), a Mouse Model for Obesity and Insulin Resistance	PLOS ONE			English	Article							GTPASE-ACTIVATING-PROTEIN; MUSCLE SATELLITE CELLS; ALSTROM-SYNDROME; GLUCOSE-HOMEOSTASIS; SUBCELLULAR-LOCALIZATION; AMINO-ACIDS; ZUCKER RATS; MICE; ADIPOCYTES; ALMS1	Dysregulation of signaling pathways in adipose tissue leading to insulin resistance can contribute to the development of obesity-related metabolic disorders. Alstrom Syndrome, a recessive ciliopathy, caused by mutations in ALMS1, is characterized by progressive metabolic alterations such as childhood obesity, hyperinsulinemia, and type 2 diabetes. Here we investigated the role of Alms1 disruption in AT expansion and insulin responsiveness in a murine model for Alstrom Syndrome. A gene trap insertion in Alms1 on the insulin sensitive C57BL6/Ei genetic background leads to early hyperinsulinemia and a progressive increase in body weight. At 6 weeks of age, before the onset of the metabolic disease, the mutant mice had enlarged fat depots with hypertrophic adipocytes, but without signs of inflammation. Expression of lipogenic enzymes was increased. Pre-adipocytes isolated from mutant animals demonstrated normal adipogenic differentiation but gave rise to mature adipocytes with reduced insulin-stimulated glucose uptake. Assessment of whole body glucose homeostasis revealed glucose intolerance. Insulin stimulation resulted in proper AKT phosphorylation in adipose tissue. However, the total amount of glucose transporter 4 (SLC4A2) and its translocation to the plasma membrane were reduced in mutant adipose depots compared to wildtype littermates. Alterations in insulin stimulated trafficking of glucose transporter 4 are an early sign of metabolic dysfunction in Alstrom mutant mice, providing a possible explanation for the reduced glucose uptake and the compensatory hyperinsulinemia. The metabolic signaling deficits either reside downstream or are independent of AKT activation and suggest a role for ALMS1 in GLUT4 trafficking. Alstrom mutant mice represent an interesting model for the development of metabolic disease in which adipose tissue with a reduced glucose uptake can expand by de novo lipogenesis to an obese state.	[Favaretto, Francesca; Milan, Gabriella; Stasi, Fabio; Maffei, Pietro; Vettor, Roberto] Univ Padua, Dept Med, Padua, Italy; [Collin, Gayle B.; Marshall, Jan D.; Naggert, Juergen K.] Jackson Lab, Bar Harbor, ME 04609 USA	University of Padua; Jackson Laboratory	Favaretto, F (corresponding author), Univ Padua, Dept Med, Padua, Italy.	francesca.favaretto@unipd.it; gabriella.milan@unipd.it	VETTOR, ROBERTO/K-7121-2016; Milan, Gabriella/AAB-6234-2022	Milan, Gabriella/0000-0001-8987-5310; Vettor, Roberto/0000-0003-0625-6667; Maffei, Pietro/0000-0002-1717-263X	European Union [EU-20101205]; Italian MIUR [2010329EKE_005]; United States National Institute of Health [NIH-HD036878]; EURO-WABB project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036878] Funding Source: NIH RePORTER	European Union(European Commission); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EURO-WABB project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the EURO-WABB project, which has received funding from the European Union, in the framework of the Health Programme [EU-20101205 RV, FF, GM, PM], by the PRIN from the Italian MIUR (2010329EKE_005 to RV, FF, GM, FS) and by the United States National Institute of Health [NIH-HD036878; JKN, GBC, JDM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Aston-Mourney K, 2007, DIABETOLOGIA, V50, P2476, DOI 10.1007/s00125-007-0814-x; BAHARY N, 1990, P NATL ACAD SCI USA, V87, P8642, DOI 10.1073/pnas.87.21.8642; Bays H, 2005, FUTUR CARDIOL, V1, P39, DOI 10.1517/14796678.1.1.39; Bettini V, 2012, PEDIATR DIABETES, V13, P59, DOI 10.1111/j.1399-5448.2011.00789.x; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; Collin GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037925; Collin GB, 2005, HUM MOL GENET, V14, P2323, DOI 10.1093/hmg/ddi235; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; CUSIN I, 1990, BIOCHEM SOC T, V18, P1127, DOI 10.1042/bst0181127; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Foster LJ, 2006, J PROTEOME RES, V5, P64, DOI 10.1021/pr0502626; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Heydet D, 2013, DEV NEUROBIOL, V73, P1, DOI 10.1002/dneu.22031; Huang-Doran I, 2010, INT J OBESITY, V34, P1554, DOI 10.1038/ijo.2010.92; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Jurczyk A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011812; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Lodh S, 2014, J CELL SCI; Maffei P, 2007, CLIN ENDOCRINOL, V66, P269, DOI 10.1111/j.1365-2265.2007.02721.x; Marshall JD, 2007, EUR J HUM GENET, V15, P1193, DOI 10.1038/sj.ejhg.5201933; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Marshall JD, 2010, ALSTROM SYNDROME; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mokashi A, 2011, PEDIATR DIABETES, V12, P270, DOI 10.1111/j.1399-5448.2010.00698.x; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; SALANS LB, 1971, J CLIN INVEST, V50, P1399, DOI 10.1172/JCI106623; Sanna M, 2009, CLIN LIPIDOL, V4, P245, DOI 10.2217/CLP.09.8; Scarda A, 2010, INT J OBESITY, V34, P1319, DOI 10.1038/ijo.2010.47; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shenje LT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4416; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Talior-Volodarsky I, 2008, J BIOL CHEM, V283, P25115, DOI 10.1074/jbc.M801750200; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Tsuji Y, 2001, DIABETES, V50, P1455, DOI 10.2337/diabetes.50.6.1455; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zulato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019081	53	49	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109540	10.1371/journal.pone.0109540	http://dx.doi.org/10.1371/journal.pone.0109540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299671	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200057
J	Foerster, J; Maskarinec, G; Reichardt, N; Tett, A; Narbad, A; Blaut, M; Boeing, H				Foerster, Jana; Maskarinec, Gertraud; Reichardt, Nicole; Tett, Adrian; Narbad, Arjan; Blaut, Michael; Boeing, Heiner			The Influence of Whole Grain Products and Red Meat on Intestinal Microbiota Composition in Normal Weight Adults: A Randomized Crossover Intervention Trial	PLOS ONE			English	Article							GUT MICROBIOME; RISK; COMMUNITY; BACTERIA; DISEASE; OBESITY; COLON; MEN	Intestinal microbiota is related to obesity and serum lipid levels, both risk factors for chronic diseases constituting a challenge for public health. We investigated how a diet rich in whole grain (WG) products and red meat (RM) influences microbiota. During a 10-week crossover intervention study, 20 healthy adults consumed two isocaloric diets, one rich in WG products and one high in RM. Repeatedly data on microbiota were assessed by 16S rRNA based denaturing gradient gel electrophoresis (DGGE). A blood sample and anthropometric data were collected. Mixed models and logistic regression were used to investigate effects. Microbiota showed interindividual variability. However, dietary interventions modified microbiota appearance: 8 bands changed in at least 4 participants during the interventions. One of the bands appearing after WG and one increasing after RM remained significant in regression models and were identified as Collinsella aerofaciens and Clostridium sp. The WG intervention lowered obesity parameters, while the RM diet increased serum levels of uric acid and creatinine. The study showed that diet is a component of major relevance regarding its influence on intestinal microbiota and that WG has an important role for health. The results could guide investigations of diet and microbiota in observational prospective cohort studies.	[Foerster, Jana; Maskarinec, Gertraud; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Maskarinec, Gertraud] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Reichardt, Nicole; Tett, Adrian; Narbad, Arjan] Inst Food Res, Gut Hlth & Food Safety, Colney, England; [Blaut, Michael] German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Cancer Research Center of Hawaii; University of Hawaii System; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Foerster, J (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	Jana.Foerster@dife.de		Tett, Adrian/0000-0003-3141-3943; Blaut, Michael/0000-0002-6628-2907	European Union [FP7 - KBBE 222720]; 7th Framework Programme, EU; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; BBSRC [BBS/E/F/00042572] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00042572] Funding Source: researchfish	European Union(European Commission); 7th Framework Programme, EU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was supported by the European Union funded project TORNADO (FP7 - KBBE 222720). Sources of financial support: 7th Framework Programme, EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Andoh A, 2012, J GASTROENTEROL, V47, P1298, DOI 10.1007/s00535-012-0605-0; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bischoff SC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-24; Brandt K, 2012, CLINICS, V67, P113, DOI 10.6061/clinics/2012(02)05; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Hur IY, 2012, J ACAD NUTR DIET, V112, P46, DOI 10.1016/j.jada.2011.08.028; Immundiagnostik A, 2012, PHICAL R CALPR ELISA; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kageyama A, 2000, INT J SYST EVOL MICR, V50, P1767, DOI 10.1099/00207713-50-5-1767; Kumar V, 2012, CRIT REV FOOD SCI, V52, P899, DOI 10.1080/10408398.2010.512671; Waitzberg DL, 2012, NUTR HOSP, V27, P123, DOI [10.1590/S0212-16112012000100014, 10.3305/nh.2012.27.1.5445]; Lundberg JO, 2012, GUT, P1; Malinen E, 2010, WORLD J GASTROENTERO, V16, P4532, DOI 10.3748/wjg.v16.i36.4532; Maukonen J, 2006, FEMS MICROBIOL ECOL, V58, P517, DOI 10.1111/j.1574-6941.2006.00179.x; Mendelsohn AR, 2013, REJUV RES, V16, P241, DOI 10.1089/rej.2013.1447; Montonen J, 2013, EUR J NUTR, V52, P337, DOI 10.1007/s00394-012-0340-6; Nubel U, 1996, J BACTERIOL, V178, P5636; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Paturi G, 2012, NUTRITION, V28, P324, DOI 10.1016/j.nut.2011.07.018; Schneider H, 1999, ARCH MICROBIOL, V171, P81, DOI 10.1007/s002030050682; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Te Morenga L. A., 2011, NUTR J, V10, P1; Tehrani AB, 2012, NEUROGASTROENT MOTIL, V24, P305, DOI 10.1111/j.1365-2982.2012.01895.x; Tourlomousis P, 2010, MICROB ECOL, V59, P776, DOI 10.1007/s00248-009-9613-x; Tuohy KM, 2012, J AGR FOOD CHEM, V60, P8776, DOI 10.1021/jf2053959; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vendrame S, 2011, J AGR FOOD CHEM, V59, P12815, DOI 10.1021/jf2028686; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wells C, 1996, BARONS MED MICROBIOL; *WMA, 2000, WORLD MED ASS DECL H; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	41	39	40	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109606	10.1371/journal.pone.0109606	http://dx.doi.org/10.1371/journal.pone.0109606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299601	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200063
J	Lin, LY				Lin, Ling-Yi			Quality of Life of Taiwanese Adults with Autism Spectrum Disorder	PLOS ONE			English	Article							EMPLOYMENT; DISABILITY; MEN	Background: To date, few recent studies have investigated the quality of life of adults with autism spectrum disorder (ASD). It remains unclear how individuals with ASD view their own quality of life. Objective: The primary purpose of this study was to compare the quality of life scores among adults with ASD with those of a non-ASD control group and the Taiwanese health population reference group. Methods: The study comprised 41 adults with ASD (M age = 26.9, SD = 5.0), and without intellectual disabilities (IQ>70). A comparison sample of 41 adults without ASD was selected by matching the age and sex of the participants with ASD. A validated measure, the Taiwanese version of the World Health Organization Quality of Life-BREF (WHOQOL-BREF), was used. Independent t-tests were performed to examine the differences in the quality of life between groups. Results: The highest quality of life was scored in the environment domain, followed by the physical health and psychological health domains. The lowest quality of life score was found in the social relationship domain. Adults with ASD scored significantly lower in all domains than did the non-ASD control group. Additionally, adults with ASD scored significantly lower in the physical health, psychological health, and social relationship domains than did the Taiwanese health population reference group. Comorbid psychiatric disorders, self-rated health status, and perceived happiness were correlated with quality of life among adults with ASD. Conclusion: The preliminary findings suggest that adults with ASD need more supportive social contexts and interventions to promote their quality of life. Based on our findings, social relationship must be considered in designing and applying treatment programs for adults with ASD.	Natl Cheng Kung Univ, Coll Med, Dept Occupat Therapy, Tainan 70101, Taiwan	National Cheng Kung University	Lin, LY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Occupat Therapy, Tainan 70101, Taiwan.	lingyi@mail.ncku.edu.tw	Lin, Ling-Yi/ABI-4935-2020	Lin, Ling-Yi/0000-0002-1438-0820	Taiwan National Science Council [NSC 101-2815-C-006-083-B, NSC 102-2314-B-006-068]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	Support for this research was provided by grant NSC 101-2815-C-006-083-B and NSC 102-2314-B-006-068 from the Taiwan National Science Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Billstedt E, 2005, J AUTISM DEV DISORD, V35, P351, DOI 10.1007/s10803-005-3302-5; Billstedt E, 2011, AUTISM, V15, P7, DOI 10.1177/1362361309346066; Burgess Audrey F, 2007, Child Adolesc Ment Health, V12, P80, DOI 10.1111/j.1475-3588.2006.00432.x; Eaves LC, 2008, J AUTISM DEV DISORD, V38, P739, DOI 10.1007/s10803-007-0441-x; Esbensen AJ, 2010, AJIDD-AM J INTELLECT, V115, P277, DOI 10.1352/1944-7558-115.4.277; Garcia-Villamisar D, 2013, RES AUTISM SPECT DIS, V7, P624, DOI 10.1016/j.rasd.2012.12.009; Gerber F, 2008, J AUTISM DEV DISORD, V38, P1654, DOI 10.1007/s10803-008-0547-9; Henninger NA, 2013, AUTISM, V17, P103, DOI 10.1177/1362361312441266; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Howlin P, 2000, AUTISM, V4, P63, DOI [10.1177/1362361300004001005, DOI 10.1177/1362361300004001005]; Howlin P, 2013, J AM ACAD CHILD PSY, V52, P897, DOI 10.1016/j.jaac.2013.06.010; Jennes-Coussens M, 2006, AUTISM, V10, P403, DOI 10.1177/1362361306064432; Kamio Y, 2013, AUTISM, V17, P15, DOI 10.1177/1362361312436848; Kamp-Becker Inge, 2010, Psychosoc Med, V7, DOI 10.3205/psm000065; Laslett LL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-168; Levy A, 2011, RES AUTISM SPECT DIS, V5, P1271, DOI 10.1016/j.rasd.2011.01.023; Lin JD, 2009, RES AUTISM SPECT DIS, V3, P269, DOI 10.1016/j.rasd.2008.07.002; Lin LY, 2012, INT J REHABIL RES, V35, P109, DOI 10.1097/MRR.0b013e32835108b1; Mazurek MO, 2014, AUTISM, V18, P223, DOI 10.1177/1362361312474121; Morisse F, 2013, SCI WORLD J, DOI 10.1155/2013/491918; Persson B, 2000, J AUTISM DEV DISORD, V30, P61, DOI 10.1023/A:1005464128544; Plimley, 2007, BR J LEARN DISABIL, V35, P205, DOI [10.1111/j.1468-3156.2007.00448.x, DOI 10.1111/J.1468-3156.2007.00448.X]; Renty J, 2006, AUTISM, V10, P511, DOI 10.1177/1362361306066604; Saldana D, 2009, AUTISM, V13, P303, DOI 10.1177/1362361309103792; Taiwan Ministry of the Interior, 2014, STAT YB INT; Taiwan Ministry of the Interior, 2008, STAT YB INT; Taylor JL, 2011, J AUTISM DEV DISORD, V41, P566, DOI 10.1007/s10803-010-1070-3; The WHOQOL-Taiwan Group, 2001, US MAN DEV WHOQOL BR; Totsika V, 2010, J AUTISM DEV DISORD, V40, P1171, DOI 10.1007/s10803-010-0975-1; United States Centers for Disease Control and Prevention, 2014, PREV AUT SPECTR DIS; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	34	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109567	10.1371/journal.pone.0109567	http://dx.doi.org/10.1371/journal.pone.0109567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AP	25299379	Green Published, gold, Green Submitted			2022-12-27	WOS:000343941200061
J	Lou, ZF; Xing, HB; Li, D				Lou, Zhifeng; Xing, Haibo; Li, Da			Alcohol Consumption and the Neoplastic Progression in Barrett's Esophagus: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RISK-FACTORS; CANCER-RISK; ADENOCARCINOMA; PATHOGENESIS; METAPLASIA; SMOKING; DISEASE	Purpose: In the developed countries, the incidence of esophageal adenocarcinoma (EAC) is increasing over recent decades. The purpose of this meta-analysis was to arrive at quantitative conclusions about the contribution of alcohol intakes and the progression of Barrett's esophagus. Methods: A comprehensive, systematic bibliographic search of medical literature published up to Oct 2013 was conducted to identify relevant studies. A meta-analysis was conducted for alcohol consumption on the Barrett's esophagus progression. Results: A total of 882 cases in 6,867 individuals from 14 observational studies were indemnified in this meta-analysis. The result of this current meta-analysis, including 10 case-control and 4 cohort studies, indicated that alcohol consumption was not associated with the neoplastic progression in Barrett's esophagus (RR, 1.17; 95% CI, 0.93-1.48). When stratified by the study designs, no significant association was detected in either high vs low group or ever vs never group. Conclusions: Alcohol drinking is not associated with risk of neoplastic progression in Barrett's esophagus. Further well designed studies are needed in this area.	[Lou, Zhifeng] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Stomatol, Hangzhou 310003, Zhejiang, Peoples R China; [Xing, Haibo] Xiasha Hosp, Dept Intens Care Unit, Hangzhou, Zhejiang, Peoples R China; [Li, Da] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, D (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	prlida@163.com			Chinese National Natural Science Foundation [81001034]; Zhejiang Medicines Health Science and Technology Program [2009B087]; Sir Run Run Shaw Hospital Potential Doctor Foundation	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Medicines Health Science and Technology Program; Sir Run Run Shaw Hospital Potential Doctor Foundation	The authors acknowledge the financial support from Chinese National Natural Science Foundation (Project NO. 81001034), Zhejiang Medicines Health Science and Technology Program (NO. 2009B087) and Sir Run Run Shaw Hospital Potential Doctor Foundation for Da Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHKAR JP, 1995, AM J GASTROENTEROL, V90, P39; Anandasabapathy S, 2007, CANCER-AM CANCER SOC, V109, P668, DOI 10.1002/cncr.22451; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Bani-Hani KE, 2005, WORLD J GASTROENTERO, V11, P6807, DOI 10.3748/wjg.v11.i43.6807; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bosetti C, 2013, EUR J CANC PREV; Bresalier Robert, 2005, Semin Oncol, V32, P21, DOI 10.1053/j.seminoncol.2005.07.021; Casson AG, 2005, CARCINOGENESIS, V26, P1536, DOI 10.1093/carcin/bgi115; Coleman HG, 2012, GASTROENTEROLOGY, V142, P233, DOI 10.1053/j.gastro.2011.10.034; de Jonge PJF, 2006, AM J GASTROENTEROL, V101, P1421, DOI 10.1111/j.1572-0241.2006.00626.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Francis AM, 2013, ANN SURG, V258, P500, DOI 10.1097/SLA.0b013e3182a196f4; Gatenby PAC, 2008, DIGEST DIS SCI, V53, P1175, DOI 10.1007/s10620-007-0023-y; GRAY MR, 1993, GUT, V34, P727, DOI 10.1136/gut.34.6.727; HANSSON LE, 1993, INT J CANCER, V54, P402, DOI 10.1002/ijc.2910540309; Hardikar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052192; Jung KW, 2011, AM J GASTROENTEROL, V106, P1447, DOI 10.1038/ajg.2011.130; Li WQ, 2013, CLIN GASTROENTEROL H, V11, P1130, DOI 10.1016/j.cgh.2013.03.023; Lukic M, 2010, COLLEGIUM ANTROPOL, V34, P905; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Olliver JR, 2005, CANCER EPIDEM BIOMAR, V14, P620, DOI 10.1158/1055-9965.EPI-04-0509; Salehi M, 2013, NUTR REV, V71, P257, DOI 10.1111/nure.12028; Sikkema M, 2011, AM J GASTROENTEROL, V106, P1231, DOI 10.1038/ajg.2011.153; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008	25	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e105612	10.1371/journal.pone.0105612	http://dx.doi.org/10.1371/journal.pone.0105612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299129	gold, Green Submitted, Green Published			2022-12-27	WOS:000343941200003
J	Guardado-Estrada, M; Juarez-Torres, E; Roman-Bassaure, E; Medina-Martinez, I; Alfaro, A; Benuto, RE; Dean, M; Villegas-Sepulveda, N; Berumen, J				Guardado-Estrada, Mariano; Juarez-Torres, Eligia; Roman-Bassaure, Edgar; Medina-Martinez, Ingrid; Alfaro, Ana; Elba Benuto, Rosa; Dean, Michael; Villegas-Sepulveda, Nicolas; Berumen, Jaime			The Distribution of High-Risk Human Papillomaviruses Is Different in Young and Old Patients with Cervical Cancer	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; INFECTION; WOMEN; AMPLIFICATION; METAANALYSIS; PREVALENCE; HUMAN-PAPILLOMAVIRUS-16; CARCINOMA; COFACTORS; GENOTYPES	Despite numerous human papillomavirus (HPV) frequency studies in women with cervical cancer (CC), little is known of HPV frequency trends according to patient age. In this work, we compare the mean age and frequency distribution by age of CC patients positive for different HPVs. This study included 462 CC patients. HPVs were detected by PCR and typed using DNA sequencing. A total of 456 patients (98.7%) were positive for HPV: 418 (90.5%) had single and 38 (8.2%) had double HPV infections. HPV16 (46.5%), HPV18 (10.4%), HPV45 (6.7%), and HPV31 (4.1%) were the most frequent viral types in single-infected patients. The mean ages of single-infected patients with HPV16 (49.2 +/- 13.3), HPV18 (47.9 +/- 12.2), HPV45 (47.9 +/- 11.7), or HPV39 (42.6 +/- 8.9) were significantly lower than the mean ages of patients singly (53.9 +/- 12.7; p<0.001, t-test) or doubly (55.4 +/- 12.7; p<0.05, t-test) infected with the remaining HPVs. Three different trends were identified: one for HPV16, another for HPVs18/45/39, and a third for the rest of HPVs. The frequency trend of HPV16 shows two peaks. The first (63.2%) was found in the youngest women (<= 35 years), followed by a decreasing trend until the age of 5560 years (31.1%). The second peak arose at 6165 years (52.5%), followed by a decreasing trend. The trend for HPVs18/45/39 declined from the youngest (19.3%) to the oldest (>70 years; 12.8%) women. In contrast, the trend for the remaining HPVs increased from the youngest (15.8%) to the oldest (46.2%) women. Unlike other life-style factors, low-risk sexual behavior was associated with late onset of CC independent of low-oncogenic HPV types (p<0.05, Wald chi-square statistic). The data indicate that most CCs in young women depend on the presence of high-oncogenic HPVs. In contrast, almost half of CCs in older patients had low-oncogenic HPVs, suggesting they could depend on the presence of other factors.	[Guardado-Estrada, Mariano; Juarez-Torres, Eligia; Medina-Martinez, Ingrid; Alfaro, Ana; Berumen, Jaime] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med, Mexico City 04510, DF, Mexico; [Roman-Bassaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Elba Benuto, Rosa] Acad Mexicana Dermatol, Mexico City, DF, Mexico; [Dean, Michael] NCI, Expt Immunol Lab, Frederick, MD 21701 USA; [Villegas-Sepulveda, Nicolas] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Fac Med, Unidad Med, Mexico City 04510, DF, Mexico.	jaimeberumen@hotmail.com	Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Berumen, Jaime/F-7914-2018; Berumen, Jaime/AAL-5577-2020	Dean, Michael C/0000-0003-2234-0631; Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; Villegas-Sepulveda, Nicolas/0000-0001-9489-2545	National Council of Science and Technology (CONACYT) [8135/A1, 24341]; National University of Mexico [SDI.PTID.05.2]; NATIONAL CANCER INSTITUTE [ZIABC011300] Funding Source: NIH RePORTER	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Council of Science and Technology (CONACYT, www.conacyt.mx), grant numbers 8135/A1, 24341 and the National University of Mexico (www.unam.mx), grant number SDI.PTID.05.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany L, 2012, GYNECOL ONCOL, V124, P512, DOI 10.1016/j.ygyno.2011.11.024; Bekkers RLM, 2003, BRIT J CANCER, V89, P886, DOI 10.1038/sj.bjc.6601204; Bernard E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-373; Berois N, 2013, INT J GYNECOL CANCER, V23, P527, DOI 10.1097/IGC.0b013e318285e753; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Chan PKS, 2010, INT J CANCER, V126, P297, DOI 10.1002/ijc.24731; Ciapponi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025493; Cuzick J, 2010, GYNECOL ONCOL, V117, pS11, DOI 10.1016/j.ygyno.2010.01.025; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Forman D, 2013, CANC INCIDENCE 5 CON, VX; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garcia-Pineres AJ, 2006, CANCER RES, V66, P11070, DOI 10.1158/0008-5472.CAN-06-2034; Gargano JW, 2012, CANCER EPIDEM BIOMAR, V21, P111, DOI 10.1158/1055-9965.EPI-11-0664; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grassmann K, 1996, VIROLOGY, V223, P185, DOI 10.1006/viro.1996.0467; Gravitt Patti E, 2012, Open Virol J, V6, P198, DOI 10.2174/1874357901206010198; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guan Peng, 2012, Int J Cancer, V131, P2349, DOI 10.1002/ijc.27485; Guardado-Estrada M, 2009, J HUM GENET, V54, P695, DOI 10.1038/jhg.2009.98; Guimera N, 2013, HISTOPATHOLOGY, V63, P287, DOI 10.1111/his.12137; HernandezAvila M, 1997, ARCH MED RES, V28, P265; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kane MA, 2012, VACCINE, V30, pF192, DOI 10.1016/j.vaccine.2012.06.075; Kasamatsu E, 2012, J MED VIROL, V84, P1628, DOI 10.1002/jmv.23373; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kim CJ, 2000, INT J GYNECOL CANCER, V10, P157, DOI 10.1046/j.1525-1438.2000.00016.x; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Lazcano-Ponce E, 2008, CANCER EPIDEM BIOMAR, V17, P2808, DOI 10.1158/1055-9965.EPI-07-2659; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Maglennon Gareth Adam, 2012, Open Virol J, V6, P190, DOI 10.2174/1874357901206010190; Matos A, 2005, EUR J CANCER PREV, V14, P485, DOI 10.1097/01.cej.0000174780.44260.32; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ordonez RM, 2004, J GEN VIROL, V85, P1433, DOI 10.1099/vir.0.19317-0; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; SANG BC, 1992, P NATL ACAD SCI USA, V89, P8063, DOI 10.1073/pnas.89.17.8063; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schmitt M, 2013, INT J CANCER, V132, P2395, DOI 10.1002/ijc.27891; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x	50	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109406	10.1371/journal.pone.0109406	http://dx.doi.org/10.1371/journal.pone.0109406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295590	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000069
J	Smith, MJ; Weinberger, C; Bruna, EM; Allesina, S				Smith, Matthew J.; Weinberger, Cody; Bruna, Emilio M.; Allesina, Stefano			The Scientific Impact of Nations: Journal Placement and Citation Performance	PLOS ONE			English	Article							MEDICAL JOURNALS; BIAS; SCIENCE; AGE	International collaboration is becoming increasingly important for the advancement of science. To gain a more precise understanding of how factors such as international collaboration influence publication success, we divide publication success into two categories: journal placement and citation performance. Analyzing all papers published between 1996 and 2012 in eight disciplines, we find that those with more countries in their affiliations performed better in both categories. Furthermore, specific countries vary in their effects both individually and in combination. Finally, we look at the relationship between national output (in papers published) and input (in citations received) over the 17 years, expanding upon prior depictions by also plotting an expected proportion of citations based on Journal Placement. Discrepancies between this expectation and the realized proportion of citations illuminate trends in performance, such as the decline of the Global North in response to rapidly developing countries, especially China. Yet, most countries' show little to no discrepancy, meaning that, in most cases, citation proportion can be predicted by Journal Placement alone. This reveals an extreme asymmetry between the opinions of a few reviewers and the degree to which paper acceptance and citation rates influence career advancement.	[Smith, Matthew J.; Weinberger, Cody; Allesina, Stefano] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Bruna, Emilio M.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL USA; [Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Allesina, Stefano] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Smith, Matthew J.; Allesina, Stefano] Northern Plains Ctr Human Potential, St Paul, MN USA	University of Chicago; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Chicago	Smith, MJ (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	mjsmith@uchicago.edu	Michalska-Smith, Matthew J/H-3268-2019; Allesina, Stefano/A-2255-2009; Bruna, Emilio M/H-2769-2012	Michalska-Smith, Matthew J/0000-0002-0369-412X; Bruna, Emilio M/0000-0003-3381-8477; Allesina, Stefano/0000-0003-0313-8374	National Science Foundation Science of Science Policy [1042164]; University of Florida Center for Latin American Studies Faculty Research Award	National Science Foundation Science of Science Policy; University of Florida Center for Latin American Studies Faculty Research Award	MJS, CW, and SA were supported by National Science Foundation Science of Science Policy #1042164. EMB was supported by a University of Florida Center for Latin American Studies Faculty Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2013, NATURE, V497, P557, DOI 10.1038/497557a; Akre O, 2011, J EPIDEMIOL COMMUN H, V65, P119, DOI 10.1136/jech.2009.088690; Aksnes DW, 2012, J INFORMETR, V6, P36, DOI 10.1016/j.joi.2011.08.002; Bornmann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056768; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; LINDSEY D, 1980, SOC STUD SCI, V10, P145, DOI 10.1177/030631278001000202; Link AM, 1998, JAMA-J AM MED ASSOC, V280, P246, DOI 10.1001/jama.280.3.246; Lozano GA, 2012, J AM SOC INF SCI TEC, V63, P2140, DOI 10.1002/asi.22731; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; May RM, 1998, SCIENCE, V281, P49, DOI 10.1126/science.281.5373.49; MOLLER AP, 1990, NATURE, V348, P480, DOI 10.1038/348480c0; Opthof T, 2002, CARDIOVASC RES, V56, P339, DOI 10.1016/S0008-6363(02)00712-5; Paris G, 1998, NATURE, V396, P210, DOI 10.1038/24249; PETERS DP, 1982, BEHAV BRAIN SCI, V5, P187, DOI 10.1017/S0140525X00011183; Stocks G, 2008, BIOTROPICA, V40, P397, DOI 10.1111/j.1744-7429.2007.00393.x; van Raan AFJ., 1997, SCI PUBL POLICY, V24, P290, DOI [DOI 10.1093/SPP/24.5.290, 10.1093/spp/24.5.290]	19	81	82	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109195	10.1371/journal.pone.0109195	http://dx.doi.org/10.1371/journal.pone.0109195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296039	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000044
J	Ye, ZL; Zheng, Y; Li, BY; Borrusch, MS; Storms, R; Walton, JD				Ye, Zhuoliang; Zheng, Yun; Li, Bingyao; Borrusch, Melissa S.; Storms, Reginald; Walton, Jonathan D.			Enhancement of Synthetic Trichoderma-Based Enzyme Mixtures for Biomass Conversion with an Alternative Family 5 Glycosyl Hydrolase from Sporotrichum thermophile	PLOS ONE			English	Article							THERMOASCUS-AURANTIACUS ENDOGLUCANASE; SUBSTRATE-SPECIFICITY; DEGRADING ENZYMES; CELLULOSE; OPTIMIZATION; DECONSTRUCTION; HYDROLYSIS; POLYSACCHARIDES; MECHANISMS; KINETICS	Enzymatic conversion of lignocellulosic materials to fermentable sugars is a limiting step in the production of biofuels from biomass. We show here that combining enzymes from different microbial sources is one way to identify superior enzymes. Extracts of the thermophilic fungus Sporotrichum thermophile (synonym Myceliophthora thermophila) gave synergistic release of glucose (Glc) and xylose (Xyl) from pretreated corn stover when combined with an 8-component synthetic cocktail of enzymes from Trichoderma reesei. The S. thermophile extracts were fractionated and an enhancing factor identified as endo-beta 1,4-glucanase (StCel5A or EG2) of subfamily 5 of Glycosyl Hydrolase family 5 (GH5_5). In multicomponent optimization experiments using a standard set of enzymes and either StCel5A or the ortholog from T. reesei (TrCel5A), reactions containing StCel5A yielded more Glc and Xyl. In a five-component optimization experiment (i.e., varying four core enzymes and the source of Cel5A), the optimal proportions for TrCel5A vs. StCel5A were similar for Glc yields, but markedly different for Xyl yields. Both enzymes were active on lichenan, glucomannan, and oat beta-glucan; however, StCel5A but not TrCel5A was also active on beta 1,4-mannan, two types of galactomannan, and beta 1,4-xylan. Phylogenetically, fungal enzymes in GH5_5 sorted into two clades, with StCel5A and TrCel5A belonging to different clades. Structural differences with the potential to account for the differences in performance were deduced based on the known structure of TrCel5A and a homology-based model of StCel5A, including a loop near the active site of TrCel5A and the presence of four additional Trp residues in the active cleft of StCel5A. The results indicate that superior biomass-degrading enzymes can be identified by exploring taxonomic diversity combined with assays in the context of realistic enzyme combinations and realistic substrates. Substrate range may be a key factor contributing to superior performance within GH5_5.	[Ye, Zhuoliang; Li, Bingyao; Borrusch, Melissa S.; Walton, Jonathan D.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, Dept Energy, E Lansing, MI 48824 USA; [Ye, Zhuoliang; Li, Bingyao; Borrusch, Melissa S.; Walton, Jonathan D.] Michigan State Univ, Dept Energy Plant, Res Lab, E Lansing, MI 48824 USA; [Zheng, Yun; Storms, Reginald] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Michigan State University; United States Department of Energy (DOE); Michigan State University; Concordia University - Canada	Walton, JD (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, Dept Energy, E Lansing, MI 48824 USA.	walton@msu.edu			United States Department of Energy Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; United States Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences [DE-FG02-91ER200021]	United States Department of Energy Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); United States Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences(United States Department of Energy (DOE))	This work was funded by the United States Department of Energy Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494). Additional funding was provided by grant DE-FG02-91ER200021 to the MSU-Plant Research Laboratory from the United States Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Banerjee G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-16; Banerjee G, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-22; Banerjee G, 2010, BIORESOURCE TECHNOL, V101, P9097, DOI 10.1016/j.biortech.2010.07.028; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Ding SJ, 2001, EUR J BIOCHEM, V268, P5687, DOI 10.1046/j.0014-2956.2001.02503.x; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Falls M, 2011, BIORESOURCE TECHNOL, V102, P11072, DOI 10.1016/j.biortech.2011.03.035; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao DH, 2010, BIOENERG RES, V3, P67, DOI 10.1007/s12155-009-9066-6; Gusakov AV, 2011, US Patent, Patent No. [7,883,872 B2, 7883872]; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; Kim E, 1998, BIOTECHNOL BIOENG, V58, P494, DOI 10.1002/(SICI)1097-0290(19980605)58:5<494::AID-BIT5>3.0.CO;2-8; Kostylev M, 2012, BIOFUELS-UK, V3, P61, DOI 10.4155/BFS.11.150; Lee TM, 2011, PROTEIN SCI, V20, P1935, DOI 10.1002/pro.730; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Lo Leggio L, 2002, FEBS LETT, V523, P103, DOI 10.1016/S0014-5793(02)02954-X; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nagendran S, 2009, FUNGAL GENET BIOL, V46, P427, DOI 10.1016/j.fgb.2009.02.001; Pollet A, 2010, CRIT REV BIOTECHNOL, V30, P176, DOI 10.3109/07388551003645599; Scott-Craig JS, 2011, J BIOL CHEM, V286, P42848, DOI 10.1074/jbc.M111.307397; Selig MJ, 2008, BIORESOURCE TECHNOL, V99, P4997, DOI 10.1016/j.biortech.2007.09.064; SHEPHERD MG, 1981, BIOCHEM J, V193, P67, DOI 10.1042/bj1930067; Srikrishnan S, 2012, BIOTECHNOL BIOENG, V109, P1595, DOI 10.1002/bit.24414; Takasuka TE, 2012, METHODS MOL IN PRESS; Tambor JH, 2012, APPL MICROBIOL BIOT, V93, P203, DOI 10.1007/s00253-011-3419-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van Petegem F, 2002, BIOCHEM BIOPH RES CO, V296, P161, DOI 10.1016/S0006-291X(02)00775-1; WEIMER PJ, 1990, APPL ENVIRON MICROB, V56, P2421, DOI 10.1128/AEM.56.8.2421-2429.1990; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Ye ZL, 2011, BIORESOURCE TECHNOL, V102, P11194, DOI 10.1016/j.biortech.2011.09.044; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang X, 2012, US Patent Application, Patent No. [0208235 A1, 0208235]	44	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109885	10.1371/journal.pone.0109885	http://dx.doi.org/10.1371/journal.pone.0109885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295862	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204000099
J	Jespers, V; Crucitti, T; Menten, J; Verhelst, R; Mwaura, M; Mandaliya, K; Ndayisaba, GF; Delany-Moretlwe, S; Verstraelen, H; Hardy, L; Buve, A; van de Wijgert, J				Jespers, Vicky; Crucitti, Tania; Menten, Joris; Verhelst, Rita; Mwaura, Mary; Mandaliya, Kishor; Ndayisaba, Gilles F.; Delany-Moretlwe, Sinead; Verstraelen, Hans; Hardy, Liselotte; Buve, Anne; van de Wijgert, Janneke		Vaginal Biomarkers Study Grp	Prevalence and Correlates of Bacterial Vaginosis in Different Sub-Populations of Women in Sub-Saharan Africa: A Cross-Sectional Study	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; HIV ACQUISITION; RISK-FACTORS; INFECTIONS; LACTOBACILLI; ASSOCIATION	Background: Clinical development of vaginally applied products aimed at reducing the transmission of HIV and other sexually transmitted infections, has highlighted the need for a better characterisation of the vaginal environment. We set out to characterise the vaginal environment in women in different settings in sub-Saharan Africa. Methods: A longitudinal study was conducted in Kenya, Rwanda and South-Africa. Women were recruited into pre-defined study groups including adult, non-pregnant, HIV-negative women; pregnant women; adolescent girls; HIV-negative women engaging in vaginal practices; female sex workers; and HIV-positive women. Consenting women were interviewed and underwent a pelvic exam. Samples of vaginal fluid and a blood sample were taken and tested for bacterial vaginosis (BV), HIV and other reproductive tract infections (RTIs). This paper presents the cross-sectional analyses of BV Nugent scores and RTI prevalence and correlates at the screening and the enrolment visit. Results: At the screening visit 38% of women had BV defined as a Nugent score of 7-10, and 64% had more than one RTI (N. gonorrhoea, C. trachomatis, T. vaginalis, syphilis) and/or Candida. At screening the likelihood of BV was lower in women using progestin-only contraception and higher in women with more than one RTI. At enrolment, BV scores were significantly associated with the presence of prostate specific antigen (PSA) in the vaginal fluid and with being a self-acknowledged sex worker. Further, sex workers were more likely to have incident BV by Nugent score at enrolment. Conclusions: Our study confirmed some of the correlates of BV that have been previously reported but the most salient finding was the association between BV and the presence of PSA in the vaginal fluid which is suggestive of recent unprotected sexual intercourse.	[Jespers, Vicky; Hardy, Liselotte; Buve, Anne] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Menten, Joris] Inst Trop Med, Dept Clin Sci, Clin Trials Unit, B-2000 Antwerp, Belgium; [Verhelst, Rita] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Mwaura, Mary; Mandaliya, Kishor] ICRH Kenya, Mombasa, Kenya; [Ndayisaba, Gilles F.] Rinda Ubuzima, Kigali, Rwanda; [Delany-Moretlwe, Sinead] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Verstraelen, Hans] Univ Ghent, Fac Med & Hlth Sci, Dept Obstet & Gynecol, B-9000 Ghent, Belgium; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [van de Wijgert, Janneke] AMC CPCD, Amsterdam, Netherlands	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Ghent University; University of Witwatersrand; Ghent University; University of Liverpool	Jespers, V (corresponding author), Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium.	vjespers@itg.be	Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AEQ-9792-2022; Verstraelen, Hans/AAA-8694-2019; Hardy, Liselotte/AAF-3515-2019; Verstraelen, Hans/A-5602-2008; Crucitti, Tania/AAB-9967-2019; Kestelyn, Evelyne/AAD-6052-2019; Masha, Simon/R-4419-2017	Crucitti, Tania/0000-0002-2235-6038; Verstraelen, Hans/0000-0002-4070-1587; Crucitti, Tania/0000-0002-2235-6038; Kestelyn, Evelyne/0000-0002-5728-0918; Andreasen, Aura/0000-0003-0664-7342; Hardy, Liselotte/0000-0002-8785-5081; Thiongo, Mary/0000-0002-0598-995X; Vaneechoutte, Mario/0000-0002-4586-203X; Masha, Simon/0000-0002-6283-2430; Cools, Piet/0000-0003-2980-5307; Kapiga, Saidi/0000-0003-1753-4060; de Assis Rosa, Debra/0000-0002-9342-2661; Jaoko, Walter/0000-0002-7134-6581; Hayes, Richard/0000-0002-1729-9892; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	European & Developing Countries Clinical Trials Partnership [IP_2007_33070_001]; Research Foundation Flanders [FWO-3GA13210]	European & Developing Countries Clinical Trials Partnership; Research Foundation Flanders(FWO)	The project was funded by the European & Developing Countries Clinical Trials Partnership (IP_2007_33070_001) ( http://www.edctp.org/) and the Research Foundation Flanders (FWO-3GA13210) (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Collett D, 2003, C&H TEXT STAT SCI, P45; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Govender L, 1996, INT J GYNECOL OBSTET, V55, P23, DOI 10.1016/0020-7292(96)02744-0; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; LEPPALUOTO PA, 1971, ACTA CYTOL, V15, P211; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Pendharkar S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-43; Rifkin SB, 2009, CONTRACEPTION, V80, P63, DOI 10.1016/j.contraception.2009.01.008; Riggs M, 2007, SEX TRANSM DIS, V34, P954, DOI 10.1097/OLQ.0b013e31811ed0e4; Thoma ME, 2011, SEX TRANSM DIS, V38, P111, DOI 10.1097/OLQ.0b013e3181f0bdd0; Thurman Andrea Ries, 2011, Infect Dis Obstet Gynecol, V2011, P1, DOI 10.1155/2011/429403; UNAIDS, 2013, UNAIDSJC25021E; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695	20	66	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109670	10.1371/journal.pone.0109670	http://dx.doi.org/10.1371/journal.pone.0109670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289640	Green Published, gold, Green Accepted			2022-12-27	WOS:000342798000076
J	Kazem, S; van der Meijden, E; Wang, RC; Rosenberg, AS; Pope, E; Benoit, T; Fleckman, P; Feltkamp, MCW				Kazem, Siamaque; van der Meijden, Els; Wang, Richard C.; Rosenberg, Arlene S.; Pope, Elena; Benoit, Taylor; Fleckman, Philip; Feltkamp, Mariet C. W.			Polyomavirus-Associated Trichodysplasia Spinulosa Involves Hyperproliferation, pRB Phosphorylation and Upregulation of p16 and p21	PLOS ONE			English	Article							VIRAL-ASSOCIATED TRICHODYSPLASIA; LARGE TUMOR-ANTIGEN; RETINOBLASTOMA PROTEIN; T-ANTIGEN; SUPPRESSOR; CYCLE; GENE; P53; E6; DIFFERENTIATION	Trichodysplasia spinulosa (TS) is a proliferative skin disease observed in severely immunocompromized patients. It is characterized by papule and trichohyalin-rich spicule formation, epidermal acanthosis and distention of dysmorphic hair follicles overpopulated by inner root sheath cells (IRS). TS probably results from active infection with the TS-associated polyomavirus (TSPyV), as indicated by high viral-load, virus protein expression and particle formation. The underlying pathogenic mechanism imposed by TSPyV infection has not been solved yet. By analogy with other polyomaviruses, such as the Merkel cell polyomavirus associated with Merkel cell carcinoma, we hypothesized that TSPyV T-antigen promotes proliferation of infected IRS cells. Therefore, we analyzed TS biopsy sections for markers of cell proliferation (Ki-67) and cell cycle regulation (p16(ink4a), p21(waf), pRB, phosphorylated pRB), and the putatively transforming TSPyV early large tumor (LT) antigen. Intense Ki-67 staining was detected especially in the margins of TS hair follicles, which colocalized with TSPyV LT-antigen detection. In this area, staining was also noted for pRB and particularly phosphorylated pRB, as well as p16(ink4a) and p21(waf). Healthy control hair follicles did not or hardly stained for these markers. Trichohyalin was particularly detected in the center of TS follicles that stained negative for Ki-67 and TSPyVLT-antigen. In summary, we provide evidence for clustering of TSPyVLT-antigen-expressing and proliferating cells in the follicle margins that overproduce negative cell cycle regulatory proteins. These data are compatible with a scenario of TSPyVT-antigen-mediated cell cycle progression, potentially creating a pool of proliferating cells that enable viral DNA replication and drive papule and spicule formation.	[Kazem, Siamaque; van der Meijden, Els; Feltkamp, Mariet C. W.] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, South Holland, Netherlands; [Wang, Richard C.] UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA; [Rosenberg, Arlene S.] Case Western Reserve Univ, Dept Dermatol, Metrohlth Med Ctr, Cleveland, OH 44106 USA; [Pope, Elena] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Benoit, Taylor] Med Univ S Carolina, Dept Dermatol, Charleston, SC 29425 USA; [Fleckman, Philip] Univ Washington, Div Dermatol, Seattle, WA 98195 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; MetroHealth System; University of Toronto; Medical University of South Carolina; University of Washington; University of Washington Seattle	Feltkamp, MCW (corresponding author), Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, South Holland, Netherlands.	m.c.w.feltkamp@lumc.nl	Feltkamp, Mariet/A-3788-2010; Wang, Richard/AAW-3066-2021	Feltkamp, Mariet/0000-0001-5993-9846; Wang, Richard/0000-0003-4543-8295	Leiden University Medical Center, The Netherlands; NATIONAL CANCER INSTITUTE [K08CA164047] Funding Source: NIH RePORTER	Leiden University Medical Center, The Netherlands; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Leiden University Medical Center, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit T, 2010, ARCH DERMATOL, V146, P871, DOI 10.1001/archdermatol.2010.175; Boxman ILA, 2001, J INVEST DERMATOL, V117, P1397, DOI 10.1046/j.0022-202x.2001.01602.x; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DYSON N, 1990, J VIROL, V64, P1353, DOI 10.1128/JVI.64.3.1353-1356.1990; Feltkamp MCW, 2013, J GEN VIROL, V94, P482, DOI 10.1099/vir.0.048462-0; Frisque RJ, 2006, ADV EXP MED BIOL, V577, P288; Harris KF, 1998, MOL CELL BIOL, V18, P1746, DOI 10.1128/MCB.18.3.1746; Haycox CL, 1999, J INVEST DERM SYMP P, V4, P268, DOI 10.1038/sj.jidsp.5640227; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Kanitakis J, 2011, EUR J DERMATOL, V21, P453, DOI 10.1684/ejd.2011.1395; Kazem S, 2013, APMIS, V121, P770, DOI 10.1111/apm.12092; Kazem S, 2012, J CLIN VIROL, V53, P225, DOI 10.1016/j.jcv.2011.11.007; Kazem S, 2012, VIRUS RES, V163, P609, DOI 10.1016/j.virusres.2011.12.015; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Malanchi I, 2004, J VIROL, V78, P13769, DOI 10.1128/JVI.78.24.13769-13778.2004; Matthews MR, 2011, J CUTAN PATHOL, V38, P420, DOI 10.1111/j.1600-0560.2010.01664.x; Pipas JM, 2009, VIROLOGY, V384, P294, DOI 10.1016/j.virol.2008.11.024; Pipas JM, 2001, SEMIN CANCER BIOL, V11, P23, DOI 10.1006/scbi.2000.0343; Portari EA, 2013, INT J GYNECOL PATHOL, V32, P501, DOI 10.1097/PGP.0b013e31826f5cf6; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Schwieger-Briel A, 2010, PEDIATR DERMATOL, V27, P509, DOI 10.1111/j.1525-1470.2010.01278.x; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shivakumar CV, 1996, ONCOGENE, V13, P323; Struijk L, 2008, J GEN VIROL, V89, P2303, DOI 10.1099/vir.0.83317-0; Todorovic B, 2012, J VIROL, V86, P13313, DOI 10.1128/JVI.01637-12; Topalis D, 2013, ANTIVIR RES, V97, P122, DOI 10.1016/j.antiviral.2012.11.007; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; van Drongelen V, 2014, TISSUE ENG A	29	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108947	10.1371/journal.pone.0108947	http://dx.doi.org/10.1371/journal.pone.0108947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291363	gold, Green Published			2022-12-27	WOS:000342798000031
J	Nakajima-Adachi, H; Kikuchi, A; Fujimura, Y; Shibahara, K; Makino, T; Goseki-Sone, M; Kihara-Fujioka, M; Nochi, T; Kurashima, Y; Igarashi, O; Yamamoto, M; Kunisawa, J; Toda, M; Kaminogawa, S; Sato, R; Kiyono, H; Hachimura, S				Nakajima-Adachi, Haruyo; Kikuchi, Akira; Fujimura, Yoko; Shibahara, Kyoko; Makino, Tsuyoshi; Goseki-Sone, Masae; Kihara-Fujioka, Miran; Nochi, Tomonori; Kurashima, Yosuke; Igarashi, Osamu; Yamamoto, Masafumi; Kunisawa, Jun; Toda, Masako; Kaminogawa, Shuichi; Sato, Ryuichiro; Kiyono, Hiroshi; Hachimura, Satoshi			Peyer's Patches and Mesenteric Lymph Nodes Cooperatively Promote Enteropathy in a Mouse Model of Food Allergy	PLOS ONE			English	Article							RECEPTOR TRANSGENIC MICE; ORAL TOLERANCE; DENDRITIC CELLS; T-CELLS; GASTROINTESTINAL-TRACT; ANTIGEN; IMMUNITY; INFLAMMATION; RESPONSES; DIARRHEA	Background and Objective: To improve the efficacy and safety of tolerance induction for food allergies, identifying the tissues responsible for inducing intestinal inflammation and subsequent oral tolerance is important. We used OVA23-3 mice, which express an ovalbumin-specific T-cell receptor, to elucidate the roles of local and systemic immune tissues in intestinal inflammation. Methods and Results: OVA23-3 mice developed marked enteropathy after consuming a diet containing egg white (EW diet) for 10 days but overcame the enteropathy (despite continued moderate inflammation) after receiving EW diet for a total of 28 days. Injecting mice with anti-IL-4 antibody or cyclosporine A confirmed the involvement of Th2 cells in the development of the enteropathy. To assess the individual contributions of Peyer's patches (PPs), mesenteric lymph nodes (MLNs), and the spleen to the generation of effector CD4(+) T-cells, we analyzed the IL-4 production, proliferation in response to ovalbumin, and CD4(+) T-cell numbers of these tissues. EW feeding for 10 days induced significant IL-4 production in PPs, the infiltration of numerous CD4(+) T-cells into MLNs, and a decrease in CD4(+) T-cell numbers in spleen. On day 28, CD4(+) T-cells from all tissues had attenuated responses to ovalbumin, suggesting tolerance acquisition, although MLN CD4(+) T-cells still maintained IL-4 production with proliferation. In addition, removal of MLNs but not the spleen decreased the severity of enteropathy and PP-disrupted mice showed delayed onset of EW-induced inflammatory responses. Disruption of peripheral lymphoid tissues or of both PPs and MLNs almost completely prevented the enteropathy. Conclusions: PPs and MLNs coordinately promote enteropathy by generating effector T-cells during the initial and exacerbated phases, respectively; the spleen is dispensable for enteropathy and shows tolerogenic responses throughout EW-feeding. The regulation of PPs may suppress the initiation of intestinal inflammation, subsequently restricting MLNs and inhibiting the progression of food-allergic enteropathy.	[Nakajima-Adachi, Haruyo; Kikuchi, Akira; Fujimura, Yoko; Shibahara, Kyoko; Kihara-Fujioka, Miran; Sato, Ryuichiro; Hachimura, Satoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Nakajima-Adachi, Haruyo; Nochi, Tomonori; Kurashima, Yosuke; Igarashi, Osamu; Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Makino, Tsuyoshi] Japan SLC Inc, Biotech Ctr, BT Ctr, Shizuoka, Japan; [Goseki-Sone, Masae] Japan Womens Univ, Fac Human Sci & Design, Dept Food & Nutr, Tokyo 112, Japan; [Kurashima, Yosuke; Kunisawa, Jun; Kiyono, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Yamamoto, Masafumi] Nihon Univ, Sch Dent Matsudo, Dept Microbiol & Immunol, Chiba, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Osaka, Japan; [Toda, Masako] Paul Ehrlich Inst, Vice Presidents Res Grp Mol Allergol, Langen, Germany; [Kaminogawa, Shuichi] Nihon Univ, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Nakajima-Adachi, Haruyo; Shibahara, Kyoko; Hachimura, Satoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Womens University; Japan Science & Technology Agency (JST); Nihon University; University of Tokyo; National Institute of Health Sciences - Japan; Paul Ehrlich Institute; Nihon University; University of Tokyo; University of Tokyo; University of Tokyo	Nakajima-Adachi, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.	aryu@mail.ecc.u-tokyo.ac.jp	Nochi, Tomonori/U-2533-2019; Kiyono, Hiroshi/AAC-6735-2022; Toda, Masako/S-9810-2019	Nochi, Tomonori/0000-0003-1800-6972; 	Japan Society for the Promotion of Science; Food Science Institute Foundation and Food Safety Commission	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Food Science Institute Foundation and Food Safety Commission	The authors received financial support from the Restart Postdoctoral Program of the Japan Society for the Promotion of Science and from The Food Science Institute Foundation and Food Safety Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Dourado LPA, 2010, CELL IMMUNOL, V262, P62, DOI 10.1016/j.cellimm.2009.12.010; Beck Lisa A., 2000, Journal of Allergy and Clinical Immunology, V106, pS258; Bedoret D, 2012, MUCOSAL IMMUNOL, V5, P267, DOI 10.1038/mi.2012.5; Blazquez AB, 2010, GASTROENTEROLOGY, V138, P275, DOI 10.1053/j.gastro.2009.09.016; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Burggraf M, 2011, MOL NUTR FOOD RES, V55, P1475, DOI 10.1002/mnfr.201000634; Cardoso CR, 2009, AM J PHYSIOL-GASTR L, V296, pG593, DOI 10.1152/ajpgi.90431.2008; Chambers SJ, 2004, IMMUNOLOGY, V112, P72, DOI 10.1111/j.1365-2567.2004.01846.x; Costes LMM, 2013, ORGANOGENESIS, V9, P216, DOI 10.4161/org.25646; Dubois B, 2005, CELL MOL LIFE SCI, V62, P1322, DOI 10.1007/s00018-005-5036-0; Fecek RJ, 2010, IMMUNOBIOLOGY, V215, P941, DOI 10.1016/j.imbio.2010.02.004; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Haraikawa M, 2011, J NUTR SCI VITAMINOL, V57, P274, DOI 10.3177/jnsv.57.274; Hu W, 2007, ALLERGY, V62, P709, DOI 10.1111/j.1398-9995.2007.01315.x; Knight AK, 2007, AM J PHYSIOL-GASTR L, V293, pG1234, DOI 10.1152/ajpgi.00323.2007; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Mohrenschlager M, 2011, GERONTOLOGY, V57, P33, DOI 10.1159/000316576; Morita H, 2013, ALLERGOL INT, V62, P297, DOI 10.2332/allergolint.13-RA-0542; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Nakajima-Adachi H, 2006, J ALLERGY CLIN IMMUN, V117, P1125, DOI 10.1016/j.jaci.2006.01.016; Nakajima-Adachi H, 2012, BIOSCI BIOTECH BIOCH, V76, P1979, DOI 10.1271/bbb.120349; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Ruiter B, 2012, J ALLERGY CLIN IMMUN, V129, P921, DOI 10.1016/j.jaci.2012.01.080; SATO T, 1994, EUR J IMMUNOL, V24, P1512, DOI 10.1002/eji.1830240708; Scurlock AM, 2010, MUCOSAL IMMUNOL, V3, P345, DOI 10.1038/mi.2010.21; Steele L, 2012, IMMUNOL RES, V54, P75, DOI 10.1007/s12026-012-8308-4; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Ternblay JN, 2007, J ALLERGY CLIN IMMUN, V120, P659, DOI 10.1016/j.jaci.2007.04.044; Wang J, 2011, J CLIN INVEST, V121, P827, DOI [10.1172/JCI45434, 10.1186/1710-1492-7-S1-S7]; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yamamoto M, 2004, J IMMUNOL, V173, P762, DOI 10.4049/jimmunol.173.2.762; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	42	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e107492	10.1371/journal.pone.0107492	http://dx.doi.org/10.1371/journal.pone.0107492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290461	Green Submitted, Green Published, gold			2022-12-27	WOS:000342798000005
J	Oliveira, H; Thiagarajan, V; Walmagh, M; Sillankorva, S; Lavigne, R; Neves-Petersen, MT; Kluskens, LD; Azeredo, J				Oliveira, Hugo; Thiagarajan, Viruthachalam; Walmagh, Maarten; Sillankorva, Sanna; Lavigne, Rob; Neves-Petersen, Maria Teresa; Kluskens, Leon D.; Azeredo, Joana			A Thermostable Salmonella Phage Endolysin, Lys68, with Broad Bactericidal Properties against Gram-Negative Pathogens in Presence of Weak Acids	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; LYSOZYME	Resistance rates are increasing among several problematic Gram-negative pathogens, a fact that has encouraged the development of new antimicrobial agents. This paper characterizes a Salmonella phage endolysin (Lys68) and demonstrates its potential antimicrobial effectiveness when combined with organic acids towards Gram-negative pathogens. Biochemical characterization reveals that Lys68 is more active at pH 7.0, maintaining 76.7% of its activity when stored at 4 degrees C for two months. Thermostability tests showed that Lys68 is only completely inactivated upon exposure to 100 degrees C for 30 min, and circular dichroism analysis demonstrated the ability to refold into its original conformation upon thermal denaturation. It was shown that Lys68 is able to lyse a wide panel of Gram-negative bacteria (13 different species) in combination with the outer membrane permeabilizers EDTA, citric and malic acid. While the EDTA/Lys68 combination only inactivated Pseudomonas strains, the use of citric or malic acid broadened Lys68 antibacterial effect to other Gram-negative pathogens (lytic activity against 9 and 11 species, respectively). Particularly against Salmonella Typhimurium LT2, the combinatory effect of malic or citric acid with Lys68 led to approximately 3 to 5 log reductions in bacterial load/CFUs after 2 hours, respectively, and was also able to reduce stationary-phase cells and bacterial biofilms by approximately 1 log. The broad killing capacity of malic/citric acid-Lys68 is explained by the destabilization and major disruptions of the cell outer membrane integrity due to the acidity caused by the organic acids and a relatively high muralytic activity of Lys68 at low pH. Lys68 demonstrates good (thermo) stability properties that combined with different outer membrane permeabilizers, could become useful to combat Gram-negative pathogens in agricultural, food and medical industry.	[Oliveira, Hugo; Sillankorva, Sanna; Kluskens, Leon D.; Azeredo, Joana] Univ Minho, Ctr Biol Engn, Braga, Portugal; [Thiagarajan, Viruthachalam] Bharathidasan Univ, Sch Chem, Tiruchirappalli, Tamil Nadu, India; [Walmagh, Maarten; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Leuven, Belgium; [Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab, Nanomed Dept, Braga, Portugal; [Neves-Petersen, Maria Teresa] Aalborg Univ, Fac Med, Aalborg, Denmark	Universidade do Minho; Bharathidasan University; KU Leuven; International Iberian Nanotechnology Laboratory; Aalborg University	Azeredo, J (corresponding author), Univ Minho, Ctr Biol Engn, Braga, Portugal.	jazeredo@deb.uminho.pt	Viruthachalam, Thiagarajan/I-2503-2013; Sillankorva, Sanna/AAF-9356-2021; INL, Citations/K-3436-2015; Kluskens, Leon/J-3019-2013; Oliveira, Hugo/AAH-1071-2021; Oliveira, Hugo/O-5972-2015; Sillankorva, Sanna/J-2621-2013	Sillankorva, Sanna/0000-0002-8408-8550; INL, Citations/0000-0002-3745-5100; Kluskens, Leon/0000-0002-0070-7837; Oliveira, Hugo/0000-0001-9564-5714; Sillankorva, Sanna/0000-0002-8408-8550; Thiagarajan, Viruthachalam/0000-0003-4197-2255; Azeredo, Joana/0000-0002-5180-7133; Lavigne, Rob/0000-0001-7377-1314; Neves-Petersen, Maria Teresa/0000-0003-3178-3709	"Fundacao para a Ciencia e Tecnologia" (FCT), Portugal [FCOMP-01-0124-FEDER-019446, FCOMP-01-0124-FEDER-027462, PEst-OE/EQB/LA0023/2013]; BioHealth - Biotechnology and Bioengineering approaches to improve health quality [NORTE-07-0124-FEDER-000027]; Programa Operacional Regional do Norte [ON. 2 - O Novo Norte]; QREN; FEDER; FCT [SFRH/BD/63734/2009]; IWT Vlaanderen	"Fundacao para a Ciencia e Tecnologia" (FCT), Portugal(Portuguese Foundation for Science and Technology); BioHealth - Biotechnology and Bioengineering approaches to improve health quality; Programa Operacional Regional do Norte; QREN; FEDER(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); IWT Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the projects FCOMP-01-0124-FEDER-019446, FCOMP-01-0124-FEDER-027462 and PEst-OE/EQB/LA0023/2013 from "Fundacao para a Ciencia e Tecnologia" (FCT), Portugal. The authors thank the Project "BioHealth - Biotechnology and Bioengineering approaches to improve health quality", Ref. NORTE-07-0124-FEDER-000027, co-funded by the Programa Operacional Regional do Norte (ON. 2 - O Novo Norte), QREN, FEDER. Hugo Oliveira acknowledges the FCT grant SFRH/BD/63734/2009. Maarten Walmagh held a PhD scholarship of the IWT Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Alakomi HL, 2007, THESIS U HELSINKI; Briers Y, 2011, J APPL MICROBIOL, V110, P778, DOI 10.1111/j.1365-2672.2010.04931.x; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Briers Y, 2007, J BIOCHEM BIOPH METH, V70, P531, DOI 10.1016/j.jbbm.2006.10.009; Briers Y, 2009, BIOCHEM BIOPH RES CO, V383, P187, DOI 10.1016/j.bbrc.2009.03.161; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Doores S., 1993, ANTIMICROBIALS FOODS, P95; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Kim SA, 2013, APPL ENVIRON MICROB, V79, P6552, DOI 10.1128/AEM.02164-13; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; Lim JA, 2012, RES MICROBIOL, V163, P233, DOI 10.1016/j.resmic.2012.01.002; Mastromatteo M, 2010, J FOOD SCI, V75, pM178, DOI 10.1111/j.1750-3841.2010.01556.x; NAKAGAWA H, 1985, J VIROL, V54, P460, DOI 10.1128/JVI.54.2.460-466.1985; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Schuch Raymond, 2009, V502, P307, DOI 10.1007/978-1-60327-565-1_18; Sillankorva S, 2010, J APPL MICROBIOL, V108, P1175, DOI 10.1111/j.1365-2672.2009.04549.x; Theron MM, 2011, ORGANIC ACIDS FOOD P, P117; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vollmer W, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P15; Walmagh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036991; Warnecke T, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-25; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Webb H, 2011, PROTEINS, V79, P685, DOI 10.1002/prot.22886; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388; WREN BW, 1991, MOL MICROBIOL, V5, P797, DOI 10.1111/j.1365-2958.1991.tb00752.x	35	108	115	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108376	10.1371/journal.pone.0108376	http://dx.doi.org/10.1371/journal.pone.0108376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290100	Green Published, gold			2022-12-27	WOS:000342798000015
J	Cai, L; Zhang, JW; Xue, XX; Wang, ZG; Wang, JJ; Tang, SD; Tang, SW; Wang, J; Zhang, Y; Xia, X				Cai, Li; Zhang, Jin-wei; Xue, Xing-xin; Wang, Zhi-gang; Wang, Jia-jia; Tang, Shai-di; Tang, Shao-wen; Wang, Jie; Zhang, Yun; Xia, Xian			Meta-Analysis of Associations of IL1 Receptor Antagonist and Estrogen Receptor Gene Polymorphisms with Systemic Lupus Erythematosus Susceptibility	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CYTOKINE PRODUCTION; AUTOIMMUNE-DISEASES; REVISED CRITERIA; HUMAN MONOCYTES; TANDEM REPEAT; LUTEAL-PHASE; INTERLEUKIN-1; EXPRESSION; ALPHA	Systemic lupus erythematosus (SLE) is an autoimmune disease that affects a number of different organs and tissues. Interleukin-1 (IL1) and estrogen are considered potential elements in the pathology of SLE. Recently, the variable number of tandem repeats (VNTR) polymorphism in the IL1 receptor antagonist gene (IL1-RN) and PvuII (rs2234693) and XbaI (rs9340799) polymorphisms in the estrogen receptor 1 gene (ESR1) have been associated with a predisposition to SLE. However, the evidence for these associations is inconclusive. We therefore conducted a meta-analysis to validate the roles of these polymorphisms in SLE susceptibility. We searched four databases and identified a total of 17 eligible articles comprising 24 studies. The Newcastle-Ottawa quality assessment scale was used to assess the qualities of the selected studies. We assessed the strengths of the associations using odds ratios (ORs) with 95% confidence intervals (95% CIs). Regarding the IL-1RN VNTR, the 2 allele significantly increased SLE susceptibility (2 vs. L: OR = 1.34, 95% CI = 1.03-1.73, P = 0.03). The ESR1 PvuII CC/CT genotype was also associated with SLE susceptibility (CC/CT vs. TT: OR = 1.25, 95% CI = 1.06-1.47, P = 0.01), and the difference was especially pronounced among Asians (CC/CT vs. TT: OR = 1.33, 95% CI = 1.04-1.69, P = 0.02). No significant association between the ESR1 XbaI polymorphism and SLE susceptibility was observed in the overall analysis. However, a marginally significant association between the GG/GA genotype was found in individuals of Asian descent (GG/GA vs. AA: OR = 1.30, 95% CI = 1.01-1.67, P = 0.04). These results indicate that the IL1-RN VNTR 2 allele, ESR1 PvuII CC/CT genotype and ESR1 XbaI GG/GA genotype may increase SLE susceptibility, especially in Asian individuals.	[Cai, Li; Xue, Xing-xin; Wang, Jia-jia; Tang, Shai-di; Tang, Shao-wen; Zhang, Yun] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhang, Jin-wei] Nanjing Univ, Affiliated Drum Tower Hosp, Coll Med, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Wang, Zhi-gang; Xia, Xian] Gen Hosp Beijing Mil Reg, Dept Nosocomial Infect Control, Beijing, Peoples R China; [Wang, Jie] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Jie] Nanjing Med Univ, Dept Gen Practice, Kangda Coll, Nanjing, Jiangsu, Peoples R China; [Zhang, Yun] Huadong Res Inst Med & Biotech, Inst Epidemiol & Microbiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Seventh Medical Center of Chinese PLA General Hospital; Nanjing Medical University; Nanjing Medical University	Zhang, Y (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhangyunvip@126.com; r_summer@163.com		Tang, Shaowen/0000-0001-5879-8594	National Natural Science Foundation of China [81273146, 81102165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81273146, 81102165). (http://www.nsfc.gov.cn) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1985, AM J PATHOL, V121, P531; BLAKEMORE AIF, 1994, ARTHRITIS RHEUM, V37, P1380, DOI 10.1002/art.1780370917; BOSWELL JM, 1988, J IMMUNOL, V141, P3050; Bouman A, 2001, FERTIL STERIL, V76, P555, DOI 10.1016/S0015-0282(01)01971-9; CANNON JG, 1985, SCIENCE, V227, P1247, DOI 10.1126/science.3871966; Chen Hong, 2008, Zhonghua Pifuke Zazhi, V41, P46; COHEN JHM, 1983, J IMMUNOL, V131, P2767; Cunningham M, 2011, CLIN REV ALLERG IMMU, V40, P66, DOI 10.1007/s12016-010-8203-5; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; He YH, 2004, RHEUMATOL INT, V24, P133, DOI 10.1007/s00296-003-0337-9; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; Heward J, 1999, THYROID, V9, P627, DOI 10.1089/thy.1999.9.627; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HSIEH SC, 1995, BRIT J RHEUMATOL, V34, P107; Huang CM, 2002, CLIN RHEUMATOL, V21, P255, DOI 10.1007/s10067-002-8292-5; Johansson M, 2005, ANN RHEUM DIS, V64, P1611, DOI 10.1136/ard.2004.032425; Jonsen A, 2004, ARTHRITIS RES THER, V6, pR557, DOI 10.1186/ar1224; Kanda N, 1999, ARTHRITIS RHEUM, V42, P328, DOI 10.1002/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#; Kim C, 2010, ARCH MED SCI, V6, P321, DOI 10.5114/aoms.2010.14250; Kisiel BM, 2011, LUPUS, V20, P85, DOI 10.1177/0961203310381514; Korthagen NM, 2012, IMMUNOGENETICS, V64, P371, DOI 10.1007/s00251-012-0604-6; Lee YJ, 2004, ANN RHEUM DIS, V63, P1244, DOI 10.1136/ard.2003.012583; [李枫 LI Feng], 2008, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V26, P112; Liu ZH, 2002, NEPHRON, V90, P174, DOI 10.1159/000049039; Lu ZM, 2009, CROAT MED J, V50, P117, DOI 10.3325/cmj.2009.50.117; NILSSON N, 1994, CELL IMMUNOL, V158, P131, DOI 10.1006/cimm.1994.1262; Paharkova-Vatchkova V, 2004, J IMMUNOL, V172, P1426, DOI 10.4049/jimmunol.172.3.1426; Parks CG, 2004, ANN RHEUM DIS, V63, P91, DOI 10.1136/ard.2003.007336; POLAN ML, 1994, AM J OBSTET GYNECOL, V170, P1000, DOI 10.1016/S0002-9378(94)70093-1; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; Rus V, 2002, CLIN IMMUNOL, V102, P283, DOI 10.1006/clim.2001.5182; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Segal R, 1997, J IMMUNOL, V158, P3009; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Speirs V, 1999, INT J ONCOL, V15, P1251; Suzuki H, 1997, ARTHRITIS RHEUM, V40, P389, DOI 10.1002/art.1780400227; Suzuki T, 2007, AM J PHYSIOL-CELL PH, V292, pC2103, DOI 10.1152/ajpcell.00488.2006; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TARLOW JK, 1993, HUM GENET, V91, P403; Tjernstrom F, 1999, LUPUS, V8, P103, DOI 10.1191/096120399678847560; Tsai LJ, 2006, TISSUE ANTIGENS, V68, P493, DOI 10.1111/j.1399-0039.2006.00704.x; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; TUCKER LB, 1995, BRIT J RHEUMATOL, V34, P866; Vamvakopoulos J, 2002, EUR J IMMUNOL, V32, P2988, DOI 10.1002/1521-4141(2002010)32:10<2988::AID-IMMU2988>3.0.CO;2-9; Vamvakopoulos JE, 2002, EUR J IMMUNOGENET, V29, P337, DOI 10.1046/j.1365-2370.2002.00319.x; Wang J, 2010, LUPUS, V19, P734, DOI 10.1177/0961203309359517; Wells GA, OUR RES RES PROGRAMS; Yap DYH, 2013, NEPHROLOGY, V18, P243, DOI 10.1111/nep.12047; Yuan Y, 2008, WORLD J GASTROENTERO, V14, P2200, DOI 10.3748/wjg.14.2200; Zhu W, 2000, CHINESE J DERMATOL, V33, P35	55	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109712	10.1371/journal.pone.0109712	http://dx.doi.org/10.1371/journal.pone.0109712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286391	gold, Green Submitted, Green Published			2022-12-27	WOS:000345743700085
J	Maruyama, Y; Miyazaki, T; Ikeda, K; Okumura, T; Sato, W; Horie-Inoue, K; Okamoto, K; Takeda, S; Inoue, S				Maruyama, Yojiro; Miyazaki, Toshiaki; Ikeda, Kazuhiro; Okumura, Toshiyuki; Sato, Wataru; Horie-Inoue, Kuniko; Okamoto, Koji; Takeda, Satoru; Inoue, Satoshi			Short Hairpin RNA Library-Based Functional Screening Identified Ribosomal Protein L31 That Modulates Prostate Cancer Cell Growth via p53 Pathway	PLOS ONE			English	Article							ANDROGEN DEPRIVATION THERAPY; GENE-EXPRESSION; RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE; MESSENGER-RNA; RECEPTOR GENE; MDM2; TRANSCRIPTION; MECHANISM	Androgen receptor is a primary transcription factor involved in the proliferation of prostate cancer cells. Thus, hormone therapy using antiandrogens, such as bicalutamide, is a first-line treatment for the disease. Although hormone therapy initially reduces the tumor burden, many patients eventually relapse, developing tumors with acquired endocrine resistance. Elucidation of the molecular mechanisms underlying endocrine resistance is therefore a fundamental issue for the understanding and development of alternative therapeutics for advanced prostate cancer. In the present study, we performed short hairpin RNA (shRNA)-mediated functional screening to identify genes involved in bicalutamide-mediated effects on LNCaP prostate cancer cells. Among such candidate genes selected by screening using volcano plot analysis, ribosomal protein L31 (RPL31) was found to be essential for cell proliferation and cell-cycle progression in bicalutamide-resistant LNCaP (BicR) cells, based on small interfering RNA (siRNA)-mediated knockdown experiments. Of note, RPL31 mRNA is more abundantly expressed in BicR cells than in parental LNCaP cells, and clinical data from ONCOMINE and The Cancer Genome Altas showed that RPL31 is overexpressed in prostate carcinomas compared with benign prostate tissues. Intriguingly, protein levels of the tumor suppressor p53 and its targets, p21 and MDM2, were increased in LNCaP and BicR cells treated with RPL31 siRNA. We observed decreased degradation of p53 protein after RPL31 knockdown. Moreover, the suppression of growth and cell cycle upon RPL31 knockdown was partially recovered with p53 siRNA treatment. These results suggest that RPL31 is involved in bicalutamide-resistant growth of prostate cancer cells. The shRNA-mediated functional screen in this study provides new insight into the molecular mechanisms and therapeutic targets of advanced prostate cancer.	[Maruyama, Yojiro; Miyazaki, Toshiaki; Ikeda, Kazuhiro; Okumura, Toshiyuki; Sato, Wataru; Horie-Inoue, Kuniko; Inoue, Satoshi] Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Saitama, Japan; [Maruyama, Yojiro; Takeda, Satoru] Juntendo Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Okamoto, Koji] Natl Canc Ctr, Div Canc Differentiat, Tokyo, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Tokyo, Japan	Saitama Medical University; Juntendo University; National Cancer Center - Japan; University of Tokyo; University of Tokyo	Inoue, S (corresponding author), Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Saitama, Japan.	INOUE-GER@h.u-tokyo.ac.jp		Takeda, Satoru/0000-0001-9547-1435	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science, Japan; Ministry of Health, Labour, and Welfare, Japan; National Institute of Biomedical Innovation, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation)	This work was supported by Cell Innovation Program, Grants-in-Aid, and Support Project of Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by Grants from the Japan Society for the Promotion of Science, Japan; by Grants-in-Aid from the Ministry of Health, Labour, and Welfare, Japan; by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, CANCER SCI, V103, P806, DOI 10.1111/j.1349-7006.2012.02201.x; Al-Jubran K, 2013, RNA, V19, P1669, DOI 10.1261/rna.038356.113; Antonarakis ES, 2010, CANCER LETT, V291, P1, DOI 10.1016/j.canlet.2009.08.012; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen J, 2012, J BIOL CHEM, V287, P16467, DOI 10.1074/jbc.M112.349274; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; CHESTER KA, 1989, BIOCHIM BIOPHYS ACTA, V1009, P297, DOI 10.1016/0167-4781(89)90119-X; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Chu LW, 2008, PROSTATE CANCER P D, V11, P342, DOI 10.1038/sj.pcan.4501024; Compagno D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001006; Cui D, 2014, ONCOGENE, V33, P2225, DOI 10.1038/onc.2013.170; Dahlman KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034414; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, J BIOL CHEM, V281, P24304; de Marval PLM, 2011, ONCOTARGET, V2, P234; Fumagalli S, 2011, SEMIN HEMATOL, V48, P97, DOI 10.1053/j.seminhematol.2011.02.004; Gan L, 2011, PROSTATE, V71, P1158, DOI 10.1002/pros.21331; Gregory CW, 2001, CANCER RES, V61, P2892; Gregory CW, 2001, CANCER RES, V61, P4315; Gustavsson H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-288; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Izumiya M, 2010, CARCINOGENESIS, V31, P1354, DOI 10.1093/carcin/bgq112; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Koivisto P, 1997, CANCER RES, V57, P314; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Linja MJ, 2001, CANCER RES, V61, P3550; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Murata T, 2012, CLIN CANCER RES, V18, P5617, DOI 10.1158/1078-0432.CCR-12-0281; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Peisker K, 2003, NAT REV CANCER, V3, P179; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Ray S, 2013, GENE, V526, P46, DOI 10.1016/j.gene.2013.04.018; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ricciardelli C, 2011, AM J PATHOL, V179, P3075, DOI 10.1016/j.ajpath.2011.08.021; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shu J, 2006, CELL MOL IMMUNOL, V3, P53; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Su XL, 2012, MOL BIOL REP, V39, P8945, DOI 10.1007/s11033-012-1763-0; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Tan ID, 2013, INT J CANCER, V133, P2263, DOI 10.1002/ijc.28127; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Ueyama K, 2010, CANCER GENE THER, V17, P624, DOI 10.1038/cgt.2010.19; Vis AN, 2009, BJU INT, V104, P438, DOI 10.1111/j.1464-410X.2009.08695.x; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; Yamaga R, 2013, HORM CANCER-US, V4, P222, DOI 10.1007/s12672-013-0140-3; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Yusupova G, 2014, ANN REV BIO IN PRESS; Zhang Q, 2011, J BIOL CHEM, V286, P38264, DOI 10.1074/jbc.M111.277012; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhou X, 2013, ONCOGENE, V32, P388, DOI 10.1038/onc.2012.63; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014; Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648	60	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108743	10.1371/journal.pone.0108743	http://dx.doi.org/10.1371/journal.pone.0108743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285958	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700032
J	Park, S; Park, AR; Im, S; Han, YJ; Lee, S; Back, K; Kim, JI; Kim, YS				Park, Sangkyu; Park, Ae Ran; Im, Soonduk; Han, Yun-Jeong; Lee, Sungbeom; Back, Kyoungwhan; Kim, Jeong-Il; Kim, Young Soon			Developmentally Regulated Sesquiterpene Production Confers Resistance to Colletotrichum gloeosporioides in Ripe Pepper Fruits	PLOS ONE			English	Article							CAPSICUM-ANNUUM L.; CAPSIDIOL ACCUMULATION; SQUALENE SYNTHETASE; GENE-EXPRESSION; TOBACCO CELLS; BACTERIAL EXPRESSION; NICOTIANA-TABACUM; ELICITOR; CYCLASE; CULTURES	Sesquiterpenoid capsidiol, exhibiting antifungal activity against pathogenic fungus, is accumulated in infected ripe pepper fruits. In this study, we found a negative relation between the capsidiol level and lesion size in fruits infected with Colletotrichum gloeosporioides, depending on the stage of ripening. To understand the developmental regulation of capsidiol biosynthesis, fungal-induced gene expressions in the isoprenoid biosynthetic pathways were examined in unripe and ripe pepper fruits. The sterol biosynthetic pathway was almost shut down in healthy ripe fruits, showing very low expression of hydroxymethyl glutaryl CoA reductase (HMGR) and squalene synthase (SS) genes. In contrast, genes in the carotenoid pathway were highly expressed in ripe fruits. In the sesquiterpene pathway, 5-epi-aristolochene synthase (EAS), belonging to a sesquiterpene cyclase (STC) family, was significantly induced in the ripe fruits upon fungal infection. Immunoblot and enzyme activity analyses showed that the STCs were induced both in the infected unripe and ripe fruits, while capsidiol was synthesized discriminatively in the ripe fruits, implying diverse enzymatic specificity of multiple STCs. Thereby, to divert sterol biosynthesis into sesquiterpene production, infected fruits were pretreated with an SS inhibitor, zaragozic acid (ZA), resulting in increased levels of capsidiol by more than 2-fold in the ripe fruits, with concurrent reduction of phytosterols. Taken together, the present results suggest that the enhanced expression and activity of EAS in the ripe fruits play an important role in capsidiol production, contributing to the incompatibility between the anthracnose fungus and the ripe pepper fruits.	[Park, Sangkyu; Back, Kyoungwhan; Kim, Jeong-Il] Chonnam Natl Univ, Dept Biotechnol, Kwangju, South Korea; [Park, Ae Ran; Im, Soonduk; Han, Yun-Jeong; Kim, Jeong-Il; Kim, Young Soon] Chonnam Natl Univ, Kumho Life Sci Lab, Kwangju, South Korea; [Lee, Sungbeom] Adv Radiat Technol Inst, Res Div Biotechnol, Jeongeup, South Korea	Chonnam National University; Chonnam National University; Korea Atomic Energy Research Institute (KAERI)	Kim, JI (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Kwangju, South Korea.	kimji@chonnam.ac.kr; youngskim@chonnam.ac.kr						Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Araceli AC, 2007, PHYSIOL MOL PLANT P, V70, P69, DOI 10.1016/j.pmpp.2007.07.002; BACH TJ, 1982, Z NATURFORSCH C, V37, P46; BACK K, 1995, J BIOL CHEM, V270, P7375, DOI 10.1074/jbc.270.13.7375; Back KW, 1998, PLANT CELL PHYSIOL, V39, P899, DOI 10.1093/oxfordjournals.pcp.a029452; Bohlmann J, 2002, PHYTOCHEMISTRY, V60, P109, DOI 10.1016/S0031-9422(02)00080-8; BROOKS CJW, 1986, PHYTOCHEMISTRY, V25, P1089, DOI 10.1016/S0031-9422(00)81559-9; De Marino S, 2006, J AGR FOOD CHEM, V54, P7508, DOI 10.1021/jf061404z; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Egea C, 1996, J PLANT PHYSIOL, V149, P762, DOI 10.1016/S0176-1617(96)80104-0; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Guedes MEM, 1980, PHYTOCHEMISTRY, V21, P2987; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; Huchelmann A, 2014, PLANT PHYSIOL, V164, P935, DOI 10.1104/pp.113.232546; Hugueney P, 1996, PLANT PHYSIOL, V111, P619, DOI 10.1104/pp.111.2.619; Keller H, 1998, PLANTA, V205, P467, DOI 10.1007/s004250050345; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Literakova P, 2010, J CHROMATOGR SCI, V48, P436, DOI 10.1093/chromsci/48.6.436; Ma CJ, 2008, BIOTECHNOL LETT, V30, P961, DOI 10.1007/s10529-007-9624-y; Maldonado-Bonilla LD, 2008, EUR J PLANT PATHOL, V121, P439, DOI 10.1007/s10658-007-9262-1; MILAT ML, 1991, PHYTOCHEMISTRY, V30, P2171, DOI 10.1016/0031-9422(91)83608-N; Oh BJ, 1998, J PHYTOPATHOL, V146, P301, DOI 10.1111/j.1439-0434.1998.tb04695.x; Osbourn AE, 2003, NEW PHYTOL, V159, P101, DOI 10.1046/j.1469-8137.2003.00759.x; PRUSKY D, 1991, PLANT PATHOL, V40, P45, DOI 10.1111/j.1365-3059.1991.tb02291.x; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Takahashi S, 2005, J BIOL CHEM, V280, P3686, DOI 10.1074/jbc.M411870200; THRELFALL DR, 1988, PHYTOCHEMISTRY, V27, P2567, DOI 10.1016/0031-9422(88)87028-6; Tugizimana F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087846; VOGELI U, 1988, PLANT PHYSIOL, V88, P1291, DOI 10.1104/pp.88.4.1291; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wentzinger LF, 2002, PLANT PHYSIOL, V130, P334, DOI 10.1104/pp.004655; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; ZOOK MN, 1991, PHYSIOL MOL PLANT P, V39, P377, DOI 10.1016/0885-5765(91)90018-D	37	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109453	10.1371/journal.pone.0109453	http://dx.doi.org/10.1371/journal.pone.0109453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286411	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700066
J	Sabir, H; Walloe, L; Dingley, J; Smit, E; Liu, X; Thoresen, M				Sabir, Hemmen; Walloe, Lars; Dingley, John; Smit, Elisa; Liu, Xun; Thoresen, Marianne			Combined Treatment of Xenon and Hypothermia in Newborn Rats - Additive or Synergistic Effect?	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEONATAL ENCEPHALOPATHY; BRAIN-DAMAGE; SYSTEMIC HYPOTHERMIA; MODERATE HYPOTHERMIA; NEUROPROTECTION; INJURY; ASPHYXIA; OUTCOMES; TRIAL	Background: Breathing the inert gas Xenon (Xe) enhances hypothermic (HT) neuroprotection after hypoxia-ischemia (HI) in small and large newborn animal models. The underlying mechanism of the enhancement is not yet fully understood, but the combined effect of Xe and HT could either be synergistic (larger than the two effects added) or simply additive. A previously published study, using unilateral carotid ligation followed by hypoxia in seven day old (P7) rats, showed that the combination of mild HT (35 degrees C) and low Xe concentration (20%), both not being neuroprotective alone, had a synergistic effect and was neuroprotective when both were started with a 4 h delay after a moderate HI insult. To examine whether another laboratory could confirm this finding, we repeated key aspects of the study. Design/ Methods: After the HI-insult 120 pups were exposed to different post-insult treatments: three temperatures (normothermia (NT) NT37 degrees C, HT35 degrees C, HT32 degrees C) or Xe concentrations (0%, 20% or 50%) starting either immediately or with a 4 h delay. To assess the synergistic potency of Xe-HT, a second set (n = 101) of P7 pups were exposed to either HT35 degrees C+Xe-0%, NT+ Xe-20% or a combination of HT35 degrees C+Xe-20% starting with a 4 h delay after the insult. Brain damage was analyzed using relative hemispheric (ligated side/ unligated side) brain tissue area loss after seven day survival. Results: Immediate HT32 degrees C (p = 0.042), but not HT35 degrees C significantly reduced brain injury compared to NT37 degrees C. As previously shown, adding immediate Xe-50% to HT32 degrees C increased protection. Neither 4 h-delayed Xe-20%, nor Xe-50% at (37 degrees C) significantly reduced brain injury (p>0.050). In addition, neither 4 h-delayed HT35 degrees C alone, nor HT35 degrees C+Xe-20% reduced brain injury. Wefound no synergistic effect of the combined treatments in this experimental model. Conclusions: Combining two treatments that individually were ineffective (delayed HT35 degrees C and delayed Xe-20%) did not exert neuroprotection when combined, and therefore did not show a synergistic treatment effect.	[Sabir, Hemmen; Smit, Elisa; Liu, Xun; Thoresen, Marianne] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Walloe, Lars; Thoresen, Marianne] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Dingley, John] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Sabir, Hemmen] Univ Dusseldorf, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany	University of Bristol; University of Oslo; Swansea University; Heinrich Heine University Dusseldorf	Thoresen, M (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	marianne.thoresen@bristol.ac.uk	walloe, lars/P-6947-2018	Smit, Elisa/0000-0002-3039-7251	Norwegian Research Council; Laerdal Foundation for Acute Medicine; SPARKS UK; Sparks Charity [05BTL01] Funding Source: researchfish	Norwegian Research Council(Research Council of NorwayEuropean Commission); Laerdal Foundation for Acute Medicine; SPARKS UK; Sparks Charity	This work received support from the following sources of funding: Norwegian Research Council, Laerdal Foundation for Acute Medicine and SPARKS UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDINE P, 1990, J NEUROSCI METH, V35, P253, DOI 10.1016/0165-0270(90)90131-X; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Baumert JH, 2007, ANESTH ANALG, V105, P1200, DOI 10.1213/01.ane.0000284697.73471.9c; Chakkarapani E, 2009, ANESTH ANALG, V109, P451, DOI 10.1213/ane.0b013e3181aa9550; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; Charriaut-Marlangue C, 2013, EXP NEUROL, V248, P316, DOI 10.1016/j.expneurol.2013.06.022; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Faulkner S, 2011, ANN NEUROL, V70, P133, DOI 10.1002/ana.22387; Feng YZ, 2006, BRAIN RES BULL, V69, P117, DOI 10.1016/j.brainresbull.2005.11.011; Gessner PK, 1995, TOXICOLOGY, V105, P161, DOI 10.1016/0300-483X(95)03210-7; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Guillet R, 2012, PEDIATR RES, V71, P205, DOI 10.1038/pr.2011.30; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Martin JL, 2007, BRIT J ANAESTH, V98, P236, DOI 10.1093/bja/ael340; McQuillen PS, 2004, PEDIATR NEUROL, V30, P227, DOI 10.1016/j.pediatrneurol.2003.10.001; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Preckel B, 2000, ANESTH ANALG, V91, P1327, DOI 10.1097/00000539-200012000-00003; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Sabir H, 2013, ANESTHESIOLOGY, V119, P345, DOI 10.1097/ALN.0b013e318294934d; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Scafidi J, 2009, INT J DEV NEUROSCI, V27, P863, DOI 10.1016/j.ijdevneu.2009.05.009; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Thoresen M, 1996, NEUROREPORT, V7, P481, DOI 10.1097/00001756-199601310-00025; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; YOUNG R S K, 1983, Stroke, V14, P929; Zhao P, 2004, ANESTHESIOLOGY, V101, P695, DOI 10.1097/00000542-200409000-00018; Zhou WH, 2010, J PEDIATR-US, V157, P367, DOI 10.1016/j.jpeds.2010.03.030; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109845	10.1371/journal.pone.0109845	http://dx.doi.org/10.1371/journal.pone.0109845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286345	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700095
J	Bang, S; Kwon, H; Hwang, HS; Park, KD; Kim, SU; Bahn, YS				Bang, Soohyun; Kwon, Hyojeong; Hwang, Hyun Sook; Park, Ki Duk; Kim, Sung Uk; Bahn, Yong-Sun			9-O-butyl-13-(4-isopropylbenzyl)berberine, KR-72, Is a Potent Antifungal Agent That Inhibits the Growth of Cryptococcus neoformans by Regulating Gene Expression	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; OXYSTEROL-BINDING PROTEIN; MITOCHONDRIAL HSP70; YEAST HOMOLOG; GRPE; OVEREXPRESSION; CHAPERONIN-10; FLUCONAZOLE; RESISTANCE; BERBERINE	In this study we explored the mode of action of KR-72, a 9-O-butyl-13-(4-sopropylbenzyl)berberine derivative previously shown to exhibit potent antifungal activity against a variety of human fLingal pathogens. The DNA microarray data revealed that KR-72 treatment significantly changed the transcription profiles of C. neoformans, affecting the expression of more than 2,000 genes. Genes involved in translation and transcription were mostly upregulated, whereas those involved in the cytoskeleton, intracellular trafficking, and lipid metabolism were dovvnregulated. KR-72 also exhibited a strong synergistic effect with the antifungal agent FK506. KR-72 treatment regulated the expression of several essential genes, including ECM16, NOP14, HSP10 and MGE1 which are required for C. neoformans growth. The KR-72-mediated induction of MGE1 also likely reduced the viability of C. neaformans by impairing cell cycle or the DNA repair system. In conclusion, KR-72 showed antifungal activity by modulating diverse biological processes throLigh a mode of action distinct from those of clinically available antifLingal drugs such as polyene and azole drugs	[Bang, Soohyun; Kwon, Hyojeong; Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea; [Hwang, Hyun Sook; Park, Ki Duk] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea; [Kim, Sung Uk] Korea Res Inst Biosci & Biotechnol, Ind Biomat Res Ctr, Taejon, South Korea	Yonsei University; Korea Institute of Science & Technology (KIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, SU (corresponding author), Korea Res Inst Biosci & Biotechnol, Ind Biomat Res Ctr, Taejon, South Korea.	kimsu@kribb.re.kr; ysbahn@yonsei.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752	National Research Foundation of Korea from MEST [2010-0029117]; Republic of Korea as well as a grant from the Technology Development Program [S2059210]; Korea Technology & Information Promotion Agency for Small and Medium Enterprises	National Research Foundation of Korea from MEST(National Research Foundation of Korea); Republic of Korea as well as a grant from the Technology Development Program; Korea Technology & Information Promotion Agency for Small and Medium Enterprises	This work was supported, in part, by the National Research Foundation of Korea Grants (No. 2010-0029117) from MEST (to Y.S.B.) in the Republic of Korea as well as a grant from the Technology Development Program (S2059210) for the use of research facilities funded by the Korea Technology & Information Promotion Agency for Small and Medium Enterprises (to S.U.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beh CT, 2001, GENETICS, V157, P1117; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Craig E, 1995, COLD SPRING HARB SYM, V60, P441, DOI 10.1101/SQB.1995.060.01.049; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; HOFMANN M, 1994, EUR J BIOCHEM, V221, P741, DOI 10.1111/j.1432-1033.1994.tb18787.x; HOHFELD J, 1994, J CELL BIOL, V126, P305, DOI 10.1083/jcb.126.2.305; IKEDA E, 1994, FEBS LETT, V339, P265, DOI 10.1016/0014-5793(94)80428-1; JIANG B, 1994, YEAST, V10, P341, DOI 10.1002/yea.320100307; Johnson MD, 2004, ANTIMICROB AGENTS CH, V48, P693, DOI 10.1128/AAC.48.3.693-715.2004; Jung KW, 2011, FUNGAL GENET BIOL, V48, P154, DOI 10.1016/j.fgb.2010.10.006; Kim MS, 2010, GENETICS, V185, P1207, DOI 10.1534/genetics.110.118315; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Kontoyiannis DP, 1999, ANTIMICROB AGENTS CH, V43, P2798, DOI 10.1128/AAC.43.11.2798; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Marada A, 2013, MOL BIOL CELL, V24, P692, DOI 10.1091/mbc.E12-10-0719; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Moro F, 2006, J MOL BIOL, V358, P1367, DOI 10.1016/j.jmb.2006.03.027; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park KD, 2006, BIOORG MED CHEM LETT, V16, P3913, DOI 10.1016/j.bmcl.2006.05.033; Park KD, 2010, BIOORG MED CHEM LETT, V20, P6551, DOI 10.1016/j.bmcl.2010.09.045; Park KS, 1999, J ANTIMICROB CHEMOTH, V43, P667, DOI 10.1093/jac/43.5.667; Pentchev P G, 1997, Subcell Biochem, V28, P437; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; ROSPERT S, 1993, FEBS LETT, V335, P358, DOI 10.1016/0014-5793(93)80419-U; SCHMALIX WA, 1994, BBA-GENE STRUCT EXPR, V1219, P205, DOI 10.1016/0167-4781(94)90273-9; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Strub A, 2000, BIOL CHEM, V381, P943, DOI 10.1515/BC.2000.115; Upadhya R, 2013, MOL MICROBIOL, V90, P630, DOI 10.1111/mmi.12388; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1	37	6	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109863	10.1371/journal.pone.0109863	http://dx.doi.org/10.1371/journal.pone.0109863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302492	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400089
J	Chen, XJ; Stojanovic, A; Hua, YJ; Eidet, JR; Hu, D; Wang, JT; Utheim, TP				Chen, Xiangjun; Stojanovic, Aleksandar; Hua, Yanjun; Eidet, Jon Roger; Hu, Di; Wang, Jingting; Utheim, Tor Paaske			Reliability of Corneal Dynamic Scheimpflug Analyser Measurements in Virgin and Post-PRK Eyes	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; BIOMECHANICAL PROPERTIES; INTRAOCULAR-PRESSURE; REFRACTIVE SURGERY; RISK-FACTORS; DEFORMATION; KERATOCONUS; ELASTICITY; STIFFNESS; GLAUCOMA	Purpose: To determine the measurement reliability of CorVis ST, a dynamic Scheimpflug analyser, in virgin and postphotorefractive keratectomy (PRK) eyes and compare the results between these two groups. Methods: Forty virgin eyes and 42 post-PRK eyes underwent CorVis ST measurements performed by two technicians. Repeatability was evaluated by comparing three consecutive measurements by technician A. Reproducibility was determined by comparing the first measurement by technician A with one performed by technician B. Intraobserver and interobserver intraclass correlation coefficients (IC(s) were calculated. Univariate analysis of covariance (ANCOVA) was used to compare measured parameters between virgin and post-PRK eyes. Results: The intraocular pressure (IOP), central corneal thickness (CCT) and 1st applanation time demonstrated good intraobserver repeatability and interobserver reproducibility (ICC >= 0.90) in virgin and post-PRK eyes. The deformation amplitude showed a good or close to good repeatability and reproducibility in both groups (ICC >= 0.88). The (CT correlated positively with 1st applanation time (r 0.437 and 0.483, respectively, p<0.05) and negatively with deformation amplitude (r = -0.384 and -0.375, respectively, p<0.05) in both groups. Compared to post-PRK eyes, virgin eyes showed longer 1st applanation time (7.29 +/- 0.21 vs. 6.96 +/- 0.17 ms, p<0.05) and lower deformation amplitude (1.06 +/- 0.07 vs. 1.17 +/- 0.08 mm, p<0.05). Conclusions: CorVis ST demonstrated reliable measurements for CCT, IOP, and 1st applanation time, as well as relatively reliable measurement for deformation amplitude in both virgin and post-PRK eyes. There were differences in 1st applanation time and deformation amplitude between virgin and post-PRK eyes, which may reflect corneal biomechanical changes occurring after the surgery in the latter.	[Chen, Xiangjun; Stojanovic, Aleksandar] SynsLaser Kirurgi, Oslo, Norway; [Chen, Xiangjun; Stojanovic, Aleksandar] SynsLaser Kirurgi, Tromso, Norway; [Chen, Xiangjun; Stojanovic, Aleksandar] Univ Oslo, Oslo, Norway; [Stojanovic, Aleksandar] Univ Hosp North Norway, Eye Dept, Tromso, Norway; [Hua, Yanjun] Hubei Med Univ, Taihe Hosp, Dept Ophthalmol, Shijiazhuang, Hubei, Peoples R China; [Hua, Yanjun; Hu, Di; Wang, Jingting] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Hua, Yanjun; Hu, Di; Wang, Jingting] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Eidet, Jon Roger; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Tor Paaske] Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway	University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; Wenzhou Medical University; Wenzhou Medical University; University of Oslo; University of Oslo	Chen, XJ (corresponding author), SynsLaser Kirurgi, Oslo, Norway.	chenxiangjun1101@gmail.com	Stojanovic, Aleksandar/AAG-9933-2019	Chen, Xiangjun/0000-0003-0331-9028; HUA, YANJUN/0000-0001-6461-3576				Ali NQ, 2014, INVESTIGATIVE OPHTHA; Asejczyk-Widlicka M, 2008, BRIT J OPHTHALMOL, V92, P1415, DOI 10.1136/bjo.2008.140178; Boyce BL, 2008, BIOMATERIALS, V29, P3896, DOI 10.1016/j.biomaterials.2008.06.011; del Buey MA, 2009, INVEST OPHTH VIS SCI, V50, P3199, DOI 10.1167/iovs.08-3312; Dupps WJ, 2005, J REFRACT SURG, V21, P186; Elsheikh A, 2008, J REFRACT SURG, V24, P178, DOI 10.3928/1081597X-20080201-09; Elsheikh A, 2008, EXP EYE RES, V86, P445, DOI 10.1016/j.exer.2007.12.002; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Guirao A, 2005, J REFRACT SURG, V21, P176; Han ZL, 2014, J REFRACT SURG, V30, P208, DOI 10.3928/1081597X-20140212-02; Hon Y, 2013, OPTOMETRY VISION SCI, V90, pE1, DOI 10.1097/OPX.0b013e318279eb87; Kida T, 2008, AM J OPHTHALMOL, V146, P567, DOI 10.1016/j.ajo.2008.05.026; Klein SR, 2006, CORNEA, V25, P388, DOI 10.1097/01.ico.0000222479.68242.77; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P5078, DOI 10.1167/iovs.13-12509; Leung CKS, 2013, INVEST OPHTH VIS SCI, V54, P2885, DOI 10.1167/iovs.12-11563; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; NASH IS, 1982, EXP EYE RES, V35, P413, DOI 10.1016/0014-4835(82)90040-9; Nemeth G, 2013, J REFRACT SURG, V29, P558, DOI 10.3928/1081597X-20130719-06; Ortiz D, 2007, J CATARACT REFR SURG, V33, P1371, DOI 10.1016/j.jcrs.2007.04.021; Read SA, 2009, OPTOMETRY VISION SCI, V86, P170, DOI 10.1097/OPX.0b013e3181981b7e; Reznicek L, 2013, BRIT J OPHTHALMOL, V97, P1410, DOI 10.1136/bjophthalmol-2013-303400; Roberts C, 2005, J CATARACT REFR SURG, V31, P2, DOI 10.1016/j.jcrs.2004.11.032; Roy AS, 2013, INDIAN J OPHTHALMOL, V61, P392, DOI 10.4103/0301-4738.116057; Roy AS, 2009, J REFRACT SURG, V25, P875, DOI 10.3928/1081597X-20090917-09; Shen Y, 2014, J REFRACT SURG, V30, P310, DOI 10.3928/1081597X-20140422-01; Sullivan-Mee M, 2008, OPTOMETRY VISION SCI, V85, P463, DOI 10.1097/OPX.0b013e3181784673	26	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109577	10.1371/journal.pone.0109577	http://dx.doi.org/10.1371/journal.pone.0109577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302580	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400068
J	Craiem, D; Chironi, G; Casciaro, ME; Graf, S; Simon, A				Craiem, Damian; Chironi, Gilles; Casciaro, Mariano E.; Graf, Sebastian; Simon, Alain			Calcifications of the Thoracic Aorta on Extended Non-Contrast-Enhanced Cardiac CT	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; HEINZ NIXDORF RECALL; ALL-CAUSE MORTALITY; COMPUTED-TOMOGRAPHY; ATHEROSCLEROSIS MESA; HEART-DISEASE; RISK-FACTORS; BLOOD-FLOW; ARCH; POPULATION	Background: The presence of calcified atherosclerosis in different vascular beds has been associated with a higher risk of mortality. Thoracic aorta calcium (TAC) can be assessed from computed tomography (CT) scans, originally aimed at coronary artery calcium (C AC) assessment. CAC screening improves cardiovascular risk prediction, beyond standard risk assessment, whereas TAC performance remains controversial. However, the curvilinear portion of the thoracic aorta (TA), that includes the aortic arch, is systematically excluded from TAC analysis. We investigated the prevalence and spatial distribution of TAC all along the TA, to see how those segments that remain invisible in standard TA evaluation were affected. Methods and Results: A total of 970 patients (77% men) underwent extended non-contrast cardiac CT scans including the aortic arch. An automated algorithm was designed to extract the vessel centerline and to estimate the vessel diameter in perpendicular planes. Then, calcifications were quantified using the Agatston score and associated with the corresponding thoracic aorta segment. The aortic arch and the proximal descending aorta, "invisible" in routine CAC screening, appeared as two vulnerable sites concentrating 60% of almost 11000 calcifications. The aortic arch was the most affected segment per cm length. Using the extended measurement method, TAC prevalence doubled from 31% to 64%, meaning that 52% of patients would escape detection with a standard scan. In a stratified analysis for CAC and/or TAC assessment, 111 subjects (46% women) were exclusively identified with the enlarged scan. Conclusions: Calcium screening in the TA revealed that the aortic arch and the proximal descending aorta, hidden in standard TA evaluations, concentrated most of the calcifications. Middle-aged women were more prone to have calcifications in those hidden portions and became candidates for reclassification.	[Craiem, Damian; Casciaro, Mariano E.; Graf, Sebastian] Favaloro Univ, Fac Ingn Ciencias Exactas & Nat, CONICET, RA-1033 Buenos Aires, DF, Argentina; [Craiem, Damian; Chironi, Gilles; Simon, Alain] Univ Paris 05, INSERM U970, Hop Europ Georges Pompidou, AP HP, Paris, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Craiem, D (corresponding author), Favaloro Univ, Fac Ingn Ciencias Exactas & Nat, CONICET, RA-1033 Buenos Aires, DF, Argentina.	dcraiem@favaloro.edu.ar	Craiem, Damian/AAN-1069-2021; Casciaro, Mariano/AAS-3757-2021	Craiem, Damian/0000-0003-1065-799X; Casciaro, Mariano/0000-0001-6793-1502	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Grant PIP [11220090100734]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Grant PIP	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (www.conicet.gov.ar), Grant PIP number 11220090100734. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Agmon Y, 2000, CIRCULATION, V102, P2087, DOI 10.1161/01.CIR.102.17.2087; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Budoff MJ, 2011, ATHEROSCLEROSIS, V215, P196, DOI 10.1016/j.atherosclerosis.2010.11.017; Cohen A, 1997, CIRCULATION, V96, P3838; Craiem D, 2013, J HUM HYPERTENS, V27, P504, DOI 10.1038/jhh.2012.69; Craiem D, 2012, ANN BIOMED ENG, V40, P1028, DOI 10.1007/s10439-011-0487-y; de Jong PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102036; Demertzis S, 2010, J ANAT, V217, P588, DOI 10.1111/j.1469-7580.2010.01297.x; Erbel R, 2008, EUR HEART J, V29, P2782, DOI 10.1093/eurheartj/ehn439; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; GIDDENS DP, 1993, J BIOMECH ENG-T ASME, V115, P588, DOI 10.1115/1.2895545; Hartnell GG, 2001, J THORAC IMAG, V16, P35, DOI 10.1097/00005382-200101000-00006; Itani Y, 2004, CIRC J, V68, P538, DOI 10.1253/circj.68.538; Jacobs PC, 2010, ATHEROSCLEROSIS, V209, P455, DOI 10.1016/j.atherosclerosis.2009.09.031; Kalsch H, 2013, INT J CARDIOVAS IMAG, V29, P207, DOI 10.1007/s10554-012-0051-3; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Liu X, 2009, AM J PHYSIOL-HEART C, V297, pH163, DOI 10.1152/ajpheart.00266.2009; Nasir K, 2007, ARTERIOSCL THROM VAS, V27, P1220, DOI 10.1161/ATVBAHA.107.140079; Rivera JJ, 2009, AM J CARDIOL, V103, P1562, DOI 10.1016/j.amjcard.2009.02.004; Santos RD, 2010, ATHEROSCLEROSIS, V209, P131, DOI 10.1016/j.atherosclerosis.2009.08.025; Shahcheraghi N, 2002, J BIOMECH ENG-T ASME, V124, P378, DOI 10.1115/1.1487357; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; TAKASU J, 1992, ATHEROSCLEROSIS, V97, P107, DOI 10.1016/0021-9150(92)90124-Y; Vincent PE, 2011, J R SOC INTERFACE, V8, P1708, DOI 10.1098/rsif.2011.0116; Voros S, 2011, J CARDIOVASC COMPUT, V5, P75, DOI 10.1016/j.jcct.2011.01.003; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong ND, 2009, JACC-CARDIOVASC IMAG, V2, P319, DOI 10.1016/j.jcmg.2008.12.010; Wong ND, 2003, AM J CARDIOL, V92, P951, DOI 10.1016/S0002-9149(03)00976-7; Yeboah J, 2013, EUR J PREV CARDIOL; Zhu Dongxing, 2012, Front Endocrinol (Lausanne), V3, P95, DOI 10.3389/fendo.2012.00095	31	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109584	10.1371/journal.pone.0109584	http://dx.doi.org/10.1371/journal.pone.0109584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302677	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400069
J	Santos, DMV; Katzmarzyk, PT; Diego, VP; Blangero, J; Souza, MC; Freitas, DL; Chaves, RN; Gomes, TN; Santos, FK; Maia, JAR				Santos, Daniel M. V.; Katzmarzyk, Peter T.; Diego, Vincent P.; Blangero, John; Souza, Michele C.; Freitas, Duarte L.; Chaves, Raquel N.; Gomes, Thayse N.; Santos, Fernanda K.; Maia, Jose A. R.			Genotype by Sex and Genotype by Age Interactions with Sedentary Behavior: The Portuguese Healthy Family Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; RECEPTOR GENE; QUEBEC FAMILY; ADULTS; INACTIVITY; ADIPOSITY; PEDIGREES; CHILDREN; LOCUS	Sedentary behavior (SB) expression and its underlying causal factors have been progressively studied, as it is a major determinant of decreased health quality. In the present study we applied Genotype x Age (GxAge) and Genotype x Sex (GxSex) interaction methods to determine if the phenotypic expression of different SB traits is influenced by an interaction between genetic architecture and both age and sex. A total of 1345 subjects, comprising 249 fathers, 327 mothers, 334 sons and 325 daughters, from 339 families of The Portuguese Healthy Family Study were included in the analysis. SB traits were assessed by means of a 3-d physical activity recall, the Baecke and IPAQ questionnaires. GxAge and GxSex interactions were analyzed using SOLAR 4.0 software. Sedentary behaviour heritability estimates were not always statistically significant (p>0.05) and ranged from 3% to 27%. The GxSex and GxAge interaction models were significantly better than the single polygenic models for TV (min/day), EEsed (kcal/day), personal computer (PC) usage and physical activty (PA) tertiles. The GxAge model is also significantly better than the polygenic model for Sed (min/day). For EEsed, PA tertiles, PC and Sed, the GxAge interaction was significant because the genetic correlation between SB environments was significantly different from 1. Further, PC and Sed variance heterogeneity among distinct ages were observed. The GxSex interaction was significant for EEsed due to genetic variance heterogeneity between genders and for PC due to a genetic correlation less than 1 across both sexes. Our results suggest that SB expression may be influenced by the interactions between genotype with both sex and age. Further, different sedentary behaviors seem to have distinct genetic architectures and are differentially affected by age and sex.	[Santos, Daniel M. V.; Souza, Michele C.; Gomes, Thayse N.; Santos, Fernanda K.; Maia, Jose A. R.] Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, P-4100 Oporto, Portugal; [Katzmarzyk, Peter T.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Diego, Vincent P.; Blangero, John] Texas Biomed Res Inst, San Antonio, TX USA; [Freitas, Duarte L.] Univ Madeira, Sport & Phys Educ Dept, Funchal, Portugal; [Chaves, Raquel N.] Univ Tecnol Fed Parana, Dept Phys Educ, Curitiba, Parana, Brazil	Universidade do Porto; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Texas Biomedical Research Institute; Universidade da Madeira; Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana	Santos, DMV (corresponding author), Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	d.monteiro.santos13@gmail.com	de Souza Ribas, Michele/AAG-5110-2021; Gomes, Thayse Natacha Queiroz Ferreira/AAL-5002-2020; Katzmarzyk, Peter T/N-1974-2017; Blangero, John/ABA-7175-2021; de Freitas, Duarte Luís/V-7590-2019	Katzmarzyk, Peter T/0000-0002-9280-6022; de Freitas, Duarte Luís/0000-0001-6642-3370; Santos, Daniel/0000-0001-8193-4689; Blangero, John/0000-0001-6250-5723; Queiroz Ferreira Gomes, Thayse Natacha/0000-0003-4991-1238	FCT - Fundacao para a Ciencia e a Tecnologia [PTDC/DES/67569/2006 FCOMP-01-0124-FEDEB-09608]	FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by the FCT - Fundacao para a Ciencia e a Tecnologia (www.fct.pt): PTDC/DES/67569/2006 FCOMP-01-0124-FEDEB-09608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 2004, CHILDR PEER REL DEV, Vxvi; Blangero J, 2009, HUM BIOL, V81, P523, DOI 10.3378/027.081.0603; Blangero J, 2013, ADV GENET, V81, P1, DOI 10.1016/B978-0-12-407677-8.00001-4; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Butte NF, 2006, AM J CLIN NUTR, V84, P646, DOI 10.1093/ajcn/84.3.646; Cai GW, 2006, OBESITY, V14, P1596, DOI 10.1038/oby.2006.184; Casper JM, 2013, ANN BEHAV MED, V45, pS49, DOI 10.1007/s12160-012-9435-9; Christensen U, 2006, SCAND J MED SCI SPOR, V16, P245, DOI 10.1111/j.1600-0838.2005.00459.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Santos DMDE, 2012, BEHAV GENET, V42, P559, DOI 10.1007/s10519-012-9534-1; Diego VP, 2007, AM J HUM GENET, V80, P168, DOI 10.1086/510497; Diego VP, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S34; Diego VP, 2005, GENOTYPE X AGE INTER, P317; Durnin J., 1967, ENERGY WORK LEISURE; Fisher A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010110; Gopinath B, 2012, PEDIATRICS, V130, pE167, DOI 10.1542/peds.2011-3637; Gretebeck RJ, 2012, AM J HEALTH BEHAV, V36, P385, DOI 10.5993/AJHB.36.3.9; Hoed M. D., 2013, AM J CLIN NUTR, V98, P1317; Horimoto AR, 2011, BMC MED GENET, V12, P155, DOI DOI 10.1186/1471-2350-12-155; Judice PB, 2014, J SPORT SCI, V32, P1760, DOI 10.1080/02640414.2014.926382; Katzmarzyk PT, 1998, PEDIATR EXERC SCI, V10, P378, DOI 10.1123/pes.10.4.378; Kesse-Guyot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047831; Klinker Charlotte D, 2014, Int J Behav Nutr Phys Act, V11, P8, DOI 10.1186/1479-5868-11-8; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Loos RJF, 2005, INT J OBESITY, V29, P420, DOI 10.1038/sj.ijo.0802869; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Rosa M. J. V., 2010, PORTUGAL NUMEROS; Salvy SJ, 2008, J PEDIATR PSYCHOL, V33, P39, DOI 10.1093/jpepsy/jsm039; Simonen RL, 2003, PHYSIOL BEHAV, V78, P751, DOI 10.1016/S0031-9384(03)00084-2; Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110025	10.1371/journal.pone.0110025	http://dx.doi.org/10.1371/journal.pone.0110025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302714	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400102
J	Yang, N; Hu, F; Zhou, LX; Tang, JJ				Yang, Ning; Hu, Fei; Zhou, Lingxi; Tang, Jijun			Reconstruction of Ancestral Gene Orders Using Probabilistic and Gene Encoding Approaches	PLOS ONE			English	Article							HALVING PROBLEMS; GENOME; SEQUENCES; EVOLUTION	Current tools used in the reconstruction of ancestral gene orders often fall into event-based and adjacency-based methods according to the principles they follow. Event-based methods such as GRAPPA are very accurate but with extremely high complexity, while more recent methods based on gene adjacencies such as InferCARsPro is relatively faster, but often produces an excessive number of chromosomes. This issue is mitigated by newer methods such as GapAdj, however it sacrifices a considerable portion of accuracy. We recently developed an adjacency-based method in the probabilistic framework called PMAG to infer ancestral gene orders. PMAG relies on calculating the conditional probabilities of gene adjacencies that are found in the leaf genomes using the Bayes' theorem. It uses a novel transition model which accounts for adjacency changes along the tree branches as well as a re-rooting procedure to prevent any information loss. In this paper, we improved PMAG with a new method to assemble gene adjacencies into valid gene orders, using an exact solver for traveling salesman problem (TSP) to maximize the overall conditional probabilities. We conducted a series of simulation experiments using a wide range of configurations. The first set of experiments was to verify the effectiveness of our strategy of using the better transition model and re-rooting the tree under the targeted ancestral genome. PMAG was then thoroughly compared in terms of three measurements with its four major competitors including InferCARsPro, GapAdj, GASTS and SCJ in order to assess their performances. According to the results, PMAG demonstrates superior performance in terms of adjacency, distance and assembly accuracies, and yet achieves comparable running time, even all TSP instances were solved exactly. PMAG is available for free at http://phylo.cse.sc.edu.	[Hu, Fei; Zhou, Lingxi; Tang, Jijun] Tianjin Univ, Tianjin Key Lab Cognit Comp & Applicat, Tianjin 300072, Peoples R China; [Hu, Fei; Zhou, Lingxi; Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Yang, Ning] Northwestern Polytech Univ, Sch Automat, Xian 710072, Shaanxi, Peoples R China	Tianjin University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Northwestern Polytechnical University	Tang, JJ (corresponding author), Tianjin Univ, Tianjin Key Lab Cognit Comp & Applicat, Tianjin 300072, Peoples R China.	jtang@cse.sc.edu	Tang, Jijun/ABH-6528-2020		NSF [IIS 1161586]; Tianjin University, China	NSF(National Science Foundation (NSF)); Tianjin University, China	The authors were funded by NSF IIS 1161586 and an internal grant from Tianjin University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyev MA, 2009, GENOME RES, V19, P943, DOI 10.1101/gr.082784.108; Applegate D., 2003, CONCORDE TSP SOLVER; Biller P, 2013, IEEE ACM T COMPUT BI, V10, P122, DOI 10.1109/TCBB.2012.168; Bourque G, 2002, GENOME RES, V12, P26; Caprara A., 1999, P 3 ANN INT C COMP M, P84; Feijao P, 2009, LECT N BIOINFORMAT, V5724, P85, DOI 10.1007/978-3-642-04241-6_8; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gagnon Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S4; Hannenhalli S., 1995, Proceedings of the Twenty-Seventh Annual ACM Symposium on the Theory of Computing, P178, DOI 10.1145/225058.225112; Hu F., 2011, P 8 IEEE S COMP BIOI, P117; Hu F, 2011, P 9 INT S BIOINF RES, P17; Jahn K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S8; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Lin Y, 2011, J COMPUT BIOL, V18, P1131, DOI 10.1089/cmb.2011.0114; Lin Yu, 2013, Pac Symp Biocomput, P285; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Ma J, 2010, IEEE INT C BIOINFORM, P179, DOI 10.1109/BIBM.2010.5706559; Moret B M, 2001, Pac Symp Biocomput, P583; Muller K, 2008, PLANT BIOLOGY, V6, P477; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tang JJ, 2005, BIBE 2005: 5TH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, P137; Tannier E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-120; Tesler G, 2002, J COMPUT SYST SCI, V65, P587, DOI 10.1016/S0022-0000(02)00011-9; Xu Andrew Wei, 2011, Algorithms in Bioinformatics. Proceedings of the 11th International Workshop, WABI 2011, P351, DOI 10.1007/978-3-642-23038-7_29; Xu AW, 2008, 8 INT WORKSH ALG BIO, P25; Yancopoulos S, 2005, BIOINFORMATICS, V21, P3340, DOI 10.1093/bioinformatics/bti535; YANG ZH, 1995, GENETICS, V141, P1641	27	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108796	10.1371/journal.pone.0108796	http://dx.doi.org/10.1371/journal.pone.0108796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302942	Green Published, gold			2022-12-27	WOS:000343730400027
J	Radosevich, AJ; Mutyal, NN; Rogers, JD; Gould, B; Hensing, TA; Ray, D; Backman, V; Roy, HK				Radosevich, Andrew J.; Mutyal, Nikhil N.; Rogers, Jeremy D.; Gould, Bradley; Hensing, Thomas A.; Ray, Daniel; Backman, Vadim; Roy, Hemant K.			Buccal Spectral Markers for Lung Cancer Risk Stratification	PLOS ONE			English	Article							ENHANCED BACKSCATTERING; BRONCHIAL EPITHELIUM; OPTICAL-PROPERTIES; GENE-EXPRESSION; SPECTROSCOPY; SMOKING; SMOKERS; AIRWAY	Lung cancer remains the leading cause of cancer deaths in the US with >150,000 deaths per year. In order to more effectively reduce lung cancer mortality, more sophisticated screening paradigms are needed. Previously, our group demonstrated the use of low-coherence enhanced backscattering (LEBS) spectroscopy to detect and quantify the micro/nano-architectural correlates of colorectal and pancreatic field carcinogenesis. In the lung, the buccal (cheek) mucosa has been suggested as an excellent surrogate site in the "field of injury". We, therefore, wanted to assess whether LEBS could similarly sense the presence of lung. To this end, we applied a fiber-optic LEBS probe to a dataset of 27 smokers without diagnosed lung cancer (controls) and 46 with lung cancer (cases), which was divided into a training and a blinded validation set (32 and 41 subjects, respectively). LEBS readings of the buccal mucosa were taken from the oral cavity applying gentle contact. The diagnostic LEBS marker was notably altered in patients harboring lung cancer compared to smoking controls. The prediction rule developed on training set data provided excellent diagnostics with 94% sensitivity, 80% specificity, and 95% accuracy. Applying the same threshold to the blinded validation set yielded 79% sensitivity and 83% specificity. These results were not confounded by patient demographics or impacted by cancer type or location. Moreover, the prediction rule was robust across all stages of cancer including stage I. We envision the use of LEBS as the first part of a two-step paradigm shift in lung cancer screening in which patients with high LEBS risk markers are funnelled into more invasive screening for confirmation.	[Radosevich, Andrew J.; Mutyal, Nikhil N.; Gould, Bradley; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Rogers, Jeremy D.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Hensing, Thomas A.; Ray, Daniel] NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA; [Roy, Hemant K.] Boston Univ, Dept Med, Boston, MA 02215 USA	Northwestern University; University of Wisconsin System; University of Wisconsin Madison; NorthShore University Health System; Boston University	Radosevich, AJ (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	arad@u.northwestern.edu	Backman, Vadim/B-6689-2009; Rogers, Jeremy/A-4572-2008; Roy, Hemant/AAC-9096-2020	Rogers, Jeremy/0000-0003-3049-2803; 	National Institutes of Health [R01CA128641, R01CA155284]; National Science Foundation [CBET-1240416]; National Science Foundation Graduate Research Fellowship [DGE-0824162]; NATIONAL CANCER INSTITUTE [R01CA128641, R01CA155284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was made possible by National Institutes of Health grants R01CA128641, R01CA155284 and National Science Foundation grant CBET-1240416. AJR is supported by a National Science Foundation Graduate Research Fellowship under Grant No. DGE-0824162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsky SH, 1998, JNCI-J NATL CANCER I, V90, P1198, DOI 10.1093/jnci/90.16.1198; Blomquist T, 2009, CANCER RES, V69, P8629, DOI 10.1158/0008-5472.CAN-09-1568; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Cherkezyan L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-189; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Ishimaru A., 1997, WAVE PROPAGATION SCA; Kim YL, 2005, APPL OPTICS, V44, P366, DOI 10.1364/AO.44.000366; Kim YL, 2004, OPT LETT, V29, P1906, DOI 10.1364/OL.29.001906; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Metze K, 2013, EXPERT REV MOL DIAGN, V13, P719, DOI 10.1586/14737159.2013.828889; Mutyal NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057206; Mutyal NN, 2012, OPT EXPRESS, V20, P19643, DOI 10.1364/OE.20.019643; Radosevich AJ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.097002; Radosevich AJ, 2012, IEEE J SEL TOP QUANT, V18, P1313, DOI 10.1109/JSTQE.2011.2173659; Radosevich AJ, 2011, OPT LETT, V36, P4737, DOI 10.1364/OL.36.004737; Rogers JD, 2014, SELECTED TOPICS QUAN, V20, P1; Rogers JD, 2011, OPT EXPRESS, V19, P11922, DOI 10.1364/OE.19.011922; Rogers JD, 2009, OPT LETT, V34, P1891, DOI 10.1364/OL.34.001891; Roy HK, 2010, CANCER RES, V70, P7748, DOI 10.1158/0008-5472.CAN-10-1686; Roy HK, 2009, CANCER RES, V69, P4476, DOI 10.1158/0008-5472.CAN-08-4780; Sanz-Ortega J, 2007, HISTOL HISTOPATHOL, V22, P541, DOI 10.14670/HH-22.541; Sidransky D, 2008, CANCER PREV RES, V1, P12, DOI 10.1158/1940-6207.CAPR-08-0093; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Spira A, 2010, CANCER PREV RES, V3, P255, DOI 10.1158/1940-6207.CAPR-10-0013; Sridhar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-259; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Turzhitsky V, 2011, J BIOMED OPT; Turzhitsky V, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3625402; Turzhitsky V, 2010, BIOMED OPT EXPRESS, V1, P1034, DOI 10.1364/BOE.1.001034; Turzhitsky V, 2008, DIS MARKERS, V25, P313, DOI 10.1155/2008/958214; Yi J, 2014, J BIOM IN PRESS 1702	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e110157	10.1371/journal.pone.0110157	http://dx.doi.org/10.1371/journal.pone.0110157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299667	gold, Green Published			2022-12-27	WOS:000343941200105
J	Zhang, M; Mahoney, E; Zuo, T; Manchanda, PK; Davuluri, RV; Kirschner, LS				Zhang, Mei; Mahoney, Emilia; Zuo, Tao; Manchanda, Parmeet K.; Davuluri, Ramana V.; Kirschner, Lawrence S.			Protein Kinase A Activation Enhances beta-Catenin Transcriptional Activity through Nuclear Localization to PML Bodies	PLOS ONE			English	Article							INHIBITS OSTEOGENIC DIFFERENTIATION; MCCUNE-ALBRIGHT SYNDROME; MESENCHYMAL STEM-CELLS; CARNEY COMPLEX; CYCLIC-AMP; OSTEOBLASTIC CELLS; WNT; PATHWAY; PHOSPHORYLATION; PROLIFERATION	The Protein Kinase A (PKA) and Wnt signaling cascades are fundamental pathways involved in cellular development and maintenance. In the osteoblast lineage, these pathways have been demonstrated functionally to be essential for the production of mineralized bone. Evidence for PKA-Wnt crosstalk has been reported both during tumorigenesis and during organogenesis, and the nature of the interaction is thought to rely on tissue and cell context. In this manuscript, we analyzed bone tumors arising from mice with activated PKA caused by mutation of the PKA regulatory subunit Prkar1a. In primary cells from these tumors, we observed relocalization of beta-catenin to intranuclear punctuate structures, which were identified as PML bodies. Cellular redistribution of beta-catenin could be recapitulated by pharmacologic activation of PKA. Using 3T3-E1 pre-osteoblasts as a model system, we found that PKA phosphorylation sites on beta-catenin were required for nuclear re-localization. Further, beta-catenin's transport to the nucleus was accompanied by an increase in canonical Wnt-dependent transcription, which also required the PKA sites. PKA-Wnt crosstalk in the cells was bi-directional, including enhanced interactions between beta-catenin and the cAMP-responsive element binding protein (CREB) and transcriptional crosstalk between the Wnt and PKA signaling pathways. Increases in canonical Wnt/beta-catenin signaling were associated with a decrease in the activity of the non-canonical Wnt/Ror2 pathway, which has been shown to antagonize canonical Wnt signaling. Taken together, this study provides a new understanding of the complex regulation of the subcellular distribution of beta-catenin and its differential protein-protein interaction that can be modulated by PKA signaling.	[Zhang, Mei; Mahoney, Emilia; Zuo, Tao; Manchanda, Parmeet K.; Davuluri, Ramana V.; Kirschner, Lawrence S.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Kirschner, Lawrence S.] Ohio State Univ, Div Endocrinol Diabets & Metab, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kirschner, LS (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	Lawrence.Kirschner@osumc.edu			National Institutes of Health [CA112268, AR057168, CA16058]; NATIONAL CANCER INSTITUTE [R01CA112268, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the following National Institutes of Health grants: CA112268 (LSK), AR057168 (LSK), and CA16058 (to the Ohio State University Comprehensive Cancer Center). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MQ, 2010, MOL CELL ENDOCRINOL; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Brudvik KW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-149; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; Ewan KBR, 2008, CURR DRUG TARGETS, V9, P532, DOI 10.2174/138945008784911787; Gupta R, 2011, NUCLEIC ACIDS RES, V39, pD92, DOI 10.1093/nar/gkq1171; Hildesheim J, 2005, J BIOL CHEM, V280, P17221, DOI 10.1074/jbc.M410440200; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kang MA, 2012, J BIOL CHEM, V287, P16246, DOI 10.1074/jbc.M111.337212; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Niehrs C, NAT REV MOL CELL BIO, V13, P767; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Pavel E, 2008, MOL ENDOCRINOL, V22, P430, DOI 10.1210/me.2007-0369; Regard J. B., 2012, COLD SPRING HARB PER, V4; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Rudolf R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00290; Salpea P, 2014, MOL CELL ENDOCRINOL, V386, P85, DOI 10.1016/j.mce.2013.08.022; Satow R, 2012, GASTROENTEROLOGY, V142, P572, DOI 10.1053/j.gastro.2011.11.041; Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504; Siddappa R, 2009, TISSUE ENG PT A, V15, P2135, DOI 10.1089/ten.tea.2008.0512; Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441; Sun J, 2013, ONCOL REP, V30, P2785, DOI 10.3892/or.2013.2786; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Walkinshaw DR, 2013, J BIOL CHEM, V288, P5591, DOI 10.1074/jbc.M112.445668; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang M, 2014, MOL ENDOCRINOL, V28, P295, DOI 10.1210/me.2013-1152; Zhang S, 2012, HORM METAB RES, V44, P724, DOI 10.1055/s-0032-1321845	42	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109523	10.1371/journal.pone.0109523	http://dx.doi.org/10.1371/journal.pone.0109523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299576	Green Submitted, gold, Green Published			2022-12-27	WOS:000343941200055
J	Araki, A; Mitsui, T; Miyashita, C; Nakajima, T; Naito, H; Ito, S; Sasaki, S; Cho, K; Ikeno, T; Nonomura, K; Kishi, R				Araki, Atsuko; Mitsui, Takahiko; Miyashita, Chihiro; Nakajima, Tamie; Naito, Hisao; Ito, Sachiko; Sasaki, Seiko; Cho, Kazutoshi; Ikeno, Tamiko; Nonomura, Katsuya; Kishi, Reiko			Association between Maternal Exposure to di(2-ethylhexyl) Phthalate and Reproductive Hormone Levels in Fetal Blood: The Hokkaido Study on Environment and Children's Health	PLOS ONE			English	Article							HUMAN BREAST-MILK; URINARY PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; INTERNAL EXPOSURE; NEONATAL-RATS; HUMAN SERUM; IN-UTERO; METABOLITES; DEHP; BIOMARKERS	Prenatal di(2-ethylhexyl) phthalate (DEHP) exposure can produce reproductive toxicity in animal models. Only limited data exist from human studies on maternal DEHP exposure and its effects on infants. We aimed to examine the associations between DEHP exposure in utero and reproductive hormone levels in cord blood. Between 2002 and 2005, 514 pregnant women agreed to participate in the Hokkaido Study Sapporo Cohort. Maternal blood samples were taken from 23-35 weeks of gestation and the concentration of the primary metabolite of DEHP, mono(2-ethylhexyl) phthalate (MEHP), was measured. Concentrations of infant reproductive hormones including estradiol (E2), total testosterone (T), and progesterone (P4), inhibin B, insulin-like factor 3 (INSL3), steroid hormone binding globulin, follicle-stimulating hormone, and luteinizing hormone were measured from cord blood. Two hundred and two samples with both MEHP and hormones' data were included in statistical analysis. The participants completed a self-administered questionnaire regarding information on maternal characteristics. Gestational age, birth weight and infant sex were obtained from birth records. In an adjusted linear regression analysis fit to all study participants, maternal MEHP levels were found to be associated with reduced levels of T/E2, P4, and inhibin B. For the stratified analyses for sex, inverse associations between maternal MEHP levels T/E2, P4, inhibin B, and INSL3 were statistically significant for males only. In addition, the MEHP quartile model showed a significant p-value trend for P4, inhibin B, and INSL3 decrease in males. Since inhibin B and INSL3 are major secretory products of Sertoli and Leydig cell, respectively, the results of this study suggest that DEHP exposure in utero may have adverse effects on both Sertoli and Leydig cell development in males, which agrees with the results obtained from animal studies. Comprehensive studies investigating phthalates' exposure in humans, as well as their long-term effects on reproductive development are needed.	[Araki, Atsuko; Miyashita, Chihiro; Ito, Sachiko; Ikeno, Tamiko; Kishi, Reiko] Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan; [Mitsui, Takahiko] Hokkaido Univ Hosp, Dept Urol, Sapporo, Hokkaido 060, Japan; [Nakajima, Tamie; Naito, Hisao] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Sasaki, Seiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Cho, Kazutoshi] Hokkaido Univ Hosp, Dept Obstet & Genecol, Sapporo, Hokkaido 060, Japan; [Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Nagoya University; Hokkaido University; Hokkaido University; Hokkaido University	Kishi, R (corresponding author), Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan.	rkishi@med.hokudai.ac.jp	Ikeda-Araki, Atsuko/A-4105-2012; , Takahiko/H-6660-2019	Ikeda-Araki, Atsuko/0000-0002-3065-262X; Nakajima, Tamie/0000-0002-0474-7019; Naito, Hisao/0000-0003-4228-637X	Japanese Ministry of Health, Labour and Welfare, Health and Labour Sciences; Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science and Technology; Ministry of the Environment, Japan; Grants-in-Aid for Scientific Research [26670321, 25860434, 24390172] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare, Health and Labour Sciences; Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science and Technology; Ministry of the Environment, Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by a Grant-in Aid from the Japanese Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants (RK), http://mhlw-grants.niph.go.jp/; Grants in Aid of Scientific Research from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science and Technology (RK), http://www.jsps.go.jp/english/e-grants/index.html; the Environment Research and Technology Development Fund (5C-1252) from the Ministry of the Environment, Japan (KN), http://www.env.go.jp/policy/kenkyu/suishin/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69; David RM, 2006, TOXICOL PATHOL, V34, P209, DOI 10.1080/01926230600642625; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7; Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656; Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005; Duty SM, 2002, ENV HLTH PERSPECT, V111, P1164; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006; Hart R, 2014, REPRODUCTION, V147, P379, DOI 10.1530/REP-13-0331; Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hayashi Y, 2012, ARCH TOXICOL, V86, P563, DOI 10.1007/s00204-011-0790-2; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515, DOI 10.1289/ehp.02110515; Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009; Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001; Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012; Ito Y, 2005, ARCH TOXICOL, V79, P147, DOI 10.1007/s00204-004-0615-7; Ivell R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108969; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Japan Plasticizer Industry Association and Ministry of Economy Trade and Industry, 2012, INF JAP PLAST IND; Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01; Kato K, 2003, J ANAL TOXICOL, V27, P284, DOI 10.1093/jat/27.5.284; Kessler W, 2012, TOXICOL APPL PHARM, V264, P284, DOI 10.1016/j.taap.2012.08.009; Kishi R, 2013, ENV HLTH PREV MED, P1; Kishi R, 2011, INT J EPIDEMIOL, V40, P611, DOI 10.1093/ije/dyq071; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270; Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012; Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Lind PM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-21; Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047; Main KM, 2006, J CLIN ENDOCR METAB, V91, P2732, DOI 10.1210/jc.2005-2443; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; ORTH JM, 1990, ENDOCRINOLOGY, V127, P2812, DOI 10.1210/endo-127-6-2812; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3; Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; TOWNSEND MK, 2013, ENV HLTH, V12; WHO, 2012, END DISR CHILD HLTH; Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012; Wirth JJ, 2008, SYST BIOL REPROD MED, V54, P143, DOI 10.1080/19396360802055921; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009; Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690; Yamashita K, 2007, J CHROMATOGR A, V1173, P120, DOI 10.1016/j.chroma.2007.10.023; Yamashita K, 2007, STEROIDS, V72, P819, DOI 10.1016/j.steroids.2007.07.003; Zhou L, 2013, REPROD TOXICOL, V42, P95, DOI 10.1016/j.reprotox.2013.07.025	55	87	88	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109039	10.1371/journal.pone.0109039	http://dx.doi.org/10.1371/journal.pone.0109039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296284	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000032
J	Han, SB; Ko, JS; Jin, SM; Park, HW; Kim, JM; Joh, JW; Kim, G; Choi, SJ				Han, Sangbin; Ko, Justin Sangwook; Jin, Sang-Man; Park, Hyo-Won; Kim, Jong Man; Joh, Jae-Won; Kim, Gaabsoo; Choi, Soo Joo			Intraoperative Hyperglycemia during Liver Resection: Predictors and Association with the Extent of Hepatocytes Injury	PLOS ONE			English	Article							SURGICAL SITE INFECTION; BLOOD-GLUCOSE CONTROL; PERIOPERATIVE GLUCOSE; HEPATIC RESECTION; PRINGLE MANEUVER; INSULIN; ISCHEMIA; ULTRASTRUCTURE; COMPLICATIONS; METABOLISM	Background: Patients undergoing liver resection are at risk for intraoperative hyperglycemia and acute hyperglycemia is known to induce hepatocytes injury. Thus, we aimed to evaluate whether intraoperative hyperglycemia during liver resection is associated with the extent of hepatic injury. Methods: This 1 year retrospective observation consecutively enrolled 85 patients undergoing liver resection for hepatocellular carcinoma. Blood glucose concentrations were measured at predetermined time points including every start/end of intermittent hepatic inflow occlusion (IHIO) via arterial blood analysis. Postoperative transaminase concentrations were used as surrogate parameters indicating the extent of surgery-related acute hepatocytes injury. Results: Thirty (35.5%) patients developed hyperglycemia (blood glucose > 180 mg/dl) during surgery. Prolonged (>= 3 rounds) IHIO (odds ratio [OR] 7.34, P = 0.004) was determined as a risk factors for hyperglycemia as well as cirrhosis (OR 4.07, P = 0.022), lower prothrombin time (OR 0.01, P = 0.025), and greater total cholesterol level (OR 1.04, P = 0.003). Hyperglycemia was independently associated with perioperative increase in transaminase concentrations (aspartate transaminase, beta 105.1, standard error 41.7, P = 0.014; alanine transaminase, beta 81.6, standard error 38.1, P = 0.035). Of note, blood glucose > 160 or 140 mg/dl was not associated with postoperative transaminase concentrations. Conclusions: Hyperglycemia during liver resection might be associated with the extent of hepatocytes injury. It would be rational to maintain blood glucose concentration < 180 mg/dl throughout the surgery in consideration of parenchymal disease, coagulation status, lipid profile, and the cumulative hepatic ischemia in patients undergoing liver resection for hepatocellular carcinoma.	[Han, Sangbin; Ko, Justin Sangwook; Park, Hyo-Won; Kim, Gaabsoo; Choi, Soo Joo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Jin, Sang-Man] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul, South Korea; [Kim, Jong Man; Joh, Jae-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	csjoo@skku.edu	kim, jm/O-5935-2014; Kim, Jong Man/AAH-5295-2020; Jin, Sang-Man/AFO-5933-2022	Han, Sangbin/0000-0002-4129-301X; Joh, Jae-Won/0000-0003-1732-6210				Akhtar S, 2010, ANESTH ANALG, V110, P478, DOI 10.1213/ANE.0b013e3181c6be63; Ambiru S, 2008, J HOSP INFECT, V68, P230, DOI 10.1016/j.jhin.2007.12.002; Bai H, 2006, FREE RADICAL BIO MED, V40, P1796, DOI 10.1016/j.freeradbiomed.2006.01.007; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Behrends M, 2010, J GASTROINTEST SURG, V14, P528, DOI 10.1007/s11605-009-1112-3; Chau GY, 2005, WORLD J SURG, V29, P1374, DOI 10.1007/s00268-005-7766-4; Chiolero R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009; David WH, 2000, APPL LOGISTIC REGRES, P92; Derichard A, 2009, BRIT J ANAESTH, V103, P678, DOI 10.1093/bja/aep267; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Duncan AE, 2010, ANESTHESIOLOGY, V112, P860, DOI 10.1097/ALN.0b013e3181d3d4b4; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Dunki-Jacobs EM, 2014, ANN SURG ONCOL, V21, P473, DOI 10.1245/s10434-013-3323-9; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Gandhi GY, 2005, MAYO CLIN PROC, V80, P862, DOI 10.4065/80.7.862; Giugliano D, 1997, CIRCULATION, V95, P1783; Greenhill C, 2014, NAT REV GASTROENTERO; Han S, 2014, LIVER TRANSPL; Han SB, 2013, TRANSPL INT, V26, P623, DOI 10.1111/tri.12092; Hirose R, 2008, ANESTHESIOLOGY, V108, P402, DOI 10.1097/ALN.0b013e318164cff8; Kaji N, 2013, J VET MED SCI, V75, P1245, DOI 10.1292/jvms.13-0029; Kannerup AS, 2008, J GASTROINTEST SURG, V12, P319, DOI 10.1007/s11605-007-0359-9; Kersten JR, 1998, AM J PHYSIOL-HEART C, V275, pH721, DOI 10.1152/ajpheart.1998.275.2.H721; Kuriyama S, 2007, J CLIN BIOCHEM NUTR, V40, P116, DOI 10.3164/jcbn.40.116; Lippi G, 2009, CLIN BIOCHEM, V42, P118, DOI 10.1016/j.clinbiochem.2008.10.012; Maeda H, 2010, AM J SURG, V199, P8, DOI 10.1016/j.amjsurg.2008.11.046; Man K, 2003, BRIT J SURG, V90, P183, DOI 10.1002/bjs.4027; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Martin A, 2006, STROKE, V37, P1288, DOI 10.1161/01.STR.0000217389.55009.f8; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Okabayashi T, 2011, WORLD J SURG, V35, P2773, DOI 10.1007/s00268-011-1299-9; Paolisso G, 1996, DIABETOLOGIA, V39, P357, DOI 10.1007/BF00418354; Parekh J, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/652458; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; Puskas F, 2007, ANN THORAC SURG, V84, P1467, DOI 10.1016/j.athoracsur.2007.06.023; Sato H, 2010, ANESTH ANALG, V110, P1711, DOI 10.1213/ANE.0b013e3181d90087; Shangraw R E, 1996, Liver Transpl Surg, V2, P443, DOI 10.1002/lt.500020607; Sugiyama Y, 2010, BRIT J SURG, V97, P1062, DOI 10.1002/bjs.7039; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Vriesendorp TM, 2004, CRIT CARE, V8, pR437, DOI 10.1186/cc2970	41	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109120	10.1371/journal.pone.0109120	http://dx.doi.org/10.1371/journal.pone.0109120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25295519	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204000040
J	Michalowski, JM; Weymar, M; Hamm, AO				Michalowski, Jaroslaw M.; Weymar, Mathias; Hamm, Alfons O.			Remembering the Object You Fear: Brain Potentials during Recognition of Spiders in Spider-Fearful Individuals	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; AFFECTIVE PICTURES; PHOBIA-RELEVANT; MEMORY; EMOTION; AMYGDALA; AROUSAL; MODULATION; ACTIVATION; RESPONSES	In the present study we investigated long-term memory for unpleasant, neutral and spider pictures in 15 spider-fearful and 15 non-fearful control individuals using behavioral and electrophysiological measures. During the initial (incidental) encoding, pictures were passively viewed in three separate blocks and were subsequently rated for valence and arousal. A recognition memory task was performed one week later in which old and new unpleasant, neutral and spider pictures were presented. Replicating previous results, we found enhanced memory performance and higher confidence ratings for unpleasant when compared to neutral materials in both animal fearful individuals and controls. When compared to controls high animal fearful individuals also showed a tendency towards better memory accuracy and significantly higher confidence during recognition of spider pictures, suggesting that memory of objects prompting specific fear is also facilitated in fearful individuals. In line, spider-fearful but not control participants responded with larger ERP positivity for correctly recognized old when compared to correctly rejected new spider pictures, thus showing the same effects in the neural signature of emotional memory for feared objects that were already discovered for other emotional materials. The increased fear memory for phobic materials observed in the present study in spider-fearful individuals might result in an enhanced fear response and reinforce negative beliefs aggravating anxiety symptomatology and hindering recovery.	[Weymar, Mathias; Hamm, Alfons O.] Ernst Moritz Arndt Univ Greifswald, Dept Biol & Clin Psychol, Greifswald, Germany; [Michalowski, Jaroslaw M.] Univ Warsaw, Fac Psychol, Warsaw, Poland	Ernst Moritz Arndt Universitat Greifswald; University of Warsaw	Michalowski, JM (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	jmichalowski@psych.uw.edu.pl	Michałowski, Jarosław/Q-1728-2016	Michałowski, Jarosław/0000-0002-5811-740X; Weymar, Mathias/0000-0002-3968-9656	University of Warsaw [BST 164600/2015]; National Science Centre [2013/11/N/HS6/01401]	University of Warsaw; National Science Centre(National Science Centre, Poland)	The research was supported in part by a grant from the University of Warsaw to the first author, BST 164600/2015 and in part by a grant from the National Science Centre to the first author, 2013/11/N/HS6/01401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahs F, 2011, PSYCHOPHYSIOLOGY, V48, P1463, DOI 10.1111/j.1469-8986.2011.01231.x; Bentz D, 2013, PSYCHONEUROENDOCRINO, V38, P1186, DOI 10.1016/j.psyneuen.2012.12.018; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Carlsson K, 2004, EMOTION, V4, P340, DOI 10.1037/1528-3542.4.4.340; Cowan N., 1995, ATTENTION MEMORY INT; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Craik FIM, 1975, J MEM LANG, V27, P23; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Cuthbert BN, 2003, PSYCHOPHYSIOLOGY, V40, P407, DOI 10.1111/1469-8986.00043; de Quervain DJF, 2011, P NATL ACAD SCI USA, V108, P6621, DOI 10.1073/pnas.1018214108; Dewhurst SA, 2000, EUR J COGN PSYCHOL, V12, P541, DOI 10.1080/095414400750050222; Dietrich DE, 2001, NEUROPSYCHOBIOLOGY, V43, P96, DOI 10.1159/000054874; Dilger S, 2003, NEUROSCI LETT, V348, P29, DOI 10.1016/S0304-3940(03)00647-5; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Ferrari V, 2013, SOC COGN AFFECT NEUR, V8, P847, DOI 10.1093/scan/nss081; FREDRIKSON M, 1995, PSYCHOPHYSIOLOGY, V32, P43, DOI 10.1111/j.1469-8986.1995.tb03404.x; Fredrikson M, 2003, ANN NY ACAD SCI, V985, P341; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Globisch J, 1999, PSYCHOPHYSIOLOGY, V36, P66, DOI 10.1017/S0048577299970634; Gruhn D, 2007, PSYCHOL AGING, V22, P644, DOI 10.1037/0882-7974.22.3.644; Hadley CB, 2006, J EXP PSYCHOL LEARN, V32, P79, DOI 10.1037/0278-7393.32.1.79; Hamm A., 2006, SPEZIFISCHE PHOBIEN; Hamm AO, 1997, PSYCHOPHYSIOLOGY, V34, P97, DOI 10.1111/j.1469-8986.1997.tb02420.x; Inaba M, 2005, INT J PSYCHOPHYSIOL, V57, P165, DOI 10.1016/j.ijpsycho.2005.01.002; Johansson M, 2004, J COGNITIVE NEUROSCI, V16, P1840, DOI 10.1162/0898929042947883; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Keil A, 2006, PROG BRAIN RES, V156, P217, DOI 10.1016/S0079-6123(06)56011-X; Kolassa IT, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-38; Kolassa IT, 2005, PSYCHOPHYSIOLOGY, V42, P520, DOI 10.1111/j.1469-8986.2005.00315.x; Kuhlmann S, 2005, J NEUROSCI, V25, P2977, DOI 10.1523/JNEUROSCI.5139-04.2005; Kulas JF, 2003, J ANXIETY DISORD, V17, P103, DOI 10.1016/S0887-6185(02)00177-9; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lang P.J., 2008, A8 U FLOR; Leutgeb V, 2009, BIOL PSYCHOL, V82, P293, DOI 10.1016/j.biopsycho.2009.09.003; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mecklinger A, 2000, PSYCHOPHYSIOLOGY, V37, P565, DOI 10.1111/1469-8986.3750565; Michalowski JM, 2012, INT J PSYCHOPHYSIOL, V85, P55, DOI 10.1016/j.ijpsycho.2011.09.009; Michalowski JM, 2009, EMOTION, V9, P306, DOI 10.1037/a0015550; Miltner WHR, 2005, INT J PSYCHOPHYSIOL, V57, P43, DOI 10.1016/j.ijpsycho.2005.01.012; Muhlberger A, 2006, J ABNORM PSYCHOL, V115, P580, DOI 10.1037/0021-843X.115.3.580; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Paquette V, 2003, NEUROIMAGE, V18, P401, DOI 10.1016/S1053-8119(02)00030-7; Pflugshaupt T, 2007, J ANXIETY DISORD, V21, P353, DOI 10.1016/j.janxdis.2006.05.005; Quevedo J, 2003, NEUROBIOL LEARN MEM, V79, P132, DOI 10.1016/S1074-7427(02)00034-5; Rugg MD, 2000, OXFORD HDB MEMORY, P521; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Schaefer A, 2011, NEUROIMAGE, V54, P714, DOI 10.1016/j.neuroimage.2010.07.030; Schienle A, 2005, COGNITION EMOTION, V19, P1229, DOI 10.1080/02699930500286364; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; Sharot T, 2008, COGNITION, V106, P538, DOI 10.1016/j.cognition.2007.03.002; Sharot T, 2004, COGN AFFECT BEHAV NE, V4, P294, DOI 10.3758/CABN.4.3.294; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Soravia LM, 2006, P NATL ACAD SCI USA, V103, P5585, DOI 10.1073/pnas.0509184103; Spielberger CD, 1983, MANUAL TRAIT STATE A; Straube T, 2006, BIOL PSYCHIAT, V59, P162, DOI 10.1016/j.biopsych.2005.06.013; Thorpe SJ, 2000, J ANXIETY DISORD, V14, P359, DOI 10.1016/S0887-6185(00)00028-1; Tolin DF, 1999, BEHAV RES THER, V37, P63, DOI 10.1016/S0005-7967(98)00111-9; Voss JL, 2008, NEUROPSYCHOLOGIA, V46, P3021, DOI 10.1016/j.neuropsychologia.2008.07.010; WATTS FN, 1986, BRIT J CLIN PSYCHOL, V25, P253, DOI 10.1111/j.2044-8260.1986.tb00705.x; WATTS FN, 1991, COGNITION EMOTION, V5, P313, DOI 10.1080/02699939108411043; Watts S, 2014, PSYCHOPHYSIOLOGY, V51, P673, DOI 10.1111/psyp.12211; Wendt J, 2008, PSYCHOPHYSIOLOGY, V45, P205, DOI 10.1111/j.1469-8986.2007.00620.x; Weymar M, 2014, SOC COGN AFFECT NEUR, V9, P723, DOI 10.1093/scan/nst044; Weymar M, 2013, ELSEV INSIGHT, P21, DOI 10.1016/B978-0-12-398393-0.00002-X; Weymar M, 2013, PSYCHOPHYSIOLOGY, V50, P139, DOI 10.1111/psyp.12008; Weymar M, 2011, HUM BRAIN MAPP, V32, P632, DOI 10.1002/hbm.21051; Weymar M, 2009, PSYCHOPHYSIOLOGY, V46, P1200, DOI 10.1111/j.1469-8986.2009.00869.x; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.	74	7	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109537	10.1371/journal.pone.0109537	http://dx.doi.org/10.1371/journal.pone.0109537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TE	25296032	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000079
J	Schratzberger, M; Larcombe, P				Schratzberger, Michaela; Larcombe, Piers			The Role of the Sedimentary Regime in Shaping the Distribution of Subtidal Sandbank Environments and the Associated Meiofaunal Nematode Communities: An Example from the Southern North Sea	PLOS ONE			English	Article							BENTHIC DISTURBANCE REGIMES; SIZE DISTRIBUTIONS; CONTINENTAL-SHELF; DIVERSITY; COMPETITION; DISPERSAL; BANKS; WATER; MICROHABITAT; SURROGATES	We combined sediment and faunal data to explore the role of the sedimentary regime in shaping the distribution of subtidal sandbank environments and the associated meiofaunal nematode communities at Broken Bank and Swarte Bank, in the southern North Sea. A variety of sediment transport processes occur in the area, differing in the frequency and magnitude of sediment mobility, and the continuum between erosion, translation and sediment accumulation. The seabed contained a variety of bedforms, including longitudinal furrows, and small to very large sandwaves. The bed sediments were dominated by fine and medium sands, with admixtures of silt and gravel. Based on sedimentary bedforms and grain size analysis, a total of 11 sedimentary facies were delineated, of which 8 were analysed in detail for their relationships with the meiofauna. The sedimentary facies fell clearly into groups of facies, respectively representing high, high-moderate and moderate, and episodic sediment mobility. For those sedimentary facies where daily movement of sediments and bedforms occurred ('high' sediment mobility), the resulting spatially homogeneous environments were dominated by an impoverished nematode community comprising small deposit feeders and large predators. Resistance to sediment movement and the ability to exploit alternative food sources were prominent functional features of the successful colonisers. Those facies characterised by relatively infrequent sediment mobility ('episodic' and 'high-moderate and moderate' sediment mobility) comprised a heterogeneous suite of benthic habitats, containing taxonomically and functionally diverse assemblages of nematodes of various sizes, feeding types and reproductive potential. Faunal distribution patterns here indicated trade-offs between the resistance to sediment movement, environmental tolerance and competitive abilities. Our focus on diverse assemblages of organisms with high turnover times, inhabiting highly dynamic sedimentary environments, has revealed new animal-sediment relationships of relevance to pure and applied science.	[Schratzberger, Michaela] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft, Suffolk, England; [Larcombe, Piers] RPS MetOcean, Subiaco, WA, Australia	Centre for Environment Fisheries & Aquaculture Science	Schratzberger, M (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft, Suffolk, England.	michaela.schratzberger@cefas.co.uk		Schratzberger, Michaela/0000-0002-4973-6698; Larcombe, Piers/0000-0003-0964-3144	Department for Environment, Food and Rural Affairs (Defra) [AE1148]; EDF Energy; RPS Met Ocean; Marine Environment Protection Fund (MEPF)	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); EDF Energy; RPS Met Ocean; Marine Environment Protection Fund (MEPF)	The work was supported by the Department for Environment, Food and Rural Affairs (Defra, research project AE1148), by EDF Energy and by RPS Met Ocean. Early work on the manuscript was supported by the Marine Environment Protection Fund (MEPF), a delivery partner of Defra's Aggregate Levy Sustainability Fund (ALSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from EDF Energy does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Balson PS, 1988, 8638 BRIT GEOL SOC; Baptist MJ, 2006, ESTUAR COAST SHELF S, V68, P538, DOI 10.1016/j.ecss.2006.02.023; Belderson R.H., 1982, OFFSHORE TIDAL SANDS, P27; BELDERSON RH, 1972, SONOGRAPHS SEA FLOOR; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bongers Tom, 1995, Russian Journal of Nematology, V3, P61; BRANCH GM, 1984, OCEANOGR MAR BIOL, V22, P429; CASTON VND, 1972, SEDIMENTOLOGY, V18, P63, DOI 10.1111/j.1365-3091.1972.tb00003.x; Clements AJ, 2010, ICES J MAR SCI, V67, P628, DOI 10.1093/icesjms/fsp280; COLLINS MB, 1995, MAR GEOL, V123, P125, DOI 10.1016/0025-3227(95)00010-V; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DELGADO M, 1991, J EXP MAR BIOL ECOL, V145, P221, DOI 10.1016/0022-0981(91)90177-X; Deprez T, 2005, NEMYS DATABASE; Dyer KR, 1999, CONT SHELF RES, V19, P1285, DOI 10.1016/S0278-4343(99)00028-X; Ellis JR, 2011, J MAR BIOL ASSOC UK, V91, P1319, DOI 10.1017/S0025315410001062; Foden J, 2009, MAR ECOL PROG SER, V390, P15, DOI 10.3354/meps08169; FORREST J, 1989, SEDIMENTOLOGY, V36, P711, DOI 10.1111/j.1365-3091.1989.tb02095.x; Galparsoro I, 2010, GEOMORPHOLOGY, V118, P314, DOI 10.1016/j.geomorph.2010.01.012; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gorley C.K., 2006, GETTING STARTED PRIM; HALL SJ, 1994, OCEANOGR MAR BIOL, V32, P179; Harris PT, 2014, MAR GEOL, V353, P169, DOI 10.1016/j.margeo.2014.03.023; Harris PT, 2012, ELSEV INSIGHT, P93, DOI 10.1016/B978-0-12-385140-6.00005-0; Harris PT, 2012, MAR ECOL PROG SER, V449, P13, DOI 10.3354/meps09463; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOGUE EW, 1981, J EXP MAR BIOL ECOL, V53, P181, DOI 10.1016/0022-0981(81)90018-6; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huntley DA, 1991, P EUROMECH SAND TRNA, P17; HUSTON MA, 1996, BIOL DIVERSITY; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2001, MAR ECOL PROG SER, V213, P127, DOI 10.3354/meps213127; JENSEN P, 1987, OECOLOGIA, V71, P564, DOI 10.1007/BF00379298; Johnson MA, 1984, ASSESSMENT OWER BANK; Joint Nature Conservation Committee, 2012, OFFSH SPEC AR CONS N; LANGHORNE DN, 1982, SEDIMENTOLOGY, V29, P571, DOI 10.1111/j.1365-3091.1982.tb01734.x; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; Mikkelsen OA, 2007, ESTUAR COAST SHELF S, V72, P615, DOI 10.1016/j.ecss.2006.11.027; Nio S.D., 1991, CLASTIC TIDAL SEDIME, V16, P3; Okada T, 2009, MAR POLLUT BULL, V58, P1164, DOI 10.1016/j.marpolbul.2009.03.023; Orpin AR, 2006, MAR GEOL, V225, P209, DOI 10.1016/j.margeo.2005.09.002; PALMER MA, 1988, MAR ECOL PROG SER, V48, P81, DOI 10.3354/meps048081; PALMER MA, 1985, J MAR RES, V43, P179, DOI 10.1357/002224085788437280; Pedersen SA, 2009, ICES J MAR SCI, V66, P155, DOI 10.1093/icesjms/fsn193; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Platt H.M., 1983, SYNOPSES BRIT FAUNA, V28; Platt H.M., 1988, FREE LIVING MARINE 2; Post AL, 2006, MAR FRESHWATER RES, V57, P469, DOI 10.1071/MF05182; Pravotorov IA, 1983, GEOMORPHOLOGIYA, V2, P39; Raes M, 2006, DEEP-SEA RES PT I, V53, P1880, DOI 10.1016/j.dsr.2006.08.012; Reading HG, 1996, SEDIMENTARY ENV PROC, V5, P36; Reineck H.E., 1980, DEPOSITIONAL SEDIMEN, P5; Riemann F., 1974, MIKROFAUNA MEERESBOD, V40, P1; Rundell RJ, 2010, BIOESSAYS, V32, P430, DOI 10.1002/bies.200900116; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schratzberger M, 2007, MAR ENVIRON RES, V63, P368, DOI 10.1016/j.marenvres.2006.10.006; Semple R K, 1972, 28 OH STAT U DEP GEO; Shennan I, 2000, GEOL SOC SPEC PUBL, V166, P299, DOI 10.1144/GSL.SP.2000.166.01.15; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; SOMERFIELD P, 1996, MEIOFAUNA MARINE POL; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; THISTLE D, 1985, DEEP-SEA RES, V32, P1077, DOI 10.1016/0198-0149(85)90063-9; Thistle D, 1995, VIE MILIEU, V45, P107; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Vanaverbeke J, 2004, MAR ECOL PROG SER, V273, P139, DOI 10.3354/meps273139; Vanaverbeke J, 2008, MAR ENVIRON RES, V66, P240, DOI 10.1016/j.marenvres.2008.02.066; VISSER MJ, 1980, GEOLOGY, V8, P543, DOI 10.1130/0091-7613(1980)8<543:NCRIHS>2.0.CO;2; WARD AR, 1975, MAR BIOL, V30, P217, DOI 10.1007/BF00390744; Ward I, 2008, ENVIRON ARCHAEOL, V13, P59, DOI 10.1179/174963108x279229; WARWICK RM, 1998, FREE LIVING MARINE 3; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wilber DH, 2008, J EXP MAR BIOL ECOL, V365, P13, DOI 10.1016/j.jembe.2008.07.029; Wilson J.B., 1982, OFFSHORE TIDAL SANDS, P126; WILSON WH, 1990, ANNU REV ECOL SYST, V21, P221, DOI 10.1146/annurev.ecolsys.21.1.221; WOOLFE KJ, 1995, COMPUT GEOSCI, V21, P447, DOI 10.1016/0098-3004(94)00092-9; Woolfe KJ, 2000, AUST J EARTH SCI, V47, P301, DOI 10.1046/j.1440-0952.2000.00782.x; WRIGHT KA, 1987, J PARASITOL, V73, P1077, DOI 10.2307/3282284	80	4	4	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109445	10.1371/journal.pone.0109445	http://dx.doi.org/10.1371/journal.pone.0109445			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296029	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204000072
J	Smith, DJ; Hill, GR; Bell, SC; Reid, DW				Smith, Daniel J.; Hill, Geoffrey R.; Bell, Scott C.; Reid, David W.			Reduced Mucosal Associated Invariant T-Cells Are Associated with Increased Disease Severity and Pseudomonas aeruginosa Infection in Cystic Fibrosis	PLOS ONE			English	Article							AIRWAY INFLAMMATION; LUNG-DISEASE; MAIT CELLS; INNATE; TUBERCULOSIS; LYMPHOCYTES; ACTIVATION; DECREASE; IMMUNITY	Background: Primary defects in host immune responses have been hypothesised to contribute towards an inability of subjects with cystic fibrosis (CF) to effectively clear pulmonary infections. Innate T-lymphocytes provide rapid pathogenspecific responses prior to the development of classical MHC class I and II restricted T-cell responses and are essential to the initial control of pulmonary infection. We aimed to examine the relationship between peripheral blood lymphocyte phenotype and clinical outcomes in adults with CF. Methods: We studied 41 subjects with CF and 22, age matched, non-smoking healthy control subjects. Lymphocytes were extracted from peripheral blood samples and phenotyped by flow-cytometry. Lymphocyte phenotype was correlated with sputum microbiology and clinical parameters. Results: In comparison to healthy control subjects, mucosal associated invariant T (MAIT)-lymphocytes were significantly reduced in the peripheral blood of subjects with CF (1.1% versus 2.0% of T-lymphocytes, P = 0.002). MAIT cell concentration was lowest in CF subjects infected with P. aeruginosa and in subjects receiving treatment for a pulmonary exacerbation. Furthermore a reduced MAIT cell concentration correlated with severity of lung disease. Conclusion: Reduced numbers of MAIT cells in subjects with CF were associated with P. aeruginosa pulmonary infection, pulmonary exacerbations and more severe lung disease. These findings provide the impetus for future studies examining the utility of MAIT cells in immunotherapies and vaccine development. Longitudinal studies of MAIT cells as biomarkers of CF pulmonary infection are awaited.	[Smith, Daniel J.; Bell, Scott C.; Reid, David W.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Smith, Daniel J.; Bell, Scott C.; Reid, David W.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Hill, Geoffrey R.] QIMR Berghofer Med Res Inst, Bone Marrow Transplant Lab, Brisbane, Qld, Australia; [Smith, Daniel J.; Reid, David W.] QIMR Berghofer Med Res Inst, Infect & Inflammat Lab, Brisbane, Qld, Australia; [Bell, Scott C.] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	Prince Charles Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Royal Children's Hospital Brisbane	Smith, DJ (corresponding author), Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia.	daniel.smith@health.qld.gov.au	Bell, Scott/AAJ-4298-2020; Hill, Geoffrey/O-2630-2016; Reid, David/Y-2343-2018; Smith, Daniel/K-4978-2018	Bell, Scott/0000-0001-8651-7139; Hill, Geoffrey/0000-0003-2994-0429; Reid, David/0000-0001-9517-8212; Smith, Daniel/0000-0002-8945-1531	QIMR Berghofer Medical Research Institute	QIMR Berghofer Medical Research Institute	Internal funding was received from QIMR Berghofer Medical Research Institute. The institute had no role in decision to publish the manuscript.	Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; DALEY L, 1985, J IMMUNOL, V134, P3089; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Grimaldi D, 2014, INTENS CARE MED, V40, P192, DOI 10.1007/s00134-013-3163-x; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Hausler M, 2002, RESP MED, V96, P87, DOI 10.1053/rmed.2001.1217; ITO M, 1992, CHEST, V102, P195, DOI 10.1378/chest.102.1.195; Jiang J, 2014, AM J RESP CRIT CARE, V190, P329, DOI 10.1164/rccm.201401-0106OC; Lanier LL, 2013, NAT REV IMMUNOL, V13, P73, DOI 10.1038/nri3389; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Levy H, 2007, PEDIATR PULM, V42, P256, DOI 10.1002/ppul.20563; Lopez-Sagaseta J, 2013, J IMMUNOL, V191, P5268, DOI 10.4049/jimmunol.1301958; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Moser C, 2011, BIOFILM INFECTIONS, P201, DOI 10.1007/978-1-4419-6084-9_12; Novak J., 2014, SCAND J IMMUNOL; Raga S, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-9; Ratner D, 2012, AM J RESP CELL MOL B; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Wesselkamper SC, 2008, J IMMUNOL, V181, P5481, DOI 10.4049/jimmunol.181.8.5481; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474	34	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2014	9	10							e109891	10.1371/journal.pone.0109891	http://dx.doi.org/10.1371/journal.pone.0109891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TE	25296025	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204000100
J	Choi, J; Cooper, ML; Alahmari, B; Ritchey, J; Collins, L; Holt, M; DiPersio, JF				Choi, Jaebok; Cooper, Matthew L.; Alahmari, Bader; Ritchey, Julie; Collins, Lynne; Holt, Matthew; DiPersio, John F.			Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; BONE-MARROW-TRANSPLANTATION; HOST-DISEASE LETHALITY; JAK2 INHIBITOR; IN-VIVO; MYELOPROLIFERATIVE NEOPLASMS; SUPPRESSOR-CELLS; HODGKIN LYMPHOMA; SOLID TUMORS; MECHANISM	We have recently reported that interferon gamma receptor deficient (IFN gamma R-/-) allogeneic donor T cells result in significantly less graft-versus-host disease (GvHD) than wild-type (WT) T cells, while maintaining an anti-leukemia or graft-versus-leukemia (GvL) effect after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We demonstrated that IFN gamma R signaling regulates alloreactive T cell trafficking to GvHD target organs through expression of the chemokine receptor CXCR3 in alloreactive T cells. Since IFN gamma R signaling is mediated via JAK1/JAK2, we tested the effect of JAK1/JAK2 inhibition on GvHD. While we demonstrated that pharmacologic blockade of JAK1/JAK2 in WT T cells using the JAK1/JAK2 inhibitor, INCB018424 (Ruxolitinib), resulted in a similar effect to IFN gamma R-/- T cells both in vitro (reduction of CXCR3 expression in T cells) and in vivo (mitigation of GvHD after allo-HSCT), it remains to be determined if in vivo administration of INCB018424 will result in preservation of GvL while reducing GvHD. Here, we report that INCB018424 reduces GvHD and preserves the beneficial GvL effect in two different murine MHC-mismatched allo-HSCT models and using two different murine leukemia models (lymphoid leukemia and myeloid leukemia). In addition, prolonged administration of INCB018424 further improves survival after allo-HSCT and is superior to other JAK1/JAK2 inhibitors, such as TG101348 or AZD1480. These data suggest that pharmacologic inhibition of JAK1/JAK2 might be a promising therapeutic approach to achieve the beneficial anti-leukemia effect and overcome HLA-barriers in allo-HSCT. It might also be exploited in other diseases besides GvHD, such as organ transplant rejection, chronic inflammatory diseases and autoimmune diseases.	[Choi, Jaebok; Cooper, Matthew L.; Alahmari, Bader; Ritchey, Julie; Holt, Matthew; DiPersio, John F.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Collins, Lynne] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Collins, Lynne] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Collins, Lynne] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Choi, J (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	jchoi@dom.wustl.edu		Choi, Jaebok/0000-0002-5590-087X; Alahmari, Bader/0000-0002-6026-1347	Siteman Cancer Center Research Development Awards; SPORE-CDP [P50 CA171063-01]; National Cancer Institute [P50 CA171063-01, P50 CA94056-09]; Bryan Thomas Campbell Foundation; NATIONAL CANCER INSTITUTE [P50CA171963, P50CA094056, P01CA023766] Funding Source: NIH RePORTER	Siteman Cancer Center Research Development Awards; SPORE-CDP; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bryan Thomas Campbell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.C. is supported by the Siteman Cancer Center Research Development Awards and SPORE-CDP (P50 CA171063-01). J.F.D. is supported by the National Cancer Institute (P50 CA94056-09 and P50 CA171063-01) and the Bryan Thomas Campbell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Choi J, 2012, BLOOD, V120, P4093, DOI 10.1182/blood-2012-01-403196; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Derenzini E, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.46; Dey BR, 1998, BLOOD, V91, P3315, DOI 10.1182/blood.V91.9.3315.3315_3315_3322; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Hao YS, 2014, CLIN CANCER RES, V20, P2674, DOI 10.1158/1078-0432.CCR-13-3007; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Lee HJ, 2013, CLIN CANCER RES, V19, P327, DOI 10.1158/1078-0432.CCR-12-2087; Markowitz J, 2013, BREAST CANCER RES TR, V140, P13, DOI 10.1007/s10549-013-2618-7; Miller JS, 2010, BIOL BLOOD MARROW TR, V16, P565, DOI 10.1016/j.bbmt.2010.02.005; Paczesny S, 2010, BONE MARROW TRANSPL, V45, P1, DOI 10.1038/bmt.2009.328; Plimack ER, 2013, ONCOLOGIST, V18, P819, DOI 10.1634/theoncologist.2013-0198; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rettig MP, 2004, J IMMUNOL, V173, P3620, DOI 10.4049/jimmunol.173.6.3620; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sonbol MB, 2013, THER ADV HEMATOL, V4, P15, DOI 10.1177/2040620712461047; Spoerl S, 2014, BLOOD; Tyner JW, 2010, BLOOD, V115, P5232, DOI 10.1182/blood-2009-05-223727; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; Vogtenhuber C, 2010, BLOOD, V116, P466, DOI 10.1182/blood-2009-11-252825; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wilson LJ, 2010, EXPERT OPIN THER PAT, V20, P609, DOI 10.1517/13543771003709767; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402	29	88	93	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109799	10.1371/journal.pone.0109799	http://dx.doi.org/10.1371/journal.pone.0109799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289677	Green Published, gold			2022-12-27	WOS:000342798000088
J	Demir, H; Donner, I; Kivipelto, L; Kuismin, O; Schalin-Jantti, C; De Menis, E; Karhu, A				Demir, Hande; Donner, Iikki; Kivipelto, Leena; Kuismin, Outi; Schalin-Jantti, Camilla; De Menis, Ernesto; Karhu, Auli			Mutation Analysis of Inhibitory Guanine Nucleotide Binding Protein Alpha (GNAI) Loci in Young and Familial Pituitary Adenomas	PLOS ONE			English	Article							STIMULATORY G-PROTEIN; MCCUNE-ALBRIGHT SYNDROME; ACTIVATING MUTATIONS; REGULATORY SUBUNIT; SOMATIC MUTATIONS; COUPLED RECEPTORS; ADENYLATE-CYCLASE; UVEAL MELANOMA; CARNEY COMPLEX; GENE-MUTATIONS	Pituitary adenomas are neoplasms of the anterior pituitary lobe and account for 15-20% of all intracranial tumors. Although most pituitary tumors are benign they can cause severe symptoms related to tumor size as well as hypopituitarism and/or hypersecretion of one or more pituitary hormones. Most pituitary adenomas are sporadic, but it has been estimated that 5% of patients have a familial background. Germline mutations of the tumor suppressor gene aryl hydrocarbon receptor-interacting protein (AIP) predispose to hereditary pituitary neoplasia. Recently, it has been demonstrated that AIP mutations predispose to pituitary tumorigenesis through defective inhibitory GTP binding protein (G alpha(i)) signaling. This finding prompted us to examine whether germline loss-of-function mutations in inhibitory guanine nucleotide (GTP) binding protein alpha (GNAI) loci are involved in genetic predisposition of pituitary tumors. To our knowledge, this is the first time GNAI genes are sequenced in order to examine the occurrence of inactivating germline mutations. Thus far, only somatic gain-of-function hot-spot mutations have been studied in these loci. Here, we have analyzed the coding regions of GNAI1, GNAI2, and GNAI3 in a set of young sporadic somatotropinoma patients (n = 32; mean age of diagnosis 32 years) and familial index cases (n = 14), thus in patients with a disease phenotype similar to that observed in AIP mutation carriers. In addition, expression of Gai proteins was studied in human growth hormone (GH), prolactin (PRL), adrenocorticotropic hormone (ACTH)-secreting and non-functional pituitary tumors. No pathogenic germline mutations affecting the Gai proteins were detected. The result suggests that loss-of-function mutations of GNAI loci are rare or nonexistent in familial pituitary adenomas.	[Demir, Hande; Donner, Iikki; Karhu, Auli] Univ Helsinki, Biomed Helsinki, Inst Biomed, Dept Med Genet,Genome Scale Biol Res Program, Helsinki, Finland; [Kivipelto, Leena] Univ Helsinki, Dept Neurosurg, Cent Hosp, Helsinki, Finland; [Kuismin, Outi] Oulu Univ Hosp, Dept Clin Genet, Oulu, Finland; [Schalin-Jantti, Camilla] Univ Helsinki, Dept Med, Cent Hosp, Div Endocrinol, Helsinki, Finland; [De Menis, Ernesto] Gen Hosp, Dept Internal Med, Treviso, Italy	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Helsinki; Helsinki University Central Hospital	Karhu, A (corresponding author), Univ Helsinki, Biomed Helsinki, Inst Biomed, Dept Med Genet,Genome Scale Biol Res Program, Helsinki, Finland.	auli.karhu@helsinki.fi		Kuismin, Outi/0000-0002-0157-8985; Karhu, Auli/0000-0002-7927-0796	Worldwide Cancer Research [13-1075]	Worldwide Cancer Research	This study was supported by the Worldwide Cancer Research (Grant no: 13-1075, http://www.worldwidecancerresearch.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafah BM, 2001, ENDOCR-RELAT CANCER, V8, P287, DOI 10.1677/erc.0.0080287; Asa SL, 2009, ANNU REV PATHOL-MECH, V4, P97, DOI 10.1146/annurev.pathol.4.110807.092259; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Boikos SA, 2007, HUM MOL GENET, V16, pR80, DOI 10.1093/hmg/ddm019; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; Cazabat L, 2012, J CLIN ENDOCR METAB, V97, pE663, DOI 10.1210/jc.2011-2291; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P3316, DOI 10.1210/jc.2005-2671; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fragoso MCBV, 1998, J CLIN ENDOCR METAB, V83, P2074, DOI 10.1210/jc.83.6.2074; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Georgitsi M, 2008, J CLIN ENDOCR METAB, V93, P4146, DOI 10.1210/jc.2008-1003; GUPTA SK, 1992, MOL BIOL CELL, V3, P123, DOI 10.1091/mbc.3.1.123; Heaney AP, 2004, NAT REV CANCER, V4, P285, DOI 10.1038/nrc1320; Kan Beki, 2003, Pituitary, V6, P75, DOI 10.1023/B:PITU.0000004797.89592.5e; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KOBAYASHI I, 1990, EUR J BIOCHEM, V191, P499, DOI 10.1111/j.1432-1033.1990.tb19149.x; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Petersenn S, 2000, CLIN ENDOCRINOL, V52, P35, DOI 10.1046/j.1365-2265.2000.00880.x; Peverelli E, 2013, J CELL SCI, V126, P638, DOI 10.1242/jcs.116434; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Reid TJ, 2010, CLIN ENDOCRINOL, V72, P203, DOI 10.1111/j.1365-2265.2009.03626.x; REINCKE M, 1993, J CLIN ENDOCR METAB, V77, P1419, DOI 10.1210/jc.77.5.1419; Ruggeri RM, 2008, J ENDOCRINOL INVEST, V31, P946, DOI 10.1007/BF03345630; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Shen Y, 1996, J CLIN ENDOCR METAB, V81, P4159, DOI 10.1210/jc.81.11.4159; Spiegel AM, 1996, J CLIN ENDOCR METAB, V81, P2434, DOI 10.1210/jc.81.7.2434; Swearingen B, 1998, J CLIN ENDOCR METAB, V83, P3419, DOI 10.1210/jc.83.10.3419; Tichomirowa MA, 2009, J INTERN MED, V266, P5, DOI 10.1111/j.1365-2796.2009.02109.x; TORDJMAN K, 1993, J CLIN ENDOCR METAB, V77, P765, DOI 10.1210/jc.77.3.765; Tuominen I, 2014, ONCOGENE, DOI [10.1038/onc.2014.50, DOI 10.1038/ONC.2014.50]; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; WILLIAMSON EA, 1995, EUR J CLIN INVEST, V25, P128, DOI 10.1111/j.1365-2362.1995.tb01537.x; WILLIAMSON EA, 1994, CLIN ENDOCRINOL, V41, P815, DOI 10.1111/j.1365-2265.1994.tb02798.x	50	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109897	10.1371/journal.pone.0109897	http://dx.doi.org/10.1371/journal.pone.0109897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25291362	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000097
J	Li, YY; Yu, JF; Lu, Q; Xu, J; Ye, H				Li, Yan-Ying; Yu, Jin-Feng; Lu, Qin; Xu, Jin; Ye, Hui			Female and Male Moths Display Different Reproductive Behavior when Facing New versus Previous Mates	PLOS ONE			English	Article							SPERM COMPETITION; SPODOPTERA-LITURA; GENETIC BENEFITS; SEXUAL SELECTION; EVOLUTION; POLYANDRY; DISCRIMINATION; POLYMORPHISM; LEPIDOPTERA; PREFERENCE	Multiple mating allows females to obtain material (more sperm and nutrient) and/or genetic benefits. The genetic benefit models require sperm from different males to fertilize eggs competitively or the offspring be fathered by multiple males. To maximize genetic benefits from multiple mating, females have evolved strategies to prefer novel versus previous mates in their subsequent matings. However, the reproductive behavior during mate encounter, mate choice and egg laying in relation to discrimination and preference between sexes has been largely neglected. In the present study, we used novel and previous mate treatments and studied male and female behavior and reproductive output in Spodoptera litura. The results of this study do not support the sperm and nutrient replenishment hypotheses because neither the number of mates nor the number of copulations achieved by females significantly increased female fecundity, fertility and longevity. However, females showed different oviposition patterns when facing new versus previous mates by slowing down oviposition, which allows the last male has opportunities to fertilize her eggs and the female to promote offspring diversity. Moreover, females that have novel males present called earlier and more than females that have their previous mates present, whereas no significant differences were found on male courtship between treatments. These results suggest that S. litura females can distinguish novel from previous mates and prefer the former, whereas males generally remate regardless of whether the female is a previous mate or not. In S. litura, eggs are laid in large clusters and offspring competition, inbreeding and disease transfer risks are thus increased. Therefore, offspring diversity should be valuable for S. litura, and genetic benefits should be the main force behind the evolution of female behavioral strategies found in the present study.	[Li, Yan-Ying; Yu, Jin-Feng; Xu, Jin] Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Ecosecu, Kunming, Peoples R China; [Lu, Qin; Ye, Hui] Yunnan Univ, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Kunming, Peoples R China	Yunnan University; Yunnan University	Xu, J (corresponding author), Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Ecosecu, Kunming, Peoples R China.	xujin2798@126.com; yehui@ynu.edu.cn			National Natural Science Foundation Program of China [31160434]	National Natural Science Foundation Program of China(National Natural Science Foundation of China (NSFC))	Funding was provided by 31160434, http://www.nsfc.gov.cn/, National Natural Science Foundation Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer MS, 1999, ANIM BEHAV, V58, P669, DOI 10.1006/anbe.1999.1172; Armes NJ, 1997, PESTIC SCI, V50, P240, DOI 10.1002/(SICI)1096-9063(199707)50:3&lt;240::AID-PS579&gt;3.0.CO;2-9; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bateman PW, 1998, ECOL ENTOMOL, V23, P473, DOI 10.1046/j.1365-2311.1998.00156.x; Caspers BA, 2014, MOL ECOL, V23, P239, DOI 10.1111/mec.12577; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Eakley AL, 2004, P ROY SOC B-BIOL SCI, V271, pS299, DOI 10.1098/rsbl.2004.0165; Fromhage L, 2005, NATURWISSENSCHAFTEN, V92, P423, DOI 10.1007/s00114-005-0011-z; Fukuda T, 2007, B ENTOMOL RES, V97, P185, DOI 10.1017/S0007485307004841; Ivy TM, 2005, P ROY SOC B-BIOL SCI, V272, P2475, DOI 10.1098/rspb.2005.3222; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jimenez-Perez A, 2003, J INSECT BEHAV, V16, P797, DOI 10.1023/B:JOIR.0000018321.81949.25; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; LaDage LD, 2007, BEHAVIOUR, V144, P515, DOI 10.1163/156853907780713091; Li C, 2012, GSTF J BIOSCI, V2, P25, DOI DOI 10.5176/2251-3140_2.1.18; Li Guanghong, 1998, Acta Scientiarum Naturalium Universitatis Sunyatseni, V37, P1; Li Wei, 2006, Southwest China Journal of Agricultural Sciences, V19, P85; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Parker G., 1984, SPERM COMPETITION EV, P2; Raina AK, 2000, ARTHROPOD STRUCT DEV, V29, P343, DOI 10.1016/S1467-8039(01)00014-7; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; *SAS I INC, 2006, US MAN; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; Seth RK, 2002, PHYSIOL ENTOMOL, V27, P1, DOI 10.1046/j.1365-3032.2002.00260.x; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sun Fan, 2002, Acta Entomologica Sinica, V45, P404; Suzaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083278; Tan CKW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1691; Thonhauser KE, 2013, BEHAV ECOL SOCIOBIOL, V67, P1961, DOI 10.1007/s00265-013-1604-8; Thornhill R., 1983, pi; TOOBY J, 1982, J THEOR BIOL, V97, P557, DOI 10.1016/0022-5193(82)90358-7; Wang Q, 1997, ANN ENTOMOL SOC AM, V90, P380, DOI 10.1093/aesa/90.3.380; Wang Q, 2006, J INSECT BEHAV, V19, P337, DOI 10.1007/s10905-006-9027-2; WATANABE M, 1988, Journal of Insect Behavior, V1, P17, DOI 10.1007/BF01052501; Wedell N, 1996, AM NAT, V148, P1075, DOI 10.1086/285972; Wilson N, 1999, J INSECT BEHAV, V12, P295, DOI 10.1023/A:1020883220643; Xu J, 2010, REPROD BEHAV EPHESTI; Xu J, 2011, J INSECT PHYSIOL, V57, P385, DOI 10.1016/j.jinsphys.2010.12.006; Xu J, 2009, ANIM BEHAV, V78, P1309, DOI 10.1016/j.anbehav.2009.09.028; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Yasui Y, 2001, ECOL RES, V16, P605, DOI 10.1046/j.1440-1703.2001.00423.x; Yu JF, 2014, J INSECT BEHAV, V27, P105, DOI 10.1007/s10905-013-9414-4; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zeh JA, 1998, P NATL ACAD SCI USA, V95, P13732, DOI 10.1073/pnas.95.23.13732	49	4	5	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109564	10.1371/journal.pone.0109564	http://dx.doi.org/10.1371/journal.pone.0109564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290195	gold, Green Published, Green Submitted			2022-12-27	WOS:000342798000070
J	Mannucci, S; Ghin, L; Conti, G; Tambalo, S; Lascialfari, A; Orlando, T; Benati, D; Bernardi, P; Betterle, N; Bassi, R; Marzola, P; Sbarbati, A				Mannucci, Silvia; Ghin, Leonardo; Conti, Giamaica; Tambalo, Stefano; Lascialfari, Alessandro; Orlando, Tomas; Benati, Donatella; Bernardi, Paolo; Betterle, Nico; Bassi, Roberto; Marzola, Pasquina; Sbarbati, Andrea			Magnetic Nanoparticles from Magnetospirillum gryphiswaldense Increase the Efficacy of Thermotherapy in a Model of Colon Carcinoma	PLOS ONE			English	Article							AMB-1 MAGNETOTACTIC BACTERIA; CONTRAST AGENTS; IN-VIVO; MAGNETOSOMES; HYPERTHERMIA; CANCER; CELLS; MANIPULATION; FEASIBILITY; CHAINS	Magnetic nanoparticles (MNPs) are capable of generate heating power under the influence of alternating magnetic fields (AMF); this behaviour recently opened new scenarios for advanced biomedical applications, mainly as new promising tumor therapies. In this paper we have tested magnetic nanoparticles called magnetosomes (MNs): a class of MNPs naturally produced by magnetotactic bacteria. We extracted MNs from Magnetospirillum gryphiswaldense strain MSR-1 and tested the interaction with cellular elements and anti-neoplastic activity both in vitro and in vivo, with the aim of developing new therapeutic approaches for neoplastic diseases. In vitro experiments performed on Human Colon Carcinoma HT-29 cell cultures demonstrated a strong uptake of MNs with no evident signs of cytotoxicity and revealed three phases in the interaction: adherence, transport and accumulation in Golgi vesicles. In vivo studies were performed on subcutaneous tumors in mice; in this model MNs are administered by direct injection in the tumor volume, then a protocol consisting of three exposures to an AMF rated at 187 kHz and 23kA/m is carried out on alternate days, over a week. Tumors were monitored by Magnetic Resonance Imaging (MRI) to obtain information about MNs distribution and possible tissue modifications induced by hyperthermia. Histological analysis showed fibrous and necrotic areas close to MNs injection sites in mice subjected to a complete thermotherapy protocol. These results, although concerning a specific tumor model, could be useful to further investigate the feasibility and efficacy of protocols based on MFH. Magnetic nanoparticles naturally produced and extracted from bacteria seem to be promising candidates for theranostic applications in cancer therapy.	[Mannucci, Silvia; Conti, Giamaica; Tambalo, Stefano; Benati, Donatella; Bernardi, Paolo; Sbarbati, Andrea] Univ Verona, Human Anat & Histol Sect, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Ghin, Leonardo; Betterle, Nico; Bassi, Roberto] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Tambalo, Stefano; Lascialfari, Alessandro; Orlando, Tomas; Sbarbati, Andrea] Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Florence, Italy; [Lascialfari, Alessandro; Orlando, Tomas] Univ Milan, Dept Phys, Milan, Italy; [Lascialfari, Alessandro; Orlando, Tomas] Univ Pavia, Dept Phys, I-27100 Pavia, Italy; [Marzola, Pasquina] Univ Verona, Dept Comp Sci, I-37100 Verona, Italy	University of Verona; University of Verona; University of Milan; University of Pavia; University of Verona	Sbarbati, A (corresponding author), Univ Verona, Human Anat & Histol Sect, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	andrea.sbarbati@univr.it	Orlando, Tomas/J-8161-2019; Betterle, Nico/AAE-1004-2021	Orlando, Tomas/0000-0001-7261-2119; Betterle, Nico/0000-0002-7556-6696; Tambalo, Stefano/0000-0003-2562-1324; MARZOLA, Pasquina/0000-0001-6936-8901; bassi, roberto/0000-0002-4140-8446	AIRC [11993]; Italian MIUR through FIRB [RBAP114AMK]	AIRC; Italian MIUR through FIRB	The authors wish to thank AIRC for the financial support (project number: 11993 Area: targeted therapy, type of grant: IG). The financial support of Italian MIUR through project FIRB Riname RBAP114AMK is also acknowledged. The funders had no role in study design, data collection and analysis.	Alphandery E, 2012, INT J PHARMACEUT, V434, P444, DOI 10.1016/j.ijpharm.2012.06.015; Alphandery E, 2011, ACS NANO, V5, P6279, DOI 10.1021/nn201290k; Bellini  S., 1963, ULTERIORI STUDI BATT; Bellini S., 1963, PARTICOLARE COMPORTA; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Gojzewski H, 2012, SCANNING, V34, P159, DOI 10.1002/sca.20292; Greene SE, 2012, CURR OPIN CELL BIOL, V24, P490, DOI 10.1016/j.ceb.2012.05.008; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Hartung A, 2007, J MAGN MAGN MATER, V311, P454, DOI 10.1016/j.jmmm.2006.10.1153; Hergt R, 2005, J MAGN MAGN MATER, V293, P80, DOI 10.1016/j.jmmm.2005.01.047; Hilger I, 2002, INVEST RADIOL, V37, P580, DOI 10.1097/00004424-200210000-00008; Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1; Johannsen M, 2007, EUR UROL, V52, P1653, DOI 10.1016/j.eururo.2006.11.023; Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559; Jordan A, 2006, J NEURO-ONCOL, V78, P7, DOI 10.1007/s11060-005-9059-z; Lee N, 2011, P NATL ACAD SCI USA, P108; Lisy MR, 2007, INVEST RADIOL, V42, P235, DOI 10.1097/01.rli.0000255832.44443.e7; Liu F, 2014, CHEM COMMUN, V50, P6200, DOI 10.1039/c4cc01266f; Maier-Hauff K, 2011, J NEURO-ONCOL, V103, P317, DOI 10.1007/s11060-010-0389-0; Masotti A, 2009, MAGN RESON MATER PHY, V22, P77, DOI 10.1007/s10334-008-0147-x; Mustafa T, 2013, BIOMATER SCI-UK, V1, P870, DOI 10.1039/c3bm60015g; Pan Y, 2012, CHEM SOC REV, V41, P2912, DOI 10.1039/c2cs15315g; Saokar A, 2006, ABDOM IMAGING, V31, P660, DOI 10.1007/s00261-006-9006-2; Senn MS, 2012, NATURE, V481, P173, DOI 10.1038/nature10704; Shin J, 2014, INTEGR BIOL-UK, V6, P532, DOI 10.1039/c3ib40195b; Timko M, 2009, J MAGN MAGN MATER, V321, P1521, DOI 10.1016/j.jmmm.2009.02.077; Valero E, 2011, J AM CHEM SOC, V133, P4889, DOI 10.1021/ja110014p; Wilhelm C, 2007, J NANOSCI NANOTECHNO, V7, P2933, DOI 10.1166/jnn.2007.668; Won J, 2005, SCIENCE, V309, P121, DOI 10.1126/science.1112869; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Xiang L, 2007, LETT APPL MICROBIOL, V45, P75, DOI 10.1111/j.1472-765X.2007.02143.x; Zeytuni N, 2012, ACTA CRYSTALLOGR F, V68, P927, DOI 10.1107/S1744309112025638	32	42	48	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e108959	10.1371/journal.pone.0108959	http://dx.doi.org/10.1371/journal.pone.0108959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25289664	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000033
J	Dsouza, M; Taylor, MW; Turner, SJ; Aislabie, J				Dsouza, Melissa; Taylor, Michael W.; Turner, Susan J.; Aislabie, Jackie			Genome-Based Comparative Analyses of Antarctic and Temperate Species of Paenibacillus	PLOS ONE			English	Article							ROSS SEA REGION; SOIL BACTERIAL COMMUNITY; COLD SHOCK RESPONSE; 16S RIBOSOMAL-RNA; SP-NOV.; BACILLUS-SUBTILIS; PERMAFROST BACTERIUM; MICROBIAL DIVERSITY; LAKE WELLMAN; SEQUENCE	Antarctic soils represent a unique environment characterised by extremes of temperature, salinity, elevated UV radiation, low nutrient and low water content. Despite the harshness of this environment, members of 15 bacterial phyla have been identified in soils of the Ross Sea Region (RSR). However, the survival mechanisms and ecological roles of these phyla are largely unknown. The aim of this study was to investigate whether strains of Paenibacillus darwinianus owe their resilience to substantial genomic changes. For this, genome-based comparative analyses were performed on three P. darwinianus strains, isolated from gamma-irradiated RSR soils, together with nine temperate, soil-dwelling Paenibacillus spp. The genome of each strain was sequenced to over 1,000-fold coverage, then assembled into contigs totalling approximately 3 Mbp per genome. Based on the occurrence of essential, single-copy genes, genome completeness was estimated at approximately 88%. Genome analysis revealed between 3,043-3,091 protein-coding sequences (CDSs), primarily associated with two-component systems, sigma factors, transporters, sporulation and genes induced by cold-shock, oxidative and osmotic stresses. These comparative analyses provide an insight into the metabolic potential of P. darwinianus, revealing potential adaptive mechanisms for survival in Antarctic soils. However, a large proportion of these mechanisms were also identified in temperate Paenibacillus spp., suggesting that these mechanisms are beneficial for growth and survival in a range of soil environments. These analyses have also revealed that the P. darwinianus genomes contain significantly fewer CDSs and have a lower paralogous content. Notwithstanding the incompleteness of the assemblies, the large differences in genome sizes, determined by the number of genes in paralogous clusters and the CDS content, are indicative of genome content scaling. Finally, these sequences are a resource for further investigations into the expression of physiological attributes that enable survival under extreme conditions and selection processes that affect prokaryotic genome evolution.	[Dsouza, Melissa; Taylor, Michael W.; Turner, Susan J.] Univ Auckland, Ctr Microbial Innovat, Sch Biol Sci, Auckland 1, New Zealand; [Turner, Susan J.] BioDiscovery New Zealand Ltd, Auckland, New Zealand; [Aislabie, Jackie] Landcare Res, Hamilton, New Zealand	University of Auckland; Landcare Research - New Zealand	Dsouza, M (corresponding author), Univ Auckland, Ctr Microbial Innovat, Sch Biol Sci, Auckland 1, New Zealand.	melissa33in@gmail.com		Taylor, Michael/0000-0002-0463-7813	Ministry of Business, Innovation and Employment's Science and Innovation Group, New Zealand	Ministry of Business, Innovation and Employment's Science and Innovation Group, New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This research was supported by Core funding for Crown Research Institutes from the Ministry of Business, Innovation and Employment's Science and Innovation Group, New Zealand (www.mbie.govt.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam LS, 2010, ANTARCT SCI, V22, P45, DOI 10.1017/S0954102009990460; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Aislabie J, 2009, CAN J MICROBIOL, V55, P21, DOI 10.1139/W08-126; Aislabie JM, 2008, GEODERMA, V144, P9, DOI 10.1016/j.geoderma.2007.10.006; Aislabie J, 2012, ANTARCT SCI, V24, P154, DOI 10.1017/S0954102011000873; Aislabie JM, 2013, EXTREMOPHILES, V17, P775, DOI 10.1007/s00792-013-0560-6; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Allen MA, 2009, ISME J, V3, P1012, DOI 10.1038/ismej.2009.45; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Ayala-del-Rio HL, 2010, APPL ENVIRON MICROB, V76, P2304, DOI 10.1128/AEM.02101-09; Ayton J, 2010, ENVIRON MICROBIOL, V12, P689, DOI 10.1111/j.1462-2920.2009.02111.x; Bachar A, 2010, MICROB ECOL, V60, P453, DOI 10.1007/s00248-010-9727-1; Barrett JE, 2005, ARCT ANTARCT ALP RES, V37, P108, DOI 10.1657/1523-0430(2005)037[0108:PSOMTI]2.0.CO;2; Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; Bockheim JG, 1997, SOIL SCI SOC AM J, V61, P224, DOI 10.2136/sssaj1997.03615995006100010031x; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bottos EM, 2014, MICROB ECOL, V67, P120, DOI 10.1007/s00248-013-0296-y; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Campbell I. B., 1987, Antarctica : soils, weathering processes and environment., P368; Chan QWT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-450; Chattopadhyay MK, 2002, CURR SCI INDIA, V83, P109; Dsouza M, 2014, INT J SYST EVOL MICR, V64, P1406, DOI 10.1099/ijs.0.056697-0; Elo S, 2001, INT J SYST EVOL MICR, V51, P535, DOI 10.1099/00207713-51-2-535; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; Felske A, 2000, APPL ENVIRON MICROB, V66, P3998, DOI 10.1128/AEM.66.9.3998-4003.2000; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; Graf S, 2014, J BACTERIOL, V196, P1084, DOI 10.1128/JB.01154-13; Graumann Peter L., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P203; Guan XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-820; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; Hartmann M, 2014, ISME J, V8, P226, DOI 10.1038/ismej.2013.141; Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003; Helmann JD, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P31; Hesami S, 2011, APPL ENVIRON MICROB, V77, P1593, DOI 10.1128/AEM.01717-10; Hirsch P, 2004, SYST APPL MICROBIOL, V27, P636, DOI 10.1078/0723202042370008; Hirsch P.R., 2013, MOL MICROBIAL ECOLOG, V1, P45; Hoffmann T, 2008, APPL ENVIRON MICROB, V74, P2454, DOI 10.1128/AEM.01573-07; Hopkins DW, 2009, ENVIRON MICROBIOL, V11, P597, DOI 10.1111/j.1462-2920.2008.01830.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jers C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014653; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Kaan T, 2002, MICROBIOL-SGM, V148, P3441, DOI 10.1099/00221287-148-11-3441; Kawamura K, 1996, J GEOPHYS RES-ATMOS, V101, P18721, DOI 10.1029/96JD01541; KEMPF B, 1995, J BIOL CHEM, V270, P16701, DOI 10.1074/jbc.270.28.16701; Kim BC, 2009, J MICROBIOL, V47, P530, DOI 10.1007/s12275-009-0270-z; Kishore KH, 2010, INT J SYST EVOL MICR, V60, P1909, DOI 10.1099/ijs.0.015271-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Lee FL, 2007, INT J SYST EVOL MICR, V57, P1351, DOI 10.1099/ijs.0.64764-0; Logan NA, 2004, INT J SYST EVOL MICR, V54, P1071, DOI 10.1099/ijs.0.02967-0; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; MARSHALL BJ, 1966, J GEN MICROBIOL, V44, P41, DOI 10.1099/00221287-44-1-41; McKay C.P., 1993, ANTARCTIC METEOROLOG, V61, P201, DOI DOI 10.1029/AR061P0201; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Montes MJ, 2004, INT J SYST EVOL MICR, V54, P1521, DOI 10.1099/ijs.0.63078-0; Mykytczuk NCS, 2013, ISME J, V7, P1211, DOI 10.1038/ismej.2013.8; Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nelson DM, 2009, INT J SYST EVOL MICR, V59, P1708, DOI 10.1099/ijs.0.004572-0; Niederberger TD, 2008, ENVIRON MICROBIOL, V10, P1713, DOI 10.1111/j.1462-2920.2008.01593.x; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Priest FG, 2009, BERGEYS MANUAL SYSTE, P1422; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Rabus R, 2004, ENVIRON MICROBIOL, V6, P887, DOI 10.1111/j.1462-2920.2004.00665.x; Ranea JAG, 2005, TRENDS GENET, V21, P21, DOI 10.1016/j.tig.2004.11.014; Ranea JAG, 2004, J MOL BIOL, V336, P871, DOI 10.1016/j.jmb.2003.12.044; Riley M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-210; Rodriguez-Diaz M, 2005, INT J SYST EVOL MICR, V55, P2093, DOI 10.1099/ijs.0.63395-0; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rosario MML, 1996, MOL MICROBIOL, V21, P511, DOI 10.1111/j.1365-2958.1996.tb02560.x; Saul DJ, 2005, FEMS MICROBIOL ECOL, V53, P141, DOI 10.1016/j.femsec.2004.11.007; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Sirota-Madi A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-710; Sun GF, 1996, MOL MICROBIOL, V19, P941, DOI 10.1046/j.1365-2958.1996.422952.x; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Teinila K, 2000, J GEOPHYS RES-ATMOS, V105, P3893, DOI 10.1029/1999JD901033; Tiao G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1645; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van Horn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066103; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120; Wiegeshoff F, 2006, J BACTERIOL, V188, P3130, DOI 10.1128/JB.188.8.3130-3133.2006; Wilson K., 2001, CURR PROTOC MOL BIOL, V71, P27, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Wood JM, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P133; Xie CH, 2007, INT J SYST EVOL MICR, V57, P70, DOI 10.1099/ijs.0.64311-0; Xu GJ, 2013, J GEOPHYS RES-ATMOS, V118, P13303, DOI 10.1002/2013JD019496; Youssef NH, 2009, ISME J, V3, P305, DOI 10.1038/ismej.2008.106; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	100	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108009	10.1371/journal.pone.0108009	http://dx.doi.org/10.1371/journal.pone.0108009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25285990	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700012
J	Hsiao, HC; Gonzalez, KL; Catanese, DJ; Jordy, KE; Matthews, KS; Bondos, SE				Hsiao, Hao-Ching; Gonzalez, Kim L.; Catanese, Daniel J., Jr.; Jordy, Kristopher E.; Matthews, Kathleen S.; Bondos, Sarah E.			The Intrinsically Disordered Regions of the Drosophila melanogaster Hox Protein Ultrabithorax Select Interacting Proteins Based on Partner Topology	PLOS ONE			English	Article							CONFORMATIONAL EQUILIBRIA; TRANSCRIPTION FACTORS; FLEXIBLE NETS; HUB PROTEINS; DNA-BINDING; INDUCED FIT; HOMEODOMAIN; EXTRADENTICLE; DOMAIN; SPECIFICITY	Interactions between structured proteins require a complementary topology and surface chemistry to form sufficient contacts for stable binding. However, approximately one third of protein interactions are estimated to involve intrinsically disordered regions of proteins. The dynamic nature of disordered regions before and, in some cases, after binding calls into question the role of partner topology in forming protein interactions. To understand how intrinsically disordered proteins identify the correct interacting partner proteins, we evaluated interactions formed by the Drosophila melanogaster Hox transcription factor Ultrabithorax (Ubx), which contains both structured and disordered regions. Ubx binding proteins are enriched in specific folds: 23 of its 39 partners include one of 7 folds, out of the 1195 folds recognized by SCOP. For the proteins harboring the two most populated folds, DNA-RNA binding 3-helical bundles and alpha-alpha superhelices, the regions of the partner proteins that exhibit these preferred folds are sufficient for Ubx binding. Three disorder-containing regions in Ubx are required to bind these partners. These regions are either alternatively spliced or multiply phosphorylated, providing a mechanism for cellular processes to regulate Ubx-partner interactions. Indeed, partner topology correlates with the ability of individual partner proteins to bind Ubx spliceoforms. Partners bind different disordered regions within Ubx to varying extents, creating the potential for competition between partners and cooperative binding by partners. The ability of partners to bind regions of Ubx that activate transcription and regulate DNA binding provides a mechanism for partners to modulate transcription regulation by Ubx, and suggests that one role of disorder in Ubx is to coordinate multiple molecular functions in response to tissue-specific cues.	[Hsiao, Hao-Ching; Gonzalez, Kim L.; Bondos, Sarah E.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 78665 USA; [Catanese, Daniel J., Jr.; Jordy, Kristopher E.; Matthews, Kathleen S.; Bondos, Sarah E.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Rice University	Bondos, SE (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Reynolds Med Bldg, College Stn, TX 78665 USA.	sebondos@tamhsc.edu		Gonzalez, Kim/0000-0003-2961-3081	Texas A&M Health Science Center Research Development and Enhancement Awards Program; National Science Foundation [1151394]; Robert A. Welch Foundation [C-576]; Direct For Mathematical & Physical Scien [1151394] Funding Source: National Science Foundation	Texas A&M Health Science Center Research Development and Enhancement Awards Program; National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by a grant from the Texas A&M Health Science Center Research Development and Enhancement Awards Program and a CAREER award from the National Science Foundation (1151394) to S.E.B. and a grant from the Robert A. Welch Foundation (C-576) to K.S.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Auerbach D, 2002, PROTEOMICS, V2, P611, DOI 10.1002/1615-9861(200206)2:6<611::AID-PROT611>3.0.CO;2-Y; Ball KA, 2011, BIOCHEMISTRY-US, V50, P7612, DOI 10.1021/bi200732x; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BEACHY PA, 1993, MOL CELL BIOL, V13, P6941, DOI 10.1128/MCB.13.11.6941; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Bondos SE, 2006, MOL CELL PROTEOMICS, V5, P824, DOI 10.1074/mcp.M500256-MCP200; Bondos SE, 2004, J BIOL CHEM, V279, P26433, DOI 10.1074/jbc.M312842200; Bondos SE, 2001, CRIT REV EUKAR GENE, V11, P145; Boube M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004303; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Butz M, 2014, J STRUCT BIOL, V185, P168, DOI 10.1016/j.jsb.2013.03.008; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Clarke D, 2012, J STRUCT BIOL, V179, P320, DOI 10.1016/j.jsb.2012.02.001; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Drobnak I, 2013, J AM CHEM SOC, V135, P1288, DOI 10.1021/ja305081b; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Fisher CK, 2010, J AM CHEM SOC, V132, P14919, DOI 10.1021/ja105832g; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Ganguly D, 2012, MOL BIOSYST, V8, P198, DOI 10.1039/c1mb05156c; GAVIS ER, 1991, DEVELOPMENT, V112, P1077; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Greer AM, 2009, BIOMACROMOLECULES, V10, P829, DOI 10.1021/bm801315v; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jemth P, 2014, J BIOL CHEM, V289, P5528, DOI 10.1074/jbc.M113.537068; Jimenez JL, 2005, PROTEINS, V59, P757, DOI 10.1002/prot.20448; JOHNSON FB, 1995, P NATL ACAD SCI USA, V92, P739, DOI 10.1073/pnas.92.3.739; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Khan H, 2013, J MOL BIOL, V425, P1011, DOI 10.1016/j.jmb.2013.01.005; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Light S, 2013, MOL BIOL EVOL, V30, P2645, DOI 10.1093/molbev/mst157; Liu Y, 2008, J BIOL CHEM, V283, P20874, DOI 10.1074/jbc.M800375200; Liu Y, 2009, J MOL BIOL, V390, P760, DOI 10.1016/j.jmb.2009.05.059; Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048; Lopez AJ, 1996, ROUX ARCH DEV BIOL, V205, P450, DOI 10.1007/BF00377226; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; Marsh JA, 2010, STRUCTURE, V18, P1094, DOI 10.1016/j.str.2010.05.015; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miller JH, 1972, ASSAYS LAC OPERON EN, P352; Miller JH., 1992, SHORT COURSE BACTERI, P72; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Morgan JL, 2011, J BIOL CHEM, V286, P39349, DOI 10.1074/jbc.M111.296277; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagulapalli M, 2012, STRUCTURE, V20, P522, DOI 10.1016/j.str.2012.01.021; Narayan V, 2011, J BIOL CHEM, V286, P14291, DOI 10.1074/jbc.M110.204602; OCONNOR MB, 1988, EMBO J, V7, P435, DOI 10.1002/j.1460-2075.1988.tb02831.x; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Panni S, 2011, PROTEOMICS, V11, P128, DOI 10.1002/pmic.201000030; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; RAUSKOLB C, 1994, EMBO J, V13, P3561, DOI 10.1002/j.1460-2075.1994.tb06663.x; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Reed HC, 2010, GENETICS, V184, P745, DOI 10.1534/genetics.109.112086; Rogers JM, 2013, J AM CHEM SOC, V135, P1415, DOI 10.1021/ja309527h; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Saadaoui M, 2011, P NATL ACAD SCI USA, V108, P2276, DOI 10.1073/pnas.1006964108; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Slupsky CM, 2001, PROTEIN SCI, V10, P1244, DOI 10.1110/ps.50901; SUBRAMANIAM V, 1994, GENETICS, V136, P979; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tan XX, 2002, BIOCHEMISTRY-US, V41, P2774, DOI 10.1021/bi011967y; Thomas J, 2009, PROTEINS, V76, P911, DOI 10.1002/prot.22398; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tran HT, 2008, J AM CHEM SOC, V130, P7380, DOI 10.1021/ja710446s; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; Vitalis A, 2008, J MOL BIOL, V384, P279, DOI 10.1016/j.jmb.2008.09.026; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yura K, 2009, BIOINFORMATICS, V25, P3108, DOI 10.1093/bioinformatics/btp563; Zen A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-26; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029	95	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e108217	10.1371/journal.pone.0108217	http://dx.doi.org/10.1371/journal.pone.0108217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286318	Green Published, gold, Green Submitted			2022-12-27	WOS:000345743700015
J	Moriniere, J; Hendrich, L; Hausmann, A; Hebert, P; Haszprunar, G; Gruppe, A				Moriniere, Jerome; Hendrich, Lars; Hausmann, Axel; Hebert, Paul; Haszprunar, Gerhard; Gruppe, Axel			Barcoding Fauna Bavarica: 78% of the Neuropterida Fauna Barcoded!	PLOS ONE			English	Article							EVOLUTION	This publication provides the first comprehensive DNA barcode data set for the Neuropterida of Central Europe, including 80 of the 102 species (78%) recorded from Bavaria (Germany) and three other species from nearby regions (Austria, France and the UK). Although the 286 specimens analyzed had a heterogeneous conservation history (60% dried; 30% in 80% EtOH; 10% fresh specimens in 95% EtOH), 237 (83%) generated a DNA barcode. Eleven species (13%) shared a BIN, but three of these taxa could be discriminated through barcodes. Four pairs of closely allied species shared barcodes including Chrysoperla pallida Henry et al., 2002 and C. lucasina Lacroix, 1912; Wesmaelius concinnus (Stephens, 1836) and W. quadrifasciatus (Reuter, 1894); Hemerobius handschini Tjeder, 1957 and H. nitidulus Fabricius, 1777; and H. atrifrons McLachlan, 1868 and H. contumax Tjeder, 1932. Further studies are needed to test the possible synonymy of these species pairs or to determine if other genetic markers permit their discrimination. Our data highlight five cases of potential cryptic diversity within Bavarian Neuropterida: Nineta flava (Scopoli, 1763), Sympherobius pygmaeus (Rambur, 1842), Sisyra nigra (Retzius, 1783), Semidalis aleyrodiformis (Stephens, 1836) and Coniopteryx pygmaea Enderlein, 1906 are each split into two or three BINs. The present DNA barcode library not only allows the identification of adult and larval stages, but also provides valuable information for alpha-taxonomy, and for ecological and evolutionary research.	[Moriniere, Jerome; Hendrich, Lars; Hausmann, Axel; Haszprunar, Gerhard] Bavarian State Collect Zool SNSB ZSM, Munich, Germany; [Hebert, Paul] Univ Guelph, BIO, Guelph, ON N1G 2W1, Canada; [Gruppe, Axel] Tech Univ Munich, Inst Anim Ecol, Freising Weihenstephan, Germany	University of Guelph; Technical University of Munich	Moriniere, J (corresponding author), Bavarian State Collect Zool SNSB ZSM, Munich, Germany.	Moriniere@zsm.mwn.de			Bavarian State Government (BFB); German Federal Ministry of Education and Research [GBOL2:01LI1101B]; Government of Canada to Genome Canada through the Ontario Genomics Institute; Ontario Ministry of Research and Innovation; NSERC	Bavarian State Government (BFB); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Government of Canada to Genome Canada through the Ontario Genomics Institute; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The project was supported by grants from the Bavarian State Government (BFB) and the German Federal Ministry of Education and Research (GBOL2:01LI1101B). The sequencing work was supported by funding from the Government of Canada to Genome Canada through the Ontario Genomics Institute, while the Ontario Ministry of Research and Innovation and NSERC supported development of the BOLD informatics platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPOCK H., 1980, NEUROPTEREN EUROPAS; Aspock U., 2007, Denisia, P451; Daane K.M., 2001, P398, DOI 10.1017/CBO9780511666117.024; Grimaldi David, 2005, pi; Gruppe A, 2014, BARCODING FAUN UNPUB; Gruppe Axel, 2011, Beitraege zur Bayerischen Entomofaunistik, V11, P39; Hausmann A, 2013, BIOSYST EU 2013 GLOB; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, COMPREHENSIVE UNPUB; Henry CS, 2013, BIOL REV, V88, P787, DOI 10.1111/brv.12027; Henry CS, 2012, BIOL J LINN SOC, V105, P776, DOI 10.1111/j.1095-8312.2011.01845.x; Monserrat V.J., 2001, Journal of Neuropterology, V3, P61; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Saure Christoph, 2003, Entomofauna Germanica, V6, P276; Saure Christoph, 2003, Entomofauna Germanica, V6, P279; Saure Christoph, 2003, Entomofauna Germanica, V6, P282; Senior L.J., 2001, P296, DOI 10.1017/CBO9780511666117.014; Voith J, 2003, SCHRIFTENREIHE BAYER, V116, P11	20	36	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109719	10.1371/journal.pone.0109719	http://dx.doi.org/10.1371/journal.pone.0109719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286434	Green Submitted, Green Published, gold			2022-12-27	WOS:000345743700086
J	Vizcaino-Palomar, N; Revuelta-Eugercios, B; Zavala, MA; Alia, R; Gonzalez-Martinez, SC				Vizcaino-Palomar, Natalia; Revuelta-Eugercios, Barbara; Zavala, Miguel A.; Alia, Ricardo; Gonzalez-Martinez, Santiago C.			The Role of Population Origin and Microenvironment in Seedling Emergence and Early Survival in Mediterranean Maritime Pine (Pinus pinaster Aiton)	PLOS ONE			English	Article							LOCAL ADAPTATION; ESTABLISHMENT SUCCESS; NATURAL REGENERATION; CLIMATE-CHANGE; PLANT; RECRUITMENT; TREE; GROWTH; SYLVESTRIS; RESPONSES	Understanding tree recruitment is needed to forecast future forest distribution. Many studies have reported the relevant ecological factors that affect recruitment success in trees, but the potential for genetic-based differences in recruitment has often been neglected. In this study, we established a semi-natural reciprocal sowing experiment to test for local adaptation and microenvironment effects (evaluated here by canopy cover) in the emergence and early survival of maritime pine (Pinus pinaster Aiton), an emblematic Mediterranean forest tree. A novel application of molecular markers was also developed to test for family selection and, thus, for potential genetic change over generations. Overall, we did not find evidence to support local adaptation at the recruitment stage in our semi-natural experiment. Moreover, only weak family selection (if any) was found, suggesting that in stressful environments with low survival, stochastic processes and among-year climate variability may drive recruitment. Nevertheless, our study revealed that, at early stages of recruitment, microenvironments may favor the population with the best adapted life strategy, irrespectively of its (local or non-local) origin. We also found that emergence time is a key factor for seedling survival in stressful Mediterranean environments. Our study highlights the complexity of the factors influencing the early stages of establishment of maritime pine and provides insights into possible management actions aimed at environmental change impact mitigation. In particular, we found that the high stochasticity of the recruitment process in stressful environments and the differences in population-specific adaptive strategies may difficult assisted migration schemes.	[Vizcaino-Palomar, Natalia; Alia, Ricardo; Gonzalez-Martinez, Santiago C.] Forest Res Ctr INIA, Dept Forest Ecol & Genet, Madrid, Spain; [Vizcaino-Palomar, Natalia; Zavala, Miguel A.] Univ Alcala, Dept Life Sci, Madrid, Spain; [Revuelta-Eugercios, Barbara] Lund Univ, Ctr Econ Demog, Lund, Sweden; [Alia, Ricardo; Gonzalez-Martinez, Santiago C.] Univ Valladolid INIA, Sustainable Forest Management Res Inst, Palencia, Spain; [Gonzalez-Martinez, Santiago C.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Alcala; Lund University; Universidad de Valladolid; University of Lausanne	Gonzalez-Martinez, SC (corresponding author), Forest Res Ctr INIA, Dept Forest Ecol & Genet, Madrid, Spain.	santiago@inia.es	Gonzalez-Martinez, Santiago C/H-2014-2012; Alia, Ricardo/B-5160-2011; Zavala, Miguel A./H-3603-2015; Palomar, Natalia Vizcaino/AAA-8838-2020	Gonzalez-Martinez, Santiago C/0000-0002-4534-3766; Alia, Ricardo/0000-0002-9426-0967; Zavala, Miguel A./0000-0003-1456-0132; Palomar, Natalia Vizcaino/0000-0002-3481-7567; Revuelta-Eugercios, Barbara Ana/0000-0002-2449-037X	Spanish Ministry of Science and Innovation [CGL2008-04503-C03-01/03]; Spanish National Institute for Agricultural and Food Research and Technology [RTA2010-00120-C02-02]; REMEDINAL2 (CAM) [S2009/AMB-1783]; FPI-MCI [BES-2009-025151]; Senior Marie Curie Intra European Fellowship within European Community [PIEF-GA-2012-328146]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute for Agricultural and Food Research and Technology; REMEDINAL2 (CAM); FPI-MCI; Senior Marie Curie Intra European Fellowship within European Community	This work was supported by the Spanish Ministry of Science and Innovation through grant CGL2008-04503-C03-01/03, the Spanish National Institute for Agricultural and Food Research and Technology (grant RTA2010-00120-C02-02) and REMEDINAL2 (CAM, S2009/AMB-1783). NVP was supported by fellowship FPI-MCI (BES-2009-025151). SCGM acknowledges the support of a Senior Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2012-328146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, ECOL RES, V23, P681, DOI 10.1007/s11284-007-0428-2; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alberto F, 2013, GLOBAL CHANGE BIOL, P1; Allison PaulD., 1982, SOCIOL METHODOL, V13, P61, DOI [10.2307/270718, DOI 10.2307/270718]; ANDERSON MC, 1964, J ECOL, V52, P27, DOI 10.2307/2257780; [Anonymous], 2001, DESIGN ANAL ECOLOGIC; Aranda I, 2010, TREE GENET GENOMES, V6, P169, DOI 10.1007/s11295-009-0238-5; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; Barton NH, 1999, GENET RES, V74, P223, DOI 10.1017/S001667239900422X; Garzon MB, 2011, GLOBAL ECOL BIOGEOGR, V20, P766, DOI 10.1111/j.1466-8238.2010.00646.x; Castro J, 2005, PLANT ECOL, V181, P191, DOI 10.1007/s11258-005-6626-5; Castro J, 2006, ANN BOT-LONDON, V98, P1233, DOI 10.1093/aob/mcl208; Chagne D, 2004, THEOR APPL GENET, V109, P1204, DOI 10.1007/s00122-004-1683-z; Chambers JC, 2001, J VEG SCI, V12, P27, DOI 10.1111/j.1654-1103.2001.tb02614.x; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Del Re AC, 2012, PACKAGE COMPUTE EFFE; DEVLIN B, 1988, THEOR APPL GENET, V76, P369, DOI 10.1007/BF00265336; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Endler J.A., 1977, Monographs in Population Biology, pi; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Gimenez-Benavides L, 2007, ANN BOT-LONDON, V99, P723, DOI [10.1093/aol/mcm007, 10.1093/aob/mcm007]; Gomez JM, 2004, PLANT ECOL, V172, P287, DOI 10.1023/B:VEGE.0000026327.60991.f9; Gomez-Aparicio L, 2008, J ECOL, V96, P1128, DOI 10.1111/j.1365-2745.2008.01431.x; Gonzalez-Martinez SC, 2002, HEREDITY, V89, P199, DOI 10.1038/sj.hdy.6800114; Gonzalez-Martinez SC, 2003, ANN FOREST SCI, V60, P115, DOI 10.1051/forest:2003003; Gonzalo Jimenez J, 2008, THESIS U POLITECNICA; Gordo J., 2012, REGENERACION NATURAL; Harper J. L., 1974, Annual Review of Ecology and Systematics, V5, P419, DOI 10.1146/annurev.es.05.110174.002223; Harper J. L., 1977, POPULATION BIOL PLAN; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; HOSMER DW, 1989, APPL LOGISTIC REGRES; Ishizuka W, 2012, EVOL APPL, V5, P229, DOI 10.1111/j.1752-4571.2011.00216.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Joslin JD, 2000, NEW PHYTOL, V147, P117, DOI 10.1046/j.1469-8137.2000.00692.x; Juez L, 2014, FOREST ECOL MANAG, V313, P329, DOI 10.1016/j.foreco.2013.10.033; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI, DOI [10.1002/9781118032985, DOI 10.1002/9781118032985]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Klein T, 2013, TREE PHYSIOL, V33, P26, DOI 10.1093/treephys/tps116; Klenner W, 2009, FOREST ECOL MANAG, V258, pS5, DOI 10.1016/j.foreco.2009.08.035; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Kollmann Johannes, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P29, DOI 10.1078/1433-8319-00003; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; McNair JN, 2012, SEED SCI RES, V22, P77, DOI 10.1017/S0960258511000547; MILLER TE, 1987, OECOLOGIA, V72, P272, DOI 10.1007/BF00379278; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Onofri A, 2010, WEED RES, V50, P5, DOI 10.1111/j.1365-3180.2009.00758.x; PEET RK, 1987, BIOSCIENCE, V37, P586, DOI 10.2307/1310669; Perez-Ramos IM, 2013, PERSPECT PLANT ECOL, V15, P106, DOI 10.1016/j.ppees.2012.12.005; PIGOTT CD, 1993, J ECOL, V81, P557, DOI 10.2307/2261534; Pommel B, 2002, EUR J AGRON, V16, P263, DOI 10.1016/S1161-0301(01)00130-7; PRIMACK RB, 1989, ANNU REV ECOL SYST, V20, P367, DOI 10.1146/annurev.es.20.110189.002055; R Core Team, 2021, R LANGUAGE ENV STAT; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; Reich PB, 2003, INT J PLANT SCI, V164, pS143, DOI 10.1086/374368; Rodriguez-Garcia E, 2011, FOREST ECOL MANAG, V262, P244, DOI 10.1016/j.foreco.2011.03.029; Rodriguez-Garcia E, 2011, ANN FOREST SCI, V68, P337, DOI 10.1007/s13595-011-0039-5; Rodriguez-Garcia E, 2010, EUR J FOREST RES, V129, P1119, DOI 10.1007/s10342-010-0399-7; Rojo A, 1994, INVEST AGRAR-SIST R, V3, P107; ROSS MA, 1972, J ECOL, V60, P77, DOI 10.2307/2258041; Ruano I, 2009, FOREST ECOL MANAG, V258, P2647, DOI 10.1016/j.foreco.2009.09.027; Sanchez-Gomez D, 2013, ENVIRON EXP BOT, V87, P110, DOI 10.1016/j.envexpbot.2012.09.011; Savolainen O, 2004, FOREST ECOL MANAG, V197, P79, DOI 10.1016/j.foreco.2004.05.006; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; SORK VL, 1993, AM NAT, V142, P928, DOI 10.1086/285581; StataCorp, 2009, STAT STAT SOFTW REL; Tapias R, 2004, PLANT ECOL, V171, P53, DOI 10.1023/B:VEGE.0000029383.72609.f0; Terry T, 2012, PACKAGE SURVIVAL ANA; Verdu M, 2007, J ECOL, V95, P1316, DOI 10.1111/j.1365-2745.2007.01300.x; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Voltas J, 2008, TREES-STRUCT FUNCT, V22, P759, DOI 10.1007/s00468-008-0236-5	79	24	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2014	9	10							e109132	10.1371/journal.pone.0109132	http://dx.doi.org/10.1371/journal.pone.0109132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6XC	25286410	Green Published, Green Submitted, gold			2022-12-27	WOS:000345743700047
J	Zhang, M; Hou, M; Ge, LH; Miao, CC; Zhang, JF; Jing, XY; Shi, N; Chen, T; Tang, XF				Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Shi, Ni; Chen, Tong; Tang, Xiaofei			Induction of Peroxiredoxin 1 by Hypoxia Regulates Heme Oxygenase-1 via NF-kappa B in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; I EXPRESSION; NUCLEAR; ACTIVATION; ASTROCYTES; GENE; HYPOXIA/REOXYGENATION; KERATINOCYTES; EPIDEMIOLOGY; MICROGLIA	Overexpression of peroxiredoxin 1 (Prx1) has been observed in numerous cancers including oral squamous cell carcinoma (OSCC). The precise molecular mechanism of up-regulation of Prx1 in carcinogenesis, however, is still poorly understood. The objective of this study is to investigate the relationship between Prx1 and hypoxia, and potential mechanism(s) of Prx1 in OSCC cell line SCC15 and xenograft model. We treated wild-type and Prx1 knockdown SCC15 cells with transient hypoxia followed by reoxygenation. We detected the condition of hypoxia, production of reactive oxygen species (ROS), and expression and/or activity of Prx1, heme oxygenase 1 (HO-1) and nuclear factor-kappa B (NF-kappa B). We found that hypoxia induces ROS accumulation, up-regulates Prx1, increases NF-kappa B translocation and DNA binding activity, and down-regulates HO-1 in vitro. In Prx1 knockdown cells, the expression level of HO-1 was increased, while NF kappa B translocation and DNA binding activity were decreased after hypoxia or hypoxia/reoxygenation treatment. Moreover, we mimicked the dynamic oxygenation tumor microenvironment in xenograft model and assessed the above indices in tumors with the maximal diameter of 2 mm, 5 mm, 10 mm or 15 mm, respectively. Our data showed that tumor hypoxic condition and expression of Prx1 are significantly associated with tumor growth. The expression of HO-1 and NF-kappa B, and NF-kappa B DNA binding activity were significantly elevated in 15 mm tumors, and the level of 8-hydroxydeoxyguanosine was increased in 10 mm and 15 mm tumors, compared to those in size of 2 mm. The results from this study provide experimental evidence that overexpression of Prx1 is associated with hypoxia, and Prx1/NF-kappa B/HO-1 signaling pathway may be involved in oral carcinogenesis.	[Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Tang, Xiaofei] Capital Med Univ, Beijing Stomatol Hosp, Inst Dent Res, Beijing, Peoples R China; [Zhang, Min; Hou, Min; Ge, Lihua; Miao, Congcong; Zhang, Jianfei; Jing, Xinying; Tang, Xiaofei] Capital Med Univ, Sch Stomatol, Beijing, Peoples R China; [Shi, Ni; Chen, Tong] Ohio State Univ, Arthur G James Canc Hosp, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA; [Shi, Ni; Chen, Tong] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA	Capital Medical University; Capital Medical University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chen, T (corresponding author), Ohio State Univ, Arthur G James Canc Hosp, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA.	tong.chen@osumc.edu; xftang10@yahoo.com	Chen, Tong/E-2879-2011; zhang, min/GQR-1387-2022		National Natural Science Foundation [81070836]; Beijing Natural Science Foundation [7102065]; Beijing Municipal Administration of Hospital Key Medical Development Project [ZYLX201407]; NATIONAL CANCER INSTITUTE [R01CA131073] Funding Source: NIH RePORTER	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Administration of Hospital Key Medical Development Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation (81070836), the Beijing Natural Science Foundation (7102065) and ZYLX201407, Beijing Municipal Administration of Hospital Key Medical Development Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan ME, 2012, CELL BIOCHEM FUNCT, V30, P166, DOI 10.1002/cbf.1832; Bach FH, 2005, FASEB J, V19, P1216, DOI 10.1096/fj.04-3485cmt; Bagan JV, 2008, ORAL ONCOL, V44, P103, DOI 10.1016/j.oraloncology.2008.01.008; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; dos Santos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045228; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Guo GW, 2006, ANTIOXID REDOX SIGN, V8, P911, DOI 10.1089/ars.2006.8.911; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Jeong SI, 2010, ARCH PHARM RES, V33, P1867, DOI 10.1007/s12272-010-1120-6; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7; Lee HJ, 2008, J ORAL PATHOL MED, V37, P278, DOI 10.1111/j.1600-0714.2007.00616.x; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Mazza E, 2001, J APPL PHYSIOL, V91, P379, DOI 10.1152/jappl.2001.91.1.379; Miyazaki Y, 2008, INT J ONCOL, V32, P145; Miyoshi A, 2006, INT J ONCOL, V29, P1533; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nakaso K, 2000, NEUROSCI LETT, V293, P49, DOI 10.1016/S0304-3940(00)01491-9; Nakayama H, 2001, CANCER, V92, P3037, DOI 10.1002/1097-0142(20011215)92:12<3037::AID-CNCR10171>3.0.CO;2-#; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Riddell JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050394; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Ruiz-Ramos R, 2009, MUTAT RES-GEN TOX EN, V674, P109, DOI 10.1016/j.mrgentox.2008.09.021; Rushworth SA, 2010, CANCER RES, V70, P2973, DOI 10.1158/0008-5472.CAN-09-3407; Stanimirovic D, 2001, J NEUROIMMUNOL, V119, P365, DOI 10.1016/S0165-5728(01)00402-7; Wang XM, 2010, MOL BIOL CELL, V21, P2987, DOI 10.1091/mbc.E10-02-0160; Warnakulasuriya S, 2009, BRIT DENT J, V207, P471, DOI 10.1038/sj.bdj.2009.1009; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yanagawa T, 2005, INT J ORAL MAX SURG, V34, P915, DOI 10.1016/j.ijom.2005.04.015; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1	36	91	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2014	9	8							e105994	10.1371/journal.pone.0105994	http://dx.doi.org/10.1371/journal.pone.0105994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UR	25295523	gold, Green Published, Green Submitted			2022-12-27	WOS:000340880900070
J	Wennstrom, M; Surova, Y; Hall, S; Nilsson, C; Minthon, L; Bostrom, F; Hansson, O; Nielsen, HM				Wennstrom, Malin; Surova, Yulia; Hall, Sara; Nilsson, Christer; Minthon, Lennart; Bostrom, Fredrik; Hansson, Oskar; Nielsen, Henrietta M.			Low CSF Levels of Both alpha-Synuclein and the alpha-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy	PLOS ONE			English	Article							MULTIPLE-SYSTEM ATROPHY; HUMAN CEREBROSPINAL-FLUID; HUMAN KALLIKREIN 6; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; LEWY BODIES; SERINE-PROTEASE; NEURODEGENERATIVE DISORDERS; SUBSTRATE-SPECIFICITY; DIAGNOSTIC-CRITERIA	Neurosin is a protease that in vitro degrades alpha-synuclein, the main constituent of Lewy bodies found in brains of patients with synucleinopathy including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Several studies have reported reduced cerebrospinal fluid (CSF) levels of alpha-synuclein in synucleinopathy patients and recent data also proposes a significant role of alpha-synuclein in the pathophysiology of Alzheimer's disease (AD). To investigate potential links between neurosin and its substrate alpha-synuclein in vivo we used a commercially available sandwich ELISA and an in-house developed direct ELISA to quantify CSF levels of alpha-synuclein and neurosin in patients diagnosed with DLB, PD and PD dementia (PDD) versus AD patients and non-demented controls. We found that patients with synucleinopathy displayed lower CSF levels of neurosin and alpha-synuclein compared to controls and AD patients. In contrast, AD patients demonstrated significantly increased CSF alpha-synuclein but similar neurosin levels compared to non-demented controls. Further, CSF neurosin and alpha-synuclein concentrations were positively associated in controls, PD and PDD patients and both proteins were highly correlated to CSF levels of phosphorylated tau in all investigated groups. We observed no effect of gender or presence of the apolipoprotein E epsilon 4 allele on neither neurosin or alpha-synuclein CSF levels. In concordance with the current literature our study demonstrates decreased CSF levels of alpha-synuclein in synucleinopathy patients versus AD patients and controls. Importantly, decreased alpha-synuclein levels in patients with synucleinopathy appear linked to low levels of the alpha-synuclein cleaving enzyme neurosin. In contrast, elevated levels of alpha-synuclein in AD patients were not related to any altered CSF neurosin levels. Thus, altered CSF levels of alpha-synuclein and neurosin in patients with synucleinopathy versus AD may not only mirror disease-specific neuropathological mechanisms but may also serve as fit candidates for future biomarker studies aiming at identifying specific markers of synucleinopathy.	[Wennstrom, Malin; Minthon, Lennart; Nielsen, Henrietta M.] Lund Univ, Dept Clin Sci Malmo, Mol Memory Res Unit, Skane Univ Hosp,Wellenberg Lab, Malmo, Sweden; [Surova, Yulia; Hall, Sara; Hansson, Oskar] Lund Univ, Dept Clin Sci Lund, Neurol Clin, Skane Univ Hosp, Malmo, Sweden; [Nilsson, Christer; Minthon, Lennart; Bostrom, Fredrik; Hansson, Oskar] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Memory Clin,Skane Univ Hosp, Malmo, Sweden; [Nielsen, Henrietta M.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Mayo Clinic	Nielsen, HM (corresponding author), Lund Univ, Dept Clin Sci Malmo, Mol Memory Res Unit, Skane Univ Hosp,Wellenberg Lab, Malmo, Sweden.	nielsen.henrietta@mayo.edu	Hansson, Oskar/A-7134-2013; Nielsen, Henrietta M/B-1746-2013	Hansson, Oskar/0000-0001-8467-7286; Brundin, Lena/0000-0002-8327-6242; Bay-Richter, Cecilie/0000-0002-2254-4020; Nielsen, Henrietta M/0000-0001-9664-7068	Swedish Dementia Foundation; Swedish Alzheimer Foundation; Swedish Research Council; Gamla tjanarinnor; Torsten and Ragnar Soderberg Foundation; Swedish Society of Medicine; Skane County Council; Lund University; Swedish Brain Power	Swedish Dementia Foundation; Swedish Alzheimer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gamla tjanarinnor; Torsten and Ragnar Soderberg Foundation; Swedish Society of Medicine; Skane County Council; Lund University; Swedish Brain Power	The Swedish Dementia Foundation (H.M.N.), the Swedish Alzheimer Foundation (H.M.N., O.H.), the Swedish Research Council (O.H.), Gamla tjanarinnor (H.M.N., O.H.), Torsten and Ragnar Soderberg Foundation (O.H.), the Swedish Society of Medicine (O.H.), the regional agreement on medical training and clinical research (A. L. F.) between the Skane County Council and Lund University (L. M., M. W., H.M.N., O.H.) and Swedish Brain Power (L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; Ashby EL, 2010, BRAIN RES, V1363, P1, DOI 10.1016/j.brainres.2010.09.017; Bayani J, 2012, CLIN CHEM LAB MED, V50, P211, DOI 10.1515/CCLM.2011.750; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cheng FR, 2011, J CHEM NEUROANAT, V42, P242, DOI 10.1016/j.jchemneu.2010.12.001; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Diamandis EP, 2000, CLIN BIOCHEM, V33, P369, DOI 10.1016/S0009-9120(00)00145-4; Diamandis EP, 2000, CLIN BIOCHEM, V33, P663, DOI 10.1016/S0009-9120(00)00185-5; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Gai WP, 1998, LANCET, V352, P547, DOI 10.1016/S0140-6736(05)79256-4; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kasuga K, 2010, J NEUROL NEUROSUR PS, V81, P608, DOI 10.1136/jnnp.2009.197483; Kawakami F, 2011, FEBS J, V278, P4895, DOI 10.1111/j.1742-4658.2011.08389.x; Kim CY, 2008, J NEUROCHEM, V107, P303, DOI 10.1111/j.1471-4159.2008.05612.x; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Little SP, 1997, J BIOL CHEM, V272, P25135, DOI 10.1074/jbc.272.40.25135; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; McKeith Ian G, 2003, Semin Clin Neuropsychiatry, V8, P46; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Menendez-Gonzalez M, 2008, J ALZHEIMERS DIS, V14, P59; Mitsui S, 2002, ANN NY ACAD SCI, V977, P216, DOI 10.1111/j.1749-6632.2002.tb04818.x; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Mukaetova-Ladinska E.B., 2010, INT J ALZHEIMERS DIS; Nielsen HM, 2010, ALZHEIMERS DEMENT S1, V6, P363; Ogawa K, 2000, PSYCHIAT CLIN NEUROS, V54, P419, DOI 10.1046/j.1440-1819.2000.00731.x; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Okui A, 2001, NEUROREPORT, V12, P1345, DOI 10.1097/00001756-200105250-00011; Pampalakis G, 2004, BIOCHEM BIOPH RES CO, V320, P54, DOI 10.1016/j.bbrc.2004.04.205; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Spencer B, 2012, MOL THERAPY J AM SOC; Spies PE, 2009, J ALZHEIMERS DIS, V16, P363, DOI 10.3233/JAD-2009-0955; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Takeda A, 1998, AM J PATHOL, V152, P367; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Tateno F, 2011, ALZHEIMER DIS ASS DI; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Trojanowski JQ, 2007, NEUROPATH APPL NEURO, V33, P615, DOI 10.1111/j.1365-2990.2007.00907.x; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Wennstrom M, 2012, J ALZHEIMERS DIS, V29, P125, DOI [10.3233/JAD-2011-111655, 10.3233/JAD-2012-111655]; Yamashiro K, 1997, BBA-GENE STRUCT EXPR, V1350, P11, DOI 10.1016/S0167-4781(96)00187-X	58	133	135	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53250	10.1371/journal.pone.0053250	http://dx.doi.org/10.1371/journal.pone.0053250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308173	gold, Green Published, Green Submitted			2022-12-27	WOS:000313429800033
J	Wang, QM; Liu, SP; Tang, Y; Liu, QH; Yao, YJ				Wang, Qingmin; Liu, Shupeng; Tang, Ying; Liu, Qiuhong; Yao, Yongjie			MPT64 Protein from Mycobacterium tuberculosis Inhibits Apoptosis of Macrophages through NF-kB-miRNA21-Bcl-2 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; BCL-2 UP-REGULATION; ANTIGEN MPT64; MICRORNAS; EXPRESSION; VIRULENT; IMMUNITY; NECROSIS; PLAYERS	MPT64 is one of the secreted proteins from Mycobacterium tuberculosis. Little is known about its role in infection by Mycobacterium tuberculosis. In this study, we demonstrated that MPT64 could dose-dependently inhibit the apoptosis of RAW264.7 macrophages induced by PPD-BCG. Quantitative real-time PCR results showed that the expression of bcl-2 increased in macrophages treated with MPT64 compared with PPD-treated cells. Furthermore, the results provided strong evidence that bcl-2 up-regulation was positively controlled by miRNA-21. Finally, NF-kappa B was identified as the transcription factor for miRNA-21 using a ChIP assay. It can be concluded from our study that MPT64 could inhibit the apoptosis of RAW264.7 macrophages through the NF-kappa B-miRNA21-Bcl-2 pathway.	[Wang, Qingmin; Tang, Ying; Liu, Qiuhong; Yao, Yongjie] Naval Med Res Inst, Div Aviat Med, Shanghai, Peoples R China; [Liu, Shupeng] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University	Wang, QM (corresponding author), Naval Med Res Inst, Div Aviat Med, Shanghai, Peoples R China.	wqm_8888@hotmail.com	; Lau, Susanna Kar Pui/C-4321-2009; Woo, Patrick Chiu Yat/C-4449-2009	liu, fei/0000-0003-1175-4070; Lau, Susanna Kar Pui/0000-0002-1383-7374; Woo, Patrick Chiu Yat/0000-0001-9401-1832	National Natural Science Foundation [31070121]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This article is supported by the grants of National Natural Science Foundation (Nos. 31070121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061925; Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hossein A, 2004, J NEUROSCI, V24, P2963; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Lin XJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/258695; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; Mogga SJ, 2002, SCAND J IMMUNOL, V56, P383, DOI 10.1046/j.1365-3083.2002.01140.x; Mustafa T, 2008, VIRCHOWS ARCH, V452, P449, DOI 10.1007/s00428-008-0575-z; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.3.CO;2-V; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sanchez A, 2009, SCAND J IMMUNOL, V69, P20, DOI 10.1111/j.1365-3083.2008.02193.x; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001; Yamamoto T, 2006, YAKUGAKU ZASSHI, V126, P1235, DOI 10.1248/yakushi.126.1235; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	36	74	79	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100949	10.1371/journal.pone.0100949	http://dx.doi.org/10.1371/journal.pone.0100949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000291	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300020
J	Li, Y; Yang, D; Wang, JY; Yao, Y; Zhang, WZ; Wang, LJ; Cheng, DC; Yang, FK; Zhang, FM; Zhuang, M; Ling, H				Li, Yan; Yang, Dan; Wang, Jia-Ye; Yao, Yuan; Zhang, Wei-Zhe; Wang, Lu-Jing; Cheng, De-Chun; Yang, Feng-Kun; Zhang, Feng-Min; Zhuang, Min; Ling, Hong			Critical Amino Acids within the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein V4 N- and C-Terminals Contribute to Virus Entry	PLOS ONE			English	Article							HIV-1 GP120; NEUTRALIZING ANTIBODIES; DISEASE PROGRESSION; VIRAL ENTRY; V3 LOOP; CORECEPTOR; INFECTION; EVOLUTION; CCR5; REGIONS	The importance of the fourth variable (V4) region of the human immunodeficiency virus 1 (HIV-1) envelope glycoprotein (Env) in virus infection has not been well clarified, though the polymorphism of this region has been found to be associated with disease progression to acquired immunodeficiency syndrome (AIDS). In the present work, we focused on the correlation between HIV-1 gp120 V4 region polymorphism and the function of the region on virus entry, and the possible mechanisms for how the V4 region contributes to virus infectivity. Therefore, we analyzed the differences in V4 sequences along with coreceptor usage preference from CCR5 to CXCR4 and examined the importance of the amino acids within the V4 region for CCR5- and CXCR4-tropic virus entry. In addition, we determined the influence of the V4 amino acids on Env expression and gp160 processing intracellularly, as well as the amount of Env on the pseudovirus surface. The results indicated that V4 tended to have a shorter length, fewer potential N-linked glycosylation sites (PNGS), greater evolutionary distance, and a lower negative net charge when HIV-1 isolates switched from a coreceptor usage preference for CCR5 to CXCR4. The N- and C-terminals of the HIV-1 V4 region are highly conserved and critical to maintain virus entry ability, but only the mutation at position 417 in the context of ADA (a R5-tropic HIV-1 strain) resulted in the ability to utilize CXCR4. In addition, 390L, 391F, 414I, and 416L are critical to maintain gp160 processing and maturation. It is likely that the hydrophobic properties and the electrostatic surface potential of gp120, rather than the conformational structure, greatly contribute to this V4 functionality. The findings provide information to aid in the understanding of the functions of V4 in HIV-1 entry and offer a potential target to aid in the development of entry inhibitors.	[Li, Yan; Wang, Jia-Ye; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China; [Yang, Dan] Harbin Med Univ, Dept Forens Med, Harbin, Peoples R China; [Yao, Yuan] Harbin Inst Technol, Acad Fundamental & Interdisciplinary Sci, Harbin 150006, Peoples R China; [Zhang, Wei-Zhe; Cheng, De-Chun; Yang, Feng-Kun; Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Peoples R China; [Wang, Lu-Jing] Harbin Med Univ, Dept Biochem, Harbin, Peoples R China; [Li, Yan; Wang, Jia-Ye; Zhang, Wei-Zhe; Cheng, De-Chun; Yang, Feng-Kun; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Heilongjiang Prov Educ Bur, Key Lab Etiol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Institute of Technology; Harbin Medical University; Harbin Medical University	Zhuang, M (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China.	zhuangm@ems.hrbmu.edu.cn; lingh@ems.hrbmu.edu.cn	Sun, Duanping/M-4632-2017	Sun, Duanping/0000-0003-1760-2975; ling, hong/0000-0002-1886-1242	Scientific Research Foundation of Heilongjiang Provincial Education Department [12511184]; Heilongjiang Innovation Program in Graduate Education [YJSCX2009-222HLJ]; Harbin Medical University Innovation Program in Graduate Education [HCXB2009014]; Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province [ZJY0601-01]	Scientific Research Foundation of Heilongjiang Provincial Education Department; Heilongjiang Innovation Program in Graduate Education; Harbin Medical University Innovation Program in Graduate Education; Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by Scientific Research Foundation of Heilongjiang Provincial Education Department (Grant 12511184); Heilongjiang Innovation Program in Graduate Education (YJSCX2009-222HLJ); Harbin Medical University Innovation Program in Graduate Education (HCXB2009014); Grant for Innovation Team Program of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province (Grant ZJY0601-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archary D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-92; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Belair M, 2009, AIDS RES HUM RETROV, V25, P199, DOI 10.1089/aid.2008.0162; Berger EA, 1997, AIDS, V11, pS3; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Boonchawalit S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027098; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Castro E, 2008, AIDS RES HUM RETROV, V24, P106, DOI 10.1089/aid.2007.0139; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Guo HY, 2012, J GEN VIROL, V93, P2635, DOI 10.1099/vir.0.046771-0; HATTORI T, 1987, JPN J CANCER RES, V78, P235; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Ling H, 2002, BIOCHEM BIOPH RES CO, V297, P625, DOI 10.1016/S0006-291X(02)02253-2; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Riddle TM, 2006, J VIROL, V80, P10591, DOI 10.1128/JVI.00644-06; Rivera-Amill V, 2007, VIROLOGY, V358, P373, DOI 10.1016/j.virol.2006.08.039; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Wu F, 2012, J VIROL, V86, P8835, DOI 10.1128/JVI.00923-12; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Yeh WW, 2012, J VIROL, V86, P7052, DOI 10.1128/JVI.00107-12; Zhuang M, 2012, J BIOL CHEM, V287, P8297, DOI 10.1074/jbc.M111.324483	39	65	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86083	10.1371/journal.pone.0086083	http://dx.doi.org/10.1371/journal.pone.0086083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	25299226	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500179
J	Li, YP; Song, B; Fang, H; Gao, Y; Zhao, L; Xu, YM				Li, Yapeng; Song, Bo; Fang, Hui; Gao, Yuan; Zhao, Lu; Xu, Yuming			External Validation of the A(2)DS(2) Score to Predict Stroke-Associated Pneumonia in a Chinese Population: A Prospective Cohort Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; IN-HOSPITAL MORTALITY; MEDICAL COMPLICATIONS; RISK-FACTORS; INFECTION; CARE; TRANSIENT; OUTCOMES; COST	Background and Purpose: The A(2)DS(2) score was recently developed from the Berlin Stroke Registry for predicting in-hospital pneumonia after acute ischemic stroke and performed well in an external validation in the North-west Germany Stroke Registry. It could be a useful tool for risk stratification in clinical practice or stroke trials. We aimed to prospectively validate the predictive value of A(2)DS(2) score in a Chinese stroke population. Methods: The prognostic model was used to predict stroke-associated pneumonia (SAP) from Henan Province Stroke Registry (HNSR) in which data were prospectively collected. The receiver-operating characteristic curves were plotted, and the C statistics were calculated to assess the discrimination ability. The Hosmer-Lemeshow goodness-of-fit test and the plot of observed versus predicted SAP risk were used to assess model calibration. Results: Among 1142 eligible patients, the overall in-hospital SAP was 18.8%, which ranged from 9.0% in patients with lower A(2)DS(2) scores (0-4) to 65.0% in those with higher scores of 5 to 10 (P for trend <0.001). The C statistic was 0.836 (95% confidence interval, 0.803-0.868) through the A(2)DS(2) score, suggesting excellent discrimination in the HNSR. The A(2)DS(2) score also showed excellent calibration (Cox and Snell R-2 = 0.243) in the external validation sample from the HNSR. Conclusions: The A(2)DS(2) score could reliably predict in-hospital SAP in Chinese stroke patients. It might be helpful for the assessment of increased risk monitoring and prophylactic treatment in identified high-risk patients for SAP in clinical routine.	[Li, Yapeng; Song, Bo; Fang, Hui; Gao, Yuan; Zhao, Lu; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China	Zhengzhou University	Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China.	xuyuming@zzu.edu.cn	Sun, Duanping/M-4632-2017	Sun, Duanping/0000-0003-1760-2975; ling, hong/0000-0002-1886-1242	Health Department of Henan Province [201202005]; Education Department of Henan Province [12A320046]	Health Department of Henan Province; Education Department of Henan Province	This study was funded by the Health Department of Henan Province (201202005) and the Education Department of Henan Province (12A320046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Stroke, V20, P1407; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Forti P, 2013, NEUROLOGY, V80, P29, DOI 10.1212/WNL.0b013e31827b1a41; Galovic M, 2013, STROKE, V44, P2760, DOI 10.1161/STROKEAHA.113.001690; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Grube MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075719; Harms H, 2013, ACTA NEUROL SCAND, V128, P178, DOI 10.1111/ane.12095; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Ji RJ, 2013, STROKE, V44, P1303, DOI 10.1161/STROKEAHA.111.000598; Kammersgaard L P, 2001, J Stroke Cerebrovasc Dis, V10, P217, DOI 10.1053/jscd.2001.30366; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kemmling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071141; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kumar Sandeep, 2010, Lancet Neurol, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Kwon HM, 2006, AM J INFECT CONTROL, V34, P64, DOI 10.1016/j.ajic.2005.06.011; Pandian JD, 2012, J STROKE CEREBROVASC, V21, P695, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.003; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Song B, 2013, STROKE, V44, P1244, DOI 10.1161/STROKEAHA.113.000969; Tong X, 2010, STROKE, V41, P980, DOI 10.1161/STROKEAHA.110.578674; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002	33	65	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2014	9	10							e109665	10.1371/journal.pone.0109665	http://dx.doi.org/10.1371/journal.pone.0109665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AP	25299226	Green Published, Green Submitted, gold			2022-12-27	WOS:000343941200068
J	Martin-Murphy, BV; You, Q; Wang, H; De La Houssaye, BA; Reilly, TP; Friedman, JE; Ju, C				Martin-Murphy, Brittany V.; You, Qiang; Wang, Hong; De La Houssaye, Becky A.; Reilly, Timothy P.; Friedman, Jacob E.; Ju, Cynthia			Mice Lacking Natural Killer T Cells Are More Susceptible to Metabolic Alterations following High Fat Diet Feeding	PLOS ONE			English	Article							INDUCED LIVER-INJURY; ADIPOSE-TISSUE; INSULIN-RESISTANCE; NKT CELLS; DEFICIENT MICE; NONALCOHOLIC STEATOHEPATITIS; MACROPHAGE POLARIZATION; GLUCOSE-INTOLERANCE; INDUCED OBESITY; BALB/C MICE	Current estimates suggest that over one-third of the adult population has metabolic syndrome and three-fourths of the obese population has non-alcoholic fatty liver disease (NAFLD). Inflammation in metabolic tissues has emerged as a universal feature of obesity and its co-morbidities, including NAFLD. Natural Killer T (NKT) cells are a subset of innate immune cells that abundantly reside within the liver and are readily activated by lipid antigens. There is general consensus that NKT cells are pivotal regulators of inflammation; however, disagreement exists as to whether NKT cells exert pathogenic or suppressive functions in obesity. Here we demonstrate that CD1d(-/-) mice, which lack NKT cells, were more susceptible to weight gain and fatty liver following high fat diet (HFD) feeding. Compared with their WT counterparts, CD1d(-/-) mice displayed increased adiposity and greater induction of inflammatory genes in the liver suggestive of the precursors of NAFLD. Calorimetry studies revealed a significant increase in food intake and trends toward decreased metabolic rate and activity in CD1d(-/-) mice compared with WT mice. Based on these findings, our results suggest that NKT cells play a regulatory role that helps to prevent diet-induced obesity and metabolic dysfunction and may play an important role in mechanisms governing cross-talk between metabolism and the immune system to regulate energy balance and liver health.	[You, Qiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Biotherapy, Nanjing, Jiangsu, Peoples R China; [You, Qiang; Ju, Cynthia] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Martin-Murphy, Brittany V.] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA; [Wang, Hong] Univ Colorado, Div Endocrinol Diabet & Metab, Aurora, CO USA; [De La Houssaye, Becky A.; Friedman, Jacob E.] Univ Colorado, Dept Pediat, Aurora, CO USA; [Reilly, Timothy P.] Bristol Myers Squibb Co, Drug Safety Evaluat Res & Dev, Princeton, NJ USA	Nanjing Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Bristol-Myers Squibb	Ju, C (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	Cynthia.ju@ucdenver.edu	Wang, Huaqing/A-9179-2017	Wang, Huaqing/0000-0001-5333-0829; Marteinsdottir, Bryndis/0000-0003-3779-7327	National Institute of Health [F31DK082269, RO1ES012914, R01-DK059767, P30DK048520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R01DK059767, F31DK082269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012914] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health grants F31DK082269 (BVM), RO1ES012914 (CJ), R01-DK059767 (JEF) and P30DK048520 to the Colorado Nutrition and Obesity Research Center (NORC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bourdi M, 2007, CHEM RES TOXICOL, V20, P208, DOI 10.1021/tx060228l; BRENNER GJ, 1994, CELL IMMUNOL, V157, P510, DOI 10.1006/cimm.1994.1246; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159, DOI 10.4049/jimmunol.173.3.2159; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; GUIDA JD, 1995, J VIROL, V69, P7674, DOI 10.1128/JVI.69.12.7674-7681.1995; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Jensen DR, 2001, J APPL PHYSIOL, V90, P912, DOI 10.1152/jappl.2001.90.3.912; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Li ZP, 2004, HEPATOLOGY, V40, P434, DOI 10.1002/hep.20320; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Miyagi T, 2010, J GASTROENTEROL, V45, P1247, DOI 10.1007/s00535-010-0272-y; Monroy-Ostria A, 1994, Arch Med Res, V25, P401; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; NIEWIESK S, 1993, J VIROL, V67, P75, DOI 10.1128/JVI.67.1.75-81.1993; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Novak J, 2007, INT REV IMMUNOL, V26, P49, DOI 10.1080/08830180601070229; Omar B, 2012, NUTRIENTS, V4, P1367, DOI 10.3390/nu4101367; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Sell H, 2012, NAT REV ENDOCRINOL, DOI [10.1038/nrendo.2012.114, DOI 10.1038/NRENDO.2012.114.]; Tajiri K, 2009, EUR J GASTROEN HEPAT, V21, P673, DOI 10.1097/MEG.0b013e32831bc3d6; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Umetsu DT, 2012, CELL RES, V22, P1210, DOI 10.1038/cr.2012.65; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Werner JM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-26; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603; You Q, 2006, HEPATOLOGY, V44, P1421, DOI 10.1002/hep.21425	61	87	90	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e80949	10.1371/journal.pone.0080949	http://dx.doi.org/10.1371/journal.pone.0080949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	25057815	gold, Green Submitted, Green Published			2022-12-27	WOS:000330240500002
J	Zhang, YG; Qiu, L; Li, SJ; Xiang, YC; Chen, JY; Ren, YG				Zhang, Yiguo; Qiu, Lu; Li, Shaojun; Xiang, Yuancai; Chen, Jiayu; Ren, Yonggang			The C-Terminal Domain of Nrf1 Negatively Regulates the Full-Length CNC-bZIP Factor and Its Shorter Isoform LCR-F1/Nrf1 beta; Both Are Also Inhibited by the Small Dominant-Negative Nrf1 gamma/delta Isoforms that Down-Regulate ARE-Battery Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF1; TNF-ALPHA PROMOTER; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BINDING DOMAIN; BETA-TRCP; KEAP1	The C-terminal domain (CTD, aa 686-741) of nuclear factor-erythroid 2 p45-related factor 1 (Nrf1) shares 53% amino acid sequence identity with the equivalent Neh3 domain of Nrf2, a homologous transcription factor. The Neh3 positively regulates Nrf2, but whether the Neh3-like (Neh3L) CTD of Nrf1 has a similar role in regulating Nrf1-target gene expression is unknown. Herein, we report that CTD negatively regulates the full-length Nrf1 (i.e. 120-kDa glycoprotein and 95-kDa deglycoprotein) and its shorter isoform LCR-F1/Nrf1 beta (55-kDa). Attachment of its CTD-adjoining 112-aa to the C-terminus of Nrf2 yields the chimaeric Nrf2-C112(Nrf1) factor with a markedly decreased activity. Live-cell imaging of GFP-CTD reveals that the extra-nuclear portion of the fusion protein is allowed to associate with the endoplasmic reticulum (ER) membrane through the amphipathic Neh3L region of Nrf1 and its basic c-tail. Thus removal of either the entire CTD or the essential Neh3L portion within CTD from Nrf1, LCR-F1/Nrf1 beta and Nrf2-C112(Nrf1), results in an increase in their transcriptional ability to regulate antioxidant response element (ARE)-driven reporter genes. Further examinations unravel that two smaller isoforms, 36-kDa Nrf1 gamma and 25-kDa Nrf1 delta, act as dominant-negative inhibitors to compete against Nrf1, LCR-F1/Nrf1 beta and Nrf2. Relative to Nrf1, LCR-F1/Nrf1 beta is a weak activator, that is positively regulated by its Asn/Ser/Thr-rich (NST) domain and acidic domain 2 (AD2). Like AD1 of Nrf1, both AD2 and NST domain of LCR-F1/Nrf1 beta fused within two different chimaeric contexts to yield Gal4D:Nrf1 beta(607) and Nrf1 beta:C270(Nrf2), positively regulate their transactivation activity of cognate Gal4- and Nrf2-target reporter genes. More importantly, differential expression of endogenous ARE-battery genes is attributable to up-regulation by Nrf1 and LCR-F1/Nrf1 beta and down-regulation by Nrf1 gamma and Nrf1 delta.	[Zhang, Yiguo] Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China; Chongqing Univ, Fac Life Sci, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Zhang, YG (corresponding author), Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China.	yiguozhang@cqu.edu.cn		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	National Natural Science Foundation of China [91129703, 31270879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (key program 91129703 and project 31270879) awarded to Prof. Yiguo Zhang (University of Chongqing, China). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Husberg C, 2001, J BIOL CHEM, V276, P17641, DOI 10.1074/jbc.M007951200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwong EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048404; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prieschl EE, 1998, NUCLEIC ACIDS RES, V26, P2291, DOI 10.1093/nar/26.10.2291; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rupert PB, 1998, NAT STRUCT BIOL, V5, P484, DOI 10.1038/nsb0698-484; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; Schultz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087204; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2013, MOL CELL BIOL, V33, P3461, DOI 10.1128/MCB.01271-12; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Xiao H, 2013, CURR CHEM BIOL, V7, P151, DOI [DOI 10.2174/2212796811307020008, 10.2174/2212796811307020008]; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang Y, 2014, MS1305858; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093458; Zhang YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02006; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhang Y, 2009, J BIOL CHEM, V284, P3195, DOI 10.1074/jbc.M805337200; [张玉台 Zhang Yutai], 2009, [管理世界, Management World], P1; Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798	71	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109159	10.1371/journal.pone.0109159	http://dx.doi.org/10.1371/journal.pone.0109159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290918	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000041
J	Zhang, YJ; Wang, DM; Yang, LN; Zhou, D; Zhang, JF				Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang			Purification and Characterization of Flavonoids from the Leaves of Zanthoxylum bungeanum and Correlation between Their Structure and Antioxidant Activity	PLOS ONE			English	Article							ALDOSE REDUCTASE; DNA-DAMAGE; EXTRACTS; ALKYLAMIDES; PROTECTION; PERICARPS; QUERCETIN; CHROMATOGRAPHY; CONSTITUENTS; INHIBITION	Nine flavonoids were isolated and characterized from the leaves of Zanthoxylum bungeanum. Their structures were elucidated by spectroscopic techniques as quercetin (1), afzelin (2), quercitrin (3), trifolin (4), quercetin-3-O-beta-D-glucoside (5), isorhamnetin 3-O-alpha-L-rhamnoside (6), hyperoside (7), vitexin (8) and rutin (9). All compounds were isolated from the leaves of Z. bungeanum for the first time. Five compounds (2, 4, 5, 6 and 8) were found for the first time in the genus Zanthoxylum. To learn the mechanisms underlying its health benefits, in vitro (DPPH, ABTS, FRAP and lipid peroxidation inhibition assays) and in vivo (protective effect on Escherichia coli under peroxide stress) antioxidant activities of the nine flavonoids were measured. Quercetin and quercetin glycosides (compounds 1, 3, 5, 7, 9) showed the highest antioxidant activity. Structure-activity relationships indicated that the -OH in 49 position on the B ring and the -OH in 7 position on the A ring possessed high antioxidant activity; B ring and/or A ring with adjacent -OH groups could greatly increase their antioxidant ability. Also, due to the different structures of various flavonoids, they will certainly exhibit different antioxidant capacity when the reactions occur in solution or in oil-in-water emulsion. These findings suggest that Z. bungeanum leaves may have health benefits when consumed. It could become a useful supplement for pharmaceutical products and functional food ingredients in both nutraceutical and food industries as a potential source of natural antioxidants.	[Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Wang, DM (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	dmwli@163.com		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	Special Fund for Forestry Scientific Research in the Public Interest of China [201304811]; Fundamental Research Funds for the Central Universities [ZD2013010]	Special Fund for Forestry Scientific Research in the Public Interest of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to the research fund from the Special Fund for Forestry Scientific Research in the Public Interest of China (201304811) and the Fundamental Research Funds for the Central Universities (ZD2013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Azimova SS, 2013, PHYSICOCHEMCIAL PHAR; Bauer R, 2011, CURR CLIN UROL, P191, DOI 10.1007/978-1-60327-420-3_10; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Chang ZQ, 1981, ACTA PHARM SINICA, V16, P394; Costantino L, 1997, EXPERT OPIN THER PAT, V7, P843, DOI 10.1517/13543776.7.8.843; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; Decker EA, 2005, J AGR FOOD CHEM, V53, P4303, DOI 10.1021/jf058012x; [邓振义 Deng Zhenyi], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P179; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Dorman H. J. D., 1995, Journal of Essential Oil Research, V7, P645; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Duke J. A., 1985, MED PLANTS CHINA, P705; Ferrali M, 1997, FEBS LETT, V416, P123, DOI 10.1016/S0014-5793(97)01182-4; GALVEZ J, 1993, J PHARM PHARMACOL, V45, P157, DOI 10.1111/j.2042-7158.1993.tb03706.x; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HUANG XL, 1993, PHYTOTHER RES, V7, P41, DOI 10.1002/ptr.2650070111; Ibrahim LF, 2002, MOLECULES, V7, P245; Jung HA, 2011, FOOD CHEM TOXICOL, V49, P376, DOI 10.1016/j.fct.2010.11.012; KIMUYA Y, 1981, CHEM PHARM BULL, V29, P2610; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Li H, 2012, FOOD CHEM, V135, P2942, DOI 10.1016/j.foodchem.2012.07.048; Li Y, 2001, Zhong Yao Cai, V24, P572; Ma XF, 2005, J CHROMATOGR A, V1070, P211, DOI 10.1016/j.chroma.2005.02.052; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Miguel G, 2004, FOOD CHEM, V86, P183, DOI 10.1016/j.foodchem.2003.08.031; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2362, DOI 10.1248/cpb.36.2362; Nassar M. I., 2010, Revista Latinoamericana de Quimica, V38, P103; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; OSHIMA R, 1982, CARBOHYD RES, V107, P169, DOI 10.1016/S0008-6215(00)80536-4; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1151, DOI 10.1016/S0968-0896(00)00052-3; Ren L, 1981, XAOXUE XUEBAO, V16, P672; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez P, 2010, FITOTERAPIA, V81, P1220, DOI 10.1016/j.fitote.2010.08.007; Smirnova GV, 2010, WORLD J MICROB BIOT, V26, P2269, DOI 10.1007/s11274-010-0417-4; Smirnova GV, 2009, FREE RADICAL BIO MED, V46, P759, DOI 10.1016/j.freeradbiomed.2008.11.017; Tachakittirungrod S, 2007, FOOD CHEM, V103, P381, DOI 10.1016/j.foodchem.2006.07.034; Tirillini B., 1994, Journal of Essential Oil Research, V6, P249; TK Lim, 2012, ZANTHOXYLUM SIMULANS, P904; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Wang DM, 2013, ALLELOPATHY J, V32, P67; Wang S, 2011, J LIQ CHROMATOGR R T, V34, P2640, DOI 10.1080/10826076.2011.593219; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; XIONG QB, 1995, PHYTOCHEMISTRY, V39, P723, DOI 10.1016/0031-9422(94)00965-V; Xiong QB, 1997, PHYTOCHEMISTRY, V46, P1123, DOI 10.1016/S0031-9422(97)84398-1; Xu HR, 2010, TEXTBOOK OF PERINATAL EPIDEMIOLOGY, P111; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yeung H., 1985, HDB CHINESE HERBS FO, VVolume 1; Zhou X, 2005, J CHROMATOGR A, V1092, P216, DOI 10.1016/j.chroma.2005.07.064	56	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105725	10.1371/journal.pone.0105725	http://dx.doi.org/10.1371/journal.pone.0105725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25290918	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200055
